{"meta":{"query_hash":"aa5babbbc3fc","filters":{"venue":"Breast Cancer Research and Treatment"},"cohort_total":814,"direct_labels_cover":3,"predictions_cover":814,"exported":814,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/aa5babbbc3fc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Breast+Cancer+Research+and+Treatment"},"results":[{"id":"W1447575175","doi":"10.1007/s10549-015-3547-4","title":"Octreotide LAR and tamoxifen versus tamoxifen in phase III randomize early breast cancer trials: NCIC CTG MA.14 and NSABP B-29","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sunnybrook Health Science Centre; University of Toronto; Jewish General Hospital; McGill University; Queen's University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Medicine; Internal medicine; Breast cancer; Tamoxifen; Hazard ratio; Cancer; Oncology; Gastroenterology; Gynecology; Confidence interval","score_opus":0.18917399873553203,"score_gpt":0.4822184187308608,"score_spread":0.29304441999532876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1447575175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454319,0.032288827,0.0016870842,0.0067077857,0.0009439142,0.002973173,0.001937114,0.00028560648,0.00774464],"genre_scores_gemma":[0.9775892,0.0070708105,0.0022730634,0.0026337083,0.000539713,0.0023991282,0.0014838584,0.000060973493,0.0059495308],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99758494,0.0020302264,0.000076702956,0.000091558184,0.0000884737,0.00012806126],"domain_scores_gemma":[0.9971425,0.0015772141,0.00053230167,0.00013833551,0.00013371467,0.00047595275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00470554,0.0009129834,0.0018185144,0.00042896817,0.00026840196,0.000884474,0.00065482175,0.0012207237,0.006130554],"category_scores_gemma":[0.0054772897,0.0003253912,0.0015891993,0.00038411407,0.00059105986,0.0012119112,0.00044841715,0.002966372,0.0005466627],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94826156,0.001731255,0.00079226686,0.00054662424,0.0016376255,0.000038940292,0.00005091764,0.0010139096,0.0012006706,0.00042159786,0.0027773455,0.04152737],"study_design_scores_gemma":[0.9423705,0.04530152,0.0041812127,0.00020997056,0.0019104931,0.00006449339,0.000055827626,0.0017289827,0.00045529977,0.0008992902,0.0027913963,0.00003114045],"about_ca_topic_score_codex":0.0013432192,"about_ca_topic_score_gemma":0.006760107,"teacher_disagreement_score":0.006130554,"about_ca_system_score_codex":0.0008104082,"about_ca_system_score_gemma":0.0011704916,"threshold_uncertainty_score":0.024885535},"labels":[],"label_agreement":null},{"id":"W1526044470","doi":"10.1007/s10549-015-3462-8","title":"Benefits and risks of contralateral prophylactic mastectomy in women undergoing treatment for sporadic unilateral breast cancer: a decision analysis","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; BC Cancer Agency; National Institutes of Health","keywords":"Medicine; Breast cancer; Life expectancy; Stage (stratigraphy); Mastectomy; Quality of life (healthcare); Cancer; Gynecology; Cohort; Oncology; Univariate analysis; Surgery; Internal medicine; Demography; Multivariate analysis; Population; Environmental health","score_opus":0.08617029810907283,"score_gpt":0.3818282270115268,"score_spread":0.29565792890245396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526044470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912777,0.004957702,0.0007967908,0.00048177145,0.000033485827,0.00006513343,0.0004130642,0.000003886234,0.0019705722],"genre_scores_gemma":[0.9983814,0.00070674304,0.0003183302,0.00008021996,0.000037968755,0.000020783487,0.00018234478,0.0000021160354,0.00026999463],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954379,0.0033895143,0.0002718964,0.00026282825,0.0003702664,0.0002676805],"domain_scores_gemma":[0.9749892,0.022273775,0.00137762,0.00040316972,0.00023454752,0.0007216853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006762432,0.00051858986,0.0009947754,0.0011348331,0.00039414442,0.0010339627,0.00076478743,0.0008730968,0.0043884786],"category_scores_gemma":[0.017960144,0.00044454477,0.0032877845,0.00084958156,0.00083596323,0.0008991619,0.00079869415,0.0010470569,0.00018681746],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07385106,0.0009863663,0.8354925,0.00070921547,0.0061332723,0.00044450868,0.0003600397,0.0075783604,0.0010450175,0.0025503833,0.0006857112,0.07016351],"study_design_scores_gemma":[0.0034599972,0.015816176,0.9113507,0.00038376867,0.015395314,0.0020800591,0.001850792,0.03390946,0.0015223895,0.010119509,0.0039545665,0.00015724738],"about_ca_topic_score_codex":0.002017605,"about_ca_topic_score_gemma":0.0038170442,"teacher_disagreement_score":0.006762432,"about_ca_system_score_codex":0.0010606525,"about_ca_system_score_gemma":0.0007506026,"threshold_uncertainty_score":0.03576356},"labels":[],"label_agreement":null},{"id":"W1531458427","doi":"10.1007/s10549-015-3464-6","title":"A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Thunder Bay Regional Health Sciences Centre; Mount Sinai Hospital; Kingston General Hospital; Juravinski Hospital; London Health Sciences Centre; Health Sciences North; University of Toronto; Ottawa Hospital; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Genomic Health","keywords":"Medicine; Ductal carcinoma; Breast cancer; Hazard ratio; Internal medicine; Cohort; Breast-conserving surgery; Population; Oncology; Proportional hazards model; Mastectomy; Gynecology; Cancer; Confidence interval","score_opus":0.06391129614555653,"score_gpt":0.3411308198548659,"score_spread":0.27721952370930936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1531458427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993864,0.000040695624,0.00023568606,0.000011880648,0.0000038795074,0.00001735595,0.00011504971,0.000002580337,0.00018631629],"genre_scores_gemma":[0.9992625,0.000026856078,0.0001651592,0.000029521747,0.000012718778,0.000022795935,0.00033981074,0.000003206192,0.00013729915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858224,0.0005829954,0.000077821285,0.00040616508,0.00022497556,0.00012582036],"domain_scores_gemma":[0.997191,0.00094742473,0.00059971126,0.00070241874,0.0003016872,0.00025770662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021224783,0.00035474295,0.00045222876,0.00057702244,0.0005215269,0.00054401485,0.00039164914,0.0005276826,0.0008385701],"category_scores_gemma":[0.005110887,0.00030902465,0.0006163074,0.00057019637,0.00042218945,0.00043726398,0.00048178015,0.000734631,0.00036832565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034299208,0.00015956548,0.9973828,0.000003846065,0.00011101519,0.000043960335,0.00007017162,0.000069854796,0.0003755794,0.000020277594,0.00007900728,0.0013408451],"study_design_scores_gemma":[0.000053884432,0.00094183016,0.99751186,0.0000025878517,0.0000900748,0.0002444933,0.000082233404,0.000615784,0.00013327779,0.000037205285,0.00028027178,0.0000064891833],"about_ca_topic_score_codex":0.0028546373,"about_ca_topic_score_gemma":0.0025243883,"teacher_disagreement_score":0.0028546373,"about_ca_system_score_codex":0.0003352357,"about_ca_system_score_gemma":0.0003620231,"threshold_uncertainty_score":0.011224866},"labels":[],"label_agreement":null},{"id":"W1831196039","doi":"10.1007/s10549-015-3612-z","title":"Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; Susan G. Komen for the Cure; Pfizer; Ipsen Fund; Canadian Cancer Society Research Institute; Ipsen; National Institute for Health and Care Research; Cancer Research UK; National Health and Medical Research Council; Breast Cancer Research Foundation; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Oncosuisse","keywords":"Exemestane; Breast cancer; Medicine; Tamoxifen; Internal medicine; Progesterone receptor; Oncology; Estrogen receptor; Population; Cancer; Hormone receptor; Gynecology; Endocrinology","score_opus":0.06265246098170117,"score_gpt":0.3926188715416153,"score_spread":0.3299664105599141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1831196039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183345,0.005026297,0.00025645312,0.00025084443,0.00009591876,0.00013481807,0.00049209676,0.000018154224,0.0018920355],"genre_scores_gemma":[0.9979595,0.0006740216,0.00017999468,0.00013795868,0.00014859372,0.000034959176,0.00044818383,0.0000051365423,0.00041172127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987128,0.00080176786,0.000101889025,0.00016287147,0.00014324681,0.00007741823],"domain_scores_gemma":[0.9909383,0.006121317,0.0012675446,0.0006587478,0.00039756094,0.0006165483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003731598,0.00104502,0.0014200939,0.00081162574,0.00035414353,0.0012852938,0.0006774738,0.0013775771,0.0023901728],"category_scores_gemma":[0.011974912,0.00040411745,0.0014592828,0.00067358906,0.00084634306,0.0012930952,0.00057002605,0.0009632165,0.00040524954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44314697,0.0025613562,0.469821,0.00061888626,0.0051925518,0.00015079386,0.00025246645,0.0015705754,0.0038123822,0.00020309807,0.0007684456,0.07190144],"study_design_scores_gemma":[0.056914847,0.07357643,0.8362939,0.00027775404,0.016360654,0.00046183207,0.00039634114,0.0068813562,0.0042349584,0.0017154143,0.0027398234,0.0001466286],"about_ca_topic_score_codex":0.001048658,"about_ca_topic_score_gemma":0.0016504436,"teacher_disagreement_score":0.003731598,"about_ca_system_score_codex":0.00042210572,"about_ca_system_score_gemma":0.00040172492,"threshold_uncertainty_score":0.0197348},"labels":[],"label_agreement":null},{"id":"W1857523518","doi":"10.1007/s10549-015-3382-7","title":"Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital; Toronto Public Health","funders":"Canadian Cancer Society; Gilead Sciences; Sanofi","keywords":"Medicine; Entecavir; Lamivudine; Hepatitis B virus; Breast cancer; Internal medicine; Oncology; Hepatitis B; Chemotherapy; Cost effectiveness; Cost-effectiveness analysis; Adjuvant; Cancer; Immunology; Virus","score_opus":0.057641937622267644,"score_gpt":0.3721125597162981,"score_spread":0.3144706220940304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1857523518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8951586,0.092908435,0.0022460122,0.0014169698,0.00033389343,0.0015369133,0.0026273925,0.000026498255,0.0037453533],"genre_scores_gemma":[0.9849855,0.011639882,0.0012771821,0.00038071256,0.00008653952,0.00027970705,0.0009624466,0.0000067597593,0.00038121978],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99202627,0.006404852,0.00041796258,0.00026344307,0.00046731843,0.0004201815],"domain_scores_gemma":[0.98890465,0.008846816,0.001136654,0.00030871792,0.00042624612,0.00037691783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070800046,0.0015524989,0.0035875821,0.0020977296,0.0003288281,0.0015985874,0.0010448328,0.0015568791,0.0038188996],"category_scores_gemma":[0.019710783,0.0010643151,0.0110749435,0.0025331622,0.0006100612,0.0016002198,0.00086282066,0.0020623421,0.0001474485],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5043519,0.0072561516,0.117956474,0.018917304,0.1499592,0.0006959248,0.0002621803,0.04252254,0.0015079633,0.0033719726,0.0021928789,0.15100548],"study_design_scores_gemma":[0.17609923,0.097596854,0.22321375,0.006808997,0.42772558,0.0013665337,0.0011358766,0.051457934,0.0019272903,0.0041851616,0.008092625,0.00039026255],"about_ca_topic_score_codex":0.01344846,"about_ca_topic_score_gemma":0.0147750685,"teacher_disagreement_score":0.01344846,"about_ca_system_score_codex":0.004382586,"about_ca_system_score_gemma":0.0024640427,"threshold_uncertainty_score":0.0374431},"labels":[],"label_agreement":null},{"id":"W1905072147","doi":"10.1007/s10549-015-3596-8","title":"Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; University of Toronto; Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; BRCA mutation; Cancer; First-degree relatives; Oncology; Family history; Relative risk; Internal medicine; Germline mutation; Risk factor; Gynecology; Obstetrics; Mutation; Genetics; Biology","score_opus":0.044369779793213236,"score_gpt":0.35989029603212774,"score_spread":0.31552051623891453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1905072147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898067,0.006076742,0.00017972477,0.0011420685,0.0001369294,0.0000046710024,0.00063678756,0.000010118118,0.0020061978],"genre_scores_gemma":[0.9975988,0.0012963158,0.0000833598,0.000138262,0.00010062603,0.000001974601,0.00023732349,0.000007765599,0.00053556677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928516,0.00026934163,0.000058871683,0.00012354052,0.00008421173,0.00017895897],"domain_scores_gemma":[0.9957386,0.0015725028,0.001401199,0.0003158848,0.00026209606,0.0007096991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001063678,0.00036991888,0.00071893184,0.0007998865,0.00050348265,0.0009486381,0.00059292663,0.0014073832,0.0042662024],"category_scores_gemma":[0.008416813,0.00034930487,0.0015758759,0.001224312,0.00030857007,0.0010817627,0.00033134368,0.0008882703,0.0007987029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008546001,0.00006702125,0.9927287,0.00002663248,0.00022580857,0.00034010634,0.00009158029,0.000061002487,0.00032689027,0.000052365478,0.0002374259,0.004987858],"study_design_scores_gemma":[0.000011296986,0.00018245143,0.9978988,0.000018278517,0.00022329316,0.000695449,0.0002171861,0.00010737342,0.000101413345,0.00014118197,0.0003948699,0.000008379089],"about_ca_topic_score_codex":0.006843447,"about_ca_topic_score_gemma":0.006777203,"teacher_disagreement_score":0.006843447,"about_ca_system_score_codex":0.00035646156,"about_ca_system_score_gemma":0.00046077787,"threshold_uncertainty_score":0.014271855},"labels":[],"label_agreement":null},{"id":"W1945994099","doi":"10.1007/s10549-015-3622-x","title":"Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto; University Health Network; Cancer Care Ontario; Women's College Hospital; Public Health Ontario","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance; Association Canadienne des Radiologistes; Cancer Research Institute","keywords":"Mammography; Medicine; Breast cancer; Digital mammography; Gynecology; Hormone therapy; Confidence interval; Breast cancer screening; Logistic regression; Cancer; Obstetrics; Oncology; Internal medicine","score_opus":0.062020918554932705,"score_gpt":0.36262297298133245,"score_spread":0.30060205442639976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1945994099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98248047,0.012190559,0.0003233892,0.0010861668,0.00024947294,0.000032766602,0.000385037,0.000018731143,0.0032334018],"genre_scores_gemma":[0.997129,0.001444037,0.00018067469,0.00019334437,0.00013052936,0.0000060731,0.00013034785,0.0000067280553,0.0007791548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808747,0.0010927146,0.00011593329,0.0002639821,0.00028653158,0.0001533791],"domain_scores_gemma":[0.98937804,0.008625184,0.0009287425,0.00027621377,0.00023391485,0.0005579985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032451767,0.0004250981,0.0009177991,0.00042777782,0.00022001023,0.0013955375,0.0005615654,0.0007085355,0.00392503],"category_scores_gemma":[0.020316033,0.00019592915,0.0013122575,0.00053383684,0.00043541886,0.0009913056,0.0006037039,0.0007064056,0.00030199002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13684133,0.0011231501,0.74479854,0.00053766463,0.003366245,0.00020731761,0.00032029732,0.0007526893,0.0021167705,0.00042856793,0.00084789237,0.10865954],"study_design_scores_gemma":[0.0022265667,0.019573009,0.9579885,0.00018406702,0.00845593,0.0006586811,0.0010298401,0.0040419525,0.0014499133,0.00085929595,0.0034850077,0.00004732582],"about_ca_topic_score_codex":0.0028823758,"about_ca_topic_score_gemma":0.0041864244,"teacher_disagreement_score":0.00392503,"about_ca_system_score_codex":0.0004558464,"about_ca_system_score_gemma":0.00072699727,"threshold_uncertainty_score":0.017162323},"labels":[],"label_agreement":null},{"id":"W1964124861","doi":"10.1007/s10549-005-9076-9","title":"Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Doxorubicin; Nitric oxide; Human breast; Breast cancer; Breast carcinoma; Cancer research; Medicine; Internal medicine; Carcinoma; Oncology; Chemistry; Cancer; Chemotherapy","score_opus":0.03540775068055349,"score_gpt":0.3362510553822657,"score_spread":0.30084330470171217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964124861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960238,0.0015776878,0.0010299637,0.00015421449,0.000065555476,0.000025110154,0.00018542235,0.0000379944,0.00090023916],"genre_scores_gemma":[0.99623364,0.00062898657,0.0007835587,0.000047096986,0.000018514642,0.00002645686,0.0004050286,0.000013142615,0.0018436922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969983,0.00008418235,0.00003104199,0.00004259665,0.00006812608,0.000074224794],"domain_scores_gemma":[0.9997867,0.00007339358,0.000035956047,0.000038883467,0.000022363998,0.00004262026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034746237,0.000256387,0.0005107309,0.0002304085,0.00025213216,0.00039110729,0.00032915396,0.00035374047,0.00094367],"category_scores_gemma":[0.00022400015,0.00023511227,0.00029859092,0.00016689974,0.0001986837,0.00023957537,0.00026032937,0.0007630977,0.0002536802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036437143,0.00011834339,0.00017868228,0.000034078737,0.0000132446385,0.000055246976,0.00006729372,0.00013478851,0.99782014,0.000069367896,0.000086897875,0.001057696],"study_design_scores_gemma":[0.000074069336,0.000647675,0.0071617565,0.000007186921,0.000032915843,0.00014671998,0.00007922198,0.0025025166,0.98762953,0.00003819594,0.0016729864,0.000007207024],"about_ca_topic_score_codex":0.001891347,"about_ca_topic_score_gemma":0.0027435252,"teacher_disagreement_score":0.001891347,"about_ca_system_score_codex":0.00031549676,"about_ca_system_score_gemma":0.00023433033,"threshold_uncertainty_score":0.003760755},"labels":[],"label_agreement":null},{"id":"W1964246208","doi":"10.1007/s10549-006-9315-8","title":"Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency; University of Ottawa","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; Canada Research Chairs; Breast Cancer Alliance","keywords":"Breast cancer; Carcinogenesis; Malignancy; Oncology; Lymph node; Mammary gland; Internal medicine; Cancer research; Biology; Messenger RNA; Cancer; Medicine; Gene; Genetics","score_opus":0.033912338862238045,"score_gpt":0.32761106539204504,"score_spread":0.293698726529807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964246208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984176,0.0005133488,0.00013014468,0.00008234639,0.000015847958,0.0000028508741,0.00020393895,0.0000075959174,0.0006262364],"genre_scores_gemma":[0.9989681,0.00017151596,0.00007234143,0.000025019111,0.000027998385,0.0000049242344,0.00035109522,0.000004190778,0.00037471732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998585,0.000038259263,0.000012662829,0.0000256407,0.000026441561,0.00003847092],"domain_scores_gemma":[0.999116,0.0002444625,0.0002968843,0.000055713583,0.00007739617,0.00020947687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038574575,0.00023933107,0.00035333802,0.0007632868,0.0003224906,0.0005266452,0.00019439175,0.0004278443,0.0014080395],"category_scores_gemma":[0.0013480207,0.00016495012,0.00021611771,0.0006063016,0.00031798196,0.00018981096,0.00024459005,0.00045832864,0.00027707094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011982595,0.000056468918,0.98899955,0.0000107864535,0.000053095522,0.00017888869,0.000024591038,0.00008520139,0.006861825,0.00003231281,0.0002013693,0.0022976599],"study_design_scores_gemma":[0.000010708317,0.0000965643,0.99678063,0.0000027658734,0.00005235135,0.0006071196,0.00006883123,0.00033422798,0.001600055,0.000083410356,0.0003594897,0.0000039763677],"about_ca_topic_score_codex":0.00077485584,"about_ca_topic_score_gemma":0.0007466058,"teacher_disagreement_score":0.0014080395,"about_ca_system_score_codex":0.00023776878,"about_ca_system_score_gemma":0.00016755925,"threshold_uncertainty_score":0.0047103763},"labels":[],"label_agreement":null},{"id":"W1964291161","doi":"10.1007/s10549-013-2561-7","title":"Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Princess Margaret Cancer Centre; Ottawa Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Mastectomy; Radiation therapy; Chemotherapy; Clinical trial; Randomized controlled trial; Cancer; Regimen; Internal medicine; Oncology; Surgery","score_opus":0.0528082912743622,"score_gpt":0.3990265585996078,"score_spread":0.3462182673252456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964291161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001411409,0.9992244,0.00005778198,0.00025305396,0.00007332272,0.0000012549428,0.000036254307,0.0000023435853,0.00021042791],"genre_scores_gemma":[0.0010582359,0.99834347,0.00011306305,0.00014379366,0.00011762775,0.000002469804,0.00003708487,0.0000010953607,0.00018319995],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99970764,0.000055511926,0.000040789695,0.00008176535,0.00008474606,0.000029577912],"domain_scores_gemma":[0.99904305,0.0005413591,0.00017145081,0.00001935012,0.0001790141,0.000045776564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009645696,0.000653429,0.0016849305,0.0021012041,0.00020809153,0.001102588,0.0008461831,0.0011228417,0.0023982888],"category_scores_gemma":[0.0021395008,0.00024046557,0.00070493214,0.0030416935,0.0006290552,0.0009874918,0.0005834948,0.0012808485,0.0007307119],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011774571,0.000027257054,0.0026210619,0.012140264,0.0002430083,0.00016026876,0.000074538,0.00042042945,0.00044349977,0.0022648124,0.01859653,0.96289057],"study_design_scores_gemma":[0.00004533356,0.00016704736,0.021644952,0.014005986,0.0011158572,0.0042950804,0.00047386557,0.00026058918,0.0005250752,0.005409953,0.9519689,0.00008730726],"about_ca_topic_score_codex":0.004358654,"about_ca_topic_score_gemma":0.0076441015,"teacher_disagreement_score":0.004358654,"about_ca_system_score_codex":0.0010210974,"about_ca_system_score_gemma":0.0016050311,"threshold_uncertainty_score":0.008666575},"labels":[],"label_agreement":null},{"id":"W1964349843","doi":"10.1007/s10549-011-1941-0","title":"Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Oophorectomy; Prophylactic Mastectomy; Prophylactic Surgery; Breast cancer; Population; Genetic testing; BRCA mutation; Ovarian cancer; Gynecology; Distress; Mastectomy; Psychosocial; Obstetrics; Cancer; Oncology; Internal medicine; Hysterectomy; Surgery; Psychiatry","score_opus":0.034217249389368445,"score_gpt":0.33473027357828633,"score_spread":0.3005130241889179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964349843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992237,0.00016510885,0.000033163917,0.000044818127,0.000007691161,0.0000051077973,0.00018079422,0.0000032493526,0.00033627465],"genre_scores_gemma":[0.99897504,0.000075844866,0.00003128571,0.00004756332,0.000009960756,0.000006112883,0.0003474016,0.0000017852846,0.00050497876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997223,0.000051549992,0.000028625696,0.000044842287,0.000032669257,0.000119993194],"domain_scores_gemma":[0.99892646,0.00019636971,0.00022550601,0.00009956801,0.00023812662,0.00031390207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004541611,0.00031912207,0.0004789679,0.0010572956,0.0016057625,0.0005535682,0.00039960718,0.00095556024,0.0011903181],"category_scores_gemma":[0.00187599,0.00028963847,0.0007656858,0.0009720271,0.00042872247,0.0005709684,0.0005047541,0.0008117484,0.00039356056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069959863,0.0001475578,0.9937127,0.000006991757,0.000051616786,0.0021155372,0.00037820684,0.000055403983,0.0007636236,0.00001386515,0.00007906912,0.0019757368],"study_design_scores_gemma":[0.000016707903,0.0005321159,0.9968155,0.0000054409657,0.00010344313,0.0014858362,0.0005268837,0.000095152616,0.00013639059,0.000023848099,0.00024809514,0.000010598862],"about_ca_topic_score_codex":0.026328245,"about_ca_topic_score_gemma":0.025002103,"teacher_disagreement_score":0.026328245,"about_ca_system_score_codex":0.0005627539,"about_ca_system_score_gemma":0.0005117616,"threshold_uncertainty_score":0.052349985},"labels":[],"label_agreement":null},{"id":"W1964407943","doi":"10.1007/s10549-012-2369-x","title":"A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Research Resources; GlaxoSmithKline","keywords":"Lapatinib; Pazopanib; Medicine; Clinical endpoint; Internal medicine; Cohort; Adverse effect; Breast cancer; Oncology; Cancer; Pharmacology; Randomized controlled trial; Trastuzumab; Sunitinib","score_opus":0.07212824753998884,"score_gpt":0.4215965446262711,"score_spread":0.34946829708628224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964407943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698953,0.004244644,0.0019760467,0.0012726977,0.00097265036,0.016762896,0.0017264728,0.00019825864,0.0029511394],"genre_scores_gemma":[0.9622519,0.003527656,0.00484586,0.0024072472,0.00079324737,0.019883176,0.0018772887,0.000050060124,0.004363682],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99883085,0.00073871406,0.00005482167,0.00016598358,0.00007899411,0.00013078893],"domain_scores_gemma":[0.9986162,0.00033963125,0.00034453615,0.000111079455,0.00008388348,0.00050462503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002980293,0.002024104,0.003068432,0.0006507334,0.0004736902,0.0010164672,0.0009231102,0.001618854,0.0048508435],"category_scores_gemma":[0.0023805029,0.0010109537,0.0019957104,0.00056220545,0.0009933548,0.0011054856,0.0005477246,0.0036575033,0.0009618234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9492108,0.021039246,0.0008743967,0.00039944894,0.0008223501,0.000049510883,0.000058129433,0.0007100343,0.0052900854,0.00014530701,0.0010883978,0.020312263],"study_design_scores_gemma":[0.90266436,0.09498002,0.00081924244,0.000012042054,0.00020977546,0.000027088605,0.000009714397,0.00038100674,0.00028685405,0.00011633616,0.0004826393,0.000010901097],"about_ca_topic_score_codex":0.0005942199,"about_ca_topic_score_gemma":0.0019829292,"teacher_disagreement_score":0.0048508435,"about_ca_system_score_codex":0.000842868,"about_ca_system_score_gemma":0.0017462025,"threshold_uncertainty_score":0.016227663},"labels":[],"label_agreement":null},{"id":"W1964423199","doi":"10.1007/s10549-010-0763-9","title":"Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":212,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Breast Cancer Research Alliance","keywords":"AMPK; PI3K/AKT/mTOR pathway; Metformin; Protein kinase B; Phosphorylation; RPTOR; Cell growth; Signal transduction; Cancer research; mTORC1; Protein kinase A; Chemistry; Cell biology; Endocrinology; Biology; Biochemistry; Insulin","score_opus":0.020428991629397448,"score_gpt":0.31669560324967083,"score_spread":0.2962666116202734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964423199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075854,0.0052958117,0.00026455417,0.00034877853,0.00016388817,0.000019902815,0.0005840239,0.00004514961,0.0025192208],"genre_scores_gemma":[0.9915592,0.0037228263,0.0005959545,0.00020916926,0.000049031223,0.00008343491,0.0010087161,0.000016223756,0.002755262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974996,0.00005359651,0.000032561416,0.000023556828,0.000059278478,0.0000811485],"domain_scores_gemma":[0.99986804,0.000032689724,0.000022718223,0.000016772467,0.000013010405,0.000046737176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018801923,0.00028942592,0.0004393177,0.0005651432,0.00036844893,0.00048508763,0.00020000373,0.00050631975,0.0019237514],"category_scores_gemma":[0.00026336533,0.00028139402,0.00044719584,0.00044016694,0.00029204143,0.00030109537,0.00024443757,0.00082276925,0.00036983847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009747181,0.0005665488,0.0018428791,0.0002310578,0.00008155413,0.00027792828,0.000108196225,0.00041712192,0.96857643,0.0012645496,0.0011510819,0.015735464],"study_design_scores_gemma":[0.0006716669,0.0040260735,0.040235713,0.00002943667,0.00019017298,0.00090388354,0.00034446307,0.0011460731,0.9397653,0.0003657729,0.012273667,0.000047834634],"about_ca_topic_score_codex":0.001053892,"about_ca_topic_score_gemma":0.0025939052,"teacher_disagreement_score":0.0019237514,"about_ca_system_score_codex":0.00045143176,"about_ca_system_score_gemma":0.0005750292,"threshold_uncertainty_score":0.006435573},"labels":[],"label_agreement":null},{"id":"W1964988865","doi":"10.1007/s10549-012-2215-1","title":"Improving size, lymph node metastatic rate, breast conservation, and mortality of invasive breast cancer in Rhode Island women, a well-screened population","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Chronic Disease Prevention and Health Promotion","keywords":"Medicine; Breast cancer; Mammography; Cancer; Mortality rate; Population; Internal medicine; Cancer registry; Demography; Oncology; Gynecology; Environmental health","score_opus":0.09048571225189866,"score_gpt":0.39106305328487073,"score_spread":0.30057734103297207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964988865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839956,0.00034524052,0.000018197677,0.00042850032,0.000004744762,0.000008190516,0.00008927133,0.0000021355443,0.00070416136],"genre_scores_gemma":[0.99888545,0.00026457568,0.000100441226,0.00010429166,0.00001122968,0.000009439931,0.00014118172,0.0000014569706,0.00048198435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982774,0.00008229393,0.000011527358,0.000015331902,0.0000293944,0.00003354654],"domain_scores_gemma":[0.9996369,0.000063360574,0.00012498903,0.000019513704,0.000050184226,0.000105061976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003862922,0.0001364561,0.00016092653,0.00022630939,0.00025889697,0.0002517447,0.00036494614,0.00028473532,0.001034079],"category_scores_gemma":[0.0018997552,0.00009354685,0.00025225958,0.00019374651,0.00020862215,0.0002929829,0.00029459933,0.00036377314,0.00014094463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032127643,0.00034456886,0.9865806,0.000024900213,0.00005275685,0.00015692819,0.00017261441,0.000121315235,0.0010237737,0.000040071158,0.00059332926,0.010567811],"study_design_scores_gemma":[0.00001762291,0.00021968901,0.9988023,0.0000063139237,0.000035108063,0.00009210993,0.00028821366,0.00018806523,0.00011019006,0.000013920411,0.00022437841,0.0000021448573],"about_ca_topic_score_codex":0.07040154,"about_ca_topic_score_gemma":0.12061795,"teacher_disagreement_score":0.07040154,"about_ca_system_score_codex":0.0004374418,"about_ca_system_score_gemma":0.00068299286,"threshold_uncertainty_score":0.13998353},"labels":[],"label_agreement":null},{"id":"W1965727743","doi":"10.1007/s10549-004-8693-z","title":"The potential role of breast conservation surgery and adjuvant breast radiation for adenoid cystic carcinoma of the breast","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Adenoid cystic carcinoma; Radiation therapy; Mastectomy; Surgery; Male breast cancer; Breast carcinoma; Lymph node; Breast surgery; Cancer; Carcinoma; Internal medicine","score_opus":0.025312484445296175,"score_gpt":0.3033161825256824,"score_spread":0.2780036980803862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965727743","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3371211,0.5797263,0.0012894346,0.03817805,0.001588524,0.000052165677,0.0002508209,0.000040879957,0.041752808],"genre_scores_gemma":[0.8593456,0.12577072,0.0014592169,0.0036545051,0.004349242,0.00005031469,0.00015416938,0.000015094537,0.005201081],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99971384,0.00015652439,0.00002057485,0.000020140329,0.000039914074,0.000048952883],"domain_scores_gemma":[0.99702543,0.0024255896,0.00016496588,0.000068388814,0.00011495154,0.00020069789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018699915,0.00026474296,0.0005137148,0.00038623626,0.00025316048,0.00077206385,0.0005004923,0.0010742049,0.0069981236],"category_scores_gemma":[0.0050107646,0.00011799207,0.0008238111,0.00032280592,0.00075257145,0.0008574279,0.00023238173,0.00070975395,0.00029618858],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02795701,0.0015848582,0.06711118,0.0018579483,0.0006706984,0.0026011558,0.00017624209,0.004494928,0.0066685798,0.013123676,0.007281939,0.86647177],"study_design_scores_gemma":[0.011415862,0.040720053,0.5731435,0.004976411,0.00604265,0.036268458,0.0029549017,0.012182375,0.010697628,0.052961078,0.2483867,0.00025050447],"about_ca_topic_score_codex":0.002313379,"about_ca_topic_score_gemma":0.0052890927,"teacher_disagreement_score":0.0069981236,"about_ca_system_score_codex":0.0006704962,"about_ca_system_score_gemma":0.0019669002,"threshold_uncertainty_score":0.023411036},"labels":[],"label_agreement":null},{"id":"W1965788714","doi":"10.1007/s10549-004-3779-1","title":"Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Hospital Anxiety and Depression Scale; Anxiety; Psychosocial; Depression (economics); Cancer; Internal medicine; Distress; Ambulatory; Oncology; Psychiatry; Clinical psychology","score_opus":0.11682865259918873,"score_gpt":0.4211137130642144,"score_spread":0.3042850604650257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965788714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939599,0.0031852105,0.00009062059,0.00035051873,0.000025849436,0.000011373019,0.00010829803,0.0000023766868,0.0022658454],"genre_scores_gemma":[0.9981285,0.0012488442,0.00016336715,0.000108455584,0.000034999826,0.00000464362,0.00005745297,0.000001040572,0.0002527422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990609,0.00052381994,0.00007353485,0.0000712795,0.0002091324,0.00006136432],"domain_scores_gemma":[0.98862016,0.0045389924,0.0050527942,0.0003994906,0.0006221632,0.0007663803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009458822,0.00019097934,0.0003049899,0.0007225815,0.0003421662,0.00081860536,0.00020637269,0.00066020014,0.0032983972],"category_scores_gemma":[0.008137357,0.0002644909,0.0007301602,0.00082179415,0.0003214905,0.0003600176,0.000401036,0.0009942837,0.00013279454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052320026,0.00038004885,0.99092484,0.00011406636,0.00058948196,0.00007420154,0.00022958906,0.00003781374,0.00046902406,0.000067649664,0.00009426288,0.006495783],"study_design_scores_gemma":[0.000010925843,0.00013659759,0.9990532,0.000023705996,0.000105459854,0.00010855089,0.0002213699,0.00007510027,0.000040048897,0.000052574345,0.00016799163,0.000004383717],"about_ca_topic_score_codex":0.0049456432,"about_ca_topic_score_gemma":0.004993461,"teacher_disagreement_score":0.0049456432,"about_ca_system_score_codex":0.00024631832,"about_ca_system_score_gemma":0.0003607281,"threshold_uncertainty_score":0.01103425},"labels":[],"label_agreement":null},{"id":"W1965830162","doi":"10.1007/s10549-012-2170-x","title":"Metformin and breast cancer risk: a meta-analysis and critical literature review","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Metformin; Breast cancer; Meta-analysis; Cochrane Library; Internal medicine; Observational study; Cohort study; Cohort; Odds ratio; Oncology; Hazard ratio; Cancer; Confidence interval; Insulin","score_opus":0.11443133663161735,"score_gpt":0.4424164480234159,"score_spread":0.32798511139179853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965830162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035752286,0.99919266,0.00009138847,0.00017103732,0.000056780227,0.000009154579,0.00006602936,0.0000021507108,0.000053296008],"genre_scores_gemma":[0.0075687473,0.991256,0.00046760356,0.0003305639,0.00018865308,0.000029334626,0.000101810314,0.0000028641468,0.00005442507],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9983564,0.00068661605,0.0004509376,0.00021953587,0.0002242342,0.0000622392],"domain_scores_gemma":[0.9921151,0.006429484,0.00083810225,0.00015883522,0.00038982587,0.00006868378],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0063437615,0.0014768196,0.0065390547,0.0032331669,0.0002597747,0.0015041749,0.0016351552,0.0013755497,0.002959916],"category_scores_gemma":[0.011760618,0.000814376,0.0069775726,0.0046806163,0.0003247385,0.0010383931,0.00091948884,0.0011815565,0.00025108454],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034497185,0.00010573231,0.006405672,0.4800044,0.19307627,0.00046801163,0.00011400945,0.0012428863,0.0006392688,0.0010163925,0.009449949,0.30402768],"study_design_scores_gemma":[0.0012222228,0.0006161433,0.020020444,0.108738124,0.78360814,0.0012461959,0.00020253188,0.00066570484,0.00071190327,0.0034548875,0.07936917,0.00014449062],"about_ca_topic_score_codex":0.0022891436,"about_ca_topic_score_gemma":0.006398259,"teacher_disagreement_score":0.99346095,"about_ca_system_score_codex":0.0010556068,"about_ca_system_score_gemma":0.002320294,"threshold_uncertainty_score":0.033549428},"labels":[],"label_agreement":null},{"id":"W1965959593","doi":"10.1007/s10549-015-3355-x","title":"Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sunnybrook Health Science Centre; University of Ottawa; Ontario Clinical Oncology Group; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Saint John Regional Hospital; London Health Sciences Centre; McMaster University; Queen's University; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Vitamin D and neurology; Population; Proportional hazards model; Gastroenterology; Cancer","score_opus":0.10448639879685911,"score_gpt":0.44953964984056544,"score_spread":0.3450532510437063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965959593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945576,0.0036618828,0.00013422397,0.00026458045,0.000058885802,0.0001957833,0.0005274773,0.000012209121,0.00058737537],"genre_scores_gemma":[0.99775296,0.00060581526,0.00016085853,0.00015496797,0.00006215817,0.00013188826,0.0006546821,0.0000053609997,0.00047122527],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984231,0.0010654059,0.00010131501,0.00015976785,0.00013760469,0.00011288513],"domain_scores_gemma":[0.9973072,0.001093273,0.00063560525,0.00036357233,0.00016495175,0.0004354571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025427155,0.00058007514,0.0013052735,0.00031144702,0.00038634412,0.0009896915,0.00084445206,0.0009820893,0.001893178],"category_scores_gemma":[0.0054506757,0.00029848015,0.001061081,0.0005132354,0.0005513839,0.0005162548,0.00038193638,0.0013623481,0.00025033898],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9013461,0.002548542,0.058446374,0.0003379401,0.004183884,0.00003632062,0.000084011306,0.00066349877,0.0061365035,0.00014595309,0.0010394676,0.025031455],"study_design_scores_gemma":[0.36058405,0.20614736,0.40273657,0.00022219948,0.015900793,0.00023577968,0.00018952803,0.0023425887,0.005824339,0.0007818666,0.0049363514,0.00009858791],"about_ca_topic_score_codex":0.0019571753,"about_ca_topic_score_gemma":0.0032484897,"teacher_disagreement_score":0.0025427155,"about_ca_system_score_codex":0.00064381014,"about_ca_system_score_gemma":0.00090389664,"threshold_uncertainty_score":0.013447344},"labels":[],"label_agreement":null},{"id":"W1966037324","doi":"10.1007/s10549-015-3307-5","title":"Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital; University Health Network; Ontario Institute for Cancer Research","funders":"Breast Cancer Research Trust; National Institute for Health and Care Research","keywords":"Metformin; Medicine; Breast cancer; Biomarker; Insulin; Internal medicine; Oncology; Cancer; Endocrinology; Biology","score_opus":0.14630624488955238,"score_gpt":0.4327590834056447,"score_spread":0.28645283851609227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966037324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579793,0.03321956,0.0015852754,0.0024542855,0.0017196682,0.0007461304,0.0006345296,0.0000705643,0.0015906576],"genre_scores_gemma":[0.9909672,0.004748037,0.001015408,0.0011589254,0.0006347523,0.00039247685,0.00046010714,0.000017536604,0.00060556934],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99743503,0.0017558496,0.000201217,0.00027701,0.00013219134,0.00019873171],"domain_scores_gemma":[0.9935974,0.0035962686,0.0012323176,0.0006124534,0.00018714317,0.0007744647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005330617,0.001317469,0.0038132207,0.00035770136,0.0004206885,0.0019550612,0.0007389449,0.002341656,0.0035317743],"category_scores_gemma":[0.009161694,0.0005158832,0.004274152,0.000672606,0.0012944451,0.0017470106,0.0006986341,0.003403712,0.00038800357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97718257,0.00075475196,0.0044301446,0.0007013732,0.0061106966,0.00004284909,0.000035219047,0.00018949118,0.0011732535,0.0001618305,0.00021564717,0.0090021705],"study_design_scores_gemma":[0.8328641,0.09607098,0.031404253,0.00047093607,0.032142542,0.00013690088,0.0001338951,0.0009567049,0.0016319698,0.001749753,0.0023494372,0.00008846609],"about_ca_topic_score_codex":0.00046770906,"about_ca_topic_score_gemma":0.00076041545,"teacher_disagreement_score":0.005330617,"about_ca_system_score_codex":0.0005934999,"about_ca_system_score_gemma":0.0009778789,"threshold_uncertainty_score":0.028191388},"labels":[],"label_agreement":null},{"id":"W1966205301","doi":"10.1007/s10549-010-1025-6","title":"Amplification of the prolactin receptor gene in mammary lobular neoplasia","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Lobular carcinoma; Breast cancer; Ductal carcinoma; Immunohistochemistry; Biology; Comparative genomic hybridization; Pathology; Gene duplication; Mammary gland; Invasive lobular carcinoma; Prolactin receptor; Progesterone receptor; Cancer; Prolactin; Cancer research; Estrogen receptor; Gene; Medicine; Endocrinology; Hormone; Genetics; Invasive ductal carcinoma; Genome","score_opus":0.038361203222155624,"score_gpt":0.33377232164607096,"score_spread":0.2954111184239153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966205301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196273,0.0023703026,0.00051776285,0.00020358698,0.000014461358,0.000012863094,0.00009542613,0.000034286702,0.0047887205],"genre_scores_gemma":[0.9980229,0.00053368317,0.00018268342,0.000020184149,0.000017775455,0.000004532605,0.000090126014,0.0000044088993,0.0011237311],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998248,0.000044038814,0.000016208114,0.000020318053,0.000050284405,0.000044370292],"domain_scores_gemma":[0.9996698,0.0001653211,0.00005948211,0.00002144311,0.000042251766,0.000041674015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027401594,0.00014604711,0.00015105474,0.0015356592,0.00016919298,0.0003286958,0.00019339564,0.00027687734,0.0020066882],"category_scores_gemma":[0.0007777502,0.00022322005,0.000125586,0.00033457097,0.0003488699,0.00017232163,0.00021129748,0.00021060355,0.00034573855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005406187,0.00016045898,0.1898664,0.00016764588,0.00006812356,0.022916794,0.0003668801,0.00038659456,0.7404602,0.0013029064,0.00084227446,0.0380555],"study_design_scores_gemma":[0.00016154184,0.00085130305,0.72493213,0.000027352893,0.00023745246,0.069735646,0.0007187828,0.0016872791,0.19111632,0.00090441067,0.009601569,0.000026312673],"about_ca_topic_score_codex":0.001499822,"about_ca_topic_score_gemma":0.0012469247,"teacher_disagreement_score":0.0020066882,"about_ca_system_score_codex":0.00040119296,"about_ca_system_score_gemma":0.00018888983,"threshold_uncertainty_score":0.0067130327},"labels":[],"label_agreement":null},{"id":"W1966365049","doi":"10.1023/b:brea.0000036897.92513.72","title":"Enumeration of Circulating Tumor Cells in the Blood of Breast Cancer Patients After Filtration Enrichment: Correlation with Disease Stage","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"University of Toronto","keywords":"Circulating tumor cell; Breast cancer; Medicine; Population; Immunostaining; Incidence (geometry); Pathology; Internal medicine; Cancer; Blood sampling; Cytokeratin; Oncology; Immunohistochemistry; Metastasis","score_opus":0.02083046803186057,"score_gpt":0.30442768584026025,"score_spread":0.2835972178083997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966365049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996139,0.0010380152,0.001506645,0.0000614763,0.000020194908,0.000012502048,0.00031588465,0.000047293826,0.00085892476],"genre_scores_gemma":[0.99486995,0.00043992267,0.0015564696,0.00007097325,0.00003119788,0.000019689134,0.0008641398,0.000011086858,0.002136621],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998042,0.000035158628,0.000012430052,0.000034962228,0.000049097485,0.000064148386],"domain_scores_gemma":[0.9997358,0.00011585639,0.000028149774,0.000014818222,0.00005311804,0.000052248164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018535632,0.0001507901,0.00029700014,0.0004333088,0.00019734997,0.00039992065,0.000121445264,0.0002554985,0.0018233889],"category_scores_gemma":[0.00070779613,0.00010253473,0.00008758431,0.0003536833,0.00010374366,0.00016649315,0.00012219102,0.00030686765,0.00045807243],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035498901,0.00023272145,0.26740396,0.00011972633,0.000061609084,0.00032485637,0.00055755593,0.00017925753,0.68899494,0.00017627202,0.00090814533,0.037491057],"study_design_scores_gemma":[0.000056502253,0.0024940793,0.7039335,0.000018647965,0.00016699302,0.002328765,0.00034380553,0.001976793,0.28487134,0.00019961073,0.0035884136,0.000021565607],"about_ca_topic_score_codex":0.0009916598,"about_ca_topic_score_gemma":0.0010950514,"teacher_disagreement_score":0.0018233889,"about_ca_system_score_codex":0.000110350964,"about_ca_system_score_gemma":0.00016810783,"threshold_uncertainty_score":0.0060998797},"labels":[],"label_agreement":null},{"id":"W1966382361","doi":"10.1023/a:1024417331304","title":"Breast Cancer Diagnosis by Scintimammography: A Meta-analysis and Review of the Literature","year":2003,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal; McGill University; Montreal General Hospital","funders":"","keywords":"Scintimammography; Medicine; Breast cancer; Mammography; Radiology; Cancer; Meta-analysis; Medical physics; Nuclear medicine; Internal medicine","score_opus":0.11885321628177652,"score_gpt":0.42283689946956643,"score_spread":0.3039836831877899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966382361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006373825,0.9929676,0.00021884455,0.00009310566,0.00006249584,0.000023186443,0.0001696582,0.0000060433267,0.00008525639],"genre_scores_gemma":[0.11806709,0.8799372,0.0010301785,0.0002546811,0.00016076941,0.00007604377,0.00034832832,0.000007976767,0.00011772702],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99717027,0.0011636479,0.0007299959,0.00048829475,0.00036437015,0.000083514125],"domain_scores_gemma":[0.98959446,0.008183938,0.0013022698,0.00025651386,0.00055748544,0.000105382955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005480244,0.0019191909,0.010235063,0.0037769815,0.00035096816,0.0013003381,0.0012789298,0.0012139203,0.0016958428],"category_scores_gemma":[0.012681925,0.00080946466,0.013137371,0.006106336,0.00039911282,0.00079449,0.0006168728,0.0006692156,0.000171583],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007173891,0.00009867031,0.044300977,0.23506077,0.6246427,0.00075806596,0.00015307154,0.00095591653,0.0009946644,0.00014129934,0.00163383,0.08408614],"study_design_scores_gemma":[0.0005557293,0.00035980227,0.018969199,0.009618851,0.9664206,0.00067787076,0.00007214276,0.00019735536,0.00033681755,0.00014529163,0.002613645,0.000032761855],"about_ca_topic_score_codex":0.004603992,"about_ca_topic_score_gemma":0.011104798,"teacher_disagreement_score":0.010235063,"about_ca_system_score_codex":0.0009521419,"about_ca_system_score_gemma":0.001779357,"threshold_uncertainty_score":0.02898264},"labels":[],"label_agreement":null},{"id":"W1966385883","doi":"10.1007/s10549-014-3221-2","title":"Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Ottawa Regional Cancer Foundation; Montreal General Hospital; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"NSABP Foundation; GlaxoSmithKline","keywords":"Pazopanib; Medicine; Cyclophosphamide; Oncology; Breast cancer; Paclitaxel; Doxorubicin; Internal medicine; Neoadjuvant therapy; Chemotherapy; Cancer","score_opus":0.048088481825683545,"score_gpt":0.43952695847675566,"score_spread":0.3914384766510721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966385883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951133,0.0014737982,0.00030743508,0.00023700982,0.0001281194,0.00082212716,0.0004455683,0.000072557275,0.0014000587],"genre_scores_gemma":[0.9889698,0.0031723282,0.0014820975,0.00044576416,0.0002567118,0.001138801,0.0015301219,0.000047803063,0.002956657],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994221,0.00022823083,0.00003394646,0.00010211193,0.00006298599,0.0001506093],"domain_scores_gemma":[0.9991242,0.00015275762,0.00014466069,0.00010516514,0.000030081766,0.00044300442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016271578,0.0014168277,0.0028504708,0.00070729374,0.0004574648,0.0012376321,0.0011590907,0.00135783,0.0027292455],"category_scores_gemma":[0.0011163603,0.0008713582,0.0016124302,0.00068907975,0.0013305106,0.0014457578,0.00044261533,0.00433417,0.0010784448],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7577937,0.09852014,0.0038750828,0.00050957646,0.0011538031,0.0002029261,0.00022234717,0.0033592272,0.020901347,0.00020407887,0.0016357566,0.11162208],"study_design_scores_gemma":[0.42867526,0.55225974,0.011512286,0.000044382246,0.00060159323,0.000350706,0.000069285656,0.0012907962,0.0032109718,0.0001641402,0.0017746086,0.000046245754],"about_ca_topic_score_codex":0.0016472372,"about_ca_topic_score_gemma":0.0058770804,"teacher_disagreement_score":0.0028504708,"about_ca_system_score_codex":0.0010639157,"about_ca_system_score_gemma":0.0017561577,"threshold_uncertainty_score":0.00913018},"labels":[],"label_agreement":null},{"id":"W1966738468","doi":"10.1007/s10549-011-1529-8","title":"Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; McGill University; Vancouver Hospital and Health Sciences Centre; Jewish General Hospital; BC Cancer Agency","funders":"Sanofi","keywords":"Breast cancer; Insulin-like growth factor; Internal medicine; Oestrogen receptor; Endocrinology; Receptor; Cancer; Medicine; Mammary gland; Oncology; Growth factor; Cancer research; Biology","score_opus":0.07488335036378008,"score_gpt":0.33336262611638967,"score_spread":0.2584792757526096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966738468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721878,0.01661798,0.0003234481,0.00092262303,0.000088930676,0.000024442974,0.0016880158,0.000014983414,0.008131842],"genre_scores_gemma":[0.9925236,0.0036809116,0.00021829468,0.000120223456,0.00009129387,0.000017733468,0.0009465384,0.0000071170925,0.0023942785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977034,0.000045187284,0.000024570101,0.000039165974,0.00005521013,0.00006556977],"domain_scores_gemma":[0.99954116,0.00012490975,0.00012883241,0.000032206164,0.0000610869,0.00011182494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045748905,0.00014125166,0.0004286054,0.0008840241,0.00027903236,0.00053214334,0.0005623512,0.00043668476,0.0033587485],"category_scores_gemma":[0.0013884029,0.00021529134,0.00051193504,0.0011191682,0.00020779035,0.00037943068,0.00029307735,0.00055747526,0.0004245073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019127878,0.00005643556,0.9589574,0.00004482847,0.00012110546,0.00017223622,0.00006922409,0.00025172057,0.0011685699,0.00024293743,0.0008448277,0.036157884],"study_design_scores_gemma":[0.00003996107,0.0001102864,0.995707,0.000027080407,0.00011693889,0.00059433066,0.00018199044,0.00033520954,0.00024239221,0.00023786562,0.002401178,0.0000059237527],"about_ca_topic_score_codex":0.017483983,"about_ca_topic_score_gemma":0.02464715,"teacher_disagreement_score":0.017483983,"about_ca_system_score_codex":0.00069863175,"about_ca_system_score_gemma":0.0005527241,"threshold_uncertainty_score":0.03476441},"labels":[],"label_agreement":null},{"id":"W1966774810","doi":"10.1007/s10549-006-9257-1","title":"Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nausea and vomiting management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ontario Institute for Cancer Research","funders":"","keywords":"Doxorubicin; Medicine; Breast cancer; Oncology; Internal medicine; Clinical trial; Metastatic breast cancer; Quality of life (healthcare); Cancer; Chemotherapy","score_opus":0.2719247156265156,"score_gpt":0.523883179990982,"score_spread":0.2519584643644664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966774810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808319,0.008397459,0.00060478254,0.0017086591,0.00026423775,0.0015283076,0.00392869,0.00004659659,0.0026894098],"genre_scores_gemma":[0.99081564,0.0016937231,0.0008578989,0.0007346369,0.00018949264,0.00150285,0.0027226931,0.000014012229,0.001469021],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977913,0.0016687578,0.00010545088,0.00016534532,0.00010120822,0.0001678979],"domain_scores_gemma":[0.9975858,0.00094809895,0.0005929104,0.00018533452,0.00011574248,0.0005721401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036494306,0.0010854345,0.0019079762,0.00034985977,0.0002923671,0.0007882167,0.000649727,0.0010162077,0.005581916],"category_scores_gemma":[0.0045221895,0.00031207563,0.0035500082,0.00051562313,0.00056929386,0.0007347157,0.00060762465,0.0024672025,0.0004148394],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9724903,0.0021539463,0.003602985,0.00039396502,0.0064375857,0.000038521517,0.000034667795,0.00070594705,0.0011740242,0.00011916857,0.0013977493,0.011451098],"study_design_scores_gemma":[0.8810988,0.085468024,0.023317503,0.00007275191,0.0070815617,0.000062798965,0.000040295763,0.0008471944,0.00044127007,0.00031407506,0.0012240825,0.00003158164],"about_ca_topic_score_codex":0.0012209358,"about_ca_topic_score_gemma":0.0026935453,"teacher_disagreement_score":0.005581916,"about_ca_system_score_codex":0.00096468366,"about_ca_system_score_gemma":0.00082369416,"threshold_uncertainty_score":0.019300282},"labels":[],"label_agreement":null},{"id":"W1966799993","doi":"10.1007/s10549-008-9987-3","title":"Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University; Ottawa Hospital; BC Cancer Agency; University of Ottawa; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Aerobic exercise; Physical therapy; Randomized controlled trial; Guideline; Internal medicine; Body mass index; Psychosocial; Cancer; Pathology","score_opus":0.03904323051247313,"score_gpt":0.3323640962548608,"score_spread":0.2933208657423877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966799993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989396,0.000434102,0.000057324996,0.00009867591,0.000042847558,0.000061696424,0.00014630942,0.000006133109,0.00021324366],"genre_scores_gemma":[0.99913824,0.00013908536,0.00007586788,0.00006284284,0.00003828928,0.00007181993,0.00023478323,0.0000022542952,0.00023684479],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9990429,0.0004435951,0.000076938675,0.00015946549,0.000076927594,0.00020016282],"domain_scores_gemma":[0.99634016,0.0014823359,0.0008098947,0.0003073864,0.0001484276,0.00091172045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019139122,0.0005225584,0.0013253916,0.0003160555,0.00054843066,0.0005655942,0.00055914465,0.0014076105,0.0018049577],"category_scores_gemma":[0.0053376686,0.00035719856,0.0012073927,0.0005371435,0.0004436181,0.00064974965,0.00046560058,0.0017280804,0.0002517183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6286671,0.016777424,0.32825324,0.00016210109,0.0018140452,0.00008715451,0.00013131868,0.0009004316,0.001797428,0.000060443497,0.0006137313,0.020735549],"study_design_scores_gemma":[0.027279895,0.06955903,0.8966673,0.00006156358,0.0020338867,0.000073041316,0.00014025264,0.0026415456,0.00087012415,0.00015769494,0.00047761013,0.000038037695],"about_ca_topic_score_codex":0.0033574111,"about_ca_topic_score_gemma":0.004491699,"teacher_disagreement_score":0.0033574111,"about_ca_system_score_codex":0.000457222,"about_ca_system_score_gemma":0.0008279131,"threshold_uncertainty_score":0.010121822},"labels":[],"label_agreement":null},{"id":"W1966927770","doi":"10.1023/b:brea.0000032978.67677.9f","title":"The Addition of Manual Lymph Drainage to Compression Therapy For Breast Cancer Related Lymphedema: a Randomized Controlled Trial","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Lymphedema; Medicine; Massage; Randomized controlled trial; Breast cancer; Surgery; Physical therapy; Cancer; Internal medicine; Pathology","score_opus":0.03319399409630322,"score_gpt":0.3849892178740019,"score_spread":0.3517952237776987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966927770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9586061,0.019306345,0.0013816839,0.001928472,0.0037766816,0.009331705,0.0012276705,0.00034639135,0.004094868],"genre_scores_gemma":[0.97462434,0.0065679154,0.0027317489,0.0017484751,0.0020951137,0.007832991,0.00075462554,0.000034168603,0.0036107001],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99822026,0.00092945946,0.00014239347,0.0003176239,0.00015537922,0.00023482986],"domain_scores_gemma":[0.9976578,0.0011907641,0.0004019839,0.00013596263,0.0001136343,0.00049996516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025587804,0.0024601219,0.0064097224,0.0010077001,0.00085903157,0.0014000282,0.0018989769,0.0041029947,0.011748692],"category_scores_gemma":[0.004463957,0.001159163,0.0028404142,0.000976865,0.002692161,0.0016305627,0.00083670835,0.005046144,0.0012229512],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99172616,0.0021778275,0.00011035125,0.00065673003,0.000566932,0.000016539347,0.000018644572,0.00008130671,0.0002967268,0.000059739323,0.00027008678,0.0040189293],"study_design_scores_gemma":[0.983898,0.015113478,0.00022511101,0.000034324494,0.00038313458,0.0000066224907,0.0000068910704,0.00010565633,0.00006618895,0.00004262726,0.000112434966,0.000005515296],"about_ca_topic_score_codex":0.0021881692,"about_ca_topic_score_gemma":0.0025190578,"teacher_disagreement_score":0.011748692,"about_ca_system_score_codex":0.0011623002,"about_ca_system_score_gemma":0.0016038318,"threshold_uncertainty_score":0.039303303},"labels":[],"label_agreement":null},{"id":"W1966934989","doi":"10.1007/s10549-012-2229-8","title":"GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cyclin D1; Breast cancer; Cancer research; Cyclin D; GSK-3; Biology; Cyclin B; Protein kinase B; Tissue microarray; Cancer; PI3K/AKT/mTOR pathway; Cyclin; Kinase; Cell cycle; Phosphorylation; Signal transduction; Genetics","score_opus":0.050114836549128884,"score_gpt":0.36570891294081825,"score_spread":0.31559407639168935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966934989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832624,0.0005514808,0.000040203828,0.00010039246,0.000011271072,0.0000033332863,0.00020711239,0.0000036908998,0.0007562701],"genre_scores_gemma":[0.9988287,0.00028704066,0.000036680252,0.000032925684,0.000020828562,0.0000044650205,0.0003487654,0.0000019988258,0.00043855322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998933,0.00001797414,0.000009510898,0.000016317423,0.000018485123,0.000044352473],"domain_scores_gemma":[0.9994198,0.000120443496,0.00020883756,0.000022146622,0.000045373887,0.00018335322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023283064,0.00020984586,0.00034092725,0.0005109354,0.00029086907,0.00066994206,0.00019772159,0.00041714197,0.0017743602],"category_scores_gemma":[0.0011468738,0.00017534921,0.00029049936,0.0005313658,0.00020858277,0.0002915974,0.00027084842,0.0006253994,0.00030254418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007843389,0.000053819982,0.9946972,0.000011265198,0.000032534816,0.00016467657,0.000037293954,0.000063860236,0.0010037284,0.000025271294,0.0002055709,0.0029203251],"study_design_scores_gemma":[0.000025513184,0.00012644967,0.9978811,0.000007900203,0.00005707098,0.0006286913,0.0001367411,0.00017157574,0.00043423753,0.00013149573,0.00039454384,0.00000447043],"about_ca_topic_score_codex":0.001357554,"about_ca_topic_score_gemma":0.0022922005,"teacher_disagreement_score":0.0017743602,"about_ca_system_score_codex":0.00033330894,"about_ca_system_score_gemma":0.00029819206,"threshold_uncertainty_score":0.0059358478},"labels":[],"label_agreement":null},{"id":"W1967224938","doi":"10.1023/b:brea.0000032983.87966.4e","title":"Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Internal medicine; Tamoxifen; Oncology; Quality of life (healthcare); Cyclophosphamide; Population; Placebo; Cancer; Chemotherapy; Pathology","score_opus":0.0513906635509203,"score_gpt":0.36493863860264397,"score_spread":0.31354797505172366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967224938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909866,0.00048457005,0.000009579639,0.000061213315,0.000009055569,0.0000049551804,0.00013913597,4.912843e-7,0.00019229771],"genre_scores_gemma":[0.99950624,0.00015838005,0.000012403427,0.000047827565,0.000013178685,0.0000049634223,0.00016884021,6.6399394e-7,0.000087479944],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99931777,0.00037974206,0.00004638544,0.00007112465,0.00006406101,0.00012090487],"domain_scores_gemma":[0.9985291,0.0005485235,0.00035474566,0.00005463717,0.00010134509,0.0004117288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010765782,0.00025436367,0.0006692813,0.0005498921,0.0003161372,0.0005666942,0.00031126058,0.0004968006,0.0012475817],"category_scores_gemma":[0.002953044,0.0001877634,0.00093027315,0.0008576588,0.00031664906,0.00046408628,0.00040025625,0.0006534517,0.0001345589],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025586594,0.000599128,0.963604,0.00006903122,0.00093991484,0.0000831444,0.00028201952,0.00014995008,0.000763646,0.00004499888,0.00030349186,0.0075741108],"study_design_scores_gemma":[0.00040021574,0.0022738262,0.9964302,0.000007793366,0.00025865846,0.00004300651,0.0002817028,0.00009025075,0.000059535996,0.000029231525,0.00011989189,0.000005653139],"about_ca_topic_score_codex":0.007759034,"about_ca_topic_score_gemma":0.011226174,"teacher_disagreement_score":0.007759034,"about_ca_system_score_codex":0.00042121898,"about_ca_system_score_gemma":0.000330002,"threshold_uncertainty_score":0.015427768},"labels":[],"label_agreement":null},{"id":"W1967912275","doi":"10.1007/s10549-007-9503-1","title":"Quantitative exploration of possible reasons for the recent improvement in breast cancer survival","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Université Laval; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement","funders":"","keywords":"Breast cancer; Medicine; Relative survival; Relative risk; Cancer; Internal medicine; Oncology; Gynecology; Cancer registry; Confidence interval","score_opus":0.11461337665519251,"score_gpt":0.41978686506358315,"score_spread":0.30517348840839065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967912275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98293763,0.004182118,0.008209853,0.0010387598,0.000045412242,0.00002432268,0.0018242751,0.000061951774,0.0016757309],"genre_scores_gemma":[0.9978096,0.00032942867,0.00077187613,0.000061559025,0.000029865192,0.000008870541,0.00035704346,0.000010142144,0.00062156905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956614,0.00018708112,0.000028441667,0.000104998144,0.000066738656,0.000046591358],"domain_scores_gemma":[0.99676514,0.0019457904,0.00060987554,0.00031486774,0.00025761497,0.00010669258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022978594,0.00019056225,0.0002940146,0.00081966957,0.00015455704,0.00066435325,0.00038705213,0.00031503598,0.002660638],"category_scores_gemma":[0.005184413,0.00012907296,0.0004485445,0.0010348398,0.00040085727,0.00040419435,0.0002293875,0.0004196555,0.00016425685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004550592,0.00019271066,0.7316636,0.00062092004,0.0013823565,0.00020362921,0.00036403103,0.005197839,0.14892375,0.015083222,0.0009807021,0.090836644],"study_design_scores_gemma":[0.000024236133,0.00019802764,0.9873403,0.000008725582,0.00017120842,0.00018001534,0.0000976068,0.002372169,0.0057456032,0.0025259436,0.0013250367,0.000011120644],"about_ca_topic_score_codex":0.001206762,"about_ca_topic_score_gemma":0.0010443635,"teacher_disagreement_score":0.002660638,"about_ca_system_score_codex":0.00037718366,"about_ca_system_score_gemma":0.0002539062,"threshold_uncertainty_score":0.012152433},"labels":[],"label_agreement":null},{"id":"W1967929812","doi":"10.1007/s10549-004-0594-7","title":"A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; McGill University Health Centre; Hôpital du Saint-Sacrement; Université Laval; Université de Montréal; Institut National de Santé Publique du Québec","funders":"Canadian Breast Cancer Research Alliance; Breast Cancer Alliance","keywords":"Medicine; Radiation therapy; Breast cancer; Hazard ratio; Confidence interval; Proportional hazards model; Surgery; Population; Mastectomy; Cohort; Survival analysis; Multivariate analysis; Cancer; Oncology; Internal medicine","score_opus":0.044198950670300045,"score_gpt":0.38333009864972706,"score_spread":0.339131147979427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967929812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991221,0.00024113778,0.00006423522,0.00010209618,0.000014752572,0.000008215633,0.00014392596,0.0000022853228,0.00030123428],"genre_scores_gemma":[0.99930394,0.00013867754,0.00006279012,0.00008082527,0.000021110951,0.000012438475,0.00012554295,0.000002567804,0.0002520146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979759,0.0010998949,0.00012366172,0.00039963133,0.00016587615,0.00023517573],"domain_scores_gemma":[0.9960573,0.0013167108,0.0010144586,0.00047944247,0.00033612055,0.0007959642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016175715,0.00057948823,0.0005331516,0.00066888396,0.0013517876,0.0009910605,0.0006416616,0.0017848162,0.0021975331],"category_scores_gemma":[0.006742565,0.00087888696,0.0013694539,0.0013808938,0.0007630716,0.0007601304,0.00067179144,0.0022586046,0.00031998666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002586138,0.001047195,0.9919417,0.000025096597,0.0007178063,0.0002534355,0.0004239484,0.00008047302,0.0006434184,0.000064218984,0.00019021325,0.0020262555],"study_design_scores_gemma":[0.00015037502,0.002515958,0.99540776,0.000008334747,0.00043643202,0.00029118118,0.0005938632,0.0001734934,0.000058418744,0.000049603983,0.0002978539,0.000016583213],"about_ca_topic_score_codex":0.025931323,"about_ca_topic_score_gemma":0.020878512,"teacher_disagreement_score":0.025931323,"about_ca_system_score_codex":0.0007553811,"about_ca_system_score_gemma":0.00085285306,"threshold_uncertainty_score":0.05156076},"labels":[],"label_agreement":null},{"id":"W1968061919","doi":"10.1007/s10549-012-2198-y","title":"Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case–control study","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Jewish General Hospital","keywords":"Medicine; Tamoxifen; Breast cancer; Cohort; Internal medicine; Cohort study; Gynecology; Obstetrics; Estrogen; Cancer; Aromatase inhibitor; Case-control study; Oncology","score_opus":0.01707642250554791,"score_gpt":0.31094180846286945,"score_spread":0.29386538595732153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968061919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939,0.00028728115,0.000116490366,0.000012359325,0.000005289384,0.000012377018,0.000059199352,0.0000028275847,0.00011414271],"genre_scores_gemma":[0.9995426,0.00008119482,0.000073153475,0.000019847046,0.000007907382,0.0000118459475,0.00009034455,0.0000024814074,0.00017072135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990534,0.00039383792,0.00006581541,0.0002627014,0.000114655886,0.00010946115],"domain_scores_gemma":[0.9985942,0.00036769712,0.00035938635,0.0003436711,0.00009821883,0.00023685516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010192303,0.00043375985,0.0010336299,0.00049426954,0.0007732268,0.00074290566,0.00064359425,0.000641931,0.0012558043],"category_scores_gemma":[0.0018502692,0.0008518777,0.0010168741,0.00073243876,0.0006909993,0.00033200742,0.00037663575,0.00070017274,0.00024298416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011285415,0.0014029698,0.9730809,0.00006939771,0.0014771682,0.0007837972,0.0006824389,0.0001805197,0.008130975,0.00007735757,0.00020872026,0.002620468],"study_design_scores_gemma":[0.00073997065,0.0019847187,0.99351853,0.000010278051,0.0009872944,0.00094739633,0.00034523266,0.00052560377,0.00048727344,0.00004977206,0.00038535343,0.000018557197],"about_ca_topic_score_codex":0.0088460585,"about_ca_topic_score_gemma":0.008867163,"teacher_disagreement_score":0.0088460585,"about_ca_system_score_codex":0.0005134898,"about_ca_system_score_gemma":0.0004286575,"threshold_uncertainty_score":0.017589092},"labels":[],"label_agreement":null},{"id":"W1968765579","doi":"10.1007/s10549-011-1894-3","title":"Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Myoepithelial cell; Ductal carcinoma; Breast cancer; Biology; Pathology; Stromal cell; Cancer research; Carcinoma in situ; Stroma; Tumor progression; Cancer; Carcinoma; Medicine; Immunohistochemistry; Genetics","score_opus":0.07384498753671576,"score_gpt":0.34841275109072956,"score_spread":0.2745677635540138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968765579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486095,0.0014065186,0.0008203423,0.000076877535,0.000012156405,0.000021103735,0.00036475496,0.000044197397,0.0023928734],"genre_scores_gemma":[0.9961577,0.0007967505,0.00036655954,0.00002830808,0.000008763674,0.000022452105,0.00045191232,0.0000073027413,0.0021602835],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999892,0.000014587525,0.000007432021,0.000016046799,0.0000326567,0.00003729217],"domain_scores_gemma":[0.99983597,0.000024150657,0.000052433203,0.000012646058,0.00003886952,0.000035920802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014368411,0.00012721372,0.0002172269,0.0005323896,0.00022579341,0.00042873208,0.00008916923,0.00013431405,0.0014963455],"category_scores_gemma":[0.00019683299,0.00016091886,0.0001485787,0.0003299894,0.00016819987,0.00020685888,0.0002560831,0.00037707208,0.0003906124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009366237,0.00021362268,0.052319475,0.00009095603,0.000025986104,0.00047045713,0.00021785429,0.00016306344,0.9335691,0.00079023786,0.00044965933,0.0107530225],"study_design_scores_gemma":[0.000024489233,0.000545791,0.78484184,0.000013536201,0.000034940782,0.0015396768,0.00068864354,0.00086160813,0.20398276,0.000422481,0.0070313388,0.000012838657],"about_ca_topic_score_codex":0.0005870409,"about_ca_topic_score_gemma":0.0009579431,"teacher_disagreement_score":0.0014963455,"about_ca_system_score_codex":0.000163613,"about_ca_system_score_gemma":0.00020419224,"threshold_uncertainty_score":0.005005777},"labels":[],"label_agreement":null},{"id":"W1968846760","doi":"10.1007/s10549-015-3378-3","title":"CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"National Cancer Institute; National Institutes of Health; National Institute of General Medical Sciences; Breast Cancer Research Foundation","keywords":"Letrozole; Breast cancer; Tamoxifen; Medicine; Internal medicine; Oncology; Aromatase; Proportional hazards model; Adverse effect; Cancer; Gynecology","score_opus":0.03524408952665578,"score_gpt":0.35707696325956345,"score_spread":0.3218328737329077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968846760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755604,0.0074889148,0.00016936686,0.0012444822,0.00027341058,0.00012382897,0.0008650813,0.00004163366,0.0022372112],"genre_scores_gemma":[0.99269754,0.0027746698,0.00026438522,0.0008133231,0.00034713597,0.00017448602,0.0012874182,0.000014988832,0.0016261343],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997075,0.00015640193,0.000016294734,0.000043203505,0.000025516723,0.00005102004],"domain_scores_gemma":[0.99952495,0.00014584292,0.00011711958,0.000056248635,0.000019001276,0.00013689819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087654364,0.0007992697,0.0018787625,0.00018129013,0.00024543708,0.0009326866,0.00045019112,0.00089741335,0.002756803],"category_scores_gemma":[0.0014120162,0.00037438888,0.0012932571,0.00034342438,0.00046381165,0.0005633131,0.00034063403,0.0019993065,0.00031734235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9267131,0.0013772427,0.023812093,0.00095973257,0.007337775,0.00024318662,0.0000719575,0.0010308592,0.00523924,0.00041843226,0.0055497778,0.027246507],"study_design_scores_gemma":[0.7606898,0.044352278,0.1643395,0.00029511403,0.016703352,0.00057976524,0.00018891547,0.0022480756,0.0018698086,0.0023595134,0.0062640267,0.000109864355],"about_ca_topic_score_codex":0.0005679741,"about_ca_topic_score_gemma":0.0014549792,"teacher_disagreement_score":0.002756803,"about_ca_system_score_codex":0.00034875385,"about_ca_system_score_gemma":0.0003591767,"threshold_uncertainty_score":0.009222448},"labels":[],"label_agreement":null},{"id":"W1968847679","doi":"10.1023/a:1022133219353","title":"Estradiol Promotes Growth and Angiogenesis in Polyoma Middle T Transgenic Mouse Mammary Tumor Explants","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Angiogenesis; Estrogen; Carcinogenesis; Biology; Breast cancer; Mammary gland; Cancer research; Genetically modified mouse; In vivo; Transgene; Mammary tumor; Cancer; Neovascularization; Internal medicine; Endocrinology; Medicine; Genetics; Gene","score_opus":0.02715513530787614,"score_gpt":0.285743818448838,"score_spread":0.25858868314096184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968847679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849635,0.0023326413,0.0050575016,0.0001944181,0.000099977406,0.000052464984,0.0010157977,0.00022681165,0.006056932],"genre_scores_gemma":[0.97372764,0.0015851151,0.004244608,0.000100457175,0.00007887726,0.000077376426,0.0013471359,0.00014173056,0.01869693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972254,0.00004585888,0.000024767858,0.0000513223,0.000075401134,0.00008005967],"domain_scores_gemma":[0.9994381,0.00020733358,0.0000880263,0.00006627184,0.000036797184,0.0001634128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706871,0.0005275905,0.00033432222,0.0008901898,0.0002593011,0.00041379116,0.00029857608,0.00037599393,0.0022385686],"category_scores_gemma":[0.00016407261,0.00033367393,0.00039876733,0.00037058332,0.00031027428,0.00035179793,0.00028541152,0.0010695267,0.0008523072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028955314,0.00005658871,0.00012127635,0.000014165497,0.000002732434,0.00007760947,0.000024618115,0.000028917024,0.9986527,0.00012697137,0.000032079555,0.0005727671],"study_design_scores_gemma":[0.00001932558,0.0002270235,0.0015896274,0.0000038656726,0.000009144188,0.00012691581,0.000024494186,0.00026282622,0.9964864,0.00003684563,0.0012106482,0.0000028445947],"about_ca_topic_score_codex":0.0014296678,"about_ca_topic_score_gemma":0.0021029797,"teacher_disagreement_score":0.0022385686,"about_ca_system_score_codex":0.000368883,"about_ca_system_score_gemma":0.00029270037,"threshold_uncertainty_score":0.007488787},"labels":[],"label_agreement":null},{"id":"W1969103199","doi":"10.1007/s10549-012-2077-6","title":"Adjuvant bisphosphonate treatment for breast cancer: Why did something so elegant become so complicated?","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; Bisphosphonate; Oncology; Breast cancer; Adjuvant therapy; Internal medicine; Clinical trial; Randomized controlled trial; Cancer; Osteoporosis","score_opus":0.2034249712387361,"score_gpt":0.475218991803003,"score_spread":0.2717940205642669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969103199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006888781,0.9992931,0.000022998183,0.00036331007,0.00009066599,0.0000018215725,0.0000074960117,0.0000014307357,0.00015032812],"genre_scores_gemma":[0.0006529855,0.9984079,0.00011451583,0.0005062015,0.00013682309,0.0000033715771,0.00001313209,7.4524826e-7,0.00016445959],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999723,0.00006169196,0.000060891343,0.000046478435,0.00008273809,0.000025155245],"domain_scores_gemma":[0.9994344,0.00032702813,0.00009031883,0.0000103791845,0.00011254948,0.000025283056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010278549,0.0006208269,0.0019483374,0.0012296109,0.00022898302,0.0009156639,0.0008626801,0.001454925,0.002897745],"category_scores_gemma":[0.0015848208,0.00029129896,0.0006905912,0.0019481389,0.0004842311,0.0011745777,0.00048707254,0.0020715385,0.0008071209],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020650588,0.00007135495,0.00018554297,0.032108314,0.0002502623,0.00009822991,0.00005477082,0.00014181265,0.00080721854,0.0014075403,0.025579391,0.939089],"study_design_scores_gemma":[0.00032177093,0.0003370603,0.002677659,0.026392313,0.0014212941,0.0016375119,0.00017012843,0.00013179133,0.00046571405,0.002477292,0.9639257,0.000041740303],"about_ca_topic_score_codex":0.0021216332,"about_ca_topic_score_gemma":0.0064835134,"teacher_disagreement_score":0.002897745,"about_ca_system_score_codex":0.00064583664,"about_ca_system_score_gemma":0.00151199,"threshold_uncertainty_score":0.009693921},"labels":[],"label_agreement":null},{"id":"W1969287659","doi":"10.1007/s10549-012-2303-2","title":"Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses’ Health Studies","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Body mass index; MAMMOGRAPHIC DENSITY; Overweight; Confounding; Insulin-like growth factor; Breast cancer; Internal medicine; Endocrinology; Nurses' Health Study; Oncology; Mammography; Growth factor; Cancer; Epidemiology; Receptor","score_opus":0.07731476026916892,"score_gpt":0.36455894828575985,"score_spread":0.2872441880165909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969287659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90970707,0.072754234,0.0003429052,0.007534906,0.00046787056,0.000043990298,0.0012362783,0.0000062974473,0.007906536],"genre_scores_gemma":[0.98885006,0.00922135,0.00032157873,0.00048162715,0.00020595039,0.00004902543,0.0003155622,0.0000026781238,0.00055213505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682933,0.002134962,0.00028729122,0.00013259234,0.00047515167,0.000140543],"domain_scores_gemma":[0.98956233,0.00636153,0.0016900159,0.00040196234,0.0006249896,0.001359235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005937201,0.00024687484,0.00044986984,0.0019878282,0.0008398232,0.001071424,0.0006495744,0.00068833877,0.0018259656],"category_scores_gemma":[0.022616485,0.00034008533,0.0008301677,0.004137641,0.00066207844,0.00079114095,0.0010307545,0.0013275475,0.0000797098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016025009,0.00007349263,0.9917094,0.00007026091,0.00026199967,0.000059453403,0.00016448314,0.000052020077,0.000027350534,0.00023775373,0.0005255019,0.0066580432],"study_design_scores_gemma":[0.000027656926,0.000083691295,0.99679583,0.0001793837,0.00029944006,0.000109061315,0.0006229248,0.00018892222,0.000034311714,0.00029278683,0.0013580042,0.000008105317],"about_ca_topic_score_codex":0.07671357,"about_ca_topic_score_gemma":0.10893826,"teacher_disagreement_score":0.07671357,"about_ca_system_score_codex":0.00104662,"about_ca_system_score_gemma":0.0018976416,"threshold_uncertainty_score":0.15253407},"labels":[],"label_agreement":null},{"id":"W1969405269","doi":"10.1023/a:1012564620853","title":"Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"MCF-7; Signal transduction; Breast cancer; Cytotoxicity; Human breast; Cancer research; Cancer; Biology; Oncology; Internal medicine; Medicine; Chemistry; Cell biology; In vitro; Genetics","score_opus":0.04192190424934354,"score_gpt":0.3113636838953381,"score_spread":0.26944177964599453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969405269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416006,0.0023312925,0.0011789519,0.00019322145,0.000048694765,0.000024049217,0.0004511601,0.00008294278,0.0015296983],"genre_scores_gemma":[0.99572635,0.00091001677,0.00073056313,0.00004198699,0.000010143716,0.00003314183,0.0006433319,0.000013935431,0.0018905557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997923,0.00005204473,0.000021583082,0.00002219404,0.000046794827,0.00006507291],"domain_scores_gemma":[0.99985826,0.000049138172,0.000021755,0.000029105022,0.000018541095,0.000023029941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017690126,0.00031848619,0.00029560406,0.00035613225,0.0002766462,0.0003386661,0.00019798533,0.0002540934,0.0018115384],"category_scores_gemma":[0.00018910968,0.00016420722,0.00027333677,0.00030966548,0.00020259386,0.00021224911,0.00016447237,0.00056529266,0.0004491857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026793077,0.00004518323,0.00011526592,0.000023401884,0.000006290662,0.000054600172,0.000019111762,0.00004565323,0.99872017,0.00011255403,0.000040856143,0.000548981],"study_design_scores_gemma":[0.00002127982,0.00024676588,0.0016216426,0.000002936835,0.000012019581,0.00016729419,0.00002622475,0.0002791239,0.9965578,0.000028641904,0.0010335353,0.0000027055523],"about_ca_topic_score_codex":0.001123283,"about_ca_topic_score_gemma":0.0015081994,"teacher_disagreement_score":0.0018115384,"about_ca_system_score_codex":0.0003834038,"about_ca_system_score_gemma":0.00023635566,"threshold_uncertainty_score":0.006060183},"labels":[],"label_agreement":null},{"id":"W1969405636","doi":"10.1007/s10549-009-0559-y","title":"Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Adoptive cell transfer; CD8; Stroma; Pathology; Cytotoxic T cell; Infiltration (HVAC); Ovalbumin; Lymph node; Immunotherapy; Stromal cell; Cancer research; T cell; Breast cancer; Biology; Medicine; Immunology; Cancer; Immune system; Immunohistochemistry; Internal medicine; In vitro","score_opus":0.04772655796454484,"score_gpt":0.34449636715946963,"score_spread":0.2967698091949248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969405636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843305,0.00026915534,0.0004784543,0.000030974992,0.0000086209075,0.000013111736,0.00015113286,0.000024992953,0.00059042015],"genre_scores_gemma":[0.9978683,0.00015302139,0.00027155047,0.000014929024,0.000008994921,0.00002616789,0.0002515921,0.00000818402,0.001397107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967456,0.000053783035,0.00002594114,0.000038451522,0.00010367079,0.0001035305],"domain_scores_gemma":[0.99907875,0.00019066957,0.00031008257,0.00007542865,0.00007882917,0.00026612205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026987022,0.00028721697,0.00030847627,0.00070025417,0.00017896653,0.00041807888,0.00017311476,0.00042311812,0.0012617987],"category_scores_gemma":[0.00033496125,0.0002649073,0.00021652425,0.00022320154,0.00028972686,0.00032802744,0.00029700607,0.0009708104,0.0002964462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015786663,0.0003138659,0.002993426,0.000020345231,0.000014302145,0.00008500714,0.000042330776,0.00024012,0.99357283,0.00006623458,0.0000490145,0.0010239606],"study_design_scores_gemma":[0.00007418404,0.0038940343,0.07167591,0.0000083845325,0.00007729768,0.000676391,0.000145287,0.004051832,0.91846347,0.00015575356,0.000755574,0.00002183244],"about_ca_topic_score_codex":0.00068590563,"about_ca_topic_score_gemma":0.0008445067,"teacher_disagreement_score":0.0012617987,"about_ca_system_score_codex":0.00029072518,"about_ca_system_score_gemma":0.00015395033,"threshold_uncertainty_score":0.0042211413},"labels":[],"label_agreement":null},{"id":"W1969932910","doi":"10.1007/s10549-014-3231-0","title":"No effect of scalp cooling on survival among women with breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Scalp; Breast cancer; Hazard ratio; Proportional hazards model; Chemotherapy; Internal medicine; Confidence interval; Cancer; Oncology; Surgery","score_opus":0.01676497524236144,"score_gpt":0.32749751872038146,"score_spread":0.31073254347802004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969932910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298286,0.003527712,0.000050265986,0.00048199968,0.00012536196,0.000009550855,0.00034651492,0.0000080057725,0.0024677545],"genre_scores_gemma":[0.9982986,0.0007899744,0.000021907797,0.00012287138,0.00006058249,0.0000037850732,0.00013493701,0.0000032173907,0.00056425435],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997261,0.0001020575,0.000013503393,0.00003820261,0.00003009033,0.00009010314],"domain_scores_gemma":[0.99781823,0.0011012964,0.00035073003,0.00021057553,0.00012727136,0.00039183575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047835882,0.00015865921,0.00026091654,0.0001933182,0.0003211832,0.00034918202,0.00027070206,0.0004713824,0.0054940507],"category_scores_gemma":[0.0033494793,0.00012652825,0.00092399237,0.00026725823,0.0002609317,0.00040583446,0.00029151648,0.0006625392,0.00025748447],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035012685,0.0005525923,0.9153806,0.00023049033,0.0007847631,0.00034473673,0.00016109642,0.00028737696,0.0031981468,0.00011408249,0.00085226103,0.043081302],"study_design_scores_gemma":[0.00022599717,0.002726846,0.99454945,0.00003619781,0.0007790016,0.0001674247,0.0002018374,0.00012104326,0.0002626588,0.000104347506,0.0008181809,0.000007028296],"about_ca_topic_score_codex":0.004521891,"about_ca_topic_score_gemma":0.0062298737,"teacher_disagreement_score":0.0054940507,"about_ca_system_score_codex":0.00032956622,"about_ca_system_score_gemma":0.00055423845,"threshold_uncertainty_score":0.01837945},"labels":[],"label_agreement":null},{"id":"W1971110586","doi":"10.1007/s10549-010-0893-0","title":"Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Breast cancer; Breast density; Medicine; Mammography; Breast cancer screening; Gynecology; Hormone replacement therapy (female-to-male); Mammography screening; Oncology; Hormone therapy; Internal medicine; Cancer; Obstetrics","score_opus":0.12247844376528955,"score_gpt":0.39445871199187826,"score_spread":0.2719802682265887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971110586","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.079945244,0.21126513,0.04698295,0.3777605,0.017233862,0.0066424147,0.18803084,0.0025344566,0.069604576],"genre_scores_gemma":[0.36780912,0.19158277,0.22045824,0.06469377,0.007154775,0.011212933,0.10960289,0.0008143886,0.026671074],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.96954614,0.00930292,0.009102745,0.0011671331,0.009982304,0.0008988097],"domain_scores_gemma":[0.90586454,0.033329945,0.007582822,0.0026161445,0.04603596,0.0045706523],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.037802238,0.0023290862,0.003962991,0.006833605,0.0016953666,0.002774044,0.005417545,0.004806807,0.0027750465],"category_scores_gemma":[0.05331904,0.0012066937,0.0034861781,0.009602108,0.0010445078,0.0021412075,0.0016545297,0.0046917275,0.001664696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015095886,0.0010421432,0.4892645,0.008226361,0.0012183018,0.00033823663,0.0010909544,0.0033728494,0.0010304563,0.0012503691,0.25349215,0.23816413],"study_design_scores_gemma":[0.0007341994,0.0014932228,0.79835093,0.015976857,0.005530534,0.00067636033,0.0038239975,0.0064532855,0.0038899456,0.0014456797,0.16126096,0.00036401456],"about_ca_topic_score_codex":0.11077518,"about_ca_topic_score_gemma":0.16086838,"teacher_disagreement_score":0.9621978,"about_ca_system_score_codex":0.0042229244,"about_ca_system_score_gemma":0.014519762,"threshold_uncertainty_score":0.2202608},"labels":[],"label_agreement":null},{"id":"W1971156035","doi":"10.1007/s10549-007-9865-4","title":"The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"London Health Sciences Centre","keywords":"Osteopontin; Argatroban; Cancer research; Metastasis; Thrombin; Metastatic breast cancer; Medicine; Breast cancer; Tissue factor; Cancer; Chemistry; Immunology; Internal medicine","score_opus":0.03295216863307312,"score_gpt":0.3426368816376451,"score_spread":0.309684713004572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971156035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800249,0.013327445,0.001326328,0.0010506938,0.00014270021,0.00003616908,0.00017103364,0.00022628217,0.003694626],"genre_scores_gemma":[0.98949486,0.006238594,0.00088012306,0.0001916876,0.00007787058,0.000029166507,0.00026134207,0.000027559572,0.0027987105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998653,0.00003211054,0.000008814639,0.000012473671,0.00004684173,0.000034494984],"domain_scores_gemma":[0.9998839,0.000025838319,0.00003874462,0.000009758718,0.000009890828,0.000031838375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016005074,0.00029405553,0.00039126351,0.00027647667,0.00014604963,0.00034630395,0.00026582472,0.00034906785,0.0018443939],"category_scores_gemma":[0.00030245015,0.0001468831,0.00020066428,0.00015733091,0.00024152851,0.00026135996,0.00017524992,0.0011175431,0.00043584948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004396032,0.00055756187,0.00052929844,0.00012245451,0.00008217162,0.0001309004,0.000023181616,0.00022713361,0.9591193,0.0003016467,0.00068941555,0.033820845],"study_design_scores_gemma":[0.001709164,0.010313369,0.015285157,0.000021852202,0.00023417523,0.0013847887,0.00007394605,0.0017425119,0.95951027,0.0005397386,0.00916251,0.000022553564],"about_ca_topic_score_codex":0.00054098014,"about_ca_topic_score_gemma":0.0009747461,"teacher_disagreement_score":0.0018443939,"about_ca_system_score_codex":0.00022863394,"about_ca_system_score_gemma":0.00028555686,"threshold_uncertainty_score":0.0061701536},"labels":[],"label_agreement":null},{"id":"W1971387210","doi":"10.1023/a:1006470206271","title":"Management of familial breast cancer risk","year":2000,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Breast cancer; Medicine; Psychosocial; Family history; Prophylactic Surgery; Quality of life (healthcare); Genetic testing; Cancer; Gynecology; Family medicine; Intensive care medicine; Surgery; Internal medicine; Nursing; Psychiatry","score_opus":0.051487458461725734,"score_gpt":0.40341821352556717,"score_spread":0.3519307550638414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971387210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022034194,0.9953685,0.00089396245,0.0012431839,0.000428025,0.000009401699,0.000017020886,0.000021350703,0.0017982988],"genre_scores_gemma":[0.0024680712,0.99268496,0.0012766708,0.0010830296,0.0010353111,0.000028851577,0.000053671683,0.000003770565,0.0013656364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996748,0.00008463731,0.00003416794,0.00005352746,0.00012434792,0.000028547023],"domain_scores_gemma":[0.9995871,0.00022593465,0.00005162798,0.000011638169,0.000082377686,0.00004139442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078897865,0.0010719171,0.0019780123,0.0020945768,0.00034429968,0.00087108754,0.0014615211,0.0017856013,0.0026055623],"category_scores_gemma":[0.0016645985,0.00020585033,0.0005395799,0.0011733404,0.0005279379,0.00067526894,0.000629548,0.0023597528,0.0012954201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006302429,0.00009462889,0.00042594885,0.0026091535,0.00006389089,0.0006415879,0.000033006167,0.00043841018,0.00034814232,0.0016971875,0.035295464,0.95828956],"study_design_scores_gemma":[0.00016571878,0.00029123135,0.006486081,0.009329202,0.00037181764,0.013798553,0.00020904036,0.0005378417,0.0006169759,0.0067379987,0.9614001,0.000055354692],"about_ca_topic_score_codex":0.0016068843,"about_ca_topic_score_gemma":0.0026430325,"teacher_disagreement_score":0.0026055623,"about_ca_system_score_codex":0.00079530233,"about_ca_system_score_gemma":0.0008493642,"threshold_uncertainty_score":0.008716464},"labels":[],"label_agreement":null},{"id":"W1972287988","doi":"10.1007/s10549-009-0595-7","title":"The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; U.S. Public Health Service; Cancer Research UK","keywords":"Ovarian cancer; Breast cancer; Oncology; Hazard ratio; Biology; Internal medicine; Genotype; Proportional hazards model; Allele; Genetics; Cancer; Medicine; Gene; Confidence interval","score_opus":0.06402901765703548,"score_gpt":0.38023421231836935,"score_spread":0.3162051946613339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972287988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997019,0.000069110814,0.000043972133,0.000016903075,0.0000036403403,0.0000041100184,0.00006930102,0.0000012672218,0.00008971999],"genre_scores_gemma":[0.99957055,0.000041595635,0.000052660394,0.000032337022,0.000008855157,0.0000056110052,0.00014827088,0.0000036233314,0.00013658298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994929,0.00020127345,0.00003687501,0.0001424061,0.00005527693,0.00007133413],"domain_scores_gemma":[0.9992638,0.00019372912,0.00023743794,0.00011784538,0.000053407974,0.00013379203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008106252,0.0007662888,0.00059541076,0.0004481846,0.0007741016,0.00058332266,0.00051300525,0.00079357106,0.0012693579],"category_scores_gemma":[0.001545189,0.0005379264,0.0005933088,0.0007858093,0.00060783635,0.0004441635,0.0002865037,0.00062238384,0.0002353895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004260316,0.0003972763,0.98391336,0.0000135176315,0.000514435,0.0006685551,0.0004943818,0.00006951074,0.0074398187,0.000038957867,0.00013025275,0.0020596376],"study_design_scores_gemma":[0.00027405447,0.0009884465,0.99588674,0.0000065755785,0.00044672695,0.00093680096,0.00036207304,0.00020524419,0.00059297495,0.000037990332,0.00025212552,0.000010177541],"about_ca_topic_score_codex":0.0076012453,"about_ca_topic_score_gemma":0.0035509851,"teacher_disagreement_score":0.0076012453,"about_ca_system_score_codex":0.00023558104,"about_ca_system_score_gemma":0.000224371,"threshold_uncertainty_score":0.01511395},"labels":[],"label_agreement":null},{"id":"W1972332868","doi":"10.1007/s10549-011-1739-0","title":"Are genetic and environmental components of variance in mammographic density measures that predict breast cancer risk independent of within-twin pair differences in body mass index?","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Medical Research Council; National Health and Medical Research Council","keywords":"Statistics; Correlation; Covariance; Twin study; Body mass index; Bivariate analysis; Breast cancer; Mathematics; Variance (accounting); Risk factors for breast cancer; Heritability; Cancer; Medicine; Biology; Internal medicine; Genetics","score_opus":0.050608320636071034,"score_gpt":0.2719646859470027,"score_spread":0.22135636531093164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972332868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957956,0.00081987353,0.0018621206,0.00036671106,0.000050203515,0.0000087202525,0.00019900728,0.000021893755,0.00087578956],"genre_scores_gemma":[0.99804497,0.00018812956,0.0009916998,0.00006691047,0.00003105824,0.0000106473735,0.00016591944,0.000023568766,0.00047704045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99538136,0.002435032,0.0002604353,0.0010909841,0.00042486243,0.00040731963],"domain_scores_gemma":[0.9918568,0.003954615,0.0013952941,0.0017585774,0.0005351647,0.0004995877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030270922,0.0012872394,0.0010563743,0.0014581812,0.001043806,0.0013493468,0.0011458521,0.0016664506,0.0022082762],"category_scores_gemma":[0.011010408,0.0012574939,0.0020346746,0.0018183871,0.0016929674,0.0010611417,0.0011591043,0.0012365121,0.00029000183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049314584,0.00015981476,0.98512197,0.000024657562,0.0022554877,0.00034683512,0.00073188246,0.0004311005,0.0036136,0.0010825112,0.00018065501,0.005558419],"study_design_scores_gemma":[0.000019891446,0.000081052254,0.9959204,0.000018569572,0.00046673923,0.00045993607,0.00028080572,0.0011378562,0.00034505766,0.0009788837,0.0002667733,0.000024088722],"about_ca_topic_score_codex":0.008133298,"about_ca_topic_score_gemma":0.0098583335,"teacher_disagreement_score":0.008133298,"about_ca_system_score_codex":0.00039304895,"about_ca_system_score_gemma":0.0007393207,"threshold_uncertainty_score":0.016171873},"labels":[],"label_agreement":null},{"id":"W1972688314","doi":"10.1007/s10549-004-1368-y","title":"Prognostic factors affecting the natural history of node-negative breast cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Health Sciences Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Natural history; Oncology; Medicine; Internal medicine; Cancer; Gynecology","score_opus":0.03288019039236431,"score_gpt":0.32847918109117213,"score_spread":0.2955989906988078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972688314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953596,0.0030229273,0.00019770332,0.00012517483,0.000017561297,0.0000049320947,0.00019653612,0.0000050155477,0.0010705444],"genre_scores_gemma":[0.99922836,0.0004039024,0.00006562979,0.00001583432,0.000025258614,0.000002290624,0.00012906591,0.0000016469428,0.00012807873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996861,0.00016941874,0.000022617423,0.000031887466,0.00004040009,0.00004956569],"domain_scores_gemma":[0.99683565,0.0015617893,0.00083338824,0.00022314739,0.00014516088,0.00040083152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089567754,0.00019174826,0.0002517891,0.0005092337,0.0002687533,0.00034030684,0.00026919282,0.0003258857,0.0011914093],"category_scores_gemma":[0.0047438666,0.00014252179,0.00022121993,0.0008031199,0.00036802905,0.00032873562,0.00014587537,0.00045464476,0.00010656606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082885625,0.00004128323,0.9943488,0.000011642648,0.000044037984,0.000086427586,0.000039367384,0.000084248466,0.0009774752,0.000055847417,0.00006895506,0.0034130036],"study_design_scores_gemma":[0.000010772726,0.00015338846,0.99878365,0.0000040612417,0.00005853129,0.00025968088,0.00004776547,0.0000931107,0.00024240863,0.00009097453,0.00025261258,0.0000030493654],"about_ca_topic_score_codex":0.0015090448,"about_ca_topic_score_gemma":0.0024178433,"teacher_disagreement_score":0.0015090448,"about_ca_system_score_codex":0.00020294245,"about_ca_system_score_gemma":0.00035852345,"threshold_uncertainty_score":0.0047368407},"labels":[],"label_agreement":null},{"id":"W1973041508","doi":"10.1007/s10549-011-1708-7","title":"Lifecourse predictors of mammographic density: the Newcastle Thousand Families cohort Study","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Menarche; Body mass index; Demography; Breast cancer; Logistic regression; Odds ratio; Family history; Cohort study; Obstetrics; Gynecology; Cancer; Internal medicine","score_opus":0.0842099793428427,"score_gpt":0.3648000963490076,"score_spread":0.28059011700616493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973041508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236804,0.0008263642,0.00020231101,0.00017783465,0.00003770312,0.000042174423,0.0054053036,0.0000075882726,0.00093271997],"genre_scores_gemma":[0.99240243,0.0005877577,0.00049702614,0.00006474408,0.000022624567,0.00010092673,0.0042833854,0.000011897491,0.0020292178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986603,0.0003397221,0.0001706224,0.00030883588,0.00030229316,0.00021822896],"domain_scores_gemma":[0.99655044,0.00047830716,0.00078258663,0.0008059139,0.0007447399,0.0006379232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013920903,0.00036055362,0.00080968876,0.0010444302,0.0015766977,0.0010600429,0.0017242578,0.001203439,0.0017165722],"category_scores_gemma":[0.0048236544,0.0012440971,0.0014597559,0.0017097986,0.00045855562,0.0011700307,0.001704174,0.0016393891,0.00047178223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029049366,0.00009005169,0.99638426,0.000028667138,0.00032242906,0.00011375765,0.0004826175,0.00008101217,0.00016432234,0.00007468973,0.000980807,0.0009869246],"study_design_scores_gemma":[0.000016219841,0.000023410115,0.99891794,0.000013983871,0.0000846469,0.00007481249,0.00027088067,0.00012264466,0.000020461335,0.000018004033,0.00042603622,0.000010903245],"about_ca_topic_score_codex":0.34283912,"about_ca_topic_score_gemma":0.43756932,"teacher_disagreement_score":0.34283912,"about_ca_system_score_codex":0.0017971788,"about_ca_system_score_gemma":0.00180518,"threshold_uncertainty_score":0.6816871},"labels":[],"label_agreement":null},{"id":"W1973137836","doi":"10.1007/s10549-011-1649-1","title":"A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Male Breast Health Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Lymphedema; Medicine; Breast cancer; Incidence (geometry); Population; Cohort; Cumulative incidence; Epidemiology; Cancer; Surgery; Internal medicine","score_opus":0.06917526963028543,"score_gpt":0.40258284184004367,"score_spread":0.33340757220975825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973137836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966658,0.00057372224,0.00006157906,0.00012373552,0.000012713448,0.00002351542,0.0019382683,0.0000039901006,0.0005966294],"genre_scores_gemma":[0.99754,0.00024474022,0.000057241406,0.00010425374,0.00003070092,0.000021972723,0.0014660055,0.0000027922931,0.00053239014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984308,0.00069648994,0.00017883649,0.00022490756,0.00025037234,0.00021851383],"domain_scores_gemma":[0.9976891,0.0003749844,0.0010603216,0.00021882245,0.00030092595,0.00035587692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017577702,0.00033644403,0.00047507702,0.0015696738,0.0007970037,0.0009618432,0.00064618356,0.0008572588,0.001687047],"category_scores_gemma":[0.0036867405,0.0005321126,0.0012707271,0.0025653217,0.00030230315,0.000908707,0.0009491068,0.0009106468,0.00037731224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036831372,0.000111526,0.9979534,0.000016608874,0.0002497279,0.00003490839,0.00015252434,0.00001852661,0.0000867227,0.000031628693,0.00027231328,0.0007038238],"study_design_scores_gemma":[0.00001771634,0.00007496432,0.99936014,0.0000051208594,0.00007172833,0.00004261862,0.00019416508,0.00004560935,0.000017867284,0.000008354843,0.00015916419,0.0000025380452],"about_ca_topic_score_codex":0.033147205,"about_ca_topic_score_gemma":0.04125883,"teacher_disagreement_score":0.033147205,"about_ca_system_score_codex":0.0007457709,"about_ca_system_score_gemma":0.0008164343,"threshold_uncertainty_score":0.06590855},"labels":[],"label_agreement":null},{"id":"W1973550734","doi":"10.1007/s10549-005-1409-1","title":"Breast cancer predisposing alleles in Poland","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; CHEK2; Missense mutation; Allele; Genetics; Population; Odds ratio; Biology; Mutation; Cancer; Oncology; Internal medicine; Medicine; Gene; Germline mutation","score_opus":0.02986733416414252,"score_gpt":0.3628503013709281,"score_spread":0.3329829672067856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973550734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751925,0.00041969895,0.00021919348,0.00008812087,0.0000058823907,0.000017339242,0.0001174251,0.000008991835,0.0016040996],"genre_scores_gemma":[0.9978861,0.0005557158,0.00027802584,0.00005030032,0.0000073721335,0.000015764715,0.00013239837,0.0000072135795,0.0010669976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997712,0.0000383577,0.00003429788,0.000051062918,0.00003089747,0.00007423831],"domain_scores_gemma":[0.9997843,0.000021959577,0.0000728499,0.000014444549,0.000018662995,0.000087776505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021028792,0.00026947274,0.00031871797,0.0017024161,0.00051727047,0.0004229024,0.0002176801,0.00023193506,0.0018755622],"category_scores_gemma":[0.0004977133,0.00026805262,0.00026393897,0.0010591839,0.00034732925,0.00017166596,0.0006682137,0.00029184547,0.00021073091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030599344,0.00037212714,0.90058404,0.00021498304,0.0002200466,0.0109027885,0.0021024996,0.00030736806,0.027933212,0.003487987,0.0009795675,0.049835578],"study_design_scores_gemma":[0.00014475876,0.00034313335,0.9782622,0.000040460938,0.00016011114,0.011120675,0.0013667684,0.00021993626,0.0016735404,0.00089418935,0.0057566096,0.000017652204],"about_ca_topic_score_codex":0.0054254713,"about_ca_topic_score_gemma":0.004725504,"teacher_disagreement_score":0.0054254713,"about_ca_system_score_codex":0.00043688001,"about_ca_system_score_gemma":0.0006317463,"threshold_uncertainty_score":0.010787785},"labels":[],"label_agreement":null},{"id":"W1973729526","doi":"10.1007/s10549-008-0267-z","title":"Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomas","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research; CancerCare Manitoba Foundation; National Cancer Institute; University of Manitoba; Manitoba Health Research Council","keywords":"Immunohistochemistry; Estrogen receptor; Breast cancer; Tissue microarray; Cancer research; Estrogen receptor alpha; Estrogen receptor beta; Antibody; Phosphorylation; Estrogen; Biology; Epitope; Cancer; Internal medicine; Pathology; Medicine; Immunology; Cell biology","score_opus":0.0845461179765854,"score_gpt":0.39014807308163685,"score_spread":0.30560195510505145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973729526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96204334,0.0038088176,0.027895425,0.00025933434,0.00010295892,0.00014895413,0.0006825936,0.00019874886,0.0048599252],"genre_scores_gemma":[0.94228244,0.0032759504,0.04440844,0.00019367595,0.00006484159,0.00043102395,0.0025184853,0.00007371095,0.006751538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965405,0.00006202045,0.000041467603,0.000080987644,0.00007361179,0.00008778358],"domain_scores_gemma":[0.99965453,0.00008782029,0.000042479147,0.000050540002,0.0001300292,0.000034615594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000565949,0.00046692215,0.00037338145,0.000622606,0.00045187544,0.00034132937,0.00040986214,0.00042255037,0.0022725717],"category_scores_gemma":[0.00041821742,0.0004708823,0.00033619508,0.0005144292,0.00021109972,0.00037477986,0.00027453134,0.00045486234,0.0006383644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012216019,0.000025120886,0.0004701023,0.00006564799,0.000015258849,0.000041771607,0.000031194086,0.000055805132,0.9980186,0.0000861689,0.000038861042,0.0010292964],"study_design_scores_gemma":[0.00005428588,0.00041783776,0.034973938,0.000026681522,0.00017771141,0.0013117134,0.00021921338,0.0035982635,0.95396715,0.00019974077,0.0050397185,0.00001378507],"about_ca_topic_score_codex":0.00071600924,"about_ca_topic_score_gemma":0.0014629944,"teacher_disagreement_score":0.0022725717,"about_ca_system_score_codex":0.0002530724,"about_ca_system_score_gemma":0.00023069557,"threshold_uncertainty_score":0.007602513},"labels":[],"label_agreement":null},{"id":"W1974605217","doi":"10.1007/s10549-012-2364-2","title":"Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ministry of the Environment, Conservation and Parks","funders":"","keywords":"Breast cancer; Meta-analysis; Oncology; Medicine; Cancer; Internal medicine","score_opus":0.1438262219065846,"score_gpt":0.4211886928827429,"score_spread":0.2773624709761583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974605217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005329278,0.9930951,0.00064509915,0.00022825667,0.00012814239,0.00001677965,0.0003427993,0.000013875866,0.00020060265],"genre_scores_gemma":[0.11498043,0.88015103,0.0020657862,0.00076681306,0.0004221377,0.00008525843,0.0008746764,0.000017644245,0.0006360973],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99912053,0.000371594,0.00015678351,0.00018518645,0.00011519243,0.000050807863],"domain_scores_gemma":[0.9985442,0.0010353555,0.00019223976,0.00007412415,0.000113944465,0.000040192863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025580502,0.0015732253,0.005130043,0.00089655054,0.00015587249,0.0009264466,0.0010454053,0.0009309753,0.0025529638],"category_scores_gemma":[0.0033039043,0.0005947772,0.007489146,0.0020676493,0.00016709672,0.0004904975,0.0005089139,0.0010190576,0.0002750606],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012450882,0.00013797064,0.028751548,0.112848856,0.6404653,0.0005778525,0.00006727918,0.002480268,0.0020778945,0.0005357601,0.00944272,0.1901637],"study_design_scores_gemma":[0.0019845734,0.00061947986,0.03152031,0.005109491,0.9399353,0.0005501682,0.00006629043,0.00079070014,0.0006359252,0.0013273901,0.017389262,0.000071062845],"about_ca_topic_score_codex":0.0022842784,"about_ca_topic_score_gemma":0.0057988944,"teacher_disagreement_score":0.005130043,"about_ca_system_score_codex":0.0005763793,"about_ca_system_score_gemma":0.0006983864,"threshold_uncertainty_score":0.013528466},"labels":[],"label_agreement":null},{"id":"W1974795335","doi":"10.1007/s10549-014-2900-3","title":"Experiences and attitudes toward risk of recurrence testing in women with breast cancer: a systematic review","year":2014,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; South Health Campus","funders":"","keywords":"Breast cancer; Medicine; Oncology; Gynecology; Cancer; Internal medicine; Obstetrics","score_opus":0.07104179607564236,"score_gpt":0.40652804225889766,"score_spread":0.3354862461832553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974795335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028667494,0.9961372,0.00004504072,0.00029454054,0.00004635017,0.00003439102,0.00041442784,0.0000020852813,0.0001590974],"genre_scores_gemma":[0.027464673,0.9712036,0.00026846264,0.0006689727,0.000041042356,0.000075698445,0.0001964506,0.0000016779258,0.000079358004],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99729234,0.0008698541,0.0010433521,0.00026271289,0.00042819127,0.00010349302],"domain_scores_gemma":[0.98681855,0.009304147,0.0028977552,0.00009929488,0.000662449,0.00021781646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034942064,0.00061088277,0.0028812687,0.003402695,0.0002866206,0.0012584692,0.00082738156,0.0013055806,0.0026024412],"category_scores_gemma":[0.023619596,0.00061960536,0.0037783019,0.004978942,0.00042466776,0.001329919,0.001175247,0.0009766569,0.00012026737],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005431864,0.000053104213,0.021071883,0.83228403,0.028579082,0.00030622687,0.0010538502,0.00018030232,0.00018945664,0.00029246704,0.0048330296,0.11061355],"study_design_scores_gemma":[0.00048167858,0.00036738982,0.058479164,0.7670321,0.13043545,0.0016304108,0.0022016235,0.00011810189,0.00017107282,0.0004910285,0.038450927,0.00014099618],"about_ca_topic_score_codex":0.009799776,"about_ca_topic_score_gemma":0.037330765,"teacher_disagreement_score":0.009799776,"about_ca_system_score_codex":0.0013976711,"about_ca_system_score_gemma":0.0037490572,"threshold_uncertainty_score":0.019485474},"labels":[],"label_agreement":null},{"id":"W1975324908","doi":"10.1007/s10549-012-1998-4","title":"Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian cancer; Breast cancer; Germline mutation; Genetic testing; Genetics; Biology; Genetic predisposition; Population; Germline; Mutation; Allele; Cancer; Gene; Oncology; Medicine","score_opus":0.10591137902812836,"score_gpt":0.42233003686826603,"score_spread":0.3164186578401377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975324908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992964,0.0000697008,0.00006381927,0.000067606474,0.0000025244137,0.000008722598,0.00006658119,0.0000046581517,0.00041995116],"genre_scores_gemma":[0.9995117,0.000063984844,0.00006958151,0.00007636148,0.00001116904,0.0000063420553,0.00007749612,0.000005227111,0.00017813359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960476,0.00009779715,0.000031742155,0.00010792749,0.00007462357,0.00008321923],"domain_scores_gemma":[0.99927145,0.00030291,0.00008862142,0.000044494212,0.00008615974,0.00020644574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031995645,0.0005160639,0.00045069927,0.0014954717,0.0015885253,0.0008983994,0.00041184318,0.0009182369,0.0028911806],"category_scores_gemma":[0.0025697777,0.00037575152,0.0003978245,0.00097229745,0.00066966476,0.00039917429,0.0006450683,0.0007648126,0.00050647394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003508035,0.00021749949,0.9718965,0.000012718511,0.000028601016,0.019011158,0.0006626996,0.000078406294,0.004904894,0.00006848555,0.00019949264,0.002568606],"study_design_scores_gemma":[0.000045436132,0.00073119934,0.95284617,0.000011503116,0.00012864948,0.0415592,0.0020948863,0.000810378,0.0010652919,0.00016724196,0.0005195092,0.000020517751],"about_ca_topic_score_codex":0.0044268477,"about_ca_topic_score_gemma":0.003792187,"teacher_disagreement_score":0.0044268477,"about_ca_system_score_codex":0.00036543427,"about_ca_system_score_gemma":0.0004312441,"threshold_uncertainty_score":0.009671986},"labels":[],"label_agreement":null},{"id":"W1975678666","doi":"10.1007/s10549-010-0970-4","title":"DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Peter MacCallum Cancer Centre; Cancer Institute NSW","keywords":"CDKN2A; Methylation; DNA methylation; Phyllodes tumor; Cancer research; Biology; Fibroadenoma; Epigenetics; Breast cancer; Pathology; CDH1; Cancer; Medicine; Gene; Genetics; Gene expression","score_opus":0.04022654585722239,"score_gpt":0.34706439247897075,"score_spread":0.30683784662174834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975678666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970776,0.0010863098,0.0003729558,0.000042879754,0.000005097405,0.000006350427,0.00041811116,0.000015848982,0.00097493257],"genre_scores_gemma":[0.9978179,0.00041259234,0.00030987646,0.000022110808,0.000005046468,0.000009819334,0.0004662067,0.00000535029,0.0009512081],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985456,0.000019992776,0.000011108994,0.000033018896,0.00003996041,0.000041346862],"domain_scores_gemma":[0.999856,0.000038563903,0.0000354276,0.000012416633,0.000031379666,0.000026254294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017175192,0.000101606194,0.0001972341,0.0008129272,0.00019172687,0.00026152696,0.0001245886,0.00021312437,0.0010328542],"category_scores_gemma":[0.0004009215,0.000138743,0.00012362163,0.00036655844,0.00016042493,0.00012579921,0.00015222552,0.0001828184,0.0002199089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015811755,0.00003016912,0.07573405,0.00008181818,0.000072154595,0.0003846735,0.0002545851,0.0001342702,0.9101516,0.00011687992,0.00014171403,0.0113169225],"study_design_scores_gemma":[0.000023140537,0.00029169684,0.8217393,0.000010911881,0.00010531716,0.003274698,0.00048837706,0.0006841152,0.17048155,0.00012415407,0.0027670043,0.000009643927],"about_ca_topic_score_codex":0.0017614395,"about_ca_topic_score_gemma":0.0021226096,"teacher_disagreement_score":0.0017614395,"about_ca_system_score_codex":0.00016467087,"about_ca_system_score_gemma":0.00011423584,"threshold_uncertainty_score":0.003502369},"labels":[],"label_agreement":null},{"id":"W1975696113","doi":"10.1023/a:1023926401227","title":"Risk Factors for Colorectal Cancer Following Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Colorectal cancer; Family history; Cancer; Oncology; Internal medicine; Odds ratio; Gynecology; Cancer registry; Population; Epidemiology; Epidemiology of cancer; Body mass index","score_opus":0.05558737688816778,"score_gpt":0.3786550019926228,"score_spread":0.323067625104455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975696113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98715323,0.004312779,0.00016445122,0.00077499414,0.000114804585,0.000029121697,0.0017245793,0.000027698476,0.0056982376],"genre_scores_gemma":[0.99660146,0.0012017741,0.00021758847,0.00011726158,0.00016897442,0.0000121848525,0.0006712246,0.0000060288107,0.0010035618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996319,0.00007813403,0.000048688526,0.000045828754,0.00009232605,0.00010300404],"domain_scores_gemma":[0.99574995,0.00082394475,0.0019294068,0.00019562733,0.0003470027,0.0009540896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029658191,0.00025973486,0.0004550096,0.0010876164,0.0006180719,0.000538329,0.0003642187,0.00080186117,0.0054528113],"category_scores_gemma":[0.003744985,0.00024733215,0.0007762941,0.0015291105,0.000212723,0.00038117927,0.0004028816,0.0011643214,0.00040626508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020172038,0.0000710615,0.9967997,0.00004111896,0.000070803086,0.00035741302,0.000026624537,0.00003084356,0.00016295919,0.000024576306,0.0003205842,0.0018925233],"study_design_scores_gemma":[0.0000067827273,0.00007881616,0.9984452,0.000016178588,0.00007022821,0.00083020306,0.000092918,0.00007246924,0.000042610434,0.000025613006,0.00031400018,0.00000496796],"about_ca_topic_score_codex":0.015335272,"about_ca_topic_score_gemma":0.024471672,"teacher_disagreement_score":0.015335272,"about_ca_system_score_codex":0.00037119642,"about_ca_system_score_gemma":0.0008037354,"threshold_uncertainty_score":0.030492008},"labels":[],"label_agreement":null},{"id":"W1975803034","doi":"10.1007/s10549-015-3312-8","title":"The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Cancer Institute; Breast Cancer Research Foundation; National Institutes of Health; American Cancer Society","keywords":"Breast cancer; Triple-negative breast cancer; Medicine; Founder effect; BRCA mutation; Mutation; Cancer; Oncology; Internal medicine; Genetics; Haplotype; Genotype; Biology; Gene","score_opus":0.02954017966565936,"score_gpt":0.3382651798742503,"score_spread":0.30872500020859095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975803034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992951,0.00011608518,0.000018061022,0.000051663083,0.0000031412333,0.000002958916,0.00013143517,0.0000013334551,0.00038023083],"genre_scores_gemma":[0.9994498,0.00014366156,0.000021841053,0.000029538263,0.0000067657,0.0000047189114,0.000097971846,8.215267e-7,0.0002448709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998671,0.000029429157,0.000013000446,0.000024541963,0.000025368843,0.00004059462],"domain_scores_gemma":[0.9995321,0.000071637165,0.00022086412,0.000020315787,0.000047807644,0.00010728485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029648835,0.00017213162,0.00018412099,0.00096196774,0.00045847197,0.00048755357,0.0001888819,0.0004457019,0.0020321163],"category_scores_gemma":[0.0011043425,0.00025812574,0.00023166742,0.00061380555,0.00020111997,0.00036262185,0.00029048027,0.00036095426,0.00020530091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006962851,0.00003993216,0.99836284,0.000005735731,0.000011186053,0.00006944456,0.00022977685,0.0000048118136,0.00027202597,0.000011482226,0.000047472877,0.00087551714],"study_design_scores_gemma":[0.0000029737894,0.000042931766,0.99858594,0.000004057198,0.000013511733,0.00019895437,0.00095710123,0.000032485998,0.00003047397,0.00000724287,0.00012254067,0.0000018826598],"about_ca_topic_score_codex":0.009956116,"about_ca_topic_score_gemma":0.009653713,"teacher_disagreement_score":0.009956116,"about_ca_system_score_codex":0.00023295477,"about_ca_system_score_gemma":0.00019902708,"threshold_uncertainty_score":0.019796312},"labels":[],"label_agreement":null},{"id":"W1975881851","doi":"10.1007/s10549-007-9583-y","title":"A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bisphosphonate; Bone pain; Breast cancer; Palliative care; Regimen; Metastatic breast cancer; Progressive disease; Internal medicine; Cancer; N-terminal telopeptide; Bone disease; Surgery; Oncology; Urology; Chemotherapy; Osteoporosis","score_opus":0.08039643999595886,"score_gpt":0.45607334339596967,"score_spread":0.3756769034000108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975881851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886746,0.0030187308,0.0004165322,0.0009483813,0.00034085935,0.0026496856,0.0013090939,0.00007712209,0.0025650868],"genre_scores_gemma":[0.98522526,0.0025699795,0.0013969466,0.0014727298,0.00036667148,0.0035404146,0.0022741805,0.000026891717,0.003126988],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99977046,0.00011337096,0.0000089248615,0.000043580283,0.000015176027,0.00004853949],"domain_scores_gemma":[0.99929583,0.00018426157,0.00008708483,0.000045643792,0.000028253493,0.0003589642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008371187,0.0014743339,0.0025631313,0.00040569904,0.00040459618,0.0007698253,0.0008111661,0.0017869729,0.00643523],"category_scores_gemma":[0.0010210956,0.00047178444,0.0015006985,0.00039464128,0.000988992,0.00057511666,0.000308103,0.0038681084,0.00085296604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9488226,0.015031218,0.0010231459,0.00053766806,0.0007337045,0.000111010704,0.00008874387,0.000953123,0.009155947,0.00017687093,0.0014860067,0.02187999],"study_design_scores_gemma":[0.8815909,0.11460965,0.0016923201,0.00002273147,0.00026046144,0.00008316547,0.00002535221,0.0003470333,0.00048769245,0.00010747765,0.0007623888,0.000010816396],"about_ca_topic_score_codex":0.0014010933,"about_ca_topic_score_gemma":0.0036440524,"teacher_disagreement_score":0.00643523,"about_ca_system_score_codex":0.00074485404,"about_ca_system_score_gemma":0.0012938491,"threshold_uncertainty_score":0.021527946},"labels":[],"label_agreement":null},{"id":"W1976191178","doi":"10.1007/s10549-008-0137-8","title":"Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review","year":2008,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cancer Care Ontario; Kingston General Hospital; Queen's University","funders":"","keywords":"Anastrozole; Fulvestrant; Medicine; Exemestane; Oncology; Breast cancer; Internal medicine; Metastatic breast cancer; Clinical trial; Adjuvant therapy; Hormonal therapy; Systemic therapy; Cancer; Tamoxifen; Gynecology","score_opus":0.04683582102131132,"score_gpt":0.39792989292549813,"score_spread":0.3510940719041868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976191178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003595576,0.99918526,0.00005343246,0.00007310654,0.000037761984,0.000027011349,0.00009338136,0.0000033254908,0.00016704183],"genre_scores_gemma":[0.0043012938,0.99505484,0.00020229832,0.00020932493,0.000027978665,0.00002832435,0.000069080525,0.0000012948905,0.00010549627],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99965894,0.000087600594,0.00011430362,0.00005369973,0.00006717103,0.000018308087],"domain_scores_gemma":[0.99874026,0.00082086097,0.00030057487,0.000017158669,0.000091445065,0.000029690727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010460872,0.00069702265,0.0033775158,0.0018699531,0.00015961152,0.0006315109,0.0010544428,0.00065500586,0.0039140503],"category_scores_gemma":[0.0029495165,0.00029623264,0.0023974103,0.0024391506,0.00028180936,0.0006098174,0.00044973625,0.0004883901,0.0002521641],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007594707,0.000040444844,0.0006342385,0.63230294,0.0071847555,0.00018795501,0.00007727258,0.0003111741,0.00062950957,0.00032383626,0.008315369,0.34923312],"study_design_scores_gemma":[0.0029971283,0.0015891821,0.014254798,0.5235442,0.17747873,0.0023522084,0.00035913338,0.0004279884,0.0011270735,0.0012701326,0.27446753,0.00013192635],"about_ca_topic_score_codex":0.0038652413,"about_ca_topic_score_gemma":0.01283129,"teacher_disagreement_score":0.0039140503,"about_ca_system_score_codex":0.00083704694,"about_ca_system_score_gemma":0.0017060596,"threshold_uncertainty_score":0.013093829},"labels":[],"label_agreement":null},{"id":"W1976684510","doi":"10.1007/s10549-008-9938-z","title":"Germline RAP80 mutations and susceptibility to breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Women's College Hospital; University of Toronto","funders":"McGill University","keywords":"Breast cancer; Medicine; Oncology; Germline mutation; Germline; Cancer; Internal medicine; Mutation; Biology; Genetics; Gene","score_opus":0.04105073879634214,"score_gpt":0.3579217438125442,"score_spread":0.3168710050162021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976684510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962608,0.0012743297,0.00021878275,0.00018633094,0.000015627847,0.0000030974159,0.00011659514,0.000029603549,0.001894759],"genre_scores_gemma":[0.9987469,0.00028340128,0.000134754,0.000026623582,0.000025651158,0.0000024894116,0.000055798795,0.0000062113822,0.00071825733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997603,0.00008273195,0.000019372845,0.000042352294,0.00005856082,0.000036649115],"domain_scores_gemma":[0.99883157,0.0003606403,0.00046883067,0.000092048955,0.00008016144,0.00016684213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030628484,0.00031606393,0.00023246066,0.0014786919,0.0002395153,0.00038570326,0.0003234627,0.0008961833,0.0043209326],"category_scores_gemma":[0.0016288141,0.00025009972,0.00019935051,0.0006331837,0.00031735023,0.00026868054,0.00031545915,0.00045662702,0.00045242105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008162936,0.0005299863,0.83960056,0.000114178125,0.0005804469,0.008323702,0.0002980151,0.0007539934,0.10823032,0.0015897217,0.0012037294,0.030612385],"study_design_scores_gemma":[0.00017439722,0.000862884,0.9380361,0.000045259294,0.00042268637,0.035070453,0.00025391785,0.0016298366,0.018183878,0.0016193154,0.0036699716,0.00003126257],"about_ca_topic_score_codex":0.00050943415,"about_ca_topic_score_gemma":0.0003040214,"teacher_disagreement_score":0.0043209326,"about_ca_system_score_codex":0.00016785189,"about_ca_system_score_gemma":0.000114749615,"threshold_uncertainty_score":0.014454901},"labels":[],"label_agreement":null},{"id":"W1977541054","doi":"10.1007/s10549-006-9433-3","title":"Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Statistics Canada; Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Family history; Lymphovascular invasion; Internal medicine; Oncology; Population; Cancer; Gynecology; Cohort; Ovarian cancer; Metastasis","score_opus":0.02923286623180769,"score_gpt":0.34057521312709343,"score_spread":0.3113423468952857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977541054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991025,0.0001698388,0.00005996337,0.00005965707,0.000016346426,0.0000058710134,0.0003259016,0.000003911927,0.0002560501],"genre_scores_gemma":[0.9992778,0.000106457184,0.000043493965,0.000033082346,0.00001444179,0.0000070001497,0.00022037582,0.000004400769,0.00029308174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989895,0.00032138318,0.000089042296,0.00026897245,0.00012537137,0.00020558562],"domain_scores_gemma":[0.9965641,0.0006755811,0.0007888685,0.0006132849,0.00037448548,0.0009838153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014831369,0.00058110664,0.00079381076,0.001012808,0.0012748082,0.001336189,0.000867993,0.0013101596,0.0018977363],"category_scores_gemma":[0.00395776,0.0010574396,0.001806472,0.0015447572,0.00049347983,0.0008255698,0.0007909208,0.0015827776,0.00030928373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004519365,0.00010044,0.99806386,0.0000047053086,0.00028235742,0.000175875,0.00013241527,0.000028551049,0.0002883383,0.000016370725,0.00008734913,0.0003678646],"study_design_scores_gemma":[0.000019413706,0.0001505773,0.99906975,0.0000025976121,0.00013477712,0.00017690625,0.00019061366,0.00011655003,0.000033947665,0.000018504135,0.000080001286,0.00000642578],"about_ca_topic_score_codex":0.028744055,"about_ca_topic_score_gemma":0.027147356,"teacher_disagreement_score":0.028744055,"about_ca_system_score_codex":0.00053928426,"about_ca_system_score_gemma":0.0008716904,"threshold_uncertainty_score":0.057153463},"labels":[],"label_agreement":null},{"id":"W1977543422","doi":"10.1023/a:1024549729256","title":"Inhibition of Invasion and Metastasis by Glypican-3 in a Syngeneic Breast Cancer Model","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Glypican 3; Metastasis; Cancer research; Transfection; Biology; Mammary tumor; Apoptosis; Tumor progression; Cancer; Cell; Cell culture; Breast cancer; Cell biology","score_opus":0.04035635674864079,"score_gpt":0.34279847778590916,"score_spread":0.30244212103726836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977543422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391866,0.0007936412,0.0023204954,0.00023305076,0.00007278336,0.00009634886,0.0005991501,0.000089520036,0.0018762936],"genre_scores_gemma":[0.98966086,0.00088698906,0.0032909913,0.00010631694,0.000021441361,0.00015879703,0.0007284413,0.000046126755,0.005099973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999668,0.00008205965,0.000024639337,0.00004483737,0.00009069879,0.00008974751],"domain_scores_gemma":[0.99971455,0.000066323046,0.00006209392,0.00004822036,0.00001772237,0.00009098476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003911028,0.0007200975,0.00040074458,0.00084360724,0.00039591547,0.00031307008,0.00047173887,0.00046060194,0.0010658421],"category_scores_gemma":[0.00015257152,0.0003400192,0.00050234626,0.00039800114,0.00051199796,0.00028865543,0.0002907773,0.0013882151,0.00038579592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005855974,0.00017827253,0.00010509487,0.000025050193,0.000008243883,0.00011273615,0.000027666043,0.00021165865,0.99764377,0.00034874355,0.00008927856,0.0006639525],"study_design_scores_gemma":[0.00007712492,0.0008186278,0.0013607504,0.0000035067412,0.000018609506,0.00026904227,0.000036875965,0.0015648264,0.9944917,0.00009474954,0.0012574433,0.000006620898],"about_ca_topic_score_codex":0.0025293243,"about_ca_topic_score_gemma":0.0036683485,"teacher_disagreement_score":0.0025293243,"about_ca_system_score_codex":0.0006005896,"about_ca_system_score_gemma":0.00063940283,"threshold_uncertainty_score":0.0050292015},"labels":[],"label_agreement":null},{"id":"W1977677856","doi":"10.1007/s10549-014-3018-3","title":"Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Meta-analysis; Breast cancer; Oncology; Stage (stratigraphy); Odds ratio; Disease; Confidence interval; Cancer","score_opus":0.09569241060622743,"score_gpt":0.44817271916201196,"score_spread":0.3524803085557845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977677856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038920096,0.9952828,0.00025867816,0.00008075093,0.000076154,0.00005484304,0.00024720863,0.000010475695,0.000097089636],"genre_scores_gemma":[0.16934063,0.826827,0.0016995149,0.0007575637,0.00020835207,0.00025641947,0.0005193819,0.000021026864,0.00037011976],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99645126,0.0014051227,0.0010390381,0.0005602555,0.00037586023,0.00016854519],"domain_scores_gemma":[0.9931097,0.0049392013,0.001159169,0.00025500552,0.0004175242,0.00011935308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061961985,0.0024468445,0.0129645085,0.002939004,0.000465552,0.0020008152,0.0018584649,0.0021266819,0.0035368826],"category_scores_gemma":[0.014351321,0.0013729603,0.026751697,0.00449142,0.00060854264,0.0013503219,0.0014365729,0.0018188441,0.00026498537],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024000376,0.000041152394,0.0078116097,0.2689561,0.70381075,0.00014609563,0.00008791234,0.00045880277,0.0002862987,0.000113156304,0.0006887994,0.015199287],"study_design_scores_gemma":[0.00047766435,0.00014334598,0.00482599,0.008428133,0.9845462,0.00008164041,0.000043263484,0.0000886681,0.000063873944,0.00014297312,0.0011343322,0.000023960292],"about_ca_topic_score_codex":0.00826272,"about_ca_topic_score_gemma":0.024631897,"teacher_disagreement_score":0.0129645085,"about_ca_system_score_codex":0.0015433833,"about_ca_system_score_gemma":0.0022268328,"threshold_uncertainty_score":0.032769024},"labels":[],"label_agreement":null},{"id":"W1978388294","doi":"10.1007/s10549-012-2387-8","title":"Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider–patient communication","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; American Cancer Society","keywords":"Medicine; Breast cancer; Tamoxifen; Patient satisfaction; Internal medicine; Population; Logistic regression; Multivariate analysis; Odds ratio; Hormone therapy; Cancer; Gynecology; Physical therapy; Surgery","score_opus":0.04881053203288777,"score_gpt":0.3616095271244036,"score_spread":0.3127989950915158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978388294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905398,0.0023399678,0.00008891434,0.0033002435,0.000041796262,0.00001763306,0.000049250288,0.0000036502083,0.0036187111],"genre_scores_gemma":[0.99877995,0.0006509863,0.00008382334,0.00023643381,0.00002787092,0.0000068781133,0.000025147217,0.0000014615899,0.00018752195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975809,0.0014520867,0.00018124939,0.00009144263,0.00040575664,0.0002885467],"domain_scores_gemma":[0.98810565,0.006984714,0.0032524683,0.00025191426,0.0005823157,0.0008228447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002294724,0.00011031593,0.00032699085,0.00044592773,0.00082430535,0.0010120205,0.00037250752,0.00081778824,0.0025792723],"category_scores_gemma":[0.022136016,0.00020819016,0.0003661589,0.0006483331,0.0003637109,0.00064006343,0.0005223849,0.0012742268,0.000107357555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016650655,0.0005002956,0.9683129,0.00005847238,0.00011269502,0.00018275398,0.0015399479,0.0000495638,0.000082575185,0.00018171524,0.00060706254,0.02820546],"study_design_scores_gemma":[0.000021382082,0.00015170519,0.9958118,0.000097750875,0.000087838846,0.00028287768,0.0021856439,0.00045848088,0.00004721742,0.00021033818,0.00063634315,0.000008617361],"about_ca_topic_score_codex":0.009069827,"about_ca_topic_score_gemma":0.011978642,"teacher_disagreement_score":0.009069827,"about_ca_system_score_codex":0.00061880716,"about_ca_system_score_gemma":0.0011733583,"threshold_uncertainty_score":0.0180341},"labels":[],"label_agreement":null},{"id":"W1978585547","doi":"10.1007/s10549-005-9051-5","title":"Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Coalition for Research in Women's Health; Women's College Hospital","funders":"","keywords":"Breast cancer; Menarche; Medicine; Ovarian cancer; Gynecology; Obstetrics; Case-control study; Oncology; Population; Cancer; Oophorectomy; Internal medicine; Environmental health; Surgery; Hysterectomy","score_opus":0.014589228730126419,"score_gpt":0.31765784969409117,"score_spread":0.30306862096396475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978585547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995308,0.00012060435,0.00002361243,0.000022220192,0.0000022843724,0.0000031226082,0.00005023732,0.0000010282981,0.00024614832],"genre_scores_gemma":[0.9993599,0.00015918375,0.000032275435,0.000014402552,0.0000032062112,0.0000035967118,0.00007364102,0.0000024928502,0.00035127692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977416,0.000052882162,0.00002760629,0.00004724179,0.000029997367,0.00006807691],"domain_scores_gemma":[0.9996966,0.000045070676,0.000077661476,0.000015237699,0.00003794383,0.00012745346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001866994,0.00026478234,0.00037571823,0.0010471217,0.00051743764,0.0006200443,0.0002291269,0.0002672279,0.0012693845],"category_scores_gemma":[0.0007685517,0.00032267143,0.0004624312,0.00087285816,0.00025480834,0.00019046779,0.0005284955,0.00041587953,0.00019813962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005064531,0.00009531903,0.99420303,0.000020108737,0.00009747482,0.00044180028,0.0006881915,0.000032491807,0.0011707296,0.00004544245,0.000057214358,0.0026416057],"study_design_scores_gemma":[0.000008213709,0.00009249179,0.99877197,0.0000043150167,0.000049785067,0.00023137032,0.0005358993,0.00003767131,0.00007112337,0.000018346405,0.00017602935,0.000002895366],"about_ca_topic_score_codex":0.017858714,"about_ca_topic_score_gemma":0.014896089,"teacher_disagreement_score":0.017858714,"about_ca_system_score_codex":0.0004290947,"about_ca_system_score_gemma":0.00046225224,"threshold_uncertainty_score":0.035509527},"labels":[],"label_agreement":null},{"id":"W1978859321","doi":"10.1007/s10549-009-0356-7","title":"Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin)","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Sunnybrook Health Science Centre","funders":"","keywords":"Verteporfin; Photodynamic therapy; Medicine; Photosensitizer; Bioluminescence imaging; Breast cancer; Radiation therapy; Cancer research; Pathology; Cancer; Oncology; Internal medicine; Macular degeneration; Luciferase; Ophthalmology; Transfection; Biology; Chemistry","score_opus":0.08337442915615176,"score_gpt":0.42766954862418294,"score_spread":0.34429511946803115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978859321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757582,0.004932688,0.013335829,0.000422529,0.00009918577,0.00022644641,0.00035697836,0.00025830526,0.004609864],"genre_scores_gemma":[0.9928163,0.0009375675,0.0035114354,0.00004296724,0.000016006516,0.000060888768,0.00012316783,0.000033234435,0.002458425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998456,0.000024824307,0.000005907817,0.000031890853,0.00003258883,0.000059091442],"domain_scores_gemma":[0.99988043,0.000037900245,0.00003189853,0.000014741274,0.0000099289655,0.000025037492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003900554,0.00033854003,0.00027507104,0.0003463698,0.0002462446,0.0005907335,0.00032350156,0.00057681184,0.0019940254],"category_scores_gemma":[0.00024824974,0.00021000722,0.0002584599,0.00013237669,0.00039186823,0.00047984786,0.00014916995,0.00090484455,0.00024333563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070696004,0.00022235994,0.0001514841,0.000034774224,0.000005840118,0.000029432029,0.000031922824,0.00040625708,0.99437284,0.0006198463,0.00010821869,0.0033101202],"study_design_scores_gemma":[0.00007090634,0.0024446598,0.0010397469,0.000009288389,0.000025625113,0.00020766747,0.000033179138,0.0019422448,0.9919397,0.0001492373,0.0021313184,0.000006280099],"about_ca_topic_score_codex":0.002733004,"about_ca_topic_score_gemma":0.0029993982,"teacher_disagreement_score":0.002733004,"about_ca_system_score_codex":0.00050117663,"about_ca_system_score_gemma":0.00053651945,"threshold_uncertainty_score":0.006670654},"labels":[],"label_agreement":null},{"id":"W1979391857","doi":"10.1023/a:1006480504790","title":"Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; Kingston General Hospital; Mount Sinai Hospital; Credit Valley Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine; Tamoxifen; Tolerability; Breast cancer; Chemotherapy; Refractory (planetary science); Oncology; Endocrinology; Estrogen receptor; Gastroenterology; Cancer; Adverse effect; Biology","score_opus":0.07173302003090129,"score_gpt":0.420558018104273,"score_spread":0.34882499807337175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979391857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84579813,0.13630562,0.00077243656,0.0038694423,0.0003865315,0.00020111403,0.0004836807,0.00030077418,0.011882217],"genre_scores_gemma":[0.95744,0.03648504,0.0005240172,0.0005697298,0.0002548823,0.00004087769,0.0003150532,0.000011974168,0.0043583354],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99989414,0.000044131506,0.000011439196,0.0000095157875,0.000018313025,0.000022416798],"domain_scores_gemma":[0.9999144,0.000018815337,0.000023100305,0.0000047331328,0.000007253232,0.000031631098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028519583,0.00030233167,0.0004667235,0.00038722096,0.00021068269,0.00029264844,0.0002941531,0.00054339354,0.0014176948],"category_scores_gemma":[0.00042719938,0.00009401491,0.0003451311,0.00035680836,0.00017179942,0.00020396826,0.00017169396,0.00062125636,0.0003306394],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09228038,0.0022005392,0.008533523,0.0017213128,0.00087115925,0.0030936394,0.000307503,0.0022163729,0.10999625,0.0015881179,0.010097387,0.7670938],"study_design_scores_gemma":[0.10009426,0.21002561,0.17979628,0.0011075983,0.006367427,0.019995399,0.001235356,0.006607386,0.13920954,0.0031574948,0.33213714,0.00026657476],"about_ca_topic_score_codex":0.0016911478,"about_ca_topic_score_gemma":0.0059364582,"teacher_disagreement_score":0.0016911478,"about_ca_system_score_codex":0.00032342755,"about_ca_system_score_gemma":0.00037633427,"threshold_uncertainty_score":0.004742682},"labels":[],"label_agreement":null},{"id":"W1979560051","doi":"10.1007/s10549-014-3063-y","title":"Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; BC Cancer Agency; McGill University; McGill Genome Centre; McGill University Health Centre; Public Health Ontario; University of Toronto","funders":"Canada Research Chairs","keywords":"Breast cancer; Medicine; Mammography; Hazard ratio; Cancer; Oncology; Internal medicine; Gynecology; Obstetrics; Confidence interval","score_opus":0.016129579865925288,"score_gpt":0.32847137247388386,"score_spread":0.3123417926079586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979560051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990237,0.00038722143,0.000055140645,0.000031558524,0.0000066683515,0.000008142551,0.00015294443,0.000003480512,0.00033125465],"genre_scores_gemma":[0.9990767,0.00019510386,0.000071557835,0.000027442475,0.000013737388,0.00001027416,0.00019446427,0.0000033566175,0.00040734283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935395,0.00024127126,0.00005118101,0.00013984271,0.000079971855,0.0001337167],"domain_scores_gemma":[0.9979632,0.0005825718,0.0005148552,0.00023358707,0.0001321766,0.0005735776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010079752,0.0008743885,0.0006009449,0.0012348549,0.0011269307,0.0011096066,0.0006544337,0.0018992707,0.0028180226],"category_scores_gemma":[0.0031511546,0.001525798,0.001022527,0.0017176085,0.00076472113,0.0010058758,0.00071520347,0.0016967495,0.0005517598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016422686,0.0003673865,0.9964902,0.00000791402,0.00014187054,0.00018215583,0.000108680826,0.00004055691,0.00038903995,0.000029574578,0.0000471261,0.00055318914],"study_design_scores_gemma":[0.000058179074,0.00081996364,0.99747676,0.0000063187936,0.00019692448,0.0005983037,0.00029892477,0.00022055021,0.00010283197,0.00005699353,0.00015266406,0.000011633572],"about_ca_topic_score_codex":0.006981274,"about_ca_topic_score_gemma":0.004747477,"teacher_disagreement_score":0.006981274,"about_ca_system_score_codex":0.00035066533,"about_ca_system_score_gemma":0.0004843262,"threshold_uncertainty_score":0.013881266},"labels":[],"label_agreement":null},{"id":"W1980050427","doi":"10.1007/s10549-005-9121-8","title":"The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Hôpital du Saint-Sacrement; McGill University","funders":"Canadian Breast Cancer Research Alliance; Fondation du cancer du sein du Québec; Breast Cancer Alliance; Cancer Research Institute","keywords":"Breast cancer; Tissue microarray; CA 15-3; Progesterone receptor; Pathology; Ductal carcinoma; Oncology; Breast carcinoma; CA15-3; Cancer; Medicine; Breast disease; Hormone receptor; Internal medicine; Cancer research; Biology; Estrogen receptor","score_opus":0.022639050688655554,"score_gpt":0.3620899242659409,"score_spread":0.3394508735772853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980050427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926399,0.0016245944,0.002930736,0.00021092547,0.000014685262,0.000034492128,0.0015394324,0.00003082915,0.0009743208],"genre_scores_gemma":[0.9908076,0.0008673562,0.0039543123,0.00017813675,0.000032511824,0.00010264009,0.0021689706,0.000024010262,0.0018645619],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994986,0.00016099757,0.000024869945,0.000110369976,0.00011938109,0.000085704196],"domain_scores_gemma":[0.9996811,0.00011930091,0.000054088458,0.00006090749,0.000054214,0.000030349356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073877245,0.00021112387,0.00047908208,0.00052651245,0.0004942024,0.00054413365,0.00024619975,0.00031968567,0.0013014657],"category_scores_gemma":[0.00053774,0.00027788786,0.0003114556,0.00068845286,0.0002506258,0.00026893913,0.00033285137,0.00042482893,0.00033540465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002078779,0.00025018264,0.18464318,0.00014792019,0.00036726502,0.000253652,0.00025743866,0.00055171485,0.76964265,0.00027049036,0.0015390003,0.039997686],"study_design_scores_gemma":[0.000044509234,0.00039193555,0.9596327,0.000010548053,0.00036708286,0.001142111,0.00034251882,0.0016209915,0.031158393,0.000135794,0.0051284716,0.000025055006],"about_ca_topic_score_codex":0.002962184,"about_ca_topic_score_gemma":0.0072341715,"teacher_disagreement_score":0.002962184,"about_ca_system_score_codex":0.00040831335,"about_ca_system_score_gemma":0.0004251378,"threshold_uncertainty_score":0.005889833},"labels":[],"label_agreement":null},{"id":"W1980168308","doi":"10.1007/s10549-007-9656-y","title":"HER2/neu in systemic therapy for women with breast cancer: a systematic review","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Cancer Care Ontario; McMaster University; Mount Sinai Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Taxane; Oncology; Internal medicine; Anthracycline; Breast cancer; Hazard ratio; Meta-analysis; Adjuvant therapy; Confidence interval; Regimen; Relative risk; Cochrane Library; Clinical trial; Randomized controlled trial; Cancer; Gynecology","score_opus":0.17333335732310998,"score_gpt":0.5007484195405519,"score_spread":0.327415062217442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980168308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008035183,0.99845016,0.00006880929,0.00016738551,0.000064812506,0.00010504339,0.00016802638,0.0000052401965,0.00016693835],"genre_scores_gemma":[0.016162869,0.9826199,0.0004028287,0.0004219924,0.000051135106,0.0001492237,0.000082972765,0.0000030273425,0.00010619465],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99773324,0.00090754527,0.00070799445,0.00023524593,0.0003289445,0.00008690233],"domain_scores_gemma":[0.9915175,0.005875717,0.0018615193,0.00010462847,0.00048681427,0.00015373567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003614519,0.0010666766,0.008476938,0.004000103,0.00031445656,0.0011475392,0.0010299496,0.0013238468,0.0045672082],"category_scores_gemma":[0.013709386,0.00088358327,0.005769443,0.0049153147,0.0005114424,0.0012379698,0.00091346103,0.0010136613,0.00021440208],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008768121,0.000039048948,0.0010670172,0.8973447,0.024298776,0.000187431,0.00014020434,0.00018955594,0.00032721125,0.0001496361,0.003108652,0.0722709],"study_design_scores_gemma":[0.003047304,0.0012222378,0.0108747175,0.5425907,0.39981598,0.0010426252,0.00035201135,0.00022731541,0.0005357502,0.00039181608,0.03982483,0.00007474415],"about_ca_topic_score_codex":0.0067820614,"about_ca_topic_score_gemma":0.028425232,"teacher_disagreement_score":0.008476938,"about_ca_system_score_codex":0.00220687,"about_ca_system_score_gemma":0.004500612,"threshold_uncertainty_score":0.019115627},"labels":[],"label_agreement":null},{"id":"W1980674859","doi":"10.1007/s10549-006-9471-x","title":"Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Diabetes Canada; Statistics Canada; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Oncology; Hazard ratio; Tissue microarray; Stage (stratigraphy); Biomarker; Cancer; Proportional hazards model; Insulin; Cohort; Progesterone receptor; Multivariate analysis; Clinical significance; Estrogen receptor; Biology; Confidence interval","score_opus":0.04349744498317911,"score_gpt":0.3569988510324634,"score_spread":0.31350140604928434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980674859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716717,0.0010086241,0.00016721665,0.00020536094,0.000046662564,0.0000056324916,0.00023398355,0.000016039967,0.0011492475],"genre_scores_gemma":[0.9985964,0.0003741728,0.0001013724,0.00003879679,0.000069471,0.00000407551,0.0002426215,0.0000042155725,0.00056872336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998305,0.000048350525,0.000015537738,0.000022665734,0.00003784591,0.00004503525],"domain_scores_gemma":[0.9981548,0.00049389276,0.00059938926,0.000103791455,0.00014493926,0.00050325337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046837583,0.0003060554,0.00046927636,0.00070684426,0.0003456507,0.00070170383,0.0003520187,0.0006679759,0.002033793],"category_scores_gemma":[0.0018564669,0.0002859688,0.00038489097,0.0008150922,0.0003041139,0.00027251604,0.00025501565,0.001098574,0.00030034792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010910216,0.00008547828,0.99436295,0.0000132050445,0.00006262981,0.00018801932,0.000018290099,0.00007391577,0.0015048727,0.0000242764,0.0001689646,0.0024064062],"study_design_scores_gemma":[0.0000156485,0.00012334292,0.99860543,0.0000036862148,0.000074785086,0.00047931154,0.00004047316,0.00022372654,0.00023192949,0.00005559867,0.00014083773,0.0000052150003],"about_ca_topic_score_codex":0.0016536957,"about_ca_topic_score_gemma":0.001988007,"teacher_disagreement_score":0.002033793,"about_ca_system_score_codex":0.00021213785,"about_ca_system_score_gemma":0.00033662803,"threshold_uncertainty_score":0.006803751},"labels":[],"label_agreement":null},{"id":"W1980909734","doi":"10.1023/a:1013095329825","title":"Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; London Health Sciences Centre; Western University","funders":"","keywords":"Urokinase receptor; Transfection; Matrigel; Osteopontin; Cell migration; Antibody; Biology; Cancer research; Plasminogen activator; Cell culture; Gentamicin protection assay; Vitronectin; Cell; Chemistry; Molecular biology; Cell biology; Immunology; Endocrinology; Fibronectin; Cancer; Metastasis; Angiogenesis; Biochemistry","score_opus":0.06318551601446971,"score_gpt":0.3640298236820039,"score_spread":0.30084430766753417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980909734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908202,0.0036456664,0.0015152884,0.00020038932,0.00007365973,0.00007397285,0.00062116946,0.00007698395,0.0029726122],"genre_scores_gemma":[0.9882483,0.0019349586,0.0015975533,0.000117807926,0.000025456717,0.00010432258,0.0012836878,0.0000179566,0.0066699306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998385,0.000021140702,0.000009376604,0.00002275669,0.000046513516,0.00006168884],"domain_scores_gemma":[0.9998543,0.000034760542,0.000018820829,0.000023008732,0.000024345463,0.000044709926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013752331,0.00033219485,0.0002843864,0.00031217028,0.00016218169,0.0002642177,0.00010165707,0.00024111646,0.0028773712],"category_scores_gemma":[0.00020729187,0.00020184787,0.0004131599,0.00024608217,0.00028704942,0.00024368202,0.00034532693,0.0009361909,0.00048460072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005620802,0.00012761995,0.0003498848,0.000050508443,0.000008411381,0.00016873295,0.000028383214,0.000027433089,0.99599093,0.0001284968,0.00010600102,0.0024515407],"study_design_scores_gemma":[0.00005343876,0.00085233594,0.04244506,0.000013492133,0.000019473096,0.0007089559,0.00008381671,0.00040238813,0.95204604,0.00013816444,0.0032307291,0.0000060518223],"about_ca_topic_score_codex":0.0013239855,"about_ca_topic_score_gemma":0.001993864,"teacher_disagreement_score":0.0028773712,"about_ca_system_score_codex":0.00036484454,"about_ca_system_score_gemma":0.0003066597,"threshold_uncertainty_score":0.0096257925},"labels":[],"label_agreement":null},{"id":"W1981065236","doi":"10.1007/s10549-011-1695-8","title":"Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Institute of Cancer Research","funders":"","keywords":"Bevacizumab; Metastatic breast cancer; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Surgery; Chemotherapy","score_opus":0.1811653887197427,"score_gpt":0.43949079744762376,"score_spread":0.25832540872788107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981065236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896902,0.0058493568,0.0002066032,0.0005336027,0.00019149209,0.000085335734,0.0008925152,0.00002346858,0.0025274896],"genre_scores_gemma":[0.9947331,0.0012924211,0.00022944198,0.0004755364,0.00017021046,0.00012498087,0.0014931997,0.000013664495,0.0014676013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99950373,0.00023876806,0.000028674322,0.000100680016,0.000036647536,0.000091375776],"domain_scores_gemma":[0.9993554,0.00016168407,0.00016523285,0.00009183954,0.00002886521,0.00019705297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014888942,0.0006491359,0.0015675895,0.00017160378,0.00027083504,0.000899051,0.00048224875,0.0008140831,0.0015777458],"category_scores_gemma":[0.0014550006,0.0002209282,0.0021544173,0.0002236939,0.0004088713,0.0006890407,0.00044864588,0.0020139953,0.0003171757],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90165937,0.0020171453,0.017167052,0.0008169038,0.010362417,0.0002107956,0.0001314366,0.0036570227,0.007593992,0.0005621771,0.0039443406,0.051877346],"study_design_scores_gemma":[0.5025998,0.17468502,0.267988,0.0004441236,0.02660935,0.0008933844,0.00024618933,0.0038067312,0.0040422017,0.003375975,0.015127531,0.00018171172],"about_ca_topic_score_codex":0.00097461295,"about_ca_topic_score_gemma":0.0040450776,"teacher_disagreement_score":0.0015777458,"about_ca_system_score_codex":0.0007991186,"about_ca_system_score_gemma":0.0005763274,"threshold_uncertainty_score":0.007874131},"labels":[],"label_agreement":null},{"id":"W1981231327","doi":"10.1007/s10549-013-2429-x","title":"Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; University of Toronto; Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Chemotherapy; Internal medicine; Hazard ratio; Oncology; Stage (stratigraphy); Cancer; Estrogen receptor; Gynecology; Biology","score_opus":0.038989030391196805,"score_gpt":0.35569087951047423,"score_spread":0.31670184911927746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981231327","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22777689,0.05307477,0.0019203378,0.6602583,0.0101554,0.00022290887,0.0011271539,0.00016431889,0.045299947],"genre_scores_gemma":[0.8090295,0.030563563,0.0044316696,0.12789975,0.014916411,0.00027984366,0.0009281979,0.000049410137,0.011901606],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9996697,0.00009202994,0.000037523158,0.000053691907,0.000066299835,0.000080846294],"domain_scores_gemma":[0.9980572,0.00063349464,0.00033806104,0.000108106455,0.00026547397,0.0005977279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008596764,0.00025497554,0.00077015406,0.00027713642,0.00078136276,0.00070717244,0.00047920932,0.0034971647,0.0051721036],"category_scores_gemma":[0.007918211,0.00020144333,0.00037964867,0.00042085035,0.0005384327,0.0012978986,0.0002922935,0.0018736912,0.0012465857],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058199214,0.001519247,0.35123098,0.0007780773,0.00020974707,0.0043850476,0.00043466405,0.0012719771,0.00461049,0.0036768024,0.23890339,0.38715965],"study_design_scores_gemma":[0.0019634701,0.0037511818,0.61411613,0.0027293628,0.0008317254,0.017989391,0.0031106456,0.0018413864,0.0044128564,0.02031975,0.32877365,0.0001605461],"about_ca_topic_score_codex":0.0036944393,"about_ca_topic_score_gemma":0.008438869,"teacher_disagreement_score":0.0051721036,"about_ca_system_score_codex":0.00062812574,"about_ca_system_score_gemma":0.001581997,"threshold_uncertainty_score":0.017302394},"labels":[],"label_agreement":null},{"id":"W1981831148","doi":"10.1007/s10549-009-0590-z","title":"Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Institutes of Health","keywords":"Transforming growth factor; Breast cancer; Carcinogenesis; Immunohistochemistry; Biology; Cancer research; Tumor progression; Internal medicine; Oncology; Transforming growth factor beta; Medicine; Cancer; Pathology","score_opus":0.05042146044234101,"score_gpt":0.3176550100840627,"score_spread":0.2672335496417217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981831148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980914,0.0009916599,0.00022033953,0.00003521088,0.0000059642216,0.0000020651012,0.00016694586,0.000008059293,0.0004782997],"genre_scores_gemma":[0.99881315,0.00036598407,0.00010732051,0.000010972037,0.000012448833,0.0000036439712,0.00015204174,0.0000042084935,0.0005302289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983346,0.000036918238,0.00001829643,0.00003204271,0.000031570526,0.000047599475],"domain_scores_gemma":[0.9982408,0.00069356326,0.00052137184,0.00011359697,0.00016261762,0.00026795288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038736753,0.0001488013,0.00029828644,0.0007533122,0.00018241287,0.0005303088,0.00015891311,0.00032782112,0.0016318813],"category_scores_gemma":[0.0017261633,0.00021103534,0.00020194912,0.0007382055,0.00017412128,0.00036367224,0.00018853588,0.0005011442,0.00032101333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015049301,0.00005332754,0.97058964,0.000016658836,0.000045635654,0.00018507805,0.00013497693,0.00008364227,0.022654602,0.00006472454,0.00006542488,0.004601422],"study_design_scores_gemma":[0.0000048242714,0.00014594565,0.9950466,0.000003067406,0.000035131663,0.0007518956,0.00014036741,0.00022221604,0.0032322886,0.000068468806,0.00034543534,0.000003843326],"about_ca_topic_score_codex":0.0006462717,"about_ca_topic_score_gemma":0.0006023834,"teacher_disagreement_score":0.0016318813,"about_ca_system_score_codex":0.00016919074,"about_ca_system_score_gemma":0.00019433654,"threshold_uncertainty_score":0.0054591894},"labels":[],"label_agreement":null},{"id":"W1981987902","doi":"10.1007/s10549-005-9026-6","title":"cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University; Sudbury Regional Hospital","funders":"","keywords":"Paclitaxel; Doxorubicin; Breast cancer; Microarray; Drug resistance; Biology; Complementary DNA; Microarray analysis techniques; Cancer research; Gene expression; Gene expression profiling; Gene; Cancer; Chemotherapy; Genetics","score_opus":0.018142472858571426,"score_gpt":0.3005116334721571,"score_spread":0.2823691606135857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981987902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790907,0.0010014061,0.010709271,0.000291069,0.0001156315,0.000111294765,0.0051668007,0.00028105357,0.003232828],"genre_scores_gemma":[0.9521787,0.0016424446,0.012765158,0.00026111034,0.000061828345,0.00026118208,0.021269284,0.00021005653,0.011350185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999688,0.000036716883,0.00003054929,0.0000766746,0.00009427244,0.000073862946],"domain_scores_gemma":[0.9996687,0.00013464408,0.00004705287,0.00004720195,0.000056162648,0.000046262197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019840522,0.00039661943,0.0005902014,0.0007127217,0.00029151177,0.0004662781,0.00030383278,0.0003257146,0.0021772606],"category_scores_gemma":[0.0002673793,0.0002962174,0.0004486187,0.0006110878,0.00026704837,0.00026250875,0.00019654456,0.0010239693,0.001033589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065450855,0.000017891733,0.000115839895,0.0000100217285,0.0000026017215,0.000012837791,0.000009856632,0.000022721277,0.9992599,0.000054714197,0.000026821916,0.0004014583],"study_design_scores_gemma":[0.000016880005,0.00021123212,0.016428936,0.000004493119,0.000040563915,0.0002855001,0.00007573034,0.001153731,0.9794303,0.000088767534,0.0022530996,0.000010793388],"about_ca_topic_score_codex":0.0010293557,"about_ca_topic_score_gemma":0.0015026589,"teacher_disagreement_score":0.0021772606,"about_ca_system_score_codex":0.00046056858,"about_ca_system_score_gemma":0.00028541152,"threshold_uncertainty_score":0.0072836876},"labels":[],"label_agreement":null},{"id":"W1982207478","doi":"10.1007/s10549-007-9537-4","title":"BARD1 and breast cancer in Poland","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"Breast cancer; CHEK2; Medicine; Oncology; Internal medicine; Cancer; Allele; Mutation; Germline mutation; Genetics; Biology; Gene","score_opus":0.027706546212335214,"score_gpt":0.37339352001416376,"score_spread":0.34568697380182856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982207478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585907,0.029783161,0.0004880238,0.0024177541,0.000063991225,0.000020818106,0.00032652757,0.000021085732,0.008288005],"genre_scores_gemma":[0.98728824,0.009702539,0.0002306525,0.00021846218,0.000038423685,0.0000096369995,0.00013009204,0.0000052192527,0.0023768763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998889,0.000024309393,0.0000149450225,0.000020059164,0.000015919062,0.000035807232],"domain_scores_gemma":[0.99989474,0.000015409405,0.000040675186,0.0000053811477,0.000008926695,0.00003485423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022737157,0.00015137932,0.00018172455,0.0009336669,0.00034831956,0.00052582135,0.00017118573,0.00029071854,0.0011431266],"category_scores_gemma":[0.00037035727,0.00016810528,0.0001775715,0.00091876986,0.00032170326,0.00019721905,0.00057714427,0.00039274484,0.00015467028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006460833,0.0004753415,0.7443991,0.0009803466,0.00047312316,0.010453306,0.0016949737,0.0010852395,0.01808022,0.016054409,0.0056016883,0.19424137],"study_design_scores_gemma":[0.00025836157,0.0004008672,0.93410826,0.00019951312,0.00032285144,0.009722683,0.0017317404,0.0006430347,0.0021662752,0.0035704137,0.04684821,0.000027767772],"about_ca_topic_score_codex":0.0077735414,"about_ca_topic_score_gemma":0.007235715,"teacher_disagreement_score":0.0077735414,"about_ca_system_score_codex":0.00078299694,"about_ca_system_score_gemma":0.00077722303,"threshold_uncertainty_score":0.015456617},"labels":[],"label_agreement":null},{"id":"W1982234365","doi":"10.1007/s10549-013-2814-5","title":"Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Exemestane; Everolimus; Medicine; Hazard ratio; Breast cancer; Aromatase inhibitor; Internal medicine; Oncology; Clinical endpoint; Cancer; Discontinuation; Randomized controlled trial; Aromatase; Confidence interval","score_opus":0.04306472712332436,"score_gpt":0.37923311203474724,"score_spread":0.33616838491142287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982234365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944359,0.0043078065,0.00006682511,0.000098977594,0.000020196616,0.00017629996,0.00024523464,0.0000042730576,0.00064450805],"genre_scores_gemma":[0.99268323,0.004242498,0.00044772692,0.00029147152,0.000060336417,0.0002881593,0.0010272173,0.000005473118,0.0009539414],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996896,0.00017506369,0.000018608127,0.000048403363,0.000024630706,0.000043746724],"domain_scores_gemma":[0.99960595,0.000110773595,0.000116385934,0.000024483032,0.000013256871,0.00012914755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011925254,0.00037576247,0.0013236445,0.0002905678,0.0001676203,0.0006277128,0.00031007885,0.00025346575,0.0015338594],"category_scores_gemma":[0.000997866,0.00023255352,0.0010701576,0.0002759263,0.00032815224,0.00031375312,0.00058607286,0.0007763329,0.0002015292],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80734867,0.012098431,0.06421459,0.0014526045,0.0032540723,0.000325253,0.00027071597,0.0022444888,0.018865656,0.00022619599,0.0008021497,0.088897176],"study_design_scores_gemma":[0.32776168,0.32912934,0.32055658,0.00037295072,0.004939843,0.0008853665,0.00029881945,0.0021019683,0.0037852249,0.0004105648,0.009677191,0.000080492966],"about_ca_topic_score_codex":0.0007131698,"about_ca_topic_score_gemma":0.0027634297,"teacher_disagreement_score":0.0015338594,"about_ca_system_score_codex":0.0008655067,"about_ca_system_score_gemma":0.00068296975,"threshold_uncertainty_score":0.0063067675},"labels":[],"label_agreement":null},{"id":"W1982980985","doi":"10.1007/s10549-009-0342-0","title":"Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement; Université Laval","funders":"Mach-Gaensslen Foundation of Canada","keywords":"Scalp; Medicine; Incidence (geometry); Breast cancer; Retrospective cohort study; Surgery; Cohort; Chemotherapy; Internal medicine; Cancer","score_opus":0.03366203268161049,"score_gpt":0.37550479586299856,"score_spread":0.34184276318138807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982980985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940085,0.00011657076,0.00002430432,0.000012682782,0.000003213187,0.000004032385,0.00022271366,0.0000014791073,0.0002141945],"genre_scores_gemma":[0.9995596,0.00011496445,0.000021254182,0.000010750098,0.000004833449,0.000003400698,0.00015641742,0.000001461239,0.00012730685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997911,0.000032831107,0.000019792207,0.00005131877,0.000035807283,0.000069261354],"domain_scores_gemma":[0.9992168,0.00011100559,0.00034213136,0.00008377951,0.00007774533,0.00016857494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017781973,0.0002013621,0.0002676323,0.0006240832,0.0005017758,0.00050855626,0.0003167623,0.0005089954,0.0021634889],"category_scores_gemma":[0.0011212555,0.0004717116,0.00055861834,0.0011443475,0.00024104082,0.00045484284,0.00026156064,0.00058988755,0.00024626995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001472181,0.000028306094,0.9990932,0.0000032722496,0.000025951731,0.000102089034,0.000033427466,0.000013109472,0.00022371569,0.000004148592,0.000031805645,0.00029378448],"study_design_scores_gemma":[0.0000055491746,0.000091828144,0.9990532,0.0000024072572,0.000028153929,0.00043309337,0.00018984765,0.00005486767,0.000056016837,0.000006498615,0.00007570951,0.0000028567918],"about_ca_topic_score_codex":0.014623006,"about_ca_topic_score_gemma":0.013500925,"teacher_disagreement_score":0.014623006,"about_ca_system_score_codex":0.00029464738,"about_ca_system_score_gemma":0.00030187544,"threshold_uncertainty_score":0.029075801},"labels":[],"label_agreement":null},{"id":"W1982994560","doi":"10.1007/s10549-009-0621-9","title":"Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cyclin D1; Cancer research; Cyclin D; JAG1; Cyclin B; Cyclin A2; Notch signaling pathway; Biology; Breast cancer; Cell cycle; Cyclin A; Cyclin; Cancer; Signal transduction; Cell biology; Genetics","score_opus":0.02505003455872102,"score_gpt":0.347420285084259,"score_spread":0.32237025052553797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982994560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675474,0.017131647,0.0031207828,0.00066417933,0.000087799934,0.00003817219,0.00064903003,0.000109134446,0.010651889],"genre_scores_gemma":[0.9946167,0.0015542277,0.0005035112,0.00005413178,0.000009689034,0.000012162929,0.00023960805,0.000008607552,0.0030013672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999299,0.000011180386,0.0000052898195,0.000015022659,0.000022572725,0.000016134814],"domain_scores_gemma":[0.9999465,0.000010670305,0.000013375598,0.0000051958987,0.00000797205,0.000016351672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015579966,0.00012727013,0.00015735102,0.00036209504,0.00027172346,0.00044149,0.0002397079,0.00018197995,0.0015334331],"category_scores_gemma":[0.0002140022,0.0001369201,0.000105163694,0.00020110194,0.00017498876,0.00015828312,0.0001710159,0.0003857042,0.00029155624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004647759,0.000037967726,0.0024264008,0.00008816074,0.000017233426,0.0002879374,0.000029739087,0.00022640504,0.98670703,0.00094777526,0.0003832272,0.008383325],"study_design_scores_gemma":[0.00004721048,0.00014703574,0.021222807,0.000008298583,0.000029054814,0.0011698449,0.00009177188,0.00086745265,0.9642924,0.00030457482,0.011814204,0.0000053666154],"about_ca_topic_score_codex":0.00087939505,"about_ca_topic_score_gemma":0.0020419105,"teacher_disagreement_score":0.0015334331,"about_ca_system_score_codex":0.0007076447,"about_ca_system_score_gemma":0.00031660922,"threshold_uncertainty_score":0.005134344},"labels":[],"label_agreement":null},{"id":"W1985698558","doi":"10.1023/a:1026394718897","title":"Consensus on Medical Treatment of Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Metastatic breast cancer; Oncology; Cancer; Internal medicine","score_opus":0.11568431217018388,"score_gpt":0.4625313005886781,"score_spread":0.3468469884184942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985698558","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061925565,0.5082766,0.004050344,0.42304626,0.04537587,0.00008179828,0.00040736736,0.00007561837,0.018067015],"genre_scores_gemma":[0.022693336,0.53399307,0.014803754,0.370054,0.0451475,0.00044125062,0.0009316089,0.00010448815,0.011830978],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98765326,0.0042614983,0.0027601125,0.00094384316,0.003600351,0.0007810416],"domain_scores_gemma":[0.96967465,0.0142489765,0.002255962,0.0008547702,0.01102716,0.0019385066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018275678,0.00089593825,0.003185232,0.003087227,0.002459366,0.0032448263,0.005066806,0.011492272,0.006817249],"category_scores_gemma":[0.029910924,0.0005990384,0.0026959225,0.0030049887,0.0038552408,0.003143798,0.003251805,0.018286418,0.003234504],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038241755,0.00013230473,0.00037275173,0.014531568,0.00030013575,0.00037186424,0.00049342884,0.0007338398,0.0009910301,0.03322197,0.5175366,0.4309321],"study_design_scores_gemma":[0.00013741794,0.00010961881,0.00089143857,0.016319664,0.00026115842,0.00037451307,0.00026035847,0.00015843475,0.0003534859,0.013978366,0.9671144,0.000041204745],"about_ca_topic_score_codex":0.007916851,"about_ca_topic_score_gemma":0.013800697,"teacher_disagreement_score":0.018275678,"about_ca_system_score_codex":0.004974928,"about_ca_system_score_gemma":0.015518976,"threshold_uncertainty_score":0.09665215},"labels":[],"label_agreement":null},{"id":"W1986014640","doi":"10.1007/s10549-008-0099-x","title":"Columnar cell lesions, mammographic density and breast cancer risk","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Occupational Cancer Research Centre","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Breast cancer; Breast tissue; Medicine; Pathology; Ductal carcinoma; Mammography; Mammary gland; MAMMOGRAPHIC DENSITY; Mastectomy; Cancer; Internal medicine","score_opus":0.03611311614348632,"score_gpt":0.3186660573304242,"score_spread":0.28255294118693786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986014640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923902,0.0033831866,0.00020041266,0.00061297097,0.0000408212,0.000008014679,0.0002950053,0.000016616877,0.0030528144],"genre_scores_gemma":[0.99758196,0.0007207029,0.000175213,0.000060563547,0.00009298875,0.000004470224,0.00014499523,0.0000038064563,0.0012152587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997646,0.00008202455,0.000021509539,0.000034740122,0.000064670035,0.000032395903],"domain_scores_gemma":[0.99737716,0.0010842027,0.0007257044,0.00013211231,0.00015884594,0.00052199943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005077416,0.0002587896,0.00030458136,0.00080449553,0.0003548101,0.0009168853,0.00035733002,0.0010641499,0.0054798257],"category_scores_gemma":[0.006021253,0.00030107642,0.000355877,0.00095194735,0.00035692845,0.0005761168,0.00025159185,0.00085792557,0.00048697155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023146976,0.00007565944,0.9964264,0.000013030117,0.000066029046,0.00010042154,0.000033878874,0.0000528634,0.0001650447,0.00007147106,0.00014913402,0.002614576],"study_design_scores_gemma":[0.000010685155,0.0001116085,0.9977216,0.0000074181667,0.000105766194,0.0008212059,0.00013921624,0.00047050053,0.000053617696,0.00020227641,0.00035119895,0.000004913407],"about_ca_topic_score_codex":0.0071614524,"about_ca_topic_score_gemma":0.008046543,"teacher_disagreement_score":0.0071614524,"about_ca_system_score_codex":0.00029528295,"about_ca_system_score_gemma":0.0004850009,"threshold_uncertainty_score":0.018331826},"labels":[],"label_agreement":null},{"id":"W1986150776","doi":"10.1007/s10549-008-9960-1","title":"Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975–2001","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; Windsor Regional Hospital; Ontario Tech University; Sunnybrook Health Science Centre; Western University; University of Windsor","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Socioeconomic status; Demography; Ethnic group; Gerontology; Disease; Health care; African american; Cancer; Race (biology); Health equity; Cancer registry; Public health; Environmental health; Population; Internal medicine; Pathology; Biology","score_opus":0.23468526276644805,"score_gpt":0.39945608154670104,"score_spread":0.164770818780253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986150776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841516,0.007300231,0.00014947016,0.001768704,0.000051286905,0.000006255632,0.00073271815,0.0000050733042,0.0058346954],"genre_scores_gemma":[0.9973122,0.0017904743,0.000057427336,0.00017043873,0.000086451684,0.0000021145072,0.00027430698,0.0000018500347,0.0003047749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996295,0.000087688626,0.000025055044,0.0001036009,0.00004710135,0.00010715256],"domain_scores_gemma":[0.99698323,0.00068980304,0.0012316846,0.0002498985,0.00048344975,0.00036191955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009634156,0.00011886955,0.0001265746,0.0015458858,0.000693982,0.0005931889,0.0003477719,0.0005745468,0.0025406447],"category_scores_gemma":[0.0038131753,0.00017000642,0.00020747201,0.0025816814,0.0008103198,0.00073255156,0.00057610276,0.0008064347,0.00010440251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016802458,0.000056220884,0.985735,0.000042012074,0.000092024144,0.00010836281,0.0007942663,0.00009785125,0.00032158504,0.0012217003,0.00065341726,0.010709483],"study_design_scores_gemma":[0.000002768827,0.000013743398,0.99834585,0.000016820786,0.000031059513,0.000059178175,0.0002709159,0.000033568933,0.000060051883,0.00007222745,0.0010913954,0.0000025227846],"about_ca_topic_score_codex":0.051914036,"about_ca_topic_score_gemma":0.087495916,"teacher_disagreement_score":0.051914036,"about_ca_system_score_codex":0.0008353493,"about_ca_system_score_gemma":0.0006426212,"threshold_uncertainty_score":0.10322374},"labels":[],"label_agreement":null},{"id":"W1986794350","doi":"10.1007/s10549-012-2294-z","title":"Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Queen's University; University of British Columbia","funders":"National Cancer Institute; Avon Foundation for Women","keywords":"Letrozole; Medicine; Tamoxifen; Internal medicine; Cholesterol; Lipid profile; Placebo; Endocrinology; Breast cancer; Cancer","score_opus":0.017774811491571584,"score_gpt":0.32614693511733583,"score_spread":0.30837212362576427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986794350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984856,0.00041839486,0.0000319595,0.00001845544,0.0000053417225,0.00002818609,0.0006956705,0.000005422594,0.00031107428],"genre_scores_gemma":[0.99557483,0.00035494516,0.000091590235,0.000075610136,0.000030946143,0.00006396035,0.0021562316,0.0000070796814,0.0016447777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997892,0.000050515533,0.000026023114,0.000036567882,0.000053398664,0.00004442239],"domain_scores_gemma":[0.99957293,0.000052622265,0.00012921155,0.00006179833,0.00006750817,0.00011588038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003888649,0.00070692686,0.0008209313,0.00090623973,0.00049646146,0.00056936254,0.00042226468,0.0008669751,0.0012378142],"category_scores_gemma":[0.0008128842,0.0004180992,0.0007160021,0.0010084901,0.00022702085,0.00038833293,0.0003516846,0.00058884895,0.0006000718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059121963,0.0015302895,0.9138976,0.000091932234,0.0012661574,0.000836025,0.0004287941,0.000120360266,0.012649493,0.0000389931,0.0007154499,0.009302904],"study_design_scores_gemma":[0.0010094743,0.0043247626,0.9911445,0.000009921566,0.000806197,0.00034051764,0.00022645063,0.00011488574,0.0009969221,0.000020816327,0.0009904092,0.000015052897],"about_ca_topic_score_codex":0.0121159,"about_ca_topic_score_gemma":0.009941163,"teacher_disagreement_score":0.0121159,"about_ca_system_score_codex":0.0006277278,"about_ca_system_score_gemma":0.00049583527,"threshold_uncertainty_score":0.024090767},"labels":[],"label_agreement":null},{"id":"W1986975696","doi":"10.1007/s10549-007-9764-8","title":"Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sudbury Regional Hospital","funders":"","keywords":"GSTP1; Internal medicine; Breast cancer; Hazard ratio; Oncology; Medicine; SOD2; Genotype; Metastatic breast cancer; Single-nucleotide polymorphism; Cancer; Gastroenterology; Immunology; Biology; Confidence interval; Superoxide dismutase; Genetics","score_opus":0.033955207029171826,"score_gpt":0.34253263078740903,"score_spread":0.3085774237582372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986975696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988716,0.00053903856,0.00007816363,0.00014582947,0.00001725218,0.0000020808104,0.00010677662,0.000003913907,0.0002353031],"genre_scores_gemma":[0.999311,0.00012733457,0.000037364454,0.00003880941,0.000018001861,0.00000355632,0.00012505689,0.0000025207746,0.0003363717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997613,0.00009678297,0.00001722493,0.000041556385,0.00003196867,0.00005119147],"domain_scores_gemma":[0.99891984,0.00038920125,0.00029285048,0.000054538898,0.00007234263,0.00027118227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042512262,0.00023145236,0.00045197926,0.0003231221,0.00032544328,0.00028154644,0.00024047452,0.0005696923,0.0014180634],"category_scores_gemma":[0.0014939578,0.00018339718,0.0005178852,0.0005935551,0.00022711307,0.00021684737,0.00013467456,0.00080770213,0.000120609846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060114134,0.00025477287,0.9811109,0.000017323115,0.0003302593,0.00025825857,0.00007942367,0.00025692416,0.0060283407,0.000078701945,0.00029410073,0.005279578],"study_design_scores_gemma":[0.00006399266,0.00062894507,0.99762446,0.0000040277514,0.00015550583,0.00032913423,0.000047661466,0.00032661212,0.0005039965,0.0000705644,0.00024013242,0.0000049482505],"about_ca_topic_score_codex":0.0034242368,"about_ca_topic_score_gemma":0.0028025084,"teacher_disagreement_score":0.0034242368,"about_ca_system_score_codex":0.00039240706,"about_ca_system_score_gemma":0.00029853653,"threshold_uncertainty_score":0.006808579},"labels":[],"label_agreement":null},{"id":"W1987598375","doi":"10.1007/s10549-006-9229-5","title":"Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Chromatin immunoprecipitation; Immunoprecipitation; Polyclonal antibodies; Gene isoform; Immunohistochemistry; Western blot; Monoclonal antibody; Estrogen receptor; Antibody; Molecular biology; Biology; Blot; Estrogen; Estrogen receptor alpha; Estrogen receptor beta; Endocrinology; Immunology; Breast cancer; Gene expression; Cancer; Biochemistry; Promoter; Genetics; Gene","score_opus":0.02177698084999967,"score_gpt":0.3525843592866273,"score_spread":0.3308073784366276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987598375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81806016,0.010409497,0.15398708,0.0015680784,0.0009910556,0.00090299395,0.002026612,0.0013700979,0.010684426],"genre_scores_gemma":[0.7618022,0.009938885,0.17906179,0.0023245418,0.00046524146,0.0027727014,0.02161875,0.00085907476,0.0211568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968881,0.0006073637,0.00051687274,0.0006607426,0.000643774,0.00068320177],"domain_scores_gemma":[0.99624985,0.0017834803,0.0002561629,0.00047524876,0.0009463266,0.00028897767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027110828,0.0029624698,0.001385096,0.0016170762,0.0013083913,0.0010776941,0.0015798955,0.0010410735,0.0047462718],"category_scores_gemma":[0.0017477501,0.0015183613,0.0020096295,0.0016277077,0.0007904992,0.0008685171,0.0010759239,0.004032206,0.0017387286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002457695,0.00019929271,0.00021881553,0.000117832366,0.00010054687,0.000033992987,0.00004069929,0.00006907882,0.99738747,0.00016155277,0.000105661726,0.0013193435],"study_design_scores_gemma":[0.00007654608,0.00049949455,0.0034134716,0.00001569943,0.00019496682,0.00021896891,0.000033889977,0.0009331244,0.99179006,0.00009015239,0.002718768,0.000014907546],"about_ca_topic_score_codex":0.0021942013,"about_ca_topic_score_gemma":0.0049833404,"teacher_disagreement_score":0.0047462718,"about_ca_system_score_codex":0.00092869886,"about_ca_system_score_gemma":0.0008219641,"threshold_uncertainty_score":0.015877843},"labels":[],"label_agreement":null},{"id":"W1987656036","doi":"10.1007/s10549-007-9616-6","title":"Breast cancer in pregnancy: a literature review","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Pregnancy; Breast cancer; Cancer; Disease; MEDLINE; Obstetrics; Gynecology; Intensive care medicine; Oncology; Internal medicine","score_opus":0.1276499342256845,"score_gpt":0.4842009717356825,"score_spread":0.356551037509998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987656036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012315836,0.9993637,0.000025997035,0.00016648842,0.00006273199,0.0000074468053,0.000035893772,0.0000017151435,0.00021280121],"genre_scores_gemma":[0.00058547413,0.99908257,0.00008927805,0.000113154514,0.00004447554,0.0000074994086,0.000017357095,3.8437213e-7,0.000059851685],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993224,0.00015497746,0.00027070518,0.00008539622,0.0001329204,0.000033643104],"domain_scores_gemma":[0.9973169,0.0017626592,0.00057617173,0.000030708663,0.00024624736,0.00006742406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001191773,0.0010130941,0.0028397134,0.007070441,0.0003652871,0.0013361578,0.00086514966,0.0012240643,0.0042643673],"category_scores_gemma":[0.004107793,0.0005194806,0.001120165,0.00863995,0.00046663164,0.0016239261,0.0008289021,0.0008436393,0.00055749604],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016735792,0.00009128627,0.001520345,0.27924982,0.00077069853,0.0011875363,0.00025316208,0.00023562624,0.00054809387,0.0008361949,0.022640036,0.69249994],"study_design_scores_gemma":[0.00015055547,0.00033677623,0.010961514,0.3398225,0.010702762,0.009884819,0.0009162898,0.00016143033,0.00060464925,0.0011536627,0.62521553,0.000089574714],"about_ca_topic_score_codex":0.0041161873,"about_ca_topic_score_gemma":0.010568579,"teacher_disagreement_score":0.007070441,"about_ca_system_score_codex":0.0010149378,"about_ca_system_score_gemma":0.003990682,"threshold_uncertainty_score":0.014265716},"labels":[],"label_agreement":null},{"id":"W1987764512","doi":"10.1007/s10549-008-0064-8","title":"No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec; Université Laval","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK","keywords":"Breast cancer; Medicine; Genotype; Oncology; Mutation; Internal medicine; Allele; Cancer; Population; Genetics; Biology; Gene","score_opus":0.021839199231650036,"score_gpt":0.33036640146881474,"score_spread":0.3085272022371647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987764512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990054,0.0001466177,0.00013508562,0.000060534505,0.000016905804,0.000005288902,0.00031176323,0.0000067512797,0.0003116283],"genre_scores_gemma":[0.99903,0.000057523182,0.0000780992,0.000041185463,0.000013508231,0.00001023183,0.00023835785,0.000009075451,0.0005220911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990828,0.0002755445,0.00006567245,0.00029667464,0.00011614379,0.00016320989],"domain_scores_gemma":[0.9975689,0.00055738405,0.0006090852,0.0005049205,0.00021806032,0.00054159266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010691208,0.0006999189,0.0008465225,0.0008318127,0.0011541009,0.0009346353,0.0011102516,0.0011788736,0.004720304],"category_scores_gemma":[0.002614782,0.0009864462,0.0010002047,0.00094671035,0.0004402152,0.00059782946,0.00047262263,0.0013012096,0.0004993903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018614123,0.00015131204,0.9921462,0.000015010137,0.00043171048,0.00051275635,0.0002526958,0.00004763034,0.00333381,0.00004886679,0.00021081533,0.0009877442],"study_design_scores_gemma":[0.00011218319,0.0005950795,0.9958768,0.000009024626,0.00044232464,0.0013623682,0.0003477431,0.00034067992,0.00045934127,0.000059309565,0.00037754842,0.000017616328],"about_ca_topic_score_codex":0.010431773,"about_ca_topic_score_gemma":0.008639983,"teacher_disagreement_score":0.010431773,"about_ca_system_score_codex":0.00034289114,"about_ca_system_score_gemma":0.00062600145,"threshold_uncertainty_score":0.020742118},"labels":[],"label_agreement":null},{"id":"W1988243755","doi":"10.1007/s10549-011-1938-8","title":"The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; Canadian Institutes of Health Research; National Cancer Institute; Cancer Research UK; National Institutes of Health; ZonMw","keywords":"Breast cancer; Ovarian cancer; Internal medicine; Medicine; Oncology; Cancer; Mutation; BRCA2 Protein; BRCA mutation; Germline mutation; Cancer research; Biology; Genetics; Gene","score_opus":0.054248114749286626,"score_gpt":0.39405635770966085,"score_spread":0.3398082429603742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988243755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993587,0.00015031392,0.000036295885,0.00004586607,0.0000073990554,0.0000020129248,0.00007379025,0.0000033785266,0.00032223033],"genre_scores_gemma":[0.9994025,0.000051639574,0.00005415312,0.000019978976,0.0000123547425,0.0000021573467,0.000079867976,0.000002676782,0.00037462672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998412,0.000040099905,0.000018841682,0.000039129474,0.000027393318,0.00003333797],"domain_scores_gemma":[0.9989641,0.00043200533,0.00029455952,0.00003917046,0.000046752495,0.00022330163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022697996,0.00031875537,0.0003022193,0.0009339298,0.00037723078,0.000438938,0.00028574993,0.00075365265,0.0044402233],"category_scores_gemma":[0.0023861965,0.00024261652,0.00031734447,0.00050278124,0.0003094589,0.00029833167,0.0002478907,0.0005254824,0.00028933323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038165573,0.00021831959,0.97555,0.000020371768,0.00014703625,0.0035825996,0.0003547325,0.00019648416,0.010617956,0.0002028835,0.00021428014,0.0050787022],"study_design_scores_gemma":[0.000098365424,0.0007527005,0.9835579,0.00001740376,0.00021692537,0.011080411,0.00046278583,0.0010099245,0.0015886999,0.00049067003,0.00069692987,0.000027227055],"about_ca_topic_score_codex":0.0042586187,"about_ca_topic_score_gemma":0.0022649826,"teacher_disagreement_score":0.0044402233,"about_ca_system_score_codex":0.00020128016,"about_ca_system_score_gemma":0.00017661205,"threshold_uncertainty_score":0.014854014},"labels":[],"label_agreement":null},{"id":"W1988337574","doi":"10.1023/a:1014993006190","title":"Expression of Ets-related Transcription Factors and Matrix Metalloproteinase Genes in Human Breast Cancer Cells","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; Hamilton Regional Laboratory Medicine Program; Cancer Care Ontario","funders":"","keywords":"Cell culture; Matrix metalloproteinase; Messenger RNA; Gene expression; Cancer research; Biology; Molecular biology; Breast cancer; Gene; Cell; Transcription factor; Cancer; Genetics","score_opus":0.03330726156533099,"score_gpt":0.31611025138801857,"score_spread":0.2828029898226876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988337574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99109954,0.0042916876,0.0014134053,0.00012996372,0.000034953282,0.000023244236,0.00087658066,0.000034610766,0.0020960316],"genre_scores_gemma":[0.9880365,0.00250385,0.0011590914,0.00004675992,0.000023779132,0.000047602392,0.0024425804,0.000012789401,0.0057269307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998642,0.000022979486,0.000011639807,0.000019578074,0.00004070227,0.000040824805],"domain_scores_gemma":[0.9998727,0.000061455605,0.000009444721,0.000018572015,0.000021774784,0.000016065489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018081591,0.00015473769,0.00023282488,0.0003314767,0.00024186821,0.00039486517,0.00015270148,0.00021159646,0.0020308625],"category_scores_gemma":[0.00025855753,0.00019320028,0.00019178865,0.00045192428,0.00020471508,0.00022625159,0.00013360626,0.00028801328,0.00041124606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007470139,0.000060954375,0.001353032,0.00005317641,0.000014096044,0.00016602888,0.00013237784,0.00011045847,0.99437815,0.00063748495,0.00015838056,0.0021887731],"study_design_scores_gemma":[0.00007299158,0.00047282825,0.046545573,0.000012462725,0.000054894746,0.001150628,0.00037213427,0.0015280073,0.9411286,0.00037466592,0.008275934,0.000011262313],"about_ca_topic_score_codex":0.0019719726,"about_ca_topic_score_gemma":0.0015566177,"teacher_disagreement_score":0.0020308625,"about_ca_system_score_codex":0.00031448892,"about_ca_system_score_gemma":0.00023551434,"threshold_uncertainty_score":0.0067938566},"labels":[],"label_agreement":null},{"id":"W1988434980","doi":"10.1007/s10549-006-9172-5","title":"Diabetes mellitus and breast cancer: a retrospective population-based cohort study","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Breast cancer; Diabetes mellitus; Hyperinsulinemia; Population; Hazard ratio; Incidence (geometry); Internal medicine; Cancer; Retrospective cohort study; Type 2 diabetes; Cohort study; Insulin resistance; Gynecology; Obstetrics; Confidence interval; Endocrinology; Environmental health","score_opus":0.012875956593008143,"score_gpt":0.30655907241789215,"score_spread":0.293683115824884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988434980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981054,0.00034453731,0.00017064408,0.000072172465,0.000019957191,0.000017408915,0.0009577941,0.0000073151564,0.00030471757],"genre_scores_gemma":[0.9984169,0.00028993207,0.00017544362,0.00006700228,0.000020524714,0.00002118545,0.00064809853,0.0000050802664,0.00035585862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990784,0.0002601971,0.00007589729,0.00029226887,0.00015481998,0.00013847723],"domain_scores_gemma":[0.9986058,0.0001592895,0.00033712407,0.00036884987,0.00018888785,0.0003400928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012009317,0.00068901206,0.0009022661,0.00085310015,0.0013177735,0.0010807995,0.00069192686,0.0011499779,0.0015120886],"category_scores_gemma":[0.0017503452,0.0017664833,0.0010242006,0.0021289112,0.00048640772,0.00080362934,0.0006218318,0.0014765321,0.00047868132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070909923,0.00015976801,0.9966775,0.000008471796,0.00037424354,0.000234647,0.00012538936,0.000050523166,0.0007750957,0.00002887855,0.00019754811,0.0006588175],"study_design_scores_gemma":[0.00008237355,0.00025674718,0.9980367,0.000005130956,0.00025236324,0.0006058197,0.00024930423,0.00014885726,0.000077728415,0.000025660924,0.00024774444,0.000011621004],"about_ca_topic_score_codex":0.019773783,"about_ca_topic_score_gemma":0.017752064,"teacher_disagreement_score":0.019773783,"about_ca_system_score_codex":0.00058212713,"about_ca_system_score_gemma":0.00076289196,"threshold_uncertainty_score":0.03931737},"labels":[],"label_agreement":null},{"id":"W1988499760","doi":"10.1023/b:brea.0000003956.11376.5b","title":"MR Imaging-guided Focused Ultrasound Surgery of Breast Cancer: Correlation of Dynamic Contrast-enhanced MRI with Histopathologic Findings","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Magnetic resonance imaging; Medicine; Breast cancer; Ultrasound; Histopathology; Receiver operating characteristic; Radiology; Breast tumor; Cutoff; Dynamic contrast; Dynamic contrast-enhanced MRI; Breast MRI; Nuclear medicine; Contrast-enhanced ultrasound; Cancer; Mammography; Pathology; Internal medicine","score_opus":0.0339412082897941,"score_gpt":0.33782703545551884,"score_spread":0.30388582716572476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988499760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898633,0.0031800305,0.0019730981,0.00029842084,0.000039776318,0.000050040733,0.00004908765,0.000029305816,0.004516908],"genre_scores_gemma":[0.9965486,0.0012369679,0.0016890907,0.00009997668,0.000098958655,0.000013043714,0.000071816205,0.000007692071,0.00023386673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995826,0.000110968416,0.000068017274,0.00006323218,0.00010435997,0.00007074864],"domain_scores_gemma":[0.996167,0.0021081674,0.0005929345,0.00028594534,0.00055320223,0.00029274783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016536115,0.0004938222,0.00040319047,0.0018315328,0.00031620832,0.00056221645,0.0005778238,0.0009855002,0.0012396737],"category_scores_gemma":[0.009380827,0.0004613318,0.00024063667,0.0007128559,0.00073995366,0.0010982837,0.00036732928,0.0005958595,0.0004253462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015893214,0.00025192657,0.912236,0.00011931225,0.00011619116,0.021807203,0.00017767948,0.00030463733,0.045095902,0.00016457384,0.00029299117,0.017844254],"study_design_scores_gemma":[0.00009136456,0.0013783283,0.8414091,0.00006181918,0.0003590869,0.13316064,0.00045191144,0.0034850345,0.017517101,0.0003488393,0.0017035541,0.00003332812],"about_ca_topic_score_codex":0.00077529496,"about_ca_topic_score_gemma":0.0010308792,"teacher_disagreement_score":0.0018315328,"about_ca_system_score_codex":0.00024013796,"about_ca_system_score_gemma":0.0004088027,"threshold_uncertainty_score":0.008745253},"labels":[],"label_agreement":null},{"id":"W1989466967","doi":"10.1007/s10549-010-1322-0","title":"A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Bone remodeling; Bone mineral; Internal medicine; Femoral neck; Endocrinology; Exemestane; N-terminal telopeptide; Bone density; Placebo; Bone resorption; Breast cancer; Osteoporosis; Osteocalcin; Urology; Aromatase; Cancer; Alkaline phosphatase; Biology","score_opus":0.041634602959741585,"score_gpt":0.3285250110864677,"score_spread":0.2868904081267261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989466967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532139,0.019927448,0.0011883868,0.0028151185,0.00231336,0.010328512,0.004295291,0.00044904262,0.005469095],"genre_scores_gemma":[0.96080005,0.008188558,0.0035531872,0.0040338333,0.0018618773,0.0110492045,0.0027904692,0.00005128094,0.0076714484],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993944,0.00032500597,0.000044251017,0.00011136615,0.000053186162,0.0000719193],"domain_scores_gemma":[0.99916255,0.0002797195,0.00017649766,0.000075086864,0.000070616195,0.00023544999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011953065,0.0019054979,0.0043599824,0.00075886596,0.0006265378,0.0010382961,0.00095332414,0.003154657,0.009548516],"category_scores_gemma":[0.0025994503,0.0007813705,0.0018351959,0.0005572413,0.0011004668,0.0010170334,0.0004879669,0.002943585,0.0012345503],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9917489,0.0016461746,0.00013563395,0.0005786988,0.00047435897,0.000018046727,0.0000136014705,0.000058893584,0.00096700364,0.000040324278,0.00042642932,0.0038919642],"study_design_scores_gemma":[0.9877402,0.011175666,0.00040155157,0.000022802367,0.00026540118,0.0000096190115,0.0000053264225,0.000055247318,0.000089818175,0.000040801126,0.00018863389,0.0000048661586],"about_ca_topic_score_codex":0.0018636219,"about_ca_topic_score_gemma":0.0038609034,"teacher_disagreement_score":0.009548516,"about_ca_system_score_codex":0.00063056755,"about_ca_system_score_gemma":0.0013143722,"threshold_uncertainty_score":0.031942964},"labels":[],"label_agreement":null},{"id":"W1989960002","doi":"10.1007/s10549-011-1351-3","title":"Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Ottawa Hospital; Pfizer (Canada); University of Ottawa","funders":"Pfizer","keywords":"Medicine; Tamoxifen; Aromatase; Breast cancer; Aromatase inhibitor; Adjuvant; Adjuvant therapy; Hormonal therapy; Internal medicine; Oncology; Cancer; Anastrozole; Gynecology","score_opus":0.03316697567197469,"score_gpt":0.3340144727176574,"score_spread":0.3008474970456827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989960002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009604421,0.99921644,0.0000974202,0.00015686933,0.00007731218,0.0000026822702,0.000012740504,0.0000036693841,0.00033670093],"genre_scores_gemma":[0.0006102671,0.9985643,0.00018862098,0.00016385283,0.00012115177,0.0000038161065,0.00002340803,0.000001074158,0.00032359743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998216,0.000032683907,0.000026943826,0.000027911006,0.00007566462,0.000015204909],"domain_scores_gemma":[0.9996195,0.00019580108,0.00006504137,0.000007950829,0.00008166579,0.00003002458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006492315,0.0008600714,0.0017582278,0.0015436977,0.0002229918,0.00080714433,0.0010336096,0.0009335921,0.0021689269],"category_scores_gemma":[0.0008483426,0.00026907813,0.00045825526,0.0018055222,0.0003452499,0.000767193,0.00045116612,0.0016749509,0.0010891991],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010291752,0.00006231771,0.000180464,0.0072663845,0.00008499716,0.00017121057,0.00002034261,0.00035757408,0.0008451167,0.0008661905,0.019704254,0.9703382],"study_design_scores_gemma":[0.0001037523,0.00025479932,0.002279851,0.0048948093,0.00035852264,0.0031790256,0.00007189933,0.00029187265,0.0006426455,0.001672122,0.986214,0.00003671716],"about_ca_topic_score_codex":0.0014977134,"about_ca_topic_score_gemma":0.0053524408,"teacher_disagreement_score":0.0021689269,"about_ca_system_score_codex":0.00062708976,"about_ca_system_score_gemma":0.0007760101,"threshold_uncertainty_score":0.0072557926},"labels":[],"label_agreement":null},{"id":"W1990195000","doi":"10.1007/s10549-011-1756-z","title":"Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Gefitinib; Metabolite; Breast cancer; Phosphorylation; Cancer research; Pharmacology; Chemistry; Medicine; Internal medicine; Cancer; Epidermal growth factor receptor; Biochemistry","score_opus":0.11291987091672188,"score_gpt":0.3855439548003682,"score_spread":0.2726240838836463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990195000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215186,0.0023827814,0.0009489378,0.00011235606,0.000040664618,0.00004769784,0.001136633,0.000097308875,0.0030818784],"genre_scores_gemma":[0.9916598,0.0015869853,0.0012124095,0.0000452363,0.000012656616,0.00007152677,0.003039715,0.000013471857,0.002358319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997675,0.000044310953,0.00001766922,0.000033943947,0.000058526395,0.00007806404],"domain_scores_gemma":[0.99994147,0.000015336233,0.000009826166,0.00000895111,0.0000089416735,0.000015525924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020547931,0.00055312144,0.00051897333,0.00039060737,0.0002494629,0.00025903448,0.0001924538,0.00023514143,0.0029957686],"category_scores_gemma":[0.00011188383,0.00018293488,0.0005126511,0.0003473637,0.00013063122,0.0001505407,0.00015395004,0.00044970732,0.00067218527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008210356,0.00034201678,0.0013923729,0.00009981901,0.00004699274,0.000079993246,0.000037606635,0.00022074988,0.9898756,0.000069599555,0.00060734514,0.0064068553],"study_design_scores_gemma":[0.000070249145,0.0019311196,0.024599388,0.00000580832,0.000054652155,0.0006706217,0.000052257536,0.0005911604,0.96882105,0.000023523762,0.0031712777,0.000008922136],"about_ca_topic_score_codex":0.0021262667,"about_ca_topic_score_gemma":0.0046770857,"teacher_disagreement_score":0.0029957686,"about_ca_system_score_codex":0.00032443958,"about_ca_system_score_gemma":0.0002224346,"threshold_uncertainty_score":0.010021806},"labels":[],"label_agreement":null},{"id":"W1990549321","doi":"10.1007/s10549-010-0849-4","title":"Role of ferritin alterations in human breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge","funders":"","keywords":"Ferritin; Breast cancer; Transferrin receptor; Ectopic expression; Cancer; Cancer research; Cancer cell; Biology; Ferroportin; Phenotype; Transferrin; Cell biology; Chemistry; Hepcidin; Immunology; Endocrinology; Biochemistry; Gene; Genetics","score_opus":0.024313338801978192,"score_gpt":0.3542347627396116,"score_spread":0.3299214239376334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990549321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339926,0.0029233703,0.0011500405,0.00016544679,0.000023426328,0.000010332419,0.00031085004,0.000057693673,0.0019596552],"genre_scores_gemma":[0.9964994,0.0006786688,0.0003612366,0.00002772562,0.0000068303493,0.000005689717,0.0003489966,0.000009061895,0.0020623973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999254,0.000023443179,0.0000051430397,0.0000111979625,0.00001538151,0.000019451396],"domain_scores_gemma":[0.9999318,0.000022084805,0.000009936646,0.000010753138,0.000014733527,0.000010647704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015991573,0.00013915225,0.00013054267,0.0002035558,0.00019246538,0.0002566477,0.00009383784,0.00020346306,0.001439128],"category_scores_gemma":[0.00016220489,0.00007997086,0.000113604365,0.00014906915,0.00013796685,0.00011764415,0.00010472368,0.00015080534,0.0003209558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081961934,0.000021181373,0.0016889494,0.000040988627,0.000009720494,0.00024811135,0.000084331856,0.0000571818,0.9931759,0.00025902176,0.00013186006,0.0034631006],"study_design_scores_gemma":[0.000029908759,0.00046110337,0.029682353,0.000008428803,0.000037687976,0.0015751247,0.00019366677,0.00085246057,0.95946574,0.00027289576,0.007414324,0.000006403373],"about_ca_topic_score_codex":0.0013650424,"about_ca_topic_score_gemma":0.0010620189,"teacher_disagreement_score":0.001439128,"about_ca_system_score_codex":0.00024530117,"about_ca_system_score_gemma":0.00011514619,"threshold_uncertainty_score":0.0048143268},"labels":[],"label_agreement":null},{"id":"W1990635160","doi":"10.1007/s10549-009-0566-z","title":"Prognosis of BRCA-associated breast cancer: a summary of evidence","year":2009,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; McMaster University; Mount Sinai Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; BRCA mutation; Prospective cohort study; Cancer; Cohort study; Gynecology","score_opus":0.16344018365029997,"score_gpt":0.44749654594798965,"score_spread":0.2840563622976897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990635160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000069167065,0.9994217,0.00004275547,0.0002230816,0.00006957857,0.0000015596836,0.000030780135,0.0000019562033,0.00013944894],"genre_scores_gemma":[0.0008148586,0.9986986,0.000108096414,0.00013681776,0.0001273607,0.0000029962678,0.000039606395,6.409389e-7,0.00007097707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960774,0.00007696822,0.00008068446,0.00008222453,0.00012383901,0.000028567549],"domain_scores_gemma":[0.9988318,0.00069624395,0.00017561013,0.000016548072,0.0002215504,0.000058231224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015514614,0.0010609066,0.0027869444,0.0022913052,0.00021417876,0.0011089721,0.0015133836,0.0011238968,0.0023266408],"category_scores_gemma":[0.0030356927,0.00026063708,0.0008421555,0.0033930535,0.00043051218,0.0009866966,0.00049803406,0.0011570619,0.0007436919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031256265,0.000045670684,0.001919862,0.026558263,0.00043034254,0.00021751455,0.000032258675,0.0006584847,0.00033485368,0.0011771005,0.041881718,0.92643154],"study_design_scores_gemma":[0.00020837873,0.0004718544,0.014996675,0.05587954,0.004326128,0.004459355,0.00031262072,0.0006507409,0.00048455517,0.005049036,0.9130583,0.00010279464],"about_ca_topic_score_codex":0.002817453,"about_ca_topic_score_gemma":0.0048612957,"teacher_disagreement_score":0.002817453,"about_ca_system_score_codex":0.001098346,"about_ca_system_score_gemma":0.0013957203,"threshold_uncertainty_score":0.008204997},"labels":[],"label_agreement":null},{"id":"W1990685855","doi":"10.1007/s10549-006-9381-y","title":"The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Ovariectomized rat; Toremifene; Letrozole; Endocrinology; Uterus; Medicine; Internal medicine; Antiestrogen; Urology; Breast cancer; Tamoxifen; Estrogen; Cancer","score_opus":0.008242784768469388,"score_gpt":0.27686911209751175,"score_spread":0.26862632732904235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990685855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629503,0.0018015003,0.0002465797,0.0003021198,0.00014485956,0.000051357983,0.000419831,0.000049316972,0.00068927766],"genre_scores_gemma":[0.98940605,0.0030400085,0.00120915,0.00013223763,0.0001420678,0.00013187909,0.0005138737,0.000015591322,0.005409002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995685,0.00012406631,0.00003058429,0.00006335853,0.000063180356,0.00015022895],"domain_scores_gemma":[0.999566,0.00008627683,0.0000691715,0.00005347214,0.000029737359,0.00019514564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043678776,0.0012208208,0.0019973952,0.0010939577,0.00047182874,0.00047468545,0.00073473074,0.0010443993,0.0027515315],"category_scores_gemma":[0.0005476893,0.0007416875,0.0009059993,0.00058291643,0.0010390893,0.0009858457,0.00032417057,0.0018839093,0.00039125196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28850818,0.005055812,0.0015424496,0.00040519427,0.0005056866,0.00054808514,0.00019729183,0.0008448422,0.67951864,0.00045194608,0.00071961374,0.021702196],"study_design_scores_gemma":[0.013640736,0.16650587,0.018362645,0.000053041756,0.0020264424,0.0008464069,0.00078525045,0.0024850464,0.7874911,0.00075499946,0.0068634944,0.00018493697],"about_ca_topic_score_codex":0.0025136122,"about_ca_topic_score_gemma":0.007875261,"teacher_disagreement_score":0.0027515315,"about_ca_system_score_codex":0.0004127269,"about_ca_system_score_gemma":0.0011098625,"threshold_uncertainty_score":0.009204805},"labels":[],"label_agreement":null},{"id":"W1990710094","doi":"10.1007/s10549-009-0540-9","title":"Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Institute for Health and Care Research","keywords":"CHEK2; PALB2; Breast cancer; Medicine; Population; Internal medicine; Oncology; Cohort; Cancer; Germline mutation; Mutation; Genetics; Biology; Gene; Environmental health","score_opus":0.06853346983228717,"score_gpt":0.41524389056027156,"score_spread":0.3467104207279844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990710094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863786,0.000047202815,0.000098492324,0.00004517951,0.0000046571113,0.000011983508,0.0003931104,0.0000033767271,0.00075819116],"genre_scores_gemma":[0.9976447,0.00007355678,0.00020090492,0.00006880429,0.0000059477643,0.00003497022,0.0007506495,0.000013993831,0.0012063696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992931,0.0001154149,0.00005069321,0.00023238533,0.00013638617,0.0001719621],"domain_scores_gemma":[0.9993438,0.00010709415,0.00012503368,0.00008381965,0.0001561266,0.00018403825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077583635,0.00057755585,0.00043730479,0.0009911116,0.0011649483,0.00078333466,0.0006416689,0.0006198889,0.0025958242],"category_scores_gemma":[0.0019475808,0.00046119877,0.00065901986,0.0010929127,0.00051008846,0.00031280215,0.0008918389,0.0008028077,0.0006754861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011092307,0.00015322366,0.98468196,0.000019993693,0.00011989332,0.0018263364,0.0009394703,0.0001737968,0.0063512265,0.00011053066,0.0005023421,0.0040120035],"study_design_scores_gemma":[0.00005976372,0.00028255445,0.9937855,0.000013655266,0.00009824228,0.002082547,0.001149618,0.00029207388,0.0007617226,0.00004107872,0.0014169841,0.000016296413],"about_ca_topic_score_codex":0.055290066,"about_ca_topic_score_gemma":0.029543834,"teacher_disagreement_score":0.055290066,"about_ca_system_score_codex":0.0010855348,"about_ca_system_score_gemma":0.00076945865,"threshold_uncertainty_score":0.109936476},"labels":[],"label_agreement":null},{"id":"W1990719422","doi":"10.1007/s10549-012-2157-7","title":"Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pertuzumab; Medicine; Rash; Internal medicine; Oncology; Trastuzumab; Incidence (geometry); Breast cancer; Docetaxel; Clinical trial; Cancer","score_opus":0.271116512031164,"score_gpt":0.5036414260120149,"score_spread":0.2325249139808509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990719422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03332068,0.9635773,0.0013751764,0.00023027508,0.0002677435,0.00008266542,0.0006880825,0.00004232554,0.0004157886],"genre_scores_gemma":[0.55472225,0.43973643,0.0021251212,0.0009002076,0.00040031172,0.00021933838,0.00083606876,0.00005719293,0.0010030457],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968556,0.0014614511,0.0006361398,0.0005922812,0.00029783064,0.00015669865],"domain_scores_gemma":[0.99346536,0.0047121937,0.0009175192,0.00036771485,0.00041699037,0.000120282566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004829545,0.0024312956,0.008779495,0.0016221806,0.00033581755,0.0015063665,0.0014343351,0.0017948638,0.0034416397],"category_scores_gemma":[0.010689022,0.001323826,0.03126746,0.0027608199,0.00033918748,0.00094945176,0.00096878596,0.00207253,0.00028803304],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009263736,0.00004040058,0.012110521,0.043290973,0.9222466,0.00018705553,0.000042005347,0.0008060075,0.00036542054,0.00010020078,0.00072477787,0.010822371],"study_design_scores_gemma":[0.0007748349,0.00023210756,0.006331849,0.0011410699,0.9900774,0.00011293285,0.000023029414,0.00023133057,0.00011603756,0.00015530194,0.00078456115,0.000019562824],"about_ca_topic_score_codex":0.0048861126,"about_ca_topic_score_gemma":0.008307474,"teacher_disagreement_score":0.008779495,"about_ca_system_score_codex":0.0009860769,"about_ca_system_score_gemma":0.00093615305,"threshold_uncertainty_score":0.025541365},"labels":[],"label_agreement":null},{"id":"W1991519982","doi":"10.1007/s10549-009-0662-0","title":"A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Niagara Health System; Ontario Institute for Cancer Research","funders":"","keywords":"Letrozole; Medicine; Breast cancer; Aromatase inhibitor; Placebo; Tamoxifen; Internal medicine; Bone mineral; Hormone replacement therapy (female-to-male); Bone density; Clinical endpoint; Randomized controlled trial; Urology; Gynecology; Endocrinology; Oncology; Cancer; Osteoporosis; Testosterone (patch)","score_opus":0.018448964902709336,"score_gpt":0.3055030780993978,"score_spread":0.2870541131966885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991519982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96896744,0.016924338,0.0009202621,0.0021495642,0.0013065462,0.0038326485,0.0021399113,0.00030083075,0.0034584685],"genre_scores_gemma":[0.9807686,0.005487329,0.0017652375,0.0021071732,0.00073682464,0.0035751583,0.0011882423,0.000023622637,0.004347894],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99959475,0.00020515884,0.000025545156,0.00008317405,0.0000388783,0.000052543783],"domain_scores_gemma":[0.9994431,0.0001982178,0.00012456832,0.00004129454,0.000036294692,0.00015642619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094603404,0.0013649826,0.0032064174,0.0005913199,0.0005095702,0.0007326535,0.0007910384,0.0021727236,0.0075073014],"category_scores_gemma":[0.0022493845,0.00057333324,0.0013640079,0.00040971526,0.0009775194,0.00085997133,0.00036122327,0.0024574413,0.0007467776],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9883442,0.0014676405,0.00018075656,0.00064971775,0.00058767066,0.000023233682,0.000017459288,0.00009582721,0.001432953,0.00006674319,0.00049354776,0.0066402894],"study_design_scores_gemma":[0.97494406,0.02304513,0.000704495,0.000027237817,0.00051562866,0.000014858117,0.000009883171,0.00010253998,0.00021570563,0.00007370163,0.00033983676,0.000006763754],"about_ca_topic_score_codex":0.0017059003,"about_ca_topic_score_gemma":0.0036029557,"teacher_disagreement_score":0.0075073014,"about_ca_system_score_codex":0.0006752615,"about_ca_system_score_gemma":0.0011266909,"threshold_uncertainty_score":0.025114417},"labels":[],"label_agreement":null},{"id":"W1991742579","doi":"10.1007/s10549-013-2800-y","title":"Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Institute of Cancer Research; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Canada Research Chairs; Ontario Institute for Cancer Research; University of Pennsylvania","keywords":"Fluvastatin; Breast cancer; Cancer research; Cancer; Estrogen receptor; Oncogene; Biology; Molecular medicine; Medicine; Pharmacology; Internal medicine; Cell cycle; Simvastatin","score_opus":0.025579619097234024,"score_gpt":0.31896972401594903,"score_spread":0.293390104918715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991742579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628675,0.0009829414,0.0009820021,0.00008813387,0.000008504426,0.00002407792,0.00051075465,0.000036400426,0.0010803048],"genre_scores_gemma":[0.99689734,0.0004333912,0.00071338343,0.00004899939,0.0000071655054,0.000017518187,0.00093694485,0.000007060566,0.00093825796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999074,0.000010792305,0.0000095992045,0.000015064901,0.000024072287,0.000033058197],"domain_scores_gemma":[0.9999076,0.000018074024,0.000019977064,0.000012097466,0.000019633131,0.000022551909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010977331,0.00016896568,0.00029647053,0.0008018891,0.0002240623,0.00039077966,0.00014671528,0.0003638628,0.001326585],"category_scores_gemma":[0.00020091105,0.00013626716,0.00027807627,0.00040476327,0.00015798335,0.00023294054,0.00017288861,0.00028080307,0.00040677062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040131283,0.000023894658,0.009265363,0.000025326783,0.000012155701,0.00007701266,0.00002760372,0.000039722643,0.98696005,0.0001003276,0.000053388823,0.0030138665],"study_design_scores_gemma":[0.000034222827,0.0004967575,0.28434357,0.0000087798835,0.00008073823,0.0016556238,0.0002831538,0.0008982163,0.7094904,0.00021350078,0.002479569,0.000015457408],"about_ca_topic_score_codex":0.0013118035,"about_ca_topic_score_gemma":0.0020927836,"teacher_disagreement_score":0.001326585,"about_ca_system_score_codex":0.0002748045,"about_ca_system_score_gemma":0.00016865227,"threshold_uncertainty_score":0.004437864},"labels":[],"label_agreement":null},{"id":"W1991822158","doi":"10.1007/s10549-008-0271-3","title":"A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Doxorubicin; Cancer; Mitomycin C; Multiple drug resistance; Human breast; Cancer research; Breast cancer; Medicine; Biology; Chemotherapy; Drug resistance; Internal medicine; Microbiology; Surgery","score_opus":0.03710128094177855,"score_gpt":0.3397939369125332,"score_spread":0.3026926559707546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991822158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517447,0.0011437363,0.002110286,0.00009550201,0.000034368793,0.000032569897,0.00009383293,0.00005605195,0.0012591626],"genre_scores_gemma":[0.9968701,0.00034461467,0.0014626136,0.000023432856,0.000007745759,0.000013775005,0.00008035139,0.000011611871,0.0011857755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999496,0.0000088099705,0.0000048777783,0.000014776313,0.000010393689,0.000011535856],"domain_scores_gemma":[0.9999578,0.000011526846,0.000008232312,0.0000042597508,0.0000064124442,0.000011767595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010885881,0.0002160042,0.0002464273,0.0001423022,0.00013345425,0.00017406784,0.00016570729,0.0002720698,0.00079168845],"category_scores_gemma":[0.00008047062,0.00010930432,0.00012434684,0.0000948455,0.0001205505,0.00015950183,0.00010779814,0.00024065205,0.00018657002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014480694,0.00004076498,0.000069764035,0.00003345627,0.000004087287,0.000052945932,0.000014840877,0.000097752796,0.99744534,0.00006739506,0.000071028626,0.0019578054],"study_design_scores_gemma":[0.00003495461,0.00052883255,0.0010428098,0.0000025223712,0.000019955076,0.00017109541,0.000008466538,0.0009206266,0.9958157,0.000008864432,0.0014419983,0.0000041871253],"about_ca_topic_score_codex":0.0008734634,"about_ca_topic_score_gemma":0.001453044,"teacher_disagreement_score":0.0008734634,"about_ca_system_score_codex":0.00020433012,"about_ca_system_score_gemma":0.00016003304,"threshold_uncertainty_score":0.0026484728},"labels":[],"label_agreement":null},{"id":"W1992069532","doi":"10.1023/a:1014965726663","title":"Purging of Contaminating Breast Cancer Cells From Hematopoietic Progenitor Cell Preparations Using Activation Enhanced Cell Death","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Arthritis Research Centre of Canada; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Econazole; Progenitor cell; Cancer research; Cancer cell; Breast cancer; Haematopoiesis; Biology; Immunology; Cancer; Stem cell; Internal medicine; Medicine; Cell biology","score_opus":0.07928790543226419,"score_gpt":0.3651955292932847,"score_spread":0.28590762386102053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992069532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83095336,0.004777395,0.15394796,0.00046033604,0.0002740905,0.00077833846,0.0009156832,0.0008805845,0.007012228],"genre_scores_gemma":[0.8814669,0.0027428898,0.09705872,0.0004825221,0.00011678751,0.00073351816,0.003885675,0.00028375455,0.013229242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994485,0.000124139,0.00005462092,0.00009560478,0.00015010952,0.00012708869],"domain_scores_gemma":[0.9995561,0.00020478129,0.000030423393,0.00011766779,0.00005576019,0.000035308723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062990474,0.00061942317,0.00067114,0.00039974455,0.0003670099,0.000735969,0.0005666923,0.00040948298,0.001913375],"category_scores_gemma":[0.00040715063,0.00025079265,0.0003287848,0.00044916768,0.00027928868,0.00026883144,0.00061665,0.001261685,0.0009209153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020104296,0.0000624515,0.00044613966,0.000053791293,0.000013365344,0.00007907856,0.00007517859,0.00012775096,0.99134934,0.00036800577,0.00017890001,0.007045],"study_design_scores_gemma":[0.000020541056,0.00008428775,0.001185742,0.000005031211,0.000023851575,0.00013931042,0.000012049305,0.00071881036,0.9943363,0.000045334655,0.0034248175,0.0000039656256],"about_ca_topic_score_codex":0.0004546467,"about_ca_topic_score_gemma":0.0011532975,"teacher_disagreement_score":0.001913375,"about_ca_system_score_codex":0.00021994792,"about_ca_system_score_gemma":0.0002941248,"threshold_uncertainty_score":0.006400883},"labels":[],"label_agreement":null},{"id":"W1992180550","doi":"10.1007/s10549-006-9286-9","title":"Lewis x Antigen Mediates Adhesion of Human Breast Carcinoma Cells to Activated Endothelium. Possible Involvement of the Endothelial Scavenger Receptor C-type Lectin","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Consejo Nacional de Investigaciones Científicas y Técnicas; Agencia Nacional de Promoción Científica y Tecnológica; Directorate for Biological Sciences; Fundación Sales; Wellcome Trust","keywords":"Molecular biology; Monoclonal antibody; Chemistry; Antigen; Cancer cell; Endothelium; Biology; Cell biology; Cancer research; Antibody; Immunology; Cancer","score_opus":0.028687858565122862,"score_gpt":0.31403052753793553,"score_spread":0.2853426689728127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992180550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357903,0.0017549036,0.00096555834,0.000104439045,0.00002396188,0.000017527575,0.000076637145,0.000023716482,0.0034542708],"genre_scores_gemma":[0.99088424,0.0012518354,0.00044329575,0.00005758351,0.000020009258,0.000015244761,0.0003693615,0.0000073769693,0.0069510997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998252,0.00004393915,0.000006410567,0.00001280523,0.000036994268,0.00007475813],"domain_scores_gemma":[0.99988604,0.000037442835,0.000014292064,0.000016017453,0.00002039124,0.000025804688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001900676,0.00027657553,0.000113536036,0.00022255041,0.00022147827,0.0004392657,0.00027604654,0.00025942895,0.0034526868],"category_scores_gemma":[0.00035447895,0.00012018642,0.0002081568,0.00014772771,0.0001617963,0.00027561028,0.00032906485,0.00029639705,0.0010941859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003096505,0.00006485281,0.0012437066,0.00006040913,0.000015913294,0.00039243288,0.00011375968,0.00006980228,0.9928725,0.000543977,0.00027391166,0.0040391986],"study_design_scores_gemma":[0.00009053889,0.0007653713,0.039891224,0.00003127738,0.00006417273,0.0015332468,0.00044050987,0.002554371,0.94686,0.00053902774,0.0072086146,0.000021578622],"about_ca_topic_score_codex":0.001943677,"about_ca_topic_score_gemma":0.0014279758,"teacher_disagreement_score":0.0034526868,"about_ca_system_score_codex":0.00026799718,"about_ca_system_score_gemma":0.00020332108,"threshold_uncertainty_score":0.011550367},"labels":[],"label_agreement":null},{"id":"W1992261227","doi":"10.1007/s10549-008-0295-8","title":"Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Basal (medicine); Cytokeratin; Estrogen receptor; Progesterone receptor; Medicine; Internal medicine; Oncology; Estrogen; Triple-negative breast cancer; Cancer; Immunohistochemistry; Pathology","score_opus":0.02613883904658297,"score_gpt":0.33701894609479943,"score_spread":0.31088010704821645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992261227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981104,0.0010988924,0.00008768714,0.000037781523,0.0000026494583,0.000003961054,0.00017986093,0.000003988369,0.0004747412],"genre_scores_gemma":[0.9992292,0.00025845607,0.000044435936,0.000010792949,0.0000047738013,0.0000033176384,0.00018259625,0.0000026364742,0.00026388493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963236,0.00010650866,0.000054956574,0.00004635263,0.000080506834,0.000079243204],"domain_scores_gemma":[0.9985983,0.00038586243,0.00055299787,0.00012428891,0.00019806571,0.00014057451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005203506,0.00010608204,0.00038711337,0.0009881402,0.00022918724,0.00044327867,0.00030851242,0.00021424351,0.0012961797],"category_scores_gemma":[0.00249795,0.0001268969,0.0003781794,0.00078230037,0.00025300242,0.00030518186,0.00028900185,0.00027040363,0.0001532064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070653076,0.000015911326,0.99141383,0.000022924725,0.000047689322,0.00008618563,0.00026943994,0.000033655124,0.0019542526,0.000057039153,0.00007563252,0.0053169234],"study_design_scores_gemma":[0.0000028102936,0.000058753685,0.9988385,0.0000045175248,0.000025195095,0.00036994577,0.0002936953,0.00007248119,0.00017351074,0.000036043493,0.00012165875,0.0000028916484],"about_ca_topic_score_codex":0.005417578,"about_ca_topic_score_gemma":0.007920473,"teacher_disagreement_score":0.005417578,"about_ca_system_score_codex":0.00022827933,"about_ca_system_score_gemma":0.00026305745,"threshold_uncertainty_score":0.010772109},"labels":[],"label_agreement":null},{"id":"W1992316696","doi":"10.1007/s10549-014-2855-4","title":"Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Research England; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Docetaxel; Tact; Taxane; Oncology; Breast cancer; Medicine; Tau protein; Internal medicine; Population; Immunohistochemistry; Tissue microarray; Cancer; Psychology","score_opus":0.02646158200281549,"score_gpt":0.3715063833433568,"score_spread":0.3450448013405413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992316696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960167,0.0019430781,0.00023034356,0.00024209585,0.00010227762,0.00045782884,0.00019925278,0.00001896536,0.00078944035],"genre_scores_gemma":[0.99729484,0.0007149639,0.000436421,0.0001740587,0.00012347674,0.00038450968,0.00029424822,0.0000090470485,0.0005684514],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99837327,0.0010171941,0.00009503403,0.0002223118,0.000109819994,0.00018229966],"domain_scores_gemma":[0.99776506,0.0007170108,0.00041143928,0.0002975732,0.00017202056,0.0006369629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037086215,0.0017624752,0.003016951,0.00069266674,0.00061928655,0.0013008583,0.0007930925,0.00193071,0.001570674],"category_scores_gemma":[0.0032613191,0.0006358757,0.0012157689,0.00095720903,0.0015943476,0.0016565385,0.00039907114,0.003284074,0.00045496927],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9664511,0.0055122045,0.005415674,0.0001010153,0.0005465272,0.000041577,0.000070219336,0.00061812205,0.0036726429,0.000065718625,0.00019634594,0.017308809],"study_design_scores_gemma":[0.49725428,0.47033337,0.022372503,0.000047683257,0.002166935,0.0001546009,0.00008934508,0.0016340357,0.0041669817,0.00028505045,0.0014310216,0.000064237756],"about_ca_topic_score_codex":0.001237279,"about_ca_topic_score_gemma":0.002666541,"teacher_disagreement_score":0.0037086215,"about_ca_system_score_codex":0.0012706819,"about_ca_system_score_gemma":0.0015037168,"threshold_uncertainty_score":0.019613266},"labels":[],"label_agreement":null},{"id":"W1992360936","doi":"10.1007/s10549-009-0473-3","title":"Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"University of Toronto","keywords":"Multiple drug resistance; Microsphere; Cytotoxicity; Mechanism of action; Breast cancer; Mechanism (biology); Cancer research; Cancer cell; Medicine; Pharmacology; Cancer; Drug resistance; Chemistry; Biology; In vitro; Internal medicine; Genetics; Physics; Biochemistry","score_opus":0.050553072486108866,"score_gpt":0.3565520283039898,"score_spread":0.30599895581788095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992360936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98798615,0.002676587,0.0076129274,0.00021981914,0.00005013644,0.000083873434,0.00015209142,0.00007107284,0.0011472313],"genre_scores_gemma":[0.9940714,0.0008705146,0.0035255558,0.000048763242,0.000015544789,0.000036433452,0.00012429304,0.000016560365,0.0012907895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999926,0.000018331973,0.0000052781984,0.000015054438,0.000017400349,0.000017985134],"domain_scores_gemma":[0.99990416,0.000031493244,0.00002326544,0.0000108880295,0.000018823148,0.000011376082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030738505,0.00021505622,0.00023500381,0.00011722399,0.00015575005,0.00014953225,0.00031028377,0.00035282792,0.00065796496],"category_scores_gemma":[0.0001799729,0.000114352995,0.00020853106,0.00008062163,0.00014418602,0.00031785647,0.00010578778,0.00041853727,0.00011317975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015574065,0.000030494848,0.00005966856,0.000049323815,0.000004815851,0.000044488974,0.000019944668,0.00017710666,0.996976,0.00022102133,0.000050136972,0.0022111672],"study_design_scores_gemma":[0.000020462418,0.0004979548,0.00040752866,0.000002275988,0.000010150393,0.00007268982,0.00000632017,0.00089109945,0.9971366,0.000030819985,0.00092084485,0.000003369526],"about_ca_topic_score_codex":0.0007142829,"about_ca_topic_score_gemma":0.00062858715,"teacher_disagreement_score":0.0007142829,"about_ca_system_score_codex":0.00027816222,"about_ca_system_score_gemma":0.00021817672,"threshold_uncertainty_score":0.00220114},"labels":[],"label_agreement":null},{"id":"W1992858366","doi":"10.1007/s10549-010-0793-3","title":"Effect of air travel on lymphedema risk in women with history of breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Breast cancer; Medicine; Lymphedema; Cancer; Population; Air travel; Gynecology; Demography; Obstetrics; Surgery; Internal medicine; Environmental health","score_opus":0.017535173679999072,"score_gpt":0.32432764275137044,"score_spread":0.30679246907137137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992858366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968681,0.0012130522,0.000042498847,0.00017615753,0.000047358015,0.00000874551,0.00028527546,0.000006224402,0.0013525735],"genre_scores_gemma":[0.9987148,0.00040321136,0.000034691002,0.000041579566,0.000054890053,0.00000549782,0.00013523786,0.0000020913071,0.00060802646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996619,0.00014748392,0.000023597317,0.000048446538,0.000034084544,0.00008444111],"domain_scores_gemma":[0.99800605,0.0008242985,0.00039828778,0.000119379605,0.000105990046,0.0005459187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004854653,0.00030777827,0.0004169925,0.00041096078,0.00047370663,0.0006236171,0.00029463417,0.00075488933,0.0038192808],"category_scores_gemma":[0.003735848,0.00031768502,0.0013177941,0.0005415512,0.00025411593,0.0005940795,0.0005013224,0.000929889,0.00027422424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007448716,0.00042854794,0.9863252,0.000052860825,0.00047353038,0.00017192366,0.00008504729,0.00013151922,0.00029278465,0.000025816835,0.00013583055,0.0044283154],"study_design_scores_gemma":[0.00006586802,0.0011381533,0.99766123,0.000012910772,0.00030191956,0.00011534362,0.00018368739,0.00022004428,0.000050449136,0.00003515994,0.00020804645,0.000007221975],"about_ca_topic_score_codex":0.0096652815,"about_ca_topic_score_gemma":0.008627844,"teacher_disagreement_score":0.0096652815,"about_ca_system_score_codex":0.00026716347,"about_ca_system_score_gemma":0.00044100356,"threshold_uncertainty_score":0.019218028},"labels":[],"label_agreement":null},{"id":"W1993584752","doi":"10.1007/s10549-011-1816-4","title":"IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Senescence; Breast cancer; Apoptosis; Cancer research; Breast tumor; Signal transduction; Cellular senescence; Mammary gland; Medicine; Internal medicine; Oncology; Biology; Cancer; Cell biology; Genetics; Gene; Phenotype","score_opus":0.08185198898811565,"score_gpt":0.3178326369158198,"score_spread":0.23598064792770418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993584752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637135,0.020737354,0.0014787229,0.0018885308,0.00049668946,0.00006357909,0.001177618,0.00062788685,0.009816105],"genre_scores_gemma":[0.9774851,0.0066894917,0.0012633662,0.0004949117,0.000112729074,0.000048703136,0.0014773342,0.00004104921,0.012387392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982953,0.000032736167,0.000011305972,0.00001005666,0.000056148012,0.00006020184],"domain_scores_gemma":[0.9998778,0.000019932892,0.000019463887,0.000013837125,0.000026065685,0.00004281281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014904313,0.0004001544,0.0003244464,0.00040028928,0.0002939375,0.00042049782,0.00028758988,0.000385932,0.004971582],"category_scores_gemma":[0.00024249649,0.00018928936,0.00043578882,0.00016664689,0.00022654083,0.00015367079,0.00017302584,0.0008745743,0.00089753605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009394185,0.00092880375,0.0015116212,0.0003006394,0.00014891305,0.00016323643,0.00004913742,0.0003743304,0.935179,0.00038448095,0.0040787547,0.047486875],"study_design_scores_gemma":[0.0012166516,0.009609288,0.041229915,0.00006139349,0.00032587384,0.0008414514,0.00022289228,0.0018644184,0.91175914,0.00036888826,0.03244919,0.000050884853],"about_ca_topic_score_codex":0.0051093935,"about_ca_topic_score_gemma":0.010729629,"teacher_disagreement_score":0.0051093935,"about_ca_system_score_codex":0.00067610055,"about_ca_system_score_gemma":0.0009026204,"threshold_uncertainty_score":0.016631663},"labels":[],"label_agreement":null},{"id":"W1993747196","doi":"10.1007/s10549-012-2073-x","title":"Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"University of Toronto","keywords":"Medicine; Breast cancer; Internal medicine; Hazard ratio; Meta-analysis; Oncology; Obesity; Gynecology; Estrogen receptor; Estrogen; Hormone receptor; Cancer; Endocrinology; Confidence interval","score_opus":0.19044661725629475,"score_gpt":0.4518748275884921,"score_spread":0.2614282103321974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993747196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026906846,0.9702867,0.0010583217,0.00022623567,0.0003381706,0.00008353168,0.00074717,0.00004899334,0.0003041078],"genre_scores_gemma":[0.5033454,0.48898393,0.002933057,0.0013077914,0.0004637295,0.00029155222,0.0012435913,0.000055165325,0.0013757729],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9982064,0.00072172924,0.00039156186,0.0003794086,0.00016988677,0.00013091399],"domain_scores_gemma":[0.9965155,0.002343117,0.0005503068,0.00023128523,0.00024596832,0.00011380128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038915367,0.0025943988,0.009305677,0.0015561404,0.00044477812,0.0015081966,0.001662864,0.0016884491,0.004055896],"category_scores_gemma":[0.0072639263,0.0014264643,0.02874549,0.0029090715,0.00042154637,0.0009438198,0.0010522081,0.0018387283,0.00035941647],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061822273,0.00006055135,0.016313855,0.05950924,0.90430325,0.00016945337,0.000057525423,0.0005737316,0.00051137706,0.00008502176,0.000768182,0.0114656575],"study_design_scores_gemma":[0.0006525244,0.00020181663,0.0074356287,0.0013117131,0.9890786,0.00006665489,0.00002520838,0.00013203108,0.000072036564,0.00010545215,0.0009011275,0.00001725132],"about_ca_topic_score_codex":0.008605737,"about_ca_topic_score_gemma":0.021351282,"teacher_disagreement_score":0.009305677,"about_ca_system_score_codex":0.0009987644,"about_ca_system_score_gemma":0.0013946514,"threshold_uncertainty_score":0.020580709},"labels":[],"label_agreement":null},{"id":"W1994219760","doi":"10.1007/s10549-012-1991-y","title":"Which prediction models best identify additional axillary disease after a positive sentinel node biopsy for breast cancer?","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Island Health; University of Victoria; BC Cancer Agency","funders":"Fonds De La Recherche Scientifique - FNRS; Memorial Sloan-Kettering Cancer Center","keywords":"Breast cancer; Sentinel node; Medicine; Biopsy; Oncology; Breast disease; Axillary nodes; Internal medicine; Cancer","score_opus":0.033391358338302535,"score_gpt":0.34224878293590105,"score_spread":0.3088574245975985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994219760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89739925,0.016413266,0.052809287,0.018439397,0.0013750044,0.00019777917,0.006924099,0.0005259194,0.0059160343],"genre_scores_gemma":[0.98638153,0.0017746442,0.006054775,0.0009106855,0.00057212485,0.000057870187,0.002922302,0.000060242073,0.0012657399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811494,0.0012268372,0.00009558026,0.0002533266,0.00013479144,0.00017456205],"domain_scores_gemma":[0.9778438,0.01785341,0.0015559033,0.0009599978,0.0011185941,0.0006682998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010354891,0.0013937935,0.0019275434,0.0013557277,0.0003849508,0.0021027375,0.0013582206,0.0016966027,0.0039446424],"category_scores_gemma":[0.030141823,0.0004717539,0.0019692979,0.00090228155,0.00047467506,0.0026009232,0.00054341526,0.0018277281,0.0014106293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004080468,0.0006771521,0.8214428,0.00034630395,0.0020401746,0.0002037465,0.0001136327,0.034560867,0.00047950365,0.0010457794,0.011599631,0.12341],"study_design_scores_gemma":[0.00086105836,0.0021141085,0.3504466,0.0008278273,0.0065995995,0.00088828575,0.0009132701,0.5948271,0.0022758872,0.030922959,0.00914625,0.00017700615],"about_ca_topic_score_codex":0.0038162067,"about_ca_topic_score_gemma":0.005394662,"teacher_disagreement_score":0.010354891,"about_ca_system_score_codex":0.00054234185,"about_ca_system_score_gemma":0.0010837528,"threshold_uncertainty_score":0.054762542},"labels":[],"label_agreement":null},{"id":"W1994262858","doi":"10.1007/s10549-014-3026-3","title":"Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Women's College Hospital; Cancer Care Ontario; McGill University; University of Toronto; BC Cancer Agency; University of Alberta; Université de Montréal","funders":"National Cancer Institute","keywords":"Breast cancer; Tamoxifen; Medicine; Oncology; Internal medicine; Duration (music); Mutation; Cancer; Gynecology; Biology; Genetics; Gene","score_opus":0.017140606873584603,"score_gpt":0.31306727539047224,"score_spread":0.29592666851688765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994262858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977411,0.0014073678,0.000037628626,0.00007052906,0.000012608099,0.0000017739916,0.00026063283,0.0000056143504,0.00046263065],"genre_scores_gemma":[0.9986382,0.00035582396,0.000025139574,0.000030687974,0.000027107648,0.000002525351,0.0002139331,0.0000041813983,0.00070234924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979705,0.000047956826,0.000020524547,0.000037266913,0.00002796718,0.00006926183],"domain_scores_gemma":[0.9966903,0.0010668397,0.0011413934,0.00015980101,0.00011349475,0.0008282531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055666716,0.00022865925,0.00037519776,0.0008563791,0.00033134935,0.000621887,0.0003427047,0.0009399067,0.004291306],"category_scores_gemma":[0.0034650152,0.00036484684,0.00076159614,0.00067819626,0.00026345626,0.00056256994,0.00033047298,0.00071408076,0.00035566674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005643214,0.000088969304,0.98932475,0.000016464623,0.00020355434,0.00030831053,0.00010710409,0.00007462097,0.0011319293,0.00003372691,0.00009138681,0.0029759791],"study_design_scores_gemma":[0.000030799492,0.00034498615,0.99833786,0.000008164743,0.00015443457,0.00048579843,0.00013229204,0.00020336313,0.000080315134,0.00003750241,0.00017746718,0.000006960171],"about_ca_topic_score_codex":0.0070868125,"about_ca_topic_score_gemma":0.0051752995,"teacher_disagreement_score":0.0070868125,"about_ca_system_score_codex":0.00028677698,"about_ca_system_score_gemma":0.00033181123,"threshold_uncertainty_score":0.014355838},"labels":[],"label_agreement":null},{"id":"W1994685129","doi":"10.1007/s10549-012-2288-x","title":"Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Internal medicine; Regimen; Adverse effect; Breast cancer; Oncology; Odds ratio; Cancer; Progression-free survival; Gastroenterology; Surgery; Chemotherapy; Colorectal cancer","score_opus":0.3623807112931028,"score_gpt":0.5579478726196762,"score_spread":0.19556716132657337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994685129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80095,0.14910603,0.02009,0.00052640104,0.0007080154,0.0013444833,0.022051018,0.00041753892,0.0048064967],"genre_scores_gemma":[0.9830111,0.0049642217,0.002746343,0.00029027378,0.00020643689,0.00067134015,0.007298968,0.00009309029,0.0007181061],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9654961,0.023098812,0.005159015,0.00327037,0.0021555538,0.00082009606],"domain_scores_gemma":[0.94865113,0.03508511,0.008251145,0.005936956,0.0016088976,0.00046673225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027653374,0.0016676189,0.011586873,0.0024117655,0.00032353733,0.002317589,0.00089139806,0.0012479936,0.002817662],"category_scores_gemma":[0.054613885,0.0009618601,0.01834049,0.0028293056,0.0005000641,0.0016346019,0.0011332721,0.0013710982,0.00033645605],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16907534,0.00016785707,0.059960406,0.008968477,0.71121144,0.0003647886,0.00017496638,0.0068189544,0.0035328125,0.00028854303,0.002326003,0.03711048],"study_design_scores_gemma":[0.019007575,0.012928765,0.21837604,0.00074587774,0.73054814,0.00092597964,0.00021051594,0.006145838,0.002440661,0.0014889844,0.0069788136,0.00020278878],"about_ca_topic_score_codex":0.0010327375,"about_ca_topic_score_gemma":0.002007004,"teacher_disagreement_score":0.027653374,"about_ca_system_score_codex":0.00089178205,"about_ca_system_score_gemma":0.000763428,"threshold_uncertainty_score":0.14624679},"labels":[],"label_agreement":null},{"id":"W1994760694","doi":"10.1007/s10549-004-2622-z","title":"PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Mammaglobin; Breast cancer; Gene; Biology; Sequence (biology); Cancer; Genetics; Cancer research; Computational biology","score_opus":0.04839983044940402,"score_gpt":0.33050966087985434,"score_spread":0.28210983043045035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994760694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9590354,0.008544434,0.021968137,0.0004679863,0.00012013038,0.0000657046,0.0010755016,0.0008852526,0.007837349],"genre_scores_gemma":[0.9809368,0.0013532168,0.006822082,0.00026568113,0.000044778357,0.00006460837,0.0025786357,0.00009341596,0.007840735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997985,0.000025560306,0.000008778599,0.000054710337,0.000060450922,0.000052054133],"domain_scores_gemma":[0.99973875,0.00005624586,0.00006506303,0.000034475128,0.00003469668,0.00007078851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017063328,0.00054052914,0.00033177738,0.00049127865,0.0005193816,0.00042730343,0.00040636907,0.00048178906,0.0024565216],"category_scores_gemma":[0.00029466482,0.00022058637,0.00054407713,0.00037348643,0.00036386348,0.000279359,0.0004564658,0.0008634737,0.0012644267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015315259,0.000013637798,0.00063071784,0.000031285927,0.000008555757,0.00021524384,0.000017415166,0.000030406325,0.9951775,0.0001890129,0.0000971151,0.003435987],"study_design_scores_gemma":[0.000049950584,0.0002309685,0.050565097,0.000019829367,0.000047404515,0.0035581833,0.00014757588,0.0010530637,0.93477297,0.001048909,0.008486385,0.000019784979],"about_ca_topic_score_codex":0.0010870901,"about_ca_topic_score_gemma":0.0015227499,"teacher_disagreement_score":0.0024565216,"about_ca_system_score_codex":0.00057504507,"about_ca_system_score_gemma":0.00031249336,"threshold_uncertainty_score":0.008217871},"labels":[],"label_agreement":null},{"id":"W1995517580","doi":"10.1007/s10549-011-1896-1","title":"TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Adjuvant; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.056476571669289696,"score_gpt":0.3589421221986461,"score_spread":0.30246555052935636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995517580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154484,0.006145463,0.0002314513,0.00051778887,0.0001374438,0.000024089664,0.00036580738,0.000029982357,0.0010030696],"genre_scores_gemma":[0.9974324,0.0010384861,0.0003757129,0.00009918755,0.00014403186,0.000018084611,0.00040553958,0.0000048307957,0.0004817576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996138,0.00015243464,0.000041157295,0.00005642299,0.00007826201,0.00005800656],"domain_scores_gemma":[0.9988539,0.0004879819,0.00021084436,0.000049461418,0.000069635535,0.00032807232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011565941,0.00086942455,0.0018866621,0.0006824258,0.00023430755,0.00087293884,0.00044295614,0.000615782,0.0012511791],"category_scores_gemma":[0.002205858,0.00031935913,0.0007372016,0.0005717177,0.00021840548,0.0005416173,0.00028063555,0.0010674325,0.0003376358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13793974,0.0018078269,0.7489717,0.00030388072,0.0025502823,0.00060940423,0.00014191717,0.004809976,0.014057439,0.00018401703,0.0022062247,0.08641767],"study_design_scores_gemma":[0.0057995627,0.018564627,0.92692274,0.00020833891,0.005445551,0.0014849484,0.00028036078,0.029494246,0.0069145486,0.0010057879,0.0037608112,0.000118551354],"about_ca_topic_score_codex":0.0008520246,"about_ca_topic_score_gemma":0.0027196826,"teacher_disagreement_score":0.0018866621,"about_ca_system_score_codex":0.00051247375,"about_ca_system_score_gemma":0.0005637237,"threshold_uncertainty_score":0.006116748},"labels":[],"label_agreement":null},{"id":"W1995791488","doi":"10.1007/s10549-015-3268-8","title":"Germ line knockout of IGFBP-3 reveals influences of the gene on mammary gland neoplasia","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital","funders":"","keywords":"Knockout mouse; Endocrinology; Internal medicine; Gene knockout; Biology; Carcinogenesis; Mammary gland; Metastasis; Mammary tumor; DMBA; Cancer research; Cancer; Breast cancer; Receptor; Gene; Medicine; Genetics","score_opus":0.09393618233507531,"score_gpt":0.36794795206356307,"score_spread":0.27401176972848773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995791488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133576,0.0015086789,0.008204349,0.00073523703,0.00040305016,0.000046281813,0.003174342,0.0006958808,0.0038965226],"genre_scores_gemma":[0.97845227,0.00079012185,0.0043410845,0.000386202,0.000042589516,0.00004034214,0.0012841831,0.00073888013,0.013924358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995272,0.00005193733,0.000052264324,0.000098222314,0.0001599729,0.000110253306],"domain_scores_gemma":[0.9991314,0.0001773141,0.00028410068,0.00007489708,0.000047897207,0.00028443034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019943378,0.0008218963,0.0005378418,0.0012628686,0.0004397027,0.00076140964,0.00058784464,0.0009350659,0.0070505138],"category_scores_gemma":[0.00033969973,0.0006473816,0.00075275893,0.00037911988,0.0009295121,0.00034053126,0.0005253126,0.0024065557,0.0014747677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024101081,0.000023747905,0.00012352964,0.000011868761,0.000007477015,0.0001306501,0.000010866114,0.000043220174,0.99878174,0.00014128503,0.00006241049,0.0004221997],"study_design_scores_gemma":[0.000072319366,0.00016140133,0.0068431403,0.000013345449,0.0000712506,0.0008686667,0.000106811814,0.00087442587,0.98775566,0.00013075591,0.0030847262,0.000017594855],"about_ca_topic_score_codex":0.003295829,"about_ca_topic_score_gemma":0.006386556,"teacher_disagreement_score":0.0070505138,"about_ca_system_score_codex":0.00069454004,"about_ca_system_score_gemma":0.000745013,"threshold_uncertainty_score":0.023586333},"labels":[],"label_agreement":null},{"id":"W1996044800","doi":"10.1007/s10549-011-1533-z","title":"Effects of music therapy on pain among female breast cancer patients after radical mastectomy: results from a randomized controlled trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Music Therapy and Health","field":"Psychology","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Mastectomy; Physical therapy; McGill Pain Questionnaire; Anxiety; Modified Radical Mastectomy; Radical mastectomy; Music therapy; Breast surgery; Cancer; Surgery; Internal medicine; Visual analogue scale","score_opus":0.057789338278717926,"score_gpt":0.35697362497440327,"score_spread":0.29918428669568536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996044800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97530156,0.014693609,0.00071915827,0.0010654877,0.0010879184,0.0044664224,0.0009422294,0.00010290729,0.0016205724],"genre_scores_gemma":[0.9824027,0.00772749,0.0014554146,0.0010852825,0.0011839581,0.003982612,0.00061932526,0.000018905168,0.0015242174],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99829596,0.0009247566,0.00021228031,0.000249461,0.00012860994,0.0001888541],"domain_scores_gemma":[0.9973404,0.0013353582,0.0006025714,0.00019069973,0.00013182643,0.00039920173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002446733,0.001561857,0.0047432114,0.000641953,0.0008836413,0.0011792628,0.0012237664,0.0031345272,0.007811482],"category_scores_gemma":[0.0048288098,0.0009574704,0.0035289275,0.0008646737,0.0017153829,0.0011307131,0.00057419646,0.0029152108,0.000686422],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9838606,0.0039691706,0.00056808715,0.001368925,0.0021124955,0.000024079307,0.000042331816,0.000074044474,0.0006294578,0.000028771101,0.00022397972,0.0070980676],"study_design_scores_gemma":[0.97248185,0.023878044,0.001379988,0.00005437691,0.0018249194,0.000009646787,0.000023020131,0.00007198132,0.00009572376,0.000037617,0.00013383412,0.0000089015575],"about_ca_topic_score_codex":0.0020122747,"about_ca_topic_score_gemma":0.003442091,"teacher_disagreement_score":0.007811482,"about_ca_system_score_codex":0.00085763785,"about_ca_system_score_gemma":0.001240624,"threshold_uncertainty_score":0.026132047},"labels":[],"label_agreement":null},{"id":"W1996079450","doi":"10.1007/s10549-006-9208-x","title":"Pre-menopausal breast cancer and aromatase inhibitors: treating a new generation of women","year":2006,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Aromatase; Breast cancer; Medicine; Cancer; Internal medicine; Oncology; Gynecology; Endocrine system; Aromatase inhibitor; Menopause; Population; Anastrozole; Hormone","score_opus":0.03804621043606593,"score_gpt":0.3665825666742077,"score_spread":0.32853635623814176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996079450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007938808,0.99853516,0.00013796482,0.0003655906,0.00035029484,0.000003998377,0.000010404257,0.000008058433,0.00050910324],"genre_scores_gemma":[0.00038065627,0.99801046,0.00026231728,0.00033841486,0.000322753,0.00000614605,0.000022051494,0.0000013106628,0.00065579754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982005,0.000028312941,0.000023716162,0.000030961455,0.000077532226,0.00001937293],"domain_scores_gemma":[0.99970275,0.00012638798,0.000040505198,0.000009014964,0.0000819316,0.00003944204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006292459,0.0011255982,0.0021454052,0.001554077,0.00029246995,0.0009272926,0.0011738474,0.0016280612,0.003206518],"category_scores_gemma":[0.0007501953,0.00032033247,0.00040357347,0.0019394617,0.00048543033,0.0013725373,0.0005524942,0.001950498,0.0023065195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018526797,0.00010083533,0.00015984186,0.0069371685,0.00008007111,0.00027627786,0.000033556094,0.0002585205,0.0015570448,0.0012730046,0.060708053,0.9284304],"study_design_scores_gemma":[0.00008120131,0.00013086812,0.00068492215,0.0012730571,0.00014964376,0.0018129993,0.000057461093,0.000092986935,0.00034023394,0.00093529234,0.9944252,0.00001612781],"about_ca_topic_score_codex":0.0013228535,"about_ca_topic_score_gemma":0.0034677447,"teacher_disagreement_score":0.003206518,"about_ca_system_score_codex":0.0005355712,"about_ca_system_score_gemma":0.0010115018,"threshold_uncertainty_score":0.010726869},"labels":[],"label_agreement":null},{"id":"W1996146233","doi":"10.1023/a:1017371013487","title":"Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Cytotoxic T cell; Apoptosis; Biology; Programmed cell death; Cytotoxicity; Cancer cell; Cell culture; In vitro; Sense (electronics); Cancer research; Estrogen receptor; Molecular biology; Cell biology; Cancer; Chemistry; Biochemistry; Breast cancer","score_opus":0.01924259500436479,"score_gpt":0.3053459202519247,"score_spread":0.2861033252475599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996146233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958896,0.0013069912,0.0005932883,0.00011278235,0.00007224351,0.000037862043,0.00026141983,0.00007208549,0.0016537927],"genre_scores_gemma":[0.9964978,0.0007797685,0.0006245005,0.000041882737,0.000020449404,0.00003503775,0.0003888701,0.000016438174,0.0015952806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997898,0.00005002732,0.000019129273,0.000026390066,0.000041107185,0.000073473086],"domain_scores_gemma":[0.9998098,0.00008517453,0.000021342954,0.0000336357,0.000017632296,0.00003245758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022011137,0.000348516,0.00038310586,0.00027020698,0.0002980215,0.0003086413,0.00020245038,0.00032631814,0.00244852],"category_scores_gemma":[0.00022288255,0.00018597789,0.00027070334,0.00025920125,0.00025009114,0.000188606,0.00017035837,0.00057436747,0.00039166037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008397581,0.00012613532,0.00014860374,0.000033407687,0.0000072837784,0.00006279389,0.00003557603,0.000055029446,0.99704033,0.00013682697,0.00006172382,0.001452533],"study_design_scores_gemma":[0.0000795566,0.00091502786,0.0018861889,0.000003653804,0.000015181225,0.00011173866,0.000023368102,0.0003273619,0.9955243,0.000040270785,0.0010706158,0.0000028056875],"about_ca_topic_score_codex":0.0016232985,"about_ca_topic_score_gemma":0.0027546224,"teacher_disagreement_score":0.00244852,"about_ca_system_score_codex":0.00025026262,"about_ca_system_score_gemma":0.00038826445,"threshold_uncertainty_score":0.008191168},"labels":[],"label_agreement":null},{"id":"W1996457137","doi":"10.1007/s10549-007-9600-1","title":"Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Docetaxel; Medicine; Oncology; Taxane; Breast cancer; Internal medicine; Chemotherapy; Adjuvant; Anthracycline; Doxorubicin; Cancer","score_opus":0.015603138609867487,"score_gpt":0.3381825811488379,"score_spread":0.3225794425389704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996457137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924331,0.0041887457,0.00008339336,0.0007830228,0.0000680929,0.000031001404,0.0004629946,0.000007849147,0.0019417943],"genre_scores_gemma":[0.9979317,0.00061611785,0.000038242055,0.00024221942,0.00004264217,0.000023249904,0.00046088337,0.0000029256832,0.0006420166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972504,0.00011275628,0.00002582611,0.00004190005,0.000035581652,0.000058812897],"domain_scores_gemma":[0.99897975,0.0005318732,0.00018351122,0.000040901425,0.0000725115,0.00019140106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005634175,0.00016638523,0.00060914585,0.00035809012,0.0001780469,0.0002526435,0.00020548832,0.0005052629,0.0014876698],"category_scores_gemma":[0.0034967512,0.00009839751,0.00047816438,0.0003290614,0.00016801682,0.0002563496,0.00023516967,0.0005596893,0.0001880472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03274537,0.0005155822,0.9142102,0.00015310239,0.00038124213,0.0004131063,0.00024355322,0.0013031531,0.0032651736,0.00006160345,0.0008167836,0.04589104],"study_design_scores_gemma":[0.00025214456,0.0025127546,0.9943486,0.000023351147,0.0002357056,0.00032092907,0.00015732838,0.0005750711,0.00039141503,0.00008053323,0.0010940534,0.000008102692],"about_ca_topic_score_codex":0.0016860699,"about_ca_topic_score_gemma":0.0027500442,"teacher_disagreement_score":0.0016860699,"about_ca_system_score_codex":0.0004861998,"about_ca_system_score_gemma":0.00027271177,"threshold_uncertainty_score":0.0049767494},"labels":[],"label_agreement":null},{"id":"W1996524730","doi":"10.1007/s10549-008-9892-9","title":"Early radiation exposures and BRCA1-associated breast cancer in young women from Poland","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Odds ratio; Risk factor; Oncology; Cancer; Internal medicine; Confidence interval; Gynecology","score_opus":0.021728225115792536,"score_gpt":0.31387175186650146,"score_spread":0.2921435267507089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996524730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924517,0.00024497116,0.0000306527,0.00003213209,0.0000025339511,0.0000058124438,0.000090008194,0.0000013744179,0.00034741088],"genre_scores_gemma":[0.9987697,0.00042956974,0.000034083558,0.000031538104,0.0000045350835,0.0000061715264,0.000116361785,0.0000021039934,0.0006059083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998573,0.000021689559,0.000017017837,0.0000303757,0.000022149641,0.00005143212],"domain_scores_gemma":[0.9997738,0.000029184497,0.00007071575,0.0000082306415,0.000028641916,0.00008947122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017562597,0.00020579812,0.00031063598,0.0009987064,0.00050319644,0.00049314316,0.0002287216,0.00032370145,0.0012581863],"category_scores_gemma":[0.00059765513,0.00042155583,0.00033869132,0.0007971647,0.00022208238,0.00023453799,0.00049967266,0.0003434339,0.00020365228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021230626,0.00005625159,0.99485093,0.00003185604,0.000029632867,0.0007315886,0.0008140184,0.000024611792,0.00084725936,0.000027865126,0.00007832995,0.0022953986],"study_design_scores_gemma":[0.00000604299,0.00009005202,0.997917,0.000008717538,0.000028106815,0.00064203003,0.00080529996,0.000019852787,0.000093179784,0.000016016247,0.00037043195,0.0000033203926],"about_ca_topic_score_codex":0.026274113,"about_ca_topic_score_gemma":0.028625853,"teacher_disagreement_score":0.026274113,"about_ca_system_score_codex":0.00050806307,"about_ca_system_score_gemma":0.0007191436,"threshold_uncertainty_score":0.05224234},"labels":[],"label_agreement":null},{"id":"W1996713943","doi":"10.1007/s10549-012-2223-1","title":"Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Statistics Canada; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; Susan G. Komen","keywords":"Metformin; Medicine; Breast cancer; Internal medicine; Endocrinology; Leptin; Gastroenterology; Insulin; Cancer; Oncology; Obesity","score_opus":0.04864406748858407,"score_gpt":0.3631630840645098,"score_spread":0.31451901657592574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996713943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984682,0.0007408441,0.00005659105,0.00006894874,0.0000144194555,0.000022881733,0.00015026279,0.0000017115046,0.00047611352],"genre_scores_gemma":[0.9987061,0.00036949286,0.000075668984,0.00006961627,0.00004460347,0.000026863352,0.00020598625,0.0000020801658,0.00049957377],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997621,0.00010322101,0.000011428636,0.000036784306,0.000020115618,0.00006624289],"domain_scores_gemma":[0.99931943,0.0001755031,0.000148397,0.000068263944,0.00003091669,0.0002574319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007800344,0.00038724035,0.0007393682,0.00027880844,0.0004643153,0.00086997106,0.0002471947,0.00061456946,0.0015221215],"category_scores_gemma":[0.001010234,0.0002949287,0.00040469342,0.00053437264,0.00033237733,0.00072710257,0.00037243616,0.0009034395,0.00021189729],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38909894,0.007648281,0.55794275,0.00011177518,0.0006033186,0.0009468933,0.00020414221,0.00034106965,0.017485466,0.00042711786,0.00043287687,0.024757445],"study_design_scores_gemma":[0.0034686418,0.037868418,0.95178485,0.000027849384,0.00085879676,0.00068270246,0.00032012913,0.0005270296,0.0018875276,0.0005209566,0.0020002425,0.0000529656],"about_ca_topic_score_codex":0.0006674891,"about_ca_topic_score_gemma":0.0010771787,"teacher_disagreement_score":0.0015221215,"about_ca_system_score_codex":0.00041984717,"about_ca_system_score_gemma":0.0004861254,"threshold_uncertainty_score":0.005092025},"labels":[],"label_agreement":null},{"id":"W1996813547","doi":"10.1007/s10549-008-0039-9","title":"A pilot genome-wide association study of early-onset breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"National Cancer Institute; Cancer Care Ontario; Deutsches Krebsforschungszentrum","keywords":"Single-nucleotide polymorphism; Breast cancer; Genome-wide association study; Biology; Multiple comparisons problem; Genetics; Bonferroni correction; Haplotype; False discovery rate; Population; Genetic association; Genotype; Oncology; Cancer; Gene; Medicine","score_opus":0.04908902431718378,"score_gpt":0.3512812746081813,"score_spread":0.30219225029099755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996813547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959549,0.0003030056,0.0010038522,0.0003088926,0.00005525883,0.00023800222,0.001326155,0.000036573772,0.00077354675],"genre_scores_gemma":[0.9953408,0.00014012758,0.0012231952,0.0002236473,0.00006110411,0.00023922087,0.0012534916,0.000024965639,0.0014935351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972127,0.0015674746,0.000118423945,0.00057455874,0.00019508168,0.00033178212],"domain_scores_gemma":[0.995933,0.0015077103,0.00024425745,0.00085132715,0.0004738275,0.0009899326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036744534,0.0014154898,0.0011819832,0.0007899462,0.002304064,0.001020673,0.0011763748,0.0018436961,0.0038412574],"category_scores_gemma":[0.0056525767,0.0007621784,0.0012731344,0.0014598256,0.0007610636,0.000769437,0.0013314766,0.0014320688,0.0006557963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034605566,0.00490356,0.8900533,0.00019855764,0.0019006686,0.008417729,0.002446343,0.0003534279,0.037971452,0.00068933796,0.0032942242,0.015165819],"study_design_scores_gemma":[0.0021375068,0.005680322,0.98495525,0.000011811296,0.00082771166,0.0017710797,0.0005083962,0.00034273323,0.0009922992,0.00023552612,0.002504343,0.000032930064],"about_ca_topic_score_codex":0.019507611,"about_ca_topic_score_gemma":0.01746269,"teacher_disagreement_score":0.019507611,"about_ca_system_score_codex":0.00061249273,"about_ca_system_score_gemma":0.0012404562,"threshold_uncertainty_score":0.03878814},"labels":[],"label_agreement":null},{"id":"W1997376045","doi":"10.1007/s10549-011-1517-z","title":"Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; Single-nucleotide polymorphism; Adiponectin; Leptin receptor; Odds ratio; Internal medicine; Adipokine; Haplotype; Biology; Endocrinology; Population; Case-control study; Leptin; Oncology; Medicine; Genotype; Cancer; Genetics; Obesity; Insulin resistance; Gene","score_opus":0.03271795817379406,"score_gpt":0.31027126334338884,"score_spread":0.27755330516959476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997376045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984664,0.00052283966,0.00022013285,0.00009407852,0.000013492913,0.00000627066,0.00017686853,0.000006642385,0.00049331895],"genre_scores_gemma":[0.9992706,0.00014692455,0.00017618963,0.00003191339,0.000015812775,0.0000048021548,0.00012585065,0.0000061383307,0.0002216456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990953,0.00029558231,0.00012563386,0.00024580234,0.0001259478,0.00011174959],"domain_scores_gemma":[0.9983845,0.00058708637,0.0005402616,0.00016780235,0.000116735966,0.0002036397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074843696,0.00036759482,0.0005708933,0.001080114,0.00034707753,0.00052177726,0.0005139428,0.00067369593,0.0024104386],"category_scores_gemma":[0.0018078645,0.00035583717,0.0008134375,0.0012897182,0.00040923594,0.0002384371,0.0003334059,0.0005572907,0.00018738389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018802575,0.00011562926,0.97229224,0.00003863662,0.0012840689,0.00078489777,0.00022162664,0.00029986998,0.017741593,0.00040959666,0.00020796362,0.0047236974],"study_design_scores_gemma":[0.000044080385,0.00009767144,0.9971589,0.000010551292,0.0002710421,0.0009070384,0.00012214006,0.00051398226,0.00044361697,0.00023231977,0.00019001319,0.000008669932],"about_ca_topic_score_codex":0.004238054,"about_ca_topic_score_gemma":0.004290737,"teacher_disagreement_score":0.004238054,"about_ca_system_score_codex":0.00024621314,"about_ca_system_score_gemma":0.00021288736,"threshold_uncertainty_score":0.0084267855},"labels":[],"label_agreement":null},{"id":"W1997404594","doi":"10.1007/s10549-008-0255-3","title":"Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Family history; Oncology; Internal medicine; Cancer; Mammary gland; Epidemiology of cancer","score_opus":0.07866127971220313,"score_gpt":0.3612386082702602,"score_spread":0.28257732855805706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997404594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177,0.00057618617,0.00013889058,0.00024495233,0.000023139803,0.000007850106,0.006149873,0.000025043128,0.0010638804],"genre_scores_gemma":[0.9967303,0.00032454138,0.00009122727,0.000052600382,0.000022667953,0.000013306106,0.00221876,0.0000060267967,0.0005405117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943036,0.00021056925,0.000064860855,0.00013516229,0.00007339331,0.00008573571],"domain_scores_gemma":[0.99480927,0.0014573651,0.0019910417,0.0005368494,0.00043538646,0.0007701109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001032208,0.00019943815,0.00043837872,0.001390689,0.0005694808,0.0005203908,0.0005720322,0.0006812162,0.0034249818],"category_scores_gemma":[0.005701727,0.0004128625,0.00066775567,0.0017359019,0.00021506523,0.0009112656,0.000448691,0.0008110621,0.00046346406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048233833,0.000015288379,0.9989968,0.000004398101,0.000053080552,0.000060085422,0.000023424313,0.0000683634,0.000031958516,0.000014771036,0.00030771113,0.00037583575],"study_design_scores_gemma":[0.00000576555,0.000025502517,0.99891937,0.0000060735,0.000049158232,0.0003820168,0.00010251788,0.00027557852,0.000032939253,0.000020597336,0.00017539521,0.0000051066895],"about_ca_topic_score_codex":0.026010185,"about_ca_topic_score_gemma":0.02113142,"teacher_disagreement_score":0.026010185,"about_ca_system_score_codex":0.0004580434,"about_ca_system_score_gemma":0.00066409813,"threshold_uncertainty_score":0.05171758},"labels":[],"label_agreement":null},{"id":"W1997695524","doi":"10.1007/s10549-009-0501-3","title":"An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Biology; Transcriptome; Gene; Copy number analysis; Breast cancer; Copy-number variation; Microarray; Gene expression profiling; Gene expression; Cancer research; Cancer; Genetics; Genome","score_opus":0.015352931415507658,"score_gpt":0.32121499504678835,"score_spread":0.3058620636312807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997695524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289167,0.0010516273,0.0037377805,0.00009137885,0.000009474249,0.000017544673,0.0013010681,0.000076399345,0.0008230182],"genre_scores_gemma":[0.99000895,0.00061293406,0.0050620935,0.00006809365,0.000015555835,0.00002836823,0.0028691678,0.000028628567,0.0013062458],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998585,0.000016329526,0.000007180199,0.00004464765,0.000043018386,0.000030383762],"domain_scores_gemma":[0.9998963,0.00002707954,0.000031809876,0.000012872015,0.000012195396,0.000019810304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002066586,0.00024391215,0.00039067556,0.00073860696,0.00027940347,0.00042815763,0.0002282778,0.00013178147,0.0011700451],"category_scores_gemma":[0.00017563182,0.0001498664,0.000382901,0.000577413,0.00020983086,0.00021383862,0.0002643568,0.00032554974,0.0001676059],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037943496,0.000027541448,0.004395279,0.000042178963,0.00003044917,0.0000700954,0.000041297124,0.0003808432,0.9900434,0.00027450913,0.00005950746,0.0042554513],"study_design_scores_gemma":[0.000087092565,0.0008060717,0.5433228,0.00002420259,0.0005411191,0.0012943206,0.00041203166,0.01704959,0.42943287,0.0012990326,0.0056896065,0.000041299845],"about_ca_topic_score_codex":0.0016258268,"about_ca_topic_score_gemma":0.0038105857,"teacher_disagreement_score":0.0016258268,"about_ca_system_score_codex":0.00031362002,"about_ca_system_score_gemma":0.0003951702,"threshold_uncertainty_score":0.0039141774},"labels":[],"label_agreement":null},{"id":"W1997716402","doi":"10.1023/a:1010615124301","title":"Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Myoepithelial cell; Progenitor cell; Biology; Cell biology; Keratin; Progenitor; Epithelial cell adhesion molecule; Population; Stem cell; Epithelium; Immunology; Cell adhesion molecule; Immunohistochemistry; Medicine; Genetics","score_opus":0.033298330805041326,"score_gpt":0.33878690125845745,"score_spread":0.30548857045341615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997716402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703264,0.00745481,0.011224884,0.00013409607,0.0000400935,0.00014126621,0.0033776513,0.000094865165,0.0072057447],"genre_scores_gemma":[0.9708133,0.0034859097,0.0069425264,0.0001530876,0.000050464834,0.00025399972,0.009089178,0.00008850995,0.009123094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998642,0.00001830474,0.00002145925,0.000023944383,0.00004026853,0.000031822965],"domain_scores_gemma":[0.9997632,0.00006281778,0.000014825102,0.000033338572,0.00006502691,0.0000608039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024228457,0.00013075396,0.00027433824,0.0007761192,0.000292213,0.0005231555,0.00024073353,0.0002146766,0.0019468294],"category_scores_gemma":[0.0002589362,0.00012673184,0.00014591432,0.00059956533,0.00012117008,0.0002390082,0.0003035725,0.0004353736,0.0009958181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006703933,0.0000816703,0.0035539763,0.00009595438,0.0000121917865,0.000338959,0.00017841836,0.00005723783,0.985134,0.0006722845,0.0001807789,0.009024131],"study_design_scores_gemma":[0.00007495709,0.00069719437,0.13454974,0.000054743745,0.00011774246,0.0045612804,0.0008214028,0.0016351016,0.8143582,0.0005552187,0.04255796,0.000016453143],"about_ca_topic_score_codex":0.0009900484,"about_ca_topic_score_gemma":0.00080847647,"teacher_disagreement_score":0.0019468294,"about_ca_system_score_codex":0.00012509704,"about_ca_system_score_gemma":0.00018679503,"threshold_uncertainty_score":0.0065128207},"labels":[],"label_agreement":null},{"id":"W1997802902","doi":"10.1007/s10549-014-3179-0","title":"Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"DNA methylation; Breast cancer; Peripheral blood; Methylation; Triple-negative breast cancer; Cancer research; Medullary cavity; Biology; Promoter; Cancer; DNA; Medicine; Oncology; Pathology; Genetics; Internal medicine; Gene; Gene expression","score_opus":0.020562067851148447,"score_gpt":0.316476736448199,"score_spread":0.29591466859705057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997802902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990496,0.0003517365,0.00014244532,0.000033489665,0.0000042741567,0.0000018792781,0.00011211392,0.000008712771,0.00029571258],"genre_scores_gemma":[0.99945253,0.00006606273,0.000068027504,0.000011471214,0.000006667417,0.0000023615073,0.000073815696,0.0000025943382,0.00031644612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998559,0.00003627964,0.000011131545,0.00003940815,0.00003095206,0.000026388036],"domain_scores_gemma":[0.99933666,0.00020117023,0.00025320746,0.000038941802,0.000051603434,0.00011843456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001684607,0.0001688072,0.00024945123,0.0007680463,0.00025246292,0.00028728376,0.00024940012,0.0003608108,0.0020005868],"category_scores_gemma":[0.0010726296,0.00022757349,0.00015272565,0.00050400436,0.00022136678,0.00015284264,0.00016790055,0.00038410106,0.0002278992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014522827,0.0000903407,0.93451524,0.0000441704,0.000094549294,0.0006837368,0.00025704913,0.00009395282,0.055373643,0.00007597626,0.00017966445,0.007139413],"study_design_scores_gemma":[0.000006489562,0.00007427215,0.9957717,0.000004127157,0.000033052525,0.0017467388,0.000070524635,0.00017289275,0.0018995274,0.00007165607,0.00014571336,0.000003234584],"about_ca_topic_score_codex":0.0014316351,"about_ca_topic_score_gemma":0.0014759874,"teacher_disagreement_score":0.0020005868,"about_ca_system_score_codex":0.00013119783,"about_ca_system_score_gemma":0.000116626936,"threshold_uncertainty_score":0.006692648},"labels":[],"label_agreement":null},{"id":"W1999461982","doi":"10.1007/s10549-008-0033-2","title":"Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Calgary; Western University; Cancer Care Ontario","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Metastatic breast cancer; Multivariate analysis; Oncology; Univariate analysis; Cancer; Proportional hazards model; Prognostic variable","score_opus":0.11164049616071636,"score_gpt":0.4002757301324612,"score_spread":0.28863523397174484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999461982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801195,0.0008126657,0.00019358055,0.000061125924,0.000020282374,0.000004122784,0.00032331204,0.0000106846355,0.00056230533],"genre_scores_gemma":[0.9991391,0.00016549842,0.00008698503,0.000019644962,0.000022362346,0.000004278524,0.0002623058,0.0000017631332,0.00029797672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983203,0.000039177212,0.000021572705,0.000038651862,0.00003210243,0.000036505753],"domain_scores_gemma":[0.99892384,0.0003475097,0.0003789652,0.00007104151,0.00012858644,0.00015008624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048628345,0.00021881527,0.00033892336,0.0007613675,0.00022133006,0.0005676275,0.00018453067,0.0004580336,0.0010689645],"category_scores_gemma":[0.0020538666,0.00011433914,0.00026205936,0.00090496265,0.00020348789,0.0004642896,0.0001825277,0.0003973161,0.0002982043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003285222,0.000084684936,0.97971493,0.000021749802,0.00009058547,0.00027144133,0.00007040736,0.00023292679,0.0056304648,0.000043891963,0.00018965984,0.010364122],"study_design_scores_gemma":[0.000011659441,0.00031370908,0.9959198,0.0000046993755,0.000061380066,0.0006395415,0.00008448456,0.00080831256,0.001566818,0.000087481516,0.0004950152,0.00000699286],"about_ca_topic_score_codex":0.0011727298,"about_ca_topic_score_gemma":0.0011622483,"teacher_disagreement_score":0.0011727298,"about_ca_system_score_codex":0.00024736326,"about_ca_system_score_gemma":0.00013703047,"threshold_uncertainty_score":0.0035759807},"labels":[],"label_agreement":null},{"id":"W1999636411","doi":"10.1007/s10549-014-3011-x","title":"Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Juravinski Hospital","funders":"","keywords":"Multiplex ligation-dependent probe amplification; Loss of heterozygosity; Breast cancer; Germline mutation; Germline; Biology; Genetic testing; Genetics; Exon; Cancer research; Cancer; Mutation; Medicine; Gene; Allele","score_opus":0.03100624167884535,"score_gpt":0.35346964939144404,"score_spread":0.3224634077125987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999636411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875207,0.0016450476,0.000636112,0.0030074061,0.00022037262,0.000063607156,0.00021889155,0.00008053338,0.006607419],"genre_scores_gemma":[0.99617434,0.00072024425,0.00034224472,0.00068675895,0.00034525085,0.000008455302,0.00006638343,0.000021281394,0.0016349567],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997236,0.000027733877,0.0000276466,0.000066466,0.000052081865,0.000102481026],"domain_scores_gemma":[0.9989857,0.00031819317,0.000183061,0.00004317663,0.00007072473,0.00039913147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023645168,0.0012361241,0.00090299547,0.003130001,0.0019541727,0.00084536505,0.0009335792,0.0030724006,0.002600829],"category_scores_gemma":[0.0020829013,0.00094389886,0.0006559554,0.0011416794,0.0010492817,0.0007590526,0.00081191276,0.0021925922,0.00056660967],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013955365,0.00007551372,0.016269771,0.0000121982375,0.0000076097817,0.98026514,0.00018006445,0.000027309276,0.0017514077,0.00008265639,0.0002161439,0.0009725715],"study_design_scores_gemma":[0.000019585377,0.00024878912,0.029309262,0.00001183757,0.000046008852,0.96853983,0.0003342869,0.0001994126,0.000727428,0.00013562042,0.00040934177,0.000018650004],"about_ca_topic_score_codex":0.0044584298,"about_ca_topic_score_gemma":0.004949799,"teacher_disagreement_score":0.0044584298,"about_ca_system_score_codex":0.0008262678,"about_ca_system_score_gemma":0.00072225905,"threshold_uncertainty_score":0.008864939},"labels":[],"label_agreement":null},{"id":"W2000057619","doi":"10.1007/s10549-007-9607-7","title":"Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Letrozole; Tamoxifen; Medicine; Breast cancer; Oncology; Gynecology; Population; Internal medicine; Antiestrogen; Quality-adjusted life year; Adjuvant therapy; Hormone therapy; Cancer; Cost effectiveness","score_opus":0.03176024745410351,"score_gpt":0.36129349442144953,"score_spread":0.32953324696734604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000057619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73218167,0.16630287,0.0013499534,0.042466123,0.00087927666,0.00094650674,0.012222227,0.000085638414,0.04356575],"genre_scores_gemma":[0.9750685,0.01831118,0.0012691355,0.0016881083,0.0001746977,0.00008589009,0.0011694712,0.000015216704,0.0022176914],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978897,0.0008966761,0.00013269299,0.0001159312,0.0004848226,0.00048019717],"domain_scores_gemma":[0.997632,0.0009958566,0.00030131073,0.000034648037,0.00046799844,0.000568107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002444832,0.0009518298,0.0020094928,0.0011523514,0.0009024764,0.0020499309,0.0012681724,0.0016535769,0.0076864217],"category_scores_gemma":[0.009751747,0.0004325843,0.0035978702,0.0024450074,0.0007810817,0.0007121826,0.0006617977,0.0017813304,0.00016317551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3299311,0.0019019481,0.09031376,0.009244428,0.020937167,0.0014307935,0.0007952311,0.10149885,0.0035274995,0.018069739,0.02749992,0.39484957],"study_design_scores_gemma":[0.11701153,0.030230857,0.5500547,0.0077321567,0.10208989,0.0021418424,0.005278158,0.110084645,0.002955624,0.01564646,0.055716984,0.0010570919],"about_ca_topic_score_codex":0.91413796,"about_ca_topic_score_gemma":0.9443986,"teacher_disagreement_score":0.08586204,"about_ca_system_score_codex":0.053681385,"about_ca_system_score_gemma":0.04952929,"threshold_uncertainty_score":0.38948756},"labels":[],"label_agreement":null},{"id":"W2000536166","doi":"10.1007/s10549-009-0318-0","title":"Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver General Hospital","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance","keywords":"Breast cancer; Medicine; Oncology; Tamoxifen; Internal medicine; Lymphovascular invasion; Proportional hazards model; Estrogen receptor; Progesterone receptor; Adjuvant therapy; Cohort; Population; Hormonal therapy; Cancer; Tissue microarray; Gynecology; Metastasis","score_opus":0.0242336923018934,"score_gpt":0.35889228611744545,"score_spread":0.3346585938155521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000536166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973699,0.0013973524,0.000056928868,0.00026240377,0.000023501218,0.0000038440094,0.00020424396,0.0000041464946,0.0006775342],"genre_scores_gemma":[0.99901915,0.0003158676,0.000034370078,0.000050775583,0.000043411692,0.0000032181104,0.00017433737,0.0000014723456,0.0003574112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974984,0.00006956346,0.000030856998,0.000037622704,0.000046955196,0.000065107946],"domain_scores_gemma":[0.9986022,0.00045069258,0.00053824036,0.00006715482,0.00007808385,0.0002636092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032401425,0.00019410596,0.00035338165,0.00035013104,0.00031623605,0.00048033,0.0002670178,0.00053491845,0.0022337034],"category_scores_gemma":[0.0029308898,0.00019204906,0.00054405094,0.0006270413,0.00023367864,0.0002858306,0.00019669642,0.0006518796,0.00022208304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007332305,0.000052837047,0.9954852,0.000012092403,0.0001026474,0.00015213172,0.00003077294,0.000034857836,0.0009547164,0.000023688854,0.00012585644,0.0022919825],"study_design_scores_gemma":[0.00001743114,0.000094921576,0.99893373,0.0000040747373,0.000092859176,0.0003346546,0.00004374952,0.000114128474,0.00010491811,0.000035821988,0.0002212126,0.0000025052307],"about_ca_topic_score_codex":0.0025316484,"about_ca_topic_score_gemma":0.0032533663,"teacher_disagreement_score":0.0025316484,"about_ca_system_score_codex":0.00023251872,"about_ca_system_score_gemma":0.00039306548,"threshold_uncertainty_score":0.007472515},"labels":[],"label_agreement":null},{"id":"W2000550559","doi":"10.1007/s10549-006-9207-y","title":"Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Letrozole; Medicine; Placebo; Breast cancer; Adjuvant; Adjuvant therapy; Duration (music); Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Cancer; Tamoxifen; Alternative medicine","score_opus":0.02032681081597929,"score_gpt":0.3338940062184454,"score_spread":0.3135671954024661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000550559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97167575,0.022327757,0.00019131466,0.0013470139,0.00031185528,0.00014017784,0.0013816631,0.000044566677,0.002579966],"genre_scores_gemma":[0.99290997,0.0030718779,0.00013103435,0.0005855573,0.00028933006,0.00018722215,0.00092258875,0.000005640069,0.00189673],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995926,0.0002580188,0.00002104054,0.000037083286,0.000032552845,0.000058671616],"domain_scores_gemma":[0.99906534,0.00027997786,0.00026343958,0.00009312062,0.00003850204,0.00025966123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001339935,0.00048123987,0.0013575436,0.00019010527,0.00021153533,0.0004903619,0.0004633969,0.00085968047,0.0036158827],"category_scores_gemma":[0.0022221897,0.0001598101,0.0007212033,0.00024414668,0.00034496354,0.0004432563,0.00023011409,0.0013389617,0.00030080043],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9654579,0.0006936931,0.0038087035,0.00048860913,0.0017596408,0.00006328553,0.000036273443,0.00042568732,0.002633555,0.0002718156,0.002094155,0.022266624],"study_design_scores_gemma":[0.78566843,0.117211856,0.07631158,0.000413239,0.008449123,0.00020651393,0.00009314288,0.0013049592,0.0014377623,0.001334172,0.007517221,0.000051955853],"about_ca_topic_score_codex":0.0014500611,"about_ca_topic_score_gemma":0.0026011285,"teacher_disagreement_score":0.0036158827,"about_ca_system_score_codex":0.0005556682,"about_ca_system_score_gemma":0.0006720892,"threshold_uncertainty_score":0.012096345},"labels":[],"label_agreement":null},{"id":"W2000765979","doi":"10.1007/s10549-008-9974-8","title":"Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; CDKN2A; CHEK2; Genetic predisposition; Oncology; Medicine; Cancer; Internal medicine; Population; Pathology; Biology; Disease; Germline mutation; Gene; Genetics","score_opus":0.050699307951924864,"score_gpt":0.329127639426374,"score_spread":0.2784283314744492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000765979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98540777,0.00027649067,0.010737062,0.00022279493,0.0000072702196,0.000049120878,0.00034096988,0.0000368084,0.0029217594],"genre_scores_gemma":[0.99334854,0.00042775503,0.0030157093,0.000046036093,0.000006178905,0.00004433336,0.000223935,0.000023617458,0.0028638924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956137,0.00012821054,0.000014670118,0.000110693894,0.0000512181,0.00013384309],"domain_scores_gemma":[0.99940217,0.000209999,0.00011032786,0.00013660127,0.00004564038,0.00009524345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006849242,0.00063938607,0.0008587664,0.0010731387,0.0006063394,0.0008163587,0.0004734999,0.00035638767,0.0022804064],"category_scores_gemma":[0.0013667861,0.0003041397,0.0009877769,0.0006198921,0.0008170253,0.00029055754,0.0015269332,0.00054916553,0.00023390821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00910871,0.0006377418,0.70553404,0.0002655407,0.0016216249,0.003132837,0.0017208442,0.019688094,0.119684495,0.053004455,0.0012139052,0.08438772],"study_design_scores_gemma":[0.00050305575,0.00224328,0.8676179,0.00007472815,0.0020219462,0.008220901,0.0016268586,0.052437395,0.016760271,0.036615897,0.011783217,0.00009455808],"about_ca_topic_score_codex":0.01098942,"about_ca_topic_score_gemma":0.010182005,"teacher_disagreement_score":0.01098942,"about_ca_system_score_codex":0.00047941259,"about_ca_system_score_gemma":0.0011044403,"threshold_uncertainty_score":0.021850944},"labels":[],"label_agreement":null},{"id":"W2000970249","doi":"10.1007/s10549-014-3126-0","title":"Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"GlaxoSmithKline","keywords":"Capecitabine; Lapatinib; Rash; Medicine; Breast cancer; Oncology; Internal medicine; Diarrhea; Cancer; Trastuzumab; Colorectal cancer","score_opus":0.03625959730007277,"score_gpt":0.3316780500213907,"score_spread":0.29541845272131795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000970249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8611368,0.0012851736,0.13036817,0.0009383759,0.00010756153,0.0007083216,0.0018052954,0.0017374472,0.0019129154],"genre_scores_gemma":[0.9519413,0.00027557652,0.04613204,0.0000905086,0.000045045148,0.00034273262,0.000823477,0.000039120827,0.00031013583],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99637955,0.002223897,0.00033910898,0.00028502612,0.00059965655,0.00017272859],"domain_scores_gemma":[0.9776534,0.017212352,0.0026000321,0.00050275004,0.0016897433,0.00034169073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007665784,0.0011518335,0.001463186,0.0028831528,0.00025810066,0.0014298959,0.00081811834,0.0006299297,0.00080395455],"category_scores_gemma":[0.031240778,0.00056082057,0.0014830134,0.0012205435,0.00020674098,0.00070104375,0.0007876351,0.0013114017,0.00031052937],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021186587,0.001006075,0.6670387,0.00018497668,0.0012239115,0.00039042736,0.00028150354,0.1183826,0.0013119269,0.00070628256,0.0035234366,0.20383158],"study_design_scores_gemma":[0.00012295421,0.0008304686,0.07560603,0.000060674913,0.00035460977,0.0002608248,0.000102008074,0.91967434,0.0011289829,0.0010772264,0.00072473317,0.00005708187],"about_ca_topic_score_codex":0.004378352,"about_ca_topic_score_gemma":0.004985999,"teacher_disagreement_score":0.007665784,"about_ca_system_score_codex":0.00081479317,"about_ca_system_score_gemma":0.0012902706,"threshold_uncertainty_score":0.040540993},"labels":[],"label_agreement":null},{"id":"W2001223590","doi":"10.1007/s10549-006-9189-9","title":"Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Telomerase; Mammary gland; Cancer research; BRCA2 Protein; Breast cancer; Human breast; Mutation; Biology; Medicine; Cancer; Gene; Genetics; Germline mutation","score_opus":0.031848657849421855,"score_gpt":0.3337428080592382,"score_spread":0.30189415020981636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001223590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932334,0.0018796916,0.00166758,0.00014390615,0.00006791469,0.000041461095,0.0006241842,0.000053708198,0.0022880665],"genre_scores_gemma":[0.9923994,0.0008841906,0.0007621178,0.0000569938,0.00002708712,0.000033505374,0.0014369827,0.000027975144,0.0043718363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998791,0.000020573816,0.0000182655,0.00002081784,0.000027551085,0.000033707463],"domain_scores_gemma":[0.99977404,0.00009845348,0.000015745904,0.000059224585,0.00002267066,0.000029877565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002989307,0.00014997806,0.0003032939,0.00044452105,0.00025634543,0.00035348983,0.00018137711,0.000309994,0.0023793334],"category_scores_gemma":[0.00043013453,0.0001195329,0.00036977028,0.00026994536,0.00015947112,0.00019712206,0.00018303347,0.00040292135,0.0004784988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049106294,0.000054862383,0.00063308567,0.000025114165,0.000009777456,0.00081611046,0.0001224293,0.00004897216,0.9947977,0.00047913857,0.00013669455,0.0023850335],"study_design_scores_gemma":[0.00007261461,0.00069300213,0.019204311,0.00001672656,0.00006150262,0.005287304,0.00022114853,0.0010670862,0.96144634,0.00025159077,0.011666058,0.000012156084],"about_ca_topic_score_codex":0.0010554042,"about_ca_topic_score_gemma":0.00059021206,"teacher_disagreement_score":0.0023793334,"about_ca_system_score_codex":0.00012892485,"about_ca_system_score_gemma":0.00022399503,"threshold_uncertainty_score":0.007959664},"labels":[],"label_agreement":null},{"id":"W2001366190","doi":"10.1007/s10549-007-9502-2","title":"Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"University of Pennsylvania","keywords":"Gefitinib; Breast cancer; In vivo; Medicine; Cancer research; PI3K/AKT/mTOR pathway; Epidermal growth factor receptor; MCF-7; EGFR inhibitors; Cancer; Protein kinase B; Pharmacology; Oncology; Internal medicine; Biology; Signal transduction","score_opus":0.05867916153529029,"score_gpt":0.33964189797129685,"score_spread":0.28096273643600655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001366190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340075,0.0022443084,0.001043849,0.00018101084,0.00003785909,0.000010382337,0.00096605835,0.000093639515,0.002022087],"genre_scores_gemma":[0.99396175,0.00071918266,0.0012073627,0.00008113421,0.000020680436,0.000038722013,0.0011545038,0.0000269526,0.0027896194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998312,0.000018869834,0.000012257998,0.000025845484,0.000055029188,0.000056748606],"domain_scores_gemma":[0.99990284,0.000010695207,0.000026682372,0.000006804585,0.000014699895,0.00003826045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009439814,0.00021584319,0.00046128515,0.0004714057,0.00034981375,0.00033918972,0.00014121676,0.00032077378,0.0024181665],"category_scores_gemma":[0.000097263226,0.00018455497,0.00016882684,0.00027521193,0.00022240894,0.00024030375,0.0001699732,0.00048035884,0.00033103238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047618494,0.00003138792,0.0010945796,0.000029772546,0.000015362586,0.00010274854,0.000030185092,0.000039204977,0.99667895,0.00007250819,0.000111994326,0.0013172004],"study_design_scores_gemma":[0.000021353328,0.00044218046,0.07335099,0.0000043475934,0.000050998195,0.0013773545,0.0001489092,0.00062043197,0.9211414,0.00007825187,0.0027536978,0.000010119038],"about_ca_topic_score_codex":0.0014511097,"about_ca_topic_score_gemma":0.0014775174,"teacher_disagreement_score":0.0024181665,"about_ca_system_score_codex":0.00031211818,"about_ca_system_score_gemma":0.00017936576,"threshold_uncertainty_score":0.008089542},"labels":[],"label_agreement":null},{"id":"W2002401135","doi":"10.1007/s10549-007-9608-6","title":"Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital; Jewish General Hospital; University of Toronto; Hôtel-Dieu de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; Women's College Hospital; Hôpital Notre-Dame; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Germline mutation; Breast cancer; Germline; Mutation; Genetics; Oncology; BRCA2 Protein; Medicine; Cancer; Biology; Internal medicine; Gene","score_opus":0.025190900524258555,"score_gpt":0.35051350757310173,"score_spread":0.3253226070488432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002401135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99012965,0.002116796,0.00018087443,0.0005755289,0.000032273318,0.00002565964,0.0009023403,0.000020887534,0.0060160924],"genre_scores_gemma":[0.99529946,0.001251264,0.00037433498,0.00015525662,0.000015219134,0.000012387402,0.00024276624,0.00001463226,0.0026347418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992625,0.0000697378,0.000035689583,0.00012823711,0.00017995283,0.00032380794],"domain_scores_gemma":[0.9992472,0.00016766984,0.00009966916,0.000027515927,0.00025253132,0.00020542361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004142399,0.00087887567,0.00043648086,0.002801541,0.004351756,0.00085120177,0.0010560538,0.0010875486,0.0060654995],"category_scores_gemma":[0.0022170858,0.0004819655,0.00061715214,0.002472917,0.0012435747,0.00025392944,0.0006431444,0.00055856054,0.0003463132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012325447,0.00020214269,0.83292323,0.00018869246,0.00018179079,0.089570925,0.0108858645,0.0014459946,0.012540139,0.0029137041,0.0061374325,0.041777566],"study_design_scores_gemma":[0.00010870694,0.00019336406,0.88242203,0.00015738567,0.0002854203,0.091907755,0.0068484806,0.0014890422,0.0025116892,0.0005042457,0.013452966,0.00011888583],"about_ca_topic_score_codex":0.9480909,"about_ca_topic_score_gemma":0.94265485,"teacher_disagreement_score":0.05190909,"about_ca_system_score_codex":0.013976593,"about_ca_system_score_gemma":0.009647314,"threshold_uncertainty_score":0.10442954},"labels":[],"label_agreement":null},{"id":"W2002541650","doi":"10.1007/s10549-013-2519-9","title":"Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Hazard ratio; Body mass index; Internal medicine; Proportional hazards model; Confidence interval; Cancer; Oncology; Metastasis; Cohort; Cohort study; Gastroenterology","score_opus":0.04558825852869533,"score_gpt":0.37693081841342935,"score_spread":0.33134255988473404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002541650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990595,0.00022148153,0.00007960137,0.000038592323,0.000015140265,0.000008688446,0.0003976952,0.0000036862982,0.00017549544],"genre_scores_gemma":[0.9988432,0.00018854307,0.000083701154,0.000030333867,0.000017958773,0.000011515194,0.0004286901,0.0000042135434,0.00039183057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924845,0.00017704304,0.00007050228,0.00023061321,0.00008062962,0.00019267113],"domain_scores_gemma":[0.99817884,0.00020992926,0.0004705476,0.0004839296,0.00016996099,0.00048690112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011430559,0.00088487146,0.0007519775,0.0007529017,0.001512257,0.0012965451,0.0009493356,0.001106361,0.002068349],"category_scores_gemma":[0.0018907324,0.0013312325,0.0018808865,0.0015922375,0.00053703855,0.0010619477,0.0008798631,0.0016347972,0.00045827508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012489144,0.00022260132,0.996289,0.000008469618,0.000539585,0.0002302721,0.00014539696,0.000041225667,0.00053399615,0.000027835264,0.00013519052,0.0005775207],"study_design_scores_gemma":[0.000070852555,0.00040815587,0.99794346,0.000007151038,0.00033161166,0.00040289937,0.00037289472,0.00017054514,0.0000733551,0.000031825504,0.00017170284,0.000015454389],"about_ca_topic_score_codex":0.028494056,"about_ca_topic_score_gemma":0.025427409,"teacher_disagreement_score":0.028494056,"about_ca_system_score_codex":0.0006871213,"about_ca_system_score_gemma":0.0009092124,"threshold_uncertainty_score":0.05665642},"labels":[],"label_agreement":null},{"id":"W2002873340","doi":"10.1007/s10549-015-3293-7","title":"Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Medical Research Council; Cancer Institute NSW; National Breast Cancer Foundation; National Health and Medical Research Council; Hunter Cancer Research Alliance","keywords":"Triple-negative breast cancer; Breast cancer; Germline mutation; Medicine; Oncology; BRCA mutation; Mutation; Ovarian cancer; Internal medicine; Genetic testing; Cancer; Cancer research; Genetics; Biology; Gene","score_opus":0.03149279560625292,"score_gpt":0.3441734918046504,"score_spread":0.3126806961983975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002873340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841,0.00037691882,0.000035387264,0.00006699804,0.0000069698003,0.0000023572652,0.00027298872,0.000004556644,0.00082376],"genre_scores_gemma":[0.9994861,0.00013481772,0.000021130229,0.00002524297,0.000013217765,0.000003315164,0.00014471792,0.0000017618494,0.0001697066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996774,0.000065499626,0.000044320066,0.000074412514,0.000057395027,0.00008095062],"domain_scores_gemma":[0.99863976,0.0003861354,0.00052664394,0.00006439283,0.000108770786,0.0002742251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033095694,0.00020493302,0.00038862493,0.0013983547,0.00050138,0.00067525473,0.00033987983,0.00072016515,0.004189097],"category_scores_gemma":[0.0024840755,0.00029967833,0.00037081676,0.0011372599,0.000323217,0.00053829333,0.0004001357,0.00060748303,0.00044084594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085355925,0.000019352194,0.998728,0.0000052827554,0.000015792495,0.00012046646,0.000049059785,0.000013556497,0.0002120039,0.00001463946,0.000060907536,0.00067554554],"study_design_scores_gemma":[0.0000027855842,0.000040144045,0.9986039,0.0000034267032,0.000019258145,0.000894776,0.00022764395,0.0000596826,0.000033460103,0.000024606585,0.000086986365,0.0000034479547],"about_ca_topic_score_codex":0.0024406593,"about_ca_topic_score_gemma":0.0019131692,"teacher_disagreement_score":0.004189097,"about_ca_system_score_codex":0.00020843207,"about_ca_system_score_gemma":0.00026869358,"threshold_uncertainty_score":0.014013946},"labels":[],"label_agreement":null},{"id":"W2003490109","doi":"10.1023/a:1020552501345","title":"Mega-Dose Vitamins and Minerals in the Treatment of Non-Metastatic Breast Cancer: An Historical Cohort Study","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QUAD Engineering (Canada); Institute for Clinical Evaluative Sciences; University of Waterloo; BC Cancer Agency; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Hazard ratio; Proportional hazards model; Cancer; Cohort; Oncology; Vitamin; Surgery; Gastroenterology; Confidence interval","score_opus":0.09230364693574779,"score_gpt":0.39290898740478786,"score_spread":0.3006053404690401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003490109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984024,0.0008857425,0.00008613022,0.000042624582,0.000008593269,0.000006843922,0.00018253044,0.0000026648825,0.0003825194],"genre_scores_gemma":[0.9988129,0.00048149223,0.000043362514,0.000029805547,0.000015867847,0.0000050476337,0.0001653925,0.0000020330842,0.00044411578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997205,0.000081520826,0.000023646595,0.00007789498,0.000034820318,0.00006166932],"domain_scores_gemma":[0.9992261,0.000113768,0.00022502466,0.00012252467,0.00008686378,0.00022573462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055562105,0.0002721131,0.0004818302,0.0004559863,0.0007532908,0.0005492752,0.00035087302,0.00053839444,0.0018321335],"category_scores_gemma":[0.0012153183,0.00042347968,0.00044981643,0.00085784344,0.00031123596,0.00036092984,0.00029014508,0.0006615073,0.0002526712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040917206,0.0004623528,0.9889264,0.000031425832,0.00038451725,0.00044782175,0.00026272112,0.00005944962,0.0016213509,0.000092777416,0.00018698208,0.0034324639],"study_design_scores_gemma":[0.00012061852,0.0015013902,0.9956579,0.000009532119,0.00037713355,0.0007143437,0.00024841866,0.00014369858,0.00028441768,0.000060930874,0.0008702516,0.000011412828],"about_ca_topic_score_codex":0.007357209,"about_ca_topic_score_gemma":0.006309313,"teacher_disagreement_score":0.007357209,"about_ca_system_score_codex":0.000329309,"about_ca_system_score_gemma":0.00035668132,"threshold_uncertainty_score":0.014628768},"labels":[],"label_agreement":null},{"id":"W2003626943","doi":"10.1007/s10549-008-0265-1","title":"Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Cancer; Incidence (geometry); Oncology; Cumulative incidence; Univariate analysis; Breast disease; Stage (stratigraphy); Gynecology; Multivariate analysis; Cohort","score_opus":0.028317651783944173,"score_gpt":0.33704377711293665,"score_spread":0.30872612532899246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003626943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810624,0.00082775456,0.00010943342,0.00004210549,0.0000046994805,0.0000023639423,0.00020048556,0.000003401432,0.00070354674],"genre_scores_gemma":[0.9996026,0.00012497163,0.000027100517,0.000008560998,0.000009253962,0.000001139174,0.000116247335,0.0000020477107,0.000108080836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995158,0.00018289125,0.000041978423,0.000080131715,0.000065688066,0.00011360699],"domain_scores_gemma":[0.9981719,0.00063558086,0.0006045546,0.00021825082,0.00010418079,0.00026535438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011512586,0.00018981386,0.00046007847,0.0011446119,0.000266025,0.0004564884,0.00030889595,0.000310498,0.0019889069],"category_scores_gemma":[0.0023961894,0.00013385889,0.00071831007,0.0014334857,0.0003147664,0.00041210925,0.0004035204,0.0003230833,0.00017171998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007237896,0.000011812065,0.99515355,0.000013107461,0.00012262701,0.00006668997,0.000049758117,0.000054197164,0.0005629197,0.00005197418,0.00003770126,0.0031518778],"study_design_scores_gemma":[0.0000064550986,0.00008930343,0.9990959,0.0000026265516,0.00008646906,0.0002647806,0.00009748317,0.00009315385,0.00008148217,0.00004897813,0.0001313194,0.000002082332],"about_ca_topic_score_codex":0.003417188,"about_ca_topic_score_gemma":0.004377955,"teacher_disagreement_score":0.003417188,"about_ca_system_score_codex":0.0002386839,"about_ca_system_score_gemma":0.00029395212,"threshold_uncertainty_score":0.0067946315},"labels":[],"label_agreement":null},{"id":"W2004009193","doi":"10.1007/s10549-012-2056-y","title":"Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Cancer Care Ontario; Public Health Ontario; University of Toronto","funders":"National Health and Medical Research Council; National Institutes of Health; National Cancer Institute; Medical Research Council; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Odds ratio; Menarche; Population; Cancer registry; Family history; Internal medicine; Cancer; Not Otherwise Specified; Mucinous carcinoma; Oncology; Confidence interval; Gynecology; Pathology; Adenocarcinoma","score_opus":0.07866602275306618,"score_gpt":0.3852750301401786,"score_spread":0.30660900738711244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004009193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952545,0.0006545292,0.00032121045,0.000076306176,0.000007330015,0.000027698747,0.0026090464,0.000015884481,0.0010335397],"genre_scores_gemma":[0.9982253,0.00017332156,0.000245648,0.00001493398,0.000009270456,0.000012115064,0.001191174,0.000003598358,0.0001247145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734074,0.0010040356,0.00031674205,0.0005905659,0.0004380732,0.00030982814],"domain_scores_gemma":[0.99181247,0.0017724396,0.0042452486,0.0009188326,0.0007741288,0.00047685506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016800961,0.00019594915,0.00038382984,0.0022225343,0.0004084798,0.00079737324,0.00070346746,0.00030406896,0.0015989976],"category_scores_gemma":[0.007966342,0.00035789167,0.0005228429,0.0032308595,0.00023601629,0.00067959866,0.00070420967,0.00046138966,0.00015004944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033223183,0.000007979329,0.9990144,0.0000055727337,0.00003306842,0.000022872971,0.00001996291,0.000040456118,0.00007758805,0.000025209963,0.00011013907,0.00060950196],"study_design_scores_gemma":[0.000003802921,0.000017196671,0.99908304,0.000006601094,0.000044099826,0.00018350675,0.00012625652,0.00023834073,0.00010192214,0.000028010045,0.00016435373,0.0000028394497],"about_ca_topic_score_codex":0.027943173,"about_ca_topic_score_gemma":0.036184732,"teacher_disagreement_score":0.027943173,"about_ca_system_score_codex":0.0007222084,"about_ca_system_score_gemma":0.0012817694,"threshold_uncertainty_score":0.055561006},"labels":[],"label_agreement":null},{"id":"W2006033910","doi":"10.1007/s10549-004-1250-y","title":"The 3020insC allele of NOD2 predisposes to early-onset breast cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"Warszawski Uniwersytet Medyczny","keywords":"Breast cancer; Allele; Medicine; Oncology; Cancer; Internal medicine; Genetics; Biology; Gene","score_opus":0.046368982688401096,"score_gpt":0.3790881616826772,"score_spread":0.3327191789942761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006033910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554414,0.0003050539,0.0006818842,0.0003729395,0.00007623905,0.000025259544,0.00029232074,0.00004750269,0.0026547255],"genre_scores_gemma":[0.9968437,0.00018490422,0.0005077346,0.000100931364,0.000097921235,0.000014565247,0.00016754307,0.000026281605,0.0020564145],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996382,0.00014142077,0.000034564295,0.00006200682,0.000060938688,0.00006290104],"domain_scores_gemma":[0.99891615,0.00032443154,0.00026023475,0.00007444255,0.00007022269,0.00035451885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029664836,0.001127676,0.00051695626,0.0016121938,0.00061968184,0.00036400714,0.0005162093,0.001205956,0.008295932],"category_scores_gemma":[0.0011984468,0.0003894429,0.00051473035,0.0007091738,0.00044258623,0.00021062505,0.0005056397,0.0007537531,0.00072287634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014300252,0.002316468,0.30457672,0.00020155891,0.00048506426,0.10455142,0.00076943205,0.00058593065,0.55135167,0.0022389628,0.0023082665,0.016314259],"study_design_scores_gemma":[0.000529139,0.0016379595,0.8193221,0.00010261978,0.00047861438,0.13995956,0.0007217515,0.0019259522,0.027822072,0.0017314594,0.00565051,0.00011821245],"about_ca_topic_score_codex":0.0019060206,"about_ca_topic_score_gemma":0.0014151077,"teacher_disagreement_score":0.008295932,"about_ca_system_score_codex":0.00026632598,"about_ca_system_score_gemma":0.00025101443,"threshold_uncertainty_score":0.027752638},"labels":[],"label_agreement":null},{"id":"W2006325063","doi":"10.1023/a:1023338718974","title":"SR Protein Expression and CD44 Splicing Pattern in Human Breast Tumours","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research","keywords":"RNA splicing; CD44; Breast cancer; Protein expression; Alternative splicing; Biology; Cancer research; Expression (computer science); Human breast; Oncology; Medicine; Internal medicine; Pathology; Exon; Genetics; Gene; Cancer; Computer science; Cell","score_opus":0.027548543326596318,"score_gpt":0.3413254758276895,"score_spread":0.3137769325010932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006325063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979784,0.00059237273,0.0002707436,0.00002492011,0.000004102314,0.0000033767055,0.000102931284,0.000013412273,0.0010098408],"genre_scores_gemma":[0.9964986,0.0005940778,0.0004343615,0.00001540142,0.000009040921,0.000008383203,0.00040526944,0.000009767906,0.0020251311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998779,0.000020962732,0.000012985172,0.000021843827,0.000034649423,0.000031626983],"domain_scores_gemma":[0.9998273,0.000062335836,0.000027464714,0.00001877015,0.000038200174,0.000025902336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017286338,0.000087362096,0.00018343862,0.0006559326,0.00019758081,0.000284506,0.00008221522,0.00018934422,0.0016202758],"category_scores_gemma":[0.00033081375,0.00012695802,0.00013848432,0.0003758993,0.00020753374,0.0001472181,0.00013352947,0.0001556831,0.00044096907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010186605,0.000040503808,0.01779654,0.00006384784,0.000022389499,0.00066550233,0.00021125712,0.00011847784,0.9730585,0.00040066586,0.00012722495,0.006476349],"study_design_scores_gemma":[0.00007296571,0.0009215207,0.5464219,0.000020607284,0.00014361192,0.011116059,0.0009526171,0.002433694,0.42734843,0.00050204014,0.010043305,0.000023326358],"about_ca_topic_score_codex":0.0008526784,"about_ca_topic_score_gemma":0.0007893671,"teacher_disagreement_score":0.0016202758,"about_ca_system_score_codex":0.00014757157,"about_ca_system_score_gemma":0.0001265425,"threshold_uncertainty_score":0.005420327},"labels":[],"label_agreement":null},{"id":"W2006789505","doi":"10.1007/s10549-014-2840-y","title":"Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the “biological window therapy”","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University","funders":"","keywords":"Zoledronic acid; Breast cancer; Medicine; Metastatic breast cancer; Internal medicine; In vivo; Metastasis; Oncology; Cancer; Bone metastasis; Cancer research; Biology","score_opus":0.0327818350417973,"score_gpt":0.3671359964887995,"score_spread":0.33435416144700225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006789505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756656,0.015328374,0.0020577882,0.0015714923,0.000344871,0.000083650855,0.00038280315,0.00009982047,0.0044655185],"genre_scores_gemma":[0.9937835,0.0036138261,0.0007442586,0.00039492457,0.00014504125,0.000019728082,0.0001794279,0.000013821276,0.0011055856],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999006,0.000024411993,0.0000068961217,0.000011830914,0.000019064806,0.000037144375],"domain_scores_gemma":[0.9998735,0.000053344986,0.000013084039,0.000023088149,0.000008591875,0.00002830633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003309762,0.00025259485,0.0008533782,0.00025916123,0.00017414636,0.00040583848,0.00048529392,0.00037350995,0.0024082952],"category_scores_gemma":[0.0004990161,0.00022582874,0.00050903735,0.00020412334,0.00053835113,0.0003807596,0.00021784664,0.0010566667,0.00026882402],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1181142,0.0039631804,0.0036793721,0.0010538377,0.0009837312,0.00096889236,0.00026660963,0.0016870796,0.5905575,0.0062174588,0.005026087,0.26748207],"study_design_scores_gemma":[0.04695816,0.18709186,0.12682909,0.00021217664,0.004619712,0.00607865,0.0008140119,0.008242268,0.5512608,0.015951602,0.0517631,0.00017866537],"about_ca_topic_score_codex":0.0014779726,"about_ca_topic_score_gemma":0.0034698993,"teacher_disagreement_score":0.0024082952,"about_ca_system_score_codex":0.00025796067,"about_ca_system_score_gemma":0.000588422,"threshold_uncertainty_score":0.008056581},"labels":[],"label_agreement":null},{"id":"W2007270591","doi":"10.1007/s10549-013-2637-4","title":"Tumour diploidy and survival in breast cancer patients with BRCA2 mutations","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Oncology; Internal medicine; Hazard ratio; BRCA2 Protein; Medicine; Cancer; Aneuploidy; Proportional hazards model; BRCA mutation; Mutation; Biology; Germline mutation; Genetics; Confidence interval; Chromosome","score_opus":0.018803501404523058,"score_gpt":0.31632309282025073,"score_spread":0.29751959141572765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007270591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988187,0.00056339306,0.0000350845,0.000052396095,0.0000074542163,0.0000010108206,0.00014416287,0.0000027048384,0.0003750137],"genre_scores_gemma":[0.99938834,0.00013199299,0.00001157359,0.000017750006,0.000007539767,0.0000010518772,0.00014556441,0.0000010482161,0.00029512699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999269,0.000016233811,0.000008195633,0.000014694978,0.000011036836,0.000022782373],"domain_scores_gemma":[0.99939394,0.0001896147,0.00017851377,0.000029810148,0.000033125212,0.00017497988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021477693,0.0001377602,0.0002406727,0.00043775674,0.00020750902,0.0003359932,0.00014196082,0.00039653623,0.0020795916],"category_scores_gemma":[0.0015036731,0.00012645227,0.00021083822,0.00040265155,0.00019174606,0.00033918084,0.00027865806,0.0003802282,0.00022826063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019176116,0.00004901736,0.9916693,0.000013860372,0.00005788576,0.00046021535,0.00009311125,0.00023539396,0.001049294,0.00004589476,0.00014757055,0.0042608203],"study_design_scores_gemma":[0.00002098432,0.0002743233,0.99759126,0.000004101458,0.000047110778,0.0011581666,0.00013647394,0.00027335182,0.00013968078,0.0001048027,0.0002449749,0.0000047255958],"about_ca_topic_score_codex":0.0018677489,"about_ca_topic_score_gemma":0.0017953756,"teacher_disagreement_score":0.0020795916,"about_ca_system_score_codex":0.00020651796,"about_ca_system_score_gemma":0.00016510511,"threshold_uncertainty_score":0.0069569945},"labels":[],"label_agreement":null},{"id":"W2007353846","doi":"10.1007/s10549-009-0336-y","title":"Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ontario Institute for Cancer Research; Hospital for Sick Children; Public Health Ontario; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"Breast cancer; Allele; Risk factor; Internal medicine; Oncology; Genotype; Medicine; Endocrinology; Cancer; Biology; Genetics; Gene","score_opus":0.030105275037020537,"score_gpt":0.31913652509318136,"score_spread":0.2890312500561608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007353846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989563,0.00014893519,0.00025103003,0.000044420198,0.000010847006,0.0000073099864,0.00020436078,0.000008052011,0.00036873642],"genre_scores_gemma":[0.99915576,0.00006093787,0.00022513613,0.000022122198,0.000008590195,0.00000958833,0.00010411832,0.000004499565,0.00040924316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918526,0.00039488022,0.00005307057,0.0002174943,0.00008014846,0.000069055925],"domain_scores_gemma":[0.99829143,0.00067812006,0.0003580259,0.00019932805,0.00016083196,0.00031232456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008617102,0.0005830681,0.0004708556,0.0015041657,0.0015976089,0.0003840683,0.00053614244,0.00057156215,0.0045167427],"category_scores_gemma":[0.0036977103,0.0004850298,0.00068056927,0.0013829113,0.00046500866,0.00035804184,0.0004296395,0.00069696223,0.00036209007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014984646,0.00030350016,0.98842674,0.00001722437,0.00052197685,0.0014451233,0.0005234411,0.00015667954,0.00398827,0.00014850101,0.00030512505,0.0026648925],"study_design_scores_gemma":[0.000079952144,0.00073982694,0.99309444,0.000013934564,0.0003735438,0.0031198312,0.00038911926,0.0009827926,0.00054571324,0.00014898986,0.0004932575,0.000018625748],"about_ca_topic_score_codex":0.012821437,"about_ca_topic_score_gemma":0.009634948,"teacher_disagreement_score":0.012821437,"about_ca_system_score_codex":0.00037810171,"about_ca_system_score_gemma":0.0004192888,"threshold_uncertainty_score":0.025493622},"labels":[],"label_agreement":null},{"id":"W2007894844","doi":"10.1007/s10549-013-2795-4","title":"Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Depression (economics); Prospective cohort study; Oncology; Internal medicine; Cohort study; Cancer survival; Population; Cancer; Environmental health","score_opus":0.02339133766689157,"score_gpt":0.3337348880804718,"score_spread":0.31034355041358025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007894844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991179,0.00020017783,0.000070284106,0.000039257648,0.000007651152,0.00001501716,0.00039738862,0.0000023600662,0.00014999464],"genre_scores_gemma":[0.9992698,0.00012335238,0.0000666127,0.000030614603,0.000009438512,0.0000135677465,0.00038909868,0.0000013890586,0.000096089374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994332,0.00017731101,0.000058401693,0.0001450308,0.00009854341,0.00008752746],"domain_scores_gemma":[0.9987231,0.00017982413,0.00039864826,0.000238484,0.00018365892,0.0002762516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010865062,0.00030875107,0.0004571501,0.00061023136,0.0005449576,0.00083865115,0.00048120227,0.00057722017,0.0007628404],"category_scores_gemma":[0.002502243,0.0005459774,0.0006437651,0.0011570482,0.0002470606,0.0005469001,0.0005114829,0.0010453749,0.00021267535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014790508,0.000053879587,0.99908054,0.0000039707083,0.00009178215,0.0000404703,0.000049416292,0.000015932486,0.00010535367,0.0000052467863,0.000052847136,0.00035264183],"study_design_scores_gemma":[0.000016402117,0.00009360045,0.9994734,0.000002496488,0.000047047084,0.0001114995,0.00006438809,0.000104573315,0.000016587168,0.00000963657,0.000057335776,0.000003117567],"about_ca_topic_score_codex":0.011755143,"about_ca_topic_score_gemma":0.014569113,"teacher_disagreement_score":0.011755143,"about_ca_system_score_codex":0.00038505153,"about_ca_system_score_gemma":0.00039366752,"threshold_uncertainty_score":0.023373425},"labels":[],"label_agreement":null},{"id":"W2008478049","doi":"10.1007/s10549-012-2255-6","title":"Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; University of Toronto; Cancer Care Ontario","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Cancer Research UK","keywords":"Breast cancer; Germline mutation; Ovarian cancer; Oncology; Medicine; Population; BRCA2 Protein; Mutation; Cancer; Internal medicine; Genetics; Hazard ratio; Confidence interval; Biology; Gene","score_opus":0.05697026537657951,"score_gpt":0.3964929683591961,"score_spread":0.3395227029826166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008478049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995919,0.000109289766,0.00006112532,0.000020408623,0.0000033179817,0.00000927161,0.00005741787,0.0000026071468,0.00014462201],"genre_scores_gemma":[0.99937576,0.00006282303,0.00008104899,0.000018696317,0.0000072085604,0.000012701467,0.00010450299,0.0000030002443,0.00033425522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996797,0.00011078008,0.000018974772,0.00006865921,0.000045820805,0.00007615706],"domain_scores_gemma":[0.9991985,0.0002984808,0.0001079184,0.00006371225,0.00010025869,0.00023114287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007073282,0.00060944026,0.0005135077,0.0014938996,0.0011527039,0.0005689152,0.00053645304,0.00080380205,0.0014406438],"category_scores_gemma":[0.0022280568,0.00031750122,0.00046585963,0.0010090547,0.00035979392,0.00044609653,0.00036396272,0.00065589696,0.0002548997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004181517,0.00071833126,0.9761563,0.00001404541,0.000076604534,0.0033357216,0.00047703827,0.000073121526,0.011109797,0.000040533367,0.0000765413,0.0037404886],"study_design_scores_gemma":[0.00008399183,0.0019804859,0.9929274,0.0000041826324,0.00015968167,0.0021197258,0.00038010263,0.00030872607,0.0016842141,0.000051028423,0.00029251465,0.000008057485],"about_ca_topic_score_codex":0.0065514753,"about_ca_topic_score_gemma":0.0033970322,"teacher_disagreement_score":0.0065514753,"about_ca_system_score_codex":0.00031127394,"about_ca_system_score_gemma":0.00040642993,"threshold_uncertainty_score":0.013026655},"labels":[],"label_agreement":null},{"id":"W2009929157","doi":"10.1007/s10549-012-2247-6","title":"Impact of biomarkers on clinical trial risk in breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Taxane; Medicine; Anthracycline; Breast cancer; Oncology; Internal medicine; Clinical trial; Biomarker; Context (archaeology); Ixabepilone; Trastuzumab; Metastatic breast cancer; Cancer","score_opus":0.6218604223864977,"score_gpt":0.5987315367021722,"score_spread":0.023128885684325584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009929157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56655306,0.29924825,0.03162287,0.07464838,0.0029430164,0.0004718068,0.0041016913,0.0003648849,0.020046119],"genre_scores_gemma":[0.9850424,0.008110421,0.0022324268,0.0024407047,0.00095044635,0.000095759795,0.00044267418,0.000046117966,0.0006391312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.863612,0.12326123,0.0050902953,0.002577751,0.00403532,0.0014233766],"domain_scores_gemma":[0.3344046,0.60237676,0.039970294,0.014246851,0.0057127737,0.0032887366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11553385,0.0008636552,0.002929714,0.0016851785,0.0005250411,0.004427934,0.00086583913,0.0037137608,0.003748687],"category_scores_gemma":[0.43263105,0.0006224509,0.0037294305,0.0035141157,0.0018454118,0.0037792732,0.0014349192,0.0047768997,0.00034660817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0653323,0.0009117613,0.59486586,0.004236513,0.02618194,0.0008429069,0.00044948002,0.05457689,0.0005118572,0.035252657,0.013154852,0.20368302],"study_design_scores_gemma":[0.0098334635,0.012457508,0.46099028,0.00333841,0.056161497,0.0019678127,0.00060075306,0.18534178,0.0023401158,0.24209188,0.024358269,0.00051812356],"about_ca_topic_score_codex":0.002075577,"about_ca_topic_score_gemma":0.0018197385,"teacher_disagreement_score":0.11553385,"about_ca_system_score_codex":0.0015961562,"about_ca_system_score_gemma":0.0024465036,"threshold_uncertainty_score":0.6110087},"labels":[],"label_agreement":null},{"id":"W2010239645","doi":"10.1023/a:1012942910375","title":"The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; John Abbott College; Jewish General Hospital","funders":"","keywords":"Androgen receptor; Biology; Androgen; Allele; Population; Endocrinology; Internal medicine; Breast cancer; Estrogen receptor; Estrogen; Trinucleotide repeat expansion; Cancer; Genetics; Gene; Prostate cancer; Medicine; Hormone","score_opus":0.013941638964458068,"score_gpt":0.3009653057125309,"score_spread":0.28702366674807284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010239645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996329,0.002091595,0.00012776777,0.00023888928,0.000024403005,0.000005408518,0.0002451295,0.000010289988,0.00092748663],"genre_scores_gemma":[0.9974789,0.001231662,0.00021912024,0.00011404064,0.00005479249,0.0000042856755,0.00017131059,0.00000404747,0.0007218721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999553,0.0000122661495,0.0000036412664,0.00000951332,0.000008959706,0.000010337116],"domain_scores_gemma":[0.99979156,0.00005535423,0.00007160774,0.0000064708765,0.000013177569,0.00006179929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010176832,0.00021966855,0.0002025363,0.00055558136,0.00028900872,0.00023218551,0.0002397968,0.00036045702,0.001859093],"category_scores_gemma":[0.0006016504,0.00011212745,0.00014717627,0.00079548353,0.00026862186,0.00019624719,0.00012303342,0.00030330924,0.00017499276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016579601,0.00011752229,0.94592816,0.00008713001,0.00008613815,0.0043527046,0.0003680308,0.00016766982,0.023455344,0.00042141555,0.00063081144,0.022727141],"study_design_scores_gemma":[0.000018569195,0.0003709839,0.99131876,0.000011062664,0.000091878384,0.0056343316,0.00020120248,0.00021791305,0.0006102216,0.000322595,0.0011922547,0.000010178699],"about_ca_topic_score_codex":0.003215417,"about_ca_topic_score_gemma":0.0034298957,"teacher_disagreement_score":0.003215417,"about_ca_system_score_codex":0.00012849332,"about_ca_system_score_gemma":0.00018832603,"threshold_uncertainty_score":0.006393373},"labels":[],"label_agreement":null},{"id":"W2010561252","doi":"10.1007/s10549-009-0421-2","title":"Breast-conserving therapy after previous irradiation for lymphoma","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Breast cancer; Lymphoma; Radiation therapy; Mammary gland; Oncology; Internal medicine; Cancer","score_opus":0.031898760510876444,"score_gpt":0.3440546179234882,"score_spread":0.31215585741261176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010561252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97751117,0.015397094,0.00028087833,0.00020840405,0.00011968997,0.000105189945,0.00013330305,0.000021745253,0.0062226234],"genre_scores_gemma":[0.9913693,0.0058447844,0.00020156652,0.000161751,0.00012620738,0.00003692272,0.00014693996,0.000008443119,0.0021040754],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99971586,0.00011173969,0.000021040445,0.00003242743,0.000045992772,0.000072836716],"domain_scores_gemma":[0.9996278,0.0001953167,0.00006427705,0.000050920997,0.000017939623,0.000043652508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006854923,0.00021531658,0.00058100774,0.000692545,0.00062401424,0.00031750184,0.000400791,0.00040086263,0.0033232425],"category_scores_gemma":[0.0011821402,0.00015346959,0.0003875358,0.0009009492,0.0005092101,0.00040564785,0.00020613238,0.00051089865,0.00028723283],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14774832,0.013339475,0.11454531,0.002501037,0.0010976971,0.014576165,0.0020155495,0.0016732535,0.29182014,0.0018868144,0.0031949908,0.40560126],"study_design_scores_gemma":[0.004112108,0.15540144,0.58155155,0.00040474374,0.002243961,0.031456888,0.0010919642,0.0007419499,0.17104286,0.0011383162,0.050749633,0.000064488246],"about_ca_topic_score_codex":0.0016429691,"about_ca_topic_score_gemma":0.0023377247,"teacher_disagreement_score":0.0033232425,"about_ca_system_score_codex":0.0003915495,"about_ca_system_score_gemma":0.0004518709,"threshold_uncertainty_score":0.011117399},"labels":[],"label_agreement":null},{"id":"W2011219564","doi":"10.1007/s10549-009-0373-6","title":"Breast cancer-related preferences among women with and without BRCA mutations","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; BRCA mutation; Mammography; Logistic regression; Cancer; Demography; Health care; Life expectancy; Genetic testing; Gynecology; Magnetic resonance imaging; Ovarian cancer; Oncology; Obstetrics; Internal medicine; Environmental health; Radiology; Population","score_opus":0.023421966442109792,"score_gpt":0.3335802362583102,"score_spread":0.31015826981620037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011219564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988011,0.00016408483,0.000016754124,0.00013040245,0.00000927944,0.000005274499,0.000121117526,6.8692816e-7,0.0007513086],"genre_scores_gemma":[0.9991829,0.00010108971,0.000023902661,0.00011562503,0.000008804474,0.0000038481735,0.00008774905,9.988635e-7,0.0004750784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974936,0.000087743065,0.000017709168,0.00003181894,0.00003621138,0.00007711183],"domain_scores_gemma":[0.99903905,0.0003082255,0.0002096638,0.00002804329,0.00007152062,0.00034354115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038566688,0.00012940248,0.00032103353,0.000633692,0.0004798556,0.00062261045,0.00016234462,0.00051490014,0.0038128763],"category_scores_gemma":[0.0028330954,0.00012278905,0.00040328773,0.0005193303,0.0002922411,0.00035145736,0.00042081325,0.0005206046,0.00030346832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029181382,0.00044349793,0.9822253,0.000031602573,0.00015162464,0.0003356816,0.0017302535,0.000117757125,0.0010910657,0.00015619355,0.0004733034,0.010325634],"study_design_scores_gemma":[0.00007032776,0.00073031633,0.99240136,0.000010973273,0.00006292062,0.00043189275,0.0049344897,0.0003155159,0.000107927524,0.00016430543,0.0007510172,0.000018937832],"about_ca_topic_score_codex":0.008123072,"about_ca_topic_score_gemma":0.010205995,"teacher_disagreement_score":0.008123072,"about_ca_system_score_codex":0.00033203937,"about_ca_system_score_gemma":0.00019831273,"threshold_uncertainty_score":0.016151547},"labels":[],"label_agreement":null},{"id":"W2012493093","doi":"10.1007/s10549-008-0221-0","title":"Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Phosphorylation; Protein kinase B; Wortmannin; Estrogen receptor; Kinase; Serine; LY294002; Signal transduction; Reactive oxygen species; Chemistry; Endocrinology; Internal medicine; Biology; Cell biology; Medicine; Cancer; Breast cancer","score_opus":0.03430026739182796,"score_gpt":0.3098260020718944,"score_spread":0.27552573468006647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012493093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954288,0.0013375061,0.0006144911,0.0002072227,0.00007129996,0.00002537153,0.00013440817,0.000026408852,0.0021545102],"genre_scores_gemma":[0.9958592,0.0011338212,0.0004534171,0.00009953273,0.00002275236,0.000020038848,0.0004849189,0.0000072639605,0.0019190689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999149,0.000015416963,0.000004906718,0.000008118855,0.000016786887,0.000039919476],"domain_scores_gemma":[0.99989045,0.000028476494,0.00003532703,0.000009179048,0.000012447247,0.000024189916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014614267,0.00031820455,0.00015427318,0.0002752568,0.00019000162,0.00013828915,0.00021433484,0.00023595756,0.003801479],"category_scores_gemma":[0.0002810594,0.00018411643,0.00026682898,0.00014945897,0.00015635001,0.00017416113,0.00017498243,0.00035197238,0.00048473798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033783952,0.00022434045,0.0010625145,0.00012476738,0.000032678796,0.00037533895,0.000048279413,0.00010735125,0.9853681,0.0004424613,0.0003933115,0.008442502],"study_design_scores_gemma":[0.00043186065,0.0019391114,0.03217167,0.000027589951,0.000046693203,0.0011211387,0.0001229619,0.000950335,0.95964617,0.00049507304,0.0030323477,0.000015050163],"about_ca_topic_score_codex":0.0005182511,"about_ca_topic_score_gemma":0.0005938236,"teacher_disagreement_score":0.003801479,"about_ca_system_score_codex":0.00025837123,"about_ca_system_score_gemma":0.00015511751,"threshold_uncertainty_score":0.012717187},"labels":[],"label_agreement":null},{"id":"W2012604818","doi":"10.1007/s10549-009-0667-8","title":"Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Breast cancer; Cancer; Biology; Cancer research; Immunology; Medicine; Internal medicine","score_opus":0.01741225436293152,"score_gpt":0.3089028144996538,"score_spread":0.29149056013672225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012604818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937955,0.0006691522,0.0013130666,0.000333925,0.000046567588,0.00003729502,0.0008743226,0.00020548348,0.0027246356],"genre_scores_gemma":[0.9887052,0.00045800302,0.0010765962,0.00021419361,0.000030941173,0.00006682293,0.0009106124,0.000080989106,0.008456661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951756,0.00006179621,0.000027098264,0.00008184209,0.000102610684,0.00020913382],"domain_scores_gemma":[0.9996555,0.00003350349,0.00012491902,0.00004009353,0.000023700435,0.0001223371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019481166,0.00049503124,0.00033338618,0.0012857278,0.0003334984,0.0006766797,0.00032215012,0.0007853306,0.0032931282],"category_scores_gemma":[0.00015485681,0.0003621384,0.00043516987,0.00029347325,0.00046753636,0.0004873807,0.00024067776,0.0026614708,0.0013690868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008513955,0.0002532739,0.00036441785,0.000018014141,0.0000051767547,0.00007791061,0.000019092,0.000074745985,0.9967212,0.00026560476,0.00013036763,0.0012187127],"study_design_scores_gemma":[0.00013391355,0.00078294444,0.0063815736,0.000009814565,0.000031107385,0.0004364817,0.00008539326,0.0014100677,0.98760146,0.0002613744,0.0028548166,0.0000111458],"about_ca_topic_score_codex":0.000542725,"about_ca_topic_score_gemma":0.00091380137,"teacher_disagreement_score":0.0032931282,"about_ca_system_score_codex":0.0006691368,"about_ca_system_score_gemma":0.00024161972,"threshold_uncertainty_score":0.011016607},"labels":[],"label_agreement":null},{"id":"W2013195626","doi":"10.1007/s10549-014-2911-0","title":"Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Ministry of Health, Saskatchewan; University of Washington","keywords":"Breast cancer; Medicine; Odds ratio; Cancer; Gynecology; Population; Incidence (geometry); Confidence interval; Internal medicine; Hormone therapy; Estrogen; Oncology","score_opus":0.022704338020877856,"score_gpt":0.30986566470017063,"score_spread":0.2871613266792928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013195626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908879,0.0040020198,0.00022650065,0.00015403562,0.000046238063,0.00001157497,0.0011331487,0.00003367887,0.003505024],"genre_scores_gemma":[0.99749374,0.00080455735,0.00009713037,0.00003324149,0.000072832736,0.000005713717,0.00038930422,0.0000061444266,0.0010972775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996408,0.00011960915,0.000033249944,0.00006355781,0.00006890133,0.00007391865],"domain_scores_gemma":[0.99645823,0.0013581963,0.001060235,0.0002764913,0.0001992651,0.0006475431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005469191,0.00030072784,0.00047267033,0.0010908621,0.00031283795,0.0006971595,0.0003616249,0.00057272287,0.003311173],"category_scores_gemma":[0.004055767,0.00036196547,0.00093964976,0.0008416954,0.0002941548,0.0003241746,0.00044888796,0.0008015399,0.00036922374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007657035,0.00012890673,0.98485374,0.000038605172,0.0004988649,0.00035898888,0.00007082197,0.00044952938,0.0016004109,0.00011871605,0.00017638778,0.004048047],"study_design_scores_gemma":[0.00003725142,0.0004677159,0.99675924,0.000011142914,0.00031465513,0.00064864464,0.0001284001,0.0006949428,0.0003215219,0.00015608707,0.00044899504,0.000011453468],"about_ca_topic_score_codex":0.0057634125,"about_ca_topic_score_gemma":0.0041215406,"teacher_disagreement_score":0.0057634125,"about_ca_system_score_codex":0.00031474387,"about_ca_system_score_gemma":0.00037621876,"threshold_uncertainty_score":0.011459708},"labels":[],"label_agreement":null},{"id":"W2013307908","doi":"10.1007/s10549-013-2729-1","title":"The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Women's College Hospital; Cancer Care Ontario; Université de Montréal; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Breast cancer; Medicine; Hazard ratio; BRCA mutation; Pregnancy; Cancer; Obstetrics; Proportional hazards model; Gynecology; Oncology; Cohort; Survival rate; Internal medicine; Cohort study; Confidence interval; Genetics; Biology","score_opus":0.06689507586734411,"score_gpt":0.41182794638977055,"score_spread":0.34493287052242644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013307908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898577,0.004846834,0.00008184229,0.001783754,0.000063746134,0.0000045518677,0.0004291081,0.0000041785825,0.0029284167],"genre_scores_gemma":[0.9970701,0.0020720125,0.00004673716,0.00014757732,0.000052684838,0.000004014457,0.00020096276,0.000003366202,0.00040256305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949384,0.00021874276,0.000033267228,0.000040804236,0.00004773065,0.00016555513],"domain_scores_gemma":[0.99704176,0.0015132724,0.0006683726,0.00012614042,0.00012748197,0.00052299915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007847703,0.00018704454,0.00026093744,0.000359362,0.00036111672,0.0006525413,0.000316325,0.0007765331,0.0025433782],"category_scores_gemma":[0.0070611397,0.00018716355,0.0008367574,0.00055934745,0.00038383828,0.00058285554,0.00061417656,0.0011411759,0.00026469046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016638729,0.00008699768,0.9868553,0.000021137472,0.00015062763,0.0003277158,0.00009836333,0.00018833247,0.00014926968,0.00012864881,0.00023577666,0.010093862],"study_design_scores_gemma":[0.000024080355,0.00035266578,0.9970348,0.000037781534,0.00025011768,0.00058485667,0.00043667955,0.0003952222,0.000081670325,0.00029521642,0.00049732043,0.000009657541],"about_ca_topic_score_codex":0.006950865,"about_ca_topic_score_gemma":0.009197756,"teacher_disagreement_score":0.006950865,"about_ca_system_score_codex":0.00049291336,"about_ca_system_score_gemma":0.000670285,"threshold_uncertainty_score":0.013820767},"labels":[],"label_agreement":null},{"id":"W2013794829","doi":"10.1007/s10549-011-1490-6","title":"Trends in improving survival in breast cancer: two steps forward but one step back?","year":2011,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.05238118297557423,"score_gpt":0.3373133746683679,"score_spread":0.2849321916927937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013794829","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003058142,0.004897289,0.00006822485,0.98617315,0.007972608,0.0000029209334,0.000045179706,0.000009514312,0.0005253002],"genre_scores_gemma":[0.006534699,0.014903277,0.0005860024,0.90533406,0.07013546,0.000029343491,0.000083027415,0.000016266453,0.0023778046],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956136,0.0016492555,0.00066351786,0.00041376578,0.0011891208,0.00047066397],"domain_scores_gemma":[0.97076595,0.019099424,0.0018234027,0.00077875785,0.004573809,0.0029587266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008163476,0.000772691,0.0018512768,0.0006794886,0.0018602074,0.0033604873,0.0015765581,0.023351226,0.008497404],"category_scores_gemma":[0.031048076,0.00045691308,0.0010894503,0.001208472,0.002984395,0.00632798,0.0014031277,0.029596835,0.0037416555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049831055,0.00020977388,0.0030874414,0.00044445143,0.00009308846,0.0006704674,0.000103911676,0.000110512075,0.00039571556,0.007438262,0.91119856,0.075749435],"study_design_scores_gemma":[0.0008861134,0.0006695219,0.009555333,0.0014013285,0.00033390246,0.0016780866,0.0013620822,0.00072849746,0.00079339236,0.03951552,0.94292706,0.00014909066],"about_ca_topic_score_codex":0.0044227033,"about_ca_topic_score_gemma":0.009534803,"teacher_disagreement_score":0.023351226,"about_ca_system_score_codex":0.0038540708,"about_ca_system_score_gemma":0.0057179774,"threshold_uncertainty_score":0.043173134},"labels":[],"label_agreement":null},{"id":"W2013923368","doi":"10.1007/s10549-010-0828-9","title":"Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Agency; Terry Fox Foundation","keywords":"Trastuzumab; Cancer research; Breast cancer; Lentivirus; Cancer; Cancer cell; Medicine; Metastatic breast cancer; Biology; Virology; Immunology; Virus; Internal medicine; Viral disease","score_opus":0.028904149008519522,"score_gpt":0.32780717820901434,"score_spread":0.29890302920049483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013923368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693878,0.0015513486,0.02183858,0.00045248587,0.00023500081,0.00022839573,0.0006802604,0.0003089876,0.0053172037],"genre_scores_gemma":[0.981187,0.0006650639,0.010074726,0.00017705782,0.00003061627,0.000101242666,0.0008139062,0.000058668396,0.0068916352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997819,0.000026841992,0.00002181371,0.000034045523,0.00008023013,0.00005514152],"domain_scores_gemma":[0.99991274,0.000024271287,0.000018181267,0.000017051076,0.000011104852,0.000016642656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035552503,0.0004849702,0.000323063,0.00033496512,0.0002507893,0.0009069575,0.00043069504,0.00060326443,0.0010278935],"category_scores_gemma":[0.00017975442,0.0002666408,0.00038245777,0.00020144775,0.00032404577,0.00037603232,0.00029162515,0.0010953717,0.00037729103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007031072,0.00005414684,0.00014927085,0.000021050073,0.000015685871,0.000056123572,0.000032443226,0.00015809418,0.996888,0.000875823,0.00011907245,0.0015599572],"study_design_scores_gemma":[0.000056972123,0.00013144007,0.0007818707,0.000005390533,0.000035659144,0.0002605424,0.000018354427,0.003514853,0.98886335,0.00010142112,0.006223275,0.000006980114],"about_ca_topic_score_codex":0.0018493191,"about_ca_topic_score_gemma":0.0016373892,"teacher_disagreement_score":0.0018493191,"about_ca_system_score_codex":0.000829726,"about_ca_system_score_gemma":0.0004193764,"threshold_uncertainty_score":0.0060201287},"labels":[],"label_agreement":null},{"id":"W2014321261","doi":"10.1007/s10549-015-3374-7","title":"Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Cancer Institute; Moffitt Cancer Center; American Cancer Society","keywords":"Medicine; Referral; Breast cancer; Genetic counseling; Population; Socioeconomic status; Family medicine; Genetic testing; Cancer registry; Health equity; Health care; Cancer screening; Cancer; Demography; Gerontology; Public health; Environmental health; Internal medicine; Nursing","score_opus":0.06674894701991176,"score_gpt":0.3347987882895532,"score_spread":0.26804984126964143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014321261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996178,0.000060690385,0.000027867607,0.00004778403,0.0000037968982,0.000003771596,0.00005532535,9.554833e-7,0.00018191381],"genre_scores_gemma":[0.9995277,0.000060600243,0.000040794093,0.000046186153,0.0000072239445,0.0000068988966,0.000074214135,0.0000016610365,0.00023475943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960524,0.00012227881,0.000029472336,0.00007298009,0.00008260198,0.00008750447],"domain_scores_gemma":[0.9988595,0.00032129232,0.0003458467,0.00004813811,0.00010401719,0.00032125157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043256732,0.0002644957,0.00036221812,0.00087130006,0.000961927,0.000716598,0.00035738572,0.00076925114,0.0016770845],"category_scores_gemma":[0.002422728,0.0004284418,0.00040407391,0.0009173904,0.0003653249,0.00040671052,0.0004003009,0.00090761494,0.00022878223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000674546,0.00010219269,0.99878937,0.000002478951,0.000023652929,0.00008270751,0.00019016332,0.000010345761,0.00026389354,0.000012314977,0.00004122057,0.00041420007],"study_design_scores_gemma":[0.000004183496,0.00008089791,0.998838,0.0000026796108,0.000020857757,0.0002155649,0.00063107634,0.000088439316,0.00003061693,0.000015755319,0.0000692513,0.0000026755915],"about_ca_topic_score_codex":0.01816051,"about_ca_topic_score_gemma":0.015385077,"teacher_disagreement_score":0.01816051,"about_ca_system_score_codex":0.0003187742,"about_ca_system_score_gemma":0.00047305733,"threshold_uncertainty_score":0.036109626},"labels":[],"label_agreement":null},{"id":"W2014331129","doi":"10.1007/s10549-008-0087-1","title":"Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Breast cancer; BRCA2 Protein; Oncology; Gene expression profiling; Medicine; Internal medicine; Cancer research; Pathology; Biology; Gene expression; Cancer; Mutation; Gene; Genetics; Germline mutation","score_opus":0.03850682409171169,"score_gpt":0.32766626291087814,"score_spread":0.28915943881916645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014331129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906796,0.00025494845,0.00022063928,0.000010936366,0.0000012935654,0.000001993857,0.00018370745,0.000013748421,0.00024472343],"genre_scores_gemma":[0.9987509,0.00011100009,0.0003986945,0.000012426424,0.000003285695,0.0000049885884,0.00034703873,0.0000039356996,0.0003676633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999069,0.000008935721,0.000006111406,0.000030140493,0.000028066044,0.000019986008],"domain_scores_gemma":[0.9998964,0.00002355747,0.000042419542,0.000007154613,0.000013334505,0.00001713638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001071813,0.00014767687,0.000115073635,0.00046765912,0.00013992598,0.00014465864,0.00005737014,0.00014422562,0.0010907842],"category_scores_gemma":[0.00023656758,0.00007480092,0.000107739266,0.00024096039,0.00011324043,0.000061311024,0.00008624054,0.00010727118,0.00015597134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029083103,0.0000169791,0.08139481,0.000054324,0.00003857692,0.00059696136,0.00012177802,0.00013687483,0.91396487,0.000038045036,0.00014231917,0.0032036689],"study_design_scores_gemma":[0.000012959195,0.00017632381,0.8634816,0.0000073680853,0.00005200479,0.0051730904,0.0001247392,0.0006376243,0.12910981,0.00005667971,0.0011613402,0.0000064755977],"about_ca_topic_score_codex":0.0008383169,"about_ca_topic_score_gemma":0.0013604427,"teacher_disagreement_score":0.0010907842,"about_ca_system_score_codex":0.0001657433,"about_ca_system_score_gemma":0.00008705191,"threshold_uncertainty_score":0.003649056},"labels":[],"label_agreement":null},{"id":"W2015001695","doi":"10.1007/s10549-007-9617-5","title":"Melatonin, environmental light, and breast cancer","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital","funders":"","keywords":"Melatonin; Breast cancer; Endocrinology; Internal medicine; Cancer; Antiestrogen; Pineal gland; Estrogen; Estrogen receptor; Cancer cell; Cancer research; Medicine; Biology","score_opus":0.11612045912851582,"score_gpt":0.40314067199142356,"score_spread":0.28702021286290774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015001695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041436426,0.999131,0.000037925765,0.00017979862,0.00021005298,0.0000015772456,0.0000069610724,0.000002876768,0.00038832388],"genre_scores_gemma":[0.00025322344,0.9989222,0.000067081855,0.00011952943,0.00029058164,0.000002934455,0.00001134083,4.4082594e-7,0.00033263126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984026,0.000025672287,0.000026261192,0.000030566363,0.00006309906,0.000014191083],"domain_scores_gemma":[0.99972886,0.00011201812,0.000047690723,0.000009035444,0.00007173318,0.000030618092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007164253,0.0011022657,0.0018441543,0.002063516,0.00038819006,0.0011800639,0.0010625437,0.001630385,0.0029383067],"category_scores_gemma":[0.0008439409,0.0003564707,0.0004096354,0.0034870927,0.00066685164,0.0013764395,0.00072534016,0.0019053248,0.0016734822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016039668,0.000110392306,0.00036263137,0.012504913,0.00013708325,0.0002508056,0.000046785815,0.00032497244,0.0013800849,0.0026742127,0.06564296,0.91640466],"study_design_scores_gemma":[0.00004071502,0.000078509824,0.0016944341,0.0031117718,0.00018872652,0.0010783094,0.000090799724,0.00010552871,0.00029340351,0.002106043,0.9911918,0.00002001589],"about_ca_topic_score_codex":0.0029935418,"about_ca_topic_score_gemma":0.007682866,"teacher_disagreement_score":0.0029935418,"about_ca_system_score_codex":0.00091276114,"about_ca_system_score_gemma":0.0016196743,"threshold_uncertainty_score":0.009829581},"labels":[],"label_agreement":null},{"id":"W2015413901","doi":"10.1007/s10549-008-0102-6","title":"Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Lymph node; Lymph; Correlation; Cancer; Pathology","score_opus":0.02333632885157947,"score_gpt":0.29120852132197145,"score_spread":0.26787219247039196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015413901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948488,0.0018414173,0.00052137405,0.00017300584,0.000054336215,0.00000807819,0.00033105153,0.000013836673,0.0022080808],"genre_scores_gemma":[0.9986594,0.00038548018,0.00016477234,0.000026251199,0.00003821185,0.0000058847127,0.00026355716,0.000009589976,0.0004469478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996094,0.0001651036,0.000047643025,0.000038195598,0.00010164194,0.00003806004],"domain_scores_gemma":[0.9925069,0.004231845,0.0016643257,0.00043112464,0.00046175465,0.0007039735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011744156,0.00034660552,0.00053995295,0.0006639479,0.00024019062,0.00041326016,0.0002699446,0.00028037533,0.0017555101],"category_scores_gemma":[0.00600751,0.00014995402,0.00028667037,0.0007597936,0.00042065862,0.00057808426,0.0003215383,0.000404819,0.00059689773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051061733,0.000012108058,0.992939,0.000021507769,0.000038653925,0.00014669578,0.000028494223,0.0000972197,0.002514272,0.000015642729,0.000080253965,0.0035954146],"study_design_scores_gemma":[0.0000072563244,0.00032503024,0.9971765,0.000007533398,0.00005849108,0.00083892024,0.00007400992,0.00027136973,0.0008564689,0.000082714796,0.00029744074,0.000004234886],"about_ca_topic_score_codex":0.0009716469,"about_ca_topic_score_gemma":0.0022460234,"teacher_disagreement_score":0.0017555101,"about_ca_system_score_codex":0.0001986121,"about_ca_system_score_gemma":0.00030783404,"threshold_uncertainty_score":0.006210983},"labels":[],"label_agreement":null},{"id":"W2015564512","doi":"10.1007/s10549-010-1241-0","title":"Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Tissue microarray; Immunohistochemistry; Breast cancer; Protein kinase B; Cancer research; Biology; Cancer; Pathology; Oncology; Medicine; Internal medicine; Signal transduction; Genetics","score_opus":0.042785451384319106,"score_gpt":0.36029989975908927,"score_spread":0.31751444837477016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015564512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98884726,0.00255667,0.0033211773,0.00028350094,0.00003347296,0.00005104523,0.0015818279,0.00008245391,0.003242682],"genre_scores_gemma":[0.99441916,0.0005001504,0.002218161,0.00011696955,0.00003150749,0.00006800557,0.0011054749,0.000015156796,0.0015254354],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99951684,0.00012535504,0.00003198061,0.00011097762,0.00013527961,0.00007968583],"domain_scores_gemma":[0.9995757,0.00018327238,0.00008990128,0.00005129152,0.00006801169,0.00003191808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050916837,0.00019436098,0.00034263855,0.0009665438,0.00036380748,0.0006070177,0.0002689681,0.00032747534,0.0028487851],"category_scores_gemma":[0.0009260098,0.00021651248,0.000223814,0.00076984585,0.00025905375,0.0002902123,0.00028360068,0.00047316417,0.00063585903],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023155485,0.0002852475,0.2327008,0.00016300107,0.00038455048,0.00029325116,0.00020064699,0.0004889897,0.7346643,0.00028385955,0.0013450264,0.026874738],"study_design_scores_gemma":[0.00012793051,0.0010778734,0.7794141,0.000015951235,0.00062608114,0.0029943814,0.00042823987,0.004327601,0.20216432,0.00038459935,0.008403843,0.00003507985],"about_ca_topic_score_codex":0.0005787244,"about_ca_topic_score_gemma":0.0014656298,"teacher_disagreement_score":0.0028487851,"about_ca_system_score_codex":0.00018332497,"about_ca_system_score_gemma":0.00018052047,"threshold_uncertainty_score":0.009530127},"labels":[],"label_agreement":null},{"id":"W2015996473","doi":"10.1007/s10549-009-0510-2","title":"Patterns of relapse in breast cancer: changes over time","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Anthracycline; Cumulative incidence; Internal medicine; Oncology; Chemotherapy; Cohort; Tamoxifen; Incidence (geometry); Metastasis; Cancer","score_opus":0.022743885802643027,"score_gpt":0.33342011629744,"score_spread":0.310676230494797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015996473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451375,0.0027024234,0.00022250642,0.00034872993,0.0000136035615,0.000013993859,0.0009129769,0.000023068826,0.0012488839],"genre_scores_gemma":[0.9984281,0.0005493591,0.00009026274,0.000040315903,0.000013330754,0.000010458002,0.00048084932,0.0000090205995,0.0003784085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868065,0.000499719,0.00017837207,0.00020575522,0.00023110153,0.00020442872],"domain_scores_gemma":[0.9919531,0.0019844093,0.0035512885,0.00062996283,0.001199307,0.0006820106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022497259,0.00019584269,0.00057127024,0.002699237,0.0005105201,0.0011158612,0.0007999247,0.00081183424,0.0024609808],"category_scores_gemma":[0.009944491,0.00024384285,0.00063133816,0.0036805088,0.00049192976,0.0011068907,0.0008849681,0.0007230541,0.00063580845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078321464,0.000056846467,0.98967546,0.000033269207,0.00009096125,0.00005027872,0.0004993012,0.000055642962,0.0003515578,0.00005954051,0.00020095594,0.008143122],"study_design_scores_gemma":[0.000002297759,0.00005355517,0.99909127,0.00000579735,0.000015244151,0.00010364875,0.00035890422,0.000050810206,0.000046412933,0.00002659824,0.000241467,0.0000040629075],"about_ca_topic_score_codex":0.008177635,"about_ca_topic_score_gemma":0.009006254,"teacher_disagreement_score":0.008177635,"about_ca_system_score_codex":0.00060049235,"about_ca_system_score_gemma":0.00047193965,"threshold_uncertainty_score":0.016260087},"labels":[],"label_agreement":null},{"id":"W2016583530","doi":"10.1007/s10549-006-9223-y","title":"Cosmetic outcomes following breast conservation therapy: in search of a reliable scale","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Health Sciences Centre Foundation","keywords":"Cosmesis; Kappa; Confidence interval; Reliability (semiconductor); Medicine; Scale (ratio); Cohen's kappa; Statistics; Physical therapy; Surgery; Mathematics; Internal medicine","score_opus":0.0471245885774082,"score_gpt":0.3521505025220145,"score_spread":0.3050259139446063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016583530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9510532,0.017981986,0.006397829,0.0045782276,0.00079642236,0.0003524621,0.0015531275,0.000038441995,0.017248245],"genre_scores_gemma":[0.9965132,0.00093347934,0.0013252791,0.00023635007,0.00017507937,0.000061825645,0.00035752982,0.000013727998,0.00038341893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9907947,0.0036949425,0.0016189894,0.00042279685,0.0031375024,0.00033105258],"domain_scores_gemma":[0.95895886,0.019866752,0.009906319,0.00226391,0.007697246,0.001306769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017754743,0.00041882045,0.00089954544,0.002686287,0.00057675026,0.0016878656,0.0012239494,0.00073599815,0.002621431],"category_scores_gemma":[0.054651406,0.0001371055,0.0010607899,0.0023294385,0.0020906057,0.002357467,0.0019908044,0.001245476,0.00043667768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031502077,0.0003987689,0.8005106,0.0006310716,0.00076285104,0.00014266491,0.0008722574,0.0008640534,0.0007767308,0.0016286715,0.0033870023,0.1868751],"study_design_scores_gemma":[0.00014773571,0.0033583806,0.97680795,0.0005536574,0.0005755243,0.0007023103,0.0031143958,0.0032848539,0.0013622784,0.0036235834,0.0063787634,0.00009060725],"about_ca_topic_score_codex":0.00091925584,"about_ca_topic_score_gemma":0.002166366,"teacher_disagreement_score":0.017754743,"about_ca_system_score_codex":0.001233973,"about_ca_system_score_gemma":0.00082738156,"threshold_uncertainty_score":0.09389722},"labels":[],"label_agreement":null},{"id":"W2016905991","doi":"10.1007/s10549-010-1101-y","title":"Commentary on: “Effect of obesity on survival in women with breast cancer: systematic review and meta-analysis” (Melinda Protani, Michael Coory, Jennifer H. Martin)","year":2010,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Meta-analysis; Obesity; Medicine; Gerontology; Cancer; Oncology; Internal medicine; Gynecology","score_opus":0.045910721086821565,"score_gpt":0.357944472115379,"score_spread":0.31203375102855746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016905991","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013379754,0.001555572,0.000056112185,0.96264035,0.034625556,0.000020685342,0.0003246789,0.000029128141,0.0006140844],"genre_scores_gemma":[0.0009076731,0.0008234436,0.00013969507,0.96515864,0.030623388,0.00006865034,0.00008079682,0.000020955507,0.0021766769],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98990405,0.0039107967,0.001486683,0.0012384512,0.002810397,0.000649654],"domain_scores_gemma":[0.95887846,0.026227841,0.003049072,0.00075127685,0.008091385,0.0030020121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011905061,0.0015049386,0.003763148,0.0018015724,0.0039785723,0.0035992654,0.0043949625,0.05565953,0.009860689],"category_scores_gemma":[0.078718096,0.0015585679,0.003115503,0.0026354152,0.0022433824,0.0034491331,0.00197581,0.039565757,0.009760584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079657315,0.0000063778402,0.00011063574,0.00012261792,0.000028029574,0.00013383006,0.000027933134,0.000022351856,0.00003523836,0.00019703305,0.99722666,0.0020095513],"study_design_scores_gemma":[0.0010870254,0.00021936247,0.0026364285,0.0029980063,0.0004992159,0.0014271365,0.0004110868,0.00070568913,0.0005102144,0.0076152636,0.9817115,0.00017900292],"about_ca_topic_score_codex":0.016160179,"about_ca_topic_score_gemma":0.023837319,"teacher_disagreement_score":0.05565953,"about_ca_system_score_codex":0.0066228868,"about_ca_system_score_gemma":0.012108875,"threshold_uncertainty_score":0.062960744},"labels":[],"label_agreement":null},{"id":"W2016981231","doi":"10.1007/s10549-005-9009-7","title":"Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; Institute of Cancer Research","funders":"National Cancer Institute","keywords":"Docetaxel; Biology; Breast cancer; Doxorubicin; Gene expression; Cancer research; Cyclophosphamide; Gene expression profiling; Chemotherapy regimen; Oncology; Internal medicine; Cancer; Gene; Medicine; Chemotherapy; Genetics","score_opus":0.025910436644172457,"score_gpt":0.3337307440364717,"score_spread":0.3078203073922992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016981231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919756,0.0011343996,0.0012059498,0.00012130407,0.00003191622,0.000035845515,0.002885426,0.00005403326,0.0025554062],"genre_scores_gemma":[0.98289835,0.0007729994,0.0014075419,0.00011514851,0.000026806236,0.00011617245,0.002900316,0.00003654967,0.011726082],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998084,0.00002457694,0.0000164117,0.000061781124,0.00002926137,0.00005952401],"domain_scores_gemma":[0.9996735,0.00013069707,0.00005264834,0.00002341147,0.00005196951,0.00006780066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017934489,0.00017826314,0.00029032107,0.00082217436,0.00017401704,0.00034633366,0.00013126565,0.0003365494,0.003635187],"category_scores_gemma":[0.0002985348,0.00016833865,0.0004103074,0.0006164843,0.00029104354,0.00026238163,0.00017624364,0.00045272245,0.0007684533],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007085984,0.000035220928,0.003997099,0.000027078451,0.0000129681075,0.000053541036,0.00007173915,0.00005802825,0.993284,0.00011513649,0.00006656379,0.0015700588],"study_design_scores_gemma":[0.00005809136,0.0011335505,0.39319706,0.00001443948,0.00008104493,0.0009321745,0.000423767,0.0013757433,0.5989842,0.00016238439,0.0036103318,0.000027174834],"about_ca_topic_score_codex":0.0012149903,"about_ca_topic_score_gemma":0.001393493,"teacher_disagreement_score":0.003635187,"about_ca_system_score_codex":0.00030225964,"about_ca_system_score_gemma":0.00016295908,"threshold_uncertainty_score":0.012160957},"labels":[],"label_agreement":null},{"id":"W2016999745","doi":"10.1007/s10549-014-3088-2","title":"Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Association Canadienne des Radiologistes; Cancer Care Ontario; Breast Cancer Alliance; Cancer Research Institute","keywords":"Medicine; Mammography; Confidence interval; Breast cancer; Odds ratio; Radiography; Computed radiography; Radiology; Logistic regression; Stage (stratigraphy); Cancer; Internal medicine","score_opus":0.033356529873166625,"score_gpt":0.3583288994832844,"score_spread":0.3249723696101178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016999745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994578,0.00012083062,0.00002677493,0.000043966298,0.0000037860514,0.000004810985,0.000048922426,0.000002218047,0.00029093545],"genre_scores_gemma":[0.9997507,0.000040655676,0.000029478058,0.000014245811,0.000006524758,0.0000019220383,0.000057908535,6.727476e-7,0.00009799461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997044,0.000115929564,0.00002053343,0.00004374729,0.000044513068,0.000070806134],"domain_scores_gemma":[0.9982691,0.0007083585,0.00049145747,0.000078723824,0.000082909886,0.0003694048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006254996,0.00023957035,0.00031294563,0.00075735466,0.00028391153,0.0006792681,0.00032541007,0.00045651122,0.0020238168],"category_scores_gemma":[0.004161149,0.00010959906,0.00035928164,0.0010247203,0.00027729027,0.00055454945,0.0004828642,0.00035518184,0.00012508345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024333757,0.0003503822,0.99072284,0.000014493853,0.00003909808,0.00008305632,0.000099310266,0.000090003705,0.0002617036,0.00004128702,0.0000841181,0.0057802703],"study_design_scores_gemma":[0.000073892195,0.0012482058,0.99693006,0.000009409204,0.000088030276,0.00017425358,0.0004969494,0.00062878634,0.00014634144,0.00007573285,0.00012383788,0.0000044369745],"about_ca_topic_score_codex":0.0048001623,"about_ca_topic_score_gemma":0.007059656,"teacher_disagreement_score":0.0048001623,"about_ca_system_score_codex":0.00043652387,"about_ca_system_score_gemma":0.0005985601,"threshold_uncertainty_score":0.009544432},"labels":[],"label_agreement":null},{"id":"W2017317192","doi":"10.1007/s10549-011-1796-4","title":"The BRCA2 c.9004G&gt;A (E2003K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Women's College Hospital; University of Toronto; Université de Montréal; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Breast cancer; Ovarian cancer; Cancer; Medicine; Population; Family history; Oncology; Internal medicine; Gynecology","score_opus":0.04129349429592028,"score_gpt":0.31189680347168575,"score_spread":0.27060330917576547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017317192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843359,0.0013670046,0.00063538126,0.002437772,0.00016604117,0.00005128135,0.0018055451,0.00008113745,0.009119893],"genre_scores_gemma":[0.9946576,0.0003417285,0.00060157356,0.00044139233,0.00005454479,0.0000090758895,0.0003198001,0.000031098876,0.0035431795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995746,0.00004458269,0.000027204318,0.00007312499,0.00013612775,0.0001444435],"domain_scores_gemma":[0.99935526,0.00011406399,0.0001823725,0.000026371503,0.0001273686,0.00019462056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033988958,0.0013410201,0.00048691494,0.0017189165,0.0025478872,0.0005618449,0.0010501462,0.0016136012,0.008932744],"category_scores_gemma":[0.0015839852,0.00030072185,0.0008585189,0.0023300003,0.001083213,0.00025068436,0.0004570915,0.0007908684,0.0006600146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019524898,0.0003457824,0.5393875,0.00028832493,0.0006082251,0.31786606,0.00398427,0.0012046131,0.078136094,0.0043692966,0.011664389,0.040192775],"study_design_scores_gemma":[0.00022505937,0.00031187778,0.7389551,0.00023923606,0.0007254551,0.21744467,0.0034875765,0.001638411,0.011510331,0.0011799297,0.02409925,0.00018310883],"about_ca_topic_score_codex":0.6195189,"about_ca_topic_score_gemma":0.673937,"teacher_disagreement_score":0.38048112,"about_ca_system_score_codex":0.002761974,"about_ca_system_score_gemma":0.0042672413,"threshold_uncertainty_score":0.7654437},"labels":[],"label_agreement":null},{"id":"W2017319820","doi":"10.1007/s10549-010-1036-3","title":"International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital; Women's College Hospital; University of Toronto","funders":"Ministério da Saúde; Ministerio de Ciencia e Innovación; Jewish General Hospital; Liga Portuguesa Contra o Cancro; Hospital de Clínicas de Porto Alegre; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Susan G. Komen for the Cure","keywords":"Founder effect; Breast cancer; Portuguese; Estimation; Mutation; Genetics; Medicine; Biology; Oncology; Demography; Cancer; Gene; Genotype; Haplotype; Sociology","score_opus":0.025640022634346133,"score_gpt":0.35582678334332835,"score_spread":0.33018676070898223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017319820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644924,0.0019904047,0.0010333621,0.00032093647,0.000054005628,0.000017776805,0.009096198,0.00004272046,0.022952134],"genre_scores_gemma":[0.99160624,0.00078056945,0.00067540066,0.000037562353,0.000028236793,0.000020359681,0.0037075528,0.000035579982,0.0031085722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999491,0.00011972005,0.00006231504,0.00014428342,0.000081678736,0.00010094782],"domain_scores_gemma":[0.9981998,0.0003681035,0.00060691073,0.0002433604,0.00040086132,0.00018092943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010355074,0.00030986458,0.00029180013,0.0042146654,0.0003341782,0.0005638758,0.00033109865,0.00034698306,0.0046750815],"category_scores_gemma":[0.0032106326,0.00017457014,0.0005111227,0.0030471163,0.00023710138,0.00029788094,0.00045508725,0.00033696293,0.0013628614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008072883,0.0000555704,0.9304083,0.00011189616,0.00014456059,0.0007596214,0.0014371931,0.0006848293,0.002977347,0.0017011168,0.0044027064,0.05650954],"study_design_scores_gemma":[0.000009961103,0.000095167925,0.9886883,0.00005317533,0.000052756888,0.0014727968,0.00054687023,0.00036320556,0.00047217944,0.0002605917,0.0079727,0.0000122746],"about_ca_topic_score_codex":0.014649503,"about_ca_topic_score_gemma":0.009364813,"teacher_disagreement_score":0.014649503,"about_ca_system_score_codex":0.00055604754,"about_ca_system_score_gemma":0.00032065637,"threshold_uncertainty_score":0.029128492},"labels":[],"label_agreement":null},{"id":"W2017794382","doi":"10.1007/s10549-009-0531-x","title":"Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Queen's University; University Health Network; University of Toronto; Laurentian University; Sunnybrook Health Science Centre; Sudbury Regional Hospital","funders":"Sanofi","keywords":"Breast cancer; Oncology; Medicine; Chemotherapy; Internal medicine; Cancer; Cancer research","score_opus":0.013046307017853465,"score_gpt":0.32830068417394237,"score_spread":0.3152543771560889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017794382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989215,0.00029460818,0.00006258164,0.00009551857,0.000006007966,0.0000029136086,0.00011408996,0.000004837482,0.0004979772],"genre_scores_gemma":[0.99964964,0.00005273538,0.000032162236,0.000027944183,0.00000836184,0.0000024264473,0.00010358115,0.0000020414445,0.00012109389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996941,0.00009316483,0.000045979363,0.00005342206,0.00005276071,0.000060498533],"domain_scores_gemma":[0.99681157,0.0010959295,0.0014343738,0.0001398122,0.00019879943,0.00031947801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032795084,0.00011816457,0.00030097997,0.0005600031,0.00023903759,0.0005015614,0.00019625132,0.0004528998,0.0015362485],"category_scores_gemma":[0.0028351897,0.00013982342,0.00019283146,0.000621745,0.00025555407,0.0002622016,0.00016394064,0.00060295005,0.00022343875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014650711,0.000046580466,0.99304515,0.000008639658,0.000043744283,0.00014173404,0.000040331877,0.00008226149,0.0027703282,0.000023927772,0.00006616153,0.0022660529],"study_design_scores_gemma":[0.000012079425,0.00033553177,0.99788433,0.000002545944,0.000038131537,0.000513998,0.00005790543,0.00024586054,0.00068222696,0.00004081498,0.00018281245,0.0000036702734],"about_ca_topic_score_codex":0.00066373154,"about_ca_topic_score_gemma":0.00068348576,"teacher_disagreement_score":0.0015362485,"about_ca_system_score_codex":0.00024913583,"about_ca_system_score_gemma":0.00018964995,"threshold_uncertainty_score":0.0051392913},"labels":[],"label_agreement":null},{"id":"W2018257514","doi":"10.1007/s10549-005-9092-9","title":"Genomic instability in invasive breast carcinoma measured by inter-Simple Sequence Repeat PCR","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"National Cancer Institute; American Cancer Society","keywords":"Genome instability; Breast cancer; Microsatellite instability; Biology; genomic DNA; Colorectal cancer; Breast carcinoma; Cancer; Pathology; Oncology; Internal medicine; Medicine; DNA; Gene; Genetics; DNA damage; Microsatellite","score_opus":0.04410918952510025,"score_gpt":0.3206292564878869,"score_spread":0.2765200669627867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018257514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424124,0.0011470572,0.002359228,0.00006570178,0.000016427653,0.000028352626,0.00051525206,0.00006559416,0.0015610209],"genre_scores_gemma":[0.99548763,0.0003921094,0.0019546608,0.000056357636,0.000016748732,0.000054462133,0.00063984893,0.000011779744,0.0013864195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952376,0.000114810784,0.0000387416,0.000100150726,0.00015387546,0.00006875176],"domain_scores_gemma":[0.99926037,0.00028383808,0.00016346446,0.00006105047,0.0001525529,0.00007869282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044617843,0.00022324346,0.0002652452,0.001849622,0.000237188,0.00041105208,0.00024235829,0.0003812701,0.0014263307],"category_scores_gemma":[0.0011383524,0.00017491938,0.00024442244,0.0007729756,0.00026542583,0.00019228634,0.00018609832,0.00070897513,0.00038700044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019647374,0.00020980205,0.07563367,0.00006648665,0.00009454175,0.0003137636,0.00029385492,0.00040298456,0.9088768,0.00019230919,0.00022518523,0.011725892],"study_design_scores_gemma":[0.000038334423,0.0022099107,0.5735373,0.00001990113,0.00020338099,0.002081823,0.0003656118,0.0030746404,0.41594565,0.00030763564,0.0021925948,0.000023272081],"about_ca_topic_score_codex":0.00090062,"about_ca_topic_score_gemma":0.0009317713,"teacher_disagreement_score":0.001849622,"about_ca_system_score_codex":0.00023422691,"about_ca_system_score_gemma":0.00014824246,"threshold_uncertainty_score":0.0047715902},"labels":[],"label_agreement":null},{"id":"W2018303837","doi":"10.1023/a:1024529119454","title":"Expedition Inspiration Fund for Breast Cancer Research Meeting 2003","year":2003,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Gerontology; Library science; Cancer; Medical school; Medicine; Medical education; Internal medicine","score_opus":0.2251703269098286,"score_gpt":0.4809634851581347,"score_spread":0.25579315824830606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018303837","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004868447,0.434861,0.002799859,0.060822617,0.087370954,0.0008829808,0.0023696432,0.0007365152,0.40528792],"genre_scores_gemma":[0.0058608972,0.11865171,0.0019404895,0.0062961355,0.0040246877,0.00021927858,0.0017419795,0.000062613515,0.8612022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972767,0.000032067077,0.000011678165,0.000030339772,0.00014950559,0.000048807186],"domain_scores_gemma":[0.99965465,0.0000362722,0.00001914072,0.000014981616,0.00018294806,0.00009201786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092319696,0.0006878305,0.00075075025,0.0009220774,0.00062653597,0.0012442227,0.0010067136,0.002458683,0.054340746],"category_scores_gemma":[0.00086474454,0.00022809528,0.00035409,0.000732666,0.00027286625,0.00059686217,0.000986808,0.0018580457,0.031795543],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039945295,0.000075114345,0.00017832316,0.0005324647,0.00001957368,0.00016290236,0.000013963141,0.00006880769,0.0010034669,0.0012385932,0.8105194,0.18578795],"study_design_scores_gemma":[0.000039113704,0.000036772282,0.00067488744,0.000080455895,0.000009298093,0.00014067838,0.000010966179,0.000020707601,0.00017329071,0.00013218173,0.99867886,0.000002798063],"about_ca_topic_score_codex":0.0037915907,"about_ca_topic_score_gemma":0.017107042,"teacher_disagreement_score":0.054340746,"about_ca_system_score_codex":0.0012383815,"about_ca_system_score_gemma":0.0023474768,"threshold_uncertainty_score":0.18178791},"labels":[],"label_agreement":null},{"id":"W2018588434","doi":"10.1007/s10549-012-2113-6","title":"Incidence of invasive breast cancer in the presence of competing mortality: the Canadian National Breast Screening Study","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Metropolitan University; Public Health Ontario; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Health Canada","keywords":"Breast cancer; Medicine; Mammography; Incidence (geometry); Cancer; Population; Internal medicine; Oncology; Gynecology; Obstetrics","score_opus":0.19767025833083124,"score_gpt":0.4425919888036684,"score_spread":0.24492173047283716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018588434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96127194,0.0046259942,0.0002309424,0.0010548256,0.00006428703,0.00006620417,0.027428504,0.000030652915,0.0052266833],"genre_scores_gemma":[0.9907703,0.0012144282,0.00018884066,0.000105644096,0.000028205373,0.000021241029,0.007151613,0.000007214157,0.0005124747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978867,0.00024838257,0.00018065944,0.00031273853,0.00082308374,0.000548452],"domain_scores_gemma":[0.9959329,0.00027610525,0.00085078215,0.0002905008,0.001705347,0.0009443795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002063306,0.0008825916,0.0012127571,0.002574644,0.0024973704,0.001740233,0.0035260145,0.0014778262,0.0020097098],"category_scores_gemma":[0.0050761006,0.0008462532,0.0021420147,0.008669381,0.00082286337,0.0010135677,0.001781434,0.0022726064,0.00026692872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017566423,0.000028995504,0.99638957,0.000037579448,0.0002884991,0.000048805738,0.00015531837,0.00014996383,0.000041602845,0.00016040205,0.0012598383,0.001263678],"study_design_scores_gemma":[0.000012635325,0.00001218825,0.99871206,0.000019822954,0.00011897766,0.000054381315,0.00028393054,0.0002841746,0.000013206169,0.000034431087,0.0004342559,0.000019959041],"about_ca_topic_score_codex":0.9806464,"about_ca_topic_score_gemma":0.9862931,"teacher_disagreement_score":0.019353628,"about_ca_system_score_codex":0.015425059,"about_ca_system_score_gemma":0.020993838,"threshold_uncertainty_score":0.11191714},"labels":[],"label_agreement":null},{"id":"W2019063845","doi":"10.1007/s10549-014-3150-0","title":"Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review","year":2014,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Tamoxifen; Breast cancer; Medicine; Oncology; Antiestrogen; Mammary gland; Cancer; Gynecology; Internal medicine","score_opus":0.04883813600671446,"score_gpt":0.42225619526383873,"score_spread":0.3734180592571243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019063845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014877424,0.997656,0.0000719607,0.00014891788,0.00006230965,0.0000072988073,0.000045011373,0.00000415956,0.00051668606],"genre_scores_gemma":[0.008730493,0.99026394,0.00020147949,0.0003666596,0.00014407866,0.0000055345045,0.00006160837,0.0000018407742,0.00022428612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995733,0.00007261315,0.0001623289,0.00007978013,0.00007888647,0.00003310021],"domain_scores_gemma":[0.99894446,0.00062992086,0.00027962594,0.000024702083,0.00008641136,0.00003486038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004076421,0.00060077535,0.0010737353,0.002491335,0.00034054945,0.0011795093,0.0006947853,0.0008747077,0.0026444294],"category_scores_gemma":[0.0017831296,0.00026400693,0.000929892,0.002785418,0.00040841164,0.0012905606,0.00068359,0.00074317685,0.00037127093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025339634,0.00016588307,0.012442804,0.10357571,0.001208695,0.017676927,0.0006739682,0.0003736791,0.0026313707,0.00085292524,0.021485474,0.83865917],"study_design_scores_gemma":[0.00012637253,0.0004642023,0.047118492,0.08510895,0.008194033,0.26005715,0.0024964141,0.00031723088,0.0019406506,0.0023570769,0.59163684,0.00018258765],"about_ca_topic_score_codex":0.0010654879,"about_ca_topic_score_gemma":0.0032197621,"teacher_disagreement_score":0.0026444294,"about_ca_system_score_codex":0.00033115264,"about_ca_system_score_gemma":0.0008074809,"threshold_uncertainty_score":0.008846462},"labels":[],"label_agreement":null},{"id":"W2019395174","doi":"10.1007/s10549-009-0326-0","title":"Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Quality of life (healthcare); Medicine; Population; Breast cancer; Logistic regression; Distress; Cancer; Gerontology; Demography; Clinical psychology; Internal medicine; Environmental health","score_opus":0.039179824033028436,"score_gpt":0.34855917412847703,"score_spread":0.3093793500954486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019395174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963665,0.000097816686,0.000009802021,0.000021838574,0.0000020002292,0.0000010770287,0.000051634677,4.711714e-7,0.00017864807],"genre_scores_gemma":[0.9998325,0.00005608257,0.0000102355,0.000007502841,0.0000023380887,0.0000012456281,0.000055687113,5.09718e-7,0.000033794015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997619,0.000084176885,0.000027912107,0.000031588257,0.000033583703,0.00006080701],"domain_scores_gemma":[0.9988187,0.00029839296,0.00046121186,0.000055352233,0.00011594699,0.0002503438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041321642,0.00015981909,0.00033784396,0.0006307362,0.0003560664,0.000610122,0.00014603153,0.00027181284,0.00084691995],"category_scores_gemma":[0.0029034202,0.0001518383,0.0004300675,0.000815345,0.00032567355,0.0002978,0.0005185483,0.0005510437,0.00007343921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009624491,0.000027767033,0.9985934,0.000004525837,0.000053941927,0.000023846904,0.00015137857,0.000026720081,0.00009503631,0.000016214279,0.000025105768,0.0008857522],"study_design_scores_gemma":[0.0000013856016,0.000037873815,0.99947375,0.0000014326563,0.00001757415,0.00003853872,0.00031512143,0.000046615005,0.000013497024,0.00001635283,0.00003628944,0.0000016132584],"about_ca_topic_score_codex":0.004283979,"about_ca_topic_score_gemma":0.004891671,"teacher_disagreement_score":0.004283979,"about_ca_system_score_codex":0.0002039144,"about_ca_system_score_gemma":0.0002302449,"threshold_uncertainty_score":0.00851804},"labels":[],"label_agreement":null},{"id":"W2019417464","doi":"10.1023/a:1006334132303","title":"Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Antiestrogen; Mifepristone; Progesterone receptor; Endocrinology; Internal medicine; Progestin; Estrogen; Transfection; Estrogen receptor; Biology; Medicine; Chemistry; Cell culture; Breast cancer; Cancer","score_opus":0.026281251553891726,"score_gpt":0.3560375136717094,"score_spread":0.32975626211781767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019417464","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33124,0.36833936,0.0031685708,0.21929856,0.011197951,0.00011868884,0.0037226912,0.00044917222,0.062464975],"genre_scores_gemma":[0.56562734,0.3068093,0.0040774886,0.056413222,0.012872517,0.00015084085,0.002106656,0.000076143224,0.051866464],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997099,0.00005557,0.000047631416,0.00004364448,0.000074615185,0.00006856079],"domain_scores_gemma":[0.99930847,0.00017559895,0.00020594524,0.000042108873,0.00013697536,0.00013084548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010211141,0.0003740437,0.0011353277,0.0003271848,0.00044154326,0.0013251228,0.00052990235,0.0022716692,0.0052457815],"category_scores_gemma":[0.001448463,0.00027018096,0.0005458661,0.0005564966,0.0010004153,0.0017604362,0.00022676493,0.0012691903,0.0020982318],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01143401,0.00074742315,0.023514604,0.0025346843,0.00087421754,0.00459779,0.00023935875,0.00045617615,0.07695121,0.012354903,0.09170346,0.7745923],"study_design_scores_gemma":[0.0015727042,0.005606941,0.10381453,0.00072726235,0.0020142866,0.012242149,0.00165783,0.00037953188,0.028209401,0.010211476,0.8333459,0.00021792605],"about_ca_topic_score_codex":0.0032792015,"about_ca_topic_score_gemma":0.008518212,"teacher_disagreement_score":0.0052457815,"about_ca_system_score_codex":0.0009353974,"about_ca_system_score_gemma":0.0018612222,"threshold_uncertainty_score":0.01754886},"labels":[],"label_agreement":null},{"id":"W2019934381","doi":"10.1007/s10549-007-9803-5","title":"The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Cancer Care Ontario; BC Cancer Agency; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Discontinuation; Metastatic breast cancer; Internal medicine; Breast cancer; Cardiac toxicity; Heart failure; Toxicity; Chemotherapy; Area under the curve; Oncology; Cancer; Surgery","score_opus":0.04501115047012002,"score_gpt":0.39700351303797365,"score_spread":0.35199236256785366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019934381","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34319374,0.0005327879,0.64988685,0.0014812032,0.00012280958,0.0001872112,0.0012238338,0.0015447605,0.0018267775],"genre_scores_gemma":[0.9591598,0.0001769472,0.038216155,0.00015435259,0.000058399764,0.0001407443,0.0009224434,0.000029511291,0.0011416593],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996307,0.00013509375,0.000031327236,0.00008965707,0.000066815184,0.00004630537],"domain_scores_gemma":[0.9962961,0.0029182862,0.00021826946,0.00009418861,0.00038205186,0.00009102974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00232717,0.00081718294,0.000978206,0.0010028572,0.00037239533,0.0010119091,0.0010437613,0.0009827042,0.0009853195],"category_scores_gemma":[0.0068283225,0.00044600363,0.0008387655,0.00045331448,0.00025567226,0.0005457722,0.00049786887,0.0012329614,0.00026256754],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027185425,0.00022145396,0.028478267,0.000035087392,0.00016891489,0.00016410513,0.000036141435,0.923649,0.00077298156,0.0013697526,0.0011139663,0.04371844],"study_design_scores_gemma":[0.000006522505,0.000020620313,0.000837236,0.0000021908788,0.000017922725,0.000018960594,0.0000029138362,0.9985061,0.00013325969,0.00038750315,0.00006390962,0.0000028514123],"about_ca_topic_score_codex":0.0131764505,"about_ca_topic_score_gemma":0.0082590515,"teacher_disagreement_score":0.0131764505,"about_ca_system_score_codex":0.0008669395,"about_ca_system_score_gemma":0.0014643031,"threshold_uncertainty_score":0.02619952},"labels":[],"label_agreement":null},{"id":"W2020372142","doi":"10.1007/s10549-009-0325-1","title":"Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy?","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Estrogen; Estrogen receptor; Cytotoxic T cell; Medicine; Breast cancer; Hormone; Hormonal therapy; Internal medicine; Oncology; Endocrinology; Biology; Cancer","score_opus":0.02540817436267295,"score_gpt":0.36298349340947766,"score_spread":0.3375753190468047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020372142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700317,0.019237565,0.00092642347,0.00350539,0.00035671293,0.000019569805,0.000754272,0.00003876052,0.005129622],"genre_scores_gemma":[0.9961732,0.0017479422,0.00024175755,0.00031442515,0.00032986625,0.000008098068,0.0002802017,0.000008530699,0.00089605054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994229,0.00023670969,0.00006423832,0.00008128558,0.00010707464,0.000087775916],"domain_scores_gemma":[0.9965581,0.0019528365,0.0006211433,0.00030777635,0.00025342984,0.00030664017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024904048,0.0003829859,0.0010153203,0.00062619505,0.00023099205,0.0009972474,0.0005303409,0.0010403745,0.0037612393],"category_scores_gemma":[0.0049605053,0.00025255777,0.0006230236,0.00086121616,0.0007378925,0.00078403583,0.0002347257,0.000992382,0.000935679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015461124,0.00006994982,0.9703186,0.00005727773,0.00028565436,0.00023258754,0.00004718926,0.00024835908,0.0035649023,0.00017905036,0.0006670803,0.022783307],"study_design_scores_gemma":[0.00006053815,0.0006789733,0.98745817,0.00004528403,0.000619796,0.00221005,0.0002709584,0.0012705423,0.002412884,0.00084652554,0.004100213,0.000026136498],"about_ca_topic_score_codex":0.00068508676,"about_ca_topic_score_gemma":0.0011545538,"teacher_disagreement_score":0.0037612393,"about_ca_system_score_codex":0.0002415161,"about_ca_system_score_gemma":0.00030715918,"threshold_uncertainty_score":0.01317066},"labels":[],"label_agreement":null},{"id":"W2020563819","doi":"10.1007/s10549-008-9967-7","title":"Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Breast cancer; Receiver operating characteristic; Confidence interval; Prospective cohort study; Axillary Lymph Node Dissection; Sentinel lymph node; Internal medicine; Cut-off; Positive predicative value; Area under the curve; Predictive value of tests; Oncology; Cancer; Predictive value","score_opus":0.025347054671272237,"score_gpt":0.3123230993911312,"score_spread":0.28697604471985894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020563819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938273,0.00006319699,0.000108135304,0.0000196018,0.000010604898,0.000029948755,0.00011573874,0.0000014292166,0.0002685994],"genre_scores_gemma":[0.9989017,0.00005852615,0.00027615877,0.000021729753,0.000016087986,0.000049713388,0.00044478857,0.0000038373037,0.00022746029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976845,0.001326411,0.00018832866,0.0002854759,0.00034061517,0.00017476288],"domain_scores_gemma":[0.99574405,0.0010391698,0.0010660621,0.0004787127,0.0010840353,0.00058797235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070762075,0.0010306829,0.00071710185,0.0010260117,0.00061235554,0.00083427824,0.00077073084,0.0006619324,0.00084483717],"category_scores_gemma":[0.0068713003,0.00037116316,0.00068681786,0.0009264144,0.0006426166,0.00084381865,0.0007569989,0.00054924306,0.00034303192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001988553,0.00026191224,0.9943487,0.0000087874505,0.00016280827,0.000037713726,0.00013674653,0.00009314842,0.000829004,0.000025853582,0.000112680784,0.001994005],"study_design_scores_gemma":[0.00027800578,0.001866932,0.9952226,0.000008267882,0.00022088399,0.00024754682,0.0003413578,0.00083221577,0.0004540043,0.000055341043,0.00045961075,0.000013214041],"about_ca_topic_score_codex":0.0038459313,"about_ca_topic_score_gemma":0.004267428,"teacher_disagreement_score":0.0070762075,"about_ca_system_score_codex":0.0004952975,"about_ca_system_score_gemma":0.00071761553,"threshold_uncertainty_score":0.037423015},"labels":[],"label_agreement":null},{"id":"W2020658618","doi":"10.1023/a:1021853302033","title":"A Comparison of Risk Perception and Psychological Morbidity in Women with Ductal Carcinoma in situ and Early Invasive Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Ductal carcinoma; Anxiety; Distress; Internal medicine; Cancer; Depression (economics); Oncology; Gynecology; Obstetrics; Clinical psychology; Psychiatry","score_opus":0.07948844193845597,"score_gpt":0.39191328070559156,"score_spread":0.31242483876713556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020658618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999527,0.00010142412,0.0000126509185,0.00002713488,0.0000041660096,0.0000045701463,0.00003465547,3.9556315e-7,0.0002879627],"genre_scores_gemma":[0.99974984,0.0000648845,0.00001587725,0.000014793552,0.0000045936536,0.0000026997848,0.000044620625,3.698481e-7,0.000102308135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996846,0.00011907398,0.000033143126,0.0000292089,0.00006175498,0.00007235845],"domain_scores_gemma":[0.9984428,0.00055411115,0.00040433282,0.00004362846,0.00013858275,0.00041654776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054639834,0.0001979219,0.00033857653,0.0007154114,0.0004504214,0.00074734003,0.0002411691,0.00042119954,0.0013067332],"category_scores_gemma":[0.0045430143,0.00020414143,0.00052096124,0.0007845643,0.0002762972,0.00043628865,0.0005518468,0.0005893107,0.00012310757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009023388,0.00019004308,0.99555016,0.000017191367,0.000069894486,0.00009721218,0.0008101915,0.000025867792,0.00022478668,0.000027358179,0.000035650533,0.0020493616],"study_design_scores_gemma":[0.000020842128,0.0005842527,0.997003,0.0000039876536,0.00003823884,0.0001660709,0.0019409778,0.00007434031,0.00003247542,0.000024706349,0.00010663716,0.0000045258485],"about_ca_topic_score_codex":0.006536097,"about_ca_topic_score_gemma":0.007339786,"teacher_disagreement_score":0.006536097,"about_ca_system_score_codex":0.00038707705,"about_ca_system_score_gemma":0.00038087976,"threshold_uncertainty_score":0.012996078},"labels":[],"label_agreement":null},{"id":"W2021343669","doi":"10.1007/s10549-010-1043-4","title":"Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Prophylactic Mastectomy; Breast cancer; Mammography; Cohort; Quality-adjusted life year; BRCA mutation; Medicaid; Psychological intervention; Cost effectiveness; Gynecology; Oncology; Mastectomy; Internal medicine; Health care; Cancer","score_opus":0.03267088001044264,"score_gpt":0.3829762191240329,"score_spread":0.35030533911359024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021343669","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928479,0.0037902615,0.000111790905,0.0003495787,0.00007214371,0.00011924482,0.00035425986,0.000016989672,0.0023376322],"genre_scores_gemma":[0.99791294,0.0010542908,0.00013903288,0.00011503729,0.000067339395,0.00006546494,0.00023084218,0.000004014553,0.0004110259],"study_design_codex":"randomized_trial","study_design_gemma":"systematic_review","domain_scores_codex":[0.99760866,0.0013320004,0.00019769346,0.0002666029,0.00025989508,0.00033521684],"domain_scores_gemma":[0.99500835,0.0032788177,0.00047281056,0.00019222681,0.00017521021,0.00087256334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027043573,0.00070694333,0.0018175495,0.001323645,0.00059933215,0.00063619454,0.0006957892,0.0019597597,0.0066604298],"category_scores_gemma":[0.010635408,0.00036315032,0.0021846604,0.00085361564,0.00059236825,0.0010861078,0.000536087,0.00085667946,0.00041498296],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6878771,0.029335525,0.06600697,0.0013196146,0.0029264982,0.0007612315,0.0008727503,0.003963859,0.0027631307,0.0011369531,0.0013273808,0.20170897],"study_design_scores_gemma":[0.07231077,0.41927433,0.479997,0.00054356526,0.010895357,0.0011938883,0.0015615218,0.0059649427,0.0032979453,0.0020078188,0.002811017,0.00014183142],"about_ca_topic_score_codex":0.0060669403,"about_ca_topic_score_gemma":0.0055346605,"teacher_disagreement_score":0.0066604298,"about_ca_system_score_codex":0.0010632895,"about_ca_system_score_gemma":0.0013618396,"threshold_uncertainty_score":0.022281349},"labels":[],"label_agreement":null},{"id":"W2021349245","doi":"10.1007/s10549-012-2276-1","title":"Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Hazard ratio; Cancer; Prospective cohort study; Cohort study; Internal medicine; Epidemiology; Epidemiology of cancer; Oncology; Confidence interval; Observational study; Gynecology","score_opus":0.24884560950274656,"score_gpt":0.4741760083714476,"score_spread":0.22533039886870102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021349245","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008704131,0.9890233,0.00013493536,0.00015643986,0.00010056102,0.000109267734,0.001624051,0.000006040334,0.00014123826],"genre_scores_gemma":[0.10766084,0.8891375,0.0007550636,0.0006953398,0.00008991344,0.000319391,0.0011260096,0.0000073630254,0.00020853391],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965346,0.00082654733,0.0015535683,0.00051558187,0.00039790425,0.00017175912],"domain_scores_gemma":[0.9884807,0.0070333052,0.0030751429,0.00032583557,0.00082627864,0.0002587075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038133583,0.0011639888,0.0054576774,0.004191027,0.0004284144,0.0013534114,0.0011486384,0.0014452559,0.002928913],"category_scores_gemma":[0.016296668,0.0011845862,0.009737544,0.0066517885,0.00053005916,0.0010962773,0.0012991632,0.0010391526,0.00024237794],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014794406,0.000097966076,0.05159286,0.73075175,0.17726831,0.0003608777,0.0003563986,0.00025815892,0.0003201593,0.00016728458,0.0035391983,0.033807456],"study_design_scores_gemma":[0.0010683759,0.0004754284,0.091740325,0.15483975,0.7375785,0.0007919701,0.00052703574,0.00015264655,0.00019493705,0.00029519512,0.012231829,0.00010400689],"about_ca_topic_score_codex":0.01618552,"about_ca_topic_score_gemma":0.050008714,"teacher_disagreement_score":0.01618552,"about_ca_system_score_codex":0.00186055,"about_ca_system_score_gemma":0.0055121356,"threshold_uncertainty_score":0.032182634},"labels":[],"label_agreement":null},{"id":"W2021616811","doi":"10.1007/s10549-007-9546-3","title":"Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Sanofi","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Hazard ratio; Tissue microarray; Stromal cell; Lymph node; Survival analysis; Confidence interval; Pathology; Cancer","score_opus":0.042426689733371735,"score_gpt":0.3213423895869035,"score_spread":0.27891569985353176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021616811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99960643,0.00013673217,0.00009223622,0.0000062293993,0.0000017077443,0.000006039762,0.0000574895,0.0000032081216,0.00009013748],"genre_scores_gemma":[0.999426,0.00008244402,0.00011904954,0.0000046793543,0.000006123398,0.0000137116485,0.00021337702,0.0000014052997,0.00013329051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957675,0.00008716184,0.000039277475,0.000118381926,0.00011225751,0.00006609444],"domain_scores_gemma":[0.9994161,0.00016665726,0.00015679908,0.00010489223,0.00006187373,0.000093697876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054158195,0.00032067316,0.00043688776,0.0009027481,0.00053958764,0.00038268114,0.00041416567,0.00038082164,0.0012474962],"category_scores_gemma":[0.0017355153,0.00037473437,0.0003240964,0.00058085937,0.00039071392,0.00027669052,0.00051411305,0.0002608337,0.00033784172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031881843,0.000056906174,0.99308735,0.000019966996,0.000048770195,0.000953771,0.00014466127,0.00008242456,0.0021268332,0.000014203132,0.00007651811,0.0030698082],"study_design_scores_gemma":[0.000022592274,0.00021475875,0.993919,0.000005285098,0.00006166235,0.004007262,0.00022364901,0.0003394147,0.0007207666,0.000031763495,0.00044818918,0.000005641065],"about_ca_topic_score_codex":0.0011079415,"about_ca_topic_score_gemma":0.0009893657,"teacher_disagreement_score":0.0012474962,"about_ca_system_score_codex":0.00024424586,"about_ca_system_score_gemma":0.00022494466,"threshold_uncertainty_score":0.004173279},"labels":[],"label_agreement":null},{"id":"W2021717793","doi":"10.1007/s10549-006-9382-x","title":"CDKN2A-positive breast cancers in young women from Poland","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"CDKN2A; Breast cancer; Oncology; Medicine; Odds ratio; Population; Cancer; Internal medicine; Estrogen receptor; Gynecology","score_opus":0.014236543515193885,"score_gpt":0.31414302533981653,"score_spread":0.29990648182462265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021717793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990252,0.00024224145,0.0000406199,0.000038232734,0.0000039973347,0.000013096385,0.00013038196,0.0000018449525,0.0005042774],"genre_scores_gemma":[0.99856335,0.0005075552,0.000045413457,0.000051326337,0.000006662501,0.000011344825,0.00016821508,0.0000023130233,0.0006437903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998266,0.000019721761,0.000023737679,0.000040007188,0.00002811828,0.00006179403],"domain_scores_gemma":[0.9998356,0.000021414171,0.000037903028,0.0000061160895,0.000020769623,0.00007824236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016662561,0.00024060365,0.00035364303,0.0010632966,0.000732813,0.00045152276,0.00023931784,0.00031841788,0.0011628601],"category_scores_gemma":[0.00058397604,0.0004098856,0.00029304886,0.00073631766,0.00029845544,0.00023453799,0.00063438655,0.00026304487,0.00022819053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023799729,0.00006067278,0.98967206,0.000050351002,0.000029067454,0.002982062,0.0013736801,0.00003228604,0.0013370162,0.00005276609,0.00017930062,0.0039927065],"study_design_scores_gemma":[0.000019768397,0.00012970857,0.9935869,0.000012428523,0.00004153863,0.0033641837,0.001691679,0.00004597114,0.00017239335,0.000033277178,0.0008963622,0.0000057667353],"about_ca_topic_score_codex":0.031019162,"about_ca_topic_score_gemma":0.033902302,"teacher_disagreement_score":0.031019162,"about_ca_system_score_codex":0.00070045906,"about_ca_system_score_gemma":0.00079631933,"threshold_uncertainty_score":0.061677217},"labels":[],"label_agreement":null},{"id":"W2021833052","doi":"10.1007/s10549-010-1156-9","title":"A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Cancer; Ovarian cancer; Medicine; Genetic counseling; Oncology; Population; Mutation; Family history; Incidence (geometry); Internal medicine; Genetic testing; Gynecology; Genetics; Gene; Biology","score_opus":0.01819576058975373,"score_gpt":0.32152399937327747,"score_spread":0.3033282387835237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021833052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984848,0.00035992163,0.000043555923,0.00021549995,0.000009261403,0.000004892766,0.00018690545,0.0000035678113,0.0006917244],"genre_scores_gemma":[0.9994677,0.00021970394,0.000029504332,0.00007958493,0.00000892495,0.0000033280076,0.00007833158,0.0000011922458,0.00011180702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997818,0.00005305816,0.000020305095,0.000029055262,0.000048212565,0.000067526395],"domain_scores_gemma":[0.99964786,0.000062406434,0.00013125504,0.00002018353,0.000050310136,0.00008806552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002745824,0.00019314299,0.00035985067,0.00087408035,0.0007941675,0.00082007627,0.0002771647,0.0003744328,0.002754768],"category_scores_gemma":[0.0011031369,0.0001934993,0.00018996865,0.001121358,0.00032785363,0.00030239797,0.000362527,0.0003366301,0.00016582188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006163907,0.000021188976,0.9940196,0.000022439688,0.000027633318,0.00031202758,0.0011308264,0.000013974879,0.0013108844,0.00006498702,0.00020271247,0.0028120726],"study_design_scores_gemma":[0.000005538801,0.000038408012,0.9956689,0.000012327559,0.000023703757,0.00078691763,0.0027593628,0.000043331063,0.00009826696,0.000036348927,0.0005219626,0.0000049542973],"about_ca_topic_score_codex":0.045156434,"about_ca_topic_score_gemma":0.045972493,"teacher_disagreement_score":0.045156434,"about_ca_system_score_codex":0.0006040939,"about_ca_system_score_gemma":0.0004148271,"threshold_uncertainty_score":0.089787185},"labels":[],"label_agreement":null},{"id":"W2021977870","doi":"10.1007/s10549-013-2659-y","title":"The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Carleton University; Centre de Santé et de Services Sociaux de Chicoutimi","funders":"","keywords":"Medicine; Distress; Breast cancer; Sexual function; Sexual dysfunction; Gynecology; Prospective cohort study; Sex organ; Endocrine system; Libido; Cancer; Obstetrics; Internal medicine; Clinical psychology; Hormone","score_opus":0.04819211191692865,"score_gpt":0.3726339190914514,"score_spread":0.32444180717452276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021977870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749349,0.021797532,0.00023623151,0.00019652215,0.000038326736,0.00012987833,0.00065697794,0.0000043934338,0.0020053326],"genre_scores_gemma":[0.9900018,0.008303467,0.00022451924,0.00025716817,0.00006657404,0.00005940981,0.0005637019,0.0000033967317,0.00051993644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902785,0.00058384996,0.000099918674,0.0000724152,0.00014692417,0.000068996866],"domain_scores_gemma":[0.99512404,0.0028474717,0.0009731362,0.0004183683,0.00031279432,0.0003242564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042123403,0.0005277651,0.0006536302,0.0005186954,0.0004914297,0.00088636973,0.00030884144,0.0004390276,0.001421778],"category_scores_gemma":[0.005253553,0.00023337337,0.0009053862,0.0012614292,0.00063356,0.00049138896,0.00044885802,0.0006229244,0.00015927083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015919665,0.0014117548,0.9467631,0.0005158958,0.0022675358,0.00025290577,0.0003465226,0.00011583057,0.0018108507,0.00008170181,0.00018693865,0.030327331],"study_design_scores_gemma":[0.00062969694,0.008717629,0.98684967,0.000079562065,0.0014787003,0.00031415262,0.0002946576,0.00002951924,0.0004186218,0.000057535526,0.0011153909,0.000014828903],"about_ca_topic_score_codex":0.0025464732,"about_ca_topic_score_gemma":0.0044496236,"teacher_disagreement_score":0.0042123403,"about_ca_system_score_codex":0.00024437488,"about_ca_system_score_gemma":0.0006328365,"threshold_uncertainty_score":0.022277236},"labels":[],"label_agreement":null},{"id":"W2022309076","doi":"10.1007/s10549-012-2188-0","title":"Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Office of Science; Breast Cancer Research Foundation; Pfizer; National Cancer Institute; National Institutes of Health; Cancer Research UK; Belgian American Educational Foundation; Stand Up To Cancer; U.S. Department of Energy","keywords":"Olaparib; Synthetic lethality; Biology; DNA repair; PARP inhibitor; Homologous recombination; Cancer research; Gene; Genetics; DNA damage; Molecular biology; Poly ADP ribose polymerase; DNA; Polymerase","score_opus":0.07377723545298644,"score_gpt":0.41215573030947594,"score_spread":0.3383784948564895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022309076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955409,0.00011737699,0.0034811436,0.000012058818,0.0000015598641,0.00001749732,0.00045636194,0.000121257566,0.00025186257],"genre_scores_gemma":[0.99253345,0.00006628914,0.0054313154,0.00001733747,0.0000014713579,0.00003797126,0.0015694994,0.0000135714645,0.0003291585],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983287,0.000023660305,0.000014434318,0.00006520073,0.000032208376,0.000031687567],"domain_scores_gemma":[0.9996811,0.0001539371,0.000071899325,0.000019746009,0.000039443818,0.00003386119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027923356,0.0002605583,0.000326149,0.0010498615,0.00013801857,0.00036262692,0.00016071337,0.00033079262,0.00091714],"category_scores_gemma":[0.0006656271,0.00011883464,0.0002445278,0.0005493255,0.00013097758,0.0001243906,0.00024482803,0.00020814808,0.00020745263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018549148,0.0003150809,0.45886827,0.00012679069,0.00017558664,0.0002641118,0.0001448748,0.014909853,0.47571197,0.0001982993,0.00031063115,0.047119666],"study_design_scores_gemma":[0.000036465088,0.0007178252,0.7347405,0.000011412263,0.000105577135,0.0005758368,0.0001878275,0.16145028,0.10085414,0.00045553243,0.0008394908,0.00002511858],"about_ca_topic_score_codex":0.0013587938,"about_ca_topic_score_gemma":0.0015299108,"teacher_disagreement_score":0.0013587938,"about_ca_system_score_codex":0.0002877498,"about_ca_system_score_gemma":0.0001760327,"threshold_uncertainty_score":0.003068149},"labels":[],"label_agreement":null},{"id":"W2022667742","doi":"10.1007/s10549-014-3212-3","title":"Stearidonic acid-enriched flax oil reduces the growth of human breast cancer in vitro and in vivo","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Innovates; University of Saskatchewan; University of Alberta","funders":"Alberta Innovates; Shandong Academy of Sciences; Canada Research Chairs; Government of Alberta","keywords":"Docosapentaenoic acid; Apoptosis; Polyunsaturated fatty acid; In vivo; Arachidonic acid; Phospholipid; In vitro; Eicosapentaenoic acid; Fatty acid; Docosahexaenoic acid; Biochemistry; Biology; Chemistry; Cancer research; Membrane; Enzyme; Biotechnology","score_opus":0.018887495915533993,"score_gpt":0.31822417438425127,"score_spread":0.29933667846871725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022667742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995776,0.0015606702,0.0005086151,0.00015065233,0.00004304,0.000011864457,0.00036901096,0.00006797962,0.0015121695],"genre_scores_gemma":[0.9892356,0.0016883748,0.00038979025,0.000064962995,0.000013706766,0.000018998517,0.0012324414,0.000025899732,0.007330256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989784,0.00002132229,0.000007572847,0.000012021249,0.000022261042,0.000038847684],"domain_scores_gemma":[0.99989414,0.000029698083,0.000014125361,0.00001877219,0.000014048383,0.000029155628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011600338,0.0003262463,0.0002853533,0.0003541096,0.00016696485,0.00026660087,0.00018055335,0.0002461967,0.002454187],"category_scores_gemma":[0.00012081185,0.00016656525,0.00025822173,0.00020674276,0.00016593559,0.0001335091,0.00014401054,0.0005182178,0.00050821993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020942087,0.00026509404,0.00029134468,0.000029308401,0.000012015888,0.000039072856,0.000017398934,0.00007458911,0.9948152,0.00004180639,0.0001517667,0.002168238],"study_design_scores_gemma":[0.000050153747,0.0012778465,0.0032919657,0.000003998622,0.000023928578,0.00008130911,0.00003682079,0.00027263712,0.9937635,0.000019791078,0.0011754388,0.0000027157082],"about_ca_topic_score_codex":0.004114886,"about_ca_topic_score_gemma":0.004461307,"teacher_disagreement_score":0.004114886,"about_ca_system_score_codex":0.00029089514,"about_ca_system_score_gemma":0.00033281138,"threshold_uncertainty_score":0.008210063},"labels":[],"label_agreement":null},{"id":"W2023466774","doi":"10.1007/s10549-014-2880-3","title":"Dermcidin expression is associated with disease progression and survival among breast cancer patients","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Disease; Cancer","score_opus":0.025981955336902555,"score_gpt":0.33915990255071304,"score_spread":0.3131779472138105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023466774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984326,0.00050784426,0.0000789325,0.000065127046,0.000010236854,0.0000041676517,0.00016612925,0.000004246254,0.00073067116],"genre_scores_gemma":[0.99898,0.00012338742,0.0000741466,0.000028785931,0.0000141861765,0.0000037818386,0.00020699599,0.0000013834083,0.0005673932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983907,0.00002960655,0.00001622152,0.000035410823,0.000038780996,0.000040953822],"domain_scores_gemma":[0.999602,0.00006115835,0.00020764147,0.000015144167,0.000042188865,0.00007181675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001599101,0.00010697842,0.0001995696,0.00038696505,0.00024040713,0.0005237889,0.00017186053,0.00024239664,0.0017289914],"category_scores_gemma":[0.0007006507,0.00010993107,0.00014995704,0.00049068965,0.00017606057,0.0002521913,0.00022068419,0.00046821136,0.00016390264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006029327,0.00004242946,0.9888516,0.0000150609585,0.000039319577,0.0001289249,0.000044739925,0.00004640296,0.0049661607,0.00005365791,0.00020601023,0.005002739],"study_design_scores_gemma":[0.000013195641,0.000072424125,0.9971796,0.000005432799,0.00003720875,0.00050166924,0.0001329151,0.00037379237,0.0009823241,0.000060925606,0.00063626864,0.000004188388],"about_ca_topic_score_codex":0.0010721745,"about_ca_topic_score_gemma":0.0016773854,"teacher_disagreement_score":0.0017289914,"about_ca_system_score_codex":0.0002869542,"about_ca_system_score_gemma":0.00014947908,"threshold_uncertainty_score":0.0057840347},"labels":[],"label_agreement":null},{"id":"W2023484110","doi":"10.1007/s10549-014-2865-2","title":"Survival from breast cancer in patients with CHEK2 mutations","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"CHEK2; Breast cancer; Medicine; Internal medicine; Hazard ratio; Oncology; Proportional hazards model; Cancer; Survival analysis; Mutation; Gynecology; Biology; Genetics; Germline mutation; Confidence interval; Gene","score_opus":0.019214568044670345,"score_gpt":0.3208714521491739,"score_spread":0.30165688410450353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023484110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996498,0.0011628278,0.00007952717,0.00023453515,0.000030088599,0.0000021150668,0.0006252434,0.000008798587,0.0013588613],"genre_scores_gemma":[0.99843365,0.00031340477,0.000021131,0.00007475675,0.000031551077,0.0000023457067,0.00059216726,0.0000028261695,0.0005281277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998784,0.000015733734,0.0000070497736,0.000031360592,0.000014166487,0.00005322283],"domain_scores_gemma":[0.9996264,0.000090563386,0.00008586832,0.000023944991,0.000035315177,0.00013791303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021463177,0.00019578816,0.00034719898,0.00037934203,0.00031555872,0.00041646196,0.00023867113,0.00050421746,0.0023969691],"category_scores_gemma":[0.0009530685,0.0001403738,0.00042188668,0.00049169373,0.00017541542,0.0004399857,0.0003359269,0.0005605214,0.00025979406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014407344,0.0000494661,0.98755425,0.000016296159,0.000109790344,0.0004993029,0.000060788083,0.00036925575,0.00096770003,0.000086921165,0.00078163313,0.00806383],"study_design_scores_gemma":[0.000031927833,0.00022834544,0.9967925,0.000007135267,0.000109112756,0.0013546571,0.00012610998,0.00040502474,0.00014240586,0.00018125112,0.0006142784,0.0000072144067],"about_ca_topic_score_codex":0.00324002,"about_ca_topic_score_gemma":0.0029106762,"teacher_disagreement_score":0.00324002,"about_ca_system_score_codex":0.00032516077,"about_ca_system_score_gemma":0.0002682876,"threshold_uncertainty_score":0.0080186725},"labels":[],"label_agreement":null},{"id":"W2023760479","doi":"10.1007/s10549-012-2065-x","title":"Tumour characteristics among women with very low-risk breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Overdiagnosis; Medicine; Breast cancer; Oncology; Internal medicine; Cancer; Lymph node; Mammography; Immunohistochemistry; Gynecology","score_opus":0.016654471103451172,"score_gpt":0.29816142628799386,"score_spread":0.28150695518454266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023760479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984876,0.00057477725,0.000042563664,0.000030436959,0.0000040110463,0.0000057935376,0.00024623852,0.0000012308561,0.00060722936],"genre_scores_gemma":[0.9993499,0.000136839,0.000019961371,0.000019642437,0.000005734304,0.0000061935066,0.00021048485,0.0000011056276,0.00025016823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996879,0.00012099337,0.000039584196,0.000047107835,0.000042434287,0.00006197821],"domain_scores_gemma":[0.99901867,0.00036156183,0.00029090582,0.00007020364,0.000104977174,0.00015368656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003664608,0.00012140914,0.00027138143,0.0010771623,0.0003762245,0.0004519956,0.0002512565,0.00035946065,0.0015419216],"category_scores_gemma":[0.00268803,0.00017722981,0.00022693667,0.0011487637,0.0002670692,0.00039788106,0.00033953946,0.00035380386,0.00024241397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007119732,0.000042988304,0.9965329,0.00002038581,0.00003545455,0.000087598666,0.00020341968,0.000021429953,0.0006731518,0.000029052575,0.00005587398,0.001585795],"study_design_scores_gemma":[0.000007174581,0.00014854223,0.99908185,0.0000031880274,0.000021155754,0.00017973405,0.00023997347,0.000017165617,0.00008896166,0.000017309145,0.00019280479,0.0000020854625],"about_ca_topic_score_codex":0.0059195934,"about_ca_topic_score_gemma":0.005348908,"teacher_disagreement_score":0.0059195934,"about_ca_system_score_codex":0.00028895307,"about_ca_system_score_gemma":0.00019617817,"threshold_uncertainty_score":0.011770308},"labels":[],"label_agreement":null},{"id":"W2024302667","doi":"10.1007/s10549-007-9610-z","title":"Gemcitabine in the management of metastatic breast cancer: a systematic review","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; Ottawa Hospital","funders":"","keywords":"Gemcitabine; Docetaxel; Medicine; Oncology; Taxane; Metastatic breast cancer; Internal medicine; Breast cancer; Capecitabine; Clinical trial; Randomized controlled trial; Chemotherapy; Anthracycline; Cancer; Colorectal cancer","score_opus":0.20374862271191702,"score_gpt":0.5221446010040509,"score_spread":0.3183959782921339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024302667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037455477,0.9992816,0.00004113232,0.0000724756,0.000039270748,0.000028018416,0.000046904435,0.0000020957013,0.00011399991],"genre_scores_gemma":[0.004179699,0.9953242,0.00019122372,0.00016361363,0.000033826946,0.000024560437,0.00003214335,8.962346e-7,0.000049884256],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99899036,0.0003837977,0.00030649317,0.00010268536,0.00018144281,0.000035158737],"domain_scores_gemma":[0.9968984,0.0022110732,0.0006160352,0.00003439115,0.00017608544,0.00006390318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018154286,0.0008582919,0.0052205296,0.0025258965,0.00028343013,0.0009067579,0.0010600766,0.001002926,0.0026977654],"category_scores_gemma":[0.0062767123,0.00043732006,0.003053771,0.0038713375,0.0003921081,0.000857951,0.000634302,0.000761545,0.000202478],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009661006,0.00005681879,0.0007709112,0.76271623,0.0119659845,0.00023563855,0.000102905564,0.00040451952,0.00040436778,0.0002602112,0.004774492,0.21734184],"study_design_scores_gemma":[0.0023310008,0.0017304315,0.012635395,0.6399622,0.21732509,0.0021182944,0.00042501919,0.00045555524,0.00087829295,0.0010169907,0.121005796,0.00011585984],"about_ca_topic_score_codex":0.0044202455,"about_ca_topic_score_gemma":0.017602764,"teacher_disagreement_score":0.0052205296,"about_ca_system_score_codex":0.0010098111,"about_ca_system_score_gemma":0.0023493827,"threshold_uncertainty_score":0.009600997},"labels":[],"label_agreement":null},{"id":"W2024879187","doi":"10.1007/s10549-008-9900-0","title":"25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada","funders":"National Cancer Institute; National Institutes of Health","keywords":"Mammary gland; Autocrine signalling; Paracrine signalling; Organ culture; Endocrinology; Internal medicine; Vitamin D and neurology; Carcinogen; Hormone; Biology; Prohormone; In vivo; Cancer research; Breast cancer; Cancer; Medicine; Receptor; In vitro; Biochemistry","score_opus":0.059275673196970045,"score_gpt":0.35501026543766057,"score_spread":0.29573459224069054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024879187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97279865,0.009409863,0.0069667925,0.0005405137,0.00023150025,0.00015338094,0.003437625,0.00032101784,0.00614069],"genre_scores_gemma":[0.96860236,0.0051807263,0.007322146,0.00015835243,0.00006485199,0.00015765807,0.0040684193,0.000060420924,0.014385068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995003,0.00011790407,0.000084246814,0.00010177604,0.00009843722,0.000097363714],"domain_scores_gemma":[0.99948883,0.00019975146,0.0000488405,0.000101304635,0.000060002698,0.00010124591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060529145,0.000445232,0.000569486,0.0009028982,0.0004981402,0.00044265247,0.0006641428,0.00040330735,0.0026050801],"category_scores_gemma":[0.00020038015,0.00039104687,0.00074831065,0.0005993965,0.00039673742,0.00032761367,0.00024028291,0.0010736213,0.0008436711],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005274204,0.00009251106,0.00022590405,0.00006520143,0.000012313064,0.00009843817,0.000048101236,0.00005344273,0.9978879,0.00010563825,0.00010690448,0.0007761625],"study_design_scores_gemma":[0.00003152477,0.00045958784,0.0018003187,0.000008193449,0.00004430773,0.000096673844,0.000046424982,0.0002653016,0.99515164,0.000038024937,0.0020532294,0.000004700944],"about_ca_topic_score_codex":0.0050148265,"about_ca_topic_score_gemma":0.008097682,"teacher_disagreement_score":0.0050148265,"about_ca_system_score_codex":0.00043517607,"about_ca_system_score_gemma":0.000551292,"threshold_uncertainty_score":0.009971321},"labels":[],"label_agreement":null},{"id":"W2024981400","doi":"10.1007/s10549-010-1183-6","title":"Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Zoledronic acid; Medicine; Breast cancer; Regimen; Internal medicine; Clinical endpoint; Oncology; N-terminal telopeptide; Biomarker; Urology; Cancer; Metastatic breast cancer; Bone remodeling; Gastroenterology; Randomized controlled trial; Osteocalcin; Alkaline phosphatase","score_opus":0.0648832606274134,"score_gpt":0.3964893727552942,"score_spread":0.3316061121278808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024981400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971129,0.0018505482,0.00011009761,0.00014546086,0.000016629388,0.000010443308,0.00022786422,0.000010971812,0.00051512447],"genre_scores_gemma":[0.9994579,0.00014753781,0.00010372655,0.00004730338,0.000012541312,0.000004951651,0.00012501684,0.0000013625796,0.00009967867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999665,0.00008269969,0.000043882872,0.000058260128,0.00009538013,0.000054865308],"domain_scores_gemma":[0.99923515,0.00023723805,0.0003199153,0.000036072288,0.00009917709,0.00007235725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029836353,0.0002769917,0.00064449926,0.0006702276,0.00023673974,0.00061515695,0.00030682056,0.0004903752,0.001132563],"category_scores_gemma":[0.0026853944,0.00020205523,0.0005270151,0.0009615477,0.00021689906,0.00043795104,0.00018046884,0.0003959483,0.0001605195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010699654,0.00012925183,0.94962853,0.00009532842,0.0005195934,0.0005389018,0.00006136303,0.00029606363,0.014560378,0.000057676803,0.00027223674,0.023141038],"study_design_scores_gemma":[0.00011465107,0.0011196218,0.9935917,0.0000078149105,0.00036043528,0.0010239991,0.000066969194,0.0004852975,0.0027140458,0.000103931656,0.00039961038,0.000011887158],"about_ca_topic_score_codex":0.0016207704,"about_ca_topic_score_gemma":0.0024163588,"teacher_disagreement_score":0.0016207704,"about_ca_system_score_codex":0.0004479512,"about_ca_system_score_gemma":0.00039546168,"threshold_uncertainty_score":0.0037888288},"labels":[],"label_agreement":null},{"id":"W2024991157","doi":"10.1007/s10549-006-9261-5","title":"Direct-to-patient BRCA1 testing: the Twoj Styl experience","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Coalition for Research in Women's Health","funders":"","keywords":"Genetic testing; Genetic counseling; Breast cancer; Medicine; BRCA mutation; Family medicine; Population; Test (biology); Cancer; Gynecology; Family history; Breast cancer screening; Demography; Oncology; Mammography; Internal medicine; Genetics; Environmental health; Biology","score_opus":0.04806330212111851,"score_gpt":0.35334629772245674,"score_spread":0.3052829956013382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024991157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82401925,0.014289873,0.011729093,0.023404026,0.0022537766,0.00035992052,0.0009724548,0.00069167867,0.122279935],"genre_scores_gemma":[0.92591393,0.013464554,0.010745634,0.013024855,0.0011726998,0.00012210736,0.00088611123,0.00049443677,0.034175716],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988292,0.0003532609,0.000066330824,0.00018979133,0.000264331,0.00029704827],"domain_scores_gemma":[0.9961366,0.0008865843,0.000190483,0.0003246003,0.00024817762,0.002213573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023025637,0.0005105822,0.00042230153,0.0008911136,0.0016789192,0.0020347561,0.0008559015,0.0019944194,0.013479748],"category_scores_gemma":[0.005671975,0.00040195146,0.00073565665,0.0009247392,0.0010555092,0.0012545312,0.002620733,0.0024370907,0.0028564378],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024492454,0.0085288985,0.2177199,0.00024775244,0.00020049459,0.065380506,0.0055539105,0.0017642447,0.006198004,0.0064334664,0.052739937,0.63278365],"study_design_scores_gemma":[0.0010928867,0.010454102,0.28191718,0.0005530861,0.0003829804,0.3778784,0.009124895,0.0030751307,0.006661326,0.009840241,0.29854056,0.0004792163],"about_ca_topic_score_codex":0.0038089443,"about_ca_topic_score_gemma":0.012245484,"teacher_disagreement_score":0.013479748,"about_ca_system_score_codex":0.0017352741,"about_ca_system_score_gemma":0.00212323,"threshold_uncertainty_score":0.045094192},"labels":[],"label_agreement":null},{"id":"W2025322874","doi":"10.1007/s10549-007-9498-7","title":"Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; ADH1B; Acetaldehyde; Alcohol; Medicine; Cancer; Internal medicine; Alcohol dehydrogenase; Oncology; Physiology; Ethanol; Biology; Biochemistry; Enzyme","score_opus":0.18628811876911067,"score_gpt":0.4670998357307335,"score_spread":0.2808117169616228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025322874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978775,0.000111936046,0.000251516,0.000044706852,0.000007584832,0.000013674772,0.0014609463,0.000008022181,0.00022413325],"genre_scores_gemma":[0.99575883,0.00014131799,0.0005624918,0.000025054136,0.00001595044,0.000045923625,0.002825767,0.00001801655,0.0006066809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969187,0.00199432,0.00019003339,0.00036920074,0.0003303698,0.00019734676],"domain_scores_gemma":[0.99439985,0.0019143615,0.0011087168,0.0015479953,0.00039534763,0.0006337511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003363085,0.00085617474,0.001332833,0.001783701,0.0015370307,0.0008260305,0.0011979487,0.00058986683,0.0033590996],"category_scores_gemma":[0.008744495,0.00098458,0.0024491153,0.0030877113,0.00042254757,0.000842316,0.0016075615,0.0010446984,0.0006289293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001321994,0.00012902814,0.99531186,0.000018702423,0.000965738,0.00017399796,0.00016204047,0.00017263452,0.00045771326,0.000051721203,0.00033383066,0.00090058503],"study_design_scores_gemma":[0.0001864463,0.00039720963,0.9943169,0.000012886933,0.0012863199,0.0007876085,0.0004844004,0.0014001789,0.00044572595,0.00006223224,0.00059731305,0.000022894836],"about_ca_topic_score_codex":0.034718666,"about_ca_topic_score_gemma":0.032761097,"teacher_disagreement_score":0.034718666,"about_ca_system_score_codex":0.0005517075,"about_ca_system_score_gemma":0.0013390324,"threshold_uncertainty_score":0.069033146},"labels":[],"label_agreement":null},{"id":"W2025598781","doi":"10.1007/s10549-007-9654-0","title":"The impact of diabetes on survival following breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Cancer Care Ontario; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Breast cancer; Diabetes mellitus; Hyperinsulinemia; Hazard ratio; Comorbidity; Internal medicine; Cancer; Population; Proportional hazards model; Type 2 diabetes; Oncology; Gynecology; Confidence interval; Insulin resistance; Endocrinology","score_opus":0.03054989329367037,"score_gpt":0.37886227572146386,"score_spread":0.3483123824277935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025598781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674123,0.019144723,0.00020555996,0.004218352,0.00028754098,0.000009931774,0.0020037543,0.000016600026,0.006701231],"genre_scores_gemma":[0.99386036,0.004093784,0.00005741871,0.0002817152,0.00030022996,0.0000041516537,0.00073815975,0.000004665035,0.00065942976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993262,0.00022809579,0.000050646955,0.000059775917,0.00008577633,0.0002494738],"domain_scores_gemma":[0.9958807,0.0012749993,0.0010102036,0.00022925434,0.00037033577,0.0012345762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096050743,0.00025489216,0.00042687758,0.0005457326,0.0004651441,0.00076787645,0.00036643774,0.0008261679,0.0027725827],"category_scores_gemma":[0.0053792456,0.00014647961,0.00090277474,0.0012235373,0.0002802671,0.00057516294,0.00060954166,0.0015397655,0.00033277427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023192267,0.00015251737,0.97011435,0.000043546443,0.00032417482,0.00024375856,0.000048314414,0.00036570078,0.0002435782,0.00015074278,0.00083444244,0.025159681],"study_design_scores_gemma":[0.0000138789765,0.00017085415,0.9985215,0.000014047545,0.00016937345,0.00019782133,0.000084689265,0.00016228728,0.00003632252,0.00017718357,0.00044630643,0.000005781156],"about_ca_topic_score_codex":0.0071770386,"about_ca_topic_score_gemma":0.010861915,"teacher_disagreement_score":0.0071770386,"about_ca_system_score_codex":0.0005305052,"about_ca_system_score_gemma":0.0007191271,"threshold_uncertainty_score":0.014270484},"labels":[],"label_agreement":null},{"id":"W2026055570","doi":"10.1023/a:1023979226714","title":"2. Survival Impact of HER-2/Neu, Cox-2, Urokinase Plasminogen Activator (upa), Cytokeratin 17/5,6 and other Markers with Long-Term Outcome of Early Breast Cancer. Report from the British Columbia Tissue Micro-Array Project (BCTMAP)","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytokeratin; Breast cancer; Immunohistochemistry; Internal medicine; Oncology; Medicine; Pathology; Urokinase receptor; Biology; Cancer; Plasminogen activator","score_opus":0.047285448596771855,"score_gpt":0.36464497862614403,"score_spread":0.31735953002937217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026055570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95776,0.009740473,0.0003738676,0.0020709778,0.0001545763,0.000050303363,0.022255272,0.00004649382,0.0075480207],"genre_scores_gemma":[0.9763373,0.0020349496,0.0002682029,0.00037893292,0.00014053195,0.000036603218,0.012620466,0.000021242338,0.008161866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986553,0.000018571332,0.0000059092417,0.000018246936,0.00004454113,0.000047132206],"domain_scores_gemma":[0.9982797,0.0006744028,0.00022002117,0.0001122171,0.00038309736,0.00033058805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000696862,0.0002265808,0.0003450181,0.0003947991,0.0002674252,0.00039766362,0.00036022018,0.00042480015,0.0031686437],"category_scores_gemma":[0.0018448207,0.00009807022,0.00033751316,0.00042448763,0.00020888129,0.00017690597,0.00030149723,0.00065559853,0.0006647991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024642373,0.0003366037,0.8674442,0.00015636822,0.0005392844,0.0008841927,0.00016807008,0.0008063644,0.008467371,0.00017306123,0.024173368,0.072208844],"study_design_scores_gemma":[0.00005385448,0.00032065512,0.99579144,0.000016167749,0.00024409419,0.0003640805,0.000049668317,0.00014395652,0.0007843635,0.00004189238,0.0021834637,0.0000064557894],"about_ca_topic_score_codex":0.084864505,"about_ca_topic_score_gemma":0.11779992,"teacher_disagreement_score":0.9151355,"about_ca_system_score_codex":0.00062925223,"about_ca_system_score_gemma":0.0010270859,"threshold_uncertainty_score":0.16874105},"labels":[],"label_agreement":null},{"id":"W2026727525","doi":"10.1007/s10549-006-9441-3","title":"Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Western University; University of British Columbia; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; London Health Sciences Centre; Women's College Hospital; Université du Québec à Montréal; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Breast cancer; Medicine; BRCA mutation; Obstetrics; Childbirth; Pregnancy; Ovarian cancer; Gynecology; Population; Genetic counseling; Oncology; Cancer; Internal medicine; Genetics; Biology","score_opus":0.02720911644467028,"score_gpt":0.3515969487490057,"score_spread":0.32438783230433543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026727525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791294,0.0011238763,0.000033515138,0.0001608535,0.000022755989,0.0000023704754,0.00017286345,0.0000046881373,0.00056618184],"genre_scores_gemma":[0.99854004,0.00049424707,0.000048607988,0.000041306244,0.000035396297,0.0000035700916,0.00014732334,0.0000048672437,0.0006846335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996475,0.00012130516,0.00003345692,0.00005344525,0.0000448702,0.00009937749],"domain_scores_gemma":[0.9939545,0.0022232637,0.0019323771,0.0002398915,0.00021203083,0.0014379276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008383148,0.0003394909,0.000615892,0.0014068949,0.00064856914,0.00087535253,0.00055194995,0.0014753087,0.0052605327],"category_scores_gemma":[0.0073622703,0.0006355273,0.00092049775,0.0010258885,0.00040100102,0.00071483146,0.0004278561,0.0014492307,0.0004363115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011785151,0.00013769865,0.9960348,0.000013902243,0.00008949529,0.00042933252,0.00017835067,0.000069356465,0.00038981496,0.000059230057,0.000119969525,0.0012996249],"study_design_scores_gemma":[0.00002965928,0.0003549792,0.99728394,0.000016928063,0.00011961699,0.0012065344,0.000358774,0.00021753098,0.00009571523,0.000113145084,0.00019136666,0.000011672172],"about_ca_topic_score_codex":0.01015604,"about_ca_topic_score_gemma":0.0041619833,"teacher_disagreement_score":0.01015604,"about_ca_system_score_codex":0.00035315214,"about_ca_system_score_gemma":0.00044650026,"threshold_uncertainty_score":0.020193815},"labels":[],"label_agreement":null},{"id":"W2026828661","doi":"10.1007/s10549-011-1380-y","title":"EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; St. Michael's Hospital; Hamilton Health Sciences; University of Toronto; McMaster University","funders":"National Cancer Institute","keywords":"Breast cancer; Gene duplication; Cyclin D1; Cancer research; Tissue microarray; Oncogene; Cancer; Biology; Immunohistochemistry; Fluorescence in situ hybridization; Oncology; Internal medicine; Medicine; Gene; Genetics; Chromosome; Cell cycle","score_opus":0.05200347077717383,"score_gpt":0.32036979620263584,"score_spread":0.268366325425462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026828661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97485435,0.0005432285,0.00015531841,0.00047679764,0.000013300028,0.00007009635,0.017180022,0.000013873446,0.0066930465],"genre_scores_gemma":[0.99040645,0.0006972696,0.00020466323,0.00011384904,0.000014976575,0.00004534752,0.005538668,0.000011756805,0.0029670082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989792,0.00010750883,0.00008515735,0.00015152952,0.0003609448,0.0003156713],"domain_scores_gemma":[0.99630415,0.0002616928,0.0009456943,0.0002678754,0.0015262781,0.0006943913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006117267,0.00029998706,0.00043699163,0.0021429963,0.0020549207,0.0008526654,0.0011276642,0.00051679445,0.0039947783],"category_scores_gemma":[0.003099548,0.00062191987,0.0004726843,0.0069377944,0.00048398974,0.00046555666,0.001208944,0.0004656454,0.0005804498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047812762,0.000009106674,0.996424,0.000015768632,0.00002202018,0.00022184051,0.0005676797,0.00005533128,0.00014341171,0.00004638744,0.0013372861,0.0011093419],"study_design_scores_gemma":[0.00000524047,0.000006101657,0.9981737,0.00001292629,0.000017423692,0.00014380319,0.0005755657,0.000073742056,0.000032104217,0.000012910877,0.00093996467,0.0000066367725],"about_ca_topic_score_codex":0.9590428,"about_ca_topic_score_gemma":0.9850701,"teacher_disagreement_score":0.9590428,"about_ca_system_score_codex":0.008558994,"about_ca_system_score_gemma":0.012963978,"threshold_uncertainty_score":0.082396805},"labels":[],"label_agreement":null},{"id":"W2026880258","doi":"10.1007/s10549-008-0019-0","title":"High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Fluidigm (Canada); Grand River Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Hyperinsulinemia; Insulin resistance; Breast cancer; Medicine; Internal medicine; Insulin; Endocrinology; Cancer; Hyperinsulinism","score_opus":0.09092112607861139,"score_gpt":0.34092410055802186,"score_spread":0.25000297447941044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026880258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982931,0.0005579887,0.00012683915,0.00006927329,0.000017026963,0.0000053863496,0.00019723625,0.0000066955354,0.00072651496],"genre_scores_gemma":[0.9992767,0.00021000147,0.00014918116,0.000037238027,0.000023742414,0.00000349326,0.00018402483,0.0000018077775,0.000113931965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971145,0.00007484422,0.000047061345,0.000057096655,0.000070951886,0.000038631468],"domain_scores_gemma":[0.99822897,0.00039411793,0.0009937935,0.00006416862,0.00007908585,0.00023991201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025365528,0.0002879128,0.00045553167,0.00090150855,0.00029899998,0.0008281967,0.00020699798,0.00050826406,0.0016491361],"category_scores_gemma":[0.0019839637,0.00032688267,0.00027670292,0.0015418122,0.0002392987,0.00042892463,0.0002473984,0.0009179552,0.00018276647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017816614,0.000024217436,0.9980464,0.000008208275,0.000033551285,0.00011596146,0.000023718496,0.000018102493,0.00047809276,0.000011347021,0.000034309018,0.0010280297],"study_design_scores_gemma":[0.0000054859547,0.000052568244,0.9987249,0.0000025516315,0.000021514361,0.0008493083,0.000065023334,0.00008793296,0.00010936256,0.000025167183,0.000053372656,0.0000028536313],"about_ca_topic_score_codex":0.0011679556,"about_ca_topic_score_gemma":0.0018559969,"teacher_disagreement_score":0.0016491361,"about_ca_system_score_codex":0.0002567309,"about_ca_system_score_gemma":0.00015669821,"threshold_uncertainty_score":0.0055169463},"labels":[],"label_agreement":null},{"id":"W2027262675","doi":"10.1007/s10549-006-9309-6","title":"The decision-making experience among women diagnosed with stage I and II breast cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Cancer Care Nova Scotia; Dalhousie University","funders":"","keywords":"Regret; Breast cancer; Logistic regression; Medicine; Family medicine; Cancer; Disease; Patient participation; Patient satisfaction; Health care; Gynecology; Nursing; Internal medicine","score_opus":0.1281766421984513,"score_gpt":0.47077575486975515,"score_spread":0.34259911267130383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027262675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965417,0.00029418617,0.000026814338,0.0012224404,0.000026601,0.000010209324,0.000056935653,0.0000020499267,0.001818979],"genre_scores_gemma":[0.9985684,0.0002422039,0.00006130219,0.0004413686,0.000018585079,0.000008280667,0.00005555177,0.0000015270481,0.00060268195],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99852824,0.00084015116,0.00010304713,0.00006850129,0.000167839,0.00029215642],"domain_scores_gemma":[0.992607,0.004162371,0.0013066684,0.00008380761,0.00036136672,0.0014787669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001453581,0.00016221416,0.00029769694,0.00051384285,0.0016816877,0.0017866021,0.00029811956,0.0008801901,0.0033503184],"category_scores_gemma":[0.016380375,0.00022378561,0.00034927094,0.00037355942,0.000704007,0.0010967238,0.0010221676,0.0013277885,0.00025610797],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013259705,0.0010403503,0.8215108,0.00012694499,0.0001219381,0.002306812,0.1266635,0.00026605825,0.000773514,0.00071948965,0.004302949,0.040841676],"study_design_scores_gemma":[0.0001465616,0.0013965127,0.6528882,0.00017569067,0.00011200622,0.004031855,0.32686308,0.0013122602,0.00037178752,0.0010002323,0.011571437,0.00013037534],"about_ca_topic_score_codex":0.010567666,"about_ca_topic_score_gemma":0.013763237,"teacher_disagreement_score":0.010567666,"about_ca_system_score_codex":0.0009217682,"about_ca_system_score_gemma":0.001367734,"threshold_uncertainty_score":0.021012306},"labels":[],"label_agreement":null},{"id":"W2027341444","doi":"10.1007/s10549-013-2692-x","title":"Clinical characteristics of breast cancer in patients with an NBS1 mutation","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Mutation; Internal medicine; Nijmegen breakage syndrome; Cancer; Mutation rate; Oncology; Proportional hazards model; Stage (stratigraphy); Genetics; Biology; Gene; Population; DNA; DNA damage","score_opus":0.02856917325298508,"score_gpt":0.37048999503713004,"score_spread":0.34192082178414496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027341444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977575,0.0002613866,0.00005914138,0.00007243446,0.000011489566,0.000008120233,0.0005911604,0.0000059246468,0.001232791],"genre_scores_gemma":[0.9986247,0.000101918624,0.000039625447,0.000059656526,0.000027596094,0.000013242809,0.00077281543,0.0000037212258,0.00035663432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997358,0.000041770116,0.00003917553,0.000061083,0.000037769027,0.000084346575],"domain_scores_gemma":[0.99822146,0.00049144315,0.0005031701,0.0000473046,0.000119067074,0.0006175125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024886755,0.00022542516,0.00046028223,0.0010324823,0.00045443114,0.00044199047,0.00023814947,0.00064464763,0.0031779606],"category_scores_gemma":[0.0023030601,0.00017178305,0.00032927888,0.0010815411,0.0003253375,0.00045254594,0.0003769364,0.00048036152,0.00058208697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078831177,0.00005396718,0.9961068,0.000008145199,0.000018470686,0.0006072979,0.00004913477,0.00007196746,0.0008792962,0.000024657083,0.00016152996,0.0012304352],"study_design_scores_gemma":[0.000011983456,0.00017755225,0.9974095,0.0000028874456,0.000012356992,0.0017852992,0.00014954477,0.000101865015,0.0000775675,0.00003083166,0.00023471209,0.000005822918],"about_ca_topic_score_codex":0.0016684795,"about_ca_topic_score_gemma":0.0013856681,"teacher_disagreement_score":0.0031779606,"about_ca_system_score_codex":0.00030890974,"about_ca_system_score_gemma":0.0003178692,"threshold_uncertainty_score":0.010631382},"labels":[],"label_agreement":null},{"id":"W2027584166","doi":"10.1007/s10549-011-1753-2","title":"Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cancer research; Proto-oncogene tyrosine-protein kinase Src; Breast cancer; Cancer cell; Cell migration; Bone metastasis; Cell culture; Cell; Chemistry; Cancer; Biology; Cell biology; Internal medicine; Medicine; Kinase; Biochemistry","score_opus":0.03846310560150481,"score_gpt":0.30697270034432383,"score_spread":0.26850959474281905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027584166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782145,0.011881481,0.0020465406,0.00072756235,0.000065832406,0.000023159477,0.00024260499,0.000038827053,0.0067594703],"genre_scores_gemma":[0.99295217,0.0024934188,0.0009759294,0.000064733686,0.000034779852,0.00001818316,0.00025306706,0.000008096462,0.0031995117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997799,0.000061250736,0.000014702798,0.000020809623,0.000058430087,0.000064983855],"domain_scores_gemma":[0.9999008,0.000018911325,0.000014043091,0.000009578703,0.000024552084,0.000032041076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024072871,0.00025489533,0.00027289827,0.00029225866,0.00039013365,0.00047781653,0.0002027707,0.00024784534,0.001638857],"category_scores_gemma":[0.00021551683,0.00015957058,0.0002539982,0.00017393411,0.0002556625,0.00028975806,0.0003312145,0.00044228867,0.000438483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009755132,0.00015712313,0.0031558513,0.00017214438,0.000032858497,0.00076566136,0.00010576661,0.0002641485,0.9777133,0.001835995,0.00067076547,0.014150883],"study_design_scores_gemma":[0.0003314685,0.0016600238,0.13176979,0.000056639692,0.00022900234,0.006153392,0.0008383263,0.006655028,0.82623464,0.001538544,0.024497505,0.00003573563],"about_ca_topic_score_codex":0.0012218405,"about_ca_topic_score_gemma":0.002756711,"teacher_disagreement_score":0.001638857,"about_ca_system_score_codex":0.00027971505,"about_ca_system_score_gemma":0.0003849431,"threshold_uncertainty_score":0.0054825544},"labels":[],"label_agreement":null},{"id":"W2027797732","doi":"10.1007/s10549-004-7260-y","title":"Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expression","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Metaplastic carcinoma; Adenosquamous carcinoma; Carcinosarcoma; Medicine; Sarcomatoid carcinoma; Pathology; Cytokeratin; Carcinoma; Adenocarcinoma; Breast cancer; Spindle cell carcinoma; Immunohistochemistry; Cancer; Oncology; Internal medicine","score_opus":0.09494441713047135,"score_gpt":0.3988335281646542,"score_spread":0.30388911103418287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027797732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972548,0.0005073642,0.00020128427,0.000077022625,0.0000102740805,0.000011800746,0.00020226739,0.00000819809,0.0017270432],"genre_scores_gemma":[0.9992601,0.00009285365,0.00016024694,0.000016808308,0.000029820654,0.0000094842135,0.0001726573,0.000002994758,0.00025507263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997373,0.000062354775,0.00004767285,0.00004029715,0.000054384473,0.00005804671],"domain_scores_gemma":[0.998988,0.00026437,0.00029770756,0.00007199571,0.00011897297,0.00025896207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047191625,0.0002848681,0.00032844083,0.0012390893,0.00042621337,0.00047229673,0.00025533704,0.00035937742,0.0029035732],"category_scores_gemma":[0.0018907802,0.00019678628,0.00022190588,0.00092207425,0.00029751903,0.0005427623,0.00030847482,0.00028720137,0.0005596299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013750116,0.000073782736,0.9825881,0.000019886023,0.000036536738,0.0027086611,0.00009181604,0.00014422198,0.007461453,0.000091522656,0.00018346308,0.0052255495],"study_design_scores_gemma":[0.000020126268,0.00028517368,0.9786184,0.000006285628,0.00004186438,0.017208092,0.00034605674,0.00058691925,0.0015987316,0.00019725767,0.0010811881,0.000009884532],"about_ca_topic_score_codex":0.0006444351,"about_ca_topic_score_gemma":0.0008976896,"teacher_disagreement_score":0.0029035732,"about_ca_system_score_codex":0.0002881624,"about_ca_system_score_gemma":0.000258437,"threshold_uncertainty_score":0.009713471},"labels":[],"label_agreement":null},{"id":"W2028064456","doi":"10.1007/s10549-015-3290-x","title":"Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-κB signaling pathways","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Osteoclast; RANKL; Cancer research; Bone resorption; Osteolysis; Bone metastasis; Breast cancer; MAPK/ERK pathway; In vivo; Medicine; Cancer; Internal medicine; Signal transduction; Biology; Activator (genetics); Cell biology; Receptor","score_opus":0.0613645076142955,"score_gpt":0.33678396590846427,"score_spread":0.27541945829416875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028064456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850462,0.008258803,0.0018590426,0.0005622658,0.000100549594,0.000059524602,0.00058267114,0.00045684577,0.0030741617],"genre_scores_gemma":[0.99282646,0.0032146303,0.00052015786,0.00006692622,0.000025105332,0.000017938295,0.00031166195,0.000012674479,0.0030045903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992347,0.000011069867,0.000004695079,0.000006303343,0.000023883656,0.00003071502],"domain_scores_gemma":[0.9999535,0.000009587643,0.000012289734,0.0000052769037,0.0000065442932,0.000012748358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008060602,0.00026957886,0.00032147946,0.00036592962,0.00019005472,0.00021701718,0.0002962733,0.0002451167,0.0016111471],"category_scores_gemma":[0.00018955956,0.000101971535,0.00025547927,0.00018452451,0.0002568161,0.000106519125,0.000089473135,0.000573257,0.0002870081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031326942,0.0006306455,0.0012856355,0.00016835025,0.00007799607,0.00033109626,0.000048148177,0.00024409422,0.9658365,0.00050031126,0.0012950334,0.026449572],"study_design_scores_gemma":[0.001842542,0.0057948227,0.02977901,0.0000291638,0.00025467086,0.001970604,0.0001289155,0.0022658424,0.9356443,0.0003336309,0.021923542,0.00003300509],"about_ca_topic_score_codex":0.005630866,"about_ca_topic_score_gemma":0.012539812,"teacher_disagreement_score":0.005630866,"about_ca_system_score_codex":0.00036686155,"about_ca_system_score_gemma":0.0006055081,"threshold_uncertainty_score":0.011196196},"labels":[],"label_agreement":null},{"id":"W2028616390","doi":"10.1023/a:1026118602273","title":"A Novel Pure SERM Achieves Complete Regression of the Majority of Human Breast Cancer Tumors in Nude Mice","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Tamoxifen; Breast cancer; Estrogen; Estrogen receptor; Cancer; Selective estrogen receptor modulator; Medicine; Mammary gland; Internal medicine; Antiestrogen; Cancer research; Oncology","score_opus":0.02919191251859132,"score_gpt":0.3384126851941826,"score_spread":0.3092207726755913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028616390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455773,0.00889703,0.030663865,0.00028931265,0.00021723016,0.0002844063,0.0010725476,0.0010704993,0.011927804],"genre_scores_gemma":[0.9611983,0.004901348,0.023122711,0.0002705389,0.000115113,0.00010626432,0.0012603529,0.00017343923,0.008851963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999033,0.000019502753,0.0000069323874,0.000017873159,0.000029215236,0.000023125993],"domain_scores_gemma":[0.9999207,0.00001581935,0.000016053335,0.000015191052,0.000008448791,0.000023652254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034248343,0.00042669,0.00035088253,0.00056508067,0.00012746105,0.00026851587,0.00035249523,0.00025942078,0.0010711566],"category_scores_gemma":[0.00012453135,0.00018144697,0.00028175133,0.00020241932,0.00017033191,0.00022936714,0.00023509255,0.00035683846,0.0005827081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029981497,0.00017057577,0.0002140959,0.00009965702,0.000023000273,0.00008733062,0.000014828327,0.00018800162,0.98729426,0.0003517847,0.00030100247,0.010955658],"study_design_scores_gemma":[0.00009449328,0.0014403436,0.0016117858,0.0000072486832,0.00006188995,0.00041420167,0.000009265568,0.00071789656,0.9861779,0.00008871863,0.009368938,0.000007282017],"about_ca_topic_score_codex":0.00014052942,"about_ca_topic_score_gemma":0.00033318475,"teacher_disagreement_score":0.0010711566,"about_ca_system_score_codex":0.00014413489,"about_ca_system_score_gemma":0.0001523937,"threshold_uncertainty_score":0.0035833716},"labels":[],"label_agreement":null},{"id":"W2028943787","doi":"10.1007/s10549-014-3181-6","title":"Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Menstrual cycle; Estrogen; RANKL; Breast cancer; Internal medicine; Endocrinology; Biology; Gene expression; Estrogen receptor; Gene; Cancer research; Cancer; Medicine; Hormone; Genetics","score_opus":0.012007515480124005,"score_gpt":0.3039143559152082,"score_spread":0.2919068404350842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028943787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975157,0.0011673465,0.00009142279,0.00003720358,0.000007303963,0.000006404292,0.00048986945,0.0000099733425,0.00067494373],"genre_scores_gemma":[0.9964844,0.00068593345,0.00009876579,0.000024644705,0.000010687448,0.000022721548,0.0004696904,0.00000526258,0.0021979932],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999006,0.000014327495,0.000005545197,0.000014751962,0.000015525524,0.00004920342],"domain_scores_gemma":[0.99984884,0.000034605753,0.000040256622,0.000013163779,0.000031811127,0.000031201438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011523813,0.00008790276,0.0002493057,0.000564868,0.00019675156,0.00031289252,0.00010202405,0.00013846371,0.001662921],"category_scores_gemma":[0.00043019463,0.00015458933,0.00013036579,0.00054088316,0.00016684723,0.00013872949,0.0001502612,0.00016093589,0.0002724529],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074271564,0.00018273198,0.20837918,0.00017196492,0.00009526649,0.00051110325,0.00081008486,0.00018356898,0.75615853,0.0002286652,0.0006606615,0.025191013],"study_design_scores_gemma":[0.0000307842,0.00038601432,0.9778732,0.000007377716,0.000043773493,0.0003909998,0.00041359043,0.00016242622,0.018916426,0.00008098314,0.0016873908,0.000007005916],"about_ca_topic_score_codex":0.002624033,"about_ca_topic_score_gemma":0.0031569893,"teacher_disagreement_score":0.002624033,"about_ca_system_score_codex":0.00023452412,"about_ca_system_score_gemma":0.00023631216,"threshold_uncertainty_score":0.005562961},"labels":[],"label_agreement":null},{"id":"W2029231174","doi":"10.1007/s10549-012-2197-z","title":"Diagnostic values of GHSR DNA methylation pattern in breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"Bundesministerium für Bildung und Forschung","keywords":"DNA methylation; Breast cancer; Epigenetics; Methylation; Cancer; Biology; Bisulfite sequencing; Cancer research; Tissue microarray; Oncology; Pathology; Internal medicine; Medicine; Genetics; DNA; Gene; Gene expression","score_opus":0.040028576653925375,"score_gpt":0.3690601095094921,"score_spread":0.3290315328555667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029231174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249166,0.0026331786,0.00092602614,0.00022333124,0.000030656593,0.00001102966,0.00028238582,0.00004281687,0.003358809],"genre_scores_gemma":[0.99868697,0.0003158433,0.000577201,0.000032972286,0.000021440012,0.000005896302,0.000106990185,0.0000034321886,0.00024928187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960655,0.00013353281,0.00003524473,0.00006299305,0.00010344589,0.000058302405],"domain_scores_gemma":[0.9993088,0.0003039489,0.000118417935,0.000057199366,0.00012718221,0.0000843535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008927189,0.00033123852,0.00028968212,0.0019031914,0.0002775897,0.00041870546,0.0003427256,0.00045242172,0.0016208652],"category_scores_gemma":[0.0019293755,0.00019658354,0.00023553723,0.00063762773,0.00042530362,0.00028787297,0.00038486748,0.0003932744,0.0002986316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000894751,0.000026250598,0.95945567,0.000046777965,0.00006994408,0.00032269733,0.00012623801,0.00020627599,0.02068135,0.00014561048,0.00018238164,0.017841998],"study_design_scores_gemma":[0.00002975458,0.0002981686,0.96808213,0.00002525289,0.00019252882,0.0031344194,0.00055252336,0.002589788,0.022771526,0.00077789754,0.0015298915,0.00001604169],"about_ca_topic_score_codex":0.0009801012,"about_ca_topic_score_gemma":0.00091070886,"teacher_disagreement_score":0.0019031914,"about_ca_system_score_codex":0.00030222794,"about_ca_system_score_gemma":0.00022053126,"threshold_uncertainty_score":0.005422294},"labels":[],"label_agreement":null},{"id":"W2029338166","doi":"10.1007/s10549-004-5780-0","title":"Detection of genetic instability at HER-2/neu and p53 loci in breast cancer cells sing Comet–FISH","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"U.S. Department of Defense","keywords":"Breast cancer; Fish <Actinopterygii>; Comet assay; Biology; Microsatellite instability; Comet; Cancer; Oncology; Genetics; Gene; Cancer research; Medicine; DNA damage; DNA; Fishery; Microsatellite; Allele","score_opus":0.023698229468976616,"score_gpt":0.31240054757294294,"score_spread":0.28870231810396635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029338166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649204,0.0018015783,0.023959998,0.0004874164,0.00009154318,0.00011593959,0.0013300567,0.000549703,0.0067434055],"genre_scores_gemma":[0.98131657,0.00059540936,0.008752787,0.00017539377,0.000035030378,0.0001385481,0.0013251486,0.00010687254,0.007554294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952734,0.00009712921,0.00004832282,0.00011347295,0.00012885373,0.00008490371],"domain_scores_gemma":[0.9989717,0.0004001881,0.00015166991,0.0002528807,0.00011552697,0.0001080359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007426452,0.00035025607,0.0005316287,0.0013910605,0.00061019004,0.00050898694,0.0002761945,0.0007945215,0.0044078548],"category_scores_gemma":[0.0005403522,0.00036795365,0.0005792765,0.00041190934,0.00060021394,0.0005248352,0.00063159433,0.001241694,0.0015111046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076520424,0.000011496694,0.0006031379,0.000018542049,0.000008821776,0.000068548594,0.00005178184,0.00002001618,0.9983041,0.000094858944,0.00003333303,0.00070878613],"study_design_scores_gemma":[0.0000161458,0.00023297373,0.014449247,0.0000044516996,0.000028844443,0.0008952024,0.00008811488,0.0007369358,0.9819302,0.00013491203,0.0014747328,0.0000083201785],"about_ca_topic_score_codex":0.00091918703,"about_ca_topic_score_gemma":0.0013413823,"teacher_disagreement_score":0.0044078548,"about_ca_system_score_codex":0.00031515854,"about_ca_system_score_gemma":0.00011880938,"threshold_uncertainty_score":0.014745712},"labels":[],"label_agreement":null},{"id":"W2029440783","doi":"10.1007/s10549-006-9371-0","title":"Diet quality and BRCA-associated breast cancer risk","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Mediterranean diet; Odds ratio; Logistic regression; Breast cancer; Demography; Confidence interval; Cohort; Lower risk; Cancer; Internal medicine; Oncology","score_opus":0.06965200471431934,"score_gpt":0.4053019056244485,"score_spread":0.33564990091012914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029440783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863564,0.010706128,0.00013084455,0.0006471807,0.000040985196,0.0000080497175,0.00045432828,0.0000061027263,0.0016499001],"genre_scores_gemma":[0.99678206,0.0020860685,0.0002019085,0.0001183658,0.000031582324,0.0000042138004,0.00020440097,0.0000026629766,0.00056867546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959964,0.00023988796,0.000034454424,0.000043098516,0.000050816714,0.000032223717],"domain_scores_gemma":[0.9973116,0.001053741,0.0009628074,0.00017402826,0.00017585277,0.0003220506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010792608,0.0002335677,0.0002985633,0.00084531505,0.00033969083,0.0007084646,0.00022899894,0.00065243803,0.002736895],"category_scores_gemma":[0.00450648,0.00029145536,0.00051510386,0.0012036613,0.00027886135,0.00034175706,0.00032421015,0.0006967481,0.00015859083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002152135,0.0002499629,0.98918426,0.00008710433,0.0010627533,0.00006538531,0.000075333286,0.000071242954,0.0005693843,0.00012394339,0.00019248114,0.0061660195],"study_design_scores_gemma":[0.000036340974,0.00027591534,0.9982145,0.00002250724,0.000437863,0.00016162971,0.000050762417,0.00011888924,0.00012594037,0.00016047698,0.00039006266,0.0000051715974],"about_ca_topic_score_codex":0.0053120437,"about_ca_topic_score_gemma":0.0068874946,"teacher_disagreement_score":0.0053120437,"about_ca_system_score_codex":0.00030994994,"about_ca_system_score_gemma":0.00022939556,"threshold_uncertainty_score":0.010562301},"labels":[],"label_agreement":null},{"id":"W2029461912","doi":"10.1007/s10549-015-3345-z","title":"Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer","year":2015,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Breast cancer; Triple-negative breast cancer; Oncology; Chemotherapy; Medicine; Internal medicine; Triple negative; Platinum; Cancer; Biology","score_opus":0.06377048360085881,"score_gpt":0.42867668471138654,"score_spread":0.36490620111052774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029461912","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016241118,0.0033430764,0.00015696263,0.058099505,0.9354996,0.000022578413,0.00020919977,0.000060496364,0.0024461795],"genre_scores_gemma":[0.0085964175,0.027160034,0.0022573092,0.20671846,0.6170485,0.00012624382,0.0009575584,0.00035321468,0.13678238],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700767,0.00042040643,0.00089922047,0.0002772372,0.0011594673,0.00023596027],"domain_scores_gemma":[0.98678315,0.0038227334,0.0012481072,0.0005678842,0.00665648,0.00092168484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031229907,0.0019429917,0.0022684182,0.0035712537,0.002345519,0.0027341726,0.0020169385,0.008440557,0.015918773],"category_scores_gemma":[0.027684214,0.0012080013,0.0019916366,0.0017875037,0.0018060602,0.0019738832,0.0011952053,0.0088820355,0.0149113275],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006361827,0.000021331227,0.00015976952,0.00018088623,0.000020508545,0.00070614566,0.000015983682,0.000059675043,0.00005242747,0.00039353914,0.9891495,0.009176565],"study_design_scores_gemma":[0.00008426724,0.000086399865,0.0014794511,0.0007288522,0.0001080638,0.0014761046,0.00007607547,0.00028827818,0.00035941182,0.00081195706,0.9944565,0.000044523982],"about_ca_topic_score_codex":0.008536073,"about_ca_topic_score_gemma":0.014548125,"teacher_disagreement_score":0.015918773,"about_ca_system_score_codex":0.003837258,"about_ca_system_score_gemma":0.004783081,"threshold_uncertainty_score":0.05325359},"labels":[],"label_agreement":null},{"id":"W2029865157","doi":"10.1007/s10549-006-9171-6","title":"Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institute on Aging; American Society of Clinical Oncology","keywords":"Breast cancer; Medicine; Cognition; Prospective cohort study; Chemotherapy; Cancer; Internal medicine; Oncology; Psychiatry","score_opus":0.017949360312446833,"score_gpt":0.34688876033058025,"score_spread":0.32893940001813343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029865157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693085,0.027602738,0.000039973824,0.000373352,0.000077388184,0.000018526833,0.0001414971,0.0000012331759,0.002436821],"genre_scores_gemma":[0.9940188,0.005122807,0.00005672266,0.00025521754,0.00015673028,0.000007325502,0.000077256635,5.335384e-7,0.00030458247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993673,0.0003983217,0.000054754688,0.00003846816,0.00007357102,0.00006751642],"domain_scores_gemma":[0.9972717,0.0017688359,0.00049532094,0.0001036002,0.00013657368,0.00022401963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018430627,0.00028039643,0.0007625569,0.000454393,0.0002225222,0.0004639339,0.00017757998,0.00039942723,0.0013329687],"category_scores_gemma":[0.004550477,0.00010841988,0.0012482621,0.000548686,0.00024358957,0.00035295996,0.00026110394,0.0006855224,0.00005803978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18978404,0.0062299073,0.62440646,0.002515614,0.013607813,0.0010677831,0.00063893915,0.000782152,0.003610504,0.00069548935,0.0017437125,0.15491761],"study_design_scores_gemma":[0.004429811,0.059304748,0.9179338,0.0003653456,0.0114441905,0.00065604324,0.0004617972,0.00028886172,0.00115857,0.00035697327,0.0035617484,0.000038147187],"about_ca_topic_score_codex":0.0031874673,"about_ca_topic_score_gemma":0.005414421,"teacher_disagreement_score":0.0031874673,"about_ca_system_score_codex":0.00026733673,"about_ca_system_score_gemma":0.00043224337,"threshold_uncertainty_score":0.009747148},"labels":[],"label_agreement":null},{"id":"W2029938510","doi":"10.1023/b:brea.0000004377.12288.3c","title":"Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":307,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer research; Metastasis; Doxorubicin; Chemotherapy; Metastatic breast cancer; Cytotoxic T cell; Population; Breast cancer; Cancer cell; Cancer; Circulating tumor cell; Internal medicine; Biology; In vitro","score_opus":0.08703821062688523,"score_gpt":0.37438539857049397,"score_spread":0.28734718794360875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029938510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287003,0.002051062,0.0008055207,0.00017404366,0.00014576784,0.00007058075,0.0005324507,0.00008606891,0.0032645],"genre_scores_gemma":[0.9942305,0.00074365234,0.0004917204,0.000043439384,0.000034988978,0.000043900953,0.0005230105,0.000025161393,0.0038635866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982685,0.00004388713,0.00001690219,0.00003561532,0.000027165344,0.000049634637],"domain_scores_gemma":[0.999323,0.00035181633,0.00003779284,0.00011574187,0.000041198917,0.00013047094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003448149,0.00029738972,0.0006717888,0.00034108036,0.00022692954,0.00026611786,0.00028829815,0.00034886875,0.0038616832],"category_scores_gemma":[0.00051864446,0.00018674621,0.00021640763,0.00015404871,0.00032057415,0.0003242457,0.00020914654,0.0006889185,0.00052533695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001945892,0.0003728805,0.00079169037,0.000105324216,0.00002276035,0.00014026613,0.000074724245,0.00045886345,0.9859248,0.00038125608,0.00047859031,0.009302892],"study_design_scores_gemma":[0.00019112979,0.004357817,0.009267239,0.000016032063,0.00004129945,0.00041585515,0.0000537213,0.0016102426,0.9796622,0.00010630997,0.004267262,0.000010795039],"about_ca_topic_score_codex":0.0010930924,"about_ca_topic_score_gemma":0.0018939413,"teacher_disagreement_score":0.0038616832,"about_ca_system_score_codex":0.00037761108,"about_ca_system_score_gemma":0.00037683596,"threshold_uncertainty_score":0.012918651},"labels":[],"label_agreement":null},{"id":"W2030373227","doi":"10.1007/s10549-008-0034-1","title":"Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Docetaxel; Breast cancer; Oncology; Internal medicine; Cyclophosphamide; Quality-adjusted life year; Cohort; Doxorubicin; Cost effectiveness; Gynecology; Cancer; Chemotherapy","score_opus":0.045291526933460904,"score_gpt":0.3582560225071904,"score_spread":0.3129644955737295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030373227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96063954,0.0071207993,0.014222381,0.002815627,0.00012875423,0.00075467204,0.0026527822,0.000080045495,0.0115855],"genre_scores_gemma":[0.99356973,0.0012588532,0.0024755371,0.00020075175,0.00003209403,0.00018746502,0.00042032183,0.000016127493,0.0018391946],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99819046,0.0013911832,0.000042972384,0.000087747554,0.000084667656,0.00020289807],"domain_scores_gemma":[0.98746896,0.011181146,0.0005805043,0.00015501647,0.00026273826,0.00035164368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004432776,0.0018658023,0.0020664237,0.0012079449,0.00032738512,0.0016309415,0.0017151984,0.001747919,0.0061386973],"category_scores_gemma":[0.014979852,0.0010659111,0.0028870131,0.0012655992,0.00072501786,0.0012975576,0.000625668,0.001619282,0.00026374328],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004061159,0.00040706783,0.0037490104,0.00022503383,0.00057306624,0.00012269686,0.000021895044,0.97922266,0.0002315971,0.0021585652,0.00046895602,0.0087582525],"study_design_scores_gemma":[0.00198776,0.0027043116,0.005552235,0.00011726706,0.0024694102,0.0001696476,0.00011495954,0.9825645,0.00039183113,0.0030637379,0.0008224666,0.000041966385],"about_ca_topic_score_codex":0.034858428,"about_ca_topic_score_gemma":0.020097593,"teacher_disagreement_score":0.034858428,"about_ca_system_score_codex":0.0055090752,"about_ca_system_score_gemma":0.003591682,"threshold_uncertainty_score":0.06931108},"labels":[],"label_agreement":null},{"id":"W2030812135","doi":"10.1007/s10549-007-9805-3","title":"JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; SickKids Foundation; University Health Network; University of Toronto; Discovery Centre","funders":"","keywords":"Breast cancer; Lymph node; Phenotype; Medicine; Basal (medicine); Oncology; Cancer; Internal medicine; Biology; Pathology; Gene; Genetics","score_opus":0.026894653847062598,"score_gpt":0.34112431678307203,"score_spread":0.31422966293600946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030812135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909866,0.0004408843,0.00007809415,0.000034075703,0.000004389347,0.000002332728,0.000084852,0.0000104460105,0.00024628936],"genre_scores_gemma":[0.99923396,0.00012730641,0.00006939084,0.000018884766,0.000007185411,0.000004870803,0.00016669062,0.000005132273,0.00036668754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985576,0.000029468536,0.000014779535,0.000029832969,0.000037144233,0.000032961863],"domain_scores_gemma":[0.99926037,0.00012068757,0.0003491002,0.000062412524,0.0000442775,0.00016306105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024148753,0.00018465723,0.0003448889,0.0009109636,0.00032146476,0.00060835475,0.00032200274,0.0004096356,0.0012721308],"category_scores_gemma":[0.00074220187,0.00020796635,0.00020839988,0.0006254206,0.00039210852,0.0001913636,0.0002178888,0.0005673446,0.00030232273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003906165,0.00017155154,0.68877536,0.00008218378,0.00013934755,0.0018756835,0.00025439108,0.00011739166,0.29767504,0.00013422155,0.00032292175,0.006545824],"study_design_scores_gemma":[0.000017998169,0.00015250809,0.9881612,0.0000044052304,0.00006243289,0.0036536395,0.00013722003,0.00017941574,0.0070987237,0.00008220065,0.00044353615,0.0000067537626],"about_ca_topic_score_codex":0.00044237298,"about_ca_topic_score_gemma":0.0005289095,"teacher_disagreement_score":0.0012721308,"about_ca_system_score_codex":0.00017465971,"about_ca_system_score_gemma":0.00012615863,"threshold_uncertainty_score":0.004255712},"labels":[],"label_agreement":null},{"id":"W2030865526","doi":"10.1007/s10549-011-1453-y","title":"Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; The Quebec Population Health Research Network; Hôpital du Saint-Sacrement","funders":"","keywords":"Scalp; Medicine; Breast cancer; Metastasis; Chemotherapy; Metastatic breast cancer; Cancer; Surgery; Internal medicine","score_opus":0.08529247172079103,"score_gpt":0.3766334539889901,"score_spread":0.2913409822681991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030865526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959032,0.00060812157,0.0005370017,0.00014887928,0.000049175585,0.00003331705,0.00020359439,0.000033771947,0.0024830885],"genre_scores_gemma":[0.998439,0.00021401285,0.00013192558,0.000051746923,0.00006363882,0.000009473718,0.00014626177,0.00000902136,0.00093487534],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997038,0.000015229557,0.000018393492,0.00004853662,0.000037783993,0.00017627173],"domain_scores_gemma":[0.9988545,0.00022458109,0.00029324944,0.00015826756,0.00013191618,0.00033748164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016559688,0.0005415425,0.00049805804,0.001373029,0.0013320271,0.00064494356,0.0006038573,0.0011983515,0.0032494597],"category_scores_gemma":[0.0014494288,0.000384243,0.00088261056,0.0007556097,0.0006452995,0.0005306959,0.0007139804,0.0009842099,0.0006922431],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067029794,0.000256981,0.28374857,0.000053849835,0.000049517,0.7016328,0.0009883642,0.00018804887,0.0036726233,0.00015098715,0.0005148528,0.008073109],"study_design_scores_gemma":[0.00004279641,0.00042279612,0.28926867,0.000018752493,0.00013847735,0.7037651,0.0010812293,0.0004458247,0.0027070837,0.00022034295,0.0018353922,0.00005353604],"about_ca_topic_score_codex":0.0061119613,"about_ca_topic_score_gemma":0.005947392,"teacher_disagreement_score":0.0061119613,"about_ca_system_score_codex":0.00058854534,"about_ca_system_score_gemma":0.0004862547,"threshold_uncertainty_score":0.012152731},"labels":[],"label_agreement":null},{"id":"W2030904903","doi":"10.1007/s10549-007-9500-4","title":"CYP1B1 and predisposition to breast cancer in Poland","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Haplotype; Breast cancer; CYP1B1; Single-nucleotide polymorphism; Genotype; Case-control study; Biology; Genetics; Cancer; Oncology; SNP; Internal medicine; Gene; Medicine; Cytochrome P450","score_opus":0.019012723710637936,"score_gpt":0.3436053615714442,"score_spread":0.3245926378608063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030904903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738604,0.0012449275,0.00016253866,0.00015996456,0.000007919632,0.000010262096,0.0001701783,0.0000057968623,0.00085238676],"genre_scores_gemma":[0.997988,0.0009317327,0.00013198539,0.00004400614,0.000012661423,0.000008510381,0.00013233148,0.0000046905157,0.0007459981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997677,0.0000576352,0.00002969563,0.00006648782,0.000029780229,0.000048666912],"domain_scores_gemma":[0.99967134,0.000055305834,0.00013738926,0.000023996361,0.000025958381,0.00008599633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031009864,0.00022798179,0.00034949288,0.0013358614,0.00041685457,0.0004432436,0.00019388029,0.0002964855,0.0020415802],"category_scores_gemma":[0.0007256918,0.00034686268,0.00034857186,0.001511941,0.0002756158,0.00018682494,0.0004405187,0.00047949166,0.00019260598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001747216,0.00015523347,0.97934043,0.00010129943,0.00032162972,0.0012470059,0.0004487115,0.00014807367,0.0047528534,0.00048770293,0.00034902905,0.010900758],"study_design_scores_gemma":[0.0000497044,0.00013368786,0.99683607,0.000015538966,0.000121297155,0.001087534,0.00023171338,0.00011619257,0.00028862784,0.00011952269,0.0009957551,0.0000042608817],"about_ca_topic_score_codex":0.0075317454,"about_ca_topic_score_gemma":0.006093382,"teacher_disagreement_score":0.0075317454,"about_ca_system_score_codex":0.0004361845,"about_ca_system_score_gemma":0.00044121337,"threshold_uncertainty_score":0.014975786},"labels":[],"label_agreement":null},{"id":"W2031260154","doi":"10.1007/s10549-006-9448-9","title":"Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Male Breast Health Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Nova Scotia; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Tissue microarray; Breast cancer; Immunohistochemistry; Internal medicine; Lymphovascular invasion; Aromatase; Cancer; Pathology; Oncology; Estrogen receptor; Metastasis","score_opus":0.08044941361650544,"score_gpt":0.4548057215700024,"score_spread":0.37435630795349695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031260154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354905,0.0017480099,0.0016101141,0.0002271633,0.000022693324,0.00002466593,0.00048767586,0.000024079634,0.002306547],"genre_scores_gemma":[0.9972893,0.0003970195,0.0008232895,0.00007878244,0.000032746208,0.000020791782,0.00036631981,0.000007772619,0.0009841704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994294,0.00022735419,0.000045668527,0.000081003425,0.00014538947,0.00007125066],"domain_scores_gemma":[0.9992874,0.0002796795,0.00015592853,0.000084511936,0.00012361622,0.000068790585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007939303,0.000110381276,0.0002602487,0.00082491233,0.0002675504,0.00040611016,0.00015922298,0.0001903861,0.0017274956],"category_scores_gemma":[0.001399971,0.00013900053,0.00010780339,0.0006830515,0.00024296444,0.00023977853,0.00025285172,0.00026053545,0.0003514917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013727044,0.00011443038,0.88922125,0.00007743847,0.000117262156,0.0006104301,0.00029276442,0.00012720787,0.079569764,0.00027513874,0.00069425825,0.027527392],"study_design_scores_gemma":[0.000011452908,0.00028387058,0.9735875,0.00000752392,0.00008463765,0.0033125386,0.00032785532,0.0003484117,0.019097727,0.00011551209,0.0028158913,0.0000071643885],"about_ca_topic_score_codex":0.00050556374,"about_ca_topic_score_gemma":0.0013006551,"teacher_disagreement_score":0.0017274956,"about_ca_system_score_codex":0.00019381597,"about_ca_system_score_gemma":0.0001712347,"threshold_uncertainty_score":0.005779028},"labels":[],"label_agreement":null},{"id":"W2031705055","doi":"10.1007/s10549-014-2990-y","title":"Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Abcg2; Estrone; Biology; Stroma; Transporter; Efflux; Cancer research; Cancer; Cancer cell; Internal medicine; Hormone; Endocrinology; Medicine; Pathology; ATP-binding cassette transporter; Biochemistry; Immunohistochemistry; Gene","score_opus":0.025182883007751875,"score_gpt":0.3226950226792409,"score_spread":0.297512139671489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031705055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954325,0.0017224075,0.0008663833,0.00006262696,0.000007548705,0.000007648649,0.00045649597,0.000018707153,0.0014255829],"genre_scores_gemma":[0.99255157,0.0011008215,0.00045281622,0.000023177325,0.0000071251575,0.000016128182,0.0007753114,0.00000856091,0.005064472],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990404,0.000016521031,0.000008586419,0.000019248053,0.000019750336,0.000031860007],"domain_scores_gemma":[0.9998692,0.000040393814,0.000022233035,0.000011850711,0.000032946376,0.000023347042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012410921,0.00010074301,0.00018239791,0.00037340366,0.0001861931,0.0003917513,0.00010295446,0.00021429826,0.0022540875],"category_scores_gemma":[0.00026972464,0.00014838502,0.00020474473,0.0004542157,0.00019872689,0.00023683389,0.00016368213,0.00021424575,0.0005082522],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018241426,0.0000317878,0.01090254,0.000100073274,0.000031888758,0.00035371757,0.00030677838,0.00016171423,0.9803939,0.00049792486,0.00011885288,0.0052766656],"study_design_scores_gemma":[0.0000603627,0.0007623712,0.33015808,0.000034606568,0.00017717558,0.0036858518,0.0018568196,0.002352562,0.64903116,0.0006436186,0.011212673,0.000024601477],"about_ca_topic_score_codex":0.0015772367,"about_ca_topic_score_gemma":0.0009710296,"teacher_disagreement_score":0.0022540875,"about_ca_system_score_codex":0.00023158925,"about_ca_system_score_gemma":0.00019786549,"threshold_uncertainty_score":0.007540703},"labels":[],"label_agreement":null},{"id":"W2032132964","doi":"10.1007/s10549-010-1259-3","title":"Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Toronto General Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Biology; Metastasis; Lymph; Cytotoxic T cell; Immune system; Cancer research; Ectopic expression; Nod; Tumor progression; Genetically modified mouse; Breast cancer; Mammary tumor; Immunology; Cell culture; Transgene; Cancer; Pathology; Endocrinology; Medicine; In vitro; Gene","score_opus":0.020645975451165748,"score_gpt":0.2931483030660704,"score_spread":0.27250232761490467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032132964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924259,0.0010131444,0.0021309594,0.0003732539,0.00004119243,0.000029203791,0.00084336154,0.00021542204,0.0029275767],"genre_scores_gemma":[0.98954004,0.00049631053,0.0016249823,0.00013855148,0.000017910008,0.000037413378,0.00062225707,0.000055355482,0.0074671954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973816,0.00003508828,0.000017107495,0.00005064928,0.000061690356,0.00009715628],"domain_scores_gemma":[0.9997482,0.000021913429,0.000084521074,0.000027952266,0.000022600843,0.00009477808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000163545,0.0003527857,0.00025687195,0.00091008167,0.0002343576,0.000534474,0.00025285123,0.0005499814,0.0026595022],"category_scores_gemma":[0.0001367201,0.00024558435,0.00031223605,0.00020827235,0.00032964887,0.00036909984,0.00019059044,0.0014999191,0.0006673539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006543132,0.000108766275,0.00039430702,0.00001870452,0.0000043189016,0.000081693855,0.0000121452795,0.000059802944,0.9965396,0.0003227159,0.000089166395,0.0017144742],"study_design_scores_gemma":[0.000052360796,0.00046419012,0.006387937,0.000006920737,0.00002345582,0.00035721043,0.000050053204,0.0011457888,0.9891803,0.00023463035,0.0020895288,0.0000076200085],"about_ca_topic_score_codex":0.0006266049,"about_ca_topic_score_gemma":0.0009068396,"teacher_disagreement_score":0.0026595022,"about_ca_system_score_codex":0.0005453671,"about_ca_system_score_gemma":0.0002515506,"threshold_uncertainty_score":0.008896887},"labels":[],"label_agreement":null},{"id":"W2032304812","doi":"10.1023/b:brea.0000021048.52430.c0","title":"Selective Cytotoxicity of a Red Grape Wine Flavonoid Fraction Against MCF-7 Cells","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Phytochemicals and Antioxidant Activities","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"MCF-7; Flavonoid; Wine; Cytotoxicity; Naringenin; Cancer cell; Biochemistry; Polyphenol; Flavanone; Chemistry; Quercetin; Biology; Cancer; Food science; In vitro; Human breast; Antioxidant","score_opus":0.03569384585860146,"score_gpt":0.34103724005528224,"score_spread":0.3053433941966808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032304812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940434,0.002754003,0.00061016605,0.0000888914,0.000042958025,0.000017632678,0.0003878716,0.000031611165,0.002023547],"genre_scores_gemma":[0.9922895,0.0018041029,0.0007615314,0.00004809769,0.00001690263,0.000011135321,0.0008620929,0.000008018865,0.004198577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999449,0.000010569678,0.0000053951694,0.000009794091,0.000010570404,0.000018783066],"domain_scores_gemma":[0.9999603,0.000011593342,0.0000040554423,0.000006480257,0.000008826001,0.0000087146855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009716506,0.00027943862,0.00021765377,0.00027684277,0.00021318694,0.00015344632,0.00010766789,0.00019557023,0.0012631544],"category_scores_gemma":[0.00006659956,0.000088198314,0.00024986922,0.00014684699,0.000100644684,0.00009614714,0.00010846403,0.00018308128,0.0002878118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030957418,0.00003430982,0.00019360747,0.00004592672,0.000010091947,0.00007614581,0.000027837774,0.00005006529,0.9974722,0.000051607905,0.00007232036,0.0016561971],"study_design_scores_gemma":[0.000019765088,0.0006818679,0.005920207,0.0000072487924,0.0000372343,0.00021789226,0.000042827203,0.00021981682,0.9907686,0.000023361215,0.0020569756,0.000004162314],"about_ca_topic_score_codex":0.0022597923,"about_ca_topic_score_gemma":0.002700321,"teacher_disagreement_score":0.0022597923,"about_ca_system_score_codex":0.00014157745,"about_ca_system_score_gemma":0.0001433808,"threshold_uncertainty_score":0.004493296},"labels":[],"label_agreement":null},{"id":"W2032931935","doi":"10.1007/s10549-013-2534-x","title":"Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Alberta Cancer Foundation; University of British Columbia; Sunnybrook Hospital; University of British Columbia, Okanagan Campus; Ontario Institute for Cancer Research; University of Alberta; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Internal medicine; Endocrinology; Adiponectin; Estrone; Leptin; Adipokine; Body mass index; Breast cancer; Adipose tissue; Medicine; Waist; Sex hormone-binding globulin; Hormone; Obesity; Cancer; Insulin resistance","score_opus":0.013551181937667264,"score_gpt":0.2707518839931218,"score_spread":0.25720070205545453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032931935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869543,0.00069008063,0.000028078273,0.000059868788,0.0000068724303,0.0000027643132,0.00010545055,0.0000015427212,0.00040986098],"genre_scores_gemma":[0.9995105,0.00018037813,0.000023598852,0.000027747672,0.000010852576,0.000003141512,0.000059298713,5.7410676e-7,0.00018383072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998753,0.00003578292,0.00001414286,0.000022722894,0.000025395195,0.000026598915],"domain_scores_gemma":[0.99960166,0.0001285405,0.00011710021,0.000028800328,0.000037480837,0.00008632723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002675267,0.00014667514,0.00025742847,0.00032220356,0.00026611556,0.00035695755,0.00014561438,0.00034247412,0.0012083931],"category_scores_gemma":[0.0012696981,0.00023575943,0.00025526402,0.0005272238,0.0001770984,0.00018497513,0.00018596245,0.0004411009,0.00011465884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003193171,0.00003558591,0.9980117,0.0000064010146,0.000060958017,0.000055740547,0.000045201585,0.00001179786,0.00035741972,0.000011286244,0.00004036463,0.0010441092],"study_design_scores_gemma":[0.000011562382,0.000096078875,0.99934834,0.0000028276422,0.00005398266,0.00012155961,0.00013145832,0.00007355349,0.000037605656,0.000020645264,0.000100702186,0.0000016907858],"about_ca_topic_score_codex":0.005326743,"about_ca_topic_score_gemma":0.006217346,"teacher_disagreement_score":0.005326743,"about_ca_system_score_codex":0.00016207223,"about_ca_system_score_gemma":0.0001888502,"threshold_uncertainty_score":0.010591507},"labels":[],"label_agreement":null},{"id":"W2033334824","doi":"10.1007/s10549-014-3052-1","title":"Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"Amgen","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Internal medicine; Medical record; Triple-negative breast cancer; Oncology; Estrogen receptor; Cancer; Chemotherapy; Disease; Gynecology","score_opus":0.03378045138910681,"score_gpt":0.37574872362221473,"score_spread":0.34196827223310794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033334824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595803,0.00083014375,0.0000562272,0.00018468867,0.0000075760267,0.000008158068,0.002051891,0.0000067669725,0.0008964702],"genre_scores_gemma":[0.99842924,0.0004248885,0.00006493581,0.000082467515,0.000011625409,0.000007576168,0.00074226956,0.0000014259383,0.00023556747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994517,0.00016900564,0.000092509465,0.00010814957,0.00009939356,0.00007930953],"domain_scores_gemma":[0.9976839,0.0005783803,0.0012223929,0.000098250646,0.00019190257,0.00022513272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053124555,0.00015362553,0.00027626482,0.0012252185,0.00040386926,0.0006740851,0.00040788116,0.00043204337,0.0018048271],"category_scores_gemma":[0.0022199156,0.00025919036,0.00032283054,0.0018887448,0.0001821195,0.0005956778,0.00041824093,0.00048685694,0.00013391557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002369203,0.000020654845,0.9989428,0.000009607446,0.000022675522,0.000017943974,0.00005318855,0.00000764593,0.00006148528,0.000009987049,0.00010796613,0.0007222176],"study_design_scores_gemma":[0.000001992076,0.000016352813,0.9993861,0.000009369689,0.000013849551,0.00011120772,0.00029297237,0.00003600154,0.000020275967,0.000006475745,0.00010373552,0.0000017385339],"about_ca_topic_score_codex":0.030333234,"about_ca_topic_score_gemma":0.037438903,"teacher_disagreement_score":0.030333234,"about_ca_system_score_codex":0.0003652018,"about_ca_system_score_gemma":0.0004312542,"threshold_uncertainty_score":0.060313344},"labels":[],"label_agreement":null},{"id":"W2033894890","doi":"10.1023/a:1010635328299","title":"Are medical oncologists biased in their treatment of the large woman with breast cancer?","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.08736655512268195,"score_gpt":0.4045667950867029,"score_spread":0.31720023996402097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033894890","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27403978,0.024260586,0.0016682551,0.65085083,0.0036338794,0.000115439834,0.00064134866,0.00004003539,0.04474983],"genre_scores_gemma":[0.7752728,0.0069123716,0.001952924,0.20610593,0.0070949164,0.000105426305,0.00017152278,0.00006549166,0.0023185895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97365236,0.01619815,0.0017363013,0.0011954189,0.005317811,0.0019000702],"domain_scores_gemma":[0.77666026,0.1113337,0.05810296,0.008411657,0.029565092,0.01592627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030789252,0.0002322637,0.0008291988,0.0020932886,0.0023075917,0.0027273162,0.0013126514,0.003677595,0.008391544],"category_scores_gemma":[0.28118965,0.00044714301,0.0004139843,0.0018132507,0.003113858,0.0026166853,0.0013570989,0.0031079312,0.0020388074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010354363,0.00025623775,0.73708034,0.00058188936,0.0006962704,0.00088104577,0.009917714,0.00017983389,0.0007002892,0.007820846,0.10105516,0.13979498],"study_design_scores_gemma":[0.00042939803,0.000441698,0.7985045,0.0037880365,0.0011240143,0.0055496823,0.043882187,0.000985735,0.0014880428,0.0207146,0.122890875,0.00020117401],"about_ca_topic_score_codex":0.022228919,"about_ca_topic_score_gemma":0.041620467,"teacher_disagreement_score":0.030789252,"about_ca_system_score_codex":0.00247675,"about_ca_system_score_gemma":0.003973257,"threshold_uncertainty_score":0.16283107},"labels":[],"label_agreement":null},{"id":"W2034401336","doi":"10.1007/s10549-004-4259-3","title":"Should oral bisphosphonates be standard of care in women with early breast cancer?","year":2005,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Zoledronic acid; Breast cancer; Oncology; Adjuvant; Internal medicine; Cancer; Randomized controlled trial; Gynecology","score_opus":0.10254552758640122,"score_gpt":0.4515989075656492,"score_spread":0.34905337997924796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034401336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030348438,0.9954075,0.000054396707,0.0029723297,0.0004273056,0.0000060752964,0.000026948026,0.0000045124566,0.00079738675],"genre_scores_gemma":[0.0032242227,0.9927434,0.0002844128,0.0027102043,0.00053980504,0.000012780505,0.000042507294,0.0000013822745,0.00044129742],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954754,0.0001155616,0.00010945514,0.00005677711,0.00013692142,0.000033719105],"domain_scores_gemma":[0.9989484,0.00050041196,0.00028860872,0.000017690762,0.00018646478,0.00005835566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001222875,0.0004650036,0.002876311,0.0010248886,0.00023376242,0.0008405545,0.0007583166,0.001850056,0.0035301049],"category_scores_gemma":[0.0032846325,0.0002909509,0.0007755321,0.0013069615,0.0004020124,0.0009153399,0.00033595765,0.0020907084,0.00079426816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007628362,0.00008250578,0.0007632681,0.025408665,0.0003724277,0.00024895562,0.000046464153,0.00013670542,0.0004887474,0.0010607018,0.031971294,0.93865734],"study_design_scores_gemma":[0.0022802292,0.0009474856,0.017287187,0.07090951,0.004751355,0.004603786,0.00045265158,0.00030385927,0.00083228265,0.004168012,0.8933848,0.00007900273],"about_ca_topic_score_codex":0.004349397,"about_ca_topic_score_gemma":0.014804172,"teacher_disagreement_score":0.004349397,"about_ca_system_score_codex":0.0010044373,"about_ca_system_score_gemma":0.0025240437,"threshold_uncertainty_score":0.011809409},"labels":[],"label_agreement":null},{"id":"W2034849620","doi":"10.1007/s10549-014-3033-4","title":"Platinum-based chemotherapy in triple-negative advanced breast cancer","year":2014,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Chemotherapy; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Triple-negative breast cancer; Cancer","score_opus":0.04969153023903283,"score_gpt":0.4083813426675538,"score_spread":0.358689812428521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034849620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076132885,0.99935573,0.000052993943,0.00011703076,0.000059624126,0.00000278824,0.000011036435,0.0000028507704,0.00032194343],"genre_scores_gemma":[0.0006288697,0.9989229,0.000086096006,0.00011122065,0.000056989466,0.0000029891228,0.000015547681,6.547771e-7,0.00017476351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999866,0.000027290944,0.000026207303,0.000025957495,0.000043153726,0.000011371092],"domain_scores_gemma":[0.9997408,0.00014773123,0.00004507069,0.000007779288,0.000041283765,0.00001739651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054558803,0.0005557754,0.0015609879,0.0013909043,0.00016019824,0.00068699394,0.00078234955,0.0006932169,0.0019598969],"category_scores_gemma":[0.00086746836,0.00026691012,0.00042913746,0.0017720559,0.0003258565,0.0007402121,0.0004935869,0.0012990353,0.00073955604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009408789,0.000048936046,0.00019842474,0.016699806,0.00013844937,0.00012065868,0.000022518512,0.0003072691,0.0006954979,0.0011641767,0.018525027,0.9619852],"study_design_scores_gemma":[0.00010351339,0.000200912,0.0018783949,0.007667144,0.000631896,0.0018582786,0.000057417623,0.00021550231,0.00081450155,0.0018140964,0.9847297,0.000028714438],"about_ca_topic_score_codex":0.0011127817,"about_ca_topic_score_gemma":0.0030341474,"teacher_disagreement_score":0.0019598969,"about_ca_system_score_codex":0.00051053305,"about_ca_system_score_gemma":0.0007596007,"threshold_uncertainty_score":0.006556511},"labels":[],"label_agreement":null},{"id":"W2034897616","doi":"10.1007/s10549-013-2511-4","title":"CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Tamoxifen; CYP2D6; Breast cancer; Pharmacogenetics; Medicine; Oncology; Internal medicine; Pharmacogenomics; Pharmacology; CYP3A5; Selective estrogen receptor modulator; Genotype; Prospective cohort study; Cancer; Bioinformatics; Biology; Genetics; Cytochrome P450","score_opus":0.16394551591650738,"score_gpt":0.4609639978878481,"score_spread":0.29701848197134073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034897616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381787,0.0026221867,0.0012513135,0.00024323016,0.000042787324,0.00001750312,0.0007018948,0.000028450282,0.0012747735],"genre_scores_gemma":[0.99827003,0.00029044176,0.00046350935,0.000068412955,0.000022876298,0.0000075723965,0.00029433324,0.000011510671,0.0005713013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995666,0.00013426415,0.000046782563,0.00010861372,0.00009488086,0.000048871745],"domain_scores_gemma":[0.99899083,0.00029145423,0.0003768494,0.00013255911,0.00014322251,0.00006511004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004102167,0.0002144947,0.00046120695,0.0004827487,0.000220908,0.00054564344,0.00025413264,0.00044473997,0.0013478224],"category_scores_gemma":[0.0015927189,0.00021313065,0.0005219255,0.0007355129,0.00015824779,0.00020289235,0.00016188133,0.00042446723,0.00017527767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021847973,0.000100845675,0.94985086,0.000062217034,0.000687938,0.00023915846,0.00012836755,0.0003769208,0.023815678,0.00011318019,0.00038282233,0.022057075],"study_design_scores_gemma":[0.000011079498,0.0001186657,0.99641174,0.0000056921363,0.00011668912,0.00029047282,0.00006623557,0.00045543603,0.0018277897,0.00006902349,0.00062180654,0.0000053901313],"about_ca_topic_score_codex":0.005113923,"about_ca_topic_score_gemma":0.007702401,"teacher_disagreement_score":0.005113923,"about_ca_system_score_codex":0.00036568588,"about_ca_system_score_gemma":0.00025872374,"threshold_uncertainty_score":0.010168314},"labels":[],"label_agreement":null},{"id":"W2035182098","doi":"10.1007/s10549-007-9869-0","title":"Familial association of laryngeal, lung, stomach and early-onset breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Larynx; Cancer; Stomach; Stomach cancer; Incidence (geometry); Lung cancer; Internal medicine; Population; Mammary gland; Laryngeal Neoplasm; Oncology; Gastroenterology; Surgery","score_opus":0.020202317185290003,"score_gpt":0.35458650552474436,"score_spread":0.3343841883394544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035182098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989746,0.0022150392,0.00076242944,0.00041491468,0.00007910939,0.000018619095,0.00057308184,0.00008958097,0.006101283],"genre_scores_gemma":[0.99769884,0.0004092447,0.0002268175,0.000060679104,0.00009994204,0.0000067713963,0.00015426391,0.000013192594,0.0013302941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993579,0.00015578077,0.0000643852,0.0001303995,0.000138174,0.0001533896],"domain_scores_gemma":[0.99849653,0.0004497836,0.00038624043,0.0001592048,0.00015151841,0.00035667684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048135914,0.00094991503,0.0007553621,0.002214742,0.0016145548,0.0005283087,0.0005556756,0.0011168678,0.0067168786],"category_scores_gemma":[0.0025236448,0.00057312124,0.0007246165,0.0018825461,0.0007608732,0.0004059815,0.0006796984,0.0006863441,0.0006321721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012865448,0.00015750814,0.80353147,0.000110350455,0.00024155935,0.16668208,0.0006968307,0.00030425852,0.017208507,0.00073023536,0.002032127,0.0070184874],"study_design_scores_gemma":[0.0000427999,0.00022906243,0.6244537,0.000046874567,0.00037931724,0.36662734,0.0005056603,0.0006287199,0.0040015406,0.00052118284,0.0025219815,0.000041761978],"about_ca_topic_score_codex":0.0039071795,"about_ca_topic_score_gemma":0.004872231,"teacher_disagreement_score":0.0067168786,"about_ca_system_score_codex":0.00045830003,"about_ca_system_score_gemma":0.00044224528,"threshold_uncertainty_score":0.022470176},"labels":[],"label_agreement":null},{"id":"W2035431183","doi":"10.1007/s10549-009-0557-0","title":"Learning to predict relapse in invasive ductal carcinomas based on the subcellular localization of junctional proteins","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Machine Learning in Bioinformatics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University; University of Saskatchewan; University of Alberta","funders":"","keywords":"Classifier (UML); Breast cancer; Subcellular localization; Decision tree; Machine learning; PTEN; Artificial intelligence; Biology; Decision tree learning; Bioinformatics; Computer science; Cancer; Cytoplasm; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.018101540308751243,"score_gpt":0.2895833958624085,"score_spread":0.2714818555536573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035431183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771399,0.0007817278,0.019511033,0.0008032878,0.000047971007,0.000029985353,0.0007914152,0.0003256505,0.00056900905],"genre_scores_gemma":[0.9934134,0.00019840004,0.004341008,0.00008082456,0.000048478665,0.000024607234,0.0015746121,0.000015957961,0.00030279154],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996939,0.000077223674,0.00003682149,0.00008525721,0.000049467664,0.00005741327],"domain_scores_gemma":[0.99859554,0.0008240982,0.00022455586,0.00007843882,0.00017034893,0.00010705479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011666568,0.00049419183,0.0010559638,0.0009487619,0.00022341529,0.000892519,0.0006371281,0.00069838244,0.0006234207],"category_scores_gemma":[0.0037596764,0.00021243193,0.00062535447,0.00053784664,0.0002456684,0.00054046675,0.00034604143,0.001031424,0.00038989665],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018923708,0.0008869033,0.68665403,0.00015549295,0.00045941304,0.00028272078,0.00007672431,0.068360485,0.008852712,0.0005359759,0.004875992,0.2269673],"study_design_scores_gemma":[0.00013369895,0.00035786998,0.084137745,0.000027020336,0.000272024,0.00034204448,0.00012710888,0.90353173,0.0058970586,0.004386574,0.00075783837,0.000029280269],"about_ca_topic_score_codex":0.0016947405,"about_ca_topic_score_gemma":0.0024874131,"teacher_disagreement_score":0.0016947405,"about_ca_system_score_codex":0.00036075854,"about_ca_system_score_gemma":0.00045813798,"threshold_uncertainty_score":0.006169915},"labels":[],"label_agreement":null},{"id":"W2035520465","doi":"10.1007/s10549-007-9727-0","title":"Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; Western University; Sunnybrook Health Science Centre; Juravinski Cancer Centre; University of Toronto; Ottawa Regional Cancer Foundation; Ontario Clinical Oncology Group; McMaster University","funders":"","keywords":"Breast cancer; Lymphedema; Medicine; Randomized controlled trial; Oncology; Internal medicine; Cancer; Gynecology","score_opus":0.030042860662349118,"score_gpt":0.35358589370514637,"score_spread":0.32354303304279725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035520465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943434,0.0025864136,0.0002616779,0.00036524067,0.00016870994,0.0013085717,0.0003521345,0.000012794075,0.0006010461],"genre_scores_gemma":[0.99612904,0.00056893326,0.00029642784,0.0005157767,0.00017880321,0.0013928489,0.000508291,0.0000041985004,0.00040560393],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.995274,0.003113776,0.00044833648,0.00051211467,0.00022003063,0.00043170716],"domain_scores_gemma":[0.99558485,0.0021350316,0.0009120977,0.00034540112,0.00021773354,0.00080481975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043178704,0.0010351347,0.0033134916,0.00041559956,0.0007669101,0.0015461456,0.0006172342,0.0025589094,0.00408257],"category_scores_gemma":[0.00936926,0.00070484384,0.0030788085,0.0008085461,0.0012326997,0.0016055807,0.00066060235,0.0019667945,0.000434942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96100116,0.0026078695,0.02694277,0.00038865648,0.0027555125,0.00008835098,0.00009425249,0.00012446266,0.0008730388,0.00011300617,0.00032599966,0.004684881],"study_design_scores_gemma":[0.83127165,0.104268216,0.055004153,0.00014846331,0.0061724475,0.00018001844,0.00020988782,0.0006654626,0.000463795,0.0005491977,0.0010119941,0.000054754284],"about_ca_topic_score_codex":0.0007386703,"about_ca_topic_score_gemma":0.0011389246,"teacher_disagreement_score":0.0043178704,"about_ca_system_score_codex":0.00075627357,"about_ca_system_score_gemma":0.001365738,"threshold_uncertainty_score":0.022835314},"labels":[],"label_agreement":null},{"id":"W2035582761","doi":"10.1023/a:1020820103126","title":"Satisfaction and Anxiety for Women During Investigation of an Abnormal Screening Mammogram","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; Vancouver Hospital and Health Sciences Centre; University of British Columbia; Providence Health Care; BC Cancer Agency","funders":"","keywords":"Anxiety; Medicine; Referral; Patient satisfaction; Mammography; Breast cancer; Family medicine; Physical therapy; Psychiatry; Cancer; Nursing; Internal medicine","score_opus":0.12926372579539006,"score_gpt":0.3800738350420897,"score_spread":0.25081010924669966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035582761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963308,0.0006458532,0.000043983964,0.00096314424,0.000048724178,0.000024666931,0.00038120057,0.0000050638923,0.0015565981],"genre_scores_gemma":[0.9987079,0.00024720185,0.000067666486,0.00031535566,0.00004166466,0.000013822028,0.00021930423,0.0000021242704,0.00038497458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990677,0.00037974538,0.00008869517,0.000043205142,0.0001631808,0.0002575129],"domain_scores_gemma":[0.9900932,0.002843598,0.0034147152,0.00019996747,0.0007266068,0.0027220356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014110645,0.00023958154,0.00052959454,0.00066299055,0.0009033676,0.0013049546,0.00030619756,0.0010912826,0.0030920869],"category_scores_gemma":[0.014594795,0.00026228308,0.0013120632,0.0008910749,0.0004257494,0.00065507425,0.00070071546,0.0016100194,0.00030037027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006568182,0.00029877704,0.9903833,0.000047582635,0.00016663992,0.00016811611,0.0014032869,0.00008681054,0.00013680705,0.00006936086,0.0005467871,0.006035736],"study_design_scores_gemma":[0.00002788288,0.00046969778,0.9958494,0.000016208429,0.000080853475,0.0002026335,0.0027001493,0.0002327873,0.000032972617,0.000050785253,0.00032290322,0.000013711109],"about_ca_topic_score_codex":0.01434228,"about_ca_topic_score_gemma":0.024611639,"teacher_disagreement_score":0.01434228,"about_ca_system_score_codex":0.0010522683,"about_ca_system_score_gemma":0.0008883258,"threshold_uncertainty_score":0.028517604},"labels":[],"label_agreement":null},{"id":"W2035680293","doi":"10.1023/a:1025476722493","title":"Necrosis and Hypoxia in Invasive Breast Carcinoma","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Manitoba","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Bayer Corporation","keywords":"Hypoxia (environmental); Necrosis; Stromal cell; Pathology; Biology; Breast cancer; Ductal carcinoma; Immunohistochemistry; Tumor hypoxia; Cancer research; Medicine; Internal medicine; Cancer; Chemistry","score_opus":0.029285284114546187,"score_gpt":0.30727222591627046,"score_spread":0.2779869418017243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035680293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8325789,0.1470861,0.0012143601,0.0039953813,0.00020965029,0.000033147142,0.00018114863,0.000036860638,0.014664591],"genre_scores_gemma":[0.94547373,0.048262686,0.00023420966,0.0002442969,0.00041047766,0.000015439848,0.00014404792,0.0000040387067,0.005210997],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999442,0.000016202815,0.000005304505,0.0000059043105,0.000016137923,0.000012376491],"domain_scores_gemma":[0.9998599,0.000035258403,0.000045634337,0.0000070585434,0.000016813234,0.000035266006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018561594,0.000120611905,0.00022142928,0.00046403386,0.00017771158,0.00035450057,0.00016590631,0.00030251447,0.00079545204],"category_scores_gemma":[0.00023816105,0.0001082168,0.000078733974,0.00034237193,0.00032237935,0.00031196498,0.00017309662,0.00039178363,0.00010802638],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022370042,0.0013272901,0.22081703,0.0022436676,0.00025398054,0.017661773,0.0013113922,0.0027248098,0.48753068,0.024552634,0.006671571,0.21253514],"study_design_scores_gemma":[0.00045520253,0.0029986447,0.76863295,0.0002567001,0.00033384035,0.0343508,0.0017517473,0.0023892203,0.094798446,0.017621035,0.076355696,0.000055788452],"about_ca_topic_score_codex":0.0008573389,"about_ca_topic_score_gemma":0.000824384,"teacher_disagreement_score":0.0008573389,"about_ca_system_score_codex":0.00039922452,"about_ca_system_score_gemma":0.000268127,"threshold_uncertainty_score":0.0028966665},"labels":[],"label_agreement":null},{"id":"W2035758649","doi":"10.1007/s10549-010-0863-6","title":"Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer","year":2010,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre; Ministry of the Environment, Conservation and Parks; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"ERCC2; Breast cancer; Oncology; Genotype; Medicine; Biology; Genetics; Internal medicine; Cancer; Gene; Single-nucleotide polymorphism","score_opus":0.13125206721973165,"score_gpt":0.42374773907280827,"score_spread":0.2924956718530766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035758649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004767364,0.9940528,0.00040543595,0.00027682603,0.000111746536,0.000008412469,0.00020616724,0.000010841909,0.00016029517],"genre_scores_gemma":[0.09461286,0.90149266,0.0017179175,0.0005853499,0.00042981436,0.00003271045,0.00076336676,0.000013723975,0.0003516059],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9988403,0.0004974431,0.00019862317,0.00023327878,0.00018436526,0.00004614924],"domain_scores_gemma":[0.9976381,0.0016793777,0.00030500538,0.00010121739,0.00022261425,0.00005357472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032037257,0.0013465573,0.005625451,0.0011647219,0.00016370522,0.0008285543,0.0010148387,0.0009154314,0.0014666778],"category_scores_gemma":[0.003838428,0.00049283466,0.0049564326,0.0023785695,0.00017727341,0.00039528153,0.00048656834,0.0007810136,0.000190442],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009856509,0.00012282733,0.04575973,0.08814951,0.38941777,0.0011363594,0.00008158969,0.0022122127,0.0038235544,0.00065936946,0.010813821,0.44796672],"study_design_scores_gemma":[0.0022088434,0.0012482525,0.10442234,0.0082129175,0.8223083,0.002963124,0.000101229,0.0011159626,0.0025338647,0.0023199744,0.05244803,0.00011714226],"about_ca_topic_score_codex":0.0021127537,"about_ca_topic_score_gemma":0.006409752,"teacher_disagreement_score":0.005625451,"about_ca_system_score_codex":0.0005466223,"about_ca_system_score_gemma":0.00093611464,"threshold_uncertainty_score":0.016943097},"labels":[],"label_agreement":null},{"id":"W2035903801","doi":"10.1007/s10549-007-9887-y","title":"New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Breast Cancer Research Alliance; Sanofi; Breast Cancer Alliance","keywords":"Breast cancer; Immunohistochemistry; Internal medicine; Oncology; Fluorescence in situ hybridization; Population; Cancer; Medicine; Cohort; Trastuzumab; Fish <Actinopterygii>; Pathology; Biology; Gene; Genetics","score_opus":0.05632076209097779,"score_gpt":0.43925768052665604,"score_spread":0.38293691843567823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035903801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749833,0.00027475672,0.0012834511,0.00005571846,0.000020222005,0.000026828255,0.000572836,0.000018424464,0.00024930594],"genre_scores_gemma":[0.9974022,0.00008125061,0.0010500776,0.000047784633,0.000023537441,0.00007086818,0.0009626135,0.000013607895,0.00034796403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989077,0.00034219061,0.00009798223,0.00035270778,0.00017989546,0.00011953259],"domain_scores_gemma":[0.99780995,0.0009714753,0.00039411825,0.0003593371,0.00026073933,0.00020450192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024943335,0.0007640633,0.001064016,0.0011048212,0.0007013632,0.0013702498,0.0009796689,0.0012091865,0.0013215522],"category_scores_gemma":[0.0057333605,0.00038251645,0.0009274389,0.0010258416,0.00044903284,0.0006868303,0.000636955,0.0011419528,0.0002981116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017903211,0.00015153385,0.9866564,0.000015632577,0.00040671774,0.00030658266,0.00017677368,0.00041469204,0.0030578044,0.00009098462,0.0004592795,0.006473282],"study_design_scores_gemma":[0.00012241448,0.0003704942,0.9953101,0.0000068042646,0.00026843807,0.00083367596,0.00014939262,0.0016388438,0.0005408097,0.00020195384,0.000539677,0.00001743301],"about_ca_topic_score_codex":0.002539736,"about_ca_topic_score_gemma":0.0028784398,"teacher_disagreement_score":0.002539736,"about_ca_system_score_codex":0.00036268774,"about_ca_system_score_gemma":0.0003955043,"threshold_uncertainty_score":0.013191462},"labels":[],"label_agreement":null},{"id":"W2035948281","doi":"10.1007/s10549-008-9895-6","title":"Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"MTRR; Breast cancer; Methylenetetrahydrofolate reductase; Single-nucleotide polymorphism; Genotype; Case-control study; Biology; Genetics; Cancer; Internal medicine; Medicine; Oncology; Gene; Bioinformatics; Physiology","score_opus":0.045041733796689756,"score_gpt":0.3396557810745558,"score_spread":0.29461404727786605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035948281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948479,0.002684456,0.0004548067,0.00055702805,0.000048362395,0.0000066017337,0.0003804971,0.00001688795,0.0010035263],"genre_scores_gemma":[0.99761283,0.00072351366,0.00034701853,0.00008224235,0.00007230573,0.000007714994,0.00020611193,0.000009122062,0.00093913375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937075,0.00029907026,0.00005613611,0.00011831566,0.000082616716,0.0000731561],"domain_scores_gemma":[0.9981755,0.0009566285,0.0004470679,0.000109428394,0.000118239535,0.00019309742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007414677,0.0005175849,0.0006208837,0.0010786636,0.0004397461,0.00069299625,0.00037500396,0.0015562018,0.0028734964],"category_scores_gemma":[0.002894973,0.0005108207,0.00069215737,0.0015637907,0.00041930279,0.00031559065,0.00019110886,0.0009996179,0.00031398024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009083729,0.00043391855,0.9593243,0.00009303463,0.0015625911,0.001284568,0.00028124722,0.00083311566,0.016875355,0.0006632164,0.00073732843,0.008827688],"study_design_scores_gemma":[0.0002720142,0.0006736851,0.98723197,0.000045861267,0.0013267128,0.0024096747,0.0001766184,0.0019868263,0.0029644645,0.0010807385,0.0018015591,0.000029864417],"about_ca_topic_score_codex":0.006014675,"about_ca_topic_score_gemma":0.002633988,"teacher_disagreement_score":0.006014675,"about_ca_system_score_codex":0.00030722216,"about_ca_system_score_gemma":0.0002955522,"threshold_uncertainty_score":0.011959314},"labels":[],"label_agreement":null},{"id":"W2036335583","doi":"10.1023/a:1006320122711","title":"Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Alberta Cancer Foundation; Toronto General Hospital","funders":"","keywords":"Metastatic breast cancer; Medicine; Breast cancer; Oncology; Internal medicine; Cancer; Postmenopausal women; Estrogen receptor; Cancer research","score_opus":0.06413388611206063,"score_gpt":0.41164285071278633,"score_spread":0.3475089646007257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036335583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8051414,0.1665536,0.0028876322,0.003980124,0.0005737695,0.00022030668,0.0006810807,0.00072417216,0.019237962],"genre_scores_gemma":[0.94038504,0.049278427,0.0013032806,0.00072577933,0.00024453914,0.000049279384,0.00049513415,0.000019075327,0.0074994657],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999541,0.000012518516,0.0000042876327,0.000006027233,0.000007797677,0.000015290512],"domain_scores_gemma":[0.9999691,0.000004843132,0.000007834304,0.0000019195893,0.0000041073936,0.000012172998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014089988,0.0002566685,0.00038901152,0.00025785345,0.00018856053,0.00021136558,0.00032949334,0.00035193836,0.0014521402],"category_scores_gemma":[0.00014313398,0.00005725766,0.00022993446,0.00023151062,0.0001337234,0.00014602958,0.00012818628,0.0004934427,0.00043880453],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015824372,0.0011247926,0.004119389,0.0014182721,0.00025230128,0.0025405118,0.00019186402,0.0011963687,0.1727088,0.0018105265,0.012472186,0.78634065],"study_design_scores_gemma":[0.027060995,0.0934929,0.06732712,0.0007267613,0.0020047412,0.022169853,0.0007445808,0.0056656417,0.28948057,0.002200837,0.48891038,0.00021558037],"about_ca_topic_score_codex":0.0015464547,"about_ca_topic_score_gemma":0.005502525,"teacher_disagreement_score":0.0015464547,"about_ca_system_score_codex":0.00028612424,"about_ca_system_score_gemma":0.00029056557,"threshold_uncertainty_score":0.0048578978},"labels":[],"label_agreement":null},{"id":"W2036650093","doi":"10.1007/s10549-014-3015-6","title":"Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Cancer Centre; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; University of Toronto; Sunnybrook Health Science Centre; Grand River Hospital; McMaster University; Ontario Clinical Oncology Group; Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital; University of Ottawa","funders":"AstraZeneca","keywords":"Medicine; Vandetanib; Internal medicine; Fulvestrant; Breast cancer; Placebo; Oncology; Metastatic breast cancer; Gastroenterology; Cancer; Endocrinology; Estrogen receptor; Pathology; Receptor","score_opus":0.030848549326914144,"score_gpt":0.3687571923549521,"score_spread":0.3379086430280379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036650093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720273,0.0082831215,0.0011983197,0.0017784962,0.0015958187,0.0065144654,0.004166606,0.000329999,0.0041059055],"genre_scores_gemma":[0.9727676,0.005099968,0.0017662551,0.0020607798,0.00056525384,0.006114251,0.003023032,0.000060379825,0.008542571],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994942,0.00020825065,0.0000256362,0.00010672789,0.00003413412,0.00013114628],"domain_scores_gemma":[0.99925905,0.00017646421,0.0001787885,0.00009133016,0.00004884837,0.00024544157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015196357,0.0028241447,0.0041820672,0.0005398945,0.0005753562,0.001397518,0.0014399051,0.0020785301,0.011333624],"category_scores_gemma":[0.0021152627,0.0012006979,0.0018662191,0.00058013125,0.0017439465,0.001223249,0.0006002797,0.0041252337,0.0019398957],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98883677,0.0019352636,0.0002514485,0.00039895193,0.00069273356,0.000020668458,0.000042248095,0.00020403822,0.0017145721,0.00011671738,0.00077698426,0.005009622],"study_design_scores_gemma":[0.9876929,0.010797337,0.0007232164,0.00001205973,0.0002036615,0.000011511293,0.000015531232,0.00007429893,0.00006917784,0.00007183137,0.00032127165,0.0000070900282],"about_ca_topic_score_codex":0.004163578,"about_ca_topic_score_gemma":0.008801806,"teacher_disagreement_score":0.011333624,"about_ca_system_score_codex":0.0011226604,"about_ca_system_score_gemma":0.0012033548,"threshold_uncertainty_score":0.037914693},"labels":[],"label_agreement":null},{"id":"W2036971299","doi":"10.1007/s10549-006-9181-4","title":"Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Internal medicine; Metastatic breast cancer; Mammary gland; Pathology; Cancer research","score_opus":0.027501155498999393,"score_gpt":0.3145756197281938,"score_spread":0.2870744642291944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036971299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851114,0.0005697779,0.00021334806,0.000038827715,0.000017323047,0.0000041998123,0.00013410613,0.000014369995,0.0004968322],"genre_scores_gemma":[0.9986487,0.0001319421,0.00017682023,0.000034493678,0.000032648557,0.000008474721,0.00026260523,0.0000056321946,0.000698659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982256,0.000027466156,0.0000126078485,0.00003248704,0.000038407437,0.000066527486],"domain_scores_gemma":[0.99923587,0.00038628466,0.00009995292,0.00003347154,0.00007681511,0.00016765053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019094767,0.00018211342,0.0003701314,0.00062183896,0.00028738377,0.00066807424,0.00025683106,0.0005436572,0.0024015857],"category_scores_gemma":[0.0015362961,0.00013990342,0.0001249827,0.00039189137,0.00019282503,0.00029737895,0.00018547299,0.00046868582,0.00037140332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006189316,0.00019365302,0.8930833,0.000054868247,0.000076612836,0.000882936,0.00025170814,0.0003053256,0.07781905,0.00020285374,0.0006896698,0.02025066],"study_design_scores_gemma":[0.00003786135,0.00063088146,0.9849059,0.000008831892,0.00008897958,0.0015683715,0.00017130078,0.0010063528,0.010577613,0.00012516508,0.0008677496,0.000010912163],"about_ca_topic_score_codex":0.00086954713,"about_ca_topic_score_gemma":0.0009013793,"teacher_disagreement_score":0.0024015857,"about_ca_system_score_codex":0.00022079491,"about_ca_system_score_gemma":0.00014439363,"threshold_uncertainty_score":0.00803411},"labels":[],"label_agreement":null},{"id":"W2037273883","doi":"10.1007/s10549-010-0889-9","title":"Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Osteopontin; Homing (biology); Cancer research; Bone marrow; Breast cancer; Bone metastasis; Tumor microenvironment; Cancer cell; Cancer; In vitro; Chemistry; Medicine; Biology; Pathology; Immunology; Internal medicine; Biochemistry","score_opus":0.027739022219463717,"score_gpt":0.3390864961475258,"score_spread":0.31134747392806206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037273883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98506814,0.006406302,0.00354291,0.0002595103,0.00006219646,0.000051931813,0.00023232489,0.000021864726,0.0043547167],"genre_scores_gemma":[0.9866518,0.002690792,0.00514925,0.00021362463,0.00003173984,0.000085214786,0.0007865616,0.000022544727,0.0043684975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995079,0.00018744433,0.000032949014,0.00004579983,0.00011617193,0.00010964377],"domain_scores_gemma":[0.99964786,0.00019458694,0.00003680856,0.000032762546,0.00004447995,0.000043488584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047374365,0.0003937465,0.00040315322,0.00040349268,0.0004932301,0.00056396256,0.00034390274,0.00043892924,0.002901912],"category_scores_gemma":[0.0003576405,0.0002791508,0.00039340547,0.0003118065,0.0003109311,0.00037626666,0.00045806877,0.0011214954,0.0007110552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043458096,0.00014624934,0.0012384382,0.00009450901,0.0000216496,0.00020643708,0.00013368066,0.00008326021,0.99417555,0.0004269117,0.00013730077,0.00290139],"study_design_scores_gemma":[0.00007286319,0.0013306028,0.025908718,0.000027834643,0.00008406617,0.0012880089,0.00049896655,0.0012238825,0.96291864,0.00025913597,0.0063773743,0.000009928364],"about_ca_topic_score_codex":0.002074938,"about_ca_topic_score_gemma":0.004248565,"teacher_disagreement_score":0.002901912,"about_ca_system_score_codex":0.00033413968,"about_ca_system_score_gemma":0.00025564496,"threshold_uncertainty_score":0.009707868},"labels":[],"label_agreement":null},{"id":"W2037503359","doi":"10.1007/s10549-015-3271-0","title":"Meta-analyses of etiologic studies should account for the underlying biologic mechanisms","year":2015,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Breast cancer; Medicine; MEDLINE; Biology; Bioinformatics; Computational biology; Internal medicine; Cancer","score_opus":0.8604205539923171,"score_gpt":0.5845997363599873,"score_spread":0.2758208176323298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037503359","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009357366,0.1645303,0.042826623,0.7445404,0.029879238,0.0003277946,0.0019118943,0.00037897608,0.0062473235],"genre_scores_gemma":[0.21346433,0.041844998,0.051496465,0.5943713,0.09390869,0.0009983644,0.00093117624,0.00026776604,0.0027168554],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.85090494,0.117689654,0.016150309,0.006525022,0.007431349,0.0012987487],"domain_scores_gemma":[0.32694262,0.62719876,0.015130498,0.018755898,0.010815794,0.001156413],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12709874,0.002297799,0.00686633,0.002832495,0.0016244821,0.005375145,0.0057617677,0.016201383,0.003949132],"category_scores_gemma":[0.42880532,0.0016482844,0.008677204,0.0035132542,0.0027726684,0.0065526054,0.0020357226,0.017265158,0.0011498333],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008144563,0.0003519823,0.14782356,0.018511545,0.17100136,0.008291116,0.0012577665,0.007029101,0.0014599157,0.04171366,0.36156896,0.2328465],"study_design_scores_gemma":[0.008479106,0.0012954035,0.050957948,0.013942275,0.13675481,0.009394577,0.0013047593,0.020887606,0.002489734,0.48661867,0.26697165,0.00090349605],"about_ca_topic_score_codex":0.0038215416,"about_ca_topic_score_gemma":0.011551118,"teacher_disagreement_score":0.87290126,"about_ca_system_score_codex":0.0029757272,"about_ca_system_score_gemma":0.0045783515,"threshold_uncertainty_score":0.6721704},"labels":[],"label_agreement":null},{"id":"W2037750236","doi":"10.1007/s10549-013-2727-3","title":"Preference weights for chemotherapy side effects from the perspective of women with breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; Royal Victoria Hospital; University of Ottawa","funders":"","keywords":"Nausea; Breast cancer; Medicine; Vomiting; Chemotherapy; Side effect (computer science); Quality of life (healthcare); Cancer; Internal medicine; Oncology; Surgery","score_opus":0.24794265711861302,"score_gpt":0.4349916345598271,"score_spread":0.18704897744121407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037750236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9080719,0.0074720196,0.041385427,0.013493569,0.00019803678,0.00012122381,0.0014015958,0.000023438266,0.027832823],"genre_scores_gemma":[0.9965031,0.0007590606,0.0016389376,0.00024783463,0.00005308289,0.000017632114,0.0001631565,0.0000047206076,0.00061245076],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9967535,0.0025159991,0.0001104219,0.00013699073,0.00028492976,0.00019810692],"domain_scores_gemma":[0.9889353,0.009043466,0.0007765873,0.00029679472,0.00046838424,0.0004795232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043224525,0.00056112086,0.0009186587,0.0011702926,0.00024140444,0.0021143598,0.00046493267,0.0011777759,0.0050849994],"category_scores_gemma":[0.022641385,0.000308606,0.0010369982,0.0013816542,0.0006471321,0.0013375431,0.000566211,0.0022056964,0.00015382486],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011099036,0.0011361057,0.21559665,0.0014537286,0.006588187,0.0018866393,0.0022212286,0.18988083,0.0037164518,0.23677857,0.014341891,0.3153007],"study_design_scores_gemma":[0.0011957618,0.002518401,0.15461078,0.0007330785,0.002379497,0.0028924348,0.004500265,0.23786794,0.000941507,0.57934916,0.012749474,0.00026162114],"about_ca_topic_score_codex":0.0045510256,"about_ca_topic_score_gemma":0.006547796,"teacher_disagreement_score":0.0050849994,"about_ca_system_score_codex":0.0016195971,"about_ca_system_score_gemma":0.00051843096,"threshold_uncertainty_score":0.022859573},"labels":[],"label_agreement":null},{"id":"W2037989702","doi":"10.1007/s10549-012-2392-y","title":"Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Public Health Ontario; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; University Health Network; University of Michigan","keywords":"Breast cancer; Lymphatic system; Medicine; Lymphovascular invasion; Lymph node; Oncology; Basal (medicine); Phenotype; Pathology; Internal medicine; Axilla; Cancer; Biology; Metastasis; Gene","score_opus":0.05086456171990781,"score_gpt":0.3682715124770857,"score_spread":0.3174069507571779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037989702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995334,0.00013490744,0.000053155476,0.0000203351,0.0000026220946,0.0000012666591,0.0000459593,0.0000032670544,0.00020510692],"genre_scores_gemma":[0.9996339,0.000060345938,0.00004465291,0.000007396302,0.000005046698,0.000001572784,0.000086084605,0.0000013683231,0.00015963851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987984,0.000026194895,0.000011739106,0.00002252985,0.000028750103,0.00003103183],"domain_scores_gemma":[0.9993894,0.00007278883,0.0002970803,0.000031965163,0.0000465761,0.00016214202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020652641,0.00015825896,0.00019484137,0.00053598767,0.0002993174,0.00056739006,0.0002414325,0.00028942592,0.001107914],"category_scores_gemma":[0.0006762078,0.00015785384,0.00015876771,0.0006290091,0.00025500593,0.00020190811,0.000297691,0.00042920702,0.00013944421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000709705,0.000049161496,0.9842212,0.0000133022995,0.000047752947,0.00029019933,0.00006126005,0.000040746552,0.012502291,0.000036015164,0.000081331265,0.0019470033],"study_design_scores_gemma":[0.0000060862403,0.00004722469,0.99832636,0.000002340233,0.00002550975,0.00047808938,0.000105723775,0.00019505441,0.000637506,0.0000494659,0.00012401641,0.0000027265883],"about_ca_topic_score_codex":0.0011753959,"about_ca_topic_score_gemma":0.0012983109,"teacher_disagreement_score":0.0011753959,"about_ca_system_score_codex":0.00023839709,"about_ca_system_score_gemma":0.0001678679,"threshold_uncertainty_score":0.0037062764},"labels":[],"label_agreement":null},{"id":"W2038284593","doi":"10.1007/s10549-012-2146-x","title":"Beyond radiation therapy: photodynamic therapy maintains structural integrity of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Photodynamic therapy; Breast cancer; Bone metastasis; Metastasis; Radiation therapy; In vivo; Cancer; Pathology; Thoracic vertebrae; Lumbar vertebrae; Radiology; Urology; Internal medicine; Lumbar; Biology","score_opus":0.09382280355459754,"score_gpt":0.432882584476253,"score_spread":0.33905978092165545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038284593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787217,0.0022918778,0.012549505,0.00041871515,0.00013805633,0.00013906948,0.00058238633,0.0001642953,0.0049944627],"genre_scores_gemma":[0.9851362,0.0009015205,0.0047360407,0.00008792961,0.00001604835,0.00007737164,0.0003957912,0.00005790001,0.008591251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967146,0.00004863847,0.00001540899,0.00008587202,0.000106441046,0.00007229894],"domain_scores_gemma":[0.9996841,0.00006330739,0.00007265825,0.0000787756,0.000043139375,0.000058060174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046211877,0.0003783312,0.000495961,0.00041555794,0.000529286,0.0007284699,0.00087616494,0.0010419228,0.003565435],"category_scores_gemma":[0.0003102302,0.00038282527,0.00046573643,0.00028479096,0.0008675883,0.0006505976,0.00028898448,0.0016743866,0.0007186948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005694584,0.00031147464,0.00020320975,0.000055666467,0.000010845292,0.000086233784,0.000066151544,0.00035837028,0.9959033,0.0003300166,0.00012953277,0.0019757103],"study_design_scores_gemma":[0.00011712224,0.0042828564,0.004851784,0.000022432934,0.000068230394,0.00062760134,0.00016645998,0.0025814904,0.9824991,0.0002739879,0.00449102,0.00001790805],"about_ca_topic_score_codex":0.0044585145,"about_ca_topic_score_gemma":0.007114005,"teacher_disagreement_score":0.0044585145,"about_ca_system_score_codex":0.000602963,"about_ca_system_score_gemma":0.0007227627,"threshold_uncertainty_score":0.011927545},"labels":[],"label_agreement":null},{"id":"W2038304935","doi":"10.1007/s10549-013-2714-8","title":"Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Health Science Centre; Juravinski Cancer Centre; University of British Columbia; University of Toronto; Mount Sinai Hospital; BC Cancer Agency; Ottawa Hospital; McMaster University; Queen's University; University of Ottawa","funders":"","keywords":"Medicine; Stage (stratigraphy); Breast cancer; Oncology; Internal medicine; Disease; Cancer; Mammary gland; Gynecology","score_opus":0.09370750888913441,"score_gpt":0.4498117588831009,"score_spread":0.35610424999396645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038304935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8238486,0.13788764,0.0042791395,0.01132546,0.0010426668,0.0011874975,0.005132832,0.000074380536,0.015221759],"genre_scores_gemma":[0.9741876,0.014201385,0.004847223,0.0025487505,0.00093576056,0.00043484112,0.0014458781,0.000025610756,0.0013728873],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99132895,0.0070118443,0.0004596364,0.00043193836,0.00055464316,0.000213096],"domain_scores_gemma":[0.9841129,0.008774502,0.003967145,0.0017054897,0.00091918936,0.0005207522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017205091,0.000755838,0.0024482766,0.0010942969,0.00033631446,0.0015072096,0.00074940216,0.001958887,0.0028995369],"category_scores_gemma":[0.015406076,0.00029899826,0.002396529,0.0017044029,0.0010662382,0.0021540658,0.00048200405,0.0010213401,0.00062248117],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22603847,0.0018291122,0.35867113,0.0029634146,0.012045228,0.000094630195,0.00024215212,0.002317177,0.0046832347,0.0013613246,0.0040334794,0.38572064],"study_design_scores_gemma":[0.06181561,0.085127726,0.7786605,0.0016673454,0.02188008,0.00068155123,0.00037686658,0.0035531449,0.0050527663,0.0062444434,0.034646045,0.00029403798],"about_ca_topic_score_codex":0.0013876297,"about_ca_topic_score_gemma":0.006799589,"teacher_disagreement_score":0.017205091,"about_ca_system_score_codex":0.00047451784,"about_ca_system_score_gemma":0.0006769881,"threshold_uncertainty_score":0.090990305},"labels":[],"label_agreement":null},{"id":"W2038343200","doi":"10.1007/s10549-006-9470-y","title":"Aromatase inhibitors and cardiac toxicity: getting to the heart of the matter","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Tamoxifen; Medicine; Aromatase; Breast cancer; Context (archaeology); Cardiac toxicity; Adjuvant; Internal medicine; Toxicity; Oncology; Pharmacology; Gynecology; Bioinformatics; Cancer; Biology","score_opus":0.034722581199259965,"score_gpt":0.3740143037781945,"score_spread":0.33929172257893453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038343200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043348395,0.99820864,0.000097247816,0.0007156279,0.0004555882,0.0000017326164,0.000007104933,0.000005328088,0.00046523425],"genre_scores_gemma":[0.00031432702,0.9976209,0.00015686412,0.0006223542,0.00054633705,0.0000029611115,0.000014138236,0.0000014095741,0.00072065473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977225,0.000042064265,0.000029327442,0.000033481203,0.000101406644,0.000021451933],"domain_scores_gemma":[0.9993913,0.00031061235,0.00006015124,0.000018844845,0.00015467643,0.00006440843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081892754,0.001008111,0.0024280478,0.0013417329,0.00034100364,0.001287785,0.0013373145,0.0022909117,0.004176735],"category_scores_gemma":[0.0010331662,0.00029878112,0.00045311314,0.0018775093,0.0007840127,0.0018713955,0.00064193405,0.0029014177,0.0029323783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013147506,0.00008014544,0.00018833218,0.0059386133,0.00009221192,0.0003803098,0.00003470614,0.0002486789,0.0011660876,0.003133564,0.11395167,0.8746543],"study_design_scores_gemma":[0.00004649563,0.00006821066,0.0005514973,0.0015231785,0.000084497966,0.0016135505,0.00005753069,0.00006927419,0.00025031695,0.0022626678,0.9934557,0.000017014003],"about_ca_topic_score_codex":0.001155685,"about_ca_topic_score_gemma":0.0037303837,"teacher_disagreement_score":0.004176735,"about_ca_system_score_codex":0.00075191015,"about_ca_system_score_gemma":0.001022677,"threshold_uncertainty_score":0.01397258},"labels":[],"label_agreement":null},{"id":"W2039267747","doi":"10.1007/s10549-014-2953-3","title":"Adolescent dietary fiber, vegetable fat, vegetable protein, and nut intakes and breast cancer risk","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Public Health Ontario; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Odds ratio; Population; Confidence interval; Cancer; Case-control study; Logistic regression; Environmental health; Internal medicine","score_opus":0.038499536076881564,"score_gpt":0.33020529806905197,"score_spread":0.2917057619921704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039267747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978629,0.0011884975,0.000041366824,0.00010209789,0.000007771802,0.0000028434242,0.00020329528,0.000002184235,0.0005890487],"genre_scores_gemma":[0.9975358,0.0010379775,0.00013526925,0.000040118477,0.000007760428,0.000005455407,0.00022391103,0.0000024437024,0.0010113355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998889,0.00003502803,0.000008547906,0.000021177686,0.000026657532,0.00001965845],"domain_scores_gemma":[0.99940455,0.00014507519,0.00020903203,0.000022292112,0.0001052105,0.00011385247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038043704,0.00014980813,0.00018204538,0.000321103,0.000247561,0.00044295087,0.00013366564,0.0002753715,0.0017972951],"category_scores_gemma":[0.000988969,0.00022326219,0.00021056499,0.00040299952,0.00010474395,0.00022536928,0.0002042226,0.00045589657,0.00014619467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021223612,0.00011089723,0.994158,0.000024201572,0.00007755729,0.000032902048,0.0002256578,0.00003085672,0.00047096182,0.0000954387,0.00019043019,0.0043708794],"study_design_scores_gemma":[0.0000074021673,0.000105383406,0.9982185,0.000022510529,0.00007952891,0.00011406764,0.00027355968,0.00010907468,0.00023040714,0.000052106312,0.00078586105,0.000001621463],"about_ca_topic_score_codex":0.014283424,"about_ca_topic_score_gemma":0.02594437,"teacher_disagreement_score":0.014283424,"about_ca_system_score_codex":0.00026763152,"about_ca_system_score_gemma":0.0002707307,"threshold_uncertainty_score":0.02840054},"labels":[],"label_agreement":null},{"id":"W2039755267","doi":"10.1023/a:1006314010958","title":"Effect of social housing condition on heat shock protein (HSP) expression in the Shionogi mouse mammary carcinoma (SC115)","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health","keywords":"Heat shock protein; Downregulation and upregulation; Endocrinology; Internal medicine; Biology; In vivo; In vitro; Medicine; Gene; Biochemistry; Genetics","score_opus":0.02155190910100523,"score_gpt":0.3448273884151004,"score_spread":0.32327547931409517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039755267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847907,0.00044957182,0.00018957035,0.000112840324,0.000056453508,0.0000075746248,0.00023701946,0.00002157851,0.00044633495],"genre_scores_gemma":[0.99656963,0.00028130034,0.00035862764,0.00007444993,0.000028376639,0.000039917726,0.00041795635,0.000019359271,0.0022103915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971944,0.000060887236,0.000018065746,0.000055403787,0.000032643253,0.00011347268],"domain_scores_gemma":[0.99960417,0.00006677265,0.00006750384,0.000039211413,0.000026916805,0.00019547979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015333194,0.00044560095,0.00043355356,0.00035394944,0.00039866735,0.00036390635,0.0002842967,0.00033996443,0.0023897793],"category_scores_gemma":[0.00017657282,0.00019021353,0.00036127804,0.00017008213,0.0005343961,0.0002685289,0.00035934726,0.00097441045,0.00024886496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024801819,0.0004413286,0.0010166441,0.000037280242,0.000020688936,0.00011730966,0.00008960182,0.00005609427,0.9939323,0.00010053951,0.00013947298,0.0015684367],"study_design_scores_gemma":[0.00008461154,0.004864454,0.043057606,0.000016135447,0.00008975296,0.00020751536,0.00042751685,0.0009509616,0.9490135,0.000108371416,0.0011474736,0.000032099117],"about_ca_topic_score_codex":0.0020437993,"about_ca_topic_score_gemma":0.005181986,"teacher_disagreement_score":0.0023897793,"about_ca_system_score_codex":0.00046066058,"about_ca_system_score_gemma":0.00036635617,"threshold_uncertainty_score":0.007994652},"labels":[],"label_agreement":null},{"id":"W2039874815","doi":"10.1007/s10549-011-1761-2","title":"Non-existence of caveolin-1 gene mutations in human breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Biology; Microdissection; Cancer research; Gene; Mutation; Germline mutation; Cancer; Caveolae; Genetics; Cell","score_opus":0.052825803208286316,"score_gpt":0.3515259007903604,"score_spread":0.29870009758207405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039874815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579763,0.0014431408,0.00028913506,0.00011764768,0.000021787926,0.000008585788,0.0002417072,0.000012380868,0.0020679273],"genre_scores_gemma":[0.9989273,0.00027820497,0.0001337699,0.000031090323,0.000013607534,0.000003759847,0.00016507073,0.0000068794366,0.00044025495],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996728,0.000060125734,0.000051445484,0.000055843542,0.00010488875,0.000054863278],"domain_scores_gemma":[0.9989151,0.0005037027,0.0001762844,0.00013944047,0.00014797553,0.00011757865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045941144,0.0001384228,0.0002727505,0.0014896068,0.0004306125,0.00037635115,0.00036704275,0.00052653026,0.0022310386],"category_scores_gemma":[0.0021198338,0.00017977225,0.00018728724,0.00062594475,0.00046796797,0.00024538912,0.00027987643,0.00027013666,0.00025661933],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005381474,0.00019575405,0.64246255,0.00029138854,0.000220671,0.024299404,0.000731085,0.0006381382,0.28291708,0.0032478743,0.00095183385,0.03866271],"study_design_scores_gemma":[0.000100216894,0.00043943067,0.87457603,0.00003652749,0.00032844188,0.060587324,0.0004272822,0.0010984254,0.053435594,0.0021147698,0.0068265023,0.000029514302],"about_ca_topic_score_codex":0.0017016052,"about_ca_topic_score_gemma":0.001956379,"teacher_disagreement_score":0.0022310386,"about_ca_system_score_codex":0.00023669258,"about_ca_system_score_gemma":0.00029367534,"threshold_uncertainty_score":0.007463515},"labels":[],"label_agreement":null},{"id":"W2039952097","doi":"10.1007/s10549-014-3046-z","title":"Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Axial skeleton; Confidence interval; Skeleton (computer programming); Vertebra; Bone marrow; Odds ratio; Internal medicine; Proportional hazards model; Metastasis; Metastatic breast cancer; Cancer; Oncology; Bone metastasis; Radiology; Surgery; Anatomy","score_opus":0.0223751291011141,"score_gpt":0.35027601802357217,"score_spread":0.32790088892245806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039952097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891773,0.005329258,0.00043892206,0.00043771797,0.000043285138,0.000008781657,0.0005223622,0.000016887452,0.004025542],"genre_scores_gemma":[0.99793905,0.0009873887,0.00021842247,0.00005030472,0.00012750195,0.0000043245213,0.00024726868,0.0000037929228,0.00042182935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995371,0.0001712151,0.000053636224,0.00008691501,0.000092302515,0.000058831967],"domain_scores_gemma":[0.9972806,0.00072642736,0.0012952159,0.00017256357,0.00018365776,0.00034142574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078110065,0.0003529206,0.00039872358,0.0008923699,0.00025693025,0.00082137296,0.0004562496,0.00084420556,0.0026345141],"category_scores_gemma":[0.0038164058,0.0002663816,0.00057671533,0.0015334608,0.0004108002,0.0007405324,0.0004528105,0.0009491366,0.00040452214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001687226,0.000016893071,0.9971787,0.000008486831,0.000085388085,0.00007744541,0.000011370017,0.000037749604,0.00025802018,0.00002605417,0.000058390608,0.0020728332],"study_design_scores_gemma":[0.000003992711,0.00007351179,0.99852836,0.000005840613,0.00009326142,0.0006843549,0.00007111633,0.00022371933,0.000054882163,0.00006201356,0.00019457082,0.000004419979],"about_ca_topic_score_codex":0.0019465226,"about_ca_topic_score_gemma":0.0028271878,"teacher_disagreement_score":0.0026345141,"about_ca_system_score_codex":0.0001828306,"about_ca_system_score_gemma":0.00028296272,"threshold_uncertainty_score":0.008813381},"labels":[],"label_agreement":null},{"id":"W2040775711","doi":"10.1023/a:1026389427983","title":"Psychosocial Support for Women with Advanced Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Psychosocial; Psychological intervention; Coping (psychology); Breast cancer; Distress; Anxiety; Social support; Clinical psychology; Medicine; Mood; Cognitive behavioral therapy; Randomized controlled trial; Psychology; Psychiatry; Psychotherapist; Cancer; Internal medicine","score_opus":0.03623766347127115,"score_gpt":0.3806411013339931,"score_spread":0.34440343786272193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040775711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530528,0.01396921,0.000075115924,0.020779282,0.0005539394,0.00012587615,0.0002560293,0.000012494107,0.011175229],"genre_scores_gemma":[0.9910821,0.006085056,0.00016587022,0.001146717,0.00031380486,0.00006795352,0.00012829294,0.00000143725,0.001008727],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998124,0.00008426259,0.0000126496325,0.000010037727,0.000026746195,0.000054013857],"domain_scores_gemma":[0.9991732,0.00017471396,0.00014568414,0.000010203934,0.000042483443,0.00045367258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035389952,0.00013406965,0.00019624869,0.00028361633,0.0009500758,0.00029822133,0.00022807092,0.00054461515,0.00458073],"category_scores_gemma":[0.004005765,0.00007167042,0.0002770667,0.0002711523,0.00014696171,0.0002916424,0.00058480015,0.0004826933,0.0001692998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037907984,0.0030760965,0.4123269,0.0016891753,0.00034037855,0.001790211,0.005166427,0.00026059477,0.0016356902,0.00052035396,0.026919762,0.54248357],"study_design_scores_gemma":[0.0011188653,0.0049345633,0.95363396,0.00076013023,0.00038862103,0.0019385595,0.013119652,0.00028846943,0.00029655575,0.0009515058,0.022538481,0.000030526393],"about_ca_topic_score_codex":0.0022591797,"about_ca_topic_score_gemma":0.0076089543,"teacher_disagreement_score":0.00458073,"about_ca_system_score_codex":0.00030867985,"about_ca_system_score_gemma":0.0009435037,"threshold_uncertainty_score":0.015324116},"labels":[],"label_agreement":null},{"id":"W2040952105","doi":"10.1007/s10549-006-9390-x","title":"Estrogen receptor-β regulates psoriasin (S100A7) in human breast cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Estrogen receptor; In vivo; Biology; Internal medicine; Estrogen; Cancer research; Agonist; Endocrinology; Estrogen receptor alpha; Breast cancer; Receptor; Cancer; Medicine","score_opus":0.022942941050483088,"score_gpt":0.335898476955694,"score_spread":0.3129555359052109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040952105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884316,0.0068780747,0.0009656721,0.00029972353,0.00004611764,0.000016177299,0.0002939359,0.000092918664,0.002975877],"genre_scores_gemma":[0.9918013,0.0024731893,0.00031105286,0.00006959291,0.000010542691,0.00001120124,0.00034648177,0.000011346741,0.004965354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999013,0.00002240172,0.0000067251385,0.000012988412,0.000029529829,0.000027107428],"domain_scores_gemma":[0.9999399,0.000011065668,0.000013137461,0.000007051787,0.000013488235,0.000015337775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012271541,0.00014019175,0.00016929595,0.0004013691,0.0001555064,0.00033412213,0.000118952776,0.00023820806,0.0018959434],"category_scores_gemma":[0.0001637363,0.00016542217,0.00017279288,0.00024080744,0.00014775165,0.00014957074,0.00014773349,0.00030042554,0.00052622095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047096936,0.000060086426,0.0031801285,0.000033722117,0.000013471561,0.0002609418,0.000031956275,0.00007693178,0.9902007,0.0002985445,0.0002773666,0.0050951866],"study_design_scores_gemma":[0.00009466956,0.00040353552,0.16421646,0.000013348069,0.000058205194,0.0025937762,0.00026921896,0.001342463,0.81817406,0.0007069548,0.012116171,0.000011134175],"about_ca_topic_score_codex":0.0013371559,"about_ca_topic_score_gemma":0.0012676712,"teacher_disagreement_score":0.0018959434,"about_ca_system_score_codex":0.0003901482,"about_ca_system_score_gemma":0.00019299702,"threshold_uncertainty_score":0.0063425303},"labels":[],"label_agreement":null},{"id":"W2041398470","doi":"10.1023/a:1023951616696","title":"Hormone Replacement Therapy after Treatment for Breast Cancer: Physicians' Attitudes towards Randomized Trials","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"College of Family Physicians of Canada","keywords":"Medicine; Randomized controlled trial; Hormone replacement therapy (female-to-male); Breast cancer; Hormone therapy; Internal medicine; Gynecology; Clinical trial; Cancer","score_opus":0.16751463954046367,"score_gpt":0.4715420834103193,"score_spread":0.3040274438698556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041398470","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07842204,0.5304543,0.018436465,0.288224,0.033900715,0.020005226,0.001476466,0.00033089565,0.028749976],"genre_scores_gemma":[0.6722314,0.091223024,0.04929063,0.15023069,0.01856161,0.014147307,0.000663136,0.0001623877,0.0034898054],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.55560356,0.38381913,0.039993647,0.0062247817,0.012281608,0.0020772466],"domain_scores_gemma":[0.20843178,0.7290398,0.03634391,0.009250266,0.012771322,0.0041629532],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.37751022,0.001303947,0.004520979,0.0020368707,0.0022138972,0.006766225,0.0025025036,0.01406772,0.006371363],"category_scores_gemma":[0.6066217,0.0018484866,0.0050051785,0.0025675616,0.0068290634,0.006496688,0.0027840063,0.010242606,0.00072067144],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43208063,0.0018231694,0.013861221,0.05928685,0.039508812,0.0003910384,0.00591684,0.0012731665,0.0019562382,0.025231998,0.0420739,0.37659612],"study_design_scores_gemma":[0.61737597,0.024791973,0.016330525,0.07032177,0.052620664,0.0006522421,0.0025066219,0.004742464,0.0025837298,0.043851376,0.16384107,0.00038168032],"about_ca_topic_score_codex":0.002106869,"about_ca_topic_score_gemma":0.004049506,"teacher_disagreement_score":0.6224898,"about_ca_system_score_codex":0.0039245975,"about_ca_system_score_gemma":0.0064780572,"threshold_uncertainty_score":0.7676407},"labels":[],"label_agreement":null},{"id":"W2041693178","doi":"10.1007/s10549-009-0418-x","title":"Treatment-related symptoms among underserved women with breast cancer: the impact of physician–patient communication","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; American Cancer Society","keywords":"Medicine; Nausea; Depression (economics); Breast cancer; Ethnic group; Psychological intervention; Logistic regression; Family medicine; Psychiatry; Internal medicine; Cancer","score_opus":0.02747994388320609,"score_gpt":0.3393087514497406,"score_spread":0.3118288075665345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041693178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972174,0.00044036817,0.000013649275,0.00080078654,0.00001488478,0.000005871684,0.00003943602,0.0000012467046,0.0014663856],"genre_scores_gemma":[0.99954754,0.00016256841,0.000018256307,0.00014539903,0.00001709285,0.0000030360166,0.000023391316,0.0000010057022,0.0000816378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983981,0.0008539315,0.00010380785,0.00007694198,0.00026944975,0.00029776228],"domain_scores_gemma":[0.99124205,0.004469716,0.0024102458,0.00014404558,0.0005710065,0.0011630299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010631902,0.00015249735,0.0003399142,0.00056680845,0.0009885837,0.0011305037,0.0003358118,0.0006471345,0.0027221825],"category_scores_gemma":[0.014415352,0.00018551349,0.00034693445,0.00063484744,0.00044138188,0.0009209974,0.00090989436,0.0009823088,0.00009154305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028314497,0.0004192662,0.9805809,0.000054434484,0.00009601859,0.00033446745,0.0034723203,0.0000656619,0.00012632603,0.0000906703,0.0006917751,0.01378504],"study_design_scores_gemma":[0.0000148727395,0.00014400636,0.9909939,0.00003933234,0.00007659654,0.00033436646,0.007647647,0.00022841456,0.000050224473,0.00009827324,0.0003631461,0.000009307816],"about_ca_topic_score_codex":0.013544101,"about_ca_topic_score_gemma":0.019932644,"teacher_disagreement_score":0.013544101,"about_ca_system_score_codex":0.0009536312,"about_ca_system_score_gemma":0.001386254,"threshold_uncertainty_score":0.02693057},"labels":[],"label_agreement":null},{"id":"W2041865709","doi":"10.1007/s10549-012-2278-z","title":"Aromatase inhibitors in obese breast cancer patients are not associated with increased plasma estradiol levels","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement","funders":"","keywords":"Breast cancer; Medicine; Aromatase; Internal medicine; Body mass index; Endocrinology; Lean body mass; Obesity; Estrogen; Postmenopausal women; Cancer; Menopause; Body weight","score_opus":0.06283885054474149,"score_gpt":0.3479244630373585,"score_spread":0.28508561249261705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041865709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977428,0.0008616567,0.000056300465,0.00008823541,0.000026773274,0.0000046888176,0.00016466473,0.0000053122044,0.0010496685],"genre_scores_gemma":[0.9991399,0.0002471254,0.000041956035,0.000050037586,0.000025682211,0.0000028655425,0.0001819349,0.0000024524545,0.0003078932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981517,0.000047128928,0.000021872554,0.000027572452,0.0000424989,0.000045700624],"domain_scores_gemma":[0.9988416,0.0003926924,0.00048172675,0.0000669033,0.000038046626,0.00017899471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023254752,0.00028268446,0.00047810242,0.00041949394,0.00021699566,0.00057845004,0.00018677738,0.00046769818,0.0027447531],"category_scores_gemma":[0.002162686,0.00029977577,0.0005756077,0.0005871508,0.00019033799,0.00036522234,0.00018708431,0.00080977246,0.00023695991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00606437,0.0001646881,0.9824436,0.00003728799,0.00035653939,0.00064525823,0.000049026203,0.000060574097,0.0033227468,0.00005020467,0.00015991129,0.006645878],"study_design_scores_gemma":[0.00007142848,0.0003244827,0.9979462,0.0000068714735,0.0001543307,0.0008689907,0.00007045111,0.000095919735,0.00016933319,0.000057562134,0.00022959929,0.000004924726],"about_ca_topic_score_codex":0.0015695647,"about_ca_topic_score_gemma":0.0019426331,"teacher_disagreement_score":0.0027447531,"about_ca_system_score_codex":0.00014666296,"about_ca_system_score_gemma":0.00022277738,"threshold_uncertainty_score":0.009182155},"labels":[],"label_agreement":null},{"id":"W2041940241","doi":"10.1007/s10549-011-1786-6","title":"Is knowledge translation adequate? A quality assurance study of staging investigations in early stage breast cancer patients","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Breast cancer; Radiological weapon; Cancer; Cohort; Disease; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.712849734848584,"score_gpt":0.6218271399634635,"score_spread":0.09102259488512054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041940241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004542612,0.99320364,0.00029227696,0.0011606122,0.00007368217,0.0001157526,0.000087209984,0.000003740176,0.00052042346],"genre_scores_gemma":[0.0766383,0.9188692,0.0025772776,0.0013107188,0.00008262974,0.0001865734,0.0002387605,0.0000062490412,0.00009025516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9717149,0.013589132,0.007226534,0.001121661,0.0059047043,0.00044311074],"domain_scores_gemma":[0.83078986,0.12692465,0.023373418,0.0029945176,0.015124001,0.0007935548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04345332,0.00045598304,0.0029879555,0.0036423528,0.0005313005,0.00280958,0.0019764493,0.0012678698,0.0012661779],"category_scores_gemma":[0.15902123,0.00061487645,0.002301149,0.0063440655,0.0013019788,0.0027679815,0.0017038283,0.0013907679,0.000115532224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005356562,0.000104564344,0.016327683,0.20612523,0.0032567799,0.00014266759,0.002322654,0.00020444785,0.00020193476,0.001148125,0.0027144337,0.7669158],"study_design_scores_gemma":[0.0010509001,0.0012212532,0.11800192,0.7211978,0.036221065,0.001863537,0.004615132,0.0006957608,0.0014480316,0.0029525368,0.110539675,0.00019240889],"about_ca_topic_score_codex":0.013217814,"about_ca_topic_score_gemma":0.021578152,"teacher_disagreement_score":0.04345332,"about_ca_system_score_codex":0.0044381283,"about_ca_system_score_gemma":0.018826004,"threshold_uncertainty_score":0.22980589},"labels":[],"label_agreement":null},{"id":"W2042133498","doi":"10.1007/s10549-009-0447-5","title":"Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; U.S. Public Health Service; American Cancer Society","keywords":"Medicine; Kappa; Breast cancer; Cohen's kappa; Radiation therapy; Medical record; Internal medicine; Cancer; Chemotherapy; Oncology","score_opus":0.17785279513291283,"score_gpt":0.45649015420389366,"score_spread":0.27863735907098086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042133498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985367,0.00013500924,0.000054394586,0.0002202399,0.000018068411,0.000015793506,0.00017128844,0.0000013744759,0.00084703974],"genre_scores_gemma":[0.9993925,0.00006869352,0.0000799026,0.00011698084,0.000017535456,0.00002023366,0.00020046346,0.0000014198743,0.000102306585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995574,0.002285548,0.00056495477,0.00025590052,0.0010131578,0.0003064294],"domain_scores_gemma":[0.9666136,0.01731709,0.009156981,0.0013594985,0.0040670168,0.0014858774],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0054833423,0.00019315846,0.00045101088,0.0011613508,0.00085418817,0.0008700209,0.0006469508,0.00057732884,0.0009851444],"category_scores_gemma":[0.04165671,0.00024524506,0.00043231674,0.0009601544,0.0008072262,0.0005808215,0.0011678543,0.0007270284,0.000137665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006658024,0.000072445444,0.9974503,0.000014081621,0.00005690431,0.000013499212,0.00053009146,0.000025098656,0.00005200007,0.000030666997,0.00012325853,0.0015649642],"study_design_scores_gemma":[0.000008926076,0.00007216354,0.99780494,0.000016541722,0.00002631598,0.000064507585,0.0014421372,0.00024796583,0.00007220485,0.000044606462,0.00019566946,0.0000040754617],"about_ca_topic_score_codex":0.01880334,"about_ca_topic_score_gemma":0.023401875,"teacher_disagreement_score":0.9945167,"about_ca_system_score_codex":0.000999998,"about_ca_system_score_gemma":0.0010712673,"threshold_uncertainty_score":0.03738779},"labels":[],"label_agreement":null},{"id":"W2042193506","doi":"10.1023/a:1016089215070","title":"Delay in adjuvant radiation treatment and outcomes of breast cancer – a review","year":2002,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Hôpital du Saint-Sacrement; McGill University Health Centre; Institut National de Santé Publique du Québec","funders":"National Cancer Institute","keywords":"Medicine; Radiation therapy; Breast cancer; Randomized controlled trial; Chemotherapy; Oncology; Observational study; Systemic therapy; Retrospective cohort study; Cancer; Internal medicine; Dose fractionation; Surgery","score_opus":0.07252365505762283,"score_gpt":0.41555783561019716,"score_spread":0.34303418055257434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042193506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000098991586,0.999603,0.00003278401,0.000091479196,0.00005957436,0.0000018900688,0.000011376474,0.0000011909298,0.00009969999],"genre_scores_gemma":[0.00061699224,0.99909544,0.00007649408,0.00006866603,0.00007436742,0.0000031627362,0.000015767451,4.5904036e-7,0.000048698697],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99968493,0.00006894776,0.00007899112,0.000068395675,0.000082618564,0.00001618975],"domain_scores_gemma":[0.9986406,0.00097086036,0.00019243405,0.00002134147,0.00014355456,0.00003127425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011245995,0.00073501124,0.002513341,0.001749119,0.00019102287,0.00077294506,0.0011478208,0.0009795527,0.0019463855],"category_scores_gemma":[0.0025052368,0.00031480903,0.0006307184,0.0029344298,0.00038951458,0.00093717047,0.0004033254,0.0008369604,0.00045687848],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028399628,0.00006336728,0.0010687021,0.043404732,0.00035554456,0.0002462414,0.000054113985,0.00044289188,0.00045265077,0.0010753701,0.0131139085,0.9394384],"study_design_scores_gemma":[0.00021756522,0.00062319246,0.011669175,0.042072836,0.0036790452,0.0051661762,0.0003282771,0.00026227886,0.0008862327,0.0027300937,0.93228406,0.00008098231],"about_ca_topic_score_codex":0.0027480402,"about_ca_topic_score_gemma":0.0046436507,"teacher_disagreement_score":0.0027480402,"about_ca_system_score_codex":0.00068581116,"about_ca_system_score_gemma":0.0016939136,"threshold_uncertainty_score":0.0065113306},"labels":[],"label_agreement":null},{"id":"W2044015759","doi":"10.1007/s10549-014-2963-1","title":"Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Hot flash; Tamoxifen; Medicine; CYP2D6; Internal medicine; Oncology; Breast cancer; Prospective cohort study; Odds ratio; Genotype; Cohort study; Cancer; Biology; Genetics","score_opus":0.013932030625085075,"score_gpt":0.2812390889153647,"score_spread":0.2673070582902796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044015759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967871,0.0011830576,0.0004021444,0.0000848148,0.000020279478,0.000011294283,0.00043067744,0.000033594926,0.001046943],"genre_scores_gemma":[0.9985839,0.0002123782,0.0001469082,0.00003641549,0.000022513057,0.000006555917,0.00029265624,0.0000056339945,0.00069304375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998394,0.000046307,0.000014763248,0.000032907457,0.000041028154,0.000025555357],"domain_scores_gemma":[0.99848855,0.0003152888,0.0008747239,0.000079758116,0.00010609773,0.00013561569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017740228,0.00023788738,0.0003197601,0.00041459562,0.00013683148,0.00027518097,0.00014643981,0.0002699433,0.002871183],"category_scores_gemma":[0.0011649206,0.00014321752,0.0004077107,0.00042218156,0.00012818359,0.00011442379,0.00015453628,0.0003070942,0.00029593284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018704121,0.000103217695,0.96614975,0.000058658694,0.000482352,0.00030096574,0.000038240665,0.00007082894,0.021485003,0.000022739403,0.00031360224,0.009104102],"study_design_scores_gemma":[0.0000035412768,0.0000734487,0.999131,0.0000013351919,0.00004024583,0.0002045137,0.000007579281,0.0000531651,0.00039221003,0.00000669358,0.00008447518,0.0000016724554],"about_ca_topic_score_codex":0.0009801012,"about_ca_topic_score_gemma":0.0015738672,"teacher_disagreement_score":0.002871183,"about_ca_system_score_codex":0.00011959789,"about_ca_system_score_gemma":0.00008764831,"threshold_uncertainty_score":0.00960505},"labels":[],"label_agreement":null},{"id":"W2044057692","doi":"10.1007/s10549-010-0981-1","title":"Prognostic factors for skeletal complications from metastatic bone disease in breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Cancer Research UK","keywords":"Medicine; Zoledronic acid; Internal medicine; Breast cancer; Oncology; Multivariate analysis; Pathologic fracture; Proportional hazards model; Spinal cord compression; Bone metastasis; Radiation therapy; Univariate analysis; Palliative care; Cancer; Surgery","score_opus":0.08067297305541712,"score_gpt":0.4229164110805938,"score_spread":0.34224343802517665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044057692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949297,0.0028076621,0.00020967801,0.00018850327,0.000024292667,0.000009432293,0.0005039735,0.000008962506,0.0013177664],"genre_scores_gemma":[0.9989942,0.0003311615,0.00009159462,0.000027633305,0.00004660637,0.0000045608413,0.00033287288,0.0000030475833,0.00016834254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956983,0.000119674136,0.00006051305,0.000046724086,0.000117024574,0.00008616828],"domain_scores_gemma":[0.9972567,0.0007710049,0.0011631395,0.000108613516,0.00022619391,0.00047437174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000580368,0.00028281144,0.0004907519,0.00077252276,0.00043321832,0.000604895,0.0006252206,0.0007565427,0.0022083363],"category_scores_gemma":[0.004725312,0.00025531053,0.0008626863,0.0014775046,0.0003328714,0.00035778046,0.00042960493,0.0009292345,0.00019368832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028297273,0.00002020444,0.997366,0.000009678834,0.000050453018,0.00011217642,0.000011861097,0.000066916815,0.00012250821,0.000014322394,0.00008839602,0.001854566],"study_design_scores_gemma":[0.000011611507,0.00009364424,0.99869055,0.0000054730995,0.00007083227,0.00070688874,0.00005610363,0.00015406084,0.00003976977,0.000044719007,0.00012257163,0.0000037688417],"about_ca_topic_score_codex":0.00513576,"about_ca_topic_score_gemma":0.00855702,"teacher_disagreement_score":0.00513576,"about_ca_system_score_codex":0.0003829114,"about_ca_system_score_gemma":0.00052544655,"threshold_uncertainty_score":0.010211766},"labels":[],"label_agreement":null},{"id":"W2044166564","doi":"10.1007/s10549-011-1692-y","title":"Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":328,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research","keywords":"Aldehyde dehydrogenase; Breast cancer; Cancer stem cell; Cancer; Chemotherapy; Cancer research; Medicine; Stem cell; Oncology; Internal medicine; Biology; Enzyme; Biochemistry; Genetics","score_opus":0.06497320140829642,"score_gpt":0.3488083949856305,"score_spread":0.28383519357733406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044166564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813974,0.00033615387,0.0005355601,0.00005664753,0.000021149253,0.0000110833225,0.0001553935,0.000047578695,0.000696634],"genre_scores_gemma":[0.99667895,0.00029482302,0.00050494575,0.000037550304,0.000008450861,0.000015389538,0.00045420337,0.000010978422,0.0019947733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998839,0.00001854831,0.000010558051,0.000014134675,0.000030159756,0.000042645876],"domain_scores_gemma":[0.99993646,0.00001623477,0.000010378794,0.000011713713,0.000006508419,0.00001868541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011429347,0.00016513409,0.00021972365,0.0002082495,0.0001393113,0.000260566,0.00013320328,0.00015122221,0.0023372765],"category_scores_gemma":[0.00007420746,0.0001367424,0.00019985829,0.00019680803,0.00013793292,0.00010832501,0.00012229243,0.0004699798,0.0003056495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024482457,0.00014741391,0.00063722086,0.000020335523,0.000012406353,0.000026432832,0.000019652865,0.00014164265,0.9956118,0.00013590304,0.00018012042,0.0028221116],"study_design_scores_gemma":[0.000027556864,0.0005008734,0.0055707027,0.0000013158095,0.000015969572,0.0001151867,0.000029210154,0.0009898737,0.9907176,0.00003448799,0.0019949386,0.0000023226294],"about_ca_topic_score_codex":0.0006358202,"about_ca_topic_score_gemma":0.00085402414,"teacher_disagreement_score":0.0023372765,"about_ca_system_score_codex":0.00013303268,"about_ca_system_score_gemma":0.00016076687,"threshold_uncertainty_score":0.007818997},"labels":[],"label_agreement":null},{"id":"W2044891501","doi":"10.1007/s10549-008-0296-7","title":"A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"Breast cancer; Cancer; Biology; Oncology; Computational biology; Medicine; Cancer research; Genetics","score_opus":0.024530577804032686,"score_gpt":0.3270845703817999,"score_spread":0.3025539925777672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044891501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78388256,0.00530476,0.19219203,0.00039844876,0.00006450882,0.00018100852,0.010333743,0.0015753936,0.0060675526],"genre_scores_gemma":[0.83267343,0.0028583538,0.14318702,0.00022930147,0.00003876758,0.00034174748,0.013245796,0.00035718197,0.0070683938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972993,0.000033265027,0.000015088595,0.000063709434,0.000109434724,0.000048585865],"domain_scores_gemma":[0.99978906,0.00005670013,0.00002620696,0.000049113412,0.000054948676,0.000024036983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003218459,0.00024863204,0.00046854862,0.0008218705,0.0002703232,0.0007996911,0.0003278458,0.00031367416,0.00089803734],"category_scores_gemma":[0.00023335622,0.00026216783,0.00037073033,0.00086253666,0.00014528513,0.0003156276,0.00029827878,0.0006951361,0.000850276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003120805,0.000006543634,0.00028794367,0.0000130748485,0.000005502337,0.000008630549,0.000007774738,0.000042509906,0.99742043,0.000029212368,0.00003912948,0.0021081371],"study_design_scores_gemma":[0.0000098196315,0.0001059862,0.032205664,0.000004673642,0.000060820865,0.00041042164,0.000045291647,0.0029529342,0.959149,0.00010652438,0.004937117,0.000011670246],"about_ca_topic_score_codex":0.0011491391,"about_ca_topic_score_gemma":0.001977856,"teacher_disagreement_score":0.0011491391,"about_ca_system_score_codex":0.00021575596,"about_ca_system_score_gemma":0.00020344811,"threshold_uncertainty_score":0.0030041933},"labels":[],"label_agreement":null},{"id":"W2045150799","doi":"10.1007/s10549-014-3171-8","title":"Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Nursing Research","keywords":"Medicine; Treadmill; Repeated measures design; Lymphedema; Physical therapy; Cardiorespiratory fitness; Breast cancer; Internal medicine; Cancer; Mathematics","score_opus":0.035137598675195204,"score_gpt":0.34228229533642335,"score_spread":0.3071446966612281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045150799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992124,0.00016795192,0.000014455051,0.00003644467,0.000013346291,0.0000073347323,0.00009956527,0.0000010632308,0.00044757055],"genre_scores_gemma":[0.99927574,0.00011832528,0.000017513988,0.000031640207,0.000012680238,0.000009158449,0.0001828721,0.000001008021,0.00035118993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997439,0.000054421096,0.000020027277,0.000040019906,0.000040866085,0.000100778365],"domain_scores_gemma":[0.9992055,0.00022185259,0.00020078447,0.000023951352,0.00009219089,0.00025565608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002461486,0.0002654352,0.0004335023,0.0005949765,0.00044444136,0.00052635215,0.00026638643,0.0008228061,0.0011906463],"category_scores_gemma":[0.0022403756,0.00018975433,0.00045481877,0.00061687455,0.00021413853,0.00036990776,0.00032521592,0.0006492182,0.0002271603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002001932,0.0004571904,0.99169207,0.000024113331,0.000058384576,0.00029711443,0.0003043997,0.00006115226,0.0006490653,0.000013117895,0.00009347177,0.0043479856],"study_design_scores_gemma":[0.0000070625424,0.00051802356,0.9989029,0.000005303734,0.000026782176,0.00005934303,0.0003064596,0.000044919125,0.0000451411,0.0000074311156,0.00007331856,0.0000032165394],"about_ca_topic_score_codex":0.011595461,"about_ca_topic_score_gemma":0.02054477,"teacher_disagreement_score":0.011595461,"about_ca_system_score_codex":0.00044401773,"about_ca_system_score_gemma":0.000373143,"threshold_uncertainty_score":0.023055911},"labels":[],"label_agreement":null},{"id":"W2045403268","doi":"10.1007/s10549-010-1123-5","title":"The CYP17A1 −34T &gt; C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Cancer Research UK; Canadian Institutes of Health Research; Deutsches Krebsforschungszentrum","keywords":"Breast cancer; Oncology; Medicine; Internal medicine; BRCA2 Protein; Mutation; Cancer; Germline mutation; Biology; Genetics; Gene","score_opus":0.014901733678744578,"score_gpt":0.3240505956699931,"score_spread":0.3091488619912485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045403268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870133,0.0005112703,0.0000832551,0.00011610487,0.00002487536,0.0000052612363,0.00015938832,0.000005972347,0.00039247982],"genre_scores_gemma":[0.9987658,0.00019473072,0.00008684066,0.000038968807,0.0000326507,0.000007458792,0.0001485869,0.000007521767,0.00071745383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997396,0.00009819335,0.000023715793,0.000051187384,0.000040955416,0.000046312005],"domain_scores_gemma":[0.9986051,0.00057153584,0.00033648705,0.00007808996,0.00006298783,0.00034580723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003798878,0.0005781273,0.00069545745,0.0014364285,0.0005536539,0.00049898063,0.00033541347,0.0010256423,0.005109088],"category_scores_gemma":[0.0024896127,0.0005421098,0.00068683556,0.0012256019,0.0003952542,0.00035950524,0.00021997308,0.0009855462,0.00052931067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049185734,0.0002393279,0.98334056,0.000022753144,0.00028952604,0.0015981478,0.00026677272,0.00011221727,0.00487905,0.00013732216,0.0002387161,0.0039570024],"study_design_scores_gemma":[0.00015708966,0.0007507068,0.99193597,0.000012917205,0.00041292678,0.0040012007,0.00028115796,0.00063377875,0.00085447484,0.00030482467,0.0006335497,0.000021332524],"about_ca_topic_score_codex":0.0056275185,"about_ca_topic_score_gemma":0.0025332926,"teacher_disagreement_score":0.0056275185,"about_ca_system_score_codex":0.00029568464,"about_ca_system_score_gemma":0.00025804184,"threshold_uncertainty_score":0.017091632},"labels":[],"label_agreement":null},{"id":"W2045484627","doi":"10.1007/s10549-009-0479-x","title":"Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; McGill University","keywords":"Tamoxifen; Breast cancer; Oncology; Medicine; Internal medicine; Adverse effect; Mammary gland; Cyclin D1; Cancer","score_opus":0.02925380219239061,"score_gpt":0.3459557256285886,"score_spread":0.316701923436198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045484627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987348,0.0005149183,0.00015571437,0.00007539463,0.000007514793,0.0000033340525,0.00008143757,0.000010841508,0.0004161543],"genre_scores_gemma":[0.99938667,0.00012485505,0.00011543616,0.0000166316,0.000014794045,0.0000038452013,0.0000957653,0.0000039560778,0.00023799766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995602,0.00010515445,0.000051589184,0.00006713385,0.00013739403,0.00007858134],"domain_scores_gemma":[0.9960544,0.0009361776,0.0020914082,0.0002247363,0.00023081033,0.00046232005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048035354,0.0002984984,0.0004131674,0.001296694,0.00040008134,0.00048336966,0.0003794616,0.0005717768,0.0018220919],"category_scores_gemma":[0.002430685,0.0002627694,0.00033929257,0.0009563367,0.0004373909,0.0002689345,0.000410817,0.00055205834,0.00023759472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003501838,0.00011409083,0.90700597,0.000041438634,0.00020975832,0.0032256062,0.00008845817,0.00015073165,0.08016103,0.00008110707,0.00020053414,0.0052194404],"study_design_scores_gemma":[0.000016327105,0.00015659761,0.9895477,0.0000041526,0.000113480426,0.0048231343,0.000085379856,0.00034666806,0.0044961744,0.0000637691,0.00033826177,0.000008291932],"about_ca_topic_score_codex":0.00087479275,"about_ca_topic_score_gemma":0.0012224178,"teacher_disagreement_score":0.0018220919,"about_ca_system_score_codex":0.00030177415,"about_ca_system_score_gemma":0.00029169247,"threshold_uncertainty_score":0.006095469},"labels":[],"label_agreement":null},{"id":"W2046248898","doi":"10.1007/s10549-010-1162-y","title":"Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Breast cancer; Medicine; Oncology; Internal medicine; Population; CYP2D6; Cancer; Cohort; Cohort study; Gynecology","score_opus":0.01617350504155061,"score_gpt":0.3061668766328374,"score_spread":0.2899933715912868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046248898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97963583,0.01677675,0.00019997738,0.00035522,0.00006895069,0.000013280907,0.00041807012,0.000022087832,0.0025098182],"genre_scores_gemma":[0.9967649,0.001958089,0.00013850669,0.000072331415,0.000106262,0.00000626124,0.00020564292,0.0000047933945,0.0007431922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995024,0.00014473617,0.00006454859,0.0000859182,0.00013854657,0.000063786],"domain_scores_gemma":[0.99615735,0.0010942988,0.0017790229,0.00031464093,0.0002350115,0.00041972392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006908077,0.0002160965,0.00057203136,0.0007105099,0.00028260011,0.00068769616,0.00027742118,0.0007030637,0.0022411337],"category_scores_gemma":[0.0044116294,0.00032102742,0.00076466723,0.0012132735,0.00022503259,0.0004303987,0.0002839873,0.00082285784,0.00028874792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062621143,0.00013349451,0.9696082,0.00007510851,0.0008208934,0.00050137244,0.000050862556,0.00019411986,0.0026745654,0.00007585505,0.00026009078,0.019343413],"study_design_scores_gemma":[0.00009688934,0.00097108167,0.9931206,0.000020966962,0.0008752376,0.0020120684,0.0000599775,0.00055702607,0.00076586305,0.00008005397,0.0014274226,0.000012807011],"about_ca_topic_score_codex":0.0019182521,"about_ca_topic_score_gemma":0.0027839695,"teacher_disagreement_score":0.0022411337,"about_ca_system_score_codex":0.0003457061,"about_ca_system_score_gemma":0.0003830547,"threshold_uncertainty_score":0.0074973702},"labels":[],"label_agreement":null},{"id":"W2046425053","doi":"10.1007/s10549-010-0829-8","title":"Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency; University of British Columbia","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Mastectomy; Breast cancer; Radiation therapy; Internal medicine; Randomized controlled trial; Cancer; Oncology; Proportional hazards model; Survival analysis; Clinical trial; Surgery","score_opus":0.028204354898924925,"score_gpt":0.3374733766171007,"score_spread":0.3092690217181758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046425053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800783,0.000496835,0.000053095104,0.00011317529,0.000013989503,0.0000043435857,0.00008012902,0.0000045641486,0.0012260026],"genre_scores_gemma":[0.9991937,0.00014548152,0.000027692515,0.000057257832,0.00001741097,0.0000035530113,0.000068900736,0.000002124708,0.00048383963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998274,0.00005340534,0.000012017433,0.000034717727,0.000025193189,0.000047231195],"domain_scores_gemma":[0.99894065,0.00032377554,0.00041651266,0.00012215544,0.00004782499,0.00014895246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030573664,0.00017389166,0.0003097556,0.0004141043,0.00032316125,0.00033669526,0.00019241455,0.0004672256,0.0028701704],"category_scores_gemma":[0.0020219523,0.00015376166,0.0004256739,0.0005003011,0.00025670204,0.00030759728,0.0001576801,0.0004842987,0.00029761635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060815463,0.00006139023,0.99491227,0.000010121406,0.00007549521,0.0001807099,0.00011931478,0.000023484146,0.0010271785,0.000021014986,0.000060740775,0.002900143],"study_design_scores_gemma":[0.000008994724,0.00030405368,0.9985776,0.0000025280456,0.000077296725,0.0004628953,0.00014041498,0.000023174185,0.00013338188,0.000023803857,0.00024360833,0.000002304311],"about_ca_topic_score_codex":0.0030049612,"about_ca_topic_score_gemma":0.0036940654,"teacher_disagreement_score":0.0030049612,"about_ca_system_score_codex":0.00013563817,"about_ca_system_score_gemma":0.00019567675,"threshold_uncertainty_score":0.009601712},"labels":[],"label_agreement":null},{"id":"W2047044229","doi":"10.1007/s10549-005-6941-5","title":"Celecoxib Inhibits Urokinase-Type Plasminogen Activator (uPA) Production in MDA-MB-231 Breast Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"National Cancer Institute; Pfizer Canada; University of British Columbia; Pfizer","keywords":"Plasminogen activator; Urokinase; Celecoxib; Breast cancer; Cancer research; Metastatic breast cancer; Medicine; Internal medicine; Activator (genetics); Oncology; Endocrinology; Cancer; Receptor","score_opus":0.03470165394724399,"score_gpt":0.3392442076448864,"score_spread":0.3045425536976424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047044229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779559,0.012198576,0.0013552215,0.0010721809,0.0004365887,0.00005887501,0.00222848,0.00019502388,0.004499281],"genre_scores_gemma":[0.9686567,0.011554785,0.0014667603,0.00024629346,0.00013066559,0.00010153273,0.0050679124,0.0000235877,0.012751658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995951,0.000048005062,0.000039538645,0.00002172125,0.00012848525,0.00016712947],"domain_scores_gemma":[0.9998913,0.000031593765,0.00001377104,0.000016055035,0.000022150141,0.000025090301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021607486,0.00042503714,0.000718488,0.0005393611,0.00043833148,0.0006125108,0.00023799467,0.0002952638,0.0026039022],"category_scores_gemma":[0.00023256172,0.00029041685,0.0005042088,0.00066968607,0.00022100068,0.00027187038,0.00022942421,0.00094385666,0.00097177894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013335668,0.00034100583,0.00057461194,0.00021576839,0.000032450822,0.00028621437,0.000095521646,0.0001356465,0.98835933,0.00019642245,0.0013099445,0.007119505],"study_design_scores_gemma":[0.00013814206,0.00086078455,0.010001406,0.000016416927,0.00005753123,0.0005194523,0.00015438662,0.0012104391,0.97742873,0.00007065073,0.009529294,0.000012617245],"about_ca_topic_score_codex":0.0057255593,"about_ca_topic_score_gemma":0.0057968437,"teacher_disagreement_score":0.0057255593,"about_ca_system_score_codex":0.0005737019,"about_ca_system_score_gemma":0.00061419996,"threshold_uncertainty_score":0.011384487},"labels":[],"label_agreement":null},{"id":"W2047045989","doi":"10.1007/s10549-006-9299-4","title":"Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Nova Scotia; Dalhousie University","funders":"","keywords":"Exemestane; Anastrozole; Medicine; Tamoxifen; Breast cancer; Gynecology; Quality-adjusted life year; Oncology; Cost effectiveness; Internal medicine; Cancer; Risk analysis (engineering)","score_opus":0.01945983161690895,"score_gpt":0.32450126921322836,"score_spread":0.3050414375963194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047045989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841164,0.008710193,0.001027814,0.002357487,0.000097718614,0.00008563696,0.0008331001,0.000032297376,0.0027394914],"genre_scores_gemma":[0.997988,0.00086178095,0.00041886108,0.00012827707,0.00003148849,0.000015877438,0.00021456057,0.0000033820656,0.0003377218],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99945813,0.00032092433,0.00003445185,0.000031979955,0.00008330817,0.00007126631],"domain_scores_gemma":[0.9980708,0.0011836934,0.00025074172,0.00006161238,0.00015014053,0.00028314273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010499811,0.00055428623,0.0007258364,0.0005090184,0.000140728,0.00067258964,0.0004490697,0.00067492406,0.0040530753],"category_scores_gemma":[0.0052085426,0.0001981657,0.0011766881,0.000551946,0.00023717534,0.000618322,0.0003784349,0.0005527017,0.00018758641],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.216553,0.002356089,0.18929338,0.0007371613,0.0027212033,0.00075821416,0.00017640772,0.042875387,0.0048761647,0.0022672215,0.0043214085,0.5330643],"study_design_scores_gemma":[0.011252182,0.044766404,0.8056069,0.00043891757,0.014275229,0.0019680567,0.0009286605,0.104675956,0.0046502603,0.0041549024,0.0071456577,0.00013693799],"about_ca_topic_score_codex":0.007892556,"about_ca_topic_score_gemma":0.011304791,"teacher_disagreement_score":0.007892556,"about_ca_system_score_codex":0.0018862609,"about_ca_system_score_gemma":0.0015053047,"threshold_uncertainty_score":0.015693247},"labels":[],"label_agreement":null},{"id":"W2048250189","doi":"10.1007/s10549-011-1840-4","title":"Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; BC Cancer Agency; University of British Columbia; McMaster University; Queen's University; St. Michael's Hospital; Hamilton Health Sciences; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Gene duplication; Oncology; Internal medicine; Anthracycline; Medicine; Breast cancer; Biology; Chromosome; Genetics; Cancer; Gene","score_opus":0.4511763596314084,"score_gpt":0.5504747129697497,"score_spread":0.0992983533383413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048250189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95131314,0.040230174,0.0002814685,0.0022453964,0.00033023293,0.00015790925,0.0017911961,0.000037571277,0.0036128159],"genre_scores_gemma":[0.988064,0.007169996,0.0003500365,0.0010875078,0.0003728224,0.00012304277,0.0016361875,0.000012155843,0.0011842628],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989932,0.0007129918,0.000056082805,0.000103410915,0.00007162326,0.00006267298],"domain_scores_gemma":[0.9946684,0.0032495302,0.0011174208,0.00028017152,0.00017494753,0.00050951034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023525984,0.00060018105,0.0014855921,0.00021195144,0.00023926835,0.00064791983,0.00054760923,0.00091530196,0.0035798247],"category_scores_gemma":[0.006312247,0.00018983702,0.0013433485,0.00046321427,0.00043280862,0.00053795124,0.0002852714,0.0018117082,0.0003511186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7811393,0.00125256,0.08892507,0.0021886893,0.015427615,0.00022501883,0.00014278588,0.0019934631,0.0023509993,0.00051905925,0.0072603063,0.09857525],"study_design_scores_gemma":[0.3404046,0.07358587,0.5114152,0.0016959541,0.04492896,0.0009373235,0.00022925378,0.0039143297,0.0021017175,0.0020371787,0.018639613,0.00010992454],"about_ca_topic_score_codex":0.0017287353,"about_ca_topic_score_gemma":0.0038649184,"teacher_disagreement_score":0.0035798247,"about_ca_system_score_codex":0.00045200833,"about_ca_system_score_gemma":0.0006179205,"threshold_uncertainty_score":0.012441874},"labels":[],"label_agreement":null},{"id":"W2048287458","doi":"10.1023/a:1024435101619","title":"Pain and Quality of Life after Surgery for Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Quality of life (healthcare); Modified Radical Mastectomy; Mastectomy; McGill Pain Questionnaire; Disease; Surgery; Incidence (geometry); Distress; Cancer; Internal medicine","score_opus":0.09943990230683844,"score_gpt":0.39526729723299675,"score_spread":0.2958273949261583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048287458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921686,0.0049038297,0.00003877673,0.000745236,0.000061661915,0.000016582884,0.00036266702,0.0000027808753,0.0016998843],"genre_scores_gemma":[0.9978709,0.0011497559,0.000071563,0.00020934337,0.000054144846,0.0000131848565,0.00026283925,0.000001341356,0.000367021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990262,0.00041104655,0.000109129214,0.00005566412,0.00020065485,0.00019732404],"domain_scores_gemma":[0.99419457,0.0015002806,0.0022562006,0.00011416107,0.00043916915,0.0014955536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013102251,0.00023406351,0.0005325421,0.00067909044,0.00054810557,0.0009368187,0.00040305173,0.0008953643,0.0025172853],"category_scores_gemma":[0.007750155,0.00019023096,0.0010375852,0.00086630945,0.0004564621,0.00063347066,0.0007164611,0.0014020195,0.00021968385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013547777,0.0006325647,0.9855392,0.00010597518,0.0005427753,0.00017040901,0.0003414296,0.00016423184,0.00023746495,0.00007480915,0.0004086697,0.010427728],"study_design_scores_gemma":[0.000021053324,0.0003467391,0.99883217,0.000019429148,0.00006543713,0.00010062791,0.00022986009,0.00008761759,0.000022833103,0.00004985002,0.00021643724,0.000008051426],"about_ca_topic_score_codex":0.0059237895,"about_ca_topic_score_gemma":0.0151419025,"teacher_disagreement_score":0.0059237895,"about_ca_system_score_codex":0.0008403498,"about_ca_system_score_gemma":0.0007225902,"threshold_uncertainty_score":0.011778593},"labels":[],"label_agreement":null},{"id":"W2048556868","doi":"10.1007/s10549-004-4023-8","title":"The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"lékařská fakulta Univerzity Karlovy; Terry Fox Foundation","keywords":"CHEK2; Breast cancer; Germline mutation; Germline; Czech; Mutation; Oncology; Medicine; Internal medicine; Cancer; Biology; Cancer research; Genetics; Gene","score_opus":0.034267851845965085,"score_gpt":0.3631714933122224,"score_spread":0.32890364146625733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048556868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943487,0.0008640306,0.0002705101,0.00009461863,0.000010923828,0.000013316002,0.00037749618,0.000019493003,0.004000958],"genre_scores_gemma":[0.9990921,0.00025428855,0.000056302346,0.000025040381,0.000002481453,0.0000037591226,0.00013055118,0.0000067406327,0.0004287489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995522,0.00008606074,0.00006456843,0.00008989798,0.000091762195,0.00011548512],"domain_scores_gemma":[0.99945146,0.00012119708,0.00017155084,0.00006925519,0.00007700449,0.00010954309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045543877,0.0001668046,0.00032561086,0.0015550872,0.000468308,0.0005620286,0.00026518933,0.00025882316,0.0023508742],"category_scores_gemma":[0.001292271,0.0002121344,0.00037117343,0.00068332226,0.00036259042,0.00013974942,0.00050565053,0.00024455835,0.00024086348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033586419,0.00024894017,0.80522865,0.0003849971,0.00040160606,0.023063498,0.0008878568,0.0012399062,0.09213547,0.002601488,0.0026093633,0.06783972],"study_design_scores_gemma":[0.00017438488,0.0004372518,0.9479508,0.00010053937,0.00023768196,0.031385556,0.00086314685,0.00059836206,0.009132916,0.0003734045,0.008706636,0.000039427432],"about_ca_topic_score_codex":0.014247771,"about_ca_topic_score_gemma":0.0138534885,"teacher_disagreement_score":0.014247771,"about_ca_system_score_codex":0.00070327905,"about_ca_system_score_gemma":0.0011771903,"threshold_uncertainty_score":0.02832967},"labels":[],"label_agreement":null},{"id":"W2048687800","doi":"10.1007/s10549-015-3309-3","title":"Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Febrile neutropenia; Filgrastim; Epirubicin; Pegfilgrastim; Breast cancer; Internal medicine; Cost effectiveness; Granulocyte colony-stimulating factor; Quality-adjusted life year; Neutropenia; Oncology; Surgery; Chemotherapy; Cancer","score_opus":0.14494848483956724,"score_gpt":0.4282421451940865,"score_spread":0.28329366035451925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048687800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079424,0.0067935223,0.00018600098,0.0007746243,0.00008613949,0.000107171974,0.0001909749,0.00001045164,0.0010568253],"genre_scores_gemma":[0.9989863,0.00055406976,0.00013661658,0.000108355904,0.000027821967,0.000019575422,0.00009884715,7.644291e-7,0.000067591434],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99928313,0.00037621087,0.00006733784,0.00005081676,0.00008320912,0.0001393315],"domain_scores_gemma":[0.998718,0.00053303846,0.0003389779,0.000036881833,0.0000600039,0.00031311132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073428696,0.00029592155,0.00090657175,0.00035428046,0.00018644074,0.00067860907,0.00040319565,0.00066426524,0.001893523],"category_scores_gemma":[0.004536769,0.0001985873,0.002201356,0.0004020628,0.00026316303,0.0004965674,0.00037865073,0.0009692642,0.0000742471],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37262517,0.006567033,0.22479662,0.001628582,0.0061257672,0.00087172666,0.00014813828,0.023071414,0.0026795408,0.001724876,0.0026294547,0.3571317],"study_design_scores_gemma":[0.052874893,0.15915477,0.7184974,0.000942787,0.014038164,0.0020262445,0.000783607,0.042894308,0.002214263,0.0018407787,0.0045844098,0.00014839882],"about_ca_topic_score_codex":0.0046253037,"about_ca_topic_score_gemma":0.005195139,"teacher_disagreement_score":0.0046253037,"about_ca_system_score_codex":0.0024959394,"about_ca_system_score_gemma":0.0015700199,"threshold_uncertainty_score":0.01810944},"labels":[],"label_agreement":null},{"id":"W2049142360","doi":"10.1007/s10549-010-1318-9","title":"Age of diagnosis, tumor size, and survival after breast cancer: implications for mammographic screening","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Mammography; Cohort; Cancer; Oncology; Survival rate; Internal medicine; Breast cancer screening; Cohort study; Gynecology","score_opus":0.16070610030501684,"score_gpt":0.40739271373478164,"score_spread":0.2466866134297648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049142360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837992,0.0067463703,0.0003746234,0.0047087083,0.00014175111,0.000010210314,0.00085846003,0.000016914102,0.0033437428],"genre_scores_gemma":[0.9978677,0.0010042994,0.0001808965,0.00020204071,0.00017822722,0.0000052502915,0.00023881048,0.000006003746,0.0003167849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991892,0.00043671386,0.0000688643,0.00009749395,0.00009896986,0.00010870553],"domain_scores_gemma":[0.9888166,0.0060786954,0.002919707,0.00044465624,0.00043468317,0.0013055843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017454156,0.00031655037,0.00046215096,0.00079250627,0.00036216996,0.0007354277,0.0005625043,0.0010777059,0.0033599173],"category_scores_gemma":[0.018727712,0.00023584376,0.000936289,0.0012549673,0.00044686004,0.000952601,0.00045335467,0.0010758486,0.0002801258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020620864,0.00004542179,0.996258,0.000009249451,0.00006281222,0.00006293694,0.00003765304,0.00008867747,0.00005229248,0.00007278747,0.00022213972,0.0028818727],"study_design_scores_gemma":[0.000009472668,0.0000859444,0.99870265,0.00001118684,0.000097740485,0.00016601293,0.00014339256,0.0003491936,0.000028339506,0.00020242817,0.00019968934,0.0000039971383],"about_ca_topic_score_codex":0.007071589,"about_ca_topic_score_gemma":0.0102566825,"teacher_disagreement_score":0.007071589,"about_ca_system_score_codex":0.00041140686,"about_ca_system_score_gemma":0.00076687464,"threshold_uncertainty_score":0.014060855},"labels":[],"label_agreement":null},{"id":"W2049167941","doi":"10.1007/s10549-014-3050-3","title":"ERβ splice variant expression in four large cohorts of human breast cancer patient tumors","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Institutes of Health","keywords":"Breast cancer; Estrogen receptor; Cancer research; Biomarker; Gene knockdown; Context (archaeology); Oncology; Cancer; RNA splicing; Medicine; Alternative splicing; splice; Triple-negative breast cancer; Immunohistochemistry; Biology; Internal medicine; Gene isoform; Genetics; Gene; RNA","score_opus":0.014128819075056729,"score_gpt":0.3131417675354952,"score_spread":0.29901294846043847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049167941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991714,0.00012824219,0.00009790711,0.000016445536,0.000002444266,0.0000031171185,0.00042349575,0.0000039592337,0.0001530778],"genre_scores_gemma":[0.99777776,0.00012018221,0.00008290299,0.000026479323,0.0000059036215,0.000008710704,0.0016441129,0.000010606987,0.00032329102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996846,0.000073736985,0.000026899725,0.00011110152,0.000050262923,0.000053338976],"domain_scores_gemma":[0.99942577,0.0001609711,0.0001292677,0.00010916121,0.00009686838,0.000078007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041096,0.00020442053,0.00033699232,0.00075549557,0.0005073722,0.0007854825,0.0002593874,0.00026577304,0.0011390559],"category_scores_gemma":[0.0012198264,0.00020777094,0.00027133123,0.00083117606,0.00030727166,0.00022668127,0.0004994175,0.000266859,0.00024127994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001427528,0.000039284078,0.9804323,0.000014118134,0.00017182915,0.00036373732,0.00030519068,0.000116868825,0.01240003,0.00008118152,0.00035306378,0.004294928],"study_design_scores_gemma":[0.000035301542,0.00012161733,0.9945952,0.000003487648,0.00011022916,0.0017639381,0.0003668654,0.00019635803,0.0016866742,0.00009255292,0.0010199158,0.000007870569],"about_ca_topic_score_codex":0.0025407872,"about_ca_topic_score_gemma":0.0023668467,"teacher_disagreement_score":0.0025407872,"about_ca_system_score_codex":0.00028424006,"about_ca_system_score_gemma":0.00017460043,"threshold_uncertainty_score":0.0050519705},"labels":[],"label_agreement":null},{"id":"W2049627106","doi":"10.1007/s10549-011-1506-2","title":"The use of atypical antipsychotics and the risk of breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Olanzapine; Risperidone; Internal medicine; Retrospective cohort study; Relative risk; Atypical antipsychotic; Antipsychotic; Cohort; Population; Cohort study; Oncology; Cancer; Pediatrics; Obstetrics; Gynecology; Psychiatry; Confidence interval; Schizophrenia (object-oriented programming)","score_opus":0.1340612527554656,"score_gpt":0.377450515793547,"score_spread":0.2433892630380814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049627106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752058,0.019095272,0.00015764037,0.0008628101,0.00008009049,0.000007936032,0.000976767,0.000014117774,0.0035995862],"genre_scores_gemma":[0.9947672,0.0041414807,0.000111538204,0.000077618446,0.0000899076,0.0000028605618,0.00023545718,0.0000036261831,0.0005704151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993562,0.00026120114,0.00007476726,0.00005596702,0.00015667459,0.0000951923],"domain_scores_gemma":[0.993457,0.0016667604,0.0033816,0.0003748332,0.00042305063,0.0006967105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076709426,0.00021929022,0.00035271322,0.0009222531,0.00031262537,0.00094725844,0.0002794943,0.0007483506,0.0024388698],"category_scores_gemma":[0.0055200015,0.0003882961,0.0010612413,0.0012540084,0.00024290099,0.00041113963,0.00032059953,0.0010721352,0.00018277553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017631798,0.000063316795,0.99052036,0.000057902238,0.0006035382,0.00027616028,0.00004632484,0.00015257971,0.00056755537,0.00012399405,0.00021906974,0.0056061293],"study_design_scores_gemma":[0.000032365166,0.00017735538,0.9973598,0.00003214348,0.00029080024,0.0006479436,0.0001158923,0.0004154217,0.0001482377,0.00020769062,0.0005589393,0.000013370753],"about_ca_topic_score_codex":0.009612112,"about_ca_topic_score_gemma":0.008658349,"teacher_disagreement_score":0.009612112,"about_ca_system_score_codex":0.0005032552,"about_ca_system_score_gemma":0.00057690724,"threshold_uncertainty_score":0.019112349},"labels":[],"label_agreement":null},{"id":"W2049786577","doi":"10.1023/a:1021112121782","title":"Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; Centers for Disease Control and Prevention","keywords":"Breast cancer; Genotype; Internal medicine; Endocrinology; Risk factors for breast cancer; Menopause; Allele; Medicine; Hormone; Breast density; Biology; Oncology; Gene; Mammography; Genetics; Cancer","score_opus":0.03640984360185148,"score_gpt":0.3104847936234778,"score_spread":0.2740749500216263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049786577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960375,0.0010426611,0.0005466484,0.00049688295,0.000052878964,0.000015167873,0.00047240712,0.000017708722,0.001318166],"genre_scores_gemma":[0.99759835,0.0003598551,0.00043881199,0.00009718178,0.000057582583,0.00001714039,0.00022906419,0.000012889058,0.0011890954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999097,0.00046338481,0.0000896057,0.00015647973,0.00011646543,0.000077094955],"domain_scores_gemma":[0.9954646,0.002907781,0.00083171984,0.00022832262,0.00016337258,0.00040408617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074520934,0.0009118245,0.00062894047,0.001499869,0.00058087846,0.00075280666,0.00047855973,0.0015199481,0.0065063806],"category_scores_gemma":[0.0043613818,0.00060138956,0.00081705995,0.0015068315,0.0005621612,0.00040642876,0.00029148092,0.0011569748,0.00045152495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045131603,0.00060304557,0.971208,0.00007843111,0.0009579245,0.0025003182,0.0004550516,0.00037505705,0.012105104,0.0006127717,0.0003841901,0.0062070102],"study_design_scores_gemma":[0.00025792624,0.000506439,0.9876087,0.00004424843,0.0007751898,0.005199953,0.00028564266,0.0012224558,0.0020976516,0.0008651237,0.0011132902,0.000023512563],"about_ca_topic_score_codex":0.004143864,"about_ca_topic_score_gemma":0.0026330096,"teacher_disagreement_score":0.0065063806,"about_ca_system_score_codex":0.00033021223,"about_ca_system_score_gemma":0.00036238946,"threshold_uncertainty_score":0.021766007},"labels":[],"label_agreement":null},{"id":"W2050416584","doi":"10.1007/s10549-007-9532-9","title":"Quantitative detection of circulating epithelial cells by Q-RT-PCR","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Circulating tumor cell; Mammaglobin; Serial dilution; Cytokeratin; RNA extraction; Reverse transcriptase; Breast cancer; Real-time polymerase chain reaction; Biology; Molecular biology; Cancer; Cancer research; Medicine; RNA; Pathology; Internal medicine; Metastasis; Immunology; Gene; Immunohistochemistry","score_opus":0.07077639996544038,"score_gpt":0.39660214206040895,"score_spread":0.32582574209496856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050416584","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.190126,0.0038371773,0.77968824,0.0011084187,0.0014452155,0.004052533,0.0065830247,0.0037609,0.00939854],"genre_scores_gemma":[0.18525423,0.0021787223,0.7833807,0.00092464295,0.00053120876,0.0061514284,0.005894622,0.00083914236,0.014845324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950766,0.0014586418,0.00052734953,0.0013521782,0.0008328471,0.00075239455],"domain_scores_gemma":[0.9962831,0.0021960542,0.00017586151,0.0004390502,0.00072931167,0.00017656261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037970375,0.0019456001,0.0016229646,0.0020110856,0.000833772,0.0019533946,0.0014162604,0.0013316859,0.009308851],"category_scores_gemma":[0.0030931174,0.0011950698,0.0009097535,0.0015802123,0.0017434359,0.0010652768,0.00063176587,0.003866189,0.0040622284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008642257,0.00039771615,0.0019018768,0.000443519,0.000045864217,0.0000943337,0.00036697675,0.00038803133,0.97817093,0.001586949,0.0008146534,0.014924985],"study_design_scores_gemma":[0.0004584979,0.0013011441,0.0044308654,0.000097862656,0.0001329264,0.0002661487,0.00017460003,0.012812298,0.9666989,0.0016184618,0.011954652,0.00005359962],"about_ca_topic_score_codex":0.0009857547,"about_ca_topic_score_gemma":0.0015519814,"teacher_disagreement_score":0.009308851,"about_ca_system_score_codex":0.00074862124,"about_ca_system_score_gemma":0.001299196,"threshold_uncertainty_score":0.031141162},"labels":[],"label_agreement":null},{"id":"W2050939151","doi":"10.1007/s10549-008-0042-1","title":"Mutations of the MYH gene do not substantially contribute to the risk of breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Gene; Medicine; Oncology; Cancer; Genetics; Mutation; Biology; Internal medicine; Cancer research","score_opus":0.02861996030288757,"score_gpt":0.31702780802881747,"score_spread":0.2884078477259299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050939151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955383,0.00096643553,0.00055804936,0.00023525572,0.00004705801,0.0000072194366,0.00019754693,0.000025880561,0.00242407],"genre_scores_gemma":[0.9988341,0.00020894459,0.00014707595,0.00003093924,0.000045356508,0.0000020232799,0.00010577149,0.0000062053755,0.0006194881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996123,0.00011508746,0.00003567328,0.000064083986,0.000117806005,0.000055148306],"domain_scores_gemma":[0.9987741,0.0004993262,0.00032517675,0.00015295434,0.000072343246,0.00017608613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036879527,0.0002637737,0.00033439844,0.0006664136,0.000193201,0.0002448306,0.00035746957,0.0005165824,0.0029809123],"category_scores_gemma":[0.0023528074,0.00018052563,0.00024218942,0.0003421794,0.00038381724,0.00027753678,0.00027482386,0.00039541986,0.000396496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053027994,0.00017791243,0.81685615,0.00008601232,0.00037073594,0.0047087893,0.00014985715,0.00040991412,0.13266164,0.001393613,0.0007781834,0.037104394],"study_design_scores_gemma":[0.00007831839,0.00058426964,0.9661519,0.000015868825,0.00018647996,0.014405287,0.00007985836,0.00047268986,0.014527084,0.0008521593,0.0026334166,0.000012765412],"about_ca_topic_score_codex":0.00047048635,"about_ca_topic_score_gemma":0.00043049981,"teacher_disagreement_score":0.0029809123,"about_ca_system_score_codex":0.00014019254,"about_ca_system_score_gemma":0.00011007708,"threshold_uncertainty_score":0.009972155},"labels":[],"label_agreement":null},{"id":"W2051557651","doi":"10.1007/s10549-012-1960-5","title":"Willingness to use tamoxifen to prevent breast cancer among diverse women","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Institute on Aging; Agency for Healthcare Research and Quality","keywords":"Tamoxifen; Breast cancer; Medicine; Ethnic group; Logistic regression; Family medicine; Oncology; Cancer; Demography; Gynecology; Gerontology; Internal medicine","score_opus":0.04352565877806177,"score_gpt":0.3600465472212384,"score_spread":0.31652088844317666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051557651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822825,0.00014348597,0.000029276762,0.00023380404,0.000004623641,0.0000069958996,0.000073879484,7.603089e-7,0.0012788967],"genre_scores_gemma":[0.9993851,0.000089829475,0.000022242839,0.00016592309,0.000006285127,0.0000045259585,0.00004405397,9.580233e-7,0.00028107755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994772,0.00019190826,0.00004495022,0.000068787645,0.00011317827,0.00010406048],"domain_scores_gemma":[0.998044,0.0007342993,0.00054462225,0.00008317991,0.00017034417,0.00042341062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074854743,0.00011560011,0.00022349798,0.00079366897,0.0006630512,0.000980423,0.00028605634,0.00067055464,0.0043461975],"category_scores_gemma":[0.0045923507,0.00013619625,0.00029087017,0.0005904326,0.00036052044,0.00048289046,0.00057771447,0.00055513455,0.00037743797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032108193,0.0001990197,0.9880702,0.000016367594,0.00009528047,0.00025787135,0.0028746675,0.000051871266,0.0009464102,0.00016252471,0.00026470763,0.006739987],"study_design_scores_gemma":[0.000014669588,0.00017107157,0.9910643,0.000014899351,0.000038005775,0.00046349483,0.006920508,0.00023012997,0.0001376249,0.00015692331,0.0007769743,0.000011364356],"about_ca_topic_score_codex":0.004672779,"about_ca_topic_score_gemma":0.005162691,"teacher_disagreement_score":0.004672779,"about_ca_system_score_codex":0.0002630647,"about_ca_system_score_gemma":0.00018685614,"threshold_uncertainty_score":0.01453948},"labels":[],"label_agreement":null},{"id":"W2051714896","doi":"10.1007/s10549-009-0477-z","title":"Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Hôpital Notre-Dame; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Ductal carcinoma; Quality of life (healthcare); Distress; Internal medicine; Disease; Psychological distress; Gynecology; Cancer; Oncology; Mental health; Clinical psychology; Psychiatry","score_opus":0.06613567858472585,"score_gpt":0.4247944006821579,"score_spread":0.35865872209743205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051714896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981933,0.0004450903,0.000025518199,0.00016031603,0.000033809472,0.000010893383,0.00031958116,0.0000023689918,0.00080910645],"genre_scores_gemma":[0.9991227,0.00018159635,0.000024031868,0.00005140232,0.00003433285,0.000005547497,0.00025042618,5.7314884e-7,0.00032944436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963605,0.00010129414,0.000033318098,0.000033624085,0.000054934506,0.00014069874],"domain_scores_gemma":[0.99696773,0.00046415324,0.0011025447,0.000064981774,0.00020292238,0.0011977762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006876565,0.00018849364,0.00038423564,0.0008174197,0.00053791684,0.000759414,0.0003294811,0.0008189119,0.0020157087],"category_scores_gemma":[0.0045632212,0.00015964196,0.00075401436,0.0008455326,0.0004128477,0.0007305521,0.0006554445,0.0015774792,0.00021948747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081081054,0.00020388955,0.99678504,0.0000144395035,0.000057913614,0.000092731745,0.00013718319,0.00006401233,0.00008971615,0.000020374619,0.00016320843,0.0015606077],"study_design_scores_gemma":[0.0000047343765,0.00020348206,0.9993505,0.0000032040778,0.000017388842,0.00006841441,0.00020906895,0.00004713012,0.000013500226,0.000009702745,0.00006871473,0.00000409571],"about_ca_topic_score_codex":0.014633777,"about_ca_topic_score_gemma":0.026689043,"teacher_disagreement_score":0.014633777,"about_ca_system_score_codex":0.00057484506,"about_ca_system_score_gemma":0.000536544,"threshold_uncertainty_score":0.0290972},"labels":[],"label_agreement":null},{"id":"W2051771186","doi":"10.1007/s10549-006-9439-x","title":"Provider’s volume and quality of breast cancer detection and treatment","year":2006,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Institut National de Santé Publique du Québec; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Mammography; Breast cancer; Psychological intervention; Breast cancer screening; Medical physics; Cancer; Gynecology; Family medicine; Oncology; Internal medicine; Nursing","score_opus":0.3010050145181978,"score_gpt":0.4954629894190316,"score_spread":0.19445797490083383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051771186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063320535,0.99857605,0.000032714746,0.00022969664,0.000050085382,0.000003754824,0.000046482128,0.0000012677034,0.00042670392],"genre_scores_gemma":[0.006068569,0.9934048,0.00015711297,0.0001383689,0.00007507334,0.0000043748296,0.000052667623,6.3140595e-7,0.000098403674],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990171,0.0003065835,0.0001889226,0.00011663896,0.00033144397,0.00003928796],"domain_scores_gemma":[0.9951591,0.0032060663,0.001047986,0.000048316797,0.00047726827,0.0000612715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018062976,0.0003526305,0.0016289963,0.0021000307,0.00012224184,0.0007820566,0.0006644894,0.00065608113,0.0029075549],"category_scores_gemma":[0.007176379,0.00035039717,0.0011392268,0.0037438835,0.0002163777,0.0008219664,0.0003231255,0.0006543981,0.00023746814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002761752,0.00008023273,0.008812548,0.07428921,0.0030485848,0.000102599064,0.00010525765,0.00039505644,0.00028463587,0.0010687276,0.012223628,0.8993134],"study_design_scores_gemma":[0.0005429809,0.00096979353,0.19778855,0.13176487,0.024438117,0.005932134,0.0007874168,0.0009875209,0.0014545738,0.002862138,0.6323439,0.00012796947],"about_ca_topic_score_codex":0.008822152,"about_ca_topic_score_gemma":0.017193468,"teacher_disagreement_score":0.008822152,"about_ca_system_score_codex":0.0012648941,"about_ca_system_score_gemma":0.0017778202,"threshold_uncertainty_score":0.017541587},"labels":[],"label_agreement":null},{"id":"W2051838333","doi":"10.1007/s10549-006-9320-y","title":"A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"Breast cancer; CHEK2; Oncology; Internal medicine; Medicine; Cancer; Cancer research; Biology; Genetics; Gene; Mutation","score_opus":0.020181245418625888,"score_gpt":0.3487212990047873,"score_spread":0.32854005358616145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051838333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813974,0.00018636785,0.00047801711,0.00008278941,0.000010861005,0.000021152418,0.00017123732,0.000020582573,0.0008893407],"genre_scores_gemma":[0.9984994,0.00022650881,0.00030943583,0.00004088534,0.000015127937,0.000008824183,0.00010273184,0.000015018173,0.0007820552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996551,0.000047287278,0.000053659183,0.00011713595,0.000053337302,0.000073461364],"domain_scores_gemma":[0.999571,0.0000974492,0.00017652637,0.00002878588,0.000022708442,0.00010345829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018279313,0.0011673416,0.0005944859,0.0020545723,0.0007885357,0.0004143272,0.00053955754,0.00069457386,0.003663089],"category_scores_gemma":[0.00087108836,0.00055420544,0.00074305467,0.0010860938,0.0007030395,0.00021710886,0.00096643105,0.00053159706,0.00037344266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011348149,0.00084895786,0.4324773,0.00039871488,0.0008897469,0.22362258,0.0029210623,0.0005872828,0.29904473,0.0018187502,0.0009993595,0.025043383],"study_design_scores_gemma":[0.00035186604,0.0013194254,0.8007916,0.00009611275,0.00082489057,0.17177431,0.0013075311,0.0008514205,0.018224714,0.0004999137,0.0038884056,0.00006971943],"about_ca_topic_score_codex":0.0037231143,"about_ca_topic_score_gemma":0.002071773,"teacher_disagreement_score":0.0037231143,"about_ca_system_score_codex":0.00037096508,"about_ca_system_score_gemma":0.00037131764,"threshold_uncertainty_score":0.012254238},"labels":[],"label_agreement":null},{"id":"W2052100668","doi":"10.1007/s10549-011-1854-y","title":"Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective?","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Ontario Institute for Cancer Research","keywords":"Medicine; Photodynamic therapy; Osteolysis; Cancer; Pathology; Breast cancer; Prostate cancer; Internal medicine; Surgery","score_opus":0.0696665296868817,"score_gpt":0.3696950802209022,"score_spread":0.3000285505340205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052100668","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20328031,0.7295984,0.0055529345,0.033576876,0.00088799046,0.0001005599,0.00011623133,0.0000830153,0.026803644],"genre_scores_gemma":[0.8062499,0.1800166,0.0025773665,0.004348906,0.002712221,0.00007294662,0.000102659535,0.000027461314,0.0038920194],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996617,0.00009711244,0.000033802324,0.000043353448,0.000086361484,0.000077583034],"domain_scores_gemma":[0.99944955,0.00027861973,0.00014296545,0.000026048532,0.000051819457,0.00005093649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094252074,0.00023080142,0.0013672437,0.00040838303,0.00024564404,0.00070940907,0.00035295708,0.001013193,0.0030920634],"category_scores_gemma":[0.001779799,0.00013543281,0.0005865588,0.00045394473,0.00079853815,0.00081995863,0.00018095838,0.00091513497,0.000490078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003775702,0.0010134112,0.012243131,0.0022133924,0.0004222994,0.0015400765,0.00010642855,0.00066110067,0.017439963,0.0023771396,0.0056614284,0.95254594],"study_design_scores_gemma":[0.008410815,0.048048228,0.33200496,0.008701597,0.008985038,0.09293673,0.0042654797,0.0053374153,0.106754415,0.028975137,0.35517952,0.00040062584],"about_ca_topic_score_codex":0.00064801954,"about_ca_topic_score_gemma":0.002275327,"teacher_disagreement_score":0.0030920634,"about_ca_system_score_codex":0.00048931205,"about_ca_system_score_gemma":0.00070664054,"threshold_uncertainty_score":0.010343969},"labels":[],"label_agreement":null},{"id":"W2052566490","doi":"10.1007/s10549-014-2973-z","title":"Associations between anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; University of Calgary; University of Alberta; Cancer Care Ontario; Public Health Ontario; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Hazard ratio; Anthropometry; Cohort; Metabolic equivalent; Prospective cohort study; Cohort study; Obesity; Cancer; Proportional hazards model; Body mass index; Internal medicine; Confidence interval; Demography; Gynecology; Physical therapy; Physical activity","score_opus":0.04429318119086831,"score_gpt":0.3915358403306941,"score_spread":0.34724265913982577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052566490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991503,0.0010779719,0.00016452218,0.0004727557,0.000030721298,0.000041034124,0.0045048995,0.000018986975,0.0021860343],"genre_scores_gemma":[0.99477935,0.0008674843,0.00031961544,0.00016445946,0.000014544762,0.000025425248,0.0021027394,0.000011031712,0.0017153609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916947,0.000043198746,0.00004323914,0.00018391579,0.000251012,0.00030922386],"domain_scores_gemma":[0.99872404,0.000053131636,0.00016742057,0.00007937546,0.00057127234,0.00040477642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006942794,0.0008535051,0.00072337565,0.0019720916,0.0053584627,0.0016194731,0.001730349,0.0009834624,0.003021142],"category_scores_gemma":[0.0012938651,0.00095066114,0.0016625372,0.0043828753,0.00082154904,0.00048563196,0.000900366,0.0015508964,0.0003936313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024187642,0.0000850087,0.994101,0.000028786266,0.0001773353,0.00014347277,0.00064562564,0.00010347645,0.00042615115,0.000113575355,0.0014397397,0.002494025],"study_design_scores_gemma":[0.000022399468,0.000033191765,0.9976216,0.000025404443,0.00009060761,0.00009070911,0.0007483202,0.00027320403,0.000045762856,0.000033966386,0.0009960438,0.000018857838],"about_ca_topic_score_codex":0.9951981,"about_ca_topic_score_gemma":0.99565166,"teacher_disagreement_score":0.020783683,"about_ca_system_score_codex":0.020783683,"about_ca_system_score_gemma":0.025395744,"threshold_uncertainty_score":0.15079689},"labels":[],"label_agreement":null},{"id":"W2053810161","doi":"10.1007/s10549-010-0943-7","title":"DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Cancer Foundation; Cancer Research Institute","keywords":"Breast cancer; Medicine; Oncology; Cancer; Internal medicine","score_opus":0.03230631072071268,"score_gpt":0.3349686635094247,"score_spread":0.30266235278871206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053810161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950033,0.0019228599,0.0010168538,0.00016039703,0.000031380423,0.000010639207,0.0009982261,0.000032703847,0.00082347565],"genre_scores_gemma":[0.9956899,0.00043109048,0.0011100505,0.00004846231,0.00004202672,0.000012563737,0.0011962763,0.0000064840433,0.0014629962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998392,0.000026705264,0.000011738292,0.00004069182,0.00004793054,0.000033847497],"domain_scores_gemma":[0.9996377,0.000082749495,0.00015981232,0.00002491044,0.00002513981,0.000069631446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004220884,0.00030955512,0.0003803027,0.00069020264,0.00027971584,0.00067990704,0.00044329494,0.00054342335,0.0022855264],"category_scores_gemma":[0.000748403,0.00017830037,0.00019025925,0.00067728234,0.00028021203,0.00029625156,0.00035217695,0.0005423984,0.00058449834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035438233,0.00020311115,0.8302401,0.00020627269,0.00016482595,0.0014861142,0.00020873743,0.0009221162,0.099045135,0.0008075664,0.0021148769,0.061057337],"study_design_scores_gemma":[0.00015504236,0.0006554,0.93523705,0.000035031804,0.00027394242,0.008149564,0.00028455476,0.005904369,0.037375566,0.0018146491,0.0100660855,0.000048668022],"about_ca_topic_score_codex":0.00028226353,"about_ca_topic_score_gemma":0.00047485429,"teacher_disagreement_score":0.0022855264,"about_ca_system_score_codex":0.00026114774,"about_ca_system_score_gemma":0.00019500547,"threshold_uncertainty_score":0.007645905},"labels":[],"label_agreement":null},{"id":"W2053822585","doi":"10.1023/a:1010665603732","title":"Incidence of Second Primary Breast Cancer Among Women with a First Primary in Manitoba, Canada","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Manitoba; Manitoba Health; Health Canada; University of Ottawa","funders":"Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research; Health Canada","keywords":"Breast cancer; Medicine; Incidence (geometry); Cancer; Population; Epidemiology; Gynecology; Obstetrics; Internal medicine; Oncology; Environmental health","score_opus":0.016294957436057675,"score_gpt":0.27401527607006454,"score_spread":0.25772031863400685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053822585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97210264,0.003255271,0.00020757456,0.0012677645,0.00008273472,0.00011978761,0.015051875,0.000090860856,0.007821466],"genre_scores_gemma":[0.9905557,0.0024681264,0.00025305623,0.00027196942,0.00002463854,0.000034204488,0.0025281312,0.000020425834,0.0038437909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999126,0.00006659613,0.000081195976,0.000118622316,0.00030269986,0.00030492386],"domain_scores_gemma":[0.99737096,0.00011305054,0.00037699006,0.000063869484,0.001268997,0.00080612756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004073327,0.0006104003,0.00068694184,0.0038455254,0.0025671877,0.0014669509,0.0021093646,0.00084169983,0.004044874],"category_scores_gemma":[0.002005951,0.0007290283,0.001071622,0.006501719,0.00064100936,0.00043864665,0.0011168347,0.0011759883,0.0005461596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008150723,0.000039600593,0.9941947,0.0000470945,0.00008114123,0.0002561875,0.00034841313,0.00017975277,0.0002586103,0.00009465514,0.0017468878,0.0026713877],"study_design_scores_gemma":[0.00001935441,0.000032085456,0.996516,0.000048159593,0.000046808,0.0003752292,0.0016022571,0.0003096029,0.00008658259,0.00002710993,0.0009187143,0.000017990264],"about_ca_topic_score_codex":0.99608386,"about_ca_topic_score_gemma":0.997322,"teacher_disagreement_score":0.028268462,"about_ca_system_score_codex":0.028268462,"about_ca_system_score_gemma":0.036987193,"threshold_uncertainty_score":0.20510304},"labels":[],"label_agreement":null},{"id":"W2053852384","doi":"10.1007/s10549-011-1847-x","title":"A plea for the biopsy marker: how, why and why not clipping after breast biopsy?","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Biopsy; Radiology; Breast cancer; Mammography; Breast MRI; CLIPS; Mastectomy; Breast biopsy; Percutaneous; Breast imaging; Magnetic resonance imaging; Sentinel lymph node; Breast ultrasound; Neoadjuvant therapy; Surgery; Cancer; Internal medicine","score_opus":0.1500653269298619,"score_gpt":0.390934296911341,"score_spread":0.2408689699814791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053852384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006155092,0.9969355,0.00013324956,0.0022152946,0.00036872664,0.0000015702057,0.000009332259,0.000003873612,0.000270923],"genre_scores_gemma":[0.000894767,0.99492884,0.00035178044,0.0026195785,0.0007949598,0.0000038849153,0.000024823901,0.000003897926,0.00037752464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991786,0.0002433487,0.00014060015,0.00014522855,0.00024117417,0.000051075593],"domain_scores_gemma":[0.9969823,0.0021500576,0.00029986733,0.000066824694,0.00040061394,0.00010028257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002238068,0.0007378215,0.002745732,0.0015682246,0.000485756,0.0014851515,0.0012563547,0.0028500045,0.0031103815],"category_scores_gemma":[0.0050171916,0.0004036762,0.00089698884,0.0018503757,0.0017275615,0.0033911755,0.00067036744,0.004068808,0.0019385472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011458252,0.00003109952,0.0005107457,0.01507709,0.00015203812,0.00030120462,0.00008720571,0.00012242241,0.00064869877,0.0029921813,0.069144204,0.91081846],"study_design_scores_gemma":[0.000057369336,0.0000926755,0.0028404365,0.019724756,0.0004997107,0.006025061,0.0004130953,0.00010232224,0.0006470355,0.005306419,0.9642246,0.00006651305],"about_ca_topic_score_codex":0.0029002097,"about_ca_topic_score_gemma":0.0060166335,"teacher_disagreement_score":0.0031103815,"about_ca_system_score_codex":0.0011432682,"about_ca_system_score_gemma":0.0019457614,"threshold_uncertainty_score":0.011836171},"labels":[],"label_agreement":null},{"id":"W2054327739","doi":"10.1007/s10549-010-1264-6","title":"Acquisition of metastatic tissue from patients with bone metastases from breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Trephine; Biopsy; Bone marrow; Iliac crest; Bone metastasis; Metastasis; Breast cancer; Cancer; Radiology; Metastatic breast cancer; Pathology; Surgery; Internal medicine","score_opus":0.030765640557984617,"score_gpt":0.35374861379259953,"score_spread":0.3229829732346149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054327739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945351,0.0008936038,0.00039975523,0.00014185994,0.000015226427,0.000037786394,0.0007311645,0.000017313867,0.003228245],"genre_scores_gemma":[0.9971103,0.00030606546,0.00043244244,0.00010096097,0.000020897136,0.000022815751,0.0009535543,0.000007968308,0.0010450457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997317,0.00004930036,0.00002241788,0.000047949987,0.00007958766,0.00006899696],"domain_scores_gemma":[0.999617,0.000121906705,0.000057367262,0.000039989263,0.00010242837,0.00006131064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027041367,0.00015478094,0.00030232995,0.0007075537,0.0004599261,0.0006377721,0.00021584917,0.0003650476,0.004384988],"category_scores_gemma":[0.0015484594,0.00017189725,0.00016997934,0.00035591095,0.0001971074,0.00021567843,0.00036196443,0.00034578965,0.00072386215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040310384,0.000247097,0.686543,0.00022537014,0.000078591314,0.014443122,0.0010555122,0.0001493217,0.25794905,0.0004925434,0.0021773016,0.03260807],"study_design_scores_gemma":[0.000093455106,0.0009943622,0.8917823,0.000035089175,0.00011281442,0.06338842,0.0012893515,0.00055114465,0.03277234,0.00019740948,0.008767603,0.000015802649],"about_ca_topic_score_codex":0.0025353453,"about_ca_topic_score_gemma":0.0021653974,"teacher_disagreement_score":0.004384988,"about_ca_system_score_codex":0.00023457692,"about_ca_system_score_gemma":0.0002648442,"threshold_uncertainty_score":0.0146692395},"labels":[],"label_agreement":null},{"id":"W2054350484","doi":"10.1007/s10549-013-2490-5","title":"MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using 111In-labeled bispecific radioimmunoconjugates","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cancer research; Chimera (genetics); Pathology; Biology; Gene","score_opus":0.0593012011594051,"score_gpt":0.39596892794450966,"score_spread":0.3366677267851046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054350484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94607556,0.0029369295,0.04023004,0.00040424013,0.00007622619,0.00023220966,0.0014495286,0.0005139918,0.008081253],"genre_scores_gemma":[0.94473296,0.0016979594,0.04033718,0.00018151112,0.000038546932,0.0002554844,0.0017508788,0.00030608234,0.010699388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998005,0.000042197324,0.000008680333,0.00004923971,0.00004038927,0.00005892446],"domain_scores_gemma":[0.99983144,0.000059050326,0.00003597028,0.00002059319,0.000020615966,0.00003229082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006137825,0.00070213224,0.0004024442,0.00055965415,0.0002834736,0.00037464293,0.0005083961,0.0006609569,0.0019714797],"category_scores_gemma":[0.00016476086,0.00040060957,0.00033374203,0.0003484647,0.00034997237,0.0005572546,0.00024778084,0.0012853972,0.00037954916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000355364,0.00005842011,0.00012834561,0.00003792442,0.000009072836,0.000077772536,0.000026642225,0.00041199697,0.9976265,0.00023838328,0.00013474796,0.00089495577],"study_design_scores_gemma":[0.000070434915,0.00036327893,0.002479068,0.000005799741,0.00003405097,0.00041658277,0.00003358232,0.0072141653,0.9880434,0.000059250066,0.0012712409,0.000009093868],"about_ca_topic_score_codex":0.005274625,"about_ca_topic_score_gemma":0.004339008,"teacher_disagreement_score":0.005274625,"about_ca_system_score_codex":0.0006149283,"about_ca_system_score_gemma":0.0005410162,"threshold_uncertainty_score":0.0104878545},"labels":[],"label_agreement":null},{"id":"W2054386542","doi":"10.1023/a:1006356502820","title":"Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Androgen receptor; Allele; Breast cancer; Biology; Prostate cancer; Trinucleotide repeat expansion; Internal medicine; Cancer; Androgen; Genetics; Gene; Cancer research; Oncology; Endocrinology; Medicine; Hormone","score_opus":0.025064109010404317,"score_gpt":0.327860753974465,"score_spread":0.30279664496406067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054386542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912745,0.0001952705,0.00015778538,0.00006883955,0.000011249608,0.0000026671025,0.000118874115,0.000017292114,0.00030060543],"genre_scores_gemma":[0.9987313,0.000106496314,0.00017865367,0.00004267829,0.000049844602,0.000004658182,0.00023094624,0.000010230527,0.00064519834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978596,0.000053232987,0.000025206322,0.00005733375,0.000046994166,0.00003141783],"domain_scores_gemma":[0.9981567,0.00037048524,0.00092072116,0.000092596885,0.00012189684,0.00033761468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018692472,0.00045662175,0.00038858716,0.001460598,0.00043578882,0.00032009312,0.0002923381,0.00060518447,0.0034144353],"category_scores_gemma":[0.001057762,0.00020855374,0.00041006185,0.0011458255,0.00032363698,0.00019028065,0.00021761807,0.00080683746,0.00030788922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024200142,0.0003029835,0.87962687,0.000072679984,0.00044952973,0.005096259,0.0003026055,0.00039197912,0.10185914,0.00029523982,0.00073328125,0.008449375],"study_design_scores_gemma":[0.000018378916,0.00017941694,0.99251705,0.0000054217826,0.00007994858,0.0052192295,0.00006490081,0.0002571257,0.0011614476,0.00014816521,0.00033737143,0.000011642521],"about_ca_topic_score_codex":0.001656779,"about_ca_topic_score_gemma":0.0014507629,"teacher_disagreement_score":0.0034144353,"about_ca_system_score_codex":0.00014703852,"about_ca_system_score_gemma":0.00017851693,"threshold_uncertainty_score":0.011422396},"labels":[],"label_agreement":null},{"id":"W2054541910","doi":"10.1007/s10549-010-1232-1","title":"The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"PI3K/AKT/mTOR pathway; ErbB; Lapatinib; Protein kinase B; Erlotinib; Cancer research; Gefitinib; Breast cancer; Pharmacology; EGFR inhibitors; Drug resistance; Medicine; Cancer; Phosphorylation; Biology; Signal transduction; Internal medicine; Epidermal growth factor receptor; Trastuzumab; Cell biology","score_opus":0.016603159093930408,"score_gpt":0.31025268447063814,"score_spread":0.29364952537670774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054541910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340606,0.0019279948,0.001338725,0.000104771585,0.000046497917,0.0000318623,0.00045614375,0.00016186335,0.002526114],"genre_scores_gemma":[0.9958424,0.00080970593,0.0011683579,0.000048327158,0.000009209529,0.000023187888,0.0006240115,0.00001728159,0.0014574135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982136,0.000024655812,0.000021761023,0.000026638298,0.000060393126,0.00004512564],"domain_scores_gemma":[0.99995124,0.000012463137,0.000009988069,0.000010261209,0.000006540298,0.000009480144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100953905,0.0002801335,0.00044537443,0.00020332751,0.00012070523,0.00033011747,0.00018486862,0.00017347929,0.0011574511],"category_scores_gemma":[0.000120819685,0.00010466577,0.0002751807,0.000218579,0.000101946935,0.000120184945,0.00014096627,0.00051205873,0.00036280672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031108136,0.00016794214,0.0005795332,0.00007589023,0.0000195527,0.00011506357,0.00002811127,0.00031591087,0.98869157,0.00018101522,0.00032436592,0.0091899205],"study_design_scores_gemma":[0.000039592967,0.0008237074,0.004831083,0.0000043677815,0.0000311718,0.00046618003,0.000032675645,0.0014233303,0.98879457,0.000033288325,0.0035145953,0.0000055378623],"about_ca_topic_score_codex":0.00094269816,"about_ca_topic_score_gemma":0.0013772058,"teacher_disagreement_score":0.0011574511,"about_ca_system_score_codex":0.00022083639,"about_ca_system_score_gemma":0.0002553648,"threshold_uncertainty_score":0.0038720965},"labels":[],"label_agreement":null},{"id":"W2055726268","doi":"10.1023/a:1006425809069","title":"p53 Protein Accumulation in Non-Invasive Lesions Surrounding p53 Mutation Positive Invasive Breast Cancers","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Pathology; Biology; Invasive lobular carcinoma; Carcinogenesis; Missense mutation; Ductal carcinoma; Breast cancer; Carcinoma; Cancer research; Staining; Hyperplasia; Immunohistochemistry; Mutation; Cancer; Medicine; Invasive ductal carcinoma; Gene; Genetics","score_opus":0.07248034722259618,"score_gpt":0.38080819312264935,"score_spread":0.3083278459000532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055726268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710125,0.0010033677,0.0004615467,0.000029390716,0.000010442649,0.000008701246,0.000065871616,0.000021378348,0.0012979931],"genre_scores_gemma":[0.9982003,0.00041806296,0.0003181338,0.000011998403,0.000014842155,0.00001280465,0.000088991976,0.0000045293305,0.00093029306],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998915,0.000016241938,0.000011659245,0.00001796403,0.00003373039,0.000028859358],"domain_scores_gemma":[0.9996798,0.00008839541,0.00006372745,0.000026276968,0.000057018508,0.00008479389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002243862,0.00016005746,0.00027471883,0.0012835537,0.0003046705,0.000395667,0.00015948739,0.0002787553,0.0022410867],"category_scores_gemma":[0.00046123134,0.00022336865,0.00012156473,0.00042415256,0.00028591754,0.0003261048,0.00027502884,0.00032390738,0.00035586584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031004408,0.00011135172,0.031105699,0.00015728752,0.000034726698,0.0033927355,0.00024134757,0.000088558234,0.9539154,0.00023640855,0.00017933325,0.0074366736],"study_design_scores_gemma":[0.00010067849,0.0010156643,0.603499,0.000022313963,0.00015333713,0.018585892,0.0008411542,0.0012902883,0.36938477,0.00042432302,0.004665164,0.000017397533],"about_ca_topic_score_codex":0.0006178739,"about_ca_topic_score_gemma":0.00046585454,"teacher_disagreement_score":0.0022410867,"about_ca_system_score_codex":0.00016095999,"about_ca_system_score_gemma":0.00013086048,"threshold_uncertainty_score":0.007497132},"labels":[],"label_agreement":null},{"id":"W2056242601","doi":"10.1007/s10549-011-1482-6","title":"FOXA1 is an independent prognostic marker for ER-positive breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Sanofi","keywords":"FOXA1; Breast cancer; Oncology; Estrogen receptor; Internal medicine; Medicine; Tamoxifen; Population; Cancer; Survival analysis","score_opus":0.06705456540238168,"score_gpt":0.34609874910648863,"score_spread":0.27904418370410694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056242601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98697853,0.007690951,0.00070407894,0.0010648922,0.00009339454,0.000010220644,0.00068281323,0.00004179504,0.0027333307],"genre_scores_gemma":[0.996145,0.0012650841,0.00032943502,0.00009029163,0.0000750096,0.0000070594106,0.00050970784,0.000008930104,0.0015694929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998548,0.000026276004,0.00000855657,0.000031203646,0.000043049455,0.000036106125],"domain_scores_gemma":[0.9996113,0.00007271847,0.00013805437,0.00003509447,0.00004275416,0.000099984565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061168824,0.00023264403,0.00043047377,0.0005013862,0.00028352416,0.00042863522,0.00027901694,0.00032483914,0.0030184945],"category_scores_gemma":[0.0010519711,0.00020554043,0.0002498759,0.0005994798,0.00035428096,0.00031705142,0.00028818272,0.00043868035,0.00043334658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044507543,0.00015112206,0.8797347,0.00014247371,0.00025974947,0.00030451603,0.00008188414,0.0002926534,0.06427982,0.00044909606,0.0023339917,0.047519237],"study_design_scores_gemma":[0.00007214748,0.00028830933,0.98371786,0.000019654512,0.00024685086,0.0008801353,0.00007616812,0.0009082821,0.008750372,0.0005138964,0.004513086,0.000013103781],"about_ca_topic_score_codex":0.0013145756,"about_ca_topic_score_gemma":0.002047937,"teacher_disagreement_score":0.0030184945,"about_ca_system_score_codex":0.00042263657,"about_ca_system_score_gemma":0.00039707002,"threshold_uncertainty_score":0.010097861},"labels":[],"label_agreement":null},{"id":"W2056416478","doi":"10.1007/s10549-009-0586-8","title":"Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University Health Network; University of Toronto; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Internal medicine; Endocrinology; Hyperinsulinemia; Insulin resistance; Mammary gland; Mammary tumor; Insulin; Biology; Carcinogenesis; Protein kinase B; Breast cancer; Basal (medicine); Cancer; Medicine; Phosphorylation","score_opus":0.035314030834319284,"score_gpt":0.34088451383687596,"score_spread":0.3055704830025567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056416478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794536,0.010198283,0.0030557725,0.0005373443,0.00009588982,0.000033882206,0.0005883565,0.00014554369,0.005891392],"genre_scores_gemma":[0.9885076,0.0062741893,0.0014554159,0.00022152235,0.000057175403,0.000030746283,0.0005257745,0.00002476825,0.0029026943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986947,0.000028637993,0.0000125921215,0.00002268803,0.000036315683,0.000030196963],"domain_scores_gemma":[0.99937195,0.00015925626,0.00012115104,0.00014898578,0.0000688463,0.00012982482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046921129,0.00043903006,0.00023856037,0.00094724575,0.00019233549,0.00044209012,0.00021333947,0.00026678698,0.0022327949],"category_scores_gemma":[0.0004363833,0.00021455465,0.0003624221,0.00039823411,0.0004929841,0.0002842444,0.00030380703,0.00061532407,0.00025159953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014405625,0.0007300844,0.022715313,0.0004780799,0.00020950678,0.00086516177,0.00008458279,0.00016127512,0.9308218,0.00267728,0.00043180332,0.026419554],"study_design_scores_gemma":[0.00065143727,0.0041604564,0.372566,0.0001091918,0.0006234569,0.0038318012,0.00020517365,0.0007378117,0.60356283,0.0021163023,0.011391796,0.000043792686],"about_ca_topic_score_codex":0.0006137333,"about_ca_topic_score_gemma":0.0006180227,"teacher_disagreement_score":0.0022327949,"about_ca_system_score_codex":0.00024442826,"about_ca_system_score_gemma":0.00027747406,"threshold_uncertainty_score":0.0074694157},"labels":[],"label_agreement":null},{"id":"W2057247490","doi":"10.1023/a:1006326432340","title":"Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Hormone replacement therapy (female-to-male); Medicine; MAMMOGRAPHIC DENSITY; Menopause; Breast cancer; Postmenopausal women; Breast density; Bone density; Gynecology; Mammography; Internal medicine; Obstetrics; Cancer; Osteoporosis","score_opus":0.017901321356885193,"score_gpt":0.316782695086249,"score_spread":0.2988813737293638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057247490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722034,0.021671066,0.0004564203,0.0010568218,0.000105690786,0.000027878163,0.00040618138,0.000016999022,0.0040555894],"genre_scores_gemma":[0.9970079,0.0021726813,0.00012281603,0.00015753823,0.000115211486,0.0000055623104,0.00014289186,0.000004505656,0.00027088713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916816,0.00028052652,0.000094954,0.00012423337,0.00025234258,0.00007980844],"domain_scores_gemma":[0.99088436,0.005757883,0.001951669,0.0006038098,0.0004320206,0.00037038804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001976155,0.00020439306,0.00085583783,0.00049639447,0.00029690444,0.00057532743,0.0004295253,0.00066783687,0.0016482491],"category_scores_gemma":[0.017317744,0.00029003777,0.00045573906,0.0006830475,0.0007016938,0.0006511711,0.00038100613,0.0006417615,0.00028360498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028767688,0.00014679378,0.9637969,0.00013301994,0.00021006232,0.00028214132,0.00020035726,0.00017226094,0.0008415894,0.00016487463,0.00023873064,0.030936416],"study_design_scores_gemma":[0.00002153466,0.00023854652,0.9985049,0.000014622657,0.000075713644,0.00025919056,0.00008793891,0.00014731548,0.00012745225,0.00013872703,0.00037973092,0.000004385584],"about_ca_topic_score_codex":0.0037646017,"about_ca_topic_score_gemma":0.0069921645,"teacher_disagreement_score":0.0037646017,"about_ca_system_score_codex":0.00037946235,"about_ca_system_score_gemma":0.0004936189,"threshold_uncertainty_score":0.010451078},"labels":[],"label_agreement":null},{"id":"W2058298653","doi":"10.1007/s10549-011-1929-9","title":"Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case–control studies","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre; Dalhousie University","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Parity (physics); Breast cancer; Medicine; Obstetrics; Odds ratio; Logistic regression; Gynecology; Case-control study; Body mass index; Demography; Cancer; Internal medicine","score_opus":0.051893235375858174,"score_gpt":0.3585277819972429,"score_spread":0.30663454662138473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058298653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803156,0.0011935432,0.00040355022,0.000015569789,0.000009398155,0.00005466862,0.00013337824,0.0000050169783,0.00015332444],"genre_scores_gemma":[0.99843675,0.00041552435,0.00054701406,0.000022662909,0.000011952792,0.000062615014,0.00036151547,0.0000059285276,0.00013613356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99275523,0.004141218,0.0007018019,0.0012955928,0.00071309373,0.00039298556],"domain_scores_gemma":[0.98772407,0.007324359,0.0018039669,0.0018013805,0.000783569,0.0005626024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008325497,0.0013774696,0.0018629238,0.0027224168,0.0016374914,0.0016046751,0.0020687103,0.0016633668,0.0016851032],"category_scores_gemma":[0.01194673,0.0017645218,0.0027230964,0.0031541951,0.0019184,0.00077630224,0.0011219436,0.0010522538,0.0001785125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012855004,0.0008689868,0.9725299,0.0001940521,0.007258341,0.0005304411,0.00047685762,0.0002561456,0.0022385914,0.00008276698,0.0000998285,0.0026091493],"study_design_scores_gemma":[0.0011712511,0.0015735044,0.9901966,0.00002928897,0.00471219,0.00064310984,0.00035714477,0.0005485762,0.00039170237,0.00006281533,0.00027108868,0.000042609954],"about_ca_topic_score_codex":0.01610459,"about_ca_topic_score_gemma":0.009804315,"teacher_disagreement_score":0.01610459,"about_ca_system_score_codex":0.0009333676,"about_ca_system_score_gemma":0.0006681816,"threshold_uncertainty_score":0.04403001},"labels":[],"label_agreement":null},{"id":"W2058771273","doi":"10.1023/a:1015229630260","title":"Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Hazard ratio; Internal medicine; Oncology; Hormonal therapy; Cancer; Gynecology; Confidence interval","score_opus":0.018635356274463413,"score_gpt":0.3463511523647948,"score_spread":0.3277157960903314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058771273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824654,0.0047710445,0.0009151065,0.001778141,0.0013837484,0.0032009364,0.0022726671,0.00020693846,0.0030060094],"genre_scores_gemma":[0.9772729,0.0036736329,0.0017906283,0.0021336572,0.00074931775,0.0042862883,0.0028930875,0.00007679733,0.007123656],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994186,0.00029672653,0.000023954997,0.00010260601,0.0000346898,0.00012347609],"domain_scores_gemma":[0.9986273,0.00041162132,0.00019557466,0.000121078665,0.00006519674,0.00057917077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00186579,0.002373071,0.0047222064,0.0005162949,0.0005446279,0.0014526533,0.0015503139,0.0020079738,0.009601378],"category_scores_gemma":[0.002091813,0.001074099,0.0019083649,0.0005477974,0.0018528688,0.0015438484,0.0005564168,0.0049417703,0.0016465435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98922217,0.0031322239,0.0002240914,0.00017110881,0.0004705322,0.000017414506,0.000026127243,0.00030515518,0.001038619,0.00007970749,0.00054456474,0.0047682705],"study_design_scores_gemma":[0.9776945,0.020907305,0.00048636398,0.000007773119,0.00019989579,0.00001583167,0.000015858886,0.00021695647,0.0001153977,0.00008056557,0.00025234034,0.0000072511434],"about_ca_topic_score_codex":0.0025616784,"about_ca_topic_score_gemma":0.006312746,"teacher_disagreement_score":0.009601378,"about_ca_system_score_codex":0.00134549,"about_ca_system_score_gemma":0.0016505443,"threshold_uncertainty_score":0.03211981},"labels":[],"label_agreement":null},{"id":"W2058947545","doi":"10.1007/s10549-007-9711-8","title":"Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; University of Illinois at Urbana-Champaign","keywords":"Progesterone receptor; Breast cancer; Internal medicine; Endocrinology; Gene isoform; Mechanism (biology); Oestrogen receptor; Estrogen receptor; Receptor; Cancer; Medicine; Biology; Cancer research; Physics; Gene; Biochemistry","score_opus":0.016519584736764042,"score_gpt":0.31877682925233586,"score_spread":0.3022572445155718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058947545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841999,0.00965739,0.0011047644,0.00049034005,0.00012067248,0.000020853964,0.000370338,0.000065494336,0.0039701336],"genre_scores_gemma":[0.9919286,0.0028781109,0.00031941425,0.00011247999,0.000026261536,0.000018857228,0.00040349455,0.0000082446195,0.004304498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999193,0.00001920938,0.0000045316647,0.000011361812,0.000017848526,0.000027703534],"domain_scores_gemma":[0.9999404,0.000013424025,0.0000075525923,0.000014360897,0.000010954072,0.000013373782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013840974,0.00016990949,0.00017135966,0.00018263963,0.0002191627,0.00030533786,0.00025475855,0.00021237138,0.0024651543],"category_scores_gemma":[0.0001370472,0.0001280354,0.00020719289,0.00015095872,0.00016065055,0.00023357528,0.00012027207,0.00035301613,0.0005065157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005882405,0.00007796659,0.00040852744,0.00007286885,0.000010112791,0.00014581728,0.000039326213,0.000058540034,0.99260265,0.00084625767,0.00025557046,0.0048941732],"study_design_scores_gemma":[0.0001351105,0.000757614,0.01631,0.000014558282,0.000033427656,0.0009675928,0.00018322688,0.00077671383,0.96361357,0.00027842712,0.016922945,0.0000068618756],"about_ca_topic_score_codex":0.0012419784,"about_ca_topic_score_gemma":0.00089382415,"teacher_disagreement_score":0.0024651543,"about_ca_system_score_codex":0.00030589322,"about_ca_system_score_gemma":0.00021593562,"threshold_uncertainty_score":0.008246779},"labels":[],"label_agreement":null},{"id":"W2059179380","doi":"10.1007/s10549-014-2906-x","title":"A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Medicine; N-terminal telopeptide; Internal medicine; Clinical endpoint; Population; Bone sialoprotein; Breast cancer; Bisphosphonate; Gastroenterology; Bone pain; Cancer; Oncology; Surgery; Randomized controlled trial; Alkaline phosphatase; Osteocalcin; Osteoporosis","score_opus":0.053121955901301435,"score_gpt":0.4272503795736377,"score_spread":0.3741284236723363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059179380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686533,0.00082472485,0.00019855722,0.00015638665,0.00006426333,0.0011824104,0.00026666326,0.000030528587,0.0004111032],"genre_scores_gemma":[0.99282116,0.00077748543,0.001383283,0.0005055269,0.0001598189,0.002067257,0.0009787738,0.000012383737,0.0012942876],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99943084,0.00034745602,0.000025964811,0.000077622324,0.000035095894,0.00008289823],"domain_scores_gemma":[0.9989279,0.00027733415,0.00024372655,0.00011234031,0.00005716966,0.00038145596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001774202,0.001134858,0.0020691,0.00038907197,0.00028024224,0.00067608315,0.00073404313,0.0011098392,0.0028628674],"category_scores_gemma":[0.001478278,0.00038198588,0.00085938646,0.00038385033,0.0007017965,0.00053580734,0.00035876894,0.0026077651,0.000600638],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8935551,0.03324781,0.004515706,0.0004240647,0.00052013516,0.000084016516,0.00013989599,0.0013331139,0.021055935,0.000091381895,0.0006786734,0.044354096],"study_design_scores_gemma":[0.6670762,0.31930748,0.010794107,0.000017934703,0.00020673184,0.000096767384,0.000026324467,0.00063014124,0.001066761,0.000103556,0.00065814785,0.000015902197],"about_ca_topic_score_codex":0.0005123253,"about_ca_topic_score_gemma":0.0012223317,"teacher_disagreement_score":0.0028628674,"about_ca_system_score_codex":0.0005258048,"about_ca_system_score_gemma":0.00091882324,"threshold_uncertainty_score":0.009577274},"labels":[],"label_agreement":null},{"id":"W2059715164","doi":"10.1023/a:1026548320063","title":"Utilization of Professional Supportive Care Services by Women with Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Cancer Care Ontario","keywords":"Breast cancer; Medicine; Family medicine; Service (business); Social work; Nursing; Cancer; Internal medicine; Business","score_opus":0.027532835504544946,"score_gpt":0.36447422792504186,"score_spread":0.3369413924204969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059715164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650407,0.0008945386,0.000014290868,0.00055450917,0.000012226822,0.000009220228,0.00033510075,0.0000020592427,0.0016740767],"genre_scores_gemma":[0.99843496,0.0007843036,0.00003264082,0.00014196981,0.000015850106,0.000007300279,0.00016652557,0.0000012223201,0.00041527723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995763,0.00014080454,0.000055081986,0.000027706288,0.00007899368,0.00012120204],"domain_scores_gemma":[0.9983583,0.00045460826,0.000600194,0.000041128347,0.00023016948,0.0003155214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003948426,0.00008717319,0.00015940041,0.0005632299,0.0005035256,0.00051017356,0.00020900702,0.00044934286,0.0023775082],"category_scores_gemma":[0.005917293,0.0001350865,0.00031948704,0.00078196457,0.0001633477,0.0004709925,0.00044706053,0.00036402413,0.0001333348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012999852,0.000096969634,0.9882207,0.000028432723,0.000033195887,0.0001069454,0.00062545727,0.000033527474,0.00010709104,0.000037323996,0.00050546345,0.010074943],"study_design_scores_gemma":[0.000008931387,0.000118108765,0.9954354,0.00003182719,0.000028756676,0.00033522586,0.003129338,0.0001155408,0.00004320966,0.00002812637,0.00072225544,0.0000033508518],"about_ca_topic_score_codex":0.032651417,"about_ca_topic_score_gemma":0.05489355,"teacher_disagreement_score":0.032651417,"about_ca_system_score_codex":0.0006682414,"about_ca_system_score_gemma":0.000973764,"threshold_uncertainty_score":0.06492275},"labels":[],"label_agreement":null},{"id":"W2059844610","doi":"10.1007/s10549-013-2596-9","title":"Moderate-to-vigorous intensity physical activity across the life course and risk of pre- and post-menopausal breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Metabolic equivalent; Demography; Cancer; Logistic regression; Odds ratio; Mammography; Gerontology; Physical activity; Gynecology; Internal medicine; Physical therapy","score_opus":0.04756663479404434,"score_gpt":0.4050079688395043,"score_spread":0.35744133404545997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059844610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975489,0.0013649336,0.000055695255,0.00010582405,0.000019117877,0.000007591277,0.00035375296,0.000002964404,0.0005411803],"genre_scores_gemma":[0.9985663,0.0004212438,0.000039250164,0.00003436459,0.000018322942,0.0000058221876,0.00024143797,0.000001842885,0.0006713173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979943,0.000040560604,0.000014957273,0.000042880754,0.00002457602,0.00007773461],"domain_scores_gemma":[0.99943143,0.000049456277,0.0001858317,0.000026825393,0.000047741505,0.00025862554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003120004,0.000217493,0.00030593696,0.00037830631,0.00037552146,0.00048422648,0.00027321247,0.0005071686,0.0015503576],"category_scores_gemma":[0.00095017266,0.00026961588,0.00063715666,0.00053499924,0.0001417982,0.0002954857,0.00044918506,0.0007118074,0.00014037044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008029632,0.00013330413,0.995262,0.000018549492,0.00017745083,0.000042876196,0.00006404578,0.00003914525,0.00050953584,0.000024929192,0.000118091455,0.0028071445],"study_design_scores_gemma":[0.0000035805276,0.000061810744,0.9997279,0.0000024889118,0.00002017562,0.000023357683,0.000046438392,0.00003471027,0.000014132552,0.000009101665,0.00005514906,0.000001077687],"about_ca_topic_score_codex":0.011097511,"about_ca_topic_score_gemma":0.023833126,"teacher_disagreement_score":0.011097511,"about_ca_system_score_codex":0.00021870491,"about_ca_system_score_gemma":0.00024019474,"threshold_uncertainty_score":0.022065878},"labels":[],"label_agreement":null},{"id":"W2059896643","doi":"10.1023/a:1006359308505","title":"Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Lumpectomy; Margin (machine learning); Lobular carcinoma; Medicine; Carcinoma; Invasive lobular carcinoma; Breast cancer; Resection; Mastectomy; Radiology; Pathology; Oncology; Cancer; Internal medicine; Surgery; Ductal carcinoma; Invasive ductal carcinoma","score_opus":0.028683931229322526,"score_gpt":0.32702396156524727,"score_spread":0.29834003033592477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059896643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890924,0.00039781458,0.000048541864,0.00000984886,0.000002870334,0.0000042552633,0.00006892357,0.0000022752488,0.00055634446],"genre_scores_gemma":[0.9989473,0.000242376,0.00009105272,0.0000122720985,0.000004257431,0.0000071829318,0.00018328243,0.0000015854604,0.000510654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998565,0.000043267548,0.000022323087,0.000020494394,0.000026913332,0.00003057651],"domain_scores_gemma":[0.9997323,0.000103685976,0.000054176828,0.000027851827,0.000039111856,0.000042856544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004356366,0.00014958116,0.00016225562,0.0005867131,0.00022926372,0.00027298127,0.00012993687,0.00018180617,0.0009457479],"category_scores_gemma":[0.000763405,0.000119452685,0.0000660182,0.00035257288,0.00021732406,0.00021219671,0.00018658942,0.00012985042,0.00020722747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055799363,0.0001719468,0.69613063,0.0001866641,0.000054097614,0.0017237408,0.00084276183,0.00020551523,0.28358793,0.00022317663,0.00022829506,0.011065226],"study_design_scores_gemma":[0.000020449912,0.0005717784,0.97546864,0.000008460953,0.000057594916,0.0015563387,0.00058062054,0.00017369766,0.020345146,0.000051801107,0.0011602775,0.0000050778813],"about_ca_topic_score_codex":0.0015541975,"about_ca_topic_score_gemma":0.0024413036,"teacher_disagreement_score":0.0015541975,"about_ca_system_score_codex":0.00015142784,"about_ca_system_score_gemma":0.00017903616,"threshold_uncertainty_score":0.0031638145},"labels":[],"label_agreement":null},{"id":"W2060064180","doi":"10.1007/s10549-009-0681-x","title":"Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Hazard ratio; Lignan; Confounding; Proportional hazards model; Body mass index; Quartile; Internal medicine; Cancer; Lower risk; Confidence interval; Physiology; Biology","score_opus":0.05102093157981926,"score_gpt":0.35936822730773255,"score_spread":0.3083472957279133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060064180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974227,0.0002842883,0.000053513064,0.000045341338,0.000010064458,0.000014152517,0.0017717131,0.000003830895,0.00039432084],"genre_scores_gemma":[0.99569076,0.0003811001,0.00011037847,0.000052919775,0.000023952382,0.00004103105,0.0023193117,0.000006654369,0.0013739265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998394,0.000040583276,0.000018642822,0.000035603105,0.000032710435,0.00003305362],"domain_scores_gemma":[0.9992853,0.00009101544,0.00025608303,0.00009240713,0.00008284538,0.00019236574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039748393,0.00048163848,0.00047820355,0.00069692306,0.00067424576,0.00077148393,0.00040110727,0.000730313,0.0018341971],"category_scores_gemma":[0.0006428077,0.0005627847,0.0005479298,0.0020506722,0.0002573561,0.00064870826,0.0006254054,0.0010679791,0.0003488852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021144364,0.00031117987,0.99436414,0.00002577272,0.0003395779,0.00007353646,0.00022909151,0.0000549471,0.00073356624,0.000024296603,0.00051605667,0.0012133372],"study_design_scores_gemma":[0.00006092225,0.000115335904,0.99903405,0.000005525126,0.0001377112,0.000036849546,0.00018311036,0.00009762347,0.000051680432,0.000008865999,0.00026336528,0.0000049695345],"about_ca_topic_score_codex":0.061154623,"about_ca_topic_score_gemma":0.110905476,"teacher_disagreement_score":0.061154623,"about_ca_system_score_codex":0.00047513001,"about_ca_system_score_gemma":0.00053301995,"threshold_uncertainty_score":0.12159735},"labels":[],"label_agreement":null},{"id":"W2060708771","doi":"10.1007/s10549-014-2950-6","title":"Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Quality-adjusted life year; Cost effectiveness; Oncology; Letrozole; Gynecology; Internal medicine; Cancer","score_opus":0.019094182184641956,"score_gpt":0.3353691531732998,"score_spread":0.31627497098865787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060708771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532461,0.028937299,0.0050600087,0.0024886217,0.0002922454,0.0012068995,0.0031339738,0.0000809687,0.005553798],"genre_scores_gemma":[0.99588567,0.0021448638,0.00069598143,0.0001883516,0.00004494727,0.00015440721,0.00045506036,0.0000043085456,0.00042636183],"study_design_codex":"simulation_or_modeling","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99761957,0.0018186322,0.0001088615,0.00009866307,0.00014495937,0.00020927328],"domain_scores_gemma":[0.9965283,0.002567314,0.0003685799,0.00006815176,0.00011568067,0.00035192957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002791374,0.0010712454,0.002215642,0.0011261458,0.00020894961,0.0012155882,0.0008936304,0.001131268,0.005641443],"category_scores_gemma":[0.008972283,0.00048630292,0.0046586,0.001057634,0.00041431416,0.00092433364,0.00078701694,0.0014967204,0.00015192245],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35737574,0.00473861,0.03167426,0.004928759,0.020688457,0.00083739,0.00013948158,0.41254047,0.002228058,0.004569159,0.002216719,0.15806289],"study_design_scores_gemma":[0.11826104,0.10839592,0.18868238,0.0025718582,0.070101134,0.001963006,0.0011674582,0.48791152,0.002000346,0.009394083,0.009215767,0.00033548134],"about_ca_topic_score_codex":0.0128019815,"about_ca_topic_score_gemma":0.008738814,"teacher_disagreement_score":0.0128019815,"about_ca_system_score_codex":0.0039790617,"about_ca_system_score_gemma":0.002430988,"threshold_uncertainty_score":0.028870225},"labels":[],"label_agreement":null},{"id":"W2060804848","doi":"10.1007/s10549-009-0441-y","title":"Is red meat intake a risk factor for breast cancer among premenopausal women?","year":2009,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Breast cancer; Medicine; Risk factor; Red meat; Gynecology; Oncology; Cancer; Internal medicine; Obstetrics; Physiology; Pathology","score_opus":0.13200443142069018,"score_gpt":0.435175200862149,"score_spread":0.3031707694414588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060804848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007402287,0.99888355,0.00001678743,0.00013820287,0.000047319907,0.0000023198256,0.000036857702,0.0000010120921,0.00013380029],"genre_scores_gemma":[0.0047790636,0.9947819,0.00007075794,0.00017512993,0.00006022687,0.000005034771,0.000039504375,3.854453e-7,0.00008804625],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99975806,0.00005842463,0.000055870365,0.000047414393,0.00006495561,0.000015284455],"domain_scores_gemma":[0.99909127,0.000573009,0.00022642338,0.000015110136,0.00007604461,0.000018193237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008433665,0.00048884796,0.0022894265,0.0015011186,0.00015964106,0.00057463936,0.0005916567,0.0009222127,0.0023683344],"category_scores_gemma":[0.0020446437,0.00038465366,0.0014142623,0.0022972943,0.0002854164,0.00046304325,0.00033389794,0.00060202694,0.0002975976],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012321976,0.000123171,0.01826943,0.16700779,0.011182067,0.00036501462,0.00012099722,0.0001483223,0.00096640096,0.00038543783,0.009522289,0.7906768],"study_design_scores_gemma":[0.0011238263,0.002048205,0.2808796,0.16830856,0.1349832,0.006451478,0.001167122,0.0004945805,0.0018475775,0.0028033296,0.3996942,0.00019839077],"about_ca_topic_score_codex":0.0054833423,"about_ca_topic_score_gemma":0.011449049,"teacher_disagreement_score":0.0054833423,"about_ca_system_score_codex":0.00034430524,"about_ca_system_score_gemma":0.00096528814,"threshold_uncertainty_score":0.010902822},"labels":[],"label_agreement":null},{"id":"W2060950189","doi":"10.1007/s10549-013-2694-8","title":"Post-surgical highly sensitive C-reactive protein and prognosis in early-stage breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Custom Security Industries (Canada); Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Hazard ratio; C-reactive protein; Body mass index; Oncology; Confidence interval; Proportional hazards model; Cancer; Gastroenterology; Estrogen receptor; Leptin; Obesity; Inflammation","score_opus":0.025754107686817043,"score_gpt":0.3313247333024965,"score_spread":0.3055706256156795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060950189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965642,0.0024602509,0.000101437494,0.00016639533,0.000043370525,0.000006829276,0.0001588699,0.0000060637703,0.0004926492],"genre_scores_gemma":[0.9987759,0.00060993526,0.000090480724,0.000038939852,0.000054285407,0.0000043631508,0.00017945399,0.0000013832167,0.00024530277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973196,0.000083383944,0.00003202889,0.000026338834,0.00005587295,0.000070398164],"domain_scores_gemma":[0.9982572,0.00047060678,0.00060581486,0.00007004551,0.00022735992,0.0003688653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006121317,0.00029134782,0.0003965937,0.00073600374,0.0002920729,0.00048438204,0.00031981315,0.0006061011,0.0006721462],"category_scores_gemma":[0.0026516847,0.00016093788,0.00028166594,0.00092231634,0.0002650076,0.00037375538,0.00024811982,0.0008175767,0.00015611984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011557702,0.00010818592,0.9931015,0.000026141226,0.00004493289,0.0001665846,0.000028952425,0.00006019163,0.00049214007,0.000016104741,0.0001317451,0.0046677236],"study_design_scores_gemma":[0.000012418646,0.0002938818,0.9984238,0.0000095700925,0.00006156556,0.0003702737,0.00009213273,0.00021267045,0.0002570139,0.000057213605,0.00020301032,0.000006466377],"about_ca_topic_score_codex":0.0015805712,"about_ca_topic_score_gemma":0.002473731,"teacher_disagreement_score":0.0015805712,"about_ca_system_score_codex":0.00029536488,"about_ca_system_score_gemma":0.0003966181,"threshold_uncertainty_score":0.0032372475},"labels":[],"label_agreement":null},{"id":"W2061054340","doi":"10.1007/s10549-005-2116-7","title":"The importance of temporal effects in evaluating the prognostic impact of joint ERPR expression in premenopausal women with node-positive breast cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research; Queen's University","funders":"","keywords":"Breast cancer; Medicine; Estrogen receptor; Internal medicine; Oncology; Progesterone receptor; Cancer; Clinical significance; Phenotype; Estrogen; Stage (stratigraphy); Gynecology; Biology; Gene","score_opus":0.018504170252758894,"score_gpt":0.3556940460050919,"score_spread":0.337189875752333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061054340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924993,0.0032803458,0.0012495752,0.00010734442,0.00003577569,0.0000130029475,0.0002878502,0.000013153875,0.002513766],"genre_scores_gemma":[0.9983224,0.0004247987,0.00043967713,0.00002872564,0.00004100675,0.000008596179,0.00015403565,0.0000051077277,0.0005755795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962544,0.00017100178,0.000040241717,0.000043137585,0.00005872079,0.00006135784],"domain_scores_gemma":[0.9986858,0.0007101608,0.0002502794,0.000121306635,0.00013599853,0.00009652398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017271028,0.00019727285,0.00027628825,0.0006072422,0.0002278162,0.0004972531,0.00020655518,0.00027888955,0.0010266477],"category_scores_gemma":[0.0032018197,0.00016290687,0.0002465695,0.0006650222,0.00023514523,0.00049757666,0.00020992952,0.00030561106,0.00023395062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003930263,0.000048418595,0.9633138,0.00003935878,0.000095799995,0.00048959,0.00006448117,0.00038796169,0.013941676,0.00010632771,0.00007961701,0.017502712],"study_design_scores_gemma":[0.00001932978,0.0005767596,0.9926374,0.000008236855,0.0001719388,0.0013732631,0.00011009634,0.0008901961,0.003197971,0.00015563432,0.00085114007,0.000007994931],"about_ca_topic_score_codex":0.0011887533,"about_ca_topic_score_gemma":0.0030477727,"teacher_disagreement_score":0.0017271028,"about_ca_system_score_codex":0.00015306813,"about_ca_system_score_gemma":0.00019025488,"threshold_uncertainty_score":0.009133935},"labels":[],"label_agreement":null},{"id":"W2061224075","doi":"10.1007/s10549-008-9977-5","title":"Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; Université de Montréal; University of Toronto; University Health Network; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; BRCA mutation; Case-control study; Odds ratio; Oncology; Internal medicine; Gynecology; Cancer; Family history; Risk factor; Obstetrics","score_opus":0.027397824379992157,"score_gpt":0.3371516323105158,"score_spread":0.30975380793052365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061224075","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016442734,0.99279153,0.00022760942,0.0026455896,0.0011596518,0.0000067960946,0.00013536785,0.000017278571,0.0013719236],"genre_scores_gemma":[0.0054607955,0.98684597,0.00048294428,0.0021926872,0.0038734158,0.000011522039,0.00016639933,0.000005066452,0.0009611421],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996044,0.000067126246,0.000088949884,0.000057662946,0.00015278849,0.000029151628],"domain_scores_gemma":[0.9971998,0.0020364358,0.00023009036,0.000062484025,0.00036273233,0.00010851041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013850703,0.0009096278,0.002578486,0.0023061573,0.0002715261,0.0016382041,0.0010158418,0.0023872694,0.0017446305],"category_scores_gemma":[0.002873536,0.00047355902,0.0009933008,0.0023260675,0.0004982159,0.0018524377,0.00055753376,0.0024838971,0.00068832625],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005583793,0.00022044504,0.022355288,0.0060177655,0.00066924724,0.00083924923,0.00016680549,0.00027359842,0.0005846635,0.0011926373,0.05343939,0.91368246],"study_design_scores_gemma":[0.00020848471,0.00052719127,0.06415847,0.008022975,0.0039413474,0.007422407,0.00040191307,0.00057403464,0.00069477805,0.0030476127,0.9108702,0.00013061753],"about_ca_topic_score_codex":0.004994902,"about_ca_topic_score_gemma":0.00939405,"teacher_disagreement_score":0.004994902,"about_ca_system_score_codex":0.0005550393,"about_ca_system_score_gemma":0.0009786666,"threshold_uncertainty_score":0.009931624},"labels":[],"label_agreement":null},{"id":"W2062097521","doi":"10.1007/s10549-009-0712-7","title":"Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Ontario Institute for Cancer Research","keywords":"Medicine; Breast cancer; Photodynamic therapy; Metastasis; Bone metastasis; Cancer; Metastatic breast cancer; Pathology; Oncology; Internal medicine","score_opus":0.030440550754109237,"score_gpt":0.35544167378601343,"score_spread":0.3250011230319042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062097521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66517293,0.22063604,0.030052382,0.012140362,0.0008650576,0.00016946303,0.00048131842,0.0003680757,0.07011432],"genre_scores_gemma":[0.9354101,0.04264875,0.0073456084,0.00096698845,0.0001498949,0.000029249852,0.00014918469,0.000035199213,0.013265119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991417,0.00001548008,0.000002963212,0.0000136011295,0.00002807096,0.000025708683],"domain_scores_gemma":[0.9999422,0.000017817012,0.000010836637,0.0000076204265,0.000010980805,0.000010620543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018682014,0.00022444355,0.00024007178,0.00032559474,0.00030586726,0.0006418234,0.00031592566,0.00056652626,0.0036432995],"category_scores_gemma":[0.00014367752,0.000108385764,0.00019755594,0.00027790957,0.00040338965,0.00055960234,0.00028617092,0.00048351777,0.0006498394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006333902,0.00024256665,0.0011185564,0.00056951895,0.00004370734,0.00032436103,0.0000972481,0.00067678955,0.8552034,0.012292368,0.0023245073,0.1264735],"study_design_scores_gemma":[0.00022399476,0.0029295657,0.011547831,0.00013659098,0.00024280361,0.0044299075,0.0003541934,0.0018243422,0.7396271,0.0069867084,0.23166142,0.000035497473],"about_ca_topic_score_codex":0.00161495,"about_ca_topic_score_gemma":0.0038621838,"teacher_disagreement_score":0.0036432995,"about_ca_system_score_codex":0.0005220031,"about_ca_system_score_gemma":0.0006209603,"threshold_uncertainty_score":0.012188077},"labels":[],"label_agreement":null},{"id":"W2062165579","doi":"10.1007/s10549-013-2626-7","title":"Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"CTL*; HER2/neu; Biology; Immunology; Cytotoxic T cell; Immune system; Cancer research; CD8; Trastuzumab; Immunotherapy; Cancer; Breast cancer","score_opus":0.03457243733282276,"score_gpt":0.32486445629961336,"score_spread":0.2902920189667906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062165579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929998,0.00058591535,0.003603221,0.0001957966,0.0001091631,0.00008434505,0.0003155674,0.00012337178,0.0019828482],"genre_scores_gemma":[0.9951847,0.00025318077,0.0016233444,0.000085328764,0.000042811862,0.000078202815,0.00039777797,0.000026790316,0.0023079142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974114,0.0000385672,0.000021080365,0.0000603,0.00004434115,0.00009461792],"domain_scores_gemma":[0.99986005,0.000035582896,0.000030058707,0.000023261797,0.00001279774,0.000038265123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021818235,0.0004869263,0.00027661482,0.000244322,0.00015047225,0.00029821027,0.00026165493,0.00048296573,0.0013373233],"category_scores_gemma":[0.00014895534,0.00020363735,0.00022663028,0.000109391905,0.00022739562,0.00028135887,0.00016697534,0.0015739436,0.0004981727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038469565,0.00017106009,0.00006791665,0.000021225067,0.000005332021,0.000033891985,0.000013167399,0.00017061646,0.9980704,0.00017748428,0.000089956746,0.00079421926],"study_design_scores_gemma":[0.0001240755,0.0008424651,0.0009293198,0.000005203775,0.000019077033,0.0001538051,0.000014326378,0.0023676194,0.9942697,0.00007155584,0.001199067,0.0000037221423],"about_ca_topic_score_codex":0.00032615612,"about_ca_topic_score_gemma":0.00030221354,"teacher_disagreement_score":0.0013373233,"about_ca_system_score_codex":0.00033520343,"about_ca_system_score_gemma":0.00020433226,"threshold_uncertainty_score":0.0044738054},"labels":[],"label_agreement":null},{"id":"W2062390900","doi":"10.1007/s10549-004-5168-1","title":"Accuracy of breast screening among women with and without a family history of breast and/or ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital; Cancer Care Ontario","funders":"Cancer Care Ontario","keywords":"Family history; Medicine; Breast cancer; Gynecology; Mammography; Obstetrics; Confidence interval; Breast cancer screening; Cancer; Population; Confounding; Ovarian cancer; Demography; Internal medicine","score_opus":0.03561525537177414,"score_gpt":0.33144724538063564,"score_spread":0.2958319900088615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062390900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963158,0.0011428278,0.00020667679,0.00028744544,0.00005288618,0.0000062939,0.00061965646,0.00001703983,0.0013514537],"genre_scores_gemma":[0.99901986,0.00021967693,0.00009915761,0.00005969733,0.000030759224,0.000002471562,0.0003426245,0.0000032908388,0.00022241886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792933,0.00074624235,0.00021969408,0.0004331837,0.00041232648,0.00025918818],"domain_scores_gemma":[0.980027,0.013475069,0.0020226494,0.0019140486,0.0019700825,0.0005911243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038515874,0.00035543813,0.0007637954,0.0017067371,0.0004295834,0.0009849403,0.0009601667,0.0015281594,0.0010727707],"category_scores_gemma":[0.02737605,0.00040833926,0.00070302817,0.00084675325,0.00059322454,0.0010047508,0.00072494877,0.00072217407,0.00047807302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000462338,0.000017465341,0.99633765,0.000012078163,0.0000776183,0.00005258051,0.0000897742,0.000121068624,0.00017387955,0.000021976315,0.00011436625,0.0025192006],"study_design_scores_gemma":[0.000016259433,0.00016291911,0.9967134,0.000012427924,0.00016624732,0.0005316513,0.00013951102,0.0015792176,0.00033791093,0.00008171107,0.0002509135,0.000007811754],"about_ca_topic_score_codex":0.011646702,"about_ca_topic_score_gemma":0.009882556,"teacher_disagreement_score":0.011646702,"about_ca_system_score_codex":0.00052219845,"about_ca_system_score_gemma":0.00035751113,"threshold_uncertainty_score":0.023157775},"labels":[],"label_agreement":null},{"id":"W2063692243","doi":"10.1007/s10549-012-2338-4","title":"Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Radiation; Cancer research; Medicine; Radiation therapy; Cancer; Colloidal gold; Oncology; Breast tumor; Nanoparticle; Internal medicine; Materials science; Nanotechnology; Optics; Physics","score_opus":0.022541539130855888,"score_gpt":0.34813490992427665,"score_spread":0.32559337079342077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063692243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541676,0.0012291466,0.0016505232,0.000104635605,0.00003070741,0.000016083359,0.00003737785,0.000073631156,0.0014411401],"genre_scores_gemma":[0.9956317,0.0003946698,0.0011529747,0.000053481308,0.000006881896,0.000010430143,0.000057979818,0.00001966263,0.0026722846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998661,0.000026088981,0.0000065682675,0.000026503512,0.000036392772,0.000038363425],"domain_scores_gemma":[0.9999064,0.00003249051,0.000018505298,0.000011256038,0.000013307375,0.0000180174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017802142,0.00032899677,0.00034221026,0.00018452364,0.00011346579,0.00026168211,0.00016779508,0.0005178151,0.00089819566],"category_scores_gemma":[0.00015214788,0.00023584533,0.00021924547,0.00008663684,0.00022421405,0.00022766725,0.00022663566,0.00039109177,0.00022977777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093037066,0.000022234379,0.000048711525,0.000021848915,0.0000046073887,0.000012979308,0.000016043516,0.00016597549,0.99893457,0.00006237499,0.00003735993,0.00058020855],"study_design_scores_gemma":[0.000009382524,0.00015469277,0.0005003452,0.0000017307857,0.000008047954,0.00003127457,0.000009169558,0.0008235695,0.9978721,0.00001601235,0.00057158957,0.000001983928],"about_ca_topic_score_codex":0.0007199277,"about_ca_topic_score_gemma":0.00091006,"teacher_disagreement_score":0.00089819566,"about_ca_system_score_codex":0.0003710807,"about_ca_system_score_gemma":0.00013085113,"threshold_uncertainty_score":0.0030047297},"labels":[],"label_agreement":null},{"id":"W2064182120","doi":"10.1007/s10549-006-9452-0","title":"Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Missense mutation; Breast cancer; Mutation; Oncology; Exon; Medicine; Internal medicine; Cancer; Disease; Cancer research; Biology; Genetics; Gene","score_opus":0.06260978444270525,"score_gpt":0.39554597439757233,"score_spread":0.33293618995486707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064182120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999212,0.0003040444,0.000046824967,0.00004604585,0.000008068734,0.0000014331883,0.000053037584,0.0000031848388,0.00032536278],"genre_scores_gemma":[0.99948835,0.00011927721,0.000034933055,0.000018573217,0.000008540164,0.000001748556,0.00005654669,0.0000041634694,0.00026776298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982435,0.00006175908,0.000020786469,0.000025009173,0.000031509895,0.0000366836],"domain_scores_gemma":[0.99932706,0.00028743842,0.00016460188,0.000038326696,0.00004235312,0.00014013266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045186034,0.00023378828,0.00034391126,0.0007237352,0.00019055935,0.00033572904,0.0003287055,0.00042951934,0.0029732664],"category_scores_gemma":[0.0014309455,0.0001767898,0.00030162287,0.0004697481,0.0003189672,0.00035092403,0.00023259546,0.0002659829,0.00040669172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009288329,0.00025470986,0.8666117,0.00005031353,0.0002218716,0.002546661,0.00017277218,0.00041396552,0.105363905,0.00014111398,0.00038507234,0.014549667],"study_design_scores_gemma":[0.00006179557,0.0006711848,0.98730695,0.000008335674,0.00016846885,0.0057289926,0.00017444036,0.00045790937,0.004686665,0.00024457177,0.00048088795,0.0000098587425],"about_ca_topic_score_codex":0.00042124267,"about_ca_topic_score_gemma":0.0007344549,"teacher_disagreement_score":0.0029732664,"about_ca_system_score_codex":0.00018186476,"about_ca_system_score_gemma":0.00014272743,"threshold_uncertainty_score":0.009946525},"labels":[],"label_agreement":null},{"id":"W2064366286","doi":"10.1007/s10549-012-2120-7","title":"Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Placebo; Randomized controlled trial; Internal medicine; Oncology; Cancer; Vitamin D and neurology; Gynecology; Alternative medicine; Pathology","score_opus":0.04200335594353122,"score_gpt":0.37890104902178684,"score_spread":0.3368976930782556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064366286","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92048275,0.007468405,0.004931313,0.007804175,0.0080517065,0.042916115,0.0025715628,0.0005859909,0.0051879687],"genre_scores_gemma":[0.9581269,0.0016179264,0.0066554607,0.0026421407,0.0020039347,0.02492504,0.0007049499,0.00005876157,0.0032648742],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9880834,0.008585144,0.0008572365,0.0012588446,0.00044949446,0.00076581485],"domain_scores_gemma":[0.98639154,0.008549159,0.0014193655,0.0012524185,0.00073386007,0.0016536624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01449939,0.0030515362,0.007040359,0.0010001299,0.001717261,0.0021190604,0.0021071977,0.0077572875,0.016734414],"category_scores_gemma":[0.021281833,0.0027012918,0.004544207,0.0008350421,0.0036452247,0.0035966928,0.0018217796,0.006052709,0.001995288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9958556,0.0017310291,0.00008052532,0.00012452883,0.00019343586,0.00000819307,0.000018885647,0.000059130354,0.00021719933,0.000052818614,0.00010491221,0.0015537005],"study_design_scores_gemma":[0.9735415,0.025594845,0.00015478327,0.000015400252,0.00023181383,0.0000035847333,0.000008706106,0.00009461296,0.00006472312,0.000114091505,0.00016973082,0.0000062660565],"about_ca_topic_score_codex":0.0027718316,"about_ca_topic_score_gemma":0.0028270816,"teacher_disagreement_score":0.016734414,"about_ca_system_score_codex":0.0019401661,"about_ca_system_score_gemma":0.004156441,"threshold_uncertainty_score":0.07668108},"labels":[],"label_agreement":null},{"id":"W2064546724","doi":"10.1007/s10549-008-0292-y","title":"Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; Hotel Dieu Hospital; Occupational Cancer Research Centre; Hôtel-Dieu de Montréal; Coalition for Research in Women's Health","funders":"","keywords":"Breast cancer; Odds ratio; Confidence interval; Oncology; Quartile; BRCA mutation; Body mass index; Medicine; Internal medicine; Demography; Logistic regression; Cancer; Diversity (politics); Genetics; Biology","score_opus":0.02305968930899543,"score_gpt":0.3335742201694428,"score_spread":0.3105145308604474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064546724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935935,0.0029297771,0.00051703036,0.0004984536,0.000021883709,0.000005102222,0.00044623902,0.000034351357,0.0019534912],"genre_scores_gemma":[0.99859446,0.00034936247,0.00018118077,0.000035377776,0.000035880374,0.0000033192327,0.000110463174,0.000009818846,0.0006801942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839133,0.0008974751,0.000074682684,0.00028079966,0.00015400718,0.00020178405],"domain_scores_gemma":[0.9925881,0.0036646335,0.0013260341,0.0008327609,0.0002988499,0.0012895685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014101953,0.0004175231,0.0007982498,0.0014906086,0.0006419172,0.0012155164,0.0004599493,0.0011825406,0.004810878],"category_scores_gemma":[0.0056699943,0.00062315067,0.0011821988,0.0015354961,0.0006916275,0.00046277253,0.0010351732,0.0015367884,0.00037368055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035853267,0.000107279455,0.98412895,0.000021926948,0.0011541562,0.00050034194,0.000105419815,0.0005866543,0.004921951,0.0003612809,0.00014762918,0.004379033],"study_design_scores_gemma":[0.000022393699,0.00024190388,0.99680746,0.0000059556737,0.00029929483,0.0008655887,0.00009996021,0.0007314066,0.0003036319,0.00041637942,0.00019322635,0.000012909988],"about_ca_topic_score_codex":0.0036966759,"about_ca_topic_score_gemma":0.0032669802,"teacher_disagreement_score":0.004810878,"about_ca_system_score_codex":0.00030494193,"about_ca_system_score_gemma":0.00037297996,"threshold_uncertainty_score":0.01609397},"labels":[],"label_agreement":null},{"id":"W2065019417","doi":"10.1007/s10549-005-2415-z","title":"Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Alberta","funders":"","keywords":"Docosahexaenoic acid; Cell growth; Eicosapentaenoic acid; Omega 3 fatty acid; Apoptosis; Protein kinase B; Biology; Linoleic acid; DNA fragmentation; Fatty acid; Endocrinology; Biochemistry; Internal medicine; Cancer research; Molecular biology; Programmed cell death; Polyunsaturated fatty acid; Medicine","score_opus":0.059033834624936346,"score_gpt":0.37828050893314547,"score_spread":0.31924667430820913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065019417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9399444,0.036335815,0.004139312,0.0017714688,0.0003092882,0.00016923224,0.0034547467,0.00034815306,0.013527629],"genre_scores_gemma":[0.98137397,0.008744495,0.0006754716,0.0002593013,0.000023203474,0.00011831352,0.001594205,0.000021485223,0.0071895006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997527,0.000041280164,0.000015743793,0.000023168708,0.000060383045,0.00010668945],"domain_scores_gemma":[0.99988985,0.000027598926,0.0000220101,0.00001847371,0.00003002196,0.000012019491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023302075,0.0005242439,0.0004359789,0.00047731007,0.00034978875,0.0005024737,0.00048415287,0.00047370343,0.0030355947],"category_scores_gemma":[0.00015057242,0.00033402533,0.00094857335,0.0003982112,0.00024692545,0.0003425538,0.0002725015,0.0008803181,0.0009201549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011382797,0.00020039215,0.0007340313,0.0002460225,0.00004718728,0.000252199,0.00013034456,0.00023856304,0.988817,0.0013070686,0.0008558386,0.0060331332],"study_design_scores_gemma":[0.00010598796,0.0007025974,0.018923547,0.000038911745,0.00008032493,0.0003712034,0.00027726943,0.0012585884,0.96885294,0.0003700243,0.009001123,0.000017466304],"about_ca_topic_score_codex":0.007473295,"about_ca_topic_score_gemma":0.005617476,"teacher_disagreement_score":0.007473295,"about_ca_system_score_codex":0.0009677242,"about_ca_system_score_gemma":0.00046235227,"threshold_uncertainty_score":0.014859557},"labels":[],"label_agreement":null},{"id":"W2065331919","doi":"10.1007/s10549-010-1138-y","title":"Bone mineral density and risk of postmenopausal breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Saskatchewan; University of Manitoba; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Medicine; Breast cancer; Bone mineral; Quartile; Femoral neck; Osteoporosis; Internal medicine; Hazard ratio; Proportional hazards model; Gynecology; Cancer; Oncology; Urology; Confidence interval","score_opus":0.028851675810217674,"score_gpt":0.35618031905782804,"score_spread":0.32732864324761035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065331919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774147,0.017818946,0.00023845099,0.0007020432,0.000053655134,0.000009683402,0.0006702544,0.000022167598,0.0030700578],"genre_scores_gemma":[0.9967794,0.0021701697,0.00012524512,0.000057887664,0.00007671657,0.0000035260214,0.00016781947,0.0000020181726,0.0006173477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998247,0.000056178218,0.000015146313,0.000024620815,0.00004632796,0.00003301747],"domain_scores_gemma":[0.99930346,0.00019298923,0.00022478942,0.000049541617,0.00008208638,0.00014717733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042673005,0.00022054494,0.00033922173,0.00061897415,0.00027839834,0.00047138575,0.00028428802,0.0006559704,0.0018646758],"category_scores_gemma":[0.0023012212,0.0002727084,0.00044376787,0.0007924821,0.00020772677,0.00020882873,0.00024774397,0.00070589484,0.0001553881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011219847,0.000077928395,0.99157894,0.00004200327,0.0003020442,0.000101443424,0.000044515466,0.00012076048,0.00047415332,0.00013834052,0.0002046302,0.0057932376],"study_design_scores_gemma":[0.00004260144,0.00017500638,0.9976739,0.000016416661,0.00025628798,0.0003720391,0.00006612969,0.00039825204,0.00010496072,0.0002990566,0.00058995635,0.0000054106163],"about_ca_topic_score_codex":0.012566812,"about_ca_topic_score_gemma":0.009003561,"teacher_disagreement_score":0.012566812,"about_ca_system_score_codex":0.0002715538,"about_ca_system_score_gemma":0.0003344756,"threshold_uncertainty_score":0.02498734},"labels":[],"label_agreement":null},{"id":"W2065386366","doi":"10.1007/s10549-013-2799-0","title":"Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada; McGill University","funders":"","keywords":"Osteolysis; Medicine; Breast cancer; Intractable pain; Oncology; Surgery; Cancer; Internal medicine","score_opus":0.03547872215611514,"score_gpt":0.35286030306586497,"score_spread":0.3173815809097498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065386366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903948,0.004695858,0.0010270702,0.0004662826,0.00020380208,0.00007016676,0.0005259212,0.00020728452,0.0024088311],"genre_scores_gemma":[0.99259675,0.0023934483,0.0010723376,0.00012172953,0.00012399709,0.00015488052,0.00082603097,0.00004462099,0.0026662026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930716,0.00020214355,0.000051717143,0.00006497358,0.00012831624,0.00024575132],"domain_scores_gemma":[0.999501,0.000113990136,0.00014458447,0.00005894536,0.000028893435,0.00015273217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005087803,0.000910452,0.0012514681,0.0011546566,0.0005389346,0.0005118296,0.0005559278,0.00083990925,0.0044855927],"category_scores_gemma":[0.0005530706,0.0004545132,0.0010102764,0.0006098508,0.0013484013,0.0004841665,0.0003892779,0.0023462353,0.0006146638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037357837,0.0053231227,0.0012992573,0.0003596128,0.0001542442,0.0005316963,0.000106619846,0.00067732116,0.93390995,0.0007032958,0.0015866074,0.017990572],"study_design_scores_gemma":[0.0037311222,0.03426237,0.028358478,0.000061193816,0.00032961002,0.0022692275,0.00029956046,0.0027488074,0.9208965,0.00040246636,0.0065558786,0.00008492939],"about_ca_topic_score_codex":0.0015566576,"about_ca_topic_score_gemma":0.0025068435,"teacher_disagreement_score":0.0044855927,"about_ca_system_score_codex":0.0003227382,"about_ca_system_score_gemma":0.00076693384,"threshold_uncertainty_score":0.015005827},"labels":[],"label_agreement":null},{"id":"W2065705923","doi":"10.1007/s10549-012-1989-5","title":"Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Cohort; Oncology; Internal medicine; Population; Quality-adjusted life year; Gynecology; Disease; Cancer; Cost effectiveness; Environmental health","score_opus":0.05948690056745847,"score_gpt":0.3615667509758435,"score_spread":0.30207985040838503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065705923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865587,0.008195644,0.0010875062,0.0005246848,0.000084725594,0.00005665977,0.0009845893,0.00001187515,0.0024956244],"genre_scores_gemma":[0.99782723,0.00078466313,0.0005580505,0.00005783876,0.000039933202,0.000018304281,0.00029169556,0.000004100222,0.00041808092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978242,0.0016542461,0.00006243556,0.000088456785,0.00029167323,0.00007903259],"domain_scores_gemma":[0.99423283,0.0040309033,0.00051572634,0.00033086582,0.0006108766,0.00027881417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028555032,0.0004878383,0.00063158193,0.001027612,0.00014350981,0.0006146849,0.0007496768,0.00050786644,0.0015387163],"category_scores_gemma":[0.010408536,0.00016505238,0.00078451156,0.0009844309,0.00032389874,0.00044511975,0.00032096097,0.0003607233,0.00020643961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028277485,0.00045803428,0.86318606,0.00025828995,0.00092884724,0.00025550803,0.000079805766,0.006919997,0.0029126399,0.000910873,0.00086008065,0.09495236],"study_design_scores_gemma":[0.000514938,0.008031026,0.958115,0.000083009465,0.002135678,0.0010255479,0.00026442745,0.022013972,0.0037208828,0.0010840119,0.0029569075,0.000054602042],"about_ca_topic_score_codex":0.008025721,"about_ca_topic_score_gemma":0.010430197,"teacher_disagreement_score":0.008025721,"about_ca_system_score_codex":0.0014907725,"about_ca_system_score_gemma":0.00072805147,"threshold_uncertainty_score":0.015958011},"labels":[],"label_agreement":null},{"id":"W2065838490","doi":"10.1007/s10549-008-9986-4","title":"Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Dalhousie University; Cancer Care Ontario; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Mammography; Breast cancer; Medicine; Series (stratigraphy); Population; Gynecology; Mammography screening; Oncology; Cancer; Obstetrics; Internal medicine; Environmental health; Biology","score_opus":0.027138275832885785,"score_gpt":0.31410798431997733,"score_spread":0.2869697084870915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065838490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994789,0.0001011348,0.00005097613,0.000035938807,0.0000030178185,0.0000062414,0.000045895915,0.0000024349472,0.00027553967],"genre_scores_gemma":[0.999696,0.00009289778,0.00003856851,0.00001668723,0.000010151264,0.000004894162,0.00007763114,0.0000015892747,0.000061621904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991973,0.00023576982,0.00009452659,0.00017780332,0.00012360365,0.00017090718],"domain_scores_gemma":[0.9980076,0.0005483422,0.0006422712,0.00023284834,0.00021702798,0.00035186458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056998665,0.0005628641,0.0008010586,0.0019079045,0.0016918635,0.0011661524,0.00078318315,0.0015619679,0.0015026861],"category_scores_gemma":[0.0038392853,0.00068862346,0.00084180245,0.0017929998,0.0010696149,0.0010632611,0.0008489378,0.00094094564,0.00026517088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008652844,0.00014171682,0.9919751,0.000005258939,0.000033638233,0.0064020217,0.00030405045,0.000026792379,0.000196545,0.00002362749,0.00006514414,0.0007395479],"study_design_scores_gemma":[0.000016960186,0.00049539644,0.94258195,0.000010742269,0.00008673984,0.054234017,0.0019115143,0.00026269865,0.00016285079,0.0000784157,0.00013088898,0.000027825488],"about_ca_topic_score_codex":0.005834949,"about_ca_topic_score_gemma":0.005352836,"teacher_disagreement_score":0.005834949,"about_ca_system_score_codex":0.00068853656,"about_ca_system_score_gemma":0.00055570155,"threshold_uncertainty_score":0.011601925},"labels":[],"label_agreement":null},{"id":"W2065931400","doi":"10.1007/s10549-014-3216-z","title":"Effects of the BEAT Cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors: a multicenter randomized controlled trial","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Canada Research Chairs; National Comprehensive Cancer Network; University of Alabama at Birmingham","keywords":"Medicine; Breast cancer; Randomized controlled trial; Physical therapy; Aerobic exercise; Confidence interval; Cancer; Odds ratio; Physical fitness; Quality of life (healthcare); Internal medicine","score_opus":0.060612306172521155,"score_gpt":0.4042363232032189,"score_spread":0.3436240170306977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065931400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99121666,0.0025036817,0.00043717716,0.00053564826,0.0004861002,0.0031933163,0.0006599315,0.000088588255,0.00087894284],"genre_scores_gemma":[0.9846662,0.0020553963,0.0017548767,0.00093457085,0.000632197,0.0070645693,0.00083360606,0.000023925877,0.0020346143],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989986,0.0004093585,0.00008965439,0.0002318589,0.00010875302,0.00016175928],"domain_scores_gemma":[0.9986915,0.00039298102,0.00028132802,0.00010536851,0.00009529233,0.00043362725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016146754,0.0017706217,0.0042649284,0.0007048955,0.00097437936,0.001029291,0.0012190581,0.0023798859,0.006821193],"category_scores_gemma":[0.0026150134,0.0010624409,0.002142467,0.0006616224,0.0013239678,0.0010475258,0.000901881,0.003439751,0.000705985],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9751829,0.01308564,0.0008826891,0.0005088283,0.0014273846,0.0000161351,0.000045781322,0.00014557628,0.0007003066,0.000048659702,0.00037258945,0.0075836247],"study_design_scores_gemma":[0.96091056,0.034708504,0.002942042,0.0000350787,0.000897718,0.0000067137107,0.000020824593,0.00017926609,0.00012150149,0.000034363104,0.00013479036,0.000008599365],"about_ca_topic_score_codex":0.004613078,"about_ca_topic_score_gemma":0.004423644,"teacher_disagreement_score":0.006821193,"about_ca_system_score_codex":0.00079985074,"about_ca_system_score_gemma":0.0016055087,"threshold_uncertainty_score":0.022819161},"labels":[],"label_agreement":null},{"id":"W2066327505","doi":"10.1007/s10549-006-9262-4","title":"Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"U.S. Army Medical Command; Novartis Pharma","keywords":"Letrozole; Medicine; Breast cancer; Tamoxifen; Oncology; Cost effectiveness; Adjuvant therapy; Quality-adjusted life year; Internal medicine; Clinical trial; Gynecology; Cancer","score_opus":0.03358527494242729,"score_gpt":0.345306888839836,"score_spread":0.3117216138974087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066327505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952789,0.042338103,0.00034973456,0.001621987,0.00013522166,0.00010680298,0.0006321471,0.000017831198,0.002009006],"genre_scores_gemma":[0.9950734,0.004164157,0.00018375054,0.00011556951,0.000050645504,0.000027984259,0.00014733181,0.0000014252989,0.00023567413],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989011,0.0008324377,0.00005277158,0.0000422829,0.00010087632,0.00007053298],"domain_scores_gemma":[0.9983094,0.0011391713,0.0002447273,0.000053926226,0.00004815897,0.00020470616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012121479,0.00042672618,0.001122663,0.0005151164,0.00014817307,0.0004463494,0.00032455186,0.0007767218,0.002225923],"category_scores_gemma":[0.0061241887,0.00017846674,0.0017138615,0.0005669427,0.00026384337,0.00066388835,0.0003599308,0.0008170416,0.000080154095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64319634,0.0023008923,0.0353099,0.0023298913,0.007533863,0.00045161447,0.00011335642,0.029323181,0.002816907,0.0014844921,0.0010136839,0.2741259],"study_design_scores_gemma":[0.13246088,0.25860986,0.48830414,0.0022344186,0.05186979,0.002029605,0.00087919587,0.04154497,0.004846168,0.004919096,0.012033781,0.00026806057],"about_ca_topic_score_codex":0.0056414274,"about_ca_topic_score_gemma":0.0085223485,"teacher_disagreement_score":0.0056414274,"about_ca_system_score_codex":0.0015817469,"about_ca_system_score_gemma":0.0009880154,"threshold_uncertainty_score":0.0114763975},"labels":[],"label_agreement":null},{"id":"W2066548418","doi":"10.1007/s10549-010-0795-1","title":"High levels of uPA and PAI-1 predict a good response to anthracyclines","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Breast cancer; Internal medicine; Medicine; Oncology; Cancer research; Biology; Cancer","score_opus":0.02394331461331799,"score_gpt":0.3460215584750042,"score_spread":0.3220782438616862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066548418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98894006,0.0045236573,0.0009087944,0.00044359392,0.000064873944,0.000025557272,0.0005782282,0.00008437226,0.004430847],"genre_scores_gemma":[0.9974534,0.00068282423,0.00058065774,0.00006341951,0.000060193805,0.00001761372,0.0004148947,0.000009560991,0.0007174564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997459,0.00007819551,0.0000349209,0.000025080675,0.00006390725,0.00005205949],"domain_scores_gemma":[0.9983676,0.000755235,0.000435704,0.000086298314,0.00010742508,0.00024764182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003106102,0.00033752233,0.0003992342,0.0011791824,0.00020605515,0.0006433838,0.00014271695,0.00043479045,0.002987207],"category_scores_gemma":[0.002365891,0.00019778099,0.00033757222,0.0007285147,0.00031483392,0.000255702,0.00018657626,0.00067012117,0.00048565067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037880081,0.00019441027,0.8837991,0.00013596404,0.00036425344,0.0011200947,0.000113170114,0.0006641425,0.07603027,0.00026109963,0.0009774757,0.032552067],"study_design_scores_gemma":[0.00004372795,0.0005152469,0.9766034,0.00002087982,0.00013527692,0.0035376279,0.00014495527,0.00071244565,0.015637271,0.00043774373,0.0021956228,0.000015888665],"about_ca_topic_score_codex":0.00038737126,"about_ca_topic_score_gemma":0.00044383403,"teacher_disagreement_score":0.002987207,"about_ca_system_score_codex":0.00024708087,"about_ca_system_score_gemma":0.00017527449,"threshold_uncertainty_score":0.0099931955},"labels":[],"label_agreement":null},{"id":"W2067265379","doi":"10.1007/s10549-005-9151-2","title":"XPD Common Variants and their Association with Melanoma and Breast Cancer Risk","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; Melanoma; Oncology; Internal medicine; Cancer; Genotype; Medicine; Single-nucleotide polymorphism; Haplotype; Genotyping; Linkage disequilibrium; Biology; Genetics; Cancer research; Gene","score_opus":0.013805190121544127,"score_gpt":0.2998355213465374,"score_spread":0.2860303312249933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067265379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996942,0.0013879068,0.0002786468,0.0001769468,0.0000192307,0.000006205268,0.00027181013,0.000013093628,0.00090409257],"genre_scores_gemma":[0.99878114,0.00025439492,0.000287733,0.000027986016,0.00003294965,0.000005895261,0.00011607605,0.00000530594,0.00048837624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999438,0.00021977264,0.00007756057,0.000112920796,0.000090287715,0.000061488136],"domain_scores_gemma":[0.9969188,0.0014139798,0.0008590768,0.00020758437,0.00018077878,0.00041977363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006730783,0.00039871392,0.0004912283,0.0016646904,0.00042640473,0.00054346555,0.00044169207,0.0010101916,0.004167635],"category_scores_gemma":[0.0037519473,0.00040483172,0.00053746486,0.0014695877,0.0004204245,0.0003711593,0.0003770043,0.00092889625,0.000255547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003905537,0.00016799173,0.97396743,0.00004490556,0.00064944493,0.0038801644,0.00014950929,0.00032773466,0.009000597,0.00040131595,0.00032799953,0.0071772677],"study_design_scores_gemma":[0.000091341164,0.00030188283,0.9844036,0.000013000018,0.00032464982,0.011164725,0.0001476784,0.00089455507,0.0013546452,0.0005080424,0.00078041,0.00001563398],"about_ca_topic_score_codex":0.0012681083,"about_ca_topic_score_gemma":0.0010518959,"teacher_disagreement_score":0.004167635,"about_ca_system_score_codex":0.00018908264,"about_ca_system_score_gemma":0.00019466423,"threshold_uncertainty_score":0.013942182},"labels":[],"label_agreement":null},{"id":"W2067271684","doi":"10.1007/s10549-011-1479-1","title":"The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Mastectomy; Prophylactic Mastectomy; Cancer; Oncology; Gynecology; Surgery; Internal medicine","score_opus":0.041524861021020106,"score_gpt":0.36445259441525335,"score_spread":0.32292773339423325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067271684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967188,0.0013011711,0.000055808992,0.0003619666,0.00004578716,0.0000020565951,0.00025867883,0.0000054245743,0.0012503017],"genre_scores_gemma":[0.99880624,0.0003387238,0.000026836187,0.00006825349,0.000078284,0.0000020503805,0.0002456813,0.0000039311835,0.0004300847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948287,0.0001806763,0.000027090398,0.000062608815,0.00006403634,0.00018278077],"domain_scores_gemma":[0.99773395,0.0009517151,0.0003741575,0.00014954891,0.00010432852,0.0006862417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074354024,0.00033392347,0.00051186717,0.00044821197,0.00041108282,0.0005775944,0.00043909997,0.0007856618,0.0032294653],"category_scores_gemma":[0.004452341,0.00018565224,0.0012887445,0.00044484108,0.00034449587,0.0005278667,0.0005871824,0.00080663647,0.0002956083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008835814,0.00018533083,0.97429377,0.000026560494,0.00028713362,0.00043075153,0.000059690083,0.0003787544,0.00080201426,0.00013353399,0.00046809818,0.014098574],"study_design_scores_gemma":[0.000039170376,0.00042771682,0.99825627,0.0000060640123,0.00017895023,0.00030793878,0.00010122777,0.0003508219,0.00007361528,0.000113239956,0.0001380683,0.000006798228],"about_ca_topic_score_codex":0.0058162967,"about_ca_topic_score_gemma":0.009831921,"teacher_disagreement_score":0.0058162967,"about_ca_system_score_codex":0.0005346149,"about_ca_system_score_gemma":0.0006598215,"threshold_uncertainty_score":0.01156491},"labels":[],"label_agreement":null},{"id":"W2067527491","doi":"10.1007/s10549-013-2593-z","title":"ROCK: a resource for integrative breast cancer data analysis","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Resource (disambiguation); Computational biology; Computer science; Annotation; microRNA; Cancer; Bioinformatics; Biology; Data mining; Gene; Genetics","score_opus":0.06464139213229035,"score_gpt":0.3899111970555987,"score_spread":0.3252698049233083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067527491","genre_codex":"dataset","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004988383,0.0013187152,0.15759815,0.00065509457,0.0002630219,0.0005705048,0.6183799,0.20726211,0.008964001],"genre_scores_gemma":[0.02721318,0.0014085631,0.2545193,0.0005705622,0.000140682,0.0025427411,0.6724194,0.03673269,0.004452876],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973827,0.00048697743,0.00051031803,0.00071306643,0.00071179686,0.00019509168],"domain_scores_gemma":[0.9901446,0.0045389,0.0007070098,0.0029877028,0.0010996638,0.0005221116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057091247,0.0022248747,0.002441896,0.0060505467,0.0010024799,0.0033241196,0.004057811,0.0008805333,0.06872442],"category_scores_gemma":[0.02064795,0.0012691475,0.0022457489,0.0058995,0.0006166703,0.002051459,0.003591194,0.0023649582,0.038141064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018668153,0.00020664444,0.00914454,0.0067866556,0.0020749853,0.0008896155,0.0007775509,0.006340687,0.030433625,0.018426301,0.80088663,0.12216603],"study_design_scores_gemma":[0.00091140944,0.00018965745,0.008695612,0.0009535244,0.0014732069,0.0012788108,0.0004833277,0.041218486,0.037221458,0.03573208,0.87150514,0.0003374033],"about_ca_topic_score_codex":0.0044943797,"about_ca_topic_score_gemma":0.010049479,"teacher_disagreement_score":0.06872442,"about_ca_system_score_codex":0.00090133597,"about_ca_system_score_gemma":0.004166363,"threshold_uncertainty_score":0.22990608},"labels":[],"label_agreement":null},{"id":"W2067661283","doi":"10.1007/s10549-007-9606-8","title":"Overcoming endocrine resistance in breast cancer—are signal transduction inhibitors the answer?","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Endocrine system; Hormone; Estrogen receptor; Crosstalk; Signal transduction; Medicine; Hormone receptor; Cancer research; Cancer; Internal medicine; Endocrinology; Bioinformatics; Biology; Cell biology","score_opus":0.041716346678753666,"score_gpt":0.37427800902160474,"score_spread":0.33256166234285106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067661283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016076378,0.99728036,0.00022784536,0.00097415305,0.00057252514,0.0000072742846,0.000020242087,0.000014725055,0.0007420595],"genre_scores_gemma":[0.00080938346,0.9968856,0.0002988163,0.0008078288,0.00031366342,0.000012232904,0.00003581187,0.0000021799056,0.00083452347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980706,0.00003246718,0.000024341784,0.000030291469,0.00007446426,0.00003137032],"domain_scores_gemma":[0.99973994,0.00011528495,0.000032133223,0.000010018772,0.00007062858,0.000031942694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008464786,0.0010214613,0.0021455134,0.0010258509,0.0003204562,0.0012676615,0.0014726123,0.0017318513,0.0030398013],"category_scores_gemma":[0.0008280081,0.00037937227,0.0004854507,0.0015021053,0.000778406,0.0018430057,0.00065244205,0.0033458185,0.0024518461],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000273573,0.00014355767,0.00015741575,0.005503469,0.00011253526,0.00023715428,0.00003741745,0.00050639734,0.0025104277,0.005427144,0.08340464,0.9016863],"study_design_scores_gemma":[0.00011638806,0.00015510972,0.00039545813,0.0009232477,0.00010975769,0.0006679249,0.00004445151,0.000118993456,0.000664278,0.0024320604,0.99435484,0.00001747101],"about_ca_topic_score_codex":0.0011019008,"about_ca_topic_score_gemma":0.0026369158,"teacher_disagreement_score":0.0030398013,"about_ca_system_score_codex":0.00075473177,"about_ca_system_score_gemma":0.00078438973,"threshold_uncertainty_score":0.010169148},"labels":[],"label_agreement":null},{"id":"W2067928417","doi":"10.1007/s10549-008-0114-2","title":"Cognitive impairments associated with breast cancer treatments: results from a longitudinal study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Fondation du cancer du sein du Québec","keywords":"Breast cancer; Medicine; Verbal fluency test; Radiation therapy; Chemotherapy; Cognition; Cancer; Oncology; Verbal memory; Chemotherapy regimen; Internal medicine; Neuropsychology; Verbal learning; Psychiatry","score_opus":0.10710883099612725,"score_gpt":0.39662519745529545,"score_spread":0.28951636645916823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067928417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976292,0.0014624262,0.00007101517,0.00007284652,0.000013882664,0.000041837822,0.0004415195,0.0000031591671,0.00026403484],"genre_scores_gemma":[0.99663347,0.0012931633,0.0002015406,0.0001559555,0.000029468854,0.000110587105,0.0011045631,0.0000040848786,0.00046726567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986405,0.0005801226,0.00015060838,0.00023718756,0.00019300176,0.00019864272],"domain_scores_gemma":[0.99376386,0.0011237008,0.0022687996,0.00073961425,0.0011466246,0.00095738494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004449588,0.00070006365,0.0008874688,0.0011875445,0.0017848358,0.001334289,0.000757167,0.00094362826,0.0008531843],"category_scores_gemma":[0.007402005,0.0006904619,0.0017479714,0.0023744465,0.0006163812,0.0011091433,0.0010877158,0.0014249791,0.0002446227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018907759,0.0008185069,0.9919996,0.000051023984,0.0011816481,0.00006614421,0.00063527696,0.00003320384,0.00016393376,0.000020283747,0.00023425324,0.0029053215],"study_design_scores_gemma":[0.00010459256,0.0006091534,0.99786097,0.000021128952,0.0005653304,0.0000633034,0.00042482186,0.000030261814,0.00005409115,0.000017771266,0.00023834722,0.000010340266],"about_ca_topic_score_codex":0.048201974,"about_ca_topic_score_gemma":0.056385707,"teacher_disagreement_score":0.048201974,"about_ca_system_score_codex":0.001228088,"about_ca_system_score_gemma":0.0015419524,"threshold_uncertainty_score":0.09584284},"labels":[],"label_agreement":null},{"id":"W2068553049","doi":"10.1007/s10549-007-9673-x","title":"Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Institutes of Health; Institut National Du Cancer; National Cancer Institute; Ligue Contre le Cancer; Pfizer","keywords":"Breast cancer; Oncology; Internal medicine; Epirubicin; Medicine; Cancer; Proportional hazards model; Regimen","score_opus":0.03870086731612015,"score_gpt":0.34284658746365215,"score_spread":0.304145720147532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068553049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936376,0.000051050993,0.005556486,0.00011030412,0.0000057234165,0.0000236285,0.00018377141,0.000024591624,0.00040684658],"genre_scores_gemma":[0.99830985,0.000029484687,0.001054668,0.00001607114,0.0000028384106,0.000018417202,0.00015189659,0.0000055486853,0.00041111547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998142,0.000107452266,0.0000040340988,0.000034147004,0.000014116906,0.000026121535],"domain_scores_gemma":[0.99948126,0.0003851787,0.00004161469,0.00004079026,0.000024748708,0.0000264566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010009974,0.00035677926,0.0004430759,0.00026087151,0.00019032873,0.00043210867,0.00033435543,0.00035999084,0.000881633],"category_scores_gemma":[0.0014358289,0.00017389332,0.00031242424,0.00017911522,0.00022730113,0.00022846767,0.00014594632,0.00051462196,0.00012439855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023702716,0.0045547998,0.44250098,0.0000994641,0.00074249017,0.00074505364,0.0002675329,0.28782967,0.14244707,0.006851079,0.0023551933,0.08790387],"study_design_scores_gemma":[0.0002514661,0.0026699628,0.121734776,0.00000794525,0.00030679264,0.0003611364,0.00008327825,0.8576283,0.0127096195,0.0035270222,0.0006842784,0.00003539532],"about_ca_topic_score_codex":0.003946344,"about_ca_topic_score_gemma":0.0034784155,"teacher_disagreement_score":0.003946344,"about_ca_system_score_codex":0.00041073305,"about_ca_system_score_gemma":0.0004820493,"threshold_uncertainty_score":0.007846713},"labels":[],"label_agreement":null},{"id":"W2068803310","doi":"10.1007/s10549-011-1740-7","title":"Vascular proliferation is increased in basal-like breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Universitetet i Bergen; Susan G. Komen","keywords":"Angiogenesis; Breast cancer; Basal (medicine); Cytokeratin; Immunohistochemistry; Cancer; Proliferation index; Pathology; Neovascularization; Vascular endothelial growth factor; Biology; Cancer research; Medicine; Internal medicine; VEGF receptors","score_opus":0.04833121284198428,"score_gpt":0.33150556991343805,"score_spread":0.2831743570714538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068803310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99016106,0.004312142,0.0011889173,0.0001300016,0.000053218497,0.000012411165,0.000947987,0.00017780962,0.0030164137],"genre_scores_gemma":[0.99507856,0.0011462062,0.00043901065,0.000046757956,0.000044799584,0.000024717263,0.0008464952,0.000013848926,0.002359575],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985194,0.000028678212,0.000008154386,0.000025945943,0.000043865635,0.00004140436],"domain_scores_gemma":[0.99974304,0.00004289781,0.000049143197,0.000018533001,0.000037864622,0.00010846994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014360549,0.00014324307,0.00033270702,0.00094840536,0.00032202146,0.0006366076,0.000121735706,0.0002925115,0.0021250378],"category_scores_gemma":[0.00029425242,0.00023244934,0.00018703884,0.0005690983,0.00019327048,0.00022832154,0.00015912479,0.00062891043,0.00055211276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020286236,0.0001233746,0.022484642,0.000115711955,0.000028682674,0.00059652975,0.00010061266,0.000046425914,0.9647209,0.00017825392,0.00048743788,0.009088722],"study_design_scores_gemma":[0.000055158536,0.00078927324,0.6597145,0.000017651597,0.000077643184,0.0064807027,0.00059323385,0.00059652404,0.32371166,0.0003780764,0.0075670076,0.00001858912],"about_ca_topic_score_codex":0.0007302719,"about_ca_topic_score_gemma":0.00053172983,"teacher_disagreement_score":0.0021250378,"about_ca_system_score_codex":0.00023521966,"about_ca_system_score_gemma":0.00015890432,"threshold_uncertainty_score":0.007108927},"labels":[],"label_agreement":null},{"id":"W2069659635","doi":"10.1007/s10549-013-2416-2","title":"PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; U.S. Public Health Service; Universitat de Barcelona; Universitat Autònoma de Barcelona; National Cancer Institute; National Institutes of Health; Sociedad Española de Oncología Médica; Vancouver Coastal Health Research Institute; Breast Cancer Research Foundation","keywords":"Medicine; Paclitaxel; Internal medicine; Oncology; Breast cancer; Anthracycline; Clinical endpoint; Chemotherapy; Proportional hazards model; Adjuvant; Clinical trial; Randomized controlled trial; Cancer","score_opus":0.028572442873062938,"score_gpt":0.32695856392894357,"score_spread":0.29838612105588064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069659635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899,0.00040632163,0.00015525764,0.000042445685,0.0000057182506,0.000011030041,0.00007563587,0.0000051763454,0.00030849208],"genre_scores_gemma":[0.99929,0.00007739223,0.00021103138,0.00004050145,0.0000133216645,0.000011011803,0.00019970105,0.0000017619774,0.00015525053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998159,0.00008843155,0.000014312925,0.000025127538,0.000030118212,0.000026161142],"domain_scores_gemma":[0.9993319,0.00029870574,0.00019333625,0.000042950807,0.000028942595,0.00010418256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005443331,0.00015796874,0.00034210357,0.00022328518,0.0001225925,0.00028332934,0.00014932636,0.00032606442,0.0009989262],"category_scores_gemma":[0.0014284947,0.00012235227,0.00028831547,0.00025871734,0.00012538163,0.00017786975,0.00016698746,0.0004945502,0.00014494335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021396402,0.0003335515,0.9329129,0.000053872747,0.00030704652,0.00018687895,0.00003185013,0.0018955388,0.00809471,0.000092387476,0.00053945574,0.03415553],"study_design_scores_gemma":[0.0007349219,0.0033970242,0.9874741,0.000008860708,0.00028515028,0.00045882032,0.000029133438,0.0050914222,0.001440059,0.00026986728,0.00080222666,0.000008530211],"about_ca_topic_score_codex":0.00029839424,"about_ca_topic_score_gemma":0.00080929877,"teacher_disagreement_score":0.0009989262,"about_ca_system_score_codex":0.00014299633,"about_ca_system_score_gemma":0.00018104295,"threshold_uncertainty_score":0.0033416748},"labels":[],"label_agreement":null},{"id":"W2070086300","doi":"10.1007/s10549-008-0086-2","title":"Pattern of metastatic spread in triple-negative breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":558,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Triple-negative breast cancer; Internal medicine; Cancer; Progesterone receptor; Oncology; Estrogen receptor; Hazard ratio; Incidence (geometry); Metastasis; Cohort; Metastatic breast cancer; Gynecology; Confidence interval","score_opus":0.10863370371260445,"score_gpt":0.4209652545074436,"score_spread":0.31233155079483915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070086300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910659,0.0018829529,0.0004501473,0.00010577574,0.000006600797,0.000021386317,0.00086838607,0.00002633971,0.0055724964],"genre_scores_gemma":[0.9978403,0.00062822195,0.00029873074,0.000020504625,0.0000073628153,0.00000813348,0.0003523176,0.000012717584,0.00083173806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996947,0.00007668711,0.00003662983,0.000047222045,0.00007410524,0.00007067423],"domain_scores_gemma":[0.9990689,0.00026584143,0.00027691314,0.00009016654,0.00017108758,0.00012707361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030544036,0.00015779184,0.00025291173,0.0019908615,0.00033314727,0.0006052848,0.00036668323,0.0003819593,0.005551944],"category_scores_gemma":[0.002580406,0.00016475095,0.00026547443,0.0011664396,0.00027982335,0.0003942613,0.0004821649,0.00028182412,0.0008222273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00143959,0.000042489857,0.9591746,0.00009960015,0.000051984254,0.0017531415,0.00033706153,0.000330198,0.012431854,0.00043393503,0.0005902535,0.023315392],"study_design_scores_gemma":[0.000013156228,0.00014001856,0.98531914,0.00003945399,0.000040111972,0.010698576,0.00074255466,0.00064217293,0.00089426484,0.0004300418,0.001029596,0.000010842546],"about_ca_topic_score_codex":0.00541082,"about_ca_topic_score_gemma":0.009010971,"teacher_disagreement_score":0.005551944,"about_ca_system_score_codex":0.00034351757,"about_ca_system_score_gemma":0.00025745673,"threshold_uncertainty_score":0.018573046},"labels":[],"label_agreement":null},{"id":"W2070618523","doi":"10.1007/s10549-009-0352-y","title":"Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Essar Steel Algoma (Canada)","funders":"AstraZeneca; Amgen","keywords":"Denosumab; Medicine; Femoral neck; Bone mineral; Breast cancer; Placebo; Internal medicine; Aromatase inhibitor; Subgroup analysis; Oncology; Osteoporosis; Tamoxifen; Urology; Cancer; Meta-analysis; Pathology","score_opus":0.054963915460917084,"score_gpt":0.450782485112127,"score_spread":0.3958185696512099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070618523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825174,0.014661421,0.00044614624,0.00024597681,0.0001759846,0.00037586948,0.0010589517,0.00003573592,0.00048246005],"genre_scores_gemma":[0.99524814,0.0021100848,0.00034728952,0.00027714967,0.00015082958,0.00023187126,0.0011006793,0.000019366284,0.00051462813],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970847,0.0016220352,0.00036257546,0.00034691754,0.00030277303,0.00028111576],"domain_scores_gemma":[0.9978644,0.00095701596,0.00041117196,0.0004083182,0.00015237408,0.00020659334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005350699,0.002224897,0.0058923983,0.00073189416,0.0005681038,0.0012613817,0.0010257678,0.0014520322,0.0016257787],"category_scores_gemma":[0.00499136,0.00093726953,0.0121009555,0.0010845012,0.0005980691,0.0008229523,0.0007754579,0.0019921076,0.00021265993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.873335,0.00088632514,0.030428724,0.0009553916,0.07474004,0.00014138037,0.00013276783,0.0008489466,0.0041972836,0.000058964946,0.0005229855,0.013752227],"study_design_scores_gemma":[0.43855026,0.06299298,0.26107496,0.00022864358,0.22842303,0.00037338922,0.00040880236,0.0021540083,0.0026816588,0.0008534657,0.00206869,0.00019014865],"about_ca_topic_score_codex":0.0036733449,"about_ca_topic_score_gemma":0.009536784,"teacher_disagreement_score":0.0058923983,"about_ca_system_score_codex":0.0008692457,"about_ca_system_score_gemma":0.0010973504,"threshold_uncertainty_score":0.028297484},"labels":[],"label_agreement":null},{"id":"W2070651249","doi":"10.1007/s10549-010-0774-6","title":"Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the breast cancer family registry","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Body mass index; Hazard ratio; Overweight; Internal medicine; Cancer; Proportional hazards model; Cancer registry; Population; National Death Index; Confidence interval; Demography; Oncology; Environmental health","score_opus":0.08919298459098243,"score_gpt":0.41875437041422353,"score_spread":0.3295613858232411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070651249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864676,0.0002713933,0.00013551903,0.000066570865,0.000011379596,0.000027110733,0.012188662,0.000014372541,0.00081726874],"genre_scores_gemma":[0.9880718,0.0003676187,0.00022558052,0.000059764967,0.000023923445,0.00007080027,0.01039368,0.000011157087,0.00077579194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993056,0.00023125231,0.000107149615,0.00013086232,0.00014489863,0.00008033045],"domain_scores_gemma":[0.99737597,0.00048804184,0.0010510851,0.00032202378,0.00038080322,0.00038206825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001020265,0.00032360613,0.00064166094,0.0011210808,0.00053386175,0.000562511,0.0006514461,0.0005763005,0.0017581208],"category_scores_gemma":[0.0033983511,0.0005515492,0.0008434991,0.0023335589,0.0001850344,0.0008176285,0.000684337,0.00067716814,0.0004923332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010609715,0.0000388514,0.99895453,0.000009872234,0.000075500444,0.000016573702,0.000026009178,0.000046337107,0.000042288306,0.0000049852874,0.0002356022,0.0004434277],"study_design_scores_gemma":[0.000007960941,0.000030727904,0.999605,0.0000026545647,0.000041512456,0.00005086882,0.000052569078,0.000067903566,0.000019093044,0.0000035504117,0.000115815936,0.0000023873647],"about_ca_topic_score_codex":0.025554068,"about_ca_topic_score_gemma":0.040893517,"teacher_disagreement_score":0.025554068,"about_ca_system_score_codex":0.00042719772,"about_ca_system_score_gemma":0.0005905514,"threshold_uncertainty_score":0.050810635},"labels":[],"label_agreement":null},{"id":"W2071102398","doi":"10.1023/a:1017938608460","title":"Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; Health Sciences Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Medical Research Council","keywords":"Androgen receptor; Cancer research; Biology; Transactivation; Breast cancer; Endocrinology; Internal medicine; Cancer; Gene expression; Medicine; Prostate cancer; Gene","score_opus":0.052325602305618654,"score_gpt":0.3874648457897417,"score_spread":0.33513924348412305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071102398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907196,0.00025523655,0.000093156945,0.000023399527,0.0000030804845,0.0000028941538,0.000076831144,0.000008035668,0.00046548966],"genre_scores_gemma":[0.9994004,0.00012619814,0.000049509104,0.0000124868975,0.0000065330923,0.0000027168894,0.00010829015,0.000002585726,0.000291231],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999248,0.000008600924,0.0000051857423,0.000009417635,0.000023577177,0.000028304405],"domain_scores_gemma":[0.99987674,0.000021921596,0.00003070878,0.0000145555205,0.00001970275,0.000036388752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095068885,0.00011113812,0.00020717629,0.000500221,0.00019751319,0.0003410799,0.00017277738,0.00015867676,0.000903715],"category_scores_gemma":[0.00031767925,0.00008447245,0.00012577498,0.0002793238,0.00015377368,0.00012886684,0.00014985926,0.00017716223,0.00023036281],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001555568,0.00015216075,0.16337898,0.00004653533,0.00006268412,0.003093336,0.00018549274,0.00024634475,0.80894184,0.00028270375,0.00058804377,0.021466311],"study_design_scores_gemma":[0.000029733888,0.0004773583,0.93457025,0.0000044556255,0.00006267876,0.018597115,0.00036128968,0.0006773058,0.042615775,0.00021056544,0.0023820722,0.000011456571],"about_ca_topic_score_codex":0.0007220539,"about_ca_topic_score_gemma":0.0006331843,"teacher_disagreement_score":0.000903715,"about_ca_system_score_codex":0.0001242532,"about_ca_system_score_gemma":0.00011146033,"threshold_uncertainty_score":0.0030232668},"labels":[],"label_agreement":null},{"id":"W2071523786","doi":"10.1007/s10549-013-2591-1","title":"Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Guelph; Juravinski Hospital; McMaster University; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Juravinski Cancer Centre","funders":"National Institutes of Health; Ontario Institute for Cancer Research; National Cancer Institute; Cancer Care Ontario","keywords":"Breast cancer; CD24; CD44; Medicine; Oncology; Cancer stem cell; Cancer; Pathology; Internal medicine; Cancer research; Biology; Cell; Genetics","score_opus":0.07837988311216067,"score_gpt":0.3962498067276852,"score_spread":0.3178699236155246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071523786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989956,0.00029462553,0.00004720356,0.00001920013,0.0000015600507,0.0000032058003,0.00013492825,0.0000029539583,0.0005008261],"genre_scores_gemma":[0.9996916,0.00005406979,0.00004582332,0.0000047898498,0.000002515552,0.0000024223918,0.00012974431,7.669038e-7,0.0000682856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996822,0.00006567658,0.000038450053,0.00006374334,0.00008618947,0.00006369995],"domain_scores_gemma":[0.9991555,0.00021230956,0.00030208472,0.0000576464,0.00014208326,0.00013039845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040108187,0.00016014937,0.00019032657,0.0009911625,0.00047634853,0.00036166125,0.00018075695,0.00021925676,0.0010790809],"category_scores_gemma":[0.0018053562,0.00011015089,0.00011764415,0.00080614205,0.00041866276,0.00014218353,0.00018277814,0.00011541628,0.000111529866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011227149,0.0000054801635,0.9965599,0.0000075919206,0.000011277073,0.00049146434,0.00006380993,0.00004284323,0.001310023,0.000013015097,0.000050643102,0.0013316876],"study_design_scores_gemma":[0.0000022642544,0.000024505027,0.9976665,0.0000018359832,0.0000111191885,0.0016816019,0.00008982204,0.00008345733,0.00025303752,0.000020961359,0.00016331083,0.0000017079707],"about_ca_topic_score_codex":0.011091684,"about_ca_topic_score_gemma":0.019893086,"teacher_disagreement_score":0.011091684,"about_ca_system_score_codex":0.00054662075,"about_ca_system_score_gemma":0.0004130788,"threshold_uncertainty_score":0.022054255},"labels":[],"label_agreement":null},{"id":"W2071551172","doi":"10.1007/s10549-012-2342-8","title":"Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; National Institutes of Health; Susan G. Komen; Georgetown University","keywords":"Breast cancer; Medicine; Body mass index; Quartile; Odds ratio; Cancer; Confidence interval; Cohort study; Internal medicine; Prospective cohort study; Cohort; Demography; Logistic regression; European Prospective Investigation into Cancer and Nutrition; Oncology; Gynecology","score_opus":0.047433011367195306,"score_gpt":0.3498053930371468,"score_spread":0.3023723816699515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071551172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949033,0.00031603334,0.000085308704,0.00007318297,0.000011746073,0.000010337331,0.0037810374,0.0000066705925,0.0008123877],"genre_scores_gemma":[0.9944055,0.0005406387,0.00022140147,0.0000494515,0.000018846926,0.000028092769,0.0037685265,0.000008697813,0.000958897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999539,0.00014889946,0.00006654987,0.00010690403,0.00008952266,0.00004908395],"domain_scores_gemma":[0.9988086,0.0001597346,0.00043166653,0.00021827301,0.00017591195,0.00020593668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080916425,0.0002784663,0.0005481654,0.00095998374,0.00079331885,0.00050114177,0.0004463662,0.00046788677,0.0021595254],"category_scores_gemma":[0.0028882914,0.00058810855,0.00053821923,0.0023110248,0.0001581624,0.0006928097,0.00070921576,0.00050199515,0.00049037684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001437652,0.000026135058,0.9984219,0.00001079176,0.00007106943,0.00010282786,0.00015299156,0.000016053918,0.00018676824,0.000013118067,0.00028163914,0.000573051],"study_design_scores_gemma":[0.00001489874,0.000052866082,0.9983327,0.0000107125725,0.00006254254,0.00049344724,0.00041609688,0.00006882922,0.00007859531,0.0000141699975,0.00045001975,0.0000052768387],"about_ca_topic_score_codex":0.030202,"about_ca_topic_score_gemma":0.041013468,"teacher_disagreement_score":0.030202,"about_ca_system_score_codex":0.00032223796,"about_ca_system_score_gemma":0.0004907346,"threshold_uncertainty_score":0.060052395},"labels":[],"label_agreement":null},{"id":"W2071635593","doi":"10.1007/s10549-008-0009-2","title":"RETRACTED ARTICLE: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Wnt signaling pathway; Glypican 3; Cancer research; Biology; Cell biology; Actin cytoskeleton; Cell migration; Signal transduction; Metastasis; LRP5; Cell growth; Cell; Cancer; Cytoskeleton","score_opus":0.026058663316471838,"score_gpt":0.28695819469347694,"score_spread":0.2608995313770051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071635593","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077776397,0.01178087,0.0028677804,0.1415121,0.83144265,0.000044608267,0.000774608,0.0005692104,0.0032305112],"genre_scores_gemma":[0.092850916,0.02820465,0.009335415,0.16074225,0.51099056,0.00018495582,0.004010695,0.00078315637,0.19289738],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986676,0.0001433833,0.00023099319,0.00015793009,0.0006102767,0.00018988826],"domain_scores_gemma":[0.99591196,0.0011828477,0.00043405447,0.0002754341,0.0015298298,0.0006659447],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002090001,0.001469438,0.0015759674,0.0029034547,0.00205557,0.0020032914,0.0031285374,0.007402373,0.013181332],"category_scores_gemma":[0.008328336,0.0006772514,0.0013870504,0.0013369439,0.0016155366,0.0018164235,0.0014581374,0.0055346033,0.007364832],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007279121,0.000099586774,0.0011377328,0.0007096857,0.00011085576,0.015573366,0.0001988582,0.00029204323,0.0052598445,0.0016044488,0.91715485,0.05713084],"study_design_scores_gemma":[0.0001266542,0.00018528188,0.0050423066,0.00024304262,0.00020419569,0.012270485,0.00023391399,0.0010938541,0.008803718,0.001573848,0.97013915,0.000083475585],"about_ca_topic_score_codex":0.0030495247,"about_ca_topic_score_gemma":0.003911283,"teacher_disagreement_score":0.99259764,"about_ca_system_score_codex":0.0032071932,"about_ca_system_score_gemma":0.002241126,"threshold_uncertainty_score":0.044095933},"labels":[],"label_agreement":null},{"id":"W2071788805","doi":"10.1007/s10549-010-0909-9","title":"Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T&gt;A/c.130T&gt;A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Frameshift mutation; Mutation; Genetics; Biology; Founder effect; BRCA2 Protein; Single-nucleotide polymorphism; Ovarian cancer; Nonsense mutation; Cancer; Population; Germline mutation; Gene; Medicine; Haplotype; Missense mutation; Genotype","score_opus":0.024354477158658,"score_gpt":0.33440656325665474,"score_spread":0.3100520860979967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071788805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979448,0.00016245888,0.0002446239,0.00033772815,0.00002244032,0.000021642187,0.00021500478,0.0000121978555,0.0010390732],"genre_scores_gemma":[0.998276,0.00008358927,0.0005633345,0.00016719058,0.00001792878,0.00001185219,0.00012883263,0.000009518353,0.0007417145],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998248,0.000016987351,0.000015017098,0.000059867143,0.000043208944,0.000040065992],"domain_scores_gemma":[0.9996197,0.00012248037,0.00008680118,0.0000131431525,0.000029088644,0.00012879855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016053465,0.0007886987,0.00034083298,0.0012719459,0.0009181026,0.00031824916,0.00058361073,0.0016091503,0.002311565],"category_scores_gemma":[0.00069639954,0.00028860202,0.000342762,0.0005590602,0.0006858557,0.00018342918,0.00035842007,0.00049307925,0.0002304597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005764786,0.00032759868,0.1433498,0.00008058508,0.00009769979,0.73301387,0.0034077805,0.00045701626,0.10638089,0.0009337234,0.001153699,0.010220813],"study_design_scores_gemma":[0.00016352453,0.00054415513,0.41912735,0.00007949327,0.00027887005,0.54964024,0.0017937328,0.0022582994,0.020382928,0.00064905925,0.0049967235,0.00008552688],"about_ca_topic_score_codex":0.023473836,"about_ca_topic_score_gemma":0.02891236,"teacher_disagreement_score":0.023473836,"about_ca_system_score_codex":0.00063408824,"about_ca_system_score_gemma":0.000520361,"threshold_uncertainty_score":0.04667437},"labels":[],"label_agreement":null},{"id":"W2071831087","doi":"10.1007/s10549-004-3778-2","title":"Pathology of breast cancer in women with constitutional CHEK2 mutations","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"CHEK2; Breast cancer; Missense mutation; Medicine; Male breast cancer; Oncology; Histology; Pathology; Cancer; Internal medicine; Mutation; Germline mutation; Biology; Gene; Genetics","score_opus":0.02212291869023115,"score_gpt":0.34282543578039465,"score_spread":0.3207025170901635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071831087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99119216,0.0018006185,0.00030165957,0.00015477158,0.000025221421,0.000016249656,0.00035451312,0.00005422661,0.0061006397],"genre_scores_gemma":[0.99870014,0.00049309625,0.00018994407,0.000027145343,0.000018152708,0.000005501426,0.00012887988,0.000007009046,0.0004301855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985564,0.00002214141,0.0000125726765,0.000026606762,0.00003257871,0.000050571194],"domain_scores_gemma":[0.9996716,0.00008795003,0.0000844673,0.000033213317,0.000048298734,0.00007451611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027615397,0.00028207386,0.00018777451,0.0024825626,0.0004617603,0.0005810036,0.00026646975,0.00041613635,0.0032158329],"category_scores_gemma":[0.0011675991,0.00033527534,0.00015386227,0.00076358655,0.0004960967,0.00032519177,0.00042106622,0.0002574128,0.00048961345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003656812,0.000058999864,0.8801979,0.000107437874,0.00006926035,0.028575778,0.00032607175,0.00030495704,0.06652081,0.000557303,0.0009733506,0.01865138],"study_design_scores_gemma":[0.000040071525,0.00020168502,0.9103359,0.000013831322,0.00009152009,0.07329283,0.0005484799,0.0005501314,0.012109939,0.0004019402,0.0023997605,0.000013972464],"about_ca_topic_score_codex":0.0016924951,"about_ca_topic_score_gemma":0.0012122979,"teacher_disagreement_score":0.0032158329,"about_ca_system_score_codex":0.0003512999,"about_ca_system_score_gemma":0.0003127595,"threshold_uncertainty_score":0.010757983},"labels":[],"label_agreement":null},{"id":"W2072319283","doi":"10.1023/b:brea.0000019951.32001.93","title":"BAG-1 Expression Correlates with Bcl-2, p53, Differentiation, Estrogen and Progesterone Receptors in Invasive Breast Carcinoma","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Manitoba; Memorial University of Newfoundland; McGill University","funders":"Sylvester Comprehensive Cancer Center, University of Miami Health Systems; National Cancer Institute; Health Research Board; Canadian Institutes of Health Research; University of Miami","keywords":"Carcinogenesis; Breast cancer; Estrogen receptor; Cancer research; Progesterone receptor; Estrogen; Cancer; Biology; Internal medicine; Oncology; CA15-3; Medicine","score_opus":0.020179549061222404,"score_gpt":0.29708731940540034,"score_spread":0.27690777034417796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072319283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985464,0.0006064818,0.00014456255,0.00003340414,0.000007447644,0.000002586941,0.00010253895,0.0000126146415,0.000543837],"genre_scores_gemma":[0.99851817,0.0002273699,0.0000847508,0.000017514536,0.000010234588,0.0000066790203,0.00025272564,0.0000030417302,0.0008795707],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998956,0.000015383019,0.0000073286683,0.000011052681,0.000026287782,0.000044315577],"domain_scores_gemma":[0.9996592,0.000060268667,0.00008521564,0.000025817146,0.00004927676,0.000120188095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014304582,0.00012344871,0.0001516651,0.00076538563,0.00022683239,0.000439409,0.00017472183,0.00019768049,0.0020045023],"category_scores_gemma":[0.00034766964,0.00018053871,0.00010986986,0.0005371957,0.00021595931,0.00029136587,0.0002529824,0.00043401733,0.00054073834],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002853575,0.00022163616,0.2605202,0.00007690692,0.00005905686,0.00046754972,0.00021503707,0.00013412896,0.7261958,0.0003779145,0.00041465493,0.0084636],"study_design_scores_gemma":[0.000032392694,0.0002721299,0.9587423,0.000008009898,0.000050052513,0.0012282466,0.0003024659,0.0005241808,0.037320197,0.00018843434,0.0013218314,0.0000098305045],"about_ca_topic_score_codex":0.00058832805,"about_ca_topic_score_gemma":0.00074308336,"teacher_disagreement_score":0.0020045023,"about_ca_system_score_codex":0.00019495602,"about_ca_system_score_gemma":0.00015783985,"threshold_uncertainty_score":0.006705761},"labels":[],"label_agreement":null},{"id":"W2073204385","doi":"10.1007/s10549-012-2216-0","title":"Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Tristetraprolin; Breast cancer; Immunostaining; Prolactin; Cancer research; Biology; Messenger RNA; Cancer; Mammary gland; Gene expression; Mammary tumor; Internal medicine; Endocrinology; Immunohistochemistry; Medicine; Hormone; RNA-binding protein; Gene; Immunology; Genetics","score_opus":0.03688845181477152,"score_gpt":0.33323685891707167,"score_spread":0.29634840710230015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073204385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98599744,0.0021731304,0.005902816,0.0002604206,0.00008624604,0.000039637758,0.00068526185,0.0003946408,0.0044602538],"genre_scores_gemma":[0.98628485,0.00075025175,0.0030758092,0.00010051275,0.000015989472,0.00003438041,0.0015075469,0.00010832517,0.008122275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980694,0.000026817588,0.000017347444,0.00003977442,0.00006348253,0.000045514178],"domain_scores_gemma":[0.9997713,0.000047194146,0.00006221078,0.000025488145,0.000021657102,0.00007214884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014301855,0.000326052,0.00019422425,0.00045720066,0.00021388674,0.00037651943,0.00021076447,0.00026920388,0.0010065368],"category_scores_gemma":[0.0001428452,0.00023637347,0.00027307472,0.00023380031,0.00025497482,0.00014157582,0.00025521705,0.00059055927,0.00056607684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005505152,0.0000067586943,0.000049724946,0.0000067161395,0.0000012965436,0.000024230952,0.0000058191736,0.00001188822,0.99948275,0.000056071345,0.00001958433,0.00028001764],"study_design_scores_gemma":[0.0000049794894,0.000047861464,0.0015564342,0.0000018086429,0.000006294274,0.00013658045,0.00001479882,0.00032093207,0.9963437,0.00002438866,0.0015400678,0.0000022534612],"about_ca_topic_score_codex":0.0010845094,"about_ca_topic_score_gemma":0.0019776716,"teacher_disagreement_score":0.0010845094,"about_ca_system_score_codex":0.00078791176,"about_ca_system_score_gemma":0.0003091776,"threshold_uncertainty_score":0.005716741},"labels":[],"label_agreement":null},{"id":"W2073212579","doi":"10.1007/s10549-014-2908-8","title":"Microsatellite genotyping reveals a signature in breast cancer exomes","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; National Science Foundation","keywords":"Breast cancer; Microsatellite; Genotyping; Biology; Exome; Microsatellite instability; Genetics; Exome sequencing; Cancer; Genotype; Allele; Gene; Mutation","score_opus":0.041833705064124316,"score_gpt":0.36168945988465556,"score_spread":0.31985575482053125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073212579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98208076,0.0010483541,0.010215144,0.00027738538,0.000029816361,0.000038204038,0.0047321278,0.00024357477,0.001334544],"genre_scores_gemma":[0.9768077,0.00041170928,0.015731864,0.00028817554,0.00001886585,0.00004787304,0.0054432037,0.0000515178,0.0011990522],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99938524,0.00011188399,0.00006795276,0.00020325446,0.00016711572,0.00006459361],"domain_scores_gemma":[0.99918514,0.00030003794,0.00024114289,0.00010765844,0.00011515364,0.000050775543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000546017,0.00018462341,0.0003362332,0.0011426237,0.00025995186,0.00049325486,0.00017602816,0.0005424708,0.0012268405],"category_scores_gemma":[0.0023281535,0.00017904812,0.00028071503,0.00089486496,0.00011142548,0.00016832358,0.00043448302,0.00023995325,0.0005073923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009355858,0.000054318618,0.20321557,0.00029757633,0.0002935037,0.0010803891,0.0003223392,0.0010690332,0.7421156,0.00062404695,0.001818542,0.048173293],"study_design_scores_gemma":[0.00006503694,0.00025388552,0.8582103,0.00007988192,0.0002973665,0.006237003,0.00022075718,0.010283747,0.1094493,0.0020258077,0.01282888,0.00004800291],"about_ca_topic_score_codex":0.00053226936,"about_ca_topic_score_gemma":0.0018167201,"teacher_disagreement_score":0.0012268405,"about_ca_system_score_codex":0.00020840346,"about_ca_system_score_gemma":0.00012403444,"threshold_uncertainty_score":0.004104197},"labels":[],"label_agreement":null},{"id":"W2073550420","doi":"10.1007/s10549-008-0260-6","title":"Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; St. Boniface Hospital; University of Manitoba","funders":"","keywords":"Trastuzumab; Medicine; Cardiotoxicity; Breast cancer; Internal medicine; Cardiomyopathy; Cardiology; Asymptomatic; Ejection fraction; Oncology; Coronary artery disease; Population; Ventricle; Cancer; Heart failure; Chemotherapy","score_opus":0.052527934148644206,"score_gpt":0.3703070964892654,"score_spread":0.3177791623406212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073550420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871695,0.00064433005,0.00013287457,0.0000126573,0.0000030105873,0.000012424294,0.00006223983,0.0000014040028,0.00041421663],"genre_scores_gemma":[0.99947995,0.00021661543,0.000053800057,0.000018932988,0.000010232808,0.000006191897,0.00009475943,0.0000014468983,0.00011806707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995266,0.00013237016,0.00008308942,0.00011479348,0.00007113992,0.00007204436],"domain_scores_gemma":[0.99855894,0.00027059924,0.000681554,0.00018049793,0.00015096534,0.00015742559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006953315,0.00022751925,0.00034931686,0.0004928645,0.00037343768,0.0004825364,0.00024970036,0.00041628137,0.0011704708],"category_scores_gemma":[0.0017707986,0.00026382625,0.00041684465,0.0006474439,0.00038502182,0.00029522946,0.00037388474,0.00039126538,0.00022801831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052330364,0.000059797418,0.9962423,0.00001905669,0.00006193304,0.00079560274,0.00008611345,0.00003951629,0.0005610268,0.000033302975,0.00003441998,0.0015436546],"study_design_scores_gemma":[0.0000309166,0.0013258891,0.98814034,0.000015702517,0.00027274317,0.007844961,0.00047024785,0.0001825702,0.0006757692,0.00006123495,0.00096922787,0.000010345704],"about_ca_topic_score_codex":0.0009030724,"about_ca_topic_score_gemma":0.0008535758,"teacher_disagreement_score":0.0011704708,"about_ca_system_score_codex":0.00032120742,"about_ca_system_score_gemma":0.00035247122,"threshold_uncertainty_score":0.0039155483},"labels":[],"label_agreement":null},{"id":"W2073596729","doi":"10.1007/s10549-004-0780-7","title":"Association between the T27C polymorphism in the cytochrome P450 c17? (CYP17) gene and risk factors for breast cancer","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Children’s Health Research Institute; BC Research (Canada); Ontario Institute for Cancer Research","funders":"Health Canada","keywords":"Breast cancer; Genotype; Internal medicine; Endocrinology; Risk factors for breast cancer; Medicine; Dehydroepiandrosterone sulfate; Allele; Sex hormone-binding globulin; Hormone; Risk factor; Oncology; Cancer; Biology; Gene; Genetics; Androgen","score_opus":0.060778559392772255,"score_gpt":0.37335458773814423,"score_spread":0.31257602834537196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073596729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974722,0.0007399728,0.0002807644,0.00028557688,0.000040388855,0.000005960823,0.00027902346,0.00001642612,0.0008796194],"genre_scores_gemma":[0.9988674,0.00018380285,0.00015431474,0.000039143742,0.00005187019,0.000004568629,0.0001686985,0.000008676202,0.000521431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960726,0.00015306644,0.0000335206,0.00006339339,0.00007253961,0.00007028461],"domain_scores_gemma":[0.99756086,0.0009240982,0.00064481015,0.00016770998,0.00028157583,0.00042090993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039412075,0.0003050949,0.00047243744,0.00078900653,0.00028743502,0.0003132289,0.0002672256,0.0006999096,0.0034012592],"category_scores_gemma":[0.0022283748,0.00025689643,0.00060276734,0.0010042407,0.0003054654,0.00013695718,0.00014547227,0.0009810546,0.00031474928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020365147,0.0001465771,0.9865324,0.000023881319,0.00040790526,0.00088380027,0.000050126975,0.00020199246,0.006008842,0.00010954649,0.00049200235,0.0031064693],"study_design_scores_gemma":[0.00008849537,0.00038613583,0.99394,0.0000092400205,0.00031657456,0.0022251161,0.00008473562,0.001048539,0.0010540502,0.00017210186,0.00066358363,0.000011416215],"about_ca_topic_score_codex":0.0062534083,"about_ca_topic_score_gemma":0.0030706702,"teacher_disagreement_score":0.0062534083,"about_ca_system_score_codex":0.00027916033,"about_ca_system_score_gemma":0.00032574346,"threshold_uncertainty_score":0.012434065},"labels":[],"label_agreement":null},{"id":"W2074667852","doi":"10.1007/s10549-013-2823-4","title":"Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Alberta; Université de Montréal; University of Toronto; BC Cancer Agency; Women's College Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Odds ratio; Gynecology; Cancer; Obstetrics; Pill; Case-control study; Population; BRCA mutation; Confidence interval; Internal medicine; Oncology","score_opus":0.05342391175251379,"score_gpt":0.3844997849542203,"score_spread":0.3310758732017065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074667852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960193,0.0026864924,0.000065115775,0.000121456374,0.000032379143,0.000004129648,0.00027649497,0.00000985148,0.000784742],"genre_scores_gemma":[0.99835855,0.0007796964,0.00007754725,0.000031530293,0.00004177169,0.0000029489483,0.00015671506,0.0000071960403,0.00054409704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997466,0.00006605299,0.00002318824,0.000049243394,0.000036766833,0.00007806628],"domain_scores_gemma":[0.99668294,0.0011009753,0.001475047,0.00013998359,0.00010341202,0.000497694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053079583,0.0003042946,0.00040521016,0.0011319654,0.00038145806,0.00083165773,0.00038444943,0.000918565,0.0037927795],"category_scores_gemma":[0.0048333555,0.0005225079,0.0006664383,0.0010242922,0.00023397537,0.00052455586,0.00025870473,0.0007899152,0.00031805172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020175867,0.00010463794,0.99220794,0.000023702756,0.0001313037,0.0004140832,0.000076383585,0.000089741996,0.0009621775,0.000062724015,0.0001372464,0.0037725363],"study_design_scores_gemma":[0.000032899232,0.00045985117,0.9964496,0.00002682168,0.00018637157,0.0015351524,0.00016249635,0.00034601032,0.0002858871,0.00012292719,0.000378866,0.000013167358],"about_ca_topic_score_codex":0.0049924874,"about_ca_topic_score_gemma":0.0028687771,"teacher_disagreement_score":0.0049924874,"about_ca_system_score_codex":0.00031282005,"about_ca_system_score_gemma":0.0004135788,"threshold_uncertainty_score":0.01268816},"labels":[],"label_agreement":null},{"id":"W2074695616","doi":"10.1007/s10549-012-2236-9","title":"Management of small HER2 overexpressing tumours","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Trastuzumab; Medicine; Oncology; Internal medicine; Breast cancer; Hazard ratio; Odds ratio; Chemotherapy; Cancer; Gynecology; Confidence interval","score_opus":0.29971512262007144,"score_gpt":0.4988222990774509,"score_spread":0.19910717645737946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074695616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021263835,0.9989236,0.0001822652,0.00015751191,0.00009712749,0.0000042750075,0.000009718637,0.0000051309535,0.00040770185],"genre_scores_gemma":[0.0022752387,0.99627787,0.00036459492,0.0003235879,0.00021711182,0.000007815903,0.000046805388,0.0000023110154,0.00048462892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998466,0.000033746925,0.000022633527,0.00002610308,0.00005163331,0.000019306657],"domain_scores_gemma":[0.9997807,0.00012083221,0.000042740656,0.00000567317,0.000030611624,0.00001943336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003958426,0.0007547292,0.0015673588,0.0014977354,0.00015923954,0.0007107009,0.0008741936,0.00076267717,0.0017532053],"category_scores_gemma":[0.00081304385,0.00017642052,0.0008021447,0.00081419747,0.0003481866,0.00078849914,0.0004891034,0.0014145647,0.0007245751],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117085205,0.000051682466,0.00021426057,0.012649177,0.00011378815,0.0004907744,0.000026403946,0.00034581797,0.0014301069,0.00065008044,0.014786778,0.9691241],"study_design_scores_gemma":[0.00022886817,0.00045228904,0.0050127255,0.013301408,0.00085471524,0.013324102,0.00017142024,0.00048425084,0.0017992435,0.0031864066,0.9611212,0.000063367566],"about_ca_topic_score_codex":0.00064469245,"about_ca_topic_score_gemma":0.0019625318,"teacher_disagreement_score":0.0017532053,"about_ca_system_score_codex":0.0003725979,"about_ca_system_score_gemma":0.00042476677,"threshold_uncertainty_score":0.005865097},"labels":[],"label_agreement":null},{"id":"W2074876140","doi":"10.1007/s10549-010-1224-1","title":"Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents","year":2010,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of British Columbia; Queen's University; Université Laval; BC Cancer Agency; Centre hospitalier universitaire de Québec; University of Toronto; University Health Network; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research","funders":"","keywords":"Metformin; Medicine; Breast cancer; Cancer; Oncology; Adjuvant; Drug; Clinical trial; Internal medicine; Diabetes mellitus; Intensive care medicine; Pharmacology; Endocrinology; Insulin","score_opus":0.4426397235164595,"score_gpt":0.510092707747534,"score_spread":0.06745298423107449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074876140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018717688,0.99717027,0.0004048544,0.00096105604,0.0003073311,0.000010487347,0.000024473715,0.000009429997,0.0009249925],"genre_scores_gemma":[0.001449189,0.9952744,0.00087620143,0.0011850087,0.0004109796,0.000017965176,0.000046287376,0.000003839223,0.00073619257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995246,0.00013232432,0.00006137781,0.000074067124,0.00018073314,0.00002696636],"domain_scores_gemma":[0.99902403,0.0006038414,0.000095959345,0.00002445455,0.00019109967,0.000060487044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016262534,0.0009833473,0.002317555,0.0016609646,0.00019253291,0.0010880127,0.0014278406,0.0015473415,0.0015510487],"category_scores_gemma":[0.0016603589,0.000275646,0.00072979747,0.0014895174,0.0006610545,0.0012901059,0.0006472684,0.0037024126,0.0010730262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022371954,0.00012534841,0.00021157096,0.005264472,0.00010557569,0.00024550784,0.000028495257,0.00025449894,0.0015047527,0.0039388747,0.02384077,0.96425635],"study_design_scores_gemma":[0.00026421755,0.00033919865,0.0016754153,0.0039380845,0.00027399862,0.0022587841,0.000047659072,0.00031174926,0.001178318,0.0037196619,0.9859504,0.000042528914],"about_ca_topic_score_codex":0.0010066316,"about_ca_topic_score_gemma":0.002964397,"teacher_disagreement_score":0.002317555,"about_ca_system_score_codex":0.00092440046,"about_ca_system_score_gemma":0.0011839354,"threshold_uncertainty_score":0.008600533},"labels":[],"label_agreement":null},{"id":"W2075080356","doi":"10.1007/s10549-013-2540-z","title":"Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Mammography; Oncology; Cancer; Internal medicine; Context (archaeology); Population; Mastectomy; Breast MRI; Cancer registry; Gynecology","score_opus":0.021376112061846485,"score_gpt":0.33337332323491636,"score_spread":0.3119972111730699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075080356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984542,0.0002192707,0.00003706013,0.00009221025,0.000012854811,0.000003800393,0.0005812634,0.000004476463,0.00059487316],"genre_scores_gemma":[0.9990495,0.00008800584,0.000011620177,0.000041737065,0.000013966759,0.0000027141932,0.00059406244,0.0000012945893,0.00019707007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998022,0.000030001438,0.000016131184,0.000048603833,0.000018241917,0.00008494698],"domain_scores_gemma":[0.9992569,0.00015183176,0.00018686919,0.000040745104,0.00006148074,0.00030207905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027597498,0.00020942352,0.00042885102,0.0004921612,0.00052415323,0.0005083479,0.0003312158,0.0006263607,0.0019563613],"category_scores_gemma":[0.0016425585,0.00015385287,0.0005205872,0.00055132736,0.00020633452,0.000609761,0.00042662164,0.0006761163,0.00025721922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012304618,0.00010130318,0.99496573,0.0000095009245,0.00005409559,0.00026607924,0.00007706777,0.00029946322,0.00032208365,0.00003077372,0.00027337467,0.002369992],"study_design_scores_gemma":[0.000039302664,0.0005687045,0.99758565,0.0000072486823,0.00007880044,0.0005582023,0.000248646,0.0005434773,0.00008487894,0.00006902748,0.000206591,0.00000941859],"about_ca_topic_score_codex":0.0063262624,"about_ca_topic_score_gemma":0.0050408635,"teacher_disagreement_score":0.0063262624,"about_ca_system_score_codex":0.00042603543,"about_ca_system_score_gemma":0.00043264698,"threshold_uncertainty_score":0.012578845},"labels":[],"label_agreement":null},{"id":"W2075174350","doi":"10.1023/a:1024513815374","title":"Lignans and Tamoxifen, Alone or in Combination, Reduce Human Breast Cancer Cell Adhesion, Invasion and Migration in vitro","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; University of Toronto","keywords":"Tamoxifen; Matrigel; Cell adhesion; Metastasis; Enterolactone; Breast cancer; Cancer research; Fibronectin; Estrogen receptor; Cell migration; Antiestrogen; Cell; Cancer; Internal medicine; Chemistry; Medicine; Endocrinology; Biology; Estrogen; Phytoestrogens; Biochemistry; Angiogenesis","score_opus":0.05410302657519845,"score_gpt":0.37480094583414425,"score_spread":0.3206979192589458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075174350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920163,0.0042119576,0.00025626834,0.00016360682,0.000033832537,0.000016710845,0.00020314977,0.000032783395,0.0030653777],"genre_scores_gemma":[0.9871302,0.003663162,0.00040176522,0.0001343182,0.000033631466,0.000027822683,0.0012308017,0.000008589722,0.0073696626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998983,0.000023189945,0.0000062748513,0.00000690663,0.000024825,0.00004052093],"domain_scores_gemma":[0.9999124,0.000031494492,0.000013986996,0.000010764154,0.0000071857103,0.000024230529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009329839,0.0002107116,0.0003031595,0.00028452798,0.00015219853,0.00021660105,0.00014078882,0.00022703751,0.0025982922],"category_scores_gemma":[0.0001542523,0.00013950099,0.00026435754,0.00017830105,0.00010868291,0.00012255345,0.00016739525,0.0004334575,0.0006007199],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024789888,0.0006169052,0.00074149657,0.00010940216,0.000054063716,0.0001185536,0.000068760564,0.0001403181,0.9856206,0.000094428004,0.0005216769,0.009434807],"study_design_scores_gemma":[0.0004175125,0.007990464,0.03339721,0.00003802015,0.00019586994,0.00067137583,0.00023949171,0.0010032477,0.9477192,0.0001319321,0.008175843,0.000019751962],"about_ca_topic_score_codex":0.0016374079,"about_ca_topic_score_gemma":0.004582132,"teacher_disagreement_score":0.0025982922,"about_ca_system_score_codex":0.00012422357,"about_ca_system_score_gemma":0.00021110014,"threshold_uncertainty_score":0.008692145},"labels":[],"label_agreement":null},{"id":"W2075196112","doi":"10.1007/s10549-013-2818-1","title":"Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Ejection fraction; Cardiology; Internal medicine; Breast cancer; Asymptomatic; Anthracycline; Stress Echocardiography; Subclinical infection; Cardiac function curve; Speckle tracking echocardiography; Chemotherapy; Heart failure; Cancer; Stress testing (software); Doxorubicin; Coronary artery disease","score_opus":0.02323094352406039,"score_gpt":0.3036683898335081,"score_spread":0.28043744630944767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075196112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998601,0.0005506964,0.00021259501,0.000068938716,0.00000897456,0.00001124263,0.000045438737,0.00000414959,0.00049699796],"genre_scores_gemma":[0.99933416,0.00021238923,0.00024866432,0.00004193547,0.000017658615,0.0000074672366,0.000047399033,0.0000011485722,0.00008926606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981815,0.00007403428,0.000024674788,0.000024765503,0.00003077652,0.000027705435],"domain_scores_gemma":[0.9991709,0.0002956715,0.000180029,0.000044712957,0.00013658385,0.00017216949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068154576,0.00030786867,0.0004569011,0.0005733701,0.00015703132,0.0005331793,0.00015856937,0.00042620138,0.0002976731],"category_scores_gemma":[0.0020845693,0.0001499576,0.00024893662,0.0003103796,0.00019371805,0.00043154162,0.00020925884,0.0004634755,0.000088160305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010565057,0.00013278071,0.9877359,0.000011165832,0.000053579126,0.00022932037,0.000064384476,0.0001881749,0.003008967,0.00001690539,0.00005581654,0.00744643],"study_design_scores_gemma":[0.000047011512,0.001119604,0.9932788,0.000013142906,0.00011938136,0.0007424822,0.00025438747,0.0025090007,0.0016473143,0.000054086548,0.00020503925,0.000009766475],"about_ca_topic_score_codex":0.0007491622,"about_ca_topic_score_gemma":0.0017342055,"teacher_disagreement_score":0.0007491622,"about_ca_system_score_codex":0.00016921235,"about_ca_system_score_gemma":0.00024673436,"threshold_uncertainty_score":0.003604412},"labels":[],"label_agreement":null},{"id":"W2075804585","doi":"10.1007/s10549-006-9401-y","title":"Identifying menopause in breast cancer patients: considerations and implications","year":2006,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Comprehensive Cancer Network","keywords":"Tamoxifen; Medicine; Breast cancer; Menopause; Oncology; Aromatase; Internal medicine; Cancer; Gynecology; Hormone therapy; Adjuvant therapy; Etiology; Disease","score_opus":0.05255167148494908,"score_gpt":0.4018540546695704,"score_spread":0.3493023831846213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075804585","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009531907,0.99708897,0.00017627774,0.0018152562,0.00034585217,0.000003329736,0.000016103097,0.000004567694,0.0004543803],"genre_scores_gemma":[0.0009886726,0.9967368,0.00047341353,0.00085241615,0.0005998055,0.000008177867,0.000018725377,0.0000014593751,0.00032056277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963284,0.00009883381,0.00006194631,0.00006144525,0.00011951002,0.000025436804],"domain_scores_gemma":[0.9983342,0.0010277829,0.0001180393,0.000022596469,0.0004113844,0.00008594391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017180895,0.00083143386,0.0027823958,0.0020155695,0.00038031265,0.0013097023,0.0013788372,0.0024249698,0.002063047],"category_scores_gemma":[0.0034010138,0.0003008337,0.00049018266,0.0020166086,0.0007489467,0.001501421,0.00063545525,0.002261381,0.0011475508],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115463954,0.00005701752,0.0013660769,0.006869642,0.0000796552,0.00064813934,0.000077230245,0.0002652025,0.0003817556,0.0018723347,0.038449578,0.94981796],"study_design_scores_gemma":[0.00013165585,0.00028965872,0.008709305,0.015118426,0.00059115066,0.010316843,0.0007404398,0.00038165628,0.00047504753,0.005827322,0.9573547,0.00006381298],"about_ca_topic_score_codex":0.0028674328,"about_ca_topic_score_gemma":0.0076326,"teacher_disagreement_score":0.0028674328,"about_ca_system_score_codex":0.0008910838,"about_ca_system_score_gemma":0.00167797,"threshold_uncertainty_score":0.009086251},"labels":[],"label_agreement":null},{"id":"W2076003089","doi":"10.1023/a:1016075709022","title":"Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Quartile; Hazard ratio; Internal medicine; Insulin; Oncology; Insulin-like growth factor; Proportional hazards model; Endocrinology; Estrogen receptor; Cancer; Growth factor; Receptor; Confidence interval","score_opus":0.07211867368566989,"score_gpt":0.3393362038699912,"score_spread":0.2672175301843213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076003089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98811835,0.0039081336,0.00020841758,0.0013536491,0.000073563184,0.0000150640635,0.0018382397,0.000024080387,0.004460437],"genre_scores_gemma":[0.9962057,0.0010109771,0.00012923886,0.00021559202,0.000086699874,0.000018729037,0.00095723185,0.000006673454,0.0013691962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996387,0.00013292278,0.000028971035,0.000042576787,0.00006372446,0.00009305604],"domain_scores_gemma":[0.99664295,0.001204508,0.0012403118,0.0001318485,0.00015142244,0.00062882865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010298918,0.00040003215,0.0004850897,0.0008982025,0.0004235285,0.0008337763,0.0005106961,0.0011197062,0.0049348585],"category_scores_gemma":[0.005358953,0.00029633657,0.00075588125,0.0014265587,0.0003678742,0.00055170956,0.00041533043,0.0015948107,0.00036532228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035077347,0.0002454701,0.98613954,0.000033792607,0.00040834636,0.00014521433,0.00007337477,0.00022346576,0.0003842093,0.00020864348,0.00070380996,0.007926476],"study_design_scores_gemma":[0.00010375805,0.00021310164,0.99677974,0.000018838708,0.00036079157,0.00035263036,0.00010348037,0.0003805017,0.00020980102,0.00057767105,0.00088809297,0.000011622562],"about_ca_topic_score_codex":0.0072788955,"about_ca_topic_score_gemma":0.0077006957,"teacher_disagreement_score":0.0072788955,"about_ca_system_score_codex":0.000617768,"about_ca_system_score_gemma":0.00072046096,"threshold_uncertainty_score":0.016508698},"labels":[],"label_agreement":null},{"id":"W2079053066","doi":"10.1007/s10549-015-3347-x","title":"Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"PALB2; Breast cancer; Proband; Medicine; Cancer; Oncology; Family history; Internal medicine; Mutation; Germline mutation; Genetics; Gene; Biology","score_opus":0.05991812753315464,"score_gpt":0.35036966988727936,"score_spread":0.29045154235412474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079053066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260074,0.0003131097,0.000056766334,0.00025139956,0.000009741555,0.000013920266,0.0044580125,0.000019280278,0.002277096],"genre_scores_gemma":[0.99689627,0.00024707604,0.00006864516,0.000098394004,0.000010642282,0.0000178653,0.001851621,0.000009467897,0.0007999467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992048,0.00013876498,0.00006706845,0.00023335055,0.00017073659,0.00018536922],"domain_scores_gemma":[0.9980919,0.00028674302,0.0007438517,0.00014116375,0.00030112005,0.00043517174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006214615,0.00016330113,0.0002810661,0.0032777605,0.00068999483,0.00078021275,0.0009981318,0.000543241,0.006485165],"category_scores_gemma":[0.0028868716,0.00030899225,0.0002593597,0.0029696696,0.00029121287,0.00067664555,0.000724047,0.0004190259,0.00063040864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003426498,0.000018262355,0.9975756,0.00000646336,0.000015245168,0.00019756118,0.00007662314,0.00003494,0.00019002969,0.000045872384,0.0009322928,0.0008729129],"study_design_scores_gemma":[0.0000042449724,0.000014788783,0.9982874,0.000011133592,0.000009065333,0.0005690182,0.00036053598,0.00014603662,0.00008095571,0.000016388856,0.00049533363,0.000005041087],"about_ca_topic_score_codex":0.0467582,"about_ca_topic_score_gemma":0.03399266,"teacher_disagreement_score":0.0467582,"about_ca_system_score_codex":0.0007866885,"about_ca_system_score_gemma":0.0009636502,"threshold_uncertainty_score":0.0929721},"labels":[],"label_agreement":null},{"id":"W2079157714","doi":"10.1007/s10549-008-0153-8","title":"BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Proband; Breast cancer; Germline mutation; Mutation; Genetics; BRCA2 Protein; Medicine; Genetic counseling; Genetic testing; Germline; Cancer; Oncology; Biology; Gene","score_opus":0.10173353503980541,"score_gpt":0.4220222914369063,"score_spread":0.32028875639710086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079157714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41627905,0.009900609,0.07034649,0.06564989,0.00193021,0.034529373,0.24254392,0.007891862,0.15092868],"genre_scores_gemma":[0.5628387,0.007799997,0.17953342,0.008930025,0.0034462113,0.037639663,0.15319908,0.002468407,0.0441445],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9858057,0.007428155,0.0018599755,0.0011684255,0.0023297926,0.0014080046],"domain_scores_gemma":[0.87861544,0.04892701,0.009195672,0.02114686,0.012010226,0.030104855],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.02492294,0.00046289866,0.001517059,0.008400254,0.0032213465,0.0024730405,0.0028434626,0.0018044345,0.042311557],"category_scores_gemma":[0.06028504,0.00092414516,0.00059653947,0.008405372,0.00067657174,0.003925131,0.011086994,0.0017336939,0.008751289],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030988816,0.0034014832,0.25387684,0.0008018337,0.00018623893,0.0023494666,0.003533525,0.001171248,0.002548119,0.008143769,0.42962646,0.29126215],"study_design_scores_gemma":[0.0038569265,0.0012815219,0.5046897,0.0010038277,0.00049805944,0.0033623104,0.009245458,0.008766345,0.0032733546,0.0075841253,0.45601436,0.00042395556],"about_ca_topic_score_codex":0.013557519,"about_ca_topic_score_gemma":0.014030026,"teacher_disagreement_score":0.99715656,"about_ca_system_score_codex":0.0017991448,"about_ca_system_score_gemma":0.022579107,"threshold_uncertainty_score":0.14154625},"labels":[],"label_agreement":null},{"id":"W2079238552","doi":"10.1007/s10549-004-9454-8","title":"Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ?","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ductal carcinoma; Breast cancer; Surgical pathology; Carcinoma in situ; Anatomical pathology; Pathology; Carcinoma; Radiology; Cancer; Internal medicine","score_opus":0.040566080942962636,"score_gpt":0.3755033972629834,"score_spread":0.3349373163200207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079238552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6291587,0.0925328,0.026812065,0.15648136,0.0063301106,0.00041128357,0.0005824628,0.00044311897,0.087248154],"genre_scores_gemma":[0.9455979,0.019226495,0.019736148,0.009896618,0.0035019615,0.00008177552,0.00032613458,0.00006736795,0.0015655163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963006,0.0013470029,0.0006345781,0.0002614773,0.0010383064,0.000418048],"domain_scores_gemma":[0.97732395,0.013154064,0.001888915,0.0016294604,0.0048242765,0.0011793503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007737778,0.00043769082,0.0011092024,0.0016446406,0.00089810963,0.0015481461,0.0009779573,0.003158486,0.0025881268],"category_scores_gemma":[0.042577736,0.00039172664,0.00053591945,0.0008773537,0.0013278984,0.0029797973,0.00066085544,0.001676422,0.0012399596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017114271,0.0006529197,0.5508021,0.0012001869,0.00015859943,0.018893402,0.0009840796,0.0012091751,0.014217487,0.0023088728,0.017187303,0.39067438],"study_design_scores_gemma":[0.00021491294,0.0019157778,0.72945225,0.004182668,0.0006484736,0.13572086,0.009124702,0.0058536655,0.016581193,0.019660829,0.07636239,0.0002823508],"about_ca_topic_score_codex":0.0012328041,"about_ca_topic_score_gemma":0.0028044146,"teacher_disagreement_score":0.007737778,"about_ca_system_score_codex":0.00058320625,"about_ca_system_score_gemma":0.0017637444,"threshold_uncertainty_score":0.040921748},"labels":[],"label_agreement":null},{"id":"W2079242442","doi":"10.1007/s10549-007-9634-4","title":"Ovarian cysts and breast cancer: results from the Women’s Contraceptive and Reproductive Experiences Study","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; Centers for Disease Control and Prevention","keywords":"Medicine; Breast cancer; Odds ratio; Ovarian cancer; Gynecology; Confidence interval; Population; Epidemiology; Case-control study; Obstetrics; Cancer; Demography; Oncology; Internal medicine","score_opus":0.04891227199401871,"score_gpt":0.37506724685075754,"score_spread":0.32615497485673883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079242442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765295,0.00041541716,0.000014347353,0.00027878277,0.000010766268,0.000036151305,0.00040303607,6.190202e-7,0.0011879097],"genre_scores_gemma":[0.99784994,0.00078289746,0.000037420654,0.00016202695,0.000024920302,0.00005270579,0.00041741075,0.0000020112816,0.0006706009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989549,0.0005522682,0.000076254546,0.00006605433,0.00016922153,0.00018129993],"domain_scores_gemma":[0.9934075,0.0028253375,0.0015481623,0.00028857807,0.00059806346,0.0013323827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018934789,0.00021367149,0.00041954374,0.0012917202,0.0014180675,0.0010470444,0.00048078143,0.0007523592,0.0019025772],"category_scores_gemma":[0.009832176,0.00039961803,0.0006075453,0.0027320955,0.0008152595,0.0011568166,0.0017767138,0.00093569915,0.0002183124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003311844,0.00042641186,0.9885866,0.000056624456,0.00013874375,0.00026926462,0.0057057845,0.000021720503,0.00007663619,0.00009992584,0.0004853623,0.0038017058],"study_design_scores_gemma":[0.000044901008,0.00015355198,0.9866008,0.000030236006,0.00009640329,0.00019739551,0.01160623,0.000013287404,0.000045122077,0.000032364802,0.0011706562,0.0000090407475],"about_ca_topic_score_codex":0.028501822,"about_ca_topic_score_gemma":0.044930138,"teacher_disagreement_score":0.028501822,"about_ca_system_score_codex":0.0006602149,"about_ca_system_score_gemma":0.0015771143,"threshold_uncertainty_score":0.0566718},"labels":[],"label_agreement":null},{"id":"W2079272606","doi":"10.1023/a:1010686118469","title":"Health System Costs of Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Confidence interval; Christian ministry; Demography; Cancer; Psychological intervention; Gynecology; Gerontology; Internal medicine; Nursing","score_opus":0.08661251427354645,"score_gpt":0.3504204916679984,"score_spread":0.26380797739445194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079272606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9083169,0.016341075,0.0023776938,0.034055438,0.00033435205,0.000073775096,0.009883202,0.00007030638,0.028547283],"genre_scores_gemma":[0.99513066,0.0019268078,0.0001707014,0.00029820096,0.00014558705,0.000009423013,0.00074302487,0.0000036750878,0.0015721138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989735,0.00049604854,0.0000753698,0.000050982486,0.00013578121,0.0002683678],"domain_scores_gemma":[0.99660933,0.0016174673,0.0010034859,0.00008216237,0.0002737722,0.00041394786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083376595,0.0002451041,0.00045463935,0.0009699095,0.0003852081,0.0014982112,0.00039679394,0.001151376,0.007704726],"category_scores_gemma":[0.009394733,0.00034724185,0.00068281713,0.0016081011,0.00047627813,0.0008898468,0.00063892617,0.0013712745,0.00023846098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003994816,0.0007743001,0.50920844,0.0009926548,0.0014808369,0.0021147383,0.00051704445,0.19738856,0.0016453381,0.14540766,0.03279312,0.10368253],"study_design_scores_gemma":[0.00069011474,0.0010441636,0.71316075,0.00053174107,0.0016534093,0.0054749637,0.0020628737,0.16213042,0.0012709965,0.07753661,0.03431838,0.00012558074],"about_ca_topic_score_codex":0.037764125,"about_ca_topic_score_gemma":0.045505185,"teacher_disagreement_score":0.037764125,"about_ca_system_score_codex":0.004842982,"about_ca_system_score_gemma":0.001853205,"threshold_uncertainty_score":0.07508862},"labels":[],"label_agreement":null},{"id":"W2079398602","doi":"10.1007/s10549-005-2414-0","title":"Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathology","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University; Royal Victoria Hospital","funders":"","keywords":"Somatostatin receptor 2; Somatostatin receptor 1; Somatostatin receptor; Immunocytochemistry; Biology; Receptor; Somatostatin; Somatostatin receptor 3; Pathology; Endocrinology; Internal medicine; Breast cancer; Receptor expression; Cancer; Medicine","score_opus":0.03204289049299733,"score_gpt":0.3734229866046056,"score_spread":0.34138009611160824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079398602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991228,0.003401226,0.002204068,0.00006652631,0.00003194336,0.000046188256,0.00085536373,0.00004534892,0.0021214304],"genre_scores_gemma":[0.98979867,0.0019216128,0.0019496627,0.00006171841,0.000034320918,0.000090058944,0.0018738391,0.000026204898,0.004243957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997894,0.000036204096,0.000017472663,0.000037677622,0.000046422694,0.00007267423],"domain_scores_gemma":[0.9997899,0.00009203496,0.000020047386,0.000026581454,0.000040343413,0.000031158208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002573831,0.00016262892,0.0003273021,0.0005627805,0.0003421618,0.00033592802,0.0001595998,0.00022828019,0.001872445],"category_scores_gemma":[0.00035637984,0.00024862518,0.00026179565,0.00044361516,0.0003239287,0.00020118133,0.00020195663,0.00036546946,0.0005101458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010986361,0.000064491986,0.006742666,0.000056952744,0.000026940443,0.00013016611,0.000108195505,0.00010365226,0.9878127,0.000108691194,0.00013431047,0.0036125307],"study_design_scores_gemma":[0.00011624517,0.002097982,0.30495843,0.000014482261,0.00020773735,0.0024471504,0.00065518747,0.0015845109,0.6804153,0.00023560233,0.007240119,0.00002728083],"about_ca_topic_score_codex":0.0021351064,"about_ca_topic_score_gemma":0.0030115615,"teacher_disagreement_score":0.0021351064,"about_ca_system_score_codex":0.00022938727,"about_ca_system_score_gemma":0.00023111036,"threshold_uncertainty_score":0.0062639713},"labels":[],"label_agreement":null},{"id":"W2079507174","doi":"10.1007/s10549-011-1785-7","title":"Vascular proliferation is a prognostic factor in breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital du Sacré-Cœur de Montréal; Jewish General Hospital","funders":"Norges Forskningsråd; Jewish General Hospital; Helse Vest","keywords":"Angiogenesis; Breast cancer; Medicine; Immunohistochemistry; Context (archaeology); Cancer; Pathology; Vascular endothelial growth factor; Univariate analysis; Oncology; Breast carcinoma; Internal medicine; Cancer research; Biology; Multivariate analysis","score_opus":0.059831929706923116,"score_gpt":0.3416120181856098,"score_spread":0.2817800884786867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079507174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649173,0.025605552,0.0016989895,0.0011282287,0.00025785656,0.000017451883,0.0007154118,0.00013828496,0.0055208453],"genre_scores_gemma":[0.9952187,0.0029186383,0.00029224443,0.000060403014,0.00030874286,0.000010978325,0.00028405967,0.000006931064,0.0008992761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972683,0.0001083527,0.00001684966,0.00003397994,0.0000733065,0.000040762436],"domain_scores_gemma":[0.9987249,0.0004705615,0.00038877214,0.00007480295,0.00015530158,0.00018580024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005752383,0.00021004846,0.00032947166,0.0010385806,0.0003191254,0.00064708275,0.00025448084,0.0004914707,0.0017647495],"category_scores_gemma":[0.0023530694,0.00020478145,0.00015155756,0.0013419867,0.00036793717,0.00047410413,0.00022551372,0.0006282982,0.00039709534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026937583,0.00018835349,0.9202267,0.00014606668,0.00011372452,0.00067758124,0.00010018998,0.00046884982,0.023831138,0.00053099863,0.001682141,0.049340617],"study_design_scores_gemma":[0.000028481487,0.00044992243,0.98600256,0.000020179765,0.0001353703,0.0021878213,0.0001184891,0.0011671002,0.0055501,0.0007136837,0.003611183,0.000015066713],"about_ca_topic_score_codex":0.00056493044,"about_ca_topic_score_gemma":0.0005123179,"teacher_disagreement_score":0.0017647495,"about_ca_system_score_codex":0.00026209108,"about_ca_system_score_gemma":0.00031742372,"threshold_uncertainty_score":0.0059036613},"labels":[],"label_agreement":null},{"id":"W2079689268","doi":"10.1007/s10549-013-2530-1","title":"Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Tamoxifen; Pharmacokinetics; In vivo; Breast cancer; CYP2D6; Active metabolite; Medicine; Estrogen receptor; Pharmacology; Pharmacodynamics; Cancer; Oncology; Internal medicine; Biology; Metabolism; Cytochrome P450","score_opus":0.03416581233443016,"score_gpt":0.3727183254085206,"score_spread":0.33855251307409046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079689268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9387729,0.009936597,0.033202678,0.0006731515,0.00029472163,0.0007671505,0.003591614,0.000517025,0.012244133],"genre_scores_gemma":[0.9635205,0.00383808,0.016797213,0.0002469446,0.000064184474,0.0007177631,0.00435625,0.00017316427,0.010285845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945,0.00016271509,0.000052911273,0.00006423632,0.00018346161,0.00008668775],"domain_scores_gemma":[0.9992379,0.00038865945,0.00006102942,0.00008108798,0.00016606548,0.000065349435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012987303,0.0007343202,0.00087710965,0.0006239378,0.00038369483,0.0006093276,0.00049290305,0.000676039,0.0023960765],"category_scores_gemma":[0.000784124,0.00034580726,0.00033579962,0.0004778074,0.0004886588,0.0005168309,0.00023664655,0.0017897827,0.00079939165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005735611,0.00026554894,0.00052679825,0.000079276266,0.000026132615,0.00003262265,0.00007767978,0.0005169491,0.993193,0.00024166149,0.0003050637,0.004161741],"study_design_scores_gemma":[0.000040533498,0.0010210638,0.0018011384,0.000005640809,0.00003107094,0.00006115026,0.000038151124,0.0010551659,0.99439925,0.00004614446,0.0014948704,0.0000059290537],"about_ca_topic_score_codex":0.0015699159,"about_ca_topic_score_gemma":0.0021418903,"teacher_disagreement_score":0.0023960765,"about_ca_system_score_codex":0.0005937274,"about_ca_system_score_gemma":0.0004980825,"threshold_uncertainty_score":0.008015692},"labels":[],"label_agreement":null},{"id":"W2080076833","doi":"10.1007/s10549-009-0452-8","title":"Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Saskatoon Medical Imaging; Saskatchewan Cancer Agency; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Fulvestrant; Medicine; Breast cancer; Oncology; Internal medicine; Tamoxifen; Aromatase inhibitor; Chemotherapy; Metastatic breast cancer; Cancer","score_opus":0.017167887203761827,"score_gpt":0.31473533753378274,"score_spread":0.2975674503300209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080076833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981268,0.0008700163,0.000093678165,0.00019785971,0.000019105217,0.000008006536,0.00012839762,0.000005475292,0.00055063603],"genre_scores_gemma":[0.9992047,0.00025722542,0.000081152975,0.000056341458,0.0000361485,0.0000051385286,0.00022618404,0.0000011288281,0.00013212336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998877,0.00004001536,0.000012079218,0.000015124749,0.000018843315,0.000026219746],"domain_scores_gemma":[0.99938357,0.0002960691,0.00010032929,0.000024141547,0.000029816718,0.00016613596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040325258,0.0003674249,0.0005123822,0.00047965304,0.00018323811,0.00034292744,0.00017811568,0.00048268246,0.001046008],"category_scores_gemma":[0.0018124267,0.00010205432,0.00036599193,0.00031769107,0.00018876343,0.00026935484,0.00020508803,0.00049104524,0.00018663693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01249992,0.00020157069,0.9609997,0.000033554446,0.00012366468,0.0003822124,0.000046415887,0.0014283295,0.0034860491,0.000073280215,0.00041760658,0.020307656],"study_design_scores_gemma":[0.00040917887,0.0037552428,0.9866715,0.000020551046,0.00036256044,0.0011243048,0.0001152324,0.004785713,0.0016142383,0.00029491473,0.0008341984,0.000012464138],"about_ca_topic_score_codex":0.00091774407,"about_ca_topic_score_gemma":0.0017008691,"teacher_disagreement_score":0.001046008,"about_ca_system_score_codex":0.00032448847,"about_ca_system_score_gemma":0.00021439104,"threshold_uncertainty_score":0.0034992099},"labels":[],"label_agreement":null},{"id":"W2080558042","doi":"10.1007/s10549-013-2559-1","title":"Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Dalhousie University; Genomic Health","keywords":"Breast cancer; Medicine; Cochrane Library; Oncology; Adjuvant chemotherapy; Systematic review; MEDLINE; Medical prescription; Intensive care medicine; Internal medicine; Cancer; Bioinformatics; Gynecology; Meta-analysis; Biology; Pharmacology","score_opus":0.557476561669923,"score_gpt":0.5714956463608163,"score_spread":0.014019084690893302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080558042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004890358,0.99865156,0.00013944185,0.00018139376,0.00003932928,0.00011563167,0.00018614628,0.0000033617164,0.00019412255],"genre_scores_gemma":[0.012025047,0.9867322,0.0005501907,0.0001839496,0.0000470277,0.00025700717,0.00013232246,0.0000028416102,0.0000694395],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99270815,0.0036155884,0.0018908908,0.0003117467,0.0012929928,0.00018077563],"domain_scores_gemma":[0.953572,0.039603453,0.0044737663,0.0003411784,0.0018024575,0.00020718842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010705796,0.0015606602,0.006747277,0.009046728,0.00040479685,0.0024145632,0.0014028597,0.0014335165,0.0051724864],"category_scores_gemma":[0.055360556,0.00089246756,0.008241767,0.010551554,0.00056582066,0.0015853408,0.0012591328,0.0013249695,0.00021637937],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004218433,0.00003211353,0.00087709026,0.90328544,0.023745496,0.0000866914,0.00006299179,0.0005292579,0.000062854975,0.0006730855,0.0019294551,0.068293706],"study_design_scores_gemma":[0.0008095679,0.00032241642,0.007253733,0.7938422,0.16983941,0.0004691368,0.00016989179,0.00060306047,0.00023057978,0.0018182311,0.024580164,0.00006159084],"about_ca_topic_score_codex":0.0070547643,"about_ca_topic_score_gemma":0.01679551,"teacher_disagreement_score":0.010705796,"about_ca_system_score_codex":0.0043577477,"about_ca_system_score_gemma":0.0073906663,"threshold_uncertainty_score":0.056618333},"labels":[],"label_agreement":null},{"id":"W2081066309","doi":"10.1007/s10549-012-2205-3","title":"A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nausea and vomiting management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ottawa Hospital; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"European Society for Medical Oncology","keywords":"Medicine; Nausea; Vomiting; Breast cancer; Placebo; Epirubicin; Dexamethasone; Granisetron; Chemotherapy; Antiemetic; Internal medicine; Regimen; Anesthesia; Cancer; Surgery","score_opus":0.10521611853387895,"score_gpt":0.46507074438100804,"score_spread":0.3598546258471291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081066309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897361,0.002616289,0.0005521056,0.00047873557,0.0008939191,0.0037291148,0.00069166266,0.00009851451,0.0012034785],"genre_scores_gemma":[0.9856048,0.0020347056,0.00182467,0.00092186464,0.0006834214,0.0052971365,0.0006744827,0.000027542957,0.0029312195],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99914193,0.00040247905,0.00007313698,0.00019318046,0.000055924982,0.00013329166],"domain_scores_gemma":[0.9980476,0.00066147104,0.0003457546,0.00020100713,0.000106600564,0.00063757267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016505505,0.0017188461,0.004313174,0.00058210554,0.0007134138,0.0010704431,0.0013252521,0.002640064,0.0076362127],"category_scores_gemma":[0.0027667668,0.00085931976,0.0015694444,0.00051518047,0.002291678,0.0013274633,0.0007189753,0.0033414061,0.00096417736],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99242073,0.004345466,0.000062275016,0.00014839164,0.00014478837,0.000005950708,0.000012162655,0.000047473302,0.000591607,0.000021871972,0.00007274371,0.0021265054],"study_design_scores_gemma":[0.9605168,0.03851416,0.00041124158,0.000012770225,0.00013494115,0.0000045107145,0.000010236915,0.00009894551,0.0001431631,0.000044169206,0.00010278408,0.0000063446114],"about_ca_topic_score_codex":0.0022347206,"about_ca_topic_score_gemma":0.0027451264,"teacher_disagreement_score":0.0076362127,"about_ca_system_score_codex":0.0008970013,"about_ca_system_score_gemma":0.0014827577,"threshold_uncertainty_score":0.025545716},"labels":[],"label_agreement":null},{"id":"W2081673104","doi":"10.1007/s10549-011-1375-8","title":"Biomarkers of PARP inhibitor sensitivity","year":2011,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Sensitivity (control systems); Medicine; PARP inhibitor; Biomarker; Oncology; Internal medicine; Poly ADP ribose polymerase; Biology; Cancer; Genetics; DNA","score_opus":0.10794391362082746,"score_gpt":0.38517812548318286,"score_spread":0.2772342118623554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081673104","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028740815,0.008634537,0.0007599789,0.93672043,0.029727269,0.00006432528,0.00041919158,0.00008971177,0.020710455],"genre_scores_gemma":[0.061732933,0.010758592,0.0021073713,0.7520055,0.12033322,0.00048325537,0.00054082926,0.00006353668,0.0519747],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978701,0.0007623377,0.00020967748,0.00024598368,0.0005687576,0.00034309775],"domain_scores_gemma":[0.9958014,0.0022448967,0.0004122214,0.00019520543,0.0008530712,0.00049313577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020871845,0.0009834119,0.0016361052,0.0009875365,0.0013341169,0.0031114565,0.0007208105,0.014188371,0.008166176],"category_scores_gemma":[0.014439829,0.00036032972,0.0008693297,0.0007225454,0.0014837056,0.0016175184,0.0011801679,0.013164012,0.005268398],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038498957,0.00009961534,0.009544199,0.00023793962,0.000046721772,0.0055362843,0.00013428353,0.0002288898,0.0017805302,0.0044491654,0.9060209,0.07153653],"study_design_scores_gemma":[0.00030230742,0.0005412555,0.014685594,0.001037494,0.00012495335,0.014245288,0.0006508311,0.0014826654,0.0025772138,0.023106469,0.94113284,0.00011312218],"about_ca_topic_score_codex":0.00094156765,"about_ca_topic_score_gemma":0.001891303,"teacher_disagreement_score":0.014188371,"about_ca_system_score_codex":0.0025744177,"about_ca_system_score_gemma":0.0012001478,"threshold_uncertainty_score":0.027318537},"labels":[],"label_agreement":null},{"id":"W2081731272","doi":"10.1023/a:1006402323445","title":"Alcohol and Breast Cancer Mortality in a Cohort Study","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Centre for Addiction and Mental Health; Ontario Tobacco Research Unit; University of Toronto; Toronto Public Health","funders":"Medical Research Council Canada; U.S. Department of Agriculture","keywords":"Breast cancer; Medicine; Epidemiology; Hazard ratio; Cohort study; Cohort; Prospective cohort study; Cancer; National Death Index; Internal medicine; Lower risk; Gynecology; Oncology; Demography; Confidence interval","score_opus":0.1773226861026055,"score_gpt":0.49535624972747466,"score_spread":0.3180335636248692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081731272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982059,0.00028758042,0.00006882586,0.00008986966,0.000029767243,0.000022670294,0.00096777326,0.00000698451,0.0003207384],"genre_scores_gemma":[0.9967122,0.00049483305,0.00013679237,0.000093737224,0.00004679405,0.000036517522,0.001018594,0.000008115581,0.0014523708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923694,0.00019817935,0.00006701959,0.00018485334,0.00010616976,0.00020681616],"domain_scores_gemma":[0.99779356,0.00021180697,0.0004443131,0.000485763,0.00032535175,0.0007393043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001270718,0.00083352375,0.00077925576,0.0013791162,0.0020299754,0.0014967531,0.00091340666,0.0012147953,0.0024312367],"category_scores_gemma":[0.0022553112,0.0017534966,0.0021465998,0.0022328831,0.0005336809,0.0010383446,0.0010137646,0.0018967143,0.00067666813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019259612,0.00055283296,0.99428326,0.000015239856,0.00073066883,0.0002554413,0.0003126272,0.00003250286,0.000633759,0.000030460611,0.00034838868,0.0008788893],"study_design_scores_gemma":[0.00014687546,0.00042013061,0.9976,0.000009210952,0.00051235565,0.00025098797,0.00042785102,0.000106335625,0.00008649973,0.000021753776,0.00040094266,0.000017023098],"about_ca_topic_score_codex":0.080511115,"about_ca_topic_score_gemma":0.08932545,"teacher_disagreement_score":0.080511115,"about_ca_system_score_codex":0.0010207045,"about_ca_system_score_gemma":0.0014382614,"threshold_uncertainty_score":0.16008496},"labels":[],"label_agreement":null},{"id":"W2082075144","doi":"10.1007/s10549-005-6654-9","title":"Serum Lipids and Outcome of Early-stage Breast Cancer: Results of a Prospective Cohort Study","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Dyslipidemia; Body mass index; Cancer; Prospective cohort study; Insulin resistance; Diabetes mellitus; Oncology; Proportional hazards model; Breast disease; Cohort; Obesity; Endocrinology","score_opus":0.02649220764887728,"score_gpt":0.3534696719480105,"score_spread":0.3269774642991332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082075144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991161,0.00017930586,0.000075298645,0.000035340905,0.000008520009,0.000012078752,0.0004359845,0.0000029437679,0.00013431926],"genre_scores_gemma":[0.9987068,0.00018941893,0.000117614014,0.00003297728,0.00001406985,0.000016908345,0.00056835276,0.000004385396,0.00034942979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990183,0.00034537408,0.000073337585,0.00021008657,0.0001471856,0.00020565624],"domain_scores_gemma":[0.99769384,0.00034090466,0.0005449095,0.0004391259,0.00032861545,0.0006524952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020214182,0.0009613136,0.00089681457,0.00079622975,0.001241523,0.0011550593,0.0008193787,0.0009894713,0.0009922032],"category_scores_gemma":[0.0026884635,0.0011692452,0.0010600373,0.0017061253,0.00070924644,0.0008399425,0.0007772245,0.0015514347,0.0002942746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022144658,0.00039967344,0.99487275,0.00000994028,0.00032857465,0.00014444516,0.00018240034,0.00006030502,0.0007846408,0.00002302288,0.000120812365,0.00085899956],"study_design_scores_gemma":[0.00011532798,0.0004023918,0.99851483,0.0000035074481,0.00019849844,0.00019983029,0.00021629277,0.00008780545,0.00010584322,0.000022595234,0.00012236519,0.000010621477],"about_ca_topic_score_codex":0.024775838,"about_ca_topic_score_gemma":0.018611517,"teacher_disagreement_score":0.024775838,"about_ca_system_score_codex":0.0007532053,"about_ca_system_score_gemma":0.0010318013,"threshold_uncertainty_score":0.04926324},"labels":[],"label_agreement":null},{"id":"W2082187680","doi":"10.1007/s10549-005-9098-3","title":"Energy balance and breast cancer risk: a prospective cohort study","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Body mass index; Cohort; Cohort study; Cancer; Prospective cohort study; Internal medicine; Incidence (geometry); Demography; Gynecology; Oncology","score_opus":0.024759019839051835,"score_gpt":0.3628984870352481,"score_spread":0.33813946719619625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082187680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770266,0.00042069246,0.00017753956,0.00008512099,0.000030226933,0.000027268645,0.0012388611,0.000009827943,0.0003077592],"genre_scores_gemma":[0.99659085,0.0004352111,0.0002971116,0.000077739605,0.000029141846,0.000058530975,0.0012228547,0.00001045438,0.001278197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992619,0.00020565304,0.00006463882,0.00020994552,0.0000783818,0.00017943364],"domain_scores_gemma":[0.9983742,0.00018860467,0.00039977257,0.00042322505,0.00018637998,0.00042776432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011820084,0.0012312111,0.00092702056,0.0010183636,0.0020071294,0.0014648722,0.0009699423,0.0015756224,0.0030224018],"category_scores_gemma":[0.001807179,0.0022779028,0.0020061573,0.002306762,0.0005821291,0.0012959334,0.0011100665,0.0021454378,0.0007821334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018520056,0.00069162954,0.99427843,0.000018464141,0.00070797914,0.00022723795,0.000221167,0.00006481972,0.00071598886,0.00004027086,0.00027060864,0.00091139524],"study_design_scores_gemma":[0.0001528126,0.000754976,0.997021,0.000011516703,0.000495498,0.00037920734,0.0003820689,0.00017639656,0.00011929375,0.00005230209,0.00043224456,0.000022656992],"about_ca_topic_score_codex":0.026401866,"about_ca_topic_score_gemma":0.027211264,"teacher_disagreement_score":0.026401866,"about_ca_system_score_codex":0.0007127778,"about_ca_system_score_gemma":0.0010897866,"threshold_uncertainty_score":0.052496374},"labels":[],"label_agreement":null},{"id":"W2082486482","doi":"10.1023/b:brea.0000021046.29834.12","title":"Cross-Resistance Studies of Isogenic Drug-Resistant Breast Tumor Cell Lines Support Recent Clinical Evidence Suggesting that Sensitivity to Paclitaxel may be Strongly Compromised by Prior Doxorubicin Exposure","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; University of Sudbury; Northeast Cancer Centre","funders":"","keywords":"Paclitaxel; Doxorubicin; Docetaxel; Breast cancer; Chemotherapy; Medicine; Drug resistance; Pharmacology; Metastatic breast cancer; Crossover study; Cross-resistance; Internal medicine; Cancer research; Oncology; Cancer; Biology; Pathology; Microbiology","score_opus":0.13174036259987493,"score_gpt":0.42953747230335687,"score_spread":0.29779710970348194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082486482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842375,0.0013782211,0.009717308,0.00020435241,0.00008612921,0.00019635388,0.0008075438,0.0001492372,0.0032233375],"genre_scores_gemma":[0.9874672,0.001303221,0.005245141,0.00014264889,0.000020232455,0.00013123923,0.0018029003,0.00015540223,0.003731977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940264,0.00020046378,0.00009742256,0.00010919626,0.000136337,0.000053932126],"domain_scores_gemma":[0.99913305,0.00031574216,0.00015779033,0.00024310125,0.0000791811,0.00007114488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077707274,0.00058263505,0.0006933034,0.0007861156,0.0003563547,0.00044803234,0.00037321646,0.00047407774,0.003591438],"category_scores_gemma":[0.000701645,0.00024726326,0.0007141627,0.00043509065,0.00037078158,0.0004437226,0.0004048526,0.001387378,0.000750942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011925444,0.00017692918,0.0005164239,0.000033313292,0.000017300963,0.00005914427,0.000053290616,0.000069519716,0.9972687,0.00029327793,0.000051459483,0.0013414436],"study_design_scores_gemma":[0.000023669605,0.001909251,0.0074551813,0.000009860525,0.00006154752,0.0010147322,0.000071969385,0.0007224094,0.9862714,0.00010702493,0.0023436206,0.000009349014],"about_ca_topic_score_codex":0.0009135133,"about_ca_topic_score_gemma":0.00092947704,"teacher_disagreement_score":0.003591438,"about_ca_system_score_codex":0.00041909842,"about_ca_system_score_gemma":0.00020663475,"threshold_uncertainty_score":0.012014568},"labels":[],"label_agreement":null},{"id":"W2082717337","doi":"10.1023/a:1006481228794","title":"Characterization of a novel silencer element in the human aromatase gene PII promoter","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Aromatase; Promoter; Biology; Transcription factor; Transfection; Silencer; Gene; Cancer research; Ovarian cancer; Breast cancer; Gene expression; Molecular biology; Cancer; Genetics","score_opus":0.026163024633267286,"score_gpt":0.3177103270013942,"score_spread":0.29154730236812687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082717337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529189,0.0012431687,0.0412592,0.00038010132,0.00008338244,0.00011247052,0.0010033413,0.0002707601,0.0027286792],"genre_scores_gemma":[0.9799397,0.00036045717,0.012692074,0.00023495579,0.000045424153,0.000073093855,0.0031295638,0.000100646685,0.0034241844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998486,0.000018828638,0.000010980343,0.000051001065,0.00004495539,0.000025622627],"domain_scores_gemma":[0.99967825,0.00011571523,0.000060667084,0.000048431528,0.000031831918,0.00006516715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002321583,0.00023966652,0.00041547065,0.00026638084,0.00021550967,0.00035510332,0.00041129172,0.00038947797,0.0015949172],"category_scores_gemma":[0.00041915194,0.0002816804,0.00062085054,0.00013925898,0.00039039837,0.00016926382,0.00026755704,0.0009737413,0.0011169864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006549755,0.000016385246,0.00019229957,0.000022166467,0.0000049642617,0.00011711085,0.000019900235,0.00007894909,0.9977895,0.0002208566,0.000023861365,0.0014484227],"study_design_scores_gemma":[0.000033124797,0.00019684793,0.006548998,0.000012261403,0.00002901445,0.000825655,0.000039310424,0.0017715277,0.9865183,0.00018903603,0.0038266056,0.000009141878],"about_ca_topic_score_codex":0.000743912,"about_ca_topic_score_gemma":0.0009470676,"teacher_disagreement_score":0.0015949172,"about_ca_system_score_codex":0.000394557,"about_ca_system_score_gemma":0.0003717524,"threshold_uncertainty_score":0.0053355694},"labels":[],"label_agreement":null},{"id":"W2082724230","doi":"10.1007/s10549-007-9736-z","title":"Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"Michael Smith Health Research BC; Sanofi","keywords":"Concordance; Medicine; Kappa; Tissue microarray; Breast cancer; Estrogen receptor; Immunohistochemistry; Internal medicine; Oncology; Pathology; Breast carcinoma; Carcinoma; Tamoxifen; Cancer","score_opus":0.05338137941385647,"score_gpt":0.3904327876159716,"score_spread":0.33705140820211515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082724230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987948,0.0001192323,0.0005114279,0.000014141286,0.0000038564863,0.00000890142,0.000096685166,0.0000073208726,0.0004437028],"genre_scores_gemma":[0.99885416,0.00005008925,0.00048652245,0.000014826236,0.0000072228777,0.000013233378,0.00025141667,0.000006781035,0.00031582656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981092,0.0005693721,0.00014444305,0.00038773188,0.00062337925,0.000165864],"domain_scores_gemma":[0.9974625,0.0013185118,0.00028741945,0.00045718727,0.00039207467,0.000082389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016802208,0.00019524344,0.00047020815,0.0009780015,0.00050183944,0.000571903,0.00046204613,0.00046682535,0.0015030003],"category_scores_gemma":[0.003308483,0.00026418798,0.0002931662,0.0006185259,0.0004341098,0.0003812054,0.0003358667,0.00023451766,0.00043451242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014107618,0.00020799758,0.92557013,0.000052668976,0.00023975584,0.00073906826,0.00051804405,0.00032670324,0.054363843,0.000107047155,0.00023112928,0.016232876],"study_design_scores_gemma":[0.000024884963,0.00022384764,0.9898712,0.0000028650377,0.00007567221,0.0016109701,0.00026096447,0.0009693962,0.006358696,0.00007209917,0.00051958876,0.000009711506],"about_ca_topic_score_codex":0.0018924313,"about_ca_topic_score_gemma":0.0029216465,"teacher_disagreement_score":0.0018924313,"about_ca_system_score_codex":0.0003681245,"about_ca_system_score_gemma":0.00019543286,"threshold_uncertainty_score":0.00888598},"labels":[],"label_agreement":null},{"id":"W2082946674","doi":"10.1007/s10549-011-1856-9","title":"A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Male Breast Health Studies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute for Health and Care Research","keywords":"Breast cancer; Biomarker; Internal medicine; Oncology; Medicine; Cancer; Male breast cancer; Incidence (geometry); Basal (medicine); Lymph node; Biology; Genetics","score_opus":0.4643675474027231,"score_gpt":0.45863468818183734,"score_spread":0.005732859220885789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082946674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820805,0.00058124086,0.0002207098,0.000029188466,0.00000932745,0.0000070651445,0.00021020426,0.0000028747959,0.00073142664],"genre_scores_gemma":[0.99899536,0.0001368048,0.00009213229,0.000037200858,0.00001035757,0.000008004802,0.00023668043,0.0000035417856,0.0004799095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992706,0.00023602649,0.000060785944,0.0001869427,0.00012442289,0.00012128498],"domain_scores_gemma":[0.9990601,0.0003400565,0.0002107978,0.00016016858,0.00014600424,0.00008288155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090425636,0.00018452856,0.0005149831,0.0011508628,0.0006194515,0.00046960032,0.00027968892,0.00031850018,0.002813521],"category_scores_gemma":[0.0029448099,0.00023173104,0.00036237895,0.0010147595,0.0003054689,0.00028784692,0.0004404977,0.00018912807,0.00045985548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016048267,0.00007938121,0.97653985,0.000041260264,0.00020593846,0.00040947765,0.0006309273,0.00002865892,0.012290834,0.00018718536,0.00019944429,0.0077821645],"study_design_scores_gemma":[0.000016712089,0.0003616615,0.9959571,0.000004551001,0.00011718241,0.00092742156,0.0003944151,0.00003294764,0.0012057023,0.00007000699,0.000908048,0.0000042769584],"about_ca_topic_score_codex":0.0024989294,"about_ca_topic_score_gemma":0.0028558536,"teacher_disagreement_score":0.002813521,"about_ca_system_score_codex":0.00024782924,"about_ca_system_score_gemma":0.00019059969,"threshold_uncertainty_score":0.009412169},"labels":[],"label_agreement":null},{"id":"W2083364219","doi":"10.1007/s10549-004-2230-y","title":"Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Angiogenesis; Breast cancer; Cancer research; Cyclin; Cyclin D; Cyclin E; Cyclin A; Pathological; Cyclin D1; Biology; Cancer; Cell cycle; Oncology; Internal medicine; Medicine","score_opus":0.04087508064572197,"score_gpt":0.3566847473930762,"score_spread":0.3158096667473542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083364219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691844,0.018657882,0.0027720907,0.00020815349,0.000049836446,0.000028089979,0.0014083982,0.0001423681,0.0075488854],"genre_scores_gemma":[0.9911391,0.0027668192,0.0011508305,0.000037293044,0.000022070755,0.000021838687,0.0011554726,0.000021215244,0.0036853526],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987805,0.000016382348,0.000008091186,0.000031647385,0.000030710955,0.00003501329],"domain_scores_gemma":[0.999775,0.000037360067,0.00007916128,0.000015288531,0.000048246002,0.00004494415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013779817,0.00015883858,0.00023272034,0.0010750121,0.00033797877,0.0006030265,0.00016040244,0.00017063704,0.0019568484],"category_scores_gemma":[0.0004094703,0.00016707824,0.0001614631,0.0006943832,0.00027842727,0.00024045227,0.00020114584,0.00023416529,0.00049001776],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093226583,0.00004135473,0.0346227,0.00017737063,0.000075678916,0.0007203412,0.00021580105,0.00017620192,0.9506271,0.0012181062,0.0007221171,0.010470953],"study_design_scores_gemma":[0.000048246344,0.00035454019,0.3394622,0.0000307052,0.00012982932,0.0065453593,0.0007652479,0.001065256,0.6113399,0.0006939468,0.03953651,0.000028273202],"about_ca_topic_score_codex":0.0032375169,"about_ca_topic_score_gemma":0.0027264669,"teacher_disagreement_score":0.0032375169,"about_ca_system_score_codex":0.00072850083,"about_ca_system_score_gemma":0.00046814483,"threshold_uncertainty_score":0.0065463185},"labels":[],"label_agreement":null},{"id":"W2083471536","doi":"10.1007/s10549-009-0523-x","title":"A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"Pfizer Canada; Pfizer","keywords":"Exemestane; Anastrozole; Medicine; Breast cancer; Internal medicine; Aromatase inhibitor; Aromatase; Oncology; Biomarker; Tamoxifen; Letrozole; Cancer; Gynecology; Biology","score_opus":0.016152535485918867,"score_gpt":0.2933112284903494,"score_spread":0.2771586930044305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083471536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156284,0.0023355798,0.00045768046,0.0011123938,0.00077564677,0.001972035,0.0006201169,0.000060413102,0.0011033083],"genre_scores_gemma":[0.9895538,0.0011952636,0.0015392422,0.0010397532,0.00053350476,0.003046203,0.0008930614,0.00001625769,0.0021827796],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987895,0.00073109823,0.000086664506,0.00019719773,0.00005898485,0.00013664881],"domain_scores_gemma":[0.9975068,0.0010259605,0.0004457432,0.00024520847,0.000113223796,0.0006630015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022030775,0.0016382633,0.0038560065,0.0003654057,0.00052815105,0.0009711467,0.0008641865,0.0021765863,0.0066411323],"category_scores_gemma":[0.0039166203,0.0008259963,0.0021990708,0.00044266807,0.0015571899,0.0014522022,0.00062195066,0.003424484,0.0008345808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99607027,0.0011180288,0.00022402282,0.0000647349,0.00022781361,0.000007754971,0.000009808934,0.000081245096,0.00042866843,0.000022315422,0.00007095682,0.0016742849],"study_design_scores_gemma":[0.9443993,0.053356446,0.0009803518,0.000012171921,0.0005120848,0.000014957106,0.000016850889,0.00022513838,0.00016940647,0.000101106874,0.00020271355,0.000009403446],"about_ca_topic_score_codex":0.0014995529,"about_ca_topic_score_gemma":0.002894512,"teacher_disagreement_score":0.0066411323,"about_ca_system_score_codex":0.0009885479,"about_ca_system_score_gemma":0.0019436791,"threshold_uncertainty_score":0.022216737},"labels":[],"label_agreement":null},{"id":"W2083509136","doi":"10.1007/s10549-012-2137-y","title":"111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Aptose Biosciences (Canada); University of Toronto","funders":"","keywords":"Nimotuzumab; Cancer research; Trastuzumab; Chemistry; Monoclonal antibody; Molecular biology; Epidermal growth factor receptor; Receptor; Cancer; Medicine; Breast cancer; Immunology; Antibody; Internal medicine; Biology; Biochemistry","score_opus":0.090223480004224,"score_gpt":0.40598910964189566,"score_spread":0.31576562963767163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083509136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98572135,0.0021059935,0.008153579,0.00021903243,0.000047242673,0.00008064826,0.000066737884,0.00015468163,0.0034507508],"genre_scores_gemma":[0.98875004,0.0006931972,0.007852594,0.00008436233,0.000012875249,0.00003771787,0.000121216624,0.000039699582,0.0024082884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991274,0.000024026203,0.0000041159687,0.000018363226,0.00001761033,0.000023075958],"domain_scores_gemma":[0.9999659,0.000008922954,0.000008836907,0.000004643131,0.0000024838648,0.0000092222635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002673436,0.0002472925,0.00021086515,0.000104417246,0.000119531884,0.00018157401,0.00028647555,0.00038063366,0.0005796122],"category_scores_gemma":[0.00018692776,0.00014213866,0.00011142708,0.000099871446,0.0002015442,0.0003221953,0.00022623368,0.00031383836,0.00020163858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055356475,0.000056472192,0.00015910275,0.00006032073,0.000008418679,0.00016745168,0.000029334207,0.00025452205,0.9911823,0.00044449882,0.00015261502,0.0069314847],"study_design_scores_gemma":[0.00017280021,0.00050181587,0.0011367282,0.000006254062,0.000027795259,0.0009343958,0.000008240621,0.0016591769,0.9909238,0.000066826324,0.004554464,0.000007698484],"about_ca_topic_score_codex":0.00034794468,"about_ca_topic_score_gemma":0.00042741385,"teacher_disagreement_score":0.0005796122,"about_ca_system_score_codex":0.00033174196,"about_ca_system_score_gemma":0.00019265835,"threshold_uncertainty_score":0.0024070144},"labels":[],"label_agreement":null},{"id":"W2083569128","doi":"10.1007/s10549-007-9718-1","title":"Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; BC Cancer Agency","funders":"Sanofi","keywords":"Myoepithelial cell; Cytokeratin; Breast cancer; Immunohistochemistry; Pathology; Biology; Progesterone receptor; Cancer; Estrogen receptor; Cancer research; Medicine","score_opus":0.013952919273980915,"score_gpt":0.31327416252898177,"score_spread":0.29932124325500087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083569128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928716,0.0026266456,0.0017964618,0.00007159395,0.000015052144,0.000020736234,0.00020026125,0.000029790543,0.002367958],"genre_scores_gemma":[0.99451774,0.0012325245,0.0019551248,0.000052137697,0.000022695962,0.000050857125,0.0003506477,0.000018488077,0.001799854],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981266,0.000023648457,0.000016844697,0.0000360697,0.000039078943,0.00007178326],"domain_scores_gemma":[0.9998147,0.00006333656,0.00001859903,0.000023498465,0.000036119138,0.000043803095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032992178,0.00018850119,0.00028306365,0.00083528686,0.00040411574,0.00045006518,0.00029558377,0.00032856048,0.0013292384],"category_scores_gemma":[0.000300803,0.0002804344,0.00021793369,0.0004929768,0.00043019996,0.0005109539,0.00034526916,0.00032293395,0.00021100957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010826929,0.000071072245,0.006686752,0.00010215282,0.000025517535,0.00033416305,0.0001655162,0.000054308857,0.9870503,0.00074716104,0.000086647204,0.003593681],"study_design_scores_gemma":[0.00023223633,0.0010720496,0.47257236,0.000041318246,0.00025767495,0.013242301,0.0011877156,0.0043474794,0.49249193,0.001268502,0.013229663,0.000056822504],"about_ca_topic_score_codex":0.0018456867,"about_ca_topic_score_gemma":0.0018295612,"teacher_disagreement_score":0.0018456867,"about_ca_system_score_codex":0.00036357794,"about_ca_system_score_gemma":0.00026323507,"threshold_uncertainty_score":0.004446745},"labels":[],"label_agreement":null},{"id":"W2083583664","doi":"10.1023/a:1026114501364","title":"Ligand-Induced Regulation of ERα and ERβ is Indicative of Human Breast Cancer Cell Proliferation","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Antiestrogen; Estrogen receptor; Tamoxifen; Cell growth; Genistein; Cancer research; Estrogen receptor alpha; Breast cancer; Estrogen; Estrogen receptor beta; Biology; Cell; Selective estrogen receptor modulator; Internal medicine; Endocrinology; Cell culture; MCF-7; Cancer; Medicine; Human breast; Biochemistry","score_opus":0.022777619496728088,"score_gpt":0.3351458927874194,"score_spread":0.31236827329069133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083583664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827879,0.0061650267,0.0030545767,0.0001535767,0.0000577191,0.000038236576,0.0012715568,0.0001551023,0.006316245],"genre_scores_gemma":[0.98509467,0.002196813,0.00209013,0.00008761703,0.000030857474,0.000078151694,0.0026333826,0.000027461652,0.0077610067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999778,0.0000686898,0.000015614341,0.000027818962,0.000053840125,0.000056005912],"domain_scores_gemma":[0.99986386,0.0000369152,0.000020909649,0.000016357388,0.000029842513,0.00003218444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020820227,0.00022630465,0.00017978357,0.00078956684,0.0002855177,0.00032516077,0.00012723422,0.00017768482,0.003211707],"category_scores_gemma":[0.00018664262,0.00017480916,0.00021466371,0.0005603189,0.00018894277,0.00017275463,0.00016794265,0.00040317548,0.00066480803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044362838,0.000057662266,0.0007842131,0.0000376789,0.0000069501284,0.00006586644,0.000026468277,0.000029263476,0.99606967,0.00017563194,0.00009981405,0.0022031125],"study_design_scores_gemma":[0.000016222535,0.00041935238,0.02595344,0.0000054740954,0.00001481921,0.00049939123,0.00006729314,0.00018380253,0.9690935,0.00007191094,0.0036705718,0.000004306138],"about_ca_topic_score_codex":0.00053531193,"about_ca_topic_score_gemma":0.00087488146,"teacher_disagreement_score":0.003211707,"about_ca_system_score_codex":0.00030675708,"about_ca_system_score_gemma":0.00018228228,"threshold_uncertainty_score":0.010744214},"labels":[],"label_agreement":null},{"id":"W2083718162","doi":"10.1007/s10549-010-1102-x","title":"Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval","funders":"Bayer HealthCare","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Mammary gland; Phases of clinical research","score_opus":0.10599594354823769,"score_gpt":0.46746760014198563,"score_spread":0.3614716565937479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083718162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642783,0.0005960064,0.00033346986,0.00016986376,0.000047798134,0.0011002906,0.00041074507,0.000032523767,0.00088156987],"genre_scores_gemma":[0.9951846,0.0007004278,0.00056740927,0.00026702046,0.00011243433,0.0010667437,0.00086596765,0.000014264598,0.0012211669],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970007,0.00015500038,0.000013422528,0.00004134875,0.000023889732,0.00006636865],"domain_scores_gemma":[0.9993198,0.00013828144,0.00009726558,0.00008086904,0.00003976945,0.00032408722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095543644,0.00098077,0.0020755602,0.00037397724,0.00039282514,0.00061080244,0.00075374165,0.0008176441,0.0029699393],"category_scores_gemma":[0.00078333466,0.00040776414,0.0009011298,0.0003813406,0.0010674325,0.00067316904,0.00028015702,0.0029922056,0.0005513855],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8300924,0.07339871,0.004782681,0.00037835128,0.00072295364,0.0002334935,0.0001800355,0.0018365318,0.042783193,0.00027154904,0.0014695955,0.04385056],"study_design_scores_gemma":[0.41599947,0.56736076,0.010018289,0.00001489675,0.00029940222,0.00017116166,0.00004818563,0.00081438554,0.0038635274,0.000115677336,0.0012775036,0.000016737404],"about_ca_topic_score_codex":0.0011510465,"about_ca_topic_score_gemma":0.001796014,"teacher_disagreement_score":0.0029699393,"about_ca_system_score_codex":0.00067831686,"about_ca_system_score_gemma":0.0013350366,"threshold_uncertainty_score":0.009935498},"labels":[],"label_agreement":null},{"id":"W2084174108","doi":"10.1023/a:1019685829799","title":"The Characteristics of Cyclical and Non-Cyclical Mastalgia: A Prospective Study using a Modified McGill Pain Questionnaire","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; McGill Pain Questionnaire; Visual analogue scale; Breast cancer; Breast pain; Physical therapy; Rheumatoid arthritis; Quality of life (healthcare); Schmidt sting pain index; Arthritis; Internal medicine; Cancer","score_opus":0.04096538500900489,"score_gpt":0.33361484989696283,"score_spread":0.29264946488795796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084174108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896467,0.0002100751,0.00006223366,0.000025615116,0.000008642616,0.000039334067,0.0003564225,0.0000020696102,0.00033077327],"genre_scores_gemma":[0.99842227,0.00012849063,0.00011551982,0.000056713136,0.000016998176,0.000052912637,0.0006387086,0.0000034291559,0.00056499767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991685,0.00023762074,0.00013156359,0.00012286394,0.00018401281,0.00015532982],"domain_scores_gemma":[0.9968118,0.0005291195,0.0014056995,0.00016283532,0.0003828512,0.00070762367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010873486,0.0006166747,0.00069309596,0.0013095189,0.00079935545,0.00073294225,0.00049522385,0.0010699364,0.001765377],"category_scores_gemma":[0.0030567863,0.0006417851,0.0009219044,0.0018442228,0.0004530773,0.0009131343,0.0005078592,0.0012467627,0.0004304268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030011035,0.00022680627,0.99817574,0.000009827915,0.00006260198,0.00008117269,0.00015138266,0.000018126384,0.00039625962,0.000007807765,0.0000413385,0.00052891986],"study_design_scores_gemma":[0.000009441767,0.0003242613,0.9992206,0.0000015474914,0.00001426657,0.00012766372,0.00018069214,0.000025681444,0.000024565563,0.000005046618,0.00006230015,0.00000391227],"about_ca_topic_score_codex":0.004770258,"about_ca_topic_score_gemma":0.006262328,"teacher_disagreement_score":0.004770258,"about_ca_system_score_codex":0.00035297626,"about_ca_system_score_gemma":0.0003919607,"threshold_uncertainty_score":0.009484947},"labels":[],"label_agreement":null},{"id":"W2084312945","doi":"10.1007/s10549-010-0733-2","title":"Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"School of Medicine, Indiana University; Eli Lilly and Company","keywords":"Breast cancer; Protein kinase C; Tissue microarray; Estrogen receptor; Cancer research; Cancer; Immunohistochemistry; Medicine; Internal medicine; Pathology; Biology; Oncology; Endocrinology; Kinase; Cell biology","score_opus":0.031178596612747553,"score_gpt":0.35196370857803233,"score_spread":0.32078511196528475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084312945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591726,0.0018713156,0.0003062572,0.000053097137,0.0000132111645,0.0000057078432,0.0003980173,0.000015024689,0.0014201924],"genre_scores_gemma":[0.99788886,0.0005149917,0.0001851334,0.000016070553,0.000011799469,0.000008701046,0.00044406048,0.0000073433007,0.0009231435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983406,0.000021917254,0.000017314496,0.000038591865,0.000029176015,0.000058942172],"domain_scores_gemma":[0.99958163,0.00007087391,0.00011259687,0.00004724959,0.000095496136,0.00009223869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002186459,0.0001786707,0.0002401709,0.00089346606,0.0003467425,0.0005064544,0.000247297,0.0002509644,0.0020279796],"category_scores_gemma":[0.00053072046,0.00019452452,0.00023643115,0.0006434528,0.0002445861,0.00022590668,0.00021909837,0.00035323764,0.0005578867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060908766,0.00012728057,0.4997945,0.00012843123,0.0002178414,0.00049327186,0.00021663959,0.000232008,0.47623786,0.00034207117,0.0005928835,0.015526375],"study_design_scores_gemma":[0.00003162545,0.00014008496,0.9694635,0.000006188695,0.000064548905,0.0019650552,0.00032299082,0.0005544501,0.026166458,0.00015101579,0.001125163,0.000008859951],"about_ca_topic_score_codex":0.0016637945,"about_ca_topic_score_gemma":0.001275975,"teacher_disagreement_score":0.0020279796,"about_ca_system_score_codex":0.00035859662,"about_ca_system_score_gemma":0.00019823863,"threshold_uncertainty_score":0.00678432},"labels":[],"label_agreement":null},{"id":"W2084522014","doi":"10.1007/s10549-013-2489-y","title":"Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK; Ontario Institute for Cancer Research","keywords":"Taxane; Tact; Docetaxel; Epirubicin; Oncology; Medicine; Breast cancer; Anthracycline; Internal medicine; Chemotherapy; Cancer; Psychology","score_opus":0.027267808827154478,"score_gpt":0.3107653741352789,"score_spread":0.2834975653081244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084522014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605834,0.002016713,0.0001421042,0.0001866345,0.000029944933,0.0000074735212,0.00014809072,0.000007913699,0.001402825],"genre_scores_gemma":[0.99921453,0.00026128345,0.00007344109,0.000037017606,0.000016560793,0.0000023417165,0.00012401599,0.000001727301,0.00026910254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997522,0.00007019538,0.000025788786,0.00002807838,0.00005909308,0.00006460932],"domain_scores_gemma":[0.9987078,0.0005591036,0.0003229616,0.000073979776,0.000081538026,0.00025455048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074579904,0.00022106811,0.000496061,0.00040804487,0.00019851232,0.0005517064,0.00022519335,0.00045886176,0.0015906101],"category_scores_gemma":[0.0020967566,0.00012904132,0.00035188315,0.00033026608,0.00025443546,0.00037871877,0.00017063117,0.0006714323,0.00022103755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009005501,0.00028166975,0.937961,0.000091668386,0.0001490612,0.0006782006,0.00005917304,0.0006506778,0.020249175,0.00013087559,0.00043469708,0.03030827],"study_design_scores_gemma":[0.000060658414,0.00074845774,0.9928926,0.000019767645,0.00012115976,0.00126261,0.00007965342,0.00079852133,0.0029442501,0.00028446532,0.0007812184,0.000006643203],"about_ca_topic_score_codex":0.00073524244,"about_ca_topic_score_gemma":0.0023022965,"teacher_disagreement_score":0.0015906101,"about_ca_system_score_codex":0.00036715157,"about_ca_system_score_gemma":0.00031913663,"threshold_uncertainty_score":0.005321145},"labels":[],"label_agreement":null},{"id":"W2084718649","doi":"10.1023/a:1006344200094","title":"Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; University of Calgary; Northeast Cancer Centre","funders":"Northern Ontario Heritage Fund Corporation; Cancer Care Ontario","keywords":"Paclitaxel; Apoptosis; MCF-7; Doxorubicin; P-glycoprotein; Cytotoxicity; Pharmacology; Cancer cell; Cancer research; Necrosis; Biology; Drug resistance; Multiple drug resistance; Chemotherapy; Cancer; In vitro; Biochemistry","score_opus":0.03590449380046536,"score_gpt":0.30382672201746364,"score_spread":0.2679222282169983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084718649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268264,0.0031723243,0.0014812967,0.00020848605,0.00002608648,0.00003417759,0.0004762745,0.00010720004,0.0018116233],"genre_scores_gemma":[0.99621,0.0010899483,0.00080644066,0.00003698533,0.0000048883085,0.000027100134,0.00041069818,0.000013916959,0.0013999892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998566,0.000032990887,0.00002088104,0.000019934958,0.00002661364,0.000043026506],"domain_scores_gemma":[0.9999093,0.000022696378,0.000020199594,0.000018650382,0.000012155205,0.000017018428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014250929,0.00027595786,0.00032978939,0.0002568144,0.00022620261,0.00044559184,0.00016890993,0.00034441048,0.0009793297],"category_scores_gemma":[0.00012607026,0.00015213178,0.0002539878,0.00018822856,0.00020412351,0.00035088288,0.00013593843,0.00057812285,0.00027462037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046510348,0.0000478374,0.00036169912,0.00006545147,0.000010288752,0.00011201,0.00003146131,0.00010851662,0.9952597,0.00036732954,0.00006213343,0.0031085685],"study_design_scores_gemma":[0.000048668622,0.000341799,0.006224046,0.000010507967,0.000026475185,0.00043000796,0.000058455007,0.00070412894,0.9899762,0.00009488003,0.0020799965,0.0000049196615],"about_ca_topic_score_codex":0.0004231385,"about_ca_topic_score_gemma":0.00083299173,"teacher_disagreement_score":0.0009793297,"about_ca_system_score_codex":0.00031280215,"about_ca_system_score_gemma":0.00021695823,"threshold_uncertainty_score":0.0032761693},"labels":[],"label_agreement":null},{"id":"W2084941037","doi":"10.1007/s10549-010-1022-9","title":"Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Jewish General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"AstraZeneca","keywords":"Fulvestrant; Tolerability; Medicine; Discontinuation; Dosing; Breast cancer; Internal medicine; Clinical endpoint; Hazard ratio; Cancer; Pharmacokinetics; Aromatase inhibitor; Oncology; Gastroenterology; Urology; Confidence interval; Adverse effect; Randomized controlled trial; Tamoxifen","score_opus":0.020623715873909182,"score_gpt":0.3414630079312039,"score_spread":0.32083929205729467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084941037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916161,0.0018582322,0.0009690747,0.00052391156,0.00021687074,0.001998331,0.0016833781,0.0001243376,0.001009582],"genre_scores_gemma":[0.982797,0.0025578332,0.002796667,0.0012816003,0.00044536122,0.0028072286,0.0031975142,0.00010005878,0.0040167673],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.998968,0.0005727641,0.00005333781,0.00014732225,0.000082048966,0.00017651582],"domain_scores_gemma":[0.9980367,0.0006779028,0.00031642182,0.00027978187,0.00010216117,0.00058700505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002957294,0.002490938,0.00397871,0.00073522277,0.0006954995,0.001060061,0.0013459193,0.0023149422,0.004410718],"category_scores_gemma":[0.0025442338,0.0009343103,0.0025862912,0.0006635851,0.0017050154,0.0013078824,0.00036286257,0.003985167,0.0009357535],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9040966,0.04429935,0.0013563717,0.0002862044,0.0013866692,0.00007683423,0.00016244446,0.001083008,0.018396597,0.00007786109,0.0008181236,0.027959973],"study_design_scores_gemma":[0.57077825,0.42096585,0.0036774972,0.0000152226585,0.00075664476,0.00008757128,0.00004862098,0.00030306858,0.0025495552,0.000119375196,0.00067146117,0.000026937925],"about_ca_topic_score_codex":0.0018707331,"about_ca_topic_score_gemma":0.002530063,"teacher_disagreement_score":0.004410718,"about_ca_system_score_codex":0.0008505398,"about_ca_system_score_gemma":0.0017774504,"threshold_uncertainty_score":0.015639901},"labels":[],"label_agreement":null},{"id":"W2085412553","doi":"10.1007/s10549-010-1135-1","title":"The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Estrogen receptor; Proportional hazards model; Progesterone receptor; Multivariate analysis; Lymph node; Cancer; Univariate analysis; Mastectomy; Hormonal therapy; Gynecology; Gastroenterology","score_opus":0.04115896596853534,"score_gpt":0.3489456782147958,"score_spread":0.3077867122462604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085412553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973568,0.0018361033,0.000071370094,0.000089020636,0.000011072349,0.000002874301,0.00014254518,0.0000024124604,0.0004879431],"genre_scores_gemma":[0.99874663,0.0006998405,0.000049889695,0.000028945706,0.000020430823,0.0000028783968,0.00015358406,0.0000024661686,0.00029530676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999663,0.0001679333,0.00003129212,0.0000307792,0.000055523316,0.000051471776],"domain_scores_gemma":[0.9983537,0.00059707183,0.0005716653,0.00016883283,0.00013927894,0.00016957869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007584333,0.00013006506,0.0003520922,0.00060252525,0.00026070766,0.00049169816,0.000365463,0.00026805876,0.00092445867],"category_scores_gemma":[0.003179839,0.00018800364,0.00038498564,0.0008017611,0.0002070424,0.00028542624,0.00017631575,0.0005214499,0.00013089892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007493829,0.000035231697,0.99487334,0.0000184919,0.000073965275,0.00006918005,0.00004974586,0.000036485137,0.0008776619,0.000025158892,0.00004491328,0.0031463793],"study_design_scores_gemma":[0.000009837386,0.00008742542,0.9992042,0.000003397214,0.000052092153,0.00021491406,0.00008573012,0.000050243903,0.000147236,0.000033020555,0.0001101809,0.0000017104761],"about_ca_topic_score_codex":0.0054649473,"about_ca_topic_score_gemma":0.008685201,"teacher_disagreement_score":0.0054649473,"about_ca_system_score_codex":0.0003096484,"about_ca_system_score_gemma":0.0003111867,"threshold_uncertainty_score":0.010866284},"labels":[],"label_agreement":null},{"id":"W2085835360","doi":"10.1007/s10549-014-3259-1","title":"Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Toronto; Ontario Clinical Oncology Group; Saint John Regional Hospital; McMaster University; Queen's University; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Cancer Institute; Plexxikon; Susan G. Komen; Bristol-Myers Squibb; Amgen; Pfizer; Sanofi; Cancer Research Institute; BC Cancer Agency; Susan G. Komen for the Cure","keywords":"Epirubicin; Medicine; Internal medicine; Oncology; Cyclophosphamide; Breast cancer; Proportional hazards model; Chemotherapy; Hazard ratio; Paclitaxel; Multivariate analysis; Cancer; Confidence interval","score_opus":0.02964056418049475,"score_gpt":0.33766392108995746,"score_spread":0.3080233569094627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085835360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120754,0.0023290343,0.00016486277,0.0006395658,0.000052850173,0.00018202983,0.0012220644,0.000025309568,0.004176768],"genre_scores_gemma":[0.9944443,0.0007293936,0.00030945617,0.00036696752,0.00008558651,0.0002274413,0.002436632,0.000011921266,0.0013883228],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991391,0.00056334515,0.00003041737,0.00008579356,0.00007099497,0.00011034512],"domain_scores_gemma":[0.99881554,0.00037519104,0.00026869436,0.00015577316,0.0000719196,0.0003128407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019590177,0.0005636238,0.0009646933,0.00022545889,0.0003560932,0.0010833978,0.0006684927,0.00057924946,0.002335327],"category_scores_gemma":[0.0028658079,0.00022826278,0.00050579297,0.00052496773,0.00042012523,0.0006332597,0.00041358016,0.0012534586,0.0004956269],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48909482,0.0034443534,0.2727921,0.0005239245,0.0027199646,0.00022441527,0.0002968243,0.0066911313,0.013856461,0.0018501536,0.018801013,0.1897048],"study_design_scores_gemma":[0.07511107,0.07213132,0.8143307,0.0002644507,0.0037147445,0.0005887992,0.00023520576,0.010584941,0.0040052226,0.0032091765,0.015715102,0.00010918105],"about_ca_topic_score_codex":0.0014343931,"about_ca_topic_score_gemma":0.005305749,"teacher_disagreement_score":0.002335327,"about_ca_system_score_codex":0.0008095402,"about_ca_system_score_gemma":0.0010798712,"threshold_uncertainty_score":0.01036036},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2086036058","doi":"10.1007/s10549-010-1152-0","title":"Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Eli Lilly (Canada); University of Alberta; Ottawa Hospital","funders":"Eli Lilly and Company","keywords":"Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Placebo; Hazard ratio; Breast cancer; Taxane; Oncology; Anthracycline; Cancer; Colorectal cancer; Confidence interval","score_opus":0.07088188007729243,"score_gpt":0.42360677427515525,"score_spread":0.3527248941978628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086036058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844803,0.0036217796,0.0010321302,0.00091815856,0.0014019915,0.005023655,0.0010322415,0.00019727484,0.0022924454],"genre_scores_gemma":[0.9787472,0.0031669955,0.0019766784,0.0013853019,0.00094406604,0.0060191476,0.0011614161,0.000050097984,0.0065491064],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99928826,0.00033125802,0.000043047632,0.00017597107,0.000041627853,0.00011996832],"domain_scores_gemma":[0.9986841,0.00040246636,0.00023904121,0.00012647829,0.00007407135,0.00047387293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019109625,0.0028391276,0.006358998,0.000669839,0.0006701982,0.0013706674,0.0014945968,0.0022649835,0.00927057],"category_scores_gemma":[0.0025170567,0.0014668173,0.001977375,0.00062989065,0.0021068016,0.0017202883,0.0005335995,0.0048090564,0.0015101914],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9902914,0.0041737235,0.00010714158,0.00019470119,0.00029054776,0.000015112635,0.000022109642,0.00014708946,0.0010584065,0.000049211834,0.00022985293,0.0034206288],"study_design_scores_gemma":[0.97178775,0.027249401,0.0003281197,0.000007796235,0.00012972578,0.000008400417,0.0000082178185,0.00016796155,0.00011892507,0.00004997675,0.00013704297,0.0000066548846],"about_ca_topic_score_codex":0.0018384246,"about_ca_topic_score_gemma":0.003710278,"teacher_disagreement_score":0.00927057,"about_ca_system_score_codex":0.0011365236,"about_ca_system_score_gemma":0.0016115193,"threshold_uncertainty_score":0.03101319},"labels":[],"label_agreement":null},{"id":"W2086104261","doi":"10.1007/s10549-006-9249-1","title":"Economic Analysis of Psychosocial Group Therapy in Women with Metastatic Breast Cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Psychosocial; Breast cancer; Psychological intervention; Metastatic breast cancer; Randomized controlled trial; Physical therapy; Mood; Anxiety; Health care; Cancer; Internal medicine; Psychiatry","score_opus":0.03046380162424772,"score_gpt":0.35835915039785327,"score_spread":0.32789534877360554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086104261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652101,0.013457013,0.0022721167,0.0045680637,0.00020091585,0.0009120615,0.0027872506,0.000024791618,0.010567785],"genre_scores_gemma":[0.996591,0.0013988033,0.0003922405,0.00015691678,0.000036222784,0.00013866226,0.00046947994,0.000004655191,0.00081210356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956957,0.0030846577,0.0001332544,0.000095082985,0.00034168412,0.0006494676],"domain_scores_gemma":[0.9939964,0.0042680483,0.00072243623,0.00014259046,0.0002468891,0.0006235412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038751427,0.0006698738,0.0013299057,0.0016072447,0.00061833585,0.0013669026,0.001016519,0.0010685475,0.006517906],"category_scores_gemma":[0.01642337,0.00039895877,0.0027515409,0.0018544508,0.00064199005,0.0007571872,0.001301253,0.0014118743,0.00013847099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15933587,0.011305979,0.301769,0.0044068038,0.011782393,0.0018188837,0.00071213295,0.21533288,0.0012760998,0.044039257,0.013222808,0.23499796],"study_design_scores_gemma":[0.019294897,0.03341687,0.5614919,0.001604447,0.015960302,0.0021287329,0.0062341825,0.31138855,0.0013285334,0.02620091,0.020630905,0.0003197257],"about_ca_topic_score_codex":0.021492964,"about_ca_topic_score_gemma":0.020261927,"teacher_disagreement_score":0.021492964,"about_ca_system_score_codex":0.006127147,"about_ca_system_score_gemma":0.0033219936,"threshold_uncertainty_score":0.044455767},"labels":[],"label_agreement":null},{"id":"W2086775915","doi":"10.1007/s10549-008-0060-z","title":"A common Greenlandic Inuit BRCA1 RING domain founder mutation","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Genetics; Founder effect; Mutation; Biology; Population; Breast cancer; Single-nucleotide polymorphism; Cancer; Haplotype; Medicine; Gene; Genotype","score_opus":0.04891071369308564,"score_gpt":0.3563522990661232,"score_spread":0.30744158537303756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086775915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96623856,0.0007095997,0.001526301,0.0022520912,0.00024980016,0.00010546996,0.0019373483,0.00014620057,0.026834657],"genre_scores_gemma":[0.9879628,0.00025968006,0.0009994287,0.00082909496,0.00004114413,0.000013732241,0.00033329576,0.0000705583,0.00949034],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998267,0.000010815729,0.000014700177,0.00005789853,0.000042831045,0.00004714453],"domain_scores_gemma":[0.9997372,0.00006017533,0.00006819981,0.000015508695,0.000040939303,0.00007789265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010677347,0.0008952778,0.00047889035,0.0012934055,0.0018364106,0.00043760566,0.00070921035,0.001171568,0.00627486],"category_scores_gemma":[0.00064986356,0.00018228906,0.00039371726,0.0009895698,0.0007242903,0.00027173356,0.0005039565,0.0005473384,0.0006706595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024045864,0.00020415556,0.06258589,0.00011183026,0.00006257216,0.8720056,0.0029445922,0.00018233457,0.03864277,0.0031491912,0.005511717,0.01435888],"study_design_scores_gemma":[0.00003763341,0.00027090605,0.12515493,0.000092309165,0.00013540465,0.8442878,0.002262319,0.0006525204,0.007065541,0.0010605091,0.018913776,0.00006624002],"about_ca_topic_score_codex":0.057053294,"about_ca_topic_score_gemma":0.11596101,"teacher_disagreement_score":0.057053294,"about_ca_system_score_codex":0.00070735376,"about_ca_system_score_gemma":0.0008426821,"threshold_uncertainty_score":0.11344242},"labels":[],"label_agreement":null},{"id":"W2087029919","doi":"10.1007/s10549-007-9770-x","title":"Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Epirubicin; Docetaxel; Oncology; Internal medicine; Gynecology; Cancer","score_opus":0.0409900207940185,"score_gpt":0.39054020280051116,"score_spread":0.3495501820064927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087029919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96638805,0.014990558,0.0069205924,0.0012944278,0.00017916324,0.00078847393,0.0019649086,0.00006197748,0.007411868],"genre_scores_gemma":[0.99610436,0.0012568884,0.0013594455,0.00015261504,0.000032447755,0.000086429456,0.00037657758,0.000011310414,0.0006199189],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99591005,0.0034505622,0.000091572685,0.00013793702,0.00024192315,0.00016802814],"domain_scores_gemma":[0.98868716,0.010074,0.0005097354,0.00023503417,0.00023007618,0.00026400032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051247524,0.0009544447,0.0017797879,0.0014174397,0.00019693062,0.0014974303,0.0009892979,0.0011971182,0.0055892123],"category_scores_gemma":[0.016173854,0.00046509557,0.0035609403,0.0017532695,0.0005292456,0.0009574836,0.0005368602,0.0014391957,0.00022046737],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41105652,0.002553167,0.048337687,0.0020674658,0.012427461,0.0008583315,0.00015293878,0.2876737,0.004247666,0.011570565,0.0031769858,0.21587758],"study_design_scores_gemma":[0.04435411,0.09822754,0.17138956,0.0011477795,0.043411635,0.002534082,0.0010423204,0.60856587,0.0052687977,0.01198228,0.011722716,0.00035337175],"about_ca_topic_score_codex":0.0065569435,"about_ca_topic_score_gemma":0.003682641,"teacher_disagreement_score":0.0065569435,"about_ca_system_score_codex":0.0030293667,"about_ca_system_score_gemma":0.0010505784,"threshold_uncertainty_score":0.02710259},"labels":[],"label_agreement":null},{"id":"W2087438360","doi":"10.1007/s10549-007-9649-x","title":"Effectiveness of a self-administered, home-based exercise rehabilitation program for women following a modified radical mastectomy and axillary node dissection: a preliminary study","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Concordia University","funders":"Concordia University","keywords":"Medicine; Rehabilitation; Physical therapy; Range of motion; Modified Radical Mastectomy; Breast cancer; Mastectomy; Surgery; Cancer; Internal medicine","score_opus":0.02840656120162417,"score_gpt":0.3797113513189866,"score_spread":0.35130479011736243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087438360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994555,0.000048538357,0.00004591222,0.000020781774,0.000007958293,0.00019400776,0.0000400719,0.0000051568018,0.00018206355],"genre_scores_gemma":[0.9977429,0.00021807963,0.0007212159,0.000075437136,0.000046177916,0.00051620405,0.00016159355,0.0000032836845,0.0005152904],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994062,0.00028494658,0.00004603074,0.00009170173,0.00006949758,0.00010171862],"domain_scores_gemma":[0.99895704,0.0004462878,0.00010569124,0.00007858674,0.000064160384,0.00034815614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001309052,0.0005893585,0.0009566269,0.0006505114,0.00079072826,0.0002797057,0.00074951927,0.00085380033,0.0022353332],"category_scores_gemma":[0.0021361103,0.0003590952,0.00067228684,0.00044063863,0.00047733577,0.00040303214,0.0003713626,0.000792125,0.00024005189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17761225,0.58640033,0.049917683,0.0007344211,0.0006426392,0.00041893488,0.0018432308,0.001053575,0.016028184,0.00008792304,0.00036231254,0.16489854],"study_design_scores_gemma":[0.041397214,0.69167167,0.26076195,0.000055086362,0.00064180006,0.00013398942,0.0008038737,0.0014476194,0.0024328039,0.00006042857,0.0005550758,0.0000384549],"about_ca_topic_score_codex":0.002976934,"about_ca_topic_score_gemma":0.004853233,"teacher_disagreement_score":0.002976934,"about_ca_system_score_codex":0.00039446543,"about_ca_system_score_gemma":0.00084999163,"threshold_uncertainty_score":0.0074778795},"labels":[],"label_agreement":null},{"id":"W2088394534","doi":"10.1007/s10549-006-9312-y","title":"Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Dihydrotestosterone; Hormone; Steroid hormone; Biology; Kallikrein; Endocrinology; Internal medicine; Cancer research; Androgen; Medicine","score_opus":0.029394531098471642,"score_gpt":0.3197050283149824,"score_spread":0.29031049721651075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088394534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829562,0.0033942072,0.006764587,0.0002708237,0.00013174445,0.00013038554,0.0021813312,0.00022012835,0.0039506415],"genre_scores_gemma":[0.97944754,0.0015487593,0.0059699914,0.00014645618,0.000026945901,0.00017843093,0.0051688463,0.000064152606,0.007448809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993766,0.00009572928,0.00009682502,0.0001013782,0.00020305239,0.00012645958],"domain_scores_gemma":[0.999632,0.000109251014,0.000035917245,0.00010012986,0.00007513662,0.00004751832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031279438,0.00024191756,0.00043346558,0.00044498465,0.00036651443,0.00076617557,0.00026006813,0.00022072207,0.0016166891],"category_scores_gemma":[0.00031050746,0.00022391323,0.00038079187,0.0006060203,0.0002760705,0.0003330739,0.00032347997,0.00079550286,0.00068761257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013869611,0.000042774016,0.0003293673,0.000028204224,0.0000094892475,0.00006248882,0.0000711007,0.0000318354,0.9977188,0.00016342006,0.0001709695,0.0012327749],"study_design_scores_gemma":[0.000035247554,0.00019569682,0.009980224,0.000005650451,0.000033240725,0.00048076652,0.000109083856,0.0006755714,0.9818771,0.00004809626,0.0065496364,0.000009690943],"about_ca_topic_score_codex":0.0016487711,"about_ca_topic_score_gemma":0.00323226,"teacher_disagreement_score":0.0016487711,"about_ca_system_score_codex":0.0004729374,"about_ca_system_score_gemma":0.0004157182,"threshold_uncertainty_score":0.0054083467},"labels":[],"label_agreement":null},{"id":"W2088524487","doi":"10.1023/a:1019915101457","title":"Mitogenic Properties of Insulin-Like Growth Factors I and II, Insulin-Like Growth Factor Binding Protein-3 and Epidermal Growth Factor on Human Breast Epithelial Cells in Primary Culture","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epidermal growth factor; Growth factor receptor inhibitor; Internal medicine; Endocrinology; Growth factor; Insulin-like growth factor-binding protein; Primary culture; Insulin; Insulin-like growth factor; Biology; Cancer research; Cell culture; Chemistry; Cell biology; Medicine; Receptor; Genetics","score_opus":0.06239063904561519,"score_gpt":0.29298113534931547,"score_spread":0.23059049630370027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088524487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93534774,0.021236992,0.0085863145,0.0004940102,0.0005361139,0.0004006069,0.0063557792,0.00031477882,0.026727738],"genre_scores_gemma":[0.9437241,0.011755199,0.0075758784,0.00036759372,0.00037586765,0.0004484497,0.014445918,0.00013119788,0.021175817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950635,0.00012928355,0.000047111047,0.00005341141,0.00011464871,0.00014921116],"domain_scores_gemma":[0.9989416,0.0005983768,0.00003184355,0.000118104246,0.00016054304,0.00014965599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067326013,0.0007836057,0.0006017662,0.0007390872,0.0005447818,0.00047006184,0.0004908319,0.00028494906,0.004065436],"category_scores_gemma":[0.0005080364,0.00042137923,0.0007588421,0.0008169965,0.000368071,0.00035154884,0.00039566588,0.0009141624,0.0013894717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092811254,0.00010200558,0.00051695196,0.00014675136,0.000013678986,0.00019817964,0.00012374863,0.00008840214,0.9953323,0.00018762625,0.00033202488,0.0020302965],"study_design_scores_gemma":[0.00007313416,0.00093087764,0.01850597,0.000037955182,0.00006702187,0.0005035042,0.00014481186,0.0006343329,0.97245467,0.00015088006,0.006483639,0.000013248992],"about_ca_topic_score_codex":0.0063374476,"about_ca_topic_score_gemma":0.007708665,"teacher_disagreement_score":0.0063374476,"about_ca_system_score_codex":0.0005969532,"about_ca_system_score_gemma":0.0006779591,"threshold_uncertainty_score":0.013600171},"labels":[],"label_agreement":null},{"id":"W2088694463","doi":"10.1007/s10549-008-0146-7","title":"Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Cancer Care Ontario; Hospital for Sick Children; Public Health Ontario; University of Toronto","funders":"","keywords":"Allele; Internal medicine; Breast cancer; Endocrinology; Anthropometry; Genotype; MAMMOGRAPHIC DENSITY; Biology; Body mass index; Polymorphism (computer science); Medicine; Genetics; Mammography; Cancer; Gene","score_opus":0.09331046260386545,"score_gpt":0.34329457739254654,"score_spread":0.2499841147886811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088694463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993767,0.000113424154,0.000028158534,0.000026576143,0.0000065851814,0.0000023276098,0.00011628592,0.0000022587737,0.00032768262],"genre_scores_gemma":[0.9992889,0.00005833287,0.00005342577,0.00002203666,0.0000113080305,0.0000046364094,0.00009736244,0.0000017374301,0.00046221362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998871,0.000031638196,0.00001260133,0.00002915545,0.000014736227,0.000024692637],"domain_scores_gemma":[0.9993988,0.00015856145,0.00017510325,0.000040063438,0.000061698476,0.00016569403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025370947,0.00018578893,0.0002652566,0.000612801,0.0005231186,0.000331021,0.00020899666,0.00034297598,0.0018386374],"category_scores_gemma":[0.0011117,0.00029949038,0.00020574183,0.0005307222,0.00026619705,0.00018814315,0.00016816748,0.00040242192,0.00021788942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000689954,0.000067223744,0.99660194,0.0000055362775,0.000052156505,0.00014596133,0.00009265761,0.000016017213,0.0014557522,0.000016612466,0.00008248971,0.00077369367],"study_design_scores_gemma":[0.000007228555,0.00009568763,0.9993419,0.0000012269461,0.000026634869,0.0001721561,0.00009748718,0.00010316327,0.000066873574,0.000008382073,0.00007736666,0.0000019064468],"about_ca_topic_score_codex":0.013202517,"about_ca_topic_score_gemma":0.017416827,"teacher_disagreement_score":0.013202517,"about_ca_system_score_codex":0.00017223998,"about_ca_system_score_gemma":0.00019249639,"threshold_uncertainty_score":0.026251316},"labels":[],"label_agreement":null},{"id":"W2088871749","doi":"10.1007/s10549-014-3058-8","title":"Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Breast cancer; Internal medicine; Odds ratio; Heart failure; Cumulative dose; Cohort; Confidence interval; Population; Cardiology; Cohort study; Cancer; Oncology","score_opus":0.009894111536922922,"score_gpt":0.28435067043964346,"score_spread":0.2744565589027205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088871749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922241,0.0049523464,0.00006334832,0.0003021459,0.000038522205,0.000008352196,0.00034068266,0.000005959398,0.0020645543],"genre_scores_gemma":[0.99716717,0.001865887,0.00009513963,0.00010885116,0.00009167865,0.00000498973,0.00020662863,0.0000023634755,0.0004573545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998147,0.0000605385,0.000017899787,0.000020582753,0.000043326272,0.000042963322],"domain_scores_gemma":[0.99888176,0.00027886618,0.00049173704,0.000058831138,0.00007142655,0.00021734489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030764448,0.00024655095,0.0003225395,0.0006131636,0.00031112117,0.0006200375,0.00021018088,0.00072101876,0.0016319861],"category_scores_gemma":[0.001835846,0.00028292605,0.00072289904,0.0009534322,0.000206293,0.00033465135,0.0002639191,0.0010459592,0.00016710818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069118926,0.0000943489,0.99565494,0.000017195194,0.00015029409,0.00012231669,0.000025381387,0.000036189624,0.00018475455,0.000028117443,0.0000931386,0.0029021418],"study_design_scores_gemma":[0.000021976339,0.00016662362,0.99889994,0.000010783262,0.0001424786,0.00021658326,0.00009262007,0.00017696375,0.00003871377,0.00005672918,0.00017180563,0.0000047592566],"about_ca_topic_score_codex":0.0057814824,"about_ca_topic_score_gemma":0.007068379,"teacher_disagreement_score":0.0057814824,"about_ca_system_score_codex":0.00022202841,"about_ca_system_score_gemma":0.00026891992,"threshold_uncertainty_score":0.01149565},"labels":[],"label_agreement":null},{"id":"W2088949718","doi":"10.1007/s10549-014-2883-0","title":"Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; BC Cancer Agency; Alberta Health Services; University of British Columbia; University of Alberta","funders":"Alberta Innovates; Canadian Breast Cancer Research Alliance; Alberta Cancer Foundation; Canada Research Chairs; Breast Cancer Alliance","keywords":"Medicine; Pittsburgh Sleep Quality Index; Aerobic exercise; Breast cancer; Randomized controlled trial; Internal medicine; Physical therapy; Sleep quality; Cancer; Insomnia","score_opus":0.02446893150285202,"score_gpt":0.362233175836529,"score_spread":0.33776424433367697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088949718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467236,0.0018159826,0.00034943543,0.00042617414,0.00027723456,0.0013646387,0.0005151576,0.000035431814,0.0005435096],"genre_scores_gemma":[0.9933009,0.0010246306,0.0009440731,0.00061405206,0.00038238752,0.0019248797,0.0006367831,0.000016123653,0.0011561968],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983975,0.00089734845,0.00012757037,0.0003314678,0.000074843425,0.00017118992],"domain_scores_gemma":[0.99728847,0.0008911523,0.0006595748,0.0002887219,0.00015241429,0.0007196833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022755435,0.001986559,0.004091787,0.00041120665,0.0008345545,0.0012003868,0.0013259187,0.0024141532,0.0063031847],"category_scores_gemma":[0.0036821456,0.0010709281,0.0028115818,0.0006811182,0.0017308885,0.001317109,0.0007967193,0.0033808132,0.00066723564],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9919329,0.003176548,0.0012912393,0.0001245385,0.001106467,0.000007525259,0.000023989232,0.00008940238,0.0003709632,0.000021006857,0.00011925008,0.0017361783],"study_design_scores_gemma":[0.9426257,0.049627397,0.005115069,0.000027090817,0.0018443579,0.000011863092,0.000037145615,0.0002787984,0.00015057655,0.0000863659,0.00017852474,0.000017164062],"about_ca_topic_score_codex":0.0025298572,"about_ca_topic_score_gemma":0.0029783626,"teacher_disagreement_score":0.0063031847,"about_ca_system_score_codex":0.0008712914,"about_ca_system_score_gemma":0.0012972098,"threshold_uncertainty_score":0.021086276},"labels":[],"label_agreement":null},{"id":"W2089685822","doi":"10.1007/s10549-010-0927-7","title":"Associations between mammographic density and serum and dietary cholesterol","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Sunnybrook Health Science Centre; Sunnybrook Hospital; Ontario Institute for Cancer Research; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Breast cancer; Internal medicine; Cholesterol; MAMMOGRAPHIC DENSITY; High-density lipoprotein; Endocrinology; Alcohol consumption; Cancer; Risk factor; Cross-sectional study; Estrogen; Physiology; Mammography; Alcohol; Biology","score_opus":0.04650573720300648,"score_gpt":0.3522955712805874,"score_spread":0.3057898340775809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089685822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960997,0.0013123547,0.00020581107,0.00015919567,0.000023200804,0.0000049551936,0.00078406587,0.000026750733,0.0013839157],"genre_scores_gemma":[0.9980952,0.00030850957,0.00020681188,0.000044789973,0.000033780885,0.0000064386722,0.00033982706,0.000005475014,0.00095918606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994229,0.00025482508,0.00006986676,0.00009481151,0.00007765591,0.000080007674],"domain_scores_gemma":[0.9937257,0.0033802749,0.0013916944,0.000573692,0.00042247612,0.0005062404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011752251,0.00044211646,0.00050622417,0.0010303024,0.00031001732,0.00092500367,0.00038870348,0.00086672395,0.0033874756],"category_scores_gemma":[0.007297187,0.00076524814,0.00084564625,0.0015673,0.00037531744,0.00054952555,0.00043303482,0.0011623235,0.00041334014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085367495,0.000047383888,0.99737084,0.000010677936,0.00020609514,0.000039574337,0.000029479184,0.000047537917,0.00024261487,0.000034195993,0.000056512952,0.0010614743],"study_design_scores_gemma":[0.000015165217,0.00008323412,0.9989316,0.000003527046,0.00015410758,0.00014956674,0.00005308746,0.000345087,0.00008025659,0.000059085298,0.00012049413,0.0000048189004],"about_ca_topic_score_codex":0.008706695,"about_ca_topic_score_gemma":0.008200295,"teacher_disagreement_score":0.008706695,"about_ca_system_score_codex":0.00033614074,"about_ca_system_score_gemma":0.00037798748,"threshold_uncertainty_score":0.01731205},"labels":[],"label_agreement":null},{"id":"W2089959409","doi":"10.1007/s10549-013-2713-9","title":"Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Statistics Canada; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Hazard ratio; Meta-analysis; Vitamin D and neurology; Cancer; Observational study; Confidence interval","score_opus":0.2261282930899937,"score_gpt":0.4560924891580444,"score_spread":0.2299641960680507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089959409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058097444,0.9930936,0.00031464093,0.000111390174,0.00011296631,0.00010258084,0.0002970348,0.000016113341,0.00014202808],"genre_scores_gemma":[0.20338297,0.7919838,0.0021002968,0.00095986936,0.0001982437,0.00039973643,0.00049380044,0.000020566515,0.00046069748],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99608827,0.0015411023,0.0012267655,0.00054426567,0.00042265104,0.00017708569],"domain_scores_gemma":[0.99172336,0.005740732,0.0015207104,0.00032865687,0.0005455693,0.00014099087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066079763,0.0027187155,0.013454845,0.003810783,0.00056202326,0.002251906,0.0019891786,0.0022217806,0.0036560856],"category_scores_gemma":[0.017503342,0.0018763106,0.025089743,0.0054226085,0.0007218331,0.0014719106,0.0016571175,0.0017919324,0.00030961237],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025317317,0.000046156012,0.0067828293,0.27831584,0.69879204,0.00013532322,0.00009516683,0.0003088538,0.0003041016,0.0000905039,0.0006143607,0.011983012],"study_design_scores_gemma":[0.0006428042,0.0001474658,0.0036421295,0.008497296,0.9856149,0.00007880655,0.000041719784,0.000067517925,0.00007242856,0.0001006756,0.0010740047,0.000020334324],"about_ca_topic_score_codex":0.009149274,"about_ca_topic_score_gemma":0.02663604,"teacher_disagreement_score":0.013454845,"about_ca_system_score_codex":0.0019016549,"about_ca_system_score_gemma":0.0024557938,"threshold_uncertainty_score":0.03494674},"labels":[],"label_agreement":null},{"id":"W2090886420","doi":"10.1007/s10549-013-2455-8","title":"Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; London Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Kingston General Hospital; Canada Research Chairs; Occupational Cancer Research Centre; Thunder Bay Regional Health Sciences Centre; Health Sciences Centre","funders":"Institute for Clinical Evaluative Sciences","keywords":"Medicine; Radiation therapy; Ductal carcinoma; Breast cancer; Breast-conserving surgery; Population; Oncology; Cohort; Mastectomy; Internal medicine; Randomized controlled trial; Stage (stratigraphy); Cancer; Gynecology","score_opus":0.015223175261930755,"score_gpt":0.30284059766761573,"score_spread":0.287617422405685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090886420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368423,0.0009823481,0.0019356618,0.00083925616,0.0000545264,0.000063118685,0.0012740217,0.0000151985805,0.0011515922],"genre_scores_gemma":[0.9971426,0.00029561264,0.0006158999,0.0003651746,0.000054619828,0.0000555186,0.0011459425,0.000010805617,0.00031385082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966785,0.0017979612,0.00034682747,0.0005173015,0.0003534067,0.00030615504],"domain_scores_gemma":[0.9953121,0.0015190602,0.0012512824,0.0008987311,0.00065174064,0.00036709078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051833824,0.0006578035,0.0011759436,0.0016444025,0.00075474114,0.0013067705,0.0009993474,0.0012084098,0.0017089645],"category_scores_gemma":[0.013760131,0.0003135196,0.0021459158,0.0025371765,0.00044436345,0.0013350791,0.0010580058,0.0009921881,0.00034017954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069751276,0.00013355582,0.9895493,0.00003476564,0.0010592911,0.000082700266,0.000100231795,0.00014934195,0.00026785713,0.00016298515,0.0004810837,0.0072814003],"study_design_scores_gemma":[0.00014215389,0.00096385035,0.99232715,0.000031016312,0.0024135357,0.0002799415,0.0005802053,0.0008872671,0.00022664366,0.00094827986,0.0011789626,0.000021059846],"about_ca_topic_score_codex":0.0055637504,"about_ca_topic_score_gemma":0.0076740948,"teacher_disagreement_score":0.0055637504,"about_ca_system_score_codex":0.0003228296,"about_ca_system_score_gemma":0.0005360799,"threshold_uncertainty_score":0.027412653},"labels":[],"label_agreement":null},{"id":"W2090888216","doi":"10.1007/s10549-007-9595-7","title":"Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Interim; Interim analysis; Medicine; Hazard ratio; Breast cancer; Confidence interval; Internal medicine; Placebo; Sample size determination; Letrozole; Oncology; Clinical endpoint; Relative risk; Absolute risk reduction; Clinical trial; Adjuvant; Cancer; Statistics; Mathematics; Tamoxifen; Alternative medicine; Pathology","score_opus":0.742129627608868,"score_gpt":0.6636178839131149,"score_spread":0.07851174369575309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090888216","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1862071,0.14870782,0.25856358,0.28583714,0.0061928118,0.012509976,0.0075246417,0.0008724546,0.093584456],"genre_scores_gemma":[0.71946156,0.020452926,0.21896873,0.021525558,0.0022445456,0.009181448,0.0011636195,0.00015894488,0.0068427227],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.8637895,0.13087033,0.0014701345,0.00069776195,0.0026634014,0.0005089409],"domain_scores_gemma":[0.7866454,0.2026006,0.0035858315,0.003726636,0.002148113,0.0012934576],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.082218245,0.0010936357,0.0025878956,0.0008329747,0.0009769031,0.0025782934,0.0012577131,0.0042519174,0.005095165],"category_scores_gemma":[0.1737946,0.00036956585,0.0022584703,0.0018382856,0.0015676819,0.0022641756,0.0016642349,0.0055179964,0.00065750076],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0740921,0.0016616377,0.007921339,0.009377591,0.004939627,0.0008202007,0.0011833875,0.057090197,0.001495496,0.28919438,0.105765015,0.44645908],"study_design_scores_gemma":[0.066792384,0.010689377,0.007019985,0.005909092,0.0039244066,0.0010651425,0.0005312875,0.122733206,0.0019673891,0.6463667,0.1327343,0.00026666655],"about_ca_topic_score_codex":0.0022105332,"about_ca_topic_score_gemma":0.0037499461,"teacher_disagreement_score":0.9177818,"about_ca_system_score_codex":0.0016457558,"about_ca_system_score_gemma":0.005295649,"threshold_uncertainty_score":0.43481684},"labels":[],"label_agreement":null},{"id":"W2091640600","doi":"10.1007/s10549-014-3125-1","title":"Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Breast cancer; Oncology; Cancer; Medicine; Internal medicine; Gynecology","score_opus":0.020546513869174967,"score_gpt":0.32647086114877677,"score_spread":0.3059243472796018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091640600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757961,0.01860295,0.00030220865,0.0021662186,0.00018275544,0.000015417263,0.0012797301,0.0000068915947,0.0016477789],"genre_scores_gemma":[0.9936168,0.0046228557,0.00016308641,0.0003024197,0.00014153527,0.000008326871,0.00061866717,0.000006383739,0.00051984045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989812,0.00032213505,0.00011796652,0.00020437912,0.00014689419,0.00022746231],"domain_scores_gemma":[0.99569595,0.0011144838,0.0015312684,0.0004894363,0.0007537098,0.00041512318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028672882,0.00020310564,0.00063523604,0.0011419958,0.0005819347,0.0012311542,0.0005593984,0.0010216224,0.001567614],"category_scores_gemma":[0.011253173,0.0003171385,0.000766795,0.0031271828,0.0005852902,0.0019617707,0.000529815,0.000828582,0.00037806042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020239981,0.000020570194,0.9895689,0.000036350426,0.0001041115,0.00005419034,0.00025249095,0.000030801635,0.00019426564,0.0000800811,0.00020092318,0.009254979],"study_design_scores_gemma":[0.0000033728127,0.000049665563,0.9985481,0.000026642358,0.000054700307,0.0000887888,0.00035511088,0.00004481726,0.00005310196,0.00008578461,0.00068567664,0.000004226995],"about_ca_topic_score_codex":0.022750344,"about_ca_topic_score_gemma":0.029099558,"teacher_disagreement_score":0.022750344,"about_ca_system_score_codex":0.0005944029,"about_ca_system_score_gemma":0.0009056467,"threshold_uncertainty_score":0.045235872},"labels":[],"label_agreement":null},{"id":"W2091820323","doi":"10.1007/s10549-007-9602-z","title":"Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":273,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Medicine; Aerobic exercise; Randomized controlled trial; Quality of life (healthcare); Clinical endpoint; Physical therapy; Anxiety; Repeated measures design; Cancer; Internal medicine; Analysis of variance","score_opus":0.016608958403642037,"score_gpt":0.343406487212894,"score_spread":0.326797528809252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091820323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97997606,0.007951085,0.00083259906,0.0011210395,0.0015629808,0.0056065987,0.0009356776,0.00016276572,0.0018512941],"genre_scores_gemma":[0.9797141,0.004702203,0.0017968001,0.0011810142,0.0011906425,0.0076884334,0.0008619259,0.000027476899,0.0028373762],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99848443,0.0006388949,0.0001351609,0.0003723749,0.00011949197,0.0002495967],"domain_scores_gemma":[0.99843735,0.0006005816,0.0002478581,0.00011186018,0.000093512695,0.00050879613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022388487,0.0028255938,0.0071417377,0.0009363327,0.0010150978,0.0012298403,0.001768904,0.0043543805,0.010889716],"category_scores_gemma":[0.0032691704,0.0015974904,0.0033582314,0.0009373459,0.0017462948,0.001603848,0.00094668055,0.0050109406,0.0012346249],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9888754,0.005090791,0.00022345,0.0005457014,0.0012785553,0.000015189642,0.000023849261,0.0001064968,0.00031032812,0.000028014976,0.00017184476,0.0033303462],"study_design_scores_gemma":[0.9763346,0.021752724,0.0005980853,0.00003550393,0.00093857665,0.0000056171784,0.000012958646,0.00013112817,0.00006460701,0.00003397052,0.00008599793,0.0000063365887],"about_ca_topic_score_codex":0.0037781997,"about_ca_topic_score_gemma":0.0040027583,"teacher_disagreement_score":0.010889716,"about_ca_system_score_codex":0.0010681694,"about_ca_system_score_gemma":0.0017620492,"threshold_uncertainty_score":0.036429703},"labels":[],"label_agreement":null},{"id":"W2092759243","doi":"10.1007/s10549-013-2636-5","title":"Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Medicine; Odds ratio; Breast cancer; Confidence interval; Referral; Cohort; Cohort study; Internal medicine; Odds; Generalized estimating equation; Radiation therapy; Prospective cohort study; Cancer; Demography; Logistic regression; Family medicine","score_opus":0.013858885278677784,"score_gpt":0.31187570722963065,"score_spread":0.29801682195095286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092759243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871576,0.00010378553,0.000053358326,0.00003906091,0.000003017016,0.000015859026,0.0008409279,0.0000028758384,0.00022544834],"genre_scores_gemma":[0.9990176,0.00008484293,0.000063002546,0.0000240898,0.000003941266,0.000009964554,0.0006479133,0.0000020437933,0.00014662732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994222,0.00008089275,0.000043920187,0.00015899565,0.00012781803,0.00016610372],"domain_scores_gemma":[0.998097,0.00022119473,0.00071377546,0.0001844654,0.00039720658,0.0003864093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006830745,0.00027763733,0.0003255817,0.0005729587,0.00071232894,0.00081945444,0.0006975217,0.0005098201,0.0013335325],"category_scores_gemma":[0.0023202666,0.00035144028,0.0005007388,0.0013723315,0.0002903169,0.00039945063,0.0004237086,0.00074338046,0.00022290826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032359985,0.000013831875,0.9994918,0.0000022515321,0.000019275214,0.000020813628,0.000043352156,0.000014293161,0.000035775713,0.000004600569,0.000069192756,0.00025232203],"study_design_scores_gemma":[0.000004472794,0.000031753374,0.9995215,0.000003330581,0.000013124739,0.00006113524,0.0001085529,0.00014885128,0.000011477095,0.000005368761,0.000087751934,0.0000027754497],"about_ca_topic_score_codex":0.4545826,"about_ca_topic_score_gemma":0.46463493,"teacher_disagreement_score":0.4545826,"about_ca_system_score_codex":0.001896584,"about_ca_system_score_gemma":0.0019053329,"threshold_uncertainty_score":0.90387326},"labels":[],"label_agreement":null},{"id":"W2092763841","doi":"10.1007/s10549-005-6932-6","title":"How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Tamoxifen; Breast cancer; Medicine; Incidence (geometry); Family medicine; Gynecology; Oncology; Obstetrics; Cancer; Internal medicine","score_opus":0.024815015835870178,"score_gpt":0.3277590837720367,"score_spread":0.3029440679361665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092763841","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011567593,0.002938071,0.026256712,0.9553247,0.0039628306,0.000256657,0.00010124747,0.0001739071,0.009829094],"genre_scores_gemma":[0.086816594,0.01991635,0.25334573,0.5943045,0.020070713,0.002157611,0.00043234028,0.00030064178,0.022655573],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98238546,0.011674913,0.0014117728,0.0007072725,0.0030467494,0.000773939],"domain_scores_gemma":[0.9527772,0.026987892,0.0017450862,0.0010794828,0.010681879,0.0067285327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023970647,0.0015481197,0.0029689455,0.0033361842,0.0067505054,0.008538261,0.003751261,0.018348781,0.011732746],"category_scores_gemma":[0.07545076,0.0013508011,0.0016361449,0.001229646,0.0063561215,0.014038657,0.0057942304,0.023434067,0.0057056854],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027487273,0.0007672814,0.0062801107,0.00074123824,0.00030825927,0.0035868406,0.003753442,0.0012553108,0.0007156052,0.05108587,0.6665924,0.26463872],"study_design_scores_gemma":[0.00051864854,0.00041731854,0.0026466935,0.0027271847,0.00035970993,0.0041620927,0.008925923,0.004476169,0.00059237203,0.36753836,0.60732734,0.00030813983],"about_ca_topic_score_codex":0.006017264,"about_ca_topic_score_gemma":0.009408185,"teacher_disagreement_score":0.023970647,"about_ca_system_score_codex":0.0034280298,"about_ca_system_score_gemma":0.013061575,"threshold_uncertainty_score":0.12677044},"labels":[],"label_agreement":null},{"id":"W2093130510","doi":"10.1007/s10549-012-2393-x","title":"A systematic review of elastography, electrical impedance scanning, and digital infrared thermography for breast cancer screening and diagnosis","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Cochrane Library; Medical physics; Elastography; Meta-analysis; CINAHL; Systematic review; MEDLINE; Radiology; Cancer; Ultrasound; Internal medicine; Psychological intervention","score_opus":0.055286157672320285,"score_gpt":0.3976112877043384,"score_spread":0.34232513003201814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093130510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039717893,0.99898463,0.00008645778,0.00007764385,0.000054103846,0.000106987376,0.00017068465,0.0000037584712,0.00011848738],"genre_scores_gemma":[0.004725054,0.99417746,0.00043828905,0.00026230677,0.00005084656,0.00014046779,0.00011521686,0.0000023731839,0.000088011206],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957312,0.0012725693,0.0017644166,0.00040132744,0.0007013219,0.00012929908],"domain_scores_gemma":[0.98973036,0.007133996,0.0019940704,0.00013262758,0.000860509,0.00014845727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049133794,0.001731238,0.010411119,0.009374059,0.00056146993,0.002108643,0.0021314176,0.0017567981,0.004905764],"category_scores_gemma":[0.019952808,0.000921147,0.007861994,0.009555017,0.00077195757,0.0020177893,0.0015941566,0.0011453512,0.0003317761],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027184293,0.00001976486,0.00041925014,0.94365585,0.013105167,0.00008830972,0.00008654996,0.00008270903,0.00018265698,0.00015025842,0.0012463111,0.040691417],"study_design_scores_gemma":[0.0009461692,0.0004820897,0.005783582,0.7154198,0.24062297,0.0007019808,0.00031955267,0.00014875899,0.00027503126,0.00048550926,0.034726344,0.00008815621],"about_ca_topic_score_codex":0.008667328,"about_ca_topic_score_gemma":0.030439945,"teacher_disagreement_score":0.010411119,"about_ca_system_score_codex":0.0022114108,"about_ca_system_score_gemma":0.0067637456,"threshold_uncertainty_score":0.025984704},"labels":[],"label_agreement":null},{"id":"W2093508849","doi":"10.1007/s10549-008-9904-9","title":"Effect of a low-fat, high-carbohydrate dietary intervention on change in mammographic density over menopause","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Breast Cancer Research Alliance; Breast Cancer Alliance; American Institute for Cancer Research; Cancer Research Institute","keywords":"Medicine; Breast cancer; Menopause; Postmenopausal women; MAMMOGRAPHIC DENSITY; Post-hoc analysis; Mammography; Internal medicine; Endocrinology; Physiology; Cancer","score_opus":0.05220611703871131,"score_gpt":0.3760366224076801,"score_spread":0.3238305053689688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093508849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813265,0.00031001176,0.000121220364,0.00022599201,0.00014728303,0.00030769457,0.00020157734,0.000040996332,0.0005125635],"genre_scores_gemma":[0.9946597,0.00044592048,0.0012266679,0.00037579946,0.00016808658,0.0006696102,0.00030982177,0.000014462185,0.0021299678],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996433,0.00007973187,0.000044564116,0.00008989606,0.00003951017,0.00010291527],"domain_scores_gemma":[0.9989982,0.0003059305,0.00009139352,0.000052617645,0.00006026812,0.00049169356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058379094,0.0009661107,0.0021593722,0.00066816213,0.00077358464,0.00046477825,0.0006732361,0.0016791847,0.0074085873],"category_scores_gemma":[0.0018268698,0.0005383516,0.0010173193,0.00042207816,0.00058267417,0.0005788214,0.0007772186,0.0017362209,0.00045364082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83169526,0.11701423,0.002050176,0.00064182724,0.000900319,0.00009360859,0.00016035012,0.00040522372,0.011738293,0.00007183211,0.00043661695,0.034792326],"study_design_scores_gemma":[0.44238478,0.4504695,0.089276075,0.00017669689,0.0036339222,0.00008498919,0.00031069972,0.0027944366,0.00908472,0.00026892973,0.0014306955,0.00008455344],"about_ca_topic_score_codex":0.007246328,"about_ca_topic_score_gemma":0.007182385,"teacher_disagreement_score":0.0074085873,"about_ca_system_score_codex":0.0005001299,"about_ca_system_score_gemma":0.0012225138,"threshold_uncertainty_score":0.024784207},"labels":[],"label_agreement":null},{"id":"W2094397571","doi":"10.1007/s10549-011-1518-y","title":"Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"PTEN; Breast cancer; Gene; Biology; CDH1; Cancer research; Mutation; Genetics; Phenotype; Cancer; PI3K/AKT/mTOR pathway; Signal transduction; Cadherin; Cell","score_opus":0.048569846495085674,"score_gpt":0.29848441245210394,"score_spread":0.24991456595701828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094397571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866045,0.00019048345,0.00027351722,0.000015012862,0.000002361903,0.0000076093665,0.00022979625,0.000019064164,0.0006017261],"genre_scores_gemma":[0.99916077,0.00008482297,0.00024494182,0.00000946827,0.0000037154448,0.000007754154,0.00026756982,0.000014922608,0.00020609182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975497,0.000024881449,0.00003637946,0.000058664253,0.000060751874,0.0000643619],"domain_scores_gemma":[0.99967647,0.00007911318,0.000078296696,0.00005356416,0.00005040417,0.00006214001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032901464,0.00020611352,0.00038122284,0.0016414627,0.00034323093,0.00041395432,0.00032381382,0.00033689613,0.0014032564],"category_scores_gemma":[0.0006432128,0.000149879,0.0003346408,0.00069583894,0.00021384636,0.00018923629,0.00037259646,0.00021856443,0.00034260965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013535218,0.000058766025,0.492905,0.000073208976,0.00015719255,0.0017991125,0.00030741448,0.0003088336,0.48788705,0.00020839175,0.00021918566,0.014722269],"study_design_scores_gemma":[0.000014640234,0.00015752032,0.93929815,0.0000075647695,0.00021089388,0.01470575,0.0003371542,0.0007206426,0.042977504,0.00024490166,0.0013158161,0.000009438348],"about_ca_topic_score_codex":0.0008418803,"about_ca_topic_score_gemma":0.0011168385,"teacher_disagreement_score":0.0016414627,"about_ca_system_score_codex":0.00019614786,"about_ca_system_score_gemma":0.00014412265,"threshold_uncertainty_score":0.0046943426},"labels":[],"label_agreement":null},{"id":"W2094523134","doi":"10.1007/s10549-014-3100-x","title":"Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":269,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Chemotherapy; Oncology; Internal medicine; Cisplatin; Cancer; Stage (stratigraphy); Mastectomy; Neoadjuvant therapy; BRCA mutation; Biology","score_opus":0.02920730775215029,"score_gpt":0.34596991043679276,"score_spread":0.31676260268464246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094523134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421966,0.0025984563,0.00027785066,0.00023249966,0.000025645488,0.000028651166,0.00032426958,0.000012489676,0.0022805198],"genre_scores_gemma":[0.9984504,0.0004796699,0.0001802509,0.00005322326,0.000018623296,0.000020955655,0.00045684903,0.0000041910907,0.00033593285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982697,0.00006363745,0.000020290408,0.000026267307,0.0000319163,0.000030961466],"domain_scores_gemma":[0.99965084,0.00015259345,0.00006717586,0.000022287337,0.000027067212,0.00007996243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003699395,0.00016606554,0.00038753595,0.00035186857,0.00020516077,0.00026494925,0.00016383968,0.0001954394,0.0010936976],"category_scores_gemma":[0.0012745071,0.00013280327,0.00022997965,0.0002224452,0.00020846269,0.00027554194,0.00022166585,0.00023631261,0.00014457521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032023016,0.00038264948,0.8216335,0.0002508462,0.00022151672,0.0029133642,0.00020304402,0.006234621,0.030094495,0.00029282665,0.0021312616,0.10361884],"study_design_scores_gemma":[0.00031550732,0.0049115573,0.9758242,0.000031581967,0.00022518722,0.0046437182,0.00020374532,0.002380465,0.007800921,0.00024712432,0.0034008257,0.0000153],"about_ca_topic_score_codex":0.00078189897,"about_ca_topic_score_gemma":0.0016810291,"teacher_disagreement_score":0.0010936976,"about_ca_system_score_codex":0.0004929571,"about_ca_system_score_gemma":0.0004260734,"threshold_uncertainty_score":0.0036587715},"labels":[],"label_agreement":null},{"id":"W2094763732","doi":"10.1007/s10549-005-9094-7","title":"Can bone markers guide more effective treatment of bone metastases from breast cancer?","year":2005,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; N-terminal telopeptide; Oncology; Cancer; Internal medicine; Bone disease; Bone resorption; Bone remodeling; Osteoporosis; Osteocalcin; Alkaline phosphatase","score_opus":0.08487442535280759,"score_gpt":0.4586146276175355,"score_spread":0.3737402022647279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094763732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000068094836,0.9985392,0.00011972279,0.0007436274,0.0001912269,0.0000034477907,0.000014338408,0.0000040663476,0.0003163189],"genre_scores_gemma":[0.0009069418,0.9973955,0.00036636894,0.0007052144,0.00031875249,0.000007158374,0.000027063772,0.0000016254313,0.0002713304],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999684,0.00007301647,0.00005705448,0.00004698812,0.00011278671,0.000026225256],"domain_scores_gemma":[0.99899334,0.0006242552,0.00012396584,0.00001887795,0.00021207338,0.000027479151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012776569,0.0009739932,0.0039108964,0.0021462946,0.00024878193,0.0012530335,0.0012944507,0.0021245184,0.003764988],"category_scores_gemma":[0.0026420185,0.00042401568,0.0010677436,0.001956855,0.0006758902,0.0014021838,0.00048381236,0.0027734928,0.0018378367],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020245566,0.00007751269,0.000458287,0.012257841,0.0002972686,0.00024512492,0.00003735725,0.00030952753,0.0008356001,0.0025430964,0.025195595,0.9575404],"study_design_scores_gemma":[0.0004994065,0.00037329816,0.0049060956,0.017782371,0.0014910162,0.0033741135,0.00022529169,0.00034200877,0.0008489982,0.007957859,0.96212786,0.0000717893],"about_ca_topic_score_codex":0.0044826847,"about_ca_topic_score_gemma":0.0097601265,"teacher_disagreement_score":0.0044826847,"about_ca_system_score_codex":0.0006591574,"about_ca_system_score_gemma":0.0012243103,"threshold_uncertainty_score":0.012595117},"labels":[],"label_agreement":null},{"id":"W2095038393","doi":"10.1007/s10549-013-2426-0","title":"Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Menstrual cycle; Breast cancer; Progesterone receptor; Immunohistochemistry; Gene expression; Endocrinology; Internal medicine; Estrogen; Biology; Estrogen receptor; Cancer; Gene; Medicine; Hormone; Genetics","score_opus":0.010962770137574147,"score_gpt":0.2985710787581959,"score_spread":0.28760830862062176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095038393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703276,0.0013459779,0.00013354335,0.00005260651,0.000010019743,0.0000071752047,0.000596888,0.000008666918,0.0008124074],"genre_scores_gemma":[0.99595153,0.00089588703,0.000121420315,0.000046935795,0.000009424618,0.000023874672,0.0007580148,0.00000912685,0.002183902],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988365,0.000016104506,0.000007477416,0.00001937904,0.000018272778,0.00005505743],"domain_scores_gemma":[0.9998605,0.00004125836,0.000028731622,0.00001608369,0.000025252957,0.000028101862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010722118,0.00008211508,0.0002446948,0.00046250946,0.00018905452,0.00034208188,0.00010789728,0.0001458089,0.0012932583],"category_scores_gemma":[0.00038761817,0.00017598353,0.00016246183,0.0005607073,0.00016992474,0.00012781036,0.00019487462,0.00014286357,0.00025434862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002682625,0.00006676967,0.08322689,0.00008929624,0.00004891612,0.00028407475,0.00034925184,0.000113643175,0.90290457,0.00015698306,0.00031829614,0.009758862],"study_design_scores_gemma":[0.000027190965,0.00024199385,0.96778035,0.000010167985,0.00004150851,0.00044652334,0.0003192047,0.00015418768,0.028959082,0.00008467744,0.0019292759,0.000005800122],"about_ca_topic_score_codex":0.002524208,"about_ca_topic_score_gemma":0.004384145,"teacher_disagreement_score":0.002524208,"about_ca_system_score_codex":0.00025181696,"about_ca_system_score_gemma":0.00023738755,"threshold_uncertainty_score":0.005019009},"labels":[],"label_agreement":null},{"id":"W2095137807","doi":"10.1007/s10549-006-9302-0","title":"The management of ductal carcinoma in situ of the breast: a screened population-based analysis","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Newborn Screening Ontario; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Mastectomy; Ductal carcinoma; Breast cancer; Logistic regression; Population; Gynecology; Radiation therapy; Radiology; Obstetrics; Surgery; Cancer; Internal medicine","score_opus":0.015609847065663329,"score_gpt":0.302609252514653,"score_spread":0.28699940544898966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095137807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928266,0.00022104877,0.00009845005,0.000037910908,0.0000024602923,0.000005521939,0.000099923374,0.0000025765355,0.00024950385],"genre_scores_gemma":[0.99958676,0.00011048019,0.00003975068,0.000018369286,0.00000509301,0.000004479451,0.00011502965,0.0000018998201,0.00011813251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878114,0.00062575744,0.00008433292,0.00021745755,0.0001632691,0.00012811153],"domain_scores_gemma":[0.99892324,0.0003203643,0.000328556,0.00011130313,0.00014249253,0.00017393156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094476354,0.00047302598,0.0006059908,0.0010509634,0.0007389118,0.000698438,0.0005004785,0.000751205,0.0013705479],"category_scores_gemma":[0.0028707285,0.00046785022,0.0008230394,0.0016089964,0.0004513922,0.00045131237,0.00046194746,0.00062077807,0.00023954247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004927739,0.00012721805,0.99601054,0.0000067555297,0.00016457932,0.00032651445,0.0001200569,0.00007224925,0.0007889813,0.000028344552,0.00006121203,0.0018007696],"study_design_scores_gemma":[0.000016554233,0.0003454581,0.9983845,0.00000254003,0.0001691975,0.00048566685,0.00021629156,0.000163926,0.000088459194,0.000034644818,0.00008699446,0.000005797366],"about_ca_topic_score_codex":0.008041129,"about_ca_topic_score_gemma":0.006531983,"teacher_disagreement_score":0.008041129,"about_ca_system_score_codex":0.00042026563,"about_ca_system_score_gemma":0.000439298,"threshold_uncertainty_score":0.015988648},"labels":[],"label_agreement":null},{"id":"W2095438644","doi":"10.1007/s10549-015-3323-5","title":"The association between diabetes and breast cancer stage at diagnosis: a population-based study","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Diabetes mellitus; Odds ratio; Stage (stratigraphy); Population; Internal medicine; Cancer; Cancer registry; Incidence (geometry); Confidence interval; Gynecology; Oncology; Obstetrics; Endocrinology","score_opus":0.04400181140581558,"score_gpt":0.3521214667572862,"score_spread":0.30811965535147057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095438644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988146,0.00026484163,0.00015554678,0.000055730194,0.0000120234545,0.000008614454,0.00034507914,0.000004443103,0.0003391208],"genre_scores_gemma":[0.9991596,0.00015101294,0.00010417304,0.000056090965,0.000019528357,0.000009496725,0.00027651837,0.0000033944066,0.00022022224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906105,0.00035131344,0.0000701401,0.00028046087,0.00011999608,0.00011704145],"domain_scores_gemma":[0.998444,0.0003492562,0.0003893536,0.00028162144,0.00019526856,0.0003405008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011860032,0.0005289992,0.0007239977,0.00092455384,0.0008987787,0.0010337038,0.0005996667,0.0013282639,0.0016559298],"category_scores_gemma":[0.0021586458,0.001203098,0.0010948594,0.0021342714,0.00054346706,0.00092279894,0.00056284614,0.0015734746,0.00035251823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059952075,0.00014284709,0.99742484,0.000007152818,0.00035656916,0.00008492274,0.00009282314,0.00002972722,0.0005508428,0.000015774041,0.000077383156,0.00061754393],"study_design_scores_gemma":[0.00003673011,0.0002056977,0.9990386,0.0000024745332,0.0001638097,0.00016562181,0.00013105838,0.00010831353,0.000031740125,0.00002109285,0.00008843809,0.000006537058],"about_ca_topic_score_codex":0.01265549,"about_ca_topic_score_gemma":0.01186566,"teacher_disagreement_score":0.01265549,"about_ca_system_score_codex":0.00044016298,"about_ca_system_score_gemma":0.00038223015,"threshold_uncertainty_score":0.02516365},"labels":[],"label_agreement":null},{"id":"W2097066287","doi":"10.1007/s10549-007-9873-4","title":"Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tamoxifen; Autophagy; Cancer research; ATG5; Gene knockdown; Breast cancer; Antiestrogen; Biology; Estrogen receptor; Programmed cell death; Viability assay; Cancer cell; Cancer; Apoptosis; Medicine; Internal medicine","score_opus":0.030837105704221483,"score_gpt":0.3310155380438172,"score_spread":0.30017843233959574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097066287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991516,0.0026120048,0.0007841984,0.00048936805,0.0001120858,0.00004107859,0.00092040555,0.00015712171,0.003367741],"genre_scores_gemma":[0.9939276,0.00167553,0.00042737625,0.00011087469,0.000017672019,0.000040148687,0.00093702495,0.000028526645,0.002835228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984276,0.000021559465,0.000017204678,0.000023691835,0.0000399716,0.00005481549],"domain_scores_gemma":[0.9999033,0.00002716001,0.000019977437,0.000019681956,0.0000077447385,0.000022064136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012888305,0.0003020957,0.00055782025,0.00029136369,0.00026091753,0.0004672534,0.00023889952,0.0003744947,0.00313986],"category_scores_gemma":[0.0001832341,0.000212404,0.0002834304,0.00032760427,0.00025588833,0.000279392,0.00024674824,0.00088908366,0.0007966609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006599098,0.00009729754,0.00024287285,0.00006835651,0.000019139972,0.00008864653,0.00004038911,0.0001103367,0.9949003,0.00015610504,0.00048003666,0.0031366588],"study_design_scores_gemma":[0.0001543591,0.0012849694,0.009860182,0.000017113449,0.00004101711,0.0008722967,0.00012764058,0.00063034345,0.97867876,0.00012128816,0.0081973495,0.000014629564],"about_ca_topic_score_codex":0.00072393945,"about_ca_topic_score_gemma":0.0022528782,"teacher_disagreement_score":0.00313986,"about_ca_system_score_codex":0.00037184436,"about_ca_system_score_gemma":0.00022900486,"threshold_uncertainty_score":0.0105038285},"labels":[],"label_agreement":null},{"id":"W2097409839","doi":"10.1007/s10549-011-1511-5","title":"Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Calgary; University of British Columbia; McMaster University; BC Cancer Agency; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Topoisomerase; Breast cancer; Medicine; Anthracycline; Internal medicine; Chemotherapy; Adjuvant; Oncology; Immunohistochemistry; Cancer; Tissue microarray; Randomized controlled trial; Endocrinology; Biology; Enzyme","score_opus":0.04826573960736869,"score_gpt":0.3435125010807395,"score_spread":0.2952467614733708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097409839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906441,0.006093619,0.00015888736,0.00081869954,0.00021098716,0.00022812714,0.0005303149,0.00002615023,0.0012890352],"genre_scores_gemma":[0.9971318,0.0009393104,0.000128559,0.00030358016,0.00015897794,0.00016129602,0.0004667364,0.0000052405094,0.00070447783],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991364,0.00057486666,0.000047753547,0.00007505018,0.00006234584,0.00010367815],"domain_scores_gemma":[0.99887973,0.0004523993,0.00025794792,0.00009370128,0.000059015223,0.0002572065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017464045,0.0007637209,0.0015042566,0.00027850427,0.00021294196,0.00080671336,0.00053088565,0.0010135933,0.002184865],"category_scores_gemma":[0.0027790745,0.00025867048,0.0011201111,0.0003542933,0.0005229266,0.0005551166,0.00026331085,0.0016720432,0.000287988],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97834516,0.00064777944,0.005177901,0.00018491474,0.0011641341,0.000030020907,0.000027475111,0.00037612845,0.0029598917,0.000110566005,0.0006384875,0.010337503],"study_design_scores_gemma":[0.7110524,0.1890419,0.07907873,0.00028430932,0.008379966,0.0001898649,0.0001436735,0.002365287,0.004131852,0.00076879596,0.0045063016,0.00005691614],"about_ca_topic_score_codex":0.0017706369,"about_ca_topic_score_gemma":0.0029597667,"teacher_disagreement_score":0.002184865,"about_ca_system_score_codex":0.0009472295,"about_ca_system_score_gemma":0.0007516867,"threshold_uncertainty_score":0.009235978},"labels":[],"label_agreement":null},{"id":"W2098050195","doi":"10.1007/s10549-014-3235-9","title":"Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Women's College Hospital; Toronto Public Health; Juravinski Cancer Centre; Canada Research Chairs; Public Health Ontario; University of Toronto","funders":"Hamilton Health Sciences","keywords":"Breast cancer; Medicine; Hormone receptor; Thyroid; Oncology; Hormone; Internal medicine; Cancer; Endocrinology","score_opus":0.03680280726859021,"score_gpt":0.3528988021443068,"score_spread":0.3160959948757166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098050195","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4610422,0.5050433,0.001330929,0.017897768,0.00074716436,0.000030267083,0.0008109673,0.00004788877,0.013049386],"genre_scores_gemma":[0.9084839,0.08754107,0.00060555415,0.00070358184,0.0008883774,0.000010357173,0.00026976925,0.000007558747,0.0014898308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968815,0.00011250506,0.000026829674,0.00003125962,0.000074684394,0.000066577195],"domain_scores_gemma":[0.99909043,0.00040334475,0.00020354245,0.000064069274,0.0001492975,0.00008921748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012777615,0.00021743368,0.00033420784,0.00086370535,0.0003555908,0.0008644406,0.00042193194,0.00052566273,0.0012743736],"category_scores_gemma":[0.0026327467,0.0001643847,0.00033546877,0.001553827,0.00058933266,0.00041163538,0.0002493162,0.0006984061,0.00036200948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038411135,0.00018272032,0.71868575,0.0006264809,0.0003141677,0.0019319876,0.00040921228,0.0014892144,0.011105143,0.0031644027,0.0060463212,0.25220343],"study_design_scores_gemma":[0.00028794905,0.0010456773,0.913878,0.0005744823,0.0014816149,0.008967028,0.0017267463,0.0026113193,0.0065825535,0.009085371,0.05368953,0.00006972149],"about_ca_topic_score_codex":0.0049077915,"about_ca_topic_score_gemma":0.0051931976,"teacher_disagreement_score":0.0049077915,"about_ca_system_score_codex":0.0010426253,"about_ca_system_score_gemma":0.0011543477,"threshold_uncertainty_score":0.009758413},"labels":[],"label_agreement":null},{"id":"W2098968548","doi":"10.1007/s10549-006-9396-4","title":"Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Morphological variations and asymmetry","field":"Mathematics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Breast cancer; Quartile; Odds ratio; Medicine; Risk factor; Breast disease; Confidence interval; Oncology; Case-control study; Cancer; Internal medicine","score_opus":0.04479521697167549,"score_gpt":0.3490025195667125,"score_spread":0.30420730259503703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098968548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995521,0.00013389201,0.00011164331,0.000014078952,0.0000016891802,0.0000014953993,0.000022015405,0.0000020886855,0.0001609675],"genre_scores_gemma":[0.9997968,0.000040406838,0.00006650967,0.0000026869552,0.0000025383406,0.0000010472653,0.000031255924,7.5074865e-7,0.000057990015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978083,0.00006937607,0.00002149615,0.00003989951,0.000056568526,0.000031849882],"domain_scores_gemma":[0.9985045,0.0003455573,0.0007268782,0.00015606407,0.00008434463,0.00018261145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003893829,0.00015854821,0.00019423685,0.00057305704,0.00021787758,0.00029442416,0.00018271628,0.00020908953,0.0013722844],"category_scores_gemma":[0.0035672178,0.00018555754,0.00019945223,0.00035526534,0.00036855554,0.0001656245,0.0002746735,0.00026884477,0.00012701118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018679917,0.000019185782,0.99652183,0.0000057792154,0.00002143687,0.00012819469,0.000030960455,0.000072400995,0.0011420215,0.00004386939,0.000019816298,0.00180771],"study_design_scores_gemma":[0.0000038952676,0.00007813266,0.9979113,0.0000022691313,0.00001821353,0.0011792163,0.000054054064,0.00024694082,0.00032942515,0.000099173856,0.00007468295,0.0000027420094],"about_ca_topic_score_codex":0.0010711775,"about_ca_topic_score_gemma":0.0014441011,"teacher_disagreement_score":0.0013722844,"about_ca_system_score_codex":0.00012255124,"about_ca_system_score_gemma":0.00013364921,"threshold_uncertainty_score":0.0045907497},"labels":[],"label_agreement":null},{"id":"W2102299301","doi":"10.1023/b:brea.0000036783.88387.47","title":"HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"Amis de l'Institut Bordet","keywords":"Docetaxel; Medicine; Internal medicine; Breast cancer; Oncology; Doxorubicin; Population; Odds ratio; Cancer; Cohort; Chemotherapy","score_opus":0.049143343182379784,"score_gpt":0.3644664732989722,"score_spread":0.3153231301165924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102299301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996973,0.00010480574,0.000027900112,0.00001624535,0.0000091668835,0.000008023233,0.000028834416,0.0000012263739,0.00010652168],"genre_scores_gemma":[0.9996737,0.00005485925,0.000027704762,0.00002721392,0.000022264563,0.000008666478,0.0000589538,8.682878e-7,0.00012574017],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999635,0.000135565,0.000021080397,0.00010797605,0.000045694484,0.000054761676],"domain_scores_gemma":[0.9991984,0.00035784097,0.00013064603,0.000052639585,0.00004553908,0.00021504035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006489519,0.0003204058,0.00080483523,0.00036802347,0.00033056183,0.00055018795,0.0002163738,0.0005781802,0.0008571322],"category_scores_gemma":[0.0021059166,0.0002906171,0.0005439812,0.00030462726,0.00047773862,0.0005011578,0.00025500666,0.0007726416,0.0001700484],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18254052,0.0022339947,0.78508794,0.000042146337,0.0006064548,0.00063387945,0.0003157616,0.0012331749,0.011525086,0.00011283991,0.00032319833,0.0153450705],"study_design_scores_gemma":[0.0046871896,0.0406067,0.9445513,0.00001051554,0.0010724827,0.0011038951,0.0003968654,0.004891263,0.0016447856,0.0002846474,0.0007052956,0.000045024964],"about_ca_topic_score_codex":0.001235828,"about_ca_topic_score_gemma":0.001006413,"teacher_disagreement_score":0.001235828,"about_ca_system_score_codex":0.00033582363,"about_ca_system_score_gemma":0.00029221465,"threshold_uncertainty_score":0.0034319758},"labels":[],"label_agreement":null},{"id":"W2104730114","doi":"10.1023/a:1006380306781","title":"The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast","year":2000,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Urologic and reproductive health conditions","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Prostate-specific antigen; Prostate cancer; Prostate; Oncology; Disease; Breast disease; Internal medicine; Cancer; Gynecology","score_opus":0.12464749783058238,"score_gpt":0.4302585597617317,"score_spread":0.30561106193114934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104730114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008823443,0.9995203,0.000032299242,0.00011241422,0.00004938192,0.0000014287905,0.000011162172,0.00000141336,0.00018337095],"genre_scores_gemma":[0.0007941973,0.9988098,0.00007553833,0.00010842855,0.000106664884,0.0000014974872,0.000017430657,3.5287505e-7,0.000086033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996669,0.00007045914,0.000058811387,0.000058528996,0.00012771734,0.000017504679],"domain_scores_gemma":[0.9984787,0.0009972923,0.00016531382,0.000026583151,0.00029060335,0.00004150418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013518146,0.0007582718,0.0022367907,0.0030571234,0.00018580399,0.0008276157,0.0009868292,0.0009536857,0.0014950993],"category_scores_gemma":[0.0022649546,0.00028365257,0.0006771658,0.0033531059,0.0005469064,0.0010564498,0.00039175918,0.0011173572,0.0006381746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014468687,0.000035161218,0.0013470874,0.014691506,0.00030109813,0.00020872056,0.000036908255,0.00023730489,0.0005037998,0.0007571404,0.0144776115,0.967259],"study_design_scores_gemma":[0.00015300573,0.0003091632,0.016483484,0.017701054,0.0023236396,0.0054522124,0.00023842939,0.00042159585,0.0009485867,0.0028244692,0.9530563,0.000088025336],"about_ca_topic_score_codex":0.0032509288,"about_ca_topic_score_gemma":0.005080637,"teacher_disagreement_score":0.0032509288,"about_ca_system_score_codex":0.00057773426,"about_ca_system_score_gemma":0.0012994838,"threshold_uncertainty_score":0.00714916},"labels":[],"label_agreement":null},{"id":"W2105613608","doi":"10.1007/s10549-006-9161-8","title":"Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto; Women's College Hospital; Centre Hospitalier de l’Université de Montréal; Hôtel-Dieu de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Odds ratio; Body mass index; Confidence interval; Demography; Cohort; Logistic regression; Cancer; Family history; Internal medicine; Lower risk; Gerontology","score_opus":0.018299713241905064,"score_gpt":0.31514005445934523,"score_spread":0.2968403412174402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105613608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868521,0.0032932558,0.000103160644,0.0011958408,0.00006310241,0.000032576707,0.0040480127,0.000015038763,0.0043968726],"genre_scores_gemma":[0.9921332,0.0019585935,0.00020770045,0.00042829255,0.000032037733,0.000021724256,0.001524617,0.000008771836,0.0036851247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951637,0.000046284047,0.000033382294,0.00007924155,0.00010305216,0.00022166735],"domain_scores_gemma":[0.9990344,0.00007555287,0.00014106347,0.00003344648,0.00037412386,0.00034148773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006515501,0.0005876289,0.00057838054,0.001977841,0.004092687,0.0014099026,0.0008922342,0.0010220781,0.004862927],"category_scores_gemma":[0.0013967801,0.00046083514,0.0011547226,0.00428922,0.0005815457,0.00041916754,0.00042963852,0.001041082,0.00040118262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031346432,0.00013450686,0.9887007,0.0000556144,0.0001684218,0.00026229167,0.0012263398,0.00008142451,0.00025042085,0.00022119045,0.0023643845,0.0062212963],"study_design_scores_gemma":[0.00003798947,0.00006263017,0.9939912,0.000066699235,0.00009968028,0.00019502589,0.0022831517,0.00016444079,0.00005201119,0.000050975155,0.0029722757,0.000023892804],"about_ca_topic_score_codex":0.9913489,"about_ca_topic_score_gemma":0.9919584,"teacher_disagreement_score":0.012561086,"about_ca_system_score_codex":0.012561086,"about_ca_system_score_gemma":0.013458694,"threshold_uncertainty_score":0.09113747},"labels":[],"label_agreement":null},{"id":"W2105982533","doi":"10.1007/s10549-009-0372-7","title":"NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Ontario Genomics Institute; Genome Canada","keywords":"Breast cancer; Dynamics (music); Cell adhesion; Epithelium; Cell biology; Cancer research; Adhesion; Biology; Cell; Cancer; Medicine; Internal medicine; Chemistry; Pathology; Genetics","score_opus":0.018021987757504004,"score_gpt":0.31374011776798444,"score_spread":0.2957181300104804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105982533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223703,0.0025702843,0.001763239,0.000220945,0.000028465553,0.000017416398,0.00035039,0.000040367104,0.002771886],"genre_scores_gemma":[0.99209094,0.0011691703,0.001207979,0.00005712075,0.0000098333385,0.00003390029,0.0006040068,0.000013852717,0.0048131975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998648,0.000019039759,0.000008389882,0.000022170772,0.00004119182,0.000044330995],"domain_scores_gemma":[0.99993694,0.000011011378,0.000009169902,0.000008691234,0.000011734045,0.000022456763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108350316,0.00015622379,0.00021567698,0.00021134262,0.0003087034,0.00041183495,0.00019543753,0.00025743095,0.001357243],"category_scores_gemma":[0.00012017967,0.00017856034,0.00013577599,0.0002609643,0.00018108507,0.00028846724,0.00018186026,0.00062123383,0.00033305486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012428754,0.000016435983,0.0002831585,0.000022770886,0.0000022004274,0.00005637364,0.000016457298,0.000029967638,0.99811685,0.00018619001,0.00004440535,0.0011009648],"study_design_scores_gemma":[0.000009505275,0.000046061064,0.009322515,0.0000033221197,0.0000071019854,0.00024512017,0.00006884245,0.0009851403,0.9865414,0.000059019338,0.0027101065,0.000001890006],"about_ca_topic_score_codex":0.0014152115,"about_ca_topic_score_gemma":0.0018627146,"teacher_disagreement_score":0.0014152115,"about_ca_system_score_codex":0.0007801318,"about_ca_system_score_gemma":0.00026642124,"threshold_uncertainty_score":0.0056602955},"labels":[],"label_agreement":null},{"id":"W2107315098","doi":"10.1007/s10549-010-1269-1","title":"Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"AMPK; European Prospective Investigation into Cancer and Nutrition; Single-nucleotide polymorphism; Breast cancer; Protein kinase A; Genome-wide association study; Biology; AMP-activated protein kinase; Bioinformatics; Medicine; Prospective cohort study; Endocrinology; Internal medicine; Cancer; Gene; Cancer research; Genetics; Kinase; Genotype","score_opus":0.03844368521690159,"score_gpt":0.32411872676188347,"score_spread":0.28567504154498186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107315098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972582,0.00078051456,0.000358326,0.0000920702,0.000027430951,0.0000065327686,0.0008461823,0.000008818897,0.0006218402],"genre_scores_gemma":[0.9982674,0.00023447035,0.0002184258,0.000059020906,0.00002299468,0.000009528088,0.0006626122,0.000009321726,0.0005161367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987866,0.00062277284,0.000084808766,0.00029960522,0.00009508426,0.00011111177],"domain_scores_gemma":[0.99893004,0.00036376857,0.00027557122,0.00017002532,0.00008732802,0.00017326951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009809111,0.00048047514,0.0004707059,0.0008649374,0.00035852962,0.0005786719,0.00037265793,0.00089007703,0.0013456034],"category_scores_gemma":[0.0014879962,0.00040721038,0.00068173057,0.0014862169,0.00025194496,0.00020336492,0.0004639854,0.0006246768,0.00020168684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018697099,0.00007977786,0.9857568,0.000028993492,0.0006950825,0.00029404962,0.00016541332,0.00022398336,0.008219423,0.00022889166,0.00024752488,0.002190334],"study_design_scores_gemma":[0.000021188998,0.00007428068,0.99886227,0.000004782791,0.0001328649,0.0002350692,0.00004043596,0.00013646069,0.00019986664,0.000061695886,0.00022756911,0.0000035245516],"about_ca_topic_score_codex":0.0043678884,"about_ca_topic_score_gemma":0.0035826678,"teacher_disagreement_score":0.0043678884,"about_ca_system_score_codex":0.0002112318,"about_ca_system_score_gemma":0.00014620653,"threshold_uncertainty_score":0.008684933},"labels":[],"label_agreement":null},{"id":"W2107723446","doi":"10.1007/s10549-012-2076-7","title":"Expression of activated type I receptor tyrosine kinases in early breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"AstraZeneca","keywords":"Breast cancer; Medicine; Tissue microarray; Immunohistochemistry; Internal medicine; Oncology; Cancer; Cohort; Receptor","score_opus":0.09947066223487866,"score_gpt":0.42730410465319474,"score_spread":0.3278334424183161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107723446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799241,0.0120835565,0.0007602594,0.0002255914,0.000033659002,0.000019711993,0.000374587,0.00003537425,0.0065430827],"genre_scores_gemma":[0.98653215,0.006196038,0.00085933314,0.00006471488,0.0000545361,0.000021456452,0.00051302114,0.000010997097,0.005747776],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999826,0.000027673965,0.000012855923,0.000016899081,0.000041968357,0.00007459205],"domain_scores_gemma":[0.9998375,0.00003046384,0.000035214936,0.000012011459,0.000047973175,0.000036899306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029575403,0.0001405451,0.00018398253,0.0009290379,0.00023460755,0.000708149,0.00020243725,0.00028634394,0.0019640015],"category_scores_gemma":[0.00042326856,0.00014981555,0.00015913647,0.0005755087,0.00020866591,0.00037273575,0.00020113683,0.0004183534,0.00042055076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027023696,0.00025178408,0.05127314,0.00024819298,0.00003515549,0.001404391,0.0003737097,0.00026379977,0.89769715,0.0018632457,0.001162589,0.04272438],"study_design_scores_gemma":[0.00009707482,0.00112029,0.5419253,0.00010147676,0.00015343868,0.0096141705,0.0014726876,0.0015969491,0.40939143,0.001602484,0.03288822,0.00003649963],"about_ca_topic_score_codex":0.0011211637,"about_ca_topic_score_gemma":0.0012586124,"teacher_disagreement_score":0.0019640015,"about_ca_system_score_codex":0.00063956494,"about_ca_system_score_gemma":0.00034133898,"threshold_uncertainty_score":0.00657022},"labels":[],"label_agreement":null},{"id":"W2109875937","doi":"10.1023/a:1015261111605","title":"The Role of Dietary Long-Chain N-3 Fatty Acids in Anti-Cancer Immune Defense and R3230AC Mammary Tumor Growth in Rats: Influence of Diet Fat Composition","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Polyunsaturated fatty acid; Biology; Endocrinology; Population; Immune system; Fatty acid; Internal medicine; Mammary tumor; Phosphatidylcholine; Food science; Phospholipid; Biochemistry; Cancer; Immunology; Breast cancer; Medicine","score_opus":0.028876246275501217,"score_gpt":0.3226141468359388,"score_spread":0.2937379005604376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109875937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973917,0.0011792567,0.00043976202,0.00020536134,0.0000280782,0.000013009907,0.00020077794,0.000036054156,0.0005060455],"genre_scores_gemma":[0.992646,0.0011727696,0.0011368803,0.0001880209,0.000030217334,0.000048890757,0.00029516802,0.000049592236,0.0044324873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970406,0.000062816216,0.000017275303,0.000055460925,0.000031704705,0.00012863902],"domain_scores_gemma":[0.9989489,0.0001728971,0.00019543753,0.00013286578,0.00009909082,0.00045093783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040578493,0.0009800923,0.00062484323,0.0008459408,0.000511903,0.00057413545,0.0005195673,0.0010111897,0.0021730938],"category_scores_gemma":[0.00042824296,0.00064995926,0.0005548193,0.00036267182,0.0011577009,0.0011014327,0.00036159487,0.001309254,0.00045671494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10002379,0.0010570099,0.0029763766,0.00011438729,0.000071307295,0.0003291752,0.00014848908,0.00020614233,0.88636124,0.0004579379,0.00012708528,0.008126992],"study_design_scores_gemma":[0.0011377143,0.0076460587,0.031189714,0.000031759937,0.0002657019,0.0003306055,0.0003895516,0.0014441657,0.9552344,0.0008042337,0.0014732323,0.00005290757],"about_ca_topic_score_codex":0.004298747,"about_ca_topic_score_gemma":0.0056229713,"teacher_disagreement_score":0.004298747,"about_ca_system_score_codex":0.0007529061,"about_ca_system_score_gemma":0.0009093249,"threshold_uncertainty_score":0.008547425},"labels":[],"label_agreement":null},{"id":"W2112343680","doi":"10.1023/a:1006304518750","title":"Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Breast cancer; Prostate; Antigen; Cancer; Hormone; Prostate-specific antigen; Mammary gland; Steroid; Steroid hormone; Medicine; Cancer research; Internal medicine; Human breast; Oncology; Biology; Endocrinology; Immunology","score_opus":0.01630859523654967,"score_gpt":0.2966485263118235,"score_spread":0.28033993107527383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112343680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924212,0.0028735504,0.0017954271,0.000115391376,0.00006373799,0.00001808795,0.0011333728,0.00009120178,0.0014880531],"genre_scores_gemma":[0.9912582,0.0011140216,0.0010614638,0.00006777983,0.000016994998,0.00002299978,0.0022044296,0.000028463031,0.00422559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997482,0.000050849332,0.000032120497,0.000038987535,0.00006578015,0.00006399887],"domain_scores_gemma":[0.9997514,0.000073608564,0.000024999525,0.00005348446,0.000052575775,0.000043982698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018681408,0.00023589344,0.0003256804,0.0002914745,0.00023246287,0.00050828827,0.00016895986,0.00015100176,0.0017255174],"category_scores_gemma":[0.00020064114,0.00018887344,0.00033838872,0.0003895528,0.00026353088,0.0002744539,0.00024645598,0.00037004266,0.0005423785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023671739,0.000029301853,0.00063467864,0.000023673738,0.000009394731,0.000044342607,0.000054938202,0.000029524743,0.99785066,0.00009529694,0.00007893089,0.00091258244],"study_design_scores_gemma":[0.000019738955,0.00022371893,0.029099412,0.0000029106245,0.000028452194,0.00030363566,0.0001341728,0.00051012513,0.9662393,0.000043049462,0.0033867469,0.000008881514],"about_ca_topic_score_codex":0.0033524113,"about_ca_topic_score_gemma":0.004359637,"teacher_disagreement_score":0.0033524113,"about_ca_system_score_codex":0.00038719643,"about_ca_system_score_gemma":0.00026437847,"threshold_uncertainty_score":0.0066657662},"labels":[],"label_agreement":null},{"id":"W2112886099","doi":"10.1007/s10549-010-0921-0","title":"Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance","keywords":"Cancer research; Breast cancer; Insulin-like growth factor-binding protein; Growth factor; Cancer; Biology; Triple-negative breast cancer; Insulin-like growth factor 2; Immunohistochemistry; Medicine; Internal medicine; Insulin-like growth factor; Receptor","score_opus":0.03724598397401263,"score_gpt":0.3295307949135737,"score_spread":0.29228481093956105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112886099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911799,0.0030057426,0.001170276,0.0005032438,0.00026399412,0.000043165863,0.00082362053,0.00023453895,0.002775488],"genre_scores_gemma":[0.9842312,0.0023666741,0.0016456521,0.00016396974,0.00007935626,0.000076292956,0.003447087,0.00012552613,0.007864381],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948835,0.00013139276,0.000035495723,0.000061141895,0.00014054117,0.00014300153],"domain_scores_gemma":[0.9994149,0.00022675695,0.000061267914,0.00008906365,0.00003639384,0.00017165864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038292946,0.0008298066,0.00085873937,0.0010959483,0.00031114576,0.00050081924,0.00067760673,0.00059440715,0.00283321],"category_scores_gemma":[0.00038478532,0.0003881468,0.00055696256,0.00064212835,0.00056760776,0.0004358233,0.00029628942,0.0019496973,0.0006449522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003290055,0.0014832029,0.00038625905,0.00005843787,0.000038168855,0.00008579365,0.000041173582,0.00040602527,0.9905916,0.00020027945,0.00057142525,0.0028475348],"study_design_scores_gemma":[0.00015379088,0.0032345538,0.0032099884,0.000008278972,0.000034693076,0.00018276433,0.00007263986,0.0018267694,0.98908526,0.00007753466,0.0021048395,0.000009015134],"about_ca_topic_score_codex":0.0033993917,"about_ca_topic_score_gemma":0.0036704123,"teacher_disagreement_score":0.0033993917,"about_ca_system_score_codex":0.000722511,"about_ca_system_score_gemma":0.000723246,"threshold_uncertainty_score":0.009478033},"labels":[],"label_agreement":null},{"id":"W2114153887","doi":"10.1007/s10549-010-1336-7","title":"Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre; McGill University; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oophorectomy; Oncology; Internal medicine; Cancer; Mastectomy; Radiation therapy; BRCA mutation; Chemotherapy; Gynecology; Surgery; Hysterectomy","score_opus":0.03170857351183815,"score_gpt":0.3349142384364258,"score_spread":0.30320566492458767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114153887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665314,0.0006902672,0.00013461817,0.00015887755,0.000019340097,0.0000043294235,0.00026225823,0.000022105121,0.0020551078],"genre_scores_gemma":[0.9977664,0.0002954274,0.00008601216,0.000031045096,0.000028474948,0.0000053880476,0.00015565718,0.000008002239,0.001623658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979824,0.000055225573,0.000011702224,0.000041230345,0.000029658922,0.000063933396],"domain_scores_gemma":[0.99879456,0.0004197693,0.00024240736,0.00011583632,0.00004676525,0.00038058133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035633956,0.0003780012,0.0005754119,0.0013506898,0.0006132498,0.000660108,0.0004898506,0.0008958836,0.01159022],"category_scores_gemma":[0.002793965,0.0004934312,0.0006160667,0.00077617134,0.0003902492,0.00037953845,0.00053891586,0.0007002315,0.0008884121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001825614,0.000099784185,0.98631465,0.000024278632,0.00009825882,0.0015447458,0.00020327087,0.00016920219,0.0022195673,0.00027707336,0.00040210015,0.0068213884],"study_design_scores_gemma":[0.000032333202,0.00023243591,0.9918241,0.0000111578165,0.00017175662,0.005399323,0.00036957648,0.0005304764,0.00045859045,0.0005298884,0.00042446348,0.000015924319],"about_ca_topic_score_codex":0.0056612557,"about_ca_topic_score_gemma":0.0033447552,"teacher_disagreement_score":0.01159022,"about_ca_system_score_codex":0.00026321423,"about_ca_system_score_gemma":0.00037935056,"threshold_uncertainty_score":0.03877312},"labels":[],"label_agreement":null},{"id":"W2116214608","doi":"10.1007/s10549-005-0320-0","title":"The benefit of participating to clinical research","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Sherbrooke; Hôpital du Saint-Sacrement; Institut National de Santé Publique du Québec","funders":"Health Canada","keywords":"Hazard ratio; Medicine; Confidence interval; Breast cancer; Clinical trial; Internal medicine; Oncology; Cancer; Gynecology","score_opus":0.8161875323808384,"score_gpt":0.7275529777051931,"score_spread":0.0886345546756453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116214608","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049623776,0.006689822,0.012250845,0.7505287,0.0064692018,0.0007960028,0.00032241957,0.0001827079,0.17313655],"genre_scores_gemma":[0.70048,0.0040803333,0.01390424,0.23046736,0.014461528,0.0018441735,0.00045716812,0.00011714719,0.034188073],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.82093436,0.14909059,0.006568156,0.0031936236,0.012424277,0.0077889003],"domain_scores_gemma":[0.46662343,0.2998491,0.031894512,0.055915534,0.03631253,0.10940486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10369765,0.0006371615,0.0017197077,0.0013056489,0.0058555566,0.011394896,0.002520604,0.02205923,0.023878053],"category_scores_gemma":[0.30723825,0.00092840387,0.001692944,0.0010523063,0.010677874,0.007853091,0.011950694,0.012545333,0.007071837],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034487683,0.0033878547,0.07965732,0.0019034015,0.0006392227,0.0038285006,0.017378662,0.001418283,0.0033155982,0.3978582,0.19143029,0.2957339],"study_design_scores_gemma":[0.0022696808,0.0024307058,0.06717806,0.0034136276,0.00074113504,0.010255024,0.019056717,0.0021052742,0.0018691905,0.4483002,0.4420612,0.00031927403],"about_ca_topic_score_codex":0.0006372696,"about_ca_topic_score_gemma":0.0016910979,"teacher_disagreement_score":0.10369765,"about_ca_system_score_codex":0.0022417533,"about_ca_system_score_gemma":0.019249795,"threshold_uncertainty_score":0.54841214},"labels":[],"label_agreement":null},{"id":"W2116267931","doi":"10.1023/a:1022931403825","title":"The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Breast cancer; Gene; Internal medicine; Oncology; Value (mathematics); Cancer; Mammary gland; Medicine; Biology; Cancer research; Genetics; Enzyme; Biochemistry; Mathematics","score_opus":0.04765376970994101,"score_gpt":0.363989513318913,"score_spread":0.316335743608972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116267931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930294,0.004551545,0.00024282753,0.00065918895,0.00007015436,0.000005063012,0.00027120675,0.000008171689,0.0011624163],"genre_scores_gemma":[0.9986809,0.00064921717,0.0001358821,0.00004886277,0.000102355094,0.000002640859,0.00012581046,0.000001895378,0.0002523759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996344,0.00015507345,0.000033747678,0.000043089083,0.00006884546,0.00006485207],"domain_scores_gemma":[0.9981232,0.0008359078,0.0004891337,0.000088869776,0.0001409965,0.00032182617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065084785,0.0001907366,0.00027613685,0.00053076824,0.0002381279,0.00047033117,0.00031482702,0.000567007,0.0010502673],"category_scores_gemma":[0.003067433,0.00012436058,0.00022570603,0.0007142938,0.0003876359,0.0003534337,0.00021423923,0.0006630079,0.00023151969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014811266,0.00004223568,0.98374605,0.000022381133,0.00007718572,0.00036596632,0.000028384453,0.00022703956,0.0020703422,0.0000692318,0.00026560837,0.011604454],"study_design_scores_gemma":[0.000046817262,0.00023412472,0.99449325,0.000011394999,0.00016921318,0.0016621787,0.00009385342,0.0011589351,0.0009801441,0.00026783464,0.0008728214,0.000009376311],"about_ca_topic_score_codex":0.00092520635,"about_ca_topic_score_gemma":0.0012207453,"teacher_disagreement_score":0.0010502673,"about_ca_system_score_codex":0.00024373451,"about_ca_system_score_gemma":0.0002731846,"threshold_uncertainty_score":0.0035134554},"labels":[],"label_agreement":null},{"id":"W2120324973","doi":"10.1023/b:brea.0000003969.21267.81","title":"Potent Killing of Paclitaxel- and Doxorubicin-resistant Breast Cancer Cells by Calphostin C Accompanied by Cytoplasmic Vacuolization","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; Northeast Cancer Centre","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Calphostin C; Paclitaxel; Doxorubicin; Vacuolization; Cancer cell; Cancer research; Cell culture; Biology; Pharmacology; Chemistry; Cell biology; Cancer; Endocrinology; Chemotherapy; Protein kinase C; Signal transduction","score_opus":0.024381472443263826,"score_gpt":0.31186049900210017,"score_spread":0.28747902655883634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120324973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027807,0.0040379725,0.0013351144,0.00017426108,0.000055508037,0.00005934178,0.00065333786,0.00007261885,0.0033337728],"genre_scores_gemma":[0.99515873,0.0013867177,0.0007684,0.000044149827,0.0000104433,0.000027177282,0.00059683353,0.00001563944,0.0019919614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986005,0.000023526889,0.000012261729,0.000015841246,0.000034447297,0.0000538237],"domain_scores_gemma":[0.9999025,0.000027117232,0.00001567083,0.000020426533,0.000015983993,0.000018346618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016788741,0.00026869052,0.00030830278,0.0002443665,0.0002333222,0.00028022192,0.0001859837,0.00030497217,0.0010633548],"category_scores_gemma":[0.0001164508,0.00017246365,0.00023336068,0.0002515789,0.00018520826,0.00020719723,0.00018008775,0.00043844766,0.00025725624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002545805,0.000019948882,0.000070039554,0.000041895702,0.0000053574204,0.000057612637,0.000012443338,0.00005521037,0.99822944,0.000101602534,0.000074988355,0.0010769357],"study_design_scores_gemma":[0.000050911265,0.00024388537,0.0035793884,0.0000066852167,0.000012141864,0.00035868736,0.000017769686,0.00045188432,0.9932114,0.000024951436,0.0020383424,0.0000038627645],"about_ca_topic_score_codex":0.0017563325,"about_ca_topic_score_gemma":0.003009266,"teacher_disagreement_score":0.0017563325,"about_ca_system_score_codex":0.0005662574,"about_ca_system_score_gemma":0.00032988185,"threshold_uncertainty_score":0.0041084886},"labels":[],"label_agreement":null},{"id":"W2120386009","doi":"10.1007/s10549-015-3342-2","title":"Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Clinical trial; Oncology; Progression-free survival; Breast cancer; Chemotherapy; Clinical endpoint; Cancer; Randomized controlled trial","score_opus":0.5563596854227307,"score_gpt":0.5889062232591702,"score_spread":0.03254653783643946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120386009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053121066,0.9875823,0.0010174336,0.0008791456,0.00030442773,0.00014824416,0.001196446,0.000017406375,0.0035425208],"genre_scores_gemma":[0.079985864,0.90806115,0.0041572754,0.0027040944,0.0005867483,0.0004251256,0.0023373237,0.000015835165,0.0017266079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979431,0.0008196999,0.00047382442,0.00019879728,0.0004845264,0.000079997684],"domain_scores_gemma":[0.99687874,0.0019707188,0.00063114654,0.0000827386,0.0003753343,0.000061316416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005338919,0.0007627538,0.0035128284,0.0010863768,0.00016005288,0.00090996973,0.0009750498,0.0006362861,0.0020506645],"category_scores_gemma":[0.004763916,0.00015254504,0.0026170376,0.001229208,0.00039343775,0.0007759705,0.0005861991,0.0014717942,0.00031056668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018993136,0.00015938166,0.0050184964,0.07404088,0.00599191,0.000078603654,0.0000922424,0.0010686382,0.0011876016,0.0026128222,0.014847215,0.8930029],"study_design_scores_gemma":[0.002847677,0.007835169,0.055838913,0.10867358,0.06635927,0.0033103328,0.00071967015,0.002735113,0.0051124715,0.015083567,0.73121893,0.00026534323],"about_ca_topic_score_codex":0.001177321,"about_ca_topic_score_gemma":0.0035869703,"teacher_disagreement_score":0.005338919,"about_ca_system_score_codex":0.00085844076,"about_ca_system_score_gemma":0.0014657653,"threshold_uncertainty_score":0.028235257},"labels":[],"label_agreement":null},{"id":"W2120389505","doi":"10.1007/s10549-006-9378-6","title":"Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; BRCA2 Protein; Cancer; Mutation; Medicine; Family history; Founder effect; Oncology; Incidence (geometry); Internal medicine; Genetic testing; Genetics; Gynecology; Genotype; Germline mutation; Biology; Gene; Haplotype","score_opus":0.017170806608212838,"score_gpt":0.33225531254116697,"score_spread":0.3150845059329541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120389505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997693,0.00037803757,0.000065634966,0.00011734244,0.00000452677,0.000015372761,0.00032796364,0.0000042357783,0.0013938986],"genre_scores_gemma":[0.99920136,0.0003223044,0.00006201802,0.000046474168,0.0000031672732,0.000011167744,0.00016739569,0.0000030486453,0.00018308515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996536,0.00006833805,0.000038755166,0.00007164362,0.000078245794,0.000089451336],"domain_scores_gemma":[0.99917233,0.00017944493,0.0002572522,0.000051225616,0.00015772927,0.00018205417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038667742,0.00024849863,0.00044014808,0.0014450847,0.0006456889,0.00062935625,0.0003676451,0.00039586093,0.0021447795],"category_scores_gemma":[0.0020854513,0.00046658734,0.00039896864,0.0011261785,0.0005483838,0.00024990735,0.0004831946,0.0003062638,0.00021616778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029871226,0.00002386803,0.9963014,0.00002101102,0.000021886082,0.00021075914,0.0009477565,0.000013667725,0.00065769366,0.00009058527,0.000086818254,0.0015947281],"study_design_scores_gemma":[0.000007963062,0.000055903394,0.9959,0.000022940276,0.00003617565,0.0009866863,0.002039476,0.00007670855,0.00012372396,0.00007927037,0.00066326396,0.000007871979],"about_ca_topic_score_codex":0.069314785,"about_ca_topic_score_gemma":0.06616404,"teacher_disagreement_score":0.069314785,"about_ca_system_score_codex":0.0009445907,"about_ca_system_score_gemma":0.00086487154,"threshold_uncertainty_score":0.13782263},"labels":[],"label_agreement":null},{"id":"W2120981144","doi":"10.1007/s10549-006-9359-9","title":"Evaluating the organization and delivery of breast cancer services: use of performance measures to identify knowledge gaps","year":2006,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.39924198548159723,"score_gpt":0.5202326145872245,"score_spread":0.12099062910562725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120981144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01639419,0.9800639,0.0007176757,0.0008026943,0.00009864551,0.00014515559,0.0004215875,0.000012071124,0.001344105],"genre_scores_gemma":[0.067008324,0.927284,0.004347916,0.00027402892,0.000084105,0.00018364334,0.0006073559,0.0000052790583,0.00020531863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896209,0.0037579988,0.0022436706,0.0006003685,0.0035078228,0.000269169],"domain_scores_gemma":[0.9658432,0.02061181,0.007652655,0.00031858584,0.0051659388,0.00040775602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016238544,0.0009899301,0.004228494,0.006425079,0.00027142777,0.0021593506,0.0017881708,0.0008776735,0.00067859486],"category_scores_gemma":[0.043263163,0.00036453447,0.0017828505,0.0121430615,0.00041659694,0.0020185248,0.00094207365,0.0007030117,0.0001619363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025829914,0.00017758651,0.045067307,0.048842806,0.0031883826,0.0000615936,0.00051054975,0.0006969419,0.00018847623,0.0006996613,0.0028915526,0.8974168],"study_design_scores_gemma":[0.00078340765,0.0033886665,0.5122816,0.23978615,0.042838674,0.0016837255,0.0060817995,0.004596833,0.0035437376,0.003966355,0.1807393,0.0003097207],"about_ca_topic_score_codex":0.017409533,"about_ca_topic_score_gemma":0.024960674,"teacher_disagreement_score":0.017409533,"about_ca_system_score_codex":0.0028884972,"about_ca_system_score_gemma":0.008647353,"threshold_uncertainty_score":0.08587861},"labels":[],"label_agreement":null},{"id":"W2123712628","doi":"10.1023/a:1014405730585","title":"Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pomegranate: compositions and health benefits","field":"Nursing","cited_by":445,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Office of the Chief Scientist, Ministry of Health; Virginia Commonwealth University","keywords":"Punica; Polyphenol; Chemistry; Food science; Fermentation; Biochemistry; Traditional medicine; Antioxidant; Medicine","score_opus":0.07885890565532098,"score_gpt":0.3944234224275364,"score_spread":0.3155645167722154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123712628","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644362,0.026603436,0.0025764236,0.00074143766,0.00021978769,0.00009096452,0.00028603294,0.00009807491,0.004947717],"genre_scores_gemma":[0.9792941,0.015272312,0.0017393066,0.00021957987,0.000064586544,0.00004431498,0.0002052325,0.000013193099,0.003147368],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999709,0.0000097012635,0.0000020289833,0.0000039828064,0.000004184515,0.000009254883],"domain_scores_gemma":[0.9999554,0.000013299298,0.0000050756394,0.0000058477895,0.0000059527965,0.00001436114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019858048,0.00030972812,0.00024672705,0.0004642522,0.0002808127,0.00023023743,0.0001720952,0.0002806013,0.0022253087],"category_scores_gemma":[0.00021464427,0.00013481795,0.00028906413,0.0002479815,0.00023395997,0.00021614552,0.00018651596,0.0006569414,0.00021679587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011806317,0.001609118,0.0011247471,0.00047286847,0.000060375998,0.0003120856,0.000086382,0.0003767436,0.8910938,0.0009571032,0.00039931072,0.0917012],"study_design_scores_gemma":[0.0017234343,0.016337935,0.013828539,0.00011360714,0.00057907624,0.0009904649,0.00017351954,0.000580251,0.9383489,0.0012160785,0.026080627,0.000027638567],"about_ca_topic_score_codex":0.0004451883,"about_ca_topic_score_gemma":0.0006030116,"teacher_disagreement_score":0.0022253087,"about_ca_system_score_codex":0.00009174474,"about_ca_system_score_gemma":0.0002385922,"threshold_uncertainty_score":0.0074443817},"labels":[],"label_agreement":null},{"id":"W2126386849","doi":"10.1007/s10549-007-9584-x","title":"A Phase 2 study of perifosine in advanced or metastatic breast cancer","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Chemotherapy; Breast cancer; Nausea; Neutropenia; Regimen; Anthracycline; Gastroenterology; Progressive disease; Oncology; Toxicity; Performance status; Surgery; Cancer","score_opus":0.11632199615301068,"score_gpt":0.5141281501004372,"score_spread":0.3978061539474265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126386849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923402,0.0011999885,0.0006032751,0.0007450888,0.00019035827,0.0024654898,0.0008216062,0.000071407434,0.0015625791],"genre_scores_gemma":[0.98037416,0.0030396837,0.0021635066,0.0013898171,0.00036660288,0.005069808,0.0021600516,0.000065957815,0.005370306],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994498,0.00026961087,0.000014780341,0.00007661175,0.00004098292,0.00014818087],"domain_scores_gemma":[0.99917763,0.00015594291,0.00009162255,0.000090802954,0.00005335852,0.0004305804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018322818,0.0018237872,0.0027867164,0.00080929766,0.0006580916,0.0009362717,0.001050626,0.0019126456,0.0055137877],"category_scores_gemma":[0.0011128861,0.0006558316,0.0014476961,0.00050431286,0.0013712961,0.0012637068,0.0004307293,0.0034356443,0.0009823153],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76536137,0.11860378,0.0023080104,0.00066207413,0.0007597388,0.00032264806,0.00034788778,0.002368427,0.045168895,0.0004601077,0.0036723663,0.05996461],"study_design_scores_gemma":[0.4426566,0.54774636,0.0029035374,0.000022277272,0.00023826641,0.00021237355,0.00006922887,0.0004904242,0.0031636597,0.00025274736,0.0022246817,0.000019864747],"about_ca_topic_score_codex":0.0017618765,"about_ca_topic_score_gemma":0.0035568886,"teacher_disagreement_score":0.0055137877,"about_ca_system_score_codex":0.0009057968,"about_ca_system_score_gemma":0.001905272,"threshold_uncertainty_score":0.018445432},"labels":[],"label_agreement":null},{"id":"W2126839072","doi":"10.1007/s10549-006-9182-3","title":"BRCA1-positive breast cancers in young women from Poland","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Medullary cavity; Family history; Oncology; Ovarian cancer; Cancer; Internal medicine; Histology; Gynecology; Mammography","score_opus":0.01443610435021696,"score_gpt":0.31350085885929235,"score_spread":0.2990647545090754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126839072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992016,0.00019545306,0.00002858267,0.000035994275,0.0000034647805,0.000011968178,0.00011733275,0.0000018951711,0.00040380764],"genre_scores_gemma":[0.9985416,0.0004905599,0.00004137925,0.00005551363,0.000006718761,0.000012100483,0.00017189623,0.000002483745,0.0006778436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999811,0.000021749698,0.000023879262,0.000042293974,0.000031524054,0.000069680325],"domain_scores_gemma":[0.99981266,0.000022378425,0.000049912425,0.0000065586905,0.00002399655,0.00008447503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017040403,0.0002624014,0.0003838154,0.0011298766,0.00079914863,0.00049207796,0.00025891818,0.00035248348,0.0013446624],"category_scores_gemma":[0.00063756603,0.00048116836,0.00031940755,0.0007671257,0.00027581476,0.0002669837,0.0006660793,0.00029755675,0.00027211517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023393534,0.00007406641,0.9895684,0.00005481759,0.000028197419,0.0027684846,0.0019132125,0.000028582963,0.0011837432,0.000044852102,0.00020092654,0.0039008674],"study_design_scores_gemma":[0.000015841375,0.00013073771,0.9944107,0.000012866633,0.000034875877,0.0026372862,0.0018576706,0.000035477937,0.00012716085,0.000027037724,0.0007047809,0.000005592623],"about_ca_topic_score_codex":0.03186323,"about_ca_topic_score_gemma":0.036169913,"teacher_disagreement_score":0.03186323,"about_ca_system_score_codex":0.00068385457,"about_ca_system_score_gemma":0.0007582237,"threshold_uncertainty_score":0.063355565},"labels":[],"label_agreement":null},{"id":"W2128719333","doi":"10.1007/s10549-012-2104-7","title":"Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada); Université Laval","funders":"","keywords":"Fulvestrant; Antiestrogen; Tamoxifen; Raloxifene; Estrogen receptor; Mammary gland; Estrogen; Endocrinology; Selective estrogen receptor modulator; Internal medicine; Breast cancer; Endocrine system; Biology; Medicine; Cancer research; Cancer; Hormone","score_opus":0.036560865280086674,"score_gpt":0.3069586897008745,"score_spread":0.2703978244207878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128719333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551755,0.0013498869,0.0013890963,0.00014473093,0.000046779613,0.000016908958,0.00032699833,0.000063555926,0.0011446709],"genre_scores_gemma":[0.99212575,0.0010934421,0.0010257274,0.000113462156,0.000025625446,0.000052283533,0.0006710238,0.00006406756,0.0048286812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967647,0.000056357094,0.00002553151,0.000061815816,0.000053561704,0.00012633056],"domain_scores_gemma":[0.99960846,0.00014596712,0.00007476574,0.000039633556,0.000028252145,0.00010305035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002468259,0.0004590354,0.0004078553,0.00050273957,0.00018713124,0.00043655658,0.00028675265,0.00045620525,0.0021088729],"category_scores_gemma":[0.00027345665,0.0003482905,0.00045042593,0.00024087311,0.00052252156,0.0002228581,0.000168274,0.00069730077,0.00036761686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046822862,0.00003157655,0.00015554551,0.000012025466,0.000005320165,0.000015073822,0.000008379403,0.000053139313,0.9988588,0.00009100472,0.000015002074,0.00028581734],"study_design_scores_gemma":[0.000022356697,0.00029722575,0.0010893276,0.0000025959746,0.000019782905,0.00002981028,0.000014665223,0.00021919253,0.99799263,0.000035302844,0.00027412028,0.0000030311953],"about_ca_topic_score_codex":0.0005529667,"about_ca_topic_score_gemma":0.0009799411,"teacher_disagreement_score":0.0021088729,"about_ca_system_score_codex":0.00034636422,"about_ca_system_score_gemma":0.00024339362,"threshold_uncertainty_score":0.0070548654},"labels":[],"label_agreement":null},{"id":"W2131928438","doi":"10.1023/a:1006459613498","title":"Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Genotype; Breast cancer; Single-nucleotide polymorphism; Internal medicine; Oncology; Prostate cancer; Biology; Medicine; Breast carcinoma; Cancer research; Cancer; Gene; Genetics","score_opus":0.04569737626745415,"score_gpt":0.3270604888343454,"score_spread":0.2813631125668913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131928438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989472,0.0003327839,0.000088873014,0.00017229206,0.000023203576,0.0000016694739,0.00009146166,0.0000061418655,0.00033643848],"genre_scores_gemma":[0.99958855,0.000054432778,0.000044333035,0.000030929263,0.000028371653,0.0000012101768,0.00007799367,0.000002371749,0.00017184834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971575,0.00011552396,0.000016081483,0.00005007746,0.000046873065,0.000055766646],"domain_scores_gemma":[0.9979297,0.0010708494,0.0004274348,0.000089186346,0.00011993463,0.00036287928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043025802,0.00025741622,0.00034936913,0.00055163127,0.00031763627,0.00038631083,0.00026099937,0.00061997544,0.0015272087],"category_scores_gemma":[0.002035799,0.00017695491,0.00039936285,0.00050853105,0.0003876616,0.00012139027,0.0001553502,0.0007153906,0.00021623993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069644134,0.00026212566,0.9441918,0.000036294576,0.00036804043,0.0010641137,0.00017773375,0.00053118356,0.03703867,0.00016214896,0.00041636254,0.008787093],"study_design_scores_gemma":[0.000101937214,0.0004150723,0.9939949,0.000008443952,0.00029991262,0.0013553853,0.0000899501,0.001011301,0.0021830522,0.00019870255,0.00032843693,0.000012845306],"about_ca_topic_score_codex":0.0020470016,"about_ca_topic_score_gemma":0.0018001966,"teacher_disagreement_score":0.0020470016,"about_ca_system_score_codex":0.00014504636,"about_ca_system_score_gemma":0.00028795944,"threshold_uncertainty_score":0.0051090717},"labels":[],"label_agreement":null},{"id":"W2133154503","doi":"10.1007/s10549-009-0364-7","title":"Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Trastuzumab; Breast cancer; Cancer research; Gene silencing; Medicine; Oncology; Cancer; Internal medicine; Biology; Gene; Genetics","score_opus":0.047857390762481605,"score_gpt":0.3666355244360162,"score_spread":0.3187781336735346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133154503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883918,0.004962633,0.0031505208,0.0004140229,0.00007788874,0.00005957221,0.00052643986,0.00014746598,0.0022695954],"genre_scores_gemma":[0.9948043,0.0012528141,0.0010066319,0.000073192234,0.00001809397,0.000041453473,0.0005948759,0.00003689509,0.0021716142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954057,0.000105806546,0.00003739386,0.00006123718,0.00014097123,0.00011404423],"domain_scores_gemma":[0.99964917,0.00008013476,0.0000901097,0.00006918201,0.00004939554,0.000062000276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031278338,0.00034364004,0.00051902456,0.00041339197,0.00025184455,0.00045824278,0.0002024525,0.00057392044,0.0019364606],"category_scores_gemma":[0.0006220378,0.00029677906,0.000440609,0.00053501123,0.00028437583,0.0003012487,0.00030828928,0.000870873,0.0008365123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016204649,0.000048148435,0.00063150324,0.000046812158,0.000023317018,0.00062927074,0.000026833806,0.00013707008,0.99536777,0.00012187951,0.00032697094,0.00247833],"study_design_scores_gemma":[0.000066483844,0.0003663399,0.010312158,0.000007906096,0.000046706486,0.0070008505,0.000055815006,0.0013129594,0.97297734,0.00018044232,0.007662486,0.000010486369],"about_ca_topic_score_codex":0.0007061465,"about_ca_topic_score_gemma":0.0004326785,"teacher_disagreement_score":0.0019364606,"about_ca_system_score_codex":0.00033739288,"about_ca_system_score_gemma":0.00019424557,"threshold_uncertainty_score":0.006478131},"labels":[],"label_agreement":null},{"id":"W2134155956","doi":"10.1007/s10549-011-1559-2","title":"Associations of objectively assessed physical activity and sedentary time with biomarkers of breast cancer risk in postmenopausal women: findings from NHANES (2003–2006)","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Athabasca University; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Waist; Breast cancer; Body mass index; National Health and Nutrition Examination Survey; Internal medicine; Anthropometry; Confounding; Biomarker; Quartile; Population; Oncology; Sedentary lifestyle; Cancer; Physiology; Endocrinology; Obesity; Environmental health; Biology","score_opus":0.05180185396028153,"score_gpt":0.35842318079120106,"score_spread":0.3066213268309195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134155956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654084,0.0005722848,0.00011125147,0.000060306036,0.000016352806,0.000018013443,0.002357449,0.0000058978558,0.00031760157],"genre_scores_gemma":[0.9946878,0.00045726926,0.00032981756,0.00010149147,0.0000240368,0.00005035911,0.0038005984,0.000005796704,0.00054279057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995258,0.00012353103,0.00007924849,0.0001033477,0.00011230726,0.000055717937],"domain_scores_gemma":[0.9988269,0.0001999036,0.00048117284,0.000106422754,0.0002481495,0.00013740876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011586541,0.0003327267,0.00056616403,0.00057325314,0.00032143807,0.0007204576,0.0004685886,0.0006004365,0.00039563232],"category_scores_gemma":[0.0020311775,0.00043751934,0.0008797069,0.0012363348,0.00015878936,0.0003068975,0.00043779286,0.0006889389,0.00011870315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044229612,0.000056483037,0.9975752,0.000019391398,0.0003221265,0.000019436498,0.00006587132,0.00003657606,0.00037124864,0.0000059469353,0.00013843963,0.00094693777],"study_design_scores_gemma":[0.000008208487,0.000033434924,0.99968314,0.0000017192165,0.00005178211,0.000021321575,0.00003195038,0.000026271193,0.000040101255,0.0000018972801,0.000098767916,0.0000014354922],"about_ca_topic_score_codex":0.047436744,"about_ca_topic_score_gemma":0.07977931,"teacher_disagreement_score":0.047436744,"about_ca_system_score_codex":0.00050355226,"about_ca_system_score_gemma":0.0005887844,"threshold_uncertainty_score":0.09432125},"labels":[],"label_agreement":null},{"id":"W2134267892","doi":"10.1007/s10549-012-2012-x","title":"25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Breast cancer; Internal medicine; Body mass index; Tamoxifen; Adipokine; Vitamin D and neurology; Oncology; Population; Insulin resistance; Cancer; Odds ratio; Leptin; Endocrinology; Obesity","score_opus":0.025767386734002917,"score_gpt":0.3377148942639271,"score_spread":0.3119475075299242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134267892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980867,0.0015372677,0.00005111104,0.000038999915,0.0000030434096,0.000008370547,0.00012265357,0.0000017998121,0.00015006949],"genre_scores_gemma":[0.9992945,0.00028831692,0.00007222593,0.000016390395,0.0000068409695,0.000010218506,0.00019453134,0.000001233912,0.00011579575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993913,0.0003511719,0.000049211434,0.00008077431,0.00008664265,0.00004087451],"domain_scores_gemma":[0.9987237,0.0006076001,0.00039882207,0.00005999829,0.000037540314,0.00017235061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013912023,0.00021662004,0.00048847485,0.00041752012,0.0002548822,0.00048399158,0.0002667458,0.00038449766,0.0010665364],"category_scores_gemma":[0.0034015826,0.00024107439,0.0004760131,0.00074544444,0.0003321388,0.00026524471,0.00038679133,0.0005190854,0.00008557265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011263013,0.00008908255,0.98244596,0.000057016252,0.00030771535,0.0001765898,0.000056217265,0.00015364673,0.00055901945,0.000038154183,0.00011184948,0.0047417446],"study_design_scores_gemma":[0.0003751418,0.0011158854,0.99597234,0.000015213484,0.00037666038,0.0003526239,0.00006549535,0.0011281098,0.00015097087,0.00012685325,0.00031564152,0.0000049044884],"about_ca_topic_score_codex":0.0026472418,"about_ca_topic_score_gemma":0.0031452107,"teacher_disagreement_score":0.0026472418,"about_ca_system_score_codex":0.00018263649,"about_ca_system_score_gemma":0.00028115697,"threshold_uncertainty_score":0.007357478},"labels":[],"label_agreement":null},{"id":"W2134570780","doi":"10.1007/s10549-013-2478-1","title":"The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Cardiorespiratory fitness; Asymptomatic; Internal medicine; Adjuvant therapy; Cancer; Stage (stratigraphy); Adjuvant; Regimen; Oncology; Surgery","score_opus":0.046486842979138895,"score_gpt":0.3561632772116143,"score_spread":0.3096764342324754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134570780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984732,0.00040003072,0.000028019896,0.000134917,0.000015937432,0.0000067974415,0.0006738077,0.0000018903089,0.00026539245],"genre_scores_gemma":[0.99823016,0.00019871816,0.000035213354,0.000066295215,0.00001539307,0.000015065816,0.0009274277,0.0000023364087,0.00050943316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992588,0.00021737344,0.00004067786,0.000117858275,0.00009450573,0.0002708447],"domain_scores_gemma":[0.9968317,0.0004626782,0.0007714448,0.00030928073,0.00050489587,0.0011199291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014175376,0.00036083694,0.00055638974,0.0006279366,0.0010082244,0.00083005143,0.00080501585,0.001059535,0.000775904],"category_scores_gemma":[0.0031436787,0.0004153221,0.0007433032,0.001028085,0.0003311978,0.00053135847,0.00076607807,0.0016129375,0.00020605652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042993366,0.00018501235,0.9981679,0.0000040387026,0.00008220998,0.00004217066,0.000085709835,0.00003082357,0.00012349023,0.000011876861,0.00017373209,0.0006631167],"study_design_scores_gemma":[0.000007855472,0.000072967974,0.9996462,0.0000036861172,0.00002924379,0.000015166632,0.00009518343,0.000037308397,0.000015902211,0.000003765536,0.00006980032,0.000002835991],"about_ca_topic_score_codex":0.1143502,"about_ca_topic_score_gemma":0.15441397,"teacher_disagreement_score":0.1143502,"about_ca_system_score_codex":0.001150677,"about_ca_system_score_gemma":0.0018573313,"threshold_uncertainty_score":0.22736919},"labels":[],"label_agreement":null},{"id":"W2136107801","doi":"10.1007/s10549-008-0257-1","title":"No evidence that GATA3 rs570613 SNP modifies breast cancer risk","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research and Materiel Command; National Cancer Institute; Medical Research Council; Cancer Council Tasmania; National Institutes of Health; Sahlgrenska Universitetssjukhuset; Fox Chase Cancer Center; Lunds Universitet; Uppsala Universitet; Cancerfonden; Radboud Universiteit; Akademiska Sjukhuset; Helsingin ja Uudenmaan Sairaanhoitopiiri; Robert Bosch Stiftung; Vrije Universiteit Amsterdam; National Breast Cancer Foundation; Huntsman Cancer Institute; Breast Cancer Research Foundation; Cancer Care Ontario; Bundesministerium für Bildung und Forschung; Universiteit Leiden; National Health and Medical Research Council; Cancer Research UK","keywords":"Breast cancer; Single-nucleotide polymorphism; Allele; GATA3; Estrogen receptor; Oncology; SNP; Internal medicine; Medicine; Linkage disequilibrium; Cancer; Genotype; Biology; Genetics; Transcription factor; Gene","score_opus":0.238466334642105,"score_gpt":0.4103213373174322,"score_spread":0.1718550026753272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136107801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98998076,0.003045157,0.0012025937,0.0004353668,0.000115544135,0.000020959076,0.0008159777,0.000035391473,0.004348249],"genre_scores_gemma":[0.99704915,0.00043554005,0.0004540299,0.00019125629,0.00007914492,0.00001747233,0.0003300965,0.000026257456,0.0014170978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573493,0.002191488,0.00043328997,0.0008527752,0.00052760536,0.0002598804],"domain_scores_gemma":[0.986811,0.008392836,0.0015371043,0.0022434941,0.0004918752,0.0005238097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004799547,0.0006755203,0.00087767316,0.0012774166,0.00091013586,0.0009513018,0.0013774255,0.0019632895,0.013155226],"category_scores_gemma":[0.013124669,0.00071656046,0.0022040107,0.0016204679,0.0010406164,0.0005347566,0.00056323333,0.0010962052,0.0009355146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059292917,0.00018316405,0.96306,0.0002861521,0.0053132996,0.0019715868,0.0007370166,0.00016433273,0.012428323,0.0007016416,0.00083648594,0.008388738],"study_design_scores_gemma":[0.00042556488,0.0015297931,0.9736528,0.00011478559,0.0063901762,0.0071247504,0.0003761061,0.00054238905,0.0034747343,0.0013159926,0.0050140712,0.000038829705],"about_ca_topic_score_codex":0.0037506642,"about_ca_topic_score_gemma":0.0034255271,"teacher_disagreement_score":0.013155226,"about_ca_system_score_codex":0.00032140192,"about_ca_system_score_gemma":0.00040743733,"threshold_uncertainty_score":0.044008613},"labels":[],"label_agreement":null},{"id":"W2136957569","doi":"10.1007/s10549-008-0104-4","title":"Autoimmune hypothyroidism and breast cancer in the elderly","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; St. Michael's Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.05152938137277015,"score_gpt":0.35092351975025915,"score_spread":0.299394138377489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136957569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95318645,0.037250146,0.00005469086,0.003075082,0.00013335209,0.0000069172884,0.00015557201,0.0000061658907,0.006131597],"genre_scores_gemma":[0.98997724,0.008310058,0.000046973237,0.00048291613,0.00035614966,0.0000026525847,0.000053783377,8.5335734e-7,0.0007693159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998497,0.000053469314,0.000015280286,0.000013246175,0.000028027713,0.000040337167],"domain_scores_gemma":[0.9995184,0.00009656264,0.00018639013,0.000012296916,0.000049303195,0.00013704269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031890126,0.00009371837,0.00026025367,0.0005778375,0.0003086919,0.00035553757,0.0001062658,0.0005781598,0.0016807785],"category_scores_gemma":[0.0013796765,0.00011636344,0.00032444793,0.00064014795,0.00017319567,0.0002953753,0.0001915847,0.0003522208,0.00014045561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050607836,0.00012630838,0.97880507,0.000075865326,0.00011616946,0.0017815769,0.00016798616,0.000060102157,0.00035279713,0.00018413091,0.0014218924,0.016402092],"study_design_scores_gemma":[0.000030763535,0.00018829553,0.9948413,0.000037241633,0.00012026654,0.002979538,0.00035573935,0.00009471842,0.00003337634,0.0001729422,0.0011410561,0.0000047354647],"about_ca_topic_score_codex":0.015417275,"about_ca_topic_score_gemma":0.016928637,"teacher_disagreement_score":0.015417275,"about_ca_system_score_codex":0.00040988578,"about_ca_system_score_gemma":0.00056061323,"threshold_uncertainty_score":0.030655086},"labels":[],"label_agreement":null},{"id":"W2137506740","doi":"10.1007/s10549-012-2258-3","title":"Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Metastasis; Cancer research; Biology; Adoptive cell transfer; Mammary tumor; Breast cancer; Tumor progression; Nod; Immune system; NOD mice; Cancer; Immunology; T cell; In vivo","score_opus":0.2216355359345644,"score_gpt":0.42818234218950724,"score_spread":0.20654680625494284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137506740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98660374,0.0011897294,0.0068600215,0.00071301137,0.000073360534,0.000030492049,0.0012792224,0.0004278262,0.002822607],"genre_scores_gemma":[0.98019034,0.00081831316,0.006184441,0.00021675036,0.00003110696,0.00008995477,0.0013323518,0.00018319943,0.010953588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997607,0.000023732335,0.00002466424,0.00005746296,0.000071048016,0.00006246612],"domain_scores_gemma":[0.9996892,0.000040025083,0.000085285435,0.000038685725,0.000039123155,0.00010761746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002575768,0.0005955217,0.00041265768,0.00090910797,0.00033505744,0.0005175869,0.00037577195,0.0006935929,0.0054408903],"category_scores_gemma":[0.00017644423,0.00023900317,0.0004164562,0.0003064782,0.00039107297,0.00056270993,0.00023546089,0.0015569273,0.0010031889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001412832,0.000044458095,0.00020524266,0.00002940502,0.000004879896,0.0000683879,0.000012560327,0.000019158935,0.9986507,0.00013719297,0.000057311478,0.0006294204],"study_design_scores_gemma":[0.000021974936,0.00016930116,0.0031806503,0.000005019434,0.000025672347,0.00058052683,0.00003333693,0.0007333332,0.9932167,0.000097176526,0.0019317743,0.0000044118688],"about_ca_topic_score_codex":0.00070057256,"about_ca_topic_score_gemma":0.0012596899,"teacher_disagreement_score":0.0054408903,"about_ca_system_score_codex":0.00036292983,"about_ca_system_score_gemma":0.0002210502,"threshold_uncertainty_score":0.01820159},"labels":[],"label_agreement":null},{"id":"W2139782977","doi":"10.1007/s10549-006-9400-z","title":"MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Breast cancer; Multivariate statistics; Multivariate analysis; Internal medicine; Principal component analysis; Oncology; Magnetic resonance imaging; Medicine; Cancer; Radiology; Artificial intelligence; Mathematics; Statistics; Computer science","score_opus":0.04010344188028359,"score_gpt":0.34671713889438177,"score_spread":0.3066136970140982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139782977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982938,0.0004906494,0.0002739845,0.000068162815,0.0000071139402,0.0000053860963,0.00010768978,0.000005093592,0.0007480797],"genre_scores_gemma":[0.9993104,0.00016044111,0.00027334256,0.000019110805,0.000007490582,0.0000035311132,0.00008940638,0.000002372722,0.00013384865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998795,0.00006436329,0.000009810108,0.000015947357,0.000014224892,0.00001623293],"domain_scores_gemma":[0.99953544,0.00018241929,0.00011118055,0.000023631013,0.00005685369,0.00009052932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004571475,0.00030042784,0.00023507755,0.0006141736,0.00012224277,0.0004175161,0.00017758302,0.0003871285,0.0007128392],"category_scores_gemma":[0.0014215655,0.00014171143,0.00016917524,0.00031015626,0.00017464139,0.0001867708,0.00015948374,0.00034070257,0.0002319375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003157167,0.000058729795,0.97689086,0.00002463436,0.000080916514,0.00018514135,0.00004072779,0.00031228468,0.01220841,0.00004157463,0.00009485855,0.0069045704],"study_design_scores_gemma":[0.000052520994,0.00064131664,0.9901102,0.0000124927365,0.00017130081,0.0012517871,0.00018446708,0.003060789,0.0039808163,0.00014689463,0.00037800515,0.000009323349],"about_ca_topic_score_codex":0.0011644058,"about_ca_topic_score_gemma":0.0018786177,"teacher_disagreement_score":0.0011644058,"about_ca_system_score_codex":0.00012213673,"about_ca_system_score_gemma":0.00011553091,"threshold_uncertainty_score":0.0024176836},"labels":[],"label_agreement":null},{"id":"W2140503098","doi":"10.1007/s10549-011-1934-z","title":"Molecular insights on basal-like breast cancer","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Breast cancer; Oncology; Internal medicine; Basal (medicine); Medicine; Progesterone receptor; Epidermal growth factor receptor; Triple-negative breast cancer; Epigenetics; Estrogen receptor; Metastasis; Cancer; Cancer research; Biology; Genetics; Gene","score_opus":0.08133697763086953,"score_gpt":0.3989915856751402,"score_spread":0.3176546080442707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140503098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007641332,0.99868435,0.00016934001,0.00026820056,0.00018239906,0.000002749585,0.000013998545,0.000005189311,0.00059747125],"genre_scores_gemma":[0.0004834213,0.9985373,0.00019853793,0.00019206107,0.0001495706,0.000003887121,0.000023803805,0.0000012307049,0.00041013365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998375,0.000026679558,0.000020513087,0.000031743977,0.00005816131,0.000025390555],"domain_scores_gemma":[0.9997459,0.00011376717,0.000031382584,0.000011264626,0.00007002905,0.000027668262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071037246,0.0010516334,0.0016129568,0.0021562427,0.00029433996,0.0012020607,0.001025041,0.0011813613,0.0020010085],"category_scores_gemma":[0.00070101203,0.00040843344,0.00045050663,0.0021177067,0.00082536135,0.0013783257,0.0007061249,0.0025190304,0.001679981],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012216961,0.00008370124,0.00020813486,0.011881147,0.000075515,0.00039119864,0.000044355573,0.0004845905,0.0044425447,0.0073196082,0.03832735,0.93661964],"study_design_scores_gemma":[0.000023636461,0.000051847677,0.000604837,0.00183192,0.00010165572,0.0014965349,0.000051100986,0.00010633675,0.0013932766,0.003439838,0.9908785,0.000020511483],"about_ca_topic_score_codex":0.0011961904,"about_ca_topic_score_gemma":0.0025810627,"teacher_disagreement_score":0.0021562427,"about_ca_system_score_codex":0.0010498395,"about_ca_system_score_gemma":0.0010990959,"threshold_uncertainty_score":0.0076171756},"labels":[],"label_agreement":null},{"id":"W2141418796","doi":"10.1007/s10549-013-2735-3","title":"Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Metastasis; Lung; Lymph; Adoptive cell transfer; Medicine; CD8; Active immunization; Cancer research; Pathology; Immunology; Biology; Cancer; Immune system; Immunization; Internal medicine; T cell","score_opus":0.039157447656365384,"score_gpt":0.314476812896867,"score_spread":0.27531936524050166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141418796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545765,0.00047155656,0.0018982475,0.00013204997,0.000037504506,0.00008834576,0.0004736203,0.00016674036,0.0012743628],"genre_scores_gemma":[0.9890788,0.00069535116,0.003639509,0.0000918352,0.000019210844,0.00011894155,0.0009492334,0.000045646404,0.0053615174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997768,0.00003319116,0.000016995607,0.00003474552,0.000061661856,0.0000766214],"domain_scores_gemma":[0.9997708,0.000034532768,0.000072501956,0.00002892917,0.000015740985,0.00007750882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002417391,0.0007368139,0.00041051948,0.00040458984,0.00015296512,0.00026975805,0.00026167213,0.00044901873,0.0018642411],"category_scores_gemma":[0.00012659354,0.00017458013,0.00039966224,0.00013037672,0.00024614646,0.00024440704,0.00019848658,0.001410439,0.0004921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001482938,0.00013871137,0.00011063888,0.00002696454,0.0000048030056,0.000040232106,0.00001522066,0.0000863579,0.99834263,0.00010752756,0.000044864613,0.0009337293],"study_design_scores_gemma":[0.00005049692,0.0019144036,0.0018309216,0.000008451543,0.000014786593,0.0002621269,0.000019778045,0.001043451,0.9936406,0.000047338537,0.001163511,0.0000041813996],"about_ca_topic_score_codex":0.00030503876,"about_ca_topic_score_gemma":0.0007844518,"teacher_disagreement_score":0.0018642411,"about_ca_system_score_codex":0.000248836,"about_ca_system_score_gemma":0.0002286662,"threshold_uncertainty_score":0.006236553},"labels":[],"label_agreement":null},{"id":"W2142361869","doi":"10.1007/s10549-008-0134-y","title":"Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"","keywords":"Breast cancer; DNA repair; Genetics; Missense mutation; Gene; Biology; Single-nucleotide polymorphism; Mutation; Genotype; Cancer","score_opus":0.04864518897385026,"score_gpt":0.36562058845410506,"score_spread":0.31697539948025477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142361869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999655,0.000037431433,0.000045074303,0.0000058332625,6.9705396e-7,0.0000014431398,0.0001028733,0.000001969157,0.000149584],"genre_scores_gemma":[0.99937683,0.00003788936,0.00010413818,0.0000073551623,0.0000018505491,0.0000043504483,0.00020343409,0.0000025068389,0.00026157126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981374,0.000034453064,0.000018399762,0.000055875928,0.000041282998,0.000036379726],"domain_scores_gemma":[0.9997155,0.00009895148,0.00007685579,0.000023151082,0.00003556279,0.000050016737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001401622,0.00020422008,0.00018293926,0.001174392,0.00042317057,0.00028450356,0.00021652733,0.0003560825,0.0011691215],"category_scores_gemma":[0.000760355,0.00022097792,0.00021566486,0.00062913017,0.00022793809,0.0001219767,0.00018771882,0.00024381402,0.00019078405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066050264,0.000073357136,0.95194477,0.000016566344,0.000052854703,0.0012066804,0.00040855043,0.000096658616,0.04236169,0.00007741712,0.000096937576,0.0030040373],"study_design_scores_gemma":[0.000006312262,0.00008182994,0.99279755,0.00000164098,0.00003980792,0.0025678196,0.00027406187,0.0003246697,0.0036162194,0.000029457373,0.00025751596,0.0000031084608],"about_ca_topic_score_codex":0.0036520753,"about_ca_topic_score_gemma":0.002931485,"teacher_disagreement_score":0.0036520753,"about_ca_system_score_codex":0.00015768144,"about_ca_system_score_gemma":0.00010705373,"threshold_uncertainty_score":0.007261634},"labels":[],"label_agreement":null},{"id":"W2143129903","doi":"10.1023/a:1016387020854","title":"The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer","year":2002,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Massachusetts Institute of Technology; Brown University; York University; National Institute of Environmental Health Sciences; University of Southern California","keywords":"Breast cancer; Medicine; Demography; Family history; Population; Cancer; Case-control study; Cancer registry; Environmental health; Gynecology; Gerontology; Internal medicine","score_opus":0.09411122753734119,"score_gpt":0.40240609512593933,"score_spread":0.30829486758859814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143129903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.805192,0.0016254282,0.020314569,0.006328639,0.00075641496,0.09653106,0.050340787,0.0006005459,0.018310508],"genre_scores_gemma":[0.5961835,0.0017032782,0.112882026,0.004577267,0.00066138443,0.20258908,0.06006518,0.00043151499,0.0209068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98981375,0.0067218253,0.000563797,0.0008925027,0.0009461875,0.0010619044],"domain_scores_gemma":[0.98775846,0.0009464379,0.0009629432,0.002275474,0.0029656864,0.005091041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011654736,0.0013812819,0.0012525915,0.001970934,0.0065250304,0.0023634455,0.0023876978,0.0021397308,0.0018110506],"category_scores_gemma":[0.00798174,0.0013898821,0.0011223273,0.0038993908,0.001434643,0.0017567856,0.009679546,0.0032319112,0.0010383318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032600495,0.0083932895,0.8811147,0.0005752239,0.0008522729,0.0008258449,0.009126427,0.001114332,0.006921143,0.0011184901,0.025638536,0.06105957],"study_design_scores_gemma":[0.0015663757,0.0018776228,0.9589371,0.00016045637,0.00023524796,0.0002201456,0.00849362,0.00062473316,0.0016407731,0.00022969086,0.02591391,0.00010035207],"about_ca_topic_score_codex":0.24865037,"about_ca_topic_score_gemma":0.35579672,"teacher_disagreement_score":0.24865037,"about_ca_system_score_codex":0.0049246997,"about_ca_system_score_gemma":0.027266845,"threshold_uncertainty_score":0.4944061},"labels":[],"label_agreement":null},{"id":"W2143331437","doi":"10.1007/s10549-012-2360-6","title":"Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis","year":2013,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Natural Science Foundation of China; Memorial Sloan-Kettering Cancer Center","keywords":"Nomogram; Medicine; Micrometastasis; Sentinel lymph node; Breast cancer; Meta-analysis; Oncology; Odds ratio; Cancer; Internal medicine","score_opus":0.11466147524745779,"score_gpt":0.41129963411860365,"score_spread":0.29663815887114586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143331437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036460867,0.9948901,0.0005941153,0.00025315868,0.00017078516,0.000018053335,0.0002551593,0.000014505183,0.00015803786],"genre_scores_gemma":[0.15619479,0.83728254,0.0028486855,0.0012635023,0.0007735569,0.000105475025,0.0010886946,0.000036554444,0.00040617055],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974716,0.0012890187,0.00045094843,0.00047450562,0.00023737084,0.00007671444],"domain_scores_gemma":[0.9937809,0.0049442668,0.0005860899,0.0002483065,0.00035040948,0.00009001775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061711674,0.002362897,0.009375091,0.0019855655,0.000315748,0.001621837,0.0017063373,0.0013659234,0.002527055],"category_scores_gemma":[0.01001367,0.0008594467,0.018001275,0.002603491,0.00034892742,0.0011614288,0.00083187217,0.0016395756,0.00029884183],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050269095,0.00007508843,0.029667422,0.08561095,0.75458574,0.00015614976,0.00007306479,0.0017830908,0.0003643466,0.0003115942,0.0035806482,0.11876501],"study_design_scores_gemma":[0.0009880028,0.00047361501,0.017456947,0.0072286753,0.9646295,0.00022375597,0.00007771132,0.0009954582,0.000239773,0.0012050342,0.006408094,0.00007345136],"about_ca_topic_score_codex":0.0033547764,"about_ca_topic_score_gemma":0.009385503,"teacher_disagreement_score":0.009375091,"about_ca_system_score_codex":0.00081444654,"about_ca_system_score_gemma":0.0009863761,"threshold_uncertainty_score":0.032636642},"labels":[],"label_agreement":null},{"id":"W2146717458","doi":"10.1007/s10549-008-0128-9","title":"Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Chemotherapy; Internal medicine; Mastectomy; Cisplatin; Neoadjuvant therapy; Cancer; Clinical trial","score_opus":0.027426526070608685,"score_gpt":0.33845533326892663,"score_spread":0.31102880719831794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146717458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895704,0.00046895037,0.00004984817,0.000075641605,0.000005717277,0.000014759042,0.00005604495,0.0000027769502,0.00036926914],"genre_scores_gemma":[0.9994899,0.00012609335,0.00008465014,0.000049425224,0.000008039274,0.000020530064,0.00014707234,9.795485e-7,0.000073247626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998136,0.000080604405,0.000023757117,0.000028317483,0.000026259644,0.00002753541],"domain_scores_gemma":[0.99953055,0.00017612978,0.00013362445,0.000015167422,0.000034738085,0.00010981986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030530876,0.00012973063,0.0003338849,0.0001480406,0.00020892132,0.00021269926,0.00010792991,0.00024704155,0.0008138299],"category_scores_gemma":[0.0016289969,0.000085996966,0.00014357563,0.00013954131,0.00017474801,0.00014959871,0.00014392557,0.00025836605,0.000114625276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013990145,0.00066307705,0.92804676,0.00013620511,0.00011719174,0.001881153,0.00031348632,0.001747641,0.012420117,0.000052382704,0.0007488153,0.03988305],"study_design_scores_gemma":[0.0009250118,0.014098989,0.96300983,0.000051198153,0.00018360432,0.008726724,0.00030500712,0.0020045778,0.007874433,0.00010780404,0.0026907648,0.0000219892],"about_ca_topic_score_codex":0.00041094804,"about_ca_topic_score_gemma":0.00079771865,"teacher_disagreement_score":0.0008138299,"about_ca_system_score_codex":0.0003566745,"about_ca_system_score_gemma":0.00022716417,"threshold_uncertainty_score":0.0027225614},"labels":[],"label_agreement":null},{"id":"W2147908679","doi":"10.1007/s10549-011-1895-2","title":"Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":376,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Terry Fox Foundation; American College of Radiology Imaging Network; Breast Cancer Research Foundation","keywords":"Breast cancer; Oncology; Medicine; Chemotherapy; Internal medicine; Biomarker; Neoadjuvant therapy; Cancer; Biology","score_opus":0.08937757815703253,"score_gpt":0.3586874118529415,"score_spread":0.269309833695909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147908679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946379,0.0026167792,0.00019336485,0.00031391962,0.000026640524,0.00011454347,0.001157838,0.0000135967375,0.00092531735],"genre_scores_gemma":[0.9894097,0.0016402656,0.0008179394,0.00047936908,0.00012150334,0.00025287658,0.0064584487,0.000019898363,0.00080004754],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991431,0.0005511383,0.000042883148,0.000097338765,0.000104003666,0.00006150178],"domain_scores_gemma":[0.99858,0.00041363997,0.00045408565,0.00015580535,0.00007454422,0.00032196913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032925035,0.0004944906,0.00090522185,0.00026863776,0.00013340195,0.0005687854,0.0002998478,0.00041621286,0.0008333137],"category_scores_gemma":[0.002578161,0.0001733346,0.0008603733,0.00048717659,0.00029068196,0.00047753486,0.00044011578,0.0010496506,0.00022553954],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44746125,0.0039927564,0.34481972,0.0006482595,0.004065261,0.00007538276,0.00018710789,0.0041464916,0.009777252,0.00020255367,0.0063377516,0.17828625],"study_design_scores_gemma":[0.034306306,0.064549536,0.88621545,0.0001425852,0.0042927545,0.00022303515,0.00009338837,0.003998815,0.0015926983,0.0004497005,0.004070877,0.00006483578],"about_ca_topic_score_codex":0.0010361543,"about_ca_topic_score_gemma":0.0032923534,"teacher_disagreement_score":0.0032925035,"about_ca_system_score_codex":0.0005568877,"about_ca_system_score_gemma":0.0007507678,"threshold_uncertainty_score":0.017412603},"labels":[],"label_agreement":null},{"id":"W2151962431","doi":"10.1007/s10549-014-3141-1","title":"Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Cancer Society Research Institute; Ministero della Salute; Associazione Italiana per la Ricerca sul Cancro; Bundesministerium für Bildung und Forschung; Robert Bosch Stiftung","keywords":"Metformin; Medicine; Breast cancer; Internal medicine; Insulin resistance; Placebo; Quartile; Oncology; Endocrinology; Cancer; Insulin; Pathology","score_opus":0.014054582202154919,"score_gpt":0.31136286197566954,"score_spread":0.2973082797735146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151962431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495655,0.0026365104,0.00017657303,0.00030438375,0.00030287082,0.0008308293,0.00022710208,0.0000257235,0.0005394472],"genre_scores_gemma":[0.9953635,0.0011362187,0.00048266663,0.00068873324,0.00035220405,0.0008626092,0.0004042378,0.000007926542,0.0007018443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982487,0.0010971987,0.0001559341,0.00019343858,0.00013135439,0.00017343592],"domain_scores_gemma":[0.9981014,0.00055500254,0.00049905153,0.00020146168,0.00013157459,0.0005115503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023987212,0.0011678321,0.002634503,0.00043968888,0.00046691258,0.0011593142,0.00060759945,0.0014342498,0.0026956915],"category_scores_gemma":[0.0034068273,0.0006099676,0.0022086399,0.00041930383,0.0006932162,0.0007400298,0.0004883491,0.0022137833,0.0003079679],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98943114,0.001975282,0.0021094647,0.00013865795,0.0011996024,0.000018235623,0.000014659332,0.000050816067,0.0007423252,0.000021022652,0.00013109719,0.004167724],"study_design_scores_gemma":[0.85519946,0.11751665,0.02240765,0.0000501079,0.0027210817,0.000045352936,0.00003451872,0.00052368874,0.0007096731,0.00019449316,0.00056840864,0.000028874498],"about_ca_topic_score_codex":0.0005468881,"about_ca_topic_score_gemma":0.0015255916,"teacher_disagreement_score":0.0026956915,"about_ca_system_score_codex":0.00061740924,"about_ca_system_score_gemma":0.00080485904,"threshold_uncertainty_score":0.012685776},"labels":[],"label_agreement":null},{"id":"W2154436990","doi":"10.1007/s10549-012-2295-y","title":"The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Medical School, University of Michigan; University of Michigan","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Germline mutation; Cancer; Mutation; Family history; Tamoxifen; Prostate cancer; Gene; Genetics; Biology","score_opus":0.04792564922707676,"score_gpt":0.3595563921409384,"score_spread":0.3116307429138616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154436990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985103,0.00027905506,0.0002337722,0.00009726654,0.0000091847805,0.000004966001,0.000094192364,0.0000073000847,0.0007639961],"genre_scores_gemma":[0.99943286,0.00011905434,0.00013075174,0.000016383066,0.000007991059,0.000002345937,0.00006157585,0.0000033400886,0.0002256907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995976,0.00009071143,0.000037924303,0.000087987646,0.0001152946,0.00007045909],"domain_scores_gemma":[0.9991215,0.00021693626,0.0003712037,0.00008685352,0.00007162092,0.0001318898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028985424,0.00039152766,0.00034320197,0.00063265103,0.00040248025,0.00030305516,0.000334496,0.0005372986,0.003150265],"category_scores_gemma":[0.0018298692,0.00026966986,0.00035004877,0.0006390261,0.00063189294,0.0001394216,0.00032781766,0.00048769457,0.0002950986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011002637,0.000041963525,0.977395,0.000042542564,0.00025317815,0.0033654678,0.00009649793,0.00017989836,0.012436371,0.00017315082,0.00018613649,0.004729479],"study_design_scores_gemma":[0.0000549304,0.00021324436,0.9842166,0.000029595078,0.0002450662,0.010672407,0.0001458126,0.00078237714,0.0023591127,0.00027568356,0.0009944685,0.000010725121],"about_ca_topic_score_codex":0.009327092,"about_ca_topic_score_gemma":0.0069736294,"teacher_disagreement_score":0.009327092,"about_ca_system_score_codex":0.00025429868,"about_ca_system_score_gemma":0.0003782182,"threshold_uncertainty_score":0.018545568},"labels":[],"label_agreement":null},{"id":"W2155602686","doi":"10.1023/a:1006422302173","title":"Steroid hormone activity of flavonoids and related compounds","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Phytoestrogens; Naringenin; Genistein; Biochanin A; Dihydrotestosterone; Isoflavones; Apigenin; Endocrinology; Estrogen; Chemistry; Internal medicine; Progestin; Steroid; Luteolin; Androgen; Hormone; Steroid hormone; Pharmacology; Daidzein; Flavonoid; Biology; Medicine; Biochemistry","score_opus":0.03810150840844816,"score_gpt":0.36778092560004333,"score_spread":0.32967941719159516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155602686","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9451182,0.04385694,0.0008328317,0.00043836387,0.00009841835,0.000025050871,0.0004367048,0.000017026805,0.009176518],"genre_scores_gemma":[0.983165,0.009763441,0.00025449434,0.00013528022,0.00010942775,0.000007321658,0.00041396418,0.0000050545964,0.006145967],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99995506,0.000013412424,0.0000016954756,0.000007765151,0.000007590504,0.000014445529],"domain_scores_gemma":[0.99989057,0.000034398843,0.000015035053,0.000009724011,0.000014426701,0.000035901325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012554684,0.00016096397,0.00013491054,0.00031658687,0.00023878837,0.00021117885,0.00009839226,0.00022282389,0.0045455853],"category_scores_gemma":[0.00023970149,0.000093216666,0.00020249422,0.00019361704,0.0002533341,0.00024477177,0.0000945549,0.00017942667,0.00031772046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008484253,0.00026601137,0.010889343,0.0002580807,0.0001599557,0.00038537412,0.00025818188,0.00044451826,0.91831726,0.0033372685,0.0007691747,0.056430522],"study_design_scores_gemma":[0.0004979078,0.008643004,0.23107573,0.000092497765,0.0003105203,0.0018224281,0.0005513566,0.0007050156,0.70350486,0.0032416028,0.04950827,0.00004680438],"about_ca_topic_score_codex":0.0027785273,"about_ca_topic_score_gemma":0.002474933,"teacher_disagreement_score":0.0045455853,"about_ca_system_score_codex":0.00024112241,"about_ca_system_score_gemma":0.00018222304,"threshold_uncertainty_score":0.015206516},"labels":[],"label_agreement":null},{"id":"W2156003012","doi":"10.1007/s10549-010-0902-3","title":"Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis","year":2010,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Tamoxifen; CYP2D6; Breast cancer; Medicine; Oncology; Internal medicine; Genotype; Hazard ratio; Meta-analysis; Adjuvant therapy; Cancer; Pharmacology; Confidence interval; Biology; Cytochrome P450; Genetics","score_opus":0.5229333359174899,"score_gpt":0.5894168278163905,"score_spread":0.06648349189890057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156003012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034597393,0.96280587,0.0009939948,0.00021833534,0.00015828118,0.000055944744,0.00085311243,0.000030617673,0.00028646537],"genre_scores_gemma":[0.4457185,0.54860586,0.002367353,0.0005736695,0.0003265642,0.00015304136,0.0015850321,0.000034848632,0.0006350936],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99780744,0.0010886826,0.0003538401,0.00039693492,0.00025993475,0.00009322626],"domain_scores_gemma":[0.99606824,0.0028885528,0.0005409708,0.00019130297,0.00023978253,0.000071208044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004411981,0.0018528997,0.00831158,0.001079751,0.0002422885,0.0010580049,0.0011267955,0.0009677546,0.0019326214],"category_scores_gemma":[0.006843165,0.0008595237,0.017135806,0.0024881174,0.00025073095,0.0005911562,0.00063860137,0.0012749096,0.00019126727],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018474568,0.00008741223,0.02164269,0.050865225,0.86488664,0.00022394737,0.0000527834,0.0014145469,0.00077266595,0.00012975116,0.0017506654,0.03969913],"study_design_scores_gemma":[0.001778197,0.00035723246,0.017097868,0.0013302042,0.9764955,0.00014413068,0.000025544143,0.00040665,0.00020172069,0.00018481103,0.0019545427,0.000023464556],"about_ca_topic_score_codex":0.005248251,"about_ca_topic_score_gemma":0.010136185,"teacher_disagreement_score":0.00831158,"about_ca_system_score_codex":0.0008403611,"about_ca_system_score_gemma":0.0008640486,"threshold_uncertainty_score":0.023333073},"labels":[],"label_agreement":null},{"id":"W2157259618","doi":"10.1007/s10549-005-9031-9","title":"The latest is the greatest? Results of a structured lecture about aromatase inhibitor use for breast cancer","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Aromatase inhibitor; Gynecology; Cancer; Aromatase; Oncology; Endocrine system; Internal medicine; Hormone","score_opus":0.01952636858013055,"score_gpt":0.32304236876057013,"score_spread":0.30351600018043956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157259618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42178226,0.02080714,0.004890571,0.30852142,0.09763699,0.0041318126,0.0035344667,0.00062702066,0.1380683],"genre_scores_gemma":[0.7628206,0.013064946,0.00901965,0.05474047,0.029993502,0.0024619368,0.002662368,0.00027977728,0.124956764],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99922717,0.0003477777,0.000040706764,0.00004766097,0.00015599244,0.00018059701],"domain_scores_gemma":[0.99693775,0.0010309166,0.00014216293,0.00007468968,0.0004242785,0.0013902471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002728611,0.0006605979,0.00066112384,0.00034711193,0.0010987055,0.00056627195,0.00046640547,0.0019232269,0.011028294],"category_scores_gemma":[0.005906574,0.00020979946,0.0010047307,0.00013829561,0.00025091536,0.0005238059,0.0011523262,0.0023964322,0.001992485],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035623584,0.021599943,0.01808227,0.0021855317,0.0004733441,0.0063044177,0.002114805,0.0027112078,0.006974751,0.0011634956,0.56559485,0.33717164],"study_design_scores_gemma":[0.021547927,0.045415007,0.23627807,0.002528553,0.0019352884,0.004623629,0.0059549683,0.0031855826,0.016384264,0.004706659,0.6569899,0.0004501865],"about_ca_topic_score_codex":0.0017688939,"about_ca_topic_score_gemma":0.004357659,"teacher_disagreement_score":0.011028294,"about_ca_system_score_codex":0.001144578,"about_ca_system_score_gemma":0.001207483,"threshold_uncertainty_score":0.03689331},"labels":[],"label_agreement":null},{"id":"W2157392918","doi":"10.1007/s10549-006-9255-3","title":"Cigarette smoking and breast cancer risk: update of a prospective cohort study","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Relative risk; Obstetrics; Prospective cohort study; Confidence interval; Cohort study; Population; Gynecology; Cohort; Pregnancy; Proportional hazards model; Cancer; Internal medicine; Demography; Environmental health","score_opus":0.02387445449442558,"score_gpt":0.35374507178532394,"score_spread":0.32987061729089834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157392918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50604445,0.4334402,0.007515311,0.008762745,0.0054214606,0.0005343872,0.024711404,0.0002877496,0.013282307],"genre_scores_gemma":[0.6746971,0.2779784,0.015208671,0.0048469454,0.0038825169,0.0005678087,0.017937416,0.00014352742,0.00473767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981012,0.000616263,0.00042039578,0.0003775218,0.00041062912,0.00007410031],"domain_scores_gemma":[0.97757316,0.01174623,0.0014704794,0.0039086235,0.0046204324,0.0006811513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009752157,0.0007045809,0.0014599896,0.002762338,0.0005977947,0.0017515479,0.0009607761,0.0008686429,0.0017484581],"category_scores_gemma":[0.012739381,0.00071000087,0.0016971817,0.004217516,0.00033684538,0.0011267005,0.0007592284,0.0009887395,0.00043313162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032176918,0.00042085967,0.8066529,0.0016693055,0.0051693297,0.0007141216,0.0006374799,0.00014770374,0.001854592,0.0005300587,0.017821405,0.1611646],"study_design_scores_gemma":[0.0004971232,0.0007088391,0.9073151,0.0010082535,0.012109318,0.0021920023,0.00066483556,0.0003161425,0.000975207,0.00040064158,0.073677026,0.00013547191],"about_ca_topic_score_codex":0.016658962,"about_ca_topic_score_gemma":0.02847151,"teacher_disagreement_score":0.016658962,"about_ca_system_score_codex":0.0005910455,"about_ca_system_score_gemma":0.0021782897,"threshold_uncertainty_score":0.051574945},"labels":[],"label_agreement":null},{"id":"W2157650294","doi":"10.1007/s10549-008-0231-y","title":"Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERα","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta","funders":"Lawrence Berkeley National Laboratory","keywords":"Antiestrogen; Tamoxifen; MCF-7; Cancer research; Protein kinase B; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Biology; Cell growth; Estrogen receptor; Cell culture; Endocrinology; Cell biology; Signal transduction; Internal medicine; Chemistry; Cancer cell; Breast cancer; Medicine; Cancer; Biochemistry","score_opus":0.02392100430216138,"score_gpt":0.2696324204286137,"score_spread":0.2457114161264523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157650294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815912,0.007851796,0.0010781501,0.00089806056,0.00018290555,0.000043452248,0.0010927051,0.00030114385,0.0069605196],"genre_scores_gemma":[0.9780844,0.006715124,0.0017722544,0.00027986756,0.00008292189,0.00011767787,0.0016367094,0.000041518142,0.011269652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998846,0.000012789783,0.000009812067,0.00001112171,0.000029687915,0.00005201207],"domain_scores_gemma":[0.99992824,0.000014120158,0.000018303574,0.000010010782,0.000008877794,0.000020440815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011957793,0.00043151388,0.00035174863,0.0005416403,0.00025421215,0.0003519967,0.00024596325,0.0003515651,0.0027153133],"category_scores_gemma":[0.00019618527,0.00023252648,0.000243183,0.00041696584,0.00023299652,0.00038281945,0.00019211041,0.0007442396,0.0007192523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012888093,0.00025212445,0.0004706268,0.00009506945,0.000021164771,0.00013642442,0.00003215951,0.0000713328,0.9873648,0.00029352488,0.00068920024,0.009284752],"study_design_scores_gemma":[0.00036657532,0.0019289649,0.013404773,0.000013904151,0.00007911463,0.0006019031,0.00010594141,0.0005068796,0.9708928,0.00016970109,0.01191596,0.000013459899],"about_ca_topic_score_codex":0.0011914048,"about_ca_topic_score_gemma":0.0039343755,"teacher_disagreement_score":0.0027153133,"about_ca_system_score_codex":0.00047063793,"about_ca_system_score_gemma":0.0003565943,"threshold_uncertainty_score":0.009083629},"labels":[],"label_agreement":null},{"id":"W2162794483","doi":"10.1007/s10549-015-3269-7","title":"The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Exemestane; Breast cancer; Internal medicine; Oncology; Tamoxifen; Adjuvant; Immune system; Endocrine system; FOXP3; Hormone; Hormone receptor; Cancer; Gastroenterology; Immunology","score_opus":0.019819838874036568,"score_gpt":0.31346079668735405,"score_spread":0.2936409578133175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162794483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932194,0.0003513926,0.00004057287,0.000011224511,0.000002551232,0.0000038605826,0.00010832959,3.5809836e-7,0.00015988637],"genre_scores_gemma":[0.99954623,0.00008907577,0.000035354395,0.0000098718465,0.000005293905,0.000005399389,0.00018578091,8.8278716e-7,0.00012207852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966085,0.00015264112,0.000031482545,0.00007435594,0.00004021249,0.000040576106],"domain_scores_gemma":[0.99946815,0.00015712174,0.00019758163,0.00004411409,0.000031043615,0.000101995945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004321173,0.00013163291,0.00031548232,0.00014629144,0.00015885569,0.00028373726,0.00015646992,0.00019318498,0.00089723413],"category_scores_gemma":[0.0011200812,0.00010343024,0.000491012,0.00033860898,0.00011173809,0.0001355182,0.00016440258,0.0001577392,0.00008560276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043312884,0.000088265835,0.9869407,0.000033131462,0.00032415325,0.0001496044,0.000078196295,0.00014789813,0.0012242297,0.000021173946,0.00014291643,0.006518326],"study_design_scores_gemma":[0.00022386003,0.00090013805,0.9968284,0.000011185723,0.0002774436,0.0003979062,0.0001236986,0.00039499797,0.00023549523,0.000037748832,0.00056394294,0.000005175174],"about_ca_topic_score_codex":0.003502861,"about_ca_topic_score_gemma":0.00560605,"teacher_disagreement_score":0.003502861,"about_ca_system_score_codex":0.00023121922,"about_ca_system_score_gemma":0.00024460824,"threshold_uncertainty_score":0.0069649816},"labels":[],"label_agreement":null},{"id":"W2165845535","doi":"10.1007/s10549-006-9166-3","title":"Increased prevalence of prior breast cancer in women with newly diagnosed diabetes","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Breast cancer; Hyperinsulinemia; Diabetes mellitus; Odds ratio; Internal medicine; Type 2 diabetes; Cancer; Population; Insulin resistance; Confidence interval; Gynecology; Oncology; Endocrinology; Environmental health","score_opus":0.011130720312564433,"score_gpt":0.28465780371699356,"score_spread":0.2735270834044291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165845535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949267,0.002409105,0.00013488997,0.00026996023,0.000051281677,0.000005613644,0.0005910145,0.000014288346,0.001597271],"genre_scores_gemma":[0.99829274,0.0007901336,0.00007584338,0.000071614144,0.000059933234,0.00000422257,0.00022746799,0.0000031740951,0.00047486593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972063,0.00006725325,0.000028128254,0.0000743743,0.000054665816,0.00005489762],"domain_scores_gemma":[0.99809676,0.00045623948,0.0007566542,0.00013393916,0.00015135798,0.00040514514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002589315,0.00019085812,0.00047548683,0.0010388809,0.00043954657,0.00059690967,0.0003298614,0.0007242033,0.004494777],"category_scores_gemma":[0.002604991,0.00043112654,0.00047243413,0.0011595053,0.00019485345,0.00040191243,0.0002801546,0.0010032849,0.00032101822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021547136,0.000033677243,0.99727505,0.000017203869,0.000048246493,0.00013278276,0.000039721395,0.000014573022,0.0003483566,0.000011395641,0.00009400795,0.001769515],"study_design_scores_gemma":[0.000004120631,0.000036823716,0.99903095,0.000004340067,0.000033171214,0.0005912012,0.00007720477,0.000048192625,0.00003046886,0.000008399907,0.00013282322,0.0000023690877],"about_ca_topic_score_codex":0.007945485,"about_ca_topic_score_gemma":0.011097726,"teacher_disagreement_score":0.007945485,"about_ca_system_score_codex":0.00022334523,"about_ca_system_score_gemma":0.0002112588,"threshold_uncertainty_score":0.01579845},"labels":[],"label_agreement":null},{"id":"W2170328295","doi":"10.1007/s10549-007-9638-0","title":"Progressive resistance training in breast cancer: a systematic review of clinical trials","year":2007,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Clinical trial; Randomized controlled trial; Adverse effect; Systematic review; Physical therapy; Quality of life (healthcare); Cancer; Psychological intervention; Lymphedema; MEDLINE; Surgery; Internal medicine","score_opus":0.4985946663743232,"score_gpt":0.6131461718920764,"score_spread":0.11455150551775323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170328295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012960926,0.9979761,0.00010170432,0.00008327259,0.000055537195,0.00019636408,0.0001572941,0.000006082585,0.00012745768],"genre_scores_gemma":[0.022629227,0.975758,0.0007618279,0.00032827473,0.00005621745,0.00022824571,0.00012347293,0.000004794779,0.000110053414],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99739057,0.00095519546,0.00092181575,0.00029296207,0.00035420366,0.00008524821],"domain_scores_gemma":[0.99043536,0.0067449184,0.0020231234,0.00013810996,0.00050880824,0.00014971293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004968929,0.0014494986,0.010826856,0.002737973,0.00038791465,0.0014105929,0.0019198001,0.001427765,0.004680161],"category_scores_gemma":[0.015172609,0.0007891557,0.006627685,0.0041893814,0.0006394095,0.0011936579,0.0009571908,0.0012448741,0.00023589165],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022123782,0.00005824933,0.0007553028,0.89621586,0.03988239,0.00009413728,0.000121695186,0.00024766134,0.00031183258,0.00012799092,0.0013065811,0.058666028],"study_design_scores_gemma":[0.008289608,0.0021663345,0.010700428,0.40867534,0.54139215,0.0006082709,0.00035478568,0.00028878468,0.0004904945,0.0005047361,0.026417842,0.00011118245],"about_ca_topic_score_codex":0.0044231275,"about_ca_topic_score_gemma":0.017287867,"teacher_disagreement_score":0.010826856,"about_ca_system_score_codex":0.0014933819,"about_ca_system_score_gemma":0.003027717,"threshold_uncertainty_score":0.026278496},"labels":[],"label_agreement":null},{"id":"W2171924126","doi":"10.1007/s10549-009-0601-0","title":"Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers","year":2009,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research UK","keywords":"GSTP1; Breast cancer; Genetics; Oncology; Biology; Proportional hazards model; Mutation; Population; Cancer; Genotype; Internal medicine; Gene; Medicine; Environmental health","score_opus":0.01754987491979572,"score_gpt":0.30051705018732433,"score_spread":0.2829671752675286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171924126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875979,0.0025297937,0.00419157,0.00025002848,0.00007829636,0.0000302517,0.0013180659,0.00013305254,0.003871049],"genre_scores_gemma":[0.9964664,0.00028397216,0.00037626384,0.000066006636,0.000049108046,0.000016179974,0.0005915677,0.000029341096,0.0021212562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779785,0.001050911,0.0001230204,0.00045623185,0.00028428595,0.00028780714],"domain_scores_gemma":[0.9964897,0.0017406977,0.00036974464,0.0009520941,0.00018302047,0.0002646794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023328797,0.0006763516,0.0016252075,0.0008799194,0.00040617236,0.00056275656,0.0004697767,0.0006504042,0.0057635247],"category_scores_gemma":[0.0043516485,0.00031036185,0.001842362,0.0008482501,0.00029090067,0.0004218541,0.00044764794,0.0006233354,0.0008161775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016681487,0.00021352098,0.9135966,0.00018635215,0.009645954,0.0014567359,0.00039070865,0.00051499106,0.024267955,0.000581186,0.0012661219,0.031198544],"study_design_scores_gemma":[0.000108437016,0.0020067126,0.98505634,0.000014567789,0.0053172796,0.0013927354,0.0001757071,0.0008359621,0.0022777927,0.00046860406,0.0023257048,0.000020176401],"about_ca_topic_score_codex":0.002356401,"about_ca_topic_score_gemma":0.00202639,"teacher_disagreement_score":0.0057635247,"about_ca_system_score_codex":0.000157545,"about_ca_system_score_gemma":0.0002685645,"threshold_uncertainty_score":0.01928091},"labels":[],"label_agreement":null},{"id":"W2174423882","doi":"10.1007/s10549-015-3643-5","title":"Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Oncology; Breast cancer; Progression-free survival; Randomized controlled trial; Clinical trial; Meta-analysis; Cancer; Overall survival; Confidence interval","score_opus":0.3655082059876479,"score_gpt":0.5081216217604009,"score_spread":0.142613415772753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174423882","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034265578,0.96110266,0.0019266657,0.00033781896,0.00039992316,0.00013146929,0.0011467932,0.00006549657,0.0006236797],"genre_scores_gemma":[0.71061844,0.2799935,0.0033587185,0.0015768982,0.0005292788,0.0003622997,0.002040615,0.000095290045,0.001425005],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99597436,0.0021864194,0.0007715274,0.0006197491,0.00028323242,0.00016472692],"domain_scores_gemma":[0.9941532,0.004120308,0.0008310925,0.0004288483,0.00032850177,0.00013795578],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0062050372,0.0022002638,0.008922909,0.0011326623,0.000364239,0.0017541911,0.0015729832,0.001561009,0.0035945894],"category_scores_gemma":[0.012986531,0.0010750362,0.030140245,0.0022906633,0.00042767794,0.0011852336,0.0010844463,0.0027501436,0.000381928],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00782719,0.000035626294,0.010435451,0.033915374,0.9369609,0.00007167797,0.000041362746,0.0007169667,0.0002849235,0.000118640084,0.0006446995,0.0089471685],"study_design_scores_gemma":[0.0010675909,0.00024327992,0.005434515,0.0010774828,0.99053687,0.000047767982,0.000021432035,0.0002486296,0.000074660325,0.00026742474,0.00096372765,0.000016675407],"about_ca_topic_score_codex":0.00394742,"about_ca_topic_score_gemma":0.011059703,"teacher_disagreement_score":0.99107707,"about_ca_system_score_codex":0.0010540396,"about_ca_system_score_gemma":0.00097566086,"threshold_uncertainty_score":0.032815754},"labels":[],"label_agreement":null},{"id":"W2175453042","doi":"10.1007/s10549-015-3633-7","title":"Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; Medical Research Council; Eisai; Celgene","keywords":"Capecitabine; Medicine; Eribulin; Metastatic breast cancer; Internal medicine; Nausea; Breast cancer; Quality of life (healthcare); Randomized controlled trial; Oncology; Cancer; Surgery; Nursing","score_opus":0.1701282498210228,"score_gpt":0.486875781200225,"score_spread":0.3167475313792022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175453042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335915,0.0028239526,0.00020894372,0.00035670915,0.00013081799,0.0018947355,0.00038023965,0.000030413732,0.0008150391],"genre_scores_gemma":[0.99189466,0.00159376,0.00070724665,0.0007282066,0.00017298665,0.0033875508,0.0007385724,0.000008209456,0.0007686936],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992118,0.0004936553,0.00004644439,0.00009568328,0.000055829292,0.000096558986],"domain_scores_gemma":[0.9994099,0.00015086535,0.0001638173,0.000034686487,0.000031580963,0.00020919809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002126532,0.0011258535,0.002563509,0.00033288662,0.0003508093,0.00092192844,0.00051130273,0.001008861,0.0032144408],"category_scores_gemma":[0.0012218759,0.00038185608,0.001747464,0.00045828996,0.0007805229,0.0006595395,0.00031804046,0.0020782582,0.0004716696],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9655637,0.010205929,0.002349023,0.0004328478,0.00070978946,0.00006637898,0.000058539314,0.00036372838,0.0032450526,0.000060426075,0.00048547346,0.016459176],"study_design_scores_gemma":[0.83585805,0.15655577,0.0057739383,0.00002872826,0.00033603818,0.000044124103,0.000024857185,0.0004528257,0.00037940673,0.00010247182,0.00043205573,0.000011791842],"about_ca_topic_score_codex":0.00049614377,"about_ca_topic_score_gemma":0.0016507399,"teacher_disagreement_score":0.0032144408,"about_ca_system_score_codex":0.00079499744,"about_ca_system_score_gemma":0.0010098562,"threshold_uncertainty_score":0.011246324},"labels":[],"label_agreement":null},{"id":"W2181389880","doi":"10.1007/s10549-015-3588-8","title":"Paclitaxel-induced transcriptional regulation of Fas signaling pathway is antagonized by dexamethasone","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Natural Sciences and Engineering Research Council of Canada; Windsor Cancer Centre Foundation; Breast Cancer Society of Canada","keywords":"Paclitaxel; Dexamethasone; Breast cancer; Medicine; Chemotherapy; Cancer; Cancer research; Internal medicine; Triple-negative breast cancer; Apoptosis; Oncology; Pharmacology; Endocrinology; Biology","score_opus":0.0753521041421698,"score_gpt":0.3392089924453275,"score_spread":0.2638568883031577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181389880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98995626,0.002799492,0.0015181208,0.0004869271,0.00014467681,0.0000468,0.00075117714,0.00021136127,0.004085276],"genre_scores_gemma":[0.9932285,0.001176062,0.00045171633,0.00007480412,0.000017766246,0.000045203586,0.0007329612,0.000018290115,0.0042546745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981755,0.000035382076,0.000014198192,0.00002386733,0.000030267242,0.00007874615],"domain_scores_gemma":[0.9998789,0.000031205112,0.000026769867,0.000023804076,0.000009694775,0.00002966519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010008003,0.00038299555,0.00030466935,0.00040248717,0.00026920516,0.00040807892,0.000255953,0.0002084613,0.0033602235],"category_scores_gemma":[0.00017125317,0.00018765691,0.00032776923,0.00031234114,0.00039042052,0.0001979891,0.00020149944,0.000748789,0.0006762571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014894069,0.00013389623,0.0002942181,0.00004153236,0.000008815006,0.00012406037,0.000024057748,0.00008527098,0.9944179,0.00037898016,0.00020475198,0.0027972294],"study_design_scores_gemma":[0.000052285166,0.00026785137,0.0031852878,0.00000578895,0.000012166714,0.00011927982,0.000048460668,0.0002867868,0.99375325,0.000060256065,0.0022041195,0.00000446926],"about_ca_topic_score_codex":0.0010248525,"about_ca_topic_score_gemma":0.0021028346,"teacher_disagreement_score":0.0033602235,"about_ca_system_score_codex":0.00055209675,"about_ca_system_score_gemma":0.0005066992,"threshold_uncertainty_score":0.011241019},"labels":[],"label_agreement":null},{"id":"W2189664995","doi":"10.1007/s10549-015-3646-2","title":"A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society; American Society of Clinical Oncology; Amgen","keywords":"Medicine; Zoledronic acid; Breast cancer; Randomized controlled trial; Internal medicine; Bisphosphonate; Palliative care; Quality of life (healthcare); Oncology; Surgery; Cancer; Gastroenterology; Osteoporosis","score_opus":0.14392511978413938,"score_gpt":0.4395517459207426,"score_spread":0.2956266261366032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189664995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862257,0.003144657,0.0008532934,0.000877373,0.0007120999,0.00485525,0.0011012969,0.00014488022,0.0020854932],"genre_scores_gemma":[0.98321354,0.0022967528,0.0025070948,0.001396066,0.00050749356,0.0061316807,0.0012262415,0.000030037545,0.0026911313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994666,0.0002820906,0.000028493048,0.00010357394,0.000032397827,0.00008685809],"domain_scores_gemma":[0.9986513,0.0005319339,0.00020170287,0.000100223086,0.000056010813,0.000458902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013749492,0.0018177304,0.0036136587,0.0004600826,0.0004886085,0.0009618409,0.0010721873,0.0021005634,0.008308161],"category_scores_gemma":[0.002244341,0.00064670114,0.0017691035,0.00046305492,0.0016780859,0.0011413944,0.00049706514,0.0037226616,0.0009827282],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98793334,0.0038932855,0.00012376942,0.00026876916,0.0002489718,0.000015166303,0.000025858631,0.00021549796,0.0014834318,0.000066796165,0.00024939407,0.00547573],"study_design_scores_gemma":[0.9679988,0.03118006,0.00025638295,0.000009097821,0.00010316622,0.000010412505,0.000008261758,0.00014933477,0.000099471195,0.00007144922,0.00010889304,0.0000047065328],"about_ca_topic_score_codex":0.0009529941,"about_ca_topic_score_gemma":0.0019723517,"teacher_disagreement_score":0.008308161,"about_ca_system_score_codex":0.00063182425,"about_ca_system_score_gemma":0.0013122876,"threshold_uncertainty_score":0.027793586},"labels":[],"label_agreement":null},{"id":"W2196791823","doi":"10.1007/s10549-015-3634-6","title":"ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute of Mining, Metallurgy and Petroleum","funders":"Novartis Pharma; National Cancer Institute; National Institutes of Health; National Institute of General Medical Sciences; Cancer Research Institute; Breast Cancer Research Foundation; Susan G. Komen for the Cure; Foundation for the National Institutes of Health","keywords":"Letrozole; Tamoxifen; Breast cancer; Single-nucleotide polymorphism; Internal medicine; Estrogen receptor alpha; Medicine; Estrogen receptor; Oncology; Selective estrogen receptor modulator; Genotype; Endocrinology; Cancer; Gynecology; Biology; Genetics; Gene","score_opus":0.15924388192302238,"score_gpt":0.3876460268976765,"score_spread":0.22840214497465414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196791823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934736,0.0037116646,0.00018618,0.0007435161,0.00026600473,0.00009231189,0.0002640303,0.00003327275,0.0012294744],"genre_scores_gemma":[0.9947825,0.0014284771,0.00035325368,0.0006248066,0.00024188304,0.00014950607,0.00049458456,0.000013251411,0.0019117278],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99964094,0.000206136,0.000022110873,0.00005424513,0.000026717085,0.000049760234],"domain_scores_gemma":[0.99954045,0.00020945798,0.00008305974,0.000038727176,0.000017343153,0.00011090417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010025544,0.0010571908,0.0021637413,0.00022614849,0.000207828,0.00072375766,0.00054961746,0.0011679232,0.003552916],"category_scores_gemma":[0.0012934203,0.0004921659,0.0015798745,0.00024039591,0.0005313131,0.0007232126,0.0002859827,0.002470735,0.00040393183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9784414,0.0010108018,0.0022670173,0.00025819335,0.0019148666,0.0000523049,0.000034816203,0.00038180343,0.0046549635,0.00013288474,0.000498368,0.010352575],"study_design_scores_gemma":[0.88975966,0.07399906,0.023521533,0.00012073397,0.0071245413,0.0001451078,0.00008656788,0.0013714648,0.0014256232,0.00081954536,0.0015832186,0.000042942083],"about_ca_topic_score_codex":0.0004835118,"about_ca_topic_score_gemma":0.001358317,"teacher_disagreement_score":0.003552916,"about_ca_system_score_codex":0.00031360867,"about_ca_system_score_gemma":0.00039895746,"threshold_uncertainty_score":0.011885703},"labels":[],"label_agreement":null},{"id":"W2203649236","doi":"10.1007/s10549-015-3666-y","title":"The relationship between local recurrence and death in early-stage breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Stage (stratigraphy); Lymphovascular invasion; Cancer; Oncology; Tamoxifen; Internal medicine; Radiation therapy; Survival rate; Gynecology; Metastasis","score_opus":0.12112372019513062,"score_gpt":0.3945836573270137,"score_spread":0.2734599371318831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2203649236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952675,0.008697999,0.00015746406,0.0002387837,0.000016548636,0.00000497249,0.00019870707,0.0000070577626,0.0011517142],"genre_scores_gemma":[0.9982095,0.0012828236,0.00004540711,0.000031431173,0.00002558682,0.0000033579604,0.00009488732,0.000002223154,0.00030490253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950874,0.0002923206,0.000034499688,0.00003498818,0.000060944458,0.00006853404],"domain_scores_gemma":[0.99593085,0.0020574196,0.001131489,0.0002563741,0.00028026156,0.00034366047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012013356,0.00016341671,0.000347695,0.0008475056,0.00025086632,0.00051964103,0.0003623931,0.00032883498,0.0014254182],"category_scores_gemma":[0.005540837,0.00019437248,0.00043650146,0.0011653429,0.00035479522,0.00034043327,0.0003015461,0.0006919393,0.00016363063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014196726,0.000060590635,0.99117416,0.000055535696,0.00014576249,0.000105654915,0.00009492964,0.0001193818,0.0003809683,0.00007951693,0.0001204451,0.006243487],"study_design_scores_gemma":[0.000009439359,0.00015763745,0.9989802,0.0000075787157,0.00010882571,0.00021888841,0.00009840082,0.000078673154,0.000107575914,0.0000674026,0.00016189365,0.0000035316907],"about_ca_topic_score_codex":0.004923209,"about_ca_topic_score_gemma":0.0076567205,"teacher_disagreement_score":0.004923209,"about_ca_system_score_codex":0.00037305587,"about_ca_system_score_gemma":0.00036674982,"threshold_uncertainty_score":0.00978905},"labels":[],"label_agreement":null},{"id":"W2228540097","doi":"10.1007/s10549-015-3669-8","title":"Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nausea and vomiting management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Breast cancer; Nausea; Medicine; Vomiting; Chemotherapy; Oncology; Chemotherapy-induced nausea and vomiting; Internal medicine; Cancer; Antiemetic","score_opus":0.2714342835148381,"score_gpt":0.4988262448922453,"score_spread":0.2273919613774072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2228540097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5124924,0.30404925,0.088858075,0.027991476,0.019033978,0.008690292,0.005512148,0.0007401521,0.03263226],"genre_scores_gemma":[0.96050763,0.009994825,0.013529537,0.0076216483,0.0025305927,0.0023663784,0.0010578745,0.00025458378,0.0021369357],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.71114814,0.24071124,0.029931398,0.008595411,0.00727247,0.0023412905],"domain_scores_gemma":[0.6976479,0.27019015,0.016478568,0.009063094,0.0033318372,0.003288539],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22169517,0.0019454603,0.0074489303,0.0014546972,0.0011143044,0.007952611,0.001960591,0.0059919767,0.0048752995],"category_scores_gemma":[0.26039767,0.00093376654,0.014359817,0.0026522207,0.0019316622,0.0042340215,0.0022340594,0.0064692027,0.00064461963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48040658,0.002391884,0.092171766,0.025728572,0.19099757,0.0007949517,0.0010369029,0.0047777616,0.00998117,0.009984721,0.009021032,0.17270707],"study_design_scores_gemma":[0.2582195,0.10695667,0.16630171,0.0109657645,0.25700372,0.0015547844,0.0013301496,0.013696021,0.016963081,0.102928415,0.06298908,0.0010910832],"about_ca_topic_score_codex":0.00028541096,"about_ca_topic_score_gemma":0.0009092387,"teacher_disagreement_score":0.7783048,"about_ca_system_score_codex":0.0009821914,"about_ca_system_score_gemma":0.0018186545,"threshold_uncertainty_score":0.95978844},"labels":[],"label_agreement":null},{"id":"W2262040041","doi":"10.1007/s10549-016-3704-4","title":"Associations of sex steroid hormones with mortality in women with breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Research Resources; National Institute of Child Health and Human Development; National Cancer Institute; National Institutes of Health; University of New Mexico","keywords":"Breast cancer; Sex hormone-binding globulin; Medicine; Estrone; Hazard ratio; Internal medicine; Proportional hazards model; Cancer; Oncology; Testosterone (patch); Body mass index; Prospective cohort study; Confidence interval; Odds ratio; Gynecology; Estrogen; Hormone; Androgen","score_opus":0.021406792836156447,"score_gpt":0.32370327539041377,"score_spread":0.30229648255425734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262040041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406093,0.0035231342,0.00014607343,0.00024355362,0.000041527706,0.0000036270178,0.0008478923,0.000010915117,0.001122312],"genre_scores_gemma":[0.99826616,0.0007486459,0.000049581176,0.00004371978,0.000053955424,0.0000036267909,0.00034785783,0.0000024601936,0.00048404097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997521,0.000092164104,0.000025908737,0.00003517481,0.000037767448,0.00005685972],"domain_scores_gemma":[0.9990281,0.0003354242,0.0003160289,0.00009582924,0.00009310489,0.00013148566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038783293,0.0002340818,0.000329918,0.00046224255,0.000226715,0.00042459733,0.00022084205,0.0004034746,0.0013527637],"category_scores_gemma":[0.0020618986,0.00023975589,0.00053693645,0.0008333435,0.00017084883,0.000214042,0.000252683,0.00064395496,0.00018405815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043202343,0.000019798961,0.9975013,0.000008461497,0.000103141036,0.00003607098,0.000019375617,0.000030047284,0.00026677107,0.000012944589,0.0000705452,0.0014995509],"study_design_scores_gemma":[0.0000053067283,0.00005346598,0.99950325,0.0000022623606,0.000051047915,0.00006407437,0.000044568922,0.000075068216,0.0000489703,0.000022533332,0.00012776136,0.000001674183],"about_ca_topic_score_codex":0.0048272377,"about_ca_topic_score_gemma":0.005021176,"teacher_disagreement_score":0.0048272377,"about_ca_system_score_codex":0.0001819999,"about_ca_system_score_gemma":0.00021644498,"threshold_uncertainty_score":0.009598255},"labels":[],"label_agreement":null},{"id":"W227417487","doi":"10.1007/s10549-015-3419-y","title":"Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Cancer; Oncology; Incidence (geometry); Internal medicine; Cumulative incidence; Cancer registry; Family history; Gynecology; Cohort","score_opus":0.04440823097639967,"score_gpt":0.3617064162398202,"score_spread":0.3172981852634205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W227417487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847053,0.0010448563,0.00025839324,0.000111955196,0.000021578684,0.000014436668,0.0120680705,0.000046622892,0.0017288007],"genre_scores_gemma":[0.9902277,0.00094955775,0.000116004616,0.000038189122,0.000024192808,0.000017734072,0.0075394814,0.0000107796495,0.0010762906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994098,0.0001001162,0.00008013773,0.00020021683,0.000090684705,0.000119034],"domain_scores_gemma":[0.99832994,0.00021066825,0.00067551434,0.00020842209,0.0002627017,0.00031280253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006353441,0.00030191345,0.0005543845,0.0021170406,0.0004962225,0.00071013893,0.0005805945,0.00062535383,0.0027974877],"category_scores_gemma":[0.0017511144,0.00046809734,0.0008105067,0.0025663443,0.00018149508,0.00075863604,0.00061419385,0.0006050175,0.0007266554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008858986,0.000020342233,0.99812907,0.00001003123,0.00006115828,0.000103804225,0.000035312958,0.00005748819,0.000087744585,0.000019792082,0.0004895188,0.0008970823],"study_design_scores_gemma":[0.0000050728186,0.00003193554,0.99866796,0.000006344302,0.000050221774,0.000546821,0.00014594985,0.00014757946,0.000050492916,0.000015069377,0.00032760203,0.000004905457],"about_ca_topic_score_codex":0.02985674,"about_ca_topic_score_gemma":0.026101334,"teacher_disagreement_score":0.02985674,"about_ca_system_score_codex":0.00047364703,"about_ca_system_score_gemma":0.0006846338,"threshold_uncertainty_score":0.05936593},"labels":[],"label_agreement":null},{"id":"W2277921451","doi":"10.1007/s10549-016-3685-3","title":"Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; University Health Network; University of Toronto; Women's College Hospital","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canada Research Chairs; Cancer Research Institute","keywords":"Menopause; Medicine; Surgical Menopause; Hormone replacement therapy (female-to-male); Breast cancer; Odds ratio; Ovarian cancer; Oophorectomy; Gynecology; Logistic regression; Internal medicine; Confidence interval; Family history; Obstetrics; Oncology; Cancer; Hysterectomy; Surgery","score_opus":0.018124525384541207,"score_gpt":0.33559999904502064,"score_spread":0.31747547366047946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277921451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887425,0.00071601017,0.00006390307,0.000018590345,0.000013036814,0.00001353954,0.00011337567,0.000004274845,0.00018300007],"genre_scores_gemma":[0.9991398,0.00026565677,0.000072144394,0.00002367888,0.000026152853,0.000017751514,0.00014470269,0.0000033842095,0.00030658927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993824,0.00017520812,0.00006533763,0.00020119573,0.000073031064,0.00010293434],"domain_scores_gemma":[0.9985884,0.00052860036,0.00037622187,0.00020406237,0.00008176865,0.00022094007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076373067,0.0006631925,0.0010779332,0.001269414,0.001025081,0.00085940567,0.00067774236,0.0013180069,0.002761396],"category_scores_gemma":[0.0023627013,0.000958258,0.0010907431,0.0013792029,0.00063536444,0.00049885106,0.00034083804,0.0008271931,0.00030861245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008575634,0.0010873833,0.9816082,0.00008876026,0.0010612211,0.0013552639,0.0004909992,0.0000764989,0.0027574245,0.00007087762,0.00019116238,0.0026365055],"study_design_scores_gemma":[0.00030883373,0.0016017532,0.9952857,0.000010711271,0.00057625124,0.001238989,0.0002270096,0.00023101037,0.00016123494,0.000039512168,0.00030127453,0.00001784217],"about_ca_topic_score_codex":0.007146986,"about_ca_topic_score_gemma":0.0041830344,"teacher_disagreement_score":0.007146986,"about_ca_system_score_codex":0.00040173964,"about_ca_system_score_gemma":0.0003357793,"threshold_uncertainty_score":0.014210761},"labels":[],"label_agreement":null},{"id":"W227897036","doi":"10.1007/s10549-015-3393-4","title":"Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Cancer Care Ontario; Women's College Hospital; University of Toronto","funders":"National Institutes of Health; Canada Research Chairs; National Cancer Institute; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Prospective cohort study; Relative risk; BRCA mutation; Proportional hazards model; Population; Internal medicine; Cohort study; Risk factor; Cancer; Oncology; Cohort; Confidence interval; Gynecology; Environmental health","score_opus":0.06334716366910739,"score_gpt":0.39776043693364155,"score_spread":0.3344132732645342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W227897036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991215,0.00024271783,0.000053143656,0.000020590052,0.0000040562936,0.000006720932,0.00023550991,0.0000038432427,0.00031193896],"genre_scores_gemma":[0.999241,0.00009097419,0.000041865267,0.000011923001,0.0000054370876,0.0000066018547,0.00023316903,0.0000024809565,0.00036647846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996233,0.00014645954,0.000032357453,0.00006713956,0.000049614693,0.00008103799],"domain_scores_gemma":[0.9982297,0.00040917416,0.0005107624,0.00014954162,0.00017606653,0.0005248211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007040037,0.00044682558,0.00040301465,0.001176431,0.0007280941,0.0007176241,0.00038790374,0.00088659313,0.0021006505],"category_scores_gemma":[0.0020531358,0.0007095791,0.00071557093,0.0012043237,0.0004229697,0.00065129495,0.00044470135,0.0008232343,0.0004386172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005816791,0.00006236662,0.99872345,0.0000029993728,0.00005953954,0.000040324212,0.000027057917,0.000020573547,0.0001745063,0.000009314413,0.000017250606,0.0002808288],"study_design_scores_gemma":[0.000009455824,0.00026875566,0.99915874,0.0000017212338,0.000058317986,0.00012703172,0.00010492563,0.00012487911,0.00006083991,0.000019306572,0.00006200367,0.0000039454185],"about_ca_topic_score_codex":0.007677698,"about_ca_topic_score_gemma":0.006105488,"teacher_disagreement_score":0.007677698,"about_ca_system_score_codex":0.00033946033,"about_ca_system_score_gemma":0.00032222047,"threshold_uncertainty_score":0.015266001},"labels":[],"label_agreement":null},{"id":"W2282118044","doi":"10.1007/s10549-016-3720-4","title":"Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Instituto de Salud Carlos III; Ministerio de Economía y Competitividad; CRIS Cancer Foundation; Fundación Científica Asociación Española Contra el Cáncer; Astellas Pharma; European Commission","keywords":"Kinase; BUB1; Biology; Cancer research; Breast cancer; Gene; Basal (medicine); Downregulation and upregulation; Cancer; Genetics; Endocrinology; Kinetochore","score_opus":0.08931231672172761,"score_gpt":0.44262706188919215,"score_spread":0.35331474516746453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282118044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938811,0.0018581647,0.0004434076,0.00021752268,0.000013980183,0.00000782308,0.0028285857,0.000020665882,0.0007287786],"genre_scores_gemma":[0.99627566,0.00065351516,0.00027530672,0.00009547431,0.000019496129,0.000013028543,0.00205632,0.000006996486,0.0006042707],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998487,0.000025408666,0.000011771049,0.00003795424,0.000034111923,0.000041960542],"domain_scores_gemma":[0.9996892,0.00008001899,0.00014734539,0.000013728071,0.000033850487,0.000035932182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002478139,0.00015747064,0.000288651,0.00067713804,0.00025243114,0.00046713074,0.00014964335,0.00020463447,0.0014213015],"category_scores_gemma":[0.0005324777,0.00009384992,0.00023188091,0.0009316684,0.00018425463,0.000197481,0.00024889412,0.00031916736,0.00018788196],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002354932,0.00010704266,0.80734587,0.00018642526,0.000425899,0.00030517997,0.00019131217,0.0007311949,0.16194417,0.00038056073,0.0013141101,0.024713285],"study_design_scores_gemma":[0.000012597568,0.00008180786,0.99375445,0.000008659874,0.00010991373,0.00020211641,0.00015582192,0.0006879981,0.0038354227,0.00026920147,0.00087535614,0.0000067276274],"about_ca_topic_score_codex":0.0012116428,"about_ca_topic_score_gemma":0.0025029322,"teacher_disagreement_score":0.0014213015,"about_ca_system_score_codex":0.0002717711,"about_ca_system_score_gemma":0.00026900606,"threshold_uncertainty_score":0.004754722},"labels":[],"label_agreement":null},{"id":"W2305750879","doi":"10.1007/s10549-016-3749-4","title":"The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Oophorectomy; Ovarian cancer; Internal medicine; Cancer; Oncology; Hazard ratio; Gynecology; Proportional hazards model; Cancer registry; Cohort; Cause of death; Survival analysis; Stage (stratigraphy); Survival rate; Obstetrics; Surgery; Hysterectomy; Disease; Confidence interval","score_opus":0.01758640418892278,"score_gpt":0.35312736952695595,"score_spread":0.3355409653380332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305750879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938885,0.003389374,0.00004514605,0.00075389986,0.00006121195,0.0000036606525,0.0003588482,0.0000037982993,0.0014954568],"genre_scores_gemma":[0.99837226,0.0007568808,0.000020975767,0.0001443584,0.000075215896,0.0000020663995,0.00030960864,0.0000024551177,0.00031623524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967265,0.00009710082,0.00002331164,0.000039246606,0.0000380348,0.00012968964],"domain_scores_gemma":[0.9985869,0.0005543391,0.0002997699,0.00005359643,0.00006999131,0.0004354175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005290678,0.00017697887,0.0003433542,0.00028249156,0.0003386911,0.000533082,0.00027080093,0.0006167209,0.0019108107],"category_scores_gemma":[0.0029900828,0.00011380147,0.0010850684,0.00043129036,0.0002559215,0.00046919537,0.00040186703,0.0007747326,0.00017284148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005322608,0.00021923316,0.97130907,0.000042167776,0.0003942014,0.00024921415,0.00008604737,0.00048436582,0.0003876488,0.0001047133,0.0005777363,0.02082289],"study_design_scores_gemma":[0.00004275721,0.0005472033,0.99812883,0.000012846444,0.0002590104,0.00018123206,0.00013850059,0.00022031082,0.00004568685,0.000111728295,0.00030620722,0.0000058156033],"about_ca_topic_score_codex":0.005336453,"about_ca_topic_score_gemma":0.010819964,"teacher_disagreement_score":0.005336453,"about_ca_system_score_codex":0.00049009087,"about_ca_system_score_gemma":0.0006090707,"threshold_uncertainty_score":0.010610819},"labels":[],"label_agreement":null},{"id":"W2307665013","doi":"10.1007/s10549-016-3689-z","title":"Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; St. Paul's Hospital; Lions Gate Hospital; University of Ottawa; BC Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"Canadian Cancer Society","keywords":"Breast cancer; Immunohistochemistry; Medicine; Estrogen receptor; Oncology; Internal medicine; Estrogen; Progesterone receptor; Cohort; Biomarker; Pathology; Cancer; Biology","score_opus":0.026931708745231913,"score_gpt":0.3289429712399911,"score_spread":0.3020112624947592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307665013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958079,0.0010969823,0.00053943857,0.000056982946,0.0000074668483,0.000025523923,0.00072211365,0.000016710304,0.0017268242],"genre_scores_gemma":[0.99362826,0.001029565,0.0008823014,0.000058278336,0.000012575407,0.000031421987,0.0014011299,0.000014502433,0.0029419807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977654,0.000036697867,0.000020457372,0.00003567111,0.000063516934,0.00006707119],"domain_scores_gemma":[0.99972874,0.000043134143,0.00006591112,0.00003638666,0.00008432861,0.000041499745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048594867,0.00014528609,0.00033665932,0.0013656184,0.00033469408,0.00063413027,0.00030739355,0.00025173702,0.0017441688],"category_scores_gemma":[0.00057832955,0.00012300373,0.0002653368,0.0009112027,0.00013408065,0.00018197283,0.00020694865,0.00025552092,0.00058029994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022383681,0.00012049294,0.7302318,0.00011221735,0.000076452634,0.0003683824,0.00034321545,0.00011905611,0.233284,0.00021388508,0.0004580343,0.032434035],"study_design_scores_gemma":[0.000021426282,0.00038324427,0.9604895,0.000022934908,0.00013169085,0.0015631603,0.000787347,0.00040583895,0.032463774,0.00016238466,0.0035614567,0.000007155003],"about_ca_topic_score_codex":0.0037932533,"about_ca_topic_score_gemma":0.006055229,"teacher_disagreement_score":0.0037932533,"about_ca_system_score_codex":0.00028915453,"about_ca_system_score_gemma":0.00030344055,"threshold_uncertainty_score":0.007542312},"labels":[],"label_agreement":null},{"id":"W2327324661","doi":"10.1023/a:1006350913243","title":"RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters","year":2000,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Women's College Hospital; Sunnybrook Health Science Centre","funders":"University of Toronto","keywords":"Breast cancer; Cytokeratin; Medicine; Circulating tumor cell; Internal medicine; Cancer; Oncology; Pathology; Stage (stratigraphy); Breast disease; Reverse transcriptase; Metastatic breast cancer; Polymerase chain reaction; Metastasis; Biology; Immunohistochemistry; Gene","score_opus":0.03399913235122605,"score_gpt":0.31841257874557444,"score_spread":0.2844134463943484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327324661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973125,0.0028235419,0.0037448097,0.00015424765,0.000097073236,0.00007757421,0.0011470771,0.00008303453,0.0021413234],"genre_scores_gemma":[0.98723966,0.001439273,0.005884039,0.00016186982,0.00012315181,0.00017495373,0.0019473288,0.000025800411,0.0030040327],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997954,0.000032363332,0.000023481141,0.000045976823,0.000045668352,0.00005718734],"domain_scores_gemma":[0.9996294,0.0002077569,0.000040999512,0.000024832598,0.000069353315,0.00002771167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026323932,0.00019729936,0.00028622246,0.0006347582,0.00026743233,0.00034467585,0.00012897207,0.00028136422,0.0027000485],"category_scores_gemma":[0.0006773243,0.00017128223,0.00014052929,0.0005084579,0.00027068864,0.00017676233,0.00008502312,0.00047741152,0.0005607287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042337743,0.0002884676,0.12200782,0.00020888165,0.00008040228,0.0009182575,0.00031753897,0.00018907904,0.8470369,0.00020375084,0.000736507,0.023778627],"study_design_scores_gemma":[0.00023138386,0.0030283737,0.40465888,0.00004453693,0.00028505112,0.005297443,0.00038591572,0.0022089873,0.5760178,0.00039290564,0.0074171606,0.000031504373],"about_ca_topic_score_codex":0.00033209793,"about_ca_topic_score_gemma":0.00058503565,"teacher_disagreement_score":0.0027000485,"about_ca_system_score_codex":0.00015866222,"about_ca_system_score_gemma":0.00019035795,"threshold_uncertainty_score":0.009032607},"labels":[],"label_agreement":null},{"id":"W2330347335","doi":"10.1007/s10549-016-3761-8","title":"Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hamilton Health Sciences; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Robarts Clinical Trials; McMaster University; Queen's University","funders":"National Institute of General Medical Sciences; National Cancer Institute; Pfizer; Canadian Cancer Society Research Institute; Avon Foundation for Women","keywords":"Medicine; Exemestane; Internal medicine; Breast cancer; Letrozole; Anastrozole; Cancer; Oncology; Cause of death; Placebo; Aromatase inhibitor; Tamoxifen; Gynecology; Disease; Pathology","score_opus":0.04899130155347559,"score_gpt":0.3543085091021927,"score_spread":0.3053172075487171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330347335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730253,0.01190679,0.00093490037,0.0017197344,0.00013532197,0.0000349842,0.005918269,0.000017605897,0.0063070348],"genre_scores_gemma":[0.99565566,0.0010881707,0.0001359133,0.00013258622,0.00006300191,0.00001965223,0.0015804683,0.0000029115704,0.0013216855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951684,0.00025178245,0.000025960062,0.000053777112,0.000054850952,0.00009678034],"domain_scores_gemma":[0.9983912,0.0007842139,0.0003766868,0.00014794589,0.000085456704,0.00021446189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008498159,0.00017560051,0.0003278639,0.0002778293,0.0001810414,0.000327738,0.00031519067,0.00033342084,0.0032950162],"category_scores_gemma":[0.0031411916,0.0001245683,0.0013043078,0.00044237403,0.00008988936,0.00020149117,0.00026200863,0.0008825025,0.00012317028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0160452,0.0001803097,0.93757087,0.0004510062,0.004341044,0.0003433228,0.00013779596,0.00260146,0.0005308053,0.0033942866,0.008396558,0.026007371],"study_design_scores_gemma":[0.0009991915,0.001225295,0.9764807,0.00016212564,0.0026984902,0.0006875671,0.0002972305,0.0074791503,0.00047178622,0.0035820717,0.00587549,0.000041061896],"about_ca_topic_score_codex":0.018825637,"about_ca_topic_score_gemma":0.024445374,"teacher_disagreement_score":0.018825637,"about_ca_system_score_codex":0.00037922763,"about_ca_system_score_gemma":0.00054158067,"threshold_uncertainty_score":0.037432134},"labels":[],"label_agreement":null},{"id":"W2335924678","doi":"10.1007/s10549-016-3782-3","title":"The incidence of bone metastasis after early-stage breast cancer in Canada","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Bone metastasis; Cumulative incidence; Incidence (geometry); Cancer; Oncology; Stage (stratigraphy); Metastasis; Tamoxifen; Cohort; Internal medicine; Cancer registry","score_opus":0.038783140537013865,"score_gpt":0.36327808745015955,"score_spread":0.3244949469131457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335924678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9440597,0.012148143,0.0003448951,0.0048203613,0.00018001143,0.00010304175,0.024905538,0.000081727885,0.013356511],"genre_scores_gemma":[0.9900535,0.0033371577,0.00013073989,0.00025160817,0.000037125545,0.000009608795,0.0029062107,0.000012857719,0.003261061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856335,0.00007424046,0.00010532455,0.00013596694,0.00056640257,0.0005547528],"domain_scores_gemma":[0.99629116,0.0001466738,0.0006565861,0.000060806633,0.0017030166,0.0011418443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042161328,0.00035697233,0.0005711401,0.0026141033,0.0019429429,0.0016142742,0.0018644158,0.0010400455,0.0054676253],"category_scores_gemma":[0.0029155517,0.00048396483,0.0010605701,0.0061811213,0.00068169,0.00049809605,0.0008556189,0.0013805006,0.0003627908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018767154,0.000045547986,0.9874735,0.00007847068,0.00009521502,0.00022867924,0.0002228425,0.00030749713,0.0001625482,0.00031211769,0.0034663656,0.0074195885],"study_design_scores_gemma":[0.000020566453,0.000028168626,0.99644524,0.00005231772,0.0000479058,0.00022304937,0.00080262666,0.00045443996,0.000061921564,0.00006105098,0.0017836522,0.000018996207],"about_ca_topic_score_codex":0.99698323,"about_ca_topic_score_gemma":0.99807703,"teacher_disagreement_score":0.040338684,"about_ca_system_score_codex":0.040338684,"about_ca_system_score_gemma":0.051724065,"threshold_uncertainty_score":0.29267895},"labels":[],"label_agreement":null},{"id":"W2343566398","doi":"10.1007/s10549-016-3808-x","title":"Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai; Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development","keywords":"Medicine; Eribulin; Taxane; Internal medicine; Metastatic breast cancer; Tolerability; Breast cancer; Neutropenia; Febrile neutropenia; Clinical endpoint; Gastroenterology; Progressive disease; Adverse effect; Oncology; Surgery; Chemotherapy; Cancer; Clinical trial","score_opus":0.07258553034229742,"score_gpt":0.4487050927202439,"score_spread":0.37611956237794647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343566398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602747,0.0013247097,0.00032317822,0.000100630066,0.00003398042,0.0013193853,0.00019730013,0.000025023446,0.00064829795],"genre_scores_gemma":[0.9920515,0.001690462,0.00142761,0.0004449743,0.00007779812,0.002085499,0.0008723639,0.000014504961,0.0013352641],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996867,0.00015070636,0.000016649117,0.000049782502,0.000027860226,0.00006829386],"domain_scores_gemma":[0.9996269,0.00003382782,0.000051804487,0.000035441175,0.000031182557,0.00022078588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011912158,0.00127229,0.0026182712,0.00035361823,0.000427032,0.0004938704,0.00057309854,0.00070927525,0.0018224724],"category_scores_gemma":[0.00049635634,0.00046153236,0.0007017075,0.00039154672,0.00079094863,0.00045540207,0.00031822425,0.0013488496,0.00038574907],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56812185,0.11494506,0.023838963,0.0011226588,0.001835222,0.00088272634,0.0008966114,0.0032083914,0.18674451,0.0005045294,0.002995222,0.094904184],"study_design_scores_gemma":[0.25552678,0.69987595,0.031105401,0.000033690045,0.00063983625,0.00054992246,0.00016807378,0.0011940321,0.0069373236,0.00014190887,0.0037893844,0.000037709764],"about_ca_topic_score_codex":0.0010498066,"about_ca_topic_score_gemma":0.0031522557,"teacher_disagreement_score":0.0026182712,"about_ca_system_score_codex":0.00064042106,"about_ca_system_score_gemma":0.0014804108,"threshold_uncertainty_score":0.0062997937},"labels":[],"label_agreement":null},{"id":"W2343845543","doi":"10.1007/s10549-016-3812-1","title":"Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Hôpital Charles-Le Moyne; Juravinski Cancer Centre; University Health Network; Hamilton Health Sciences; Princess Margaret Cancer Centre; Kingston General Hospital; Interior Health; Ottawa Hospital; BC Cancer Agency; Queen Elizabeth II Health Sciences Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Ipsen; AstraZeneca; Celgene; Genomic Health; Cancer Care Ontario; Pfizer; Cancer Research Institute","keywords":"Medicine; Internal medicine; PTEN; Cancer; Breast cancer; Oncology; Response Evaluation Criteria in Solid Tumors; Progressive disease; Metastatic breast cancer; Triple-negative breast cancer; Estrogen receptor; Clinical endpoint; Adverse effect; Clinical trial; Disease; Biology; PI3K/AKT/mTOR pathway","score_opus":0.12762285403095874,"score_gpt":0.4400756633405633,"score_spread":0.31245280930960456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343845543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9501621,0.011759578,0.0006150793,0.004174784,0.0005856257,0.0037586372,0.010569141,0.00036464268,0.018010408],"genre_scores_gemma":[0.94446343,0.010604436,0.0027790666,0.0049805846,0.00029643293,0.0020708696,0.017856125,0.00013816947,0.01681083],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99962485,0.00012845572,0.000009616922,0.00004559938,0.00006536489,0.00012601576],"domain_scores_gemma":[0.9995499,0.00006294013,0.000050495983,0.000024947572,0.000038111713,0.00027356797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013999669,0.0017585518,0.0021332502,0.0005039568,0.00077608146,0.0010644027,0.0012822596,0.0013512959,0.006843483],"category_scores_gemma":[0.0011205091,0.0005381905,0.0016116496,0.0007120605,0.0011180919,0.000618916,0.0003940653,0.0038849744,0.001059314],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7571575,0.018326163,0.0077345143,0.0017613008,0.003033408,0.0003808957,0.0003761737,0.0036388726,0.014896067,0.0013083373,0.046182122,0.1452047],"study_design_scores_gemma":[0.8645236,0.08591732,0.025606876,0.000116393945,0.0014981251,0.00042248605,0.00019009407,0.0016864868,0.0015736974,0.0005601927,0.01781142,0.00009324249],"about_ca_topic_score_codex":0.07882568,"about_ca_topic_score_gemma":0.3303452,"teacher_disagreement_score":0.07882568,"about_ca_system_score_codex":0.0048322226,"about_ca_system_score_gemma":0.0088252,"threshold_uncertainty_score":0.15673375},"labels":[],"label_agreement":null},{"id":"W2344554404","doi":"10.1007/s10549-016-3805-0","title":"An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; BRCA mutation; Breast cancer; Prophylactic Mastectomy; Ovarian cancer; Gynecology; Breast imaging; Genetic testing; Obstetrics; Oncology; Mammography; Cancer; Family medicine; Mastectomy; Internal medicine","score_opus":0.040423436684606615,"score_gpt":0.3855187853069151,"score_spread":0.34509534862230845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344554404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928846,0.00048531318,0.00018086811,0.00039363338,0.000011993336,0.00005452447,0.0030798088,0.000012901941,0.002896245],"genre_scores_gemma":[0.9944226,0.0005907264,0.00024688736,0.00026635738,0.000010481474,0.000063550106,0.0025173551,0.000007471288,0.0018746847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923265,0.00021198504,0.000121500445,0.00013153865,0.00012374461,0.00017862357],"domain_scores_gemma":[0.9960316,0.00056265877,0.0015240601,0.00026634726,0.0008021068,0.00081325544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011531799,0.00021393201,0.00019098044,0.0015411233,0.00046715926,0.0004630688,0.0004842978,0.0004298913,0.0027921956],"category_scores_gemma":[0.0037404685,0.00020137093,0.00022636162,0.002430248,0.00031468028,0.00057369756,0.00076472404,0.00042831377,0.0004952975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008121579,0.00003865773,0.993771,0.0000267568,0.000010242311,0.000051954317,0.0008468382,0.000033709734,0.00024301933,0.00007674112,0.0007678273,0.004052165],"study_design_scores_gemma":[0.0000036210718,0.0000727549,0.99668247,0.000013838611,0.0000083760215,0.00014833367,0.0015258228,0.000061053455,0.00006785552,0.000016588603,0.001396651,0.000002656557],"about_ca_topic_score_codex":0.02369027,"about_ca_topic_score_gemma":0.019424574,"teacher_disagreement_score":0.02369027,"about_ca_system_score_codex":0.0006955529,"about_ca_system_score_gemma":0.0013322313,"threshold_uncertainty_score":0.047104776},"labels":[],"label_agreement":null},{"id":"W2344570909","doi":"10.1007/s10549-016-3806-z","title":"Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; McGill University; Queen's University","funders":"Novartis Pharmaceuticals Canada; Canadian Cancer Society Research Institute; Avon Foundation for Women","keywords":"Breast cancer; Medicine; Progesterone receptor; Internal medicine; Estrogen receptor; Biomarker; Tamoxifen; Oncology; Univariate analysis; Proportional hazards model; Population; Gynecology; Cancer; Multivariate analysis; Biology","score_opus":0.024570992455228778,"score_gpt":0.332665148771888,"score_spread":0.30809415631665926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344570909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98927015,0.00068093697,0.0011391174,0.00012414332,0.000054887892,0.000023914958,0.005947976,0.000093357565,0.0026655616],"genre_scores_gemma":[0.99078333,0.00009492696,0.00021460779,0.00005202044,0.000021374,0.00005597396,0.0057287933,0.00001820782,0.0030307542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973327,0.000063058025,0.0000153895,0.00007069118,0.000039339113,0.000078225545],"domain_scores_gemma":[0.9994319,0.00023914606,0.000073076204,0.0000818655,0.00005835012,0.0001156619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066320196,0.00023300407,0.00033494883,0.00036174073,0.00014329402,0.000305848,0.00027924473,0.000356639,0.0045513995],"category_scores_gemma":[0.0009078013,0.000091291986,0.00040408372,0.00022898258,0.00019250298,0.00031799954,0.00018666558,0.000766276,0.00056153093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0763089,0.0024061636,0.5966922,0.00033931795,0.0013494922,0.001170426,0.0006484259,0.009850169,0.13799301,0.0028904683,0.030915191,0.13943624],"study_design_scores_gemma":[0.00050029944,0.0072360174,0.96092147,0.000035907993,0.00046945259,0.00091227854,0.00026551832,0.008037454,0.012451141,0.0007559024,0.008373851,0.00004064271],"about_ca_topic_score_codex":0.0027873723,"about_ca_topic_score_gemma":0.003726119,"teacher_disagreement_score":0.0045513995,"about_ca_system_score_codex":0.00049352663,"about_ca_system_score_gemma":0.0003652209,"threshold_uncertainty_score":0.0152260065},"labels":[],"label_agreement":null},{"id":"W2344988130","doi":"10.1007/s10549-016-3784-1","title":"Germline RECQL mutations in high risk Chinese breast cancer patients","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"Breast cancer; Nonsense mutation; Germline mutation; Cancer; Mutation; Genetics; Biology; Cancer research; Oncology; Gene mutation; Genome instability; Internal medicine; Medicine; Gene; Missense mutation; DNA; DNA damage","score_opus":0.013604870086532739,"score_gpt":0.3217027717941388,"score_spread":0.3080979017076061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344988130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992095,0.00014918974,0.000020010504,0.000038365335,0.0000033202002,0.0000033075842,0.00007327367,0.0000035517126,0.00049941195],"genre_scores_gemma":[0.999506,0.00007734941,0.000022073948,0.000019312933,0.0000051818456,0.000002281727,0.000068043344,0.0000015999772,0.00029828862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983823,0.000016726874,0.000017797905,0.00004225844,0.000030405465,0.000054560107],"domain_scores_gemma":[0.9997485,0.000053607273,0.0000908928,0.000016365673,0.000022048856,0.000068545516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015380229,0.00032671943,0.00030144953,0.0011547628,0.00068048364,0.00043536798,0.00028596388,0.000401868,0.0038506822],"category_scores_gemma":[0.0006460192,0.0002725415,0.00030076943,0.0011216935,0.00029673125,0.00022356297,0.00022574673,0.00027895017,0.00030215876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047455498,0.000067708264,0.98467803,0.000028224867,0.000045816236,0.0047052326,0.00043414047,0.00007798912,0.0053443676,0.00009689377,0.00019994273,0.0038470493],"study_design_scores_gemma":[0.000020556445,0.00011722985,0.9907046,0.000006951884,0.000095065814,0.006992741,0.00057202694,0.00019587664,0.0007370323,0.00010044533,0.00044691996,0.000010445692],"about_ca_topic_score_codex":0.009341277,"about_ca_topic_score_gemma":0.005934418,"teacher_disagreement_score":0.009341277,"about_ca_system_score_codex":0.00042409857,"about_ca_system_score_gemma":0.00046587162,"threshold_uncertainty_score":0.01857382},"labels":[],"label_agreement":null},{"id":"W2396057381","doi":"10.1007/s10549-016-3834-8","title":"A longitudinal analysis of chronic arm morbidity following breast cancer surgery","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Horizon Health Network; University of Ottawa; Research Institute in Oncology and Hematology; BC Cancer Agency; University of Manitoba; McGill University; Dalhousie University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Affect (linguistics); Medicine; Mood; Breast cancer; Quality of life (healthcare); Physical therapy; Range of motion; Longitudinal study; Physical medicine and rehabilitation; Internal medicine; Cancer; Psychology; Clinical psychology; Nursing","score_opus":0.0830894033442911,"score_gpt":0.386151076837384,"score_spread":0.3030616734930929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396057381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894744,0.00018041805,0.00008496466,0.00007711143,0.000008221438,0.000004962578,0.0005225065,0.00000232312,0.00017213312],"genre_scores_gemma":[0.99881315,0.00008600868,0.000063588996,0.000027543927,0.000010116652,0.000010731114,0.00068610534,0.0000013740123,0.00030143853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919647,0.00028135168,0.000079175705,0.00011289943,0.00008311435,0.00024689554],"domain_scores_gemma":[0.99665314,0.00047252738,0.001404503,0.00042830614,0.0003926018,0.00064908236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016473675,0.00022938508,0.00025731686,0.00078953826,0.0007448682,0.0006867606,0.000496874,0.0007166721,0.001400469],"category_scores_gemma":[0.0045546996,0.00034682467,0.0009119601,0.0011815678,0.00024991448,0.00065785396,0.001005833,0.0009788293,0.00031307095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025460485,0.00008992136,0.9983297,0.0000036042438,0.00007900381,0.000026458398,0.00007384585,0.00003088722,0.00009227545,0.000017484697,0.00008911512,0.0009129888],"study_design_scores_gemma":[0.0000062571185,0.00015891076,0.9992286,0.0000041234,0.00003648692,0.000040812043,0.00020678742,0.00014476842,0.000025751177,0.000016047425,0.00012777717,0.0000036431895],"about_ca_topic_score_codex":0.029704733,"about_ca_topic_score_gemma":0.03847024,"teacher_disagreement_score":0.029704733,"about_ca_system_score_codex":0.00058914284,"about_ca_system_score_gemma":0.0012233742,"threshold_uncertainty_score":0.059063613},"labels":[],"label_agreement":null},{"id":"W2408550433","doi":"10.1007/s10549-016-3842-8","title":"Long-term consequences of ovarian ablation for premenopausal breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Goserelin; Oncology; Gynecology; Population; Internal medicine; Cancer","score_opus":0.04934624895585982,"score_gpt":0.37719600023267064,"score_spread":0.3278497512768108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408550433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909808,0.005634509,0.00012892496,0.00050363597,0.00005900189,0.000010589781,0.00036083008,0.000013086215,0.0023086001],"genre_scores_gemma":[0.9978155,0.00088904967,0.00004428327,0.00010192251,0.000035097633,0.0000045009447,0.00024840154,0.0000038065414,0.0008574121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998343,0.00003756676,0.000011417064,0.000011960532,0.00003184727,0.00007290636],"domain_scores_gemma":[0.99883705,0.00040487014,0.0002770718,0.00008371437,0.000080185964,0.00031715128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039742485,0.000117977695,0.00024362301,0.00027487078,0.00041588864,0.00030351983,0.00021360487,0.0003527206,0.00249635],"category_scores_gemma":[0.0015961758,0.0000733511,0.0005224653,0.0002337807,0.0002379502,0.00019072204,0.000253524,0.00046460173,0.00019834582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028092006,0.001554802,0.73048186,0.00021193342,0.0008746829,0.017068328,0.00027703162,0.0011310491,0.061048098,0.0012211505,0.0018424329,0.15619677],"study_design_scores_gemma":[0.00007558057,0.0023576207,0.9871208,0.000021163636,0.0002953779,0.0053103967,0.00018902055,0.0001644499,0.0020600855,0.00038011026,0.0020128936,0.000012472086],"about_ca_topic_score_codex":0.0019159227,"about_ca_topic_score_gemma":0.005386046,"teacher_disagreement_score":0.00249635,"about_ca_system_score_codex":0.00039584926,"about_ca_system_score_gemma":0.00046159994,"threshold_uncertainty_score":0.008351147},"labels":[],"label_agreement":null},{"id":"W2415764626","doi":"10.1007/s10549-016-3823-y","title":"Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency; Cancer Care Ontario; Ontario Institute for Cancer Research; Public Health Ontario; Toronto Public Health; Sunnybrook Health Science Centre; St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Health Sciences Centre; University Health Network; University of Toronto","funders":"Canadian Cancer Society","keywords":"Medicine; Hazard ratio; Trastuzumab; Discontinuation; Internal medicine; Breast cancer; Population; Myocardial infarction; Clinical endpoint; Proportional hazards model; Cardiotoxicity; Cancer; Retrospective cohort study; Confidence interval; Oncology; Chemotherapy; Randomized controlled trial","score_opus":0.033026724685220006,"score_gpt":0.3275058798334186,"score_spread":0.2944791551481986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415764626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99949265,0.0001726693,0.000039792565,0.000017825145,0.0000041670187,0.000005461669,0.000108524204,0.0000012886263,0.00015761591],"genre_scores_gemma":[0.99947363,0.00009114519,0.00002659723,0.000030387017,0.000016618302,0.0000085834035,0.00021485415,0.0000013508347,0.00013685593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945503,0.00013215521,0.000048213547,0.00016202684,0.00006510036,0.00013751222],"domain_scores_gemma":[0.9990133,0.00015468399,0.00043666776,0.00009410304,0.0000790344,0.00022206198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063577294,0.0004909229,0.0006934432,0.00059161615,0.000593354,0.0009212198,0.00040678942,0.0010411136,0.0010603352],"category_scores_gemma":[0.0015209182,0.00046157723,0.001068323,0.0010995384,0.0004243596,0.0009454412,0.00051854755,0.0012909491,0.00021527409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014369778,0.00025232142,0.99610007,0.0000127505145,0.0002929949,0.0001547995,0.0000891246,0.000049322844,0.00038408968,0.00001565447,0.00006679008,0.0011451473],"study_design_scores_gemma":[0.00006240842,0.00067910267,0.9982717,0.0000048094203,0.00019086653,0.00026136322,0.00018331627,0.00012803105,0.00004717579,0.00003321226,0.00012871689,0.000009308387],"about_ca_topic_score_codex":0.0019939193,"about_ca_topic_score_gemma":0.0022869187,"teacher_disagreement_score":0.0019939193,"about_ca_system_score_codex":0.00037708608,"about_ca_system_score_gemma":0.00031676015,"threshold_uncertainty_score":0.003964603},"labels":[],"label_agreement":null},{"id":"W2466624478","doi":"10.1007/s10549-016-3901-1","title":"A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Breast cancer; Medicine; Aromatase; Estrogen; Oncology; Internal medicine; Testosterone (patch); Androgen; Population; Endocrinology; Cancer; Gynecology; Hormone","score_opus":0.03942102929699136,"score_gpt":0.345996508115373,"score_spread":0.30657547881838165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466624478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55547744,0.28227344,0.03586608,0.08346,0.0062789535,0.00055045966,0.0012343205,0.00079127663,0.034068085],"genre_scores_gemma":[0.84786975,0.08449641,0.03170508,0.015190662,0.005108853,0.00022710039,0.00039655808,0.00004893941,0.014956592],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99990726,0.000029315352,0.000008369874,0.000014870712,0.00002828734,0.000011937768],"domain_scores_gemma":[0.9998271,0.000038400292,0.000037019112,0.000009497788,0.00003846124,0.00004943044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035706628,0.00037178874,0.0004742689,0.0003880909,0.0002973506,0.0004208074,0.00036021176,0.0005716741,0.002369165],"category_scores_gemma":[0.00062001386,0.00008571778,0.00035655926,0.0002125235,0.00016524165,0.00033039486,0.0002957041,0.00072182785,0.00045133624],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031694712,0.0052565937,0.032514095,0.0019415104,0.0006145164,0.0011242647,0.00034695485,0.0008690859,0.048165657,0.0031681277,0.027261164,0.8755687],"study_design_scores_gemma":[0.0060504717,0.03670775,0.46226254,0.0025685166,0.0044589504,0.0130181955,0.0023529697,0.0050319773,0.06376842,0.020137744,0.3834038,0.00023864534],"about_ca_topic_score_codex":0.0009957412,"about_ca_topic_score_gemma":0.0026783287,"teacher_disagreement_score":0.002369165,"about_ca_system_score_codex":0.00023150712,"about_ca_system_score_gemma":0.00068158895,"threshold_uncertainty_score":0.00792563},"labels":[],"label_agreement":null},{"id":"W2472613475","doi":"10.1007/s10549-016-3900-2","title":"Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; BC Cancer Agency; Alberta Health Services; University of British Columbia; Ottawa Regional Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Sarcopenia; Medicine; Breast cancer; Internal medicine; Chemotherapy; Randomized controlled trial; Oncology; Quality of life (healthcare); Cancer; Aerobic exercise; Confidence interval; Anemia; Physical therapy","score_opus":0.028778245990266595,"score_gpt":0.38867798910665935,"score_spread":0.3598997431163928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472613475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869398,0.006207717,0.0006008337,0.0006800823,0.00068765937,0.0031068127,0.00073686836,0.00007009217,0.00097018806],"genre_scores_gemma":[0.987565,0.0028834944,0.0012824798,0.000843884,0.0006920013,0.0042547346,0.000773432,0.0000181457,0.0016869402],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987532,0.0005912827,0.00012209771,0.0002803079,0.00008366983,0.00016937882],"domain_scores_gemma":[0.9981468,0.000537024,0.0005029334,0.00014946276,0.00014521589,0.0005186056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020504654,0.0023795823,0.0052712904,0.0004978848,0.00087600003,0.001447923,0.0012028144,0.0025898716,0.0059415535],"category_scores_gemma":[0.003095406,0.0011651319,0.0032752,0.00078609504,0.0016359425,0.0013324553,0.00086424954,0.0039269845,0.0006930012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99167633,0.0028076412,0.0006644038,0.00034189553,0.0017922999,0.000009290449,0.000020060595,0.000108625005,0.0003758947,0.000028179818,0.000137156,0.0020381927],"study_design_scores_gemma":[0.9589886,0.035400648,0.0024854788,0.00004559543,0.0024248378,0.000008404084,0.000023982095,0.00023541792,0.00011584201,0.00006039353,0.00019660732,0.000014218682],"about_ca_topic_score_codex":0.0025640153,"about_ca_topic_score_gemma":0.0030535199,"teacher_disagreement_score":0.0059415535,"about_ca_system_score_codex":0.0009576223,"about_ca_system_score_gemma":0.0014439175,"threshold_uncertainty_score":0.01987642},"labels":[],"label_agreement":null},{"id":"W2475233440","doi":"10.1007/s10549-016-3894-9","title":"Impact of a prior diagnosis of DCIS on survival from invasive breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Lumpectomy; Ductal carcinoma; Mastectomy; Oncology; Stage (stratigraphy); Cancer; Radiation therapy; Internal medicine; Gynecology","score_opus":0.04430641448041019,"score_gpt":0.3713990514306787,"score_spread":0.3270926369502685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475233440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859038,0.0077324416,0.00012159316,0.0010184357,0.00010023006,0.000009229079,0.0007276499,0.0000059901413,0.00438048],"genre_scores_gemma":[0.998135,0.00087162247,0.0000380899,0.000065371685,0.00006463991,0.000002457776,0.00019874962,0.0000024038982,0.00062171015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882644,0.00054260483,0.000070177084,0.0001452757,0.00014159839,0.00027396658],"domain_scores_gemma":[0.99157727,0.004038869,0.0017268328,0.00081146136,0.00043177514,0.0014137635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001418441,0.00022535509,0.00042702796,0.0005298177,0.00053238636,0.0008358852,0.00039527117,0.0007355472,0.005057404],"category_scores_gemma":[0.008439895,0.00017833643,0.0011206665,0.0008723821,0.0003932896,0.0006608508,0.00062953174,0.0012005892,0.00022371308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00682105,0.0003519147,0.9725815,0.000090678666,0.0005817335,0.00025295545,0.000095996045,0.00031500397,0.00083789515,0.00016505524,0.00029250392,0.017613675],"study_design_scores_gemma":[0.00001780396,0.0004880205,0.9981488,0.000018664763,0.00026722596,0.00018009389,0.00009724523,0.00009736661,0.00010928363,0.000072144634,0.0004989604,0.0000045037623],"about_ca_topic_score_codex":0.010408471,"about_ca_topic_score_gemma":0.016182788,"teacher_disagreement_score":0.010408471,"about_ca_system_score_codex":0.0006731302,"about_ca_system_score_gemma":0.0008002071,"threshold_uncertainty_score":0.020695746},"labels":[],"label_agreement":null},{"id":"W2478042827","doi":"10.1007/s10549-016-3906-9","title":"Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto; Health Sciences Centre; University of British Columbia","funders":"Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Breast cancer; Medicine; Neuropsychology; Cognition; Endocrine system; Randomized controlled trial; Oncology; Cognitive decline; Effects of sleep deprivation on cognitive performance; Internal medicine; Cancer; Dementia; Disease; Psychiatry; Hormone","score_opus":0.16665830214822366,"score_gpt":0.4708245507537167,"score_spread":0.304166248605493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478042827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008200911,0.9988404,0.000022543853,0.000046868256,0.000030005098,0.000014436267,0.000102867525,0.0000012025664,0.00012164123],"genre_scores_gemma":[0.00908211,0.99039793,0.00013250206,0.00016923544,0.00004568597,0.00002215918,0.000107692074,9.8194e-7,0.000041595205],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99869436,0.00030020988,0.0005247095,0.00017400467,0.00024895844,0.000057885263],"domain_scores_gemma":[0.99488753,0.0035830496,0.0010472435,0.000073613905,0.0003350158,0.00007356281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031400898,0.0012510546,0.004715676,0.0031379324,0.00033110433,0.0017786727,0.0012414439,0.0010599995,0.0032924116],"category_scores_gemma":[0.010358151,0.0005336371,0.005708074,0.0048625763,0.00045394577,0.0009687095,0.0010532662,0.0011045334,0.00018405587],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012849622,0.000109835855,0.0058273706,0.73474276,0.049487647,0.00016120086,0.00019021513,0.00026540854,0.00029581226,0.00024923115,0.003137643,0.204248],"study_design_scores_gemma":[0.0013869089,0.0009596572,0.051798817,0.45929104,0.41690025,0.0012147069,0.0007718788,0.00018554085,0.00062989054,0.0013340787,0.065369114,0.00015811926],"about_ca_topic_score_codex":0.0059766863,"about_ca_topic_score_gemma":0.017579162,"teacher_disagreement_score":0.0059766863,"about_ca_system_score_codex":0.0009703564,"about_ca_system_score_gemma":0.002055929,"threshold_uncertainty_score":0.01660657},"labels":[],"label_agreement":null},{"id":"W2487059482","doi":"10.1007/s10549-016-3870-4","title":"A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Susan G. Komen; Susan G. Komen for the Cure","keywords":"PALB2; Breast cancer; Medicine; Cancer; Oncology; Mutation; Gynecology; Genetics; Gene; Internal medicine; Demography; Germline mutation; Biology","score_opus":0.03170213214605699,"score_gpt":0.3447986936998417,"score_spread":0.3130965615537847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487059482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759066,0.00020973434,0.000036759757,0.00015285164,0.0000032031853,0.00001730787,0.0007506156,0.0000041090193,0.0012347326],"genre_scores_gemma":[0.99756753,0.00052275293,0.00007528346,0.00018675404,0.0000030892982,0.000028827479,0.0005183362,0.0000033724648,0.0010940415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981886,0.000033182623,0.000015975647,0.000029429873,0.000032005286,0.000070473405],"domain_scores_gemma":[0.99967504,0.000041931293,0.00008820601,0.000017863083,0.00007966409,0.00009744632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021590557,0.0001930964,0.00016891702,0.0011960525,0.0006770142,0.00035847304,0.0003725544,0.00030408028,0.0018800927],"category_scores_gemma":[0.0006979297,0.0002647071,0.00016983986,0.0017132505,0.0004114406,0.00016473148,0.00079040125,0.00031451683,0.00023369445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033018303,0.000016365944,0.9952009,0.000030942632,0.000012301181,0.00036270724,0.0014298079,0.000028861296,0.00077451294,0.000034631077,0.00030963167,0.0017664057],"study_design_scores_gemma":[0.0000026770422,0.000031232248,0.9946009,0.00002058842,0.000010207279,0.00032795712,0.0041863555,0.000037634818,0.000035486988,0.000011905258,0.0007317158,0.0000034426723],"about_ca_topic_score_codex":0.39603376,"about_ca_topic_score_gemma":0.47712877,"teacher_disagreement_score":0.39603376,"about_ca_system_score_codex":0.0015605934,"about_ca_system_score_gemma":0.0017549545,"threshold_uncertainty_score":0.78745717},"labels":[],"label_agreement":null},{"id":"W2487431344","doi":"10.1007/s10549-016-3908-7","title":"Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; National Institutes of Health; Susan G. Komen; Mayo Clinic","keywords":"Quartile; Breast cancer; Medicine; Breast disease; Involution (esoterism); Odds ratio; Logistic regression; Confidence interval; Internal medicine; Cancer; Biology","score_opus":0.0329526719419565,"score_gpt":0.3106430970803345,"score_spread":0.277690425138378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487431344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991265,0.00017849407,0.00028991106,0.000011721807,0.0000075764865,0.000029233715,0.00022215027,0.0000045136544,0.00012991096],"genre_scores_gemma":[0.99888426,0.000059718546,0.00034394753,0.000016914028,0.000009161316,0.00005003285,0.00042042197,0.000004390657,0.00021117677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997806,0.0010784513,0.00019860662,0.0004780583,0.0002712545,0.00016765684],"domain_scores_gemma":[0.99629825,0.00077204924,0.001303626,0.00096740207,0.0003532601,0.0003054973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022428178,0.00057773065,0.00056411256,0.00076692144,0.000689789,0.00075661816,0.0009853265,0.000768662,0.0009127394],"category_scores_gemma":[0.005313631,0.00080938445,0.0007467609,0.0008421177,0.00067773333,0.00041934758,0.00056227617,0.00058613566,0.0001916711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016515009,0.0002951674,0.99464333,0.000020538582,0.00044399296,0.00011739705,0.0002567442,0.00006289148,0.0013865859,0.00006860914,0.0000941114,0.00095919037],"study_design_scores_gemma":[0.00008984201,0.0004410287,0.99823856,0.0000035374255,0.00016517511,0.00025446995,0.00014915428,0.00021419975,0.00020587372,0.000043206022,0.0001871929,0.000007800634],"about_ca_topic_score_codex":0.0083994,"about_ca_topic_score_gemma":0.008993853,"teacher_disagreement_score":0.0083994,"about_ca_system_score_codex":0.00059923565,"about_ca_system_score_gemma":0.0004874062,"threshold_uncertainty_score":0.016701043},"labels":[],"label_agreement":null},{"id":"W2504552842","doi":"10.1007/s10549-016-3897-6","title":"Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Orionin Tutkimussäätiö; Academy of Finland; European Commission; Cancer Research UK; Government of Canada; Canadian Institutes of Health Research; Suomen Kulttuurirahasto; Genome Canada; Nordic Cancer Union","keywords":"Breast cancer; Family history; Medicine; Odds ratio; Breast disease; Cancer; Population; Case-control study; Oncology; Disease; Internal medicine; Gynecology; Obstetrics; Environmental health","score_opus":0.020783999500772303,"score_gpt":0.31245218066802705,"score_spread":0.29166818116725474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504552842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979102,0.00029511994,0.00027375782,0.000034930392,0.0000041581206,0.000010124659,0.001244642,0.000011284634,0.00021576964],"genre_scores_gemma":[0.99685055,0.00013687114,0.00027062595,0.00001793659,0.0000059346867,0.000017589447,0.0025622717,0.0000039999622,0.00013426233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831426,0.0005020056,0.00018286852,0.0006539687,0.00019491128,0.00015193611],"domain_scores_gemma":[0.99780923,0.0011291556,0.00047689912,0.00030146082,0.00014256919,0.00014071766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001871621,0.0004297888,0.00066883967,0.0014744813,0.0010067228,0.00088547583,0.00041305515,0.00054027775,0.002597089],"category_scores_gemma":[0.007433303,0.00033051742,0.0011133373,0.0023739517,0.0005022295,0.00022079279,0.0008974107,0.00036920226,0.00023380968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005649588,0.000031095795,0.988675,0.000059387137,0.00083179807,0.0013830876,0.0005899215,0.00071948784,0.001257333,0.000094073446,0.0005960271,0.005197854],"study_design_scores_gemma":[0.00004503508,0.00007134632,0.9956126,0.000022539016,0.00040806385,0.0013958005,0.00018967097,0.0012930201,0.00016815442,0.00017626064,0.0005962593,0.000021222813],"about_ca_topic_score_codex":0.032715116,"about_ca_topic_score_gemma":0.019974602,"teacher_disagreement_score":0.032715116,"about_ca_system_score_codex":0.0005293407,"about_ca_system_score_gemma":0.00043339902,"threshold_uncertainty_score":0.06504935},"labels":[],"label_agreement":null},{"id":"W2513382862","doi":"10.1007/s10549-016-3954-1","title":"Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Pegfilgrastim; Medicine; Febrile neutropenia; Breast cancer; Internal medicine; Filgrastim; Granulocyte colony-stimulating factor; Oncology; Neutropenia; Cost effectiveness; Chemotherapy; Adjuvant; Surgery; Cancer","score_opus":0.10589650524727208,"score_gpt":0.4418618303045254,"score_spread":0.33596532505725335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513382862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038509262,0.99520075,0.00010696011,0.00013245337,0.000105200066,0.00012347708,0.00026987673,0.000008352808,0.0002019507],"genre_scores_gemma":[0.07716444,0.9207959,0.0008003801,0.00053543836,0.00011085044,0.00018505023,0.00021963526,0.000007997223,0.00018021978],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99810696,0.000694403,0.00057344174,0.00018890154,0.00032334897,0.00011280871],"domain_scores_gemma":[0.9952199,0.0034552338,0.00092085666,0.000056118377,0.00024642848,0.00010142381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027861255,0.0012756608,0.0083047245,0.0023824684,0.00027176982,0.0017255134,0.0014461874,0.0016456109,0.0051274835],"category_scores_gemma":[0.011516603,0.0008956173,0.012179954,0.003261975,0.00047233567,0.0012365981,0.0009193417,0.0020577484,0.0001997737],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041626403,0.00009559889,0.0015537778,0.84114283,0.09865547,0.000121298166,0.00009577547,0.000548213,0.00027172623,0.00027333008,0.001383388,0.051695988],"study_design_scores_gemma":[0.00565258,0.0013045341,0.009470895,0.2091775,0.7626343,0.00034857163,0.0002415441,0.0005074907,0.00025816687,0.0005564929,0.009763854,0.00008413541],"about_ca_topic_score_codex":0.009435443,"about_ca_topic_score_gemma":0.027421778,"teacher_disagreement_score":0.009435443,"about_ca_system_score_codex":0.0024093483,"about_ca_system_score_gemma":0.0033164015,"threshold_uncertainty_score":0.018761039},"labels":[],"label_agreement":null},{"id":"W2514212828","doi":"10.1007/s10549-016-3945-2","title":"Effects of a multicomponent physical activity behavior change intervention on breast cancer survivor health status outcomes in a randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; Canada Research Chairs","keywords":"Medicine; Breast cancer; Randomized controlled trial; Physical therapy; Quality of life (healthcare); Body mass index; WOMAC; Confidence interval; Cancer; Cancer survivor; Internal medicine; Osteoarthritis","score_opus":0.06251246346930821,"score_gpt":0.42510687709911643,"score_spread":0.3625944136298082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514212828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816673,0.0039966335,0.001383791,0.00092010276,0.0013967013,0.008038979,0.00076138927,0.00024226018,0.0015929373],"genre_scores_gemma":[0.9794881,0.0019328119,0.0040537925,0.0009426045,0.0008415219,0.010078805,0.0006694169,0.00004549467,0.0019474734],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961409,0.0017439185,0.0004755418,0.0008346126,0.00031198454,0.0004930711],"domain_scores_gemma":[0.99694735,0.0012557812,0.00055641425,0.00026609862,0.00020990254,0.0007645212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004570613,0.0026448532,0.0064619742,0.0010422847,0.0013848263,0.0017296005,0.0018722061,0.0038335612,0.010721377],"category_scores_gemma":[0.005968448,0.0016499503,0.004086855,0.0009347524,0.0022792534,0.0019916072,0.0016470012,0.004660212,0.0011339475],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9849423,0.007376788,0.00029851624,0.00050296495,0.0017447622,0.000013024908,0.000037862897,0.00013258724,0.00036528334,0.000042834334,0.00018594164,0.004357037],"study_design_scores_gemma":[0.9755012,0.02187042,0.0008757433,0.000050720228,0.0012636712,0.0000050048375,0.000014066604,0.00016820253,0.000102705766,0.00004615333,0.000093696595,0.000008477502],"about_ca_topic_score_codex":0.004451333,"about_ca_topic_score_gemma":0.005106779,"teacher_disagreement_score":0.010721377,"about_ca_system_score_codex":0.0016250096,"about_ca_system_score_gemma":0.002696766,"threshold_uncertainty_score":0.03586662},"labels":[],"label_agreement":null},{"id":"W2517811060","doi":"10.1007/s10549-016-3960-3","title":"The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto","funders":"","keywords":"Funnel plot; Medicine; Meta-analysis; Publication bias; Breast cancer; Oncology; Internal medicine; MEDLINE; Systematic review; Random effects model; Statistic; Adjuvant chemotherapy; Cancer; Surgery; Statistics","score_opus":0.13472492853919252,"score_gpt":0.4264882852874373,"score_spread":0.29176335674824483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517811060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029350517,0.9962541,0.00023525364,0.00008114369,0.00007702999,0.000047078913,0.0002594195,0.000009459867,0.00010153298],"genre_scores_gemma":[0.10987497,0.88677615,0.0013874976,0.0007133363,0.00019241638,0.00021510887,0.00050664466,0.000017583929,0.00031631655],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969554,0.0011155071,0.0009779964,0.00047106194,0.00033535884,0.0001446257],"domain_scores_gemma":[0.9929906,0.0051081143,0.0011608531,0.00023758847,0.00038338872,0.00011937996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050727087,0.001989009,0.01082702,0.0030198682,0.00038634153,0.0018740133,0.001670667,0.0019765773,0.0033985157],"category_scores_gemma":[0.0134683335,0.0012562027,0.022604052,0.0049043,0.0005045362,0.0012856335,0.001279277,0.0018361815,0.00029095754],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019239072,0.00004209361,0.007392479,0.3534309,0.6146434,0.00014754146,0.00009226176,0.0005143396,0.0003389178,0.00013386026,0.00081319094,0.020527096],"study_design_scores_gemma":[0.00041311604,0.00015436445,0.0053317123,0.012950385,0.97881705,0.00009196046,0.000045073328,0.00009814237,0.000081448125,0.00016252609,0.0018298212,0.000024424908],"about_ca_topic_score_codex":0.0072151036,"about_ca_topic_score_gemma":0.020143932,"teacher_disagreement_score":0.01082702,"about_ca_system_score_codex":0.0013660587,"about_ca_system_score_gemma":0.0021755488,"threshold_uncertainty_score":0.026827395},"labels":[],"label_agreement":null},{"id":"W2519236007","doi":"10.1007/s10549-016-3974-x","title":"Ten-year survival in women with primary stage IV breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Hazard ratio; Stage (stratigraphy); Cancer; Proportional hazards model; Gynecology; Epidemiology; Cancer registry; Internal medicine; Cause of death; Survival analysis; Oncology; Disease; Confidence interval","score_opus":0.02208895164619191,"score_gpt":0.31040092859549234,"score_spread":0.28831197694930044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519236007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966634,0.0012716099,0.000027610062,0.00012858774,0.000023174029,0.000005033078,0.0006936288,0.0000022669599,0.0011847917],"genre_scores_gemma":[0.99689376,0.00079457875,0.000019939334,0.00006370707,0.000025223642,0.000008249053,0.0009400445,0.0000013352089,0.0012531345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985766,0.00003872266,0.000009217933,0.000021874943,0.000016332906,0.00005619389],"domain_scores_gemma":[0.9995931,0.000086222244,0.000090141526,0.000025317666,0.00006321222,0.00014215034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043205594,0.00021671197,0.00028825612,0.0005345374,0.00038083998,0.0003204235,0.00021747369,0.00042007095,0.002109963],"category_scores_gemma":[0.0013438265,0.00012422998,0.00041669427,0.00059902406,0.00020308801,0.0003220924,0.00037186354,0.00045745788,0.0002629303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003046427,0.00015194602,0.9890731,0.00004082557,0.00010393121,0.00014653616,0.00021548482,0.00008387863,0.00047327564,0.00004259832,0.00049218093,0.0061297547],"study_design_scores_gemma":[0.000032657863,0.0006066208,0.9982572,0.000010215583,0.00008188822,0.00012046469,0.00024304388,0.000037051264,0.00006837217,0.000027526783,0.0005116511,0.000003236963],"about_ca_topic_score_codex":0.016477028,"about_ca_topic_score_gemma":0.016922027,"teacher_disagreement_score":0.016477028,"about_ca_system_score_codex":0.00043862328,"about_ca_system_score_gemma":0.0004722619,"threshold_uncertainty_score":0.03276223},"labels":[],"label_agreement":null},{"id":"W2522392425","doi":"10.1007/s10549-016-3979-5","title":"Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Jewish General Hospital","funders":"National Institute for Health and Care Research; AstraZeneca; Pfizer","keywords":"Anastrozole; Medicine; Internal medicine; Tolerability; Placebo; Breast cancer; Rash; Combination therapy; Adverse effect; Oncology; Gastroenterology; Cancer; Aromatase; Pathology","score_opus":0.041784829547201,"score_gpt":0.392317485535919,"score_spread":0.35053265598871797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522392425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938319,0.0027053456,0.00034536162,0.00042863877,0.00016300834,0.00088836555,0.00047556133,0.000083293926,0.0010785694],"genre_scores_gemma":[0.99190897,0.0026221054,0.0009449478,0.0005135863,0.00021265086,0.0011239954,0.00086749677,0.000026149506,0.0017801406],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99945456,0.0002734211,0.000027174086,0.00008812182,0.000046018566,0.00011072493],"domain_scores_gemma":[0.999471,0.0001375084,0.00008216986,0.000053216525,0.000023730729,0.00023241517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013836253,0.0014720529,0.002600249,0.00065999065,0.0004171553,0.00096540444,0.0009754322,0.0013158456,0.0032119239],"category_scores_gemma":[0.0010663967,0.0007842694,0.0013106433,0.0006167108,0.0013403478,0.0012417678,0.00039434302,0.0032095632,0.0006878174],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93277675,0.019666286,0.002017237,0.00024991433,0.00093870336,0.00005163656,0.00007520402,0.00086800224,0.008342844,0.00014083352,0.00073747046,0.034134984],"study_design_scores_gemma":[0.7753814,0.21594538,0.004706544,0.000014974348,0.00075854146,0.000056597924,0.00004062101,0.00070373167,0.0013422593,0.00015601382,0.0008716103,0.000022318289],"about_ca_topic_score_codex":0.0013191754,"about_ca_topic_score_gemma":0.003601419,"teacher_disagreement_score":0.0032119239,"about_ca_system_score_codex":0.0008935389,"about_ca_system_score_gemma":0.0011905942,"threshold_uncertainty_score":0.010744929},"labels":[],"label_agreement":null},{"id":"W2531975516","doi":"10.1007/s10549-016-4029-z","title":"Can we prevent BRCA1-associated breast cancer by RANKL inhibition?","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"RANKL; Denosumab; Breast cancer; Medicine; Cancer research; Osteoprotegerin; Carcinogenesis; Cancer; Oncology; Internal medicine; Population; Osteoporosis; Receptor; Activator (genetics)","score_opus":0.07244517315629172,"score_gpt":0.41097463733749984,"score_spread":0.3385294641812081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531975516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024042641,0.99763584,0.00009185445,0.0010103176,0.00027599113,0.0000058074343,0.000045347177,0.000011762416,0.00068264606],"genre_scores_gemma":[0.002724829,0.9948171,0.00023442016,0.0009446768,0.00033935194,0.000013352418,0.000065993234,0.0000024871308,0.0008577518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998229,0.00003694172,0.000030259844,0.000026961907,0.000055362987,0.000027525584],"domain_scores_gemma":[0.99975175,0.0001217406,0.000054174212,0.000009101395,0.000044682667,0.000018446426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006356573,0.00061653217,0.0015990393,0.00092593086,0.00021607072,0.00087443314,0.00078461814,0.0010573218,0.0054128985],"category_scores_gemma":[0.0010169859,0.00023232793,0.00084233924,0.000658931,0.000397996,0.000869097,0.00038932875,0.0025082247,0.0017682599],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003819097,0.00016889539,0.00036705536,0.018934287,0.00038832438,0.00015894104,0.000042866774,0.00033175794,0.0021699124,0.003148229,0.035523813,0.93838394],"study_design_scores_gemma":[0.0005092708,0.000555253,0.002171591,0.0072335363,0.001075919,0.0010885533,0.00008518646,0.0001618497,0.0012055441,0.003276521,0.9826003,0.000036519912],"about_ca_topic_score_codex":0.0011651064,"about_ca_topic_score_gemma":0.0033917185,"teacher_disagreement_score":0.0054128985,"about_ca_system_score_codex":0.00036833234,"about_ca_system_score_gemma":0.0009281832,"threshold_uncertainty_score":0.01810795},"labels":[],"label_agreement":null},{"id":"W2533671240","doi":"10.1007/s10549-016-4028-0","title":"Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review","year":2016,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Febrile neutropenia; Docetaxel; Internal medicine; Pegfilgrastim; Neutropenia; Cyclophosphamide; Breast cancer; Randomized controlled trial; Chemotherapy; Surgery; Oncology; Cancer","score_opus":0.04772956691183437,"score_gpt":0.3922678859825366,"score_spread":0.3445383190707022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533671240","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018950766,0.9974256,0.000074981435,0.00013353417,0.00007107838,0.000101173246,0.00012520018,0.000006901861,0.00016640166],"genre_scores_gemma":[0.05131267,0.94657594,0.00074111996,0.00086148083,0.00009249217,0.00014920584,0.00013877597,0.0000060642783,0.00012229208],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99846953,0.00050440076,0.0005830936,0.0001709882,0.00019212294,0.000079839534],"domain_scores_gemma":[0.9959306,0.0025379118,0.0011803648,0.000049337592,0.00020015484,0.000101658894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020063443,0.00094385614,0.005936084,0.0019466571,0.00028187092,0.0012158661,0.0012068287,0.0012795896,0.0042562075],"category_scores_gemma":[0.010212495,0.000762408,0.0074971286,0.0022131137,0.0004211381,0.0010528694,0.0007461452,0.0015681814,0.00016872771],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019899989,0.00008306066,0.0014528442,0.8763833,0.035187304,0.00010691301,0.00016164195,0.00036845452,0.00032971526,0.00020262843,0.0022940598,0.08144006],"study_design_scores_gemma":[0.006561447,0.001834637,0.011166257,0.47915342,0.470267,0.0005242528,0.00035041737,0.0003485421,0.0003786399,0.0005936935,0.028716382,0.00010525064],"about_ca_topic_score_codex":0.0061308183,"about_ca_topic_score_gemma":0.027660485,"teacher_disagreement_score":0.0061308183,"about_ca_system_score_codex":0.0019462968,"about_ca_system_score_gemma":0.0038258939,"threshold_uncertainty_score":0.014238477},"labels":[],"label_agreement":null},{"id":"W2542607693","doi":"10.1007/s10549-016-4015-5","title":"The impact of nodal micrometastasis on mortality among women with early-stage breast cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Micrometastasis; Stage (stratigraphy); Breast cancer; Medicine; Oncology; Cancer; Internal medicine; NODAL; Gynecology; Biology","score_opus":0.0319408832722315,"score_gpt":0.35977956595953253,"score_spread":0.32783868268730104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542607693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992767,0.005094285,0.000068464564,0.00031836715,0.000017125447,0.0000044677886,0.00034259225,0.0000027255546,0.0013850443],"genre_scores_gemma":[0.9986645,0.0008914003,0.000019904413,0.000028354887,0.000022270762,0.0000021170974,0.000110581605,0.00000133755,0.00025950038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996339,0.00018012601,0.0000223699,0.000035473007,0.00005223925,0.000075862175],"domain_scores_gemma":[0.9984835,0.0007276868,0.0003204588,0.000116925934,0.00014061171,0.00021093547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006999296,0.00021953184,0.00025633886,0.0005527078,0.00022385156,0.00043667038,0.00032438175,0.00028823825,0.0017186366],"category_scores_gemma":[0.0043251356,0.0001799674,0.00045275674,0.0007559086,0.00023039686,0.000465964,0.0004235025,0.00052719144,0.00014015818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007284334,0.00003120151,0.9933796,0.00002520893,0.00010549016,0.000050144892,0.000047902053,0.00006748325,0.00023621519,0.000031524567,0.00006945217,0.005227274],"study_design_scores_gemma":[0.000007339529,0.0000960488,0.99937576,0.0000064335986,0.00009379727,0.000060820403,0.000080109865,0.000053849115,0.000057114074,0.0000348199,0.0001323127,0.0000016557362],"about_ca_topic_score_codex":0.00889373,"about_ca_topic_score_gemma":0.016373493,"teacher_disagreement_score":0.00889373,"about_ca_system_score_codex":0.00043298962,"about_ca_system_score_gemma":0.00044791022,"threshold_uncertainty_score":0.017683923},"labels":[],"label_agreement":null},{"id":"W2544044666","doi":"10.1007/s10549-016-4018-2","title":"Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McGill University and Génome Québec Innovation Centre; McMaster University; Juravinski Hospital; Hôpital du Saint-Sacrement; Juravinski Cancer Centre; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University; Université Laval; Centre hospitalier universitaire de Québec","funders":"Jonsson Comprehensive Cancer Center; National Center for Advancing Translational Sciences; European Regional Development Fund; lékařská fakulta Univerzity Karlovy; University of California, San Francisco; National Institutes of Health; Kerry Group Kuok Foundation; Freistaat Sachsen; National Cancer Institute; Liga Portuguesa Contra o Cancro; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Medical Research Council; Uppsala Universitet; Institut National Du Cancer; Deutsche Krebshilfe; Sahlgrenska Universitetssjukhuset; Università degli Studi di Firenze; Ovarian Cancer Research Fund; Landspítali Háskólasjúkrahús; Hungarian Scientific Research Fund; National Health and Medical Research Council; Fundación Cellex; Fisher Center for Alzheimer's Research Foundation; Jewish General Hospital; Lunds Universitet; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Ministero della Salute; Generalitat de Catalunya; American Cancer Society; Fonds Wetenschappelijk Onderzoek; Cancer Center, University of Kansas; Cancerfonden; Cancer Association of South Africa; National Breast Cancer Foundation; European Commission; National Institute for Health and Care Research; KWF Kankerbestrijding; Cancer Research UK; Government of Canada; Fondation du cancer du sein du Québec; Memorial Sloan-Kettering Cancer Center; NRG Oncology; Israel Cancer Association; Institut Català de la Salut; University of Pennsylvania; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Associazione Italiana per la Ricerca sul Cancro; Genome Canada; Clalit Health Services; Deutsches Krebsforschungszentrum; Breast Cancer Research Foundation; McGill University; Univerzita Karlova v Praze; NIH Office of the Director; Ministério da Ciência, Tecnologia e Inovação; Dr. Ralph and Marian Falk Medical Research Trust; Kansas Bioscience Authority; Georgetown University; Susan G. Komen for the Cure; Canadian Institutes of Health Research; General Secretariat for Research and Technology; Beth Israel Deaconess Medical Center; Instituto de Salud Carlos III; Ohio State University; Cancer Australia; Fondation ARC pour la Recherche sur le Cancer; Istituto Oncologico Veneto; Royal Marsden NHS Foundation Trust; European Social Fund; University of Chicago; Lietuvos Mokslo Taryba","keywords":"Breast cancer; Allele; Locus (genetics); Genetics; Oncology; Biology; Cancer; Medicine; Cancer research; Gene","score_opus":0.015748540519999445,"score_gpt":0.30108115978313227,"score_spread":0.2853326192631328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544044666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938166,0.00018554533,0.00016967025,0.000019859184,0.0000019873878,0.0000037692312,0.00013689593,0.0000039806196,0.00009656877],"genre_scores_gemma":[0.9994702,0.00004886596,0.00021991391,0.00001178537,0.000004267149,0.0000046107384,0.00015155482,0.0000020911314,0.00008675798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971133,0.00007126322,0.000024385014,0.00010920051,0.00004893512,0.000034809505],"domain_scores_gemma":[0.9992136,0.00031960255,0.00029808705,0.000049649723,0.00003412242,0.00008495577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050877495,0.00031621073,0.0002446409,0.0007785095,0.00023534577,0.00026326667,0.00024135014,0.00030953888,0.0019718008],"category_scores_gemma":[0.0013246905,0.00011768274,0.00030610355,0.0006122928,0.00025961082,0.000090690766,0.000271881,0.0003261356,0.00011791876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006598529,0.000034664496,0.9740442,0.00003522926,0.00022529431,0.00046282267,0.00009445432,0.00017922538,0.020091133,0.00006277234,0.00007829642,0.004032052],"study_design_scores_gemma":[0.000022732625,0.000077980854,0.9965899,0.0000057728453,0.00013604668,0.0010649244,0.00004424584,0.00035545634,0.0014840147,0.000056635407,0.00015912554,0.0000032165553],"about_ca_topic_score_codex":0.0016803594,"about_ca_topic_score_gemma":0.0016103458,"teacher_disagreement_score":0.0019718008,"about_ca_system_score_codex":0.00015042476,"about_ca_system_score_gemma":0.00013848353,"threshold_uncertainty_score":0.0065963864},"labels":[],"label_agreement":null},{"id":"W2545442682","doi":"10.1007/s10549-016-4038-y","title":"Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Lawrence College; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society; Canadian Institutes of Health Research; National Comprehensive Cancer Network","keywords":"Breast cancer; CHEK2; PALB2; Genetic testing; Family history; Medicine; BRCA mutation; Mutation; Genetics; Cancer; Genetic counseling; Oncology; BRCA2 Protein; Germline mutation; Male breast cancer; Gene; Internal medicine; Biology","score_opus":0.07089785526257396,"score_gpt":0.3705309631384166,"score_spread":0.29963310787584263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545442682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991746,0.0013335582,0.00017943747,0.0010524594,0.0000910512,0.00007892309,0.00027373267,0.00003210798,0.0052127414],"genre_scores_gemma":[0.99612707,0.0010322724,0.0004216461,0.0006684545,0.00013570845,0.00002444254,0.00032879383,0.000016675058,0.0012449787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995777,0.00004841668,0.000057573383,0.000066776935,0.00008623268,0.00016330645],"domain_scores_gemma":[0.99929726,0.00023758905,0.00010362554,0.000049611375,0.0001258707,0.00018600194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042877338,0.00061720214,0.0006139518,0.0020978774,0.0011336029,0.0009164058,0.000655368,0.0011258578,0.0021608174],"category_scores_gemma":[0.0022292635,0.00037510498,0.0006407455,0.0010873615,0.0005044696,0.0008684294,0.00050814514,0.0009108611,0.00064709235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063343474,0.0002574371,0.9163373,0.0000662471,0.00002922258,0.061166722,0.0006937265,0.00015310514,0.0053092507,0.000064253174,0.0014802774,0.01380901],"study_design_scores_gemma":[0.000069386646,0.0011144644,0.88234717,0.00010155074,0.00022761074,0.09897439,0.0041666287,0.0009281121,0.0055399155,0.00033185235,0.006150028,0.000048914717],"about_ca_topic_score_codex":0.011014179,"about_ca_topic_score_gemma":0.018187031,"teacher_disagreement_score":0.011014179,"about_ca_system_score_codex":0.0008056344,"about_ca_system_score_gemma":0.000871643,"threshold_uncertainty_score":0.021900177},"labels":[],"label_agreement":null},{"id":"W2561642944","doi":"10.1007/s10549-016-4080-9","title":"Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Breast cancer; Cancer; Oncology; Cohort; Gynecology; Gastroenterology","score_opus":0.05852073882272807,"score_gpt":0.38370038208199975,"score_spread":0.3251796432592717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561642944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808013,0.0005881258,0.00005818457,0.000039447823,0.000007426737,0.000005107394,0.00040717892,0.0000035879323,0.00081086124],"genre_scores_gemma":[0.99894077,0.00018481264,0.000026538648,0.00001850577,0.000013233957,0.0000059057925,0.00047380445,0.000002098296,0.00033421713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977297,0.000058217873,0.000018578967,0.000057857716,0.000025038193,0.000067286666],"domain_scores_gemma":[0.9987558,0.0004320022,0.00030006087,0.000108639935,0.00006665378,0.00033682905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068708294,0.00022365848,0.00046126408,0.0006561686,0.00023170079,0.00047228552,0.00032602492,0.00044634345,0.002104919],"category_scores_gemma":[0.002420002,0.00012464267,0.0005881181,0.0004931171,0.00024385679,0.0004826277,0.0005210504,0.0005332952,0.00023451204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009871193,0.000118452896,0.9759016,0.00004780916,0.00022678057,0.00039748522,0.0003197347,0.0004613128,0.002768863,0.00013911369,0.00033736206,0.009410395],"study_design_scores_gemma":[0.000046410678,0.00087587564,0.9969868,0.000012957188,0.00010457003,0.00083717745,0.00020999835,0.00023133702,0.00026260733,0.00012296005,0.0003015124,0.000007828061],"about_ca_topic_score_codex":0.0020905004,"about_ca_topic_score_gemma":0.0025345797,"teacher_disagreement_score":0.002104919,"about_ca_system_score_codex":0.00037055684,"about_ca_system_score_gemma":0.00028178786,"threshold_uncertainty_score":0.007041633},"labels":[],"label_agreement":null},{"id":"W2576591218","doi":"10.1007/s10549-017-4114-y","title":"Response to “Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?”","year":2017,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Metastatic breast cancer; Medicine; Breast cancer; Oncology; Metastasis; Cancer; Internal medicine","score_opus":0.09692937252843159,"score_gpt":0.3927217579376347,"score_spread":0.2957923854092031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576591218","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004741256,0.00057433825,0.000038401336,0.98391104,0.013379093,0.000019101104,0.0002995045,0.000017730563,0.001286613],"genre_scores_gemma":[0.0022859322,0.00073634024,0.00008547258,0.969646,0.022571482,0.00008185327,0.00016677585,0.0000146194825,0.004411686],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997421,0.000704664,0.00035353613,0.000377438,0.00055429473,0.0005890735],"domain_scores_gemma":[0.99017835,0.0053739897,0.0009565151,0.0002710069,0.0016204793,0.0015997362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042911307,0.0009302815,0.0019949945,0.00085298275,0.003633091,0.0028178,0.0020803895,0.038652506,0.0102832625],"category_scores_gemma":[0.024972985,0.00083285687,0.0015294185,0.0010035373,0.00224594,0.0021206178,0.0017013646,0.033289652,0.009905548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001639118,0.000044864228,0.0017168024,0.000048029993,0.000023958137,0.00052927353,0.000060891583,0.00005389137,0.000066465516,0.000660919,0.9912615,0.0053694583],"study_design_scores_gemma":[0.0008099712,0.00031190948,0.009591701,0.0009095307,0.00022114784,0.0015914765,0.0012579504,0.0009345883,0.00050810893,0.009180356,0.9745296,0.000153722],"about_ca_topic_score_codex":0.009053399,"about_ca_topic_score_gemma":0.016657438,"teacher_disagreement_score":0.038652506,"about_ca_system_score_codex":0.006434705,"about_ca_system_score_gemma":0.0066370214,"threshold_uncertainty_score":0.046687305},"labels":[],"label_agreement":null},{"id":"W2583563217","doi":"10.1007/s10549-017-4128-5","title":"A comparison of serum miRNAs influencing metastatic growth of EMT6 vs 4THM tumor cells in wild-type and CD200R1KO mice","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"microRNA; Metastatic breast cancer; Biology; Cancer research; Breast cancer; Internal medicine; Mammary gland; Metastasis; Breast tumor; Oncology; Cancer; Endocrinology; Medicine; Gene; Genetics","score_opus":0.046467036384413705,"score_gpt":0.3886256419724195,"score_spread":0.3421586055880058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583563217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956203,0.0005131838,0.0013487823,0.00012761346,0.000051076036,0.000018700619,0.0011184267,0.00008982368,0.0011122685],"genre_scores_gemma":[0.98968446,0.0005324676,0.0020119622,0.000093428556,0.000020185504,0.00009169315,0.0009994252,0.000109593304,0.0064568184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996014,0.000048688806,0.00003912692,0.00009714428,0.00009043469,0.00012320564],"domain_scores_gemma":[0.9995472,0.000077020755,0.0001411667,0.000034307763,0.000040794388,0.00015954339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026551518,0.00039737823,0.00041466384,0.00069905934,0.00021288003,0.0004353533,0.00018749165,0.00045089977,0.0025387844],"category_scores_gemma":[0.00027076944,0.00022356574,0.00034466814,0.00027382007,0.00038661566,0.00040879942,0.0002124285,0.000893673,0.00051431253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011049283,0.000052464624,0.00037577774,0.00001976701,0.000006062018,0.000027901937,0.000023281567,0.000036298927,0.99737716,0.00011962589,0.000051012496,0.00080582313],"study_design_scores_gemma":[0.00003694346,0.0005949712,0.0068208515,0.0000047037415,0.00004301559,0.00012050372,0.00008278175,0.0005487933,0.99042225,0.0000888437,0.001227072,0.0000093465],"about_ca_topic_score_codex":0.0010031176,"about_ca_topic_score_gemma":0.0015934918,"teacher_disagreement_score":0.0025387844,"about_ca_system_score_codex":0.00039943733,"about_ca_system_score_gemma":0.00024194593,"threshold_uncertainty_score":0.008493006},"labels":[],"label_agreement":null},{"id":"W2587392492","doi":"10.1007/s10549-017-4145-4","title":"The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Medical Research Council; KWF Kankerbestrijding; Cancer Australia; European Organisation for Research and Treatment of Cancer; HSBC Bank USA","keywords":"Lymphovascular invasion; Medicine; Breast cancer; Radiation therapy; Mastectomy; Cancer; Pathology; Internal medicine; Oncology; Metastasis","score_opus":0.07847980045363512,"score_gpt":0.47858866135636563,"score_spread":0.4001088609027305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587392492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699497,0.011904716,0.0014326595,0.0024148836,0.0004165402,0.0056830463,0.0017653939,0.0002039196,0.0062293466],"genre_scores_gemma":[0.9822302,0.0016990384,0.0037813236,0.0017819173,0.00045089988,0.0052781613,0.001882209,0.000046372003,0.0028498997],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950499,0.0042105704,0.0001090589,0.00024934683,0.0002334914,0.00014775398],"domain_scores_gemma":[0.996843,0.0008632963,0.0011410307,0.0004140954,0.00020094996,0.0005376551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008754429,0.0008650033,0.0013611653,0.00031419823,0.00043963856,0.001262003,0.00081363367,0.0012799199,0.005794725],"category_scores_gemma":[0.0056711207,0.0003886227,0.0014845902,0.0003533803,0.0012100228,0.0007857479,0.00062186056,0.0015682665,0.0007416536],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9723943,0.0016368936,0.0015997704,0.00083616184,0.00081416854,0.00002973825,0.000081360544,0.00036769075,0.0016108943,0.00019035101,0.0017110227,0.018727712],"study_design_scores_gemma":[0.9003899,0.0826529,0.011006197,0.00017547759,0.0010461162,0.00009896847,0.00004066654,0.000427288,0.00076861173,0.00035112308,0.0030134094,0.000029351379],"about_ca_topic_score_codex":0.00044361263,"about_ca_topic_score_gemma":0.0013284119,"teacher_disagreement_score":0.008754429,"about_ca_system_score_codex":0.0009989628,"about_ca_system_score_gemma":0.0010990613,"threshold_uncertainty_score":0.046298444},"labels":[],"label_agreement":null},{"id":"W2587651410","doi":"10.1007/s10549-017-4150-7","title":"Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Natural Sciences and Engineering Research Council of Canada; Directorate for Education and Human Resources; Susan G. Komen for the Cure","keywords":"Medicine; Breast cancer; Internal medicine; Chemotherapy; Cancer; Hemoglobin; Oncology; Gastroenterology; Urology; Nuclear medicine","score_opus":0.022829970206299843,"score_gpt":0.3664419296927874,"score_spread":0.34361195948648754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587651410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985933,0.0005595161,0.00008689507,0.000044346372,0.000004138599,0.0000024985561,0.00006326123,0.0000038399253,0.00064223725],"genre_scores_gemma":[0.99942255,0.00015860045,0.00006417921,0.000014031101,0.000007742727,0.0000022413992,0.00012078454,0.0000016748206,0.00020822758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998627,0.000030323909,0.000017742788,0.000024746583,0.000032405107,0.000032003303],"domain_scores_gemma":[0.99915326,0.00016991304,0.0004477163,0.00004915366,0.000077160716,0.00010275676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021810413,0.0001583065,0.00018108697,0.00035786233,0.00013347536,0.00040462898,0.00017578615,0.00022942314,0.00094046345],"category_scores_gemma":[0.0015262135,0.00011495289,0.00016905897,0.00038677416,0.00022737893,0.0003023611,0.00022861586,0.0003084692,0.00015212453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089793256,0.000053039752,0.9838734,0.000017230755,0.00004269137,0.00019932984,0.00006845615,0.0001855628,0.004567172,0.000040914158,0.00011274162,0.0099415025],"study_design_scores_gemma":[0.0000045517995,0.00014078054,0.9981781,0.000003717324,0.00003225107,0.0004510521,0.00010259335,0.00026706207,0.0005655537,0.0000282001,0.00022307319,0.000003080912],"about_ca_topic_score_codex":0.0014961646,"about_ca_topic_score_gemma":0.0024229921,"teacher_disagreement_score":0.0014961646,"about_ca_system_score_codex":0.00023655494,"about_ca_system_score_gemma":0.00015917837,"threshold_uncertainty_score":0.0031461716},"labels":[],"label_agreement":null},{"id":"W2588836981","doi":"10.1007/s10549-017-4148-1","title":"A high frequency of PALB2 mutations in Jamaican patients with breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; Toronto Rehabilitation Institute; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"Susan G. Komen for the Cure","keywords":"PALB2; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Mutation; Genetics; Biology; Germline mutation; Gene","score_opus":0.023947965615280474,"score_gpt":0.34202613060381004,"score_spread":0.3180781649885296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588836981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970247,0.00039636114,0.000054513202,0.00021894508,0.000012434296,0.0000032863627,0.00030554633,0.00000677643,0.0019773748],"genre_scores_gemma":[0.9992368,0.00016209933,0.000040611845,0.00006147295,0.000014491485,0.0000018129539,0.00013977768,0.0000026864595,0.00034023146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997775,0.000038390364,0.000019456163,0.00004122139,0.00007411781,0.000049331124],"domain_scores_gemma":[0.99925166,0.00020983245,0.00025207357,0.00004280743,0.00008972108,0.00015394877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016249699,0.0001442794,0.00023238308,0.0009430041,0.00065201655,0.00063728995,0.0002525392,0.0004176011,0.0030077358],"category_scores_gemma":[0.001273779,0.00018634406,0.00012881253,0.0011147493,0.00035846623,0.00021181181,0.00020781235,0.00044680617,0.00024532198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007799288,0.0000219284,0.9955771,0.000010326837,0.000014702751,0.0010266119,0.00012525928,0.000022425647,0.0011013255,0.00003637398,0.00027473585,0.0017112825],"study_design_scores_gemma":[0.000004717061,0.000025031928,0.99581414,0.000006400249,0.000012298952,0.0029807712,0.0005312319,0.00010418917,0.00013110017,0.00003052369,0.00035645827,0.0000030531944],"about_ca_topic_score_codex":0.012711613,"about_ca_topic_score_gemma":0.02143667,"teacher_disagreement_score":0.012711613,"about_ca_system_score_codex":0.00036165386,"about_ca_system_score_gemma":0.00044792006,"threshold_uncertainty_score":0.02527523},"labels":[],"label_agreement":null},{"id":"W2592675053","doi":"10.1007/s10549-017-4167-y","title":"A single-institution experience of salvage therapy for patients with early and locally advanced breast cancer who progress during neoadjuvant chemotherapy","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Lymphovascular invasion; Internal medicine; Cancer; Stage (stratigraphy); Retrospective cohort study; Neoadjuvant therapy; Radiation therapy; Surgery; Metastasis","score_opus":0.05151731546310423,"score_gpt":0.3885889089770704,"score_spread":0.33707159351396615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592675053","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009450366,0.98638296,0.00045132556,0.0005974338,0.00023241123,0.0000337695,0.00011880042,0.000011427435,0.0027215274],"genre_scores_gemma":[0.03984536,0.9554913,0.0011766026,0.0011844959,0.0002131376,0.000036944202,0.00036535354,0.000010918603,0.0016758856],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998381,0.000047597878,0.000030364892,0.00002726222,0.00003620337,0.000020355097],"domain_scores_gemma":[0.99971,0.00015559242,0.000044056225,0.000015048748,0.00004132275,0.000033855096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058264425,0.0002963442,0.00068918546,0.0003827853,0.00021460844,0.00079494365,0.00052958116,0.00043405313,0.0017547114],"category_scores_gemma":[0.0010933429,0.00008852541,0.0004454797,0.00054303213,0.00022629215,0.00054445607,0.00037858522,0.00073306134,0.000451763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003889991,0.00012044103,0.002163991,0.0070755235,0.00024959625,0.000774785,0.0001681781,0.00023559855,0.0013804229,0.00077085674,0.010932413,0.9757391],"study_design_scores_gemma":[0.00031401168,0.0018181584,0.02682843,0.017050095,0.0021540779,0.021990791,0.0007752976,0.00031671426,0.0031996556,0.0019882482,0.923479,0.0000855071],"about_ca_topic_score_codex":0.00070996064,"about_ca_topic_score_gemma":0.003361928,"teacher_disagreement_score":0.0017547114,"about_ca_system_score_codex":0.00047274513,"about_ca_system_score_gemma":0.0010593114,"threshold_uncertainty_score":0.005870044},"labels":[],"label_agreement":null},{"id":"W2595590050","doi":"10.1007/s10549-017-4194-8","title":"Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer","year":2017,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"ArcelorMittal Dofasco","keywords":"Medicine; Breast cancer; Endocrine system; Oncology; Adjuvant; Internal medicine; Cancer; Gynecology; Hormone","score_opus":0.020016887309978786,"score_gpt":0.3200418893353596,"score_spread":0.3000250020253808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595590050","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051469162,0.04280583,0.00045864654,0.8695938,0.019085258,0.000094105504,0.00020740493,0.00005809849,0.01622766],"genre_scores_gemma":[0.3497867,0.029237138,0.0012315668,0.49518868,0.11372467,0.00023351524,0.00023959998,0.00004074946,0.010317379],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952364,0.00018645173,0.00006977638,0.00003955388,0.00011176616,0.00006875523],"domain_scores_gemma":[0.99819946,0.0012628606,0.00013099465,0.00005397699,0.0001028839,0.00024971017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010989452,0.00025272564,0.00090549013,0.00034200345,0.00083468854,0.0007019202,0.0004773979,0.007466298,0.0015910228],"category_scores_gemma":[0.005303127,0.00023257393,0.0005953222,0.00038536367,0.0007742373,0.00058818114,0.00041192072,0.006020947,0.00061332196],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006579617,0.0009149619,0.05320617,0.0007994761,0.00025155226,0.10076843,0.00041944257,0.0010355698,0.005297717,0.0053280466,0.5103229,0.31507608],"study_design_scores_gemma":[0.005876811,0.0060976176,0.05928637,0.0014335525,0.0007860799,0.14986582,0.0010113097,0.004566449,0.004213889,0.021911694,0.7448005,0.00014991255],"about_ca_topic_score_codex":0.0010272078,"about_ca_topic_score_gemma":0.0042384407,"teacher_disagreement_score":0.007466298,"about_ca_system_score_codex":0.0013453369,"about_ca_system_score_gemma":0.0010804213,"threshold_uncertainty_score":0.009761155},"labels":[],"label_agreement":null},{"id":"W2597614090","doi":"10.1007/s10549-017-4203-y","title":"Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Metastatic breast cancer; Chemotherapy; Cardiotoxicity; Oncology; Cancer; Gastroenterology; Surgery","score_opus":0.061904357849037736,"score_gpt":0.37300700441964424,"score_spread":0.3111026465706065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597614090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628395,0.0021352852,0.00021510065,0.00016171312,0.00003516418,0.000038296042,0.00022924438,0.000011864059,0.00088945485],"genre_scores_gemma":[0.9986708,0.000350032,0.000099151424,0.00013766285,0.00010140956,0.000026101616,0.00035996622,0.0000045469724,0.00025031602],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99918705,0.00043402036,0.00004307765,0.00013403907,0.00012011884,0.000081729086],"domain_scores_gemma":[0.99854773,0.0005722401,0.00040361803,0.00018013787,0.00007504403,0.00022125705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002606234,0.00069629867,0.00098923,0.00021756144,0.00015512445,0.00065500056,0.0003823624,0.00067720166,0.0007175458],"category_scores_gemma":[0.0030771876,0.00025789082,0.0006756178,0.00028903875,0.00054309296,0.00054539304,0.00019701757,0.0011815048,0.00018264224],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.664348,0.005616879,0.20236374,0.0002739723,0.0037205284,0.00027683892,0.00012616657,0.0030978778,0.023692505,0.00025878107,0.0014356149,0.094789095],"study_design_scores_gemma":[0.06686264,0.21557136,0.69544953,0.000064883,0.004142805,0.0006511549,0.000105265106,0.0058522187,0.00806487,0.000685178,0.0024763406,0.000073701085],"about_ca_topic_score_codex":0.00034520417,"about_ca_topic_score_gemma":0.00050182606,"teacher_disagreement_score":0.002606234,"about_ca_system_score_codex":0.00046469006,"about_ca_system_score_gemma":0.00037351385,"threshold_uncertainty_score":0.0137832165},"labels":[],"label_agreement":null},{"id":"W2601984009","doi":"10.1007/s10549-017-4223-7","title":"Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Cancer Society; Breast Cancer Society of Canada; Cure Brain Cancer Foundation; Cancer Research Institute","keywords":"Biology; Cancer research; Androgen receptor; Endocrinology; Internal medicine; Nitrotyrosine; Cancer; Nitric oxide synthase; Nitric oxide; Medicine; Prostate cancer","score_opus":0.0353913259735797,"score_gpt":0.3632009935615901,"score_spread":0.3278096675880104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601984009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843901,0.0054319697,0.004071261,0.00038210643,0.00012477579,0.00003613533,0.00077616674,0.00026615255,0.0045214766],"genre_scores_gemma":[0.98037696,0.0018808886,0.003221701,0.0001431542,0.000037973892,0.000050665018,0.0015284184,0.00006228719,0.012698058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997626,0.00003140511,0.000016659305,0.000040910683,0.00006640827,0.00008198387],"domain_scores_gemma":[0.99979836,0.000019059258,0.000046469264,0.000019435427,0.000018683559,0.00009801695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017043018,0.00047321833,0.00020591904,0.0005806457,0.0002540595,0.00034136078,0.00015053093,0.00021151335,0.0029265387],"category_scores_gemma":[0.00012055867,0.00030541996,0.00041431296,0.00026376665,0.00025854816,0.00023813425,0.00022366807,0.0008133852,0.00075007125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021604367,0.000046705256,0.00026149713,0.0000200399,0.000005725458,0.00004830434,0.000011612173,0.000011301767,0.99837166,0.00005527714,0.00008926679,0.0008625814],"study_design_scores_gemma":[0.000034971803,0.00031418962,0.010665478,0.0000056681397,0.000026787053,0.00039483616,0.00006731323,0.00031341126,0.9835963,0.000042097403,0.004534017,0.0000050245962],"about_ca_topic_score_codex":0.0017652554,"about_ca_topic_score_gemma":0.0044407817,"teacher_disagreement_score":0.0029265387,"about_ca_system_score_codex":0.00051731215,"about_ca_system_score_gemma":0.00046165907,"threshold_uncertainty_score":0.009790242},"labels":[],"label_agreement":null},{"id":"W2604242421","doi":"10.1007/s10549-017-4226-4","title":"Which women decide to take tamoxifen?","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Tamoxifen; Breast cancer; Lumpectomy; Medicine; Mastectomy; Oncology; Cancer; Internal medicine; Estrogen receptor; Gynecology; Lymph node; Obstetrics","score_opus":0.04730701913211405,"score_gpt":0.38222266416889894,"score_spread":0.3349156450367849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604242421","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34977517,0.116918154,0.0017226861,0.46199188,0.0038457206,0.0005040605,0.006069404,0.000030982752,0.05914189],"genre_scores_gemma":[0.86371464,0.053797632,0.0018750062,0.06202965,0.0025972445,0.00041642433,0.0010677148,0.000029203913,0.014472534],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985581,0.00083406584,0.00011153314,0.00012676892,0.00019809893,0.00017144835],"domain_scores_gemma":[0.99587846,0.00240135,0.0009229361,0.00013158588,0.00035159037,0.00031405344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034786356,0.0002029856,0.00073865306,0.00060187146,0.0007500688,0.0021269398,0.0005740137,0.0022550442,0.015741047],"category_scores_gemma":[0.015598005,0.0003575856,0.00056289096,0.0010787705,0.0011467192,0.0021948677,0.00040259477,0.0017555994,0.0026480693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012837653,0.00097132806,0.38623595,0.002346355,0.0013325823,0.0015129023,0.003299024,0.00023841878,0.0022101146,0.011596004,0.09755452,0.4798652],"study_design_scores_gemma":[0.0056506274,0.0023427855,0.39214423,0.007264879,0.0034967829,0.0052009546,0.043233875,0.0014180634,0.0034331717,0.101595394,0.43394938,0.00026985604],"about_ca_topic_score_codex":0.0077148825,"about_ca_topic_score_gemma":0.017101556,"teacher_disagreement_score":0.015741047,"about_ca_system_score_codex":0.0010668763,"about_ca_system_score_gemma":0.0022031341,"threshold_uncertainty_score":0.052659035},"labels":[],"label_agreement":null},{"id":"W2606387632","doi":"10.1007/s10549-017-4228-2","title":"Ablative Therapies in Metastatic Breast Cancer: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; Juravinski Cancer Centre","funders":"Hamilton Health Sciences","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Metastasectomy; Oncology; Disease; Population; Internal medicine; Cancer; Clinical trial; Observational study; Meta-analysis; Cohort; Metastasis","score_opus":0.15737470404306564,"score_gpt":0.4706398704527674,"score_spread":0.31326516640970176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606387632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019752196,0.9994894,0.000032033608,0.000053481355,0.000027891516,0.000022110875,0.00008545694,0.0000018367911,0.00009018032],"genre_scores_gemma":[0.0024817795,0.99703455,0.00012762714,0.00020533205,0.00002667,0.000026301534,0.00005103978,0.0000011018485,0.00004563237],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99899405,0.00026070792,0.0003746186,0.00013427735,0.00018394348,0.000052288528],"domain_scores_gemma":[0.99695045,0.002079469,0.0006965345,0.000041804888,0.00017939457,0.000052457082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020595659,0.0011630872,0.005476422,0.0034391726,0.00025698586,0.0014649405,0.0013538877,0.0013305784,0.005544425],"category_scores_gemma":[0.0064081643,0.0005880735,0.0046214852,0.0046219416,0.00048584928,0.0012379156,0.0009561158,0.0010409887,0.00034384994],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045121228,0.00003781427,0.0005456548,0.8770259,0.011555463,0.00009800775,0.000086893844,0.00021340005,0.00036185715,0.00030507107,0.0039001862,0.10541851],"study_design_scores_gemma":[0.0012988633,0.00062618585,0.006936863,0.67529154,0.20306051,0.00090638094,0.00035965184,0.00019778703,0.0004460725,0.0011601144,0.1096142,0.00010175612],"about_ca_topic_score_codex":0.0038435787,"about_ca_topic_score_gemma":0.014723494,"teacher_disagreement_score":0.005544425,"about_ca_system_score_codex":0.0010580195,"about_ca_system_score_gemma":0.0026776434,"threshold_uncertainty_score":0.018547952},"labels":[],"label_agreement":null},{"id":"W2606736232","doi":"10.1007/s10549-010-0979-8","title":"Erratum to: Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network","year":2010,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Breast cancer; Medicine; Breast density; Oncology; Gynecology; Cancer; Breast cancer screening; Hormone therapy; Internal medicine; Obstetrics; Mammography","score_opus":0.07088839722031119,"score_gpt":0.36910111948721835,"score_spread":0.29821272226690715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606736232","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004071295,0.0030458716,0.0006162399,0.12497735,0.86114603,0.00009158252,0.003436302,0.00022069208,0.006058779],"genre_scores_gemma":[0.01354521,0.0260374,0.0115523385,0.4114474,0.2725513,0.00074100186,0.012598378,0.0014023671,0.25012463],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947266,0.00091534597,0.001952537,0.00030220422,0.0018090066,0.0002943541],"domain_scores_gemma":[0.95371747,0.011544648,0.002605322,0.0015401328,0.029223979,0.0013683706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004683267,0.002103445,0.0022247138,0.0046751834,0.0026694133,0.0023712022,0.0023845718,0.0074082757,0.015747668],"category_scores_gemma":[0.055994138,0.0013429418,0.0015442425,0.00346575,0.0010389363,0.0017159071,0.0011137876,0.009314306,0.017021246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033281114,0.000015445174,0.00027523146,0.00009916594,0.000006597279,0.000104552084,0.000014976644,0.000027403334,0.000020697751,0.00011304183,0.9943652,0.0049243937],"study_design_scores_gemma":[0.000096316864,0.00006758048,0.008540415,0.0017573306,0.00011058022,0.000587146,0.0003289367,0.00038127953,0.00044792166,0.00042723276,0.9871859,0.00006947322],"about_ca_topic_score_codex":0.056710035,"about_ca_topic_score_gemma":0.066462204,"teacher_disagreement_score":0.056710035,"about_ca_system_score_codex":0.003556747,"about_ca_system_score_gemma":0.008619242,"threshold_uncertainty_score":0.11275989},"labels":[],"label_agreement":null},{"id":"W2606772776","doi":"10.1007/s10549-016-3898-5","title":"UK Breast Cancer Research Symposium 2016: Submitted Abstracts","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.07096547379454653,"score_gpt":0.40906914589680904,"score_spread":0.3381036721022625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606772776","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005589051,0.33933324,0.0014319429,0.09645703,0.22528425,0.00057635823,0.009139367,0.0009123919,0.32127637],"genre_scores_gemma":[0.014265148,0.09903594,0.0011589378,0.0063960464,0.043164425,0.00020065808,0.0097591225,0.00027219602,0.8257476],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980007,0.00041186588,0.00022695168,0.0003500007,0.00068578846,0.00032469668],"domain_scores_gemma":[0.99672,0.00024557087,0.00032421478,0.00021740569,0.0015105719,0.0009822675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031167709,0.001371614,0.0011589665,0.0031393676,0.0007987486,0.0036054526,0.0012374528,0.0033871986,0.28133062],"category_scores_gemma":[0.0032621191,0.00066924747,0.0009342943,0.0020502156,0.00046042373,0.0012505037,0.0020772556,0.0020930634,0.13656968],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003117893,0.000036153015,0.00047322345,0.0006840188,0.000024577123,0.000224647,0.000037469632,0.000043921224,0.0009454024,0.0005450739,0.9030136,0.093660176],"study_design_scores_gemma":[0.000036012807,0.000060727958,0.0020127369,0.00041975226,0.00001396755,0.00031160173,0.000039856233,0.000018627281,0.00022992291,0.00021762251,0.9966318,0.0000074464338],"about_ca_topic_score_codex":0.0024793383,"about_ca_topic_score_gemma":0.0070584863,"teacher_disagreement_score":0.7186694,"about_ca_system_score_codex":0.0027949095,"about_ca_system_score_gemma":0.002295568,"threshold_uncertainty_score":0.94114465},"labels":[],"label_agreement":null},{"id":"W2608642020","doi":"10.1007/s10549-017-4265-x","title":"Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of British Columbia; Centre hospitalier universitaire de Québec; BC Cancer Agency; Queen's University; University of Toronto; University Health Network; Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; Cancer Research UK; National Institutes of Health; Apotex; Canadian Cancer Society; Breast Cancer Research Foundation","keywords":"Metformin; Medicine; Breast cancer; Internal medicine; Vitamin B12; Placebo; Oncology; Endocrinology; Diabetes mellitus; Cancer; Pathology","score_opus":0.017662310273575572,"score_gpt":0.3250811798057714,"score_spread":0.3074188695321958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608642020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945551,0.0030939858,0.000042658925,0.0003994266,0.00022986147,0.00018491391,0.00046536096,0.000023729503,0.0010049541],"genre_scores_gemma":[0.9965455,0.0010616812,0.0001322514,0.0002464552,0.00014530185,0.0002531539,0.00044964126,0.000004821099,0.0011611888],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994998,0.00023335981,0.00005408778,0.000059135204,0.000027328499,0.00012633871],"domain_scores_gemma":[0.9991234,0.00023831693,0.00017842714,0.00006115153,0.000049447073,0.00034926712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075554923,0.00064458186,0.0022180693,0.00037862128,0.000398323,0.00068041944,0.00041443107,0.0009865678,0.006057037],"category_scores_gemma":[0.0023706756,0.00037636815,0.0016233247,0.0004222015,0.00033992098,0.0006307202,0.00043680362,0.0016709579,0.00039541945],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98012733,0.0031128316,0.0030903134,0.00017064744,0.0007101108,0.00005618636,0.000041331394,0.000071476585,0.0015117084,0.000026514928,0.00046724523,0.010614218],"study_design_scores_gemma":[0.5471471,0.2962658,0.14639094,0.00020540254,0.004515709,0.00011957686,0.00033675073,0.0011052336,0.0015387181,0.00026977144,0.00201841,0.00008644694],"about_ca_topic_score_codex":0.0049459767,"about_ca_topic_score_gemma":0.012066226,"teacher_disagreement_score":0.006057037,"about_ca_system_score_codex":0.00091351196,"about_ca_system_score_gemma":0.0010630403,"threshold_uncertainty_score":0.020262778},"labels":[],"label_agreement":null},{"id":"W2610118912","doi":"10.1007/s10549-017-4263-z","title":"Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; BC Cancer Agency; Statistics Canada; University of Toronto; Mount Sinai Hospital","funders":"University of Toronto; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Anthropometry; Waist; Interquartile range; Internal medicine; Diabetes mellitus; Cancer; Metabolic equivalent; Odds ratio; Body mass index; Physical therapy; Physical activity; Endocrinology","score_opus":0.14414349442341914,"score_gpt":0.43791641691025573,"score_spread":0.2937729224868366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610118912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964774,0.00013208567,0.000013435669,0.000014276494,0.0000054009315,0.0000017068493,0.00008895485,0.0000012779018,0.00009526194],"genre_scores_gemma":[0.9994647,0.00008246035,0.000014463885,0.000011647068,0.000006751576,0.0000036395043,0.00021852557,5.294218e-7,0.00019722249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990916,0.000017944125,0.000008315661,0.00002090635,0.0000121057265,0.000031500516],"domain_scores_gemma":[0.9998128,0.00003807461,0.000045339468,0.000013270721,0.000021136673,0.00006952035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016522306,0.00020401475,0.0003653916,0.00042970627,0.00023001648,0.00038923748,0.00016744345,0.00032599724,0.0009089815],"category_scores_gemma":[0.0005903066,0.0001424294,0.00037375803,0.00046365891,0.00014714203,0.00029570807,0.0003210032,0.00040390485,0.000121736404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002153687,0.00027764688,0.9927982,0.000015155629,0.000105558596,0.000107801534,0.00015998205,0.000045192533,0.0009522303,0.000011272057,0.00008727204,0.0032860592],"study_design_scores_gemma":[0.000011825914,0.00025526306,0.9992368,0.0000011917806,0.000039131715,0.00005586968,0.00025018858,0.000048049264,0.00004819939,0.00000590565,0.00004597332,0.0000017116855],"about_ca_topic_score_codex":0.009175343,"about_ca_topic_score_gemma":0.0058748466,"teacher_disagreement_score":0.009175343,"about_ca_system_score_codex":0.0002706827,"about_ca_system_score_gemma":0.0001537822,"threshold_uncertainty_score":0.01824385},"labels":[],"label_agreement":null},{"id":"W2611609325","doi":"10.1007/s10549-017-4269-6","title":"The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapy","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Institute of Health Services and Policy Research","funders":"","keywords":"Breast cancer; Chemotherapy; Medicine; Oncology; Estrogen receptor; Internal medicine; Estrogen; Cancer; Neoadjuvant therapy; Mammary gland; Gynecology","score_opus":0.053567593266640776,"score_gpt":0.3815715253022727,"score_spread":0.3280039320356319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611609325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000112162175,0.9994949,0.000036802194,0.0001364076,0.000053895972,0.0000018443789,0.000016321595,0.0000013628354,0.00014639982],"genre_scores_gemma":[0.001295627,0.9981324,0.00011185471,0.00020271953,0.00012944202,0.0000044049816,0.000029677269,7.883212e-7,0.00009313344],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997067,0.00007229281,0.000067341585,0.000056511486,0.00007894043,0.00001826108],"domain_scores_gemma":[0.998796,0.00086630986,0.00013697118,0.00001904033,0.00015061043,0.00003105305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00128112,0.0006454324,0.0021233694,0.0011879948,0.000112186586,0.00092165265,0.0008694743,0.00079679827,0.0012681416],"category_scores_gemma":[0.002127717,0.00027428623,0.0007090965,0.0014126342,0.00044771345,0.0006811309,0.00046283714,0.0014301103,0.0004659367],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033478223,0.00004805301,0.0016885328,0.018971942,0.00049672206,0.00010430852,0.000030756946,0.00029822212,0.00045627856,0.00092602393,0.010349541,0.96629477],"study_design_scores_gemma":[0.0004176556,0.00068294123,0.018430335,0.030418726,0.0054759816,0.0027563155,0.00023377893,0.0006478025,0.0012536991,0.003936853,0.93562394,0.00012179639],"about_ca_topic_score_codex":0.0014690399,"about_ca_topic_score_gemma":0.003142694,"teacher_disagreement_score":0.0021233694,"about_ca_system_score_codex":0.00051028415,"about_ca_system_score_gemma":0.0010748457,"threshold_uncertainty_score":0.0067753196},"labels":[],"label_agreement":null},{"id":"W2612229014","doi":"10.1007/s10549-017-4287-4","title":"Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Breast cancer; Biology; Germline; Genome-wide association study; Exome; Germline mutation; Oncology; Genetic association; Genetics; Genetic variation; Cancer; Single-nucleotide polymorphism; Gene; Internal medicine; Exome sequencing; Medicine; Mutation; Genotype","score_opus":0.05873789789022375,"score_gpt":0.352359507779468,"score_spread":0.29362160988924424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612229014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865993,0.008414685,0.0016485612,0.00079232577,0.000108429595,0.000009524971,0.0007636691,0.00004047566,0.0016230034],"genre_scores_gemma":[0.99817777,0.00089180574,0.00026666545,0.00014381943,0.00008672954,0.0000034507527,0.000260088,0.000011719189,0.00015792612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99107766,0.0054081795,0.0004196364,0.0018889807,0.00084069074,0.00036484312],"domain_scores_gemma":[0.927945,0.055888105,0.0058353874,0.007778681,0.001358632,0.0011941593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010016856,0.0009963186,0.0013163792,0.0008838982,0.00045728107,0.0013656645,0.0015831452,0.0014757456,0.0019555758],"category_scores_gemma":[0.04171979,0.0005610681,0.0024620267,0.0012106103,0.0014521021,0.00093202665,0.0011247686,0.0016324407,0.0002580074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003912562,0.000116723655,0.9741595,0.00011403901,0.0058662347,0.0002899977,0.000106107254,0.00096791534,0.0006273896,0.00025392705,0.00022689142,0.013358627],"study_design_scores_gemma":[0.0001495663,0.0005992048,0.99000627,0.00005826354,0.00434135,0.0003902841,0.00007263764,0.0022318857,0.00038016628,0.0012860406,0.000467592,0.00001681264],"about_ca_topic_score_codex":0.004869145,"about_ca_topic_score_gemma":0.004390164,"teacher_disagreement_score":0.010016856,"about_ca_system_score_codex":0.00023720201,"about_ca_system_score_gemma":0.0004154302,"threshold_uncertainty_score":0.05297482},"labels":[],"label_agreement":null},{"id":"W2612557208","doi":"10.1007/s10549-017-4273-x","title":"Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University","funders":"Canadian Cancer Society Research Institute; GlaxoSmithKline; Pfizer","keywords":"Lapatinib; Trastuzumab; Medicine; Oncology; Breast cancer; Internal medicine; Cancer; Metastatic breast cancer","score_opus":0.13082130753244084,"score_gpt":0.49038875891903344,"score_spread":0.35956745138659263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612557208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193054,0.0052207536,0.00004705443,0.0009216479,0.0001055257,0.000016491984,0.00026614737,0.00001494234,0.0014769172],"genre_scores_gemma":[0.9981554,0.00055720593,0.000037674417,0.00022560825,0.00011607051,0.0000127440035,0.00037381198,0.0000032891078,0.00051816186],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996542,0.00010162826,0.000023043121,0.00004950543,0.000037745533,0.00013396035],"domain_scores_gemma":[0.99919575,0.00021950701,0.00012764132,0.00003575724,0.00002790234,0.00039347186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006663393,0.00032843737,0.0010839998,0.0001972168,0.00018091731,0.0006046535,0.00045505058,0.0006527524,0.002963832],"category_scores_gemma":[0.0016523941,0.00011377999,0.0012237367,0.00021978357,0.00027596866,0.00056747656,0.0003289582,0.001243946,0.0003117747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65028703,0.0027198743,0.15533073,0.00033408013,0.0027675543,0.0003292137,0.00015590292,0.0038375128,0.0073063537,0.0005255154,0.0077264807,0.16867971],"study_design_scores_gemma":[0.029934455,0.13610195,0.80967385,0.00032695982,0.0064170025,0.0007691232,0.0004053037,0.007092272,0.002793846,0.0013478909,0.005021137,0.000116233525],"about_ca_topic_score_codex":0.0035523316,"about_ca_topic_score_gemma":0.008396465,"teacher_disagreement_score":0.0035523316,"about_ca_system_score_codex":0.00093554537,"about_ca_system_score_gemma":0.0010542901,"threshold_uncertainty_score":0.009915054},"labels":[],"label_agreement":null},{"id":"W2613080729","doi":"10.1007/s10549-017-4282-9","title":"Risk of death from cardiovascular disease following breast cancer: a systematic review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Population; Disease; Cause of death; Cancer; Internal medicine; Cohort study; Cochrane Library; Oncology; Meta-analysis; Environmental health","score_opus":0.12971090185966094,"score_gpt":0.42632055778601124,"score_spread":0.2966096559263503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613080729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015311011,0.9972905,0.00008889332,0.00017338515,0.00006911474,0.00022610625,0.00041313554,0.0000067352057,0.0002011115],"genre_scores_gemma":[0.022360826,0.9757034,0.00043193484,0.00042444703,0.000085777334,0.00056893,0.00031490947,0.0000043120344,0.00010551879],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99447364,0.0018739149,0.0020192608,0.00046430377,0.0009914862,0.0001774742],"domain_scores_gemma":[0.9774024,0.015776038,0.0046092756,0.0002581138,0.0016898863,0.0002642265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055571613,0.0012310715,0.0071595376,0.0073701846,0.0005430215,0.0022660864,0.0015280567,0.0017364632,0.0032254385],"category_scores_gemma":[0.030603914,0.0009157202,0.007584592,0.008973127,0.00066013786,0.0015062654,0.0011929282,0.0011051997,0.00023512483],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019000734,0.000011162528,0.0017714272,0.9652321,0.014787602,0.00010812115,0.00015223131,0.000083775754,0.00007575014,0.00008917575,0.00095247343,0.01654619],"study_design_scores_gemma":[0.00042263189,0.00020002136,0.011587052,0.82460374,0.15100446,0.0006245448,0.00027930771,0.00012603175,0.00015123551,0.00025973486,0.010691425,0.000049842984],"about_ca_topic_score_codex":0.009600652,"about_ca_topic_score_gemma":0.022520982,"teacher_disagreement_score":0.009600652,"about_ca_system_score_codex":0.0033907937,"about_ca_system_score_gemma":0.0073356978,"threshold_uncertainty_score":0.029389441},"labels":[],"label_agreement":null},{"id":"W2615476028","doi":"10.1007/s10549-017-4299-0","title":"Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Cancer Institute; Hologic","keywords":"Tomosynthesis; Mammography; Digital mammography; Medicine; Digital Breast Tomosynthesis; Breast cancer; Cancer detection; Breast cancer screening; Radiology; Cancer; Nuclear medicine; Internal medicine","score_opus":0.03833765043007683,"score_gpt":0.36297614639031234,"score_spread":0.32463849596023553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615476028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995395,0.0028476524,0.00015101608,0.00014884304,0.000101108635,0.000012090062,0.00011351363,0.000013095297,0.0012176889],"genre_scores_gemma":[0.99800915,0.0007288117,0.000157679,0.000050569444,0.000100916084,0.0000063105526,0.00005189615,0.000008768623,0.00088588684],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989661,0.0005591293,0.00007444031,0.00013859617,0.00011782016,0.00014392093],"domain_scores_gemma":[0.98915803,0.008329353,0.0008164842,0.00036057815,0.0003398969,0.0009956167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001618072,0.0006202556,0.0010696311,0.0004639299,0.00029904445,0.00053349935,0.00027320205,0.0007137328,0.0030181776],"category_scores_gemma":[0.010848003,0.00029637924,0.00095227157,0.0004625893,0.0002852056,0.00073863653,0.0005208354,0.00065159233,0.00027080713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4912179,0.006212211,0.4069113,0.0003984106,0.0012625459,0.0010853047,0.0006027481,0.0015545213,0.025470527,0.00022080762,0.00043040598,0.06463327],"study_design_scores_gemma":[0.0010587403,0.05904272,0.9238595,0.00008002865,0.0031479348,0.0007935685,0.0004617224,0.002604541,0.00708359,0.00025937194,0.0015511429,0.000057272002],"about_ca_topic_score_codex":0.0017530617,"about_ca_topic_score_gemma":0.0019736963,"teacher_disagreement_score":0.0030181776,"about_ca_system_score_codex":0.00025335242,"about_ca_system_score_gemma":0.0005456398,"threshold_uncertainty_score":0.010096788},"labels":[],"label_agreement":null},{"id":"W2615995330","doi":"10.1007/s10549-017-4302-9","title":"The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Cancer; Breast cancer screening; Oncology; Gynecology; Breast screening; Obstetrics; Internal medicine; Mammography","score_opus":0.5872976110480123,"score_gpt":0.5285825469658729,"score_spread":0.058715064082139334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615995330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072413626,0.9952964,0.000067097404,0.0022405072,0.0005190483,0.000021276192,0.00033439187,0.000006693458,0.0014421908],"genre_scores_gemma":[0.0009843574,0.9969758,0.00023020525,0.0010931215,0.00018507075,0.000022438979,0.00022395227,0.0000043517666,0.00028075153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528164,0.0011603972,0.00078766176,0.0003098092,0.0022062487,0.00025426337],"domain_scores_gemma":[0.9792797,0.011844469,0.001516588,0.0005256944,0.006390039,0.00044347582],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009413016,0.0011789398,0.0039306064,0.0063724923,0.0008924,0.0024579451,0.0031326984,0.0019178068,0.009109366],"category_scores_gemma":[0.029752674,0.00046716683,0.0029892386,0.010471295,0.0011182693,0.0020376018,0.0011885931,0.0030278896,0.0014401755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019091762,0.000030207582,0.0011021144,0.18246439,0.0019952527,0.00007785338,0.00013264455,0.00021064664,0.00016453624,0.0053845197,0.1256445,0.68260235],"study_design_scores_gemma":[0.00007815911,0.00005578534,0.005103292,0.1632193,0.004277743,0.00033854254,0.00024538508,0.00008174592,0.00018816693,0.0024387783,0.8239353,0.000037831007],"about_ca_topic_score_codex":0.09496823,"about_ca_topic_score_gemma":0.2168837,"teacher_disagreement_score":0.9932907,"about_ca_system_score_codex":0.0067092795,"about_ca_system_score_gemma":0.02288978,"threshold_uncertainty_score":0.18883091},"labels":[],"label_agreement":null},{"id":"W2619353077","doi":"10.1007/s10549-017-4290-9","title":"Predictors of distress in female breast cancer survivors: a systematic review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Distress; Medicine; Oncology; Cancer; Internal medicine; Gynecology; Clinical psychology","score_opus":0.13724437385951666,"score_gpt":0.44862203048864835,"score_spread":0.3113776566291317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619353077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00175571,0.997088,0.000106910105,0.00019755618,0.000060159593,0.0002103149,0.00039949405,0.000006469974,0.0001754954],"genre_scores_gemma":[0.019145958,0.9793396,0.00048195326,0.0002637223,0.00004348238,0.00040005337,0.00024685927,0.0000033465194,0.000074889605],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954461,0.0014727094,0.0016915827,0.00035995408,0.00087766856,0.00015205715],"domain_scores_gemma":[0.975497,0.017469984,0.004856391,0.00025061012,0.0016803434,0.0002456441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005291735,0.0014092777,0.006107288,0.008516897,0.0005645466,0.0024007554,0.0016266891,0.0014205809,0.0030942454],"category_scores_gemma":[0.032696318,0.001056935,0.0064710877,0.011555769,0.00076023326,0.0019813303,0.0013115561,0.0009870492,0.00022574974],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011504173,0.000014614287,0.0022977125,0.95773005,0.008495315,0.00010044162,0.00023713245,0.00008925662,0.00008048559,0.00012891008,0.0010778625,0.029633192],"study_design_scores_gemma":[0.00012281485,0.0001777485,0.011560681,0.8998473,0.07459679,0.000489251,0.00044434203,0.00010168792,0.00012306444,0.00021177661,0.01228535,0.000039107243],"about_ca_topic_score_codex":0.009332104,"about_ca_topic_score_gemma":0.028856384,"teacher_disagreement_score":0.009332104,"about_ca_system_score_codex":0.0027713582,"about_ca_system_score_gemma":0.010979779,"threshold_uncertainty_score":0.027985692},"labels":[],"label_agreement":null},{"id":"W2621449981","doi":"10.1007/s10549-017-4333-2","title":"The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Oncology; Tamoxifen; Estrogen receptor; Internal medicine; Cancer; Hazard ratio; Proportional hazards model; Gynecology; Confidence interval","score_opus":0.025642079047637253,"score_gpt":0.3612508241880705,"score_spread":0.3356087451404332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621449981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953113,0.0030201036,0.00008920788,0.00018789413,0.000030102277,0.00000206847,0.00019973624,0.0000025714553,0.0011569653],"genre_scores_gemma":[0.9984206,0.0006920326,0.000034765755,0.000072788775,0.00006455478,0.0000012801194,0.00022456663,0.000002696905,0.0004867567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996257,0.00014671027,0.000032275613,0.0000564327,0.000048216538,0.000090554255],"domain_scores_gemma":[0.9980063,0.00095935026,0.00048472206,0.00014576902,0.00010979795,0.00029409555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008864648,0.00019695371,0.0004044757,0.0005049002,0.00020793523,0.0004960993,0.0001713038,0.0003709946,0.0026275646],"category_scores_gemma":[0.0039296956,0.00011511709,0.00058976276,0.0006327218,0.0001917424,0.0005317942,0.00023834984,0.0003767846,0.0003052348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002705001,0.00003315426,0.98217314,0.000026145945,0.00019247131,0.000121899306,0.00012024449,0.00006679128,0.0017904849,0.00007872572,0.00016393616,0.012528117],"study_design_scores_gemma":[0.00002494035,0.00024370592,0.9982186,0.000010059183,0.00019196697,0.0002213711,0.00012663219,0.000070445545,0.0002503368,0.000075877906,0.00056177983,0.000004180682],"about_ca_topic_score_codex":0.0020743476,"about_ca_topic_score_gemma":0.0032776338,"teacher_disagreement_score":0.0026275646,"about_ca_system_score_codex":0.00017954715,"about_ca_system_score_gemma":0.0001827778,"threshold_uncertainty_score":0.008790016},"labels":[],"label_agreement":null},{"id":"W2622584394","doi":"10.1007/s10549-017-4323-4","title":"Lifetime moderate-to-vigorous physical activity and ER/PR/HER-defined post-menopausal breast cancer risk","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Université de Montréal; University of British Columbia; Queen's University; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Population and Public Health; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Breast cancer; Medicine; Demography; Metabolic equivalent; Logistic regression; Estrogen receptor; Internal medicine; Odds ratio; Cancer; Oncology; Gynecology; Gerontology; Physical activity; Physical therapy","score_opus":0.0662484269751112,"score_gpt":0.41045525824711826,"score_spread":0.3442068312720071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622584394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636143,0.0010192147,0.0001123679,0.000075996984,0.000018588358,0.000008556693,0.0012164215,0.000008982864,0.0011785228],"genre_scores_gemma":[0.9982822,0.0001749071,0.00004898442,0.000021999998,0.000018875418,0.000007287379,0.0006419411,0.0000022804554,0.0008015231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981266,0.000048134854,0.000022907889,0.0000415954,0.000024937382,0.000049819075],"domain_scores_gemma":[0.99946374,0.00009848526,0.00020519359,0.00003635461,0.000033895692,0.0001623783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003282361,0.00023520533,0.00025451358,0.00047179096,0.00021873787,0.00045992344,0.00031525173,0.0003805651,0.0033267383],"category_scores_gemma":[0.001301181,0.00021813012,0.0007641252,0.000510174,0.00012922812,0.00030845185,0.00040465407,0.00056233973,0.00029697633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008561014,0.00005850332,0.9968641,0.000017061993,0.0001847832,0.000038668295,0.000034503795,0.000046028337,0.00023209232,0.00003089566,0.00009652174,0.0015409096],"study_design_scores_gemma":[0.000008022512,0.000069692316,0.9993635,0.0000043134733,0.000059962167,0.000092815964,0.00007434007,0.00012495245,0.00002673862,0.000024109127,0.00014928832,0.0000023118853],"about_ca_topic_score_codex":0.0052409796,"about_ca_topic_score_gemma":0.0069335178,"teacher_disagreement_score":0.0052409796,"about_ca_system_score_codex":0.00018448757,"about_ca_system_score_gemma":0.00019985181,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2624904204","doi":"10.1007/s10549-017-4332-3","title":"Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Medical Research Council; University of Toronto; Cancer Australia; National Breast Cancer Foundation; National Institute for Health and Care Research; National Health and Medical Research Council; Amgen","keywords":"Breast cancer; BRCA mutation; Medicine; Fertility; Oncology; Gynecology; Cancer; Genetic counseling; Internal medicine; Demography; Obstetrics; Environmental health; Population; Genetics; Biology","score_opus":0.04841910130758634,"score_gpt":0.39464503095536685,"score_spread":0.34622592964778054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624904204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980247,0.0000133845915,0.00064001157,0.00010317783,0.000011314391,0.0005233048,0.00010565072,0.000004199657,0.0005742292],"genre_scores_gemma":[0.9905916,0.000070866576,0.005040132,0.00028228958,0.000022029637,0.002775112,0.00014572058,0.0000024294488,0.0010698143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957467,0.003235274,0.00022445699,0.0002332168,0.00033770778,0.00022263573],"domain_scores_gemma":[0.9803247,0.015586813,0.0020390751,0.0007702239,0.00036352818,0.0009156258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008538972,0.00052281126,0.00054900674,0.0002360604,0.0005448122,0.0011173519,0.0004822164,0.0011484617,0.005707633],"category_scores_gemma":[0.015094199,0.0003993366,0.0007797579,0.000249431,0.00080719317,0.00076304463,0.00052060507,0.0014489209,0.0005008872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15440767,0.25968057,0.37082288,0.0016929251,0.0013449565,0.0010743276,0.017534407,0.02304398,0.05824245,0.008319682,0.0038781965,0.099957965],"study_design_scores_gemma":[0.042032864,0.44653907,0.29155967,0.00037798914,0.0010064989,0.0006287767,0.010694301,0.14560127,0.030518282,0.018992428,0.011521089,0.0005277184],"about_ca_topic_score_codex":0.0007304985,"about_ca_topic_score_gemma":0.0008242273,"teacher_disagreement_score":0.008538972,"about_ca_system_score_codex":0.00047833877,"about_ca_system_score_gemma":0.00078667206,"threshold_uncertainty_score":0.045158982},"labels":[],"label_agreement":null},{"id":"W2626019450","doi":"10.1007/s10549-017-4329-y","title":"Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Novartis Pharmaceuticals Corporation; Foundation for Barnes-Jewish Hospital; University of British Columbia; Breast Cancer Research Foundation; Avon Foundation for Women","keywords":"Medicine; Breast cancer; Concordance; Internal medicine; Neoadjuvant therapy; Clinical trial; Oncology; Triage; Cancer; Clinical endpoint","score_opus":0.17084832900656038,"score_gpt":0.4824769193406639,"score_spread":0.3116285903341035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626019450","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7325744,0.010645931,0.23688027,0.0013169327,0.00036644872,0.0038264394,0.0019956722,0.002700782,0.009693161],"genre_scores_gemma":[0.8144421,0.0011785021,0.1780379,0.0004630343,0.00010306475,0.0014508554,0.0022439754,0.00018693358,0.0018936478],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99085265,0.004685592,0.0007008204,0.0006979151,0.0028031347,0.00026000186],"domain_scores_gemma":[0.9889203,0.0035019661,0.0019756062,0.0011807014,0.0039710263,0.0004503922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016792292,0.00067273196,0.00072280574,0.0031036334,0.00028913,0.002507824,0.0010472244,0.0009218823,0.0014075019],"category_scores_gemma":[0.020490544,0.0004881737,0.00051875203,0.001049757,0.00063861173,0.0006210477,0.00093665085,0.0012732368,0.0011859671],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072860434,0.0010512198,0.38997972,0.0009931945,0.0006410663,0.00029767663,0.00042469922,0.010128856,0.20339313,0.0013651004,0.0040962347,0.38034305],"study_design_scores_gemma":[0.001120902,0.011820544,0.35761338,0.00031981568,0.00082503416,0.0037520765,0.00032008893,0.15555374,0.43868944,0.0018992415,0.027815195,0.0002706356],"about_ca_topic_score_codex":0.00096988777,"about_ca_topic_score_gemma":0.0012001244,"teacher_disagreement_score":0.016792292,"about_ca_system_score_codex":0.00075193954,"about_ca_system_score_gemma":0.0012445464,"threshold_uncertainty_score":0.088807225},"labels":[],"label_agreement":null},{"id":"W2732269941","doi":"10.1007/s10549-017-4356-8","title":"Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health","keywords":"PALB2; Breast cancer; Germline mutation; Germline; Genetics; Population; Biology; Oncology; Cancer; Mutation; Medicine; Cancer research; Gene","score_opus":0.03240576977175894,"score_gpt":0.3555621382868467,"score_spread":0.3231563685150877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732269941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99958676,0.000048498183,0.000023296348,0.00001788085,0.0000011944172,0.0000024376732,0.00008874598,0.0000016700809,0.00022946516],"genre_scores_gemma":[0.99947685,0.000089974215,0.00005352431,0.0000128992715,0.000001913444,0.0000027236947,0.00009541394,9.675008e-7,0.00026582167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979025,0.000032227716,0.000033420303,0.000056176654,0.000037828657,0.000050174363],"domain_scores_gemma":[0.99968004,0.000045028002,0.00013353741,0.000017066204,0.000044025637,0.00008032821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020631308,0.00022368557,0.0001717005,0.0009877058,0.00041216938,0.00037608232,0.00042154637,0.00026077827,0.001628769],"category_scores_gemma":[0.00060736726,0.00037997492,0.0002580394,0.000692742,0.00041435086,0.00027939628,0.00036544277,0.000304276,0.00024136623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000315107,0.000025124986,0.99708647,0.000011484674,0.000013870268,0.00046463724,0.00038893326,0.000025658434,0.0007154157,0.000028661638,0.00005528101,0.0011529004],"study_design_scores_gemma":[0.0000021465455,0.000076611934,0.9948543,0.000008811805,0.000017671262,0.0025736631,0.0020082064,0.00010700509,0.00016309967,0.000024759673,0.00015830775,0.0000055474375],"about_ca_topic_score_codex":0.014626409,"about_ca_topic_score_gemma":0.013948908,"teacher_disagreement_score":0.014626409,"about_ca_system_score_codex":0.0003344871,"about_ca_system_score_gemma":0.00040578088,"threshold_uncertainty_score":0.029082537},"labels":[],"label_agreement":null},{"id":"W2734965735","doi":"10.1007/s10549-017-4376-4","title":"Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; St. Joseph’s Healthcare Hamilton; University of Toronto; York University","funders":"Canadian Institutes of Health Research","keywords":"PsycINFO; Executive dysfunction; Checklist; MEDLINE; Breast cancer; Meta-analysis; Clinical psychology; Neuropsychology; Systematic review; Medicine; Cognition; Executive functions; Psychology; Cancer; Psychiatry; Internal medicine; Cognitive psychology","score_opus":0.09627293851627458,"score_gpt":0.4325062621053616,"score_spread":0.336233323589087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734965735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019873902,0.99749607,0.000042621927,0.000064009095,0.000040905106,0.000061840605,0.0001958962,0.0000033235594,0.00010799201],"genre_scores_gemma":[0.036008045,0.96280456,0.00030408657,0.0004278908,0.00004785393,0.00013483135,0.00017894749,0.0000025777063,0.000091105205],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9985323,0.00036912147,0.00061038317,0.0002028348,0.00020657455,0.0000787539],"domain_scores_gemma":[0.99588937,0.0025921583,0.0010935426,0.00006527365,0.00027850395,0.0000811704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022199189,0.001246169,0.0061434004,0.0032859412,0.00039692599,0.0015605764,0.0010453375,0.0012351343,0.0030519858],"category_scores_gemma":[0.01153514,0.0008504976,0.008581643,0.0046467218,0.0004827337,0.001049797,0.0011990309,0.0012253567,0.00014751937],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065160915,0.00004957486,0.0052894102,0.88316774,0.06865463,0.00011785201,0.00017680634,0.00015656587,0.00017463385,0.00012374033,0.001396588,0.040040873],"study_design_scores_gemma":[0.0012373584,0.0004739495,0.029971074,0.3651254,0.5859681,0.00050230196,0.00045369228,0.0001436755,0.00021241256,0.0004060196,0.015399127,0.00010691547],"about_ca_topic_score_codex":0.015079249,"about_ca_topic_score_gemma":0.050999146,"teacher_disagreement_score":0.015079249,"about_ca_system_score_codex":0.001866011,"about_ca_system_score_gemma":0.0033156245,"threshold_uncertainty_score":0.029982984},"labels":[],"label_agreement":null},{"id":"W2740248158","doi":"10.1007/s10549-017-4436-9","title":"Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004–2013","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Breast Cancer Research Foundation","keywords":"Ductal carcinoma; Medicine; Breast cancer; Adjuvant; Oncology; Cancer; Internal medicine; Breast-conserving surgery; Mastectomy; Gynecology","score_opus":0.04945624269678677,"score_gpt":0.3457972961242214,"score_spread":0.2963410534274346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740248158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8343299,0.020754118,0.00035688025,0.0005521116,0.00008143786,0.000041062976,0.14033687,0.000059372873,0.0034882082],"genre_scores_gemma":[0.9372876,0.0074143424,0.00030104382,0.00034317817,0.000047781145,0.000090535126,0.053503215,0.000015606538,0.0009966142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999041,0.00010945154,0.00027895853,0.0002213499,0.00019739004,0.00015192103],"domain_scores_gemma":[0.997442,0.0003390961,0.001526773,0.000102125516,0.00043054015,0.00015954068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007019844,0.00019797834,0.00064875034,0.0019244527,0.00024353545,0.0005858425,0.00053956476,0.0003911557,0.0011022582],"category_scores_gemma":[0.0026334168,0.00023181923,0.0010188202,0.0063914657,0.00016102337,0.00064555876,0.00042351178,0.0005584291,0.00017680075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006008481,0.000043131236,0.9882166,0.00031153206,0.00050495035,0.000039096547,0.000047835216,0.00021189968,0.00017660885,0.00006723983,0.0035799157,0.006200266],"study_design_scores_gemma":[0.00002258867,0.00003325117,0.99734277,0.00004812395,0.00018304215,0.00008288194,0.00009542074,0.0001472232,0.00009561385,0.000016861533,0.001927357,0.00000480864],"about_ca_topic_score_codex":0.095558636,"about_ca_topic_score_gemma":0.1385074,"teacher_disagreement_score":0.095558636,"about_ca_system_score_codex":0.0013928224,"about_ca_system_score_gemma":0.0013331128,"threshold_uncertainty_score":0.19000489},"labels":[],"label_agreement":null},{"id":"W2743331008","doi":"10.1007/s10549-017-4408-0","title":"Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research; Canadian Cancer Society; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Saskatchewan Health Research Foundation","keywords":"Breast cancer; Medicine; Incidence (geometry); Cancer; Socioeconomic status; Developing country; Demography; Population; Environmental health; Economic growth; Internal medicine","score_opus":0.0984079523897632,"score_gpt":0.4330157599921215,"score_spread":0.3346078076023583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743331008","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012862125,0.9993697,0.0000207948,0.00026351155,0.00003538711,0.000001311287,0.000022725877,0.0000010750808,0.0001569007],"genre_scores_gemma":[0.0009671103,0.9987509,0.00005573844,0.00009372137,0.000055551118,0.0000016934694,0.000018029063,3.8175753e-7,0.000056896355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997621,0.000052851927,0.000046563357,0.000047981546,0.00006227544,0.000028092587],"domain_scores_gemma":[0.99935097,0.00039090042,0.00012867418,0.000010148021,0.00008845798,0.000030819312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007774794,0.0006145759,0.0015151001,0.0017508409,0.00026014453,0.0010418216,0.0006538286,0.0006968287,0.0025645408],"category_scores_gemma":[0.0015925705,0.00027389682,0.00061514694,0.0027825348,0.0004503338,0.0010725177,0.00063048257,0.0011203773,0.00031861072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015103721,0.000058865433,0.002008143,0.030135438,0.00030188507,0.00017648813,0.000084576626,0.0002228786,0.00038008753,0.0020171558,0.011660182,0.95280343],"study_design_scores_gemma":[0.00007869337,0.00021892232,0.018374007,0.04300754,0.0017223589,0.0035050728,0.00068490393,0.0002512373,0.0005223188,0.0037319257,0.9278397,0.000063262654],"about_ca_topic_score_codex":0.0040628803,"about_ca_topic_score_gemma":0.0074285096,"teacher_disagreement_score":0.0040628803,"about_ca_system_score_codex":0.00072973175,"about_ca_system_score_gemma":0.0019789594,"threshold_uncertainty_score":0.008579254},"labels":[],"label_agreement":null},{"id":"W2744491752","doi":"10.1007/s10549-017-4449-4","title":"Does obesity modify the relationship between physical activity and breast cancer risk?","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency; McMaster University","funders":"Canadian Institutes of Health Research; Killam Trusts; Michael Smith Health Research BC","keywords":"Breast cancer; Overweight; Medicine; Body mass index; Obesity; Cancer; Internal medicine; Cohort study; Relative risk; Risk factor; Oncology; Gynecology; Obstetrics; Confidence interval","score_opus":0.36800044545572513,"score_gpt":0.5267949990426872,"score_spread":0.1587945535869621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744491752","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052186206,0.99890316,0.000030017287,0.000216912,0.000097014046,0.0000026584548,0.000028256482,0.0000013972912,0.00019874919],"genre_scores_gemma":[0.004020044,0.99539304,0.00006858591,0.00018291618,0.00016764135,0.000004593958,0.000037928938,7.72513e-7,0.00012445294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962735,0.00011719639,0.000066485205,0.00007160867,0.00008136853,0.000035935478],"domain_scores_gemma":[0.99939215,0.00039420146,0.00012479753,0.0000166162,0.00004933699,0.000022839151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007891772,0.0006545653,0.0019721433,0.0010062084,0.00020435936,0.0010672188,0.00094996626,0.0014216319,0.003834769],"category_scores_gemma":[0.0019749384,0.00035263892,0.0016063177,0.0014652363,0.00038820464,0.0006861705,0.0005957843,0.0015986627,0.00056177715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012373122,0.00034877018,0.009458142,0.07279059,0.007833665,0.00021848088,0.00009712734,0.0003779795,0.00092293404,0.0018552322,0.0077009522,0.8971588],"study_design_scores_gemma":[0.0011598495,0.0020195674,0.19197083,0.09949377,0.041555382,0.0038854743,0.0006498653,0.00096715166,0.0017716369,0.009663123,0.64661616,0.00024719042],"about_ca_topic_score_codex":0.0032001704,"about_ca_topic_score_gemma":0.0054326416,"teacher_disagreement_score":0.003834769,"about_ca_system_score_codex":0.0003205769,"about_ca_system_score_gemma":0.0008135352,"threshold_uncertainty_score":0.012828529},"labels":[],"label_agreement":null},{"id":"W2746993714","doi":"10.1007/s10549-017-4469-0","title":"Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; National Medical Research Council; Cancer Council NSW; National Health and Medical Research Council; National Institutes of Health","keywords":"Breast cancer; Candidate gene; Germline mutation; Genetics; Penetrance; Cancer; Biology; Germline; Gene; Oncology; Mutation; Medicine; Phenotype","score_opus":0.039064350741587255,"score_gpt":0.36094979512906256,"score_spread":0.3218854443874753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746993714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993783,0.000044852473,0.00011231574,0.000011222746,0.0000012812274,0.00000458837,0.00025779058,0.0000040585705,0.00018552894],"genre_scores_gemma":[0.99819726,0.000082804356,0.00029382238,0.000027029866,0.0000038196654,0.000012613622,0.0006630202,0.000009829112,0.00070985267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996482,0.000053473224,0.000024322368,0.00013982509,0.000063276566,0.000070859096],"domain_scores_gemma":[0.9996928,0.00011142405,0.00004921586,0.000030304938,0.000039309583,0.000076962446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023861224,0.0004341059,0.00030629535,0.0013985616,0.0010621364,0.00045755727,0.00033254054,0.00040846792,0.0027616078],"category_scores_gemma":[0.0010285072,0.00030910096,0.00028180802,0.0008891217,0.0002690371,0.0001505453,0.0003481723,0.0003412186,0.00033709078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010505732,0.00030565725,0.9333407,0.000028804938,0.00010010208,0.007899821,0.0015158551,0.00037457838,0.045389216,0.00020289131,0.00046145907,0.009330317],"study_design_scores_gemma":[0.000033220305,0.00032644023,0.9865398,0.000008668794,0.000079716454,0.007342938,0.0005259515,0.000534468,0.0034000676,0.00008101474,0.0011149631,0.000012765876],"about_ca_topic_score_codex":0.0073335487,"about_ca_topic_score_gemma":0.005620117,"teacher_disagreement_score":0.0073335487,"about_ca_system_score_codex":0.0002819131,"about_ca_system_score_gemma":0.00030889298,"threshold_uncertainty_score":0.01458174},"labels":[],"label_agreement":null},{"id":"W2752234866","doi":"10.1007/s10549-017-4465-4","title":"Reply to Kopans","year":2017,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Gynecology; Internal medicine; Cancer","score_opus":0.2284374600326951,"score_gpt":0.4607737602601215,"score_spread":0.2323363002274264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752234866","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014339827,0.0010216717,0.0000289447,0.9817338,0.015234402,0.000007748304,0.000027398122,0.000012469028,0.0017901824],"genre_scores_gemma":[0.00087327725,0.0004539626,0.00003063374,0.9847418,0.00885074,0.000018610628,0.00001018675,0.000012837775,0.0050079273],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99285567,0.0016030212,0.00066860486,0.0010879781,0.001977779,0.0018069176],"domain_scores_gemma":[0.9835054,0.0078881215,0.0013118851,0.00045929017,0.0028606926,0.0039746035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007212109,0.001275506,0.0025813424,0.0011970191,0.010589936,0.009062104,0.0037575336,0.11066827,0.013186015],"category_scores_gemma":[0.049997784,0.0016926902,0.001849653,0.0011558501,0.0066161733,0.006354399,0.00529529,0.08916704,0.009652852],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017719585,0.000009272829,0.000227219,0.000027774204,0.000009757802,0.00047792835,0.00017145569,0.000026362099,0.000038488397,0.0015621001,0.99552,0.0019117936],"study_design_scores_gemma":[0.00007709616,0.00003933104,0.0010563232,0.00068004074,0.00004777418,0.0008759512,0.0018024528,0.00022712049,0.00018069913,0.009298517,0.9855966,0.00011794199],"about_ca_topic_score_codex":0.018494105,"about_ca_topic_score_gemma":0.030212235,"teacher_disagreement_score":0.11066827,"about_ca_system_score_codex":0.008926979,"about_ca_system_score_gemma":0.016248891,"threshold_uncertainty_score":0.06477004},"labels":[],"label_agreement":null},{"id":"W2756272086","doi":"10.1007/s10549-017-4476-1","title":"The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital","funders":"","keywords":"Mastectomy; Prophylactic Mastectomy; Breast cancer; Medicine; Incidence (geometry); BRCA mutation; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.02942241028155653,"score_gpt":0.3634506063564046,"score_spread":0.33402819607484807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756272086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96806103,0.015234188,0.002661232,0.003643052,0.00027186703,0.000035168938,0.003359424,0.00007753451,0.0066565173],"genre_scores_gemma":[0.99549013,0.001512085,0.00043204066,0.0004649171,0.00025082094,0.00001554235,0.0006564537,0.0000065398017,0.0011714535],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99919003,0.0003472708,0.000053095275,0.00011922672,0.000090774214,0.00019959216],"domain_scores_gemma":[0.99339783,0.0048038033,0.00063021225,0.0003014956,0.00023234115,0.0006342958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024133492,0.0004421403,0.00073622254,0.0004728871,0.00018792854,0.00048489464,0.0004900145,0.0015112731,0.004322984],"category_scores_gemma":[0.009569798,0.00034428787,0.0019604054,0.00037531587,0.00031629304,0.00069785916,0.0003936084,0.0009954856,0.00061679573],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06112945,0.00080669444,0.8174356,0.0007469685,0.004786305,0.0019946867,0.000112593705,0.013381532,0.0072525344,0.0034997128,0.0023212957,0.08653273],"study_design_scores_gemma":[0.0007606539,0.0040064114,0.97624606,0.00006606133,0.0037297949,0.0019306428,0.00012871854,0.00797924,0.0010767567,0.002713543,0.0013237024,0.000038545873],"about_ca_topic_score_codex":0.002608961,"about_ca_topic_score_gemma":0.002495034,"teacher_disagreement_score":0.004322984,"about_ca_system_score_codex":0.0004586416,"about_ca_system_score_gemma":0.00037410684,"threshold_uncertainty_score":0.014461815},"labels":[],"label_agreement":null},{"id":"W2760883434","doi":"10.1007/s10549-017-4538-4","title":"A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Queen's University; Ottawa Hospital; Jewish General Hospital; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Oncolytics Biotech","keywords":"Medicine; Metastatic breast cancer; Clinical endpoint; Paclitaxel; Breast cancer; Internal medicine; Randomized controlled trial; Cancer; Interim analysis; Chemotherapy; Phases of clinical research; Oncology; Gastroenterology; Surgery; Urology","score_opus":0.0964503014945268,"score_gpt":0.42715013033816457,"score_spread":0.3306998288436378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760883434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570361,0.0075351004,0.0012503123,0.0026642988,0.000732852,0.010813418,0.009987366,0.00026350096,0.009717099],"genre_scores_gemma":[0.958585,0.005753437,0.0031623468,0.003018016,0.00041596618,0.008032432,0.008045702,0.000100024045,0.012887058],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995303,0.00023101133,0.00001909353,0.000063570966,0.00004253439,0.00011348747],"domain_scores_gemma":[0.9991543,0.00020234541,0.00013738436,0.00007889358,0.000061986844,0.0003651378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016655703,0.0013533199,0.0020453336,0.0004575887,0.00053857255,0.0008672642,0.0011141299,0.0015583341,0.010044082],"category_scores_gemma":[0.001436501,0.00061367365,0.0015421353,0.0006613589,0.0008945036,0.0006477581,0.00032459426,0.0027583567,0.0011703878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9532828,0.007220719,0.0007883761,0.00037300636,0.001097166,0.000031387033,0.00005116978,0.00060597045,0.002861467,0.00018185745,0.004166268,0.029339777],"study_design_scores_gemma":[0.9507626,0.043569013,0.0025927413,0.000022777118,0.0005155087,0.000026203807,0.000024831466,0.00020688934,0.00029108065,0.00015544925,0.0018176683,0.000015321906],"about_ca_topic_score_codex":0.013155832,"about_ca_topic_score_gemma":0.039348874,"teacher_disagreement_score":0.9868442,"about_ca_system_score_codex":0.0017575986,"about_ca_system_score_gemma":0.0036626626,"threshold_uncertainty_score":0.033600748},"labels":[],"label_agreement":null},{"id":"W2765513317","doi":"10.1007/s10549-017-4525-9","title":"Serum selenium levels predict survival after breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Oncology; Selenium; Medicine; Internal medicine; Mammary gland; Cancer; Biology; Physiology; Gynecology; Chemistry","score_opus":0.10826515416267685,"score_gpt":0.39631910144367455,"score_spread":0.2880539472809977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765513317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975688,0.0009056247,0.000086291206,0.00027187262,0.000034364624,0.0000021635053,0.00010675172,0.00000688644,0.001017273],"genre_scores_gemma":[0.9989843,0.0002458587,0.000048233873,0.000040625906,0.000012300111,0.0000012590978,0.00009613478,0.0000013814063,0.00057000574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987495,0.00003529002,0.0000134755555,0.000016837088,0.00002086904,0.00003856754],"domain_scores_gemma":[0.9988136,0.00043587617,0.0003245635,0.000054028485,0.00016859888,0.00020333087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035529194,0.00020931034,0.00024580548,0.0004221578,0.00028655096,0.0005592843,0.00021519857,0.0006055751,0.0014042679],"category_scores_gemma":[0.0023035486,0.00013608875,0.00028608553,0.00050721335,0.00021985987,0.00032733704,0.00026214082,0.0007870061,0.00028300213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024433646,0.00007339664,0.9957424,0.000009015271,0.000035370245,0.00005547306,0.000044445664,0.000042431915,0.0002238421,0.000014224328,0.00014147747,0.0033736883],"study_design_scores_gemma":[0.000012262521,0.00032781065,0.9973731,0.00001347508,0.000102482656,0.00025571635,0.00040029522,0.0004641726,0.00041234156,0.00017864653,0.0004544404,0.0000052073383],"about_ca_topic_score_codex":0.0041303537,"about_ca_topic_score_gemma":0.0059277667,"teacher_disagreement_score":0.0041303537,"about_ca_system_score_codex":0.00029410853,"about_ca_system_score_gemma":0.00039914763,"threshold_uncertainty_score":0.008212626},"labels":[],"label_agreement":null},{"id":"W2765692744","doi":"10.1007/s10549-017-4523-y","title":"Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Occupational Cancer Research Centre","funders":"Novartis Institutes for BioMedical Research; Astex Pharmaceuticals; Novartis Pharmaceuticals Corporation","keywords":"Letrozole; Medicine; Breast cancer; Hazard ratio; Discontinuation; Internal medicine; Placebo; Metastatic breast cancer; Clinical endpoint; Population; Nausea; Oncology; Cancer; Surgery; Randomized controlled trial; Tamoxifen; Confidence interval","score_opus":0.02442456894890639,"score_gpt":0.33779852049377096,"score_spread":0.3133739515448646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765692744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98027724,0.013506844,0.0003048263,0.0009574082,0.0003791845,0.000795949,0.0011255112,0.000066256216,0.002586735],"genre_scores_gemma":[0.98922414,0.0035422582,0.0004953885,0.0012081121,0.0003885899,0.0010092148,0.0016150163,0.000009882239,0.0025074598],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996568,0.00021479887,0.000019609834,0.000043064538,0.000026278169,0.00003933235],"domain_scores_gemma":[0.99964106,0.0000701485,0.00012496642,0.000025821602,0.000019541641,0.000118453914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001337191,0.0007853695,0.0013001015,0.00020982906,0.00015809531,0.00060570985,0.00039777943,0.0006634598,0.0028656323],"category_scores_gemma":[0.0010828958,0.00021515139,0.0014650731,0.00020224454,0.00029450472,0.00039679772,0.00033795802,0.0013115342,0.0003496869],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9677117,0.0016994186,0.0025642253,0.0005404291,0.0019799913,0.00006780029,0.000031036525,0.00055902306,0.002856544,0.00010562411,0.0015361499,0.020348018],"study_design_scores_gemma":[0.89987165,0.077738464,0.014437509,0.00011460965,0.0025204904,0.00016829024,0.000039960392,0.0009913016,0.0007808327,0.00027875722,0.0030379614,0.000020117834],"about_ca_topic_score_codex":0.000655772,"about_ca_topic_score_gemma":0.0026478057,"teacher_disagreement_score":0.0028656323,"about_ca_system_score_codex":0.0005373004,"about_ca_system_score_gemma":0.0006712734,"threshold_uncertainty_score":0.009586513},"labels":[],"label_agreement":null},{"id":"W2767515019","doi":"10.1007/s10549-017-4561-5","title":"Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of British Columbia; University of British Columbia Hospital","funders":"University of British Columbia","keywords":"Breast cancer; Medicine; Oncology; Adjuvant; Endocrine system; Cancer; Internal medicine; Adjuvant therapy; Gynecology; Hormone","score_opus":0.3054605754013411,"score_gpt":0.5019105560680036,"score_spread":0.19644998066666253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767515019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007336789,0.9989422,0.000033359105,0.00010621429,0.000042800584,0.0000075486514,0.000038800343,0.0000010229696,0.00009439563],"genre_scores_gemma":[0.007498847,0.9917746,0.00023164848,0.00028273778,0.00009356615,0.000017599414,0.000047582136,8.6646105e-7,0.00005251274],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99894816,0.00030170247,0.00031974047,0.00014890898,0.00023083387,0.000050770617],"domain_scores_gemma":[0.9958255,0.0029894682,0.00079290493,0.00004644348,0.00028502033,0.000060641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021762508,0.0008257055,0.0026089079,0.0023677498,0.00031230095,0.0016975971,0.001019547,0.0013851646,0.002617605],"category_scores_gemma":[0.006717159,0.0004077754,0.0025795614,0.0036741756,0.00039925816,0.0012071001,0.00085789664,0.0013151629,0.0001529673],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005282594,0.00043851224,0.01683262,0.32191896,0.014064281,0.00023543385,0.0005312307,0.00038468905,0.0003602895,0.000996795,0.008070518,0.6356385],"study_design_scores_gemma":[0.00088636036,0.0013056728,0.18523377,0.47493145,0.11716015,0.0032266132,0.0023682895,0.0011596481,0.0005917706,0.0030058883,0.20973949,0.00039087192],"about_ca_topic_score_codex":0.0035992449,"about_ca_topic_score_gemma":0.011558667,"teacher_disagreement_score":0.0035992449,"about_ca_system_score_codex":0.0005425466,"about_ca_system_score_gemma":0.0018155117,"threshold_uncertainty_score":0.011509299},"labels":[],"label_agreement":null},{"id":"W2767885640","doi":"10.1007/s10549-017-4554-4","title":"The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Cancer Agency; University of British Columbia, Okanagan Campus; University of British Columbia; University of Alberta","funders":"BC Cancer Agency","keywords":"Medicine; Cardiotoxicity; Breast cancer; Internal medicine; Doxorubicin; Anthracycline; Subclinical infection; Cancer; Cardiology; Chemotherapy; Physical therapy","score_opus":0.036156392980862886,"score_gpt":0.3785445484125434,"score_spread":0.34238815543168055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767885640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97547853,0.0094807595,0.0010321516,0.0007282955,0.0012429535,0.008741013,0.00072862586,0.00007088537,0.0024967387],"genre_scores_gemma":[0.9741979,0.0061674006,0.0033276042,0.0012052559,0.001036041,0.009589589,0.0005161358,0.000022068509,0.0039380263],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99846965,0.0006983272,0.00022200846,0.0002970453,0.00010142143,0.00021161177],"domain_scores_gemma":[0.99783283,0.00080992543,0.0004415296,0.00022950358,0.00020618745,0.00048003907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023217073,0.0020210932,0.004060961,0.00044997703,0.0012939028,0.0010454416,0.00078839244,0.0038506768,0.007829783],"category_scores_gemma":[0.004973005,0.0012326685,0.0043818434,0.00054901093,0.0010790759,0.001106896,0.0010405137,0.004376783,0.0009938367],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88534343,0.064778864,0.0015544818,0.0057246075,0.012150205,0.000068271154,0.00025202087,0.00047660223,0.0030736937,0.00015325542,0.00053886726,0.025885716],"study_design_scores_gemma":[0.6319019,0.33276495,0.014892471,0.0009463245,0.015095796,0.000037054957,0.00019962914,0.00038467196,0.0007649856,0.00027472107,0.002670943,0.00006655469],"about_ca_topic_score_codex":0.0041997284,"about_ca_topic_score_gemma":0.0068636676,"teacher_disagreement_score":0.007829783,"about_ca_system_score_codex":0.0010159953,"about_ca_system_score_gemma":0.0016042107,"threshold_uncertainty_score":0.026193261},"labels":[],"label_agreement":null},{"id":"W2767899580","doi":"10.1007/s10549-017-4572-2","title":"Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Ductal carcinoma; Breast cancer; Medicine; Oncology; Cancer; Lobular carcinoma; Carcinoma in situ; Mammary gland; Internal medicine; Radiation therapy; Mammography; Epidemiology; Carcinoma; Invasive lobular carcinoma; Gynecology; Pathology; Invasive ductal carcinoma","score_opus":0.04364264707845005,"score_gpt":0.37516147601582717,"score_spread":0.3315188289373771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767899580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966462,0.0017583948,0.000035796136,0.00016519228,0.000010949497,0.0000026736388,0.0001748561,0.0000031658817,0.0012026972],"genre_scores_gemma":[0.99918395,0.00038435418,0.00001700096,0.000019215802,0.000015665843,0.0000018501513,0.0000738157,0.0000011213583,0.0003030675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997322,0.00011671833,0.000012642853,0.000026250344,0.000043763615,0.000068412344],"domain_scores_gemma":[0.99917895,0.00031871244,0.00022203293,0.00007071022,0.000080734666,0.0001288813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033606158,0.00017816255,0.00020384793,0.0003952344,0.00019590842,0.0004488174,0.00018085142,0.00024542073,0.001800129],"category_scores_gemma":[0.0019345445,0.00014479224,0.000393203,0.00043425942,0.00021310424,0.000289776,0.00035947489,0.00047680232,0.0001625652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026854812,0.00011425137,0.98452735,0.000026601138,0.00012560905,0.00013504716,0.000073279625,0.00011075777,0.0009538916,0.00007764904,0.00013709432,0.011033061],"study_design_scores_gemma":[0.000009647712,0.00028073313,0.9986681,0.0000041327835,0.00008159569,0.00017516907,0.0001481404,0.000083774,0.00025794416,0.000055917706,0.00023262012,0.0000023308223],"about_ca_topic_score_codex":0.003123215,"about_ca_topic_score_gemma":0.004053027,"teacher_disagreement_score":0.003123215,"about_ca_system_score_codex":0.00030820025,"about_ca_system_score_gemma":0.00025577564,"threshold_uncertainty_score":0.0062100887},"labels":[],"label_agreement":null},{"id":"W2768603319","doi":"10.1007/s10549-017-4583-z","title":"Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia Hospital; University of British Columbia","funders":"National Cancer Institute; BC Cancer Agency; National Institutes of Health","keywords":"Nestin; Breast cancer; Immunohistochemistry; Tissue microarray; Oncology; Medicine; Internal medicine; Estrogen receptor; Proportional hazards model; Pathology; Cancer; Biology; Stem cell; Neural stem cell","score_opus":0.03799049350481668,"score_gpt":0.3441108099052847,"score_spread":0.306120316400468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768603319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988907,0.00018785187,0.000044759974,0.0000082342485,0.00000223559,0.0000025678264,0.00058325054,0.0000021670583,0.0002782444],"genre_scores_gemma":[0.9978594,0.000119123826,0.00004119405,0.00000555267,0.000004243727,0.000006831295,0.0012931059,0.0000028370653,0.0006677292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996674,0.00004955465,0.00003779588,0.000083549385,0.0000522409,0.000109574816],"domain_scores_gemma":[0.9990693,0.00014341155,0.00034559536,0.00016093976,0.00012145452,0.00015929886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037856985,0.00020638961,0.0003662247,0.0011138051,0.0007153784,0.00045612696,0.00041623335,0.00037135906,0.0016433015],"category_scores_gemma":[0.0010805319,0.00032243435,0.00059655984,0.0016278853,0.0003357354,0.00043784082,0.00055511046,0.0003662671,0.00043887235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028880977,0.000018410172,0.99776316,0.0000064921865,0.00003666975,0.00012983593,0.000097892735,0.000038333303,0.00039642627,0.000009873106,0.00006636007,0.001147742],"study_design_scores_gemma":[0.000003854704,0.00005019149,0.99892575,0.000004155106,0.000033414533,0.0003035905,0.00018329333,0.000055113636,0.000121573576,0.000014590811,0.0003009319,0.0000035628914],"about_ca_topic_score_codex":0.015800977,"about_ca_topic_score_gemma":0.018059973,"teacher_disagreement_score":0.015800977,"about_ca_system_score_codex":0.00046216612,"about_ca_system_score_gemma":0.0003486071,"threshold_uncertainty_score":0.031418025},"labels":[],"label_agreement":null},{"id":"W2768885575","doi":"10.1007/s10549-017-4543-7","title":"Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Imperial Experimental Cancer Medicine Centre; National Institute for Health and Care Research; Pfizer UK; NIHR Imperial Biomedical Research Centre; Cancer Research UK; Imperial College London; Pfizer","keywords":"Exemestane; Medicine; Internal medicine; Oncology; Proportional hazards model; Tamoxifen; Hazard ratio; Breast cancer; Gynecology; Quartile; Adjuvant; Progesterone receptor; Population; Estrogen receptor; Cancer; Confidence interval","score_opus":0.09266416976186627,"score_gpt":0.42405101686941277,"score_spread":0.3313868471075465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768885575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944864,0.0009850783,0.002748976,0.0002779395,0.00003486656,0.00010518353,0.0008474498,0.000026287882,0.00048784507],"genre_scores_gemma":[0.9974025,0.00012778351,0.0012247947,0.00004360429,0.000036434834,0.000090356996,0.00086609094,0.000008089462,0.00020047837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569064,0.003443488,0.00012914828,0.00031898209,0.00026982505,0.00014797029],"domain_scores_gemma":[0.9897016,0.0070575327,0.0016321215,0.00059256156,0.00045888277,0.00055733096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016934423,0.00085109106,0.0008591409,0.00088750554,0.00022644321,0.00082222495,0.00085691176,0.0004982848,0.0015139544],"category_scores_gemma":[0.013663581,0.00026152347,0.001785219,0.00087519415,0.00050628715,0.0006729978,0.0012344363,0.0008585152,0.00019708897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019096203,0.0000982811,0.96217,0.0001401846,0.0028710228,0.000046782083,0.00006060059,0.003434988,0.00040898164,0.00015166937,0.00055191806,0.010969389],"study_design_scores_gemma":[0.0027765294,0.010673928,0.92368203,0.000067753914,0.004852868,0.00030402403,0.00020502102,0.052826487,0.0007506276,0.0017421767,0.0020738048,0.000044712193],"about_ca_topic_score_codex":0.0013504403,"about_ca_topic_score_gemma":0.0014700727,"teacher_disagreement_score":0.016934423,"about_ca_system_score_codex":0.00040517925,"about_ca_system_score_gemma":0.00096328114,"threshold_uncertainty_score":0.08955884},"labels":[],"label_agreement":null},{"id":"W2769260727","doi":"10.1007/s10549-017-4586-9","title":"Willingness of breast cancer patients to undergo biopsy and breast cancer clinicians’ practices around seeking biopsy at the time of breast cancer relapse","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Biopsy; Breast biopsy; Cancer; Clinical trial; Oncology; Internal medicine; Mammography","score_opus":0.12405423251317997,"score_gpt":0.4387113813448564,"score_spread":0.3146571488316764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769260727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404484,0.000537732,0.00008760374,0.0026353658,0.000022762164,0.000011679585,0.00009874647,0.0000033112706,0.0025579003],"genre_scores_gemma":[0.9988166,0.00024616372,0.0000971825,0.00051293423,0.000019461615,0.0000094941815,0.000056700537,0.0000030490648,0.00023850224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713945,0.0016183077,0.00030376116,0.00021221687,0.00035132188,0.00037498158],"domain_scores_gemma":[0.9748165,0.013744597,0.007023381,0.0005794867,0.0014546769,0.00238141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032567855,0.000084460284,0.00024953616,0.00070065766,0.0008390397,0.001679778,0.0004732032,0.0012527263,0.0053176577],"category_scores_gemma":[0.03772244,0.00026209885,0.00038335792,0.00067711156,0.0005640709,0.0012679423,0.000810692,0.001497724,0.00041800158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034680983,0.0001675339,0.9856441,0.000043608732,0.000057610814,0.00033251225,0.0041787657,0.00011272585,0.00024208677,0.00017342361,0.00096844597,0.0077324323],"study_design_scores_gemma":[0.000029842238,0.00023990046,0.96090275,0.00020952763,0.000065490996,0.0019766805,0.03269427,0.0007650999,0.00027712167,0.00043502418,0.0023553916,0.000048927624],"about_ca_topic_score_codex":0.0052518216,"about_ca_topic_score_gemma":0.0075999293,"teacher_disagreement_score":0.0053176577,"about_ca_system_score_codex":0.0006859874,"about_ca_system_score_gemma":0.0010493092,"threshold_uncertainty_score":0.017789364},"labels":[],"label_agreement":null},{"id":"W2769385365","doi":"10.1007/s10549-017-4575-z","title":"Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Education, Culture, Sports, Science and Technology; Alberta Innovates - Health Solutions; Japanese Breast Cancer Society","keywords":"Tumor-infiltrating lymphocytes; Estrogen receptor; Medicine; Oncology; Internal medicine; Breast cancer; Chemotherapy; Triple-negative breast cancer; Pathological; Estrogen; Cancer; Immunotherapy","score_opus":0.024877519237589796,"score_gpt":0.3231705649301975,"score_spread":0.29829304569260773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769385365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998566,0.0005259865,0.00006748127,0.000038774597,0.000010039717,0.0000047410385,0.000070356844,0.0000056463346,0.00071096566],"genre_scores_gemma":[0.999451,0.00012970986,0.00002905263,0.000018093633,0.000014236136,0.000003229779,0.00009740544,0.00000184781,0.00025560285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998965,0.000027740074,0.000009259278,0.000018164232,0.000017626477,0.00003056074],"domain_scores_gemma":[0.9994733,0.00013300843,0.00018999995,0.000044952703,0.000050397717,0.00010838867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015796075,0.00012495623,0.0001889871,0.0002713827,0.00019759833,0.00037644923,0.0001098222,0.00025123806,0.0015243313],"category_scores_gemma":[0.0009650214,0.00008933018,0.00010069844,0.0003178377,0.00016500251,0.00024219474,0.000192403,0.00028379163,0.00024077529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091968226,0.00008039287,0.9814217,0.000026667003,0.000025560194,0.0004024348,0.000067933965,0.00010950239,0.006708817,0.000022752965,0.00029592725,0.009918668],"study_design_scores_gemma":[0.000007943028,0.00020977798,0.99701536,0.000006479783,0.00003171009,0.00089189276,0.00013990466,0.00022120486,0.0009122874,0.00004755094,0.0005136694,0.0000023248756],"about_ca_topic_score_codex":0.00039499,"about_ca_topic_score_gemma":0.00088456215,"teacher_disagreement_score":0.0015243313,"about_ca_system_score_codex":0.00013661676,"about_ca_system_score_gemma":0.00012953408,"threshold_uncertainty_score":0.005099416},"labels":[],"label_agreement":null},{"id":"W2770320042","doi":"10.1007/s10549-017-4580-2","title":"Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"University of Toronto; Ontario Ministry of Health and Long-Term Care; Princess Margaret Cancer Foundation; Cancer Care Ontario","keywords":"Breast cancer; Metastatic breast cancer; Oncology; Medicine; Profiling (computer programming); Clinical trial; Internal medicine; Gene; Cancer; Bioinformatics; Biology; Genetics; Computer science","score_opus":0.17038149954369378,"score_gpt":0.5107144739087063,"score_spread":0.34033297436501253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770320042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98763824,0.008011501,0.0005745309,0.0008165046,0.00006452157,0.00012837532,0.00082250405,0.000024866053,0.0019189505],"genre_scores_gemma":[0.9985941,0.00031277345,0.0003072476,0.00019297992,0.000048982438,0.00008869489,0.00034979908,0.0000069321245,0.000098580094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9872667,0.008470356,0.00162077,0.001092285,0.0011560882,0.0003938413],"domain_scores_gemma":[0.9577475,0.021103228,0.015384207,0.0018870464,0.0016701388,0.0022079695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017609147,0.00020473928,0.00079464784,0.0005186865,0.00037185661,0.0013045769,0.00046206109,0.0005273253,0.0018941342],"category_scores_gemma":[0.040554464,0.00012137893,0.0007217086,0.0010643177,0.00031500083,0.00095558167,0.00064271217,0.0005991106,0.00022137376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061963107,0.00047190025,0.8200433,0.000702393,0.0029166976,0.00017024859,0.00018472892,0.0018336276,0.0018388671,0.00023458686,0.0020572557,0.107583135],"study_design_scores_gemma":[0.0021765516,0.015258105,0.9681958,0.00021427938,0.0023104511,0.0008156738,0.00017829916,0.0037625106,0.0021734207,0.00085161126,0.0040239105,0.000039397262],"about_ca_topic_score_codex":0.0003366784,"about_ca_topic_score_gemma":0.00096902833,"teacher_disagreement_score":0.017609147,"about_ca_system_score_codex":0.0007939485,"about_ca_system_score_gemma":0.0008448243,"threshold_uncertainty_score":0.09312719},"labels":[],"label_agreement":null},{"id":"W2773830972","doi":"10.1007/s10549-017-4602-0","title":"Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Health and Medical Research Council; Unicancer","keywords":"Germline; Biology; Genetics; Sanger sequencing; Gene; Coding region; Breast cancer; Promoter; Germline mutation; Ovarian cancer; Intron; Cancer research; Mutation; Cancer; Gene expression","score_opus":0.03776485083918895,"score_gpt":0.3800652218658811,"score_spread":0.34230037102669214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773830972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990252,0.00018106506,0.00010192509,0.000032209624,0.0000036493152,0.0000019886731,0.00012475696,0.0000028767624,0.0005262487],"genre_scores_gemma":[0.99965036,0.00005337328,0.00006749994,0.000012882872,0.000005698967,0.0000016474891,0.000077221935,0.000002544187,0.00012880556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946123,0.00020863718,0.00004761634,0.000113848284,0.00008913822,0.000079476944],"domain_scores_gemma":[0.9989735,0.00054358266,0.00021033375,0.00004518176,0.000076246884,0.00015119289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056674256,0.00051283685,0.00023674539,0.0011864795,0.0004494086,0.00045834915,0.00032052738,0.0005127975,0.0024258927],"category_scores_gemma":[0.0023173552,0.00014782831,0.00040372336,0.00063166383,0.00040082366,0.00020774757,0.00029925606,0.00034679426,0.00022479972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016790193,0.00014876557,0.9607475,0.000030555744,0.00019314238,0.0044443063,0.00034734793,0.00038071378,0.024956908,0.00022064241,0.00013770485,0.006713365],"study_design_scores_gemma":[0.00002359757,0.00035713683,0.9882769,0.000011098207,0.0001865322,0.0071298676,0.0003242317,0.00062927726,0.0024221742,0.00016169225,0.00046933425,0.000008217089],"about_ca_topic_score_codex":0.0024649901,"about_ca_topic_score_gemma":0.0013929636,"teacher_disagreement_score":0.0024649901,"about_ca_system_score_codex":0.00021754317,"about_ca_system_score_gemma":0.00021131882,"threshold_uncertainty_score":0.008115351},"labels":[],"label_agreement":null},{"id":"W2774434691","doi":"10.1007/s10549-017-4608-7","title":"Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Cancer Research Fund; Wereld Kanker Onderzoek Fonds; Newfoundland and Labrador; KWF Kankerbestrijding; ZonMw; Pink Ribbon Foundation","keywords":"Breast cancer; Medicine; Oncology; Chemotherapy; Inflammation; Internal medicine; Adjuvant chemotherapy; Adjuvant; Cancer; Mammary gland","score_opus":0.015087650304850254,"score_gpt":0.332562159599975,"score_spread":0.3174745092951247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774434691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988539,0.00060804887,0.000021173084,0.00006818383,0.000016572967,0.0000096256945,0.000059204962,0.0000015462952,0.00036171137],"genre_scores_gemma":[0.9994349,0.00023335066,0.000033808585,0.000036849397,0.000018084062,0.000010213939,0.000055027205,8.563207e-7,0.00017677507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997391,0.00010766523,0.000020288082,0.000027019723,0.000023168725,0.00008282225],"domain_scores_gemma":[0.9993351,0.0002043032,0.0001844207,0.000031986296,0.000046978304,0.00019727518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000327445,0.0002647003,0.00065584725,0.00017039558,0.00026790932,0.00044388397,0.00011391842,0.00034633433,0.00096983416],"category_scores_gemma":[0.0019344968,0.00014554206,0.0004911457,0.00034037858,0.00014368547,0.00022735143,0.00025284424,0.00068274746,0.00009293406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07780272,0.005349875,0.84091383,0.00032836964,0.0015676101,0.00033585614,0.000776443,0.00071077154,0.010541789,0.000063102605,0.00043257044,0.06117718],"study_design_scores_gemma":[0.00024618866,0.005373095,0.9928054,0.000020044576,0.00040090585,0.00004963148,0.0002219872,0.00019703941,0.00038071326,0.000029406576,0.0002664799,0.000009049819],"about_ca_topic_score_codex":0.0020682446,"about_ca_topic_score_gemma":0.0045524193,"teacher_disagreement_score":0.0020682446,"about_ca_system_score_codex":0.00019660097,"about_ca_system_score_gemma":0.00028419777,"threshold_uncertainty_score":0.004112363},"labels":[],"label_agreement":null},{"id":"W2774891724","doi":"10.1007/s10549-017-4605-x","title":"Predictors of survival for breast cancer patients with a BRCA1 mutation","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Peter Gilgan Foundation","keywords":"Medicine; Breast cancer; Oophorectomy; Hazard ratio; Oncology; Internal medicine; Cancer; Cause of death; Cohort; Gynecology; Chemotherapy; Cancer registry; Survival analysis; Medical record; Ovarian cancer; Surgery; Hysterectomy; Disease","score_opus":0.02994448968060479,"score_gpt":0.3520465062761707,"score_spread":0.32210201659556587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774891724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670166,0.00094531133,0.00014530438,0.00034431863,0.000035908775,0.0000036310178,0.0006679806,0.000016042652,0.0011397684],"genre_scores_gemma":[0.99879444,0.00021104443,0.000046127545,0.000035210487,0.000043036005,0.000003185093,0.0005113836,0.0000034678005,0.00035216266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998016,0.000048771337,0.000015076443,0.000031865613,0.000026902822,0.0000758409],"domain_scores_gemma":[0.9982179,0.00060153456,0.00042561404,0.00008466102,0.00013826035,0.00053198915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044894425,0.0003613914,0.0004062829,0.0006353054,0.00044769357,0.0005651499,0.00036958524,0.00091016316,0.0034947512],"category_scores_gemma":[0.0025287576,0.00020269878,0.00069339655,0.00080735586,0.00032711928,0.00055142725,0.00043928815,0.0012689197,0.0004794462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002809247,0.000024048008,0.99776864,0.0000055339906,0.00003592497,0.00005808426,0.000019570853,0.00016317733,0.00012045673,0.000021796497,0.00022366254,0.0012781231],"study_design_scores_gemma":[0.000010553874,0.00011259902,0.9981299,0.0000064601527,0.000075676624,0.0003267209,0.00013237807,0.00074947666,0.00006710207,0.0001220407,0.00026107853,0.0000059112613],"about_ca_topic_score_codex":0.0033409297,"about_ca_topic_score_gemma":0.0027979692,"teacher_disagreement_score":0.0034947512,"about_ca_system_score_codex":0.0002764519,"about_ca_system_score_gemma":0.0004613674,"threshold_uncertainty_score":0.011691093},"labels":[],"label_agreement":null},{"id":"W2775364783","doi":"10.1007/s10549-017-4594-9","title":"CD14+ HLA-DR−/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"Eberhard Karls Universität Tübingen; Deutsche Forschungsgemeinschaft","keywords":"CD14; Breast cancer; Medicine; Myeloid; Immune system; Cancer; Immunology; Immunotherapy; T cell; Internal medicine; Oncology; Cancer research","score_opus":0.030461658720075297,"score_gpt":0.32228209157422494,"score_spread":0.29182043285414966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775364783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860877,0.00046102787,0.00015972578,0.00004296695,0.000011541865,0.000012404053,0.00017202686,0.000017458988,0.00051405263],"genre_scores_gemma":[0.9984908,0.0001635682,0.00018318418,0.000060611554,0.000033879594,0.00002328588,0.0002607419,0.000007374997,0.00077645923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989533,0.000025358482,0.000010664957,0.000022247148,0.00001961726,0.000026793832],"domain_scores_gemma":[0.9998149,0.00003415898,0.00006892891,0.000013590005,0.000020574615,0.000047871454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010330485,0.0002417119,0.0003375711,0.00063797453,0.00025759323,0.00040901752,0.00013158936,0.00025469833,0.0029862074],"category_scores_gemma":[0.0004889211,0.00023810791,0.00011780097,0.00024192978,0.00015030777,0.00016627026,0.00022084144,0.00040214698,0.0004458557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063651176,0.0004751589,0.5912276,0.00020238913,0.00013209032,0.0019574827,0.00035055217,0.00027703127,0.34864268,0.00030157616,0.0019002431,0.048167985],"study_design_scores_gemma":[0.0001589334,0.0011085942,0.9668646,0.00004410783,0.00015836225,0.0044136993,0.00058965216,0.0011284214,0.02121512,0.00050284335,0.0037951635,0.00002061687],"about_ca_topic_score_codex":0.00023622341,"about_ca_topic_score_gemma":0.0003313595,"teacher_disagreement_score":0.0029862074,"about_ca_system_score_codex":0.00010677296,"about_ca_system_score_gemma":0.00012519442,"threshold_uncertainty_score":0.009989798},"labels":[],"label_agreement":null},{"id":"W2775577815","doi":"10.1007/s10549-017-4604-y","title":"A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Ottawa Hospital; University of Ottawa","funders":"European Society for Medical Oncology; Ottawa Hospital Research Institute","keywords":"Medicine; Filgrastim; Febrile neutropenia; Discontinuation; Randomized controlled trial; Breast cancer; Neutropenia; Randomization; Chemotherapy; Internal medicine; Clinical endpoint; Surgery; Cancer","score_opus":0.08349081564704279,"score_gpt":0.4204643519534432,"score_spread":0.3369735363064004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775577815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96916705,0.003630389,0.0026179748,0.0013003214,0.0011251108,0.019389225,0.0007216138,0.0001359659,0.0019123671],"genre_scores_gemma":[0.98105913,0.0007685691,0.005076726,0.0011013718,0.00038382874,0.0103540225,0.00041487062,0.000018568933,0.00082281197],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99492884,0.0036131588,0.00030555754,0.0005134151,0.00024697089,0.00039219137],"domain_scores_gemma":[0.99474734,0.0021508362,0.0011620199,0.0004443486,0.00029174658,0.0012037221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048786527,0.0016235225,0.0038307707,0.0006577913,0.0007986154,0.0013631774,0.001297806,0.0027071289,0.00723288],"category_scores_gemma":[0.008394719,0.00093598757,0.002564442,0.0006737602,0.0015916161,0.0017461975,0.0011226417,0.00342266,0.0006069839],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9819474,0.007798475,0.00028627698,0.00030516312,0.0006154276,0.000016413145,0.00003560188,0.0003286758,0.00042739496,0.00013255382,0.00023416174,0.007872523],"study_design_scores_gemma":[0.94659793,0.051547665,0.00072016724,0.0000312346,0.00028050537,0.000011434804,0.000022309974,0.0003423761,0.00007777891,0.00016535759,0.00019164044,0.000011592732],"about_ca_topic_score_codex":0.002241076,"about_ca_topic_score_gemma":0.0030631095,"teacher_disagreement_score":0.00723288,"about_ca_system_score_codex":0.0023264582,"about_ca_system_score_gemma":0.0033581546,"threshold_uncertainty_score":0.025801122},"labels":[],"label_agreement":null},{"id":"W2777306706","doi":"10.1007/s10549-017-4613-x","title":"Interventions are needed to support patient–provider decision-making for DCIS: a scoping review","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; University Health Network; Dalhousie University; University of Saskatchewan; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Psychological intervention; CINAHL; MEDLINE; Family medicine; Breast cancer; Mastectomy; Decision aids; Cochrane Library; Alternative medicine; Cancer; Nursing; Internal medicine; Pathology","score_opus":0.5766634076006307,"score_gpt":0.6166275158136431,"score_spread":0.03996410821301233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777306706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040094866,0.99659747,0.00018079809,0.0014387931,0.00025676476,0.0003261975,0.00009931607,0.000009712563,0.0006900441],"genre_scores_gemma":[0.004374127,0.99314535,0.0007077087,0.00097575726,0.00011309109,0.0004915344,0.00009727144,0.000004429097,0.00009075528],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9871122,0.0055158697,0.0042528934,0.00050105026,0.0021823929,0.00043553134],"domain_scores_gemma":[0.9221575,0.063471235,0.00807924,0.0007291742,0.005001672,0.00056110567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017384548,0.0016498239,0.0065068398,0.01104271,0.0013426438,0.0068003167,0.0025117514,0.0049166908,0.0070549883],"category_scores_gemma":[0.08407334,0.0014095381,0.0071251215,0.01125432,0.00132902,0.0056480807,0.002250411,0.0032468524,0.00078800647],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010595396,0.00004491476,0.00044858936,0.8714257,0.0019101411,0.00008527543,0.00059623097,0.00015798707,0.000090741894,0.0007593166,0.003145153,0.12122991],"study_design_scores_gemma":[0.00004102115,0.000029977677,0.0005271418,0.98155516,0.004373293,0.00006387807,0.0003416891,0.000043380882,0.00004354643,0.00029007174,0.012679572,0.000011226329],"about_ca_topic_score_codex":0.010274069,"about_ca_topic_score_gemma":0.023178095,"teacher_disagreement_score":0.017384548,"about_ca_system_score_codex":0.0060060318,"about_ca_system_score_gemma":0.025969302,"threshold_uncertainty_score":0.09193933},"labels":[],"label_agreement":null},{"id":"W2781326879","doi":"10.1007/s10549-017-4627-4","title":"Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Sunnybrook Hospital; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Department of Family and Community Medicine, University of Toronto; Canadian Federation of University Women","keywords":"Verbal memory; Breast cancer; Medicine; Cognition; Neuropsychology; Subgroup analysis; Tamoxifen; Internal medicine; Oncology; Verbal learning; Effects of sleep deprivation on cognitive performance; Adverse effect; Visual memory; Meta-analysis; Cancer; Psychology; Psychiatry","score_opus":0.4002790515465721,"score_gpt":0.528464017968056,"score_spread":0.12818496642148386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781326879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0154882185,0.9829695,0.00048231322,0.00012569911,0.00016566383,0.000073844465,0.0003861633,0.000020429898,0.0002881216],"genre_scores_gemma":[0.43793482,0.55673146,0.0018900383,0.0012542348,0.0003332829,0.00026646783,0.0008507241,0.000032973352,0.00070603075],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99706405,0.0011799682,0.00085714523,0.00044513424,0.0002777936,0.00017591429],"domain_scores_gemma":[0.99560463,0.002843188,0.0008284492,0.00028247733,0.0003284625,0.000112801914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004823979,0.0023442372,0.009048245,0.0018682381,0.00049262756,0.0018524278,0.0014747487,0.0016749741,0.0032610372],"category_scores_gemma":[0.012757685,0.0012577885,0.029131377,0.0032167763,0.00043862473,0.0012110146,0.0014206689,0.0023113713,0.00024508376],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046171146,0.000047508835,0.010615035,0.09376328,0.8770858,0.00013601329,0.000076656026,0.00036313164,0.00022647931,0.00009810984,0.0005410689,0.012429889],"study_design_scores_gemma":[0.0006986421,0.00017868496,0.0077299606,0.003670926,0.9862024,0.000066404304,0.00004063439,0.00008726492,0.00006318903,0.00014585108,0.0010949362,0.000021172638],"about_ca_topic_score_codex":0.009758252,"about_ca_topic_score_gemma":0.023989668,"teacher_disagreement_score":0.009758252,"about_ca_system_score_codex":0.0012776721,"about_ca_system_score_gemma":0.0014482595,"threshold_uncertainty_score":0.02551198},"labels":[],"label_agreement":null},{"id":"W2785301351","doi":"10.1007/s10549-017-4644-3","title":"Is invasion a necessary step for metastases in breast cancer?","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Women's College Hospital; Toronto Western Hospital","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Radiation therapy; Metastasis; CA15-3; Internal medicine","score_opus":0.12516604826931607,"score_gpt":0.43568833085996594,"score_spread":0.31052228259064985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785301351","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004946128,0.9992323,0.00003184619,0.0003528439,0.00012498409,0.0000012439949,0.00000557506,0.0000013719042,0.00020035853],"genre_scores_gemma":[0.0005800937,0.9989103,0.00003672434,0.00019582569,0.00015896681,0.0000019930922,0.000007934815,4.7491477e-7,0.00010776368],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997249,0.00006119674,0.00005614883,0.000055696786,0.00007750659,0.000024594397],"domain_scores_gemma":[0.99928135,0.0004317189,0.00012760356,0.000014649401,0.00011596486,0.000028816152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061492424,0.00060477137,0.0012382128,0.0015895647,0.00025081035,0.0010462691,0.0008015889,0.0015686646,0.002718741],"category_scores_gemma":[0.0020140135,0.00024931904,0.0006103878,0.0015275336,0.000945815,0.0017494215,0.00056782446,0.0013914899,0.000888523],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001440811,0.000040321833,0.0005734154,0.07410847,0.00021563248,0.00053548324,0.0001607373,0.00041875785,0.0011196675,0.00941132,0.032454643,0.8808175],"study_design_scores_gemma":[0.000025788195,0.00015200178,0.0024684314,0.035071794,0.00043411055,0.005624748,0.00040525262,0.00011900755,0.0006540627,0.007928448,0.94707906,0.000037268826],"about_ca_topic_score_codex":0.0014654994,"about_ca_topic_score_gemma":0.0016079558,"teacher_disagreement_score":0.002718741,"about_ca_system_score_codex":0.0006740135,"about_ca_system_score_gemma":0.001729337,"threshold_uncertainty_score":0.009095132},"labels":[],"label_agreement":null},{"id":"W2785718812","doi":"10.1007/s10549-018-4703-4","title":"Reply to K. Altundag","year":2018,"lang":"lt","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Cancer","score_opus":0.08252661129058458,"score_gpt":0.4042798192367468,"score_spread":0.3217532079461622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785718812","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015466176,0.0010301265,0.000031774398,0.9857319,0.01228631,0.000006460626,0.000066306944,0.000021963415,0.00067057344],"genre_scores_gemma":[0.0013115956,0.00050654187,0.00006432693,0.98410505,0.011766629,0.000027854425,0.000024081593,0.00001560023,0.0021783249],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656147,0.001323033,0.00053745246,0.0004646021,0.00069458125,0.00041886192],"domain_scores_gemma":[0.98573756,0.007882245,0.001107166,0.00041138876,0.0027628622,0.002098802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005672823,0.00081764295,0.0021897783,0.0010330073,0.003861606,0.0036448557,0.0024076826,0.04434146,0.008773318],"category_scores_gemma":[0.03882474,0.00093382655,0.0011306846,0.001046476,0.0026551916,0.00495142,0.0022330603,0.041080736,0.010471783],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041922456,0.0000100132875,0.0002891367,0.000040849867,0.00000864731,0.00038788244,0.000075503536,0.000011425996,0.00003329446,0.00051695073,0.9964768,0.0021075],"study_design_scores_gemma":[0.00018788493,0.00010208505,0.002084992,0.00070350897,0.000062373765,0.0026545457,0.0010113941,0.00029641413,0.00028840292,0.00693806,0.98554635,0.0001238662],"about_ca_topic_score_codex":0.0046284613,"about_ca_topic_score_gemma":0.0064792754,"teacher_disagreement_score":0.04434146,"about_ca_system_score_codex":0.0029204895,"about_ca_system_score_gemma":0.004058707,"threshold_uncertainty_score":0.030001163},"labels":[],"label_agreement":null},{"id":"W2786309762","doi":"10.1007/s10549-018-4694-1","title":"Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; Princess Margaret Cancer Centre; McGill University; Mount Sinai Hospital; North York General Hospital; Sunnybrook Health Science Centre; University of Toronto","funders":"Canada Research Chairs; Cancer Care Ontario","keywords":"Breast cancer; Medicine; BRCA mutation; Metabolic equivalent; Odds ratio; Internal medicine; Menopause; Confidence interval; Population; Case-control study; Gynecology; Cancer; Body mass index; Oncology; Demography; Physical activity; Physical therapy; Environmental health","score_opus":0.030597456011906048,"score_gpt":0.3730417773836264,"score_spread":0.3424443213717204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786309762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983741,0.000931971,0.000031646407,0.000065066124,0.000011878318,0.0000040669465,0.00015422543,0.0000020220627,0.00042486688],"genre_scores_gemma":[0.9988071,0.00045121752,0.000030377061,0.000021051772,0.00001564329,0.0000052837586,0.00017070997,0.0000023280897,0.0004963551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981445,0.00004341121,0.000015905918,0.000035688725,0.000020918707,0.000069703696],"domain_scores_gemma":[0.99906284,0.00012499376,0.0003452469,0.000034180128,0.00006531201,0.00036748292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002785659,0.0002688999,0.0003330323,0.0006817712,0.0005223719,0.0007698154,0.00024071606,0.0007499998,0.0014455478],"category_scores_gemma":[0.0014404105,0.00037175117,0.0005636995,0.0006451556,0.00021746727,0.00038312102,0.00046593315,0.0007543392,0.00021398586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017817089,0.000089458634,0.998248,0.000005799792,0.00004618028,0.000061906285,0.00007793826,0.000018731298,0.0001699473,0.000016732616,0.000035698085,0.0010514834],"study_design_scores_gemma":[0.0000023524467,0.00007291017,0.999527,0.000004902172,0.00002147596,0.000072905365,0.00013174742,0.000055055687,0.000022184808,0.000012761053,0.00007494296,0.0000017941107],"about_ca_topic_score_codex":0.013437822,"about_ca_topic_score_gemma":0.014630559,"teacher_disagreement_score":0.013437822,"about_ca_system_score_codex":0.00026368242,"about_ca_system_score_gemma":0.00024980347,"threshold_uncertainty_score":0.026719153},"labels":[],"label_agreement":null},{"id":"W2786320243","doi":"10.1007/s10549-018-4671-8","title":"Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Institution; Oncology; Lymphoma; Internal medicine; Family medicine; Gynecology; Cancer; Political science","score_opus":0.03323221631856504,"score_gpt":0.34173096650705864,"score_spread":0.3084987501884936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786320243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983181,0.00051020534,0.000057192377,0.00024592166,0.0000075504345,0.000007925997,0.0001498667,0.000003308064,0.00069997995],"genre_scores_gemma":[0.9991091,0.00042308483,0.000067103865,0.000074438045,0.000013242374,0.0000049870423,0.00012935017,0.000003055218,0.00017569088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994771,0.00011781883,0.000063363135,0.00006656326,0.000085246684,0.0001899581],"domain_scores_gemma":[0.99902916,0.00016063584,0.00035768107,0.000031805244,0.000084593776,0.00033623193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040021696,0.00018385294,0.0002886169,0.000632456,0.0009834367,0.0010490663,0.00033662724,0.00043398817,0.001510545],"category_scores_gemma":[0.0023976145,0.0002241326,0.00029119622,0.00105616,0.00038018794,0.0006101095,0.0008277593,0.00052044383,0.00017879784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008094706,0.000115558876,0.99294657,0.000011180654,0.000024274486,0.0019318402,0.0005091415,0.000066705616,0.00023250641,0.00004382002,0.00025997596,0.003777637],"study_design_scores_gemma":[0.000012194116,0.00029024342,0.9825006,0.000034310477,0.000038891547,0.009678334,0.0060840594,0.00020326588,0.00016306057,0.000080200436,0.00089932425,0.000015586176],"about_ca_topic_score_codex":0.006797683,"about_ca_topic_score_gemma":0.00941022,"teacher_disagreement_score":0.006797683,"about_ca_system_score_codex":0.0010818482,"about_ca_system_score_gemma":0.0007967076,"threshold_uncertainty_score":0.013516188},"labels":[],"label_agreement":null},{"id":"W2787929656","doi":"10.1007/s10549-018-4713-2","title":"Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Anastrozole; Medicine; Exemestane; Aromatase inhibitor; Internal medicine; Breast cancer; Hazard ratio; Discontinuation; Quality of life (healthcare); Randomized controlled trial; Clinical endpoint; Oncology; Gynecology; Cancer; Physical therapy; Tamoxifen; Confidence interval","score_opus":0.05822184799215232,"score_gpt":0.3983368100951973,"score_spread":0.340114962103045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787929656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777526,0.0009624663,0.000028449986,0.00016170208,0.00001826758,0.00002700803,0.00069567765,0.000003497898,0.00032756742],"genre_scores_gemma":[0.9987587,0.00019625698,0.000033815817,0.000089302746,0.000027894046,0.000030758045,0.00055182225,8.661184e-7,0.00031067754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969745,0.00011518434,0.000031253232,0.000045495308,0.000051268522,0.000059427624],"domain_scores_gemma":[0.99924564,0.00021077222,0.00030908527,0.00003084279,0.00003411805,0.00016954202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006893224,0.00018411713,0.0005640838,0.00017402784,0.00016460351,0.00036692538,0.00022769785,0.0006465443,0.002168446],"category_scores_gemma":[0.0018625009,0.00018820202,0.0008537532,0.00031349418,0.00012598097,0.00023605274,0.0001946245,0.00080946815,0.0001489316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10303539,0.0015929558,0.8655026,0.00019021062,0.0019459706,0.000097802666,0.00009225551,0.00046550212,0.0014712755,0.00005918125,0.0016520311,0.023894794],"study_design_scores_gemma":[0.0043912623,0.0049206563,0.98870194,0.000028049408,0.00066178496,0.00008454476,0.000045059496,0.00052003475,0.00014989267,0.00005543777,0.00042970886,0.000011631364],"about_ca_topic_score_codex":0.0027108726,"about_ca_topic_score_gemma":0.0045111887,"teacher_disagreement_score":0.0027108726,"about_ca_system_score_codex":0.00028010336,"about_ca_system_score_gemma":0.0003554227,"threshold_uncertainty_score":0.0072541833},"labels":[],"label_agreement":null},{"id":"W2787932235","doi":"10.1007/s10549-018-4662-9","title":"Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; BioTheranostics; AGE-WELL; American Society of Clinical Oncology","keywords":"Breast cancer; Medicine; Oncology; Endocrine system; Internal medicine; Cancer; Hormone receptor; Hormone; Hormone therapy; Gynecology","score_opus":0.04707387037458561,"score_gpt":0.38310566788109546,"score_spread":0.33603179750650986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787932235","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007351845,0.040486697,0.0007686793,0.92035127,0.03518025,0.00007356204,0.000069120564,0.000026894906,0.0023083691],"genre_scores_gemma":[0.018974876,0.095024265,0.0067436635,0.81281966,0.06033707,0.00032653482,0.0003972566,0.00009753713,0.005279029],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97026247,0.016303802,0.004131771,0.0016502523,0.005439684,0.0022120376],"domain_scores_gemma":[0.9225838,0.03984277,0.0048930715,0.0013406209,0.023704952,0.0076347715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.052589603,0.0010128336,0.0015400676,0.0014922788,0.0032756126,0.0061878357,0.0035930562,0.021187225,0.003992409],"category_scores_gemma":[0.068070814,0.00069526694,0.0022608784,0.0017014602,0.0036351506,0.008501165,0.0059541417,0.021271583,0.0018626809],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065670276,0.00006550515,0.0009518163,0.0017753015,0.000049135255,0.0004448534,0.0015222323,0.000203468,0.00042224894,0.0036100403,0.8887817,0.102108],"study_design_scores_gemma":[0.000047576283,0.00007021355,0.0014759819,0.008276604,0.00008113183,0.0009965724,0.0038138768,0.0002660545,0.0002612701,0.006492766,0.9781331,0.00008492956],"about_ca_topic_score_codex":0.00413177,"about_ca_topic_score_gemma":0.007818238,"teacher_disagreement_score":0.052589603,"about_ca_system_score_codex":0.005969534,"about_ca_system_score_gemma":0.016098086,"threshold_uncertainty_score":0.27812374},"labels":[],"label_agreement":null},{"id":"W2788624573","doi":"10.1007/s10549-018-4716-z","title":"A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Ductal carcinoma; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; In situ; Gynecology; Geography","score_opus":0.08642971431898802,"score_gpt":0.4298985493663145,"score_spread":0.3434688350473265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788624573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91373676,0.00953467,0.057083603,0.003377967,0.00059255236,0.00066558877,0.011176278,0.00071588834,0.003116705],"genre_scores_gemma":[0.9710142,0.0017621772,0.012193121,0.00077111856,0.0003201669,0.00042387965,0.008555891,0.0004770577,0.004482477],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9765679,0.019876957,0.00055301224,0.0016806888,0.0005665516,0.00075484865],"domain_scores_gemma":[0.8457474,0.1440817,0.0028542134,0.0035743192,0.0023449063,0.0013974507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057816703,0.0027897684,0.004750558,0.0031919624,0.00096824847,0.002718364,0.0063468106,0.0027604683,0.0077632316],"category_scores_gemma":[0.04574093,0.0011733583,0.013946573,0.0017693461,0.00078702864,0.0021510075,0.0019559043,0.003990449,0.0009497938],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08758766,0.0022399593,0.25101426,0.0023627873,0.08850585,0.0011105016,0.001065429,0.4838096,0.0016438428,0.010508352,0.015189539,0.054962195],"study_design_scores_gemma":[0.00539483,0.005782161,0.11729714,0.00029985112,0.028827015,0.0006493486,0.0010180655,0.8255244,0.00057046517,0.011118802,0.0031810773,0.00033695155],"about_ca_topic_score_codex":0.03203069,"about_ca_topic_score_gemma":0.018763265,"teacher_disagreement_score":0.057816703,"about_ca_system_score_codex":0.0024773793,"about_ca_system_score_gemma":0.0022758392,"threshold_uncertainty_score":0.3057676},"labels":[],"label_agreement":null},{"id":"W2788948172","doi":"10.1007/s10549-018-4710-5","title":"Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Meta-analysis; Internal medicine; Oncology; Subgroup analysis; Hazard ratio; Chemotherapy; Adjuvant; Confidence interval; Cancer; Paclitaxel","score_opus":0.0779080882642573,"score_gpt":0.3808844227708233,"score_spread":0.302976334506566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788948172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001915816,0.9973225,0.00021892902,0.00008222649,0.00008554485,0.000036556507,0.00016370244,0.000006848814,0.00016799435],"genre_scores_gemma":[0.08629591,0.9105362,0.0011063134,0.0009221733,0.00025203722,0.00014412495,0.00040310246,0.000020159736,0.00031986256],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976278,0.0010177209,0.00065338286,0.00035627984,0.0002514022,0.00009347476],"domain_scores_gemma":[0.994166,0.0046542813,0.00071564375,0.00016322231,0.00023318258,0.00006768155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004744166,0.0016412883,0.009896619,0.001682414,0.00024786778,0.0018281317,0.0012045387,0.0015526837,0.0039323],"category_scores_gemma":[0.011990019,0.00074420834,0.017364986,0.0027967081,0.00039749267,0.0009220616,0.0008655673,0.0018722668,0.00027122107],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007287742,0.00007531883,0.003916081,0.32159382,0.60260934,0.000116659976,0.00008909809,0.00089121255,0.0005297439,0.0003340191,0.0013461888,0.061210696],"study_design_scores_gemma":[0.0012593643,0.00038774675,0.004412605,0.0142475,0.9745258,0.000083694766,0.00004114125,0.00015814311,0.00015237102,0.00041307695,0.0042907503,0.000027777818],"about_ca_topic_score_codex":0.0036382019,"about_ca_topic_score_gemma":0.008052605,"teacher_disagreement_score":0.009896619,"about_ca_system_score_codex":0.0011092115,"about_ca_system_score_gemma":0.0011825445,"threshold_uncertainty_score":0.02508986},"labels":[],"label_agreement":null},{"id":"W2790212344","doi":"10.1007/s10549-018-4739-5","title":"Reply to Hollingsworth: does breast cancer metastasize in the clinical window between the mammogram and the mass?","year":2018,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Cancer; Medicine; Oncology; Pathology; Cancer research; Internal medicine","score_opus":0.19977631799197965,"score_gpt":0.465460740032841,"score_spread":0.26568442204086135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790212344","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016462825,0.0010071746,0.000032698,0.984657,0.013346091,0.0000043236814,0.000034226778,0.000011482096,0.0007423689],"genre_scores_gemma":[0.0022642647,0.0011232831,0.000097439624,0.9501486,0.04294749,0.00002198693,0.000033270746,0.000017685403,0.003346073],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801695,0.00063942454,0.0002983699,0.00027423524,0.00041981624,0.00035116757],"domain_scores_gemma":[0.9915081,0.00455461,0.0008784001,0.00026800804,0.0014946836,0.0012961314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028156384,0.0008071224,0.001672685,0.00078159804,0.0032384743,0.0027467012,0.0015551642,0.048479754,0.0074995984],"category_scores_gemma":[0.026838863,0.0008807053,0.00090438384,0.0006487704,0.0030733428,0.0045318296,0.001987047,0.046913106,0.007628639],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005441425,0.000021218078,0.00080403284,0.00004832476,0.000009015499,0.0009330984,0.000091993956,0.00002252698,0.00006280626,0.0008916624,0.99222493,0.0048359525],"study_design_scores_gemma":[0.00016779431,0.00011380599,0.0024804317,0.0005361553,0.000048512276,0.00313154,0.0010407647,0.00032947128,0.00021566183,0.008980166,0.9828541,0.00010152684],"about_ca_topic_score_codex":0.004469076,"about_ca_topic_score_gemma":0.007000222,"teacher_disagreement_score":0.048479754,"about_ca_system_score_codex":0.0032524741,"about_ca_system_score_gemma":0.00366394,"threshold_uncertainty_score":0.025088668},"labels":[],"label_agreement":null},{"id":"W2790923982","doi":"10.1007/s10549-018-4747-5","title":"Thirty-day postoperative morbidity and mortality in elderly women with breast cancer: an analysis of the NSQIP database","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Ottawa; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Complication; Surgery; Cancer; Mortality rate; Breast surgery; Internal medicine","score_opus":0.03657854980379744,"score_gpt":0.3604312748680924,"score_spread":0.32385272506429497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790923982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822619,0.0010025295,0.000089433306,0.00009662938,0.000009551651,0.000027857432,0.016030038,0.000006047878,0.00047593593],"genre_scores_gemma":[0.98451823,0.0007650817,0.00017335574,0.00008681342,0.000016608466,0.00007131978,0.014116719,0.0000053209187,0.00024650525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880254,0.00030029338,0.0003317522,0.00021579747,0.00021656485,0.0001330073],"domain_scores_gemma":[0.99664944,0.00056525954,0.0018097719,0.0002215566,0.00040611625,0.00034781385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012406937,0.0003331374,0.0007394923,0.0025845254,0.00038907456,0.00065409014,0.00058353035,0.00046567537,0.0011738619],"category_scores_gemma":[0.0033126525,0.00032431682,0.0012113549,0.0053897235,0.00022234362,0.0007008203,0.00093149964,0.0004262107,0.0001870911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010431682,0.000013828837,0.99871397,0.00003507253,0.0002048106,0.000023092845,0.000032916498,0.000043228163,0.0000338978,0.000017485323,0.00025837065,0.0005190977],"study_design_scores_gemma":[0.000008911817,0.00001833465,0.99942076,0.000007779038,0.000057400102,0.000044571534,0.0001212914,0.00010474836,0.000012695523,0.00000973471,0.0001904206,0.0000034496172],"about_ca_topic_score_codex":0.030214382,"about_ca_topic_score_gemma":0.034154125,"teacher_disagreement_score":0.030214382,"about_ca_system_score_codex":0.0010192906,"about_ca_system_score_gemma":0.0010834722,"threshold_uncertainty_score":0.06007701},"labels":[],"label_agreement":null},{"id":"W2793007601","doi":"10.1007/s10549-018-4737-7","title":"Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case–control study","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Queen's University; Spinal Cord Injury BC; University of British Columbia","funders":"University of British Columbia Graduate School; Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Quartile; Breast cancer; Medicine; Confounding; Akaike information criterion; Odds ratio; Statistics; Logistic regression; Case-control study; Population; Cancer; Gynecology; Demography; Internal medicine; Mathematics; Confidence interval; Environmental health","score_opus":0.028258391757759727,"score_gpt":0.33953881968694916,"score_spread":0.3112804279291894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793007601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698648,0.0037036678,0.023717782,0.00071831787,0.00023494652,0.00044830068,0.00039337963,0.00006024404,0.00085858116],"genre_scores_gemma":[0.9915127,0.00038386622,0.0067298864,0.00012929861,0.000109148896,0.00025320682,0.00020280242,0.000010504001,0.0006686419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97220415,0.0212072,0.0013791007,0.003494328,0.0007689054,0.0009463887],"domain_scores_gemma":[0.94933736,0.03959971,0.003199302,0.0062948926,0.0007535336,0.00081525306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03897539,0.0017190203,0.002813687,0.0019997414,0.002324936,0.0028043226,0.005132331,0.0044825785,0.0050417413],"category_scores_gemma":[0.058758605,0.0028509535,0.005844389,0.0016461075,0.0025522364,0.001951838,0.0021489921,0.0034845818,0.00037838912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033740308,0.006087141,0.8775718,0.0008501657,0.04632116,0.0033062673,0.002012707,0.0049782535,0.0026507357,0.0068399017,0.0008296927,0.014811897],"study_design_scores_gemma":[0.020906467,0.013699797,0.66186535,0.00056608877,0.106314644,0.0051179063,0.002889263,0.1593089,0.001737096,0.02485578,0.0023464398,0.00039228227],"about_ca_topic_score_codex":0.013855724,"about_ca_topic_score_gemma":0.0084806755,"teacher_disagreement_score":0.03897539,"about_ca_system_score_codex":0.00090639864,"about_ca_system_score_gemma":0.0014188531,"threshold_uncertainty_score":0.20612401},"labels":[],"label_agreement":null},{"id":"W2793494034","doi":"10.1007/s10549-018-4693-2","title":"Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health","keywords":"Medicine; Cohort; Proportional hazards model; Hazard ratio; Internal medicine; Breast cancer; Oncology; Cancer; Cohort study; Confidence interval","score_opus":0.13703593772350434,"score_gpt":0.4427730666125103,"score_spread":0.30573712888900595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793494034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50366104,0.44239345,0.015179618,0.0018599689,0.00027786935,0.00071100466,0.031105686,0.00022375699,0.004587587],"genre_scores_gemma":[0.9771792,0.012324789,0.0029007222,0.00034346533,0.00009443104,0.0002446803,0.006170419,0.000044940865,0.00069731224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9873904,0.0058377935,0.001806132,0.0022796816,0.0022192765,0.00046680393],"domain_scores_gemma":[0.9675145,0.014331927,0.007769486,0.006534962,0.003414781,0.00043431378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027045365,0.0014034256,0.003147542,0.0035516417,0.0006306286,0.001764925,0.001664448,0.0008092719,0.0013579568],"category_scores_gemma":[0.032397892,0.00084053166,0.013801789,0.0051964773,0.0005926405,0.00070250005,0.0016253841,0.00089580985,0.00019167695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003943422,0.000024265875,0.59159094,0.0073197223,0.3646551,0.0002685701,0.00021009299,0.0032870956,0.00080689363,0.0004248324,0.0020295714,0.025439505],"study_design_scores_gemma":[0.001018683,0.0003075043,0.6556868,0.0014391346,0.32882854,0.00036126553,0.00011597428,0.002530582,0.00036777955,0.00083428813,0.008431245,0.00007823853],"about_ca_topic_score_codex":0.15227154,"about_ca_topic_score_gemma":0.2060819,"teacher_disagreement_score":0.8477285,"about_ca_system_score_codex":0.0024932448,"about_ca_system_score_gemma":0.003194122,"threshold_uncertainty_score":0.30277044},"labels":[],"label_agreement":null},{"id":"W2794142549","doi":"10.1007/s10549-018-4734-x","title":"Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Institute of Cancer Research; Ontario Institute for Cancer Research; McMaster University; Health Sciences Centre; CancerCare Manitoba; University of Toronto; Institute of Health Services and Policy Research; Western University","funders":"Canadian Cancer Society; Canadian Institutes of Health Research; Sunnybrook Research Institute","keywords":"Medicine; Hazard ratio; Internal medicine; Trastuzumab; Proportional hazards model; Breast cancer; Metastatic breast cancer; Oncology; Confidence interval; Cancer; Metastasis","score_opus":0.06202613288929283,"score_gpt":0.3763758606711169,"score_spread":0.3143497277818241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794142549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987675,0.00036658542,0.000025054169,0.00015927746,0.000010618422,0.0000024566896,0.000110057044,0.0000018741822,0.0005565791],"genre_scores_gemma":[0.99952185,0.000112857386,0.000013917134,0.00005952097,0.000022270162,0.0000024054116,0.000113952956,0.0000010994371,0.00015221159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978715,0.000052263655,0.000019610296,0.000032281878,0.00003124072,0.00007747691],"domain_scores_gemma":[0.9990758,0.00030421637,0.00026979542,0.000031327887,0.00005837301,0.00026058828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002151838,0.00012741379,0.0002872068,0.00026584475,0.0003231169,0.0005410363,0.0001738106,0.00043706788,0.001564619],"category_scores_gemma":[0.0019720495,0.000107891836,0.00037356088,0.0006768719,0.00018824794,0.0003405014,0.00020151366,0.00059283513,0.00014732764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004123144,0.000058631846,0.99708,0.0000054327434,0.000045818124,0.00012065576,0.000045746085,0.000073997115,0.00023544552,0.000018006764,0.00015831868,0.0017455876],"study_design_scores_gemma":[0.000017554894,0.00016100374,0.99880326,0.0000041346325,0.00005867949,0.00022336365,0.00017889313,0.00020312333,0.000060583414,0.000035860165,0.00025031317,0.000003324305],"about_ca_topic_score_codex":0.0032653084,"about_ca_topic_score_gemma":0.0039635426,"teacher_disagreement_score":0.0032653084,"about_ca_system_score_codex":0.00032283823,"about_ca_system_score_gemma":0.00042423847,"threshold_uncertainty_score":0.0064926147},"labels":[],"label_agreement":null},{"id":"W2798042703","doi":"10.1007/s10549-018-4769-z","title":"Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novartis Institutes for BioMedical Research; Astex Pharmaceuticals; Novartis Pharmaceuticals Corporation","keywords":"Letrozole; Medicine; Breast cancer; Internal medicine; Quality of life (healthcare); Placebo; Oncology; Cancer; Gynecology; Tamoxifen; Pathology","score_opus":0.04369723222632609,"score_gpt":0.35752007979006534,"score_spread":0.31382284756373924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2798042703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643874,0.0025069702,0.000050416205,0.00010991725,0.000010124781,0.000056517565,0.00049435574,0.0000064379124,0.00032662615],"genre_scores_gemma":[0.99750936,0.0008141674,0.00011257173,0.00016776068,0.000021072718,0.00007546977,0.0008915699,0.00000203326,0.00040606875],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99975985,0.000114060545,0.000016153701,0.00003605989,0.000044998967,0.000028786131],"domain_scores_gemma":[0.9997148,0.000052002393,0.000110350695,0.00002131042,0.00002448159,0.00007709931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010533254,0.0003568432,0.00079628854,0.00016697917,0.00011738261,0.00033010897,0.00026338594,0.00033490156,0.0011295021],"category_scores_gemma":[0.0007958057,0.00013206451,0.0009280571,0.00019240536,0.0001676059,0.00018419807,0.0002438754,0.0004937636,0.00017659471],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48680872,0.008471862,0.2784028,0.001385052,0.0071634725,0.00020268011,0.00028352675,0.0020103343,0.019996367,0.00006807553,0.002788387,0.19241866],"study_design_scores_gemma":[0.048147935,0.087644346,0.853568,0.00009598367,0.0037317013,0.00033200043,0.000086205364,0.0012680519,0.0019890282,0.00007366085,0.003031918,0.000031135434],"about_ca_topic_score_codex":0.0009615793,"about_ca_topic_score_gemma":0.0024294574,"teacher_disagreement_score":0.0011295021,"about_ca_system_score_codex":0.00039548994,"about_ca_system_score_gemma":0.00039062047,"threshold_uncertainty_score":0.005570531},"labels":[],"label_agreement":null},{"id":"W2799587885","doi":"10.1007/s10549-018-4807-x","title":"Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Triple-negative breast cancer; Olaparib; PARP inhibitor; Immune system; Biomarker; Breast cancer; Immunology; Immunotherapy; Immunity; Medicine; Homologous recombination; Cancer research; Cancer; DNA repair; Biology; Internal medicine; Poly ADP ribose polymerase; DNA; Genetics","score_opus":0.1224340836293274,"score_gpt":0.4512091297398764,"score_spread":0.32877504611054903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799587885","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72791,0.25550267,0.0016125663,0.0045942995,0.0002323266,0.00006346727,0.0003525403,0.00007758794,0.009654567],"genre_scores_gemma":[0.9620944,0.034384932,0.0006980037,0.000972626,0.00018478718,0.000039577913,0.00028005493,0.000006024063,0.0013396118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998642,0.000041684983,0.0000117548525,0.000019879351,0.00003786874,0.00002448964],"domain_scores_gemma":[0.9997142,0.000068809335,0.00013283904,0.000009943602,0.000024725383,0.000049441598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047176826,0.00020535005,0.00024777587,0.0003136562,0.00010165542,0.00042081502,0.00014631363,0.00038535762,0.0010898171],"category_scores_gemma":[0.0004975537,0.00006738578,0.00013688525,0.00024371476,0.00027006352,0.00022558683,0.00027364364,0.0005098381,0.000208322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00545737,0.0005857433,0.38571647,0.0030911427,0.00033062353,0.0043830522,0.0006160159,0.0014219554,0.197224,0.005160195,0.010043912,0.38596955],"study_design_scores_gemma":[0.000263436,0.0042702584,0.79421437,0.0014225591,0.00058433844,0.0378669,0.0013174451,0.003943956,0.054717828,0.009011504,0.092312746,0.00007465073],"about_ca_topic_score_codex":0.000339411,"about_ca_topic_score_gemma":0.00036154367,"teacher_disagreement_score":0.0010898171,"about_ca_system_score_codex":0.0004644082,"about_ca_system_score_gemma":0.00034580895,"threshold_uncertainty_score":0.0036457777},"labels":[],"label_agreement":null},{"id":"W279966680","doi":"10.1007/s10549-015-3434-z","title":"Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Genitourinary system; Gynecology; Placebo; Cochrane Library; Meta-analysis; Internal medicine; Cancer; Pathology; Alternative medicine","score_opus":0.2813094219570841,"score_gpt":0.48626563074642914,"score_spread":0.20495620878934506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W279966680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010132495,0.9983797,0.00008411585,0.00009906025,0.000066231965,0.00011795173,0.0001251007,0.000004757722,0.000109825305],"genre_scores_gemma":[0.021070493,0.9773308,0.00069079065,0.0004874293,0.000069379894,0.00014449962,0.00012945698,0.0000037475165,0.00007338166],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972832,0.001004471,0.000919683,0.00031661746,0.00037439528,0.00010160414],"domain_scores_gemma":[0.9933648,0.0048983097,0.0012500973,0.00008301978,0.00029078042,0.000112874695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041860985,0.0013896306,0.009028519,0.0024116854,0.00040082942,0.0015898334,0.001775002,0.0016697191,0.0045548766],"category_scores_gemma":[0.016076386,0.0008305958,0.010256426,0.0027813257,0.0006491288,0.001403334,0.0010541932,0.0019648194,0.00019834356],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002498734,0.00006226048,0.0008442268,0.8945705,0.04427643,0.000068726,0.00008987673,0.00021947714,0.00021859728,0.00013598744,0.0010592865,0.055955928],"study_design_scores_gemma":[0.0070556803,0.001578778,0.0071725654,0.47143275,0.4925493,0.00040699576,0.00035005884,0.000249806,0.00034712075,0.0006716654,0.018101038,0.00008425145],"about_ca_topic_score_codex":0.0048159813,"about_ca_topic_score_gemma":0.017519781,"teacher_disagreement_score":0.009028519,"about_ca_system_score_codex":0.001559616,"about_ca_system_score_gemma":0.0028887389,"threshold_uncertainty_score":0.022138417},"labels":[],"label_agreement":null},{"id":"W2801749275","doi":"10.1007/s10549-018-4796-9","title":"The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Lymph node; Epidemiology; Stage (stratigraphy); Cohort; Mammary gland; Cancer; Oncology; Internal medicine; Biology","score_opus":0.06188312980263837,"score_gpt":0.37469691161074037,"score_spread":0.312813781808102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801749275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954497,0.0030579274,0.00011454243,0.00023978039,0.000008358812,0.000004067269,0.00043002662,0.00000204754,0.0006936512],"genre_scores_gemma":[0.99891734,0.0006912309,0.000044759414,0.000019802104,0.000016829741,0.00000212504,0.00021919173,0.0000013365878,0.000087409564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995627,0.00016062142,0.0000382993,0.00009358783,0.0000772075,0.00006767695],"domain_scores_gemma":[0.9963894,0.0013600925,0.0014414138,0.00023402544,0.0002624495,0.0003126218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079991587,0.00015171935,0.0002158862,0.00066567695,0.00015183572,0.00039677808,0.0004761313,0.00031550787,0.0019235023],"category_scores_gemma":[0.0036499542,0.00016963479,0.0004778837,0.001036374,0.00032115105,0.00039372736,0.000520549,0.00048248837,0.00020009835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000503675,0.0000043202135,0.9987244,0.0000073354518,0.000021031527,0.00003989477,0.000019009884,0.00003311167,0.000068591246,0.000016420036,0.000036552912,0.000978879],"study_design_scores_gemma":[0.0000011794974,0.000010907056,0.9995548,0.0000073885194,0.000014962572,0.00014630727,0.000037872007,0.000081503036,0.00002307333,0.000023264034,0.00009757502,0.0000011160241],"about_ca_topic_score_codex":0.005623198,"about_ca_topic_score_gemma":0.0074429354,"teacher_disagreement_score":0.005623198,"about_ca_system_score_codex":0.00027289407,"about_ca_system_score_gemma":0.00034126476,"threshold_uncertainty_score":0.011180937},"labels":[],"label_agreement":null},{"id":"W2802195249","doi":"10.1007/s10549-018-4821-z","title":"Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Breast cancer; Deductible; Medicine; Oncology; Hormonal therapy; Adjuvant; Internal medicine; Hormone; Cancer; Gynecology; Actuarial science; Business","score_opus":0.09645902789587696,"score_gpt":0.34924950570545865,"score_spread":0.2527904778095817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802195249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98336583,0.004343545,0.00020544963,0.0069933194,0.00011461896,0.000012433129,0.002100952,0.000014586291,0.0028491993],"genre_scores_gemma":[0.9980907,0.0005315279,0.000034190274,0.00017719023,0.000075240016,0.0000022243291,0.0004655501,0.0000027016608,0.00062074553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979448,0.00082599156,0.00013721544,0.00012846678,0.00024966666,0.0007138586],"domain_scores_gemma":[0.98609155,0.0067060287,0.0039599,0.00037828603,0.0004802092,0.0023839802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002357021,0.00018391569,0.00045017074,0.00073076,0.0003602684,0.0019670415,0.0006012377,0.0012357574,0.0063329535],"category_scores_gemma":[0.017134635,0.00024650063,0.0016169923,0.0011521127,0.0004921399,0.0008325704,0.0011224867,0.0020985773,0.0002704196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025011175,0.0007686506,0.9679758,0.00008181592,0.0007287199,0.00042158808,0.000083197665,0.008022975,0.00027809574,0.0027485203,0.0014879275,0.014901613],"study_design_scores_gemma":[0.000088892455,0.00036952068,0.9852646,0.000043905857,0.0007061932,0.000249526,0.0004725534,0.009121487,0.00021866449,0.0018841359,0.0015570389,0.000023448682],"about_ca_topic_score_codex":0.0362603,"about_ca_topic_score_gemma":0.036201842,"teacher_disagreement_score":0.0362603,"about_ca_system_score_codex":0.002105637,"about_ca_system_score_gemma":0.0019151898,"threshold_uncertainty_score":0.07209849},"labels":[],"label_agreement":null},{"id":"W2803463155","doi":"10.1007/s10549-018-4822-y","title":"Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Birth, Development, and Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre; Women's College Hospital; London Health Sciences Centre; Public Health Ontario; University of Toronto","funders":"Canadian Cancer Society Research Institute","keywords":"Breast cancer; Oncology; Medicine; Mutation; Term (time); Cancer; BRCA2 Protein; Gynecology; Internal medicine; Obstetrics; Genetics; Biology; Germline mutation; Gene","score_opus":0.04077077344882113,"score_gpt":0.3663778575862307,"score_spread":0.3256070841374096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803463155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986345,0.00066695985,0.000025391246,0.00008110799,0.000012918883,0.0000017667443,0.00015528887,0.000003668975,0.0004183523],"genre_scores_gemma":[0.99857867,0.0003259128,0.000031904736,0.00003421126,0.000017233027,0.0000032233552,0.0002095496,0.0000045509255,0.00079474034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976784,0.000051650662,0.000020361278,0.00005280039,0.000023780669,0.000083461404],"domain_scores_gemma":[0.9980452,0.00064550235,0.00062119256,0.00008994941,0.00007135142,0.00052673114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005476191,0.00031476098,0.00048002056,0.001124489,0.0005646575,0.00093448925,0.00048215038,0.0012583013,0.006697944],"category_scores_gemma":[0.004275289,0.00047567242,0.00087482645,0.0008282965,0.0003274104,0.0007458651,0.0005038235,0.0010633026,0.00057602837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009503462,0.00011019667,0.9959478,0.00001128246,0.00007580802,0.0003563382,0.00018970443,0.00004747022,0.00042128927,0.00006245916,0.00012826119,0.0016992026],"study_design_scores_gemma":[0.000016751854,0.0002342905,0.9977938,0.000020807181,0.00009832727,0.0007403995,0.0005500886,0.00015331026,0.00007692181,0.000108942426,0.000196822,0.000009541005],"about_ca_topic_score_codex":0.01093624,"about_ca_topic_score_gemma":0.004509339,"teacher_disagreement_score":0.01093624,"about_ca_system_score_codex":0.00030221755,"about_ca_system_score_gemma":0.0003582588,"threshold_uncertainty_score":0.022406876},"labels":[],"label_agreement":null},{"id":"W2804249484","doi":"10.1007/s10549-018-4785-z","title":"Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Cancer Research UK","keywords":"Medicine; Exemestane; Internal medicine; Oncology; Breast cancer; Hazard ratio; Tamoxifen; Cohort; Tumor-infiltrating lymphocytes; Adjuvant therapy; Univariate analysis; Cancer; Multivariate analysis; Immunotherapy; Confidence interval","score_opus":0.0863728712915903,"score_gpt":0.3953243361581453,"score_spread":0.308951464866555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804249484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982249,0.0013253235,0.00015363432,0.000031703537,0.000006388988,0.000024340747,0.00006986918,0.000003119409,0.00016064511],"genre_scores_gemma":[0.99929285,0.000179215,0.00018260685,0.000024200439,0.000019580477,0.000024382918,0.00014426486,9.719796e-7,0.00013198314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995223,0.00026642208,0.000030206349,0.00007032577,0.000071603754,0.00003900323],"domain_scores_gemma":[0.9979085,0.00105635,0.000569368,0.00014475679,0.00011613412,0.00020503809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002062409,0.00031112914,0.0006112048,0.00032997274,0.0001455855,0.00046268516,0.00029209294,0.00039818083,0.0014358308],"category_scores_gemma":[0.0028950267,0.00014465464,0.00036083677,0.00035660516,0.00031736383,0.00028198917,0.0002937728,0.00050647487,0.00021547575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048074048,0.00061679224,0.9056223,0.00022797886,0.00033860272,0.0001236989,0.00007505644,0.0006417852,0.010157632,0.000035508867,0.00017011762,0.033916596],"study_design_scores_gemma":[0.0018339759,0.01771498,0.9708685,0.000045356548,0.0007744945,0.0007553458,0.00009706748,0.0013666932,0.004915692,0.00022960572,0.00138282,0.000015464082],"about_ca_topic_score_codex":0.000174809,"about_ca_topic_score_gemma":0.00022649417,"teacher_disagreement_score":0.002062409,"about_ca_system_score_codex":0.00020246988,"about_ca_system_score_gemma":0.00026645348,"threshold_uncertainty_score":0.010907173},"labels":[],"label_agreement":null},{"id":"W2804366558","doi":"10.1007/s10549-018-4818-7","title":"Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Surgery; Retrospective cohort study; Multivariate analysis; Cohort; Body mass index; Cancer; Internal medicine","score_opus":0.03586190277192471,"score_gpt":0.3881064504678801,"score_spread":0.3522445476959554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804366558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98362124,0.0014196754,0.00018392134,0.0001946684,0.000014138183,0.00006596216,0.013883191,0.000010424773,0.00060685305],"genre_scores_gemma":[0.9860249,0.0006024055,0.00033093712,0.0001298915,0.000021827764,0.000067266956,0.01263822,0.0000071067407,0.00017740001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693465,0.0008675339,0.00062732573,0.0006652568,0.0006666289,0.00023863588],"domain_scores_gemma":[0.9898683,0.0020548496,0.0057854303,0.0006973335,0.00094790146,0.0006462209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020963997,0.00028132775,0.0009033861,0.0022836155,0.00047490996,0.001042886,0.0010587026,0.0006191263,0.0011330324],"category_scores_gemma":[0.008561406,0.00037298867,0.0016588911,0.00653306,0.00024188135,0.0008353887,0.001156311,0.000948193,0.00013542183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015207478,0.000024728904,0.99856913,0.000023394465,0.0002467544,0.00001409778,0.000025541493,0.000044150347,0.000021439815,0.000014762474,0.00018800679,0.0006758186],"study_design_scores_gemma":[0.000028049597,0.00002991747,0.9992599,0.000008544769,0.00011722998,0.00005386141,0.00008021654,0.0002309887,0.000015672531,0.000010242327,0.00016107966,0.0000043812215],"about_ca_topic_score_codex":0.0428908,"about_ca_topic_score_gemma":0.04874884,"teacher_disagreement_score":0.0428908,"about_ca_system_score_codex":0.0012652689,"about_ca_system_score_gemma":0.0014419876,"threshold_uncertainty_score":0.085282266},"labels":[],"label_agreement":null},{"id":"W2805996619","doi":"10.1007/s10549-018-4848-1","title":"Including internal mammary lymph nodes in radiation therapy for synchronous bilateral breast cancer: an international survey of treatment technique and clinical priorities","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Population; Radiation treatment planning; Medical physics; Lymph; Inclusion (mineral); Cancer; Clinical trial; Oncology; Radiology; Internal medicine; Environmental health; Pathology; Psychology","score_opus":0.0789341864661073,"score_gpt":0.43266080211547114,"score_spread":0.35372661564936386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805996619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83763146,0.13614407,0.0019160585,0.0040904847,0.00014110873,0.00013447889,0.0011550303,0.000023083,0.018764209],"genre_scores_gemma":[0.9163306,0.07976721,0.0012296406,0.00083680736,0.00015879769,0.00005283071,0.0005409807,0.000017293034,0.001065861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856085,0.0006793386,0.00022356557,0.00010498152,0.00025227072,0.00017903316],"domain_scores_gemma":[0.99444735,0.002208095,0.0019286947,0.00023357756,0.0007158821,0.00046637323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003024368,0.00021504411,0.0002761716,0.0019019082,0.00038306165,0.00089118746,0.00038216892,0.00025886585,0.00210651],"category_scores_gemma":[0.0053246515,0.00017012106,0.0003510746,0.0040133856,0.000410799,0.0010464406,0.00081209297,0.00048796032,0.00023728434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005250054,0.00014410027,0.74044454,0.001260323,0.0000969603,0.0002266233,0.0012610094,0.0004598493,0.004076423,0.0008101414,0.0008132629,0.24988171],"study_design_scores_gemma":[0.000026641363,0.0006387796,0.9637503,0.00093577534,0.00028192464,0.0015681799,0.0034935754,0.000136525,0.0021354363,0.0003299801,0.026686694,0.000016165803],"about_ca_topic_score_codex":0.004054203,"about_ca_topic_score_gemma":0.0082233865,"teacher_disagreement_score":0.004054203,"about_ca_system_score_codex":0.00062757224,"about_ca_system_score_gemma":0.002321353,"threshold_uncertainty_score":0.015994608},"labels":[],"label_agreement":null},{"id":"W2806424511","doi":"10.1007/s10549-018-4819-6","title":"Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; Österreichische Forschungsförderungsgesellschaft","keywords":"Deductible; Medicine; Breast cancer; Confidence interval; Demography; Cancer; Internal medicine; Actuarial science; Economics","score_opus":0.06032524670866213,"score_gpt":0.3325442238534717,"score_spread":0.2722189771448096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806424511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891937,0.0001357037,0.000012759633,0.000087042565,0.0000042992465,0.0000030555527,0.00052478875,0.0000010741056,0.00031196538],"genre_scores_gemma":[0.9985794,0.00010097201,0.000017161861,0.00003445686,0.0000073764672,0.0000042377187,0.00069921033,0.0000012805011,0.0005558701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966,0.00006987121,0.0000341692,0.00006214528,0.000027011041,0.00014677759],"domain_scores_gemma":[0.9991099,0.00026237272,0.00032980042,0.000032855205,0.000037862697,0.00022720826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040501874,0.00023999877,0.00044225936,0.00052192446,0.00032663002,0.00068033417,0.00034125225,0.00059790263,0.0040559825],"category_scores_gemma":[0.0023188011,0.00035166767,0.0011046797,0.0008942305,0.000249142,0.0009024668,0.0007564858,0.000843266,0.00019333018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006121968,0.000441999,0.98510957,0.000042716238,0.00035954165,0.0001741177,0.0003008811,0.0012886197,0.0003451361,0.000349441,0.000703745,0.0047622016],"study_design_scores_gemma":[0.000067975125,0.0003164529,0.9972051,0.000009568405,0.00012994102,0.0000904341,0.00078416866,0.0009020709,0.000057081892,0.0001928194,0.00023562332,0.000008686564],"about_ca_topic_score_codex":0.03233831,"about_ca_topic_score_gemma":0.044244874,"teacher_disagreement_score":0.03233831,"about_ca_system_score_codex":0.0008954262,"about_ca_system_score_gemma":0.00044282273,"threshold_uncertainty_score":0.06430018},"labels":[],"label_agreement":null},{"id":"W2807586699","doi":"10.1007/s10549-018-4830-y","title":"Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Male Breast Health Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Breast cancer; Medicine; National database; Cancer; MEDLINE; Database; General surgery; Internal medicine; Computer science; Biology","score_opus":0.18354254669944817,"score_gpt":0.5222133759541183,"score_spread":0.3386708292546702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807586699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95360506,0.003596982,0.00033581746,0.001406336,0.000027487347,0.00012057133,0.03936276,0.000014741218,0.0015302509],"genre_scores_gemma":[0.9674164,0.001412067,0.00083432335,0.0005454516,0.000039494713,0.0001244485,0.029388033,0.000013067357,0.000226858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99184763,0.0032175432,0.0018177924,0.001155031,0.0014060233,0.0005559],"domain_scores_gemma":[0.96253806,0.015404808,0.016109962,0.0016490655,0.0031242832,0.0011738085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006030349,0.00025655865,0.0009105631,0.002540791,0.0004977885,0.0013168016,0.0011681007,0.00055334397,0.0016647475],"category_scores_gemma":[0.037474677,0.00030564543,0.0014338448,0.0087290555,0.00024977158,0.0010882699,0.0013673551,0.0010394284,0.00016307738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003745395,0.00008934164,0.98807937,0.00018609394,0.00072274596,0.00003423344,0.00022938829,0.00024588493,0.000022497778,0.00020746047,0.0033089598,0.006499539],"study_design_scores_gemma":[0.00008326851,0.00005743793,0.99553657,0.00011372483,0.0003145489,0.000090343594,0.00060138403,0.00091543194,0.00005797168,0.000100355304,0.002115437,0.0000135999535],"about_ca_topic_score_codex":0.046358205,"about_ca_topic_score_gemma":0.05856039,"teacher_disagreement_score":0.046358205,"about_ca_system_score_codex":0.0021655632,"about_ca_system_score_gemma":0.0032478974,"threshold_uncertainty_score":0.092176735},"labels":[],"label_agreement":null},{"id":"W2809582497","doi":"10.1007/s10549-018-4844-5","title":"Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; McMaster University; Women's College Hospital; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Association of Medical Oncologists","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Proportional hazards model; Radiation therapy; Cancer; Hormone therapy; Prospective cohort study; Hormonal therapy; Biomarker; Chemotherapy; Cohort","score_opus":0.06837218727821881,"score_gpt":0.40600795215212787,"score_spread":0.33763576487390906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809582497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971897,0.0007050013,0.00050719373,0.00004373624,0.000018268194,0.000092102426,0.00046664468,0.000014662635,0.0009625892],"genre_scores_gemma":[0.995939,0.00032530806,0.0006661124,0.000116239666,0.000023506587,0.00010099934,0.0017390632,0.000015330363,0.0010744794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999276,0.0002247123,0.000040469105,0.00015903382,0.00017382347,0.0001259713],"domain_scores_gemma":[0.99831533,0.00055605447,0.00022150364,0.0003013452,0.000469069,0.00013684784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021398827,0.00046834504,0.0004874948,0.0006849389,0.0006090843,0.0008665344,0.00062581385,0.00069736055,0.0014543496],"category_scores_gemma":[0.0022381076,0.00042166753,0.00049126626,0.00063208904,0.0007013251,0.00033212517,0.0004991838,0.0007617351,0.0006351107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009177563,0.001810477,0.87799424,0.00023410808,0.00042581366,0.0005776112,0.0012162476,0.00051145244,0.069999196,0.00017899637,0.0015253926,0.036348924],"study_design_scores_gemma":[0.0004914221,0.0026639372,0.9763506,0.00003534482,0.0005172253,0.0017837475,0.00058884075,0.0009483323,0.011031739,0.00011714205,0.0054458994,0.000025727171],"about_ca_topic_score_codex":0.00431571,"about_ca_topic_score_gemma":0.004395693,"teacher_disagreement_score":0.00431571,"about_ca_system_score_codex":0.0006673656,"about_ca_system_score_gemma":0.0006429532,"threshold_uncertainty_score":0.0113168955},"labels":[],"label_agreement":null},{"id":"W2809955198","doi":"10.1007/s10549-018-4868-x","title":"Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Retrospective cohort study; Prospective cohort study; Surgery; Cohort study; Cancer; Cohort; Internal medicine","score_opus":0.163793670302905,"score_gpt":0.5035038284698006,"score_spread":0.33971015816689554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809955198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014080697,0.99808705,0.00006604505,0.0001016647,0.000049498347,0.00006465198,0.00011863804,0.000003194892,0.0001012443],"genre_scores_gemma":[0.032230716,0.966266,0.00061348145,0.0005209996,0.000062247855,0.00010425072,0.00012325583,0.0000034557697,0.00007566159],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99847573,0.0004772764,0.0005707132,0.000193321,0.00019530175,0.000087585824],"domain_scores_gemma":[0.99506336,0.003583721,0.0009816464,0.000051453528,0.00023749977,0.00008231571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019852861,0.0010490223,0.005593727,0.0024604448,0.00036211926,0.001674079,0.0012763275,0.0016188225,0.004624926],"category_scores_gemma":[0.013023947,0.0008145789,0.0077991155,0.0029955178,0.0004684401,0.0014965693,0.00081909646,0.0015861192,0.00019069677],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083354843,0.00006656965,0.0018659021,0.9087877,0.028740732,0.000088760426,0.00021327984,0.00024461164,0.00016841215,0.00019652737,0.0015694977,0.05722431],"study_design_scores_gemma":[0.0026501236,0.00075053365,0.009907266,0.5826927,0.38064244,0.000476356,0.0006588116,0.00026157315,0.00023123366,0.00066200324,0.02096208,0.00010488947],"about_ca_topic_score_codex":0.008463208,"about_ca_topic_score_gemma":0.032614987,"teacher_disagreement_score":0.008463208,"about_ca_system_score_codex":0.0017899616,"about_ca_system_score_gemma":0.004096854,"threshold_uncertainty_score":0.016827881},"labels":[],"label_agreement":null},{"id":"W2810309824","doi":"10.1007/s10549-018-4865-0","title":"Patient-reported factors influencing the treatment decision-making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Oncology; Qualitative research; Cancer; Metastatic breast cancer; Internal medicine; Family medicine","score_opus":0.12369454371377082,"score_gpt":0.48252609718960987,"score_spread":0.35883155347583906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810309824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019625636,0.9751761,0.00077446946,0.0014694269,0.00020161727,0.00069372036,0.0013269369,0.000006933473,0.0007251908],"genre_scores_gemma":[0.18431807,0.8072912,0.0038761022,0.0019711691,0.00008454353,0.0015378112,0.0006498075,0.000013436539,0.00025798747],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9825431,0.009752985,0.004800143,0.0008511691,0.0016048616,0.00044770978],"domain_scores_gemma":[0.90560544,0.081190646,0.008630376,0.0007127887,0.003358847,0.000501908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020875422,0.0008981939,0.003789315,0.004156514,0.0008473829,0.0029938621,0.0015643411,0.0011970567,0.002725715],"category_scores_gemma":[0.09444313,0.00080873375,0.0054356367,0.0055245813,0.0010598238,0.002711561,0.0023543313,0.0019017943,0.0001259961],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005909731,0.00008225607,0.008574338,0.86095357,0.015624325,0.00019179101,0.014921586,0.00017839318,0.00019163085,0.0007627206,0.0019088003,0.09601965],"study_design_scores_gemma":[0.00031439099,0.00022144664,0.013960859,0.9079759,0.04051968,0.0003599174,0.014940581,0.00013015892,0.00027500928,0.0010268996,0.020154243,0.000120937126],"about_ca_topic_score_codex":0.019364996,"about_ca_topic_score_gemma":0.06356799,"teacher_disagreement_score":0.020875422,"about_ca_system_score_codex":0.0059389663,"about_ca_system_score_gemma":0.01716623,"threshold_uncertainty_score":0.110401094},"labels":[],"label_agreement":null},{"id":"W2863793278","doi":"10.1007/s10549-018-4876-x","title":"CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Hot flash; Genotype; Breast cancer; Oncology; Medicine; CYP2D6; Internal medicine; Flash (photography); Biology; Cancer; Genetics; Gene","score_opus":0.019587207502468767,"score_gpt":0.3069828849859282,"score_spread":0.2873956774834594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2863793278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981153,0.0007407356,0.000102700644,0.00008444324,0.000016479149,0.0000047882572,0.00018647422,0.00000485194,0.00074434496],"genre_scores_gemma":[0.99944323,0.000105674226,0.000035046225,0.00003280845,0.000015439331,0.0000019004497,0.00014145738,0.0000022181243,0.00022214971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976057,0.00007375328,0.000029164468,0.000046046094,0.000049371985,0.000041110845],"domain_scores_gemma":[0.998623,0.0005174558,0.0005721201,0.00007268067,0.000060700335,0.00015398124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030173446,0.00022714015,0.00051975175,0.0002549979,0.00015046321,0.00040997783,0.00016263092,0.00043705082,0.0015914282],"category_scores_gemma":[0.001765072,0.00013393039,0.0005286648,0.00035108367,0.00015419273,0.00024495015,0.00012491037,0.00037090815,0.00022757717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020907174,0.00006557487,0.9896707,0.000024902283,0.0002898425,0.00018876299,0.000035487777,0.00008037665,0.0025977793,0.000019458796,0.00014677804,0.004789711],"study_design_scores_gemma":[0.000013237414,0.00014336807,0.99894637,0.0000032662845,0.00006551873,0.00027937882,0.000025190777,0.00016524889,0.00019993512,0.000021919192,0.00013412224,0.0000025055394],"about_ca_topic_score_codex":0.00093280704,"about_ca_topic_score_gemma":0.0019303573,"teacher_disagreement_score":0.0015914282,"about_ca_system_score_codex":0.00014529718,"about_ca_system_score_gemma":0.00010992833,"threshold_uncertainty_score":0.0053238273},"labels":[],"label_agreement":null},{"id":"W2883340386","doi":"10.1007/s10549-018-05096-6","title":"Clinical implications of germline mutations in breast cancer genes: RECQL","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Research Council; European Commission","keywords":"Breast cancer; Genetics; Cancer; Mutation; Germline mutation; Biology; Exome sequencing; Oncology; Gene; Medicine; Internal medicine","score_opus":0.16168826995760566,"score_gpt":0.5062160668540483,"score_spread":0.34452779689644264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883340386","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535782,0.026454514,0.00055888505,0.004740672,0.0001377097,0.000032510354,0.00058870926,0.000071881885,0.013837038],"genre_scores_gemma":[0.9959275,0.0029447416,0.00026563279,0.00029251393,0.00010193312,0.000003049136,0.00014622998,0.0000061301353,0.0003123023],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997017,0.000060094397,0.000023523162,0.00007042182,0.00008906729,0.000055299864],"domain_scores_gemma":[0.9984463,0.00065190863,0.0004308109,0.00005720878,0.00028518995,0.0001285642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052654935,0.00027622638,0.0002040988,0.0006705617,0.0003101353,0.0004380383,0.00037860379,0.00066183304,0.002586163],"category_scores_gemma":[0.0032659092,0.00007491563,0.00015164573,0.0007252441,0.00060438213,0.00018239547,0.00025772466,0.00043564822,0.00027327266],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006791273,0.000066139124,0.87958276,0.00046244534,0.00013118697,0.043011706,0.000227835,0.00042150987,0.009167721,0.00074386864,0.0035040788,0.062001523],"study_design_scores_gemma":[0.0000814776,0.0002510455,0.7618836,0.0003217364,0.00038147435,0.21901317,0.00075808633,0.000605778,0.004210854,0.0019904014,0.010479641,0.000022750182],"about_ca_topic_score_codex":0.004140428,"about_ca_topic_score_gemma":0.0032740468,"teacher_disagreement_score":0.004140428,"about_ca_system_score_codex":0.0004214869,"about_ca_system_score_gemma":0.00043294442,"threshold_uncertainty_score":0.008651555},"labels":[],"label_agreement":null},{"id":"W2883344686","doi":"10.1007/s10549-018-4888-6","title":"PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Cancer Research Society","keywords":"Vinorelbine; Olaparib; Cancer research; Vinca alkaloid; Pharmacology; Biology; Poly ADP ribose polymerase; Medicine; Internal medicine; Chemotherapy; Biochemistry; Cisplatin; Polymerase","score_opus":0.04040380798639745,"score_gpt":0.36810005989460676,"score_spread":0.3276962519082093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883344686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980452,0.0037403344,0.0017238073,0.0007972036,0.0002945197,0.00015076084,0.004660574,0.0005336916,0.0076470873],"genre_scores_gemma":[0.9843373,0.002368937,0.0013943678,0.00028867938,0.000028569615,0.00012896858,0.005607878,0.000046998957,0.005798369],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964297,0.000055368862,0.00003738471,0.000046473786,0.00009048072,0.00012736933],"domain_scores_gemma":[0.99981624,0.00004641429,0.00002480046,0.000048363898,0.00002718838,0.00003700318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022719386,0.00037883487,0.00073237455,0.0005036096,0.0003504172,0.00052752695,0.0005372974,0.00047852457,0.0055968654],"category_scores_gemma":[0.00028487135,0.0003207652,0.0006818541,0.00070334447,0.00020840188,0.0003976562,0.00034300948,0.0017199886,0.0012806783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026529678,0.0023073233,0.0016378912,0.00041351005,0.0001664742,0.0003419737,0.00022280724,0.0016405142,0.9485253,0.00058562047,0.007965863,0.033539765],"study_design_scores_gemma":[0.00057464646,0.004297046,0.024051577,0.00003513907,0.00010270352,0.00086831604,0.000239974,0.0029135288,0.943844,0.00025264328,0.022784881,0.00003551851],"about_ca_topic_score_codex":0.0025853245,"about_ca_topic_score_gemma":0.0055711875,"teacher_disagreement_score":0.0055968654,"about_ca_system_score_codex":0.00047336065,"about_ca_system_score_gemma":0.0005122142,"threshold_uncertainty_score":0.018723428},"labels":[],"label_agreement":null},{"id":"W2883564325","doi":"10.1007/s10549-018-4894-8","title":"Sexual health in long-term breast cancer survivors","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Université de Sherbrooke; Statistics Canada; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Sexual function; Cohort; Gynecology; Sexual dysfunction; Internal medicine; Cancer","score_opus":0.06725634669818031,"score_gpt":0.41034779090215595,"score_spread":0.34309144420397564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883564325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972905,0.0010908002,0.000012364994,0.00020643948,0.000013130071,0.0000058204914,0.00018441252,8.126452e-7,0.0011959275],"genre_scores_gemma":[0.9987472,0.0005433147,0.00000940077,0.00007311318,0.000010745798,0.0000035564565,0.00016620506,4.354967e-7,0.00044605264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977356,0.000062910876,0.000025209762,0.000016329024,0.00003909494,0.00008285267],"domain_scores_gemma":[0.9989398,0.00020560596,0.0003475819,0.00002825248,0.000106680905,0.00037198738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003376952,0.00011063333,0.00022163586,0.00054048304,0.00053087046,0.00079473644,0.00017313292,0.00054495945,0.0033518043],"category_scores_gemma":[0.0027606927,0.00010999775,0.00036005813,0.00075343467,0.00031554367,0.00057156215,0.00052645727,0.0006045898,0.00019601866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010157405,0.00010251549,0.9948527,0.00002069544,0.00003057987,0.00008115817,0.0003714186,0.00001917876,0.00005963343,0.000027556667,0.00011480161,0.004218143],"study_design_scores_gemma":[0.0000043764267,0.00014988592,0.99676216,0.00003294064,0.000027725311,0.00015596165,0.0024912253,0.000040142222,0.000022925764,0.00004581964,0.00026285384,0.00000391623],"about_ca_topic_score_codex":0.010674635,"about_ca_topic_score_gemma":0.020237481,"teacher_disagreement_score":0.010674635,"about_ca_system_score_codex":0.0003323735,"about_ca_system_score_gemma":0.0005519036,"threshold_uncertainty_score":0.021224976},"labels":[],"label_agreement":null},{"id":"W2884906288","doi":"10.1007/s10549-018-4893-9","title":"Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Metastasis; Oncology; Internal medicine; Stage (stratigraphy); Cancer; Population; Metastatic breast cancer; Cohort; Lung cancer; Epidemiology; Radiology","score_opus":0.08121781632641087,"score_gpt":0.4060211035996797,"score_spread":0.3248032872732688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884906288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.811578,0.004688263,0.06268899,0.003332431,0.0010231375,0.0042774407,0.06714954,0.0005346046,0.044727657],"genre_scores_gemma":[0.9209383,0.00077303295,0.0339832,0.0009536847,0.00012214336,0.004162319,0.034431495,0.00017628797,0.004459481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9857874,0.008697464,0.0015329858,0.0013699685,0.0021676712,0.00044457262],"domain_scores_gemma":[0.97977495,0.0069527607,0.0024498003,0.0036817738,0.006685101,0.00045555155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027991492,0.0004956767,0.00076765625,0.0022988752,0.0009349198,0.0011399781,0.0021116934,0.0010993021,0.0023937614],"category_scores_gemma":[0.045030743,0.00042895545,0.0011136603,0.0020509416,0.0004956583,0.000761226,0.0012489691,0.0010203365,0.0009123098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039830027,0.00012731181,0.9624071,0.00014211262,0.000388936,0.00003405902,0.00040165623,0.000941131,0.00050193956,0.0008054877,0.014529819,0.019322064],"study_design_scores_gemma":[0.0001050482,0.0001853068,0.98155427,0.00013782026,0.00032393585,0.00016238824,0.00043951935,0.0018061645,0.00052646414,0.0005459445,0.014189354,0.000023849534],"about_ca_topic_score_codex":0.024061065,"about_ca_topic_score_gemma":0.036363654,"teacher_disagreement_score":0.027991492,"about_ca_system_score_codex":0.0012155847,"about_ca_system_score_gemma":0.0023998728,"threshold_uncertainty_score":0.14803493},"labels":[],"label_agreement":null},{"id":"W2885849072","doi":"10.1007/s10549-018-4910-z","title":"Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; Centre for Addiction and Mental Health; Western University","funders":"Canadian Institutes of Health Research; Cancer Care Ontario; AstraZeneca; Canada Research Chairs; Amgen","keywords":"Letrozole; Breast cancer; Medicine; Oncology; Internal medicine; Cancer; Gynecology; Tamoxifen","score_opus":0.010075620685404409,"score_gpt":0.274370671019837,"score_spread":0.26429505033443257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885849072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801624,0.0009798554,0.00010793205,0.00009143473,0.00001591966,0.0000038059206,0.000248006,0.000009198227,0.00052749],"genre_scores_gemma":[0.9995247,0.00010032326,0.00004614692,0.000031710264,0.000017925682,0.0000022987842,0.000115323026,0.0000032216064,0.00015850039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999508,0.00015065428,0.000063541906,0.00012791045,0.00008907458,0.000060733622],"domain_scores_gemma":[0.99808705,0.0006260156,0.0008856329,0.00012986953,0.000120985234,0.0001505008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025871117,0.00025995806,0.00052478915,0.00079292816,0.00030273115,0.0005025283,0.0003040507,0.0005693731,0.0017814654],"category_scores_gemma":[0.0024265712,0.00023234077,0.00047441633,0.0012228417,0.00024499054,0.00027428727,0.00017879221,0.00056171,0.00023229401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008223866,0.000034402892,0.9934883,0.000019913165,0.00022203823,0.00027806681,0.00006634475,0.000041734947,0.0023342532,0.000025976271,0.00011505182,0.0025516541],"study_design_scores_gemma":[0.000015086211,0.000133219,0.99834204,0.0000036551342,0.00009586394,0.0007756109,0.00004964257,0.00011149593,0.00022967895,0.000032060274,0.00020689734,0.0000048138477],"about_ca_topic_score_codex":0.0016134315,"about_ca_topic_score_gemma":0.0016755571,"teacher_disagreement_score":0.0017814654,"about_ca_system_score_codex":0.00021562557,"about_ca_system_score_gemma":0.00013970106,"threshold_uncertainty_score":0.0059595704},"labels":[],"label_agreement":null},{"id":"W2888497980","doi":"10.1007/s10549-018-4905-9","title":"NRF1 motif sequence-enriched genes involved in ER/PR −ve HER2 +ve breast cancer signaling pathways","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"University of Pittsburgh; U.S. Department of Veterans Affairs","keywords":"NRF1; Biology; Breast cancer; Cancer research; Transcription factor; Estrogen receptor; Estrogen receptor alpha; Signal transduction; Cancer; Cell biology; Gene; Genetics","score_opus":0.04675702966355498,"score_gpt":0.33773324802767757,"score_spread":0.2909762183641226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888497980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98630244,0.0022768243,0.0021898448,0.00020745426,0.000046127574,0.000030132716,0.005653418,0.00011475706,0.0031789804],"genre_scores_gemma":[0.9732974,0.0010134225,0.002444244,0.00018119467,0.000016263411,0.000040852774,0.008232976,0.00003137026,0.014742309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993706,0.0000049378746,0.0000044797307,0.000021193035,0.000012471675,0.000019735116],"domain_scores_gemma":[0.99994516,0.0000058036826,0.000020210802,0.0000042222814,0.000009183219,0.00001531723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005487012,0.00023087734,0.00019616206,0.00029718026,0.00027320726,0.00017113531,0.00013331394,0.00017777429,0.0055147605],"category_scores_gemma":[0.00008687146,0.00009812766,0.00025872968,0.00022198162,0.00010507969,0.00017528034,0.0001853489,0.00023032195,0.00093347393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039441328,0.000026411648,0.0030284284,0.00014050504,0.000019953448,0.00018642405,0.00003102718,0.00005108862,0.991827,0.00030677946,0.00035164537,0.0036363497],"study_design_scores_gemma":[0.000049498274,0.00029641352,0.27101693,0.00005463259,0.00012108119,0.0028143725,0.00037499206,0.0011490982,0.7048589,0.00058030087,0.01865766,0.00002613537],"about_ca_topic_score_codex":0.0007055747,"about_ca_topic_score_gemma":0.0013432693,"teacher_disagreement_score":0.0055147605,"about_ca_system_score_codex":0.00017572279,"about_ca_system_score_gemma":0.0001357901,"threshold_uncertainty_score":0.01844877},"labels":[],"label_agreement":null},{"id":"W2888692682","doi":"10.1007/s10549-018-4916-6","title":"Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Susan G. Komen; Memorial Sloan-Kettering Cancer Center; Kettering Fund; Susan G. Komen for the Cure","keywords":"Breast cancer; Medicine; Parenchyma; Mastectomy; CD34; Breast MRI; Mammary gland; Pathology; Cancer; Internal medicine; Mammography; Biology; Stem cell","score_opus":0.10610930457847485,"score_gpt":0.4052452293432783,"score_spread":0.29913592476480344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888692682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693419,0.0028044432,0.0034113133,0.00029972283,0.00006173009,0.00020053511,0.00039482283,0.00011814535,0.023367409],"genre_scores_gemma":[0.9946037,0.0009950907,0.0019143028,0.00012051172,0.0000566198,0.000034312507,0.00029191375,0.000020041145,0.001963434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978167,0.000029975685,0.000031870815,0.000037239017,0.000050373623,0.00006891065],"domain_scores_gemma":[0.99915457,0.00019454512,0.00019703405,0.00007542264,0.00020244774,0.0001759415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055824575,0.00048076466,0.0001847636,0.001820656,0.0001971136,0.0004691404,0.0003031404,0.00044622028,0.002881311],"category_scores_gemma":[0.002188391,0.00023924462,0.00020279291,0.0006967643,0.00040956278,0.00060738117,0.0003372734,0.0003762254,0.00077883486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00548487,0.0007116748,0.43522698,0.0006221185,0.00023909088,0.14273576,0.0007737407,0.001293959,0.31445527,0.0016531068,0.0020967585,0.094706744],"study_design_scores_gemma":[0.00012005671,0.0012291766,0.67432106,0.00016330827,0.00030305557,0.2398644,0.0011316959,0.0031347505,0.06700778,0.0009058499,0.011753589,0.00006530048],"about_ca_topic_score_codex":0.0008145765,"about_ca_topic_score_gemma":0.00070493686,"teacher_disagreement_score":0.002881311,"about_ca_system_score_codex":0.00016600269,"about_ca_system_score_gemma":0.00023310607,"threshold_uncertainty_score":0.009638965},"labels":[],"label_agreement":null},{"id":"W2889150873","doi":"10.1007/s10549-018-4935-3","title":"Time to death in breast cancer patients as an indicator of treatment response","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Mortality rate; Cancer; Cause of death; Oncology; Survival analysis; Demography; Internal medicine; Disease","score_opus":0.03766983046768887,"score_gpt":0.3809153141268445,"score_spread":0.34324548365915564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889150873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923017,0.00028618117,0.003527732,0.00017107769,0.000016716176,0.000033377954,0.0022531885,0.000100866644,0.001309236],"genre_scores_gemma":[0.99770594,0.0000477107,0.0010120006,0.00002190981,0.0000067996652,0.000022269765,0.0010028054,0.0000074133964,0.00017319719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995302,0.00023560513,0.000068265195,0.000046333047,0.00008331037,0.00003628616],"domain_scores_gemma":[0.9945787,0.0028018109,0.0018933067,0.00018928545,0.00034436546,0.00019254188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013349538,0.00019922871,0.00019282998,0.001300973,0.000121325575,0.0003700818,0.00016016403,0.00026982598,0.0021941264],"category_scores_gemma":[0.008953655,0.000042751668,0.00044280928,0.00061889156,0.00020430968,0.0003867272,0.0004197307,0.00036828214,0.00022958133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012217817,0.00008548983,0.9591408,0.00014138308,0.00017764099,0.00007552283,0.00045554785,0.008836506,0.0014180364,0.0006734372,0.001020554,0.02675336],"study_design_scores_gemma":[0.00004271052,0.0012606558,0.9754131,0.000048159414,0.00010438657,0.0006950714,0.0007034415,0.015767429,0.0020365044,0.0010218696,0.0028659878,0.00004062924],"about_ca_topic_score_codex":0.00072099123,"about_ca_topic_score_gemma":0.0008793045,"teacher_disagreement_score":0.0021941264,"about_ca_system_score_codex":0.0003492461,"about_ca_system_score_gemma":0.00014295365,"threshold_uncertainty_score":0.007340133},"labels":[],"label_agreement":null},{"id":"W2890985908","doi":"10.1007/s10549-018-4936-2","title":"Prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm–Gotland cancer registry","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Cancer registry; Relative survival; Poisson regression; Internal medicine; Cancer; Proportional hazards model; Survival analysis; Population; Oncology","score_opus":0.05373934337948826,"score_gpt":0.34467687838201944,"score_spread":0.29093753500253117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890985908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093443,0.0011107556,0.000099688776,0.00014268608,0.000033036762,0.000007408357,0.006945216,0.000015039318,0.00071155437],"genre_scores_gemma":[0.98746896,0.0006699151,0.00009970138,0.00005152328,0.000021169162,0.000029251105,0.010923833,0.000013783789,0.0007218357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990815,0.00020734995,0.00011914546,0.0002716839,0.000095491414,0.00022488442],"domain_scores_gemma":[0.9986192,0.00021211001,0.0005567266,0.00020529117,0.00017028344,0.00023634346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011650105,0.0005074271,0.0006612877,0.0017003769,0.0004790088,0.0011563022,0.0008244637,0.0009421616,0.0020709175],"category_scores_gemma":[0.0022679693,0.0007585338,0.0009276112,0.0023319875,0.0003239611,0.0012399572,0.0013026089,0.0009668155,0.0007603452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027332938,0.000037874215,0.99718034,0.000018180515,0.00015181782,0.00021586676,0.00016644056,0.00017515132,0.00011731426,0.00003135553,0.0005878534,0.001044597],"study_design_scores_gemma":[0.000025747298,0.00006931725,0.9979354,0.000028333161,0.00011297427,0.00026054715,0.00045162824,0.00013204794,0.00004487168,0.00004210455,0.00088493736,0.000012116838],"about_ca_topic_score_codex":0.02706892,"about_ca_topic_score_gemma":0.020352855,"teacher_disagreement_score":0.02706892,"about_ca_system_score_codex":0.0006560855,"about_ca_system_score_gemma":0.0007493147,"threshold_uncertainty_score":0.053822696},"labels":[],"label_agreement":null},{"id":"W2891657378","doi":"10.1007/s10549-018-4965-x","title":"Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red de Cáncer; Diputación de Albacete; Ministerio de Economía y Competitividad; CRIS Cancer Foundation; Fundación Científica Asociación Española Contra el Cáncer","keywords":"FOXM1; Breast cancer; Gene knockdown; Cancer research; Gene signature; Biology; Cancer; Epigenetics; Transcription factor; Bromodomain; Gene expression; Oncology; Medicine; Gene; Genetics","score_opus":0.024728913126468365,"score_gpt":0.3411579607309338,"score_spread":0.31642904760446544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891657378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846236,0.008948292,0.002127729,0.00022572886,0.000065136,0.000021549933,0.0003963129,0.00009734177,0.003494254],"genre_scores_gemma":[0.9954406,0.0018057573,0.00046352603,0.00006667238,0.000008257304,0.000019668927,0.00028404282,0.00001153731,0.0018997861],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993527,0.000010090216,0.000003648006,0.00001419717,0.000016951404,0.000019760131],"domain_scores_gemma":[0.9999633,0.0000063425123,0.000012484307,0.0000047415238,0.000004612921,0.000008498072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015222652,0.00014244435,0.00022775322,0.00021448573,0.00017769854,0.00024033195,0.00018063548,0.0001316712,0.0017220237],"category_scores_gemma":[0.00014835545,0.00010723458,0.00019449038,0.00017138434,0.000115197145,0.00016854506,0.00015588378,0.0002935978,0.00018699138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012880485,0.00018096667,0.0038069433,0.00014474876,0.00009548477,0.00012934758,0.000044246317,0.0009777369,0.9666904,0.0013727952,0.0006898205,0.024579454],"study_design_scores_gemma":[0.00020294843,0.0009184706,0.053404,0.000026116428,0.00026180703,0.00057243824,0.00013942482,0.0077808704,0.91274047,0.00079917104,0.023138165,0.000016155318],"about_ca_topic_score_codex":0.00037041926,"about_ca_topic_score_gemma":0.0012079686,"teacher_disagreement_score":0.0017220237,"about_ca_system_score_codex":0.00031570316,"about_ca_system_score_gemma":0.00015744228,"threshold_uncertainty_score":0.005760789},"labels":[],"label_agreement":null},{"id":"W2892343964","doi":"10.1007/s10549-018-4967-8","title":"Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Hazard ratio; Oncology; Meta-analysis; Odds ratio; Randomized controlled trial; Population; Adjuvant; Confidence interval; Cancer","score_opus":0.3371883552928294,"score_gpt":0.5253974729976785,"score_spread":0.18820911770484905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892343964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010706252,0.9875492,0.00076020305,0.00016021173,0.0002028264,0.0001465461,0.0002100638,0.000022937793,0.00024178265],"genre_scores_gemma":[0.379832,0.61289376,0.0033778292,0.0014711932,0.00044884175,0.00051128445,0.000800758,0.000052284864,0.0006120645],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99376935,0.0035624965,0.00127213,0.0007439879,0.00039723061,0.00025483154],"domain_scores_gemma":[0.9894856,0.008458087,0.0012276138,0.00031207615,0.00031476773,0.00020184038],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010169067,0.0026304326,0.016020155,0.0016755244,0.00036240465,0.0023384297,0.0019680564,0.0020366197,0.0039011568],"category_scores_gemma":[0.019026391,0.0012801869,0.027333524,0.0022860342,0.0006340572,0.001951603,0.0010854691,0.00293861,0.00024371383],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032976437,0.0000844271,0.0036334333,0.15802665,0.77867484,0.00010666307,0.00007468614,0.0012153846,0.00042020774,0.00024122641,0.00061376876,0.023932273],"study_design_scores_gemma":[0.0072272634,0.00069917226,0.0026089856,0.005769156,0.98160535,0.000053917924,0.00003729343,0.000263757,0.000109457935,0.00042752913,0.0011743028,0.00002383013],"about_ca_topic_score_codex":0.0033146574,"about_ca_topic_score_gemma":0.007255404,"teacher_disagreement_score":0.9839798,"about_ca_system_score_codex":0.001868286,"about_ca_system_score_gemma":0.0017195375,"threshold_uncertainty_score":0.05377984},"labels":[],"label_agreement":null},{"id":"W2896012636","doi":"10.1007/s10549-018-5002-9","title":"Predictors of time to death after distant recurrence in breast cancer patients","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Proportional hazards model; Cancer; Hazard ratio; Cohort; Radiation therapy; Univariate analysis; Oncology; Internal medicine; Multivariate analysis; Hormonal therapy; Stage (stratigraphy); Cause of death; Disease; Confidence interval","score_opus":0.017519121006749273,"score_gpt":0.3208581104632067,"score_spread":0.30333898945645743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896012636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977518,0.0010906252,0.00006164739,0.000087528584,0.000014502413,0.000003148252,0.0003085938,0.000004178396,0.00067799137],"genre_scores_gemma":[0.99914384,0.00023889798,0.000025037403,0.000022513223,0.000017329228,0.0000033095785,0.00030553012,0.0000016870448,0.0002419156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996953,0.000104623665,0.000030549694,0.000042305703,0.000031415697,0.00009578821],"domain_scores_gemma":[0.99819034,0.0006431645,0.000519,0.0001263867,0.00013287837,0.00038815296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051357574,0.0002550186,0.0003931453,0.00062220474,0.00045296137,0.000597135,0.0003152526,0.00052810647,0.0018899399],"category_scores_gemma":[0.0027367782,0.00025300292,0.0006684169,0.0009149017,0.0002180083,0.00041818872,0.00034520004,0.0009049403,0.00021913325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058256375,0.000038239254,0.99793565,0.000010897137,0.000070092035,0.000056128676,0.00003603235,0.000082579696,0.000106954874,0.000019667163,0.000090697176,0.00097061147],"study_design_scores_gemma":[0.000011757794,0.00012291541,0.999121,0.0000054019215,0.00008682499,0.00011685897,0.00012611679,0.00014722093,0.000057610883,0.00004446211,0.00015580475,0.000004016213],"about_ca_topic_score_codex":0.00522175,"about_ca_topic_score_gemma":0.0059876335,"teacher_disagreement_score":0.00522175,"about_ca_system_score_codex":0.00025981833,"about_ca_system_score_gemma":0.0003884868,"threshold_uncertainty_score":0.010382712},"labels":[],"label_agreement":null},{"id":"W2896462385","doi":"10.1007/s10549-018-4991-8","title":"Enhanced recovery after surgery (ERAS) pathways in breast reconstruction: systematic review and meta-analysis of the literature","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast reconstruction; Mastectomy; Meta-analysis; MEDLINE; Breast surgery; Breast cancer; Mammaplasty; Subgroup analysis; Systematic review; Surgery; Incidence (geometry); Internal medicine; Cancer","score_opus":0.09536515579857086,"score_gpt":0.3654907485094829,"score_spread":0.270125592710912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896462385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027739075,0.99660933,0.00010523891,0.00011656164,0.00004843278,0.000055641205,0.00017919866,0.000003143151,0.00010861819],"genre_scores_gemma":[0.072750494,0.9250329,0.0009623631,0.00055682485,0.00012864111,0.0001713991,0.00027440375,0.0000053778185,0.00011770654],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944944,0.0023289728,0.0016887014,0.0006349821,0.000603016,0.0002499891],"domain_scores_gemma":[0.98514265,0.011474216,0.002301766,0.0002768909,0.00059696176,0.00020754396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007352429,0.0016841888,0.0077100033,0.0034697158,0.0005802454,0.002438741,0.0014464256,0.0017280589,0.0037946415],"category_scores_gemma":[0.026630625,0.0007812686,0.016701594,0.004670338,0.0005946686,0.0017167267,0.0017627925,0.0017932531,0.00019117357],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001830965,0.00009310124,0.009616435,0.6890785,0.24947739,0.000169524,0.00021974996,0.00034840644,0.00021915663,0.0002824596,0.00092629425,0.0477381],"study_design_scores_gemma":[0.00086010515,0.0004381398,0.018524822,0.11936509,0.85336685,0.0003735366,0.0002868348,0.00015736373,0.00017775923,0.0005216777,0.0058630006,0.00006488809],"about_ca_topic_score_codex":0.006475375,"about_ca_topic_score_gemma":0.021865204,"teacher_disagreement_score":0.0077100033,"about_ca_system_score_codex":0.0015578787,"about_ca_system_score_gemma":0.004311526,"threshold_uncertainty_score":0.038883805},"labels":[],"label_agreement":null},{"id":"W2897172238","doi":"10.1007/s10549-018-4993-6","title":"Improving the competency of medical students in clinical breast examination through a standardized simulation and multimedia-based curriculum","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Objective structured clinical examination; Curriculum; Test (biology); Palpation; Medicine; Physical examination; Medical education; Educational measurement; Breast cancer; Medical physics; Psychology; Radiology; Internal medicine; Pedagogy","score_opus":0.06987901911549708,"score_gpt":0.45856791453094914,"score_spread":0.38868889541545204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897172238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98753184,0.000295997,0.004942921,0.0011517684,0.00013829231,0.00045932483,0.00006341103,0.00012379125,0.0052926713],"genre_scores_gemma":[0.9671321,0.00082137325,0.02576481,0.000726122,0.000097490956,0.00041761255,0.00020116393,0.000016449483,0.0048229164],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992417,0.00026462637,0.00005923913,0.00006387599,0.00023104179,0.00013945745],"domain_scores_gemma":[0.9971546,0.00055948924,0.00035544584,0.00013768567,0.0005148145,0.0012779727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023154665,0.0005223428,0.0003421709,0.00063865737,0.00032334984,0.00090450794,0.00069253513,0.00068907253,0.0033688964],"category_scores_gemma":[0.006685108,0.00020870731,0.00030425805,0.00021278791,0.00021998589,0.00046929112,0.0015804891,0.00075949903,0.00084388664],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021857056,0.061799027,0.1617491,0.0007974996,0.00012563667,0.00073995924,0.0042554475,0.015241875,0.038285516,0.0027758318,0.016273228,0.69577116],"study_design_scores_gemma":[0.0023683477,0.04778174,0.6754914,0.0024142368,0.0003970616,0.004273202,0.0069156685,0.07453493,0.08755,0.010965362,0.08688644,0.00042167385],"about_ca_topic_score_codex":0.00085722696,"about_ca_topic_score_gemma":0.0022223536,"teacher_disagreement_score":0.0033688964,"about_ca_system_score_codex":0.0007511417,"about_ca_system_score_gemma":0.0039571207,"threshold_uncertainty_score":0.012245476},"labels":[],"label_agreement":null},{"id":"W2899955386","doi":"10.1007/s10549-018-5027-0","title":"CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Research (Canada); BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Breast cancer; CYP2D6; Medicine; Oncology; Genotyping; Context (archaeology); Metastatic breast cancer; Critical appraisal; Internal medicine; Gynecology; Cancer; Bioinformatics; Biology; Genotype; Alternative medicine; Pathology; Genetics","score_opus":0.39078011189290024,"score_gpt":0.6369050860232861,"score_spread":0.24612497413038587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899955386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027490413,0.9988029,0.00010360016,0.00031319106,0.00007637839,0.000051770327,0.00020362598,0.0000045258844,0.00016913367],"genre_scores_gemma":[0.006655123,0.9907986,0.0009962204,0.0009972584,0.000100008554,0.000093330666,0.0002212199,0.0000032287496,0.00013505669],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979754,0.00064633065,0.00078801875,0.0002357626,0.00029465943,0.000059778977],"domain_scores_gemma":[0.9936454,0.0045230803,0.0012544356,0.00007806116,0.00042700887,0.00007204855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031395138,0.0010153977,0.0042580366,0.0034655028,0.0002737916,0.0014647543,0.0012898509,0.0015764876,0.0060065757],"category_scores_gemma":[0.015047576,0.00058176246,0.0067259865,0.002970876,0.00037737683,0.0010697172,0.0007689163,0.0013655552,0.00037835972],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000915942,0.00006300628,0.0013623303,0.73517805,0.020682266,0.0001497132,0.00011106234,0.0003294716,0.00036847696,0.00069453864,0.010672636,0.22947253],"study_design_scores_gemma":[0.0024208566,0.00042985356,0.0066347197,0.65750045,0.21689108,0.00084772566,0.00022903144,0.0004097629,0.0004635402,0.0017100839,0.112341695,0.00012117756],"about_ca_topic_score_codex":0.004400493,"about_ca_topic_score_gemma":0.017413693,"teacher_disagreement_score":0.0060065757,"about_ca_system_score_codex":0.0011764164,"about_ca_system_score_gemma":0.0031893086,"threshold_uncertainty_score":0.020093977},"labels":[],"label_agreement":null},{"id":"W2903202196","doi":"10.1007/s10549-020-05903-z","title":"Prognostic associations of plasma hepcidin in women with early breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Health Sciences Centre; Mount Sinai Hospital; Western University; Sunnybrook Health Science Centre","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Hepcidin; Breast cancer; Medicine; Internal medicine; Oncology; Cancer; Physiology; Anemia","score_opus":0.0473389381710566,"score_gpt":0.3413579946223462,"score_spread":0.29401905645128956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903202196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961999,0.001579419,0.00016376493,0.00018369264,0.000034759,0.000005533928,0.00051307137,0.000010488739,0.0013094167],"genre_scores_gemma":[0.99881434,0.00025040045,0.000094141644,0.00002744092,0.00003556487,0.000003831249,0.00026137216,0.0000026459593,0.00051018613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979454,0.000064442334,0.000016827806,0.000036016118,0.000027847982,0.00006031173],"domain_scores_gemma":[0.9988788,0.00037309085,0.00036930904,0.00008061433,0.000089924404,0.00020833412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004943282,0.00029856985,0.00030221007,0.00073602406,0.0003340231,0.000543969,0.00034730724,0.00054908154,0.0025655704],"category_scores_gemma":[0.0022299828,0.0002475126,0.00033655326,0.0008590393,0.00033002655,0.00036691123,0.00039047038,0.0008656597,0.00024250089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006571651,0.000023626682,0.99658173,0.000010790512,0.00004760547,0.00009904144,0.000025966978,0.000058962672,0.0005229578,0.000034020446,0.00011125137,0.0018269765],"study_design_scores_gemma":[0.000015705371,0.00006915901,0.9985233,0.000007483511,0.00005400748,0.00031551067,0.00011643519,0.0003578298,0.00018719844,0.00008175692,0.00026689772,0.0000048379247],"about_ca_topic_score_codex":0.0030625402,"about_ca_topic_score_gemma":0.0035884806,"teacher_disagreement_score":0.0030625402,"about_ca_system_score_codex":0.00029663168,"about_ca_system_score_gemma":0.0002976714,"threshold_uncertainty_score":0.008582652},"labels":[],"label_agreement":null},{"id":"W2903357954","doi":"10.1007/s10549-018-5045-y","title":"A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Susan G. Komen","keywords":"Genetic testing; Genetic counseling; Medicine; Breast cancer; Cancer; Cancer prevention; Breast cancer screening; Family medicine; Gerontology; Demography; Gynecology; Mammography; Internal medicine; Genetics; Biology","score_opus":0.047793708537703226,"score_gpt":0.3512920786672355,"score_spread":0.3034983701295323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903357954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803846,0.00058756856,0.0010419545,0.0037432548,0.00007587312,0.0006521445,0.00035665557,0.000043361433,0.013114609],"genre_scores_gemma":[0.98795927,0.00072435546,0.0034230622,0.001124667,0.00002546384,0.0007247093,0.0002612734,0.000014052882,0.0057432153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991405,0.00046130636,0.000049420196,0.00007238414,0.00007024482,0.0002060678],"domain_scores_gemma":[0.99882966,0.00019810651,0.00014336362,0.000072660085,0.00029219416,0.00046401337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010031478,0.00023730382,0.0001794643,0.0006388062,0.002110912,0.00070381106,0.0007586606,0.00047157583,0.0042250385],"category_scores_gemma":[0.0035334965,0.00025480543,0.00010938043,0.0005203335,0.00050532626,0.00043233385,0.0021568267,0.00087170367,0.0003842503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005879025,0.0016663553,0.8029337,0.0001420632,0.000020653946,0.015590461,0.037353512,0.00068452855,0.0032691683,0.0013027001,0.0150319785,0.121416934],"study_design_scores_gemma":[0.00019780717,0.002306475,0.7901366,0.00060599745,0.000046801935,0.014984285,0.15652804,0.002544264,0.0016942385,0.0022764003,0.02856809,0.0001110038],"about_ca_topic_score_codex":0.111178026,"about_ca_topic_score_gemma":0.20807643,"teacher_disagreement_score":0.111178026,"about_ca_system_score_codex":0.0021216583,"about_ca_system_score_gemma":0.005838378,"threshold_uncertainty_score":0.22106183},"labels":[],"label_agreement":null},{"id":"W2903454478","doi":"10.1007/s10549-018-05077-9","title":"Yield of surveillance magnetic resonance imaging after bilateral mastectomy and reconstruction: a retrospective cohort study","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast MRI; Magnetic resonance imaging; Breast cancer; Mastectomy; Breast reconstruction; Retrospective cohort study; Cohort; Confidence interval; Radiology; Cohort study; Mammography; Cancer; Surgery; Internal medicine","score_opus":0.022257788119429436,"score_gpt":0.30915928009649474,"score_spread":0.2869014919770653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903454478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99935156,0.00018932624,0.000048261867,0.00001626664,0.0000032223202,0.0000029153969,0.00022239894,0.0000019821418,0.0001640028],"genre_scores_gemma":[0.99951804,0.00009019107,0.000031117757,0.000013176906,0.0000063094944,0.000003092907,0.00026727217,0.0000021825042,0.00006858856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924564,0.00015271209,0.000102013604,0.00023915463,0.000111331734,0.00014911918],"domain_scores_gemma":[0.9974251,0.00042247103,0.0011496401,0.00039721862,0.00023470366,0.0003708706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006513778,0.000374219,0.00046815243,0.0009507024,0.0005415515,0.00092313526,0.0006192954,0.0007235663,0.0017712867],"category_scores_gemma":[0.003464362,0.0006549172,0.00091647217,0.0012631598,0.00042635476,0.00087295874,0.00069794396,0.0006372948,0.00030283537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009585757,0.00001707418,0.99931586,0.0000026438563,0.000046777073,0.000092241346,0.000036072553,0.000010058225,0.000116965384,0.0000064282576,0.000022859327,0.00023715566],"study_design_scores_gemma":[0.0000045169318,0.00007797405,0.99867415,0.0000032404344,0.000046040597,0.0007595555,0.00021268563,0.00008446023,0.00004321222,0.000012678553,0.00007618828,0.000005204047],"about_ca_topic_score_codex":0.0057470687,"about_ca_topic_score_gemma":0.0051088454,"teacher_disagreement_score":0.0057470687,"about_ca_system_score_codex":0.0004327383,"about_ca_system_score_gemma":0.00042333052,"threshold_uncertainty_score":0.011427283},"labels":[],"label_agreement":null},{"id":"W2904225298","doi":"10.1007/s10549-018-05095-7","title":"The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women’s characteristics: is it the same?","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise; Université Laval; Institut National de Santé Publique du Québec","funders":"","keywords":"Ductal carcinoma; Medicine; Mammography; Breast cancer; Odds ratio; Internal medicine; Oncology; Cancer; Gynecology; Logistic regression; Carcinoma in situ; Biopsy; Radiology","score_opus":0.08524520396557766,"score_gpt":0.377005096543775,"score_spread":0.29175989257819734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904225298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85308367,0.09605555,0.0013318902,0.035425562,0.002723926,0.00006805767,0.0018191261,0.000040795425,0.009451418],"genre_scores_gemma":[0.9874866,0.0067694513,0.00053907704,0.0024568855,0.0017352897,0.000021339034,0.00051797734,0.000012366185,0.00046101876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99097145,0.0042123306,0.0012440255,0.0011062903,0.0017299022,0.0007358885],"domain_scores_gemma":[0.9677987,0.017060518,0.006900235,0.003332795,0.0033866272,0.0015211914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011994816,0.0005423605,0.0016324028,0.0033684608,0.0006929335,0.0025354212,0.0023414218,0.004463506,0.0024746563],"category_scores_gemma":[0.04636374,0.0008960847,0.0025205237,0.003954402,0.002334885,0.0040673898,0.0015749353,0.0030100744,0.00058828574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005021671,0.00006256834,0.9782759,0.0001163979,0.00062515674,0.0001157149,0.00021349173,0.00008935148,0.0001275181,0.00057854963,0.0016136062,0.017679688],"study_design_scores_gemma":[0.000042812586,0.00023927062,0.99345,0.00023333174,0.00086547,0.0005350519,0.00078244304,0.0006449528,0.00011531464,0.0009937099,0.0020591395,0.000038579547],"about_ca_topic_score_codex":0.0070483573,"about_ca_topic_score_gemma":0.009305484,"teacher_disagreement_score":0.011994816,"about_ca_system_score_codex":0.00074300723,"about_ca_system_score_gemma":0.00116068,"threshold_uncertainty_score":0.063435435},"labels":[],"label_agreement":null},{"id":"W2906970298","doi":"10.1007/s10549-018-05122-7","title":"Three-dimensional tumor visualization of invasive breast carcinomas using whole-mount serial section histopathology: implications for tumor size assessment","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; Sunnybrook Hospital; University of Toronto; Institute for Work & Health; Sunnybrook Health Science Centre","funders":"","keywords":"Undersampling; Lumpectomy; Histology; Nuclear medicine; Mathematics; Volume (thermodynamics); Medicine; Breast cancer; Histopathology; Cancer; Pathology; Mastectomy; Physics; Internal medicine","score_opus":0.039636163633089666,"score_gpt":0.365979890636119,"score_spread":0.3263437270030294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906970298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77628726,0.0043836785,0.2091933,0.00072872103,0.000104016675,0.00009662449,0.0007165012,0.0014089686,0.007081027],"genre_scores_gemma":[0.85657597,0.0022937874,0.13632192,0.00009000531,0.000040148658,0.00008724787,0.00029207338,0.00033243123,0.003966404],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99978703,0.0000724383,0.00002135342,0.00003175851,0.00006793264,0.000019484869],"domain_scores_gemma":[0.99880815,0.0005442245,0.00019702734,0.00015351648,0.00023294648,0.00006415297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011424561,0.000417545,0.00022888432,0.000858334,0.0002988193,0.00086914713,0.00041946291,0.00040158973,0.0018698873],"category_scores_gemma":[0.0011640504,0.00044235087,0.00017182367,0.00038421073,0.00037428594,0.0012746614,0.00038273132,0.00054837705,0.00039346996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014542087,0.00003886162,0.004958499,0.000106137006,0.0000125399665,0.0001079922,0.00014395012,0.0007619898,0.98124576,0.00064279867,0.00015196175,0.011684138],"study_design_scores_gemma":[0.000020866974,0.00023844164,0.16004989,0.000046634304,0.00009194358,0.0028041396,0.00071505556,0.024622573,0.80471814,0.0013373764,0.0052893353,0.00006565856],"about_ca_topic_score_codex":0.0017195598,"about_ca_topic_score_gemma":0.0045370553,"teacher_disagreement_score":0.0018698873,"about_ca_system_score_codex":0.0003044864,"about_ca_system_score_gemma":0.0003157387,"threshold_uncertainty_score":0.0062553883},"labels":[],"label_agreement":null},{"id":"W2907101057","doi":"10.1007/s10549-018-05114-7","title":"The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Ejection fraction; Anthracycline; Breast cancer; Internal medicine; Chemotherapy; Stage (stratigraphy); Cardiology; Clinical trial; Oncology; Cancer; Heart failure","score_opus":0.2477288008254014,"score_gpt":0.5368365337611267,"score_spread":0.28910773293572534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907101057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005749527,0.9931044,0.00037182446,0.00009541722,0.00013681958,0.000074740725,0.00026968017,0.000013865412,0.00018380894],"genre_scores_gemma":[0.2877473,0.7068977,0.0023086318,0.0012946472,0.0003099296,0.00029606366,0.00066747674,0.000037444926,0.0004408396],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949473,0.0021689674,0.0015317735,0.0007355942,0.00044846442,0.0001677996],"domain_scores_gemma":[0.9887305,0.008356773,0.0017580873,0.000459394,0.0005490568,0.0001462781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075837807,0.0020549488,0.012079353,0.0022794888,0.00037771082,0.0024307661,0.00160399,0.002335867,0.0030169953],"category_scores_gemma":[0.022283249,0.0012405909,0.027266625,0.0032581326,0.0006333976,0.0014529506,0.0013942695,0.0024114763,0.00028659793],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003945242,0.00004133261,0.00671986,0.2221457,0.7479526,0.0000792697,0.0000763398,0.0005108737,0.00031186716,0.00012613474,0.00047984108,0.017611004],"study_design_scores_gemma":[0.0007275287,0.00023726127,0.004543818,0.00892362,0.9839166,0.000048016365,0.000037106824,0.00013005247,0.00008258813,0.00016090243,0.00116855,0.0000240602],"about_ca_topic_score_codex":0.005623867,"about_ca_topic_score_gemma":0.0154766105,"teacher_disagreement_score":0.012079353,"about_ca_system_score_codex":0.0013140698,"about_ca_system_score_gemma":0.001869689,"threshold_uncertainty_score":0.04010737},"labels":[],"label_agreement":null},{"id":"W2907218362","doi":"10.1007/s10549-018-05109-4","title":"Is microductectomy still necessary to diagnose breast cancer: a 10-year study on the effectiveness of duct excision and galactography","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; Nipple discharge; Breast cancer; Malignancy; Mammography; Breast disease; Radiological weapon; Radiology; Incidence (geometry); Retrospective cohort study; Cancer; Surgery; Internal medicine","score_opus":0.038271335045331145,"score_gpt":0.3573218608961007,"score_spread":0.31905052585076954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907218362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948502,0.003927654,0.00011669195,0.00018187096,0.000042581578,0.000013153282,0.00010632129,0.0000037721286,0.0007578268],"genre_scores_gemma":[0.9976687,0.0014657814,0.00009645898,0.00013574438,0.00009317189,0.000005078711,0.00020790637,0.0000040907557,0.0003230899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830806,0.0007189743,0.00020076873,0.00018550214,0.0003284824,0.00025825723],"domain_scores_gemma":[0.9918183,0.004250001,0.0017796367,0.0005554721,0.00083963573,0.0007569784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037035965,0.00040544392,0.0009383601,0.00091417285,0.00038687486,0.0007240784,0.00056745036,0.0013114286,0.0008615604],"category_scores_gemma":[0.0065751914,0.00024890338,0.0015986756,0.00077954435,0.0008580888,0.0011944905,0.00034011307,0.0008343553,0.00030287058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011837564,0.0025196879,0.9361125,0.00012742679,0.00056253583,0.0010905442,0.0005282973,0.00037930202,0.0022550393,0.000058134407,0.00023970897,0.044289287],"study_design_scores_gemma":[0.0001942398,0.015968705,0.9778381,0.00006392502,0.00065093423,0.0016425246,0.0007954946,0.00041036648,0.0009466772,0.00004943226,0.0013974631,0.000042168012],"about_ca_topic_score_codex":0.003588825,"about_ca_topic_score_gemma":0.0038901689,"teacher_disagreement_score":0.0037035965,"about_ca_system_score_codex":0.00053317857,"about_ca_system_score_gemma":0.00053684355,"threshold_uncertainty_score":0.019586742},"labels":[],"label_agreement":null},{"id":"W2907259814","doi":"10.1007/s10549-018-05118-3","title":"Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case–control study","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; St. Michael's Hospital; Western University; Women's College Hospital","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","keywords":"Breast cancer; Medicine; Oncology; Mutation; Case-control study; Folic acid; Internal medicine; Genetics; Cancer; Gynecology; Biology; Gene","score_opus":0.04052469990405163,"score_gpt":0.37870936921740056,"score_spread":0.33818466931334895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907259814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990752,0.00039128034,0.00009415455,0.000018658691,0.000012814797,0.000023486728,0.00015880605,0.0000042982524,0.0002213258],"genre_scores_gemma":[0.9986211,0.00020216512,0.00015684255,0.000034591158,0.000022466967,0.00003516351,0.00025400025,0.0000047336653,0.0006689361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990246,0.0002768222,0.000104737206,0.00034633794,0.00012051741,0.00012705344],"domain_scores_gemma":[0.99864703,0.00041049198,0.00031674458,0.00024227264,0.0001518213,0.0002316182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009045187,0.00094363856,0.0011255292,0.001274858,0.0015417176,0.0011589178,0.0008645579,0.0015927341,0.003721882],"category_scores_gemma":[0.0023285134,0.001557306,0.0013021004,0.00150905,0.0008113783,0.00070683623,0.0005079957,0.0011820913,0.00048727408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010549171,0.0022366196,0.97789985,0.00009845632,0.0016713752,0.00092825317,0.00071427337,0.00006751759,0.0034287772,0.000115878654,0.00026859113,0.0020211611],"study_design_scores_gemma":[0.00061504217,0.0020605195,0.99375844,0.000016768567,0.00096980744,0.001049054,0.00042205432,0.00032881033,0.00023748595,0.000056661855,0.00046173125,0.000023539198],"about_ca_topic_score_codex":0.016555823,"about_ca_topic_score_gemma":0.010502378,"teacher_disagreement_score":0.016555823,"about_ca_system_score_codex":0.00064532814,"about_ca_system_score_gemma":0.00039529792,"threshold_uncertainty_score":0.03291893},"labels":[],"label_agreement":null},{"id":"W2907731420","doi":"10.1007/s10549-018-05076-w","title":"Age-specific risks of incident, contralateral and ipsilateral breast cancer among 1776 Polish BRCA1 mutation carriers","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"Canada Research Chairs","keywords":"Breast cancer; Medicine; BRCA mutation; Cumulative incidence; Cancer; Incidence (geometry); Oncology; Internal medicine; Gynecology; Germline mutation; Obstetrics; Cohort; Mutation; Genetics; Biology","score_opus":0.04213065313632332,"score_gpt":0.3592300690624636,"score_spread":0.31709941592614027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907731420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989961,0.00022194341,0.00006197348,0.000009631995,0.0000025630154,0.0000023759376,0.0004396175,0.0000022564927,0.0002635937],"genre_scores_gemma":[0.9986767,0.0001768203,0.000031691914,0.000007580113,0.0000027016854,0.0000043409204,0.0004899615,0.0000026898797,0.0006073792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998516,0.000017831819,0.000020534202,0.00004532121,0.000021767286,0.000042926367],"domain_scores_gemma":[0.99977237,0.00003633925,0.00008253577,0.000022159273,0.000026270984,0.000060337894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022784856,0.00025656942,0.0003108416,0.000713404,0.00021547946,0.0003215423,0.00019524418,0.0002833904,0.0016149853],"category_scores_gemma":[0.0005332151,0.00041210945,0.00041413034,0.0009654003,0.00016516699,0.00026255404,0.0002957512,0.0003217588,0.00033687783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045269835,0.00002261499,0.99657744,0.000013072722,0.00009162514,0.00015295408,0.00015406583,0.0000603266,0.0006844602,0.000029312705,0.00008416001,0.001677366],"study_design_scores_gemma":[0.000007393158,0.000060295955,0.99905556,0.0000017328085,0.000055983754,0.00021332092,0.00017197519,0.00007520007,0.00009600036,0.000019579358,0.00024016474,0.0000027930332],"about_ca_topic_score_codex":0.017266218,"about_ca_topic_score_gemma":0.015472471,"teacher_disagreement_score":0.017266218,"about_ca_system_score_codex":0.0002849493,"about_ca_system_score_gemma":0.00025618298,"threshold_uncertainty_score":0.03433144},"labels":[],"label_agreement":null},{"id":"W2908699784","doi":"10.1007/s10549-018-05125-4","title":"Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Medicine; Breast cancer; Oncology; Internal medicine; Placebo; Metastatic breast cancer; Hazard ratio; Estrogen receptor; Population; Cancer; Gynecology; Tamoxifen; Confidence interval; Pathology","score_opus":0.03527075155297768,"score_gpt":0.3551255762284284,"score_spread":0.3198548246754507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908699784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991576,0.0057158554,0.0002632643,0.00016667218,0.000047448546,0.0006034967,0.0004234433,0.000045162607,0.0011587904],"genre_scores_gemma":[0.99575126,0.0018382217,0.00049410894,0.00017731386,0.00006079443,0.00045704798,0.00060213334,0.0000056681424,0.0006134352],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99967086,0.00016354457,0.000020603436,0.00004837938,0.000056938283,0.000039618037],"domain_scores_gemma":[0.9996983,0.00007579641,0.000080067504,0.000031669166,0.000021243917,0.000092938404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012213693,0.00047655337,0.0013086026,0.00036545252,0.00020279195,0.0004160695,0.000481931,0.00036325556,0.0017887225],"category_scores_gemma":[0.0007147255,0.00020183825,0.00091347937,0.00040448707,0.00026917332,0.0003933063,0.0002412919,0.0009909832,0.00030013695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7474058,0.010789804,0.017358068,0.0010562363,0.0023503476,0.00025547927,0.00011195721,0.0021459388,0.018284464,0.00011142006,0.0016007571,0.19852974],"study_design_scores_gemma":[0.54691654,0.3427089,0.092215024,0.00016365634,0.0027164577,0.0008010418,0.00006931113,0.0025476874,0.0065378975,0.0002730345,0.00501365,0.000036905276],"about_ca_topic_score_codex":0.0006850861,"about_ca_topic_score_gemma":0.0030389747,"teacher_disagreement_score":0.0017887225,"about_ca_system_score_codex":0.00068566384,"about_ca_system_score_gemma":0.0008955521,"threshold_uncertainty_score":0.0064592957},"labels":[],"label_agreement":null},{"id":"W2908879255","doi":"10.1007/s10549-019-05132-z","title":"National consensus recommendations on patient-centered care for ductal carcinoma in situ","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Foothills Medical Centre; University of Calgary; Saskatoon City Hospital; Sunnybrook Health Science Centre; University of Saskatchewan; Dalhousie University; University Health Network; Toronto General Hospital; Health Sciences Centre","funders":"Canadian Cancer Society","keywords":"Ductal carcinoma; Breast cancer; Medicine; In situ; Carcinoma in situ; MEDLINE; Oncology; Internal medicine; Cancer; Political science; Geography","score_opus":0.19371757187776198,"score_gpt":0.450230148961514,"score_spread":0.25651257708375197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908879255","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015249155,0.084932245,0.076513104,0.6868249,0.02799309,0.008892709,0.0039684423,0.0010356429,0.09459069],"genre_scores_gemma":[0.14337721,0.09124986,0.59883714,0.12136685,0.0022158558,0.015387947,0.010001631,0.00044746682,0.017116072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8664544,0.07547298,0.026744941,0.0025982065,0.02518452,0.0035448694],"domain_scores_gemma":[0.7927152,0.07047971,0.0131481355,0.005636074,0.10706337,0.010957484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14776124,0.001327825,0.001803338,0.006712766,0.0034831099,0.0047595683,0.0074367346,0.0072539677,0.005791561],"category_scores_gemma":[0.1834874,0.00097404246,0.004045971,0.0042211586,0.0026730963,0.0043803104,0.0083220685,0.011932763,0.0025157065],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021086479,0.00070142455,0.008251503,0.023377977,0.00036537336,0.00074104656,0.01311841,0.0028078542,0.0012289704,0.024097098,0.37782887,0.5472707],"study_design_scores_gemma":[0.00041334028,0.00048400086,0.01260416,0.12393967,0.000687841,0.0011405853,0.018450195,0.0023057621,0.0019330976,0.026831867,0.8108726,0.00033686904],"about_ca_topic_score_codex":0.023960201,"about_ca_topic_score_gemma":0.027414637,"teacher_disagreement_score":0.14776124,"about_ca_system_score_codex":0.014330575,"about_ca_system_score_gemma":0.07748592,"threshold_uncertainty_score":0.7814455},"labels":[],"label_agreement":null},{"id":"W2910153650","doi":"10.1007/s10549-019-05129-8","title":"Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Cairo University","keywords":"Breast cancer; SKBR3; CXCR4; Lymph; Cancer research; Lymph node; Chemokine; Metastasis; Medicine; Pathology; Biology; Cancer; Immunology; Internal medicine; Immune system","score_opus":0.015983957341125968,"score_gpt":0.28810471208207317,"score_spread":0.2721207547409472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910153650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96880764,0.013865085,0.004054376,0.0024336001,0.00025381314,0.00011750082,0.0007564526,0.00019808882,0.00951346],"genre_scores_gemma":[0.9904022,0.002722227,0.0012922514,0.00025225978,0.00010422223,0.000043980857,0.00026045434,0.000013228136,0.0049091014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999803,0.000040851202,0.000007216017,0.0000238468,0.000038398448,0.00008662653],"domain_scores_gemma":[0.99992764,0.0000059825893,0.000021452774,0.000004040363,0.000014444968,0.000026444599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017416413,0.0002114982,0.00019031856,0.0003203462,0.00023316251,0.00044512804,0.00016964725,0.00026196768,0.003385295],"category_scores_gemma":[0.00014705955,0.00013039885,0.00017689097,0.00014513185,0.00016085917,0.00022267077,0.00039568232,0.0008605825,0.0005483096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013052485,0.00036337657,0.027041133,0.00049406936,0.0000665489,0.0010818428,0.00018684744,0.0009127022,0.88310844,0.0054209395,0.006861224,0.07315773],"study_design_scores_gemma":[0.00087169366,0.0026982639,0.26974693,0.0002829527,0.00046216956,0.0055359923,0.0020454887,0.021868024,0.53967625,0.0070659732,0.1496728,0.0000734484],"about_ca_topic_score_codex":0.0006436592,"about_ca_topic_score_gemma":0.0010231911,"teacher_disagreement_score":0.003385295,"about_ca_system_score_codex":0.00043514912,"about_ca_system_score_gemma":0.0005584674,"threshold_uncertainty_score":0.011325002},"labels":[],"label_agreement":null},{"id":"W2912504528","doi":"10.1007/s10549-019-05158-3","title":"Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Pfizer Canada; National Institutes of Health; Fashion Footwear Association of New York; U.S. Department of Defense","keywords":"Exemestane; Letrozole; Medicine; Aromatase inhibitor; Breast cancer; Internal medicine; Bone mineral; Oncology; Aromatase; Bone remodeling; Osteoporosis; Pharmacogenetics; Endocrinology; Cancer; Genotype; Biology","score_opus":0.025507966692360117,"score_gpt":0.3456521872000151,"score_spread":0.320144220507655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912504528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975587,0.0009769928,0.00020403789,0.00045147282,0.000021915312,0.000004237992,0.00013419034,0.000019701176,0.0006288901],"genre_scores_gemma":[0.9983084,0.0003951806,0.00026576957,0.00011470334,0.000013353445,0.00000343911,0.00012299068,0.000010873339,0.00076518423],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998789,0.00004648165,0.0000095940795,0.000017474193,0.000027162767,0.00002045652],"domain_scores_gemma":[0.99974316,0.000088426976,0.000089088484,0.00001868513,0.00001804699,0.000042629956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019476262,0.0002006612,0.0003698665,0.00029875804,0.00018106643,0.0003121283,0.00014427252,0.00038424646,0.0016855908],"category_scores_gemma":[0.0007199559,0.00017501964,0.0002966679,0.0001567511,0.00021346296,0.00014468555,0.00012469973,0.00037175688,0.00018712034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028995503,0.00043797455,0.31401092,0.00016420851,0.00057720917,0.0037977155,0.00019830765,0.00053009234,0.60187787,0.0005078288,0.00086259213,0.048039753],"study_design_scores_gemma":[0.0009791997,0.0065224743,0.86166584,0.00006211763,0.0011216012,0.011642765,0.0005903984,0.0010426161,0.109390385,0.0011550805,0.0057935575,0.00003400096],"about_ca_topic_score_codex":0.0011737735,"about_ca_topic_score_gemma":0.0019520313,"teacher_disagreement_score":0.0016855908,"about_ca_system_score_codex":0.00016284242,"about_ca_system_score_gemma":0.00023532467,"threshold_uncertainty_score":0.005638838},"labels":[],"label_agreement":null},{"id":"W2914478693","doi":"10.1007/s10549-019-05162-7","title":"Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Sunnybrook Health Science Centre; McGill University; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute","keywords":"Medicine; Breast cancer; Oophorectomy; Hazard ratio; Mastectomy; BRCA mutation; Cancer; Gynecology; Oncology; Proportional hazards model; Internal medicine; Prospective cohort study; Confidence interval; Obstetrics; Surgery; Hysterectomy","score_opus":0.012904818122163144,"score_gpt":0.31161599075858554,"score_spread":0.2987111726364224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914478693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999089,0.00039001516,0.00002693397,0.00003894838,0.0000087590615,0.0000014004945,0.000085058506,0.000003119267,0.00035667408],"genre_scores_gemma":[0.9991448,0.00016844581,0.00002577769,0.000021864642,0.00001339872,0.0000014494136,0.00007567603,0.0000022110216,0.0005463743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986327,0.00002821521,0.000009514241,0.000028776563,0.000020766076,0.0000494311],"domain_scores_gemma":[0.9991192,0.00027646875,0.0002724866,0.000054354117,0.000025993131,0.0002514258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003118511,0.0002172062,0.00029510228,0.0007346355,0.00034211206,0.00049428135,0.00024331773,0.0006473372,0.0032803034],"category_scores_gemma":[0.0017953524,0.00029708282,0.00046954255,0.0005868739,0.00031868424,0.00034949742,0.0002689545,0.0005795824,0.00022998644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014638619,0.000097893644,0.9946827,0.000009449451,0.000075511845,0.0002985942,0.000081170154,0.000048885686,0.00075924204,0.000048349015,0.00009836183,0.0023358362],"study_design_scores_gemma":[0.000021841384,0.00020983361,0.9982494,0.0000054798043,0.000079315876,0.0007359631,0.00019285425,0.00018929085,0.0000947037,0.00006149032,0.00015500517,0.000004682085],"about_ca_topic_score_codex":0.0076056826,"about_ca_topic_score_gemma":0.0060018175,"teacher_disagreement_score":0.0076056826,"about_ca_system_score_codex":0.00020259115,"about_ca_system_score_gemma":0.00031669374,"threshold_uncertainty_score":0.015122831},"labels":[],"label_agreement":null},{"id":"W2922459755","doi":"10.1007/s10549-019-05196-x","title":"Patient-reported symptoms following mastectomy alone or lumpectomy plus radiation for early stage breast cancer: a cohort study","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba; Institute for Clinical Evaluative Sciences; University of Calgary; Cancer Care Ontario; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"Cancer Care Ontario","keywords":"Lumpectomy; Medicine; Breast cancer; Mastectomy; Stage (stratigraphy); Cohort; Cancer; Radiation therapy; Oncology; Cohort study; Internal medicine; Surgery","score_opus":0.023678309724773004,"score_gpt":0.33610667710801256,"score_spread":0.31242836738323954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922459755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992415,0.0001960564,0.00003593843,0.000019682233,0.00001019085,0.000012412635,0.00032063696,0.0000013990608,0.0001622057],"genre_scores_gemma":[0.99896693,0.00016714059,0.00003881792,0.000030780182,0.000013450574,0.00001573487,0.00045740127,0.0000025907493,0.00030713115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992888,0.00019603745,0.00007622026,0.0001768708,0.00009285188,0.00016918448],"domain_scores_gemma":[0.9981816,0.00035930894,0.00069248874,0.00018676106,0.00015415937,0.0004255799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093996007,0.00059687695,0.00071339885,0.0007696702,0.0008171503,0.0010622496,0.0007990725,0.00097448565,0.0022011402],"category_scores_gemma":[0.002602617,0.0006412434,0.0017201287,0.0012199188,0.0004071209,0.0009658842,0.00074440945,0.0013496957,0.00043699457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010425984,0.00022149418,0.9973373,0.000012945337,0.0001978175,0.00014469711,0.00012872058,0.00001775552,0.00034079113,0.000009371961,0.00006179451,0.00048453713],"study_design_scores_gemma":[0.000032351512,0.0004013889,0.9988366,0.000004197801,0.00009167586,0.00018546321,0.00026860985,0.000042474356,0.00004513251,0.000008147643,0.00007605061,0.0000078555495],"about_ca_topic_score_codex":0.0091865435,"about_ca_topic_score_gemma":0.009262822,"teacher_disagreement_score":0.0091865435,"about_ca_system_score_codex":0.00045181965,"about_ca_system_score_gemma":0.0005473882,"threshold_uncertainty_score":0.018266141},"labels":[],"label_agreement":null},{"id":"W2929837227","doi":"10.1007/s10549-019-05209-9","title":"Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Odds ratio; Brachytherapy; Oncology; Internal medicine; Radiation therapy; Subgroup analysis; Confidence interval; Cosmesis; Randomized controlled trial; Cancer; Surgery","score_opus":0.19039169083806035,"score_gpt":0.4726006323750448,"score_spread":0.28220894153698445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929837227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063999407,0.9925028,0.0003081506,0.000080656726,0.00008881891,0.00008209309,0.00036074623,0.000014666523,0.00016206356],"genre_scores_gemma":[0.21335465,0.78255695,0.0013450806,0.0010809371,0.0002011186,0.00029818446,0.0006213607,0.000033267068,0.00050846505],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99694663,0.0012046837,0.00089819613,0.00047168086,0.0003447075,0.00013408244],"domain_scores_gemma":[0.99527365,0.00318011,0.0010135353,0.00017638337,0.00026912082,0.000087178814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047124946,0.002028387,0.011340593,0.0021253333,0.00035000805,0.0017654223,0.0014969191,0.0015971678,0.0032738927],"category_scores_gemma":[0.011326819,0.0010358228,0.026427275,0.0032617177,0.00053989474,0.000924545,0.0011927816,0.0017269359,0.00024360768],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035412041,0.000035305686,0.0047599017,0.28591213,0.68798786,0.00010571669,0.00008185194,0.00059660705,0.0003413091,0.00009222357,0.0006610306,0.015884893],"study_design_scores_gemma":[0.0007623243,0.00022785642,0.0044339565,0.009552229,0.9832516,0.000079034646,0.000038242066,0.00009493388,0.00008539842,0.00012900152,0.001323207,0.000022266548],"about_ca_topic_score_codex":0.006542661,"about_ca_topic_score_gemma":0.018345831,"teacher_disagreement_score":0.011340593,"about_ca_system_score_codex":0.0015942324,"about_ca_system_score_gemma":0.0015525756,"threshold_uncertainty_score":0.024922311},"labels":[],"label_agreement":null},{"id":"W2930733551","doi":"10.1007/s10549-019-05215-x","title":"Body mass index impacts infection rates in immediate autogenous breast reconstruction","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Breast reconstruction; Reconstructive surgery; Breast cancer; Body mass index; Surgery; Retrospective cohort study; Cancer; Risk factor; Internal medicine","score_opus":0.028081160597550007,"score_gpt":0.3366055308780903,"score_spread":0.3085243702805403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930733551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986112,0.00046244095,0.000055762597,0.000054641983,0.000013419793,0.000005102111,0.000058341695,0.0000028817362,0.00073610357],"genre_scores_gemma":[0.99936897,0.00013526088,0.00003894221,0.000027024844,0.000008122793,0.000002692309,0.000047363315,0.0000031525158,0.00036855027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914825,0.0002552682,0.00008063255,0.000099931196,0.00016564569,0.00025017717],"domain_scores_gemma":[0.99655557,0.0012906197,0.0014026087,0.00018878897,0.0001907324,0.0003715544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009138859,0.00028130683,0.00028533235,0.00048486845,0.00030375662,0.0010943047,0.0003541354,0.0005424217,0.005982748],"category_scores_gemma":[0.006123028,0.00024299479,0.001000512,0.00043232206,0.00034630013,0.0004685362,0.0005291097,0.000872881,0.00049146154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002529508,0.000532099,0.98278606,0.000047760546,0.000168566,0.00015728826,0.00013970162,0.00016203707,0.00085373584,0.00005159755,0.00015865103,0.012412944],"study_design_scores_gemma":[0.000013312357,0.0008058268,0.9976675,0.00003120816,0.00009814078,0.00030379076,0.00031585502,0.00030140622,0.00023615966,0.00004783652,0.00017218658,0.0000066772263],"about_ca_topic_score_codex":0.0023078662,"about_ca_topic_score_gemma":0.0032372477,"teacher_disagreement_score":0.005982748,"about_ca_system_score_codex":0.00034032908,"about_ca_system_score_gemma":0.0004535736,"threshold_uncertainty_score":0.020014286},"labels":[],"label_agreement":null},{"id":"W2944306293","doi":"10.1007/s10549-019-05265-1","title":"De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Denosumab; Breast cancer; Meta-analysis; Randomized controlled trial; Zoledronic acid; Relative risk; Confidence interval; Internal medicine; Oncology; Dosing; Clinical trial; Cancer; Surgery; Osteoporosis","score_opus":0.216998523895043,"score_gpt":0.46197718058548987,"score_spread":0.24497865669044686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944306293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005412554,0.9933622,0.0003016366,0.000106077154,0.00013692651,0.00014756949,0.000302241,0.000018986564,0.00021184205],"genre_scores_gemma":[0.199808,0.79520196,0.0019241453,0.001428454,0.00021409434,0.0003948342,0.0005418062,0.00003005601,0.0004565909],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962584,0.0015395358,0.0011315444,0.00049049634,0.00040459237,0.00017543235],"domain_scores_gemma":[0.99576473,0.002746641,0.0010133664,0.00015084932,0.00023476972,0.000089560235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005209437,0.00196388,0.01406977,0.0022856372,0.00032763832,0.0018164815,0.0017060498,0.0018566409,0.004211955],"category_scores_gemma":[0.01157002,0.0011779789,0.02257319,0.0029246372,0.0005133489,0.0012723834,0.001125713,0.0024446864,0.00028725198],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007614163,0.00007996284,0.0024962144,0.39772886,0.56420314,0.00010068247,0.00009792628,0.0006471584,0.00042477626,0.00012678356,0.00079565117,0.02568478],"study_design_scores_gemma":[0.0033902114,0.00053494185,0.0034254799,0.020059375,0.96982825,0.00008231263,0.000052971925,0.00018010961,0.0001174251,0.0001659056,0.002132615,0.00003041742],"about_ca_topic_score_codex":0.0059920223,"about_ca_topic_score_gemma":0.020305866,"teacher_disagreement_score":0.01406977,"about_ca_system_score_codex":0.001801057,"about_ca_system_score_gemma":0.0016829313,"threshold_uncertainty_score":0.027550459},"labels":[],"label_agreement":null},{"id":"W2944649909","doi":"10.1007/s10549-019-05266-0","title":"Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; McMaster University","funders":"","keywords":"Medicine; Breast cancer; Breast-conserving surgery; Internal medicine; Adjuvant; Population; Radiation therapy; Proportional hazards model; Stage (stratigraphy); Oncology; Cohort; Adjuvant therapy; Gynecology; Cancer; Cohort study; Mastectomy","score_opus":0.01329237496388253,"score_gpt":0.2997558694760951,"score_spread":0.2864634945122126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944649909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991854,0.000228896,0.000038712973,0.000022738897,0.0000026755827,0.000003631405,0.0003230433,0.000001315431,0.00019362378],"genre_scores_gemma":[0.9994727,0.00009243451,0.0000245648,0.000016756563,0.0000046954333,0.0000048045463,0.00029169713,9.974214e-7,0.00009155132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994106,0.0001783061,0.0000974042,0.00014122874,0.000070472044,0.00010182924],"domain_scores_gemma":[0.99880636,0.00023065257,0.0005559631,0.000097282384,0.00012627382,0.00018349286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006532161,0.00023628018,0.00049285346,0.0009707905,0.000410177,0.0005804725,0.0003476103,0.00052154186,0.0011123213],"category_scores_gemma":[0.0018138109,0.00030659276,0.0008479749,0.0019379826,0.00026632726,0.0005819535,0.0005023384,0.00046816538,0.00015236638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012516679,0.000023908691,0.99922526,0.000004222228,0.00009620888,0.000022984214,0.000039942915,0.000017449685,0.0000796616,0.00000686698,0.00002773753,0.00033067027],"study_design_scores_gemma":[0.000005145295,0.00006107233,0.99953616,0.000001917595,0.000039362276,0.00005748299,0.0001711348,0.000057653073,0.000014511234,0.000008943712,0.000044534103,0.0000022007002],"about_ca_topic_score_codex":0.011858836,"about_ca_topic_score_gemma":0.012802511,"teacher_disagreement_score":0.011858836,"about_ca_system_score_codex":0.00038674913,"about_ca_system_score_gemma":0.00030810593,"threshold_uncertainty_score":0.023579597},"labels":[],"label_agreement":null},{"id":"W2946432848","doi":"10.1007/s10549-019-05274-0","title":"Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; University of Alberta; Queen's University; Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Clinical trial; Breast cancer; Medicine; Psychological intervention; Randomized controlled trial; Health care; Accrual; Informed consent; Family medicine; Systematic review; MEDLINE; Cancer; Alternative medicine; Nursing; Surgery; Internal medicine; Pathology","score_opus":0.8370010017280224,"score_gpt":0.729580852097827,"score_spread":0.10742014963019542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946432848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037410469,0.56878805,0.035494175,0.34249645,0.025676182,0.012574669,0.00030782947,0.0007692615,0.010152316],"genre_scores_gemma":[0.08614612,0.234091,0.2961379,0.33408856,0.010809402,0.03353494,0.00045449293,0.0007816915,0.003955995],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.5105888,0.4341545,0.02801997,0.005427404,0.020086607,0.0017226939],"domain_scores_gemma":[0.29491824,0.6348033,0.022924796,0.022115737,0.017524453,0.0077135907],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.41433674,0.0012607354,0.0046549817,0.0036061807,0.001752919,0.012117321,0.005351417,0.011622122,0.0059549236],"category_scores_gemma":[0.5467188,0.0017012625,0.005050055,0.0031402106,0.0066408957,0.01360984,0.010701282,0.021805152,0.0015526717],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010751999,0.00029436886,0.00068701257,0.08903231,0.0024031461,0.00014640487,0.0030017507,0.0006685727,0.0004972278,0.049319383,0.08242211,0.7704526],"study_design_scores_gemma":[0.009366529,0.0013131778,0.003317475,0.2563233,0.006344078,0.0005433648,0.0019374888,0.0014606825,0.0009794101,0.08582285,0.6322996,0.00029208526],"about_ca_topic_score_codex":0.0019965188,"about_ca_topic_score_gemma":0.0044983155,"teacher_disagreement_score":0.58566326,"about_ca_system_score_codex":0.007473836,"about_ca_system_score_gemma":0.044954926,"threshold_uncertainty_score":0.7222271},"labels":[],"label_agreement":null},{"id":"W2947977538","doi":"10.1007/s10549-019-05273-1","title":"Is immediate breast reconstruction safe in women over 70? An analysis of the National Surgical Quality Improvement Program (NSQIP) database","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network; Women's College Hospital; Public Health Ontario","funders":"","keywords":"Medicine; Breast reconstruction; Breast cancer; Surgery; Implant; Complication; Quality of life (healthcare); Mortality rate; Database; Cancer; Internal medicine","score_opus":0.05492312856655687,"score_gpt":0.40438682442081175,"score_spread":0.34946369585425485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947977538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741067,0.0037152506,0.00010321548,0.00075590616,0.00002007552,0.00004826382,0.019966451,0.0000074187396,0.0012767023],"genre_scores_gemma":[0.9906222,0.0014932833,0.0001346723,0.0003323652,0.000021828339,0.000034452325,0.007279337,0.000004010114,0.00007777394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980003,0.00045206005,0.0005158662,0.00030029783,0.0004510928,0.0002803026],"domain_scores_gemma":[0.9874763,0.0032348034,0.0071923123,0.0004217593,0.0010250261,0.000649744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018456251,0.00016275892,0.0006465751,0.0020553293,0.0003944658,0.00082865614,0.000552081,0.0004280307,0.0011331144],"category_scores_gemma":[0.010416485,0.00016608027,0.0011543329,0.0056515364,0.00026465612,0.00068169745,0.00063088286,0.00063772645,0.00010215285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017527358,0.000026419106,0.99688905,0.00006845573,0.00019562394,0.000019307776,0.000049489172,0.00003043147,0.000018555149,0.000033498698,0.00057006767,0.0019239071],"study_design_scores_gemma":[0.000020897209,0.0000273796,0.9989441,0.0000399246,0.0001101748,0.000059415466,0.0002518372,0.00010700885,0.000013679614,0.000021767968,0.00039943983,0.0000043003865],"about_ca_topic_score_codex":0.030738592,"about_ca_topic_score_gemma":0.04415368,"teacher_disagreement_score":0.030738592,"about_ca_system_score_codex":0.0010524127,"about_ca_system_score_gemma":0.0015821379,"threshold_uncertainty_score":0.061119318},"labels":[],"label_agreement":null},{"id":"W2949402590","doi":"10.1007/s10549-019-05315-8","title":"Quality of DCIS information on the internet: a content analysis","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Toronto General Hospital; Health Sciences Centre; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Ductal carcinoma; The Internet; Confusion; Quality (philosophy); Anxiety; Medicine; Breast cancer; Information quality; Psychology; Cancer; Internal medicine; Computer science; World Wide Web; Information system; Political science; Psychiatry","score_opus":0.603513367508862,"score_gpt":0.6307397905054555,"score_spread":0.027226422996593502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949402590","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94710433,0.011010175,0.003141449,0.0025338933,0.00009153597,0.004670283,0.022189569,0.00010648375,0.009152209],"genre_scores_gemma":[0.97279716,0.0050365245,0.009520655,0.00049913785,0.00009022128,0.003222005,0.008221184,0.00005848123,0.00055463734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9752754,0.00957685,0.0069233887,0.0010628246,0.0064147436,0.00074679556],"domain_scores_gemma":[0.7961473,0.14134686,0.03697819,0.0029366454,0.020761888,0.0018290953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032830734,0.0003722324,0.0013384797,0.030631134,0.00087613653,0.0039718887,0.0010196092,0.00047399662,0.0022569313],"category_scores_gemma":[0.14596395,0.00030660242,0.0017843805,0.028272176,0.0014273783,0.0044274284,0.003983681,0.0007079554,0.00027984896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009949531,0.00021875445,0.7341781,0.023002677,0.0013046894,0.00029731487,0.021356866,0.00035742865,0.0005495418,0.0016060447,0.0073420773,0.20879158],"study_design_scores_gemma":[0.00018509022,0.0005344519,0.9051394,0.019184906,0.001715831,0.0007476199,0.03643596,0.0025048926,0.00085559377,0.0014665368,0.031047266,0.00018249596],"about_ca_topic_score_codex":0.0045798384,"about_ca_topic_score_gemma":0.005796327,"teacher_disagreement_score":0.032830734,"about_ca_system_score_codex":0.0044653816,"about_ca_system_score_gemma":0.0040424196,"threshold_uncertainty_score":0.17362756},"labels":[],"label_agreement":null},{"id":"W2954087664","doi":"10.1007/s10549-019-05334-5","title":"A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Decile; Medicine; Dormancy; Internal medicine; Oncology; Cancer; Mortality rate; Cohort; Biology","score_opus":0.04724710897080818,"score_gpt":0.33784452264436976,"score_spread":0.29059741367356157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954087664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634093,0.0011080994,0.0009391394,0.00023337067,0.000015469575,0.000020577367,0.00045477264,0.0000192017,0.0008685007],"genre_scores_gemma":[0.9993061,0.00013845543,0.00009826297,0.0000381677,0.000011804603,0.0000069807343,0.00028866198,0.000004548849,0.00010711902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873096,0.0005074712,0.00014479019,0.00029527987,0.00015945431,0.00016207444],"domain_scores_gemma":[0.9784837,0.012742021,0.004951244,0.0027657968,0.0004140519,0.0006432023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00371001,0.0003243771,0.00041717855,0.0006623353,0.00021699214,0.0005749371,0.00052596093,0.0006065316,0.003420041],"category_scores_gemma":[0.014846448,0.00024827957,0.0009022248,0.00085588923,0.00057586783,0.0005596624,0.00057852524,0.0008334892,0.00042195144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029924937,0.000015276402,0.9970126,0.000014373356,0.0001520406,0.000043560194,0.000034287867,0.00016826647,0.00024485314,0.000032237724,0.000052623807,0.0019306939],"study_design_scores_gemma":[0.000008640917,0.00009598859,0.9990569,0.000004767037,0.00005701945,0.00016655383,0.00002924378,0.00030185707,0.00006389025,0.000121121855,0.000091701506,0.0000023157959],"about_ca_topic_score_codex":0.0017083146,"about_ca_topic_score_gemma":0.0016710797,"teacher_disagreement_score":0.00371001,"about_ca_system_score_codex":0.0002900726,"about_ca_system_score_gemma":0.00034932335,"threshold_uncertainty_score":0.019620657},"labels":[],"label_agreement":null},{"id":"W2954586745","doi":"10.1007/s10549-019-05331-8","title":"Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Docetaxel; Survivin; Docosahexaenoic acid; Breast cancer; Apoptosis; Medicine; Internal medicine; Chemotherapy; Triple-negative breast cancer; Endocrinology; Cancer; Oncology; Cancer research; Biology; Polyunsaturated fatty acid; Fatty acid; Biochemistry","score_opus":0.04029556302212165,"score_gpt":0.3720375746306889,"score_spread":0.33174201160856726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954586745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430484,0.0029371611,0.0004933284,0.0001477191,0.000068910784,0.000038246475,0.0003294885,0.000032853633,0.0016474975],"genre_scores_gemma":[0.9964485,0.0011617836,0.00045811583,0.000029897754,0.000007377474,0.000012045422,0.00027774178,0.000008733897,0.0015957745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998776,0.000041921154,0.000010278924,0.000013857551,0.00001972147,0.00003672395],"domain_scores_gemma":[0.9998841,0.000034606182,0.000012767183,0.000017851013,0.000016989234,0.000033643235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018390833,0.00019528123,0.00031931928,0.0001676887,0.00016610355,0.0004707764,0.0001676943,0.00019859563,0.001393499],"category_scores_gemma":[0.00022371607,0.00009913325,0.0002539653,0.0001777609,0.0001798988,0.0002470712,0.00013190141,0.00059309445,0.00025442528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004312444,0.0005642574,0.0010588265,0.000084528896,0.000022333472,0.00015800439,0.000064669606,0.00026123438,0.9834652,0.00023730377,0.00024577545,0.009525455],"study_design_scores_gemma":[0.00018967097,0.005290811,0.0077702943,0.000015986901,0.000064052525,0.00028077816,0.00015894313,0.0008961846,0.9803791,0.000052607884,0.0048924354,0.000009111208],"about_ca_topic_score_codex":0.002466543,"about_ca_topic_score_gemma":0.0034359808,"teacher_disagreement_score":0.002466543,"about_ca_system_score_codex":0.00041586923,"about_ca_system_score_gemma":0.0004891299,"threshold_uncertainty_score":0.0049043894},"labels":[],"label_agreement":null},{"id":"W2961291484","doi":"10.1007/s10549-019-05354-1","title":"Breast pain and cancer: should we continue to work-up isolated breast pain?","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Asymptomatic; Mammography; Breast pain; Retrospective cohort study; Malignancy; Incidence (geometry); Work-up; Breast ultrasound; Medical record; Obstetrics; Cancer; Gynecology; Radiology; Internal medicine","score_opus":0.05108060971157251,"score_gpt":0.34582697931785,"score_spread":0.2947463696062775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961291484","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006734014,0.26105908,0.00053574715,0.70665413,0.017920634,0.000039306993,0.000080470396,0.0000382704,0.006938385],"genre_scores_gemma":[0.10157593,0.34674796,0.005138073,0.43095282,0.10524197,0.00022459395,0.00023340648,0.00006148337,0.009823684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970862,0.0010224372,0.00042721326,0.00023251095,0.00081724214,0.00041429998],"domain_scores_gemma":[0.97657335,0.009162633,0.0021222825,0.0007225302,0.006525272,0.0048939404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005631894,0.00055341865,0.0024289768,0.0013572081,0.0030134073,0.0042960723,0.0014946559,0.008509496,0.009953291],"category_scores_gemma":[0.026027206,0.00044979408,0.0014898621,0.0013603282,0.003192647,0.0077120685,0.0023425585,0.013356064,0.002839997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005873258,0.0013169061,0.060597353,0.003539036,0.0004400417,0.0026301916,0.0020356008,0.00016778347,0.00087466685,0.005250692,0.2987216,0.62383884],"study_design_scores_gemma":[0.0008531506,0.0015515364,0.1700988,0.034061685,0.0013854195,0.014890666,0.025035968,0.0005714038,0.00032805014,0.03858802,0.71214545,0.0004898797],"about_ca_topic_score_codex":0.01110328,"about_ca_topic_score_gemma":0.023566272,"teacher_disagreement_score":0.01110328,"about_ca_system_score_codex":0.001751241,"about_ca_system_score_gemma":0.008283443,"threshold_uncertainty_score":0.033297062},"labels":[],"label_agreement":null},{"id":"W2963140894","doi":"10.1007/s10549-019-05364-z","title":"Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Ductal carcinoma; Breast cancer; Breast-conserving surgery; Proportional hazards model; Oncology; Cohort; Population; Internal medicine; Radiation therapy; Hazard ratio; Mastectomy; Cancer; Radiology; Confidence interval","score_opus":0.019382227856688704,"score_gpt":0.2630816724768086,"score_spread":0.2436994446201199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963140894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986426,0.000807488,0.0000857992,0.000042347816,0.000005200489,0.0000031793134,0.0000337773,0.0000044075155,0.00037520536],"genre_scores_gemma":[0.999613,0.00016740874,0.000050881306,0.000008146204,0.000008373176,0.0000021409269,0.00002017432,0.0000014960096,0.00012848839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998006,0.000084019906,0.000015504887,0.000028692113,0.000041731095,0.000029485296],"domain_scores_gemma":[0.9981177,0.00060341123,0.00081919617,0.00013969945,0.00008194942,0.00023799305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029324475,0.000215152,0.00030855773,0.000741614,0.0002081709,0.0005126069,0.00024129881,0.00039471278,0.0017319402],"category_scores_gemma":[0.0019595108,0.00028220512,0.0003318533,0.00064696465,0.00030592148,0.00030107153,0.00027459025,0.0005131703,0.000122994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010047703,0.000057336685,0.993109,0.000017642718,0.000074914264,0.00028638256,0.00007418022,0.000041121955,0.00246828,0.000019371782,0.00003437474,0.0028125634],"study_design_scores_gemma":[0.0000069362827,0.00016124442,0.99830544,0.0000026752948,0.000058369515,0.00090836023,0.0001193783,0.000059486872,0.0002714322,0.000023965724,0.00008035474,0.000002333013],"about_ca_topic_score_codex":0.0013274931,"about_ca_topic_score_gemma":0.0016761611,"teacher_disagreement_score":0.0017319402,"about_ca_system_score_codex":0.00014822013,"about_ca_system_score_gemma":0.00017300372,"threshold_uncertainty_score":0.0057938695},"labels":[],"label_agreement":null},{"id":"W2963266806","doi":"10.1007/s10549-019-05367-w","title":"Risk of malignancy in papillary neoplasms of the breast","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Providence Health Care","funders":"University of British Columbia; Providence Health Care","keywords":"Atypia; Malignancy; Medicine; Breast cancer; Concordance; Biopsy; Nuclear atypia; Radiology; Pathology; Cancer; Oncology; Internal medicine; Immunohistochemistry","score_opus":0.024399315459459836,"score_gpt":0.3116737059987765,"score_spread":0.28727439053931664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963266806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975152,0.00061647414,0.00023567074,0.000095831325,0.000008507177,0.0000041766443,0.0001690044,0.000010760131,0.0013443254],"genre_scores_gemma":[0.99918324,0.00025959086,0.00006147317,0.000008617534,0.000016455002,0.0000012966075,0.000070536145,0.0000027193032,0.00039617473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974066,0.00007036508,0.000017848282,0.00004521301,0.000051113388,0.00007472722],"domain_scores_gemma":[0.99879634,0.00029013297,0.00033396936,0.00013444836,0.00011933545,0.00032571226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032801807,0.00019191176,0.00024172597,0.00078736985,0.0003499345,0.00064165913,0.00031139297,0.0004883561,0.0026030939],"category_scores_gemma":[0.002197363,0.00032261887,0.00065115374,0.0007918692,0.000257607,0.0002930075,0.00042892012,0.0005513426,0.0003000869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029076514,0.000021405098,0.9966936,0.000006674552,0.000053148717,0.00021779255,0.00005085856,0.000052389387,0.0006306263,0.00007592067,0.00006662161,0.0018401623],"study_design_scores_gemma":[0.0000050456065,0.00007572956,0.9979881,0.000004612326,0.00006401092,0.0009294564,0.00018132926,0.00028807952,0.00014096263,0.00012186601,0.00019646816,0.0000043832893],"about_ca_topic_score_codex":0.0075690635,"about_ca_topic_score_gemma":0.0050497917,"teacher_disagreement_score":0.0075690635,"about_ca_system_score_codex":0.00030092176,"about_ca_system_score_gemma":0.00045550472,"threshold_uncertainty_score":0.015050054},"labels":[],"label_agreement":null},{"id":"W2963846945","doi":"10.1007/s10549-019-05363-0","title":"National trends of synchronous bilateral breast cancer incidence in the United States","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Incidence (geometry); Mastectomy; Stage (stratigraphy); Cancer; Epidemiology; Oncology; Mammography; Internal medicine; Gynecology","score_opus":0.02719226620367043,"score_gpt":0.3522937252626555,"score_spread":0.3251014590589851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963846945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98460466,0.0017480357,0.00012884647,0.00022015102,0.000016391523,0.0000073825895,0.010828781,0.000019629484,0.002426154],"genre_scores_gemma":[0.9916255,0.0012162823,0.00013929585,0.00008140466,0.000016584305,0.000012239175,0.006273538,0.000003474072,0.00063173263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997396,0.000054910284,0.000044955505,0.000052613574,0.00006083686,0.000047128247],"domain_scores_gemma":[0.99888486,0.0001288075,0.00047156325,0.000062826904,0.0003170014,0.00013504473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030065503,0.00013043468,0.00024292554,0.0011555011,0.0002454062,0.00035612017,0.00019684725,0.0002073939,0.0016534957],"category_scores_gemma":[0.0010529526,0.00015150468,0.00032547925,0.0019554473,0.00014131874,0.0003221446,0.00039672188,0.00028147103,0.00018919156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007240212,0.000014087016,0.996369,0.000026088012,0.00003895872,0.000019264255,0.000033772445,0.00008071103,0.00012832512,0.00003370256,0.00057641236,0.0026073363],"study_design_scores_gemma":[0.0000026657988,0.000018796483,0.99898297,0.000008123046,0.000018948314,0.00010667839,0.000113375136,0.00009504683,0.000060376096,0.000010539035,0.0005810889,0.0000014817679],"about_ca_topic_score_codex":0.064210564,"about_ca_topic_score_gemma":0.10779805,"teacher_disagreement_score":0.064210564,"about_ca_system_score_codex":0.00066005293,"about_ca_system_score_gemma":0.0006961988,"threshold_uncertainty_score":0.12767363},"labels":[],"label_agreement":null},{"id":"W2964384918","doi":"10.1007/s10549-019-05381-y","title":"A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Ottawa; McMaster University; Health Sciences North; Ottawa Hospital","funders":"Canadian Cancer Society","keywords":"Chloroquine; Placebo; Medicine; Breast cancer; Adverse effect; Randomized controlled trial; Internal medicine; Oncology; Toxicity; Clinical trial; Cancer; Pharmacology; Surgery; Pathology; Malaria","score_opus":0.0904509321332827,"score_gpt":0.43191195704074076,"score_spread":0.34146102490745806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964384918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899366,0.0033694627,0.00083656586,0.0007741915,0.00073280314,0.0023969626,0.00056538574,0.0000981666,0.0012898179],"genre_scores_gemma":[0.9912327,0.0015489995,0.0014389053,0.00083613116,0.00044903785,0.0025784967,0.0003701322,0.00002001916,0.0015255009],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99914527,0.00050376495,0.000045197463,0.00014249416,0.000042073618,0.00012130193],"domain_scores_gemma":[0.99828833,0.00067819527,0.00032719655,0.00015632714,0.00008680162,0.00046320187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00147375,0.0011879671,0.0035146268,0.0004002507,0.00046726924,0.0009350593,0.0006907643,0.0019572955,0.005569225],"category_scores_gemma":[0.0027417683,0.00057422277,0.0013100111,0.0003729062,0.0014022727,0.0011706459,0.0005255928,0.0025061807,0.00057262543],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99444515,0.0014249508,0.000109499066,0.00015387934,0.00016274986,0.000008877882,0.000012631475,0.000060872684,0.0008111413,0.000041769246,0.00013399815,0.0026344392],"study_design_scores_gemma":[0.9680551,0.0306563,0.00047273704,0.000016108817,0.00016490696,0.00001374836,0.000013584714,0.0001694633,0.00017449018,0.000083633044,0.00017146302,0.000008407274],"about_ca_topic_score_codex":0.0009033633,"about_ca_topic_score_gemma":0.0013775942,"teacher_disagreement_score":0.005569225,"about_ca_system_score_codex":0.0005876099,"about_ca_system_score_gemma":0.001081877,"threshold_uncertainty_score":0.018630922},"labels":[],"label_agreement":null},{"id":"W2964461993","doi":"10.1007/s10549-019-05388-5","title":"A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Stage (stratigraphy); Chemotherapy; Internal medicine; Randomized controlled trial; Cancer; Gynecology","score_opus":0.10393096685917173,"score_gpt":0.4431091563680435,"score_spread":0.33917818950887174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964461993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401665,0.0016027106,0.00034958427,0.00038531417,0.00043233525,0.0021199577,0.00036015606,0.00003118156,0.0007019703],"genre_scores_gemma":[0.9922003,0.0009146929,0.0011108379,0.0006002376,0.00039375093,0.0029077835,0.0004541629,0.000009757016,0.0014084831],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985684,0.00088042987,0.000090675276,0.00021416637,0.000060193663,0.00018599769],"domain_scores_gemma":[0.9969162,0.0013435059,0.0006057819,0.00025526914,0.00017376791,0.00070557796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017810202,0.0014614626,0.0031831372,0.00036326994,0.0005400396,0.0011523602,0.0009196075,0.0018353226,0.007291452],"category_scores_gemma":[0.00414398,0.0006563125,0.0019850999,0.00055883726,0.0013340292,0.001226483,0.0006463579,0.0029465745,0.0007152614],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99114907,0.004694558,0.00041942118,0.00013987534,0.00042008265,0.00001365112,0.000024086501,0.000091494236,0.00034259885,0.000029799958,0.00013566134,0.0025396978],"study_design_scores_gemma":[0.943097,0.054775774,0.0013574786,0.000014143667,0.00034476805,0.000011422419,0.000023911762,0.00012752264,0.00006322288,0.000059500733,0.000119427525,0.0000059090953],"about_ca_topic_score_codex":0.0018122524,"about_ca_topic_score_gemma":0.002657267,"teacher_disagreement_score":0.007291452,"about_ca_system_score_codex":0.00096181844,"about_ca_system_score_gemma":0.0013869758,"threshold_uncertainty_score":0.024392366},"labels":[],"label_agreement":null},{"id":"W2964765340","doi":"10.1007/s10549-019-05377-8","title":"The time-varying effect of radiotherapy after breast-conserving surgery for DCIS","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Concordia University; McGill University; Sunnybrook Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Hazard ratio; Proportional hazards model; Breast cancer; Population; Internal medicine; Cohort; Cohort study; Radiation therapy; Oncology; Gynecology; Confidence interval; Cancer; Environmental health","score_opus":0.014665862742417204,"score_gpt":0.3185867611986557,"score_spread":0.3039208984562385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964765340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078876,0.0063410136,0.00032659265,0.00024175983,0.000093783434,0.000013853625,0.0007264952,0.0000140305165,0.0014537519],"genre_scores_gemma":[0.9973162,0.0010460936,0.000118619806,0.000049767434,0.00007246466,0.000008090528,0.00031924216,0.000012051784,0.0010574157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993303,0.00027619003,0.00003262276,0.00012046074,0.00006896591,0.00017143732],"domain_scores_gemma":[0.9933031,0.004755414,0.0010149939,0.00033604447,0.00027070026,0.00031969222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013595115,0.000296641,0.0006027438,0.0004563259,0.00023933862,0.00058135286,0.0004133447,0.0006101915,0.006072049],"category_scores_gemma":[0.0076536927,0.00013818608,0.00083847024,0.0007269997,0.00030804248,0.00048753773,0.00026313218,0.00066033826,0.00046345012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28324506,0.0033773368,0.45872292,0.0010059606,0.0022285182,0.0011854311,0.0008715318,0.006603782,0.09082475,0.0016290791,0.0015946731,0.14871097],"study_design_scores_gemma":[0.00013318681,0.003901912,0.9897994,0.000032506006,0.00053287356,0.0002310174,0.00020233403,0.00056365895,0.0034152695,0.00021225304,0.00095566123,0.000019894853],"about_ca_topic_score_codex":0.0051906337,"about_ca_topic_score_gemma":0.006193219,"teacher_disagreement_score":0.006072049,"about_ca_system_score_codex":0.00065662374,"about_ca_system_score_gemma":0.0006567023,"threshold_uncertainty_score":0.020313025},"labels":[],"label_agreement":null},{"id":"W2964957864","doi":"10.1007/s10549-019-05360-3","title":"A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Docetaxel; Taxane; Paclitaxel; Medicine; Adverse effect; Breast cancer; Lung cancer; Cancer; Metastatic breast cancer; Internal medicine; Pharmacology; Oncology","score_opus":0.05230859694138998,"score_gpt":0.42508213895852676,"score_spread":0.37277354201713675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964957864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439925,0.0008869108,0.0005378342,0.0003147675,0.0001263126,0.0015403243,0.00075225177,0.00009940236,0.001342814],"genre_scores_gemma":[0.9899346,0.0013535155,0.0016764993,0.0007356158,0.00019199734,0.0017132622,0.0015314021,0.000054976586,0.00280816],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993549,0.00028269735,0.000025304345,0.0001335085,0.000061927196,0.0001417306],"domain_scores_gemma":[0.99903655,0.00012458868,0.00018097734,0.00013263106,0.000048961258,0.0004763339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015718709,0.0019616578,0.0029864758,0.00077234383,0.0005452714,0.0013040426,0.0010457988,0.001405199,0.003869422],"category_scores_gemma":[0.0011181117,0.0010590471,0.0016686933,0.0008766956,0.0018838313,0.0015239931,0.00042425303,0.005699364,0.0010721122],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7932309,0.107324906,0.0032393457,0.00040938327,0.0011428375,0.00013255894,0.00030083835,0.0027384814,0.03167188,0.00034862215,0.0023644452,0.05709579],"study_design_scores_gemma":[0.56852454,0.41939783,0.0058088847,0.000018128101,0.00035057237,0.00014210123,0.00006448981,0.0012551576,0.0025019336,0.00022488837,0.001675439,0.00003598989],"about_ca_topic_score_codex":0.0017529199,"about_ca_topic_score_gemma":0.0040710713,"teacher_disagreement_score":0.003869422,"about_ca_system_score_codex":0.001495374,"about_ca_system_score_gemma":0.0022690042,"threshold_uncertainty_score":0.01294446},"labels":[],"label_agreement":null},{"id":"W2966937023","doi":"10.1007/s10549-019-05392-9","title":"Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; McMaster University; Ottawa Hospital","funders":"Canadian Cancer Society","keywords":"Medicine; Breast cancer; Vitamin D and neurology; Placebo; Cholecalciferol; Internal medicine; Randomized controlled trial; Vitamin; Gastroenterology; vitamin D deficiency; Prospective cohort study; Cancer; Adverse effect; Surgery; Pathology","score_opus":0.09183233463186527,"score_gpt":0.42480420447560946,"score_spread":0.33297186984374416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966937023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97674567,0.010207915,0.0012789773,0.0025751651,0.0020564506,0.002315245,0.0015234449,0.00012519768,0.0031720325],"genre_scores_gemma":[0.9877769,0.0024359282,0.0011738263,0.0014231692,0.0007126141,0.002398213,0.00068661186,0.000022766078,0.003369968],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986971,0.00078349945,0.00007482505,0.00019053348,0.00006332938,0.00019084265],"domain_scores_gemma":[0.99751484,0.0010508159,0.0004661438,0.00022602083,0.00009763708,0.00064459414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021941692,0.001414026,0.003766487,0.00039151756,0.00058719056,0.0015356416,0.00080580637,0.0021825896,0.00910182],"category_scores_gemma":[0.0039923466,0.00066692184,0.0023941705,0.0005076368,0.00093516655,0.001238228,0.00073408656,0.0038235974,0.0007771815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9954531,0.0009422423,0.00028435452,0.00013515918,0.00060548127,0.000010761559,0.000011331858,0.000057074227,0.0002880573,0.00006211327,0.00018479796,0.001965633],"study_design_scores_gemma":[0.9683017,0.028558232,0.0010825353,0.000029695555,0.0010434615,0.000013052525,0.000021741027,0.00017318183,0.0001402274,0.00020828328,0.00041792067,0.000009913203],"about_ca_topic_score_codex":0.001618498,"about_ca_topic_score_gemma":0.0018601649,"teacher_disagreement_score":0.00910182,"about_ca_system_score_codex":0.00081013096,"about_ca_system_score_gemma":0.0013812411,"threshold_uncertainty_score":0.030448556},"labels":[],"label_agreement":null},{"id":"W2967410501","doi":"10.1007/s10549-019-05395-6","title":"Phase II randomized controlled trial of hypnosis versus progressive muscle relaxation for body image after breast or gynecologic cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Breast Cancer Research Foundation","keywords":"Breast cancer; Hypnosis; Gynecologic cancer; Medicine; Randomized controlled trial; Relaxation (psychology); Mammary gland; Cancer; Muscle relaxation; Gynecology; Oncology; Internal medicine; Ovarian cancer; Pathology; Alternative medicine","score_opus":0.05073080516788391,"score_gpt":0.3935759177609779,"score_spread":0.34284511259309397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967410501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96301216,0.00740218,0.0020800652,0.0022671567,0.002672723,0.014388384,0.0023831378,0.00044712247,0.005346996],"genre_scores_gemma":[0.956421,0.0052003986,0.0035781162,0.0024617466,0.001480554,0.017886912,0.0013480372,0.00008062869,0.011542536],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993228,0.0003489316,0.00003667142,0.00014202397,0.000038707847,0.00011090773],"domain_scores_gemma":[0.99884987,0.0004257848,0.00022329229,0.000105261875,0.00006838066,0.00032741335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016563201,0.0026738185,0.005076734,0.00067704165,0.00066167256,0.0012601664,0.0016620196,0.0026982387,0.016406287],"category_scores_gemma":[0.0023172903,0.0011277351,0.0018345271,0.0005984937,0.0020612883,0.001339121,0.0005272447,0.0047463123,0.0018847092],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9880278,0.004790478,0.00007003753,0.00046068936,0.0003675189,0.000014273252,0.000026932308,0.00012577322,0.0009881667,0.00008707164,0.0003931795,0.004648172],"study_design_scores_gemma":[0.9819958,0.017296959,0.0001789728,0.000012519847,0.000108362285,0.0000042854185,0.000010086263,0.00009491786,0.000084971674,0.00004966768,0.00015945671,0.000003976324],"about_ca_topic_score_codex":0.002474089,"about_ca_topic_score_gemma":0.003875623,"teacher_disagreement_score":0.016406287,"about_ca_system_score_codex":0.0009986331,"about_ca_system_score_gemma":0.0015040833,"threshold_uncertainty_score":0.054884553},"labels":[],"label_agreement":null},{"id":"W2967636994","doi":"10.1007/s10549-019-05391-w","title":"Allelic modification of breast cancer risk in women with an NBN mutation","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Narodowe Centrum Nauki","keywords":"Missense mutation; Breast cancer; Genotype; Allele; Penetrance; Genetics; Genotyping; Prostate cancer; Mutation; Biology; Cancer; Oncology; Internal medicine; Medicine; Gene; Phenotype","score_opus":0.02532644674796673,"score_gpt":0.3453704890080137,"score_spread":0.32004404226004696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967636994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981244,0.00024910938,0.00021397357,0.000076611934,0.000010091951,0.0000033583724,0.00018670442,0.000008606826,0.001127175],"genre_scores_gemma":[0.999153,0.00006698661,0.00010084885,0.000015869238,0.0000061035025,0.0000024115466,0.00008969717,0.00000341411,0.0005616359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976104,0.000109194174,0.00001526108,0.000049223072,0.000033392058,0.00003186979],"domain_scores_gemma":[0.99947304,0.00011092525,0.00021381382,0.000058760907,0.000041445073,0.00010194724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030641042,0.0001639805,0.0001610538,0.00055487774,0.00023701822,0.00029821592,0.0002622223,0.0002610641,0.0019506271],"category_scores_gemma":[0.0013963712,0.0001322311,0.000241482,0.000465229,0.0002102368,0.00014992716,0.00028781756,0.00030249197,0.0002245921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015658888,0.000061290826,0.9859475,0.000008278452,0.000091525166,0.00043995056,0.00009080287,0.000100414,0.007328804,0.0001553923,0.000091549606,0.004118562],"study_design_scores_gemma":[0.0000068984336,0.00013502169,0.99817467,0.0000020287105,0.000040087816,0.00069144065,0.0000634024,0.00017445801,0.00042552437,0.00008238746,0.00020057638,0.0000034526445],"about_ca_topic_score_codex":0.004196061,"about_ca_topic_score_gemma":0.0035808352,"teacher_disagreement_score":0.004196061,"about_ca_system_score_codex":0.00019543472,"about_ca_system_score_gemma":0.00015504756,"threshold_uncertainty_score":0.00834322},"labels":[],"label_agreement":null},{"id":"W2969401789","doi":"10.1007/s10549-019-05411-9","title":"Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"PALB2; Breast cancer; Germline mutation; Medicine; Oncology; Cancer; Internal medicine; Cancer research; Mutation; Genetics; Biology; Gene","score_opus":0.020517722369330416,"score_gpt":0.32335858894469005,"score_spread":0.30284086657535964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969401789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419916,0.0005862156,0.00012525363,0.00018326042,0.000023967232,0.0000140975535,0.00054878264,0.0000047300164,0.004314612],"genre_scores_gemma":[0.9968376,0.00088840415,0.00012546059,0.00007522715,0.000016534323,0.000013794631,0.0005181254,0.0000060092334,0.0015187581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984634,0.00003377689,0.000010909051,0.000037035148,0.000027967226,0.000043801017],"domain_scores_gemma":[0.9998621,0.000026622798,0.000030590418,0.000009524452,0.00003653527,0.000034483684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015910735,0.000283803,0.00032677487,0.0006708602,0.00065832405,0.00037050454,0.00019976475,0.00025205212,0.0020305396],"category_scores_gemma":[0.0005840623,0.00021774674,0.0002209775,0.0007623498,0.00030736192,0.00007184423,0.00026998064,0.00030723563,0.0002411714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031467603,0.00011041806,0.9814571,0.000050739127,0.00005334603,0.0047304984,0.001379318,0.00008995711,0.0026104434,0.00038483553,0.0011443729,0.007674323],"study_design_scores_gemma":[0.000031050997,0.00011454862,0.9877771,0.000057959413,0.00007059795,0.0051126545,0.0016364724,0.00016080886,0.0003082877,0.00015940945,0.0045626867,0.0000085069505],"about_ca_topic_score_codex":0.07755952,"about_ca_topic_score_gemma":0.05753506,"teacher_disagreement_score":0.07755952,"about_ca_system_score_codex":0.00065758347,"about_ca_system_score_gemma":0.00038730275,"threshold_uncertainty_score":0.15421617},"labels":[],"label_agreement":null},{"id":"W2969950347","doi":"10.1007/s10549-019-05398-3","title":"Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Georgetown University; GlaxoSmithKline; Breast Cancer Research Foundation","keywords":"Trastuzumab; Lapatinib; Medicine; Oncology; Internal medicine; Breast cancer; Chemotherapy; Estrogen receptor; Proportional hazards model; Neoadjuvant therapy; Cancer","score_opus":0.05395772915114432,"score_gpt":0.38805740147013806,"score_spread":0.33409967231899373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969950347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910563,0.00044725265,0.00006421958,0.000061518236,0.000010991685,0.000074552234,0.000064965985,0.0000037887983,0.00016712092],"genre_scores_gemma":[0.99903286,0.00017350694,0.00014649035,0.000084072446,0.0000309516,0.00011976187,0.00021537596,0.0000014762787,0.00019560425],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99920076,0.0005044064,0.0000397547,0.0000805898,0.000090250614,0.00008421128],"domain_scores_gemma":[0.9990669,0.0002648464,0.00026776982,0.00006582252,0.000036056448,0.0002986522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020161825,0.0004938083,0.0008300182,0.00025027836,0.00023022118,0.00046463494,0.00027209832,0.00046934455,0.001067376],"category_scores_gemma":[0.0013937007,0.0002994704,0.00078140106,0.00018733082,0.00049768004,0.00033610823,0.00027543138,0.0009542824,0.00011973905],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88608307,0.0053853933,0.0627656,0.00022054127,0.0018475224,0.000070770104,0.00007896919,0.0015272995,0.006797959,0.000100880105,0.0006669978,0.03445495],"study_design_scores_gemma":[0.34545764,0.29688758,0.33739042,0.00010202503,0.0029308444,0.00051401433,0.0001333452,0.007446837,0.006579668,0.0006851665,0.0018176051,0.000054842363],"about_ca_topic_score_codex":0.00051027176,"about_ca_topic_score_gemma":0.0015897395,"teacher_disagreement_score":0.0020161825,"about_ca_system_score_codex":0.000673677,"about_ca_system_score_gemma":0.0010295827,"threshold_uncertainty_score":0.0106627345},"labels":[],"label_agreement":null},{"id":"W2970279264","doi":"10.1007/s10549-019-05415-5","title":"Inherited variants in XRCC2 and the risk of breast cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Pomorski Uniwersytet Medyczny W Szczecinie; Narodowym Centrum Nauki; Narodowe Centrum Nauki","keywords":"Breast cancer; Mutation; Cancer; Internal medicine; Medicine; Oncology; Genetics; Biology; Gene","score_opus":0.016981846986388757,"score_gpt":0.3111979705399772,"score_spread":0.29421612355358845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970279264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651176,0.0023975037,0.00018331641,0.00010421006,0.000010259027,0.0000039214015,0.00027509793,0.00001142936,0.00050251145],"genre_scores_gemma":[0.9989071,0.000546662,0.00014553995,0.000015891332,0.000014527433,0.000002265071,0.00017657441,0.0000033326376,0.0001881996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997142,0.00006323369,0.000035349687,0.000080678525,0.00006938884,0.000037095717],"domain_scores_gemma":[0.99903035,0.00019022988,0.0004813677,0.00006290807,0.00010452955,0.0001306106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044901163,0.0003573428,0.0002487933,0.00066124764,0.000244952,0.00036031636,0.0002469775,0.00038390871,0.0024141576],"category_scores_gemma":[0.0018545504,0.0001661419,0.00024380564,0.00093307905,0.00019366913,0.0001404098,0.00025365746,0.00036372215,0.00024397168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034517987,0.000027680162,0.99324644,0.000032987387,0.00026272627,0.00071597664,0.00004371853,0.00010201883,0.0016675787,0.00007066867,0.00015013225,0.0033349236],"study_design_scores_gemma":[0.000028981265,0.0001020964,0.99423295,0.000021657375,0.00016703033,0.0040491004,0.00003462978,0.0002826771,0.00056394795,0.0001320306,0.0003810095,0.0000038082928],"about_ca_topic_score_codex":0.0035469264,"about_ca_topic_score_gemma":0.0020983396,"teacher_disagreement_score":0.0035469264,"about_ca_system_score_codex":0.0002521312,"about_ca_system_score_gemma":0.00018113533,"threshold_uncertainty_score":0.008076191},"labels":[],"label_agreement":null},{"id":"W2970913246","doi":"10.1007/s10549-019-05407-5","title":"The microbiome and breast cancer: a review","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; Kelowna General Hospital","funders":"","keywords":"Microbiome; Breast cancer; Dysbiosis; Human microbiome; Biology; Human Microbiome Project; Cancer; Medicine; Physiology; Bioinformatics; Genetics","score_opus":0.08622918266623122,"score_gpt":0.44636865157781275,"score_spread":0.36013946891158155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970913246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034700035,0.9993426,0.000032815195,0.00020621328,0.00018449828,0.0000015646447,0.000013712362,0.0000030030305,0.00018091543],"genre_scores_gemma":[0.0002166358,0.9990546,0.00007018883,0.00019195286,0.0002980027,0.0000025373029,0.000017038717,5.688017e-7,0.0001484181],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977535,0.00004119053,0.00003617639,0.00004388424,0.000078748984,0.000024601432],"domain_scores_gemma":[0.99939847,0.0003117494,0.00009498784,0.000012161631,0.00010491839,0.000077744044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006630095,0.0010141061,0.0018119514,0.002967934,0.00031448653,0.0014686855,0.0008696938,0.0015881101,0.0042280685],"category_scores_gemma":[0.0013777904,0.00028719672,0.0005209883,0.0036960104,0.00043034682,0.0015724817,0.001189974,0.0016385565,0.0014453186],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015856598,0.00007774659,0.00034731466,0.027895467,0.00016000636,0.00025076882,0.000058435944,0.00030158064,0.001118279,0.0020408235,0.07267241,0.89491856],"study_design_scores_gemma":[0.000041445932,0.00011222347,0.001613244,0.011240176,0.00037019534,0.0015051671,0.00011881783,0.00009211745,0.00019323226,0.0019878394,0.9826889,0.000036680878],"about_ca_topic_score_codex":0.0014009918,"about_ca_topic_score_gemma":0.0031147418,"teacher_disagreement_score":0.0042280685,"about_ca_system_score_codex":0.0006135695,"about_ca_system_score_gemma":0.0016326468,"threshold_uncertainty_score":0.014144242},"labels":[],"label_agreement":null},{"id":"W2972111131","doi":"10.1007/s10549-019-05418-2","title":"Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McGill University","funders":"Fonds de Recherche du Québec - Santé; Social Sciences and Humanities Research Council of Canada; Canadian Dermatology Foundation","keywords":"Breast cancer; Incidence (geometry); Demography; Medicine; Distribution (mathematics); Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.048751547616142914,"score_gpt":0.3703935749754942,"score_spread":0.32164202735935127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972111131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98336965,0.001094858,0.00013723382,0.00032517783,0.0000089031155,0.000032970715,0.0126104085,0.000023904811,0.0023969694],"genre_scores_gemma":[0.9935529,0.00074344256,0.00015695921,0.00007243128,0.000005821773,0.000012324634,0.004640016,0.000008349164,0.0008078243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992847,0.000059693335,0.00006811422,0.00009228536,0.00022690368,0.00026827556],"domain_scores_gemma":[0.9981187,0.00014944658,0.00028371287,0.000054515014,0.0010227216,0.00037095742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035361064,0.0002300869,0.00034859512,0.002826626,0.0013100734,0.00092849584,0.0009011921,0.0003282042,0.0024729972],"category_scores_gemma":[0.0021130433,0.00028352742,0.0007962252,0.008188293,0.00037351833,0.00025296747,0.00054616295,0.0005456213,0.00023175556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012019388,0.000015283473,0.9945532,0.000023149347,0.00006140758,0.00004955143,0.00013024444,0.00021537524,0.000090235604,0.00007459948,0.0007814913,0.0038850915],"study_design_scores_gemma":[0.0000059887007,0.000015605669,0.9982474,0.000011450522,0.000035869547,0.00006414435,0.0005244481,0.00041370772,0.000049373997,0.000015430964,0.0006116775,0.00000492711],"about_ca_topic_score_codex":0.98874986,"about_ca_topic_score_gemma":0.9912948,"teacher_disagreement_score":0.016273834,"about_ca_system_score_codex":0.016273834,"about_ca_system_score_gemma":0.020220932,"threshold_uncertainty_score":0.11807549},"labels":[],"label_agreement":null},{"id":"W2972898528","doi":"10.1007/s10549-019-05438-y","title":"Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital; Vancouver General Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Cancer Society","keywords":"Medicine; Breast cancer; Oncology; MSH2; Internal medicine; MSH6; Tamoxifen; Cancer; Tissue microarray; Estrogen receptor; Lynch syndrome; Colorectal cancer; DNA mismatch repair","score_opus":0.034466873272750886,"score_gpt":0.36252316291309694,"score_spread":0.32805628964034605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972898528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606544,0.00085849117,0.0000871261,0.00014231529,0.000010867798,0.000022212633,0.0018887618,0.000014336753,0.0009104834],"genre_scores_gemma":[0.99759835,0.00038851995,0.00009389262,0.000080362406,0.0000071995155,0.000017636652,0.001181666,0.0000075354774,0.00062486675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995053,0.00004384976,0.00003246769,0.00017320784,0.000131447,0.0001138646],"domain_scores_gemma":[0.99895084,0.00007965027,0.00021925636,0.00015662628,0.0002815082,0.0003120904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050755526,0.00042154256,0.0005033557,0.0012093858,0.0018805724,0.0009278308,0.0010771516,0.00055789977,0.0024734843],"category_scores_gemma":[0.0010478696,0.0006020516,0.0003632296,0.002459696,0.0005990269,0.0003050783,0.0009710181,0.00077010965,0.00045290045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012164348,0.000026187548,0.9963862,0.000018191835,0.00007833652,0.00022174644,0.00013463153,0.000041744945,0.0005517119,0.000023584633,0.00084977143,0.0015462602],"study_design_scores_gemma":[0.000011363402,0.000012612132,0.9987307,0.000016465961,0.000042741394,0.0002419466,0.00022951476,0.00016783398,0.000039293216,0.000018763854,0.00048257955,0.000006286609],"about_ca_topic_score_codex":0.67939156,"about_ca_topic_score_gemma":0.8228991,"teacher_disagreement_score":0.32060844,"about_ca_system_score_codex":0.0032430768,"about_ca_system_score_gemma":0.0028253964,"threshold_uncertainty_score":0.64499307},"labels":[],"label_agreement":null},{"id":"W2978375464","doi":"10.1007/s10549-019-05430-6","title":"Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Canadian Centre for Applied Research in Cancer Control; University of Toronto; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"Academic Medical Organization of Southwestern Ontario","keywords":"Medicine; Breast cancer; Internal medicine; Endocrine system; Odds ratio; Population; Adjuvant therapy; Oncology; Cancer; Proportional hazards model; Survivorship curve; Hormone","score_opus":0.0807307166114365,"score_gpt":0.34417616123083683,"score_spread":0.26344544461940034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978375464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900975,0.0017415828,0.00008421097,0.0015213826,0.000042152995,0.0000748142,0.0021907317,0.000007731382,0.0042399582],"genre_scores_gemma":[0.996438,0.00090643065,0.00015525187,0.0002924836,0.000015528643,0.000026253829,0.00059211836,0.000004607328,0.001569319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989471,0.000106780615,0.00010998208,0.00011242499,0.00037453882,0.0003491279],"domain_scores_gemma":[0.9966665,0.00028325038,0.00085610105,0.00006766496,0.0012529455,0.00087344076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006617567,0.0002355514,0.0005204751,0.00093408645,0.0029589578,0.0012689227,0.0014295052,0.00058610976,0.0023944962],"category_scores_gemma":[0.00324236,0.00038444798,0.00071868935,0.0037224249,0.00057662826,0.0003197125,0.000582451,0.0010996357,0.00013748948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049410814,0.00007037811,0.99425274,0.000041409432,0.00004502412,0.00008070945,0.0010551991,0.00004409647,0.00007352422,0.000070337854,0.0010285476,0.00318864],"study_design_scores_gemma":[0.000009480693,0.000018346143,0.9975546,0.000048160342,0.00002384901,0.00003793366,0.0014589472,0.00009927068,0.000014969174,0.000011015704,0.0007176408,0.000005766257],"about_ca_topic_score_codex":0.99450845,"about_ca_topic_score_gemma":0.9973658,"teacher_disagreement_score":0.021375898,"about_ca_system_score_codex":0.021375898,"about_ca_system_score_gemma":0.03437806,"threshold_uncertainty_score":0.15509367},"labels":[],"label_agreement":null},{"id":"W2980686905","doi":"10.1007/s10549-019-05465-9","title":"The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"DAISY Foundation","keywords":"Medicine; Randomized controlled trial; Physical therapy; Mastectomy; Quality of life (healthcare); Breast cancer; McGill Pain Questionnaire; Surgery; Visual analogue scale; Cancer; Internal medicine","score_opus":0.03609315086142572,"score_gpt":0.3220452240224757,"score_spread":0.28595207316105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980686905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957553,0.00050400663,0.00034443635,0.00021015822,0.00025191272,0.0021755015,0.00026520595,0.000021511354,0.000472002],"genre_scores_gemma":[0.98971903,0.0010768237,0.0014970291,0.00059483113,0.0006811186,0.004305903,0.0005306323,0.000018388448,0.0015762997],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966972,0.0017841968,0.00022482773,0.00053615007,0.0002266827,0.00053097005],"domain_scores_gemma":[0.9952053,0.0017668969,0.0009508076,0.0006218164,0.0002430094,0.0012123005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004199541,0.0025907045,0.004936833,0.0007067884,0.0012716255,0.0014426097,0.0020095855,0.0033927439,0.008387026],"category_scores_gemma":[0.0043695807,0.001542429,0.0028783248,0.0013079577,0.003934174,0.0025747335,0.0010739502,0.0051967488,0.0013327879],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9435597,0.05010483,0.0011465894,0.00014284273,0.00030969948,0.000034371922,0.00006181296,0.00009123331,0.000893357,0.000056030014,0.00014020568,0.0034593455],"study_design_scores_gemma":[0.4958109,0.49847445,0.0041546463,0.000020250754,0.000571281,0.000022103806,0.00013808439,0.00020195798,0.00028392623,0.00009254736,0.00020378747,0.000026192907],"about_ca_topic_score_codex":0.0026546698,"about_ca_topic_score_gemma":0.0028666665,"teacher_disagreement_score":0.008387026,"about_ca_system_score_codex":0.0011900068,"about_ca_system_score_gemma":0.002799111,"threshold_uncertainty_score":0.028057396},"labels":[],"label_agreement":null},{"id":"W2981183343","doi":"10.1007/s10549-019-05468-6","title":"Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Ottawa Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"BC Cancer Foundation","keywords":"Psychosocial; Breast cancer; Distress; Medicine; Emotional distress; Gerontology; Clinical psychology; Psychiatry; Psychology; Cancer; Anxiety; Internal medicine","score_opus":0.012040421385709715,"score_gpt":0.29484959030170554,"score_spread":0.28280916891599583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981183343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879885,0.00021028996,0.000006892742,0.00014595686,0.0000067966507,0.0000061708174,0.00015019003,5.7259933e-7,0.00067430583],"genre_scores_gemma":[0.99874794,0.00027995402,0.000018404142,0.00013451738,0.0000070512647,0.000007436754,0.00017385377,0.0000011710669,0.00062974554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996915,0.000044466924,0.00003018229,0.00002646812,0.000064283166,0.00014321078],"domain_scores_gemma":[0.99913764,0.00006864411,0.0001635799,0.000009148245,0.0001531896,0.00046780892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027603813,0.00020838557,0.00039721708,0.0006865544,0.001178955,0.000967303,0.00042857518,0.0005157165,0.0026416604],"category_scores_gemma":[0.0012789394,0.00024179352,0.00028174085,0.0012641071,0.000423293,0.00046162546,0.0010213188,0.0008634466,0.0002838544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015595197,0.00008814178,0.9918208,0.000027130594,0.000028573013,0.00021197356,0.0032580644,0.000030947904,0.00021850217,0.00001970163,0.0004784053,0.0036618672],"study_design_scores_gemma":[0.0000051870043,0.00003060407,0.9905193,0.000015396708,0.000009372766,0.000057730034,0.009079682,0.00004015849,0.000013414477,0.000009615334,0.00021503013,0.000004494084],"about_ca_topic_score_codex":0.69393265,"about_ca_topic_score_gemma":0.8465114,"teacher_disagreement_score":0.30606735,"about_ca_system_score_codex":0.0034004997,"about_ca_system_score_gemma":0.002374225,"threshold_uncertainty_score":0.6157397},"labels":[],"label_agreement":null},{"id":"W2981583476","doi":"10.1007/s10549-019-05472-w","title":"Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment","year":2019,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sunnybrook Hospital; McMaster University","funders":"","keywords":"Breast cancer; Dysbiosis; Microbiome; Metagenomics; Cancer; Estrogen receptor; Bioinformatics; Biology; Carcinogenesis; Medicine; Computational biology; Internal medicine; Gene; Genetics","score_opus":0.0811881164033844,"score_gpt":0.39412676695489257,"score_spread":0.31293865055150816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981583476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006698737,0.9987546,0.000110379995,0.00049109507,0.00027239678,0.0000016313696,0.000028809698,0.000005224452,0.00026875612],"genre_scores_gemma":[0.00050975225,0.9982169,0.00016026541,0.00041857196,0.0003569662,0.000003099111,0.000042201867,0.0000015893027,0.00029056013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972886,0.00006787132,0.000030730662,0.000051103132,0.00009086579,0.000030553456],"domain_scores_gemma":[0.99911934,0.00049993326,0.000098937366,0.000026361431,0.00018804222,0.000067378125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010442989,0.00096261094,0.0019910566,0.0015418454,0.00017821795,0.0016459447,0.00083257194,0.0014906944,0.002942628],"category_scores_gemma":[0.0014122449,0.00026745145,0.00065365515,0.0019896396,0.00057207776,0.0014512298,0.00093528465,0.0022529478,0.0013334189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016730076,0.00004644273,0.00031630456,0.014111374,0.00025930093,0.00009944624,0.0000409561,0.00029413291,0.0020062628,0.0055353106,0.033138473,0.94398475],"study_design_scores_gemma":[0.000029879622,0.00010357283,0.0016874679,0.0059945467,0.00028062522,0.0005028112,0.000081377686,0.00018160287,0.00065736176,0.0049126246,0.98553467,0.00003347061],"about_ca_topic_score_codex":0.0016099986,"about_ca_topic_score_gemma":0.003246283,"teacher_disagreement_score":0.002942628,"about_ca_system_score_codex":0.0008201001,"about_ca_system_score_gemma":0.0015232023,"threshold_uncertainty_score":0.009844065},"labels":[],"label_agreement":null},{"id":"W2984443212","doi":"10.1007/s10549-019-05481-9","title":"Flat epithelial atypia: are we being too aggressive?","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Misericordia Community Hospital; Covenant Health; University of Alberta","funders":"","keywords":"Medicine; Biopsy; Atypia; Radiology; Lobular carcinoma; Breast cancer; Radiological weapon; Mammography; Ductal carcinoma; Cancer; Pathology; Internal medicine","score_opus":0.05218872426763596,"score_gpt":0.35330258818213955,"score_spread":0.30111386391450357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984443212","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08964666,0.16739854,0.0021921848,0.6849171,0.014063368,0.00006048315,0.00029352919,0.00014280096,0.041285343],"genre_scores_gemma":[0.6184459,0.1558407,0.003929094,0.186776,0.022503251,0.000050711482,0.00032258057,0.00014635784,0.011985454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967092,0.0009458,0.0003635918,0.00031357384,0.0012165977,0.00045127163],"domain_scores_gemma":[0.98169464,0.0073026707,0.0022394801,0.0008656507,0.0050436915,0.002854021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005125754,0.0003280681,0.001094064,0.0007892923,0.0018683171,0.0044071497,0.0009600349,0.003288122,0.0050562574],"category_scores_gemma":[0.03495001,0.00026312942,0.0005003673,0.0008558142,0.003514181,0.006751427,0.0011328004,0.006305204,0.0020582099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005338113,0.00023471964,0.14339967,0.0016582476,0.00037601698,0.005848692,0.0049239346,0.00017969655,0.0029716939,0.013786911,0.15681008,0.66927654],"study_design_scores_gemma":[0.00014809691,0.0007359275,0.15264599,0.008690714,0.0012051113,0.04746003,0.033650093,0.00043757015,0.0016132323,0.083072074,0.66994166,0.00039948776],"about_ca_topic_score_codex":0.003900421,"about_ca_topic_score_gemma":0.011106972,"teacher_disagreement_score":0.005125754,"about_ca_system_score_codex":0.0010472453,"about_ca_system_score_gemma":0.0024386924,"threshold_uncertainty_score":0.027107954},"labels":[],"label_agreement":null},{"id":"W2990021777","doi":"10.1007/s10549-019-05499-z","title":"Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Sunnybrook Research Institute","keywords":"Medicine; Lesion; Radiology; Occult; Lumpectomy; Mammography; Breast cancer; Radiological weapon; Nuclear medicine; Mastectomy; Surgery; Pathology; Cancer","score_opus":0.06490335096028299,"score_gpt":0.42001249533936846,"score_spread":0.3551091443790855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990021777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834383,0.0023387058,0.0011737421,0.00042549666,0.0004200749,0.010434959,0.00047027293,0.000062483,0.0012359524],"genre_scores_gemma":[0.98016125,0.0015610699,0.0031324946,0.0011516624,0.00044558,0.011177507,0.0005139258,0.000027945858,0.001828662],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9962302,0.0026953765,0.00027342333,0.0003155748,0.0002472611,0.00023818044],"domain_scores_gemma":[0.9937609,0.0033604659,0.0011880534,0.0004572524,0.00044774645,0.0007855497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005718162,0.0011374344,0.0023305602,0.00035939043,0.0006276159,0.0013954346,0.0009180628,0.0019599202,0.0056185415],"category_scores_gemma":[0.0071198307,0.0006434087,0.0014762207,0.00039318952,0.0012734582,0.0013519898,0.00035097086,0.0020625943,0.0008955742],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9516586,0.031710487,0.0019764835,0.0006150187,0.00089476927,0.00004999416,0.000118736185,0.00014695222,0.0019418497,0.000055876597,0.0002920248,0.010539215],"study_design_scores_gemma":[0.5546178,0.44037908,0.003141897,0.000045704826,0.0005354184,0.000033421595,0.00006596192,0.00017948411,0.0005276028,0.000076142795,0.0003858065,0.000011753328],"about_ca_topic_score_codex":0.00036778953,"about_ca_topic_score_gemma":0.00083262235,"teacher_disagreement_score":0.005718162,"about_ca_system_score_codex":0.00055422605,"about_ca_system_score_gemma":0.0017695953,"threshold_uncertainty_score":0.030240893},"labels":[],"label_agreement":null},{"id":"W2999894408","doi":"10.1007/s10549-020-05530-8","title":"RE: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort","year":2020,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Cohort; Oncology; Medicine; Cohort study; Internal medicine; Cancer","score_opus":0.05282480570235285,"score_gpt":0.36307017271636677,"score_spread":0.3102453670140139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999894408","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026621858,0.0019447994,0.00015124446,0.94731814,0.01195372,0.000034481858,0.0022781873,0.00006901901,0.009628544],"genre_scores_gemma":[0.11000063,0.002195001,0.00045670482,0.79538673,0.029864857,0.00014144911,0.0013573128,0.00008956094,0.06050772],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989937,0.00021637959,0.00016094232,0.0001387346,0.00028604,0.00020428425],"domain_scores_gemma":[0.9946629,0.0019079464,0.00036940345,0.00023337122,0.0015551866,0.0012712537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015267818,0.00043231633,0.0009192698,0.0007654732,0.0028754813,0.0015694585,0.0011296942,0.009585389,0.0050623924],"category_scores_gemma":[0.009384147,0.0005165381,0.00035492697,0.0012791009,0.00077673583,0.00079310685,0.000577525,0.008549607,0.0032231107],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021319946,0.00004980162,0.05195218,0.000045527835,0.000046175384,0.0023860442,0.00018679196,0.000056861456,0.00030354134,0.00026390643,0.93367016,0.010825789],"study_design_scores_gemma":[0.00082058925,0.0002394016,0.36663833,0.0012279375,0.00065721874,0.010650488,0.004616973,0.0035546753,0.0010417455,0.0044696666,0.6057879,0.00029518036],"about_ca_topic_score_codex":0.26135266,"about_ca_topic_score_gemma":0.4267975,"teacher_disagreement_score":0.73864734,"about_ca_system_score_codex":0.00392713,"about_ca_system_score_gemma":0.005688919,"threshold_uncertainty_score":0.51966286},"labels":[],"label_agreement":null},{"id":"W3008249523","doi":"10.1007/s10549-020-05549-x","title":"Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using administrative databases","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Michel-Sarrazin; Hôpital du Saint-Sacrement; Université Laval","funders":"Institut National Du Cancer; Université Laval","keywords":"Medicine; Breast cancer; Cohort; Cohort study; Internal medicine; Demography; Cancer; Discontinuation; Hormone therapy; Oncology; Database","score_opus":0.18284200853259894,"score_gpt":0.43526260606799394,"score_spread":0.25242059753539503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008249523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947299,0.0004294993,0.00011799264,0.0001135771,0.000017879205,0.000029487584,0.00413762,0.000007737374,0.00041622864],"genre_scores_gemma":[0.99578035,0.00021088145,0.00014541116,0.000069528716,0.000013338455,0.00004483443,0.003248666,0.0000052956416,0.0004816934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817586,0.00039566171,0.00033627605,0.00044445877,0.00024095814,0.00040684742],"domain_scores_gemma":[0.99493474,0.0005367901,0.0027776468,0.00058499206,0.00059499306,0.00057088997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016818054,0.00046951213,0.00072438276,0.0014594308,0.0011195826,0.0019506726,0.0012175762,0.0011458319,0.0014718153],"category_scores_gemma":[0.006360261,0.0008513214,0.0019211886,0.0039756936,0.00029149704,0.0013174257,0.0013804658,0.0019474678,0.00041127214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014687247,0.00008450882,0.99867624,0.000013029434,0.00022538051,0.000028595798,0.00014691267,0.00003079915,0.000037642705,0.000023182309,0.00013224568,0.00045453498],"study_design_scores_gemma":[0.000009278038,0.00008815115,0.99893314,0.000011999062,0.00008131924,0.00006629143,0.00036740192,0.0001930701,0.000020495256,0.000014659332,0.00020634907,0.0000078572375],"about_ca_topic_score_codex":0.075982474,"about_ca_topic_score_gemma":0.085446194,"teacher_disagreement_score":0.075982474,"about_ca_system_score_codex":0.0011531031,"about_ca_system_score_gemma":0.0014431732,"threshold_uncertainty_score":0.15108043},"labels":[],"label_agreement":null},{"id":"W3014809226","doi":"10.1007/s10549-020-05614-5","title":"Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Institute for Clinical Evaluative Sciences; Sunnybrook Hospital; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research","keywords":"Pertuzumab; Medicine; Trastuzumab; Cohort; Internal medicine; Metastatic breast cancer; Population; Breast cancer; Trastuzumab emtansine; Oncology; Randomized controlled trial; Cohort study; Cancer","score_opus":0.23654628794184537,"score_gpt":0.5262910221048149,"score_spread":0.28974473416296953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014809226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969586,0.0007926444,0.00018037991,0.00011674325,0.00003094654,0.000036189627,0.0011322624,0.0000060676275,0.00074628013],"genre_scores_gemma":[0.9977418,0.00018518347,0.000051179406,0.00007864737,0.000035907153,0.000041675834,0.0016928132,0.0000041604176,0.00016848945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970203,0.0010719916,0.00039770262,0.0006674429,0.00036718132,0.00047540088],"domain_scores_gemma":[0.99396604,0.0019978262,0.0024906588,0.00043757237,0.00048891595,0.0006190452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029912982,0.0003841789,0.0010656391,0.0010327888,0.0004352885,0.0015029896,0.0006861777,0.0009373445,0.0025247026],"category_scores_gemma":[0.011598542,0.0002293081,0.0020776037,0.0013033802,0.00038546728,0.0012065547,0.0009833932,0.000976643,0.0002670942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021587798,0.0002829415,0.96676075,0.000108619744,0.0038567884,0.00021119977,0.00011946601,0.0003687745,0.00060450786,0.00019963698,0.00073900324,0.0051604905],"study_design_scores_gemma":[0.0008939622,0.0035363587,0.9918934,0.000027420409,0.0012626031,0.0003664841,0.0003305009,0.00070232135,0.00014274806,0.00027056911,0.00055042445,0.000023165645],"about_ca_topic_score_codex":0.002395705,"about_ca_topic_score_gemma":0.002015841,"teacher_disagreement_score":0.0029912982,"about_ca_system_score_codex":0.0007554153,"about_ca_system_score_gemma":0.0006691569,"threshold_uncertainty_score":0.015819728},"labels":[],"label_agreement":null},{"id":"W3015333700","doi":"10.1007/s10549-020-05622-5","title":"Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canadian Partnership Against Cancer; University of Calgary","funders":"Ipsen Biopharmaceuticals; Pfizer","keywords":"Medicine; Depression (economics); Breast cancer; Sexual dysfunction; Quality of life (healthcare); Sexual function; Randomized controlled trial; Internal medicine; Gynecology; Pediatrics; Cancer","score_opus":0.0437331674938029,"score_gpt":0.32902405227964704,"score_spread":0.28529088478584413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015333700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990534,0.00036948404,0.000016671192,0.000049898405,0.00000874673,0.000006823884,0.000114885086,8.7926907e-7,0.00037920813],"genre_scores_gemma":[0.99952674,0.00016381583,0.000023322735,0.000023791357,0.000011497519,0.0000039399592,0.000100186364,5.2118855e-7,0.00014620008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998012,0.00007350168,0.000026540238,0.000015252408,0.000038316113,0.000045186094],"domain_scores_gemma":[0.9984372,0.00059387274,0.00056043605,0.000047881505,0.00007257338,0.00028789957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003580176,0.00017794098,0.00029309466,0.0005313083,0.0002970607,0.00054167927,0.0001997735,0.0005397605,0.0014790735],"category_scores_gemma":[0.0030732462,0.00022035975,0.0005057477,0.0007285241,0.00021329349,0.00031087623,0.00032181278,0.0006817459,0.00009833505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001760753,0.00007407891,0.9986745,0.0000058773594,0.00004230303,0.000057210073,0.00004613278,0.000028871526,0.00009988676,0.0000061693136,0.000024264684,0.0007646474],"study_design_scores_gemma":[0.000005883794,0.00009681296,0.99952483,0.000003194086,0.000024387578,0.00007762229,0.000110808774,0.00009001364,0.000017515898,0.0000072091684,0.000040150917,0.0000015451543],"about_ca_topic_score_codex":0.005726988,"about_ca_topic_score_gemma":0.012221186,"teacher_disagreement_score":0.005726988,"about_ca_system_score_codex":0.00023272476,"about_ca_system_score_gemma":0.00042561407,"threshold_uncertainty_score":0.011387289},"labels":[],"label_agreement":null},{"id":"W3022018269","doi":"10.1007/s10549-020-05664-9","title":"The impact of ductal carcinoma in situ on health services utilization","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Ductal carcinoma; Breast cancer; Anxiety; Depression (economics); Population; Comorbidity; Mammography; Cohort; Internal medicine; Cancer; Psychiatry","score_opus":0.23515660022977386,"score_gpt":0.478777041920667,"score_spread":0.24362044169089314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022018269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798732,0.0055938233,0.00008271038,0.0031257381,0.00007956509,0.0000087370445,0.0025546055,0.00001086759,0.008670772],"genre_scores_gemma":[0.9978269,0.0012389887,0.00002731978,0.00013197339,0.00006932657,0.0000025643556,0.00036404844,0.000003533499,0.00033529464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985695,0.0005489356,0.000114088274,0.000089180314,0.0002043216,0.00047411575],"domain_scores_gemma":[0.9951853,0.0019180198,0.0013470653,0.00016871806,0.00042516642,0.00095571537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011206121,0.00021422106,0.0003362446,0.0010725177,0.00039774223,0.0012343951,0.0003978333,0.00063889264,0.0051907175],"category_scores_gemma":[0.007791455,0.0001857723,0.0018000313,0.002397601,0.00039864093,0.00078278506,0.001231081,0.0011079995,0.00031622066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015115253,0.000065970205,0.99246514,0.00003247438,0.00016252932,0.00011428726,0.000065451764,0.00020902959,0.0000582401,0.00015453868,0.00033487962,0.0061862026],"study_design_scores_gemma":[0.0000020973682,0.00004255349,0.9989926,0.000017393475,0.00008359432,0.00010693121,0.00027482974,0.00012233747,0.000019843637,0.00007945528,0.00025522648,0.0000030890444],"about_ca_topic_score_codex":0.0442319,"about_ca_topic_score_gemma":0.056727495,"teacher_disagreement_score":0.0442319,"about_ca_system_score_codex":0.0011650793,"about_ca_system_score_gemma":0.0016565174,"threshold_uncertainty_score":0.08794886},"labels":[],"label_agreement":null},{"id":"W3025381089","doi":"10.1007/s10549-020-05651-0","title":"Association between the polymorphisms in MMP-2 and MMP-9 with adiposity and mammographic features","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Breast Cancer Research Alliance","keywords":"Matrix metalloproteinase; Mammography; Medicine; MAMMOGRAPHIC DENSITY; Breast cancer; Internal medicine; Oncology; Association (psychology); Endocrinology; Cancer; Psychology","score_opus":0.021955365832821424,"score_gpt":0.2822758636719979,"score_spread":0.2603204978391765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025381089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827635,0.00035073044,0.000364687,0.00007820002,0.000017603103,0.0000053522995,0.00023844029,0.0000074876134,0.00066112983],"genre_scores_gemma":[0.99882,0.00007616911,0.00023114787,0.000015151626,0.00002376073,0.000005664671,0.00012199505,0.0000043134387,0.0007017071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962676,0.00016159093,0.000039798513,0.00007647901,0.000048504746,0.000046872377],"domain_scores_gemma":[0.998382,0.00066145574,0.00051137304,0.00012862435,0.00008869906,0.0002279259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048306654,0.00044541623,0.00040581878,0.000648043,0.00026783958,0.00044049224,0.00027334274,0.0005059063,0.003742596],"category_scores_gemma":[0.0018212082,0.00032871493,0.00053400017,0.0007780953,0.00028794957,0.00022373398,0.00020932492,0.00095416704,0.000277828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002213549,0.00012792298,0.9866231,0.00001742543,0.00041346473,0.00048368686,0.000085945445,0.00010154101,0.0077874325,0.000097138145,0.00006713276,0.001981604],"study_design_scores_gemma":[0.000017273227,0.00012818677,0.9983626,0.0000023726475,0.000091388254,0.0005954048,0.000040260547,0.0002702482,0.0003336964,0.000051292678,0.00010310534,0.0000041719723],"about_ca_topic_score_codex":0.0012217636,"about_ca_topic_score_gemma":0.0011604843,"teacher_disagreement_score":0.003742596,"about_ca_system_score_codex":0.000116926705,"about_ca_system_score_gemma":0.00014412374,"threshold_uncertainty_score":0.012520254},"labels":[],"label_agreement":null},{"id":"W3027207030","doi":"10.1007/s10549-020-05691-6","title":"Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Adjuvant therapy; Population; Adjuvant; Oncology; Endocrine system; Internal medicine; Surgery; Cancer; Hormone","score_opus":0.035435332082713884,"score_gpt":0.32430379538192367,"score_spread":0.2888684632992098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027207030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964736,0.0022081211,0.000021907368,0.00018196633,0.000016668822,0.0000035584114,0.00019057345,0.0000013384918,0.00090219965],"genre_scores_gemma":[0.99845386,0.00084626337,0.000011617571,0.00009146943,0.00003251151,0.000002585303,0.00017389294,9.3740414e-7,0.00038688618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998331,0.000041759762,0.000011108056,0.000018390643,0.000018891657,0.00007668449],"domain_scores_gemma":[0.9992804,0.00019000296,0.00028053584,0.000027514847,0.000043074113,0.00017848496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037987856,0.00015166019,0.000273465,0.00047012637,0.0002946988,0.00056669285,0.0002249084,0.0005204334,0.0014154742],"category_scores_gemma":[0.002134642,0.00012463744,0.00053910026,0.00080522115,0.0002639712,0.00044056977,0.0003079873,0.00049139245,0.00017059456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009798267,0.000080456455,0.99348116,0.000023438268,0.0000940756,0.00014718165,0.00012937679,0.000059341226,0.00019573241,0.00002768789,0.00012732543,0.0046544736],"study_design_scores_gemma":[0.000019712907,0.00024111001,0.998607,0.000013485344,0.00014965949,0.00023008151,0.00025020906,0.000041817642,0.00005633547,0.000040122697,0.00034607068,0.0000044917574],"about_ca_topic_score_codex":0.008860511,"about_ca_topic_score_gemma":0.0136419805,"teacher_disagreement_score":0.008860511,"about_ca_system_score_codex":0.00027146374,"about_ca_system_score_gemma":0.0004021228,"threshold_uncertainty_score":0.017617822},"labels":[],"label_agreement":null},{"id":"W3027898627","doi":"10.1007/s10549-020-05665-8","title":"Does oncoplastic surgery increase immediate (30-day) postoperative complications? An analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network; Women's College Hospital","funders":"","keywords":"Lumpectomy; Medicine; Surgery; Complication; Breast cancer; Breast surgery; Logistic regression; Mastectomy; General surgery; Cancer; Internal medicine","score_opus":0.05566617204129754,"score_gpt":0.3923488447333212,"score_spread":0.3366826726920237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027898627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618158,0.008116199,0.00024083452,0.00053758075,0.000041984324,0.00005816224,0.027705455,0.000012999241,0.0014710207],"genre_scores_gemma":[0.98540235,0.0020831085,0.00026385923,0.00024857398,0.00004792872,0.000048464328,0.011702599,0.00000823571,0.00019485691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968838,0.00091144623,0.0008361902,0.0005892059,0.00055310456,0.00022626939],"domain_scores_gemma":[0.9837571,0.0050277407,0.008558072,0.00093559537,0.0011218117,0.00059955986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025013909,0.0002206905,0.00074311096,0.0019092552,0.00030637713,0.0008877986,0.0007256271,0.00060295407,0.001593576],"category_scores_gemma":[0.010283136,0.00027397493,0.001967634,0.0057197018,0.00020678474,0.0006633669,0.0005966435,0.0007513883,0.0001706769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019588514,0.00002083166,0.9975568,0.000072863804,0.0005149563,0.000015911115,0.000015433603,0.000029973511,0.000020370355,0.000019220972,0.0003319403,0.0012057429],"study_design_scores_gemma":[0.000016638962,0.000027488766,0.99928766,0.000020846977,0.00022014904,0.000045130764,0.00005157827,0.00008227161,0.00001735273,0.0000114325085,0.00021684014,0.0000027689903],"about_ca_topic_score_codex":0.015122999,"about_ca_topic_score_gemma":0.024053402,"teacher_disagreement_score":0.015122999,"about_ca_system_score_codex":0.0006449297,"about_ca_system_score_gemma":0.0008833017,"threshold_uncertainty_score":0.030069947},"labels":[],"label_agreement":null},{"id":"W3030098331","doi":"10.1007/s10549-020-05715-1","title":"Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer","year":2020,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Adverse effect; Internal medicine; Oncology; Odds ratio; Adjuvant therapy; Discontinuation; Cancer; Aromatase inhibitor; Gynecology; Surgery","score_opus":0.022330431814402137,"score_gpt":0.34323868389577206,"score_spread":0.3209082520813699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030098331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009641127,0.99955934,0.000037022895,0.00010016986,0.000055642704,8.7813015e-7,0.000015803653,0.0000015185988,0.00013332407],"genre_scores_gemma":[0.001040667,0.9984162,0.00008000966,0.00015063804,0.00017394626,0.000002419772,0.000024519748,6.1109927e-7,0.000111036345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976,0.000051964886,0.0000458237,0.00004861514,0.00007682813,0.000016769536],"domain_scores_gemma":[0.999223,0.00046166155,0.0001464604,0.000011164855,0.00012634805,0.000031330175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090715586,0.00060519256,0.0018403042,0.0012477618,0.00010680341,0.0007098074,0.00077458494,0.0008820876,0.0017898543],"category_scores_gemma":[0.0017161383,0.00019563944,0.0007116789,0.0015803117,0.00025318342,0.00046038468,0.0003687193,0.0011979954,0.00047818013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003468318,0.000041551062,0.0012818032,0.021381365,0.00057808246,0.00014459135,0.000027828812,0.0004281049,0.00044044806,0.0011102301,0.013334106,0.96088517],"study_design_scores_gemma":[0.0004289317,0.00091027765,0.02654512,0.029141415,0.005683709,0.0042249444,0.00017081587,0.0007500625,0.00076280633,0.004964684,0.92629695,0.00012028005],"about_ca_topic_score_codex":0.0016912636,"about_ca_topic_score_gemma":0.0032258572,"teacher_disagreement_score":0.0018403042,"about_ca_system_score_codex":0.00054437126,"about_ca_system_score_gemma":0.0008887321,"threshold_uncertainty_score":0.005987704},"labels":[],"label_agreement":null},{"id":"W3030638475","doi":"10.1007/s10549-020-05708-0","title":"Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Radiation therapy; Internal medicine; Odds ratio; Lymphovascular invasion; Cohort; Logistic regression; Surgery; Cancer; Metastasis","score_opus":0.05093524076706331,"score_gpt":0.3447732734640082,"score_spread":0.2938380326969449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030638475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982521,0.00029822113,0.000058949572,0.00007381723,0.0000017621393,0.0000032786495,0.0006625629,0.0000059168246,0.0006433264],"genre_scores_gemma":[0.99887663,0.00026873464,0.000059106675,0.00002488687,0.0000067518004,0.0000053262456,0.00044090822,0.000005090105,0.00031252613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949193,0.00010332695,0.000076937955,0.00008883798,0.00007258396,0.00016638849],"domain_scores_gemma":[0.9974081,0.00048372798,0.0011588349,0.000109983266,0.00047825061,0.00036112955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047699534,0.00010901983,0.00017923892,0.0015500305,0.00039241457,0.0005504518,0.00039917487,0.0003377348,0.002354066],"category_scores_gemma":[0.001792388,0.00020471311,0.0002861529,0.0030168549,0.0002914687,0.0005168301,0.0005442299,0.0003729245,0.00028697308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116177674,0.00002216795,0.99745005,0.000009215991,0.000016193382,0.00004863997,0.00018446929,0.00007587945,0.00033608743,0.000036988098,0.00008804378,0.0016161685],"study_design_scores_gemma":[0.0000014169531,0.000044950593,0.998348,0.0000053827835,0.000011634565,0.00015007256,0.00092397653,0.00015288792,0.00014667935,0.00000977596,0.00020206491,0.0000031128006],"about_ca_topic_score_codex":0.03945172,"about_ca_topic_score_gemma":0.054853436,"teacher_disagreement_score":0.03945172,"about_ca_system_score_codex":0.0010957625,"about_ca_system_score_gemma":0.0010552739,"threshold_uncertainty_score":0.07844418},"labels":[],"label_agreement":null},{"id":"W3036114328","doi":"10.1007/s10549-020-05745-9","title":"Correction to: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort","year":2020,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia Hospital; Vancouver General Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Breast Cancer Research Foundation","keywords":"Statement (logic); Breast cancer; Medicine; Cohort; Cohort study; Oncology; Internal medicine; Cancer; Family medicine; Political science; Law","score_opus":0.038754213873156834,"score_gpt":0.3650358402279431,"score_spread":0.3262816263547863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036114328","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040362854,0.0005286591,0.00034841395,0.068672396,0.92430156,0.000028588443,0.0038051335,0.00023565457,0.0016760512],"genre_scores_gemma":[0.035562098,0.0058277855,0.005854317,0.15168369,0.51363665,0.00045603752,0.011076287,0.0024070656,0.2734961],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974637,0.00030423715,0.00047680264,0.00042503988,0.00091553834,0.00041459833],"domain_scores_gemma":[0.98025334,0.004857717,0.000998983,0.0013195989,0.010440415,0.0021299126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003176413,0.0022335302,0.002142979,0.00376433,0.0027568096,0.0032275056,0.0036239384,0.0062015504,0.05858746],"category_scores_gemma":[0.042812757,0.0013071084,0.0015271774,0.0023956946,0.0015206104,0.0013741821,0.001505304,0.008577704,0.020720446],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045477816,0.0000045280326,0.0003075826,0.000063364816,0.000016112548,0.00033019984,0.000011563088,0.000023338529,0.000024000783,0.00012940001,0.9972253,0.0018192888],"study_design_scores_gemma":[0.0003833178,0.000046678517,0.008274653,0.00074014586,0.00025697632,0.0028743492,0.0002646095,0.0007482718,0.0004979061,0.0017878857,0.984009,0.00011614787],"about_ca_topic_score_codex":0.06633318,"about_ca_topic_score_gemma":0.08420945,"teacher_disagreement_score":0.06633318,"about_ca_system_score_codex":0.004085737,"about_ca_system_score_gemma":0.0075820293,"threshold_uncertainty_score":0.19599456},"labels":[],"label_agreement":null},{"id":"W3038504329","doi":"10.1007/s10549-020-05777-1","title":"Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research; Breast Cancer Society of Canada; Cancer Care Ontario","keywords":"Letrozole; Anastrozole; Medicine; Breast cancer; Internal medicine; Exemestane; Oncology; Prospective cohort study; Discontinuation; Aromatase inhibitor; Single-nucleotide polymorphism; Cancer; Tamoxifen; Genotype","score_opus":0.026032971647157902,"score_gpt":0.3378087130746484,"score_spread":0.3117757414274905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038504329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914265,0.00032015305,0.00002808707,0.00004337741,0.0000065585346,0.000003951372,0.0001099927,0.00000220725,0.0003430778],"genre_scores_gemma":[0.9996184,0.00008215087,0.000024232579,0.000023137622,0.000011569986,0.0000029537766,0.00011000048,8.6993475e-7,0.00012672467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998,0.00005693304,0.000022786586,0.000037811817,0.000035278892,0.00004718596],"domain_scores_gemma":[0.9991086,0.00021302889,0.00042484445,0.00003160464,0.000044890556,0.00017701506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016403319,0.00023018803,0.00026192973,0.0004880725,0.0002928366,0.00039029622,0.0002066529,0.0004701407,0.0010710214],"category_scores_gemma":[0.0014503325,0.00016044313,0.00043083073,0.00061405275,0.00018035702,0.00021041548,0.00015618282,0.0004966032,0.00013884237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009777966,0.00008025696,0.9955562,0.000010474547,0.00008846352,0.00038048488,0.000048230817,0.00008514296,0.0011977411,0.000016426118,0.00006621083,0.0014925445],"study_design_scores_gemma":[0.000013749875,0.00020014506,0.9988582,0.0000028152958,0.000052206928,0.00048289596,0.000062958265,0.00011700697,0.00009594845,0.000016868193,0.000093351235,0.0000038079147],"about_ca_topic_score_codex":0.0025399076,"about_ca_topic_score_gemma":0.003062926,"teacher_disagreement_score":0.0025399076,"about_ca_system_score_codex":0.00027909808,"about_ca_system_score_gemma":0.00025244846,"threshold_uncertainty_score":0.0050503016},"labels":[],"label_agreement":null},{"id":"W3042061226","doi":"10.1007/s10549-020-05781-5","title":"Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Cohort; Prospective cohort study; Radiation therapy; Logistic regression; Internal medicine; Cancer; Cohort study; Univariate analysis; Physical therapy; Multivariate analysis","score_opus":0.04985522990995125,"score_gpt":0.3404472129029514,"score_spread":0.29059198299300015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042061226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991509,0.00029473627,0.000017183824,0.000030633648,0.000005719935,0.0000054691714,0.00016625163,0.000001063916,0.00032803594],"genre_scores_gemma":[0.9996252,0.000087175205,0.000013442569,0.00003627649,0.000007852454,0.0000042685515,0.00015780302,4.127218e-7,0.0000675193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999681,0.00010206224,0.000050459515,0.00004363768,0.000037432797,0.00008553186],"domain_scores_gemma":[0.9990363,0.0002304462,0.0004228949,0.000023755361,0.000067902874,0.00021866556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044701918,0.00019244023,0.00037739443,0.00046723982,0.00032610854,0.00049411505,0.00013629277,0.00035795546,0.0013805914],"category_scores_gemma":[0.0024050132,0.00011422341,0.0004908302,0.00047849378,0.0002040729,0.00048161668,0.0005000541,0.0003058938,0.000115525734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006933558,0.000053888532,0.996788,0.000026614221,0.00008620863,0.00018780574,0.0002042843,0.000056335648,0.00015007445,0.000010569419,0.00008486132,0.0016580273],"study_design_scores_gemma":[0.000018651219,0.00032606523,0.9985904,0.0000082214,0.0000411591,0.0003537087,0.00044948194,0.00007387486,0.000020293142,0.000010296381,0.000103466955,0.000004282227],"about_ca_topic_score_codex":0.0022636412,"about_ca_topic_score_gemma":0.0045231725,"teacher_disagreement_score":0.0022636412,"about_ca_system_score_codex":0.00032712304,"about_ca_system_score_gemma":0.00021406566,"threshold_uncertainty_score":0.0046185255},"labels":[],"label_agreement":null},{"id":"W3044249165","doi":"10.1007/s10549-020-05795-z","title":"Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; University of British Columbia Hospital; Canada's Michael Smith Genome Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Tissue microarray; Oncology; Immunohistochemistry; Internal medicine; Clinical significance; Autophagy; Cancer; Proportional hazards model; Medicine; Biology; Biomarker; Genetics; Apoptosis","score_opus":0.030517490483007243,"score_gpt":0.3410157086576971,"score_spread":0.31049821817468987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044249165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941759,0.0041116406,0.0002314914,0.00009362933,0.00001858154,0.000004878895,0.00029743055,0.000014274759,0.0010521008],"genre_scores_gemma":[0.99862146,0.0005196116,0.00017223835,0.000029606756,0.00001732691,0.0000077793875,0.00028046314,0.0000043321365,0.0003471874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972504,0.000051778556,0.000026476888,0.000053746888,0.000054800308,0.00008808206],"domain_scores_gemma":[0.9995596,0.00010476162,0.00013030645,0.00004696211,0.000097942255,0.00006035256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004973834,0.00017129545,0.0003772076,0.0009783072,0.00036584417,0.00078661286,0.00023779846,0.0004936226,0.001101662],"category_scores_gemma":[0.0011507252,0.00017941024,0.00022079996,0.0010112841,0.00035022467,0.00029716978,0.00035004175,0.0004031209,0.00032158458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004430247,0.000059940605,0.9071676,0.00015563819,0.00026082768,0.00065019855,0.00018928191,0.00043036856,0.058307465,0.00036547257,0.00078622496,0.027196744],"study_design_scores_gemma":[0.000042472006,0.00019172895,0.9829358,0.000026493602,0.0002578689,0.0025531445,0.00045821196,0.0011214493,0.009059727,0.0005995594,0.0027328918,0.000020703981],"about_ca_topic_score_codex":0.00094502093,"about_ca_topic_score_gemma":0.0012517137,"teacher_disagreement_score":0.001101662,"about_ca_system_score_codex":0.00042436327,"about_ca_system_score_gemma":0.00021600831,"threshold_uncertainty_score":0.0036854744},"labels":[],"label_agreement":null},{"id":"W3044842013","doi":"10.1007/s10549-020-05812-1","title":"Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society; Queen's University; Université de Montréal","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Exemestane; Internal medicine; Placebo; Medicine; Joint pain; Relative risk; Menopause; Confounding; Hot flash; Breast cancer; Endocrinology; Oncology; Confidence interval; Cancer; Aromatase","score_opus":0.09674133608062481,"score_gpt":0.39016974227250945,"score_spread":0.29342840619188465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044842013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846452,0.00836526,0.00024026626,0.0009667515,0.00016235569,0.00014595751,0.0023821616,0.00004924786,0.0030428472],"genre_scores_gemma":[0.9961467,0.0009434159,0.00017396646,0.00042351108,0.0001314284,0.00014167321,0.0011423638,0.0000134985385,0.0008834261],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99967897,0.0001835145,0.000017664706,0.00004116846,0.000030755924,0.0000480117],"domain_scores_gemma":[0.99958926,0.0001509395,0.000111693684,0.000045385954,0.00003049403,0.00007231347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006315952,0.00039037698,0.001135165,0.00010733892,0.00023228693,0.000487041,0.0002450529,0.00066183903,0.0033406646],"category_scores_gemma":[0.0015722722,0.0001460112,0.0010253629,0.0003636145,0.00027442852,0.0002858895,0.00018536196,0.00110778,0.0002554851],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8944926,0.00069278775,0.029144738,0.0013330855,0.0052609006,0.00023702288,0.00011327346,0.001163739,0.00699409,0.0004512482,0.008214275,0.051902343],"study_design_scores_gemma":[0.6208416,0.05909173,0.28233004,0.0005946937,0.01624979,0.00073847716,0.00016322323,0.0023279316,0.002533451,0.0019774993,0.013060959,0.00009052025],"about_ca_topic_score_codex":0.0026214335,"about_ca_topic_score_gemma":0.0065342984,"teacher_disagreement_score":0.0033406646,"about_ca_system_score_codex":0.00036233195,"about_ca_system_score_gemma":0.00049886195,"threshold_uncertainty_score":0.0111756325},"labels":[],"label_agreement":null},{"id":"W3048905405","doi":"10.1007/s10549-020-05782-4","title":"Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pfizer","keywords":"Palbociclib; Internal medicine; Oncology; Medicine; Breast cancer; Hazard ratio; Progression-free survival; Placebo; Population; Biomarker; Cancer; Gastroenterology; Metastatic breast cancer; Confidence interval; Biology; Chemotherapy; Pathology","score_opus":0.09056274542627094,"score_gpt":0.4249490110503013,"score_spread":0.3343862656240304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048905405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97276896,0.022013664,0.0017681982,0.00026437626,0.00006139859,0.0005157711,0.0013005452,0.00006004451,0.0012471037],"genre_scores_gemma":[0.9965364,0.0013307185,0.0006398392,0.00016786465,0.000060688628,0.00020636404,0.0007766381,0.000012671336,0.000268766],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942022,0.004345336,0.00041271414,0.00036896166,0.0005145523,0.00015623252],"domain_scores_gemma":[0.9895427,0.006348071,0.0023858838,0.0007713686,0.0005601864,0.0003916778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01496074,0.0006938715,0.0023477303,0.0006377447,0.00019538292,0.0011276498,0.0007029357,0.00048322545,0.0013731192],"category_scores_gemma":[0.010635599,0.0002968436,0.006629763,0.00096024445,0.00035216974,0.00073660817,0.00058990053,0.0011340615,0.00012635403],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5016382,0.00090009026,0.25892857,0.0037861115,0.11434978,0.00018057032,0.00018261452,0.0034789734,0.00542664,0.00038750522,0.0014485295,0.109292455],"study_design_scores_gemma":[0.09860607,0.07897071,0.6855663,0.00043659913,0.114480846,0.0008526043,0.00021337195,0.011024164,0.0025894707,0.0011822522,0.0059548477,0.00012271103],"about_ca_topic_score_codex":0.000482757,"about_ca_topic_score_gemma":0.001644704,"teacher_disagreement_score":0.01496074,"about_ca_system_score_codex":0.0005219869,"about_ca_system_score_gemma":0.00083695713,"threshold_uncertainty_score":0.079120874},"labels":[],"label_agreement":null},{"id":"W3057932598","doi":"10.1007/s10549-020-05872-3","title":"Association of RAD51C germline mutations with breast cancer among Bahamians","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute","keywords":"Breast cancer; Germline; Germline mutation; Oncology; Genetics; Medicine; Internal medicine; Mutation; Biology; Cancer; Cancer research; Gene","score_opus":0.025600441470279317,"score_gpt":0.33046631461336157,"score_spread":0.3048658731430822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3057932598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992812,0.000109110035,0.000025011894,0.00007069844,0.0000032338346,0.0000018286697,0.00006870886,0.0000011846469,0.00043901935],"genre_scores_gemma":[0.9996151,0.00008450925,0.000024915576,0.000025176287,0.000003711318,0.0000018377823,0.000040725048,6.427813e-7,0.00020345171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998455,0.000026242129,0.000014235671,0.000031025316,0.000028100076,0.000054857323],"domain_scores_gemma":[0.9997422,0.00003613878,0.00010895942,0.000016158223,0.000044302233,0.000052210144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020063692,0.00019814206,0.00016714518,0.0008807498,0.0006355755,0.00035785927,0.00038621342,0.000321261,0.0026235427],"category_scores_gemma":[0.0007607583,0.00024369899,0.0002051027,0.0008268811,0.00039648393,0.00022684342,0.00034294132,0.0003108641,0.00018336537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000877332,0.000032106207,0.99507153,0.000010729964,0.000031370968,0.00034876267,0.0007671243,0.000022851198,0.0013195496,0.00009549414,0.000109510576,0.0021032738],"study_design_scores_gemma":[0.0000049622595,0.000056891695,0.99685836,0.0000081004855,0.000031215135,0.00056174834,0.0018630772,0.000109637665,0.00013755671,0.000043877968,0.00032017712,0.0000043722393],"about_ca_topic_score_codex":0.063288435,"about_ca_topic_score_gemma":0.07157432,"teacher_disagreement_score":0.063288435,"about_ca_system_score_codex":0.000629608,"about_ca_system_score_gemma":0.0003947788,"threshold_uncertainty_score":0.12584013},"labels":[],"label_agreement":null},{"id":"W3080238326","doi":"10.1007/s10549-020-05895-w","title":"Screening women at high risk for breast cancer: one program fits all?","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Mammography; Hazard ratio; Cohort; Incidence (geometry); Radiation therapy; Internal medicine; Gynecology; Cohort study; Breast cancer screening; Oncology; Cancer; Obstetrics; Confidence interval","score_opus":0.06363138168320369,"score_gpt":0.3704795236405841,"score_spread":0.3068481419573804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080238326","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017253416,0.046761956,0.002665201,0.91610104,0.0042237323,0.00012612027,0.00030517217,0.00032691273,0.012236527],"genre_scores_gemma":[0.3759474,0.15712643,0.022222206,0.40632984,0.022590816,0.00116207,0.0010098749,0.00037794106,0.01323342],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99571556,0.0018228617,0.00025561516,0.00042773204,0.001105745,0.00067243713],"domain_scores_gemma":[0.9856209,0.005058727,0.0016235732,0.00032883586,0.0020430863,0.0053247917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006721652,0.0011066656,0.0031181655,0.0018751652,0.0026461014,0.004964817,0.0019800276,0.008299722,0.013200208],"category_scores_gemma":[0.025326798,0.0006469379,0.0014589556,0.0021239049,0.0019664434,0.0062826164,0.002325884,0.007943118,0.0021003424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012704836,0.003336576,0.0717505,0.002949038,0.000918151,0.0010569084,0.00083560223,0.00044113863,0.000895928,0.008361571,0.23705576,0.67112833],"study_design_scores_gemma":[0.004509906,0.013566638,0.24565469,0.034620754,0.008066134,0.0064748214,0.025790984,0.003862795,0.0022740283,0.11642299,0.5379624,0.00079380395],"about_ca_topic_score_codex":0.005671516,"about_ca_topic_score_gemma":0.015882136,"teacher_disagreement_score":0.013200208,"about_ca_system_score_codex":0.001975571,"about_ca_system_score_gemma":0.011950762,"threshold_uncertainty_score":0.044159055},"labels":[],"label_agreement":null},{"id":"W3080892362","doi":"10.1007/s10549-020-05824-x","title":"Exercise training affects hemodynamics not cardiac function during anthracycline-based chemotherapy","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Cancer Agency; University of British Columbia; University of Alberta","funders":"BC Cancer Agency; American College of Sports Medicine","keywords":"Medicine; Anthracycline; Hemodynamics; Ejection fraction; Cardiac function curve; Cardiotoxicity; Internal medicine; Cardiology; Aerobic exercise; Cardiac output; Chemotherapy; Hematocrit; Vascular resistance; Breast cancer; Cancer; Heart failure","score_opus":0.06899440469397268,"score_gpt":0.3441263598031645,"score_spread":0.27513195510919186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080892362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894434,0.0003267082,0.00010963024,0.00005522415,0.000027279964,0.000016424308,0.000036837242,0.0000046077234,0.00047900574],"genre_scores_gemma":[0.9987704,0.0002398934,0.00009162364,0.000053894102,0.000041122767,0.000028831428,0.000064206055,0.0000023970333,0.0007075415],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989784,0.000031058622,0.0000049469427,0.000014071806,0.000009792191,0.000042204934],"domain_scores_gemma":[0.99987113,0.000028892944,0.000031084994,0.00001319995,0.000012094475,0.000043622927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001631458,0.00019747081,0.00025670545,0.00008275497,0.00012776807,0.00020422087,0.000120362485,0.00023389037,0.0012215262],"category_scores_gemma":[0.0004212154,0.00007345168,0.00013012906,0.00009261576,0.00014793407,0.0001308807,0.00013105592,0.00040062406,0.00009493997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06787112,0.0113283135,0.06770531,0.00035749457,0.0004250812,0.00041441413,0.0003730268,0.0014076489,0.73120177,0.0003080806,0.0008766201,0.11773104],"study_design_scores_gemma":[0.00045924966,0.033502907,0.9146002,0.000065039174,0.00023918536,0.00020362664,0.00018837019,0.0014435002,0.047180325,0.00016628369,0.0019329914,0.000018242767],"about_ca_topic_score_codex":0.00062878814,"about_ca_topic_score_gemma":0.0010550156,"teacher_disagreement_score":0.0012215262,"about_ca_system_score_codex":0.0001154787,"about_ca_system_score_gemma":0.0001787484,"threshold_uncertainty_score":0.004086435},"labels":[],"label_agreement":null},{"id":"W3083495364","doi":"10.1007/s10549-020-05893-y","title":"Lobular neoplasia occult on conventional imaging and diagnosed on MRI-guided biopsy: can we estimate upgrade on surgical pathology?","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sinai Health System; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Malignancy; Biopsy; Lesion; Radiology; Surgical pathology; Occult; Breast MRI; Cohort; Breast cancer; Pathology; Cancer; Mammography; Internal medicine","score_opus":0.07666782838208683,"score_gpt":0.3949243611034412,"score_spread":0.31825653272135435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083495364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.841986,0.08156884,0.010070536,0.03133837,0.0027891411,0.0001044014,0.0015708419,0.00033994557,0.030231912],"genre_scores_gemma":[0.97227234,0.013789266,0.0065884986,0.002620971,0.0023038276,0.000029371124,0.00086632057,0.000052615374,0.0014768672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895775,0.0003350609,0.0001611626,0.00014041005,0.00022050284,0.00018504365],"domain_scores_gemma":[0.99256456,0.002980706,0.0012697737,0.0004892152,0.0020944753,0.00060133764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029311548,0.0008046841,0.0012059573,0.0025283163,0.00041028045,0.0019131227,0.0014243291,0.0020835835,0.0029312843],"category_scores_gemma":[0.02331722,0.00041445458,0.0005403725,0.001470653,0.0009031013,0.0040698787,0.00077704823,0.0019595928,0.0017777365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042851397,0.000082639635,0.91940784,0.00019442136,0.00010562716,0.0014492184,0.00014878284,0.00034202874,0.0010478888,0.0006275783,0.0059119565,0.070253596],"study_design_scores_gemma":[0.00004606,0.0004598716,0.9402588,0.0010704366,0.00068781833,0.02171952,0.0022017409,0.0065408046,0.0016700659,0.0059259026,0.019320099,0.000098925615],"about_ca_topic_score_codex":0.004432915,"about_ca_topic_score_gemma":0.006178711,"teacher_disagreement_score":0.004432915,"about_ca_system_score_codex":0.0005103739,"about_ca_system_score_gemma":0.0005883878,"threshold_uncertainty_score":0.015501559},"labels":[],"label_agreement":null},{"id":"W3086503545","doi":"10.1007/s10549-020-05887-w","title":"Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG) MA.21 experience","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Queen's University; McMaster University; Health Sciences Centre; Saint John Regional Hospital; Thunder Bay Regional Health Sciences Centre; University of Ottawa","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Epirubicin; Medicine; Anthracycline; Cardiotoxicity; Breast cancer; Internal medicine; Cyclophosphamide; Ejection fraction; Dexrazoxane; Myocardial infarction; Chemotherapy; Cancer; Gastroenterology; Heart failure; Cardiology","score_opus":0.10018511868532987,"score_gpt":0.38330665242018985,"score_spread":0.28312153373486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086503545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8616504,0.060794078,0.0011305491,0.011303987,0.00041855162,0.0016111745,0.008206124,0.000085123735,0.054799948],"genre_scores_gemma":[0.96364516,0.018986905,0.0010350003,0.0042686597,0.00044409014,0.00037150868,0.0049391487,0.000042448504,0.0062671774],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99927765,0.00032838748,0.00002697626,0.00005599219,0.00019489684,0.00011619203],"domain_scores_gemma":[0.9984143,0.00037595042,0.00017731903,0.000104771796,0.00039458755,0.0005330365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034862957,0.0003440508,0.0007500513,0.00019538405,0.00062461966,0.00066188286,0.000580147,0.00040016373,0.0017117132],"category_scores_gemma":[0.0026216977,0.00009713263,0.00043426588,0.0006312519,0.00041693583,0.0002849781,0.0003010988,0.0008528807,0.00024102289],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.100012854,0.00456553,0.15631923,0.001244396,0.0013818784,0.00061990286,0.00096947944,0.0029576987,0.017342532,0.0033212702,0.06665894,0.64460635],"study_design_scores_gemma":[0.028771427,0.05597613,0.71463704,0.0006170254,0.0018762419,0.0009437522,0.0005069601,0.001058532,0.0054323776,0.0012767395,0.18881011,0.00009364083],"about_ca_topic_score_codex":0.1691205,"about_ca_topic_score_gemma":0.41936842,"teacher_disagreement_score":0.8308795,"about_ca_system_score_codex":0.0048030056,"about_ca_system_score_gemma":0.009161325,"threshold_uncertainty_score":0.33627218},"labels":[],"label_agreement":null},{"id":"W3090280703","doi":"10.1007/s10549-020-05894-x","title":"Impact of wait time from neoadjuvant chemotherapy to surgery in breast cancer: Does time to surgery affect patient outcomes?","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Surgery; Chemotherapy; Breast-conserving surgery; Neoadjuvant therapy; Confidence interval; Breast surgery; Cancer; Internal medicine","score_opus":0.02509337863301482,"score_gpt":0.32978626020928975,"score_spread":0.30469288157627494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090280703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786491,0.013983822,0.00032363657,0.0029590863,0.00024426996,0.000024906958,0.0007738034,0.0000069261414,0.0030343826],"genre_scores_gemma":[0.99686027,0.0016537342,0.0001265751,0.00036447667,0.00014073796,0.00001169763,0.00034265337,0.000007894988,0.00049192976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982351,0.00077031495,0.00017782941,0.00017959387,0.00023274735,0.00040441914],"domain_scores_gemma":[0.98530376,0.0058276183,0.005752111,0.0004939872,0.0007903403,0.0018321961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003493717,0.0002895656,0.0005685745,0.00060064404,0.00045172233,0.0013148873,0.000659902,0.0008568117,0.0042643957],"category_scores_gemma":[0.017383808,0.00020491543,0.0016412844,0.0014574738,0.0004590735,0.0013519763,0.0006619835,0.0014561609,0.00041494536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035529614,0.00027736858,0.9779483,0.00010819625,0.0008108483,0.00006645504,0.00013782232,0.0002442513,0.00017708859,0.00020754203,0.00044791514,0.01602125],"study_design_scores_gemma":[0.000057284535,0.0008987095,0.99613,0.00007840359,0.0008131881,0.00009092321,0.00035147264,0.00022817147,0.0001322564,0.0002756994,0.0009323318,0.00001163057],"about_ca_topic_score_codex":0.008483321,"about_ca_topic_score_gemma":0.013716757,"teacher_disagreement_score":0.008483321,"about_ca_system_score_codex":0.0011313629,"about_ca_system_score_gemma":0.0016458915,"threshold_uncertainty_score":0.018476725},"labels":[],"label_agreement":null},{"id":"W3093031070","doi":"10.1007/s10549-020-05960-4","title":"A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Breast cancer; Lumpectomy; Population; Cancer; Cohort; Internal medicine; Stage (stratigraphy); Cancer registry; Health care; Oncology; Gynecology; Mastectomy; Environmental health","score_opus":0.05523799174352821,"score_gpt":0.3646883773413735,"score_spread":0.30945038559784527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093031070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953891,0.00028241563,0.00004929093,0.00010255824,0.0000034142518,0.000024166715,0.003549045,0.0000033779552,0.00059667486],"genre_scores_gemma":[0.9970891,0.00017651764,0.000076920136,0.00004176101,0.0000045775587,0.000016991125,0.002376816,0.0000018324095,0.00021540346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992606,0.00006887913,0.00006496857,0.00011126685,0.0002739427,0.00022039074],"domain_scores_gemma":[0.9985739,0.00009108806,0.0006624457,0.000053414482,0.00041165427,0.0002075213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043574107,0.00033781014,0.0003311138,0.001171338,0.0010707612,0.0006109381,0.00070073083,0.00033535252,0.0014504768],"category_scores_gemma":[0.001960107,0.0002879968,0.00068876,0.0036684566,0.00041789003,0.00036945788,0.0005309504,0.0003173478,0.00012468666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062763625,0.00001520832,0.99782723,0.000020722211,0.00006654477,0.000026780803,0.00013861028,0.00008214228,0.00006852421,0.000019436626,0.00042428423,0.0012477835],"study_design_scores_gemma":[0.000005874003,0.0000136285935,0.99940145,0.0000071161576,0.000016118785,0.000026242687,0.00014968176,0.0001250973,0.000010335559,0.0000053222334,0.00023637728,0.0000028626457],"about_ca_topic_score_codex":0.9546909,"about_ca_topic_score_gemma":0.97179675,"teacher_disagreement_score":0.045309126,"about_ca_system_score_codex":0.016621524,"about_ca_system_score_gemma":0.010250744,"threshold_uncertainty_score":0.12059814},"labels":[],"label_agreement":null},{"id":"W3093782821","doi":"10.1007/s10549-020-05976-w","title":"A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Lumpectomy; Breast cancer; Trastuzumab; Stage (stratigraphy); Population; Internal medicine; Cancer; Oncology; Cancer registry; Health care; Gynecology; Mastectomy; Environmental health","score_opus":0.10140654018881648,"score_gpt":0.41887150982277555,"score_spread":0.3174649696339591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093782821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279636,0.00046611897,0.00006569941,0.00017854368,0.0000047467747,0.000030284751,0.005529478,0.000004013878,0.00092477596],"genre_scores_gemma":[0.9971143,0.00016405224,0.00007113695,0.00004200532,0.000004971251,0.000017815728,0.0024043266,0.0000015609578,0.00017969584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991592,0.00010278228,0.000071896204,0.0001264282,0.00031934446,0.00022034126],"domain_scores_gemma":[0.99867475,0.000111178175,0.0006549633,0.000047396992,0.00033308237,0.0001785652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005641505,0.0002808507,0.0003101962,0.0012334161,0.00086784706,0.0006757569,0.0006189514,0.00031226283,0.001650347],"category_scores_gemma":[0.002460403,0.00021983305,0.00073825265,0.0034710949,0.0003830719,0.00035461565,0.0005254884,0.00027590815,0.000103712795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008333839,0.000016080916,0.9971258,0.000037909584,0.00011359764,0.000028726363,0.00014459692,0.00016796715,0.0000678307,0.000035982997,0.00058095943,0.0015974243],"study_design_scores_gemma":[0.000008826164,0.000013956637,0.99933237,0.00001034145,0.000024216288,0.000023711784,0.00012278475,0.00016052056,0.000009805253,0.000008757854,0.00028183416,0.0000027549506],"about_ca_topic_score_codex":0.938063,"about_ca_topic_score_gemma":0.95561135,"teacher_disagreement_score":0.98303086,"about_ca_system_score_codex":0.016969131,"about_ca_system_score_gemma":0.009797786,"threshold_uncertainty_score":0.12460339},"labels":[],"label_agreement":null},{"id":"W3095266796","doi":"10.1007/s10549-020-06008-3","title":"COVID-19 and breast cancer at a Regional Breast Centre: our flexible approach during the pandemic","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Pandemic; Breast surgery; Cancer; General surgery; Coronavirus disease 2019 (COVID-19); Surgery; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.22772182194845397,"score_gpt":0.4578214901620437,"score_spread":0.23009966821358974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095266796","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016889997,0.010677992,0.00057298876,0.9581433,0.0035800156,0.000029922076,0.00025402833,0.000038746828,0.009812999],"genre_scores_gemma":[0.5404235,0.048307918,0.008080876,0.38045433,0.014800353,0.00020939468,0.000797396,0.00024504872,0.0066811936],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98702455,0.005918141,0.00065897236,0.00060699217,0.001582958,0.0042084074],"domain_scores_gemma":[0.960694,0.006322824,0.0032814047,0.0015373651,0.0043856646,0.023778671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017217554,0.0005400703,0.00073922484,0.001093532,0.00499552,0.009476878,0.0029000882,0.0077875555,0.010655959],"category_scores_gemma":[0.031871095,0.00054711,0.0010368954,0.0014257446,0.005572358,0.0068982756,0.01586586,0.014034987,0.0012495993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085767044,0.0006239548,0.14476039,0.0013707835,0.00033427976,0.0043822466,0.020084841,0.0020688237,0.0024750272,0.059151378,0.52401584,0.23987485],"study_design_scores_gemma":[0.00013680189,0.00067345885,0.096602455,0.0045788367,0.00019476058,0.0023801052,0.09235454,0.00085619546,0.0008067041,0.034699455,0.7663142,0.00040241878],"about_ca_topic_score_codex":0.048892636,"about_ca_topic_score_gemma":0.09012583,"teacher_disagreement_score":0.048892636,"about_ca_system_score_codex":0.013006036,"about_ca_system_score_gemma":0.035210934,"threshold_uncertainty_score":0.09721613},"labels":[],"label_agreement":null},{"id":"W3095303989","doi":"10.1007/s10549-020-05989-5","title":"Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Estrogen receptor; Oncology; Chemotherapy; Cancer; Logistic regression; Stage (stratigraphy); Estrogen; Cohort; Pathological; Prospective cohort study; Gynecology; Gastroenterology; Biology","score_opus":0.017519189565547936,"score_gpt":0.2950526082072244,"score_spread":0.27753341864167647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095303989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849343,0.00072662614,0.000026595382,0.000055558885,0.000009632642,0.000004509741,0.00011040135,0.0000013813545,0.0005718576],"genre_scores_gemma":[0.9992136,0.00024135267,0.000026933398,0.000043578777,0.000011657186,0.000005055909,0.00014591502,0.0000010392226,0.00031090944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998264,0.00007462922,0.000016407737,0.000017876386,0.00002650888,0.000038298476],"domain_scores_gemma":[0.99878913,0.00056793605,0.0003167912,0.000028048014,0.00005711785,0.00024093791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038914953,0.00012611931,0.00028037585,0.0004560041,0.00018141828,0.0002547476,0.00011094425,0.00040796885,0.000872107],"category_scores_gemma":[0.0025086745,0.00014472251,0.00028169708,0.0003681363,0.00014571674,0.00024456697,0.00014598196,0.00038280667,0.00016679442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007415048,0.00007081496,0.9970925,0.000008200148,0.000026118512,0.00013370579,0.00005696239,0.000032559958,0.0004421457,0.000007651123,0.000034536326,0.001353302],"study_design_scores_gemma":[0.00000797671,0.00034009787,0.9990169,0.0000036995445,0.00002668068,0.00023663249,0.00009135035,0.000058654157,0.00010656141,0.000009237362,0.00009979654,0.0000024403316],"about_ca_topic_score_codex":0.002757756,"about_ca_topic_score_gemma":0.0042469036,"teacher_disagreement_score":0.002757756,"about_ca_system_score_codex":0.00023391159,"about_ca_system_score_gemma":0.00026132283,"threshold_uncertainty_score":0.0054833293},"labels":[],"label_agreement":null},{"id":"W3095982111","doi":"10.1007/s10549-020-05965-z","title":"Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Cancer registry; Cohort; Population; Cancer; Odds ratio; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.028412639469136563,"score_gpt":0.32066533674966496,"score_spread":0.2922526972805284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095982111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867753,0.0022432976,0.00012891568,0.0013870009,0.00006130333,0.000037958183,0.0063241874,0.000016107093,0.003026044],"genre_scores_gemma":[0.99601316,0.00084446196,0.00008205669,0.0002682432,0.000015295227,0.000010714604,0.0011099037,0.000011907937,0.0016442821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986951,0.00012054168,0.00007394019,0.00024357055,0.00025778564,0.00060921075],"domain_scores_gemma":[0.9973272,0.00012177301,0.0007079959,0.00017623059,0.0008728262,0.0007940173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067577104,0.000444833,0.0007168323,0.0012713798,0.0025816874,0.0022751573,0.0016813563,0.0016616716,0.00398029],"category_scores_gemma":[0.002226497,0.00071994384,0.0011203971,0.005619152,0.000707578,0.00074460136,0.0011407036,0.0018769653,0.00054118026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012226995,0.00003080315,0.996588,0.000010412063,0.00012890964,0.00011427875,0.0003682174,0.00004789078,0.00010028717,0.00013830511,0.0011252462,0.0012254756],"study_design_scores_gemma":[0.000011922819,0.000016930879,0.99698406,0.00002518898,0.00006671866,0.0001068101,0.00145949,0.00014355076,0.000032012482,0.000044195767,0.0010928105,0.000016320202],"about_ca_topic_score_codex":0.98410565,"about_ca_topic_score_gemma":0.9875119,"teacher_disagreement_score":0.9896218,"about_ca_system_score_codex":0.010378196,"about_ca_system_score_gemma":0.02188827,"threshold_uncertainty_score":0.07529944},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high"}],"label_agreement":"agree"},{"id":"W3096017934","doi":"10.1007/s10549-020-06009-2","title":"A scoping review characterizing \"Choosing Wisely®\" recommendations for breast cancer management","year":2020,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Regional Cancer Foundation; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Psychological intervention; Breast cancer; MEDLINE; Modalities; Family medicine; Systematic review; Mammography; Inclusion (mineral); Data extraction; Health care; Cancer; Nursing; Psychology; Internal medicine; Political science","score_opus":0.8474534319292549,"score_gpt":0.6897045344676153,"score_spread":0.15774889746163967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096017934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073859334,0.9848214,0.0006239856,0.0082374085,0.0018253621,0.0009469944,0.0006103911,0.00002655554,0.002169338],"genre_scores_gemma":[0.006332183,0.98209226,0.003649529,0.0055306912,0.00039609653,0.0010639945,0.00040464022,0.00001585999,0.0005148003],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96691453,0.015053824,0.010891344,0.0011617815,0.0052661523,0.000712437],"domain_scores_gemma":[0.91743314,0.055719167,0.013263905,0.0012661155,0.011248967,0.0010687093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03778899,0.0017571201,0.005847648,0.01436002,0.0013981655,0.006438795,0.0023907197,0.0036405192,0.008032355],"category_scores_gemma":[0.15297276,0.001798328,0.007391481,0.013925716,0.0015100425,0.005145925,0.0035134796,0.0041663907,0.0011391216],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020260544,0.00006116443,0.0009993773,0.6209411,0.0053598136,0.000081947175,0.0008670564,0.00017273679,0.000189982,0.0021100398,0.027844049,0.34117007],"study_design_scores_gemma":[0.00013507169,0.0000623747,0.00094995846,0.94039583,0.009853477,0.00006322918,0.00039774814,0.0000620346,0.00006900932,0.0008455215,0.047140867,0.000024910543],"about_ca_topic_score_codex":0.021426976,"about_ca_topic_score_gemma":0.07397135,"teacher_disagreement_score":0.03778899,"about_ca_system_score_codex":0.00952855,"about_ca_system_score_gemma":0.038564302,"threshold_uncertainty_score":0.19984967},"labels":[],"label_agreement":null},{"id":"W3096577467","doi":"10.1007/s10549-020-06003-8","title":"International variation in breast cancer incidence and mortality in young women","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Incidence (geometry); Cancer; Demography; Mortality rate; Gynecology; Oncology; Internal medicine","score_opus":0.11200113058241642,"score_gpt":0.4217091629548931,"score_spread":0.3097080323724767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096577467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415934,0.0016373298,0.00031523252,0.00016787743,0.000032172364,0.000007453605,0.0012633284,0.000017369697,0.0023998707],"genre_scores_gemma":[0.9985764,0.00036357637,0.00007964473,0.000027483666,0.000014624193,0.000004468548,0.00058387755,0.0000071662753,0.0003427271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940157,0.0001895807,0.00007852116,0.00016108023,0.00007932893,0.00008985254],"domain_scores_gemma":[0.99790704,0.00066319125,0.0006541728,0.00023888482,0.0002952223,0.00024151178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088221626,0.00013831566,0.00028105135,0.0012980526,0.0002186134,0.00046386936,0.000250187,0.00032854543,0.0011830206],"category_scores_gemma":[0.0027710274,0.00019176946,0.0005803934,0.0021438755,0.00022096843,0.0003587168,0.00040305444,0.00032048856,0.00022592997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007597376,0.000007917743,0.99552804,0.000017018354,0.00011189424,0.000036345486,0.0003632998,0.00008041305,0.00024184096,0.00007878248,0.00020663494,0.0032519042],"study_design_scores_gemma":[7.174212e-7,0.000010708701,0.99951506,0.000003539619,0.000011787371,0.000045305136,0.00016407143,0.000041340827,0.00001660139,0.000018191377,0.00017126735,0.0000015363129],"about_ca_topic_score_codex":0.012954525,"about_ca_topic_score_gemma":0.019130357,"teacher_disagreement_score":0.012954525,"about_ca_system_score_codex":0.00030429807,"about_ca_system_score_gemma":0.00023253092,"threshold_uncertainty_score":0.025758266},"labels":[],"label_agreement":null},{"id":"W3101982531","doi":"10.1007/s10549-020-05992-w","title":"The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Anxiety; Psychosocial; Distress; Cancer; Stage (stratigraphy); Quality of life (healthcare); Internal medicine; Obstetrics; Clinical psychology; Psychiatry","score_opus":0.06081328957557633,"score_gpt":0.3407832175920043,"score_spread":0.27996992801642795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101982531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845517,0.00031225517,0.000054067797,0.00016555794,0.000015108784,0.0000035322391,0.00022488688,0.0000027758435,0.00076668983],"genre_scores_gemma":[0.9995047,0.00008792486,0.00002993065,0.000021446805,0.000017946399,0.000002442187,0.00013390751,8.5388416e-7,0.00020070998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996785,0.00014353803,0.000028082792,0.000031129493,0.00004275634,0.00007594432],"domain_scores_gemma":[0.99758995,0.0011331128,0.0006046053,0.00008907355,0.00013852434,0.00044475525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060410454,0.0003170986,0.00020777788,0.00059569086,0.0003360712,0.00066845986,0.00030735458,0.00052113633,0.0023890145],"category_scores_gemma":[0.0049538137,0.00022091724,0.00061871455,0.00044677616,0.00030789507,0.00037966986,0.00054169266,0.0010733912,0.00019537957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009421218,0.00004160062,0.99885845,0.000004216156,0.000044122135,0.000031034506,0.000024971907,0.00004613833,0.000047834143,0.000009513604,0.0000328927,0.0007650329],"study_design_scores_gemma":[0.0000031448383,0.00004284518,0.99947304,0.0000022761228,0.00002327862,0.00007993556,0.00011360235,0.0001826995,0.000014165836,0.000028070406,0.000035093228,0.0000017975556],"about_ca_topic_score_codex":0.003971645,"about_ca_topic_score_gemma":0.0053122328,"teacher_disagreement_score":0.003971645,"about_ca_system_score_codex":0.0002438605,"about_ca_system_score_gemma":0.0002878933,"threshold_uncertainty_score":0.007992029},"labels":[],"label_agreement":null},{"id":"W3106369591","doi":"10.1007/s10549-020-06012-7","title":"Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Breast cancer; Mastectomy; Breast-conserving surgery; Proportional hazards model; Cancer; Neoadjuvant therapy; Surgery; Chemotherapy; Internal medicine; Oncology","score_opus":0.04016864036281586,"score_gpt":0.29565337636344946,"score_spread":0.2554847360006336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106369591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979114,0.0007434158,0.000028664948,0.000093643575,0.000015317277,0.0000065002755,0.00026551797,0.0000013140482,0.0009341448],"genre_scores_gemma":[0.9984888,0.00037353553,0.00003576163,0.00007717149,0.000022552944,0.000011707189,0.0002697532,0.0000018594347,0.0007188453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979526,0.000047725738,0.000020116207,0.000041974825,0.000024290479,0.00007055668],"domain_scores_gemma":[0.99915874,0.00027326017,0.0003146918,0.00003652336,0.000047825666,0.00016894529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002443001,0.00013601947,0.00026681423,0.0004784033,0.00037510696,0.00042473254,0.00020367191,0.0004631105,0.0023030983],"category_scores_gemma":[0.0019903432,0.0001950423,0.00043503405,0.000748648,0.00016170392,0.0004340827,0.0002389339,0.00067234196,0.0001964801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001319353,0.00012409083,0.9954372,0.000015421416,0.000044992463,0.000106391635,0.00011693419,0.000026141808,0.00031698673,0.00002965556,0.000095066454,0.0023678022],"study_design_scores_gemma":[0.000022463599,0.00036160627,0.9983191,0.000007017813,0.0000689326,0.00017051955,0.0004924838,0.00006751949,0.00007841135,0.000033784112,0.0003729195,0.0000051963602],"about_ca_topic_score_codex":0.009644477,"about_ca_topic_score_gemma":0.01059096,"teacher_disagreement_score":0.009644477,"about_ca_system_score_codex":0.00044515668,"about_ca_system_score_gemma":0.00051497994,"threshold_uncertainty_score":0.019176662},"labels":[],"label_agreement":null},{"id":"W3110381708","doi":"10.1007/s10549-020-06027-0","title":"Tumor phenotype and concordance in synchronous bilateral breast cancer in young women","year":2020,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Breast cancer; Medicine; Concordance; Internal medicine; Cancer; Oncology; Cohort; Incidence (geometry); Prospective cohort study; Mastectomy; Male breast cancer; Disease; Gynecology","score_opus":0.02084120853245856,"score_gpt":0.3133351964906339,"score_spread":0.2924939879581753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110381708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994554,0.000107979096,0.000029721648,0.000008243697,0.0000013091726,0.0000012730413,0.000044015742,0.0000012767047,0.00035074644],"genre_scores_gemma":[0.99972075,0.00007083295,0.000025231806,0.0000041321127,0.0000023592415,0.0000013507539,0.00004796959,0.0000017943952,0.00012563878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997954,0.00007462085,0.000017673841,0.000035471632,0.00003830317,0.000038662318],"domain_scores_gemma":[0.9990048,0.0003004278,0.00034785568,0.000056688623,0.00007753664,0.0002126759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026157536,0.000107568754,0.00022382937,0.000956617,0.0003218149,0.000431409,0.0001363198,0.00020882933,0.0015063336],"category_scores_gemma":[0.002395616,0.000155623,0.000115030074,0.0005918375,0.0002332637,0.00024227233,0.00037549122,0.00018608075,0.00023285727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036438383,0.000027618738,0.9919634,0.000012017375,0.000009302786,0.0007525422,0.00036835944,0.000026534402,0.004441312,0.00003469575,0.000025212152,0.0019746998],"study_design_scores_gemma":[0.0000023416274,0.000096393276,0.9967134,0.0000020966763,0.0000072312464,0.0021189197,0.00041665928,0.000038871818,0.0004876844,0.00002589572,0.000088677414,0.0000018135222],"about_ca_topic_score_codex":0.0024978705,"about_ca_topic_score_gemma":0.0029646875,"teacher_disagreement_score":0.0024978705,"about_ca_system_score_codex":0.00016556213,"about_ca_system_score_gemma":0.00022349092,"threshold_uncertainty_score":0.0050391555},"labels":[],"label_agreement":null},{"id":"W3118628217","doi":"10.1007/s10549-020-06037-y","title":"N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"Alberta Cancer Foundation","keywords":"Breast cancer; Immunohistochemistry; Cancer; Cancer research; Biology; Apoptosis; In vivo; Pathology; Internal medicine; Oncology; Medicine; Immunology; Biochemistry","score_opus":0.02081469150852863,"score_gpt":0.3168684897439837,"score_spread":0.2960537982354551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118628217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96370435,0.03251433,0.0011592109,0.0006547238,0.00005371182,0.00005537276,0.00031313475,0.00006832956,0.001476776],"genre_scores_gemma":[0.9898431,0.006996638,0.0017618189,0.00009669095,0.00004249692,0.00003358956,0.00056881673,0.000006868997,0.00065009686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985325,0.000041115163,0.000011756248,0.000027131366,0.00004685475,0.00001981648],"domain_scores_gemma":[0.9997532,0.00005913057,0.000064288666,0.000023447235,0.00005866851,0.000041322015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010134696,0.00029491918,0.00032365302,0.00037585472,0.00017182628,0.000494442,0.00021359429,0.00032076123,0.0010361949],"category_scores_gemma":[0.0004980761,0.000114210125,0.00018746521,0.00037459415,0.0002915568,0.0002421033,0.00022390364,0.0004890849,0.00027980466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008713068,0.00045854037,0.15276629,0.00083685905,0.00022164041,0.00042035655,0.00010981469,0.001312597,0.70226675,0.00047930103,0.0016917397,0.13072297],"study_design_scores_gemma":[0.00083439326,0.00794773,0.4249736,0.00016396273,0.0007792933,0.007354424,0.0001968865,0.012586318,0.5052926,0.0005242831,0.039312236,0.000034373803],"about_ca_topic_score_codex":0.00050935504,"about_ca_topic_score_gemma":0.00090596,"teacher_disagreement_score":0.0010361949,"about_ca_system_score_codex":0.0005818143,"about_ca_system_score_gemma":0.0004690849,"threshold_uncertainty_score":0.0053598285},"labels":[],"label_agreement":null},{"id":"W3119592225","doi":"10.1007/s10549-020-06030-5","title":"A clinical calculator to predict disease outcomes in women with triple-negative breast cancer","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Center for Research Resources; Breast Cancer Research Foundation","keywords":"Medicine; Triple-negative breast cancer; Breast cancer; Internal medicine; Oncology; Anthracycline; Nomogram; Cancer; Mastectomy","score_opus":0.09590931085154607,"score_gpt":0.4649260142349547,"score_spread":0.36901670338340864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119592225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003713276,0.99840695,0.0003081768,0.00028724308,0.00015250404,0.000020293846,0.00008530977,0.000013329786,0.0003548352],"genre_scores_gemma":[0.005057826,0.99163765,0.0016548702,0.0006748487,0.00028382818,0.000065119806,0.00025509298,0.0000043294854,0.00036651958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993413,0.00021996422,0.00013029789,0.00009100007,0.00018558596,0.000031778487],"domain_scores_gemma":[0.9980743,0.001248886,0.00031725384,0.000033001026,0.00027803582,0.000048564467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017646562,0.0011675517,0.0031325684,0.0022951083,0.00019888973,0.0013576392,0.0010668219,0.0011349141,0.001962531],"category_scores_gemma":[0.0042708437,0.0003560657,0.0016968935,0.0020242077,0.00033955564,0.0007941785,0.00059876323,0.002431047,0.0006931152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004723045,0.00017209294,0.0029405772,0.021823078,0.0015037789,0.00008149486,0.000030001593,0.00040215335,0.0003337894,0.0013952983,0.014973977,0.9558715],"study_design_scores_gemma":[0.0024012886,0.0018298023,0.062444653,0.099864095,0.025652902,0.0032485358,0.0003680354,0.0051666414,0.003123288,0.012185897,0.78331774,0.0003971821],"about_ca_topic_score_codex":0.0022676447,"about_ca_topic_score_gemma":0.0035208743,"teacher_disagreement_score":0.0031325684,"about_ca_system_score_codex":0.0006146093,"about_ca_system_score_gemma":0.0013173668,"threshold_uncertainty_score":0.009332478},"labels":[],"label_agreement":null},{"id":"W3120002718","doi":"10.1007/s10549-020-06057-8","title":"Association between radiologists’ and facilities’ characteristics and mammography screening detection of ductal carcinoma in situ","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise; Université Laval; Institut National de Santé Publique du Québec","funders":"","keywords":"Medicine; Ductal carcinoma; Confidence interval; Mammography; Odds ratio; Breast cancer; Logistic regression; Radiology; Cancer detection; Cohort; Oncology; Internal medicine; Cancer","score_opus":0.040079363152228945,"score_gpt":0.31295954963310496,"score_spread":0.27288018648087603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120002718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977003,0.00032744347,0.0001547585,0.0002462272,0.000016411805,0.00000477582,0.00044963046,0.000010369488,0.0010900834],"genre_scores_gemma":[0.9995647,0.000037017657,0.00007647412,0.000026118876,0.000019110163,0.0000030905278,0.00014300089,0.00000343493,0.00012703026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958704,0.0015365122,0.0007398629,0.00060318044,0.0005893407,0.0006607549],"domain_scores_gemma":[0.949904,0.023326142,0.018330466,0.0021367702,0.0027570177,0.0035456577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026292482,0.00026045323,0.0003825978,0.002045795,0.00048524787,0.0012271665,0.00089721626,0.001304008,0.004909334],"category_scores_gemma":[0.026337465,0.00044857615,0.0010317276,0.0025782406,0.00061565754,0.0009402968,0.0008742798,0.0011882383,0.00044322078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008598542,0.000017714183,0.9992261,0.0000043032746,0.000053284322,0.000034686494,0.00003155017,0.000041739466,0.00005082617,0.000011733266,0.00005499777,0.00038705455],"study_design_scores_gemma":[0.0000056127087,0.00007991221,0.9987153,0.000006423831,0.000049966504,0.00026641876,0.00038474018,0.0002855477,0.00004081664,0.000028749746,0.00012911804,0.000007236186],"about_ca_topic_score_codex":0.009599433,"about_ca_topic_score_gemma":0.009825911,"teacher_disagreement_score":0.009599433,"about_ca_system_score_codex":0.0008842945,"about_ca_system_score_gemma":0.0014578694,"threshold_uncertainty_score":0.019087136},"labels":[],"label_agreement":null},{"id":"W3120020809","doi":"10.1007/s10549-020-06048-9","title":"HER2 fluorescent in situ hybridization signal degradation: a 10-year retrospective study","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"In situ hybridization; In situ; Fluorescence in situ hybridization; Breast cancer; Degradation (telecommunications); Fluorescence; Medicine; Retrospective cohort study; Biology; Pathology; Internal medicine; Chemistry; Genetics; Cancer; Computer science; Telecommunications; Chromosome; Optics; Physics; Gene expression","score_opus":0.07400740665816091,"score_gpt":0.40829915614598367,"score_spread":0.33429174948782275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120020809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838257,0.000429079,0.0003689834,0.000015113277,0.000005133518,0.000009738472,0.00018870953,0.0000046770465,0.00059604796],"genre_scores_gemma":[0.9984085,0.0002907897,0.00009218738,0.000029648754,0.000009656784,0.0000100001635,0.000460784,0.0000069452335,0.0006915248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993069,0.00011900221,0.000083247614,0.00021613596,0.00010488296,0.00016984681],"domain_scores_gemma":[0.9983423,0.0003226178,0.0004207408,0.00028085013,0.0003949077,0.00023867491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095731264,0.0004796798,0.00050363864,0.0013824281,0.0009520289,0.0008751075,0.00037071639,0.00070072315,0.0017369541],"category_scores_gemma":[0.0013852636,0.00056287966,0.0007850762,0.0012558952,0.0006970074,0.0006547655,0.00048906513,0.00056432013,0.0008772279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005364506,0.00014817563,0.98928773,0.000017397168,0.00006632496,0.0028083138,0.00037904014,0.00007256665,0.002414364,0.00004121644,0.000114505405,0.0041139037],"study_design_scores_gemma":[0.000017012992,0.0009643821,0.9844061,0.000010836982,0.00021467575,0.009845487,0.0009665408,0.00020707652,0.001487812,0.000053209147,0.0018034884,0.000023366754],"about_ca_topic_score_codex":0.00435221,"about_ca_topic_score_gemma":0.002972359,"teacher_disagreement_score":0.00435221,"about_ca_system_score_codex":0.00054994866,"about_ca_system_score_gemma":0.00050774496,"threshold_uncertainty_score":0.00865376},"labels":[],"label_agreement":null},{"id":"W3120827443","doi":"10.1007/s10549-020-06072-9","title":"Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Public Health Ontario; Women's College Hospital; University Health Network; University of Toronto; McGill University; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oncology; Cancer; Mutation; BRCA2 Protein; Gynecology; Internal medicine; Biology; Germline mutation; Genetics; Gene","score_opus":0.018107810407866416,"score_gpt":0.32715585689404486,"score_spread":0.30904804648617845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120827443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975694,0.0004999518,0.00003443094,0.00009654343,0.000019444135,0.000004517545,0.0004969111,0.000004982269,0.0012736929],"genre_scores_gemma":[0.99706703,0.0003475508,0.000021017,0.00005522597,0.000029149818,0.0000051189363,0.0005178761,0.000003447498,0.0019535422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978036,0.000025715735,0.000011558779,0.00004446774,0.00002600403,0.0001119152],"domain_scores_gemma":[0.99933076,0.00012329251,0.00016849002,0.000028537008,0.000050713734,0.00029829604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030452994,0.0003303596,0.0005057949,0.0012143522,0.0007264664,0.00078449806,0.00030173536,0.0009335788,0.0040423255],"category_scores_gemma":[0.0014243326,0.00035338805,0.00065312895,0.00091702945,0.00024086713,0.00069584657,0.0006254045,0.0007908748,0.0008087206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007591652,0.0001059258,0.995492,0.000007888581,0.00004492441,0.00032756422,0.00018470897,0.00003843746,0.00031097242,0.00005148286,0.0002444785,0.0024325603],"study_design_scores_gemma":[0.0000115665935,0.00015126834,0.9986089,0.0000052374926,0.00004428477,0.0002994205,0.00043537767,0.000065309665,0.000037147158,0.00006718935,0.0002690141,0.0000053388267],"about_ca_topic_score_codex":0.016220126,"about_ca_topic_score_gemma":0.011536161,"teacher_disagreement_score":0.016220126,"about_ca_system_score_codex":0.0002636912,"about_ca_system_score_gemma":0.0003238246,"threshold_uncertainty_score":0.032251418},"labels":[],"label_agreement":null},{"id":"W3121812824","doi":"10.1007/s10549-020-06086-3","title":"Can we rely on surgical clips placed during oncoplastic breast surgery to accurately delineate the tumor bed for targeted breast radiotherapy?","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Carleton University","funders":"Ministry of National Guard Health Affairs","keywords":"CLIPS; Medicine; Oncoplastic Surgery; Quadrant (abdomen); Breast surgery; Breast cancer; Breast-conserving surgery; Radiology; Surgical margin; Surgery; Mastectomy; Nuclear medicine; Resection; Cancer; Internal medicine","score_opus":0.05650922758596673,"score_gpt":0.35612650057162554,"score_spread":0.2996172729856588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121812824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51938874,0.13922842,0.2545138,0.029362831,0.015063602,0.00034828644,0.0011827562,0.0024641037,0.03844743],"genre_scores_gemma":[0.68845797,0.042177554,0.2487328,0.00869804,0.004415866,0.0001541904,0.00081157876,0.0008531903,0.005698716],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990125,0.00031385873,0.00009284311,0.00015194698,0.00029378795,0.00013503879],"domain_scores_gemma":[0.98935366,0.0049773944,0.001744851,0.0017543115,0.001678511,0.00049125304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039021573,0.0006338285,0.0010089407,0.0009799172,0.00049412803,0.0023365614,0.0011114521,0.0016612301,0.0035326032],"category_scores_gemma":[0.02072529,0.00059582,0.000587464,0.0007335543,0.0011943551,0.0031688276,0.0005975042,0.0017946981,0.0022982091],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033376273,0.00031118607,0.16379988,0.001588002,0.00049717247,0.0046905605,0.0007956606,0.0033470269,0.09460295,0.0029977532,0.017295273,0.70673686],"study_design_scores_gemma":[0.00063563057,0.004837133,0.45178616,0.0027789308,0.0028539768,0.08303741,0.005636576,0.028870376,0.15977055,0.021809781,0.23691265,0.0010708544],"about_ca_topic_score_codex":0.0039544813,"about_ca_topic_score_gemma":0.008252387,"teacher_disagreement_score":0.0039544813,"about_ca_system_score_codex":0.00036707494,"about_ca_system_score_gemma":0.0010292395,"threshold_uncertainty_score":0.020636797},"labels":[],"label_agreement":null},{"id":"W3125432354","doi":"10.1007/s10549-020-06051-0","title":"Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Interquartile range; Cancer; Population; Disease; Breast disease; Internal medicine; Pediatrics","score_opus":0.06717089342758882,"score_gpt":0.33530551983035356,"score_spread":0.26813462640276475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125432354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282116,0.0006650706,0.00009962648,0.00044189574,0.00002142117,0.00004595959,0.0035857926,0.000009562678,0.0023095638],"genre_scores_gemma":[0.9970693,0.00042250243,0.0001273069,0.00016676678,0.000010416971,0.000021264244,0.0012025074,0.0000067587844,0.00097328395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990759,0.00006940123,0.00008503858,0.00016079724,0.00027363698,0.00033520372],"domain_scores_gemma":[0.9972434,0.00019400194,0.0006195263,0.00009522769,0.0010624334,0.00078545994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004815914,0.00043008558,0.00058734446,0.0012278645,0.0034716127,0.0016755308,0.001636476,0.0008747301,0.0027006483],"category_scores_gemma":[0.001965432,0.00072828116,0.0009945239,0.0051795435,0.0008955896,0.0005492857,0.00083716575,0.0011292568,0.0002881459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005831566,0.000037650127,0.99708,0.000022464814,0.000046516092,0.00008019758,0.00077850965,0.00004184247,0.000121946745,0.000058525035,0.0008293102,0.0008446151],"study_design_scores_gemma":[0.000009686689,0.000017215458,0.9977252,0.000023593906,0.000030019768,0.000049356782,0.001524843,0.00012692352,0.000019184565,0.000015078673,0.0004492369,0.000009722774],"about_ca_topic_score_codex":0.993638,"about_ca_topic_score_gemma":0.99653256,"teacher_disagreement_score":0.024372434,"about_ca_system_score_codex":0.024372434,"about_ca_system_score_gemma":0.02925186,"threshold_uncertainty_score":0.17683524},"labels":[],"label_agreement":null},{"id":"W3125885873","doi":"10.1007/s10549-020-06093-4","title":"Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Artificial Intelligence in Medicine (Canada); York University; University of Toronto","funders":"Social Sciences and Humanities Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Terry Fox Research Institute","keywords":"Breast cancer; Medicine; Pathological; Univariate analysis; Logistic regression; Oncology; Cancer; Multivariate analysis; Stage (stratigraphy); Chemotherapy; Internal medicine; Radiology; Biology","score_opus":0.024580081631910885,"score_gpt":0.3407335780916868,"score_spread":0.3161534964597759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125885873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782807,0.00019209401,0.0013054751,0.00006350545,0.000007656754,0.0000069603993,0.00011577997,0.00001328828,0.0004671864],"genre_scores_gemma":[0.9991985,0.000043445416,0.00050530606,0.0000081234275,0.0000054675966,0.0000038133737,0.00015870015,0.000001147129,0.000075388285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985874,0.00005656975,0.00001733386,0.000021734688,0.000027316837,0.000018380384],"domain_scores_gemma":[0.99919087,0.0005465099,0.00012116548,0.000027189417,0.000069264475,0.000044956378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039098965,0.00020642228,0.00028179243,0.00063438906,0.00012923872,0.00048166577,0.00014871066,0.00022462594,0.00048501664],"category_scores_gemma":[0.0017077837,0.000078342506,0.00028330693,0.00034958238,0.0001380137,0.00016398034,0.00014536412,0.00021827036,0.00008444901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017874234,0.00024366379,0.91158783,0.00004906301,0.0002017637,0.00018789398,0.00008543897,0.014315987,0.0068420675,0.00013111548,0.0003568865,0.06421087],"study_design_scores_gemma":[0.000057924757,0.0009403116,0.74678236,0.000026268879,0.0003565037,0.000611939,0.00031862204,0.24431472,0.0052651237,0.0005526326,0.00074561656,0.000027904414],"about_ca_topic_score_codex":0.0011211502,"about_ca_topic_score_gemma":0.0013759296,"teacher_disagreement_score":0.0011211502,"about_ca_system_score_codex":0.00018378808,"about_ca_system_score_gemma":0.0001576111,"threshold_uncertainty_score":0.0022292733},"labels":[],"label_agreement":null},{"id":"W3130005770","doi":"10.1007/s10549-021-06109-7","title":"The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; National Institute for Health and Care Research; Pfizer","keywords":"Trastuzumab; Medicine; Enzalutamide; Internal medicine; Oncology; Metastatic breast cancer; Breast cancer; Response Evaluation Criteria in Solid Tumors; Regimen; Adverse effect; Androgen receptor; Cancer; Clinical endpoint; Progressive disease; Phases of clinical research; Prostate cancer; Clinical trial; Chemotherapy","score_opus":0.027840409809214116,"score_gpt":0.35712052906739994,"score_spread":0.32928011925818584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130005770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971795,0.0018450352,0.000119755816,0.00007321043,0.000010652384,0.00010279662,0.000073109535,0.00001716129,0.00057879626],"genre_scores_gemma":[0.9986449,0.00047526567,0.00019434872,0.00008871827,0.000024871937,0.00006505187,0.0001807543,0.0000029990972,0.00032303797],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978167,0.000098958786,0.000021156868,0.000031789277,0.00003928594,0.000027026903],"domain_scores_gemma":[0.99977857,0.000042693144,0.00008336891,0.000010958945,0.000012319169,0.00007211373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005477953,0.00043467732,0.0006825412,0.00017197529,0.00015531997,0.00041216976,0.0002497242,0.000270944,0.0008873335],"category_scores_gemma":[0.0006698511,0.00017646089,0.00038142514,0.00018057314,0.00028751668,0.00026743565,0.00018737209,0.0006589376,0.0001864363],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37910008,0.027474025,0.08519543,0.00088402245,0.001507783,0.00078510965,0.00037379033,0.0045598517,0.08368606,0.00014957125,0.002472648,0.4138116],"study_design_scores_gemma":[0.16717264,0.5177001,0.27949372,0.00013110063,0.0011353602,0.0023654117,0.0001228973,0.0052018617,0.016957242,0.00025518468,0.0094170775,0.00004735709],"about_ca_topic_score_codex":0.00048946805,"about_ca_topic_score_gemma":0.0014560645,"teacher_disagreement_score":0.0008873335,"about_ca_system_score_codex":0.00057081436,"about_ca_system_score_gemma":0.0005604973,"threshold_uncertainty_score":0.0041416287},"labels":[],"label_agreement":null},{"id":"W3132043293","doi":"10.1007/s10549-021-06110-0","title":"Impact of sequence order of anthracyclines and taxanes in neoadjuvant chemotherapy on pathologic complete response rate in HER2-negative breast cancer patients","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Internal medicine; Oncology; Clinical endpoint; Chemotherapy; Cancer; Neoadjuvant therapy; Cohort; Triple-negative breast cancer; Clinical trial","score_opus":0.04926383731731095,"score_gpt":0.3944026748608143,"score_spread":0.3451388375435034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132043293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986436,0.0007535924,0.00004551449,0.000057951584,0.000015565167,0.000008968508,0.00007560099,0.0000019998206,0.0003972477],"genre_scores_gemma":[0.99909997,0.0002456036,0.00008893926,0.000043306158,0.000017616601,0.000008908794,0.00015397546,0.000002988521,0.0003386433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943966,0.00029898479,0.00006369883,0.000063028085,0.000070496346,0.00006407145],"domain_scores_gemma":[0.9983909,0.00089063024,0.00026090082,0.000107225336,0.00008086294,0.00026951666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011370914,0.00014436444,0.0004579437,0.00018234401,0.00013415086,0.00034698076,0.00013484007,0.0002460526,0.0013754587],"category_scores_gemma":[0.0023388804,0.00009660039,0.00047941695,0.00017530707,0.00014932264,0.00036104425,0.00013286051,0.00039138566,0.00016693698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19060984,0.0027191504,0.68263286,0.0001911025,0.00083180645,0.00026613288,0.00021659583,0.004582717,0.0278209,0.00022443669,0.0005664254,0.089338034],"study_design_scores_gemma":[0.0015148299,0.05058326,0.93227154,0.000055145403,0.0009938102,0.0005185486,0.00030234817,0.003242929,0.007643673,0.00027298732,0.002574566,0.000026361153],"about_ca_topic_score_codex":0.00073625275,"about_ca_topic_score_gemma":0.0018508276,"teacher_disagreement_score":0.0013754587,"about_ca_system_score_codex":0.00038882595,"about_ca_system_score_gemma":0.0005689619,"threshold_uncertainty_score":0.006013572},"labels":[],"label_agreement":null},{"id":"W31325071","doi":"10.1007/s10549-019-05364-z","title":"REMOTE SENSING (LIDAR) FOR MANAGEMENT OF HIGHWAY ASSETS FOR SAFETY","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Traffic and Road Safety","field":"Engineering","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society Research Institute","keywords":"Lidar; Sight; Intersection (aeronautics); Crash; Identification (biology); Transport engineering; Computer science; Engineering; Remote sensing; Geography","score_opus":0.04031553278173334,"score_gpt":0.3242415377514173,"score_spread":0.28392600496968395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31325071","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15418878,0.0058749905,0.5820406,0.015998561,0.0015932518,0.0010594414,0.01620718,0.0125115635,0.21052563],"genre_scores_gemma":[0.6442602,0.0027052418,0.3077855,0.0018856466,0.00041803054,0.0004212405,0.0053952727,0.00042516098,0.036703743],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996413,0.000089938396,0.000013186086,0.00004086696,0.00017914879,0.000035530655],"domain_scores_gemma":[0.99938405,0.00010578049,0.000064316,0.00009243248,0.00032181657,0.000031579784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058099115,0.00047222225,0.00032198432,0.0014506612,0.0007080653,0.00074741343,0.0007604782,0.00074803864,0.017883169],"category_scores_gemma":[0.00096931314,0.00019226637,0.00033964985,0.0010235207,0.00015311148,0.001045997,0.0008787132,0.00059976534,0.0060823546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008120718,0.00013240315,0.013260288,0.00028972453,0.000034121145,0.00022810203,0.00027664038,0.0065176864,0.054695915,0.005416297,0.05323537,0.86583227],"study_design_scores_gemma":[0.00016079405,0.00072254264,0.08530794,0.00058670813,0.0002480143,0.0018139717,0.0024840687,0.18191823,0.07356384,0.032265972,0.6206606,0.00026725518],"about_ca_topic_score_codex":0.0049787676,"about_ca_topic_score_gemma":0.008313977,"teacher_disagreement_score":0.017883169,"about_ca_system_score_codex":0.0004406046,"about_ca_system_score_gemma":0.0009487501,"threshold_uncertainty_score":0.059825182},"labels":[],"label_agreement":null},{"id":"W3134342541","doi":"10.1007/s10549-021-06103-z","title":"Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Taxane; Pertuzumab; Breast cancer; Cancer registry; Trastuzumab; Oncology; Cancer; Odds ratio; Chemotherapy","score_opus":0.04727928516653658,"score_gpt":0.3718786086865928,"score_spread":0.3245993235200562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134342541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224573,0.00027231316,0.00007741372,0.00010457049,0.00000905694,0.0000100675725,0.0062084314,0.0000120148125,0.0010602981],"genre_scores_gemma":[0.9934095,0.00017094622,0.00005380324,0.00007434944,0.000015899566,0.000018381517,0.0056899996,0.0000065296385,0.0005606645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995995,0.00006806139,0.00004694993,0.00012560906,0.00005982021,0.000100109806],"domain_scores_gemma":[0.99914086,0.0001647028,0.00038070168,0.00006725502,0.00008957887,0.00015698149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036904955,0.00014622312,0.00045433693,0.00082090584,0.0003023651,0.00043117587,0.00028087053,0.0003405704,0.0030683898],"category_scores_gemma":[0.0016656606,0.00019886185,0.000470151,0.0016929576,0.00013036554,0.00058004557,0.00028230873,0.00041950832,0.00031989577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023506439,0.00004888146,0.9976024,0.000009133021,0.000049929535,0.00007372186,0.000030029874,0.000074482174,0.0001399298,0.00003442804,0.0007226324,0.0009794247],"study_design_scores_gemma":[0.000024216295,0.00008625858,0.99880767,0.0000064392566,0.000029152068,0.00018570243,0.00014053979,0.00024791193,0.00005000063,0.00002691237,0.00039037823,0.000004837373],"about_ca_topic_score_codex":0.0102327205,"about_ca_topic_score_gemma":0.013730938,"teacher_disagreement_score":0.0102327205,"about_ca_system_score_codex":0.00044071424,"about_ca_system_score_gemma":0.0005802277,"threshold_uncertainty_score":0.020346284},"labels":[],"label_agreement":null},{"id":"W3137776366","doi":"10.1007/s10549-021-06164-0","title":"Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital; Saint John Regional Hospital; Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Institutes of Health Research; Beatrice Hunter Cancer Research Institute","keywords":"Trastuzumab; Anoikis; Medicine; Breast cancer; Oncology; Cancer; Immunohistochemistry; Internal medicine; Epidermal growth factor receptor; Apoptosis; Cancer research; Cancer cell; Biology","score_opus":0.03670378781311591,"score_gpt":0.34039308619681263,"score_spread":0.30368929838369674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137776366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869823,0.00046339713,0.00008542945,0.000054661232,0.0000053722792,0.0000052320397,0.00012302754,0.000007614889,0.0005570171],"genre_scores_gemma":[0.9993086,0.00009210117,0.000049649047,0.00002084666,0.000013590391,0.0000058225883,0.00015322938,0.0000020648845,0.00035413087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998362,0.000039245544,0.000014230545,0.000024961524,0.000035281784,0.00005007709],"domain_scores_gemma":[0.9993019,0.00017144227,0.00032119898,0.000044939166,0.000057794565,0.0001027699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026456127,0.00016155165,0.0003569994,0.00044800373,0.0002000869,0.00078019017,0.0001700711,0.000313398,0.0019918724],"category_scores_gemma":[0.001189391,0.0001742249,0.00016022129,0.00040993796,0.00017220501,0.0003432985,0.00018319165,0.0006023679,0.00031247965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004457109,0.00032821152,0.9407183,0.000031693467,0.00016969218,0.00045690048,0.00014673441,0.00032557137,0.0414016,0.00019482338,0.00033544688,0.01143399],"study_design_scores_gemma":[0.000029955354,0.0004776571,0.99222696,0.000003978729,0.00008116256,0.00073013466,0.00015698445,0.0006027427,0.0049438123,0.0001556737,0.0005846062,0.0000064292394],"about_ca_topic_score_codex":0.00034145615,"about_ca_topic_score_gemma":0.00037045,"teacher_disagreement_score":0.0019918724,"about_ca_system_score_codex":0.0002118401,"about_ca_system_score_gemma":0.00016618482,"threshold_uncertainty_score":0.0066634417},"labels":[],"label_agreement":null},{"id":"W3138930066","doi":"10.1007/s10549-021-06147-1","title":"Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; Breast cancer; Bisphosphonate; Clinical trial; Internal medicine; Regimen; Oncology; Cancer; Family medicine; Adjuvant therapy; Osteoporosis","score_opus":0.0582924583654317,"score_gpt":0.359033206134235,"score_spread":0.30074074776880333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138930066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838126,0.00025011913,0.0000321791,0.0001860973,0.00000490316,0.000009941108,0.0004632843,0.0000017507901,0.00067054573],"genre_scores_gemma":[0.9985423,0.00033854778,0.000054975444,0.00017567346,0.000014191,0.000009005865,0.00041027658,9.1035935e-7,0.00045415794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965537,0.00010358372,0.000044655953,0.00004126796,0.00008080398,0.000074264615],"domain_scores_gemma":[0.9988243,0.00025470793,0.0005414809,0.000029730145,0.00013006713,0.00021965048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003383226,0.00012823677,0.0002674675,0.0006252269,0.0003003193,0.00040250365,0.00018100618,0.0006724926,0.0017157936],"category_scores_gemma":[0.0018285696,0.00025975096,0.00030594514,0.0010974047,0.0001377983,0.00048626837,0.00027712825,0.00047378027,0.00031408083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003739215,0.0000845581,0.9989755,0.000005473372,0.000015739628,0.000041777897,0.000055781715,0.00001428338,0.000059270642,0.000003108662,0.00008669288,0.00062051835],"study_design_scores_gemma":[0.0000057573675,0.00008236489,0.999305,0.0000036056736,0.000012356695,0.00012757824,0.00024188955,0.000047447353,0.000017199853,0.0000031482973,0.00015175654,0.0000018360686],"about_ca_topic_score_codex":0.019934287,"about_ca_topic_score_gemma":0.029674066,"teacher_disagreement_score":0.019934287,"about_ca_system_score_codex":0.0003249113,"about_ca_system_score_gemma":0.00039419907,"threshold_uncertainty_score":0.039636552},"labels":[],"label_agreement":null},{"id":"W3139520813","doi":"10.1007/s10549-021-06172-0","title":"A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006)","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Lumpectomy; Surgical oncology; Oncology; Mastectomy; Specialty; Neoadjuvant therapy; Clinical trial; Qualitative research; Family medicine; Multidisciplinary approach; Internal medicine; Systemic therapy; Cancer","score_opus":0.11859033199687266,"score_gpt":0.4610899640249085,"score_spread":0.3424996320280358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139520813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971238,0.000106113395,0.0002543623,0.0009611685,0.00003320553,0.00014945034,0.00017050291,0.000003166094,0.0011982714],"genre_scores_gemma":[0.9941731,0.00033766968,0.00078508415,0.0024316611,0.000024411258,0.00043854216,0.0001554406,0.000008399121,0.0016456965],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9929721,0.0051665944,0.00027698933,0.0002524637,0.00044217962,0.00088970177],"domain_scores_gemma":[0.96172565,0.025605151,0.004457708,0.000561835,0.003007778,0.0046419157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01134876,0.0002724885,0.00036459093,0.0009119887,0.0050342022,0.0017206635,0.00083946675,0.0011125003,0.002673568],"category_scores_gemma":[0.022680476,0.00039891808,0.00031683748,0.00089050794,0.0021565321,0.0012187219,0.0025004975,0.002162219,0.00032818323],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026929515,0.0010286296,0.14107697,0.00034695218,0.00002295359,0.0007392711,0.84376717,0.000050030172,0.0013367188,0.0005172497,0.0017151741,0.009129629],"study_design_scores_gemma":[0.000028258182,0.00045763285,0.024993265,0.00014789775,0.000010010559,0.00023258907,0.9695951,0.000076231416,0.00032798672,0.00009472878,0.004016491,0.000019745989],"about_ca_topic_score_codex":0.014891373,"about_ca_topic_score_gemma":0.024851449,"teacher_disagreement_score":0.014891373,"about_ca_system_score_codex":0.0037716096,"about_ca_system_score_gemma":0.004939396,"threshold_uncertainty_score":0.06001866},"labels":[],"label_agreement":null},{"id":"W3147084398","doi":"10.1007/s10549-021-06205-8","title":"Exercise and health-related fitness predictors of chemotherapy completion in breast cancer patients: pooled analysis of two multicenter trials","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Alberta Health Services; University of Alberta","funders":"Canada Research Chairs; Alberta Innovates; Canadian Breast Cancer Research Alliance; Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Medicine; Breast cancer; Internal medicine; Logistic regression; Chemotherapy; Physical therapy; Aerobic exercise; Physical fitness; Chemotherapy regimen; Cancer; Regimen; Oncology","score_opus":0.059163771315368534,"score_gpt":0.3996673073864689,"score_spread":0.34050353607110034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147084398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89137596,0.10392822,0.0010151459,0.00026714674,0.00032303832,0.00034458275,0.0019264875,0.000048447546,0.00077104376],"genre_scores_gemma":[0.9884596,0.008243752,0.0005722933,0.00023671871,0.00023167791,0.0002766374,0.0016181247,0.000020230744,0.00034099474],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9926805,0.004767008,0.000786664,0.0010872614,0.0003518854,0.00032662542],"domain_scores_gemma":[0.98802084,0.0065388153,0.0029167924,0.0014091845,0.000588967,0.0005254218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009227231,0.0021711271,0.007215972,0.0010018531,0.0005018722,0.002040576,0.0010531563,0.0020245046,0.0012975588],"category_scores_gemma":[0.0137209,0.0011239407,0.013352566,0.001738697,0.000793894,0.0011957319,0.0013063716,0.0017161678,0.00017481616],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32337937,0.00045362688,0.14836805,0.0053673564,0.506895,0.00012446332,0.00016477142,0.0016143414,0.0010062257,0.000112712194,0.0008436068,0.011670472],"study_design_scores_gemma":[0.069896914,0.013338838,0.35041916,0.0008133371,0.56060195,0.00019517093,0.00030828002,0.001619607,0.0005651838,0.000416082,0.0016683739,0.00015698675],"about_ca_topic_score_codex":0.0029671746,"about_ca_topic_score_gemma":0.0042188577,"teacher_disagreement_score":0.009227231,"about_ca_system_score_codex":0.00061365904,"about_ca_system_score_gemma":0.00072924164,"threshold_uncertainty_score":0.04879886},"labels":[],"label_agreement":null},{"id":"W3148244480","doi":"10.1007/s10549-021-06187-7","title":"DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Alberta; University of Toronto; Western University; Royal Victoria Regional Health Centre; University of Ottawa; Health Sciences Centre; Ottawa Hospital; University of Calgary; Thunder Bay Regional Health Sciences Centre; Princess Margaret Cancer Centre; McMaster University; Sunnybrook Hospital; Trillium Health Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Genomic Health","keywords":"Medicine; Ductal carcinoma; Breast cancer; Internal medicine; Oncology; Radiation therapy; Cohort; Cohort study; Cancer; Prospective cohort study; Breast-conserving surgery; Gynecology; Mastectomy","score_opus":0.04307461667470092,"score_gpt":0.35062697621047917,"score_spread":0.30755235953577825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3148244480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991271,0.00067581877,0.0002887084,0.0002928505,0.000058945032,0.00012366011,0.0021608265,0.000026662648,0.005101533],"genre_scores_gemma":[0.99558026,0.00020897559,0.0009248229,0.00008780301,0.00004147465,0.000115266375,0.0015753942,0.000007831635,0.0014582436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994221,0.00022812071,0.0000789105,0.00007027923,0.00012790531,0.000072673785],"domain_scores_gemma":[0.99799025,0.00046860642,0.0008148469,0.000084048006,0.00029102765,0.00035122698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001199826,0.00046845194,0.0007106033,0.001335813,0.00036771066,0.0008282121,0.0005814091,0.0004546558,0.0025093167],"category_scores_gemma":[0.0039060218,0.00016966504,0.0008273535,0.0009766895,0.00022908347,0.000577984,0.0006914272,0.00056414405,0.00042545245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009984957,0.00008461581,0.9916433,0.000033743112,0.00016000698,0.00003899574,0.000040578823,0.0001459862,0.00015482238,0.000056482837,0.00068212865,0.0059609055],"study_design_scores_gemma":[0.00013788926,0.00062455627,0.99551684,0.000025175068,0.00018220957,0.00019306601,0.0002275913,0.0010547019,0.00023097348,0.00014727438,0.0016448881,0.0000148763975],"about_ca_topic_score_codex":0.002964204,"about_ca_topic_score_gemma":0.004892915,"teacher_disagreement_score":0.002964204,"about_ca_system_score_codex":0.00048016862,"about_ca_system_score_gemma":0.00049684657,"threshold_uncertainty_score":0.008394539},"labels":[],"label_agreement":null},{"id":"W3161702437","doi":"10.1007/s10549-021-06238-z","title":"Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Sarcopenia; Medicine; Breast cancer; Oxidative stress; Internal medicine; Glutathione peroxidase; Cancer; Gastroenterology; Oncology; Superoxide dismutase","score_opus":0.08671372881445939,"score_gpt":0.42580158216155845,"score_spread":0.33908785334709907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161702437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841607,0.00053844217,0.000054156706,0.00013965314,0.00002355101,0.00024942466,0.00026507652,0.000005666383,0.00030788852],"genre_scores_gemma":[0.99689204,0.0004331705,0.00022334568,0.00022090535,0.00009046608,0.0009515688,0.0005661439,0.0000022797913,0.00062019646],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994522,0.0003435415,0.000036335474,0.00005742841,0.000049914845,0.000060608956],"domain_scores_gemma":[0.99915195,0.00022161526,0.0002492296,0.000074481926,0.000051303574,0.00025147267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017505835,0.00056906004,0.0010422618,0.00021464344,0.00026729112,0.00054832816,0.00030102045,0.0008536385,0.0017820946],"category_scores_gemma":[0.0020367505,0.00025466067,0.0009520262,0.00031933933,0.000300805,0.0004066731,0.0004821139,0.00081673224,0.0002484747],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8499048,0.021000916,0.08553785,0.0005854233,0.0029867226,0.000108936285,0.00023554578,0.0006513189,0.0026216644,0.000057897138,0.0007913159,0.03551756],"study_design_scores_gemma":[0.2819979,0.2755458,0.4354892,0.00014760646,0.0028273452,0.000096614254,0.00024683884,0.00076411373,0.0008442568,0.00018301043,0.001811597,0.000045763867],"about_ca_topic_score_codex":0.0009001164,"about_ca_topic_score_gemma":0.0017651981,"teacher_disagreement_score":0.0017820946,"about_ca_system_score_codex":0.0002704134,"about_ca_system_score_gemma":0.000483184,"threshold_uncertainty_score":0.009258091},"labels":[],"label_agreement":null},{"id":"W3163142692","doi":"10.1007/s10549-021-06295-4","title":"NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Ministero dello Sviluppo Economico; Ontario Ministry of Economic Development and Innovation; Novartis Pharma; Tulane University; Wellcome Trust; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Genome Canada","keywords":"Cancer research; Kinome; Metastasis; Metastatic breast cancer; Biology; Cell migration; Cell growth; Breast cancer; Cancer; Cancer cell; Gene knockdown; Cell; Cell biology; Kinase; Cell culture","score_opus":0.01839222892442476,"score_gpt":0.30797924123849457,"score_spread":0.2895870123140698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163142692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911902,0.003707038,0.00079228944,0.00022132126,0.00003867035,0.000008028022,0.00047255788,0.000031925032,0.0035380095],"genre_scores_gemma":[0.99570054,0.0007526875,0.00033625966,0.000059694037,0.0000037203815,0.00000824435,0.00038858198,0.0000063724483,0.0027439324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988747,0.00001370374,0.00001041363,0.000017933316,0.000024618392,0.000045804638],"domain_scores_gemma":[0.99994874,0.0000056709155,0.000012078665,0.000005141703,0.0000072154317,0.000021193302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090715934,0.0001491627,0.00014220916,0.00019123664,0.0002506827,0.00042734985,0.00018171864,0.0001932034,0.0013332316],"category_scores_gemma":[0.00009978663,0.000111340196,0.0001819796,0.00014337589,0.0001472838,0.00016371068,0.0001598691,0.00040444543,0.00032438082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033186522,0.000041102838,0.0012402221,0.000045102184,0.00001026288,0.0000547909,0.000018785813,0.00011567938,0.9952768,0.00032986217,0.00012773061,0.0024078886],"study_design_scores_gemma":[0.000018393128,0.0001501764,0.035282448,0.000010116467,0.00002197367,0.00021179802,0.00009998449,0.001191051,0.95740485,0.00007759846,0.005525556,0.00000608331],"about_ca_topic_score_codex":0.0019666408,"about_ca_topic_score_gemma":0.004767318,"teacher_disagreement_score":0.0019666408,"about_ca_system_score_codex":0.0005588308,"about_ca_system_score_gemma":0.0002455813,"threshold_uncertainty_score":0.0044600964},"labels":[],"label_agreement":null},{"id":"W3165029584","doi":"10.1007/s10549-021-06255-y","title":"Combinatorial targeting of microRNA-26b and microRNA-101 exerts a synergistic inhibition on cyclooxygenase-2 in brain metastatic triple-negative breast cancer cells","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation; Al Jalila Foundation","keywords":"Extravasation; Cancer research; Triple-negative breast cancer; Downregulation and upregulation; microRNA; Breast cancer; Metastasis; Matrix metalloproteinase; Cancer; Biology; Medicine; Chemistry; Immunology; Internal medicine; Gene","score_opus":0.025213571495030618,"score_gpt":0.3292433093995798,"score_spread":0.3040297379045492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165029584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990316,0.0027221923,0.0015303426,0.00024381182,0.00024234744,0.000063810636,0.0005071715,0.00017474737,0.0041995663],"genre_scores_gemma":[0.9951485,0.0008378594,0.0012985513,0.00008693838,0.00001369737,0.00006792279,0.00036671502,0.000016555763,0.0021633927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974865,0.000027951055,0.000021889296,0.000045599852,0.00008119383,0.00007469476],"domain_scores_gemma":[0.9999368,0.000011872927,0.0000109853345,0.000007527484,0.000007994188,0.000024858413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019562375,0.0004067086,0.00066897774,0.00025015717,0.00022493415,0.0004879262,0.00023106764,0.00038450645,0.001502893],"category_scores_gemma":[0.00015386126,0.0002103166,0.00036508968,0.00020444492,0.0002553811,0.00017827828,0.0002172062,0.00066802074,0.0004243054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073013717,0.00018737522,0.00019856557,0.00009322767,0.000026908498,0.0000986963,0.00002767456,0.00023600561,0.9933049,0.00017665504,0.0005348121,0.004385133],"study_design_scores_gemma":[0.0001192471,0.0012882127,0.00233446,0.000009505164,0.00006809733,0.00032691457,0.000080263984,0.0021882267,0.98884517,0.000060450686,0.004664983,0.000014329296],"about_ca_topic_score_codex":0.0008873322,"about_ca_topic_score_gemma":0.0028503407,"teacher_disagreement_score":0.001502893,"about_ca_system_score_codex":0.00030824283,"about_ca_system_score_gemma":0.00047851977,"threshold_uncertainty_score":0.0050277114},"labels":[],"label_agreement":null},{"id":"W3174437576","doi":"10.1007/s10549-021-06186-8","title":"Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Psychological intervention; Breast cancer; Family medicine; Health care; Affect (linguistics); Quality of life (healthcare); MEDLINE; Cancer; Nursing; Internal medicine; Psychology","score_opus":0.0883453615668979,"score_gpt":0.3982776545365396,"score_spread":0.30993229296964175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174437576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96514577,0.0024665466,0.0012314193,0.024702372,0.00009153845,0.0006706016,0.0004989644,0.000031455187,0.005161236],"genre_scores_gemma":[0.98952883,0.0018952775,0.0039980267,0.003747836,0.00004925025,0.00024607146,0.00020801045,0.0000071382146,0.00031953864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957633,0.002540482,0.00048464938,0.00014797712,0.0005352897,0.0005282548],"domain_scores_gemma":[0.99007213,0.0028831318,0.003269457,0.00021624664,0.0012881024,0.002270911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006861191,0.00014137427,0.00032410477,0.00073351304,0.0012446068,0.0018196078,0.00059983734,0.0008334316,0.0020585936],"category_scores_gemma":[0.021097029,0.00030611784,0.00039173095,0.00090281863,0.00039541966,0.001346763,0.0017353254,0.0013337757,0.00016773172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091596296,0.00071318465,0.9149862,0.00036770938,0.00007981853,0.00020907438,0.009109262,0.00017855593,0.00053203903,0.0003032684,0.0050094323,0.068419896],"study_design_scores_gemma":[0.00013313962,0.00082898606,0.9423096,0.0006837638,0.0000885721,0.0004781339,0.04192268,0.0011243537,0.00025388715,0.00034585863,0.011783588,0.00004738862],"about_ca_topic_score_codex":0.014391423,"about_ca_topic_score_gemma":0.024017943,"teacher_disagreement_score":0.014391423,"about_ca_system_score_codex":0.0018636556,"about_ca_system_score_gemma":0.009341533,"threshold_uncertainty_score":0.036285877},"labels":[],"label_agreement":null},{"id":"W3175806398","doi":"10.1007/s10549-021-06300-w","title":"Psychological consequences of MRI-based screening among women with strong family histories of breast cancer","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Toronto General Hospital; University of Toronto; Health Sciences North; Public Health Ontario; NOSM University; St. Michael's Hospital","funders":"Cancer Care Ontario","keywords":"Worry; Breast cancer; Anxiety; Medicine; Breast cancer screening; Family history; Clinical psychology; Cancer; Internal medicine; Mammography; Oncology; Psychiatry","score_opus":0.050517180601116034,"score_gpt":0.3636759045878075,"score_spread":0.3131587239866915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175806398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979367,0.00023598719,0.000021589713,0.0006362303,0.000021321974,0.000008231327,0.00008374722,0.000001656619,0.0010546563],"genre_scores_gemma":[0.99952936,0.00011851277,0.000024106255,0.000102386184,0.00002050884,0.0000025214745,0.00004372095,5.976617e-7,0.00015840291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969685,0.00013516971,0.000018655172,0.000021629854,0.000049436447,0.00007824433],"domain_scores_gemma":[0.9977041,0.00055713084,0.00073510315,0.0000641029,0.00014171106,0.0007979192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036895633,0.00013291514,0.0002269858,0.0005034414,0.00062633323,0.00047773455,0.00015881406,0.00047660744,0.001729463],"category_scores_gemma":[0.006007683,0.00013601259,0.0002834193,0.00044694162,0.0003290234,0.00025252864,0.0005530255,0.0009176622,0.00012538915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007297997,0.00036218742,0.98856527,0.000024989024,0.00007727662,0.0011193969,0.00043903574,0.00010860287,0.00044782902,0.00006448495,0.00036383703,0.0076973485],"study_design_scores_gemma":[0.000009959671,0.00024876537,0.99765426,0.000008160148,0.00003549725,0.00057275814,0.0011042465,0.000097565375,0.00003897406,0.000049366692,0.00017308106,0.000007408475],"about_ca_topic_score_codex":0.0048122224,"about_ca_topic_score_gemma":0.009791386,"teacher_disagreement_score":0.0048122224,"about_ca_system_score_codex":0.00032280313,"about_ca_system_score_gemma":0.00037265633,"threshold_uncertainty_score":0.009568393},"labels":[],"label_agreement":null},{"id":"W3176168168","doi":"10.1007/s10549-021-06293-6","title":"COVID-19 vaccination and breast cancer surgery timing","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Lymphadenopathy Diagnosis and Analysis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Breast cancer; Vaccination; Axillary Lymphadenopathy; Coronavirus disease 2019 (COVID-19); Sentinel lymph node; Infectious disease (medical specialty); Axillary lymph nodes; Disease; General surgery; Biopsy; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Surgery; Oncology; Internal medicine; Cancer; Pathology; Outbreak","score_opus":0.21160634276509327,"score_gpt":0.4834449782410773,"score_spread":0.271838635475984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176168168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007439168,0.9994728,0.000013344335,0.00011022618,0.00008352976,0.0000023170871,0.000028788736,0.0000014937385,0.00021312851],"genre_scores_gemma":[0.0012025932,0.99821657,0.000053042688,0.00021352772,0.000107803404,0.00000517331,0.00004632876,7.276813e-7,0.00015417801],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970895,0.00007439499,0.00008023239,0.00005039148,0.000059557497,0.000026460735],"domain_scores_gemma":[0.99899393,0.00064635905,0.0002223902,0.000015576152,0.0000863392,0.000035480603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093528867,0.00060277083,0.001565203,0.0016951382,0.00011840765,0.00073655485,0.0006141704,0.00085950195,0.007943524],"category_scores_gemma":[0.002945321,0.0003243947,0.0010809473,0.0020757546,0.0002709409,0.0007158059,0.0004972578,0.0011430231,0.00090040074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039811473,0.00006513744,0.0013218042,0.09644277,0.0008617323,0.00007159743,0.00003989644,0.00028840755,0.00028190372,0.0010500236,0.02199353,0.8771851],"study_design_scores_gemma":[0.00048370476,0.0007241021,0.013059767,0.14762098,0.009994609,0.001303193,0.00015816062,0.00023771584,0.0005186327,0.0015996698,0.82423943,0.000060075214],"about_ca_topic_score_codex":0.003379669,"about_ca_topic_score_gemma":0.0067801406,"teacher_disagreement_score":0.007943524,"about_ca_system_score_codex":0.00072198204,"about_ca_system_score_gemma":0.0017424636,"threshold_uncertainty_score":0.026573718},"labels":[],"label_agreement":null},{"id":"W3184056556","doi":"10.1007/s10549-021-06327-z","title":"Clinical outcomes and prognostic biomarkers among pregnant, post-partum and nulliparous women with breast cancer: a prospective cohort study","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Proportional hazards model; Breast cancer; Prospective cohort study; Internal medicine; Pregnancy; Oncology; Gynecology; Cancer; Cohort; Survival analysis; Obstetrics","score_opus":0.03443636033829581,"score_gpt":0.38313934093316504,"score_spread":0.34870298059486926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184056556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987311,0.00020845335,0.0000885631,0.000037855454,0.00001100493,0.000013809384,0.00071589317,0.00000277412,0.00019063993],"genre_scores_gemma":[0.99825424,0.00016625124,0.000120938355,0.000046796904,0.000012689088,0.000031722375,0.00092500553,0.0000047439858,0.0004375298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992119,0.00017342255,0.0000750555,0.00024568642,0.00008856621,0.00020530041],"domain_scores_gemma":[0.9985481,0.00020051503,0.0004750576,0.00030558536,0.00016184646,0.0003087947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000934768,0.0006860573,0.00068770663,0.00078149454,0.0011981352,0.0013164913,0.0008679934,0.0010827241,0.0017185238],"category_scores_gemma":[0.0025789335,0.0010707128,0.0011944625,0.0018392745,0.00044097583,0.0010037997,0.00094582135,0.0016060775,0.00044026514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045112733,0.00010544633,0.99815184,0.000007611369,0.00015829325,0.00011641586,0.00015152592,0.00001805585,0.00024888563,0.000021399934,0.00010247839,0.00046703548],"study_design_scores_gemma":[0.000034781337,0.00024074313,0.9984243,0.0000067125793,0.00012287327,0.00029583767,0.0005036689,0.00009970349,0.000044006116,0.00003339021,0.0001836353,0.000010359314],"about_ca_topic_score_codex":0.013293764,"about_ca_topic_score_gemma":0.012482044,"teacher_disagreement_score":0.013293764,"about_ca_system_score_codex":0.0005419062,"about_ca_system_score_gemma":0.00082551787,"threshold_uncertainty_score":0.026432812},"labels":[],"label_agreement":null},{"id":"W3186180211","doi":"10.1007/s10549-021-06393-3","title":"Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Breast cancer; Mastectomy; Breast-conserving surgery; Axillary Lymph Node Dissection; Population; Sentinel lymph node; Radiation therapy; Stage (stratigraphy); Cohort; Surgery; Gynecology; Cancer; General surgery; Internal medicine","score_opus":0.01394940512214276,"score_gpt":0.3234483958171334,"score_spread":0.30949899069499065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186180211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932873,0.00015237868,0.000043216547,0.000022325676,0.0000028611,0.000003017463,0.00019911546,0.0000015612571,0.0002468936],"genre_scores_gemma":[0.9995192,0.0000748224,0.00002304346,0.000017009908,0.0000047479775,0.000004081451,0.00020210663,0.000001179514,0.0001537511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995377,0.0001508189,0.00006229122,0.000111306515,0.00006556665,0.000072375566],"domain_scores_gemma":[0.99898666,0.00023008428,0.0003793792,0.00009371748,0.0001185334,0.00019162812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004845555,0.00022382851,0.00040029478,0.000980743,0.00046586388,0.0005265458,0.00030016215,0.000508471,0.0014513901],"category_scores_gemma":[0.0020251994,0.00026331615,0.00056913734,0.0015844573,0.0002786777,0.00044022547,0.00040202276,0.00051218393,0.00021388022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023793892,0.00004536742,0.9984628,0.000005841043,0.00007936249,0.000040013627,0.000084623505,0.00002326605,0.00023969283,0.000009910123,0.000037089514,0.00073401356],"study_design_scores_gemma":[0.000004118837,0.0000798696,0.999524,0.0000012712337,0.000022662203,0.00007353668,0.0001715111,0.000046646703,0.000015830426,0.000008614136,0.00005008409,0.000001893878],"about_ca_topic_score_codex":0.010238305,"about_ca_topic_score_gemma":0.009642423,"teacher_disagreement_score":0.010238305,"about_ca_system_score_codex":0.0002821169,"about_ca_system_score_gemma":0.00022509867,"threshold_uncertainty_score":0.02035737},"labels":[],"label_agreement":null},{"id":"W3193376311","doi":"10.1007/s10549-021-06344-y","title":"Patient and provider determinants of breast cancer screening among Ontario women aged 40–49: a population-based retrospective cohort study","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Retrospective cohort study; Mammography; Cohort; Breast cancer screening; Logistic regression; Breast cancer; Population; Cancer screening; Cohort study; Gynecology; Family medicine; Demography; Cancer; Obstetrics; Internal medicine; Environmental health","score_opus":0.06119979431892037,"score_gpt":0.3720282873998819,"score_spread":0.31082849308096155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193376311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962553,0.00016539084,0.000044936693,0.00010290154,0.000005911773,0.000027224229,0.0025955974,0.0000043419286,0.00079833495],"genre_scores_gemma":[0.9977775,0.00017395339,0.00007145497,0.00006577306,0.000007278549,0.000021553398,0.0012922552,0.0000031184331,0.00058707595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935263,0.000076916156,0.000053557837,0.00013465133,0.00015308437,0.00022904853],"domain_scores_gemma":[0.99836606,0.00012530747,0.000607068,0.00016604217,0.00035880037,0.0003766216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004540343,0.0003613392,0.00044072472,0.0009517301,0.0016877474,0.0010668184,0.00088107924,0.0007520843,0.0023969451],"category_scores_gemma":[0.0016281775,0.00079062884,0.00093553425,0.0037070045,0.0005528403,0.00060410536,0.0007671831,0.00083582266,0.00033264517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052779033,0.00003455957,0.99895453,0.0000064494475,0.00004913929,0.00004977337,0.00023375535,0.000015564654,0.000077876575,0.000016772685,0.00022842141,0.0002803732],"study_design_scores_gemma":[0.0000075516105,0.000020317297,0.9991136,0.0000058680675,0.00003171168,0.000049501698,0.00045975545,0.000067139896,0.00001246604,0.000008569926,0.00021911648,0.0000043553287],"about_ca_topic_score_codex":0.83827126,"about_ca_topic_score_gemma":0.8978327,"teacher_disagreement_score":0.16172874,"about_ca_system_score_codex":0.005711242,"about_ca_system_score_gemma":0.0060837585,"threshold_uncertainty_score":0.32536232},"labels":[],"label_agreement":null},{"id":"W3196278183","doi":"10.1007/s10549-021-06334-0","title":"Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Tolerability; Letrozole; Internal medicine; Breast cancer; Adverse effect; Neutropenia; Metastatic breast cancer; Population; Oncology; Progression-free survival; Hazard ratio; Cancer; Confidence interval; Chemotherapy; Tamoxifen","score_opus":0.1592860876520025,"score_gpt":0.48420631349289217,"score_spread":0.32492022584088964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196278183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9057022,0.0053859893,0.003635207,0.0016043675,0.00019776955,0.014878989,0.04572484,0.0006633987,0.022207333],"genre_scores_gemma":[0.87992865,0.00185695,0.005622701,0.0027392092,0.00043108725,0.0106347045,0.08577372,0.00018132626,0.012831524],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990181,0.00057293754,0.000050569855,0.00011210279,0.00014176554,0.00010451899],"domain_scores_gemma":[0.998973,0.00021418082,0.00014325873,0.00014774974,0.00014449596,0.00037741597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037205191,0.00081564573,0.00084466895,0.0003176196,0.00060044514,0.00081429677,0.0005915223,0.0007438042,0.016769042],"category_scores_gemma":[0.0021008423,0.0003076313,0.00078764337,0.00041355612,0.00034989297,0.00044732293,0.0005316227,0.0012613353,0.002521585],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5422105,0.020284884,0.051700868,0.0017311354,0.0035651897,0.0011858708,0.00045050235,0.002344803,0.05022143,0.00052750297,0.08778659,0.23799075],"study_design_scores_gemma":[0.3969037,0.1972301,0.29450095,0.00023883494,0.0033913162,0.002091277,0.00016852719,0.0013634082,0.008733806,0.0005985677,0.094708055,0.000071454095],"about_ca_topic_score_codex":0.0012852038,"about_ca_topic_score_gemma":0.0033126508,"teacher_disagreement_score":0.016769042,"about_ca_system_score_codex":0.00058403896,"about_ca_system_score_gemma":0.0013699549,"threshold_uncertainty_score":0.056098044},"labels":[],"label_agreement":null},{"id":"W3197500711","doi":"10.1007/s10549-021-06366-6","title":"Immediate breast reconstruction in locally advanced breast cancer: is it safe?","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of British Columbia","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Adjuvant therapy; Oncology; Internal medicine; Cancer; Adjuvant; Breast reconstruction; Surgery","score_opus":0.07638653743108041,"score_gpt":0.40612122213854723,"score_spread":0.3297346847074668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197500711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028704042,0.99968314,0.000013651795,0.00012376865,0.00005287291,7.5384787e-7,0.0000042115244,7.3942925e-7,0.000092177004],"genre_scores_gemma":[0.00047349746,0.9991241,0.000040763705,0.00017475303,0.00012241825,0.0000015043377,0.000007918186,5.6825246e-7,0.000054410397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994752,0.00013693879,0.000099795776,0.00009032655,0.00015634828,0.00004142339],"domain_scores_gemma":[0.99830997,0.001211715,0.00025777397,0.000022548173,0.00015237425,0.000045710745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015075024,0.00066332263,0.0032453123,0.001499116,0.0002539292,0.0015472427,0.0011958607,0.0016433538,0.004963168],"category_scores_gemma":[0.0028540308,0.0003236413,0.0011503673,0.0018228291,0.00081353594,0.0016231177,0.00058778917,0.0026657183,0.00095791655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024255144,0.000047174442,0.00028350673,0.0500642,0.00040061257,0.00013392522,0.000055880544,0.00019492103,0.00035405613,0.0015788475,0.017997412,0.92864686],"study_design_scores_gemma":[0.00036385184,0.0006422391,0.0043148296,0.09871852,0.0033700895,0.0034952718,0.00037662455,0.00024805393,0.00042235578,0.0048242738,0.88311857,0.000105390245],"about_ca_topic_score_codex":0.0013435892,"about_ca_topic_score_gemma":0.0034084045,"teacher_disagreement_score":0.004963168,"about_ca_system_score_codex":0.0005876533,"about_ca_system_score_gemma":0.0012915283,"threshold_uncertainty_score":0.01660341},"labels":[],"label_agreement":null},{"id":"W3198753429","doi":"10.1007/s10549-021-06372-8","title":"The characteristics associated with upgrade on surgical pathology of conventional imaging occult DCIS diagnosed by MRI","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sinai Health System; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Occult; Medicine; Breast MRI; Breast cancer; Radiology; Surgical pathology; Magnetic resonance imaging; Breast imaging; Pathology; Mammary gland; Mammography; Cancer; Internal medicine","score_opus":0.03626721805103881,"score_gpt":0.36208222450832,"score_spread":0.3258150064572812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198753429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505436,0.00072939746,0.00022079884,0.00015632648,0.000034961013,0.000012276626,0.00042288066,0.0000113044725,0.0033576437],"genre_scores_gemma":[0.99908924,0.00016432152,0.00013846235,0.000025015916,0.000047605427,0.000004529,0.00027359417,0.000004765355,0.00025240856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948585,0.00008888948,0.000075351374,0.00007943722,0.00011981881,0.00015063441],"domain_scores_gemma":[0.9960147,0.0010173965,0.00153961,0.0002595754,0.00054013554,0.00062860333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005139369,0.00028646982,0.00029555758,0.0015734911,0.0003587823,0.0007976932,0.00037164628,0.00059809303,0.0045833136],"category_scores_gemma":[0.006472112,0.00015518673,0.000446101,0.0015148362,0.00037299507,0.000721129,0.00045512174,0.0007020624,0.00057230133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018264653,0.000016671354,0.9967534,0.000010054223,0.000025695328,0.00041952133,0.000030327297,0.00003037103,0.00047984204,0.000035481506,0.000113376875,0.0019026126],"study_design_scores_gemma":[0.0000023147882,0.000057999438,0.99685425,0.000008798074,0.00003221758,0.0021326223,0.00019258159,0.00015601564,0.00016091086,0.00008930298,0.00030797027,0.00000485421],"about_ca_topic_score_codex":0.0015158557,"about_ca_topic_score_gemma":0.0017820988,"teacher_disagreement_score":0.0045833136,"about_ca_system_score_codex":0.0003422184,"about_ca_system_score_gemma":0.000450351,"threshold_uncertainty_score":0.015332639},"labels":[],"label_agreement":null},{"id":"W3200570903","doi":"10.1007/s10549-021-06377-3","title":"Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto","funders":"Breast Cancer Research Foundation","keywords":"Menstrual cycle; Oestrogen receptor; Breast cancer; Medicine; Internal medicine; Progesterone receptor; Estrogen; Endocrinology; Estrogen receptor; Oncology; Gynecology; Cancer; Physiology; Hormone","score_opus":0.019410505661243596,"score_gpt":0.3389526644688165,"score_spread":0.3195421588075729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200570903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923515,0.00041775568,0.00007237257,0.000008615179,0.000003394767,0.0000041188246,0.00010845051,0.000002695653,0.0001474571],"genre_scores_gemma":[0.9994068,0.00015548886,0.000084554034,0.000007934777,0.0000060975185,0.0000060012276,0.00018318532,0.000001981276,0.00014792784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998596,0.000043683955,0.000011523581,0.000026683685,0.000028263044,0.000030232628],"domain_scores_gemma":[0.9995055,0.00012997426,0.00022243152,0.000035417783,0.000050054325,0.000056631205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031582327,0.0001596164,0.00020518721,0.00038394786,0.000098925404,0.00025957145,0.00008771436,0.000118625074,0.0006059639],"category_scores_gemma":[0.0012629541,0.00007903027,0.00013977222,0.00040080873,0.00014639582,0.000098723176,0.00017972152,0.00010426532,0.0001681771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019855697,0.00004946097,0.96936184,0.000037591697,0.00006664276,0.000117837095,0.00008721854,0.00012887496,0.013527721,0.00001646668,0.000103452476,0.014517314],"study_design_scores_gemma":[0.0000058948735,0.00022424402,0.9982127,0.000002854647,0.000022273896,0.0001417399,0.00002612622,0.00012911067,0.0010308151,0.000009912526,0.00019275301,0.0000015835603],"about_ca_topic_score_codex":0.00077460374,"about_ca_topic_score_gemma":0.0011078713,"teacher_disagreement_score":0.00077460374,"about_ca_system_score_codex":0.00015342789,"about_ca_system_score_gemma":0.00013652287,"threshold_uncertainty_score":0.002027154},"labels":[],"label_agreement":null},{"id":"W3202734983","doi":"10.1007/s10549-021-06405-2","title":"Novel classes of immunotherapy for breast cancer","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Breast cancer; Immunotherapy; Tumor microenvironment; Medicine; Immune checkpoint; Cancer; Oncology; Immune system; Disease; Cancer immunotherapy; Immunology; Cancer research; Internal medicine","score_opus":0.1567430733818638,"score_gpt":0.46845098389637924,"score_spread":0.3117079105145154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202734983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077735596,0.9984592,0.00016241403,0.00026324613,0.00023291263,0.000010134741,0.000031452084,0.00000891785,0.000753937],"genre_scores_gemma":[0.00062143407,0.99782974,0.0002483606,0.00042439008,0.00021975323,0.000015041372,0.000058438705,0.0000018052855,0.00058112893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999777,0.00005019672,0.000028147766,0.000038257935,0.00006947517,0.000036914917],"domain_scores_gemma":[0.99968576,0.00016766427,0.00004847741,0.000010949905,0.000060738166,0.000026378513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084785494,0.0011603854,0.0020479516,0.0018915047,0.00023992351,0.0011240457,0.0010435405,0.0011540722,0.0055255587],"category_scores_gemma":[0.0010389185,0.00032788268,0.0007790141,0.001614332,0.00042765588,0.0014208393,0.0007730615,0.0030285448,0.0023004725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018481516,0.00011805078,0.00010611463,0.015586243,0.00014440758,0.000099230194,0.00002880161,0.00044376796,0.0018428277,0.0032387406,0.03423075,0.9439761],"study_design_scores_gemma":[0.00014415567,0.0003145396,0.0005650671,0.004244463,0.00028507865,0.0005768232,0.000027607473,0.00014076999,0.0006513367,0.002409027,0.9906212,0.000019931585],"about_ca_topic_score_codex":0.0006743769,"about_ca_topic_score_gemma":0.0018529262,"teacher_disagreement_score":0.0055255587,"about_ca_system_score_codex":0.0006244875,"about_ca_system_score_gemma":0.00085995,"threshold_uncertainty_score":0.01848483},"labels":[],"label_agreement":null},{"id":"W3206145754","doi":"10.1007/s10549-021-06414-1","title":"Comparison of upper extremity lymphedema after sentinel lymph node biopsy and axillary lymph node dissection: patient-reported outcomes in 3044 patients","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Lymphedema; Axillary Lymph Node Dissection; Biopsy; Lymph node; Radiology; Axilla; Dissection (medical); Breast cancer; Sentinel lymph node; Lymph; Axillary Dissection; Surgery; Cancer; Internal medicine; Pathology","score_opus":0.04340044689382134,"score_gpt":0.36583052213939504,"score_spread":0.3224300752455737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206145754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998982,0.00030878335,0.000033366963,0.000019859122,0.000006150133,0.0000060696825,0.0004505208,0.0000012080984,0.00019201286],"genre_scores_gemma":[0.99884474,0.00013065485,0.000024309822,0.000022823791,0.000010190526,0.000009026163,0.0008268426,0.0000010443321,0.00013024904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914575,0.00021748901,0.00011517172,0.0002066173,0.00012717528,0.00018780597],"domain_scores_gemma":[0.9984818,0.00048387202,0.0006119499,0.00008047623,0.00012966862,0.00021228238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009184097,0.0003542021,0.0006907604,0.0007142268,0.0003163633,0.00071969104,0.0004729622,0.00076870044,0.001543919],"category_scores_gemma":[0.0021405302,0.000293306,0.001004245,0.0012804711,0.0003400009,0.00080043933,0.0006397917,0.0006061049,0.0002404344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009055054,0.00007006906,0.9975305,0.00002425814,0.00023879629,0.000063665066,0.000053990167,0.00009381786,0.00009253827,0.000014869559,0.00007076436,0.00084123656],"study_design_scores_gemma":[0.000048235514,0.00036081232,0.998762,0.000008737593,0.00011949112,0.00013185214,0.00022686546,0.00017842981,0.00003302172,0.000020609003,0.0001016264,0.000008373774],"about_ca_topic_score_codex":0.0053531714,"about_ca_topic_score_gemma":0.005620444,"teacher_disagreement_score":0.0053531714,"about_ca_system_score_codex":0.00068820396,"about_ca_system_score_gemma":0.00040816973,"threshold_uncertainty_score":0.010644019},"labels":[],"label_agreement":null},{"id":"W3210722715","doi":"10.1007/s10549-021-06431-0","title":"Breast cancer immune microenvironment: from pre-clinical models to clinical therapies","year":2021,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Tumor microenvironment; Immune system; Breast cancer; Cancer research; Cancer; Immunology; Medicine; Biology; Internal medicine","score_opus":0.22796645007064711,"score_gpt":0.4921559509684505,"score_spread":0.26418950089780335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210722715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004125073,0.998895,0.00008278609,0.00043833684,0.0001807456,0.0000036910376,0.000014347716,0.000004579552,0.00033925],"genre_scores_gemma":[0.000422312,0.9984688,0.00013792144,0.00047381574,0.00022462031,0.000008008362,0.000021749229,0.0000010831587,0.0002416959],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962175,0.00010324886,0.00004494643,0.000054940167,0.0001295903,0.000045535617],"domain_scores_gemma":[0.99886215,0.00071437744,0.00010229599,0.000028401397,0.00021611869,0.00007669094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015640334,0.0010282996,0.0020738295,0.0018610178,0.00020889584,0.0020262646,0.0010287547,0.001621289,0.0028590846],"category_scores_gemma":[0.001783291,0.0003298457,0.0005610676,0.0016675275,0.00068468467,0.0016033959,0.0010939972,0.0028817113,0.00151192],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013047308,0.000083858205,0.00021263129,0.01836233,0.00009543602,0.000092288465,0.000046185814,0.00037179116,0.0010415799,0.005456961,0.045669902,0.92843664],"study_design_scores_gemma":[0.000044731947,0.00016613564,0.00066716963,0.008657702,0.00017973245,0.0005238128,0.00006683257,0.00013289457,0.00037674562,0.0035538648,0.9856082,0.000022228787],"about_ca_topic_score_codex":0.00086206343,"about_ca_topic_score_gemma":0.0025103001,"teacher_disagreement_score":0.0028590846,"about_ca_system_score_codex":0.0010592514,"about_ca_system_score_gemma":0.0017927993,"threshold_uncertainty_score":0.0095645785},"labels":[],"label_agreement":null},{"id":"W3215701750","doi":"10.1007/s10549-021-06450-x","title":"Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Breast cancer; Internal medicine; Hazard ratio; Placebo; Paclitaxel; Taxane; Oncology; Clinical endpoint; Chemotherapy; Cancer; Gastroenterology; Randomized controlled trial; Confidence interval; Pathology","score_opus":0.03520119051657982,"score_gpt":0.3610917612727934,"score_spread":0.3258905707562136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215701750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788069,0.0066854446,0.0005904328,0.00072656444,0.00030451862,0.0035733385,0.0033994855,0.00011746946,0.0057957354],"genre_scores_gemma":[0.9818764,0.004812201,0.0011859019,0.001146228,0.00044773528,0.0034663596,0.0039669643,0.000035355395,0.0030629868],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999671,0.00017905094,0.000018050008,0.000048982354,0.00003159512,0.000051468654],"domain_scores_gemma":[0.99960834,0.00010037358,0.000105868836,0.000031512012,0.00002394899,0.0001300108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001289149,0.0012288439,0.0014441238,0.0003509866,0.0002517716,0.0008171721,0.0005523628,0.0008124324,0.005247521],"category_scores_gemma":[0.0010103009,0.00044848357,0.0018844814,0.0003713189,0.0005080112,0.0005472132,0.00029394706,0.0023236775,0.00068625156],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95853716,0.0050950064,0.0014879414,0.000705317,0.0013016592,0.000050561855,0.000056584162,0.00070466177,0.003857798,0.0001697019,0.0030824174,0.024951247],"study_design_scores_gemma":[0.9361362,0.055266514,0.004282299,0.00006094464,0.0011038375,0.0000876406,0.000022159309,0.0005475454,0.0006515201,0.00023320153,0.0015929154,0.000015224568],"about_ca_topic_score_codex":0.0011211332,"about_ca_topic_score_gemma":0.0027340685,"teacher_disagreement_score":0.005247521,"about_ca_system_score_codex":0.0006830498,"about_ca_system_score_gemma":0.0010305807,"threshold_uncertainty_score":0.01755476},"labels":[],"label_agreement":null},{"id":"W3216654828","doi":"10.1007/s10549-021-06457-4","title":"Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Psychosocial; Genetic testing; Medicine; BRCA2 Protein; Oncology; Cancer; Internal medicine; Clinical psychology; Biology; Genetics; Psychiatry; Mutation; Gene; Germline mutation","score_opus":0.04670255303637044,"score_gpt":0.3774977584194234,"score_spread":0.33079520538305296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216654828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993024,0.001035325,0.00008729422,0.0013814053,0.0001922671,0.00002878128,0.00036913468,0.000012033494,0.003869731],"genre_scores_gemma":[0.998357,0.0003189977,0.00011043532,0.00012710603,0.00007104631,0.000013127126,0.00014376077,0.0000039031374,0.00085462007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993481,0.0003119303,0.000024368856,0.00006391168,0.00008927003,0.00016236387],"domain_scores_gemma":[0.99612683,0.0019446613,0.0003320796,0.0001456878,0.00020761577,0.0012430873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010710638,0.00033035045,0.00038243973,0.00019390303,0.0005840211,0.00039999138,0.00038794847,0.000493,0.0049506277],"category_scores_gemma":[0.0060247583,0.000109819695,0.0010330776,0.00017946823,0.0002458608,0.00034139495,0.00059972476,0.00087943487,0.000288382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018844277,0.014100632,0.7700079,0.00021906168,0.0010999363,0.001278315,0.00077266444,0.001954525,0.0034313025,0.0004424453,0.0027479888,0.18510085],"study_design_scores_gemma":[0.0001379056,0.0055340575,0.992176,0.000035002962,0.00022574893,0.0001301416,0.00033455677,0.00026008114,0.00018668344,0.00013763388,0.0008288927,0.000013256225],"about_ca_topic_score_codex":0.007960211,"about_ca_topic_score_gemma":0.011643809,"teacher_disagreement_score":0.007960211,"about_ca_system_score_codex":0.0005907594,"about_ca_system_score_gemma":0.0010462352,"threshold_uncertainty_score":0.016561449},"labels":[],"label_agreement":null},{"id":"W3216668262","doi":"10.1007/s10549-021-06448-5","title":"Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R","year":2021,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Nomogram; Letrozole; Medicine; Oncology; Internal medicine; Breast cancer; Placebo; Aromatase; Aromatase inhibitor; Concordance; Cancer; Pathology","score_opus":0.02995413333652299,"score_gpt":0.3482789496093993,"score_spread":0.31832481627287634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216668262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98695123,0.0021552315,0.00023195485,0.00030421984,0.000018039278,0.000042878946,0.009391261,0.000014629077,0.0008904909],"genre_scores_gemma":[0.9868151,0.00044171303,0.00023189498,0.0001358783,0.000040632774,0.000080503625,0.011422531,0.000020583324,0.00081120984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979912,0.001070805,0.00015034505,0.00027741757,0.00030345086,0.000206674],"domain_scores_gemma":[0.99434054,0.0023022671,0.0012300962,0.0008614795,0.00067934697,0.00058621925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025796585,0.0005400672,0.00076263683,0.0011035048,0.00041872126,0.000572994,0.00083564356,0.0006052277,0.0023829783],"category_scores_gemma":[0.0076659545,0.00023351294,0.0013800584,0.0019192246,0.00021176237,0.000275656,0.0004883966,0.0006440627,0.00040423957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014379502,0.00011181819,0.9667928,0.00009942774,0.0024023752,0.00012371046,0.00011300127,0.00045053862,0.0012780523,0.000067555084,0.0028698535,0.0113114705],"study_design_scores_gemma":[0.0003661008,0.00043148737,0.99599755,0.000024786068,0.0012840352,0.00006565466,0.00005124472,0.00031159772,0.00021174956,0.00003652821,0.0012088018,0.000010514066],"about_ca_topic_score_codex":0.050313484,"about_ca_topic_score_gemma":0.07306693,"teacher_disagreement_score":0.050313484,"about_ca_system_score_codex":0.0009841402,"about_ca_system_score_gemma":0.0012605614,"threshold_uncertainty_score":0.10004121},"labels":[],"label_agreement":null},{"id":"W4205172350","doi":"10.1007/s10549-021-06473-4","title":"Yield of flow cytometry in addition to cytology for lymph node sampling in patients with incidental axillary adenopathy without a concurrent diagnosis of primary breast malignancy","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphadenopathy Diagnosis and Analysis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Radiology; Malignancy; Axillary Lymphadenopathy; Fine-needle aspiration; Cytology; Lymphoma; Breast cancer; Axillary lymph nodes; Lymph node; Biopsy; Pathology; Internal medicine; Cancer","score_opus":0.04177114855228701,"score_gpt":0.33346702272891,"score_spread":0.29169587417662296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205172350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488884,0.0015864986,0.0006782258,0.00038574202,0.00006769079,0.00001545403,0.00022992546,0.000048848928,0.0020987405],"genre_scores_gemma":[0.99878424,0.00023584886,0.0004718174,0.000121256126,0.000056261222,0.000008693983,0.00015294728,0.0000064244946,0.00016254128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904937,0.00027323703,0.00011759603,0.00012913068,0.0002724964,0.00015822933],"domain_scores_gemma":[0.9960083,0.002387831,0.00042852666,0.00020426587,0.00049206155,0.00047909233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001254196,0.0005025568,0.00057205895,0.0021629063,0.00038017053,0.0010508597,0.0004481244,0.0010194877,0.0016930043],"category_scores_gemma":[0.008689875,0.00034097277,0.00048366486,0.000702789,0.00043065252,0.0008261734,0.0005180632,0.00063860044,0.00062037975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009428226,0.00006170285,0.9856675,0.000031450298,0.000028406066,0.00094919384,0.000077660574,0.00016244584,0.0046621547,0.000061388935,0.0002448958,0.0071104523],"study_design_scores_gemma":[0.00004996865,0.0012002385,0.96723515,0.000058184916,0.00026094832,0.010531176,0.0005917711,0.006037355,0.012115092,0.00053867523,0.0013517315,0.000029768094],"about_ca_topic_score_codex":0.0008768665,"about_ca_topic_score_gemma":0.0012712466,"teacher_disagreement_score":0.0021629063,"about_ca_system_score_codex":0.00044987837,"about_ca_system_score_gemma":0.00059071684,"threshold_uncertainty_score":0.006632924},"labels":[],"label_agreement":null},{"id":"W4205694647","doi":"10.1007/s10549-021-06434-x","title":"Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Center, University of Kansas; York University; Susan G. Komen; Erasmus Universiteit Rotterdam; Breast Cancer Research Foundation","keywords":"Medicine; Inflammatory breast cancer; Breast cancer; Clinical trial; Categorization; Cancer; Medical physics; Intensive care medicine; Pathology; Internal medicine; Artificial intelligence","score_opus":0.1107589988330923,"score_gpt":0.45493256197461124,"score_spread":0.3441735631415189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205694647","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021768045,0.065072834,0.52906924,0.32449374,0.010726813,0.006539107,0.002754204,0.0013464752,0.0382296],"genre_scores_gemma":[0.16781318,0.014116949,0.77457124,0.025861515,0.0049073477,0.004795942,0.003982674,0.00026019115,0.0036910158],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9616653,0.018846633,0.008540751,0.0025297555,0.006827074,0.001590492],"domain_scores_gemma":[0.9405472,0.0132878255,0.007836973,0.003102333,0.031837504,0.0033881771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051797286,0.0031847097,0.0030286557,0.0155292805,0.0034073389,0.0064362995,0.0064661326,0.004160023,0.0023643787],"category_scores_gemma":[0.08964042,0.0007147398,0.003392815,0.0060066585,0.0071393102,0.007667997,0.007296814,0.008364689,0.001752376],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005285581,0.0004779849,0.059805956,0.008376262,0.00048768058,0.0009369234,0.0049652066,0.0072501954,0.0034884403,0.22485171,0.23097023,0.45786086],"study_design_scores_gemma":[0.00047109788,0.0010327599,0.039605584,0.02030811,0.001019523,0.0077532604,0.011796834,0.037300568,0.0048312894,0.42107984,0.4542223,0.00057884393],"about_ca_topic_score_codex":0.006346555,"about_ca_topic_score_gemma":0.006393156,"teacher_disagreement_score":0.051797286,"about_ca_system_score_codex":0.012117925,"about_ca_system_score_gemma":0.025656452,"threshold_uncertainty_score":0.27393353},"labels":[],"label_agreement":null},{"id":"W4205726578","doi":"10.1007/s10549-021-06452-9","title":"Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Breast cancer; Immunohistochemistry; Cancer; Endocrine system; Gene expression; Gene expression profiling","score_opus":0.01572996857839717,"score_gpt":0.30611876618415435,"score_spread":0.2903887976057572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205726578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979267,0.00061653444,0.00014031703,0.000030427607,0.0000027435296,0.0000060685875,0.00043202328,0.0000071951436,0.00083797274],"genre_scores_gemma":[0.9989016,0.00017935698,0.000116272095,0.000017866241,0.0000048508423,0.0000051346583,0.00047596058,0.0000025629906,0.00029634993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998254,0.000029632132,0.000020643934,0.000039141247,0.000041302264,0.000043910844],"domain_scores_gemma":[0.9997806,0.000048215457,0.00006383887,0.000020932248,0.00005007937,0.000036382648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028934673,0.00014631433,0.0002302866,0.0007464866,0.00034804703,0.00030866836,0.00016070066,0.00018964018,0.0007761828],"category_scores_gemma":[0.0004391454,0.00014929617,0.0002477376,0.0007756959,0.00013322652,0.00019985963,0.00019398551,0.00021091203,0.00013286089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005281643,0.000027308855,0.97552925,0.000023560257,0.000099007426,0.0001974498,0.000104385064,0.00008495305,0.015664063,0.00005040699,0.00022832652,0.0074631707],"study_design_scores_gemma":[0.000005106024,0.00004580467,0.99760604,0.000002601446,0.00006995277,0.0006459543,0.000106719875,0.00012164034,0.0009131274,0.000027734473,0.00045286404,0.0000025822553],"about_ca_topic_score_codex":0.0040626833,"about_ca_topic_score_gemma":0.0066388138,"teacher_disagreement_score":0.0040626833,"about_ca_system_score_codex":0.00027097063,"about_ca_system_score_gemma":0.00027097654,"threshold_uncertainty_score":0.008078098},"labels":[],"label_agreement":null},{"id":"W4206303014","doi":"10.1007/s10549-021-06374-6","title":"Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population","year":2021,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Letrozole; Breast cancer; Medicine; Oncology; Population; Cancer; Phase (matter); Internal medicine; Gynecology; Tamoxifen","score_opus":0.12615718773354898,"score_gpt":0.4729401635544931,"score_spread":0.3467829758209441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206303014","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008464611,0.0006659783,0.00063871266,0.04963255,0.9414525,0.000059416983,0.0051761935,0.00030554997,0.0019845567],"genre_scores_gemma":[0.008208992,0.007281286,0.011046917,0.2709771,0.47714338,0.0010939551,0.012523427,0.0040226383,0.20770231],"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9909382,0.00213418,0.0019014291,0.0010539313,0.0032798338,0.00069237297],"domain_scores_gemma":[0.94405687,0.021293432,0.0035788126,0.0034315456,0.024978992,0.0026603683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011237782,0.00304695,0.003128784,0.0044437763,0.002653736,0.00471654,0.004640295,0.008246138,0.082690865],"category_scores_gemma":[0.12425663,0.0021428629,0.0030602103,0.0036439607,0.0021098764,0.0022643933,0.0019633165,0.015979016,0.043742713],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006438276,0.0000050389244,0.000036833742,0.00010277949,0.000016700214,0.00004785675,0.0000073750352,0.000023965726,0.000009318483,0.00016538243,0.99743193,0.0020884408],"study_design_scores_gemma":[0.0005093918,0.00003781186,0.0010026946,0.00077847793,0.00013930007,0.00031813842,0.00005408711,0.00028836736,0.0002059175,0.0016029655,0.9950118,0.000051145198],"about_ca_topic_score_codex":0.03560466,"about_ca_topic_score_gemma":0.03960802,"teacher_disagreement_score":0.082690865,"about_ca_system_score_codex":0.00599521,"about_ca_system_score_gemma":0.010036722,"threshold_uncertainty_score":0.2766285},"labels":[],"label_agreement":null},{"id":"W4210606558","doi":"10.1007/s10549-021-06475-2","title":"Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université Laval; McGill University Health Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Epirubicin; Internal medicine; Breast cancer; Amenorrhea; Quality of life (healthcare); Randomization; Cancer; Oncology; Randomized controlled trial; Pregnancy","score_opus":0.1691916945966959,"score_gpt":0.45006740860172334,"score_spread":0.2808757140050274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210606558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220544,0.004485955,0.00010045111,0.00046862132,0.00012554222,0.00018715103,0.0015447282,0.000010273233,0.0008718335],"genre_scores_gemma":[0.9947056,0.001418161,0.00016997835,0.0004931069,0.00012699566,0.00021650763,0.0018149109,0.0000058748014,0.0010488549],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982551,0.001115236,0.000108397166,0.00018481318,0.00010704156,0.00022947066],"domain_scores_gemma":[0.99758375,0.00087385625,0.00063458696,0.00024001615,0.00014171613,0.0005259933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032480177,0.0012644575,0.0019269355,0.00037847948,0.00040093542,0.00082760304,0.0007679639,0.0013835344,0.0032780624],"category_scores_gemma":[0.0035671263,0.00039820472,0.0037557404,0.00069658575,0.00076127757,0.00088838255,0.0006769181,0.0030055917,0.00027530457],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9631478,0.0025631024,0.01657611,0.0004571804,0.008257503,0.00003267539,0.00005589506,0.0005539385,0.0009952647,0.00009695711,0.0006585147,0.006605183],"study_design_scores_gemma":[0.5650865,0.112590685,0.2820851,0.0002938779,0.033670567,0.00010249131,0.00032962344,0.00092330156,0.0013854491,0.00071656215,0.0027167897,0.000098954675],"about_ca_topic_score_codex":0.005649961,"about_ca_topic_score_gemma":0.008239015,"teacher_disagreement_score":0.005649961,"about_ca_system_score_codex":0.0008885243,"about_ca_system_score_gemma":0.0010011819,"threshold_uncertainty_score":0.017177403},"labels":[],"label_agreement":null},{"id":"W4210785085","doi":"10.1007/s10549-021-06488-x","title":"Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"Canadian Cancer Society Research Institute; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Breast cancer; Internal medicine; Breast-conserving surgery; Proportional hazards model; Radiation therapy; Cohort; Hazard ratio; Oncology; Gynecology; Cancer; Mastectomy; Confidence interval","score_opus":0.03550043262724635,"score_gpt":0.33460816473508936,"score_spread":0.299107732107843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210785085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996351,0.0016550962,0.000051704246,0.00018255696,0.000023705568,0.000011698389,0.00068011053,0.000001987739,0.0010421443],"genre_scores_gemma":[0.99811697,0.00050008035,0.000019799845,0.000060760136,0.00003322406,0.000011377103,0.0007704104,0.0000014442888,0.00048600993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969137,0.00006866291,0.00003669201,0.00004520509,0.000044657307,0.000113371396],"domain_scores_gemma":[0.9982387,0.00039560962,0.0006360706,0.000089116686,0.00023380714,0.00040664148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007787629,0.00018539713,0.0003927398,0.00060083176,0.0005541708,0.00072834257,0.00031288568,0.000537627,0.0017908665],"category_scores_gemma":[0.003421982,0.000119701486,0.00078747794,0.00069523975,0.00032822578,0.00072949985,0.0006190375,0.0007041788,0.00027879223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031454943,0.00030652434,0.98669064,0.00004659018,0.0003018,0.00027495588,0.00019952882,0.00013197183,0.00035911967,0.00005268289,0.00021426169,0.0082764765],"study_design_scores_gemma":[0.00005587716,0.0011709435,0.99689853,0.000026215837,0.0003332887,0.00027342967,0.0004479756,0.00009397613,0.00009273205,0.000094739924,0.00050089613,0.000011317553],"about_ca_topic_score_codex":0.004830015,"about_ca_topic_score_gemma":0.005893633,"teacher_disagreement_score":0.004830015,"about_ca_system_score_codex":0.0006515917,"about_ca_system_score_gemma":0.0004052387,"threshold_uncertainty_score":0.009603798},"labels":[],"label_agreement":null},{"id":"W4210879173","doi":"10.1007/s10549-021-06449-4","title":"Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Vinorelbine; Medicine; Afatinib; Lapatinib; Internal medicine; Oncology; Trastuzumab; Breast cancer; Metastatic breast cancer; Clinical endpoint; Rash; Cancer; Chemotherapy; Clinical trial; Gefitinib; Epidermal growth factor receptor","score_opus":0.07544896408578985,"score_gpt":0.4259875661619342,"score_spread":0.3505386020761443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210879173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684405,0.0013302385,0.00011132629,0.00021123118,0.000048708196,0.00053082046,0.00025256965,0.000016883874,0.0006542239],"genre_scores_gemma":[0.9967481,0.00080815115,0.00032874165,0.00029763437,0.000137082,0.0004552026,0.00049833406,0.0000046608648,0.00072212995],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99957854,0.00021112755,0.00003689372,0.000073659445,0.00003099022,0.00006870977],"domain_scores_gemma":[0.99949074,0.00008903737,0.00009614748,0.000033868688,0.00002566877,0.00026454698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012417838,0.0010978434,0.0014848243,0.00028427038,0.00033112644,0.0006972147,0.00052346074,0.00097277004,0.0025314519],"category_scores_gemma":[0.0007825676,0.00045718515,0.0010513974,0.00029758373,0.000655034,0.00078040647,0.00026773848,0.0016740407,0.00049435766],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8261135,0.05409622,0.019793456,0.00057741656,0.0016484777,0.00026140801,0.0002856419,0.0015050828,0.023770612,0.00017184822,0.002322488,0.06945379],"study_design_scores_gemma":[0.63248396,0.33440152,0.026736973,0.000030098114,0.00054765504,0.00027622358,0.000070576774,0.0011183147,0.0023395536,0.00012353317,0.0018416039,0.000030032737],"about_ca_topic_score_codex":0.00045070358,"about_ca_topic_score_gemma":0.0013337902,"teacher_disagreement_score":0.0025314519,"about_ca_system_score_codex":0.0006288991,"about_ca_system_score_gemma":0.0007737598,"threshold_uncertainty_score":0.008468509},"labels":[],"label_agreement":null},{"id":"W4213114563","doi":"10.1007/s10549-022-06540-4","title":"Axillary surgery and complication rates after mastectomy and reconstruction for breast cancer: an analysis of the NSQIP database","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; University of Ottawa; McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Axillary Lymph Node Dissection; Sentinel lymph node; Breast cancer; Surgery; Mastectomy; Breast reconstruction; Breast surgery; Lymphedema; Retrospective cohort study; Sentinel node; Cancer; Internal medicine","score_opus":0.14051576390148754,"score_gpt":0.41578646223818255,"score_spread":0.27527069833669504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213114563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03725765,0.95308846,0.0001254731,0.00035151685,0.00006750858,0.00004604216,0.008461456,0.0000067055603,0.00059516745],"genre_scores_gemma":[0.14431776,0.8460809,0.00056839886,0.00060531544,0.00010659019,0.0001475857,0.007918071,0.000008523113,0.000246817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979461,0.00031761875,0.0008408209,0.00029376498,0.0005009589,0.00010079525],"domain_scores_gemma":[0.9961294,0.0018455961,0.0013760205,0.00006777713,0.00048674186,0.00009446194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016197445,0.00039035224,0.001995741,0.0047892295,0.00018901918,0.00081145484,0.0006654968,0.0005068117,0.0015631082],"category_scores_gemma":[0.0055460553,0.00025820304,0.0034020662,0.010091864,0.00025047723,0.00078342046,0.0007609751,0.000593724,0.00015416053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015022523,0.00016260339,0.488804,0.2088425,0.040753305,0.0003649225,0.00051809667,0.0006061642,0.00047549704,0.00083194545,0.017164346,0.23997444],"study_design_scores_gemma":[0.00036871,0.00025155567,0.878295,0.039555192,0.03925185,0.0013523906,0.0009884782,0.000441475,0.00022825312,0.00035897622,0.038792305,0.0001157118],"about_ca_topic_score_codex":0.012140608,"about_ca_topic_score_gemma":0.020938477,"teacher_disagreement_score":0.012140608,"about_ca_system_score_codex":0.0009128959,"about_ca_system_score_gemma":0.0022576882,"threshold_uncertainty_score":0.024139881},"labels":[],"label_agreement":null},{"id":"W4214625336","doi":"10.1007/s10549-022-06522-6","title":"A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McGill University; Sunnybrook Health Science Centre; Jewish General Hospital; BC Cancer Agency; University of Manitoba; Health Sciences Centre; McMaster University; London Health Sciences Centre; Hamilton Health Sciences; University of Toronto; Western University","funders":"Terry Fox Research Institute","keywords":"Guideline; Systemic therapy; Breast cancer; Medicine; Cancer; Neoadjuvant therapy; Oncology; Internal medicine; Pathology","score_opus":0.15927295947853704,"score_gpt":0.4140007529831589,"score_spread":0.2547277935046219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214625336","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006340809,0.17586596,0.035946414,0.47851717,0.020184357,0.007677247,0.027179075,0.0010075943,0.24728136],"genre_scores_gemma":[0.08847334,0.23993814,0.41503638,0.12044115,0.002826113,0.0067246044,0.044634122,0.0005208431,0.08140538],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9817392,0.0034938299,0.002206759,0.0005741597,0.010798316,0.0011876806],"domain_scores_gemma":[0.9586218,0.003266573,0.0014376027,0.00047335817,0.033390187,0.0028104621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014534493,0.0015776174,0.001498493,0.0062673446,0.004342481,0.0031708176,0.0058289114,0.0048467778,0.0051065846],"category_scores_gemma":[0.031007832,0.00073842716,0.0025571624,0.007202256,0.0025771004,0.0014916877,0.0023677521,0.0067758323,0.0019634904],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046302834,0.00007138116,0.0019804232,0.0030921136,0.00007934414,0.00032477823,0.0009170174,0.0011989917,0.00057294517,0.010665066,0.879148,0.10190359],"study_design_scores_gemma":[0.0000781553,0.00003289399,0.007650483,0.008552027,0.00018801857,0.00046059486,0.00046902845,0.000567024,0.00024336332,0.0028903019,0.97877306,0.00009492157],"about_ca_topic_score_codex":0.9231321,"about_ca_topic_score_gemma":0.9657331,"teacher_disagreement_score":0.92862254,"about_ca_system_score_codex":0.07137747,"about_ca_system_score_gemma":0.32435334,"threshold_uncertainty_score":0.5178822},"labels":[],"label_agreement":null},{"id":"W4220773470","doi":"10.1007/s10549-022-06569-5","title":"Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"National Cancer Institute; National Institutes of Health; Higher Education Commision, Pakistan; National Institute of General Medical Sciences; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; Fonds de Recherche du Québec - Santé; Marie Curie; European Commission; Susan G. Komen; American Cancer Society","keywords":"Triple-negative breast cancer; Breast cancer; Chemotherapy; Medicine; Oncology; Cancer; Alpha (finance); Internal medicine; Cancer research; Surgery","score_opus":0.020928638804907113,"score_gpt":0.3278867694548976,"score_spread":0.30695813064999045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220773470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919761,0.0037958603,0.00065123057,0.00029275822,0.00014597297,0.000043569606,0.0002508963,0.00013135093,0.0027124055],"genre_scores_gemma":[0.99689853,0.0010617714,0.0003210915,0.000119032724,0.000017399923,0.000028586439,0.00027186074,0.0000104824785,0.001271189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990785,0.000011542033,0.000005558161,0.000012489628,0.000027292192,0.00003516945],"domain_scores_gemma":[0.99996376,0.000004994761,0.0000088081215,0.000003350645,0.0000041235926,0.000014926029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015631632,0.00020910488,0.00035277914,0.00015416891,0.00016437641,0.00032096772,0.00013316023,0.00018079625,0.0021799183],"category_scores_gemma":[0.00014577915,0.00011847711,0.00017351237,0.00012703455,0.00014177711,0.0001427639,0.00015658604,0.0007070417,0.00040684102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004402528,0.0011177736,0.0047536786,0.00030919194,0.00011800289,0.000158786,0.000101349426,0.0008355877,0.9287107,0.00035232972,0.0028506094,0.056289498],"study_design_scores_gemma":[0.001191767,0.018065982,0.062364057,0.000099336896,0.00070966413,0.0012084239,0.000498193,0.008164847,0.86964726,0.0005782324,0.03741815,0.000054140295],"about_ca_topic_score_codex":0.000612261,"about_ca_topic_score_gemma":0.0018628918,"teacher_disagreement_score":0.0021799183,"about_ca_system_score_codex":0.0002706956,"about_ca_system_score_gemma":0.00024866217,"threshold_uncertainty_score":0.0072925687},"labels":[],"label_agreement":null},{"id":"W4220779215","doi":"10.1007/s10549-022-06528-0","title":"Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; University of Auckland; Auckland Medical Research Foundation","keywords":"Medicine; Breast cancer; Hazard ratio; Proportional hazards model; Cancer; Internal medicine; Population; Cohort; Oncology; Cohort study; Cause of death; Gynecology; Confidence interval; Disease; Environmental health","score_opus":0.05542429143326465,"score_gpt":0.35472745772879666,"score_spread":0.299303166295532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220779215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979996,0.00033454483,0.00012809275,0.00006961446,0.000010049739,0.000034825713,0.0011206986,0.0000032533173,0.00029936942],"genre_scores_gemma":[0.99803346,0.0003640023,0.00018606424,0.000054069864,0.000016080165,0.000032457432,0.0010215447,0.0000022157226,0.00029018937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944645,0.00011095722,0.000061199185,0.00015518776,0.00013894092,0.000087228305],"domain_scores_gemma":[0.99900264,0.00008663358,0.00046659377,0.00014473374,0.00014911946,0.00015035956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089586363,0.00034206526,0.0003909915,0.00062575657,0.0004307841,0.00067681033,0.0005183756,0.00045609262,0.0011438107],"category_scores_gemma":[0.0020672183,0.0003810795,0.00085983943,0.0011783313,0.00025713022,0.00042681227,0.000509116,0.0008129102,0.0002652862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010519602,0.00003096089,0.9988335,0.00001117972,0.00012436681,0.00003862733,0.00006203518,0.000015852896,0.00014806479,0.000007186094,0.0000820754,0.0005411098],"study_design_scores_gemma":[0.00001488729,0.00006260399,0.99942976,0.0000057470265,0.000059548132,0.00009960336,0.0000667566,0.00007267337,0.000020947184,0.000006760521,0.00015843575,0.000002209778],"about_ca_topic_score_codex":0.051547583,"about_ca_topic_score_gemma":0.06252234,"teacher_disagreement_score":0.051547583,"about_ca_system_score_codex":0.000673514,"about_ca_system_score_gemma":0.0008187844,"threshold_uncertainty_score":0.102495074},"labels":[],"label_agreement":null},{"id":"W4220931859","doi":"10.1007/s10549-021-06417-y","title":"Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institutes of Health","keywords":"Epirubicin; Medicine; Breast cancer; Internal medicine; Placebo; Cyclophosphamide; Clinical endpoint; Chemotherapy; Oncology; Cancer; Surgery; Clinical trial; Gastroenterology; Pathology","score_opus":0.086597028550857,"score_gpt":0.3949531656894934,"score_spread":0.3083561371386364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220931859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760887,0.0057631503,0.0011091179,0.0032525072,0.0010656303,0.0034693356,0.0031549507,0.00017416496,0.00592247],"genre_scores_gemma":[0.9699201,0.002866069,0.0033339283,0.0037408369,0.0008050053,0.003274546,0.004711903,0.000065130254,0.011282482],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992632,0.00048613254,0.0000298664,0.00008489876,0.000036158825,0.0000996298],"domain_scores_gemma":[0.99771583,0.0008224928,0.00032901502,0.00029754007,0.00010648649,0.0007287164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026179089,0.0017328489,0.0024868075,0.000333404,0.00049517094,0.0009269794,0.0009607706,0.002553203,0.009127573],"category_scores_gemma":[0.0028780005,0.00050587393,0.0019248712,0.0003682086,0.0013171529,0.0008721286,0.00036879297,0.0045495937,0.0015010042],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96471757,0.010591751,0.00059229345,0.00028535395,0.00068755646,0.000031143936,0.000059807793,0.0005699353,0.0033505266,0.00013428768,0.0015476461,0.017432079],"study_design_scores_gemma":[0.85801286,0.13520415,0.0032798196,0.000041621006,0.0005118666,0.000049029,0.00003799878,0.00027882025,0.00059058116,0.00030797947,0.0016671584,0.000018215085],"about_ca_topic_score_codex":0.0010805659,"about_ca_topic_score_gemma":0.002584974,"teacher_disagreement_score":0.009127573,"about_ca_system_score_codex":0.00063661276,"about_ca_system_score_gemma":0.0013803521,"threshold_uncertainty_score":0.030534804},"labels":[],"label_agreement":null},{"id":"W4224326647","doi":"10.1007/s10549-022-06576-6","title":"Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Family Support in Illness","field":"Social Sciences","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Calgary; Alberta Health Services; Women's College Hospital; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Anxiety; Breast cancer; Depression (economics); Cohort; Internal medicine; Cohort study; Coping (psychology); Population; History of depression; Gynecology; Cancer; Psychiatry","score_opus":0.045863586708318645,"score_gpt":0.38334073635902455,"score_spread":0.3374771496507059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224326647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995671,0.00011027674,0.000021668213,0.00003150203,0.000006661958,0.000009994919,0.00015311345,9.886869e-7,0.00009866194],"genre_scores_gemma":[0.99942905,0.00010242024,0.00004503254,0.000026104402,0.0000067828546,0.000017698934,0.00015245983,0.0000011377026,0.00021919799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953437,0.00015463411,0.00003612031,0.000074276664,0.00006107676,0.00013947769],"domain_scores_gemma":[0.998648,0.00022031233,0.00039762713,0.00012918384,0.0001270151,0.0004778445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092387537,0.00051286444,0.0006079027,0.0006708768,0.0011799909,0.0011419524,0.00062747236,0.0011693559,0.0010602907],"category_scores_gemma":[0.0022628875,0.00084328733,0.0011281478,0.0011317396,0.0004111414,0.00070236286,0.00071847055,0.0015963976,0.00020286911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019086122,0.00025038322,0.99841046,0.000005936784,0.00007378924,0.000100331636,0.0002954169,0.000018066852,0.00017387427,0.000009098239,0.000050631144,0.0004212799],"study_design_scores_gemma":[0.000012715546,0.0001278557,0.9992555,0.0000035801122,0.000033322725,0.00006443763,0.00038893585,0.000048902355,0.000017016224,0.000006367534,0.000037277212,0.000004187879],"about_ca_topic_score_codex":0.035364926,"about_ca_topic_score_gemma":0.042314734,"teacher_disagreement_score":0.035364926,"about_ca_system_score_codex":0.00060293253,"about_ca_system_score_gemma":0.0008844083,"threshold_uncertainty_score":0.07031816},"labels":[],"label_agreement":null},{"id":"W4225397966","doi":"10.1007/s10549-022-06613-4","title":"Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)","year":2022,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Hôpital du Saint-Sacrement; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Oncology; Adjuvant; Internal medicine; Gynecology; Cancer","score_opus":0.04118652091838295,"score_gpt":0.36754859889728836,"score_spread":0.32636207797890543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225397966","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007446504,0.0008097614,0.00032855678,0.047895677,0.947338,0.000035343466,0.0016881336,0.00017582769,0.0016541675],"genre_scores_gemma":[0.006895228,0.0057172226,0.003701089,0.1911697,0.64262295,0.0004295847,0.0034781133,0.0013140641,0.14467205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948561,0.0012207755,0.00091181695,0.00062067644,0.0018400757,0.0005506537],"domain_scores_gemma":[0.9708312,0.011917552,0.0019565064,0.0017310872,0.011459265,0.0021044144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069419676,0.0029847668,0.0035814831,0.0032293948,0.0022549885,0.004165981,0.0045195823,0.0099886935,0.07185081],"category_scores_gemma":[0.06587119,0.0019360487,0.0029603748,0.0021259775,0.0019444384,0.0017041926,0.0013872214,0.016327862,0.035811026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108547276,0.000007401282,0.000036245157,0.00012541287,0.000023529932,0.00009169488,0.000005404029,0.000030087089,0.000017537348,0.00017724885,0.99712485,0.0022519957],"study_design_scores_gemma":[0.0008068983,0.000069977046,0.0012628573,0.00066631095,0.0001766024,0.0004932705,0.000033882967,0.0003623976,0.00026169582,0.0014834225,0.9943347,0.00004799427],"about_ca_topic_score_codex":0.018036159,"about_ca_topic_score_gemma":0.027025899,"teacher_disagreement_score":0.07185081,"about_ca_system_score_codex":0.005724365,"about_ca_system_score_gemma":0.005812005,"threshold_uncertainty_score":0.24036491},"labels":[],"label_agreement":null},{"id":"W4239318063","doi":"10.1007/s10549-006-9165-4","title":"Erratum to: The latest is the greatest? Results of a structured lecture about aromatase inhibitor use for breast cancer","year":2006,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Aromatase; Aromatase inhibitor; Breast cancer; Medicine; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.018807523383586596,"score_gpt":0.31490275768883597,"score_spread":0.29609523430524937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239318063","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005330996,0.002127639,0.00020846876,0.10583884,0.883056,0.000085267304,0.0005108857,0.00012781694,0.007511904],"genre_scores_gemma":[0.017660227,0.01314974,0.0030418378,0.29753146,0.33270463,0.00029123627,0.002456245,0.0006563774,0.33250818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846953,0.0002408863,0.00026768682,0.000102537706,0.00075397355,0.00016536182],"domain_scores_gemma":[0.99315155,0.001743897,0.00038171542,0.00022338703,0.0036055679,0.00089385925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017309891,0.0012552895,0.001277394,0.0014238119,0.0016920295,0.0017197768,0.0013006075,0.005297531,0.035560362],"category_scores_gemma":[0.013817556,0.0005384137,0.0013819897,0.00069583766,0.0005214235,0.0009220365,0.00070843275,0.0057592113,0.020005252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001289944,0.00002926696,0.000118281976,0.000054131902,0.0000054050315,0.00023043397,0.000007121509,0.000023940316,0.000044147688,0.00006129136,0.99417806,0.0051188977],"study_design_scores_gemma":[0.0002858799,0.00024665054,0.0041897474,0.0005449985,0.00008742207,0.00078929117,0.00017826859,0.0003036346,0.00074745447,0.00037195027,0.9922058,0.00004902774],"about_ca_topic_score_codex":0.0076403148,"about_ca_topic_score_gemma":0.01644539,"teacher_disagreement_score":0.035560362,"about_ca_system_score_codex":0.0022037295,"about_ca_system_score_gemma":0.0025676324,"threshold_uncertainty_score":0.118961275},"labels":[],"label_agreement":null},{"id":"W4241563663","doi":"10.1007/s10549-008-0208-x","title":"Cognitive impairments associated with breast cancer treatments: results from a longitudinal study","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cognition; Cancer; Longitudinal study; Internal medicine; Psychiatry; Pathology","score_opus":0.10710883099612725,"score_gpt":0.39662519745529545,"score_spread":0.28951636645916823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241563663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976292,0.0014624262,0.00007101517,0.00007284652,0.000013882664,0.000041837822,0.0004415195,0.0000031591671,0.00026403484],"genre_scores_gemma":[0.99663347,0.0012931633,0.0002015406,0.0001559555,0.000029468854,0.000110587105,0.0011045631,0.0000040848786,0.00046726567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986405,0.0005801226,0.00015060838,0.00023718756,0.00019300176,0.00019864272],"domain_scores_gemma":[0.99376386,0.0011237008,0.0022687996,0.00073961425,0.0011466246,0.00095738494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004449588,0.00070006365,0.0008874688,0.0011875445,0.0017848358,0.001334289,0.000757167,0.00094362826,0.0008531843],"category_scores_gemma":[0.007402005,0.0006904619,0.0017479714,0.0023744465,0.0006163812,0.0011091433,0.0010877158,0.0014249791,0.0002446227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018907759,0.0008185069,0.9919996,0.000051023984,0.0011816481,0.00006614421,0.00063527696,0.00003320384,0.00016393376,0.000020283747,0.00023425324,0.0029053215],"study_design_scores_gemma":[0.00010459256,0.0006091534,0.99786097,0.000021128952,0.0005653304,0.0000633034,0.00042482186,0.000030261814,0.00005409115,0.000017771266,0.00023834722,0.000010340266],"about_ca_topic_score_codex":0.048201974,"about_ca_topic_score_gemma":0.056385707,"teacher_disagreement_score":0.048201974,"about_ca_system_score_codex":0.001228088,"about_ca_system_score_gemma":0.0015419524,"threshold_uncertainty_score":0.09584284},"labels":[],"label_agreement":null},{"id":"W4242719372","doi":"10.1023/b:brea.0000018384.64326.dd","title":"Mitogenic Properties of Insulin-Like Growth Factors I and II, Insulin-like Growth Factor Binding Protein-3 and Epidermal Growth Factor on Human Breast Stromal Cells in Primary Culture","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Stromal cell; Epidermal growth factor; Growth factor; Endocrinology; Growth factor receptor inhibitor; Internal medicine; Cancer research; Insulin-like growth factor; Biology; Cell growth; Insulin-like growth factor-binding protein; Medicine; Receptor; Biochemistry","score_opus":0.05255183529351035,"score_gpt":0.2998606397421739,"score_spread":0.24730880444866357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242719372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9408917,0.013515446,0.009762398,0.00039851383,0.00042084348,0.00034373358,0.006249222,0.0003407274,0.028077392],"genre_scores_gemma":[0.95088774,0.006866979,0.007984328,0.00030870666,0.0003279988,0.0003636028,0.013461834,0.00014224762,0.019656481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954444,0.0001317006,0.00004557354,0.000049580034,0.000103166865,0.00012549032],"domain_scores_gemma":[0.9988537,0.00066453934,0.000036013564,0.000113891656,0.00016141299,0.00017046952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064452505,0.0008428411,0.00059269246,0.0007413349,0.0004955806,0.000477886,0.0004747391,0.00025687634,0.004175432],"category_scores_gemma":[0.00046494196,0.00039293393,0.00068558246,0.0007944696,0.00036783004,0.00031186955,0.00039866564,0.000863338,0.0012343592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010525372,0.0000922769,0.00059881003,0.000115909395,0.000015569889,0.00021317924,0.00012843712,0.000113602706,0.9952559,0.00020376538,0.00029101767,0.0019190543],"study_design_scores_gemma":[0.00006507568,0.00083643745,0.013680588,0.000027422522,0.000056252764,0.00045192265,0.00011976055,0.00079716585,0.9786466,0.00013617982,0.0051715374,0.000011115208],"about_ca_topic_score_codex":0.0060764966,"about_ca_topic_score_gemma":0.007653606,"teacher_disagreement_score":0.0060764966,"about_ca_system_score_codex":0.00050556904,"about_ca_system_score_gemma":0.00059925794,"threshold_uncertainty_score":0.01396817},"labels":[],"label_agreement":null},{"id":"W4250267835","doi":"10.1007/s10549-011-1797-3","title":"Erratum to: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment","year":2011,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Cell; Cancer research; Medicine; Cell migration; Proto-oncogene tyrosine-protein kinase Src; Oncology; Biology; Internal medicine; Cancer; Receptor; Genetics","score_opus":0.030188439443543873,"score_gpt":0.30998261863591203,"score_spread":0.27979417919236815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250267835","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018908389,0.0027054993,0.00019157711,0.032182634,0.9623711,0.000018185068,0.00016760422,0.000055987413,0.0021182098],"genre_scores_gemma":[0.010615052,0.032572094,0.003461755,0.12155372,0.5887662,0.00017682879,0.0015484008,0.00047891072,0.24082701],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976184,0.0002837454,0.0006305923,0.00021914941,0.0009955383,0.00025263353],"domain_scores_gemma":[0.9906589,0.0023053295,0.0006454192,0.0005094188,0.0052172095,0.0006637836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025662244,0.0026295485,0.0024523956,0.0035255637,0.0028113425,0.0027299994,0.0027000064,0.009306447,0.024126122],"category_scores_gemma":[0.017732287,0.0014689077,0.0020121625,0.0020085615,0.0018859656,0.0023393466,0.001348052,0.00940511,0.022093454],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009910618,0.000022278497,0.00012531171,0.0001921905,0.00001803777,0.0009760036,0.000016921002,0.000056046283,0.00012903886,0.00037269402,0.9896784,0.008313993],"study_design_scores_gemma":[0.00008347835,0.00008259209,0.0017083646,0.0004329609,0.00012631484,0.0024097376,0.00013020229,0.00028955232,0.00083536055,0.0006541434,0.9931982,0.00004905825],"about_ca_topic_score_codex":0.008494966,"about_ca_topic_score_gemma":0.014329989,"teacher_disagreement_score":0.024126122,"about_ca_system_score_codex":0.0036323348,"about_ca_system_score_gemma":0.0038926625,"threshold_uncertainty_score":0.080709875},"labels":[],"label_agreement":null},{"id":"W4253346138","doi":"10.1007/s10549-012-2178-2","title":"Erratum to: 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1","year":2012,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Breast cancer; Tamoxifen; Medicine; Obesity; Oncology; Internal medicine; Cancer; Gynecology; Endocrinology","score_opus":0.010041688378690187,"score_gpt":0.2882597292784426,"score_spread":0.27821804089975244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253346138","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036551761,0.008442767,0.00071519875,0.09575477,0.8805234,0.00007007581,0.005621736,0.00021923488,0.0049976795],"genre_scores_gemma":[0.08016032,0.025547061,0.0071221762,0.22903016,0.33753768,0.00042150758,0.01537811,0.0012572953,0.30354574],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992267,0.00013204967,0.00025547817,0.00009204147,0.00021413348,0.0000795514],"domain_scores_gemma":[0.9928838,0.0028349771,0.00049147033,0.00039344354,0.0028819472,0.000514412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015908942,0.0013790198,0.0016521732,0.0022203317,0.0011629703,0.0015317211,0.0012068201,0.0028902832,0.02136152],"category_scores_gemma":[0.02094148,0.0006632917,0.0012940371,0.0014650716,0.0005842675,0.0009314682,0.0004492726,0.0036073187,0.010866956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032848748,0.000033748518,0.0024273442,0.00019842236,0.000053831416,0.0007680724,0.000018422445,0.00007108872,0.00007039149,0.0002549135,0.98671806,0.0090572415],"study_design_scores_gemma":[0.00062254997,0.00029606294,0.038093336,0.0014003187,0.0006505151,0.007205165,0.00037386338,0.0011169697,0.0010509549,0.0013351069,0.9477129,0.00014224507],"about_ca_topic_score_codex":0.014008953,"about_ca_topic_score_gemma":0.021254245,"teacher_disagreement_score":0.02136152,"about_ca_system_score_codex":0.0013405017,"about_ca_system_score_gemma":0.0022702797,"threshold_uncertainty_score":0.07146144},"labels":[],"label_agreement":null},{"id":"W4281399319","doi":"10.1007/s10549-022-06626-z","title":"Breast reconstruction and quality of life five years after cancer diagnosis: VICAN French National cohort","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé; Ligue Contre le Cancer","keywords":"Medicine; Breast cancer; Cohort; Quality of life (healthcare); Mastectomy; Socioeconomic status; Breast reconstruction; Mental health; Cohort study; Cancer; Gerontology; Demography; Internal medicine; Psychiatry; Population; Environmental health","score_opus":0.05271845942973064,"score_gpt":0.3620642759755856,"score_spread":0.30934581654585497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281399319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918948,0.0019537115,0.00014234315,0.00038188882,0.000037445974,0.000015750396,0.004105698,0.0000094736415,0.0014588627],"genre_scores_gemma":[0.99150956,0.00095933315,0.0001648534,0.00017986888,0.000030324401,0.00004025749,0.0048192297,0.00001051401,0.0022859576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990627,0.00020750193,0.000048325328,0.00021812979,0.00011548704,0.00034781796],"domain_scores_gemma":[0.99896467,0.000117966825,0.0003041686,0.00009522972,0.00025484187,0.00026310526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013073531,0.0007333702,0.00070736423,0.0016202219,0.0011995845,0.0016947848,0.0009690574,0.0012480441,0.0028460436],"category_scores_gemma":[0.0018514073,0.00056313834,0.0016504658,0.0020014017,0.0003106733,0.000708421,0.0010538292,0.0010230411,0.00044082938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017777907,0.00006838728,0.99518114,0.000017015118,0.00037984765,0.00014399363,0.00026752395,0.00013617723,0.0001273305,0.00012787373,0.0012609501,0.0021118682],"study_design_scores_gemma":[0.000012157864,0.00004673221,0.99771214,0.000033386576,0.00007652043,0.00014566853,0.00050519675,0.00017287121,0.000016202488,0.000028230248,0.0012395814,0.000011322449],"about_ca_topic_score_codex":0.49419534,"about_ca_topic_score_gemma":0.47171703,"teacher_disagreement_score":0.49419534,"about_ca_system_score_codex":0.0042237765,"about_ca_system_score_gemma":0.0025725742,"threshold_uncertainty_score":0.9826376},"labels":[],"label_agreement":null},{"id":"W4281620344","doi":"10.1007/s10549-022-06631-2","title":"Excision of breast fibroepithelial lesions: when is it still necessary?—A 10-year review of a regional centre","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of British Columbia","funders":"","keywords":"Medicine; Fibroadenoma; Pathological; Logistic regression; Lesion; Biopsy; Phyllodes tumor; Radiology; Surgical excision; Breast cancer; Cancer; Surgery; Internal medicine","score_opus":0.19095347585918995,"score_gpt":0.42800892669145346,"score_spread":0.2370554508322635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281620344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051013958,0.9997266,0.000014560429,0.00007242108,0.00003860233,0.0000021732903,0.00001033148,9.935445e-7,0.00008328369],"genre_scores_gemma":[0.0004152344,0.99927264,0.000056442474,0.00015861962,0.00003986402,0.0000022522925,0.000018668981,7.8616586e-7,0.000035549612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992248,0.00016634513,0.00022575005,0.00013570739,0.00019331719,0.000054113134],"domain_scores_gemma":[0.9975816,0.0014611352,0.00043374224,0.000046272806,0.00037374248,0.00010353893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019706367,0.0009958403,0.0034064597,0.0042212186,0.0003254591,0.0015010615,0.001519768,0.0013515585,0.0031315773],"category_scores_gemma":[0.0033418809,0.00052867085,0.0019060458,0.004580393,0.00073673745,0.0017976989,0.00094987254,0.0014372756,0.0008937007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003307362,0.000054983826,0.0006034086,0.13521253,0.0008022042,0.000325223,0.00012453074,0.0002504703,0.0007927463,0.0007047823,0.01892738,0.8418711],"study_design_scores_gemma":[0.00028099748,0.0005897647,0.009861772,0.21008123,0.0072933217,0.0062127616,0.0006103276,0.0001683436,0.0006380952,0.0009885104,0.76316756,0.00010727729],"about_ca_topic_score_codex":0.0028670183,"about_ca_topic_score_gemma":0.008492303,"teacher_disagreement_score":0.0042212186,"about_ca_system_score_codex":0.0010976191,"about_ca_system_score_gemma":0.0023532654,"threshold_uncertainty_score":0.010476112},"labels":[],"label_agreement":null},{"id":"W4282931672","doi":"10.1007/s10549-022-06640-1","title":"Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency; University of Waterloo","funders":"","keywords":"Medicine; Breast cancer; Breast MRI; Stage (stratigraphy); Neoadjuvant therapy; Radiology; Magnetic resonance imaging; Prospective cohort study; Cancer; Mammography; Internal medicine","score_opus":0.06731858544311073,"score_gpt":0.4083742778777368,"score_spread":0.3410556924346261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282931672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83407897,0.13238853,0.0020935559,0.003167573,0.00034689045,0.00019448031,0.0003019694,0.000054709304,0.027373262],"genre_scores_gemma":[0.9775114,0.019184034,0.0014717678,0.00030501594,0.0002872498,0.000047866746,0.00013794914,0.000011529541,0.001043166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995407,0.0003485204,0.000024375528,0.000018952747,0.00003909664,0.000028405868],"domain_scores_gemma":[0.9982425,0.0010034151,0.0002425753,0.000078968216,0.00028179752,0.00015086772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020882296,0.00035699547,0.00046226193,0.00066984055,0.0002098917,0.00057916634,0.00024607911,0.00045432738,0.0013111482],"category_scores_gemma":[0.005567049,0.00014816968,0.00016377408,0.0005930544,0.00043378113,0.0005224561,0.0001647442,0.0004637062,0.00020884008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044762235,0.0011698273,0.44648203,0.002085956,0.00034287228,0.002364824,0.00030324093,0.0023784058,0.09028507,0.00092499715,0.0027901756,0.4061104],"study_design_scores_gemma":[0.0008454909,0.021121792,0.89671093,0.0009294924,0.0013328544,0.0065287543,0.00086496223,0.0033683737,0.045164723,0.0014548794,0.021585213,0.00009248852],"about_ca_topic_score_codex":0.001547662,"about_ca_topic_score_gemma":0.0030386683,"teacher_disagreement_score":0.0020882296,"about_ca_system_score_codex":0.0004566296,"about_ca_system_score_gemma":0.0006475347,"threshold_uncertainty_score":0.011043787},"labels":[],"label_agreement":null},{"id":"W4283265318","doi":"10.1007/s10549-022-06646-9","title":"Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer: a population-based analysis","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Breast cancer; Internal medicine; Chemotherapy; Cohort; Proportional hazards model; Population; Cancer; Oncology; Mastectomy; Survival analysis; Cohort study; Confidence interval; Gynecology","score_opus":0.02704962814871996,"score_gpt":0.3511521609248528,"score_spread":0.3241025327761328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283265318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992311,0.00023337473,0.000061377104,0.000016555052,0.000003343098,0.0000036546512,0.00027995408,0.0000016353606,0.00016897397],"genre_scores_gemma":[0.99920315,0.0001475742,0.000031031774,0.00001976386,0.000009042749,0.0000064523265,0.00041405423,0.0000014056296,0.00016747294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999585,0.000119881326,0.000052508,0.00011697659,0.000050922452,0.000074776246],"domain_scores_gemma":[0.9992261,0.00016522707,0.00025294776,0.00008731592,0.0000989991,0.00016942511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007260594,0.00035296718,0.00063154794,0.0011207424,0.00057952746,0.0006809047,0.00034150857,0.00063040986,0.0012502767],"category_scores_gemma":[0.0012568772,0.00034794005,0.0010872346,0.0016437585,0.0003017241,0.0006135458,0.00051920046,0.0005956063,0.00022479157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046616307,0.00003920688,0.9981723,0.000007739696,0.00026788877,0.00007677872,0.00006443031,0.00003251127,0.00020435506,0.000009556693,0.000042275748,0.0006169135],"study_design_scores_gemma":[0.000012963154,0.00017663927,0.9991148,0.0000026831617,0.00015017408,0.00012596793,0.00020165124,0.0000818322,0.000024142075,0.000011735158,0.000093473405,0.000003938441],"about_ca_topic_score_codex":0.008657353,"about_ca_topic_score_gemma":0.008510353,"teacher_disagreement_score":0.008657353,"about_ca_system_score_codex":0.00033021538,"about_ca_system_score_gemma":0.00023742783,"threshold_uncertainty_score":0.01721394},"labels":[],"label_agreement":null},{"id":"W4283787414","doi":"10.1007/s10549-022-06656-7","title":"Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Breast cancer; Medicine; Family history; Cancer; Internal medicine; Hazard ratio; Oncology; Guideline; Gynecology; Cancer prevention; Body mass index; Obstetrics; Confidence interval; Pathology","score_opus":0.06836903123576685,"score_gpt":0.42360988495206436,"score_spread":0.35524085371629754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283787414","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06742407,0.06445824,0.056003366,0.5034356,0.024429457,0.016670007,0.053162705,0.003711616,0.21070483],"genre_scores_gemma":[0.24477573,0.065177776,0.27520528,0.23862049,0.00467148,0.02288346,0.081070215,0.0010759786,0.066519536],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.97757626,0.007202446,0.0041618464,0.00044957435,0.009642793,0.0009671406],"domain_scores_gemma":[0.95910525,0.007991015,0.005656813,0.0015741612,0.022258287,0.003414525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025131214,0.0004937156,0.0015054861,0.0021785435,0.0011917079,0.0015868518,0.0026665688,0.0043643606,0.003513877],"category_scores_gemma":[0.055097416,0.00075368246,0.002667368,0.0026534419,0.00045540358,0.0010827896,0.0015508677,0.005455845,0.0023645228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021554527,0.0011041575,0.043547884,0.0011433733,0.0004353993,0.00013120206,0.0003814109,0.0011946044,0.00042722537,0.0013389249,0.7005197,0.2495606],"study_design_scores_gemma":[0.0007976905,0.0008013079,0.34224433,0.014264388,0.0011010175,0.00063804,0.0013010947,0.0050093047,0.001164862,0.0032650284,0.6291711,0.00024183725],"about_ca_topic_score_codex":0.082196176,"about_ca_topic_score_gemma":0.14151397,"teacher_disagreement_score":0.082196176,"about_ca_system_score_codex":0.0026330887,"about_ca_system_score_gemma":0.0178438,"threshold_uncertainty_score":0.16343546},"labels":[],"label_agreement":null},{"id":"W4288902525","doi":"10.1007/s10549-022-06650-z","title":"Risk of recurrence and pregnancy outcomes in young women with breast cancer who do and do not undergo fertility preservation","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Pacific Centre for Reproductive Medicine; Sunnybrook Health Science Centre; Credit Valley Hospital; William Osler Health System; Trillium Health Centre; University of British Columbia; University of Calgary","funders":"","keywords":"Medicine; Fertility preservation; Breast cancer; Pregnancy; Fertility; Gynecology; Odds ratio; Clinical endpoint; Internal medicine; Proportional hazards model; Obstetrics; Cancer; Oncology; Population; Randomized controlled trial","score_opus":0.04964507820425152,"score_gpt":0.3550865978342504,"score_spread":0.3054415196299989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288902525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883634,0.00054606533,0.000019636762,0.00007924339,0.000007862023,0.0000034119996,0.00016072494,0.0000015875536,0.00034506922],"genre_scores_gemma":[0.9992304,0.0003075252,0.000017162998,0.000036704518,0.000011004732,0.000004263815,0.00016961529,0.0000012342787,0.0002221846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998354,0.000028296503,0.000015079685,0.000025125295,0.000026148133,0.00006996863],"domain_scores_gemma":[0.999027,0.00025430616,0.00038915576,0.00004353766,0.000039767125,0.00024618645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026812547,0.00012434708,0.00027302577,0.0004944458,0.00035992425,0.00046479685,0.00023336048,0.0005447922,0.0016605423],"category_scores_gemma":[0.0024413757,0.00022230399,0.0006828627,0.00050419895,0.00021982506,0.00041409876,0.00038093133,0.00066455815,0.00016268552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016524595,0.000026940257,0.99837625,0.0000050061585,0.000025299705,0.00009683664,0.00006802161,0.00001864608,0.000050823302,0.000014703594,0.00004841317,0.0011037329],"study_design_scores_gemma":[0.0000072644475,0.00010070064,0.99892235,0.00000773146,0.000028658764,0.00037976165,0.00031284287,0.00009217794,0.000024117637,0.000034785116,0.00008645033,0.000003240909],"about_ca_topic_score_codex":0.008340226,"about_ca_topic_score_gemma":0.00959447,"teacher_disagreement_score":0.008340226,"about_ca_system_score_codex":0.00025578783,"about_ca_system_score_gemma":0.00045019345,"threshold_uncertainty_score":0.016583383},"labels":[],"label_agreement":null},{"id":"W4288941108","doi":"10.1007/s10549-022-06674-5","title":"Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University Belfast; Queen's University; Cancer Research UK","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Cancer; Oncology; Proportional hazards model; Cohort; Cohort study; Population; Cancer registry; Epidemiology; Epidemiology of cancer; Gynecology; Confidence interval","score_opus":0.044264744456994944,"score_gpt":0.3504026034994008,"score_spread":0.3061378590424058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288941108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586123,0.0015702154,0.00014795133,0.00012104536,0.00001687043,0.000039225746,0.0015504566,0.0000067148508,0.0006864109],"genre_scores_gemma":[0.99802977,0.0006159886,0.00009618069,0.00010155402,0.000017789416,0.000028494718,0.0009434324,0.000002298575,0.0001644296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874914,0.000356911,0.00017733857,0.00030052828,0.00026931503,0.00014679412],"domain_scores_gemma":[0.99792826,0.0002365758,0.0010218773,0.00016757475,0.0003676594,0.00027797394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087062374,0.00041801194,0.0006500441,0.0011840668,0.00043985885,0.0006561386,0.0005207766,0.0006268155,0.0016237407],"category_scores_gemma":[0.003017634,0.00044280273,0.00075803406,0.0021075858,0.00042437259,0.00056653516,0.00094981823,0.0005627839,0.00040698994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067734974,0.000016404547,0.9982792,0.00004634621,0.000060434228,0.00013923216,0.0001264843,0.0000249031,0.00015917924,0.000011036518,0.00018857757,0.0008803894],"study_design_scores_gemma":[0.0000132451805,0.000063882086,0.99917406,0.000028389086,0.000029513842,0.000303617,0.00008503161,0.00006371878,0.00001938907,0.000008728361,0.00020553556,0.000004741149],"about_ca_topic_score_codex":0.04312959,"about_ca_topic_score_gemma":0.03453792,"teacher_disagreement_score":0.04312959,"about_ca_system_score_codex":0.0011287739,"about_ca_system_score_gemma":0.0006131098,"threshold_uncertainty_score":0.08575708},"labels":[],"label_agreement":null},{"id":"W4293331767","doi":"10.1007/s10549-022-06715-z","title":"Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; Western University; University of Windsor","funders":"Canadian Institutes of Health Research","keywords":"Tamoxifen; Breast cancer; Cancer research; Biology; Cancer; Medicine; Internal medicine","score_opus":0.02243779155938513,"score_gpt":0.3203811366636735,"score_spread":0.2979433451042884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293331767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941865,0.0032534944,0.00058653805,0.00025673176,0.00006248616,0.000017000964,0.00016521938,0.00008980132,0.0013822038],"genre_scores_gemma":[0.9973144,0.0009333522,0.0004440354,0.00003738773,0.000020340112,0.00001779478,0.00023579819,0.000016838347,0.0009801285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982136,0.000025840203,0.000013198791,0.000025371553,0.000059335594,0.000054809403],"domain_scores_gemma":[0.999819,0.00003714145,0.000041661562,0.00002341066,0.000019246967,0.000059553313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019059933,0.00022348581,0.00048737027,0.00031153194,0.00023230068,0.000305535,0.00025494953,0.00029234646,0.0015852042],"category_scores_gemma":[0.00030570343,0.00012731152,0.00019490287,0.00021289832,0.0002532317,0.00024362671,0.00021219064,0.0010071723,0.00031370256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012732754,0.0002746541,0.0006963134,0.000063008105,0.000021505086,0.000045648296,0.000015106279,0.00029984044,0.9844381,0.00021947865,0.000515707,0.012137327],"study_design_scores_gemma":[0.00013785799,0.0018312206,0.008029125,0.000008890892,0.000032673735,0.00032038058,0.000038819122,0.0019027205,0.98340285,0.000092105634,0.004195025,0.000008413988],"about_ca_topic_score_codex":0.00034561427,"about_ca_topic_score_gemma":0.0008109415,"teacher_disagreement_score":0.0015852042,"about_ca_system_score_codex":0.00031185852,"about_ca_system_score_gemma":0.00032494168,"threshold_uncertainty_score":0.005303085},"labels":[],"label_agreement":null},{"id":"W4296129100","doi":"10.1007/s10549-022-06744-8","title":"Impact of body mass index on survival in women receiving chemotherapy for early breast cancer","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Epirubicin; Internal medicine; Anthracycline; Body mass index; Breast cancer; Cohort; Overweight; Underweight; Retrospective cohort study; Docetaxel; Population; Cyclophosphamide; Cancer; Oncology; Chemotherapy","score_opus":0.0460481916780641,"score_gpt":0.40230897390144643,"score_spread":0.3562607822233823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296129100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951054,0.0021145036,0.000043705175,0.00052409386,0.00005747573,0.000004506533,0.0004310082,0.000006152855,0.0017131099],"genre_scores_gemma":[0.9986395,0.00048499586,0.000023958977,0.00008669332,0.000051736046,0.0000022201234,0.00026228194,0.0000028188485,0.00044569094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974245,0.00009467734,0.000016572403,0.000027605596,0.00003397276,0.00008474173],"domain_scores_gemma":[0.99870574,0.00048042627,0.00034361833,0.00006515083,0.00008213099,0.0003228784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040756457,0.0002523871,0.0003549126,0.00045543158,0.00031808417,0.00056179083,0.0002483951,0.00053926423,0.0022614754],"category_scores_gemma":[0.0029049928,0.00018779725,0.00091142795,0.0007132765,0.00023684945,0.00034129602,0.00045266587,0.0009049377,0.00020590411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016156525,0.000098011384,0.9925794,0.00001652835,0.00020675726,0.000088049084,0.000036460806,0.00014422824,0.00022503642,0.000025493926,0.00016861234,0.0047957683],"study_design_scores_gemma":[0.0000129328855,0.00015734923,0.9992556,0.0000054959887,0.00010790543,0.000052484695,0.00006451788,0.00016497892,0.00002620727,0.00002888951,0.000120965036,0.0000027659348],"about_ca_topic_score_codex":0.0085112145,"about_ca_topic_score_gemma":0.011534906,"teacher_disagreement_score":0.0085112145,"about_ca_system_score_codex":0.00036016782,"about_ca_system_score_gemma":0.0004776184,"threshold_uncertainty_score":0.016923368},"labels":[],"label_agreement":null},{"id":"W4309889494","doi":"10.1007/s10549-022-06812-z","title":"Estimating the incidence of breast cancer recurrence using administrative data","year":2022,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Breast cancer; Incidence (geometry); Metastasis; Cancer; Internal medicine; Stage (stratigraphy); Oncology; Cancer registry; Distant metastasis; Primary tumor; Comorbidity","score_opus":0.16635457659894268,"score_gpt":0.4470585430517837,"score_spread":0.280703966452841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309889494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667371,0.003160995,0.015821256,0.0005727227,0.00003414172,0.0001328555,0.011191476,0.00010679087,0.0022426485],"genre_scores_gemma":[0.98557174,0.0010396808,0.0058609205,0.00007855114,0.000039514867,0.00008895257,0.006816238,0.000009108073,0.0004953215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99378467,0.0043816706,0.0005194579,0.0005249402,0.0004964901,0.0002926921],"domain_scores_gemma":[0.9801119,0.01152489,0.0040600467,0.002930111,0.0011420598,0.00023100965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072939475,0.00040350924,0.00094681536,0.0027127012,0.00027999014,0.0011128649,0.0013200142,0.0006732845,0.0011088168],"category_scores_gemma":[0.029256007,0.00055795454,0.002071354,0.0036609317,0.00021573539,0.0007229559,0.00086228113,0.0010070058,0.0004124958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002618921,0.00009980484,0.9759409,0.00011532844,0.0011521732,0.000051428065,0.00006890583,0.0052844286,0.00014784026,0.0006428824,0.000742601,0.01549193],"study_design_scores_gemma":[0.00016097909,0.00043905817,0.9531597,0.000104108236,0.0015896099,0.00034586416,0.0004240739,0.038629036,0.0007501564,0.0021228602,0.002237457,0.00003701559],"about_ca_topic_score_codex":0.03599228,"about_ca_topic_score_gemma":0.023774322,"teacher_disagreement_score":0.03599228,"about_ca_system_score_codex":0.00077758194,"about_ca_system_score_gemma":0.0011242952,"threshold_uncertainty_score":0.07156551},"labels":[],"label_agreement":null},{"id":"W4309924041","doi":"10.1007/s10549-022-06792-0","title":"Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: a systematic review","year":2022,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Queensland","keywords":"Breast cancer; Circadian rhythm; Medicine; Cancer; Oncology; Internal medicine; Confounding; Cohort study; Cohort","score_opus":0.12611101170459846,"score_gpt":0.4197784252101648,"score_spread":0.29366741350556635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309924041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013727125,0.99759465,0.00008679592,0.00016832745,0.00006801848,0.00013151029,0.0004123844,0.000006025083,0.00015949938],"genre_scores_gemma":[0.016007489,0.9827015,0.0003020831,0.00029191966,0.00005971929,0.00027536158,0.00026991303,0.0000037745983,0.00008826435],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964359,0.0010823652,0.0013381814,0.0003591927,0.0006358948,0.00014849524],"domain_scores_gemma":[0.9789778,0.014710695,0.0043304916,0.00025832086,0.0014923008,0.00023038854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044757146,0.0011348358,0.0059398892,0.0065760263,0.00052839576,0.0020726821,0.0014452114,0.0016471674,0.0035320728],"category_scores_gemma":[0.027719796,0.00087423436,0.007162063,0.0086171245,0.00054989965,0.0014609472,0.0011718799,0.00086960517,0.00026294484],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015512835,0.0000144022115,0.0018778543,0.9599238,0.00834932,0.00008222816,0.0001614343,0.00010799157,0.00008981601,0.000115101,0.0013027686,0.027820192],"study_design_scores_gemma":[0.0001695844,0.00021357747,0.012424631,0.8898907,0.080465734,0.00042268907,0.00026142318,0.00010859074,0.00012665638,0.0002388403,0.015632624,0.000044983673],"about_ca_topic_score_codex":0.01252654,"about_ca_topic_score_gemma":0.030029928,"teacher_disagreement_score":0.01252654,"about_ca_system_score_codex":0.0025606637,"about_ca_system_score_gemma":0.010008915,"threshold_uncertainty_score":0.024907231},"labels":[],"label_agreement":null},{"id":"W4313545061","doi":"10.1007/s10549-022-06854-3","title":"A rare but persistent cause of decreased function secondary to adjuvant radiation therapy in women with breast cancer","year":2023,"lang":"en","type":"letter","venue":"Breast Cancer Research and Treatment","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Breast cancer; Medicine; Radiation therapy; Adjuvant radiotherapy; Oncology; Cancer; Internal medicine; Adjuvant; Adjuvant therapy","score_opus":0.0508902963238128,"score_gpt":0.3322693203768117,"score_spread":0.2813790240529989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313545061","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3538396,0.016402682,0.0014320874,0.54875517,0.011890183,0.000069211346,0.0005603021,0.00021103142,0.06683988],"genre_scores_gemma":[0.8650948,0.0044630016,0.000519956,0.10371508,0.017371086,0.000026509018,0.00018149345,0.000048813934,0.008579221],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994821,0.00013630767,0.00006654163,0.00005921497,0.00009447827,0.00016142061],"domain_scores_gemma":[0.9979504,0.00092555414,0.00045163714,0.00013338216,0.00019883778,0.00034027468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043452712,0.00025987308,0.0004797653,0.00054802746,0.0013240044,0.00079964305,0.000564953,0.0067631626,0.0020900758],"category_scores_gemma":[0.0062863473,0.00023874718,0.00047410256,0.0006129777,0.00078809244,0.000609075,0.0005589326,0.0037212772,0.00076778355],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041097094,0.00016857835,0.15803993,0.00015387399,0.00006684399,0.68520325,0.0009843273,0.00020564123,0.0016323763,0.00249617,0.12634882,0.024289194],"study_design_scores_gemma":[0.00010642181,0.00039553738,0.08966208,0.00028506256,0.000103672995,0.842041,0.0018008219,0.0011000511,0.000498579,0.0029311557,0.061020818,0.000054834356],"about_ca_topic_score_codex":0.002940382,"about_ca_topic_score_gemma":0.005589843,"teacher_disagreement_score":0.0067631626,"about_ca_system_score_codex":0.0010619649,"about_ca_system_score_gemma":0.00094484544,"threshold_uncertainty_score":0.0077050924},"labels":[],"label_agreement":null},{"id":"W4319293765","doi":"10.1007/s10549-023-06861-y","title":"False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Sinai Health System; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiology; Breast cancer; Breast MRI; Breast imaging; Univariate analysis; Mammography; Biopsy; Magnetic resonance imaging; Histopathology; Retrospective cohort study; Logistic regression; Lesion; Cancer; Pathology; Internal medicine; Multivariate analysis","score_opus":0.06323039931296562,"score_gpt":0.4349031769445479,"score_spread":0.37167277763158224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319293765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925625,0.0031854315,0.0010128848,0.00030881134,0.000058934926,0.00003158295,0.00010363406,0.000041086983,0.0026951078],"genre_scores_gemma":[0.9984535,0.00051724556,0.00054396567,0.00010166916,0.00009011856,0.0000064403075,0.00009596237,0.000008311818,0.00018283246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948823,0.00008079524,0.000074162395,0.00006909004,0.0001440952,0.00014372246],"domain_scores_gemma":[0.9981153,0.0007166977,0.00040805605,0.0001776711,0.00022233152,0.00035997637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007882809,0.0008260801,0.0005678835,0.0015709072,0.0005006808,0.0009446722,0.0006318694,0.0015096427,0.0013102076],"category_scores_gemma":[0.0071729347,0.00041259255,0.0004328654,0.0006778755,0.0007481142,0.0009795681,0.0005264475,0.00056219555,0.0005976133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015796586,0.0002017085,0.6340133,0.00010817571,0.000048273123,0.33502713,0.0002988625,0.00025837126,0.015811808,0.0002122689,0.0005771487,0.011863325],"study_design_scores_gemma":[0.000033980352,0.00038902808,0.2790544,0.0000394814,0.00014256849,0.7109345,0.0004904783,0.0010990939,0.0066045304,0.00030677926,0.0008782611,0.000026922384],"about_ca_topic_score_codex":0.0006259146,"about_ca_topic_score_gemma":0.00048576389,"teacher_disagreement_score":0.0015709072,"about_ca_system_score_codex":0.00033141478,"about_ca_system_score_gemma":0.00027373055,"threshold_uncertainty_score":0.0043830276},"labels":[],"label_agreement":null},{"id":"W4321168145","doi":"10.1007/s10549-022-06848-1","title":"Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Medicine; Odds ratio; Confidence interval; Breast cancer; Breast cancer screening; Stage (stratigraphy); Demography; Logistic regression; Mammography; Cancer screening; Gynecology; Cancer; Internal medicine; Obstetrics","score_opus":0.2476520295429569,"score_gpt":0.43885493192785907,"score_spread":0.19120290238490217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321168145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968816,0.00025572616,0.000048112986,0.00036536827,0.000005144964,0.000031209045,0.0012692945,0.0000044714334,0.0011390559],"genre_scores_gemma":[0.9988539,0.00013337644,0.00004436019,0.000054433614,0.0000028447935,0.000015235007,0.0005459993,0.0000012021698,0.00034869788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999445,0.00007639907,0.000023717716,0.000069891896,0.00020369297,0.00018128632],"domain_scores_gemma":[0.998741,0.00012406934,0.0005046753,0.00004551919,0.00026634382,0.00031846887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005692334,0.00013655359,0.00020344443,0.0004171853,0.001046984,0.0004778516,0.00054777105,0.00025731293,0.0013120038],"category_scores_gemma":[0.0028936754,0.00024031545,0.0002919665,0.0013200804,0.00034872626,0.00031338062,0.0004579504,0.00039600002,0.00009455905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032404205,0.00002509736,0.99771655,0.000011968434,0.000014722577,0.00002231669,0.00026441782,0.000025588724,0.00003422945,0.000014480205,0.00047367846,0.0013645674],"study_design_scores_gemma":[0.0000029732541,0.000010633335,0.9995285,0.000008667517,0.0000064265364,0.000012226259,0.0001800028,0.00006548101,0.000005616615,0.000005148009,0.00017301839,0.0000012983414],"about_ca_topic_score_codex":0.94140935,"about_ca_topic_score_gemma":0.96769565,"teacher_disagreement_score":0.05859065,"about_ca_system_score_codex":0.0070149936,"about_ca_system_score_gemma":0.008822944,"threshold_uncertainty_score":0.117871344},"labels":[],"label_agreement":null},{"id":"W4321436546","doi":"10.1007/s10549-023-06872-9","title":"Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature","year":2023,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Università degli Studi di Pavia","keywords":"Concordance; Medicine; Biopsy; Breast cancer; Context (archaeology); Progesterone receptor; Immunohistochemistry; Cancer; Oestrogen receptor; Gynecology; Oncology; Internal medicine; Estrogen receptor","score_opus":0.06707423783327625,"score_gpt":0.4024659828294986,"score_spread":0.3353917449962223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321436546","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6235958,0.36652362,0.004681738,0.00039075885,0.00023681925,0.00018255472,0.00037107116,0.00008124042,0.0039363494],"genre_scores_gemma":[0.9186884,0.07707972,0.0031532813,0.00017748502,0.0001997258,0.000068895875,0.00032658674,0.000039346985,0.00026653978],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.98820776,0.0037084885,0.0033817734,0.0015603688,0.002833404,0.0003081751],"domain_scores_gemma":[0.97136474,0.016807133,0.0046305293,0.0016168071,0.0050392817,0.0005414195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010584936,0.0006599265,0.0013988621,0.0061834943,0.00046142002,0.0015385901,0.001735042,0.0009341928,0.0006660371],"category_scores_gemma":[0.029871253,0.000568678,0.00061925204,0.005846279,0.001561933,0.00103507,0.0008754135,0.00033723304,0.00037586672],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005593023,0.00019855888,0.6376062,0.009900865,0.0010541376,0.014705246,0.0058279303,0.00044756304,0.0047835214,0.00016302505,0.0022129402,0.3225407],"study_design_scores_gemma":[0.00005046015,0.0009431914,0.8200309,0.0054884832,0.0020797146,0.14715245,0.0064879423,0.0008132113,0.0043647764,0.00025712734,0.012171327,0.0001604405],"about_ca_topic_score_codex":0.001502239,"about_ca_topic_score_gemma":0.0019210131,"teacher_disagreement_score":0.010584936,"about_ca_system_score_codex":0.0007443818,"about_ca_system_score_gemma":0.00085554965,"threshold_uncertainty_score":0.055979133},"labels":[],"label_agreement":null},{"id":"W4323036952","doi":"10.1007/s10549-023-06886-3","title":"Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; South African Medical Research Council; Medical Research Council; National Cancer Institute; National Institutes of Health; Canada Excellence Research Chairs, Government of Canada; National Research Foundation","keywords":"Subtyping; Concordance; Immunohistochemistry; Breast cancer; Oncology; Medicine; Internal medicine; Cancer; Population; Pathology","score_opus":0.02673833638178889,"score_gpt":0.3236112366129637,"score_spread":0.2968729002311748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323036952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999363,0.00011194734,0.00007251476,0.000026730118,0.0000030546453,0.000004059952,0.000048812002,0.0000014332682,0.00036851453],"genre_scores_gemma":[0.9997907,0.000034834222,0.00006655958,0.000009236287,0.0000029586222,0.000004090834,0.00004089689,0.0000010401184,0.00004961732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990128,0.00034431327,0.00010157381,0.00018255359,0.00019133512,0.00016736153],"domain_scores_gemma":[0.9983608,0.00059703103,0.00056749064,0.00017707059,0.00020354187,0.000094091534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013220822,0.00024164552,0.00019842245,0.0010811342,0.00052152766,0.00046271936,0.0003550148,0.00035356163,0.001806828],"category_scores_gemma":[0.0058722296,0.00022366786,0.00016924526,0.00077526615,0.0005706553,0.00024755934,0.0007409277,0.00024200106,0.00025955215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094803654,0.0000054488864,0.996852,0.000013406465,0.000009497653,0.00020372501,0.00037097617,0.000029305795,0.00078246515,0.000024939101,0.000047565005,0.0015659269],"study_design_scores_gemma":[0.0000042801635,0.00006356558,0.9956071,0.000019061437,0.000019311914,0.0019229086,0.00078608014,0.0002894604,0.0007801707,0.00009073719,0.00041219243,0.000005195833],"about_ca_topic_score_codex":0.0026522963,"about_ca_topic_score_gemma":0.0034378362,"teacher_disagreement_score":0.0026522963,"about_ca_system_score_codex":0.00035612273,"about_ca_system_score_gemma":0.0002484072,"threshold_uncertainty_score":0.0069918633},"labels":[],"label_agreement":null},{"id":"W4323348174","doi":"10.1007/s10549-023-06892-5","title":"BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"","keywords":"Breast cancer; Germline mutation; Genetic counseling; Germline; Genetic testing; Cancer; Family history; Mutation; Medicine; Oncology; Cohort; Genetics; Biology; Internal medicine; Gene","score_opus":0.01796588506055182,"score_gpt":0.34764649523449487,"score_spread":0.32968061017394307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323348174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987337,0.00013542807,0.00011446322,0.000043390268,0.000002414609,0.000020249945,0.0004167599,0.0000026151386,0.0005310267],"genre_scores_gemma":[0.99875975,0.00017761652,0.00010736299,0.00004947746,0.0000029048751,0.000020581418,0.0005811338,0.0000055073665,0.00029580557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996,0.00008056897,0.00003553275,0.000116685085,0.00006956609,0.000097664335],"domain_scores_gemma":[0.99936527,0.00013261866,0.00017000502,0.00008302808,0.00012933856,0.00011970602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003494731,0.00031971585,0.00059433916,0.0013351301,0.00091988884,0.0007527726,0.00047695625,0.00033118043,0.0014731839],"category_scores_gemma":[0.0021106566,0.00065007975,0.00052618637,0.0016257616,0.00057115156,0.00022262322,0.00073022215,0.0003803188,0.00028975392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039513357,0.000031619522,0.99602014,0.000014215464,0.000041728137,0.00028880718,0.0010149858,0.000026056032,0.0008385034,0.00006407451,0.00010985127,0.0015106244],"study_design_scores_gemma":[0.000011248687,0.000079311496,0.99619615,0.000018642077,0.00005861497,0.0008911169,0.0015383624,0.0001079446,0.00013634877,0.000058669324,0.0008961028,0.000007474962],"about_ca_topic_score_codex":0.10037607,"about_ca_topic_score_gemma":0.09798343,"teacher_disagreement_score":0.10037607,"about_ca_system_score_codex":0.0009841791,"about_ca_system_score_gemma":0.00095859583,"threshold_uncertainty_score":0.19958365},"labels":[],"label_agreement":null},{"id":"W4327681995","doi":"10.1007/s10549-022-06815-w","title":"Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Auckland District Health Board; Auckland Medical Research Foundation; Aarhus Universitet; Kaiser Permanente","keywords":"Breast cancer; Medicine; Oncology; Cohort; Internal medicine; Cohort study; Population; Statin; Cancer; Environmental health","score_opus":0.04986996933219678,"score_gpt":0.36258505612737263,"score_spread":0.31271508679517585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327681995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980586,0.00021550682,0.00008732702,0.000067411034,0.000007220182,0.000038955066,0.0012607416,0.0000031440015,0.0002610865],"genre_scores_gemma":[0.9977998,0.00024860929,0.00018568215,0.00005978476,0.000012121641,0.00004081635,0.0013025339,0.00000256743,0.00034802457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993788,0.00012779431,0.0000699184,0.00017262346,0.00015387808,0.00009691373],"domain_scores_gemma":[0.99903834,0.000068529764,0.00040494764,0.00016920049,0.00015181823,0.0001671358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009211808,0.0004002557,0.0004609821,0.00061263575,0.0005155897,0.0007008748,0.0005995021,0.00055748323,0.0012122886],"category_scores_gemma":[0.0020695797,0.0005292721,0.00088881474,0.0014009319,0.0003310131,0.00046097732,0.00061877596,0.00086302456,0.00036111003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000192379,0.000056369725,0.9983987,0.000015004147,0.00017739355,0.0000692357,0.00012754255,0.00001782803,0.00021192087,0.000009827412,0.0001380282,0.0005856729],"study_design_scores_gemma":[0.000028267621,0.00009041102,0.9992417,0.000006109717,0.000079258476,0.00012647231,0.00009780583,0.0000714339,0.000022059883,0.000008104372,0.00022524461,0.000003140787],"about_ca_topic_score_codex":0.06622995,"about_ca_topic_score_gemma":0.0754092,"teacher_disagreement_score":0.06622995,"about_ca_system_score_codex":0.0008718769,"about_ca_system_score_gemma":0.0009694041,"threshold_uncertainty_score":0.1316889},"labels":[],"label_agreement":null},{"id":"W4353015178","doi":"10.1007/s10549-023-06881-8","title":"Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; NSABP Foundation; GlaxoSmithKline; U.S. Department of Health and Human Services","keywords":"Medicine; Lapatinib; Breast cancer; Trastuzumab; Internal medicine; Neoadjuvant therapy; Randomized controlled trial; Gastroenterology; Surgery; Confidence interval; Cohort; Cancer","score_opus":0.16420894382315235,"score_gpt":0.45441019810179134,"score_spread":0.29020125427863896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353015178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943275,0.0032118224,0.00011513506,0.0002440584,0.00008318754,0.000019492256,0.0006512782,0.00000745924,0.0013400306],"genre_scores_gemma":[0.9962525,0.0009916114,0.000056927925,0.00020005844,0.0000580163,0.000040977455,0.001386151,0.0000039584042,0.0010097845],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996226,0.00008659702,0.000031548065,0.000055905643,0.000052311792,0.00015100931],"domain_scores_gemma":[0.9990596,0.00023841106,0.00023465128,0.00007682425,0.00006113456,0.0003294933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079054816,0.00022098908,0.00076663936,0.00019165249,0.00028839768,0.00070367265,0.00025032513,0.0004748276,0.002172822],"category_scores_gemma":[0.0013609799,0.00010216084,0.0012583145,0.00031355934,0.00041948853,0.00078898884,0.00036283972,0.0011571028,0.00039914975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44808632,0.010637964,0.19200583,0.0007624497,0.0038339826,0.0010056375,0.00052777503,0.005217837,0.011957174,0.0008929068,0.005448242,0.31962383],"study_design_scores_gemma":[0.007670097,0.19077526,0.7729618,0.0004920734,0.004629403,0.0015516633,0.0011378851,0.0033220297,0.004984247,0.0022306307,0.010109425,0.00013549427],"about_ca_topic_score_codex":0.0010283255,"about_ca_topic_score_gemma":0.0024643126,"teacher_disagreement_score":0.002172822,"about_ca_system_score_codex":0.00067631254,"about_ca_system_score_gemma":0.0005614908,"threshold_uncertainty_score":0.007268846},"labels":[],"label_agreement":null},{"id":"W4362505745","doi":"10.1007/s10549-023-06893-4","title":"Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University Hospitals Coventry and Warwickshire NHS Trust; Barts Health NHS Trust; North Bristol NHS Trust; Newcastle upon Tyne Hospitals NHS Foundation Trust; Queen's University; University of Sussex; University of Oxford; University College London; Imperial College Healthcare NHS Trust; Imperial College London; University of Warwick; Queen's University Belfast; University of Cambridge; National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust; University Hospitals Plymouth NHS Trust; Middlesex University; National and Kapodistrian University of Athens; Cambridge University Hospitals; University Hospitals of Leicester NHS Trust; University Hospital Southampton NHS Foundation Trust","keywords":"Medicine; Pandemic; Endocrine system; Breast cancer; Coronavirus disease 2019 (COVID-19); Internal medicine; Retrospective cohort study; Gynecology; Cancer; Hormone; Disease","score_opus":0.26262097849269356,"score_gpt":0.5264756326044315,"score_spread":0.263854654111738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362505745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685234,0.0009654164,0.000049258517,0.00014361339,0.000017087339,0.000034377626,0.0013818489,0.000001980835,0.0005539655],"genre_scores_gemma":[0.99611014,0.00042846956,0.000048699494,0.00016354166,0.000043173266,0.000034713896,0.002983765,0.0000032488676,0.00018431428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998928,0.00040173225,0.000110840345,0.00017375466,0.00015174891,0.00023390212],"domain_scores_gemma":[0.99623054,0.00051476096,0.0016599026,0.00043595422,0.0003436826,0.0008151764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023551479,0.00034192897,0.0005118223,0.00045208097,0.0005063832,0.00118754,0.0004386429,0.0005901727,0.0012611792],"category_scores_gemma":[0.0038871008,0.00022324409,0.00078639475,0.0011678733,0.0003190533,0.00050534983,0.0012517978,0.00085393374,0.00022779274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030192998,0.00011807882,0.99160576,0.000066612934,0.00022580194,0.00014927758,0.00017448173,0.00007680627,0.00016108461,0.000034714478,0.0005715609,0.003796539],"study_design_scores_gemma":[0.00020682004,0.0008579952,0.99674773,0.00007484127,0.00016348193,0.00026444942,0.00047838542,0.00012408095,0.000058992402,0.00002911118,0.0009804175,0.000013682562],"about_ca_topic_score_codex":0.007814332,"about_ca_topic_score_gemma":0.008670513,"teacher_disagreement_score":0.007814332,"about_ca_system_score_codex":0.0006681567,"about_ca_system_score_gemma":0.0008617345,"threshold_uncertainty_score":0.015537679},"labels":[],"label_agreement":null},{"id":"W4362506944","doi":"10.1007/s10549-023-06921-3","title":"Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; Medical Research Council; UK Research and Innovation; University of Cape Town; Irving Medical Center, Columbia University; National Commission for Science, Technology and Innovation","keywords":"Tumor-infiltrating lymphocytes; Breast cancer; Oncology; FOXP3; Immunohistochemistry; CD68; CD3; Medicine; Stroma; Internal medicine; CD20; CD8; Pathology; Cancer; Immune system; Immunology","score_opus":0.02312506720409118,"score_gpt":0.3095471636068535,"score_spread":0.28642209640276234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362506944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902034,0.00017455818,0.00005003728,0.00004417451,0.000003149406,0.0000073467204,0.0002872924,0.0000010746015,0.00041210154],"genre_scores_gemma":[0.99943167,0.00012539852,0.00006200382,0.000022265478,0.0000037945229,0.0000073852984,0.00014663859,0.0000010990108,0.00019973071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998467,0.000030588137,0.000016897451,0.000031121665,0.0000151509075,0.00005953356],"domain_scores_gemma":[0.9997316,0.0000483291,0.00011540213,0.000011618513,0.000039800143,0.000053278287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014942705,0.00021004566,0.00020889167,0.0007155556,0.000691356,0.0005206845,0.00027318747,0.00034454215,0.0022858048],"category_scores_gemma":[0.0007205771,0.00032482395,0.00016722915,0.0010262546,0.0003032063,0.00033618018,0.00042705907,0.00035270062,0.00026823414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008440206,0.000022234319,0.99720913,0.000022259313,0.000018091601,0.00013579227,0.00035282702,0.000028177452,0.00071836606,0.000026971093,0.00009404209,0.0012877727],"study_design_scores_gemma":[0.0000058327987,0.00007479045,0.9957688,0.000021309299,0.00002656268,0.00058115774,0.0027597765,0.00011416194,0.00011194189,0.00003536994,0.00049394334,0.000006368213],"about_ca_topic_score_codex":0.024073021,"about_ca_topic_score_gemma":0.040867627,"teacher_disagreement_score":0.024073021,"about_ca_system_score_codex":0.0004034794,"about_ca_system_score_gemma":0.00039260107,"threshold_uncertainty_score":0.047865808},"labels":[],"label_agreement":null},{"id":"W4365458321","doi":"10.1007/s10549-023-06935-x","title":"Associations between health-related fitness and quality of life in newly diagnosed breast cancer patients","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer survivorship and care","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University; Alberta Health Services; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Canada Research Chairs; National Institutes of Health; Alberta Cancer Foundation","keywords":"Breast cancer; Medicine; Oncology; Quality of life (healthcare); Internal medicine; Cancer; Demography","score_opus":0.1071937572969787,"score_gpt":0.4185788330390001,"score_spread":0.3113850757420214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365458321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989286,0.0002860323,0.000018663266,0.00008179222,0.000012118677,0.0000032262258,0.0002644297,0.0000012529523,0.0004039534],"genre_scores_gemma":[0.99938154,0.00011098113,0.000015538006,0.000029370187,0.000014793673,0.0000027475346,0.00025207482,6.726179e-7,0.0001922436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997533,0.00006601162,0.000033953434,0.000042187963,0.000030146584,0.00007441355],"domain_scores_gemma":[0.99879754,0.0003188081,0.00046640082,0.000048262216,0.00008292072,0.00028617564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034722345,0.00021543386,0.0003427449,0.0006178584,0.0003624145,0.00071197056,0.0002859696,0.0005107433,0.0020650562],"category_scores_gemma":[0.0022960398,0.00023248968,0.0006260722,0.0007971427,0.00020683797,0.0004246765,0.00043330897,0.00082812336,0.00015793936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009918158,0.000040123465,0.99903274,0.000005637602,0.00005464034,0.000028603277,0.0000286101,0.000021359278,0.00004662515,0.0000065155664,0.000040649036,0.0005953569],"study_design_scores_gemma":[0.000004008981,0.000038368635,0.99967,0.0000024044102,0.000018433013,0.00004023806,0.00009808619,0.00006573186,0.0000081528015,0.0000074072987,0.000045421362,0.000001723429],"about_ca_topic_score_codex":0.011618195,"about_ca_topic_score_gemma":0.01859428,"teacher_disagreement_score":0.011618195,"about_ca_system_score_codex":0.00034890484,"about_ca_system_score_gemma":0.00029217455,"threshold_uncertainty_score":0.023101151},"labels":[],"label_agreement":null},{"id":"W4366550209","doi":"10.1007/s10549-023-06938-8","title":"Patient reported symptom burden amongst immigrant and Canadian long-term resident women undergoing breast cancer surgery","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton; McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"Hamilton Health Sciences Foundation; McMaster University; Hamilton Health Sciences","keywords":"Medicine; Breast cancer; Immigration; Demography; Population; Retrospective cohort study; Cohort; Cohort study; Cancer; Gerontology; Internal medicine","score_opus":0.08878312569479602,"score_gpt":0.3666106292993172,"score_spread":0.2778275036045212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366550209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972947,0.00019424669,0.000010063473,0.00017353395,0.000007734329,0.000009928036,0.00090630195,0.0000022653737,0.0014012309],"genre_scores_gemma":[0.9988456,0.00020632686,0.0000334879,0.00010207406,0.0000060921534,0.0000061176133,0.00046977692,0.0000014266935,0.00032914168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996339,0.000042402786,0.00003306316,0.00002750228,0.00010365106,0.00015948116],"domain_scores_gemma":[0.99910575,0.00008732456,0.00022834883,0.000014592883,0.00025468713,0.00030930087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003179768,0.000174841,0.0002545723,0.0006090762,0.0012804741,0.0009032906,0.00043819193,0.00036898113,0.0026032533],"category_scores_gemma":[0.0019579579,0.0001348416,0.00037710206,0.0013705825,0.00043480517,0.0003034631,0.0007043553,0.00056197186,0.00018590945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012530974,0.000039131784,0.99387085,0.00003348029,0.000039395505,0.00014768617,0.0017865632,0.000038812894,0.00012838125,0.00003115178,0.0008680615,0.002891176],"study_design_scores_gemma":[0.0000036467602,0.000046315185,0.9918934,0.000023356108,0.000018086435,0.00014460935,0.0073158094,0.000054951204,0.00001695766,0.000008892286,0.00046246,0.000011592596],"about_ca_topic_score_codex":0.75124073,"about_ca_topic_score_gemma":0.8618124,"teacher_disagreement_score":0.24875927,"about_ca_system_score_codex":0.0035946954,"about_ca_system_score_gemma":0.005367154,"threshold_uncertainty_score":0.50044847},"labels":[],"label_agreement":null},{"id":"W4375955601","doi":"10.1007/s10549-023-06922-2","title":"Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32)","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Juravinski Cancer Centre; BC Cancer Agency; Université Laval; University of British Columbia; McMaster University; Queen's University","funders":"Canadian Cancer Society Research Institute; Division of Cancer Prevention, National Cancer Institute","keywords":"Metformin; Discontinuation; Placebo; Medicine; Breast cancer; Internal medicine; Oncology; Endocrine system; Endocrinology; Randomized controlled trial; Hormone; Cancer; Insulin; Alternative medicine","score_opus":0.06600611439713074,"score_gpt":0.37733847469914567,"score_spread":0.31133236030201494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375955601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461174,0.0023857,0.00021865341,0.00044528404,0.0004943521,0.0006642747,0.00044701638,0.000054663036,0.00067843986],"genre_scores_gemma":[0.995097,0.00092636887,0.0004957221,0.0005440731,0.00041700972,0.0009427719,0.00033583975,0.000015172017,0.0012260719],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998125,0.0010483232,0.0001560945,0.0003206433,0.00007917608,0.0002708177],"domain_scores_gemma":[0.99749786,0.0009940831,0.0005069853,0.00022486031,0.00010939134,0.00066676794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033253455,0.0018441087,0.004741427,0.0005510537,0.0008514411,0.0012413829,0.001095844,0.0038359805,0.0075739967],"category_scores_gemma":[0.0049127825,0.0012432205,0.0029637755,0.0005113354,0.0010934137,0.0014298258,0.00069503736,0.003459152,0.0006845353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99454886,0.0015408786,0.00047275762,0.00009342225,0.0003924757,0.000009674894,0.00001773745,0.000035703608,0.0003213199,0.000012735382,0.000120935314,0.0024335722],"study_design_scores_gemma":[0.9539341,0.038823396,0.00520542,0.000038736387,0.0011691025,0.00001366595,0.00003641071,0.0003023099,0.00015753004,0.00011422811,0.00018268943,0.00002237951],"about_ca_topic_score_codex":0.002326436,"about_ca_topic_score_gemma":0.003901859,"teacher_disagreement_score":0.0075739967,"about_ca_system_score_codex":0.0008871209,"about_ca_system_score_gemma":0.0014320168,"threshold_uncertainty_score":0.025337517},"labels":[],"label_agreement":null},{"id":"W4380870903","doi":"10.1007/s10549-023-06989-x","title":"Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Proportional hazards model; Cohort; Population; Mastectomy; Stage (stratigraphy); Breast-conserving surgery; Oncology; Gynecology; Cancer; Cancer registry; Surgery","score_opus":0.07992184348475317,"score_gpt":0.4203156468875517,"score_spread":0.3403938034027985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380870903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789494,0.0008114521,0.000034470337,0.0002653723,0.000024635498,0.0000060603315,0.00015933209,0.000003062908,0.00080070883],"genre_scores_gemma":[0.9993267,0.00019419119,0.000035689693,0.00008023613,0.000030892246,0.0000039133947,0.00012043239,0.0000011859172,0.00020678919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992767,0.0002414554,0.00011206937,0.00008392464,0.00012665984,0.00015927115],"domain_scores_gemma":[0.9956357,0.001205104,0.0020054842,0.00020358126,0.00029150158,0.0006585938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009038442,0.00020865796,0.0003966111,0.0005247031,0.00048221753,0.0006660155,0.0003094595,0.0007636325,0.0015028042],"category_scores_gemma":[0.007842324,0.00020118152,0.0010918343,0.00081947364,0.00020166242,0.00042956803,0.0004734931,0.0010468863,0.00012658184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021130765,0.00010986034,0.9965185,0.000012798959,0.00015478142,0.00004257309,0.00007026014,0.000029265022,0.000044443754,0.000009475852,0.000052036976,0.0027447962],"study_design_scores_gemma":[0.000006144601,0.00013346103,0.99945694,0.0000070668502,0.00007137416,0.000041431485,0.00010681678,0.00009526738,0.000012157379,0.000014750693,0.00005198313,0.0000025332656],"about_ca_topic_score_codex":0.009847745,"about_ca_topic_score_gemma":0.017558794,"teacher_disagreement_score":0.009847745,"about_ca_system_score_codex":0.0003448611,"about_ca_system_score_gemma":0.0004868119,"threshold_uncertainty_score":0.0195809},"labels":[],"label_agreement":null},{"id":"W4383873232","doi":"10.1007/s10549-023-06991-3","title":"Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Public Health Ontario; McMaster University; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Peter Gilgan Foundation; Canada Research Chairs; Canadian Cancer Society","keywords":"Breast cancer; Tamoxifen; Medicine; Oncology; Internal medicine; Gynecology; BRCA2 Protein; Antiestrogen; Mutation; Cancer; Germline mutation; Biology; Genetics; Gene","score_opus":0.022312505655089604,"score_gpt":0.33842634788156073,"score_spread":0.3161138422264711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383873232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99901927,0.0004698698,0.00008044479,0.000019145764,0.000004121627,0.000009411935,0.00025316305,0.0000025580205,0.00014197773],"genre_scores_gemma":[0.9990891,0.00022285024,0.00012378492,0.000014150188,0.000008617511,0.000014424611,0.0003399117,0.0000016586681,0.00018556532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995653,0.00015206775,0.000046495887,0.00011268763,0.00007246639,0.000051004758],"domain_scores_gemma":[0.9988887,0.00036972182,0.00045709815,0.00010224106,0.000060664857,0.00012159457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090281136,0.00020816237,0.00027419915,0.00069702236,0.00032327772,0.00041075711,0.00035846842,0.00050593546,0.0019920564],"category_scores_gemma":[0.0029266025,0.0002847418,0.0005448161,0.0008327632,0.00020796557,0.00021678203,0.00035246345,0.00037234082,0.0003387328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053305784,0.00003757637,0.99801207,0.000010835729,0.000074050105,0.000081371494,0.00002332271,0.000051182185,0.00017793961,0.000008943232,0.000035937126,0.00095360377],"study_design_scores_gemma":[0.000051703606,0.00036268288,0.99798286,0.000008239421,0.00015882861,0.00055666827,0.000056373923,0.00034101022,0.00013055457,0.000031667056,0.0003158133,0.0000034954576],"about_ca_topic_score_codex":0.0036494753,"about_ca_topic_score_gemma":0.0025851303,"teacher_disagreement_score":0.0036494753,"about_ca_system_score_codex":0.00018147276,"about_ca_system_score_gemma":0.0002540367,"threshold_uncertainty_score":0.0072564483},"labels":[],"label_agreement":null},{"id":"W4386208836","doi":"10.1007/s10549-023-07057-0","title":"Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case–control study","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; Breast cancer; Oncology; Stage (stratigraphy); Receiver operating characteristic; Internal medicine; Univariate analysis; Chemotherapy; Cancer; Trastuzumab; Multivariate analysis; Area under the curve; Biology","score_opus":0.047356041254190774,"score_gpt":0.3775125068555172,"score_spread":0.3301564656013264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386208836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973584,0.0001531969,0.0022151133,0.000036989706,0.000014260081,0.00003481167,0.00006533516,0.00001200636,0.00010994916],"genre_scores_gemma":[0.9987937,0.00005140912,0.0008285029,0.000012117965,0.00001941288,0.00003871711,0.00018457798,0.0000038300414,0.00006760857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998315,0.00082668266,0.00014546215,0.00036613166,0.00023385312,0.00011296712],"domain_scores_gemma":[0.9923145,0.005346341,0.00080955087,0.00075499393,0.00050708855,0.00026749136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010452575,0.0008547951,0.0007569069,0.0016209447,0.0005104345,0.0010707546,0.0010849604,0.00095046015,0.0013818825],"category_scores_gemma":[0.012220823,0.00056350825,0.001344964,0.00055946346,0.0005859254,0.0005767739,0.00051393715,0.0008357076,0.000246108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014085665,0.0004681303,0.9900878,0.000020716128,0.00045850896,0.00027662024,0.000087890236,0.0020557554,0.000432363,0.000060890754,0.00014947596,0.0044933544],"study_design_scores_gemma":[0.0007322217,0.004733926,0.67467815,0.000045929606,0.0020337803,0.0039837454,0.0005294856,0.31000382,0.0014014943,0.0005058797,0.0012785051,0.00007310804],"about_ca_topic_score_codex":0.0023387135,"about_ca_topic_score_gemma":0.001382041,"teacher_disagreement_score":0.010452575,"about_ca_system_score_codex":0.0006174189,"about_ca_system_score_gemma":0.0005037918,"threshold_uncertainty_score":0.055279136},"labels":[],"label_agreement":null},{"id":"W4386572692","doi":"10.1007/s10549-023-07123-7","title":"Retraction Note: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation","year":2023,"lang":"en","type":"retraction","venue":"Breast Cancer Research and Treatment","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Wnt signaling pathway; Cell biology; Actin cytoskeleton; Cytoskeleton; Actin; Signal transduction; Adhesion; Biology; Chemistry; Cell; Biochemistry","score_opus":0.03334789904950621,"score_gpt":0.3421459720676849,"score_spread":0.3087980730181787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386572692","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013965192,0.0051063485,0.00069794705,0.055174865,0.9215324,0.00018734075,0.0017077248,0.00019464329,0.0140022],"genre_scores_gemma":[0.021092689,0.01735321,0.0041637155,0.023702964,0.48284826,0.0007270269,0.0068301344,0.00037709315,0.44290486],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838126,0.00015003262,0.00029102006,0.000107091655,0.00082046574,0.00025009693],"domain_scores_gemma":[0.9916924,0.0015925638,0.0005911235,0.00038271555,0.0044841464,0.0012570854],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020196894,0.0018098768,0.0009826148,0.0024995985,0.0022162052,0.0015446609,0.0022005371,0.0046358462,0.044180825],"category_scores_gemma":[0.012743202,0.00068846863,0.0012790535,0.0015041048,0.0008395131,0.0014036115,0.0016078026,0.0044427197,0.02016451],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074356074,0.000009837141,0.00007170777,0.0002603788,0.000009148304,0.00039456243,0.000022516515,0.000027838545,0.0012529981,0.0006930749,0.986521,0.010662521],"study_design_scores_gemma":[0.000040498344,0.00003166585,0.002266736,0.00017990125,0.000030764593,0.00068587245,0.00006758178,0.00021664088,0.0018688502,0.0003371068,0.9942562,0.000018221039],"about_ca_topic_score_codex":0.0053332527,"about_ca_topic_score_gemma":0.007077782,"teacher_disagreement_score":0.9953641,"about_ca_system_score_codex":0.0028832844,"about_ca_system_score_gemma":0.0035003936,"threshold_uncertainty_score":0.14779961},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["research_integrity"],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4388492584","doi":"10.1007/s10549-023-07159-9","title":"The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital","funders":"National Cancer Institute; Genentech; National Institutes of Health; Ipsen; European Society for Medical Oncology; Servier; Max-Planck-Gesellschaft; F. Hoffmann-La Roche; Novartis; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Canadian Cancer Society; GlaxoSmithKline; Seagen; Gilead Sciences; Daiichi Sankyo Europe; U.S. Department of Defense","keywords":"Medicine; Breast cancer; Erythropoiesis; Adjuvant; Oncology; Cancer; Internal medicine; Anemia","score_opus":0.05064984620022655,"score_gpt":0.39014992459173925,"score_spread":0.3395000783915127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388492584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943791,0.0041875336,0.00008840032,0.00010920344,0.00003348473,0.00004400049,0.00062512414,0.000003415478,0.0005298971],"genre_scores_gemma":[0.99624497,0.0014390409,0.00010622694,0.00021833468,0.00013594124,0.000055578337,0.0014821711,0.0000064884252,0.00031113936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874336,0.00059143256,0.00012362919,0.00017918854,0.00013641908,0.00022603844],"domain_scores_gemma":[0.997375,0.00097515795,0.0008394226,0.00023985589,0.00020007804,0.0003704527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018693643,0.00062631356,0.0016170408,0.00040472718,0.00031213782,0.001007895,0.00044341732,0.0006244357,0.00102316],"category_scores_gemma":[0.0029280917,0.0002757401,0.0037945113,0.00092122256,0.00035703514,0.0006609339,0.0007173592,0.001344738,0.00014669332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15995677,0.0021652495,0.77553374,0.0009915339,0.025814068,0.00028195785,0.00023931598,0.0010172215,0.0019449204,0.0002105591,0.0018967823,0.029947769],"study_design_scores_gemma":[0.007302463,0.014197857,0.9613117,0.00012894548,0.013509681,0.00028520092,0.00035064894,0.00050831604,0.00036101526,0.00015853686,0.0018392939,0.000046409885],"about_ca_topic_score_codex":0.0023641933,"about_ca_topic_score_gemma":0.0045997263,"teacher_disagreement_score":0.0023641933,"about_ca_system_score_codex":0.0006153317,"about_ca_system_score_gemma":0.0008208581,"threshold_uncertainty_score":0.009886265},"labels":[],"label_agreement":null},{"id":"W4389978835","doi":"10.1007/s10549-023-07165-x","title":"Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"AstraZeneca","keywords":"Medicine; Olaparib; Metastatic breast cancer; Internal medicine; Oncology; BRCA mutation; Breast cancer; Taxane; Population; Eribulin; Cancer","score_opus":0.11391323041243315,"score_gpt":0.4893376363452184,"score_spread":0.37542440593278525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389978835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448436,0.0017807042,0.00049190386,0.000204534,0.000011572034,0.00047584224,0.0016156102,0.000039928982,0.0008955728],"genre_scores_gemma":[0.9956274,0.00037409854,0.0005216572,0.00019188362,0.000033188695,0.0004126768,0.002370033,0.000013679571,0.00045532672],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99781835,0.0014008059,0.0000860621,0.00024332934,0.0002842316,0.00016706868],"domain_scores_gemma":[0.99719465,0.0007242505,0.0011357988,0.00037618438,0.00024369774,0.0003253435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055289688,0.0006052439,0.0011286369,0.00025533608,0.0003007221,0.0010366214,0.00059451844,0.0006746777,0.0023351093],"category_scores_gemma":[0.0036592588,0.00022993557,0.0017083277,0.00040285586,0.0009694351,0.0006448338,0.0005983091,0.0008217922,0.00043227285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80984926,0.006330046,0.09251838,0.0012999618,0.0047963765,0.000393105,0.00030211805,0.005815561,0.01137709,0.000347656,0.0040760743,0.062894374],"study_design_scores_gemma":[0.2098062,0.30052063,0.45595396,0.00020814706,0.005215549,0.0013316508,0.00020340446,0.007901754,0.0075288913,0.0005493115,0.010648461,0.00013211215],"about_ca_topic_score_codex":0.0009850092,"about_ca_topic_score_gemma":0.0013335237,"teacher_disagreement_score":0.0055289688,"about_ca_system_score_codex":0.0012238532,"about_ca_system_score_gemma":0.0012052291,"threshold_uncertainty_score":0.02924037},"labels":[],"label_agreement":null},{"id":"W4390061897","doi":"10.1007/s10549-023-07185-7","title":"Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020","year":2023,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Canadian Breast Cancer Network; Sunnybrook Hospital; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"AstraZeneca Canada","keywords":"Medicine; Metastatic breast cancer; Trastuzumab; Breast cancer; Pertuzumab; Stage (stratigraphy); Internal medicine; Cohort; Cancer; Population; Oncology; Retrospective cohort study; Gynecology","score_opus":0.07276757750080395,"score_gpt":0.38936530344920967,"score_spread":0.31659772594840574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390061897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598401,0.0013876382,0.000078283985,0.0019140567,0.000036462836,0.00003084978,0.031912,0.000019040595,0.0047815586],"genre_scores_gemma":[0.989636,0.0006109,0.000061352555,0.0002251534,0.000012443612,0.000018069624,0.0074221697,0.000004796795,0.0020091457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995209,0.00002313424,0.000040517145,0.000049208807,0.00012788516,0.00023844541],"domain_scores_gemma":[0.9989097,0.000038893028,0.00037893056,0.000019501069,0.00030029495,0.0003526404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001976492,0.00019135339,0.00031377614,0.0006356712,0.00093779434,0.0006966375,0.00084326486,0.0004590376,0.0028340763],"category_scores_gemma":[0.001398111,0.00023613918,0.00086861267,0.0023008732,0.00031199353,0.0004121081,0.00058640476,0.0006204034,0.00020950999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024456688,0.000035092995,0.98821986,0.000066702094,0.00009123706,0.00014458016,0.0002821072,0.00048227547,0.00013844014,0.00021336976,0.0060087275,0.0040729386],"study_design_scores_gemma":[0.0000098999635,0.000021059403,0.99725085,0.00003144942,0.000027158243,0.00008465404,0.00047921998,0.0002751586,0.000022481374,0.000030589395,0.0017605644,0.0000069384314],"about_ca_topic_score_codex":0.9772575,"about_ca_topic_score_gemma":0.9885799,"teacher_disagreement_score":0.02274251,"about_ca_system_score_codex":0.02260897,"about_ca_system_score_gemma":0.018041797,"threshold_uncertainty_score":0.16404027},"labels":[],"label_agreement":null},{"id":"W4390775580","doi":"10.1007/s10549-023-07232-3","title":"The COVID-19 pandemic and its effects on follow-up of patients with early breast cancer: A patient survey","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; London Health Sciences Centre; Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Pandemic; Coronavirus disease 2019 (COVID-19); Cancer; Family medicine; Emergency medicine; Internal medicine; Disease","score_opus":0.10611443924969254,"score_gpt":0.4342361523645151,"score_spread":0.3281217131148226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390775580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903655,0.00066505617,0.00006975916,0.0027545956,0.00002690412,0.00004465749,0.0036919615,0.000004436287,0.002377031],"genre_scores_gemma":[0.9954401,0.00078395515,0.00009543919,0.0016349581,0.000037631173,0.000050403738,0.0015625582,0.0000032271664,0.0003917442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844885,0.00054509257,0.00021430581,0.00014597725,0.0002216237,0.00042403565],"domain_scores_gemma":[0.99597025,0.0005776248,0.001851651,0.00017184565,0.00041793732,0.0010106963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001320245,0.00014804357,0.00026489949,0.0005843187,0.00078658323,0.0008860171,0.00040783602,0.0010250483,0.0023164009],"category_scores_gemma":[0.006398971,0.00025009946,0.0005839977,0.0019068033,0.00030008345,0.0011542795,0.0016416047,0.0015503775,0.00037430698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005014762,0.00007980818,0.99660975,0.000019089772,0.000023987546,0.000041154704,0.00027577535,0.000019279903,0.000028853521,0.000032548134,0.00079199194,0.0020276047],"study_design_scores_gemma":[0.0000058800238,0.00008691857,0.9970265,0.0000400629,0.000018837352,0.000095439245,0.0016401347,0.00006393224,0.000017121778,0.000019092546,0.0009792057,0.0000069126536],"about_ca_topic_score_codex":0.042370666,"about_ca_topic_score_gemma":0.048522864,"teacher_disagreement_score":0.042370666,"about_ca_system_score_codex":0.0010396636,"about_ca_system_score_gemma":0.0018041735,"threshold_uncertainty_score":0.084248126},"labels":[],"label_agreement":null},{"id":"W4391480168","doi":"10.1007/s10549-023-07239-w","title":"MRI-visualized T2 hyperintense breast lesions: identifying clinical and imaging factors linked to malignant biopsy outcomes","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Malignancy; Breast MRI; Radiology; Biopsy; Breast cancer; Magnetic resonance imaging; Breast imaging; Lesion; Univariate analysis; Retrospective cohort study; Multivariate analysis; Pathology; Cancer; Mammography; Internal medicine","score_opus":0.19089160779728015,"score_gpt":0.5105697599208137,"score_spread":0.3196781521235335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391480168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797744,0.0006150597,0.00017031249,0.00013008283,0.0000110031715,0.000006479112,0.00011021251,0.00000520723,0.000974249],"genre_scores_gemma":[0.9993266,0.00019593834,0.000151707,0.000023359129,0.00002703999,0.0000038136475,0.000100374105,0.000003486731,0.0001676819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961793,0.00012716455,0.000046474663,0.00006209361,0.00006567899,0.000080624915],"domain_scores_gemma":[0.9973007,0.0006997533,0.0013840582,0.000112531445,0.00020600834,0.000296911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007449154,0.00040577742,0.00027622108,0.0015425017,0.00032032086,0.0009857898,0.0004927968,0.00077924767,0.0018580811],"category_scores_gemma":[0.0056377714,0.00024224783,0.00030354006,0.0011409144,0.00037154814,0.0008851835,0.00045726972,0.00062109,0.00029314638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013199403,0.0000422125,0.99765563,0.000008677816,0.00003151735,0.00011342346,0.00003263093,0.000031666787,0.000328674,0.000025655261,0.000059747057,0.0015382298],"study_design_scores_gemma":[0.000004184212,0.000067481415,0.99798167,0.000010268773,0.000047044614,0.0007075355,0.00027538757,0.0004018572,0.0002388052,0.00009326122,0.00016757923,0.000004859158],"about_ca_topic_score_codex":0.0014944816,"about_ca_topic_score_gemma":0.0020170826,"teacher_disagreement_score":0.0018580811,"about_ca_system_score_codex":0.00022701261,"about_ca_system_score_gemma":0.00033686112,"threshold_uncertainty_score":0.00621593},"labels":[],"label_agreement":null},{"id":"W4391997837","doi":"10.1007/s10549-024-07251-8","title":"Preoperative factors that predict pathologic nodal involvement in early-stage HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé","keywords":"Breast cancer; Medicine; Chemotherapy; Stage (stratigraphy); Oncology; Neoadjuvant therapy; Internal medicine; Breast surgery; Cancer","score_opus":0.05618413191922758,"score_gpt":0.33686742953934634,"score_spread":0.2806832976201188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391997837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879813,0.00050737563,0.00005519506,0.00005524072,0.000012086556,0.0000064061505,0.000046088448,7.320349e-7,0.0005186113],"genre_scores_gemma":[0.9993586,0.00017833711,0.00009620677,0.000031831296,0.00001669839,0.000005489928,0.00014082316,9.867241e-7,0.00017091195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998412,0.0000671638,0.000016314143,0.000018889685,0.000021274956,0.00003518036],"domain_scores_gemma":[0.9990608,0.00044304391,0.00014509156,0.000039798142,0.000046681856,0.00026455702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051017915,0.00027508105,0.0003212956,0.0003441241,0.00020543387,0.0004162254,0.00019249381,0.00035633365,0.0016793885],"category_scores_gemma":[0.0018484964,0.0000987437,0.00032453422,0.0004656714,0.00026256003,0.00029981037,0.0001772861,0.00032850658,0.00013592832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038772959,0.00013870439,0.987966,0.00001683237,0.000052315176,0.0000663323,0.000044430486,0.00013493618,0.0018480353,0.000026543183,0.000073757714,0.0057548294],"study_design_scores_gemma":[0.00007907234,0.0012175236,0.9964408,0.000012355838,0.00017687658,0.00024964946,0.0002466494,0.00034717887,0.0006894978,0.00007641098,0.0004588851,0.000005190726],"about_ca_topic_score_codex":0.001826407,"about_ca_topic_score_gemma":0.004289228,"teacher_disagreement_score":0.001826407,"about_ca_system_score_codex":0.00025226778,"about_ca_system_score_gemma":0.00044121424,"threshold_uncertainty_score":0.0056180954},"labels":[],"label_agreement":null},{"id":"W4392238907","doi":"10.1007/s10549-024-07243-8","title":"Pro-vegetarian dietary pattern and risk of breast cancer: a case–control study","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Agriculture Sustainability and Environmental Impact","field":"Environmental Science","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Odds ratio; Logistic regression; Confidence interval; Breast cancer; Demography; Incidence (geometry); Case-control study; Cancer; Gynecology; Population; Internal medicine; Environmental health","score_opus":0.01992499096631311,"score_gpt":0.31156479607504056,"score_spread":0.29163980510872745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392238907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990114,0.00028626612,0.00019389123,0.000026091948,0.000019442088,0.000034689063,0.00015085482,0.000004710229,0.0002725825],"genre_scores_gemma":[0.9987388,0.00014876777,0.00024340914,0.000051260115,0.00003323604,0.000037416783,0.00020453658,0.0000044070066,0.00053827115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989365,0.0003570382,0.000096833704,0.00034383347,0.00012298615,0.00014280214],"domain_scores_gemma":[0.9986425,0.00036756572,0.00025315274,0.00033165037,0.00015338318,0.00025179668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012180662,0.00088534795,0.0009059997,0.0009516535,0.0015762218,0.0010613722,0.0008686065,0.0015972803,0.0030356897],"category_scores_gemma":[0.0020269183,0.0017559505,0.0012651779,0.0013045588,0.000953937,0.0007330166,0.00055270357,0.0012614904,0.00043666558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011399521,0.0033662952,0.97664374,0.00007922704,0.0017523152,0.00071761606,0.00045260342,0.00011431293,0.003296782,0.00012584367,0.00024268594,0.0018089908],"study_design_scores_gemma":[0.0009036732,0.0029545072,0.99269027,0.000013698449,0.000834334,0.0008623707,0.000411635,0.0006001547,0.00022514936,0.00007884063,0.00039725858,0.000028184402],"about_ca_topic_score_codex":0.013175768,"about_ca_topic_score_gemma":0.009800183,"teacher_disagreement_score":0.013175768,"about_ca_system_score_codex":0.00055974774,"about_ca_system_score_gemma":0.00045018707,"threshold_uncertainty_score":0.026198149},"labels":[],"label_agreement":null},{"id":"W4392386270","doi":"10.1007/s10549-024-07258-1","title":"Primary MALT lymphoma of the breast: pathological and radiological characteristics","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lymphoma; Radiology; Radiological weapon; Breast cancer; Biopsy; Radiation therapy; Etiology; Pathology; Pathological; MALT lymphoma; Mammography; Cancer; Internal medicine","score_opus":0.048446132025886365,"score_gpt":0.3457668137984467,"score_spread":0.2973206817725603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392386270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972535,0.000715103,0.00016972977,0.00007423074,0.0000055534965,0.000013923103,0.0001807255,0.000007337421,0.0015799371],"genre_scores_gemma":[0.9993325,0.00020841663,0.0000881705,0.000020920712,0.00003092671,0.000006129053,0.00012514321,0.0000031077238,0.00018455816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960977,0.00006753256,0.000055575347,0.00007043106,0.00007731164,0.00011938662],"domain_scores_gemma":[0.9984346,0.00045838038,0.00033636641,0.00009246222,0.00021239261,0.0004658629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045919407,0.00030784283,0.00046042373,0.0018189567,0.0004555788,0.00073575164,0.00033335155,0.00052082475,0.0035458936],"category_scores_gemma":[0.0025018537,0.0002840756,0.00026048752,0.0013297107,0.0005172118,0.00080166257,0.0007238524,0.00030657437,0.0007020426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076738745,0.000120705,0.9780091,0.000028685183,0.00002165234,0.009547186,0.00018976562,0.000108235065,0.005820667,0.00009514165,0.00018481493,0.0051066107],"study_design_scores_gemma":[0.00001779354,0.00020135312,0.9511096,0.000008430497,0.000028112274,0.04659747,0.000612961,0.00031261158,0.0004889044,0.00016299637,0.000451853,0.000007932653],"about_ca_topic_score_codex":0.0011672687,"about_ca_topic_score_gemma":0.0010448273,"teacher_disagreement_score":0.0035458936,"about_ca_system_score_codex":0.00039253317,"about_ca_system_score_gemma":0.00032327865,"threshold_uncertainty_score":0.011862159},"labels":[],"label_agreement":null},{"id":"W4392911941","doi":"10.1007/s10549-024-07269-y","title":"The distribution of breast density in women aged 18 years and older","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"University of Western Australia; Cancer Australia; National Breast Cancer Foundation; Australian Government","keywords":"Breast cancer; Body mass index; Medicine; Mammography; Breast density; Breast imaging; Demography; MAMMOGRAPHIC DENSITY; Gynecology; Obstetrics; Internal medicine; Cancer","score_opus":0.02432985901848697,"score_gpt":0.33759799427778664,"score_spread":0.31326813525929964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392911941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900514,0.00024783262,0.0000843483,0.0000366133,0.0000021845237,0.000007873783,0.00022985188,0.0000024445912,0.00038378456],"genre_scores_gemma":[0.99917585,0.0002849912,0.00012214632,0.000023580533,0.000005042682,0.000010395446,0.00018149297,9.016612e-7,0.00019570933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977416,0.00005693298,0.000027920063,0.00004133691,0.000066385226,0.000033342218],"domain_scores_gemma":[0.99919945,0.00013277166,0.00041749343,0.000049618913,0.00013431406,0.000066372755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048036771,0.00014020712,0.00019242849,0.0010406089,0.00027005502,0.00030536085,0.00027704795,0.00024914104,0.0010276493],"category_scores_gemma":[0.0016668648,0.00018757982,0.00015839514,0.0009717192,0.00036708981,0.00039920607,0.00040298683,0.00023488644,0.0002382628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017442448,0.000010669393,0.9967811,0.000011747274,0.000015173712,0.000048021226,0.00038073602,0.000014837572,0.00014821175,0.000013524253,0.00006104879,0.0024974102],"study_design_scores_gemma":[5.818402e-7,0.000020661684,0.99938226,0.0000058717956,0.000004833896,0.00016731585,0.00023311327,0.000041739142,0.000025628806,0.000012005647,0.00010484537,0.0000010872477],"about_ca_topic_score_codex":0.020662757,"about_ca_topic_score_gemma":0.017847108,"teacher_disagreement_score":0.020662757,"about_ca_system_score_codex":0.00029693276,"about_ca_system_score_gemma":0.00018522893,"threshold_uncertainty_score":0.041084945},"labels":[],"label_agreement":null},{"id":"W4392959472","doi":"10.1007/s10549-024-07277-y","title":"Trends in socioeconomic inequalities in breast cancer mortality in Canada: 1992–2019","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia; Dalhousie University","funders":"University of British Columbia; Canada Research Chairs; Beatrice Hunter Cancer Research Institute","keywords":"Breast cancer; Socioeconomic status; Demography; Mortality rate; National Death Index; Census; Medicine; Population; Cancer; Gerontology; Environmental health; Confidence interval; Hazard ratio; Internal medicine; Sociology","score_opus":0.1493425231834533,"score_gpt":0.4288807224006364,"score_spread":0.2795381992171831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392959472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7430427,0.010636551,0.00043285094,0.008209709,0.0002649026,0.00010534249,0.22149016,0.00018235605,0.015635328],"genre_scores_gemma":[0.9494324,0.0038740528,0.0003884254,0.0006984665,0.00008051543,0.00004678252,0.040016454,0.00003081861,0.0054321573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849796,0.0000507056,0.00015439674,0.00016421989,0.0004097729,0.00072293496],"domain_scores_gemma":[0.9957272,0.00011588248,0.00071621547,0.000074239586,0.0024589533,0.0009074874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006184876,0.00047605118,0.0006239578,0.003745565,0.0019349793,0.0020543174,0.0016435605,0.0012261939,0.005352613],"category_scores_gemma":[0.003197981,0.00040379612,0.0015504477,0.010255564,0.00055977923,0.00095481717,0.0013332634,0.0020194473,0.00070147216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004552343,0.000082981605,0.965846,0.00023507248,0.00035503114,0.00014695655,0.00043831253,0.0006726833,0.00015518595,0.0007303903,0.018376213,0.012505908],"study_design_scores_gemma":[0.000015797776,0.000016382315,0.99381644,0.00007871412,0.000065573135,0.00007239053,0.0005543173,0.000581338,0.00006548833,0.000045024844,0.0046717515,0.000016753385],"about_ca_topic_score_codex":0.9951363,"about_ca_topic_score_gemma":0.9964271,"teacher_disagreement_score":0.03497366,"about_ca_system_score_codex":0.03497366,"about_ca_system_score_gemma":0.04913435,"threshold_uncertainty_score":0.25375283},"labels":[],"label_agreement":null},{"id":"W4395079708","doi":"10.1007/s10549-024-07306-w","title":"Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia; University of Toronto; University Health Network; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; BC Cancer Agency","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute","keywords":"Mendelian randomization; Sex hormone-binding globulin; Body mass index; Internal medicine; Breast cancer; Endocrinology; Hormone; Testosterone (patch); Phenotype; Medicine; Oncology; Biology; Cancer; Genetics; Androgen; Genotype; Gene","score_opus":0.05773142106971615,"score_gpt":0.34818569564940993,"score_spread":0.2904542745796938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395079708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6907911,0.0014666483,0.29639798,0.0011401079,0.0007177084,0.001997975,0.0019918946,0.001361268,0.0041353707],"genre_scores_gemma":[0.88440734,0.00038773482,0.10774609,0.0006492376,0.00016954879,0.0020222717,0.000538856,0.00026527472,0.003813684],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9004258,0.078542314,0.00389854,0.009785486,0.005076263,0.0022715922],"domain_scores_gemma":[0.94249725,0.04008306,0.0037884505,0.012085138,0.00094777223,0.0005982993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042747565,0.0027189353,0.0036771302,0.0035745965,0.0012921853,0.0021798043,0.0033609888,0.0035867097,0.009590629],"category_scores_gemma":[0.06459925,0.0014999991,0.00395745,0.003047374,0.0019969218,0.0020570739,0.0015314084,0.0017375959,0.00065787055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21869814,0.005060182,0.21700075,0.002963491,0.06727769,0.01956817,0.0055198823,0.020806741,0.05821774,0.19788398,0.008356137,0.17864716],"study_design_scores_gemma":[0.069900945,0.0277754,0.17895985,0.0007334398,0.049794476,0.020779733,0.0013477047,0.42128515,0.029754143,0.17389637,0.024868127,0.0009046828],"about_ca_topic_score_codex":0.0037571355,"about_ca_topic_score_gemma":0.0025697765,"teacher_disagreement_score":0.042747565,"about_ca_system_score_codex":0.0010020966,"about_ca_system_score_gemma":0.0016947541,"threshold_uncertainty_score":0.22607344},"labels":[],"label_agreement":null},{"id":"W4395467322","doi":"10.1007/s10549-024-07302-0","title":"Perspectives on shorter durations of anti-HER2 therapy in early-stage HER2-positive breast cancer: a patient survey","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Pertuzumab; Trastuzumab; Internal medicine; myalgia; Clinical trial; Cancer; Adverse effect; Oncology; Physical therapy","score_opus":0.07811656565937058,"score_gpt":0.42488924505717257,"score_spread":0.346772679397802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395467322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817135,0.0031678837,0.00024402043,0.009182877,0.00006604035,0.000018592611,0.0020828487,0.00000737185,0.003516913],"genre_scores_gemma":[0.9929403,0.001997718,0.00013230686,0.0035202533,0.00012458026,0.000025028672,0.00077463704,0.0000037047716,0.0004814946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907446,0.00041068572,0.00011791904,0.00008419172,0.00012638688,0.00018640829],"domain_scores_gemma":[0.9937575,0.0016835515,0.0028929918,0.00012285914,0.00051173096,0.0010313381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019748388,0.00011810601,0.0002900795,0.0004196699,0.00040483812,0.0007474355,0.00022189382,0.00065843825,0.003861118],"category_scores_gemma":[0.005197737,0.00010314283,0.00042852454,0.0013075449,0.00019161026,0.0010350425,0.00032075174,0.00072292663,0.0002986322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022923668,0.000101930986,0.98650867,0.000061837476,0.000048524664,0.00007007077,0.00038709174,0.00006905874,0.0002511629,0.00009128011,0.0011341878,0.011046849],"study_design_scores_gemma":[0.000018138135,0.00026428193,0.9949582,0.000036579466,0.000039108152,0.0001678517,0.0013765814,0.000059260627,0.00006215467,0.000054182805,0.0029545831,0.000009057342],"about_ca_topic_score_codex":0.00681075,"about_ca_topic_score_gemma":0.009622826,"teacher_disagreement_score":0.00681075,"about_ca_system_score_codex":0.0005428052,"about_ca_system_score_gemma":0.00074891705,"threshold_uncertainty_score":0.013542235},"labels":[],"label_agreement":null},{"id":"W4395690084","doi":"10.1007/s10549-024-07282-1","title":"Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society; Institute for Clinical Evaluative Sciences; Sunnybrook Research Institute","keywords":"Medicine; Breast cancer; Internal medicine; Trastuzumab; Oncology; Stage (stratigraphy); Triple-negative breast cancer; Population; Cancer; Cohort; Neoadjuvant therapy; Odds ratio; Logistic regression; Chemotherapy; Disease; Retrospective cohort study; Mastectomy","score_opus":0.026347154271018396,"score_gpt":0.36780957367120914,"score_spread":0.34146241940019073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395690084","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4715539,0.31757677,0.0077392776,0.17031837,0.003480314,0.00047211538,0.00039474096,0.00006156494,0.028402917],"genre_scores_gemma":[0.82409465,0.13830617,0.012962342,0.019250924,0.0020290837,0.00040790948,0.00045030416,0.00002782047,0.0024708763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979134,0.0012859716,0.00018152106,0.00008417717,0.00045345526,0.00008145973],"domain_scores_gemma":[0.9962463,0.0016462684,0.0008898535,0.00025412053,0.0004787986,0.0004846436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006335634,0.0001360423,0.0005704239,0.00024318439,0.0003589448,0.0014061534,0.00029857838,0.000464578,0.0009148338],"category_scores_gemma":[0.008381365,0.00010557958,0.00021749505,0.00048182765,0.00074550626,0.0012948064,0.00047428085,0.001263457,0.0001446483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075183613,0.0012576466,0.107792705,0.0017712318,0.00039973034,0.00019390727,0.00035954668,0.000829061,0.013551474,0.01016107,0.018258087,0.83790725],"study_design_scores_gemma":[0.0016075525,0.017892025,0.7158681,0.0053355996,0.0011756928,0.002635173,0.0032003766,0.0020999236,0.014556489,0.022786593,0.21269833,0.00014410213],"about_ca_topic_score_codex":0.0014568182,"about_ca_topic_score_gemma":0.0060807923,"teacher_disagreement_score":0.006335634,"about_ca_system_score_codex":0.0012176753,"about_ca_system_score_gemma":0.0033623464,"threshold_uncertainty_score":0.033506393},"labels":[],"label_agreement":null},{"id":"W4397290537","doi":"10.1007/s10549-024-07360-4","title":"Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort study","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Psychological intervention; Discontinuation; Physical therapy; Quality of life (healthcare); Breast cancer; Prospective cohort study; Cohort; Observational study; Internal medicine; Cancer","score_opus":0.1518513345406456,"score_gpt":0.466677174049842,"score_spread":0.3148258395091964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397290537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851902,0.00024350759,0.011125669,0.00008521995,0.000048448535,0.0014365352,0.0012768026,0.000064692154,0.0005288928],"genre_scores_gemma":[0.9836442,0.00014237525,0.012603558,0.000036024714,0.000021627355,0.0020862315,0.0011449953,0.000025139592,0.00029601023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9893048,0.007379508,0.00072420185,0.0008385368,0.0014519276,0.00030109953],"domain_scores_gemma":[0.9832585,0.008221775,0.004213993,0.0017623648,0.0020442181,0.0004991812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020934924,0.00088456465,0.0008585042,0.001634093,0.0007372856,0.0008297241,0.00082218973,0.00050458236,0.0012210319],"category_scores_gemma":[0.03212915,0.000410932,0.0030515362,0.001352548,0.00035758968,0.00093009893,0.0008898795,0.001164428,0.00026873458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043101087,0.0014419073,0.95336175,0.00011189891,0.001878104,0.000041610452,0.000566926,0.0021815202,0.0004969224,0.0002037408,0.00058845774,0.034817174],"study_design_scores_gemma":[0.0011703407,0.015235971,0.95071757,0.00008944451,0.0014597435,0.00014074147,0.00069639337,0.027200475,0.0010577327,0.00048185367,0.0016625861,0.00008710206],"about_ca_topic_score_codex":0.0051082256,"about_ca_topic_score_gemma":0.0051150466,"teacher_disagreement_score":0.020934924,"about_ca_system_score_codex":0.00085426297,"about_ca_system_score_gemma":0.0012661291,"threshold_uncertainty_score":0.11071581},"labels":[],"label_agreement":null},{"id":"W4399481017","doi":"10.1007/s10549-024-07400-z","title":"Second primary non-breast cancers in young breast cancer survivors","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Susan G. Komen; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Cumulative incidence; Internal medicine; Incidence (geometry); Population; Hazard ratio; Gynecology; Oncology; Proportional hazards model; Confidence interval; Obstetrics; Cancer; Cohort","score_opus":0.033906846359865156,"score_gpt":0.35156391040752355,"score_spread":0.31765706404765837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399481017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813616,0.0005552429,0.000021019863,0.000092435286,0.000014359586,0.0000059503477,0.00026498327,0.000002259904,0.000907511],"genre_scores_gemma":[0.99853253,0.00040307798,0.000016282507,0.000044361946,0.000014882224,0.0000049768264,0.00020887534,0.0000020065556,0.000772907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997358,0.000035901045,0.000026167205,0.000037688464,0.000048079582,0.00011643613],"domain_scores_gemma":[0.9990125,0.00017942871,0.00038229168,0.000022981641,0.00006860214,0.00033426375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023000376,0.000141845,0.00036149737,0.0008369859,0.00043635833,0.00066631386,0.00018242156,0.0005092339,0.0060907346],"category_scores_gemma":[0.0017141184,0.00025745376,0.00047288617,0.0007422574,0.00017129154,0.00046937677,0.0005279827,0.00055967836,0.00050814584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067698136,0.000033669276,0.99788,0.000013470284,0.000012825396,0.00022185576,0.00015015407,0.0000079487945,0.0001143066,0.000010839223,0.000099397235,0.0013878859],"study_design_scores_gemma":[0.000004375599,0.000086972934,0.99772626,0.000015896178,0.00002051613,0.00084977865,0.0009887951,0.0000345901,0.00004385561,0.00002330816,0.00020304522,0.000002513961],"about_ca_topic_score_codex":0.013333979,"about_ca_topic_score_gemma":0.017836513,"teacher_disagreement_score":0.013333979,"about_ca_system_score_codex":0.00035175972,"about_ca_system_score_gemma":0.00063818647,"threshold_uncertainty_score":0.026512742},"labels":[],"label_agreement":null},{"id":"W4399692189","doi":"10.1007/s10549-024-07372-0","title":"UM171 suppresses breast cancer progression by inducing KLF2","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Guizhou Medical University; National Natural Science Foundation of China","keywords":"Cancer research; Cell growth; Cancer; Breast cancer; Biology; Apoptosis; Cell cycle; Metastasis; Immunology; Cell culture; Medicine; Internal medicine","score_opus":0.05165709184154351,"score_gpt":0.4276487107807912,"score_spread":0.3759916189392477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399692189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784468,0.010654675,0.0028339182,0.00032299192,0.00014321532,0.00007290035,0.0023335665,0.00024172854,0.004950168],"genre_scores_gemma":[0.9855757,0.0054443395,0.001613913,0.00016841658,0.000029915764,0.0000777682,0.0022716247,0.000030406178,0.0047878902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999256,0.000014322198,0.000008585402,0.000010691147,0.000015014774,0.000025823632],"domain_scores_gemma":[0.9999387,0.000007991582,0.000017354943,0.0000051864326,0.00000994724,0.000020791682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108863576,0.00037172178,0.00029196625,0.0003062469,0.0001636904,0.00019290243,0.00018259158,0.00015180126,0.0027105813],"category_scores_gemma":[0.00007900827,0.00010839425,0.00033799474,0.00021202845,0.00015686236,0.00010428381,0.0001614876,0.00047790963,0.0005491305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065777375,0.00012215097,0.0008677933,0.0003540895,0.000021185784,0.00014136476,0.000019716968,0.00026854296,0.98984027,0.00023821602,0.00051941274,0.0069495332],"study_design_scores_gemma":[0.00006132438,0.000816395,0.0030661388,0.000025480515,0.000039981293,0.00027101667,0.000046058096,0.0007134447,0.98791355,0.00005988461,0.006981229,0.000005481673],"about_ca_topic_score_codex":0.00052945554,"about_ca_topic_score_gemma":0.00091091625,"teacher_disagreement_score":0.0027105813,"about_ca_system_score_codex":0.00024990615,"about_ca_system_score_gemma":0.0003243004,"threshold_uncertainty_score":0.009067774},"labels":[],"label_agreement":null},{"id":"W4401179317","doi":"10.1007/s10549-024-07443-2","title":"A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Markham Stouffville Hospital; McMaster University; Queen's University; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Discontinuation; Bisphosphonate; Breast cancer; Zoledronic acid; Internal medicine; Randomized controlled trial; Adjuvant; Oncology; Cancer; Surgery; Osteoporosis","score_opus":0.047448031603157685,"score_gpt":0.34270979006183816,"score_spread":0.29526175845868047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401179317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041826,0.003630806,0.00052181334,0.00054443855,0.0006108272,0.0030890042,0.00040173298,0.000061753395,0.0007212921],"genre_scores_gemma":[0.9868727,0.002284022,0.0020241092,0.00086059683,0.00060392707,0.004816837,0.00060126284,0.000015040856,0.0019215866],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987159,0.00075792836,0.00011374255,0.00020279974,0.000080696635,0.00012899222],"domain_scores_gemma":[0.9972761,0.0009888604,0.00068521773,0.00023441967,0.00010541171,0.00070994947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024213018,0.0012372631,0.003971945,0.00053180894,0.0004768403,0.0009814295,0.0010197462,0.0023172253,0.007393024],"category_scores_gemma":[0.0036483884,0.0006840576,0.002425625,0.00056829146,0.0013342637,0.0010703503,0.0006665546,0.002571109,0.0011984417],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9901848,0.0026130306,0.00031154585,0.00024419907,0.00027919305,0.000015003854,0.000025707974,0.00014614021,0.00076222135,0.00003409933,0.000096467214,0.0052876673],"study_design_scores_gemma":[0.94555646,0.053096145,0.00071456673,0.000015867732,0.00017151081,0.000017496803,0.000008409242,0.00013352487,0.00009956205,0.000055114215,0.00012533038,0.000006028102],"about_ca_topic_score_codex":0.00088587333,"about_ca_topic_score_gemma":0.0015648729,"teacher_disagreement_score":0.007393024,"about_ca_system_score_codex":0.000745761,"about_ca_system_score_gemma":0.0014564528,"threshold_uncertainty_score":0.024732172},"labels":[],"label_agreement":null},{"id":"W4401386337","doi":"10.1007/s10549-024-07435-2","title":"Barrier films or dressings for the prevention of acute radiation dermatitis in breast cancer: a systematic review and network meta-analysis","year":2024,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary; McGill University; Sunnybrook Health Science Centre; McGill University Health Centre; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Meta-analysis; Randomized controlled trial; Internal medicine; Dermatology; Cancer","score_opus":0.10543895501969264,"score_gpt":0.4542095488019307,"score_spread":0.34877059378223807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401386337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052709295,0.9935363,0.0002929241,0.0000807592,0.00014772941,0.00015453632,0.00027410156,0.00001685181,0.00022585523],"genre_scores_gemma":[0.113467164,0.88340795,0.0012010216,0.0006838413,0.0001791507,0.0002714512,0.00034811953,0.000019778265,0.00042146316],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970567,0.0011012905,0.0009088625,0.0004058243,0.00036474116,0.00016247848],"domain_scores_gemma":[0.99499977,0.0035211216,0.0009080299,0.00015667788,0.00031614085,0.00009833671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004136002,0.0023173718,0.012674243,0.0026514651,0.00055568037,0.00224575,0.0015089486,0.002165894,0.0044849813],"category_scores_gemma":[0.012698067,0.0011234136,0.025437566,0.003307029,0.00062141026,0.0012524084,0.0012154862,0.0024038819,0.0003467093],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00629486,0.00010227788,0.0027735645,0.48742503,0.47663245,0.00012802206,0.00010487242,0.00043993912,0.00043452453,0.00012994652,0.00085207395,0.024682486],"study_design_scores_gemma":[0.0020158426,0.00045005404,0.0035129571,0.023945654,0.96771306,0.00008136395,0.0000589906,0.00011978593,0.00015306995,0.00017695467,0.0017422579,0.000030077887],"about_ca_topic_score_codex":0.009066066,"about_ca_topic_score_gemma":0.021610977,"teacher_disagreement_score":0.012674243,"about_ca_system_score_codex":0.0016065325,"about_ca_system_score_gemma":0.0019197747,"threshold_uncertainty_score":0.021873474},"labels":[],"label_agreement":null},{"id":"W4402228524","doi":"10.1007/s10549-024-07448-x","title":"Microcalcifications in benign breast biopsies: association with lesion type and risk","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Breast cancer; Association (psychology); Breast disease; Lesion; Mammary gland; Internal medicine; Pathology; Oncology; Dermatology; Cancer; Psychology","score_opus":0.05213125450565592,"score_gpt":0.36288581112328766,"score_spread":0.31075455661763174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402228524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980361,0.00078448467,0.00015664425,0.000044300585,0.0000074001373,0.0000047181634,0.00009159182,0.000007942581,0.0008670152],"genre_scores_gemma":[0.99942243,0.00017162194,0.00011028592,0.000008238851,0.000016753293,0.00000217939,0.000051437848,0.0000028113975,0.00021422486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991573,0.0003004582,0.000105690655,0.00011102238,0.00021482939,0.0001106673],"domain_scores_gemma":[0.9942456,0.0021408068,0.0021612858,0.00042148065,0.00050027895,0.00053062616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008777343,0.0002841376,0.00033752705,0.0015015776,0.00032473105,0.00073382666,0.0004598568,0.00071050687,0.002723691],"category_scores_gemma":[0.008568147,0.0003643083,0.00042650945,0.0011365311,0.00032732583,0.00052615826,0.00039508883,0.00061404775,0.00038543073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001988553,0.000015608948,0.99833053,0.0000049364667,0.00002790491,0.000083279134,0.000018014242,0.000016618524,0.00031658233,0.000010342873,0.000013988435,0.00096321915],"study_design_scores_gemma":[0.0000020268378,0.00006170004,0.99821055,0.0000032851794,0.00003520739,0.0012321341,0.00008881417,0.00015529504,0.000121921075,0.000032704113,0.00005401003,0.000002421582],"about_ca_topic_score_codex":0.0011807048,"about_ca_topic_score_gemma":0.001634345,"teacher_disagreement_score":0.002723691,"about_ca_system_score_codex":0.0001717732,"about_ca_system_score_gemma":0.00024702388,"threshold_uncertainty_score":0.009111643},"labels":[],"label_agreement":null},{"id":"W4403616501","doi":"10.1007/s10549-024-07519-z","title":"CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"Genomic Health; Foundation Medicine; Veracyte; Genentech; Max-Planck-Gesellschaft; Eisai; Puma Biotechnology; Natera; National Institutes of Health; ECOG-ACRIN Cancer Research Group; BeiGene; Susan G. Komen; Sanofi Genzyme; Pfizer; Incyte; American College of Radiology Imaging Network; National Cancer Institute; Gilead Sciences; Sanofi; Johns Hopkins University; Susan G. Komen for the Cure; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Metastatic breast cancer; Cancer; Internal medicine; Mammary gland; Antiestrogen","score_opus":0.14977172718728982,"score_gpt":0.44882049944701197,"score_spread":0.29904877225972215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403616501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641824,0.0013746339,0.00009030468,0.00011873383,0.000014150851,0.00003452456,0.001266737,0.000013229349,0.00066941074],"genre_scores_gemma":[0.9958269,0.0006850538,0.00014654046,0.00013702245,0.000045412962,0.000025987998,0.0025781149,0.0000066068,0.0005482409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995925,0.00014272962,0.000030696006,0.000093977,0.00008887192,0.00005123152],"domain_scores_gemma":[0.99930394,0.00016515281,0.00024285987,0.00006038778,0.00008564682,0.00014201914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006718433,0.0006069202,0.0010185485,0.00043738403,0.00020247645,0.00054302334,0.0003217514,0.0006237431,0.0009276086],"category_scores_gemma":[0.0012058428,0.00022785661,0.001069084,0.0008157219,0.00022671759,0.00039138345,0.00028015647,0.00069603795,0.00028854236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059712723,0.0010021364,0.895538,0.00012097319,0.0020841488,0.00037637266,0.000107486674,0.0006797631,0.0076224813,0.000041528347,0.0011397703,0.031574715],"study_design_scores_gemma":[0.0029249657,0.0065799304,0.986016,0.000011821265,0.001180176,0.0005676031,0.00007279138,0.0005022428,0.0009496928,0.00004877828,0.0011278898,0.000018167864],"about_ca_topic_score_codex":0.0025786024,"about_ca_topic_score_gemma":0.0036343252,"teacher_disagreement_score":0.0025786024,"about_ca_system_score_codex":0.00047424066,"about_ca_system_score_gemma":0.00030561048,"threshold_uncertainty_score":0.0051271915},"labels":[],"label_agreement":null},{"id":"W4404355148","doi":"10.1007/s10549-024-07547-9","title":"Impact of the COVID-19 pandemic on breast cancer surgeries in a Canadian population","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Breast cancer; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Population; Cancer; Coronavirus Infections; Virology; Internal medicine; Environmental health; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.1903884993582467,"score_gpt":0.519642351783939,"score_spread":0.32925385242569233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404355148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9504316,0.002918933,0.00066447974,0.0040720203,0.0000939578,0.00013602931,0.03405435,0.00006071807,0.007567967],"genre_scores_gemma":[0.98730487,0.0017269271,0.0007122997,0.00055662746,0.000043836666,0.000041540665,0.008595028,0.000015206418,0.0010037835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987658,0.00008188784,0.00005957967,0.00016338029,0.00044250884,0.0004868837],"domain_scores_gemma":[0.9979966,0.0001434282,0.0006470518,0.00005986822,0.000751025,0.00040190193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008756904,0.00048366943,0.00033956522,0.0012968595,0.0015919792,0.0009901159,0.0011023207,0.00041559618,0.0032066065],"category_scores_gemma":[0.004517043,0.00027489383,0.00080434955,0.002571872,0.0006040636,0.00048815788,0.0012157406,0.0011524595,0.0002415283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010471953,0.000025814024,0.9826231,0.00013967992,0.00008821162,0.00015258719,0.0005357173,0.0006831998,0.00025654293,0.0003176859,0.0058061434,0.009266659],"study_design_scores_gemma":[0.0000067286783,0.000023464081,0.9942926,0.000093707946,0.000033272212,0.0001243514,0.0012510275,0.0011144254,0.00007274322,0.000058935497,0.0029101728,0.00001862366],"about_ca_topic_score_codex":0.98952943,"about_ca_topic_score_gemma":0.9917801,"teacher_disagreement_score":0.02789081,"about_ca_system_score_codex":0.02789081,"about_ca_system_score_gemma":0.036008842,"threshold_uncertainty_score":0.20236295},"labels":[],"label_agreement":null},{"id":"W4405096693","doi":"10.1007/s10549-024-07557-7","title":"Inference of genetic ancestry from a multi-gene cancer panel in Colombian women with cancer","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Race, Genetics, and Society","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University","funders":"National Cancer Institute; Instituto Nacional de Cancerología; Georgia Institute of Technology","keywords":"Genetic genealogy; Ancestry-informative marker; Cancer; Population; 1000 Genomes Project; Cohort; Inference; Breast cancer; Genetics; Health equity; Genetic testing; Biology; Demography; Medicine; Gene; Allele frequency; Genotype; Internal medicine; Public health; Single-nucleotide polymorphism; Environmental health; Pathology; Computer science","score_opus":0.06512567454030706,"score_gpt":0.37076375651974197,"score_spread":0.30563808197943493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126387,0.0005979727,0.0035828305,0.00015359465,0.000009792233,0.000050673665,0.0031724172,0.000035871824,0.0011328196],"genre_scores_gemma":[0.99531835,0.00015652177,0.0023751012,0.000037387843,0.0000054664915,0.000025472573,0.0018429586,0.000006981289,0.0002316719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990625,0.00043358566,0.000052887826,0.00028744398,0.00009027549,0.000073342024],"domain_scores_gemma":[0.9982444,0.0007603681,0.00037098484,0.0003003907,0.00023002825,0.00009378495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014273694,0.00039305983,0.0003852384,0.0011588648,0.0006714084,0.00076693454,0.00043405872,0.00033763368,0.0016713033],"category_scores_gemma":[0.0064754887,0.00019283312,0.00022844046,0.00095978664,0.00021905721,0.00016305622,0.00072820514,0.00029008175,0.00023248747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001637215,0.000016595017,0.98183054,0.00004402892,0.00015102206,0.00014212562,0.00032198994,0.0017607328,0.001036207,0.0000924218,0.0006540678,0.013786661],"study_design_scores_gemma":[0.00002087272,0.00005352025,0.9854506,0.000077049976,0.0001815368,0.0004867698,0.00053561124,0.009513251,0.0007986089,0.00027368142,0.0025864395,0.000022108266],"about_ca_topic_score_codex":0.08467676,"about_ca_topic_score_gemma":0.09428148,"teacher_disagreement_score":0.08467676,"about_ca_system_score_codex":0.0007594708,"about_ca_system_score_gemma":0.0005646739,"threshold_uncertainty_score":0.16836774},"labels":[],"label_agreement":null},{"id":"W4405774694","doi":"10.1007/s10549-024-07578-2","title":"Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitor","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences North; University Health Network; University of Toronto; Regional Municipality of Durham; Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Proportional hazards model; Cancer; Population; Hormonal therapy; Metastatic breast cancer","score_opus":0.05660394675775749,"score_gpt":0.3702484980170477,"score_spread":0.3136445512592902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405774694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885837,0.004820694,0.00027164005,0.0005882121,0.000052086387,0.000069547445,0.00033047827,0.00002745307,0.0052562994],"genre_scores_gemma":[0.997451,0.0009162612,0.00018875724,0.00020248997,0.00005584562,0.000017523822,0.00040127675,0.000003525296,0.0007632733],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9998926,0.000026927708,0.000014851446,0.000015724956,0.000020034842,0.000029785624],"domain_scores_gemma":[0.99980503,0.000047494144,0.000049397448,0.000009552672,0.000018930967,0.00006962331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021931196,0.0002147372,0.00049789215,0.00050943054,0.0002431262,0.00021524208,0.00012800428,0.00029454095,0.0017784932],"category_scores_gemma":[0.00046851404,0.00013047771,0.00044243582,0.0003917177,0.00016882186,0.00023801939,0.00018246542,0.00041940372,0.0001246719],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0802453,0.0011272363,0.73202,0.000511364,0.0009043861,0.04544111,0.00020370354,0.0011503084,0.027059767,0.00041298327,0.0029342333,0.107989684],"study_design_scores_gemma":[0.0014652481,0.0075119133,0.93999106,0.00010294511,0.0008703528,0.03707712,0.0003297997,0.0024865046,0.0037955728,0.0005172317,0.005818261,0.000034076824],"about_ca_topic_score_codex":0.0015250325,"about_ca_topic_score_gemma":0.003379653,"teacher_disagreement_score":0.0017784932,"about_ca_system_score_codex":0.00036066532,"about_ca_system_score_gemma":0.0003036289,"threshold_uncertainty_score":0.0059496164},"labels":[],"label_agreement":null},{"id":"W4406778471","doi":"10.1007/s10549-024-07580-8","title":"A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy ± targeted therapy in HR + HER2-negative advanced breast cancer","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Novartis (Canada); Kingston Health Sciences Centre; McGill University Health Centre; Jewish General Hospital; Ottawa Hospital; Saskatchewan Cancer Agency; Ottawa Regional Cancer Foundation; Windsor Regional Hospital; Western University; Grand River Hospital; Centre hospitalier universitaire de Québec","funders":"Novartis Pharmaceuticals Canada","keywords":"Medicine; Observational study; Oncology; Targeted therapy; Survival analysis; Internal medicine; Prospective cohort study; Endocrine system; Cancer; Hormone","score_opus":0.08490122213785031,"score_gpt":0.4171629806915637,"score_spread":0.3322617585537134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406778471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572396,0.0006562539,0.000100478595,0.00015358986,0.000009477601,0.00007920204,0.0026928934,0.0000042571305,0.0005798561],"genre_scores_gemma":[0.997134,0.0003828504,0.0003057871,0.00013476507,0.000013038488,0.000050593037,0.0017252077,0.0000025973948,0.00025112397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991178,0.00011170841,0.000060853552,0.0002189125,0.00027299422,0.00021767529],"domain_scores_gemma":[0.99776065,0.00015166022,0.0009846509,0.00010763657,0.00052185706,0.00047364295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009441251,0.00044532644,0.00051770604,0.0005614742,0.0018495288,0.0007836325,0.000802683,0.00053011323,0.001548444],"category_scores_gemma":[0.0021393267,0.00034301032,0.00079479103,0.0023205953,0.0005137126,0.0003734058,0.0005377413,0.0007725279,0.00014021434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065148924,0.000113682974,0.9952205,0.00007418907,0.00019541668,0.000045148696,0.00019607117,0.00010343661,0.00025403977,0.000047475747,0.00058772706,0.002510709],"study_design_scores_gemma":[0.00011253282,0.00027313014,0.9976477,0.000033901837,0.00015725582,0.00011229868,0.00035837642,0.00030316738,0.000062760344,0.000020294317,0.0009027196,0.00001602112],"about_ca_topic_score_codex":0.9045313,"about_ca_topic_score_gemma":0.9386836,"teacher_disagreement_score":0.0954687,"about_ca_system_score_codex":0.013751106,"about_ca_system_score_gemma":0.01756211,"threshold_uncertainty_score":0.19206184},"labels":[],"label_agreement":null},{"id":"W4407114667","doi":"10.1007/s10549-025-07612-x","title":"The association between cirrhosis and outcomes among female patients undergoing surgery for breast cancer in Ontario: a population-based study","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Kingston General Hospital; Queen's University","funders":"","keywords":"Breast cancer; Medicine; Surgery; Population; Oncology; Cirrhosis; Internal medicine; Breast surgery; Cancer; Gynecology; General surgery; Environmental health","score_opus":0.039574581809844335,"score_gpt":0.35374269347030013,"score_spread":0.3141681116604558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407114667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767107,0.00018784756,0.000039375325,0.00015801795,0.0000061028077,0.000014385976,0.0009918058,0.0000027457058,0.00092874654],"genre_scores_gemma":[0.99902964,0.00014584475,0.000035120305,0.00005294023,0.000006476474,0.000008219245,0.00038212436,0.0000017252645,0.00033790994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945694,0.00005662748,0.00004400305,0.00009721995,0.00014425142,0.00020094766],"domain_scores_gemma":[0.99841964,0.00011466361,0.00057282567,0.00008198594,0.00036251565,0.00044835417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033732675,0.00029045838,0.00043872694,0.00083714584,0.0017203015,0.00095624244,0.00070635683,0.00054496515,0.0021322577],"category_scores_gemma":[0.0015235672,0.00050555245,0.00063871645,0.002966055,0.00064768555,0.00048580347,0.0006821582,0.0006020792,0.00020516566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036833484,0.00001559201,0.99908245,0.000007624425,0.000030495868,0.00004761823,0.00025941248,0.000008215354,0.000090706635,0.000014590372,0.00012564195,0.00028076017],"study_design_scores_gemma":[0.000004403805,0.000012396457,0.99936,0.0000044392127,0.000013677272,0.000028938304,0.00041879143,0.000026500686,0.000006537765,0.0000066048956,0.000115088376,0.0000025668608],"about_ca_topic_score_codex":0.8688833,"about_ca_topic_score_gemma":0.92484695,"teacher_disagreement_score":0.13111669,"about_ca_system_score_codex":0.006772615,"about_ca_system_score_gemma":0.006574537,"threshold_uncertainty_score":0.26377767},"labels":[],"label_agreement":null},{"id":"W4407851919","doi":"10.1007/s10549-025-07646-1","title":"Genetic counseling referral rates and genetic testing outcomes in women with young breast cancer: a 20-year Canadian review","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Breast cancer; Genetic counseling; Referral; Genetic testing; Medicine; Family medicine; Demography; Oncology; Gynecology; Cancer; Obstetrics; Internal medicine; Biology; Genetics","score_opus":0.029604664406602043,"score_gpt":0.34764455930972676,"score_spread":0.31803989490312473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407851919","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0113154,0.9725867,0.00013370093,0.008843205,0.00048490995,0.000025768888,0.0024985664,0.000019743471,0.004092111],"genre_scores_gemma":[0.04594523,0.948774,0.00046184871,0.0027233928,0.00023572035,0.00002680282,0.0012176092,0.000017901602,0.0005974743],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965239,0.00026793475,0.0005345131,0.0005152643,0.001644156,0.00051425834],"domain_scores_gemma":[0.97560084,0.004936523,0.0035885293,0.00021857992,0.014096803,0.0015586582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00546417,0.0006564457,0.0018485483,0.0061915843,0.002145791,0.0028986533,0.0022361937,0.001637019,0.0040568723],"category_scores_gemma":[0.023259625,0.0007287053,0.001779063,0.019248337,0.0015874979,0.001691275,0.0013391637,0.002039377,0.00034162222],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006558976,0.00013903285,0.2501457,0.032818515,0.0017323657,0.0005093828,0.003151315,0.0006705967,0.00025956097,0.004448591,0.118123256,0.5873457],"study_design_scores_gemma":[0.00019243069,0.00013624794,0.69597286,0.07407848,0.005176136,0.0016669196,0.0056688017,0.00058465236,0.00025440054,0.0010408153,0.21490745,0.0003208697],"about_ca_topic_score_codex":0.9701293,"about_ca_topic_score_gemma":0.98218244,"teacher_disagreement_score":0.049283214,"about_ca_system_score_codex":0.049283214,"about_ca_system_score_gemma":0.10010544,"threshold_uncertainty_score":0.35757643},"labels":[],"label_agreement":null},{"id":"W4408083539","doi":"10.1007/s10549-025-07661-2","title":"Oncotype DX recurrence score in node-positive patients in the post-RxPONDER era: a single-institution experience","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Node (physics); Internal medicine; Gynecology; Cancer","score_opus":0.03492032706353536,"score_gpt":0.3531760292277033,"score_spread":0.31825570216416793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408083539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906,0.00024604952,0.000061016694,0.00003385022,0.000004751257,0.0000064133687,0.00007586882,0.000002705079,0.0005093951],"genre_scores_gemma":[0.99906296,0.00028157656,0.000096397955,0.000029883973,0.000012820875,0.0000046958726,0.00015105205,0.000004460623,0.00035615187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974626,0.00005391929,0.000021526874,0.000048129543,0.00004775773,0.00008237038],"domain_scores_gemma":[0.99956876,0.00007411731,0.00012252694,0.00003705659,0.00004113127,0.00015640946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003917584,0.0001706157,0.00031895385,0.0003549813,0.0004431557,0.00055444683,0.00028166512,0.00020659417,0.00173992],"category_scores_gemma":[0.0008943919,0.0001330451,0.00028590256,0.0005832971,0.00022853806,0.00038475322,0.000509073,0.00031979757,0.00026125408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026765701,0.00014925472,0.988644,0.000011971624,0.00003016148,0.0010661997,0.0002034164,0.00006032408,0.00047719278,0.00003085481,0.00019404336,0.008864961],"study_design_scores_gemma":[0.000024859239,0.00080329715,0.99245596,0.000013957861,0.00006946056,0.0042775585,0.0010215023,0.0001731004,0.0003578032,0.000033552686,0.00075906067,0.000009800699],"about_ca_topic_score_codex":0.0025342444,"about_ca_topic_score_gemma":0.0053215334,"teacher_disagreement_score":0.0025342444,"about_ca_system_score_codex":0.00040803905,"about_ca_system_score_gemma":0.00048329248,"threshold_uncertainty_score":0.005820632},"labels":[],"label_agreement":null},{"id":"W4408371064","doi":"10.1007/s10549-025-07654-1","title":"Evaluating PREDICT and developing outcome prediction models in early-onset breast cancer using data from Alberta, Canada","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Proportional hazards model; Breast cancer; Lasso (programming language); Cohort; Receiver operating characteristic; Cohort study; Predictive modelling; Regression analysis; Survival analysis; Demography; Mortality rate; Statistics; Cancer; Internal medicine; Mathematics","score_opus":0.1511304431035496,"score_gpt":0.4253393452398174,"score_spread":0.2742089021362678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408371064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98406434,0.0012074364,0.004813468,0.0006418789,0.000030732714,0.00018272207,0.0070509454,0.00012188175,0.0018865807],"genre_scores_gemma":[0.9830119,0.0004928365,0.0054185116,0.00012484899,0.000016267351,0.00007562752,0.009886352,0.000018350816,0.00095525413],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99864846,0.00047271498,0.000057825888,0.00017653996,0.00043106955,0.0002133652],"domain_scores_gemma":[0.99415565,0.0020281551,0.0005256703,0.00024640007,0.00262916,0.00041486873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059564398,0.00081062946,0.00046586627,0.0014524146,0.0008181799,0.0011482702,0.0012543919,0.00039318763,0.0013146406],"category_scores_gemma":[0.010136591,0.0002844008,0.0006742631,0.0015531826,0.00039371743,0.00028496995,0.0008205777,0.00062177074,0.000251684],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065321295,0.00012804537,0.92488176,0.00016626925,0.00037579288,0.00011446364,0.00024352144,0.031778105,0.00043122313,0.00038505232,0.0041038906,0.036738712],"study_design_scores_gemma":[0.00019976536,0.00026783254,0.8163418,0.00020293481,0.00029285523,0.00009037888,0.00077713036,0.1749448,0.0009616686,0.0006053766,0.0052613397,0.00005406939],"about_ca_topic_score_codex":0.94900066,"about_ca_topic_score_gemma":0.95525867,"teacher_disagreement_score":0.050999343,"about_ca_system_score_codex":0.014045748,"about_ca_system_score_gemma":0.021880895,"threshold_uncertainty_score":0.10259932},"labels":[],"label_agreement":null},{"id":"W4408921873","doi":"10.1007/s10549-025-07653-2","title":"Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Palbociclib; Medicine; Randomized controlled trial; Breast cancer; Adjuvant; Internal medicine; Cancer; Pill; Gynecology; Oncology; Metastatic breast cancer; Pharmacology","score_opus":0.03299598826769643,"score_gpt":0.40508378264795325,"score_spread":0.3720877943802568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408921873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97023153,0.0145305535,0.00070552924,0.004289143,0.0014665839,0.0012967315,0.00187288,0.00014963228,0.005457474],"genre_scores_gemma":[0.9900475,0.0023278077,0.0009339827,0.0021010332,0.00050950714,0.0011366672,0.0011729468,0.000028101998,0.001742505],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99647164,0.0025987548,0.00015595369,0.00037451822,0.00014656251,0.00025261138],"domain_scores_gemma":[0.99773526,0.00091839646,0.0005555441,0.0002194181,0.00012524455,0.00044608305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041655344,0.0013934916,0.0032807477,0.00040702,0.00037017884,0.0015427242,0.0008942479,0.001505056,0.0063827783],"category_scores_gemma":[0.0057221185,0.0005834283,0.0043319464,0.00054998667,0.0013315318,0.0015722166,0.0010361469,0.0042029964,0.0006224331],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9744518,0.0009359933,0.002009451,0.00049500377,0.004062733,0.000015000929,0.000029779778,0.00051008165,0.00031458502,0.00015943611,0.00095101283,0.016065126],"study_design_scores_gemma":[0.9480361,0.032856718,0.009635905,0.00019406147,0.005848807,0.000032826607,0.000086412554,0.000924843,0.00023256191,0.0006991528,0.001421698,0.00003080635],"about_ca_topic_score_codex":0.0022047625,"about_ca_topic_score_gemma":0.0055251787,"teacher_disagreement_score":0.0063827783,"about_ca_system_score_codex":0.0012856298,"about_ca_system_score_gemma":0.0015760065,"threshold_uncertainty_score":0.022029698},"labels":[],"label_agreement":null},{"id":"W4409118679","doi":"10.1007/s10549-025-07636-3","title":"Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institutes of Health; National Heart, Lung, and Blood Institute; Genome Canada; American Heart Association","keywords":"Medicine; Randomized controlled trial; Breast cancer; Carvedilol; Tolerability; Cardiotoxicity; Adverse effect; Internal medicine; Oncology; Cancer; Heart failure; Chemotherapy","score_opus":0.05147466225907994,"score_gpt":0.43220684244028484,"score_spread":0.3807321801812049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409118679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889531,0.002257838,0.00046276007,0.00078643067,0.00016786037,0.0047359522,0.00079520245,0.000111933594,0.001728842],"genre_scores_gemma":[0.982068,0.0022323106,0.002391818,0.0017424809,0.00038474562,0.00801889,0.0010670248,0.000019367943,0.0020753362],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996039,0.00022652227,0.000019612273,0.00006195243,0.000035733792,0.000052251235],"domain_scores_gemma":[0.9992945,0.00018759869,0.0002130592,0.000047714577,0.000043831857,0.00021317872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012544803,0.0008228179,0.0012596708,0.00024975633,0.00030183804,0.0007243807,0.0005533403,0.0012505227,0.004380716],"category_scores_gemma":[0.0014922546,0.00032903472,0.00078225747,0.00026874073,0.0005220516,0.0004247734,0.00024806094,0.0017291304,0.00052691984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93587637,0.017731234,0.0021780266,0.0007762702,0.0006197169,0.00006473666,0.00008213434,0.00049253873,0.004102846,0.00017510334,0.002091379,0.035809737],"study_design_scores_gemma":[0.9230305,0.07301705,0.0022772795,0.000032470733,0.00025008863,0.000043607684,0.000013000418,0.00032245988,0.00034594152,0.00007313283,0.00058634934,0.00000817388],"about_ca_topic_score_codex":0.00056327874,"about_ca_topic_score_gemma":0.002000242,"teacher_disagreement_score":0.004380716,"about_ca_system_score_codex":0.0004677911,"about_ca_system_score_gemma":0.0013425599,"threshold_uncertainty_score":0.014654934},"labels":[],"label_agreement":null},{"id":"W4409867429","doi":"10.1007/s10549-025-07699-2","title":"Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"Deutsches Krebsforschungszentrum; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Statin; Breast cancer; Oncology; Pertuzumab; Taxane; Proportional hazards model; Trastuzumab; Population; Cancer","score_opus":0.022854513502231732,"score_gpt":0.33885003644746725,"score_spread":0.31599552294523553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409867429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965738,0.0017662491,0.000063922525,0.00022813624,0.000031094194,0.000060380833,0.00035630586,0.0000038281273,0.0009163402],"genre_scores_gemma":[0.99794775,0.0004729684,0.0000863519,0.0001535344,0.00006172917,0.00007307263,0.00077871844,0.0000020248863,0.00042380646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992986,0.00040167777,0.00006110103,0.00007866881,0.00009017918,0.00006971877],"domain_scores_gemma":[0.9989235,0.00031312642,0.0003980104,0.000106438114,0.00006669442,0.00019227392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015488872,0.00020395369,0.0007088353,0.000112942354,0.00021321807,0.0006187205,0.00021865092,0.000395476,0.0013377564],"category_scores_gemma":[0.0023153354,0.0000867611,0.00065955805,0.00021570701,0.00022222898,0.00032595874,0.0003843617,0.00079698546,0.000116702366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37616226,0.001714856,0.57160836,0.0007653466,0.0048988583,0.00020460592,0.00017175966,0.00097037875,0.0024965622,0.00037017983,0.0027878827,0.037848942],"study_design_scores_gemma":[0.05058221,0.025318902,0.9071646,0.00032527014,0.0053718686,0.00042887533,0.0002552225,0.002741464,0.0016559093,0.0008121763,0.0053012273,0.00004228119],"about_ca_topic_score_codex":0.00050423306,"about_ca_topic_score_gemma":0.0015028307,"teacher_disagreement_score":0.0015488872,"about_ca_system_score_codex":0.00021492645,"about_ca_system_score_gemma":0.0003761811,"threshold_uncertainty_score":0.008191407},"labels":[],"label_agreement":null},{"id":"W4410101946","doi":"10.1007/s10549-025-07700-y","title":"Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy techniques","year":2025,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa; The Scarborough Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Toronto; Princess Margaret Cancer Foundation","keywords":"Meta-analysis; Breast cancer; Medicine; Radiation therapy; Oncology; Internal medicine; Cancer","score_opus":0.07128226325003369,"score_gpt":0.4472514647824135,"score_spread":0.37596920153237984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410101946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005249047,0.9938326,0.00024907218,0.000073771655,0.000080258724,0.000090846836,0.00028793386,0.000009549798,0.00012688043],"genre_scores_gemma":[0.161897,0.83467156,0.0014236094,0.0008065581,0.00014633077,0.00026932577,0.00043832717,0.000021919963,0.00032539028],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948914,0.002033894,0.0016413913,0.00068694446,0.0005333798,0.00021292138],"domain_scores_gemma":[0.99193585,0.0053611062,0.0017552743,0.00031190814,0.00051032944,0.00012554797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005288764,0.0020849658,0.012049657,0.0031565183,0.00052864966,0.0022111917,0.0015003477,0.0019277637,0.0034154544],"category_scores_gemma":[0.016941592,0.0013716905,0.028822176,0.0049555087,0.0006604471,0.0013772551,0.0017065121,0.0018078723,0.00026250875],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022359176,0.00003750613,0.006047439,0.36833408,0.6055225,0.00012008923,0.0001316075,0.00036118744,0.0003069184,0.00007570568,0.00054023333,0.016286764],"study_design_scores_gemma":[0.00064987363,0.00020975266,0.0060695014,0.019234166,0.9717397,0.000100161684,0.00006526899,0.00007299513,0.00008032145,0.00011991832,0.0016308726,0.00002758947],"about_ca_topic_score_codex":0.008557975,"about_ca_topic_score_gemma":0.025362777,"teacher_disagreement_score":0.012049657,"about_ca_system_score_codex":0.0016403315,"about_ca_system_score_gemma":0.0022989244,"threshold_uncertainty_score":0.027970016},"labels":[],"label_agreement":null},{"id":"W4411561109","doi":"10.1007/s10549-025-07749-9","title":"Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Essar Steel Algoma (Canada); North York General Hospital; London Health Sciences Centre; Queen's University; McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; AstraZeneca; Government of Ontario; Strong; Pfizer","keywords":"Anastrozole; Exemestane; Medicine; Oncology; Breast cancer; Internal medicine; Adjuvant; Clinical trial; Cancer; Gynecology; Aromatase inhibitor; Tamoxifen","score_opus":0.09989953334003839,"score_gpt":0.47022284479665905,"score_spread":0.3703233114566207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411561109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85801345,0.01582163,0.051333256,0.0061980993,0.0021860348,0.012134972,0.023598248,0.0019632357,0.028751107],"genre_scores_gemma":[0.952359,0.0006582635,0.021055985,0.0012278744,0.00029220237,0.0046857684,0.0039424268,0.00023789893,0.015540524],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9746448,0.01916677,0.00076861,0.0015953216,0.0028709725,0.0009535067],"domain_scores_gemma":[0.98848057,0.0046897326,0.0018949063,0.0029040354,0.0013711766,0.00065958325],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.019425133,0.0010428916,0.0019671968,0.00049707154,0.00066081766,0.0011547771,0.0019175741,0.0007196626,0.0061230073],"category_scores_gemma":[0.029127534,0.00038481908,0.0020796044,0.0009917289,0.0007862183,0.00059980305,0.0007139804,0.0022753216,0.00035370252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64515746,0.0012238126,0.041375723,0.0010684147,0.02659986,0.00009507838,0.0003488509,0.009049191,0.0065492666,0.0080171535,0.039974403,0.22054079],"study_design_scores_gemma":[0.21063362,0.043596677,0.51689005,0.00037657763,0.024570618,0.00023272907,0.0003973269,0.07822509,0.01440841,0.012583543,0.09764611,0.00043923117],"about_ca_topic_score_codex":0.13719715,"about_ca_topic_score_gemma":0.2017567,"teacher_disagreement_score":0.98057485,"about_ca_system_score_codex":0.0054329126,"about_ca_system_score_gemma":0.012567462,"threshold_uncertainty_score":0.2727971},"labels":[],"label_agreement":null},{"id":"W4412011848","doi":"10.1007/s10549-025-07754-y","title":"Adherence to breast screening guidelines and breast cancer mortality: a population cohort study","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oncology; Cohort study; Cohort; Gynecology; Population; Breast cancer screening; Obstetrics; Internal medicine; Cancer; Mammography; Environmental health","score_opus":0.2660464963754245,"score_gpt":0.5116750774621833,"score_spread":0.24562858108675883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412011848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974522,0.00025068718,0.00007247371,0.00012593473,0.000007902178,0.00004722998,0.0016436031,0.00000392496,0.00039610363],"genre_scores_gemma":[0.99817705,0.00022541656,0.000100137855,0.0000659657,0.000010021146,0.000045818913,0.0010600397,0.0000024070505,0.0003131716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911636,0.0001866844,0.00006804147,0.00017619418,0.00022474863,0.00022803679],"domain_scores_gemma":[0.99829,0.00016804558,0.0006852426,0.00023940693,0.0003178894,0.0002994417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013160568,0.0003252801,0.00038720857,0.00060206425,0.00094108284,0.0009383175,0.0007891889,0.000761933,0.0013583339],"category_scores_gemma":[0.002983083,0.0005977452,0.00088560523,0.0018561691,0.0003820398,0.0005523552,0.0006719384,0.0011729292,0.0002500594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011727208,0.000071534145,0.9985574,0.000010129061,0.00013842138,0.00004548696,0.00016880145,0.000020069625,0.000050074563,0.000015137822,0.0002590952,0.00054646126],"study_design_scores_gemma":[0.000025378835,0.00006978185,0.99923587,0.000011258235,0.000074969306,0.000054179418,0.00016451156,0.00011898082,0.0000082948445,0.000011815159,0.0002209377,0.0000040671007],"about_ca_topic_score_codex":0.34740362,"about_ca_topic_score_gemma":0.37848,"teacher_disagreement_score":0.34740362,"about_ca_system_score_codex":0.0020112828,"about_ca_system_score_gemma":0.002630878,"threshold_uncertainty_score":0.690763},"labels":[],"label_agreement":null},{"id":"W4412481961","doi":"10.1007/s10549-025-07779-3","title":"Repeat lumpectomy and external beam radiation therapy for ipsilateral breast cancer recurrence: a systematic review","year":2025,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; Occupational Cancer Research Centre; McGill University; University of Calgary; McGill University Health Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Lumpectomy; Breast cancer; Medicine; Radiation therapy; Mastectomy; External beam radiation; Oncology; Cancer; Radiology; Internal medicine","score_opus":0.04896347226366435,"score_gpt":0.41483092270608424,"score_spread":0.36586745044241986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412481961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005033705,0.99907625,0.000038388214,0.00007547552,0.000042693922,0.00003680948,0.00013381042,0.0000028866684,0.000090338996],"genre_scores_gemma":[0.010112066,0.98891324,0.0001893506,0.00047309062,0.00004289009,0.00006490753,0.000107841915,0.0000026189184,0.00009398311],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.998473,0.000500609,0.0004871333,0.00021187357,0.00024792223,0.00007937988],"domain_scores_gemma":[0.99575835,0.0029743458,0.0008865858,0.000059666316,0.00024320824,0.000077787336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025481463,0.00104955,0.005735489,0.0033962638,0.00030015613,0.0014228426,0.0013949635,0.0014724468,0.0053212782],"category_scores_gemma":[0.009523043,0.00072011916,0.006104504,0.0046885395,0.0005506053,0.0011223316,0.0010616023,0.0010620913,0.00032219346],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000449202,0.000023937684,0.0013058531,0.9204353,0.026945483,0.00009453634,0.00010455909,0.00017295084,0.0002217023,0.0001577713,0.0028163851,0.047272414],"study_design_scores_gemma":[0.0013502811,0.00044269726,0.011950148,0.5737456,0.37763992,0.0005943444,0.00038052574,0.00015871653,0.0002485183,0.0005535347,0.032850847,0.00008487758],"about_ca_topic_score_codex":0.0105549805,"about_ca_topic_score_gemma":0.037416294,"teacher_disagreement_score":0.0105549805,"about_ca_system_score_codex":0.0018506707,"about_ca_system_score_gemma":0.0038386309,"threshold_uncertainty_score":0.020987093},"labels":[],"label_agreement":null},{"id":"W4412989408","doi":"10.1007/s10549-025-07793-5","title":"Do regularly scheduled visits result in earlier detection of curable breast cancer recurrences?","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; Ottawa Hospital","funders":"","keywords":"Breast cancer; Medicine; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.026368319646930566,"score_gpt":0.3602977742559081,"score_spread":0.3339294546089775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412989408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889333,0.005303087,0.00017375337,0.001536172,0.00019857098,0.000022289036,0.00058667106,0.000015372783,0.0032707287],"genre_scores_gemma":[0.997276,0.0011776364,0.00022028807,0.00032404126,0.0001654118,0.000008977769,0.00021692495,0.0000068994045,0.00060381816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986609,0.0006613498,0.00009343958,0.00017415275,0.00017716485,0.00023298568],"domain_scores_gemma":[0.98568976,0.00687522,0.0046374714,0.0009053092,0.0007451154,0.0011471729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019822537,0.0003016217,0.00068865437,0.00068481814,0.00035918303,0.0012398255,0.0006952454,0.0019273015,0.004539134],"category_scores_gemma":[0.01895775,0.00041455156,0.001009311,0.0011243257,0.00031446552,0.0008871065,0.00025475028,0.0010898308,0.0005204456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010625002,0.00024062616,0.9881337,0.00005023804,0.00021411451,0.000101007514,0.000095084164,0.000032004093,0.00027329102,0.000058637615,0.00028275518,0.00945609],"study_design_scores_gemma":[0.000022522192,0.00023700442,0.9989158,0.000014673092,0.00012370372,0.00013347757,0.00013846406,0.00007446269,0.00006888413,0.00006146275,0.00020598547,0.000003569787],"about_ca_topic_score_codex":0.0070824716,"about_ca_topic_score_gemma":0.009042228,"teacher_disagreement_score":0.0070824716,"about_ca_system_score_codex":0.0003223437,"about_ca_system_score_gemma":0.00058879197,"threshold_uncertainty_score":0.015184939},"labels":[],"label_agreement":null},{"id":"W4413111991","doi":"10.1007/s10549-025-07778-4","title":"Omission of anthracyclines from neoadjuvant chemotherapy for breast cancer: a population-based analysis","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Public Health Ontario; Health Sciences Centre; Occupational Cancer Research Centre; Hamilton Health Sciences; University of Toronto; London Health Sciences Centre; Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Anthracycline; Breast cancer; Medicine; Hazard ratio; Internal medicine; Oncology; Cumulative incidence; Regimen; Population; Cohort; Proportional hazards model; Neoadjuvant therapy; Cancer; Chemotherapy; Surgery; Confidence interval","score_opus":0.02439180170157113,"score_gpt":0.3856760448875486,"score_spread":0.36128424318597746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413111991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981914,0.00086815545,0.00020150866,0.00005121619,0.000010818128,0.0000051685543,0.0002514435,0.000003903011,0.00041631758],"genre_scores_gemma":[0.9993243,0.00017192338,0.000060811883,0.000033190256,0.000010794265,0.0000049427094,0.0002606812,0.000004545524,0.00012881872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738735,0.0011403741,0.00026231506,0.000719428,0.0002922568,0.00019828905],"domain_scores_gemma":[0.9956196,0.0016703958,0.0015309167,0.00056387903,0.00033165448,0.00028358228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016847526,0.0004217598,0.00079017726,0.0007613737,0.00047814116,0.0007646326,0.00072712684,0.0009185016,0.0014800247],"category_scores_gemma":[0.0044510327,0.0005774601,0.0014710187,0.0016209825,0.0003738206,0.00057629443,0.000492512,0.0009845505,0.00020907259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008839868,0.000059098315,0.99628,0.000015134557,0.000648544,0.00008653782,0.000057169647,0.000071693066,0.00038784483,0.000023472627,0.0000688017,0.0014177775],"study_design_scores_gemma":[0.000026932747,0.00023784948,0.99842924,0.000005887757,0.00045309556,0.0002075407,0.00013068548,0.00023203966,0.00006763702,0.000025083214,0.00017766598,0.000006301371],"about_ca_topic_score_codex":0.005044952,"about_ca_topic_score_gemma":0.005421248,"teacher_disagreement_score":0.005044952,"about_ca_system_score_codex":0.00034037596,"about_ca_system_score_gemma":0.0004045777,"threshold_uncertainty_score":0.010031164},"labels":[],"label_agreement":null},{"id":"W4413414196","doi":"10.1007/s10549-025-07797-1","title":"Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancer","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Agricultural Research Institute of Ontario; Ottawa Public Health; McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Nomogram; Internal medicine; Chemotherapy; Oncology; Disease; Cancer","score_opus":0.09172001293806188,"score_gpt":0.3809760193351547,"score_spread":0.2892560063970928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413414196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703954,0.0024618558,0.00089220813,0.01569303,0.00011992498,0.000045820172,0.00009578302,0.000015019435,0.0102809435],"genre_scores_gemma":[0.99743855,0.00067279016,0.0005133817,0.001124948,0.00003458085,0.000011348788,0.000019545692,0.0000033094232,0.00018150234],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.98137146,0.014470348,0.0009829772,0.0002594565,0.0022847846,0.0006310023],"domain_scores_gemma":[0.95021015,0.033516712,0.0072991853,0.00062479405,0.00449356,0.003855692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013872817,0.0001263373,0.0002276768,0.00063863886,0.0011254267,0.0021494124,0.0003069329,0.00086094777,0.0021126815],"category_scores_gemma":[0.05540794,0.0001734859,0.0003187903,0.00050383987,0.0014583665,0.0011417598,0.0013815252,0.0013788543,0.00016979485],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00261443,0.0007943326,0.70201683,0.0008256575,0.00037832535,0.0029939488,0.09665255,0.0010635541,0.004477606,0.0038355433,0.00798982,0.17635736],"study_design_scores_gemma":[0.00030147817,0.0064898236,0.5514586,0.0016599575,0.00055951776,0.013548908,0.35539868,0.0030573583,0.0041324734,0.006126446,0.056803755,0.00046303446],"about_ca_topic_score_codex":0.0015664934,"about_ca_topic_score_gemma":0.0021924118,"teacher_disagreement_score":0.013872817,"about_ca_system_score_codex":0.0010976724,"about_ca_system_score_gemma":0.0014167926,"threshold_uncertainty_score":0.07336736},"labels":[],"label_agreement":null},{"id":"W4413940286","doi":"10.1007/s10549-025-07801-8","title":"Natural language processing for local, regional, and distant breast cancer relapse identification in pathology reports","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Breast cancer; Medicine; Cancer; Cohort; Oncology; Receiver operating characteristic; Pathology; Internal medicine","score_opus":0.02888630840797602,"score_gpt":0.37336620953311966,"score_spread":0.34447990112514365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413940286","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34546712,0.003922098,0.5681613,0.0059724147,0.00042969204,0.0031295826,0.041154906,0.02600802,0.0057548415],"genre_scores_gemma":[0.5361181,0.00085914903,0.41516975,0.00074376736,0.00023880096,0.0013412745,0.044152405,0.00040514785,0.00097157294],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99155575,0.0036668985,0.001406816,0.0018582884,0.001274782,0.00023747014],"domain_scores_gemma":[0.933487,0.048231557,0.008405922,0.0028471153,0.00648197,0.00054649025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012406953,0.0013131622,0.0007348456,0.008051055,0.0008759258,0.002516288,0.0017859438,0.00093583873,0.0014424523],"category_scores_gemma":[0.048128143,0.0005312352,0.0015656367,0.0034140816,0.000937542,0.0027432302,0.0018716484,0.0015758047,0.0014631881],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010435976,0.0008528422,0.23575851,0.0046806987,0.0006002148,0.0032713364,0.0047554066,0.07289028,0.02671909,0.0051971413,0.057608083,0.5866228],"study_design_scores_gemma":[0.00013938591,0.00028398112,0.07686171,0.0008541151,0.00038635652,0.0018447576,0.0022795785,0.8436217,0.020552505,0.017091652,0.03587342,0.00021093644],"about_ca_topic_score_codex":0.016269293,"about_ca_topic_score_gemma":0.018670501,"teacher_disagreement_score":0.016269293,"about_ca_system_score_codex":0.0024630656,"about_ca_system_score_gemma":0.003647676,"threshold_uncertainty_score":0.06561506},"labels":[],"label_agreement":null},{"id":"W4416729538","doi":"10.1007/s10549-025-07861-w","title":"High PARP1 expression is associated with proliferative tumor biology in breast cancer","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health","keywords":"Breast cancer; PARP1; Biomarker; Gene expression; Human breast; Cancer; Gene","score_opus":0.04612059288081777,"score_gpt":0.4055971153934276,"score_spread":0.3594765225126098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416729538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780425,0.013700172,0.0021774033,0.000596732,0.00009080209,0.000023384579,0.0016738803,0.0001205169,0.0035745716],"genre_scores_gemma":[0.9943131,0.0025021292,0.0005621266,0.00009554894,0.00006117949,0.00001550524,0.00088683655,0.000013305624,0.0015502298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970275,0.00006033346,0.000022499324,0.00007722995,0.00007815761,0.000058966252],"domain_scores_gemma":[0.9987816,0.00019199375,0.0007350985,0.00006511385,0.00011034004,0.00011582311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037490978,0.0002705986,0.00029365128,0.00092453795,0.00034600004,0.0012035978,0.00030664567,0.00044965692,0.0033298559],"category_scores_gemma":[0.0009121686,0.00027827307,0.00026636483,0.0010218434,0.0002875271,0.0004604641,0.00032844674,0.0008945556,0.0006554783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049079973,0.0003579461,0.5322161,0.0006362952,0.0005125263,0.0016290732,0.00025053593,0.000667238,0.38265014,0.001037568,0.003040736,0.072093785],"study_design_scores_gemma":[0.000027405837,0.0005074746,0.92430973,0.000038486334,0.00016033236,0.0049542193,0.0003051151,0.0007915171,0.06211953,0.00084721955,0.005914216,0.000024772102],"about_ca_topic_score_codex":0.00021770378,"about_ca_topic_score_gemma":0.00023511227,"teacher_disagreement_score":0.0033298559,"about_ca_system_score_codex":0.00034287744,"about_ca_system_score_gemma":0.00014814554,"threshold_uncertainty_score":0.011139452},"labels":[],"label_agreement":null},{"id":"W4416892868","doi":"10.1007/s10549-025-07869-2","title":"Using the cancer aging and research group- breast cancer (CARG-BC) predictive model in older adults (OA) with early breast cancer: an external validation study","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Cancer; Breast disease; Mammary gland; Predictive value of tests","score_opus":0.04606726158027532,"score_gpt":0.39365635795542,"score_spread":0.3475890963751447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416892868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946808,0.00031359142,0.0022333453,0.0001105469,0.000083504,0.00043205472,0.001409071,0.000030860232,0.0007061893],"genre_scores_gemma":[0.991672,0.00015876716,0.0019202566,0.00017132345,0.000050683946,0.00048437275,0.004829557,0.000048981885,0.00066402083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9882868,0.007972962,0.0007777109,0.0014236233,0.0011114466,0.00042753734],"domain_scores_gemma":[0.9482431,0.023100667,0.0051658084,0.011829807,0.0100869015,0.0015736438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04395781,0.0016767962,0.0012267838,0.0010916762,0.0013963884,0.0018470945,0.0018064126,0.0014279038,0.0015387462],"category_scores_gemma":[0.04945254,0.00061495265,0.0028680176,0.001021097,0.0014016171,0.001333024,0.0022723598,0.0026339341,0.00081077317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004549996,0.0019297911,0.979042,0.000095445255,0.0023769601,0.000055795186,0.00050152064,0.0015163363,0.00043176487,0.00025395455,0.0015214075,0.007725019],"study_design_scores_gemma":[0.0016427097,0.004684248,0.9684011,0.00016367476,0.0043915724,0.0003059618,0.000886456,0.012354043,0.0012875749,0.0006125183,0.005195005,0.00007507139],"about_ca_topic_score_codex":0.01307522,"about_ca_topic_score_gemma":0.011448768,"teacher_disagreement_score":0.04395781,"about_ca_system_score_codex":0.0011834286,"about_ca_system_score_gemma":0.0026339341,"threshold_uncertainty_score":0.23247391},"labels":[],"label_agreement":null},{"id":"W4417319238","doi":"10.1007/s10549-025-07867-4","title":"Lymphovenous bypass for the treatment of secondary lymphedema: A meta-analysis of prospective outcomes","year":2025,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cellulitis; Prospective cohort study; Complication; Breast cancer; Lymphedema; Cordotomy","score_opus":0.11163789376098228,"score_gpt":0.4299068761238484,"score_spread":0.31826898236286616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417319238","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21080859,0.78292596,0.00264907,0.0003950931,0.0006661435,0.00013331295,0.0012335685,0.000070287984,0.0011180216],"genre_scores_gemma":[0.92616457,0.07026499,0.0012625306,0.00059175224,0.0003734034,0.00011099567,0.0007817789,0.000039546918,0.00041033557],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99464524,0.0028096715,0.00079700747,0.0010166744,0.00043220038,0.0002992032],"domain_scores_gemma":[0.99244857,0.005284997,0.0011829031,0.0005771781,0.00031432175,0.00019209816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006302641,0.0017352229,0.007139868,0.0011154425,0.0005260647,0.002329146,0.0012742947,0.0017972899,0.0021336125],"category_scores_gemma":[0.011739333,0.0009949091,0.027770765,0.0020238322,0.00065240235,0.0011588378,0.0009872359,0.002505102,0.00022095158],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025652006,0.000088446846,0.041726787,0.015641924,0.9053362,0.00013138712,0.00005137456,0.00090223877,0.00059349753,0.00014737537,0.00049233035,0.009236445],"study_design_scores_gemma":[0.0028508224,0.0007959883,0.02899304,0.0010614884,0.964135,0.00011150293,0.000056636633,0.00058240665,0.00024146176,0.00038429056,0.0007554634,0.000031931195],"about_ca_topic_score_codex":0.0037425053,"about_ca_topic_score_gemma":0.005972257,"teacher_disagreement_score":0.007139868,"about_ca_system_score_codex":0.0006832455,"about_ca_system_score_gemma":0.0006756596,"threshold_uncertainty_score":0.03333193},"labels":[],"label_agreement":null},{"id":"W569551381","doi":"10.1007/s10549-015-3455-7","title":"Comparative adherence to oral hormonal agents in older women with breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Institute","keywords":"Exemestane; Medicine; Anastrozole; Letrozole; Tamoxifen; Internal medicine; Breast cancer; Proportional hazards model; Aromatase inhibitor; Oncology; Gynecology; Cancer","score_opus":0.27117940472053265,"score_gpt":0.47032884602175706,"score_spread":0.19914944130122442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W569551381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99901354,0.00039661906,0.000013063015,0.000026726302,0.000006927408,0.000007139922,0.00008214706,5.591955e-7,0.00045342773],"genre_scores_gemma":[0.9993007,0.00025876216,0.000026236086,0.000045304107,0.000012286596,0.00001042202,0.00013683512,6.6046954e-7,0.00020866258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934846,0.0002668499,0.000106036096,0.00007040418,0.00010819266,0.00010003705],"domain_scores_gemma":[0.99836725,0.00048671747,0.0005797897,0.00009299426,0.00020231679,0.00027083512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009584653,0.00016379141,0.00048946036,0.0007407329,0.00049513014,0.0004908675,0.00021159646,0.0006443534,0.0017073334],"category_scores_gemma":[0.0059893415,0.00019482317,0.0006909697,0.0012187068,0.00018843685,0.00054756616,0.00042081866,0.000481686,0.00015044858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004180893,0.0006211107,0.9831685,0.00008554729,0.0004399683,0.00011774673,0.0012797124,0.000043102937,0.00037521,0.00004037174,0.00008662234,0.009561163],"study_design_scores_gemma":[0.000061086466,0.0012355056,0.99763894,0.00000995048,0.0001157258,0.0000641242,0.0006651217,0.00003778987,0.000031859516,0.000016069182,0.00011970249,0.0000040498767],"about_ca_topic_score_codex":0.008544347,"about_ca_topic_score_gemma":0.012176317,"teacher_disagreement_score":0.008544347,"about_ca_system_score_codex":0.000404886,"about_ca_system_score_gemma":0.00026550025,"threshold_uncertainty_score":0.016989231},"labels":[],"label_agreement":null},{"id":"W634017482","doi":"10.1007/s10549-015-3441-0","title":"Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Government of Ontario; Institute for Clinical Evaluative Sciences; Genomic Health; Amgen","keywords":"Medicine; Internal medicine; Docetaxel; Epirubicin; Cyclophosphamide; Taxane; Breast cancer; Regimen; Chemotherapy; Fluorouracil; Oncology; Anthracycline; Cancer; Gynecology","score_opus":0.0761319468049118,"score_gpt":0.3889712350003227,"score_spread":0.3128392881954109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W634017482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609524,0.0008059918,0.00005416005,0.0003888765,0.000010466833,0.0000672647,0.0010110077,0.000003557905,0.0015634709],"genre_scores_gemma":[0.9979589,0.0006712741,0.000078946156,0.00010317703,0.000007594774,0.00002273272,0.00047031607,0.0000030807582,0.0006839043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986852,0.0003271409,0.00009957815,0.00012347601,0.0003587845,0.00040584643],"domain_scores_gemma":[0.9968645,0.0004501229,0.0012158998,0.00012491512,0.0007148664,0.00062958954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010423383,0.0002305654,0.0005449529,0.0006116742,0.0015877238,0.000913703,0.0006770535,0.00043469618,0.0018554033],"category_scores_gemma":[0.0040882793,0.00027979614,0.00064747105,0.0030600282,0.0009234441,0.00045976278,0.0007823361,0.00045516164,0.000119690754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0086596515,0.00053711265,0.9548657,0.00041988568,0.0003832086,0.00037336288,0.0032100198,0.0008587756,0.0012082327,0.000533009,0.002354146,0.026597006],"study_design_scores_gemma":[0.00026055402,0.00058181665,0.9943574,0.000041722727,0.00014561205,0.000064872984,0.0020650811,0.00027179043,0.000117649404,0.000051717205,0.0020225123,0.000019406423],"about_ca_topic_score_codex":0.9496596,"about_ca_topic_score_gemma":0.9819163,"teacher_disagreement_score":0.050340414,"about_ca_system_score_codex":0.029894173,"about_ca_system_score_gemma":0.025486695,"threshold_uncertainty_score":0.21689844},"labels":[],"label_agreement":null},{"id":"W802625524","doi":"10.1007/s10549-015-3466-4","title":"Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Eisai; NSABP Foundation","keywords":"Medicine; Eribulin; Breast cancer; Anthracycline; Cyclophosphamide; Taxane; Capecitabine; Chemotherapy; Internal medicine; Neoadjuvant therapy; Oncology; Epirubicin; Surgery; Randomized controlled trial; Cancer; Metastatic breast cancer; Colorectal cancer","score_opus":0.05531339928623241,"score_gpt":0.4301154364575364,"score_spread":0.374802037171304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W802625524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98246056,0.0017955948,0.0008513111,0.0015512364,0.0007485261,0.0059066024,0.00332858,0.00013648854,0.003221113],"genre_scores_gemma":[0.96038437,0.0028704717,0.0038160447,0.0026018932,0.00061876985,0.013872391,0.0057576,0.00008154834,0.009996893],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917656,0.0005053446,0.000031067044,0.00013625041,0.00003653011,0.00011411354],"domain_scores_gemma":[0.9983967,0.00041119065,0.00033748848,0.00017139757,0.00007433078,0.0006087343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022056543,0.002199463,0.0032042998,0.00043255705,0.00058330904,0.0010278921,0.0012438465,0.0019132384,0.010981715],"category_scores_gemma":[0.0018835068,0.00090090535,0.0017003105,0.0005456975,0.0016291917,0.0012029668,0.00057059765,0.003936293,0.0020884364],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9835224,0.008170055,0.00053665345,0.00012114039,0.00034478845,0.000016361284,0.000023733353,0.00030359402,0.0016614399,0.000059162317,0.0005860188,0.0046545668],"study_design_scores_gemma":[0.94357497,0.053699374,0.0014923813,0.000013220743,0.00023820034,0.000015673691,0.00001989516,0.00016301722,0.00020914365,0.000079700956,0.00048566595,0.000008781017],"about_ca_topic_score_codex":0.0025961266,"about_ca_topic_score_gemma":0.0065266597,"teacher_disagreement_score":0.010981715,"about_ca_system_score_codex":0.0013793587,"about_ca_system_score_gemma":0.0023268757,"threshold_uncertainty_score":0.0367375},"labels":[],"label_agreement":null},{"id":"W817271235","doi":"10.1007/s10549-015-3489-x","title":"Lifetime physical activity and risk of breast cancer in pre-and post-menopausal women","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Physical Activity and Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Logistic regression; Cancer; Internal medicine; Demography; Oncology; Case-control study; Gynecology; Obstetrics","score_opus":0.05370282482651702,"score_gpt":0.40417262393421166,"score_spread":0.35046979910769466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W817271235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779224,0.001281895,0.000026054813,0.00009238036,0.00001379243,0.0000042204697,0.0002723036,0.0000023306511,0.00051479106],"genre_scores_gemma":[0.9987262,0.00046082513,0.000022837912,0.000036417343,0.00002169887,0.0000044796984,0.00018023692,0.0000013481058,0.0005460485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984753,0.000041601525,0.000015002295,0.000027846803,0.000019644762,0.000048354068],"domain_scores_gemma":[0.99926025,0.00013517601,0.00023698714,0.00003354919,0.000040869465,0.0002931976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000310135,0.00023387835,0.0003275206,0.0005855145,0.0004141254,0.00057014835,0.0002684639,0.0007047491,0.0025975383],"category_scores_gemma":[0.0014024924,0.00041818095,0.00073508266,0.0007107517,0.00025079816,0.00036034675,0.00041445834,0.00063216727,0.00024462945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007726047,0.00009850324,0.99763,0.000012407008,0.000106038955,0.00004959364,0.00007733828,0.000022589058,0.0001726965,0.00001374839,0.0000611876,0.0009834002],"study_design_scores_gemma":[0.000011798539,0.0001363336,0.99947506,0.0000037125963,0.00003713788,0.00005817317,0.00013243213,0.00005261039,0.000011231682,0.000012028583,0.00006746558,0.0000019731992],"about_ca_topic_score_codex":0.011486764,"about_ca_topic_score_gemma":0.015613036,"teacher_disagreement_score":0.011486764,"about_ca_system_score_codex":0.00022521161,"about_ca_system_score_gemma":0.0002384055,"threshold_uncertainty_score":0.022839844},"labels":[],"label_agreement":null},{"id":"W979723212","doi":"10.1007/s10549-015-3498-9","title":"Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen's University; Canada Research Chairs; Sunnybrook Health Science Centre; Northeast Cancer Centre; University of Waterloo; University of Toronto; Laurentian University","funders":"Ontario Institute for Cancer Research","keywords":"Breast cancer; RNA; Chemotherapy; Oncology; Medicine; Internal medicine; Cancer; Biomarker; Cancer research; Biology; Gene","score_opus":0.04191813074431651,"score_gpt":0.36476469360936137,"score_spread":0.3228465628650449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W979723212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673647,0.0011472424,0.00033643603,0.00019741176,0.00003080057,0.0000059998,0.00023470496,0.000021539454,0.0012894629],"genre_scores_gemma":[0.9987361,0.00020888902,0.000079029865,0.00006905425,0.000018470388,0.0000045069323,0.00022009888,0.0000047709996,0.0006592289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988997,0.000028069451,0.000008734157,0.000022425684,0.000022783683,0.000028037291],"domain_scores_gemma":[0.9993104,0.00023678961,0.00026048793,0.00004923707,0.000025619851,0.00011746946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022372139,0.00013149466,0.00019274579,0.0002570275,0.00010507719,0.00026844392,0.00010946223,0.0003454641,0.0025059697],"category_scores_gemma":[0.00080736045,0.00009012358,0.00018718763,0.00016674132,0.00027032627,0.00018448792,0.0001492297,0.00044239237,0.00040774257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009707455,0.00050736923,0.70672697,0.0000650456,0.00033198492,0.0004341055,0.000052840256,0.0012603257,0.24122222,0.0005292466,0.0012278109,0.037934627],"study_design_scores_gemma":[0.000044644003,0.0014471287,0.9768405,0.000008385688,0.00016904189,0.0011024425,0.000067508925,0.0015108397,0.016342344,0.0005124331,0.0019443943,0.000010317849],"about_ca_topic_score_codex":0.00027564258,"about_ca_topic_score_gemma":0.00047032023,"teacher_disagreement_score":0.0025059697,"about_ca_system_score_codex":0.00017301773,"about_ca_system_score_gemma":0.00009821565,"threshold_uncertainty_score":0.008383274},"labels":[],"label_agreement":null},{"id":"W989188527","doi":"10.1007/s10549-015-3517-x","title":"Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada; McGill University","funders":"","keywords":"Medicine; Osteolysis; Pathology; Osteoclast; Bone metastasis; Metastasis; Cancer; Internal medicine; Receptor; Surgery","score_opus":0.10685390839493877,"score_gpt":0.3950519717475849,"score_spread":0.2881980633526461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W989188527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974751,0.0004954276,0.00075372704,0.000118857046,0.000031518863,0.000021029673,0.00015093874,0.000047210393,0.0009061777],"genre_scores_gemma":[0.99791986,0.00016904683,0.0003062319,0.00004562156,0.000008679379,0.000023061086,0.00013571965,0.000013179821,0.001378656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934846,0.000097304655,0.000031875756,0.00008900729,0.00015019775,0.00028304267],"domain_scores_gemma":[0.99949133,0.00009814088,0.0001342137,0.0000833828,0.00003683682,0.00015611123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021542789,0.00034610857,0.00044393667,0.00046996772,0.00029798772,0.00061666354,0.00039546977,0.00056979054,0.0044964566],"category_scores_gemma":[0.00037349694,0.00034369674,0.000540918,0.00025700373,0.0006863555,0.00040131286,0.0004949105,0.0017967555,0.0007020399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005173354,0.00041019137,0.0007515429,0.000032641536,0.0000062150825,0.00011701931,0.000022805314,0.00011297661,0.9963766,0.00026652592,0.00008055747,0.0013054865],"study_design_scores_gemma":[0.00021983846,0.0042753313,0.03407635,0.000023013126,0.000055271994,0.0011898711,0.0006277603,0.0027737482,0.95495814,0.0005491448,0.0012313904,0.000020165344],"about_ca_topic_score_codex":0.0007614739,"about_ca_topic_score_gemma":0.0019651663,"teacher_disagreement_score":0.0044964566,"about_ca_system_score_codex":0.00048310432,"about_ca_system_score_gemma":0.00045884005,"threshold_uncertainty_score":0.015042126},"labels":[],"label_agreement":null}]}